,words,labels,sentence_id,full sentence
92842,Therefore,O,3220.0,"Therefore , dairy products should not be recommended in a healthy vegetarian diet ."
92843,",",O,3220.0,"Therefore , dairy products should not be recommended in a healthy vegetarian diet ."
92844,dairy,B-AG.01.e,3220.0,"Therefore , dairy products should not be recommended in a healthy vegetarian diet ."
92845,products,I-AG.01.e,3220.0,"Therefore , dairy products should not be recommended in a healthy vegetarian diet ."
92846,should,O,3220.0,"Therefore , dairy products should not be recommended in a healthy vegetarian diet ."
92847,not,O,3220.0,"Therefore , dairy products should not be recommended in a healthy vegetarian diet ."
92848,be,O,3220.0,"Therefore , dairy products should not be recommended in a healthy vegetarian diet ."
92849,recommended,O,3220.0,"Therefore , dairy products should not be recommended in a healthy vegetarian diet ."
92850,in,O,3220.0,"Therefore , dairy products should not be recommended in a healthy vegetarian diet ."
92851,a,O,3220.0,"Therefore , dairy products should not be recommended in a healthy vegetarian diet ."
92852,healthy,O,3220.0,"Therefore , dairy products should not be recommended in a healthy vegetarian diet ."
92853,vegetarian,O,3220.0,"Therefore , dairy products should not be recommended in a healthy vegetarian diet ."
92854,diet,O,3220.0,"Therefore , dairy products should not be recommended in a healthy vegetarian diet ."
92855,.,O,3220.0,"Therefore , dairy products should not be recommended in a healthy vegetarian diet ."
92856,In,O,3221.0,"In the domain of nutrition , exploring the diet - health linkages is major area of research ."
92857,the,O,3221.0,"In the domain of nutrition , exploring the diet - health linkages is major area of research ."
92858,domain,O,3221.0,"In the domain of nutrition , exploring the diet - health linkages is major area of research ."
92859,of,O,3221.0,"In the domain of nutrition , exploring the diet - health linkages is major area of research ."
92860,nutrition,O,3221.0,"In the domain of nutrition , exploring the diet - health linkages is major area of research ."
92861,",",O,3221.0,"In the domain of nutrition , exploring the diet - health linkages is major area of research ."
92862,exploring,O,3221.0,"In the domain of nutrition , exploring the diet - health linkages is major area of research ."
92863,the,O,3221.0,"In the domain of nutrition , exploring the diet - health linkages is major area of research ."
92864,diet,O,3221.0,"In the domain of nutrition , exploring the diet - health linkages is major area of research ."
92865,-,O,3221.0,"In the domain of nutrition , exploring the diet - health linkages is major area of research ."
92866,health,O,3221.0,"In the domain of nutrition , exploring the diet - health linkages is major area of research ."
92867,linkages,O,3221.0,"In the domain of nutrition , exploring the diet - health linkages is major area of research ."
92868,is,O,3221.0,"In the domain of nutrition , exploring the diet - health linkages is major area of research ."
92869,major,O,3221.0,"In the domain of nutrition , exploring the diet - health linkages is major area of research ."
92870,area,O,3221.0,"In the domain of nutrition , exploring the diet - health linkages is major area of research ."
92871,of,O,3221.0,"In the domain of nutrition , exploring the diet - health linkages is major area of research ."
92872,research,O,3221.0,"In the domain of nutrition , exploring the diet - health linkages is major area of research ."
92873,.,O,3221.0,"In the domain of nutrition , exploring the diet - health linkages is major area of research ."
92874,The,O,3222.0,"The outcomes of such interventions led to widespread acceptance of functional and nutraceutical foods ; however , augmenting immunity is a major concern of dietary regimens ."
92875,outcomes,O,3222.0,"The outcomes of such interventions led to widespread acceptance of functional and nutraceutical foods ; however , augmenting immunity is a major concern of dietary regimens ."
92876,of,O,3222.0,"The outcomes of such interventions led to widespread acceptance of functional and nutraceutical foods ; however , augmenting immunity is a major concern of dietary regimens ."
92877,such,O,3222.0,"The outcomes of such interventions led to widespread acceptance of functional and nutraceutical foods ; however , augmenting immunity is a major concern of dietary regimens ."
92878,interventions,O,3222.0,"The outcomes of such interventions led to widespread acceptance of functional and nutraceutical foods ; however , augmenting immunity is a major concern of dietary regimens ."
92879,led,O,3222.0,"The outcomes of such interventions led to widespread acceptance of functional and nutraceutical foods ; however , augmenting immunity is a major concern of dietary regimens ."
92880,to,O,3222.0,"The outcomes of such interventions led to widespread acceptance of functional and nutraceutical foods ; however , augmenting immunity is a major concern of dietary regimens ."
92881,widespread,O,3222.0,"The outcomes of such interventions led to widespread acceptance of functional and nutraceutical foods ; however , augmenting immunity is a major concern of dietary regimens ."
92882,acceptance,O,3222.0,"The outcomes of such interventions led to widespread acceptance of functional and nutraceutical foods ; however , augmenting immunity is a major concern of dietary regimens ."
92883,of,O,3222.0,"The outcomes of such interventions led to widespread acceptance of functional and nutraceutical foods ; however , augmenting immunity is a major concern of dietary regimens ."
92884,functional,O,3222.0,"The outcomes of such interventions led to widespread acceptance of functional and nutraceutical foods ; however , augmenting immunity is a major concern of dietary regimens ."
92885,and,O,3222.0,"The outcomes of such interventions led to widespread acceptance of functional and nutraceutical foods ; however , augmenting immunity is a major concern of dietary regimens ."
92886,nutraceutical,O,3222.0,"The outcomes of such interventions led to widespread acceptance of functional and nutraceutical foods ; however , augmenting immunity is a major concern of dietary regimens ."
92887,foods,O,3222.0,"The outcomes of such interventions led to widespread acceptance of functional and nutraceutical foods ; however , augmenting immunity is a major concern of dietary regimens ."
92888,;,O,3222.0,"The outcomes of such interventions led to widespread acceptance of functional and nutraceutical foods ; however , augmenting immunity is a major concern of dietary regimens ."
92889,however,O,3222.0,"The outcomes of such interventions led to widespread acceptance of functional and nutraceutical foods ; however , augmenting immunity is a major concern of dietary regimens ."
92890,",",O,3222.0,"The outcomes of such interventions led to widespread acceptance of functional and nutraceutical foods ; however , augmenting immunity is a major concern of dietary regimens ."
92891,augmenting,O,3222.0,"The outcomes of such interventions led to widespread acceptance of functional and nutraceutical foods ; however , augmenting immunity is a major concern of dietary regimens ."
92892,immunity,O,3222.0,"The outcomes of such interventions led to widespread acceptance of functional and nutraceutical foods ; however , augmenting immunity is a major concern of dietary regimens ."
92893,is,O,3222.0,"The outcomes of such interventions led to widespread acceptance of functional and nutraceutical foods ; however , augmenting immunity is a major concern of dietary regimens ."
92894,a,O,3222.0,"The outcomes of such interventions led to widespread acceptance of functional and nutraceutical foods ; however , augmenting immunity is a major concern of dietary regimens ."
92895,major,O,3222.0,"The outcomes of such interventions led to widespread acceptance of functional and nutraceutical foods ; however , augmenting immunity is a major concern of dietary regimens ."
92896,concern,O,3222.0,"The outcomes of such interventions led to widespread acceptance of functional and nutraceutical foods ; however , augmenting immunity is a major concern of dietary regimens ."
92897,of,O,3222.0,"The outcomes of such interventions led to widespread acceptance of functional and nutraceutical foods ; however , augmenting immunity is a major concern of dietary regimens ."
92898,dietary,O,3222.0,"The outcomes of such interventions led to widespread acceptance of functional and nutraceutical foods ; however , augmenting immunity is a major concern of dietary regimens ."
92899,regimens,O,3222.0,"The outcomes of such interventions led to widespread acceptance of functional and nutraceutical foods ; however , augmenting immunity is a major concern of dietary regimens ."
92900,.,O,3222.0,"The outcomes of such interventions led to widespread acceptance of functional and nutraceutical foods ; however , augmenting immunity is a major concern of dietary regimens ."
92901,Indeed,O,3223.0,"Indeed , the immune system is incredible arrangement of specific organs and cells that enabled humans to carry out defense against undesired responses ."
92902,",",O,3223.0,"Indeed , the immune system is incredible arrangement of specific organs and cells that enabled humans to carry out defense against undesired responses ."
92903,the,O,3223.0,"Indeed , the immune system is incredible arrangement of specific organs and cells that enabled humans to carry out defense against undesired responses ."
92904,immune,O,3223.0,"Indeed , the immune system is incredible arrangement of specific organs and cells that enabled humans to carry out defense against undesired responses ."
92905,system,O,3223.0,"Indeed , the immune system is incredible arrangement of specific organs and cells that enabled humans to carry out defense against undesired responses ."
92906,is,O,3223.0,"Indeed , the immune system is incredible arrangement of specific organs and cells that enabled humans to carry out defense against undesired responses ."
92907,incredible,O,3223.0,"Indeed , the immune system is incredible arrangement of specific organs and cells that enabled humans to carry out defense against undesired responses ."
92908,arrangement,O,3223.0,"Indeed , the immune system is incredible arrangement of specific organs and cells that enabled humans to carry out defense against undesired responses ."
92909,of,O,3223.0,"Indeed , the immune system is incredible arrangement of specific organs and cells that enabled humans to carry out defense against undesired responses ."
92910,specific,O,3223.0,"Indeed , the immune system is incredible arrangement of specific organs and cells that enabled humans to carry out defense against undesired responses ."
92911,organs,O,3223.0,"Indeed , the immune system is incredible arrangement of specific organs and cells that enabled humans to carry out defense against undesired responses ."
92912,and,O,3223.0,"Indeed , the immune system is incredible arrangement of specific organs and cells that enabled humans to carry out defense against undesired responses ."
92913,cells,O,3223.0,"Indeed , the immune system is incredible arrangement of specific organs and cells that enabled humans to carry out defense against undesired responses ."
92914,that,O,3223.0,"Indeed , the immune system is incredible arrangement of specific organs and cells that enabled humans to carry out defense against undesired responses ."
92915,enabled,O,3223.0,"Indeed , the immune system is incredible arrangement of specific organs and cells that enabled humans to carry out defense against undesired responses ."
92916,humans,O,3223.0,"Indeed , the immune system is incredible arrangement of specific organs and cells that enabled humans to carry out defense against undesired responses ."
92917,to,O,3223.0,"Indeed , the immune system is incredible arrangement of specific organs and cells that enabled humans to carry out defense against undesired responses ."
92918,carry,O,3223.0,"Indeed , the immune system is incredible arrangement of specific organs and cells that enabled humans to carry out defense against undesired responses ."
92919,out,O,3223.0,"Indeed , the immune system is incredible arrangement of specific organs and cells that enabled humans to carry out defense against undesired responses ."
92920,defense,O,3223.0,"Indeed , the immune system is incredible arrangement of specific organs and cells that enabled humans to carry out defense against undesired responses ."
92921,against,O,3223.0,"Indeed , the immune system is incredible arrangement of specific organs and cells that enabled humans to carry out defense against undesired responses ."
92922,undesired,O,3223.0,"Indeed , the immune system is incredible arrangement of specific organs and cells that enabled humans to carry out defense against undesired responses ."
92923,responses,O,3223.0,"Indeed , the immune system is incredible arrangement of specific organs and cells that enabled humans to carry out defense against undesired responses ."
92924,.,O,3223.0,"Indeed , the immune system is incredible arrangement of specific organs and cells that enabled humans to carry out defense against undesired responses ."
92925,Its,O,3224.0,Its proper functionality is essential to maintain the body homeostasis .
92926,proper,O,3224.0,Its proper functionality is essential to maintain the body homeostasis .
92927,functionality,O,3224.0,Its proper functionality is essential to maintain the body homeostasis .
92928,is,O,3224.0,Its proper functionality is essential to maintain the body homeostasis .
92929,essential,O,3224.0,Its proper functionality is essential to maintain the body homeostasis .
92930,to,O,3224.0,Its proper functionality is essential to maintain the body homeostasis .
92931,maintain,O,3224.0,Its proper functionality is essential to maintain the body homeostasis .
92932,the,O,3224.0,Its proper functionality is essential to maintain the body homeostasis .
92933,body,O,3224.0,Its proper functionality is essential to maintain the body homeostasis .
92934,homeostasis,O,3224.0,Its proper functionality is essential to maintain the body homeostasis .
92935,.,O,3224.0,Its proper functionality is essential to maintain the body homeostasis .
92936,Array,O,3225.0,Array of plants and their components hold immunomodulating properties .
92937,of,O,3225.0,Array of plants and their components hold immunomodulating properties .
92938,plants,O,3225.0,Array of plants and their components hold immunomodulating properties .
92939,and,O,3225.0,Array of plants and their components hold immunomodulating properties .
92940,their,O,3225.0,Array of plants and their components hold immunomodulating properties .
92941,components,O,3225.0,Array of plants and their components hold immunomodulating properties .
92942,hold,O,3225.0,Array of plants and their components hold immunomodulating properties .
92943,immunomodulating,O,3225.0,Array of plants and their components hold immunomodulating properties .
92944,properties,O,3225.0,Array of plants and their components hold immunomodulating properties .
92945,.,O,3225.0,Array of plants and their components hold immunomodulating properties .
92946,Their,O,3226.0,Their possible inclusion in diets could explore new therapeutic avenues to enhanced immunity against diseases .
92947,possible,O,3226.0,Their possible inclusion in diets could explore new therapeutic avenues to enhanced immunity against diseases .
92948,inclusion,O,3226.0,Their possible inclusion in diets could explore new therapeutic avenues to enhanced immunity against diseases .
92949,in,O,3226.0,Their possible inclusion in diets could explore new therapeutic avenues to enhanced immunity against diseases .
92950,diets,O,3226.0,Their possible inclusion in diets could explore new therapeutic avenues to enhanced immunity against diseases .
92951,could,O,3226.0,Their possible inclusion in diets could explore new therapeutic avenues to enhanced immunity against diseases .
92952,explore,O,3226.0,Their possible inclusion in diets could explore new therapeutic avenues to enhanced immunity against diseases .
92953,new,O,3226.0,Their possible inclusion in diets could explore new therapeutic avenues to enhanced immunity against diseases .
92954,therapeutic,O,3226.0,Their possible inclusion in diets could explore new therapeutic avenues to enhanced immunity against diseases .
92955,avenues,O,3226.0,Their possible inclusion in diets could explore new therapeutic avenues to enhanced immunity against diseases .
92956,to,O,3226.0,Their possible inclusion in diets could explore new therapeutic avenues to enhanced immunity against diseases .
92957,enhanced,O,3226.0,Their possible inclusion in diets could explore new therapeutic avenues to enhanced immunity against diseases .
92958,immunity,O,3226.0,Their possible inclusion in diets could explore new therapeutic avenues to enhanced immunity against diseases .
92959,against,O,3226.0,Their possible inclusion in diets could explore new therapeutic avenues to enhanced immunity against diseases .
92960,diseases,O,3226.0,Their possible inclusion in diets could explore new therapeutic avenues to enhanced immunity against diseases .
92961,.,O,3226.0,Their possible inclusion in diets could explore new therapeutic avenues to enhanced immunity against diseases .
92962,The,O,3227.0,"The review intended to highlight the importance of garlic ( Allium sativum ) , green tea ( Camellia sinensis ) , ginger ( Zingiber officinale ) , purple coneflower ( Echinacea ) , black cumin ( Nigella sativa ) , licorice ( Glycyrrhiza glabra ) , Astragalus and St. John 's wort ( Hypericum perforatum ) as natural immune boosters ."
92963,review,O,3227.0,"The review intended to highlight the importance of garlic ( Allium sativum ) , green tea ( Camellia sinensis ) , ginger ( Zingiber officinale ) , purple coneflower ( Echinacea ) , black cumin ( Nigella sativa ) , licorice ( Glycyrrhiza glabra ) , Astragalus and St. John 's wort ( Hypericum perforatum ) as natural immune boosters ."
92964,intended,O,3227.0,"The review intended to highlight the importance of garlic ( Allium sativum ) , green tea ( Camellia sinensis ) , ginger ( Zingiber officinale ) , purple coneflower ( Echinacea ) , black cumin ( Nigella sativa ) , licorice ( Glycyrrhiza glabra ) , Astragalus and St. John 's wort ( Hypericum perforatum ) as natural immune boosters ."
92965,to,O,3227.0,"The review intended to highlight the importance of garlic ( Allium sativum ) , green tea ( Camellia sinensis ) , ginger ( Zingiber officinale ) , purple coneflower ( Echinacea ) , black cumin ( Nigella sativa ) , licorice ( Glycyrrhiza glabra ) , Astragalus and St. John 's wort ( Hypericum perforatum ) as natural immune boosters ."
92966,highlight,O,3227.0,"The review intended to highlight the importance of garlic ( Allium sativum ) , green tea ( Camellia sinensis ) , ginger ( Zingiber officinale ) , purple coneflower ( Echinacea ) , black cumin ( Nigella sativa ) , licorice ( Glycyrrhiza glabra ) , Astragalus and St. John 's wort ( Hypericum perforatum ) as natural immune boosters ."
92967,the,O,3227.0,"The review intended to highlight the importance of garlic ( Allium sativum ) , green tea ( Camellia sinensis ) , ginger ( Zingiber officinale ) , purple coneflower ( Echinacea ) , black cumin ( Nigella sativa ) , licorice ( Glycyrrhiza glabra ) , Astragalus and St. John 's wort ( Hypericum perforatum ) as natural immune boosters ."
92968,importance,O,3227.0,"The review intended to highlight the importance of garlic ( Allium sativum ) , green tea ( Camellia sinensis ) , ginger ( Zingiber officinale ) , purple coneflower ( Echinacea ) , black cumin ( Nigella sativa ) , licorice ( Glycyrrhiza glabra ) , Astragalus and St. John 's wort ( Hypericum perforatum ) as natural immune boosters ."
92969,of,O,3227.0,"The review intended to highlight the importance of garlic ( Allium sativum ) , green tea ( Camellia sinensis ) , ginger ( Zingiber officinale ) , purple coneflower ( Echinacea ) , black cumin ( Nigella sativa ) , licorice ( Glycyrrhiza glabra ) , Astragalus and St. John 's wort ( Hypericum perforatum ) as natural immune boosters ."
92970,garlic,B-AG.01.h.02.e,3227.0,"The review intended to highlight the importance of garlic ( Allium sativum ) , green tea ( Camellia sinensis ) , ginger ( Zingiber officinale ) , purple coneflower ( Echinacea ) , black cumin ( Nigella sativa ) , licorice ( Glycyrrhiza glabra ) , Astragalus and St. John 's wort ( Hypericum perforatum ) as natural immune boosters ."
92971,(,O,3227.0,"The review intended to highlight the importance of garlic ( Allium sativum ) , green tea ( Camellia sinensis ) , ginger ( Zingiber officinale ) , purple coneflower ( Echinacea ) , black cumin ( Nigella sativa ) , licorice ( Glycyrrhiza glabra ) , Astragalus and St. John 's wort ( Hypericum perforatum ) as natural immune boosters ."
92972,Allium,B-AG.01.h.02.e,3227.0,"The review intended to highlight the importance of garlic ( Allium sativum ) , green tea ( Camellia sinensis ) , ginger ( Zingiber officinale ) , purple coneflower ( Echinacea ) , black cumin ( Nigella sativa ) , licorice ( Glycyrrhiza glabra ) , Astragalus and St. John 's wort ( Hypericum perforatum ) as natural immune boosters ."
92973,sativum,I-AG.01.h.02.e,3227.0,"The review intended to highlight the importance of garlic ( Allium sativum ) , green tea ( Camellia sinensis ) , ginger ( Zingiber officinale ) , purple coneflower ( Echinacea ) , black cumin ( Nigella sativa ) , licorice ( Glycyrrhiza glabra ) , Astragalus and St. John 's wort ( Hypericum perforatum ) as natural immune boosters ."
92974,),O,3227.0,"The review intended to highlight the importance of garlic ( Allium sativum ) , green tea ( Camellia sinensis ) , ginger ( Zingiber officinale ) , purple coneflower ( Echinacea ) , black cumin ( Nigella sativa ) , licorice ( Glycyrrhiza glabra ) , Astragalus and St. John 's wort ( Hypericum perforatum ) as natural immune boosters ."
92975,",",O,3227.0,"The review intended to highlight the importance of garlic ( Allium sativum ) , green tea ( Camellia sinensis ) , ginger ( Zingiber officinale ) , purple coneflower ( Echinacea ) , black cumin ( Nigella sativa ) , licorice ( Glycyrrhiza glabra ) , Astragalus and St. John 's wort ( Hypericum perforatum ) as natural immune boosters ."
92976,green,B-AG.01.ac,3227.0,"The review intended to highlight the importance of garlic ( Allium sativum ) , green tea ( Camellia sinensis ) , ginger ( Zingiber officinale ) , purple coneflower ( Echinacea ) , black cumin ( Nigella sativa ) , licorice ( Glycyrrhiza glabra ) , Astragalus and St. John 's wort ( Hypericum perforatum ) as natural immune boosters ."
92977,tea,I-AG.01.ac,3227.0,"The review intended to highlight the importance of garlic ( Allium sativum ) , green tea ( Camellia sinensis ) , ginger ( Zingiber officinale ) , purple coneflower ( Echinacea ) , black cumin ( Nigella sativa ) , licorice ( Glycyrrhiza glabra ) , Astragalus and St. John 's wort ( Hypericum perforatum ) as natural immune boosters ."
92978,(,O,3227.0,"The review intended to highlight the importance of garlic ( Allium sativum ) , green tea ( Camellia sinensis ) , ginger ( Zingiber officinale ) , purple coneflower ( Echinacea ) , black cumin ( Nigella sativa ) , licorice ( Glycyrrhiza glabra ) , Astragalus and St. John 's wort ( Hypericum perforatum ) as natural immune boosters ."
92979,Camellia,B-AG.01.ac,3227.0,"The review intended to highlight the importance of garlic ( Allium sativum ) , green tea ( Camellia sinensis ) , ginger ( Zingiber officinale ) , purple coneflower ( Echinacea ) , black cumin ( Nigella sativa ) , licorice ( Glycyrrhiza glabra ) , Astragalus and St. John 's wort ( Hypericum perforatum ) as natural immune boosters ."
92980,sinensis,I-AG.01.ac,3227.0,"The review intended to highlight the importance of garlic ( Allium sativum ) , green tea ( Camellia sinensis ) , ginger ( Zingiber officinale ) , purple coneflower ( Echinacea ) , black cumin ( Nigella sativa ) , licorice ( Glycyrrhiza glabra ) , Astragalus and St. John 's wort ( Hypericum perforatum ) as natural immune boosters ."
92981,),O,3227.0,"The review intended to highlight the importance of garlic ( Allium sativum ) , green tea ( Camellia sinensis ) , ginger ( Zingiber officinale ) , purple coneflower ( Echinacea ) , black cumin ( Nigella sativa ) , licorice ( Glycyrrhiza glabra ) , Astragalus and St. John 's wort ( Hypericum perforatum ) as natural immune boosters ."
92982,",",O,3227.0,"The review intended to highlight the importance of garlic ( Allium sativum ) , green tea ( Camellia sinensis ) , ginger ( Zingiber officinale ) , purple coneflower ( Echinacea ) , black cumin ( Nigella sativa ) , licorice ( Glycyrrhiza glabra ) , Astragalus and St. John 's wort ( Hypericum perforatum ) as natural immune boosters ."
92983,ginger,B-AG.01.l.03,3227.0,"The review intended to highlight the importance of garlic ( Allium sativum ) , green tea ( Camellia sinensis ) , ginger ( Zingiber officinale ) , purple coneflower ( Echinacea ) , black cumin ( Nigella sativa ) , licorice ( Glycyrrhiza glabra ) , Astragalus and St. John 's wort ( Hypericum perforatum ) as natural immune boosters ."
92984,(,O,3227.0,"The review intended to highlight the importance of garlic ( Allium sativum ) , green tea ( Camellia sinensis ) , ginger ( Zingiber officinale ) , purple coneflower ( Echinacea ) , black cumin ( Nigella sativa ) , licorice ( Glycyrrhiza glabra ) , Astragalus and St. John 's wort ( Hypericum perforatum ) as natural immune boosters ."
92985,Zingiber,B-AG.01.l.03,3227.0,"The review intended to highlight the importance of garlic ( Allium sativum ) , green tea ( Camellia sinensis ) , ginger ( Zingiber officinale ) , purple coneflower ( Echinacea ) , black cumin ( Nigella sativa ) , licorice ( Glycyrrhiza glabra ) , Astragalus and St. John 's wort ( Hypericum perforatum ) as natural immune boosters ."
92986,officinale,I-AG.01.l.03,3227.0,"The review intended to highlight the importance of garlic ( Allium sativum ) , green tea ( Camellia sinensis ) , ginger ( Zingiber officinale ) , purple coneflower ( Echinacea ) , black cumin ( Nigella sativa ) , licorice ( Glycyrrhiza glabra ) , Astragalus and St. John 's wort ( Hypericum perforatum ) as natural immune boosters ."
92987,),O,3227.0,"The review intended to highlight the importance of garlic ( Allium sativum ) , green tea ( Camellia sinensis ) , ginger ( Zingiber officinale ) , purple coneflower ( Echinacea ) , black cumin ( Nigella sativa ) , licorice ( Glycyrrhiza glabra ) , Astragalus and St. John 's wort ( Hypericum perforatum ) as natural immune boosters ."
92988,",",O,3227.0,"The review intended to highlight the importance of garlic ( Allium sativum ) , green tea ( Camellia sinensis ) , ginger ( Zingiber officinale ) , purple coneflower ( Echinacea ) , black cumin ( Nigella sativa ) , licorice ( Glycyrrhiza glabra ) , Astragalus and St. John 's wort ( Hypericum perforatum ) as natural immune boosters ."
92989,purple,B-AG.01.h.02.i,3227.0,"The review intended to highlight the importance of garlic ( Allium sativum ) , green tea ( Camellia sinensis ) , ginger ( Zingiber officinale ) , purple coneflower ( Echinacea ) , black cumin ( Nigella sativa ) , licorice ( Glycyrrhiza glabra ) , Astragalus and St. John 's wort ( Hypericum perforatum ) as natural immune boosters ."
92990,coneflower,I-AG.01.h.02.i,3227.0,"The review intended to highlight the importance of garlic ( Allium sativum ) , green tea ( Camellia sinensis ) , ginger ( Zingiber officinale ) , purple coneflower ( Echinacea ) , black cumin ( Nigella sativa ) , licorice ( Glycyrrhiza glabra ) , Astragalus and St. John 's wort ( Hypericum perforatum ) as natural immune boosters ."
92991,(,O,3227.0,"The review intended to highlight the importance of garlic ( Allium sativum ) , green tea ( Camellia sinensis ) , ginger ( Zingiber officinale ) , purple coneflower ( Echinacea ) , black cumin ( Nigella sativa ) , licorice ( Glycyrrhiza glabra ) , Astragalus and St. John 's wort ( Hypericum perforatum ) as natural immune boosters ."
92992,Echinacea,B-AG.01.h.02.i,3227.0,"The review intended to highlight the importance of garlic ( Allium sativum ) , green tea ( Camellia sinensis ) , ginger ( Zingiber officinale ) , purple coneflower ( Echinacea ) , black cumin ( Nigella sativa ) , licorice ( Glycyrrhiza glabra ) , Astragalus and St. John 's wort ( Hypericum perforatum ) as natural immune boosters ."
92993,),O,3227.0,"The review intended to highlight the importance of garlic ( Allium sativum ) , green tea ( Camellia sinensis ) , ginger ( Zingiber officinale ) , purple coneflower ( Echinacea ) , black cumin ( Nigella sativa ) , licorice ( Glycyrrhiza glabra ) , Astragalus and St. John 's wort ( Hypericum perforatum ) as natural immune boosters ."
92994,",",O,3227.0,"The review intended to highlight the importance of garlic ( Allium sativum ) , green tea ( Camellia sinensis ) , ginger ( Zingiber officinale ) , purple coneflower ( Echinacea ) , black cumin ( Nigella sativa ) , licorice ( Glycyrrhiza glabra ) , Astragalus and St. John 's wort ( Hypericum perforatum ) as natural immune boosters ."
92995,black,B-AG.01.l.03,3227.0,"The review intended to highlight the importance of garlic ( Allium sativum ) , green tea ( Camellia sinensis ) , ginger ( Zingiber officinale ) , purple coneflower ( Echinacea ) , black cumin ( Nigella sativa ) , licorice ( Glycyrrhiza glabra ) , Astragalus and St. John 's wort ( Hypericum perforatum ) as natural immune boosters ."
92996,cumin,I-AG.01.l.03,3227.0,"The review intended to highlight the importance of garlic ( Allium sativum ) , green tea ( Camellia sinensis ) , ginger ( Zingiber officinale ) , purple coneflower ( Echinacea ) , black cumin ( Nigella sativa ) , licorice ( Glycyrrhiza glabra ) , Astragalus and St. John 's wort ( Hypericum perforatum ) as natural immune boosters ."
92997,(,O,3227.0,"The review intended to highlight the importance of garlic ( Allium sativum ) , green tea ( Camellia sinensis ) , ginger ( Zingiber officinale ) , purple coneflower ( Echinacea ) , black cumin ( Nigella sativa ) , licorice ( Glycyrrhiza glabra ) , Astragalus and St. John 's wort ( Hypericum perforatum ) as natural immune boosters ."
92998,Nigella,B-AG.01.l.03,3227.0,"The review intended to highlight the importance of garlic ( Allium sativum ) , green tea ( Camellia sinensis ) , ginger ( Zingiber officinale ) , purple coneflower ( Echinacea ) , black cumin ( Nigella sativa ) , licorice ( Glycyrrhiza glabra ) , Astragalus and St. John 's wort ( Hypericum perforatum ) as natural immune boosters ."
92999,sativa,I-AG.01.l.03,3227.0,"The review intended to highlight the importance of garlic ( Allium sativum ) , green tea ( Camellia sinensis ) , ginger ( Zingiber officinale ) , purple coneflower ( Echinacea ) , black cumin ( Nigella sativa ) , licorice ( Glycyrrhiza glabra ) , Astragalus and St. John 's wort ( Hypericum perforatum ) as natural immune boosters ."
93000,),O,3227.0,"The review intended to highlight the importance of garlic ( Allium sativum ) , green tea ( Camellia sinensis ) , ginger ( Zingiber officinale ) , purple coneflower ( Echinacea ) , black cumin ( Nigella sativa ) , licorice ( Glycyrrhiza glabra ) , Astragalus and St. John 's wort ( Hypericum perforatum ) as natural immune boosters ."
93001,",",O,3227.0,"The review intended to highlight the importance of garlic ( Allium sativum ) , green tea ( Camellia sinensis ) , ginger ( Zingiber officinale ) , purple coneflower ( Echinacea ) , black cumin ( Nigella sativa ) , licorice ( Glycyrrhiza glabra ) , Astragalus and St. John 's wort ( Hypericum perforatum ) as natural immune boosters ."
93002,licorice,B-AG.01.h.02.i,3227.0,"The review intended to highlight the importance of garlic ( Allium sativum ) , green tea ( Camellia sinensis ) , ginger ( Zingiber officinale ) , purple coneflower ( Echinacea ) , black cumin ( Nigella sativa ) , licorice ( Glycyrrhiza glabra ) , Astragalus and St. John 's wort ( Hypericum perforatum ) as natural immune boosters ."
93003,(,O,3227.0,"The review intended to highlight the importance of garlic ( Allium sativum ) , green tea ( Camellia sinensis ) , ginger ( Zingiber officinale ) , purple coneflower ( Echinacea ) , black cumin ( Nigella sativa ) , licorice ( Glycyrrhiza glabra ) , Astragalus and St. John 's wort ( Hypericum perforatum ) as natural immune boosters ."
93004,Glycyrrhiza,B-AG.01.h.02.i,3227.0,"The review intended to highlight the importance of garlic ( Allium sativum ) , green tea ( Camellia sinensis ) , ginger ( Zingiber officinale ) , purple coneflower ( Echinacea ) , black cumin ( Nigella sativa ) , licorice ( Glycyrrhiza glabra ) , Astragalus and St. John 's wort ( Hypericum perforatum ) as natural immune boosters ."
93005,glabra,I-AG.01.h.02.i,3227.0,"The review intended to highlight the importance of garlic ( Allium sativum ) , green tea ( Camellia sinensis ) , ginger ( Zingiber officinale ) , purple coneflower ( Echinacea ) , black cumin ( Nigella sativa ) , licorice ( Glycyrrhiza glabra ) , Astragalus and St. John 's wort ( Hypericum perforatum ) as natural immune boosters ."
93006,),O,3227.0,"The review intended to highlight the importance of garlic ( Allium sativum ) , green tea ( Camellia sinensis ) , ginger ( Zingiber officinale ) , purple coneflower ( Echinacea ) , black cumin ( Nigella sativa ) , licorice ( Glycyrrhiza glabra ) , Astragalus and St. John 's wort ( Hypericum perforatum ) as natural immune boosters ."
93007,",",O,3227.0,"The review intended to highlight the importance of garlic ( Allium sativum ) , green tea ( Camellia sinensis ) , ginger ( Zingiber officinale ) , purple coneflower ( Echinacea ) , black cumin ( Nigella sativa ) , licorice ( Glycyrrhiza glabra ) , Astragalus and St. John 's wort ( Hypericum perforatum ) as natural immune boosters ."
93008,Astragalus,B-AG.01.l.03,3227.0,"The review intended to highlight the importance of garlic ( Allium sativum ) , green tea ( Camellia sinensis ) , ginger ( Zingiber officinale ) , purple coneflower ( Echinacea ) , black cumin ( Nigella sativa ) , licorice ( Glycyrrhiza glabra ) , Astragalus and St. John 's wort ( Hypericum perforatum ) as natural immune boosters ."
93009,and,I-AG.01.l.03,3227.0,"The review intended to highlight the importance of garlic ( Allium sativum ) , green tea ( Camellia sinensis ) , ginger ( Zingiber officinale ) , purple coneflower ( Echinacea ) , black cumin ( Nigella sativa ) , licorice ( Glycyrrhiza glabra ) , Astragalus and St. John 's wort ( Hypericum perforatum ) as natural immune boosters ."
93010,St.,I-AG.01.l.03,3227.0,"The review intended to highlight the importance of garlic ( Allium sativum ) , green tea ( Camellia sinensis ) , ginger ( Zingiber officinale ) , purple coneflower ( Echinacea ) , black cumin ( Nigella sativa ) , licorice ( Glycyrrhiza glabra ) , Astragalus and St. John 's wort ( Hypericum perforatum ) as natural immune boosters ."
93011,John,I-AG.01.l.03,3227.0,"The review intended to highlight the importance of garlic ( Allium sativum ) , green tea ( Camellia sinensis ) , ginger ( Zingiber officinale ) , purple coneflower ( Echinacea ) , black cumin ( Nigella sativa ) , licorice ( Glycyrrhiza glabra ) , Astragalus and St. John 's wort ( Hypericum perforatum ) as natural immune boosters ."
93012,'s,I-AG.01.l.03,3227.0,"The review intended to highlight the importance of garlic ( Allium sativum ) , green tea ( Camellia sinensis ) , ginger ( Zingiber officinale ) , purple coneflower ( Echinacea ) , black cumin ( Nigella sativa ) , licorice ( Glycyrrhiza glabra ) , Astragalus and St. John 's wort ( Hypericum perforatum ) as natural immune boosters ."
93013,wort,I-AG.01.l.03,3227.0,"The review intended to highlight the importance of garlic ( Allium sativum ) , green tea ( Camellia sinensis ) , ginger ( Zingiber officinale ) , purple coneflower ( Echinacea ) , black cumin ( Nigella sativa ) , licorice ( Glycyrrhiza glabra ) , Astragalus and St. John 's wort ( Hypericum perforatum ) as natural immune boosters ."
93014,(,O,3227.0,"The review intended to highlight the importance of garlic ( Allium sativum ) , green tea ( Camellia sinensis ) , ginger ( Zingiber officinale ) , purple coneflower ( Echinacea ) , black cumin ( Nigella sativa ) , licorice ( Glycyrrhiza glabra ) , Astragalus and St. John 's wort ( Hypericum perforatum ) as natural immune boosters ."
93015,Hypericum,B-AG.01.l.03,3227.0,"The review intended to highlight the importance of garlic ( Allium sativum ) , green tea ( Camellia sinensis ) , ginger ( Zingiber officinale ) , purple coneflower ( Echinacea ) , black cumin ( Nigella sativa ) , licorice ( Glycyrrhiza glabra ) , Astragalus and St. John 's wort ( Hypericum perforatum ) as natural immune boosters ."
93016,perforatum,I-AG.01.l.03,3227.0,"The review intended to highlight the importance of garlic ( Allium sativum ) , green tea ( Camellia sinensis ) , ginger ( Zingiber officinale ) , purple coneflower ( Echinacea ) , black cumin ( Nigella sativa ) , licorice ( Glycyrrhiza glabra ) , Astragalus and St. John 's wort ( Hypericum perforatum ) as natural immune boosters ."
93017,),O,3227.0,"The review intended to highlight the importance of garlic ( Allium sativum ) , green tea ( Camellia sinensis ) , ginger ( Zingiber officinale ) , purple coneflower ( Echinacea ) , black cumin ( Nigella sativa ) , licorice ( Glycyrrhiza glabra ) , Astragalus and St. John 's wort ( Hypericum perforatum ) as natural immune boosters ."
93018,as,O,3227.0,"The review intended to highlight the importance of garlic ( Allium sativum ) , green tea ( Camellia sinensis ) , ginger ( Zingiber officinale ) , purple coneflower ( Echinacea ) , black cumin ( Nigella sativa ) , licorice ( Glycyrrhiza glabra ) , Astragalus and St. John 's wort ( Hypericum perforatum ) as natural immune boosters ."
93019,natural,O,3227.0,"The review intended to highlight the importance of garlic ( Allium sativum ) , green tea ( Camellia sinensis ) , ginger ( Zingiber officinale ) , purple coneflower ( Echinacea ) , black cumin ( Nigella sativa ) , licorice ( Glycyrrhiza glabra ) , Astragalus and St. John 's wort ( Hypericum perforatum ) as natural immune boosters ."
93020,immune,O,3227.0,"The review intended to highlight the importance of garlic ( Allium sativum ) , green tea ( Camellia sinensis ) , ginger ( Zingiber officinale ) , purple coneflower ( Echinacea ) , black cumin ( Nigella sativa ) , licorice ( Glycyrrhiza glabra ) , Astragalus and St. John 's wort ( Hypericum perforatum ) as natural immune boosters ."
93021,boosters,O,3227.0,"The review intended to highlight the importance of garlic ( Allium sativum ) , green tea ( Camellia sinensis ) , ginger ( Zingiber officinale ) , purple coneflower ( Echinacea ) , black cumin ( Nigella sativa ) , licorice ( Glycyrrhiza glabra ) , Astragalus and St. John 's wort ( Hypericum perforatum ) as natural immune boosters ."
93022,.,O,3227.0,"The review intended to highlight the importance of garlic ( Allium sativum ) , green tea ( Camellia sinensis ) , ginger ( Zingiber officinale ) , purple coneflower ( Echinacea ) , black cumin ( Nigella sativa ) , licorice ( Glycyrrhiza glabra ) , Astragalus and St. John 's wort ( Hypericum perforatum ) as natural immune boosters ."
93023,These,O,3228.0,These plants are bestowed with functional ingredients that may provide protection against various menaces .
93024,plants,O,3228.0,These plants are bestowed with functional ingredients that may provide protection against various menaces .
93025,are,O,3228.0,These plants are bestowed with functional ingredients that may provide protection against various menaces .
93026,bestowed,O,3228.0,These plants are bestowed with functional ingredients that may provide protection against various menaces .
93027,with,O,3228.0,These plants are bestowed with functional ingredients that may provide protection against various menaces .
93028,functional,O,3228.0,These plants are bestowed with functional ingredients that may provide protection against various menaces .
93029,ingredients,O,3228.0,These plants are bestowed with functional ingredients that may provide protection against various menaces .
93030,that,O,3228.0,These plants are bestowed with functional ingredients that may provide protection against various menaces .
93031,may,O,3228.0,These plants are bestowed with functional ingredients that may provide protection against various menaces .
93032,provide,O,3228.0,These plants are bestowed with functional ingredients that may provide protection against various menaces .
93033,protection,O,3228.0,These plants are bestowed with functional ingredients that may provide protection against various menaces .
93034,against,O,3228.0,These plants are bestowed with functional ingredients that may provide protection against various menaces .
93035,various,O,3228.0,These plants are bestowed with functional ingredients that may provide protection against various menaces .
93036,menaces,O,3228.0,These plants are bestowed with functional ingredients that may provide protection against various menaces .
93037,.,O,3228.0,These plants are bestowed with functional ingredients that may provide protection against various menaces .
93038,Modes,O,3229.0,"Modes of their actions include boosting and functioning of immune system , activation and suppression of immune specialized cells , interfering in several pathways that eventually led to improvement in immune responses and defense system ."
93039,of,O,3229.0,"Modes of their actions include boosting and functioning of immune system , activation and suppression of immune specialized cells , interfering in several pathways that eventually led to improvement in immune responses and defense system ."
93040,their,O,3229.0,"Modes of their actions include boosting and functioning of immune system , activation and suppression of immune specialized cells , interfering in several pathways that eventually led to improvement in immune responses and defense system ."
93041,actions,O,3229.0,"Modes of their actions include boosting and functioning of immune system , activation and suppression of immune specialized cells , interfering in several pathways that eventually led to improvement in immune responses and defense system ."
93042,include,O,3229.0,"Modes of their actions include boosting and functioning of immune system , activation and suppression of immune specialized cells , interfering in several pathways that eventually led to improvement in immune responses and defense system ."
93043,boosting,O,3229.0,"Modes of their actions include boosting and functioning of immune system , activation and suppression of immune specialized cells , interfering in several pathways that eventually led to improvement in immune responses and defense system ."
93044,and,O,3229.0,"Modes of their actions include boosting and functioning of immune system , activation and suppression of immune specialized cells , interfering in several pathways that eventually led to improvement in immune responses and defense system ."
93045,functioning,O,3229.0,"Modes of their actions include boosting and functioning of immune system , activation and suppression of immune specialized cells , interfering in several pathways that eventually led to improvement in immune responses and defense system ."
93046,of,O,3229.0,"Modes of their actions include boosting and functioning of immune system , activation and suppression of immune specialized cells , interfering in several pathways that eventually led to improvement in immune responses and defense system ."
93047,immune,O,3229.0,"Modes of their actions include boosting and functioning of immune system , activation and suppression of immune specialized cells , interfering in several pathways that eventually led to improvement in immune responses and defense system ."
93048,system,O,3229.0,"Modes of their actions include boosting and functioning of immune system , activation and suppression of immune specialized cells , interfering in several pathways that eventually led to improvement in immune responses and defense system ."
93049,",",O,3229.0,"Modes of their actions include boosting and functioning of immune system , activation and suppression of immune specialized cells , interfering in several pathways that eventually led to improvement in immune responses and defense system ."
93050,activation,O,3229.0,"Modes of their actions include boosting and functioning of immune system , activation and suppression of immune specialized cells , interfering in several pathways that eventually led to improvement in immune responses and defense system ."
93051,and,O,3229.0,"Modes of their actions include boosting and functioning of immune system , activation and suppression of immune specialized cells , interfering in several pathways that eventually led to improvement in immune responses and defense system ."
93052,suppression,O,3229.0,"Modes of their actions include boosting and functioning of immune system , activation and suppression of immune specialized cells , interfering in several pathways that eventually led to improvement in immune responses and defense system ."
93053,of,O,3229.0,"Modes of their actions include boosting and functioning of immune system , activation and suppression of immune specialized cells , interfering in several pathways that eventually led to improvement in immune responses and defense system ."
93054,immune,O,3229.0,"Modes of their actions include boosting and functioning of immune system , activation and suppression of immune specialized cells , interfering in several pathways that eventually led to improvement in immune responses and defense system ."
93055,specialized,O,3229.0,"Modes of their actions include boosting and functioning of immune system , activation and suppression of immune specialized cells , interfering in several pathways that eventually led to improvement in immune responses and defense system ."
93056,cells,O,3229.0,"Modes of their actions include boosting and functioning of immune system , activation and suppression of immune specialized cells , interfering in several pathways that eventually led to improvement in immune responses and defense system ."
93057,",",O,3229.0,"Modes of their actions include boosting and functioning of immune system , activation and suppression of immune specialized cells , interfering in several pathways that eventually led to improvement in immune responses and defense system ."
93058,interfering,O,3229.0,"Modes of their actions include boosting and functioning of immune system , activation and suppression of immune specialized cells , interfering in several pathways that eventually led to improvement in immune responses and defense system ."
93059,in,O,3229.0,"Modes of their actions include boosting and functioning of immune system , activation and suppression of immune specialized cells , interfering in several pathways that eventually led to improvement in immune responses and defense system ."
93060,several,O,3229.0,"Modes of their actions include boosting and functioning of immune system , activation and suppression of immune specialized cells , interfering in several pathways that eventually led to improvement in immune responses and defense system ."
93061,pathways,O,3229.0,"Modes of their actions include boosting and functioning of immune system , activation and suppression of immune specialized cells , interfering in several pathways that eventually led to improvement in immune responses and defense system ."
93062,that,O,3229.0,"Modes of their actions include boosting and functioning of immune system , activation and suppression of immune specialized cells , interfering in several pathways that eventually led to improvement in immune responses and defense system ."
93063,eventually,O,3229.0,"Modes of their actions include boosting and functioning of immune system , activation and suppression of immune specialized cells , interfering in several pathways that eventually led to improvement in immune responses and defense system ."
93064,led,O,3229.0,"Modes of their actions include boosting and functioning of immune system , activation and suppression of immune specialized cells , interfering in several pathways that eventually led to improvement in immune responses and defense system ."
93065,to,O,3229.0,"Modes of their actions include boosting and functioning of immune system , activation and suppression of immune specialized cells , interfering in several pathways that eventually led to improvement in immune responses and defense system ."
93066,improvement,O,3229.0,"Modes of their actions include boosting and functioning of immune system , activation and suppression of immune specialized cells , interfering in several pathways that eventually led to improvement in immune responses and defense system ."
93067,in,O,3229.0,"Modes of their actions include boosting and functioning of immune system , activation and suppression of immune specialized cells , interfering in several pathways that eventually led to improvement in immune responses and defense system ."
93068,immune,O,3229.0,"Modes of their actions include boosting and functioning of immune system , activation and suppression of immune specialized cells , interfering in several pathways that eventually led to improvement in immune responses and defense system ."
93069,responses,O,3229.0,"Modes of their actions include boosting and functioning of immune system , activation and suppression of immune specialized cells , interfering in several pathways that eventually led to improvement in immune responses and defense system ."
93070,and,O,3229.0,"Modes of their actions include boosting and functioning of immune system , activation and suppression of immune specialized cells , interfering in several pathways that eventually led to improvement in immune responses and defense system ."
93071,defense,O,3229.0,"Modes of their actions include boosting and functioning of immune system , activation and suppression of immune specialized cells , interfering in several pathways that eventually led to improvement in immune responses and defense system ."
93072,system,O,3229.0,"Modes of their actions include boosting and functioning of immune system , activation and suppression of immune specialized cells , interfering in several pathways that eventually led to improvement in immune responses and defense system ."
93073,.,O,3229.0,"Modes of their actions include boosting and functioning of immune system , activation and suppression of immune specialized cells , interfering in several pathways that eventually led to improvement in immune responses and defense system ."
93074,In,O,3230.0,"In addition , some of these plants carry free radical scavenging and anti - inflammatory activities that are helpful against cancer insurgence ."
93075,addition,O,3230.0,"In addition , some of these plants carry free radical scavenging and anti - inflammatory activities that are helpful against cancer insurgence ."
93076,",",O,3230.0,"In addition , some of these plants carry free radical scavenging and anti - inflammatory activities that are helpful against cancer insurgence ."
93077,some,O,3230.0,"In addition , some of these plants carry free radical scavenging and anti - inflammatory activities that are helpful against cancer insurgence ."
93078,of,O,3230.0,"In addition , some of these plants carry free radical scavenging and anti - inflammatory activities that are helpful against cancer insurgence ."
93079,these,O,3230.0,"In addition , some of these plants carry free radical scavenging and anti - inflammatory activities that are helpful against cancer insurgence ."
93080,plants,O,3230.0,"In addition , some of these plants carry free radical scavenging and anti - inflammatory activities that are helpful against cancer insurgence ."
93081,carry,O,3230.0,"In addition , some of these plants carry free radical scavenging and anti - inflammatory activities that are helpful against cancer insurgence ."
93082,free,O,3230.0,"In addition , some of these plants carry free radical scavenging and anti - inflammatory activities that are helpful against cancer insurgence ."
93083,radical,O,3230.0,"In addition , some of these plants carry free radical scavenging and anti - inflammatory activities that are helpful against cancer insurgence ."
93084,scavenging,O,3230.0,"In addition , some of these plants carry free radical scavenging and anti - inflammatory activities that are helpful against cancer insurgence ."
93085,and,O,3230.0,"In addition , some of these plants carry free radical scavenging and anti - inflammatory activities that are helpful against cancer insurgence ."
93086,anti,O,3230.0,"In addition , some of these plants carry free radical scavenging and anti - inflammatory activities that are helpful against cancer insurgence ."
93087,-,O,3230.0,"In addition , some of these plants carry free radical scavenging and anti - inflammatory activities that are helpful against cancer insurgence ."
93088,inflammatory,O,3230.0,"In addition , some of these plants carry free radical scavenging and anti - inflammatory activities that are helpful against cancer insurgence ."
93089,activities,O,3230.0,"In addition , some of these plants carry free radical scavenging and anti - inflammatory activities that are helpful against cancer insurgence ."
93090,that,O,3230.0,"In addition , some of these plants carry free radical scavenging and anti - inflammatory activities that are helpful against cancer insurgence ."
93091,are,O,3230.0,"In addition , some of these plants carry free radical scavenging and anti - inflammatory activities that are helpful against cancer insurgence ."
93092,helpful,O,3230.0,"In addition , some of these plants carry free radical scavenging and anti - inflammatory activities that are helpful against cancer insurgence ."
93093,against,O,3230.0,"In addition , some of these plants carry free radical scavenging and anti - inflammatory activities that are helpful against cancer insurgence ."
93094,cancer,O,3230.0,"In addition , some of these plants carry free radical scavenging and anti - inflammatory activities that are helpful against cancer insurgence ."
93095,insurgence,O,3230.0,"In addition , some of these plants carry free radical scavenging and anti - inflammatory activities that are helpful against cancer insurgence ."
93096,.,O,3230.0,"In addition , some of these plants carry free radical scavenging and anti - inflammatory activities that are helpful against cancer insurgence ."
93097,Nevertheless,O,3231.0,"Nevertheless , interaction between drugs and herbs / botanicals should be well investigated before recommended for their safe use , and such information must be disseminated to the allied stakeholders ."
93098,",",O,3231.0,"Nevertheless , interaction between drugs and herbs / botanicals should be well investigated before recommended for their safe use , and such information must be disseminated to the allied stakeholders ."
93099,interaction,O,3231.0,"Nevertheless , interaction between drugs and herbs / botanicals should be well investigated before recommended for their safe use , and such information must be disseminated to the allied stakeholders ."
93100,between,O,3231.0,"Nevertheless , interaction between drugs and herbs / botanicals should be well investigated before recommended for their safe use , and such information must be disseminated to the allied stakeholders ."
93101,drugs,O,3231.0,"Nevertheless , interaction between drugs and herbs / botanicals should be well investigated before recommended for their safe use , and such information must be disseminated to the allied stakeholders ."
93102,and,O,3231.0,"Nevertheless , interaction between drugs and herbs / botanicals should be well investigated before recommended for their safe use , and such information must be disseminated to the allied stakeholders ."
93103,herbs,B-AG.01.h.02.i,3231.0,"Nevertheless , interaction between drugs and herbs / botanicals should be well investigated before recommended for their safe use , and such information must be disseminated to the allied stakeholders ."
93104,/,O,3231.0,"Nevertheless , interaction between drugs and herbs / botanicals should be well investigated before recommended for their safe use , and such information must be disseminated to the allied stakeholders ."
93105,botanicals,O,3231.0,"Nevertheless , interaction between drugs and herbs / botanicals should be well investigated before recommended for their safe use , and such information must be disseminated to the allied stakeholders ."
93106,should,O,3231.0,"Nevertheless , interaction between drugs and herbs / botanicals should be well investigated before recommended for their safe use , and such information must be disseminated to the allied stakeholders ."
93107,be,O,3231.0,"Nevertheless , interaction between drugs and herbs / botanicals should be well investigated before recommended for their safe use , and such information must be disseminated to the allied stakeholders ."
93108,well,O,3231.0,"Nevertheless , interaction between drugs and herbs / botanicals should be well investigated before recommended for their safe use , and such information must be disseminated to the allied stakeholders ."
93109,investigated,O,3231.0,"Nevertheless , interaction between drugs and herbs / botanicals should be well investigated before recommended for their safe use , and such information must be disseminated to the allied stakeholders ."
93110,before,O,3231.0,"Nevertheless , interaction between drugs and herbs / botanicals should be well investigated before recommended for their safe use , and such information must be disseminated to the allied stakeholders ."
93111,recommended,O,3231.0,"Nevertheless , interaction between drugs and herbs / botanicals should be well investigated before recommended for their safe use , and such information must be disseminated to the allied stakeholders ."
93112,for,O,3231.0,"Nevertheless , interaction between drugs and herbs / botanicals should be well investigated before recommended for their safe use , and such information must be disseminated to the allied stakeholders ."
93113,their,O,3231.0,"Nevertheless , interaction between drugs and herbs / botanicals should be well investigated before recommended for their safe use , and such information must be disseminated to the allied stakeholders ."
93114,safe,O,3231.0,"Nevertheless , interaction between drugs and herbs / botanicals should be well investigated before recommended for their safe use , and such information must be disseminated to the allied stakeholders ."
93115,use,O,3231.0,"Nevertheless , interaction between drugs and herbs / botanicals should be well investigated before recommended for their safe use , and such information must be disseminated to the allied stakeholders ."
93116,",",O,3231.0,"Nevertheless , interaction between drugs and herbs / botanicals should be well investigated before recommended for their safe use , and such information must be disseminated to the allied stakeholders ."
93117,and,O,3231.0,"Nevertheless , interaction between drugs and herbs / botanicals should be well investigated before recommended for their safe use , and such information must be disseminated to the allied stakeholders ."
93118,such,O,3231.0,"Nevertheless , interaction between drugs and herbs / botanicals should be well investigated before recommended for their safe use , and such information must be disseminated to the allied stakeholders ."
93119,information,O,3231.0,"Nevertheless , interaction between drugs and herbs / botanicals should be well investigated before recommended for their safe use , and such information must be disseminated to the allied stakeholders ."
93120,must,O,3231.0,"Nevertheless , interaction between drugs and herbs / botanicals should be well investigated before recommended for their safe use , and such information must be disseminated to the allied stakeholders ."
93121,be,O,3231.0,"Nevertheless , interaction between drugs and herbs / botanicals should be well investigated before recommended for their safe use , and such information must be disseminated to the allied stakeholders ."
93122,disseminated,O,3231.0,"Nevertheless , interaction between drugs and herbs / botanicals should be well investigated before recommended for their safe use , and such information must be disseminated to the allied stakeholders ."
93123,to,O,3231.0,"Nevertheless , interaction between drugs and herbs / botanicals should be well investigated before recommended for their safe use , and such information must be disseminated to the allied stakeholders ."
93124,the,O,3231.0,"Nevertheless , interaction between drugs and herbs / botanicals should be well investigated before recommended for their safe use , and such information must be disseminated to the allied stakeholders ."
93125,allied,O,3231.0,"Nevertheless , interaction between drugs and herbs / botanicals should be well investigated before recommended for their safe use , and such information must be disseminated to the allied stakeholders ."
93126,stakeholders,O,3231.0,"Nevertheless , interaction between drugs and herbs / botanicals should be well investigated before recommended for their safe use , and such information must be disseminated to the allied stakeholders ."
93127,.,O,3231.0,"Nevertheless , interaction between drugs and herbs / botanicals should be well investigated before recommended for their safe use , and such information must be disseminated to the allied stakeholders ."
93128,A,O,3232.0,A dietary case - control study based on 818 newly diagnosed breast cancer ( BC ) patients was conducted in Israel between 1975 and 1978 .
93129,dietary,O,3232.0,A dietary case - control study based on 818 newly diagnosed breast cancer ( BC ) patients was conducted in Israel between 1975 and 1978 .
93130,case,O,3232.0,A dietary case - control study based on 818 newly diagnosed breast cancer ( BC ) patients was conducted in Israel between 1975 and 1978 .
93131,-,O,3232.0,A dietary case - control study based on 818 newly diagnosed breast cancer ( BC ) patients was conducted in Israel between 1975 and 1978 .
93132,control,O,3232.0,A dietary case - control study based on 818 newly diagnosed breast cancer ( BC ) patients was conducted in Israel between 1975 and 1978 .
93133,study,O,3232.0,A dietary case - control study based on 818 newly diagnosed breast cancer ( BC ) patients was conducted in Israel between 1975 and 1978 .
93134,based,O,3232.0,A dietary case - control study based on 818 newly diagnosed breast cancer ( BC ) patients was conducted in Israel between 1975 and 1978 .
93135,on,O,3232.0,A dietary case - control study based on 818 newly diagnosed breast cancer ( BC ) patients was conducted in Israel between 1975 and 1978 .
93136,818,O,3232.0,A dietary case - control study based on 818 newly diagnosed breast cancer ( BC ) patients was conducted in Israel between 1975 and 1978 .
93137,newly,O,3232.0,A dietary case - control study based on 818 newly diagnosed breast cancer ( BC ) patients was conducted in Israel between 1975 and 1978 .
93138,diagnosed,O,3232.0,A dietary case - control study based on 818 newly diagnosed breast cancer ( BC ) patients was conducted in Israel between 1975 and 1978 .
93139,breast,O,3232.0,A dietary case - control study based on 818 newly diagnosed breast cancer ( BC ) patients was conducted in Israel between 1975 and 1978 .
93140,cancer,O,3232.0,A dietary case - control study based on 818 newly diagnosed breast cancer ( BC ) patients was conducted in Israel between 1975 and 1978 .
93141,(,O,3232.0,A dietary case - control study based on 818 newly diagnosed breast cancer ( BC ) patients was conducted in Israel between 1975 and 1978 .
93142,BC,O,3232.0,A dietary case - control study based on 818 newly diagnosed breast cancer ( BC ) patients was conducted in Israel between 1975 and 1978 .
93143,),O,3232.0,A dietary case - control study based on 818 newly diagnosed breast cancer ( BC ) patients was conducted in Israel between 1975 and 1978 .
93144,patients,O,3232.0,A dietary case - control study based on 818 newly diagnosed breast cancer ( BC ) patients was conducted in Israel between 1975 and 1978 .
93145,was,O,3232.0,A dietary case - control study based on 818 newly diagnosed breast cancer ( BC ) patients was conducted in Israel between 1975 and 1978 .
93146,conducted,O,3232.0,A dietary case - control study based on 818 newly diagnosed breast cancer ( BC ) patients was conducted in Israel between 1975 and 1978 .
93147,in,O,3232.0,A dietary case - control study based on 818 newly diagnosed breast cancer ( BC ) patients was conducted in Israel between 1975 and 1978 .
93148,Israel,O,3232.0,A dietary case - control study based on 818 newly diagnosed breast cancer ( BC ) patients was conducted in Israel between 1975 and 1978 .
93149,between,O,3232.0,A dietary case - control study based on 818 newly diagnosed breast cancer ( BC ) patients was conducted in Israel between 1975 and 1978 .
93150,1975,O,3232.0,A dietary case - control study based on 818 newly diagnosed breast cancer ( BC ) patients was conducted in Israel between 1975 and 1978 .
93151,and,O,3232.0,A dietary case - control study based on 818 newly diagnosed breast cancer ( BC ) patients was conducted in Israel between 1975 and 1978 .
93152,1978,O,3232.0,A dietary case - control study based on 818 newly diagnosed breast cancer ( BC ) patients was conducted in Israel between 1975 and 1978 .
93153,.,O,3232.0,A dietary case - control study based on 818 newly diagnosed breast cancer ( BC ) patients was conducted in Israel between 1975 and 1978 .
93154,The,O,3233.0,"The role of coffee and total methylxanthine intake from coffee , tea , cola , chocolate , and cocoa drinks was evaluated in the BC patients as compared to that in two matched control populations [ surgical controls ( SC ) and neighborhood controls ( NC ) ] ."
93155,role,O,3233.0,"The role of coffee and total methylxanthine intake from coffee , tea , cola , chocolate , and cocoa drinks was evaluated in the BC patients as compared to that in two matched control populations [ surgical controls ( SC ) and neighborhood controls ( NC ) ] ."
93156,of,O,3233.0,"The role of coffee and total methylxanthine intake from coffee , tea , cola , chocolate , and cocoa drinks was evaluated in the BC patients as compared to that in two matched control populations [ surgical controls ( SC ) and neighborhood controls ( NC ) ] ."
93157,coffee,B-AG.01.ad,3233.0,"The role of coffee and total methylxanthine intake from coffee , tea , cola , chocolate , and cocoa drinks was evaluated in the BC patients as compared to that in two matched control populations [ surgical controls ( SC ) and neighborhood controls ( NC ) ] ."
93158,and,O,3233.0,"The role of coffee and total methylxanthine intake from coffee , tea , cola , chocolate , and cocoa drinks was evaluated in the BC patients as compared to that in two matched control populations [ surgical controls ( SC ) and neighborhood controls ( NC ) ] ."
93159,total,O,3233.0,"The role of coffee and total methylxanthine intake from coffee , tea , cola , chocolate , and cocoa drinks was evaluated in the BC patients as compared to that in two matched control populations [ surgical controls ( SC ) and neighborhood controls ( NC ) ] ."
93160,methylxanthine,O,3233.0,"The role of coffee and total methylxanthine intake from coffee , tea , cola , chocolate , and cocoa drinks was evaluated in the BC patients as compared to that in two matched control populations [ surgical controls ( SC ) and neighborhood controls ( NC ) ] ."
93161,intake,O,3233.0,"The role of coffee and total methylxanthine intake from coffee , tea , cola , chocolate , and cocoa drinks was evaluated in the BC patients as compared to that in two matched control populations [ surgical controls ( SC ) and neighborhood controls ( NC ) ] ."
93162,from,O,3233.0,"The role of coffee and total methylxanthine intake from coffee , tea , cola , chocolate , and cocoa drinks was evaluated in the BC patients as compared to that in two matched control populations [ surgical controls ( SC ) and neighborhood controls ( NC ) ] ."
93163,coffee,B-AG.01.ad,3233.0,"The role of coffee and total methylxanthine intake from coffee , tea , cola , chocolate , and cocoa drinks was evaluated in the BC patients as compared to that in two matched control populations [ surgical controls ( SC ) and neighborhood controls ( NC ) ] ."
93164,",",O,3233.0,"The role of coffee and total methylxanthine intake from coffee , tea , cola , chocolate , and cocoa drinks was evaluated in the BC patients as compared to that in two matched control populations [ surgical controls ( SC ) and neighborhood controls ( NC ) ] ."
93165,tea,B-AG.01.ac,3233.0,"The role of coffee and total methylxanthine intake from coffee , tea , cola , chocolate , and cocoa drinks was evaluated in the BC patients as compared to that in two matched control populations [ surgical controls ( SC ) and neighborhood controls ( NC ) ] ."
93166,",",O,3233.0,"The role of coffee and total methylxanthine intake from coffee , tea , cola , chocolate , and cocoa drinks was evaluated in the BC patients as compared to that in two matched control populations [ surgical controls ( SC ) and neighborhood controls ( NC ) ] ."
93167,cola,B-AG.01.aa,3233.0,"The role of coffee and total methylxanthine intake from coffee , tea , cola , chocolate , and cocoa drinks was evaluated in the BC patients as compared to that in two matched control populations [ surgical controls ( SC ) and neighborhood controls ( NC ) ] ."
93168,",",O,3233.0,"The role of coffee and total methylxanthine intake from coffee , tea , cola , chocolate , and cocoa drinks was evaluated in the BC patients as compared to that in two matched control populations [ surgical controls ( SC ) and neighborhood controls ( NC ) ] ."
93169,chocolate,B-AG.01.n.17.a,3233.0,"The role of coffee and total methylxanthine intake from coffee , tea , cola , chocolate , and cocoa drinks was evaluated in the BC patients as compared to that in two matched control populations [ surgical controls ( SC ) and neighborhood controls ( NC ) ] ."
93170,",",O,3233.0,"The role of coffee and total methylxanthine intake from coffee , tea , cola , chocolate , and cocoa drinks was evaluated in the BC patients as compared to that in two matched control populations [ surgical controls ( SC ) and neighborhood controls ( NC ) ] ."
93171,and,O,3233.0,"The role of coffee and total methylxanthine intake from coffee , tea , cola , chocolate , and cocoa drinks was evaluated in the BC patients as compared to that in two matched control populations [ surgical controls ( SC ) and neighborhood controls ( NC ) ] ."
93172,cocoa,B-AG.01.y,3233.0,"The role of coffee and total methylxanthine intake from coffee , tea , cola , chocolate , and cocoa drinks was evaluated in the BC patients as compared to that in two matched control populations [ surgical controls ( SC ) and neighborhood controls ( NC ) ] ."
93173,drinks,I-AG.01.y,3233.0,"The role of coffee and total methylxanthine intake from coffee , tea , cola , chocolate , and cocoa drinks was evaluated in the BC patients as compared to that in two matched control populations [ surgical controls ( SC ) and neighborhood controls ( NC ) ] ."
93174,was,O,3233.0,"The role of coffee and total methylxanthine intake from coffee , tea , cola , chocolate , and cocoa drinks was evaluated in the BC patients as compared to that in two matched control populations [ surgical controls ( SC ) and neighborhood controls ( NC ) ] ."
93175,evaluated,O,3233.0,"The role of coffee and total methylxanthine intake from coffee , tea , cola , chocolate , and cocoa drinks was evaluated in the BC patients as compared to that in two matched control populations [ surgical controls ( SC ) and neighborhood controls ( NC ) ] ."
93176,in,O,3233.0,"The role of coffee and total methylxanthine intake from coffee , tea , cola , chocolate , and cocoa drinks was evaluated in the BC patients as compared to that in two matched control populations [ surgical controls ( SC ) and neighborhood controls ( NC ) ] ."
93177,the,O,3233.0,"The role of coffee and total methylxanthine intake from coffee , tea , cola , chocolate , and cocoa drinks was evaluated in the BC patients as compared to that in two matched control populations [ surgical controls ( SC ) and neighborhood controls ( NC ) ] ."
93178,BC,O,3233.0,"The role of coffee and total methylxanthine intake from coffee , tea , cola , chocolate , and cocoa drinks was evaluated in the BC patients as compared to that in two matched control populations [ surgical controls ( SC ) and neighborhood controls ( NC ) ] ."
93179,patients,O,3233.0,"The role of coffee and total methylxanthine intake from coffee , tea , cola , chocolate , and cocoa drinks was evaluated in the BC patients as compared to that in two matched control populations [ surgical controls ( SC ) and neighborhood controls ( NC ) ] ."
93180,as,O,3233.0,"The role of coffee and total methylxanthine intake from coffee , tea , cola , chocolate , and cocoa drinks was evaluated in the BC patients as compared to that in two matched control populations [ surgical controls ( SC ) and neighborhood controls ( NC ) ] ."
93181,compared,O,3233.0,"The role of coffee and total methylxanthine intake from coffee , tea , cola , chocolate , and cocoa drinks was evaluated in the BC patients as compared to that in two matched control populations [ surgical controls ( SC ) and neighborhood controls ( NC ) ] ."
93182,to,O,3233.0,"The role of coffee and total methylxanthine intake from coffee , tea , cola , chocolate , and cocoa drinks was evaluated in the BC patients as compared to that in two matched control populations [ surgical controls ( SC ) and neighborhood controls ( NC ) ] ."
93183,that,O,3233.0,"The role of coffee and total methylxanthine intake from coffee , tea , cola , chocolate , and cocoa drinks was evaluated in the BC patients as compared to that in two matched control populations [ surgical controls ( SC ) and neighborhood controls ( NC ) ] ."
93184,in,O,3233.0,"The role of coffee and total methylxanthine intake from coffee , tea , cola , chocolate , and cocoa drinks was evaluated in the BC patients as compared to that in two matched control populations [ surgical controls ( SC ) and neighborhood controls ( NC ) ] ."
93185,two,O,3233.0,"The role of coffee and total methylxanthine intake from coffee , tea , cola , chocolate , and cocoa drinks was evaluated in the BC patients as compared to that in two matched control populations [ surgical controls ( SC ) and neighborhood controls ( NC ) ] ."
93186,matched,O,3233.0,"The role of coffee and total methylxanthine intake from coffee , tea , cola , chocolate , and cocoa drinks was evaluated in the BC patients as compared to that in two matched control populations [ surgical controls ( SC ) and neighborhood controls ( NC ) ] ."
93187,control,O,3233.0,"The role of coffee and total methylxanthine intake from coffee , tea , cola , chocolate , and cocoa drinks was evaluated in the BC patients as compared to that in two matched control populations [ surgical controls ( SC ) and neighborhood controls ( NC ) ] ."
93188,populations,O,3233.0,"The role of coffee and total methylxanthine intake from coffee , tea , cola , chocolate , and cocoa drinks was evaluated in the BC patients as compared to that in two matched control populations [ surgical controls ( SC ) and neighborhood controls ( NC ) ] ."
93189,[,O,3233.0,"The role of coffee and total methylxanthine intake from coffee , tea , cola , chocolate , and cocoa drinks was evaluated in the BC patients as compared to that in two matched control populations [ surgical controls ( SC ) and neighborhood controls ( NC ) ] ."
93190,surgical,O,3233.0,"The role of coffee and total methylxanthine intake from coffee , tea , cola , chocolate , and cocoa drinks was evaluated in the BC patients as compared to that in two matched control populations [ surgical controls ( SC ) and neighborhood controls ( NC ) ] ."
93191,controls,O,3233.0,"The role of coffee and total methylxanthine intake from coffee , tea , cola , chocolate , and cocoa drinks was evaluated in the BC patients as compared to that in two matched control populations [ surgical controls ( SC ) and neighborhood controls ( NC ) ] ."
93192,(,O,3233.0,"The role of coffee and total methylxanthine intake from coffee , tea , cola , chocolate , and cocoa drinks was evaluated in the BC patients as compared to that in two matched control populations [ surgical controls ( SC ) and neighborhood controls ( NC ) ] ."
93193,SC,O,3233.0,"The role of coffee and total methylxanthine intake from coffee , tea , cola , chocolate , and cocoa drinks was evaluated in the BC patients as compared to that in two matched control populations [ surgical controls ( SC ) and neighborhood controls ( NC ) ] ."
93194,),O,3233.0,"The role of coffee and total methylxanthine intake from coffee , tea , cola , chocolate , and cocoa drinks was evaluated in the BC patients as compared to that in two matched control populations [ surgical controls ( SC ) and neighborhood controls ( NC ) ] ."
93195,and,O,3233.0,"The role of coffee and total methylxanthine intake from coffee , tea , cola , chocolate , and cocoa drinks was evaluated in the BC patients as compared to that in two matched control populations [ surgical controls ( SC ) and neighborhood controls ( NC ) ] ."
93196,neighborhood,O,3233.0,"The role of coffee and total methylxanthine intake from coffee , tea , cola , chocolate , and cocoa drinks was evaluated in the BC patients as compared to that in two matched control populations [ surgical controls ( SC ) and neighborhood controls ( NC ) ] ."
93197,controls,O,3233.0,"The role of coffee and total methylxanthine intake from coffee , tea , cola , chocolate , and cocoa drinks was evaluated in the BC patients as compared to that in two matched control populations [ surgical controls ( SC ) and neighborhood controls ( NC ) ] ."
93198,(,O,3233.0,"The role of coffee and total methylxanthine intake from coffee , tea , cola , chocolate , and cocoa drinks was evaluated in the BC patients as compared to that in two matched control populations [ surgical controls ( SC ) and neighborhood controls ( NC ) ] ."
93199,NC,O,3233.0,"The role of coffee and total methylxanthine intake from coffee , tea , cola , chocolate , and cocoa drinks was evaluated in the BC patients as compared to that in two matched control populations [ surgical controls ( SC ) and neighborhood controls ( NC ) ] ."
93200,),O,3233.0,"The role of coffee and total methylxanthine intake from coffee , tea , cola , chocolate , and cocoa drinks was evaluated in the BC patients as compared to that in two matched control populations [ surgical controls ( SC ) and neighborhood controls ( NC ) ] ."
93201,],O,3233.0,"The role of coffee and total methylxanthine intake from coffee , tea , cola , chocolate , and cocoa drinks was evaluated in the BC patients as compared to that in two matched control populations [ surgical controls ( SC ) and neighborhood controls ( NC ) ] ."
93202,.,O,3233.0,"The role of coffee and total methylxanthine intake from coffee , tea , cola , chocolate , and cocoa drinks was evaluated in the BC patients as compared to that in two matched control populations [ surgical controls ( SC ) and neighborhood controls ( NC ) ] ."
93203,Because,O,3234.0,"Because it has been suggested that caffeine enhances mammary carcinogenesis in rats fed high polyunsaturated fat diets , analysis was done also in relation to fat consumption ."
93204,it,O,3234.0,"Because it has been suggested that caffeine enhances mammary carcinogenesis in rats fed high polyunsaturated fat diets , analysis was done also in relation to fat consumption ."
93205,has,O,3234.0,"Because it has been suggested that caffeine enhances mammary carcinogenesis in rats fed high polyunsaturated fat diets , analysis was done also in relation to fat consumption ."
93206,been,O,3234.0,"Because it has been suggested that caffeine enhances mammary carcinogenesis in rats fed high polyunsaturated fat diets , analysis was done also in relation to fat consumption ."
93207,suggested,O,3234.0,"Because it has been suggested that caffeine enhances mammary carcinogenesis in rats fed high polyunsaturated fat diets , analysis was done also in relation to fat consumption ."
93208,that,O,3234.0,"Because it has been suggested that caffeine enhances mammary carcinogenesis in rats fed high polyunsaturated fat diets , analysis was done also in relation to fat consumption ."
93209,caffeine,O,3234.0,"Because it has been suggested that caffeine enhances mammary carcinogenesis in rats fed high polyunsaturated fat diets , analysis was done also in relation to fat consumption ."
93210,enhances,O,3234.0,"Because it has been suggested that caffeine enhances mammary carcinogenesis in rats fed high polyunsaturated fat diets , analysis was done also in relation to fat consumption ."
93211,mammary,O,3234.0,"Because it has been suggested that caffeine enhances mammary carcinogenesis in rats fed high polyunsaturated fat diets , analysis was done also in relation to fat consumption ."
93212,carcinogenesis,O,3234.0,"Because it has been suggested that caffeine enhances mammary carcinogenesis in rats fed high polyunsaturated fat diets , analysis was done also in relation to fat consumption ."
93213,in,O,3234.0,"Because it has been suggested that caffeine enhances mammary carcinogenesis in rats fed high polyunsaturated fat diets , analysis was done also in relation to fat consumption ."
93214,rats,O,3234.0,"Because it has been suggested that caffeine enhances mammary carcinogenesis in rats fed high polyunsaturated fat diets , analysis was done also in relation to fat consumption ."
93215,fed,O,3234.0,"Because it has been suggested that caffeine enhances mammary carcinogenesis in rats fed high polyunsaturated fat diets , analysis was done also in relation to fat consumption ."
93216,high,O,3234.0,"Because it has been suggested that caffeine enhances mammary carcinogenesis in rats fed high polyunsaturated fat diets , analysis was done also in relation to fat consumption ."
93217,polyunsaturated,O,3234.0,"Because it has been suggested that caffeine enhances mammary carcinogenesis in rats fed high polyunsaturated fat diets , analysis was done also in relation to fat consumption ."
93218,fat,O,3234.0,"Because it has been suggested that caffeine enhances mammary carcinogenesis in rats fed high polyunsaturated fat diets , analysis was done also in relation to fat consumption ."
93219,diets,O,3234.0,"Because it has been suggested that caffeine enhances mammary carcinogenesis in rats fed high polyunsaturated fat diets , analysis was done also in relation to fat consumption ."
93220,",",O,3234.0,"Because it has been suggested that caffeine enhances mammary carcinogenesis in rats fed high polyunsaturated fat diets , analysis was done also in relation to fat consumption ."
93221,analysis,O,3234.0,"Because it has been suggested that caffeine enhances mammary carcinogenesis in rats fed high polyunsaturated fat diets , analysis was done also in relation to fat consumption ."
93222,was,O,3234.0,"Because it has been suggested that caffeine enhances mammary carcinogenesis in rats fed high polyunsaturated fat diets , analysis was done also in relation to fat consumption ."
93223,done,O,3234.0,"Because it has been suggested that caffeine enhances mammary carcinogenesis in rats fed high polyunsaturated fat diets , analysis was done also in relation to fat consumption ."
93224,also,O,3234.0,"Because it has been suggested that caffeine enhances mammary carcinogenesis in rats fed high polyunsaturated fat diets , analysis was done also in relation to fat consumption ."
93225,in,O,3234.0,"Because it has been suggested that caffeine enhances mammary carcinogenesis in rats fed high polyunsaturated fat diets , analysis was done also in relation to fat consumption ."
93226,relation,O,3234.0,"Because it has been suggested that caffeine enhances mammary carcinogenesis in rats fed high polyunsaturated fat diets , analysis was done also in relation to fat consumption ."
93227,to,O,3234.0,"Because it has been suggested that caffeine enhances mammary carcinogenesis in rats fed high polyunsaturated fat diets , analysis was done also in relation to fat consumption ."
93228,fat,O,3234.0,"Because it has been suggested that caffeine enhances mammary carcinogenesis in rats fed high polyunsaturated fat diets , analysis was done also in relation to fat consumption ."
93229,consumption,O,3234.0,"Because it has been suggested that caffeine enhances mammary carcinogenesis in rats fed high polyunsaturated fat diets , analysis was done also in relation to fat consumption ."
93230,.,O,3234.0,"Because it has been suggested that caffeine enhances mammary carcinogenesis in rats fed high polyunsaturated fat diets , analysis was done also in relation to fat consumption ."
93231,When,O,3235.0,"When comparison was done to both matched control groups , a nonsignificant negative association was found between consumption of cups of coffee and BC ( odds ratios of greater than or equal to 4 cups of coffee / day vs. less than or equal to 1 per week = 0.6 for BC / NC and 0.7 for BC / SC ) ."
93232,comparison,O,3235.0,"When comparison was done to both matched control groups , a nonsignificant negative association was found between consumption of cups of coffee and BC ( odds ratios of greater than or equal to 4 cups of coffee / day vs. less than or equal to 1 per week = 0.6 for BC / NC and 0.7 for BC / SC ) ."
93233,was,O,3235.0,"When comparison was done to both matched control groups , a nonsignificant negative association was found between consumption of cups of coffee and BC ( odds ratios of greater than or equal to 4 cups of coffee / day vs. less than or equal to 1 per week = 0.6 for BC / NC and 0.7 for BC / SC ) ."
93234,done,O,3235.0,"When comparison was done to both matched control groups , a nonsignificant negative association was found between consumption of cups of coffee and BC ( odds ratios of greater than or equal to 4 cups of coffee / day vs. less than or equal to 1 per week = 0.6 for BC / NC and 0.7 for BC / SC ) ."
93235,to,O,3235.0,"When comparison was done to both matched control groups , a nonsignificant negative association was found between consumption of cups of coffee and BC ( odds ratios of greater than or equal to 4 cups of coffee / day vs. less than or equal to 1 per week = 0.6 for BC / NC and 0.7 for BC / SC ) ."
93236,both,O,3235.0,"When comparison was done to both matched control groups , a nonsignificant negative association was found between consumption of cups of coffee and BC ( odds ratios of greater than or equal to 4 cups of coffee / day vs. less than or equal to 1 per week = 0.6 for BC / NC and 0.7 for BC / SC ) ."
93237,matched,O,3235.0,"When comparison was done to both matched control groups , a nonsignificant negative association was found between consumption of cups of coffee and BC ( odds ratios of greater than or equal to 4 cups of coffee / day vs. less than or equal to 1 per week = 0.6 for BC / NC and 0.7 for BC / SC ) ."
93238,control,O,3235.0,"When comparison was done to both matched control groups , a nonsignificant negative association was found between consumption of cups of coffee and BC ( odds ratios of greater than or equal to 4 cups of coffee / day vs. less than or equal to 1 per week = 0.6 for BC / NC and 0.7 for BC / SC ) ."
93239,groups,O,3235.0,"When comparison was done to both matched control groups , a nonsignificant negative association was found between consumption of cups of coffee and BC ( odds ratios of greater than or equal to 4 cups of coffee / day vs. less than or equal to 1 per week = 0.6 for BC / NC and 0.7 for BC / SC ) ."
93240,",",O,3235.0,"When comparison was done to both matched control groups , a nonsignificant negative association was found between consumption of cups of coffee and BC ( odds ratios of greater than or equal to 4 cups of coffee / day vs. less than or equal to 1 per week = 0.6 for BC / NC and 0.7 for BC / SC ) ."
93241,a,O,3235.0,"When comparison was done to both matched control groups , a nonsignificant negative association was found between consumption of cups of coffee and BC ( odds ratios of greater than or equal to 4 cups of coffee / day vs. less than or equal to 1 per week = 0.6 for BC / NC and 0.7 for BC / SC ) ."
93242,nonsignificant,O,3235.0,"When comparison was done to both matched control groups , a nonsignificant negative association was found between consumption of cups of coffee and BC ( odds ratios of greater than or equal to 4 cups of coffee / day vs. less than or equal to 1 per week = 0.6 for BC / NC and 0.7 for BC / SC ) ."
93243,negative,O,3235.0,"When comparison was done to both matched control groups , a nonsignificant negative association was found between consumption of cups of coffee and BC ( odds ratios of greater than or equal to 4 cups of coffee / day vs. less than or equal to 1 per week = 0.6 for BC / NC and 0.7 for BC / SC ) ."
93244,association,O,3235.0,"When comparison was done to both matched control groups , a nonsignificant negative association was found between consumption of cups of coffee and BC ( odds ratios of greater than or equal to 4 cups of coffee / day vs. less than or equal to 1 per week = 0.6 for BC / NC and 0.7 for BC / SC ) ."
93245,was,O,3235.0,"When comparison was done to both matched control groups , a nonsignificant negative association was found between consumption of cups of coffee and BC ( odds ratios of greater than or equal to 4 cups of coffee / day vs. less than or equal to 1 per week = 0.6 for BC / NC and 0.7 for BC / SC ) ."
93246,found,O,3235.0,"When comparison was done to both matched control groups , a nonsignificant negative association was found between consumption of cups of coffee and BC ( odds ratios of greater than or equal to 4 cups of coffee / day vs. less than or equal to 1 per week = 0.6 for BC / NC and 0.7 for BC / SC ) ."
93247,between,O,3235.0,"When comparison was done to both matched control groups , a nonsignificant negative association was found between consumption of cups of coffee and BC ( odds ratios of greater than or equal to 4 cups of coffee / day vs. less than or equal to 1 per week = 0.6 for BC / NC and 0.7 for BC / SC ) ."
93248,consumption,O,3235.0,"When comparison was done to both matched control groups , a nonsignificant negative association was found between consumption of cups of coffee and BC ( odds ratios of greater than or equal to 4 cups of coffee / day vs. less than or equal to 1 per week = 0.6 for BC / NC and 0.7 for BC / SC ) ."
93249,of,O,3235.0,"When comparison was done to both matched control groups , a nonsignificant negative association was found between consumption of cups of coffee and BC ( odds ratios of greater than or equal to 4 cups of coffee / day vs. less than or equal to 1 per week = 0.6 for BC / NC and 0.7 for BC / SC ) ."
93250,cups,O,3235.0,"When comparison was done to both matched control groups , a nonsignificant negative association was found between consumption of cups of coffee and BC ( odds ratios of greater than or equal to 4 cups of coffee / day vs. less than or equal to 1 per week = 0.6 for BC / NC and 0.7 for BC / SC ) ."
93251,of,O,3235.0,"When comparison was done to both matched control groups , a nonsignificant negative association was found between consumption of cups of coffee and BC ( odds ratios of greater than or equal to 4 cups of coffee / day vs. less than or equal to 1 per week = 0.6 for BC / NC and 0.7 for BC / SC ) ."
93252,coffee,B-AG.01.ad,3235.0,"When comparison was done to both matched control groups , a nonsignificant negative association was found between consumption of cups of coffee and BC ( odds ratios of greater than or equal to 4 cups of coffee / day vs. less than or equal to 1 per week = 0.6 for BC / NC and 0.7 for BC / SC ) ."
93253,and,O,3235.0,"When comparison was done to both matched control groups , a nonsignificant negative association was found between consumption of cups of coffee and BC ( odds ratios of greater than or equal to 4 cups of coffee / day vs. less than or equal to 1 per week = 0.6 for BC / NC and 0.7 for BC / SC ) ."
93254,BC,O,3235.0,"When comparison was done to both matched control groups , a nonsignificant negative association was found between consumption of cups of coffee and BC ( odds ratios of greater than or equal to 4 cups of coffee / day vs. less than or equal to 1 per week = 0.6 for BC / NC and 0.7 for BC / SC ) ."
93255,(,O,3235.0,"When comparison was done to both matched control groups , a nonsignificant negative association was found between consumption of cups of coffee and BC ( odds ratios of greater than or equal to 4 cups of coffee / day vs. less than or equal to 1 per week = 0.6 for BC / NC and 0.7 for BC / SC ) ."
93256,odds,O,3235.0,"When comparison was done to both matched control groups , a nonsignificant negative association was found between consumption of cups of coffee and BC ( odds ratios of greater than or equal to 4 cups of coffee / day vs. less than or equal to 1 per week = 0.6 for BC / NC and 0.7 for BC / SC ) ."
93257,ratios,O,3235.0,"When comparison was done to both matched control groups , a nonsignificant negative association was found between consumption of cups of coffee and BC ( odds ratios of greater than or equal to 4 cups of coffee / day vs. less than or equal to 1 per week = 0.6 for BC / NC and 0.7 for BC / SC ) ."
93258,of,O,3235.0,"When comparison was done to both matched control groups , a nonsignificant negative association was found between consumption of cups of coffee and BC ( odds ratios of greater than or equal to 4 cups of coffee / day vs. less than or equal to 1 per week = 0.6 for BC / NC and 0.7 for BC / SC ) ."
93259,greater,O,3235.0,"When comparison was done to both matched control groups , a nonsignificant negative association was found between consumption of cups of coffee and BC ( odds ratios of greater than or equal to 4 cups of coffee / day vs. less than or equal to 1 per week = 0.6 for BC / NC and 0.7 for BC / SC ) ."
93260,than,O,3235.0,"When comparison was done to both matched control groups , a nonsignificant negative association was found between consumption of cups of coffee and BC ( odds ratios of greater than or equal to 4 cups of coffee / day vs. less than or equal to 1 per week = 0.6 for BC / NC and 0.7 for BC / SC ) ."
93261,or,O,3235.0,"When comparison was done to both matched control groups , a nonsignificant negative association was found between consumption of cups of coffee and BC ( odds ratios of greater than or equal to 4 cups of coffee / day vs. less than or equal to 1 per week = 0.6 for BC / NC and 0.7 for BC / SC ) ."
93262,equal,O,3235.0,"When comparison was done to both matched control groups , a nonsignificant negative association was found between consumption of cups of coffee and BC ( odds ratios of greater than or equal to 4 cups of coffee / day vs. less than or equal to 1 per week = 0.6 for BC / NC and 0.7 for BC / SC ) ."
93263,to,O,3235.0,"When comparison was done to both matched control groups , a nonsignificant negative association was found between consumption of cups of coffee and BC ( odds ratios of greater than or equal to 4 cups of coffee / day vs. less than or equal to 1 per week = 0.6 for BC / NC and 0.7 for BC / SC ) ."
93264,4,O,3235.0,"When comparison was done to both matched control groups , a nonsignificant negative association was found between consumption of cups of coffee and BC ( odds ratios of greater than or equal to 4 cups of coffee / day vs. less than or equal to 1 per week = 0.6 for BC / NC and 0.7 for BC / SC ) ."
93265,cups,O,3235.0,"When comparison was done to both matched control groups , a nonsignificant negative association was found between consumption of cups of coffee and BC ( odds ratios of greater than or equal to 4 cups of coffee / day vs. less than or equal to 1 per week = 0.6 for BC / NC and 0.7 for BC / SC ) ."
93266,of,O,3235.0,"When comparison was done to both matched control groups , a nonsignificant negative association was found between consumption of cups of coffee and BC ( odds ratios of greater than or equal to 4 cups of coffee / day vs. less than or equal to 1 per week = 0.6 for BC / NC and 0.7 for BC / SC ) ."
93267,coffee,B-AG.01.ad,3235.0,"When comparison was done to both matched control groups , a nonsignificant negative association was found between consumption of cups of coffee and BC ( odds ratios of greater than or equal to 4 cups of coffee / day vs. less than or equal to 1 per week = 0.6 for BC / NC and 0.7 for BC / SC ) ."
93268,/,O,3235.0,"When comparison was done to both matched control groups , a nonsignificant negative association was found between consumption of cups of coffee and BC ( odds ratios of greater than or equal to 4 cups of coffee / day vs. less than or equal to 1 per week = 0.6 for BC / NC and 0.7 for BC / SC ) ."
93269,day,O,3235.0,"When comparison was done to both matched control groups , a nonsignificant negative association was found between consumption of cups of coffee and BC ( odds ratios of greater than or equal to 4 cups of coffee / day vs. less than or equal to 1 per week = 0.6 for BC / NC and 0.7 for BC / SC ) ."
93270,vs.,O,3235.0,"When comparison was done to both matched control groups , a nonsignificant negative association was found between consumption of cups of coffee and BC ( odds ratios of greater than or equal to 4 cups of coffee / day vs. less than or equal to 1 per week = 0.6 for BC / NC and 0.7 for BC / SC ) ."
93271,less,O,3235.0,"When comparison was done to both matched control groups , a nonsignificant negative association was found between consumption of cups of coffee and BC ( odds ratios of greater than or equal to 4 cups of coffee / day vs. less than or equal to 1 per week = 0.6 for BC / NC and 0.7 for BC / SC ) ."
93272,than,O,3235.0,"When comparison was done to both matched control groups , a nonsignificant negative association was found between consumption of cups of coffee and BC ( odds ratios of greater than or equal to 4 cups of coffee / day vs. less than or equal to 1 per week = 0.6 for BC / NC and 0.7 for BC / SC ) ."
93273,or,O,3235.0,"When comparison was done to both matched control groups , a nonsignificant negative association was found between consumption of cups of coffee and BC ( odds ratios of greater than or equal to 4 cups of coffee / day vs. less than or equal to 1 per week = 0.6 for BC / NC and 0.7 for BC / SC ) ."
93274,equal,O,3235.0,"When comparison was done to both matched control groups , a nonsignificant negative association was found between consumption of cups of coffee and BC ( odds ratios of greater than or equal to 4 cups of coffee / day vs. less than or equal to 1 per week = 0.6 for BC / NC and 0.7 for BC / SC ) ."
93275,to,O,3235.0,"When comparison was done to both matched control groups , a nonsignificant negative association was found between consumption of cups of coffee and BC ( odds ratios of greater than or equal to 4 cups of coffee / day vs. less than or equal to 1 per week = 0.6 for BC / NC and 0.7 for BC / SC ) ."
93276,1,O,3235.0,"When comparison was done to both matched control groups , a nonsignificant negative association was found between consumption of cups of coffee and BC ( odds ratios of greater than or equal to 4 cups of coffee / day vs. less than or equal to 1 per week = 0.6 for BC / NC and 0.7 for BC / SC ) ."
93277,per,O,3235.0,"When comparison was done to both matched control groups , a nonsignificant negative association was found between consumption of cups of coffee and BC ( odds ratios of greater than or equal to 4 cups of coffee / day vs. less than or equal to 1 per week = 0.6 for BC / NC and 0.7 for BC / SC ) ."
93278,week,O,3235.0,"When comparison was done to both matched control groups , a nonsignificant negative association was found between consumption of cups of coffee and BC ( odds ratios of greater than or equal to 4 cups of coffee / day vs. less than or equal to 1 per week = 0.6 for BC / NC and 0.7 for BC / SC ) ."
93279,=,O,3235.0,"When comparison was done to both matched control groups , a nonsignificant negative association was found between consumption of cups of coffee and BC ( odds ratios of greater than or equal to 4 cups of coffee / day vs. less than or equal to 1 per week = 0.6 for BC / NC and 0.7 for BC / SC ) ."
93280,0.6,O,3235.0,"When comparison was done to both matched control groups , a nonsignificant negative association was found between consumption of cups of coffee and BC ( odds ratios of greater than or equal to 4 cups of coffee / day vs. less than or equal to 1 per week = 0.6 for BC / NC and 0.7 for BC / SC ) ."
93281,for,O,3235.0,"When comparison was done to both matched control groups , a nonsignificant negative association was found between consumption of cups of coffee and BC ( odds ratios of greater than or equal to 4 cups of coffee / day vs. less than or equal to 1 per week = 0.6 for BC / NC and 0.7 for BC / SC ) ."
93282,BC,O,3235.0,"When comparison was done to both matched control groups , a nonsignificant negative association was found between consumption of cups of coffee and BC ( odds ratios of greater than or equal to 4 cups of coffee / day vs. less than or equal to 1 per week = 0.6 for BC / NC and 0.7 for BC / SC ) ."
93283,/,O,3235.0,"When comparison was done to both matched control groups , a nonsignificant negative association was found between consumption of cups of coffee and BC ( odds ratios of greater than or equal to 4 cups of coffee / day vs. less than or equal to 1 per week = 0.6 for BC / NC and 0.7 for BC / SC ) ."
93284,NC,O,3235.0,"When comparison was done to both matched control groups , a nonsignificant negative association was found between consumption of cups of coffee and BC ( odds ratios of greater than or equal to 4 cups of coffee / day vs. less than or equal to 1 per week = 0.6 for BC / NC and 0.7 for BC / SC ) ."
93285,and,O,3235.0,"When comparison was done to both matched control groups , a nonsignificant negative association was found between consumption of cups of coffee and BC ( odds ratios of greater than or equal to 4 cups of coffee / day vs. less than or equal to 1 per week = 0.6 for BC / NC and 0.7 for BC / SC ) ."
93286,0.7,O,3235.0,"When comparison was done to both matched control groups , a nonsignificant negative association was found between consumption of cups of coffee and BC ( odds ratios of greater than or equal to 4 cups of coffee / day vs. less than or equal to 1 per week = 0.6 for BC / NC and 0.7 for BC / SC ) ."
93287,for,O,3235.0,"When comparison was done to both matched control groups , a nonsignificant negative association was found between consumption of cups of coffee and BC ( odds ratios of greater than or equal to 4 cups of coffee / day vs. less than or equal to 1 per week = 0.6 for BC / NC and 0.7 for BC / SC ) ."
93288,BC,O,3235.0,"When comparison was done to both matched control groups , a nonsignificant negative association was found between consumption of cups of coffee and BC ( odds ratios of greater than or equal to 4 cups of coffee / day vs. less than or equal to 1 per week = 0.6 for BC / NC and 0.7 for BC / SC ) ."
93289,/,O,3235.0,"When comparison was done to both matched control groups , a nonsignificant negative association was found between consumption of cups of coffee and BC ( odds ratios of greater than or equal to 4 cups of coffee / day vs. less than or equal to 1 per week = 0.6 for BC / NC and 0.7 for BC / SC ) ."
93290,SC,O,3235.0,"When comparison was done to both matched control groups , a nonsignificant negative association was found between consumption of cups of coffee and BC ( odds ratios of greater than or equal to 4 cups of coffee / day vs. less than or equal to 1 per week = 0.6 for BC / NC and 0.7 for BC / SC ) ."
93291,),O,3235.0,"When comparison was done to both matched control groups , a nonsignificant negative association was found between consumption of cups of coffee and BC ( odds ratios of greater than or equal to 4 cups of coffee / day vs. less than or equal to 1 per week = 0.6 for BC / NC and 0.7 for BC / SC ) ."
93292,.,O,3235.0,"When comparison was done to both matched control groups , a nonsignificant negative association was found between consumption of cups of coffee and BC ( odds ratios of greater than or equal to 4 cups of coffee / day vs. less than or equal to 1 per week = 0.6 for BC / NC and 0.7 for BC / SC ) ."
93293,This,O,3236.0,This association was observed in all 3 ethnic subgroups studied .
93294,association,O,3236.0,This association was observed in all 3 ethnic subgroups studied .
93295,was,O,3236.0,This association was observed in all 3 ethnic subgroups studied .
93296,observed,O,3236.0,This association was observed in all 3 ethnic subgroups studied .
93297,in,O,3236.0,This association was observed in all 3 ethnic subgroups studied .
93298,all,O,3236.0,This association was observed in all 3 ethnic subgroups studied .
93299,3,O,3236.0,This association was observed in all 3 ethnic subgroups studied .
93300,ethnic,O,3236.0,This association was observed in all 3 ethnic subgroups studied .
93301,subgroups,O,3236.0,This association was observed in all 3 ethnic subgroups studied .
93302,studied,O,3236.0,This association was observed in all 3 ethnic subgroups studied .
93303,.,O,3236.0,This association was observed in all 3 ethnic subgroups studied .
93304,The,O,3237.0,The pattern was stronger among the high - fat consumers after controlling for several hormonal confounding factors ( two - tailed P - value for linear trend = 0.06 for SC and P = 0.05 for NC ) .
93305,pattern,O,3237.0,The pattern was stronger among the high - fat consumers after controlling for several hormonal confounding factors ( two - tailed P - value for linear trend = 0.06 for SC and P = 0.05 for NC ) .
93306,was,O,3237.0,The pattern was stronger among the high - fat consumers after controlling for several hormonal confounding factors ( two - tailed P - value for linear trend = 0.06 for SC and P = 0.05 for NC ) .
93307,stronger,O,3237.0,The pattern was stronger among the high - fat consumers after controlling for several hormonal confounding factors ( two - tailed P - value for linear trend = 0.06 for SC and P = 0.05 for NC ) .
93308,among,O,3237.0,The pattern was stronger among the high - fat consumers after controlling for several hormonal confounding factors ( two - tailed P - value for linear trend = 0.06 for SC and P = 0.05 for NC ) .
93309,the,O,3237.0,The pattern was stronger among the high - fat consumers after controlling for several hormonal confounding factors ( two - tailed P - value for linear trend = 0.06 for SC and P = 0.05 for NC ) .
93310,high,O,3237.0,The pattern was stronger among the high - fat consumers after controlling for several hormonal confounding factors ( two - tailed P - value for linear trend = 0.06 for SC and P = 0.05 for NC ) .
93311,-,O,3237.0,The pattern was stronger among the high - fat consumers after controlling for several hormonal confounding factors ( two - tailed P - value for linear trend = 0.06 for SC and P = 0.05 for NC ) .
93312,fat,O,3237.0,The pattern was stronger among the high - fat consumers after controlling for several hormonal confounding factors ( two - tailed P - value for linear trend = 0.06 for SC and P = 0.05 for NC ) .
93313,consumers,O,3237.0,The pattern was stronger among the high - fat consumers after controlling for several hormonal confounding factors ( two - tailed P - value for linear trend = 0.06 for SC and P = 0.05 for NC ) .
93314,after,O,3237.0,The pattern was stronger among the high - fat consumers after controlling for several hormonal confounding factors ( two - tailed P - value for linear trend = 0.06 for SC and P = 0.05 for NC ) .
93315,controlling,O,3237.0,The pattern was stronger among the high - fat consumers after controlling for several hormonal confounding factors ( two - tailed P - value for linear trend = 0.06 for SC and P = 0.05 for NC ) .
93316,for,O,3237.0,The pattern was stronger among the high - fat consumers after controlling for several hormonal confounding factors ( two - tailed P - value for linear trend = 0.06 for SC and P = 0.05 for NC ) .
93317,several,O,3237.0,The pattern was stronger among the high - fat consumers after controlling for several hormonal confounding factors ( two - tailed P - value for linear trend = 0.06 for SC and P = 0.05 for NC ) .
93318,hormonal,O,3237.0,The pattern was stronger among the high - fat consumers after controlling for several hormonal confounding factors ( two - tailed P - value for linear trend = 0.06 for SC and P = 0.05 for NC ) .
93319,confounding,O,3237.0,The pattern was stronger among the high - fat consumers after controlling for several hormonal confounding factors ( two - tailed P - value for linear trend = 0.06 for SC and P = 0.05 for NC ) .
93320,factors,O,3237.0,The pattern was stronger among the high - fat consumers after controlling for several hormonal confounding factors ( two - tailed P - value for linear trend = 0.06 for SC and P = 0.05 for NC ) .
93321,(,O,3237.0,The pattern was stronger among the high - fat consumers after controlling for several hormonal confounding factors ( two - tailed P - value for linear trend = 0.06 for SC and P = 0.05 for NC ) .
93322,two,O,3237.0,The pattern was stronger among the high - fat consumers after controlling for several hormonal confounding factors ( two - tailed P - value for linear trend = 0.06 for SC and P = 0.05 for NC ) .
93323,-,O,3237.0,The pattern was stronger among the high - fat consumers after controlling for several hormonal confounding factors ( two - tailed P - value for linear trend = 0.06 for SC and P = 0.05 for NC ) .
93324,tailed,O,3237.0,The pattern was stronger among the high - fat consumers after controlling for several hormonal confounding factors ( two - tailed P - value for linear trend = 0.06 for SC and P = 0.05 for NC ) .
93325,P,O,3237.0,The pattern was stronger among the high - fat consumers after controlling for several hormonal confounding factors ( two - tailed P - value for linear trend = 0.06 for SC and P = 0.05 for NC ) .
93326,-,O,3237.0,The pattern was stronger among the high - fat consumers after controlling for several hormonal confounding factors ( two - tailed P - value for linear trend = 0.06 for SC and P = 0.05 for NC ) .
93327,value,O,3237.0,The pattern was stronger among the high - fat consumers after controlling for several hormonal confounding factors ( two - tailed P - value for linear trend = 0.06 for SC and P = 0.05 for NC ) .
93328,for,O,3237.0,The pattern was stronger among the high - fat consumers after controlling for several hormonal confounding factors ( two - tailed P - value for linear trend = 0.06 for SC and P = 0.05 for NC ) .
93329,linear,O,3237.0,The pattern was stronger among the high - fat consumers after controlling for several hormonal confounding factors ( two - tailed P - value for linear trend = 0.06 for SC and P = 0.05 for NC ) .
93330,trend,O,3237.0,The pattern was stronger among the high - fat consumers after controlling for several hormonal confounding factors ( two - tailed P - value for linear trend = 0.06 for SC and P = 0.05 for NC ) .
93331,=,O,3237.0,The pattern was stronger among the high - fat consumers after controlling for several hormonal confounding factors ( two - tailed P - value for linear trend = 0.06 for SC and P = 0.05 for NC ) .
93332,0.06,O,3237.0,The pattern was stronger among the high - fat consumers after controlling for several hormonal confounding factors ( two - tailed P - value for linear trend = 0.06 for SC and P = 0.05 for NC ) .
93333,for,O,3237.0,The pattern was stronger among the high - fat consumers after controlling for several hormonal confounding factors ( two - tailed P - value for linear trend = 0.06 for SC and P = 0.05 for NC ) .
93334,SC,O,3237.0,The pattern was stronger among the high - fat consumers after controlling for several hormonal confounding factors ( two - tailed P - value for linear trend = 0.06 for SC and P = 0.05 for NC ) .
93335,and,O,3237.0,The pattern was stronger among the high - fat consumers after controlling for several hormonal confounding factors ( two - tailed P - value for linear trend = 0.06 for SC and P = 0.05 for NC ) .
93336,P,O,3237.0,The pattern was stronger among the high - fat consumers after controlling for several hormonal confounding factors ( two - tailed P - value for linear trend = 0.06 for SC and P = 0.05 for NC ) .
93337,=,O,3237.0,The pattern was stronger among the high - fat consumers after controlling for several hormonal confounding factors ( two - tailed P - value for linear trend = 0.06 for SC and P = 0.05 for NC ) .
93338,0.05,O,3237.0,The pattern was stronger among the high - fat consumers after controlling for several hormonal confounding factors ( two - tailed P - value for linear trend = 0.06 for SC and P = 0.05 for NC ) .
93339,for,O,3237.0,The pattern was stronger among the high - fat consumers after controlling for several hormonal confounding factors ( two - tailed P - value for linear trend = 0.06 for SC and P = 0.05 for NC ) .
93340,NC,O,3237.0,The pattern was stronger among the high - fat consumers after controlling for several hormonal confounding factors ( two - tailed P - value for linear trend = 0.06 for SC and P = 0.05 for NC ) .
93341,),O,3237.0,The pattern was stronger among the high - fat consumers after controlling for several hormonal confounding factors ( two - tailed P - value for linear trend = 0.06 for SC and P = 0.05 for NC ) .
93342,.,O,3237.0,The pattern was stronger among the high - fat consumers after controlling for several hormonal confounding factors ( two - tailed P - value for linear trend = 0.06 for SC and P = 0.05 for NC ) .
93343,In,O,3238.0,"In addition , when the consumption of methylxanthine of BC patients was compared to that of benign breast patients , adjusted by age and ethnic group , a diminished risk was found ( odds ratio for BC of the highest level of methylxanthine vs. lowest level = 0.59 ) ."
93344,addition,O,3238.0,"In addition , when the consumption of methylxanthine of BC patients was compared to that of benign breast patients , adjusted by age and ethnic group , a diminished risk was found ( odds ratio for BC of the highest level of methylxanthine vs. lowest level = 0.59 ) ."
93345,",",O,3238.0,"In addition , when the consumption of methylxanthine of BC patients was compared to that of benign breast patients , adjusted by age and ethnic group , a diminished risk was found ( odds ratio for BC of the highest level of methylxanthine vs. lowest level = 0.59 ) ."
93346,when,O,3238.0,"In addition , when the consumption of methylxanthine of BC patients was compared to that of benign breast patients , adjusted by age and ethnic group , a diminished risk was found ( odds ratio for BC of the highest level of methylxanthine vs. lowest level = 0.59 ) ."
93347,the,O,3238.0,"In addition , when the consumption of methylxanthine of BC patients was compared to that of benign breast patients , adjusted by age and ethnic group , a diminished risk was found ( odds ratio for BC of the highest level of methylxanthine vs. lowest level = 0.59 ) ."
93348,consumption,O,3238.0,"In addition , when the consumption of methylxanthine of BC patients was compared to that of benign breast patients , adjusted by age and ethnic group , a diminished risk was found ( odds ratio for BC of the highest level of methylxanthine vs. lowest level = 0.59 ) ."
93349,of,O,3238.0,"In addition , when the consumption of methylxanthine of BC patients was compared to that of benign breast patients , adjusted by age and ethnic group , a diminished risk was found ( odds ratio for BC of the highest level of methylxanthine vs. lowest level = 0.59 ) ."
93350,methylxanthine,O,3238.0,"In addition , when the consumption of methylxanthine of BC patients was compared to that of benign breast patients , adjusted by age and ethnic group , a diminished risk was found ( odds ratio for BC of the highest level of methylxanthine vs. lowest level = 0.59 ) ."
93351,of,O,3238.0,"In addition , when the consumption of methylxanthine of BC patients was compared to that of benign breast patients , adjusted by age and ethnic group , a diminished risk was found ( odds ratio for BC of the highest level of methylxanthine vs. lowest level = 0.59 ) ."
93352,BC,O,3238.0,"In addition , when the consumption of methylxanthine of BC patients was compared to that of benign breast patients , adjusted by age and ethnic group , a diminished risk was found ( odds ratio for BC of the highest level of methylxanthine vs. lowest level = 0.59 ) ."
93353,patients,O,3238.0,"In addition , when the consumption of methylxanthine of BC patients was compared to that of benign breast patients , adjusted by age and ethnic group , a diminished risk was found ( odds ratio for BC of the highest level of methylxanthine vs. lowest level = 0.59 ) ."
93354,was,O,3238.0,"In addition , when the consumption of methylxanthine of BC patients was compared to that of benign breast patients , adjusted by age and ethnic group , a diminished risk was found ( odds ratio for BC of the highest level of methylxanthine vs. lowest level = 0.59 ) ."
93355,compared,O,3238.0,"In addition , when the consumption of methylxanthine of BC patients was compared to that of benign breast patients , adjusted by age and ethnic group , a diminished risk was found ( odds ratio for BC of the highest level of methylxanthine vs. lowest level = 0.59 ) ."
93356,to,O,3238.0,"In addition , when the consumption of methylxanthine of BC patients was compared to that of benign breast patients , adjusted by age and ethnic group , a diminished risk was found ( odds ratio for BC of the highest level of methylxanthine vs. lowest level = 0.59 ) ."
93357,that,O,3238.0,"In addition , when the consumption of methylxanthine of BC patients was compared to that of benign breast patients , adjusted by age and ethnic group , a diminished risk was found ( odds ratio for BC of the highest level of methylxanthine vs. lowest level = 0.59 ) ."
93358,of,O,3238.0,"In addition , when the consumption of methylxanthine of BC patients was compared to that of benign breast patients , adjusted by age and ethnic group , a diminished risk was found ( odds ratio for BC of the highest level of methylxanthine vs. lowest level = 0.59 ) ."
93359,benign,O,3238.0,"In addition , when the consumption of methylxanthine of BC patients was compared to that of benign breast patients , adjusted by age and ethnic group , a diminished risk was found ( odds ratio for BC of the highest level of methylxanthine vs. lowest level = 0.59 ) ."
93360,breast,O,3238.0,"In addition , when the consumption of methylxanthine of BC patients was compared to that of benign breast patients , adjusted by age and ethnic group , a diminished risk was found ( odds ratio for BC of the highest level of methylxanthine vs. lowest level = 0.59 ) ."
93361,patients,O,3238.0,"In addition , when the consumption of methylxanthine of BC patients was compared to that of benign breast patients , adjusted by age and ethnic group , a diminished risk was found ( odds ratio for BC of the highest level of methylxanthine vs. lowest level = 0.59 ) ."
93362,",",O,3238.0,"In addition , when the consumption of methylxanthine of BC patients was compared to that of benign breast patients , adjusted by age and ethnic group , a diminished risk was found ( odds ratio for BC of the highest level of methylxanthine vs. lowest level = 0.59 ) ."
93363,adjusted,O,3238.0,"In addition , when the consumption of methylxanthine of BC patients was compared to that of benign breast patients , adjusted by age and ethnic group , a diminished risk was found ( odds ratio for BC of the highest level of methylxanthine vs. lowest level = 0.59 ) ."
93364,by,O,3238.0,"In addition , when the consumption of methylxanthine of BC patients was compared to that of benign breast patients , adjusted by age and ethnic group , a diminished risk was found ( odds ratio for BC of the highest level of methylxanthine vs. lowest level = 0.59 ) ."
93365,age,O,3238.0,"In addition , when the consumption of methylxanthine of BC patients was compared to that of benign breast patients , adjusted by age and ethnic group , a diminished risk was found ( odds ratio for BC of the highest level of methylxanthine vs. lowest level = 0.59 ) ."
93366,and,O,3238.0,"In addition , when the consumption of methylxanthine of BC patients was compared to that of benign breast patients , adjusted by age and ethnic group , a diminished risk was found ( odds ratio for BC of the highest level of methylxanthine vs. lowest level = 0.59 ) ."
93367,ethnic,O,3238.0,"In addition , when the consumption of methylxanthine of BC patients was compared to that of benign breast patients , adjusted by age and ethnic group , a diminished risk was found ( odds ratio for BC of the highest level of methylxanthine vs. lowest level = 0.59 ) ."
93368,group,O,3238.0,"In addition , when the consumption of methylxanthine of BC patients was compared to that of benign breast patients , adjusted by age and ethnic group , a diminished risk was found ( odds ratio for BC of the highest level of methylxanthine vs. lowest level = 0.59 ) ."
93369,",",O,3238.0,"In addition , when the consumption of methylxanthine of BC patients was compared to that of benign breast patients , adjusted by age and ethnic group , a diminished risk was found ( odds ratio for BC of the highest level of methylxanthine vs. lowest level = 0.59 ) ."
93370,a,O,3238.0,"In addition , when the consumption of methylxanthine of BC patients was compared to that of benign breast patients , adjusted by age and ethnic group , a diminished risk was found ( odds ratio for BC of the highest level of methylxanthine vs. lowest level = 0.59 ) ."
93371,diminished,O,3238.0,"In addition , when the consumption of methylxanthine of BC patients was compared to that of benign breast patients , adjusted by age and ethnic group , a diminished risk was found ( odds ratio for BC of the highest level of methylxanthine vs. lowest level = 0.59 ) ."
93372,risk,O,3238.0,"In addition , when the consumption of methylxanthine of BC patients was compared to that of benign breast patients , adjusted by age and ethnic group , a diminished risk was found ( odds ratio for BC of the highest level of methylxanthine vs. lowest level = 0.59 ) ."
93373,was,O,3238.0,"In addition , when the consumption of methylxanthine of BC patients was compared to that of benign breast patients , adjusted by age and ethnic group , a diminished risk was found ( odds ratio for BC of the highest level of methylxanthine vs. lowest level = 0.59 ) ."
93374,found,O,3238.0,"In addition , when the consumption of methylxanthine of BC patients was compared to that of benign breast patients , adjusted by age and ethnic group , a diminished risk was found ( odds ratio for BC of the highest level of methylxanthine vs. lowest level = 0.59 ) ."
93375,(,O,3238.0,"In addition , when the consumption of methylxanthine of BC patients was compared to that of benign breast patients , adjusted by age and ethnic group , a diminished risk was found ( odds ratio for BC of the highest level of methylxanthine vs. lowest level = 0.59 ) ."
93376,odds,O,3238.0,"In addition , when the consumption of methylxanthine of BC patients was compared to that of benign breast patients , adjusted by age and ethnic group , a diminished risk was found ( odds ratio for BC of the highest level of methylxanthine vs. lowest level = 0.59 ) ."
93377,ratio,O,3238.0,"In addition , when the consumption of methylxanthine of BC patients was compared to that of benign breast patients , adjusted by age and ethnic group , a diminished risk was found ( odds ratio for BC of the highest level of methylxanthine vs. lowest level = 0.59 ) ."
93378,for,O,3238.0,"In addition , when the consumption of methylxanthine of BC patients was compared to that of benign breast patients , adjusted by age and ethnic group , a diminished risk was found ( odds ratio for BC of the highest level of methylxanthine vs. lowest level = 0.59 ) ."
93379,BC,O,3238.0,"In addition , when the consumption of methylxanthine of BC patients was compared to that of benign breast patients , adjusted by age and ethnic group , a diminished risk was found ( odds ratio for BC of the highest level of methylxanthine vs. lowest level = 0.59 ) ."
93380,of,O,3238.0,"In addition , when the consumption of methylxanthine of BC patients was compared to that of benign breast patients , adjusted by age and ethnic group , a diminished risk was found ( odds ratio for BC of the highest level of methylxanthine vs. lowest level = 0.59 ) ."
93381,the,O,3238.0,"In addition , when the consumption of methylxanthine of BC patients was compared to that of benign breast patients , adjusted by age and ethnic group , a diminished risk was found ( odds ratio for BC of the highest level of methylxanthine vs. lowest level = 0.59 ) ."
93382,highest,O,3238.0,"In addition , when the consumption of methylxanthine of BC patients was compared to that of benign breast patients , adjusted by age and ethnic group , a diminished risk was found ( odds ratio for BC of the highest level of methylxanthine vs. lowest level = 0.59 ) ."
93383,level,O,3238.0,"In addition , when the consumption of methylxanthine of BC patients was compared to that of benign breast patients , adjusted by age and ethnic group , a diminished risk was found ( odds ratio for BC of the highest level of methylxanthine vs. lowest level = 0.59 ) ."
93384,of,O,3238.0,"In addition , when the consumption of methylxanthine of BC patients was compared to that of benign breast patients , adjusted by age and ethnic group , a diminished risk was found ( odds ratio for BC of the highest level of methylxanthine vs. lowest level = 0.59 ) ."
93385,methylxanthine,O,3238.0,"In addition , when the consumption of methylxanthine of BC patients was compared to that of benign breast patients , adjusted by age and ethnic group , a diminished risk was found ( odds ratio for BC of the highest level of methylxanthine vs. lowest level = 0.59 ) ."
93386,vs.,O,3238.0,"In addition , when the consumption of methylxanthine of BC patients was compared to that of benign breast patients , adjusted by age and ethnic group , a diminished risk was found ( odds ratio for BC of the highest level of methylxanthine vs. lowest level = 0.59 ) ."
93387,lowest,O,3238.0,"In addition , when the consumption of methylxanthine of BC patients was compared to that of benign breast patients , adjusted by age and ethnic group , a diminished risk was found ( odds ratio for BC of the highest level of methylxanthine vs. lowest level = 0.59 ) ."
93388,level,O,3238.0,"In addition , when the consumption of methylxanthine of BC patients was compared to that of benign breast patients , adjusted by age and ethnic group , a diminished risk was found ( odds ratio for BC of the highest level of methylxanthine vs. lowest level = 0.59 ) ."
93389,=,O,3238.0,"In addition , when the consumption of methylxanthine of BC patients was compared to that of benign breast patients , adjusted by age and ethnic group , a diminished risk was found ( odds ratio for BC of the highest level of methylxanthine vs. lowest level = 0.59 ) ."
93390,0.59,O,3238.0,"In addition , when the consumption of methylxanthine of BC patients was compared to that of benign breast patients , adjusted by age and ethnic group , a diminished risk was found ( odds ratio for BC of the highest level of methylxanthine vs. lowest level = 0.59 ) ."
93391,),O,3238.0,"In addition , when the consumption of methylxanthine of BC patients was compared to that of benign breast patients , adjusted by age and ethnic group , a diminished risk was found ( odds ratio for BC of the highest level of methylxanthine vs. lowest level = 0.59 ) ."
93392,.,O,3238.0,"In addition , when the consumption of methylxanthine of BC patients was compared to that of benign breast patients , adjusted by age and ethnic group , a diminished risk was found ( odds ratio for BC of the highest level of methylxanthine vs. lowest level = 0.59 ) ."
93393,The,O,3239.0,The purpose of this study was to determine the effects of consumption of different cocoa - derived products on uric acid crystallization in urine of 20 healthy volunteers .
93394,purpose,O,3239.0,The purpose of this study was to determine the effects of consumption of different cocoa - derived products on uric acid crystallization in urine of 20 healthy volunteers .
93395,of,O,3239.0,The purpose of this study was to determine the effects of consumption of different cocoa - derived products on uric acid crystallization in urine of 20 healthy volunteers .
93396,this,O,3239.0,The purpose of this study was to determine the effects of consumption of different cocoa - derived products on uric acid crystallization in urine of 20 healthy volunteers .
93397,study,O,3239.0,The purpose of this study was to determine the effects of consumption of different cocoa - derived products on uric acid crystallization in urine of 20 healthy volunteers .
93398,was,O,3239.0,The purpose of this study was to determine the effects of consumption of different cocoa - derived products on uric acid crystallization in urine of 20 healthy volunteers .
93399,to,O,3239.0,The purpose of this study was to determine the effects of consumption of different cocoa - derived products on uric acid crystallization in urine of 20 healthy volunteers .
93400,determine,O,3239.0,The purpose of this study was to determine the effects of consumption of different cocoa - derived products on uric acid crystallization in urine of 20 healthy volunteers .
93401,the,O,3239.0,The purpose of this study was to determine the effects of consumption of different cocoa - derived products on uric acid crystallization in urine of 20 healthy volunteers .
93402,effects,O,3239.0,The purpose of this study was to determine the effects of consumption of different cocoa - derived products on uric acid crystallization in urine of 20 healthy volunteers .
93403,of,O,3239.0,The purpose of this study was to determine the effects of consumption of different cocoa - derived products on uric acid crystallization in urine of 20 healthy volunteers .
93404,consumption,O,3239.0,The purpose of this study was to determine the effects of consumption of different cocoa - derived products on uric acid crystallization in urine of 20 healthy volunteers .
93405,of,O,3239.0,The purpose of this study was to determine the effects of consumption of different cocoa - derived products on uric acid crystallization in urine of 20 healthy volunteers .
93406,different,O,3239.0,The purpose of this study was to determine the effects of consumption of different cocoa - derived products on uric acid crystallization in urine of 20 healthy volunteers .
93407,cocoa,B-AG.01,3239.0,The purpose of this study was to determine the effects of consumption of different cocoa - derived products on uric acid crystallization in urine of 20 healthy volunteers .
93408,-,I-AG.01,3239.0,The purpose of this study was to determine the effects of consumption of different cocoa - derived products on uric acid crystallization in urine of 20 healthy volunteers .
93409,derived,I-AG.01,3239.0,The purpose of this study was to determine the effects of consumption of different cocoa - derived products on uric acid crystallization in urine of 20 healthy volunteers .
93410,products,I-AG.01,3239.0,The purpose of this study was to determine the effects of consumption of different cocoa - derived products on uric acid crystallization in urine of 20 healthy volunteers .
93411,on,O,3239.0,The purpose of this study was to determine the effects of consumption of different cocoa - derived products on uric acid crystallization in urine of 20 healthy volunteers .
93412,uric,O,3239.0,The purpose of this study was to determine the effects of consumption of different cocoa - derived products on uric acid crystallization in urine of 20 healthy volunteers .
93413,acid,O,3239.0,The purpose of this study was to determine the effects of consumption of different cocoa - derived products on uric acid crystallization in urine of 20 healthy volunteers .
93414,crystallization,O,3239.0,The purpose of this study was to determine the effects of consumption of different cocoa - derived products on uric acid crystallization in urine of 20 healthy volunteers .
93415,in,O,3239.0,The purpose of this study was to determine the effects of consumption of different cocoa - derived products on uric acid crystallization in urine of 20 healthy volunteers .
93416,urine,O,3239.0,The purpose of this study was to determine the effects of consumption of different cocoa - derived products on uric acid crystallization in urine of 20 healthy volunteers .
93417,of,O,3239.0,The purpose of this study was to determine the effects of consumption of different cocoa - derived products on uric acid crystallization in urine of 20 healthy volunteers .
93418,20,O,3239.0,The purpose of this study was to determine the effects of consumption of different cocoa - derived products on uric acid crystallization in urine of 20 healthy volunteers .
93419,healthy,O,3239.0,The purpose of this study was to determine the effects of consumption of different cocoa - derived products on uric acid crystallization in urine of 20 healthy volunteers .
93420,volunteers,O,3239.0,The purpose of this study was to determine the effects of consumption of different cocoa - derived products on uric acid crystallization in urine of 20 healthy volunteers .
93421,.,O,3239.0,The purpose of this study was to determine the effects of consumption of different cocoa - derived products on uric acid crystallization in urine of 20 healthy volunteers .
93422,Participants,O,3240.0,Participants were requested to select the specific diet that they wished to follow during the 12 h prior to collection of urine .
93423,were,O,3240.0,Participants were requested to select the specific diet that they wished to follow during the 12 h prior to collection of urine .
93424,requested,O,3240.0,Participants were requested to select the specific diet that they wished to follow during the 12 h prior to collection of urine .
93425,to,O,3240.0,Participants were requested to select the specific diet that they wished to follow during the 12 h prior to collection of urine .
93426,select,O,3240.0,Participants were requested to select the specific diet that they wished to follow during the 12 h prior to collection of urine .
93427,the,O,3240.0,Participants were requested to select the specific diet that they wished to follow during the 12 h prior to collection of urine .
93428,specific,O,3240.0,Participants were requested to select the specific diet that they wished to follow during the 12 h prior to collection of urine .
93429,diet,O,3240.0,Participants were requested to select the specific diet that they wished to follow during the 12 h prior to collection of urine .
93430,that,O,3240.0,Participants were requested to select the specific diet that they wished to follow during the 12 h prior to collection of urine .
93431,they,O,3240.0,Participants were requested to select the specific diet that they wished to follow during the 12 h prior to collection of urine .
93432,wished,O,3240.0,Participants were requested to select the specific diet that they wished to follow during the 12 h prior to collection of urine .
93433,to,O,3240.0,Participants were requested to select the specific diet that they wished to follow during the 12 h prior to collection of urine .
93434,follow,O,3240.0,Participants were requested to select the specific diet that they wished to follow during the 12 h prior to collection of urine .
93435,during,O,3240.0,Participants were requested to select the specific diet that they wished to follow during the 12 h prior to collection of urine .
93436,the,O,3240.0,Participants were requested to select the specific diet that they wished to follow during the 12 h prior to collection of urine .
93437,12,O,3240.0,Participants were requested to select the specific diet that they wished to follow during the 12 h prior to collection of urine .
93438,h,O,3240.0,Participants were requested to select the specific diet that they wished to follow during the 12 h prior to collection of urine .
93439,prior,O,3240.0,Participants were requested to select the specific diet that they wished to follow during the 12 h prior to collection of urine .
93440,to,O,3240.0,Participants were requested to select the specific diet that they wished to follow during the 12 h prior to collection of urine .
93441,collection,O,3240.0,Participants were requested to select the specific diet that they wished to follow during the 12 h prior to collection of urine .
93442,of,O,3240.0,Participants were requested to select the specific diet that they wished to follow during the 12 h prior to collection of urine .
93443,urine,O,3240.0,Participants were requested to select the specific diet that they wished to follow during the 12 h prior to collection of urine .
93444,.,O,3240.0,Participants were requested to select the specific diet that they wished to follow during the 12 h prior to collection of urine .
93445,The,O,3241.0,"The only restriction was that the diet could not include any product with cocoa , coffee , or caffeine ."
93446,only,O,3241.0,"The only restriction was that the diet could not include any product with cocoa , coffee , or caffeine ."
93447,restriction,O,3241.0,"The only restriction was that the diet could not include any product with cocoa , coffee , or caffeine ."
93448,was,O,3241.0,"The only restriction was that the diet could not include any product with cocoa , coffee , or caffeine ."
93449,that,O,3241.0,"The only restriction was that the diet could not include any product with cocoa , coffee , or caffeine ."
93450,the,O,3241.0,"The only restriction was that the diet could not include any product with cocoa , coffee , or caffeine ."
93451,diet,O,3241.0,"The only restriction was that the diet could not include any product with cocoa , coffee , or caffeine ."
93452,could,O,3241.0,"The only restriction was that the diet could not include any product with cocoa , coffee , or caffeine ."
93453,not,O,3241.0,"The only restriction was that the diet could not include any product with cocoa , coffee , or caffeine ."
93454,include,O,3241.0,"The only restriction was that the diet could not include any product with cocoa , coffee , or caffeine ."
93455,any,O,3241.0,"The only restriction was that the diet could not include any product with cocoa , coffee , or caffeine ."
93456,product,O,3241.0,"The only restriction was that the diet could not include any product with cocoa , coffee , or caffeine ."
93457,with,O,3241.0,"The only restriction was that the diet could not include any product with cocoa , coffee , or caffeine ."
93458,cocoa,B-AG.01,3241.0,"The only restriction was that the diet could not include any product with cocoa , coffee , or caffeine ."
93459,",",O,3241.0,"The only restriction was that the diet could not include any product with cocoa , coffee , or caffeine ."
93460,coffee,B-AG.01.ad,3241.0,"The only restriction was that the diet could not include any product with cocoa , coffee , or caffeine ."
93461,",",O,3241.0,"The only restriction was that the diet could not include any product with cocoa , coffee , or caffeine ."
93462,or,O,3241.0,"The only restriction was that the diet could not include any product with cocoa , coffee , or caffeine ."
93463,caffeine,O,3241.0,"The only restriction was that the diet could not include any product with cocoa , coffee , or caffeine ."
93464,.,O,3241.0,"The only restriction was that the diet could not include any product with cocoa , coffee , or caffeine ."
93465,On,O,3242.0,"On the first day , each volunteer followed their selected diet , and an overnight 12 h urine sample was collected as the baseline urine ."
93466,the,O,3242.0,"On the first day , each volunteer followed their selected diet , and an overnight 12 h urine sample was collected as the baseline urine ."
93467,first,O,3242.0,"On the first day , each volunteer followed their selected diet , and an overnight 12 h urine sample was collected as the baseline urine ."
93468,day,O,3242.0,"On the first day , each volunteer followed their selected diet , and an overnight 12 h urine sample was collected as the baseline urine ."
93469,",",O,3242.0,"On the first day , each volunteer followed their selected diet , and an overnight 12 h urine sample was collected as the baseline urine ."
93470,each,O,3242.0,"On the first day , each volunteer followed their selected diet , and an overnight 12 h urine sample was collected as the baseline urine ."
93471,volunteer,O,3242.0,"On the first day , each volunteer followed their selected diet , and an overnight 12 h urine sample was collected as the baseline urine ."
93472,followed,O,3242.0,"On the first day , each volunteer followed their selected diet , and an overnight 12 h urine sample was collected as the baseline urine ."
93473,their,O,3242.0,"On the first day , each volunteer followed their selected diet , and an overnight 12 h urine sample was collected as the baseline urine ."
93474,selected,O,3242.0,"On the first day , each volunteer followed their selected diet , and an overnight 12 h urine sample was collected as the baseline urine ."
93475,diet,O,3242.0,"On the first day , each volunteer followed their selected diet , and an overnight 12 h urine sample was collected as the baseline urine ."
93476,",",O,3242.0,"On the first day , each volunteer followed their selected diet , and an overnight 12 h urine sample was collected as the baseline urine ."
93477,and,O,3242.0,"On the first day , each volunteer followed their selected diet , and an overnight 12 h urine sample was collected as the baseline urine ."
93478,an,O,3242.0,"On the first day , each volunteer followed their selected diet , and an overnight 12 h urine sample was collected as the baseline urine ."
93479,overnight,O,3242.0,"On the first day , each volunteer followed their selected diet , and an overnight 12 h urine sample was collected as the baseline urine ."
93480,12,O,3242.0,"On the first day , each volunteer followed their selected diet , and an overnight 12 h urine sample was collected as the baseline urine ."
93481,h,O,3242.0,"On the first day , each volunteer followed their selected diet , and an overnight 12 h urine sample was collected as the baseline urine ."
93482,urine,O,3242.0,"On the first day , each volunteer followed their selected diet , and an overnight 12 h urine sample was collected as the baseline urine ."
93483,sample,O,3242.0,"On the first day , each volunteer followed their selected diet , and an overnight 12 h urine sample was collected as the baseline urine ."
93484,was,O,3242.0,"On the first day , each volunteer followed their selected diet , and an overnight 12 h urine sample was collected as the baseline urine ."
93485,collected,O,3242.0,"On the first day , each volunteer followed their selected diet , and an overnight 12 h urine sample was collected as the baseline urine ."
93486,as,O,3242.0,"On the first day , each volunteer followed their selected diet , and an overnight 12 h urine sample was collected as the baseline urine ."
93487,the,O,3242.0,"On the first day , each volunteer followed their selected diet , and an overnight 12 h urine sample was collected as the baseline urine ."
93488,baseline,O,3242.0,"On the first day , each volunteer followed their selected diet , and an overnight 12 h urine sample was collected as the baseline urine ."
93489,urine,O,3242.0,"On the first day , each volunteer followed their selected diet , and an overnight 12 h urine sample was collected as the baseline urine ."
93490,.,O,3242.0,"On the first day , each volunteer followed their selected diet , and an overnight 12 h urine sample was collected as the baseline urine ."
93491,After,O,3243.0,"After seven days on an unrestricted diet , each volunteer repeated the same diet with 20 g of milk chocolate , chocolate powder , or dark chocolate during breakfast and another 20 g during dinner ."
93492,seven,O,3243.0,"After seven days on an unrestricted diet , each volunteer repeated the same diet with 20 g of milk chocolate , chocolate powder , or dark chocolate during breakfast and another 20 g during dinner ."
93493,days,O,3243.0,"After seven days on an unrestricted diet , each volunteer repeated the same diet with 20 g of milk chocolate , chocolate powder , or dark chocolate during breakfast and another 20 g during dinner ."
93494,on,O,3243.0,"After seven days on an unrestricted diet , each volunteer repeated the same diet with 20 g of milk chocolate , chocolate powder , or dark chocolate during breakfast and another 20 g during dinner ."
93495,an,O,3243.0,"After seven days on an unrestricted diet , each volunteer repeated the same diet with 20 g of milk chocolate , chocolate powder , or dark chocolate during breakfast and another 20 g during dinner ."
93496,unrestricted,O,3243.0,"After seven days on an unrestricted diet , each volunteer repeated the same diet with 20 g of milk chocolate , chocolate powder , or dark chocolate during breakfast and another 20 g during dinner ."
93497,diet,O,3243.0,"After seven days on an unrestricted diet , each volunteer repeated the same diet with 20 g of milk chocolate , chocolate powder , or dark chocolate during breakfast and another 20 g during dinner ."
93498,",",O,3243.0,"After seven days on an unrestricted diet , each volunteer repeated the same diet with 20 g of milk chocolate , chocolate powder , or dark chocolate during breakfast and another 20 g during dinner ."
93499,each,O,3243.0,"After seven days on an unrestricted diet , each volunteer repeated the same diet with 20 g of milk chocolate , chocolate powder , or dark chocolate during breakfast and another 20 g during dinner ."
93500,volunteer,O,3243.0,"After seven days on an unrestricted diet , each volunteer repeated the same diet with 20 g of milk chocolate , chocolate powder , or dark chocolate during breakfast and another 20 g during dinner ."
93501,repeated,O,3243.0,"After seven days on an unrestricted diet , each volunteer repeated the same diet with 20 g of milk chocolate , chocolate powder , or dark chocolate during breakfast and another 20 g during dinner ."
93502,the,O,3243.0,"After seven days on an unrestricted diet , each volunteer repeated the same diet with 20 g of milk chocolate , chocolate powder , or dark chocolate during breakfast and another 20 g during dinner ."
93503,same,O,3243.0,"After seven days on an unrestricted diet , each volunteer repeated the same diet with 20 g of milk chocolate , chocolate powder , or dark chocolate during breakfast and another 20 g during dinner ."
93504,diet,O,3243.0,"After seven days on an unrestricted diet , each volunteer repeated the same diet with 20 g of milk chocolate , chocolate powder , or dark chocolate during breakfast and another 20 g during dinner ."
93505,with,O,3243.0,"After seven days on an unrestricted diet , each volunteer repeated the same diet with 20 g of milk chocolate , chocolate powder , or dark chocolate during breakfast and another 20 g during dinner ."
93506,20,O,3243.0,"After seven days on an unrestricted diet , each volunteer repeated the same diet with 20 g of milk chocolate , chocolate powder , or dark chocolate during breakfast and another 20 g during dinner ."
93507,g,O,3243.0,"After seven days on an unrestricted diet , each volunteer repeated the same diet with 20 g of milk chocolate , chocolate powder , or dark chocolate during breakfast and another 20 g during dinner ."
93508,of,O,3243.0,"After seven days on an unrestricted diet , each volunteer repeated the same diet with 20 g of milk chocolate , chocolate powder , or dark chocolate during breakfast and another 20 g during dinner ."
93509,milk,B-AG.01.n.17.a,3243.0,"After seven days on an unrestricted diet , each volunteer repeated the same diet with 20 g of milk chocolate , chocolate powder , or dark chocolate during breakfast and another 20 g during dinner ."
93510,chocolate,I-AG.01.n.17.a,3243.0,"After seven days on an unrestricted diet , each volunteer repeated the same diet with 20 g of milk chocolate , chocolate powder , or dark chocolate during breakfast and another 20 g during dinner ."
93511,",",O,3243.0,"After seven days on an unrestricted diet , each volunteer repeated the same diet with 20 g of milk chocolate , chocolate powder , or dark chocolate during breakfast and another 20 g during dinner ."
93512,chocolate,B-AG.01.n.17.a,3243.0,"After seven days on an unrestricted diet , each volunteer repeated the same diet with 20 g of milk chocolate , chocolate powder , or dark chocolate during breakfast and another 20 g during dinner ."
93513,powder,I-AG.01.n.17.a,3243.0,"After seven days on an unrestricted diet , each volunteer repeated the same diet with 20 g of milk chocolate , chocolate powder , or dark chocolate during breakfast and another 20 g during dinner ."
93514,",",O,3243.0,"After seven days on an unrestricted diet , each volunteer repeated the same diet with 20 g of milk chocolate , chocolate powder , or dark chocolate during breakfast and another 20 g during dinner ."
93515,or,O,3243.0,"After seven days on an unrestricted diet , each volunteer repeated the same diet with 20 g of milk chocolate , chocolate powder , or dark chocolate during breakfast and another 20 g during dinner ."
93516,dark,B-AG.01.n.17.a,3243.0,"After seven days on an unrestricted diet , each volunteer repeated the same diet with 20 g of milk chocolate , chocolate powder , or dark chocolate during breakfast and another 20 g during dinner ."
93517,chocolate,I-AG.01.n.17.a,3243.0,"After seven days on an unrestricted diet , each volunteer repeated the same diet with 20 g of milk chocolate , chocolate powder , or dark chocolate during breakfast and another 20 g during dinner ."
93518,during,O,3243.0,"After seven days on an unrestricted diet , each volunteer repeated the same diet with 20 g of milk chocolate , chocolate powder , or dark chocolate during breakfast and another 20 g during dinner ."
93519,breakfast,O,3243.0,"After seven days on an unrestricted diet , each volunteer repeated the same diet with 20 g of milk chocolate , chocolate powder , or dark chocolate during breakfast and another 20 g during dinner ."
93520,and,O,3243.0,"After seven days on an unrestricted diet , each volunteer repeated the same diet with 20 g of milk chocolate , chocolate powder , or dark chocolate during breakfast and another 20 g during dinner ."
93521,another,O,3243.0,"After seven days on an unrestricted diet , each volunteer repeated the same diet with 20 g of milk chocolate , chocolate powder , or dark chocolate during breakfast and another 20 g during dinner ."
93522,20,O,3243.0,"After seven days on an unrestricted diet , each volunteer repeated the same diet with 20 g of milk chocolate , chocolate powder , or dark chocolate during breakfast and another 20 g during dinner ."
93523,g,O,3243.0,"After seven days on an unrestricted diet , each volunteer repeated the same diet with 20 g of milk chocolate , chocolate powder , or dark chocolate during breakfast and another 20 g during dinner ."
93524,during,O,3243.0,"After seven days on an unrestricted diet , each volunteer repeated the same diet with 20 g of milk chocolate , chocolate powder , or dark chocolate during breakfast and another 20 g during dinner ."
93525,dinner,O,3243.0,"After seven days on an unrestricted diet , each volunteer repeated the same diet with 20 g of milk chocolate , chocolate powder , or dark chocolate during breakfast and another 20 g during dinner ."
93526,.,O,3243.0,"After seven days on an unrestricted diet , each volunteer repeated the same diet with 20 g of milk chocolate , chocolate powder , or dark chocolate during breakfast and another 20 g during dinner ."
93527,Overnight,O,3244.0,Overnight 12 h urine samples were then collected .
93528,12,O,3244.0,Overnight 12 h urine samples were then collected .
93529,h,O,3244.0,Overnight 12 h urine samples were then collected .
93530,urine,O,3244.0,Overnight 12 h urine samples were then collected .
93531,samples,O,3244.0,Overnight 12 h urine samples were then collected .
93532,were,O,3244.0,Overnight 12 h urine samples were then collected .
93533,then,O,3244.0,Overnight 12 h urine samples were then collected .
93534,collected,O,3244.0,Overnight 12 h urine samples were then collected .
93535,.,O,3244.0,Overnight 12 h urine samples were then collected .
93536,Urine,O,3245.0,"Urine volume , pH , oxalate , creatinine , uric acid , theobromine , and a uric acid crystallization test were determined for each sample ."
93537,volume,O,3245.0,"Urine volume , pH , oxalate , creatinine , uric acid , theobromine , and a uric acid crystallization test were determined for each sample ."
93538,",",O,3245.0,"Urine volume , pH , oxalate , creatinine , uric acid , theobromine , and a uric acid crystallization test were determined for each sample ."
93539,pH,O,3245.0,"Urine volume , pH , oxalate , creatinine , uric acid , theobromine , and a uric acid crystallization test were determined for each sample ."
93540,",",O,3245.0,"Urine volume , pH , oxalate , creatinine , uric acid , theobromine , and a uric acid crystallization test were determined for each sample ."
93541,oxalate,O,3245.0,"Urine volume , pH , oxalate , creatinine , uric acid , theobromine , and a uric acid crystallization test were determined for each sample ."
93542,",",O,3245.0,"Urine volume , pH , oxalate , creatinine , uric acid , theobromine , and a uric acid crystallization test were determined for each sample ."
93543,creatinine,O,3245.0,"Urine volume , pH , oxalate , creatinine , uric acid , theobromine , and a uric acid crystallization test were determined for each sample ."
93544,",",O,3245.0,"Urine volume , pH , oxalate , creatinine , uric acid , theobromine , and a uric acid crystallization test were determined for each sample ."
93545,uric,O,3245.0,"Urine volume , pH , oxalate , creatinine , uric acid , theobromine , and a uric acid crystallization test were determined for each sample ."
93546,acid,O,3245.0,"Urine volume , pH , oxalate , creatinine , uric acid , theobromine , and a uric acid crystallization test were determined for each sample ."
93547,",",O,3245.0,"Urine volume , pH , oxalate , creatinine , uric acid , theobromine , and a uric acid crystallization test were determined for each sample ."
93548,theobromine,O,3245.0,"Urine volume , pH , oxalate , creatinine , uric acid , theobromine , and a uric acid crystallization test were determined for each sample ."
93549,",",O,3245.0,"Urine volume , pH , oxalate , creatinine , uric acid , theobromine , and a uric acid crystallization test were determined for each sample ."
93550,and,O,3245.0,"Urine volume , pH , oxalate , creatinine , uric acid , theobromine , and a uric acid crystallization test were determined for each sample ."
93551,a,O,3245.0,"Urine volume , pH , oxalate , creatinine , uric acid , theobromine , and a uric acid crystallization test were determined for each sample ."
93552,uric,O,3245.0,"Urine volume , pH , oxalate , creatinine , uric acid , theobromine , and a uric acid crystallization test were determined for each sample ."
93553,acid,O,3245.0,"Urine volume , pH , oxalate , creatinine , uric acid , theobromine , and a uric acid crystallization test were determined for each sample ."
93554,crystallization,O,3245.0,"Urine volume , pH , oxalate , creatinine , uric acid , theobromine , and a uric acid crystallization test were determined for each sample ."
93555,test,O,3245.0,"Urine volume , pH , oxalate , creatinine , uric acid , theobromine , and a uric acid crystallization test were determined for each sample ."
93556,were,O,3245.0,"Urine volume , pH , oxalate , creatinine , uric acid , theobromine , and a uric acid crystallization test were determined for each sample ."
93557,determined,O,3245.0,"Urine volume , pH , oxalate , creatinine , uric acid , theobromine , and a uric acid crystallization test were determined for each sample ."
93558,for,O,3245.0,"Urine volume , pH , oxalate , creatinine , uric acid , theobromine , and a uric acid crystallization test were determined for each sample ."
93559,each,O,3245.0,"Urine volume , pH , oxalate , creatinine , uric acid , theobromine , and a uric acid crystallization test were determined for each sample ."
93560,sample,O,3245.0,"Urine volume , pH , oxalate , creatinine , uric acid , theobromine , and a uric acid crystallization test were determined for each sample ."
93561,.,O,3245.0,"Urine volume , pH , oxalate , creatinine , uric acid , theobromine , and a uric acid crystallization test were determined for each sample ."
93562,The,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93563,results,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93564,for,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93565,all,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93566,20,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93567,patients,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93568,show,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93569,that,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93570,uric,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93571,acid,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93572,crystallization,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93573,was,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93574,significantly,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93575,lower,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93576,following,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93577,the,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93578,consumption,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93579,of,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93580,chocolate,B-AG.01.n.17.a,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93581,powder,I-AG.01.n.17.a,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93582,or,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93583,dark,B-AG.01.n.17.a,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93584,chocolate,I-AG.01.n.17.a,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93585,relative,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93586,to,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93587,baseline,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93588,or,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93589,following,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93590,the,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93591,consumption,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93592,of,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93593,milk,B-AG.01.n.17.a,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93594,chocolate,I-AG.01.n.17.a,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93595,.,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93596,The,O,3247.0,The results indicated that increased concentrations of urinary theobromine reduced the risk of uric acid crystallization .
93597,results,O,3247.0,The results indicated that increased concentrations of urinary theobromine reduced the risk of uric acid crystallization .
93598,indicated,O,3247.0,The results indicated that increased concentrations of urinary theobromine reduced the risk of uric acid crystallization .
93599,that,O,3247.0,The results indicated that increased concentrations of urinary theobromine reduced the risk of uric acid crystallization .
93600,increased,O,3247.0,The results indicated that increased concentrations of urinary theobromine reduced the risk of uric acid crystallization .
93601,concentrations,O,3247.0,The results indicated that increased concentrations of urinary theobromine reduced the risk of uric acid crystallization .
93602,of,O,3247.0,The results indicated that increased concentrations of urinary theobromine reduced the risk of uric acid crystallization .
93603,urinary,O,3247.0,The results indicated that increased concentrations of urinary theobromine reduced the risk of uric acid crystallization .
93604,theobromine,O,3247.0,The results indicated that increased concentrations of urinary theobromine reduced the risk of uric acid crystallization .
93605,reduced,O,3247.0,The results indicated that increased concentrations of urinary theobromine reduced the risk of uric acid crystallization .
93606,the,O,3247.0,The results indicated that increased concentrations of urinary theobromine reduced the risk of uric acid crystallization .
93607,risk,O,3247.0,The results indicated that increased concentrations of urinary theobromine reduced the risk of uric acid crystallization .
93608,of,O,3247.0,The results indicated that increased concentrations of urinary theobromine reduced the risk of uric acid crystallization .
93609,uric,O,3247.0,The results indicated that increased concentrations of urinary theobromine reduced the risk of uric acid crystallization .
93610,acid,O,3247.0,The results indicated that increased concentrations of urinary theobromine reduced the risk of uric acid crystallization .
93611,crystallization,O,3247.0,The results indicated that increased concentrations of urinary theobromine reduced the risk of uric acid crystallization .
93612,.,O,3247.0,The results indicated that increased concentrations of urinary theobromine reduced the risk of uric acid crystallization .
93613,This,O,3248.0,"This study deals with a 34 - year - old female cook with no previous history of atopy , who was studied because of allergic rhinoconjunctivitis and contact urticaria in both hands associated with severe itching when she handled raw carrot ."
93614,study,O,3248.0,"This study deals with a 34 - year - old female cook with no previous history of atopy , who was studied because of allergic rhinoconjunctivitis and contact urticaria in both hands associated with severe itching when she handled raw carrot ."
93615,deals,O,3248.0,"This study deals with a 34 - year - old female cook with no previous history of atopy , who was studied because of allergic rhinoconjunctivitis and contact urticaria in both hands associated with severe itching when she handled raw carrot ."
93616,with,O,3248.0,"This study deals with a 34 - year - old female cook with no previous history of atopy , who was studied because of allergic rhinoconjunctivitis and contact urticaria in both hands associated with severe itching when she handled raw carrot ."
93617,a,O,3248.0,"This study deals with a 34 - year - old female cook with no previous history of atopy , who was studied because of allergic rhinoconjunctivitis and contact urticaria in both hands associated with severe itching when she handled raw carrot ."
93618,34,O,3248.0,"This study deals with a 34 - year - old female cook with no previous history of atopy , who was studied because of allergic rhinoconjunctivitis and contact urticaria in both hands associated with severe itching when she handled raw carrot ."
93619,-,O,3248.0,"This study deals with a 34 - year - old female cook with no previous history of atopy , who was studied because of allergic rhinoconjunctivitis and contact urticaria in both hands associated with severe itching when she handled raw carrot ."
93620,year,O,3248.0,"This study deals with a 34 - year - old female cook with no previous history of atopy , who was studied because of allergic rhinoconjunctivitis and contact urticaria in both hands associated with severe itching when she handled raw carrot ."
93621,-,O,3248.0,"This study deals with a 34 - year - old female cook with no previous history of atopy , who was studied because of allergic rhinoconjunctivitis and contact urticaria in both hands associated with severe itching when she handled raw carrot ."
93622,old,O,3248.0,"This study deals with a 34 - year - old female cook with no previous history of atopy , who was studied because of allergic rhinoconjunctivitis and contact urticaria in both hands associated with severe itching when she handled raw carrot ."
93623,female,O,3248.0,"This study deals with a 34 - year - old female cook with no previous history of atopy , who was studied because of allergic rhinoconjunctivitis and contact urticaria in both hands associated with severe itching when she handled raw carrot ."
93624,cook,O,3248.0,"This study deals with a 34 - year - old female cook with no previous history of atopy , who was studied because of allergic rhinoconjunctivitis and contact urticaria in both hands associated with severe itching when she handled raw carrot ."
93625,with,O,3248.0,"This study deals with a 34 - year - old female cook with no previous history of atopy , who was studied because of allergic rhinoconjunctivitis and contact urticaria in both hands associated with severe itching when she handled raw carrot ."
93626,no,O,3248.0,"This study deals with a 34 - year - old female cook with no previous history of atopy , who was studied because of allergic rhinoconjunctivitis and contact urticaria in both hands associated with severe itching when she handled raw carrot ."
93627,previous,O,3248.0,"This study deals with a 34 - year - old female cook with no previous history of atopy , who was studied because of allergic rhinoconjunctivitis and contact urticaria in both hands associated with severe itching when she handled raw carrot ."
93628,history,O,3248.0,"This study deals with a 34 - year - old female cook with no previous history of atopy , who was studied because of allergic rhinoconjunctivitis and contact urticaria in both hands associated with severe itching when she handled raw carrot ."
93629,of,O,3248.0,"This study deals with a 34 - year - old female cook with no previous history of atopy , who was studied because of allergic rhinoconjunctivitis and contact urticaria in both hands associated with severe itching when she handled raw carrot ."
93630,atopy,O,3248.0,"This study deals with a 34 - year - old female cook with no previous history of atopy , who was studied because of allergic rhinoconjunctivitis and contact urticaria in both hands associated with severe itching when she handled raw carrot ."
93631,",",O,3248.0,"This study deals with a 34 - year - old female cook with no previous history of atopy , who was studied because of allergic rhinoconjunctivitis and contact urticaria in both hands associated with severe itching when she handled raw carrot ."
93632,who,O,3248.0,"This study deals with a 34 - year - old female cook with no previous history of atopy , who was studied because of allergic rhinoconjunctivitis and contact urticaria in both hands associated with severe itching when she handled raw carrot ."
93633,was,O,3248.0,"This study deals with a 34 - year - old female cook with no previous history of atopy , who was studied because of allergic rhinoconjunctivitis and contact urticaria in both hands associated with severe itching when she handled raw carrot ."
93634,studied,O,3248.0,"This study deals with a 34 - year - old female cook with no previous history of atopy , who was studied because of allergic rhinoconjunctivitis and contact urticaria in both hands associated with severe itching when she handled raw carrot ."
93635,because,O,3248.0,"This study deals with a 34 - year - old female cook with no previous history of atopy , who was studied because of allergic rhinoconjunctivitis and contact urticaria in both hands associated with severe itching when she handled raw carrot ."
93636,of,O,3248.0,"This study deals with a 34 - year - old female cook with no previous history of atopy , who was studied because of allergic rhinoconjunctivitis and contact urticaria in both hands associated with severe itching when she handled raw carrot ."
93637,allergic,O,3248.0,"This study deals with a 34 - year - old female cook with no previous history of atopy , who was studied because of allergic rhinoconjunctivitis and contact urticaria in both hands associated with severe itching when she handled raw carrot ."
93638,rhinoconjunctivitis,O,3248.0,"This study deals with a 34 - year - old female cook with no previous history of atopy , who was studied because of allergic rhinoconjunctivitis and contact urticaria in both hands associated with severe itching when she handled raw carrot ."
93639,and,O,3248.0,"This study deals with a 34 - year - old female cook with no previous history of atopy , who was studied because of allergic rhinoconjunctivitis and contact urticaria in both hands associated with severe itching when she handled raw carrot ."
93640,contact,O,3248.0,"This study deals with a 34 - year - old female cook with no previous history of atopy , who was studied because of allergic rhinoconjunctivitis and contact urticaria in both hands associated with severe itching when she handled raw carrot ."
93641,urticaria,O,3248.0,"This study deals with a 34 - year - old female cook with no previous history of atopy , who was studied because of allergic rhinoconjunctivitis and contact urticaria in both hands associated with severe itching when she handled raw carrot ."
93642,in,O,3248.0,"This study deals with a 34 - year - old female cook with no previous history of atopy , who was studied because of allergic rhinoconjunctivitis and contact urticaria in both hands associated with severe itching when she handled raw carrot ."
93643,both,O,3248.0,"This study deals with a 34 - year - old female cook with no previous history of atopy , who was studied because of allergic rhinoconjunctivitis and contact urticaria in both hands associated with severe itching when she handled raw carrot ."
93644,hands,O,3248.0,"This study deals with a 34 - year - old female cook with no previous history of atopy , who was studied because of allergic rhinoconjunctivitis and contact urticaria in both hands associated with severe itching when she handled raw carrot ."
93645,associated,O,3248.0,"This study deals with a 34 - year - old female cook with no previous history of atopy , who was studied because of allergic rhinoconjunctivitis and contact urticaria in both hands associated with severe itching when she handled raw carrot ."
93646,with,O,3248.0,"This study deals with a 34 - year - old female cook with no previous history of atopy , who was studied because of allergic rhinoconjunctivitis and contact urticaria in both hands associated with severe itching when she handled raw carrot ."
93647,severe,O,3248.0,"This study deals with a 34 - year - old female cook with no previous history of atopy , who was studied because of allergic rhinoconjunctivitis and contact urticaria in both hands associated with severe itching when she handled raw carrot ."
93648,itching,O,3248.0,"This study deals with a 34 - year - old female cook with no previous history of atopy , who was studied because of allergic rhinoconjunctivitis and contact urticaria in both hands associated with severe itching when she handled raw carrot ."
93649,when,O,3248.0,"This study deals with a 34 - year - old female cook with no previous history of atopy , who was studied because of allergic rhinoconjunctivitis and contact urticaria in both hands associated with severe itching when she handled raw carrot ."
93650,she,O,3248.0,"This study deals with a 34 - year - old female cook with no previous history of atopy , who was studied because of allergic rhinoconjunctivitis and contact urticaria in both hands associated with severe itching when she handled raw carrot ."
93651,handled,O,3248.0,"This study deals with a 34 - year - old female cook with no previous history of atopy , who was studied because of allergic rhinoconjunctivitis and contact urticaria in both hands associated with severe itching when she handled raw carrot ."
93652,raw,O,3248.0,"This study deals with a 34 - year - old female cook with no previous history of atopy , who was studied because of allergic rhinoconjunctivitis and contact urticaria in both hands associated with severe itching when she handled raw carrot ."
93653,carrot,B-AG.01.h.02.a,3248.0,"This study deals with a 34 - year - old female cook with no previous history of atopy , who was studied because of allergic rhinoconjunctivitis and contact urticaria in both hands associated with severe itching when she handled raw carrot ."
93654,.,O,3248.0,"This study deals with a 34 - year - old female cook with no previous history of atopy , who was studied because of allergic rhinoconjunctivitis and contact urticaria in both hands associated with severe itching when she handled raw carrot ."
93655,The,O,3249.0,"The patient had had anaphylactic episodes after accidental ingestion of raw carrots , but she tolerated cooked carrots ."
93656,patient,O,3249.0,"The patient had had anaphylactic episodes after accidental ingestion of raw carrots , but she tolerated cooked carrots ."
93657,had,O,3249.0,"The patient had had anaphylactic episodes after accidental ingestion of raw carrots , but she tolerated cooked carrots ."
93658,had,O,3249.0,"The patient had had anaphylactic episodes after accidental ingestion of raw carrots , but she tolerated cooked carrots ."
93659,anaphylactic,O,3249.0,"The patient had had anaphylactic episodes after accidental ingestion of raw carrots , but she tolerated cooked carrots ."
93660,episodes,O,3249.0,"The patient had had anaphylactic episodes after accidental ingestion of raw carrots , but she tolerated cooked carrots ."
93661,after,O,3249.0,"The patient had had anaphylactic episodes after accidental ingestion of raw carrots , but she tolerated cooked carrots ."
93662,accidental,O,3249.0,"The patient had had anaphylactic episodes after accidental ingestion of raw carrots , but she tolerated cooked carrots ."
93663,ingestion,O,3249.0,"The patient had had anaphylactic episodes after accidental ingestion of raw carrots , but she tolerated cooked carrots ."
93664,of,O,3249.0,"The patient had had anaphylactic episodes after accidental ingestion of raw carrots , but she tolerated cooked carrots ."
93665,raw,O,3249.0,"The patient had had anaphylactic episodes after accidental ingestion of raw carrots , but she tolerated cooked carrots ."
93666,carrots,B-AG.01.h.02.a,3249.0,"The patient had had anaphylactic episodes after accidental ingestion of raw carrots , but she tolerated cooked carrots ."
93667,",",O,3249.0,"The patient had had anaphylactic episodes after accidental ingestion of raw carrots , but she tolerated cooked carrots ."
93668,but,O,3249.0,"The patient had had anaphylactic episodes after accidental ingestion of raw carrots , but she tolerated cooked carrots ."
93669,she,O,3249.0,"The patient had had anaphylactic episodes after accidental ingestion of raw carrots , but she tolerated cooked carrots ."
93670,tolerated,O,3249.0,"The patient had had anaphylactic episodes after accidental ingestion of raw carrots , but she tolerated cooked carrots ."
93671,cooked,O,3249.0,"The patient had had anaphylactic episodes after accidental ingestion of raw carrots , but she tolerated cooked carrots ."
93672,carrots,B-AG.01.h.02.a,3249.0,"The patient had had anaphylactic episodes after accidental ingestion of raw carrots , but she tolerated cooked carrots ."
93673,.,O,3249.0,"The patient had had anaphylactic episodes after accidental ingestion of raw carrots , but she tolerated cooked carrots ."
93674,Skin,O,3250.0,"Skin prick tests with carrot , celery , and olive , and birch , grass , and mugwort pollens were positive ."
93675,prick,O,3250.0,"Skin prick tests with carrot , celery , and olive , and birch , grass , and mugwort pollens were positive ."
93676,tests,O,3250.0,"Skin prick tests with carrot , celery , and olive , and birch , grass , and mugwort pollens were positive ."
93677,with,O,3250.0,"Skin prick tests with carrot , celery , and olive , and birch , grass , and mugwort pollens were positive ."
93678,carrot,B-AG.01.h.02.a,3250.0,"Skin prick tests with carrot , celery , and olive , and birch , grass , and mugwort pollens were positive ."
93679,",",O,3250.0,"Skin prick tests with carrot , celery , and olive , and birch , grass , and mugwort pollens were positive ."
93680,celery,B-AG.01.h.02.a,3250.0,"Skin prick tests with carrot , celery , and olive , and birch , grass , and mugwort pollens were positive ."
93681,",",O,3250.0,"Skin prick tests with carrot , celery , and olive , and birch , grass , and mugwort pollens were positive ."
93682,and,O,3250.0,"Skin prick tests with carrot , celery , and olive , and birch , grass , and mugwort pollens were positive ."
93683,olive,B-AG.01.h.01.e,3250.0,"Skin prick tests with carrot , celery , and olive , and birch , grass , and mugwort pollens were positive ."
93684,",",O,3250.0,"Skin prick tests with carrot , celery , and olive , and birch , grass , and mugwort pollens were positive ."
93685,and,O,3250.0,"Skin prick tests with carrot , celery , and olive , and birch , grass , and mugwort pollens were positive ."
93686,birch,O,3250.0,"Skin prick tests with carrot , celery , and olive , and birch , grass , and mugwort pollens were positive ."
93687,",",O,3250.0,"Skin prick tests with carrot , celery , and olive , and birch , grass , and mugwort pollens were positive ."
93688,grass,O,3250.0,"Skin prick tests with carrot , celery , and olive , and birch , grass , and mugwort pollens were positive ."
93689,",",O,3250.0,"Skin prick tests with carrot , celery , and olive , and birch , grass , and mugwort pollens were positive ."
93690,and,O,3250.0,"Skin prick tests with carrot , celery , and olive , and birch , grass , and mugwort pollens were positive ."
93691,mugwort,O,3250.0,"Skin prick tests with carrot , celery , and olive , and birch , grass , and mugwort pollens were positive ."
93692,pollens,O,3250.0,"Skin prick tests with carrot , celery , and olive , and birch , grass , and mugwort pollens were positive ."
93693,were,O,3250.0,"Skin prick tests with carrot , celery , and olive , and birch , grass , and mugwort pollens were positive ."
93694,positive,O,3250.0,"Skin prick tests with carrot , celery , and olive , and birch , grass , and mugwort pollens were positive ."
93695,.,O,3250.0,"Skin prick tests with carrot , celery , and olive , and birch , grass , and mugwort pollens were positive ."
93696,Total,O,3251.0,Total IgE was 411 UI / ml .
93697,IgE,O,3251.0,Total IgE was 411 UI / ml .
93698,was,O,3251.0,Total IgE was 411 UI / ml .
93699,411,O,3251.0,Total IgE was 411 UI / ml .
93700,UI,O,3251.0,Total IgE was 411 UI / ml .
93701,/,O,3251.0,Total IgE was 411 UI / ml .
93702,ml,O,3251.0,Total IgE was 411 UI / ml .
93703,.,O,3251.0,Total IgE was 411 UI / ml .
93704,Specific,O,3252.0,"Specific IgE to olive , grass , and weed pollens were 10.92 , 6.17 , and 2.4 AU / ml , respectively ."
93705,IgE,O,3252.0,"Specific IgE to olive , grass , and weed pollens were 10.92 , 6.17 , and 2.4 AU / ml , respectively ."
93706,to,O,3252.0,"Specific IgE to olive , grass , and weed pollens were 10.92 , 6.17 , and 2.4 AU / ml , respectively ."
93707,olive,B-AG.01.h.01.e,3252.0,"Specific IgE to olive , grass , and weed pollens were 10.92 , 6.17 , and 2.4 AU / ml , respectively ."
93708,",",O,3252.0,"Specific IgE to olive , grass , and weed pollens were 10.92 , 6.17 , and 2.4 AU / ml , respectively ."
93709,grass,O,3252.0,"Specific IgE to olive , grass , and weed pollens were 10.92 , 6.17 , and 2.4 AU / ml , respectively ."
93710,",",O,3252.0,"Specific IgE to olive , grass , and weed pollens were 10.92 , 6.17 , and 2.4 AU / ml , respectively ."
93711,and,O,3252.0,"Specific IgE to olive , grass , and weed pollens were 10.92 , 6.17 , and 2.4 AU / ml , respectively ."
93712,weed,O,3252.0,"Specific IgE to olive , grass , and weed pollens were 10.92 , 6.17 , and 2.4 AU / ml , respectively ."
93713,pollens,O,3252.0,"Specific IgE to olive , grass , and weed pollens were 10.92 , 6.17 , and 2.4 AU / ml , respectively ."
93714,were,O,3252.0,"Specific IgE to olive , grass , and weed pollens were 10.92 , 6.17 , and 2.4 AU / ml , respectively ."
93715,10.92,O,3252.0,"Specific IgE to olive , grass , and weed pollens were 10.92 , 6.17 , and 2.4 AU / ml , respectively ."
93716,",",O,3252.0,"Specific IgE to olive , grass , and weed pollens were 10.92 , 6.17 , and 2.4 AU / ml , respectively ."
93717,6.17,O,3252.0,"Specific IgE to olive , grass , and weed pollens were 10.92 , 6.17 , and 2.4 AU / ml , respectively ."
93718,",",O,3252.0,"Specific IgE to olive , grass , and weed pollens were 10.92 , 6.17 , and 2.4 AU / ml , respectively ."
93719,and,O,3252.0,"Specific IgE to olive , grass , and weed pollens were 10.92 , 6.17 , and 2.4 AU / ml , respectively ."
93720,2.4,O,3252.0,"Specific IgE to olive , grass , and weed pollens were 10.92 , 6.17 , and 2.4 AU / ml , respectively ."
93721,AU,O,3252.0,"Specific IgE to olive , grass , and weed pollens were 10.92 , 6.17 , and 2.4 AU / ml , respectively ."
93722,/,O,3252.0,"Specific IgE to olive , grass , and weed pollens were 10.92 , 6.17 , and 2.4 AU / ml , respectively ."
93723,ml,O,3252.0,"Specific IgE to olive , grass , and weed pollens were 10.92 , 6.17 , and 2.4 AU / ml , respectively ."
93724,",",O,3252.0,"Specific IgE to olive , grass , and weed pollens were 10.92 , 6.17 , and 2.4 AU / ml , respectively ."
93725,respectively,O,3252.0,"Specific IgE to olive , grass , and weed pollens were 10.92 , 6.17 , and 2.4 AU / ml , respectively ."
93726,.,O,3252.0,"Specific IgE to olive , grass , and weed pollens were 10.92 , 6.17 , and 2.4 AU / ml , respectively ."
93727,The,O,3253.0,"The histamine release test was positive for carrot , celery , celeriac , and olive pollen up to a dilution of 1/10(6 ) ."
93728,histamine,O,3253.0,"The histamine release test was positive for carrot , celery , celeriac , and olive pollen up to a dilution of 1/10(6 ) ."
93729,release,O,3253.0,"The histamine release test was positive for carrot , celery , celeriac , and olive pollen up to a dilution of 1/10(6 ) ."
93730,test,O,3253.0,"The histamine release test was positive for carrot , celery , celeriac , and olive pollen up to a dilution of 1/10(6 ) ."
93731,was,O,3253.0,"The histamine release test was positive for carrot , celery , celeriac , and olive pollen up to a dilution of 1/10(6 ) ."
93732,positive,O,3253.0,"The histamine release test was positive for carrot , celery , celeriac , and olive pollen up to a dilution of 1/10(6 ) ."
93733,for,O,3253.0,"The histamine release test was positive for carrot , celery , celeriac , and olive pollen up to a dilution of 1/10(6 ) ."
93734,carrot,B-AG.01.h.02.a,3253.0,"The histamine release test was positive for carrot , celery , celeriac , and olive pollen up to a dilution of 1/10(6 ) ."
93735,",",O,3253.0,"The histamine release test was positive for carrot , celery , celeriac , and olive pollen up to a dilution of 1/10(6 ) ."
93736,celery,B-AG.01.h.02.a,3253.0,"The histamine release test was positive for carrot , celery , celeriac , and olive pollen up to a dilution of 1/10(6 ) ."
93737,",",O,3253.0,"The histamine release test was positive for carrot , celery , celeriac , and olive pollen up to a dilution of 1/10(6 ) ."
93738,celeriac,B-AG.01.h.02.a,3253.0,"The histamine release test was positive for carrot , celery , celeriac , and olive pollen up to a dilution of 1/10(6 ) ."
93739,",",O,3253.0,"The histamine release test was positive for carrot , celery , celeriac , and olive pollen up to a dilution of 1/10(6 ) ."
93740,and,O,3253.0,"The histamine release test was positive for carrot , celery , celeriac , and olive pollen up to a dilution of 1/10(6 ) ."
93741,olive,B-AG.01.h.01.e,3253.0,"The histamine release test was positive for carrot , celery , celeriac , and olive pollen up to a dilution of 1/10(6 ) ."
93742,pollen,O,3253.0,"The histamine release test was positive for carrot , celery , celeriac , and olive pollen up to a dilution of 1/10(6 ) ."
93743,up,O,3253.0,"The histamine release test was positive for carrot , celery , celeriac , and olive pollen up to a dilution of 1/10(6 ) ."
93744,to,O,3253.0,"The histamine release test was positive for carrot , celery , celeriac , and olive pollen up to a dilution of 1/10(6 ) ."
93745,a,O,3253.0,"The histamine release test was positive for carrot , celery , celeriac , and olive pollen up to a dilution of 1/10(6 ) ."
93746,dilution,O,3253.0,"The histamine release test was positive for carrot , celery , celeriac , and olive pollen up to a dilution of 1/10(6 ) ."
93747,of,O,3253.0,"The histamine release test was positive for carrot , celery , celeriac , and olive pollen up to a dilution of 1/10(6 ) ."
93748,1/10(6,O,3253.0,"The histamine release test was positive for carrot , celery , celeriac , and olive pollen up to a dilution of 1/10(6 ) ."
93749,),O,3253.0,"The histamine release test was positive for carrot , celery , celeriac , and olive pollen up to a dilution of 1/10(6 ) ."
93750,.,O,3253.0,"The histamine release test was positive for carrot , celery , celeriac , and olive pollen up to a dilution of 1/10(6 ) ."
93751,Immunoblot,O,3254.0,Immunoblot of raw carrot showed a single IgE - binding 18 - kDa band .
93752,of,O,3254.0,Immunoblot of raw carrot showed a single IgE - binding 18 - kDa band .
93753,raw,O,3254.0,Immunoblot of raw carrot showed a single IgE - binding 18 - kDa band .
93754,carrot,B-AG.01.h.02.a,3254.0,Immunoblot of raw carrot showed a single IgE - binding 18 - kDa band .
93755,showed,O,3254.0,Immunoblot of raw carrot showed a single IgE - binding 18 - kDa band .
93756,a,O,3254.0,Immunoblot of raw carrot showed a single IgE - binding 18 - kDa band .
93757,single,O,3254.0,Immunoblot of raw carrot showed a single IgE - binding 18 - kDa band .
93758,IgE,O,3254.0,Immunoblot of raw carrot showed a single IgE - binding 18 - kDa band .
93759,-,O,3254.0,Immunoblot of raw carrot showed a single IgE - binding 18 - kDa band .
93760,binding,O,3254.0,Immunoblot of raw carrot showed a single IgE - binding 18 - kDa band .
93761,18,O,3254.0,Immunoblot of raw carrot showed a single IgE - binding 18 - kDa band .
93762,-,O,3254.0,Immunoblot of raw carrot showed a single IgE - binding 18 - kDa band .
93763,kDa,O,3254.0,Immunoblot of raw carrot showed a single IgE - binding 18 - kDa band .
93764,band,O,3254.0,Immunoblot of raw carrot showed a single IgE - binding 18 - kDa band .
93765,.,O,3254.0,Immunoblot of raw carrot showed a single IgE - binding 18 - kDa band .
93766,IgE,O,3255.0,"IgE reactivity for raw carrot immunoblot was completely inhibited by carrot and by celery , but not by olive or grass pollens ."
93767,reactivity,O,3255.0,"IgE reactivity for raw carrot immunoblot was completely inhibited by carrot and by celery , but not by olive or grass pollens ."
93768,for,O,3255.0,"IgE reactivity for raw carrot immunoblot was completely inhibited by carrot and by celery , but not by olive or grass pollens ."
93769,raw,O,3255.0,"IgE reactivity for raw carrot immunoblot was completely inhibited by carrot and by celery , but not by olive or grass pollens ."
93770,carrot,O,3255.0,"IgE reactivity for raw carrot immunoblot was completely inhibited by carrot and by celery , but not by olive or grass pollens ."
93771,immunoblot,O,3255.0,"IgE reactivity for raw carrot immunoblot was completely inhibited by carrot and by celery , but not by olive or grass pollens ."
93772,was,O,3255.0,"IgE reactivity for raw carrot immunoblot was completely inhibited by carrot and by celery , but not by olive or grass pollens ."
93773,completely,O,3255.0,"IgE reactivity for raw carrot immunoblot was completely inhibited by carrot and by celery , but not by olive or grass pollens ."
93774,inhibited,O,3255.0,"IgE reactivity for raw carrot immunoblot was completely inhibited by carrot and by celery , but not by olive or grass pollens ."
93775,by,O,3255.0,"IgE reactivity for raw carrot immunoblot was completely inhibited by carrot and by celery , but not by olive or grass pollens ."
93776,carrot,B-AG.01.h.02.a,3255.0,"IgE reactivity for raw carrot immunoblot was completely inhibited by carrot and by celery , but not by olive or grass pollens ."
93777,and,O,3255.0,"IgE reactivity for raw carrot immunoblot was completely inhibited by carrot and by celery , but not by olive or grass pollens ."
93778,by,O,3255.0,"IgE reactivity for raw carrot immunoblot was completely inhibited by carrot and by celery , but not by olive or grass pollens ."
93779,celery,B-AG.01.h.02.a,3255.0,"IgE reactivity for raw carrot immunoblot was completely inhibited by carrot and by celery , but not by olive or grass pollens ."
93780,",",O,3255.0,"IgE reactivity for raw carrot immunoblot was completely inhibited by carrot and by celery , but not by olive or grass pollens ."
93781,but,O,3255.0,"IgE reactivity for raw carrot immunoblot was completely inhibited by carrot and by celery , but not by olive or grass pollens ."
93782,not,O,3255.0,"IgE reactivity for raw carrot immunoblot was completely inhibited by carrot and by celery , but not by olive or grass pollens ."
93783,by,O,3255.0,"IgE reactivity for raw carrot immunoblot was completely inhibited by carrot and by celery , but not by olive or grass pollens ."
93784,olive,B-AG.01.h.01.e,3255.0,"IgE reactivity for raw carrot immunoblot was completely inhibited by carrot and by celery , but not by olive or grass pollens ."
93785,or,O,3255.0,"IgE reactivity for raw carrot immunoblot was completely inhibited by carrot and by celery , but not by olive or grass pollens ."
93786,grass,O,3255.0,"IgE reactivity for raw carrot immunoblot was completely inhibited by carrot and by celery , but not by olive or grass pollens ."
93787,pollens,O,3255.0,"IgE reactivity for raw carrot immunoblot was completely inhibited by carrot and by celery , but not by olive or grass pollens ."
93788,.,O,3255.0,"IgE reactivity for raw carrot immunoblot was completely inhibited by carrot and by celery , but not by olive or grass pollens ."
93789,Specific,O,3256.0,Specific IgE to olive pollen was not inhibited by carrot .
93790,IgE,O,3256.0,Specific IgE to olive pollen was not inhibited by carrot .
93791,to,O,3256.0,Specific IgE to olive pollen was not inhibited by carrot .
93792,olive,O,3256.0,Specific IgE to olive pollen was not inhibited by carrot .
93793,pollen,O,3256.0,Specific IgE to olive pollen was not inhibited by carrot .
93794,was,O,3256.0,Specific IgE to olive pollen was not inhibited by carrot .
93795,not,O,3256.0,Specific IgE to olive pollen was not inhibited by carrot .
93796,inhibited,O,3256.0,Specific IgE to olive pollen was not inhibited by carrot .
93797,by,O,3256.0,Specific IgE to olive pollen was not inhibited by carrot .
93798,carrot,B-AG.01.h.02.a,3256.0,Specific IgE to olive pollen was not inhibited by carrot .
93799,.,O,3256.0,Specific IgE to olive pollen was not inhibited by carrot .
93800,The,O,3257.0,The existence of monosensitization to an 18 - kDa protein in carrot and specific IgE to olive pollen has not been reported in the celery - carrot - mugwort - spice syndrome .
93801,existence,O,3257.0,The existence of monosensitization to an 18 - kDa protein in carrot and specific IgE to olive pollen has not been reported in the celery - carrot - mugwort - spice syndrome .
93802,of,O,3257.0,The existence of monosensitization to an 18 - kDa protein in carrot and specific IgE to olive pollen has not been reported in the celery - carrot - mugwort - spice syndrome .
93803,monosensitization,O,3257.0,The existence of monosensitization to an 18 - kDa protein in carrot and specific IgE to olive pollen has not been reported in the celery - carrot - mugwort - spice syndrome .
93804,to,O,3257.0,The existence of monosensitization to an 18 - kDa protein in carrot and specific IgE to olive pollen has not been reported in the celery - carrot - mugwort - spice syndrome .
93805,an,O,3257.0,The existence of monosensitization to an 18 - kDa protein in carrot and specific IgE to olive pollen has not been reported in the celery - carrot - mugwort - spice syndrome .
93806,18,O,3257.0,The existence of monosensitization to an 18 - kDa protein in carrot and specific IgE to olive pollen has not been reported in the celery - carrot - mugwort - spice syndrome .
93807,-,O,3257.0,The existence of monosensitization to an 18 - kDa protein in carrot and specific IgE to olive pollen has not been reported in the celery - carrot - mugwort - spice syndrome .
93808,kDa,O,3257.0,The existence of monosensitization to an 18 - kDa protein in carrot and specific IgE to olive pollen has not been reported in the celery - carrot - mugwort - spice syndrome .
93809,protein,O,3257.0,The existence of monosensitization to an 18 - kDa protein in carrot and specific IgE to olive pollen has not been reported in the celery - carrot - mugwort - spice syndrome .
93810,in,O,3257.0,The existence of monosensitization to an 18 - kDa protein in carrot and specific IgE to olive pollen has not been reported in the celery - carrot - mugwort - spice syndrome .
93811,carrot,B-AG.01.h.02.a,3257.0,The existence of monosensitization to an 18 - kDa protein in carrot and specific IgE to olive pollen has not been reported in the celery - carrot - mugwort - spice syndrome .
93812,and,O,3257.0,The existence of monosensitization to an 18 - kDa protein in carrot and specific IgE to olive pollen has not been reported in the celery - carrot - mugwort - spice syndrome .
93813,specific,O,3257.0,The existence of monosensitization to an 18 - kDa protein in carrot and specific IgE to olive pollen has not been reported in the celery - carrot - mugwort - spice syndrome .
93814,IgE,O,3257.0,The existence of monosensitization to an 18 - kDa protein in carrot and specific IgE to olive pollen has not been reported in the celery - carrot - mugwort - spice syndrome .
93815,to,O,3257.0,The existence of monosensitization to an 18 - kDa protein in carrot and specific IgE to olive pollen has not been reported in the celery - carrot - mugwort - spice syndrome .
93816,olive,O,3257.0,The existence of monosensitization to an 18 - kDa protein in carrot and specific IgE to olive pollen has not been reported in the celery - carrot - mugwort - spice syndrome .
93817,pollen,O,3257.0,The existence of monosensitization to an 18 - kDa protein in carrot and specific IgE to olive pollen has not been reported in the celery - carrot - mugwort - spice syndrome .
93818,has,O,3257.0,The existence of monosensitization to an 18 - kDa protein in carrot and specific IgE to olive pollen has not been reported in the celery - carrot - mugwort - spice syndrome .
93819,not,O,3257.0,The existence of monosensitization to an 18 - kDa protein in carrot and specific IgE to olive pollen has not been reported in the celery - carrot - mugwort - spice syndrome .
93820,been,O,3257.0,The existence of monosensitization to an 18 - kDa protein in carrot and specific IgE to olive pollen has not been reported in the celery - carrot - mugwort - spice syndrome .
93821,reported,O,3257.0,The existence of monosensitization to an 18 - kDa protein in carrot and specific IgE to olive pollen has not been reported in the celery - carrot - mugwort - spice syndrome .
93822,in,O,3257.0,The existence of monosensitization to an 18 - kDa protein in carrot and specific IgE to olive pollen has not been reported in the celery - carrot - mugwort - spice syndrome .
93823,the,O,3257.0,The existence of monosensitization to an 18 - kDa protein in carrot and specific IgE to olive pollen has not been reported in the celery - carrot - mugwort - spice syndrome .
93824,celery,O,3257.0,The existence of monosensitization to an 18 - kDa protein in carrot and specific IgE to olive pollen has not been reported in the celery - carrot - mugwort - spice syndrome .
93825,-,O,3257.0,The existence of monosensitization to an 18 - kDa protein in carrot and specific IgE to olive pollen has not been reported in the celery - carrot - mugwort - spice syndrome .
93826,carrot,O,3257.0,The existence of monosensitization to an 18 - kDa protein in carrot and specific IgE to olive pollen has not been reported in the celery - carrot - mugwort - spice syndrome .
93827,-,O,3257.0,The existence of monosensitization to an 18 - kDa protein in carrot and specific IgE to olive pollen has not been reported in the celery - carrot - mugwort - spice syndrome .
93828,mugwort,O,3257.0,The existence of monosensitization to an 18 - kDa protein in carrot and specific IgE to olive pollen has not been reported in the celery - carrot - mugwort - spice syndrome .
93829,-,O,3257.0,The existence of monosensitization to an 18 - kDa protein in carrot and specific IgE to olive pollen has not been reported in the celery - carrot - mugwort - spice syndrome .
93830,spice,O,3257.0,The existence of monosensitization to an 18 - kDa protein in carrot and specific IgE to olive pollen has not been reported in the celery - carrot - mugwort - spice syndrome .
93831,syndrome,O,3257.0,The existence of monosensitization to an 18 - kDa protein in carrot and specific IgE to olive pollen has not been reported in the celery - carrot - mugwort - spice syndrome .
93832,.,O,3257.0,The existence of monosensitization to an 18 - kDa protein in carrot and specific IgE to olive pollen has not been reported in the celery - carrot - mugwort - spice syndrome .
93833,Botanical,O,3258.0,Botanical products are widely used in nutritional supplementation for promotion of health or prevention of diseases .
93834,products,O,3258.0,Botanical products are widely used in nutritional supplementation for promotion of health or prevention of diseases .
93835,are,O,3258.0,Botanical products are widely used in nutritional supplementation for promotion of health or prevention of diseases .
93836,widely,O,3258.0,Botanical products are widely used in nutritional supplementation for promotion of health or prevention of diseases .
93837,used,O,3258.0,Botanical products are widely used in nutritional supplementation for promotion of health or prevention of diseases .
93838,in,O,3258.0,Botanical products are widely used in nutritional supplementation for promotion of health or prevention of diseases .
93839,nutritional,O,3258.0,Botanical products are widely used in nutritional supplementation for promotion of health or prevention of diseases .
93840,supplementation,O,3258.0,Botanical products are widely used in nutritional supplementation for promotion of health or prevention of diseases .
93841,for,O,3258.0,Botanical products are widely used in nutritional supplementation for promotion of health or prevention of diseases .
93842,promotion,O,3258.0,Botanical products are widely used in nutritional supplementation for promotion of health or prevention of diseases .
93843,of,O,3258.0,Botanical products are widely used in nutritional supplementation for promotion of health or prevention of diseases .
93844,health,O,3258.0,Botanical products are widely used in nutritional supplementation for promotion of health or prevention of diseases .
93845,or,O,3258.0,Botanical products are widely used in nutritional supplementation for promotion of health or prevention of diseases .
93846,prevention,O,3258.0,Botanical products are widely used in nutritional supplementation for promotion of health or prevention of diseases .
93847,of,O,3258.0,Botanical products are widely used in nutritional supplementation for promotion of health or prevention of diseases .
93848,diseases,O,3258.0,Botanical products are widely used in nutritional supplementation for promotion of health or prevention of diseases .
93849,.,O,3258.0,Botanical products are widely used in nutritional supplementation for promotion of health or prevention of diseases .
93850,With,O,3259.0,"With the high prevalence of obesity and type 2 diabetes , abnormalities in carbohydrate metabolism are common in the general population and obtaining glycemic control is important in reducing the complications of diabetes ."
93851,the,O,3259.0,"With the high prevalence of obesity and type 2 diabetes , abnormalities in carbohydrate metabolism are common in the general population and obtaining glycemic control is important in reducing the complications of diabetes ."
93852,high,O,3259.0,"With the high prevalence of obesity and type 2 diabetes , abnormalities in carbohydrate metabolism are common in the general population and obtaining glycemic control is important in reducing the complications of diabetes ."
93853,prevalence,O,3259.0,"With the high prevalence of obesity and type 2 diabetes , abnormalities in carbohydrate metabolism are common in the general population and obtaining glycemic control is important in reducing the complications of diabetes ."
93854,of,O,3259.0,"With the high prevalence of obesity and type 2 diabetes , abnormalities in carbohydrate metabolism are common in the general population and obtaining glycemic control is important in reducing the complications of diabetes ."
93855,obesity,O,3259.0,"With the high prevalence of obesity and type 2 diabetes , abnormalities in carbohydrate metabolism are common in the general population and obtaining glycemic control is important in reducing the complications of diabetes ."
93856,and,O,3259.0,"With the high prevalence of obesity and type 2 diabetes , abnormalities in carbohydrate metabolism are common in the general population and obtaining glycemic control is important in reducing the complications of diabetes ."
93857,type,O,3259.0,"With the high prevalence of obesity and type 2 diabetes , abnormalities in carbohydrate metabolism are common in the general population and obtaining glycemic control is important in reducing the complications of diabetes ."
93858,2,O,3259.0,"With the high prevalence of obesity and type 2 diabetes , abnormalities in carbohydrate metabolism are common in the general population and obtaining glycemic control is important in reducing the complications of diabetes ."
93859,diabetes,O,3259.0,"With the high prevalence of obesity and type 2 diabetes , abnormalities in carbohydrate metabolism are common in the general population and obtaining glycemic control is important in reducing the complications of diabetes ."
93860,",",O,3259.0,"With the high prevalence of obesity and type 2 diabetes , abnormalities in carbohydrate metabolism are common in the general population and obtaining glycemic control is important in reducing the complications of diabetes ."
93861,abnormalities,O,3259.0,"With the high prevalence of obesity and type 2 diabetes , abnormalities in carbohydrate metabolism are common in the general population and obtaining glycemic control is important in reducing the complications of diabetes ."
93862,in,O,3259.0,"With the high prevalence of obesity and type 2 diabetes , abnormalities in carbohydrate metabolism are common in the general population and obtaining glycemic control is important in reducing the complications of diabetes ."
93863,carbohydrate,O,3259.0,"With the high prevalence of obesity and type 2 diabetes , abnormalities in carbohydrate metabolism are common in the general population and obtaining glycemic control is important in reducing the complications of diabetes ."
93864,metabolism,O,3259.0,"With the high prevalence of obesity and type 2 diabetes , abnormalities in carbohydrate metabolism are common in the general population and obtaining glycemic control is important in reducing the complications of diabetes ."
93865,are,O,3259.0,"With the high prevalence of obesity and type 2 diabetes , abnormalities in carbohydrate metabolism are common in the general population and obtaining glycemic control is important in reducing the complications of diabetes ."
93866,common,O,3259.0,"With the high prevalence of obesity and type 2 diabetes , abnormalities in carbohydrate metabolism are common in the general population and obtaining glycemic control is important in reducing the complications of diabetes ."
93867,in,O,3259.0,"With the high prevalence of obesity and type 2 diabetes , abnormalities in carbohydrate metabolism are common in the general population and obtaining glycemic control is important in reducing the complications of diabetes ."
93868,the,O,3259.0,"With the high prevalence of obesity and type 2 diabetes , abnormalities in carbohydrate metabolism are common in the general population and obtaining glycemic control is important in reducing the complications of diabetes ."
93869,general,O,3259.0,"With the high prevalence of obesity and type 2 diabetes , abnormalities in carbohydrate metabolism are common in the general population and obtaining glycemic control is important in reducing the complications of diabetes ."
93870,population,O,3259.0,"With the high prevalence of obesity and type 2 diabetes , abnormalities in carbohydrate metabolism are common in the general population and obtaining glycemic control is important in reducing the complications of diabetes ."
93871,and,O,3259.0,"With the high prevalence of obesity and type 2 diabetes , abnormalities in carbohydrate metabolism are common in the general population and obtaining glycemic control is important in reducing the complications of diabetes ."
93872,obtaining,O,3259.0,"With the high prevalence of obesity and type 2 diabetes , abnormalities in carbohydrate metabolism are common in the general population and obtaining glycemic control is important in reducing the complications of diabetes ."
93873,glycemic,O,3259.0,"With the high prevalence of obesity and type 2 diabetes , abnormalities in carbohydrate metabolism are common in the general population and obtaining glycemic control is important in reducing the complications of diabetes ."
93874,control,O,3259.0,"With the high prevalence of obesity and type 2 diabetes , abnormalities in carbohydrate metabolism are common in the general population and obtaining glycemic control is important in reducing the complications of diabetes ."
93875,is,O,3259.0,"With the high prevalence of obesity and type 2 diabetes , abnormalities in carbohydrate metabolism are common in the general population and obtaining glycemic control is important in reducing the complications of diabetes ."
93876,important,O,3259.0,"With the high prevalence of obesity and type 2 diabetes , abnormalities in carbohydrate metabolism are common in the general population and obtaining glycemic control is important in reducing the complications of diabetes ."
93877,in,O,3259.0,"With the high prevalence of obesity and type 2 diabetes , abnormalities in carbohydrate metabolism are common in the general population and obtaining glycemic control is important in reducing the complications of diabetes ."
93878,reducing,O,3259.0,"With the high prevalence of obesity and type 2 diabetes , abnormalities in carbohydrate metabolism are common in the general population and obtaining glycemic control is important in reducing the complications of diabetes ."
93879,the,O,3259.0,"With the high prevalence of obesity and type 2 diabetes , abnormalities in carbohydrate metabolism are common in the general population and obtaining glycemic control is important in reducing the complications of diabetes ."
93880,complications,O,3259.0,"With the high prevalence of obesity and type 2 diabetes , abnormalities in carbohydrate metabolism are common in the general population and obtaining glycemic control is important in reducing the complications of diabetes ."
93881,of,O,3259.0,"With the high prevalence of obesity and type 2 diabetes , abnormalities in carbohydrate metabolism are common in the general population and obtaining glycemic control is important in reducing the complications of diabetes ."
93882,diabetes,O,3259.0,"With the high prevalence of obesity and type 2 diabetes , abnormalities in carbohydrate metabolism are common in the general population and obtaining glycemic control is important in reducing the complications of diabetes ."
93883,.,O,3259.0,"With the high prevalence of obesity and type 2 diabetes , abnormalities in carbohydrate metabolism are common in the general population and obtaining glycemic control is important in reducing the complications of diabetes ."
93884,If,O,3260.0,"If shown to be effective , botanical products have a unique position in potentially aiding the general public in regard to obesity and diabetes ."
93885,shown,O,3260.0,"If shown to be effective , botanical products have a unique position in potentially aiding the general public in regard to obesity and diabetes ."
93886,to,O,3260.0,"If shown to be effective , botanical products have a unique position in potentially aiding the general public in regard to obesity and diabetes ."
93887,be,O,3260.0,"If shown to be effective , botanical products have a unique position in potentially aiding the general public in regard to obesity and diabetes ."
93888,effective,O,3260.0,"If shown to be effective , botanical products have a unique position in potentially aiding the general public in regard to obesity and diabetes ."
93889,",",O,3260.0,"If shown to be effective , botanical products have a unique position in potentially aiding the general public in regard to obesity and diabetes ."
93890,botanical,O,3260.0,"If shown to be effective , botanical products have a unique position in potentially aiding the general public in regard to obesity and diabetes ."
93891,products,O,3260.0,"If shown to be effective , botanical products have a unique position in potentially aiding the general public in regard to obesity and diabetes ."
93892,have,O,3260.0,"If shown to be effective , botanical products have a unique position in potentially aiding the general public in regard to obesity and diabetes ."
93893,a,O,3260.0,"If shown to be effective , botanical products have a unique position in potentially aiding the general public in regard to obesity and diabetes ."
93894,unique,O,3260.0,"If shown to be effective , botanical products have a unique position in potentially aiding the general public in regard to obesity and diabetes ."
93895,position,O,3260.0,"If shown to be effective , botanical products have a unique position in potentially aiding the general public in regard to obesity and diabetes ."
93896,in,O,3260.0,"If shown to be effective , botanical products have a unique position in potentially aiding the general public in regard to obesity and diabetes ."
93897,potentially,O,3260.0,"If shown to be effective , botanical products have a unique position in potentially aiding the general public in regard to obesity and diabetes ."
93898,aiding,O,3260.0,"If shown to be effective , botanical products have a unique position in potentially aiding the general public in regard to obesity and diabetes ."
93899,the,O,3260.0,"If shown to be effective , botanical products have a unique position in potentially aiding the general public in regard to obesity and diabetes ."
93900,general,O,3260.0,"If shown to be effective , botanical products have a unique position in potentially aiding the general public in regard to obesity and diabetes ."
93901,public,O,3260.0,"If shown to be effective , botanical products have a unique position in potentially aiding the general public in regard to obesity and diabetes ."
93902,in,O,3260.0,"If shown to be effective , botanical products have a unique position in potentially aiding the general public in regard to obesity and diabetes ."
93903,regard,O,3260.0,"If shown to be effective , botanical products have a unique position in potentially aiding the general public in regard to obesity and diabetes ."
93904,to,O,3260.0,"If shown to be effective , botanical products have a unique position in potentially aiding the general public in regard to obesity and diabetes ."
93905,obesity,O,3260.0,"If shown to be effective , botanical products have a unique position in potentially aiding the general public in regard to obesity and diabetes ."
93906,and,O,3260.0,"If shown to be effective , botanical products have a unique position in potentially aiding the general public in regard to obesity and diabetes ."
93907,diabetes,O,3260.0,"If shown to be effective , botanical products have a unique position in potentially aiding the general public in regard to obesity and diabetes ."
93908,.,O,3260.0,"If shown to be effective , botanical products have a unique position in potentially aiding the general public in regard to obesity and diabetes ."
93909,They,O,3261.0,"They can be obtained "" over - the - counter "" and may have less side effects compared to many synthetic drugs ."
93910,can,O,3261.0,"They can be obtained "" over - the - counter "" and may have less side effects compared to many synthetic drugs ."
93911,be,O,3261.0,"They can be obtained "" over - the - counter "" and may have less side effects compared to many synthetic drugs ."
93912,obtained,O,3261.0,"They can be obtained "" over - the - counter "" and may have less side effects compared to many synthetic drugs ."
93913,"""",O,3261.0,"They can be obtained "" over - the - counter "" and may have less side effects compared to many synthetic drugs ."
93914,over,O,3261.0,"They can be obtained "" over - the - counter "" and may have less side effects compared to many synthetic drugs ."
93915,-,O,3261.0,"They can be obtained "" over - the - counter "" and may have less side effects compared to many synthetic drugs ."
93916,the,O,3261.0,"They can be obtained "" over - the - counter "" and may have less side effects compared to many synthetic drugs ."
93917,-,O,3261.0,"They can be obtained "" over - the - counter "" and may have less side effects compared to many synthetic drugs ."
93918,counter,O,3261.0,"They can be obtained "" over - the - counter "" and may have less side effects compared to many synthetic drugs ."
93919,"""",O,3261.0,"They can be obtained "" over - the - counter "" and may have less side effects compared to many synthetic drugs ."
93920,and,O,3261.0,"They can be obtained "" over - the - counter "" and may have less side effects compared to many synthetic drugs ."
93921,may,O,3261.0,"They can be obtained "" over - the - counter "" and may have less side effects compared to many synthetic drugs ."
93922,have,O,3261.0,"They can be obtained "" over - the - counter "" and may have less side effects compared to many synthetic drugs ."
93923,less,O,3261.0,"They can be obtained "" over - the - counter "" and may have less side effects compared to many synthetic drugs ."
93924,side,O,3261.0,"They can be obtained "" over - the - counter "" and may have less side effects compared to many synthetic drugs ."
93925,effects,O,3261.0,"They can be obtained "" over - the - counter "" and may have less side effects compared to many synthetic drugs ."
93926,compared,O,3261.0,"They can be obtained "" over - the - counter "" and may have less side effects compared to many synthetic drugs ."
93927,to,O,3261.0,"They can be obtained "" over - the - counter "" and may have less side effects compared to many synthetic drugs ."
93928,many,O,3261.0,"They can be obtained "" over - the - counter "" and may have less side effects compared to many synthetic drugs ."
93929,synthetic,O,3261.0,"They can be obtained "" over - the - counter "" and may have less side effects compared to many synthetic drugs ."
93930,drugs,O,3261.0,"They can be obtained "" over - the - counter "" and may have less side effects compared to many synthetic drugs ."
93931,.,O,3261.0,"They can be obtained "" over - the - counter "" and may have less side effects compared to many synthetic drugs ."
93932,Although,O,3262.0,"Although most of the popular botanicals have a long history in folk medicine , there is paucity of data regarding their efficacy and safety , particularly as it relates to human studies ."
93933,most,O,3262.0,"Although most of the popular botanicals have a long history in folk medicine , there is paucity of data regarding their efficacy and safety , particularly as it relates to human studies ."
93934,of,O,3262.0,"Although most of the popular botanicals have a long history in folk medicine , there is paucity of data regarding their efficacy and safety , particularly as it relates to human studies ."
93935,the,O,3262.0,"Although most of the popular botanicals have a long history in folk medicine , there is paucity of data regarding their efficacy and safety , particularly as it relates to human studies ."
93936,popular,O,3262.0,"Although most of the popular botanicals have a long history in folk medicine , there is paucity of data regarding their efficacy and safety , particularly as it relates to human studies ."
93937,botanicals,O,3262.0,"Although most of the popular botanicals have a long history in folk medicine , there is paucity of data regarding their efficacy and safety , particularly as it relates to human studies ."
93938,have,O,3262.0,"Although most of the popular botanicals have a long history in folk medicine , there is paucity of data regarding their efficacy and safety , particularly as it relates to human studies ."
93939,a,O,3262.0,"Although most of the popular botanicals have a long history in folk medicine , there is paucity of data regarding their efficacy and safety , particularly as it relates to human studies ."
93940,long,O,3262.0,"Although most of the popular botanicals have a long history in folk medicine , there is paucity of data regarding their efficacy and safety , particularly as it relates to human studies ."
93941,history,O,3262.0,"Although most of the popular botanicals have a long history in folk medicine , there is paucity of data regarding their efficacy and safety , particularly as it relates to human studies ."
93942,in,O,3262.0,"Although most of the popular botanicals have a long history in folk medicine , there is paucity of data regarding their efficacy and safety , particularly as it relates to human studies ."
93943,folk,O,3262.0,"Although most of the popular botanicals have a long history in folk medicine , there is paucity of data regarding their efficacy and safety , particularly as it relates to human studies ."
93944,medicine,O,3262.0,"Although most of the popular botanicals have a long history in folk medicine , there is paucity of data regarding their efficacy and safety , particularly as it relates to human studies ."
93945,",",O,3262.0,"Although most of the popular botanicals have a long history in folk medicine , there is paucity of data regarding their efficacy and safety , particularly as it relates to human studies ."
93946,there,O,3262.0,"Although most of the popular botanicals have a long history in folk medicine , there is paucity of data regarding their efficacy and safety , particularly as it relates to human studies ."
93947,is,O,3262.0,"Although most of the popular botanicals have a long history in folk medicine , there is paucity of data regarding their efficacy and safety , particularly as it relates to human studies ."
93948,paucity,O,3262.0,"Although most of the popular botanicals have a long history in folk medicine , there is paucity of data regarding their efficacy and safety , particularly as it relates to human studies ."
93949,of,O,3262.0,"Although most of the popular botanicals have a long history in folk medicine , there is paucity of data regarding their efficacy and safety , particularly as it relates to human studies ."
93950,data,O,3262.0,"Although most of the popular botanicals have a long history in folk medicine , there is paucity of data regarding their efficacy and safety , particularly as it relates to human studies ."
93951,regarding,O,3262.0,"Although most of the popular botanicals have a long history in folk medicine , there is paucity of data regarding their efficacy and safety , particularly as it relates to human studies ."
93952,their,O,3262.0,"Although most of the popular botanicals have a long history in folk medicine , there is paucity of data regarding their efficacy and safety , particularly as it relates to human studies ."
93953,efficacy,O,3262.0,"Although most of the popular botanicals have a long history in folk medicine , there is paucity of data regarding their efficacy and safety , particularly as it relates to human studies ."
93954,and,O,3262.0,"Although most of the popular botanicals have a long history in folk medicine , there is paucity of data regarding their efficacy and safety , particularly as it relates to human studies ."
93955,safety,O,3262.0,"Although most of the popular botanicals have a long history in folk medicine , there is paucity of data regarding their efficacy and safety , particularly as it relates to human studies ."
93956,",",O,3262.0,"Although most of the popular botanicals have a long history in folk medicine , there is paucity of data regarding their efficacy and safety , particularly as it relates to human studies ."
93957,particularly,O,3262.0,"Although most of the popular botanicals have a long history in folk medicine , there is paucity of data regarding their efficacy and safety , particularly as it relates to human studies ."
93958,as,O,3262.0,"Although most of the popular botanicals have a long history in folk medicine , there is paucity of data regarding their efficacy and safety , particularly as it relates to human studies ."
93959,it,O,3262.0,"Although most of the popular botanicals have a long history in folk medicine , there is paucity of data regarding their efficacy and safety , particularly as it relates to human studies ."
93960,relates,O,3262.0,"Although most of the popular botanicals have a long history in folk medicine , there is paucity of data regarding their efficacy and safety , particularly as it relates to human studies ."
93961,to,O,3262.0,"Although most of the popular botanicals have a long history in folk medicine , there is paucity of data regarding their efficacy and safety , particularly as it relates to human studies ."
93962,human,O,3262.0,"Although most of the popular botanicals have a long history in folk medicine , there is paucity of data regarding their efficacy and safety , particularly as it relates to human studies ."
93963,studies,O,3262.0,"Although most of the popular botanicals have a long history in folk medicine , there is paucity of data regarding their efficacy and safety , particularly as it relates to human studies ."
93964,.,O,3262.0,"Although most of the popular botanicals have a long history in folk medicine , there is paucity of data regarding their efficacy and safety , particularly as it relates to human studies ."
93965,In,O,3263.0,"In this review , we discuss the data that was available in the literature for nine botanicals that are frequently promoted to help manage blood glucose ."
93966,this,O,3263.0,"In this review , we discuss the data that was available in the literature for nine botanicals that are frequently promoted to help manage blood glucose ."
93967,review,O,3263.0,"In this review , we discuss the data that was available in the literature for nine botanicals that are frequently promoted to help manage blood glucose ."
93968,",",O,3263.0,"In this review , we discuss the data that was available in the literature for nine botanicals that are frequently promoted to help manage blood glucose ."
93969,we,O,3263.0,"In this review , we discuss the data that was available in the literature for nine botanicals that are frequently promoted to help manage blood glucose ."
93970,discuss,O,3263.0,"In this review , we discuss the data that was available in the literature for nine botanicals that are frequently promoted to help manage blood glucose ."
93971,the,O,3263.0,"In this review , we discuss the data that was available in the literature for nine botanicals that are frequently promoted to help manage blood glucose ."
93972,data,O,3263.0,"In this review , we discuss the data that was available in the literature for nine botanicals that are frequently promoted to help manage blood glucose ."
93973,that,O,3263.0,"In this review , we discuss the data that was available in the literature for nine botanicals that are frequently promoted to help manage blood glucose ."
93974,was,O,3263.0,"In this review , we discuss the data that was available in the literature for nine botanicals that are frequently promoted to help manage blood glucose ."
93975,available,O,3263.0,"In this review , we discuss the data that was available in the literature for nine botanicals that are frequently promoted to help manage blood glucose ."
93976,in,O,3263.0,"In this review , we discuss the data that was available in the literature for nine botanicals that are frequently promoted to help manage blood glucose ."
93977,the,O,3263.0,"In this review , we discuss the data that was available in the literature for nine botanicals that are frequently promoted to help manage blood glucose ."
93978,literature,O,3263.0,"In this review , we discuss the data that was available in the literature for nine botanicals that are frequently promoted to help manage blood glucose ."
93979,for,O,3263.0,"In this review , we discuss the data that was available in the literature for nine botanicals that are frequently promoted to help manage blood glucose ."
93980,nine,O,3263.0,"In this review , we discuss the data that was available in the literature for nine botanicals that are frequently promoted to help manage blood glucose ."
93981,botanicals,O,3263.0,"In this review , we discuss the data that was available in the literature for nine botanicals that are frequently promoted to help manage blood glucose ."
93982,that,O,3263.0,"In this review , we discuss the data that was available in the literature for nine botanicals that are frequently promoted to help manage blood glucose ."
93983,are,O,3263.0,"In this review , we discuss the data that was available in the literature for nine botanicals that are frequently promoted to help manage blood glucose ."
93984,frequently,O,3263.0,"In this review , we discuss the data that was available in the literature for nine botanicals that are frequently promoted to help manage blood glucose ."
93985,promoted,O,3263.0,"In this review , we discuss the data that was available in the literature for nine botanicals that are frequently promoted to help manage blood glucose ."
93986,to,O,3263.0,"In this review , we discuss the data that was available in the literature for nine botanicals that are frequently promoted to help manage blood glucose ."
93987,help,O,3263.0,"In this review , we discuss the data that was available in the literature for nine botanicals that are frequently promoted to help manage blood glucose ."
93988,manage,O,3263.0,"In this review , we discuss the data that was available in the literature for nine botanicals that are frequently promoted to help manage blood glucose ."
93989,blood,O,3263.0,"In this review , we discuss the data that was available in the literature for nine botanicals that are frequently promoted to help manage blood glucose ."
93990,glucose,O,3263.0,"In this review , we discuss the data that was available in the literature for nine botanicals that are frequently promoted to help manage blood glucose ."
93991,.,O,3263.0,"In this review , we discuss the data that was available in the literature for nine botanicals that are frequently promoted to help manage blood glucose ."
93992,They,O,3264.0,"They are Bitter Melon ( Momordica charantia ) , Fenugreek ( trigonella foenum graecum ) , Gymnema Sylvestre , Ivy Gourd ( Coccinia indica ) , Nopal or Prickly Pear Cactus ( Opuntia streptacantha ) , Ginseng , Aloe Vera , Russian Tarragon ( Artemisia dracunculus ) , and Garlic ( Allium sativum ) ."
93993,are,O,3264.0,"They are Bitter Melon ( Momordica charantia ) , Fenugreek ( trigonella foenum graecum ) , Gymnema Sylvestre , Ivy Gourd ( Coccinia indica ) , Nopal or Prickly Pear Cactus ( Opuntia streptacantha ) , Ginseng , Aloe Vera , Russian Tarragon ( Artemisia dracunculus ) , and Garlic ( Allium sativum ) ."
93994,Bitter,B-AG.01.h.02.i,3264.0,"They are Bitter Melon ( Momordica charantia ) , Fenugreek ( trigonella foenum graecum ) , Gymnema Sylvestre , Ivy Gourd ( Coccinia indica ) , Nopal or Prickly Pear Cactus ( Opuntia streptacantha ) , Ginseng , Aloe Vera , Russian Tarragon ( Artemisia dracunculus ) , and Garlic ( Allium sativum ) ."
93995,Melon,I-AG.01.h.02.i,3264.0,"They are Bitter Melon ( Momordica charantia ) , Fenugreek ( trigonella foenum graecum ) , Gymnema Sylvestre , Ivy Gourd ( Coccinia indica ) , Nopal or Prickly Pear Cactus ( Opuntia streptacantha ) , Ginseng , Aloe Vera , Russian Tarragon ( Artemisia dracunculus ) , and Garlic ( Allium sativum ) ."
93996,(,O,3264.0,"They are Bitter Melon ( Momordica charantia ) , Fenugreek ( trigonella foenum graecum ) , Gymnema Sylvestre , Ivy Gourd ( Coccinia indica ) , Nopal or Prickly Pear Cactus ( Opuntia streptacantha ) , Ginseng , Aloe Vera , Russian Tarragon ( Artemisia dracunculus ) , and Garlic ( Allium sativum ) ."
93997,Momordica,B-AG.01.h.02.i,3264.0,"They are Bitter Melon ( Momordica charantia ) , Fenugreek ( trigonella foenum graecum ) , Gymnema Sylvestre , Ivy Gourd ( Coccinia indica ) , Nopal or Prickly Pear Cactus ( Opuntia streptacantha ) , Ginseng , Aloe Vera , Russian Tarragon ( Artemisia dracunculus ) , and Garlic ( Allium sativum ) ."
93998,charantia,I-AG.01.h.02.i,3264.0,"They are Bitter Melon ( Momordica charantia ) , Fenugreek ( trigonella foenum graecum ) , Gymnema Sylvestre , Ivy Gourd ( Coccinia indica ) , Nopal or Prickly Pear Cactus ( Opuntia streptacantha ) , Ginseng , Aloe Vera , Russian Tarragon ( Artemisia dracunculus ) , and Garlic ( Allium sativum ) ."
93999,),O,3264.0,"They are Bitter Melon ( Momordica charantia ) , Fenugreek ( trigonella foenum graecum ) , Gymnema Sylvestre , Ivy Gourd ( Coccinia indica ) , Nopal or Prickly Pear Cactus ( Opuntia streptacantha ) , Ginseng , Aloe Vera , Russian Tarragon ( Artemisia dracunculus ) , and Garlic ( Allium sativum ) ."
94000,",",O,3264.0,"They are Bitter Melon ( Momordica charantia ) , Fenugreek ( trigonella foenum graecum ) , Gymnema Sylvestre , Ivy Gourd ( Coccinia indica ) , Nopal or Prickly Pear Cactus ( Opuntia streptacantha ) , Ginseng , Aloe Vera , Russian Tarragon ( Artemisia dracunculus ) , and Garlic ( Allium sativum ) ."
94001,Fenugreek,B-AG.01.l.03,3264.0,"They are Bitter Melon ( Momordica charantia ) , Fenugreek ( trigonella foenum graecum ) , Gymnema Sylvestre , Ivy Gourd ( Coccinia indica ) , Nopal or Prickly Pear Cactus ( Opuntia streptacantha ) , Ginseng , Aloe Vera , Russian Tarragon ( Artemisia dracunculus ) , and Garlic ( Allium sativum ) ."
94002,(,O,3264.0,"They are Bitter Melon ( Momordica charantia ) , Fenugreek ( trigonella foenum graecum ) , Gymnema Sylvestre , Ivy Gourd ( Coccinia indica ) , Nopal or Prickly Pear Cactus ( Opuntia streptacantha ) , Ginseng , Aloe Vera , Russian Tarragon ( Artemisia dracunculus ) , and Garlic ( Allium sativum ) ."
94003,trigonella,B-AG.01.l.03,3264.0,"They are Bitter Melon ( Momordica charantia ) , Fenugreek ( trigonella foenum graecum ) , Gymnema Sylvestre , Ivy Gourd ( Coccinia indica ) , Nopal or Prickly Pear Cactus ( Opuntia streptacantha ) , Ginseng , Aloe Vera , Russian Tarragon ( Artemisia dracunculus ) , and Garlic ( Allium sativum ) ."
94004,foenum,I-AG.01.l.03,3264.0,"They are Bitter Melon ( Momordica charantia ) , Fenugreek ( trigonella foenum graecum ) , Gymnema Sylvestre , Ivy Gourd ( Coccinia indica ) , Nopal or Prickly Pear Cactus ( Opuntia streptacantha ) , Ginseng , Aloe Vera , Russian Tarragon ( Artemisia dracunculus ) , and Garlic ( Allium sativum ) ."
94005,graecum,I-AG.01.l.03,3264.0,"They are Bitter Melon ( Momordica charantia ) , Fenugreek ( trigonella foenum graecum ) , Gymnema Sylvestre , Ivy Gourd ( Coccinia indica ) , Nopal or Prickly Pear Cactus ( Opuntia streptacantha ) , Ginseng , Aloe Vera , Russian Tarragon ( Artemisia dracunculus ) , and Garlic ( Allium sativum ) ."
94006,),O,3264.0,"They are Bitter Melon ( Momordica charantia ) , Fenugreek ( trigonella foenum graecum ) , Gymnema Sylvestre , Ivy Gourd ( Coccinia indica ) , Nopal or Prickly Pear Cactus ( Opuntia streptacantha ) , Ginseng , Aloe Vera , Russian Tarragon ( Artemisia dracunculus ) , and Garlic ( Allium sativum ) ."
94007,",",O,3264.0,"They are Bitter Melon ( Momordica charantia ) , Fenugreek ( trigonella foenum graecum ) , Gymnema Sylvestre , Ivy Gourd ( Coccinia indica ) , Nopal or Prickly Pear Cactus ( Opuntia streptacantha ) , Ginseng , Aloe Vera , Russian Tarragon ( Artemisia dracunculus ) , and Garlic ( Allium sativum ) ."
94008,Gymnema,B-AG.01.h.02.i,3264.0,"They are Bitter Melon ( Momordica charantia ) , Fenugreek ( trigonella foenum graecum ) , Gymnema Sylvestre , Ivy Gourd ( Coccinia indica ) , Nopal or Prickly Pear Cactus ( Opuntia streptacantha ) , Ginseng , Aloe Vera , Russian Tarragon ( Artemisia dracunculus ) , and Garlic ( Allium sativum ) ."
94009,Sylvestre,I-AG.01.h.02.i,3264.0,"They are Bitter Melon ( Momordica charantia ) , Fenugreek ( trigonella foenum graecum ) , Gymnema Sylvestre , Ivy Gourd ( Coccinia indica ) , Nopal or Prickly Pear Cactus ( Opuntia streptacantha ) , Ginseng , Aloe Vera , Russian Tarragon ( Artemisia dracunculus ) , and Garlic ( Allium sativum ) ."
94010,",",O,3264.0,"They are Bitter Melon ( Momordica charantia ) , Fenugreek ( trigonella foenum graecum ) , Gymnema Sylvestre , Ivy Gourd ( Coccinia indica ) , Nopal or Prickly Pear Cactus ( Opuntia streptacantha ) , Ginseng , Aloe Vera , Russian Tarragon ( Artemisia dracunculus ) , and Garlic ( Allium sativum ) ."
94011,Ivy,B-AG.01.h.02.i,3264.0,"They are Bitter Melon ( Momordica charantia ) , Fenugreek ( trigonella foenum graecum ) , Gymnema Sylvestre , Ivy Gourd ( Coccinia indica ) , Nopal or Prickly Pear Cactus ( Opuntia streptacantha ) , Ginseng , Aloe Vera , Russian Tarragon ( Artemisia dracunculus ) , and Garlic ( Allium sativum ) ."
94012,Gourd,I-AG.01.h.02.i,3264.0,"They are Bitter Melon ( Momordica charantia ) , Fenugreek ( trigonella foenum graecum ) , Gymnema Sylvestre , Ivy Gourd ( Coccinia indica ) , Nopal or Prickly Pear Cactus ( Opuntia streptacantha ) , Ginseng , Aloe Vera , Russian Tarragon ( Artemisia dracunculus ) , and Garlic ( Allium sativum ) ."
94013,(,O,3264.0,"They are Bitter Melon ( Momordica charantia ) , Fenugreek ( trigonella foenum graecum ) , Gymnema Sylvestre , Ivy Gourd ( Coccinia indica ) , Nopal or Prickly Pear Cactus ( Opuntia streptacantha ) , Ginseng , Aloe Vera , Russian Tarragon ( Artemisia dracunculus ) , and Garlic ( Allium sativum ) ."
94014,Coccinia,B-AG.01.h.02.i,3264.0,"They are Bitter Melon ( Momordica charantia ) , Fenugreek ( trigonella foenum graecum ) , Gymnema Sylvestre , Ivy Gourd ( Coccinia indica ) , Nopal or Prickly Pear Cactus ( Opuntia streptacantha ) , Ginseng , Aloe Vera , Russian Tarragon ( Artemisia dracunculus ) , and Garlic ( Allium sativum ) ."
94015,indica,I-AG.01.h.02.i,3264.0,"They are Bitter Melon ( Momordica charantia ) , Fenugreek ( trigonella foenum graecum ) , Gymnema Sylvestre , Ivy Gourd ( Coccinia indica ) , Nopal or Prickly Pear Cactus ( Opuntia streptacantha ) , Ginseng , Aloe Vera , Russian Tarragon ( Artemisia dracunculus ) , and Garlic ( Allium sativum ) ."
94016,),O,3264.0,"They are Bitter Melon ( Momordica charantia ) , Fenugreek ( trigonella foenum graecum ) , Gymnema Sylvestre , Ivy Gourd ( Coccinia indica ) , Nopal or Prickly Pear Cactus ( Opuntia streptacantha ) , Ginseng , Aloe Vera , Russian Tarragon ( Artemisia dracunculus ) , and Garlic ( Allium sativum ) ."
94017,",",O,3264.0,"They are Bitter Melon ( Momordica charantia ) , Fenugreek ( trigonella foenum graecum ) , Gymnema Sylvestre , Ivy Gourd ( Coccinia indica ) , Nopal or Prickly Pear Cactus ( Opuntia streptacantha ) , Ginseng , Aloe Vera , Russian Tarragon ( Artemisia dracunculus ) , and Garlic ( Allium sativum ) ."
94018,Nopal,B-AG.01,3264.0,"They are Bitter Melon ( Momordica charantia ) , Fenugreek ( trigonella foenum graecum ) , Gymnema Sylvestre , Ivy Gourd ( Coccinia indica ) , Nopal or Prickly Pear Cactus ( Opuntia streptacantha ) , Ginseng , Aloe Vera , Russian Tarragon ( Artemisia dracunculus ) , and Garlic ( Allium sativum ) ."
94019,or,I-AG.01,3264.0,"They are Bitter Melon ( Momordica charantia ) , Fenugreek ( trigonella foenum graecum ) , Gymnema Sylvestre , Ivy Gourd ( Coccinia indica ) , Nopal or Prickly Pear Cactus ( Opuntia streptacantha ) , Ginseng , Aloe Vera , Russian Tarragon ( Artemisia dracunculus ) , and Garlic ( Allium sativum ) ."
94020,Prickly,I-AG.01,3264.0,"They are Bitter Melon ( Momordica charantia ) , Fenugreek ( trigonella foenum graecum ) , Gymnema Sylvestre , Ivy Gourd ( Coccinia indica ) , Nopal or Prickly Pear Cactus ( Opuntia streptacantha ) , Ginseng , Aloe Vera , Russian Tarragon ( Artemisia dracunculus ) , and Garlic ( Allium sativum ) ."
94021,Pear,I-AG.01,3264.0,"They are Bitter Melon ( Momordica charantia ) , Fenugreek ( trigonella foenum graecum ) , Gymnema Sylvestre , Ivy Gourd ( Coccinia indica ) , Nopal or Prickly Pear Cactus ( Opuntia streptacantha ) , Ginseng , Aloe Vera , Russian Tarragon ( Artemisia dracunculus ) , and Garlic ( Allium sativum ) ."
94022,Cactus,I-AG.01,3264.0,"They are Bitter Melon ( Momordica charantia ) , Fenugreek ( trigonella foenum graecum ) , Gymnema Sylvestre , Ivy Gourd ( Coccinia indica ) , Nopal or Prickly Pear Cactus ( Opuntia streptacantha ) , Ginseng , Aloe Vera , Russian Tarragon ( Artemisia dracunculus ) , and Garlic ( Allium sativum ) ."
94023,(,O,3264.0,"They are Bitter Melon ( Momordica charantia ) , Fenugreek ( trigonella foenum graecum ) , Gymnema Sylvestre , Ivy Gourd ( Coccinia indica ) , Nopal or Prickly Pear Cactus ( Opuntia streptacantha ) , Ginseng , Aloe Vera , Russian Tarragon ( Artemisia dracunculus ) , and Garlic ( Allium sativum ) ."
94024,Opuntia,B-AG.01,3264.0,"They are Bitter Melon ( Momordica charantia ) , Fenugreek ( trigonella foenum graecum ) , Gymnema Sylvestre , Ivy Gourd ( Coccinia indica ) , Nopal or Prickly Pear Cactus ( Opuntia streptacantha ) , Ginseng , Aloe Vera , Russian Tarragon ( Artemisia dracunculus ) , and Garlic ( Allium sativum ) ."
94025,streptacantha,I-AG.01,3264.0,"They are Bitter Melon ( Momordica charantia ) , Fenugreek ( trigonella foenum graecum ) , Gymnema Sylvestre , Ivy Gourd ( Coccinia indica ) , Nopal or Prickly Pear Cactus ( Opuntia streptacantha ) , Ginseng , Aloe Vera , Russian Tarragon ( Artemisia dracunculus ) , and Garlic ( Allium sativum ) ."
94026,),O,3264.0,"They are Bitter Melon ( Momordica charantia ) , Fenugreek ( trigonella foenum graecum ) , Gymnema Sylvestre , Ivy Gourd ( Coccinia indica ) , Nopal or Prickly Pear Cactus ( Opuntia streptacantha ) , Ginseng , Aloe Vera , Russian Tarragon ( Artemisia dracunculus ) , and Garlic ( Allium sativum ) ."
94027,",",O,3264.0,"They are Bitter Melon ( Momordica charantia ) , Fenugreek ( trigonella foenum graecum ) , Gymnema Sylvestre , Ivy Gourd ( Coccinia indica ) , Nopal or Prickly Pear Cactus ( Opuntia streptacantha ) , Ginseng , Aloe Vera , Russian Tarragon ( Artemisia dracunculus ) , and Garlic ( Allium sativum ) ."
94028,Ginseng,B-AG.01.h.02.i,3264.0,"They are Bitter Melon ( Momordica charantia ) , Fenugreek ( trigonella foenum graecum ) , Gymnema Sylvestre , Ivy Gourd ( Coccinia indica ) , Nopal or Prickly Pear Cactus ( Opuntia streptacantha ) , Ginseng , Aloe Vera , Russian Tarragon ( Artemisia dracunculus ) , and Garlic ( Allium sativum ) ."
94029,",",O,3264.0,"They are Bitter Melon ( Momordica charantia ) , Fenugreek ( trigonella foenum graecum ) , Gymnema Sylvestre , Ivy Gourd ( Coccinia indica ) , Nopal or Prickly Pear Cactus ( Opuntia streptacantha ) , Ginseng , Aloe Vera , Russian Tarragon ( Artemisia dracunculus ) , and Garlic ( Allium sativum ) ."
94030,Aloe,B-AG.01,3264.0,"They are Bitter Melon ( Momordica charantia ) , Fenugreek ( trigonella foenum graecum ) , Gymnema Sylvestre , Ivy Gourd ( Coccinia indica ) , Nopal or Prickly Pear Cactus ( Opuntia streptacantha ) , Ginseng , Aloe Vera , Russian Tarragon ( Artemisia dracunculus ) , and Garlic ( Allium sativum ) ."
94031,Vera,I-AG.01,3264.0,"They are Bitter Melon ( Momordica charantia ) , Fenugreek ( trigonella foenum graecum ) , Gymnema Sylvestre , Ivy Gourd ( Coccinia indica ) , Nopal or Prickly Pear Cactus ( Opuntia streptacantha ) , Ginseng , Aloe Vera , Russian Tarragon ( Artemisia dracunculus ) , and Garlic ( Allium sativum ) ."
94032,",",O,3264.0,"They are Bitter Melon ( Momordica charantia ) , Fenugreek ( trigonella foenum graecum ) , Gymnema Sylvestre , Ivy Gourd ( Coccinia indica ) , Nopal or Prickly Pear Cactus ( Opuntia streptacantha ) , Ginseng , Aloe Vera , Russian Tarragon ( Artemisia dracunculus ) , and Garlic ( Allium sativum ) ."
94033,Russian,B-AG.01.h.02.i,3264.0,"They are Bitter Melon ( Momordica charantia ) , Fenugreek ( trigonella foenum graecum ) , Gymnema Sylvestre , Ivy Gourd ( Coccinia indica ) , Nopal or Prickly Pear Cactus ( Opuntia streptacantha ) , Ginseng , Aloe Vera , Russian Tarragon ( Artemisia dracunculus ) , and Garlic ( Allium sativum ) ."
94034,Tarragon,I-AG.01.h.02.i,3264.0,"They are Bitter Melon ( Momordica charantia ) , Fenugreek ( trigonella foenum graecum ) , Gymnema Sylvestre , Ivy Gourd ( Coccinia indica ) , Nopal or Prickly Pear Cactus ( Opuntia streptacantha ) , Ginseng , Aloe Vera , Russian Tarragon ( Artemisia dracunculus ) , and Garlic ( Allium sativum ) ."
94035,(,O,3264.0,"They are Bitter Melon ( Momordica charantia ) , Fenugreek ( trigonella foenum graecum ) , Gymnema Sylvestre , Ivy Gourd ( Coccinia indica ) , Nopal or Prickly Pear Cactus ( Opuntia streptacantha ) , Ginseng , Aloe Vera , Russian Tarragon ( Artemisia dracunculus ) , and Garlic ( Allium sativum ) ."
94036,Artemisia,B-AG.01.h.02.i,3264.0,"They are Bitter Melon ( Momordica charantia ) , Fenugreek ( trigonella foenum graecum ) , Gymnema Sylvestre , Ivy Gourd ( Coccinia indica ) , Nopal or Prickly Pear Cactus ( Opuntia streptacantha ) , Ginseng , Aloe Vera , Russian Tarragon ( Artemisia dracunculus ) , and Garlic ( Allium sativum ) ."
94037,dracunculus,I-AG.01.h.02.i,3264.0,"They are Bitter Melon ( Momordica charantia ) , Fenugreek ( trigonella foenum graecum ) , Gymnema Sylvestre , Ivy Gourd ( Coccinia indica ) , Nopal or Prickly Pear Cactus ( Opuntia streptacantha ) , Ginseng , Aloe Vera , Russian Tarragon ( Artemisia dracunculus ) , and Garlic ( Allium sativum ) ."
94038,),O,3264.0,"They are Bitter Melon ( Momordica charantia ) , Fenugreek ( trigonella foenum graecum ) , Gymnema Sylvestre , Ivy Gourd ( Coccinia indica ) , Nopal or Prickly Pear Cactus ( Opuntia streptacantha ) , Ginseng , Aloe Vera , Russian Tarragon ( Artemisia dracunculus ) , and Garlic ( Allium sativum ) ."
94039,",",O,3264.0,"They are Bitter Melon ( Momordica charantia ) , Fenugreek ( trigonella foenum graecum ) , Gymnema Sylvestre , Ivy Gourd ( Coccinia indica ) , Nopal or Prickly Pear Cactus ( Opuntia streptacantha ) , Ginseng , Aloe Vera , Russian Tarragon ( Artemisia dracunculus ) , and Garlic ( Allium sativum ) ."
94040,and,O,3264.0,"They are Bitter Melon ( Momordica charantia ) , Fenugreek ( trigonella foenum graecum ) , Gymnema Sylvestre , Ivy Gourd ( Coccinia indica ) , Nopal or Prickly Pear Cactus ( Opuntia streptacantha ) , Ginseng , Aloe Vera , Russian Tarragon ( Artemisia dracunculus ) , and Garlic ( Allium sativum ) ."
94041,Garlic,B-AG.01.h.02.e,3264.0,"They are Bitter Melon ( Momordica charantia ) , Fenugreek ( trigonella foenum graecum ) , Gymnema Sylvestre , Ivy Gourd ( Coccinia indica ) , Nopal or Prickly Pear Cactus ( Opuntia streptacantha ) , Ginseng , Aloe Vera , Russian Tarragon ( Artemisia dracunculus ) , and Garlic ( Allium sativum ) ."
94042,(,O,3264.0,"They are Bitter Melon ( Momordica charantia ) , Fenugreek ( trigonella foenum graecum ) , Gymnema Sylvestre , Ivy Gourd ( Coccinia indica ) , Nopal or Prickly Pear Cactus ( Opuntia streptacantha ) , Ginseng , Aloe Vera , Russian Tarragon ( Artemisia dracunculus ) , and Garlic ( Allium sativum ) ."
94043,Allium,B-AG.01.h.02.e,3264.0,"They are Bitter Melon ( Momordica charantia ) , Fenugreek ( trigonella foenum graecum ) , Gymnema Sylvestre , Ivy Gourd ( Coccinia indica ) , Nopal or Prickly Pear Cactus ( Opuntia streptacantha ) , Ginseng , Aloe Vera , Russian Tarragon ( Artemisia dracunculus ) , and Garlic ( Allium sativum ) ."
94044,sativum,I-AG.01.h.02.e,3264.0,"They are Bitter Melon ( Momordica charantia ) , Fenugreek ( trigonella foenum graecum ) , Gymnema Sylvestre , Ivy Gourd ( Coccinia indica ) , Nopal or Prickly Pear Cactus ( Opuntia streptacantha ) , Ginseng , Aloe Vera , Russian Tarragon ( Artemisia dracunculus ) , and Garlic ( Allium sativum ) ."
94045,),O,3264.0,"They are Bitter Melon ( Momordica charantia ) , Fenugreek ( trigonella foenum graecum ) , Gymnema Sylvestre , Ivy Gourd ( Coccinia indica ) , Nopal or Prickly Pear Cactus ( Opuntia streptacantha ) , Ginseng , Aloe Vera , Russian Tarragon ( Artemisia dracunculus ) , and Garlic ( Allium sativum ) ."
94046,.,O,3264.0,"They are Bitter Melon ( Momordica charantia ) , Fenugreek ( trigonella foenum graecum ) , Gymnema Sylvestre , Ivy Gourd ( Coccinia indica ) , Nopal or Prickly Pear Cactus ( Opuntia streptacantha ) , Ginseng , Aloe Vera , Russian Tarragon ( Artemisia dracunculus ) , and Garlic ( Allium sativum ) ."
94047,The,O,3265.0,The discussion is emphasized on the clinical aspect of these botanicals .
94048,discussion,O,3265.0,The discussion is emphasized on the clinical aspect of these botanicals .
94049,is,O,3265.0,The discussion is emphasized on the clinical aspect of these botanicals .
94050,emphasized,O,3265.0,The discussion is emphasized on the clinical aspect of these botanicals .
94051,on,O,3265.0,The discussion is emphasized on the clinical aspect of these botanicals .
94052,the,O,3265.0,The discussion is emphasized on the clinical aspect of these botanicals .
94053,clinical,O,3265.0,The discussion is emphasized on the clinical aspect of these botanicals .
94054,aspect,O,3265.0,The discussion is emphasized on the clinical aspect of these botanicals .
94055,of,O,3265.0,The discussion is emphasized on the clinical aspect of these botanicals .
94056,these,O,3265.0,The discussion is emphasized on the clinical aspect of these botanicals .
94057,botanicals,O,3265.0,The discussion is emphasized on the clinical aspect of these botanicals .
94058,.,O,3265.0,The discussion is emphasized on the clinical aspect of these botanicals .
94059,Due,O,3266.0,"Due to the lack of sufficient evidence from clinical studies for any of the botanicals reviewed , it is premature to actively recommend use of any particular herb to treat either glucose or other risk factors ."
94060,to,O,3266.0,"Due to the lack of sufficient evidence from clinical studies for any of the botanicals reviewed , it is premature to actively recommend use of any particular herb to treat either glucose or other risk factors ."
94061,the,O,3266.0,"Due to the lack of sufficient evidence from clinical studies for any of the botanicals reviewed , it is premature to actively recommend use of any particular herb to treat either glucose or other risk factors ."
94062,lack,O,3266.0,"Due to the lack of sufficient evidence from clinical studies for any of the botanicals reviewed , it is premature to actively recommend use of any particular herb to treat either glucose or other risk factors ."
94063,of,O,3266.0,"Due to the lack of sufficient evidence from clinical studies for any of the botanicals reviewed , it is premature to actively recommend use of any particular herb to treat either glucose or other risk factors ."
94064,sufficient,O,3266.0,"Due to the lack of sufficient evidence from clinical studies for any of the botanicals reviewed , it is premature to actively recommend use of any particular herb to treat either glucose or other risk factors ."
94065,evidence,O,3266.0,"Due to the lack of sufficient evidence from clinical studies for any of the botanicals reviewed , it is premature to actively recommend use of any particular herb to treat either glucose or other risk factors ."
94066,from,O,3266.0,"Due to the lack of sufficient evidence from clinical studies for any of the botanicals reviewed , it is premature to actively recommend use of any particular herb to treat either glucose or other risk factors ."
94067,clinical,O,3266.0,"Due to the lack of sufficient evidence from clinical studies for any of the botanicals reviewed , it is premature to actively recommend use of any particular herb to treat either glucose or other risk factors ."
94068,studies,O,3266.0,"Due to the lack of sufficient evidence from clinical studies for any of the botanicals reviewed , it is premature to actively recommend use of any particular herb to treat either glucose or other risk factors ."
94069,for,O,3266.0,"Due to the lack of sufficient evidence from clinical studies for any of the botanicals reviewed , it is premature to actively recommend use of any particular herb to treat either glucose or other risk factors ."
94070,any,O,3266.0,"Due to the lack of sufficient evidence from clinical studies for any of the botanicals reviewed , it is premature to actively recommend use of any particular herb to treat either glucose or other risk factors ."
94071,of,O,3266.0,"Due to the lack of sufficient evidence from clinical studies for any of the botanicals reviewed , it is premature to actively recommend use of any particular herb to treat either glucose or other risk factors ."
94072,the,O,3266.0,"Due to the lack of sufficient evidence from clinical studies for any of the botanicals reviewed , it is premature to actively recommend use of any particular herb to treat either glucose or other risk factors ."
94073,botanicals,O,3266.0,"Due to the lack of sufficient evidence from clinical studies for any of the botanicals reviewed , it is premature to actively recommend use of any particular herb to treat either glucose or other risk factors ."
94074,reviewed,O,3266.0,"Due to the lack of sufficient evidence from clinical studies for any of the botanicals reviewed , it is premature to actively recommend use of any particular herb to treat either glucose or other risk factors ."
94075,",",O,3266.0,"Due to the lack of sufficient evidence from clinical studies for any of the botanicals reviewed , it is premature to actively recommend use of any particular herb to treat either glucose or other risk factors ."
94076,it,O,3266.0,"Due to the lack of sufficient evidence from clinical studies for any of the botanicals reviewed , it is premature to actively recommend use of any particular herb to treat either glucose or other risk factors ."
94077,is,O,3266.0,"Due to the lack of sufficient evidence from clinical studies for any of the botanicals reviewed , it is premature to actively recommend use of any particular herb to treat either glucose or other risk factors ."
94078,premature,O,3266.0,"Due to the lack of sufficient evidence from clinical studies for any of the botanicals reviewed , it is premature to actively recommend use of any particular herb to treat either glucose or other risk factors ."
94079,to,O,3266.0,"Due to the lack of sufficient evidence from clinical studies for any of the botanicals reviewed , it is premature to actively recommend use of any particular herb to treat either glucose or other risk factors ."
94080,actively,O,3266.0,"Due to the lack of sufficient evidence from clinical studies for any of the botanicals reviewed , it is premature to actively recommend use of any particular herb to treat either glucose or other risk factors ."
94081,recommend,O,3266.0,"Due to the lack of sufficient evidence from clinical studies for any of the botanicals reviewed , it is premature to actively recommend use of any particular herb to treat either glucose or other risk factors ."
94082,use,O,3266.0,"Due to the lack of sufficient evidence from clinical studies for any of the botanicals reviewed , it is premature to actively recommend use of any particular herb to treat either glucose or other risk factors ."
94083,of,O,3266.0,"Due to the lack of sufficient evidence from clinical studies for any of the botanicals reviewed , it is premature to actively recommend use of any particular herb to treat either glucose or other risk factors ."
94084,any,O,3266.0,"Due to the lack of sufficient evidence from clinical studies for any of the botanicals reviewed , it is premature to actively recommend use of any particular herb to treat either glucose or other risk factors ."
94085,particular,O,3266.0,"Due to the lack of sufficient evidence from clinical studies for any of the botanicals reviewed , it is premature to actively recommend use of any particular herb to treat either glucose or other risk factors ."
94086,herb,B-AG.01.h.02.i,3266.0,"Due to the lack of sufficient evidence from clinical studies for any of the botanicals reviewed , it is premature to actively recommend use of any particular herb to treat either glucose or other risk factors ."
94087,to,O,3266.0,"Due to the lack of sufficient evidence from clinical studies for any of the botanicals reviewed , it is premature to actively recommend use of any particular herb to treat either glucose or other risk factors ."
94088,treat,O,3266.0,"Due to the lack of sufficient evidence from clinical studies for any of the botanicals reviewed , it is premature to actively recommend use of any particular herb to treat either glucose or other risk factors ."
94089,either,O,3266.0,"Due to the lack of sufficient evidence from clinical studies for any of the botanicals reviewed , it is premature to actively recommend use of any particular herb to treat either glucose or other risk factors ."
94090,glucose,O,3266.0,"Due to the lack of sufficient evidence from clinical studies for any of the botanicals reviewed , it is premature to actively recommend use of any particular herb to treat either glucose or other risk factors ."
94091,or,O,3266.0,"Due to the lack of sufficient evidence from clinical studies for any of the botanicals reviewed , it is premature to actively recommend use of any particular herb to treat either glucose or other risk factors ."
94092,other,O,3266.0,"Due to the lack of sufficient evidence from clinical studies for any of the botanicals reviewed , it is premature to actively recommend use of any particular herb to treat either glucose or other risk factors ."
94093,risk,O,3266.0,"Due to the lack of sufficient evidence from clinical studies for any of the botanicals reviewed , it is premature to actively recommend use of any particular herb to treat either glucose or other risk factors ."
94094,factors,O,3266.0,"Due to the lack of sufficient evidence from clinical studies for any of the botanicals reviewed , it is premature to actively recommend use of any particular herb to treat either glucose or other risk factors ."
94095,.,O,3266.0,"Due to the lack of sufficient evidence from clinical studies for any of the botanicals reviewed , it is premature to actively recommend use of any particular herb to treat either glucose or other risk factors ."
94096,Thus,O,3267.0,"Thus , well defined randomized clinical trials are warranted in this area ."
94097,",",O,3267.0,"Thus , well defined randomized clinical trials are warranted in this area ."
94098,well,O,3267.0,"Thus , well defined randomized clinical trials are warranted in this area ."
94099,defined,O,3267.0,"Thus , well defined randomized clinical trials are warranted in this area ."
94100,randomized,O,3267.0,"Thus , well defined randomized clinical trials are warranted in this area ."
94101,clinical,O,3267.0,"Thus , well defined randomized clinical trials are warranted in this area ."
94102,trials,O,3267.0,"Thus , well defined randomized clinical trials are warranted in this area ."
94103,are,O,3267.0,"Thus , well defined randomized clinical trials are warranted in this area ."
94104,warranted,O,3267.0,"Thus , well defined randomized clinical trials are warranted in this area ."
94105,in,O,3267.0,"Thus , well defined randomized clinical trials are warranted in this area ."
94106,this,O,3267.0,"Thus , well defined randomized clinical trials are warranted in this area ."
94107,area,O,3267.0,"Thus , well defined randomized clinical trials are warranted in this area ."
94108,.,O,3267.0,"Thus , well defined randomized clinical trials are warranted in this area ."
94109,The,O,3268.0,The Golden Syrian hamster ( Mesocricetus auratus ) has been shown to be a useful model of both human lipoprotein metabolism and the development of atherosclerosis .
94110,Golden,O,3268.0,The Golden Syrian hamster ( Mesocricetus auratus ) has been shown to be a useful model of both human lipoprotein metabolism and the development of atherosclerosis .
94111,Syrian,O,3268.0,The Golden Syrian hamster ( Mesocricetus auratus ) has been shown to be a useful model of both human lipoprotein metabolism and the development of atherosclerosis .
94112,hamster,O,3268.0,The Golden Syrian hamster ( Mesocricetus auratus ) has been shown to be a useful model of both human lipoprotein metabolism and the development of atherosclerosis .
94113,(,O,3268.0,The Golden Syrian hamster ( Mesocricetus auratus ) has been shown to be a useful model of both human lipoprotein metabolism and the development of atherosclerosis .
94114,Mesocricetus,O,3268.0,The Golden Syrian hamster ( Mesocricetus auratus ) has been shown to be a useful model of both human lipoprotein metabolism and the development of atherosclerosis .
94115,auratus,O,3268.0,The Golden Syrian hamster ( Mesocricetus auratus ) has been shown to be a useful model of both human lipoprotein metabolism and the development of atherosclerosis .
94116,),O,3268.0,The Golden Syrian hamster ( Mesocricetus auratus ) has been shown to be a useful model of both human lipoprotein metabolism and the development of atherosclerosis .
94117,has,O,3268.0,The Golden Syrian hamster ( Mesocricetus auratus ) has been shown to be a useful model of both human lipoprotein metabolism and the development of atherosclerosis .
94118,been,O,3268.0,The Golden Syrian hamster ( Mesocricetus auratus ) has been shown to be a useful model of both human lipoprotein metabolism and the development of atherosclerosis .
94119,shown,O,3268.0,The Golden Syrian hamster ( Mesocricetus auratus ) has been shown to be a useful model of both human lipoprotein metabolism and the development of atherosclerosis .
94120,to,O,3268.0,The Golden Syrian hamster ( Mesocricetus auratus ) has been shown to be a useful model of both human lipoprotein metabolism and the development of atherosclerosis .
94121,be,O,3268.0,The Golden Syrian hamster ( Mesocricetus auratus ) has been shown to be a useful model of both human lipoprotein metabolism and the development of atherosclerosis .
94122,a,O,3268.0,The Golden Syrian hamster ( Mesocricetus auratus ) has been shown to be a useful model of both human lipoprotein metabolism and the development of atherosclerosis .
94123,useful,O,3268.0,The Golden Syrian hamster ( Mesocricetus auratus ) has been shown to be a useful model of both human lipoprotein metabolism and the development of atherosclerosis .
94124,model,O,3268.0,The Golden Syrian hamster ( Mesocricetus auratus ) has been shown to be a useful model of both human lipoprotein metabolism and the development of atherosclerosis .
94125,of,O,3268.0,The Golden Syrian hamster ( Mesocricetus auratus ) has been shown to be a useful model of both human lipoprotein metabolism and the development of atherosclerosis .
94126,both,O,3268.0,The Golden Syrian hamster ( Mesocricetus auratus ) has been shown to be a useful model of both human lipoprotein metabolism and the development of atherosclerosis .
94127,human,O,3268.0,The Golden Syrian hamster ( Mesocricetus auratus ) has been shown to be a useful model of both human lipoprotein metabolism and the development of atherosclerosis .
94128,lipoprotein,O,3268.0,The Golden Syrian hamster ( Mesocricetus auratus ) has been shown to be a useful model of both human lipoprotein metabolism and the development of atherosclerosis .
94129,metabolism,O,3268.0,The Golden Syrian hamster ( Mesocricetus auratus ) has been shown to be a useful model of both human lipoprotein metabolism and the development of atherosclerosis .
94130,and,O,3268.0,The Golden Syrian hamster ( Mesocricetus auratus ) has been shown to be a useful model of both human lipoprotein metabolism and the development of atherosclerosis .
94131,the,O,3268.0,The Golden Syrian hamster ( Mesocricetus auratus ) has been shown to be a useful model of both human lipoprotein metabolism and the development of atherosclerosis .
94132,development,O,3268.0,The Golden Syrian hamster ( Mesocricetus auratus ) has been shown to be a useful model of both human lipoprotein metabolism and the development of atherosclerosis .
94133,of,O,3268.0,The Golden Syrian hamster ( Mesocricetus auratus ) has been shown to be a useful model of both human lipoprotein metabolism and the development of atherosclerosis .
94134,atherosclerosis,O,3268.0,The Golden Syrian hamster ( Mesocricetus auratus ) has been shown to be a useful model of both human lipoprotein metabolism and the development of atherosclerosis .
94135,.,O,3268.0,The Golden Syrian hamster ( Mesocricetus auratus ) has been shown to be a useful model of both human lipoprotein metabolism and the development of atherosclerosis .
94136,We,O,3269.0,We report the effects of dietary lipids on the progression and regression of atherosclerosis in this model .
94137,report,O,3269.0,We report the effects of dietary lipids on the progression and regression of atherosclerosis in this model .
94138,the,O,3269.0,We report the effects of dietary lipids on the progression and regression of atherosclerosis in this model .
94139,effects,O,3269.0,We report the effects of dietary lipids on the progression and regression of atherosclerosis in this model .
94140,of,O,3269.0,We report the effects of dietary lipids on the progression and regression of atherosclerosis in this model .
94141,dietary,O,3269.0,We report the effects of dietary lipids on the progression and regression of atherosclerosis in this model .
94142,lipids,O,3269.0,We report the effects of dietary lipids on the progression and regression of atherosclerosis in this model .
94143,on,O,3269.0,We report the effects of dietary lipids on the progression and regression of atherosclerosis in this model .
94144,the,O,3269.0,We report the effects of dietary lipids on the progression and regression of atherosclerosis in this model .
94145,progression,O,3269.0,We report the effects of dietary lipids on the progression and regression of atherosclerosis in this model .
94146,and,O,3269.0,We report the effects of dietary lipids on the progression and regression of atherosclerosis in this model .
94147,regression,O,3269.0,We report the effects of dietary lipids on the progression and regression of atherosclerosis in this model .
94148,of,O,3269.0,We report the effects of dietary lipids on the progression and regression of atherosclerosis in this model .
94149,atherosclerosis,O,3269.0,We report the effects of dietary lipids on the progression and regression of atherosclerosis in this model .
94150,in,O,3269.0,We report the effects of dietary lipids on the progression and regression of atherosclerosis in this model .
94151,this,O,3269.0,We report the effects of dietary lipids on the progression and regression of atherosclerosis in this model .
94152,model,O,3269.0,We report the effects of dietary lipids on the progression and regression of atherosclerosis in this model .
94153,.,O,3269.0,We report the effects of dietary lipids on the progression and regression of atherosclerosis in this model .
94154,In,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94155,the,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94156,first,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94157,study,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94158,",",O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94159,hamsters,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94160,fed,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94161,on,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94162,coconut,B-AG.01.f,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94163,oil,I-AG.01.f,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94164,(,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94165,150,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94166,g,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94167,/,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94168,kg,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94169,diet,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94170,),O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94171,and,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94172,cholesterol,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94173,(,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94174,30,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94175,g,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94176,/,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94177,kg,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94178,diet,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94179,),O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94180,developed,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94181,lipid,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94182,-,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94183,rich,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94184,lesions,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94185,in,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94186,the,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94187,ascending,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94188,aorta,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94189,(,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94190,0.28,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94191,(,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94192,SD,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94193,0.14,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94194,),O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94195,mm2,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94196,),O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94197,and,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94198,aortic,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94199,arch,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94200,(,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94201,0.01,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94202,(,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94203,SD,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94204,0.01,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94205,),O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94206,mm2,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94207,),O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94208,after,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94209,4,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94210,weeks,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94211,that,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94212,continued,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94213,to,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94214,progress,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94215,over,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94216,the,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94217,next,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94218,8,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94219,weeks,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94220,(,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94221,0.75,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94222,(,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94223,SD,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94224,0.41,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94225,),O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94226,mm2,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94227,and,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94228,0.12,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94229,(,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94230,SD,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94231,0.11,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94232,),O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94233,mm2,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94234,for,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94235,the,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94236,ascending,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94237,aorta,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94238,and,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94239,aortic,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94240,arch,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94241,respectively,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94242,),O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94243,.,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94244,Removal,O,3271.0,Removal of cholesterol from the diet halted this progression .
94245,of,O,3271.0,Removal of cholesterol from the diet halted this progression .
94246,cholesterol,O,3271.0,Removal of cholesterol from the diet halted this progression .
94247,from,O,3271.0,Removal of cholesterol from the diet halted this progression .
94248,the,O,3271.0,Removal of cholesterol from the diet halted this progression .
94249,diet,O,3271.0,Removal of cholesterol from the diet halted this progression .
94250,halted,O,3271.0,Removal of cholesterol from the diet halted this progression .
94251,this,O,3271.0,Removal of cholesterol from the diet halted this progression .
94252,progression,O,3271.0,Removal of cholesterol from the diet halted this progression .
94253,.,O,3271.0,Removal of cholesterol from the diet halted this progression .
94254,Furthermore,O,3272.0,"Furthermore , in animals fed on olive oil in the absence of added cholesterol , plasma LDL - cholesterol concentrations were lower ( P < 0.05 ) and the extent of atherosclerotic lesions was reduced ( P < 0.001 for both regions of the aorta ) compared with animals fed on coconut oil ( with no added cholesterol ) ."
94255,",",O,3272.0,"Furthermore , in animals fed on olive oil in the absence of added cholesterol , plasma LDL - cholesterol concentrations were lower ( P < 0.05 ) and the extent of atherosclerotic lesions was reduced ( P < 0.001 for both regions of the aorta ) compared with animals fed on coconut oil ( with no added cholesterol ) ."
94256,in,O,3272.0,"Furthermore , in animals fed on olive oil in the absence of added cholesterol , plasma LDL - cholesterol concentrations were lower ( P < 0.05 ) and the extent of atherosclerotic lesions was reduced ( P < 0.001 for both regions of the aorta ) compared with animals fed on coconut oil ( with no added cholesterol ) ."
94257,animals,O,3272.0,"Furthermore , in animals fed on olive oil in the absence of added cholesterol , plasma LDL - cholesterol concentrations were lower ( P < 0.05 ) and the extent of atherosclerotic lesions was reduced ( P < 0.001 for both regions of the aorta ) compared with animals fed on coconut oil ( with no added cholesterol ) ."
94258,fed,O,3272.0,"Furthermore , in animals fed on olive oil in the absence of added cholesterol , plasma LDL - cholesterol concentrations were lower ( P < 0.05 ) and the extent of atherosclerotic lesions was reduced ( P < 0.001 for both regions of the aorta ) compared with animals fed on coconut oil ( with no added cholesterol ) ."
94259,on,O,3272.0,"Furthermore , in animals fed on olive oil in the absence of added cholesterol , plasma LDL - cholesterol concentrations were lower ( P < 0.05 ) and the extent of atherosclerotic lesions was reduced ( P < 0.001 for both regions of the aorta ) compared with animals fed on coconut oil ( with no added cholesterol ) ."
94260,olive,B-AG.01.f,3272.0,"Furthermore , in animals fed on olive oil in the absence of added cholesterol , plasma LDL - cholesterol concentrations were lower ( P < 0.05 ) and the extent of atherosclerotic lesions was reduced ( P < 0.001 for both regions of the aorta ) compared with animals fed on coconut oil ( with no added cholesterol ) ."
94261,oil,I-AG.01.f,3272.0,"Furthermore , in animals fed on olive oil in the absence of added cholesterol , plasma LDL - cholesterol concentrations were lower ( P < 0.05 ) and the extent of atherosclerotic lesions was reduced ( P < 0.001 for both regions of the aorta ) compared with animals fed on coconut oil ( with no added cholesterol ) ."
94262,in,O,3272.0,"Furthermore , in animals fed on olive oil in the absence of added cholesterol , plasma LDL - cholesterol concentrations were lower ( P < 0.05 ) and the extent of atherosclerotic lesions was reduced ( P < 0.001 for both regions of the aorta ) compared with animals fed on coconut oil ( with no added cholesterol ) ."
94263,the,O,3272.0,"Furthermore , in animals fed on olive oil in the absence of added cholesterol , plasma LDL - cholesterol concentrations were lower ( P < 0.05 ) and the extent of atherosclerotic lesions was reduced ( P < 0.001 for both regions of the aorta ) compared with animals fed on coconut oil ( with no added cholesterol ) ."
94264,absence,O,3272.0,"Furthermore , in animals fed on olive oil in the absence of added cholesterol , plasma LDL - cholesterol concentrations were lower ( P < 0.05 ) and the extent of atherosclerotic lesions was reduced ( P < 0.001 for both regions of the aorta ) compared with animals fed on coconut oil ( with no added cholesterol ) ."
94265,of,O,3272.0,"Furthermore , in animals fed on olive oil in the absence of added cholesterol , plasma LDL - cholesterol concentrations were lower ( P < 0.05 ) and the extent of atherosclerotic lesions was reduced ( P < 0.001 for both regions of the aorta ) compared with animals fed on coconut oil ( with no added cholesterol ) ."
94266,added,O,3272.0,"Furthermore , in animals fed on olive oil in the absence of added cholesterol , plasma LDL - cholesterol concentrations were lower ( P < 0.05 ) and the extent of atherosclerotic lesions was reduced ( P < 0.001 for both regions of the aorta ) compared with animals fed on coconut oil ( with no added cholesterol ) ."
94267,cholesterol,O,3272.0,"Furthermore , in animals fed on olive oil in the absence of added cholesterol , plasma LDL - cholesterol concentrations were lower ( P < 0.05 ) and the extent of atherosclerotic lesions was reduced ( P < 0.001 for both regions of the aorta ) compared with animals fed on coconut oil ( with no added cholesterol ) ."
94268,",",O,3272.0,"Furthermore , in animals fed on olive oil in the absence of added cholesterol , plasma LDL - cholesterol concentrations were lower ( P < 0.05 ) and the extent of atherosclerotic lesions was reduced ( P < 0.001 for both regions of the aorta ) compared with animals fed on coconut oil ( with no added cholesterol ) ."
94269,plasma,O,3272.0,"Furthermore , in animals fed on olive oil in the absence of added cholesterol , plasma LDL - cholesterol concentrations were lower ( P < 0.05 ) and the extent of atherosclerotic lesions was reduced ( P < 0.001 for both regions of the aorta ) compared with animals fed on coconut oil ( with no added cholesterol ) ."
94270,LDL,O,3272.0,"Furthermore , in animals fed on olive oil in the absence of added cholesterol , plasma LDL - cholesterol concentrations were lower ( P < 0.05 ) and the extent of atherosclerotic lesions was reduced ( P < 0.001 for both regions of the aorta ) compared with animals fed on coconut oil ( with no added cholesterol ) ."
94271,-,O,3272.0,"Furthermore , in animals fed on olive oil in the absence of added cholesterol , plasma LDL - cholesterol concentrations were lower ( P < 0.05 ) and the extent of atherosclerotic lesions was reduced ( P < 0.001 for both regions of the aorta ) compared with animals fed on coconut oil ( with no added cholesterol ) ."
94272,cholesterol,O,3272.0,"Furthermore , in animals fed on olive oil in the absence of added cholesterol , plasma LDL - cholesterol concentrations were lower ( P < 0.05 ) and the extent of atherosclerotic lesions was reduced ( P < 0.001 for both regions of the aorta ) compared with animals fed on coconut oil ( with no added cholesterol ) ."
94273,concentrations,O,3272.0,"Furthermore , in animals fed on olive oil in the absence of added cholesterol , plasma LDL - cholesterol concentrations were lower ( P < 0.05 ) and the extent of atherosclerotic lesions was reduced ( P < 0.001 for both regions of the aorta ) compared with animals fed on coconut oil ( with no added cholesterol ) ."
94274,were,O,3272.0,"Furthermore , in animals fed on olive oil in the absence of added cholesterol , plasma LDL - cholesterol concentrations were lower ( P < 0.05 ) and the extent of atherosclerotic lesions was reduced ( P < 0.001 for both regions of the aorta ) compared with animals fed on coconut oil ( with no added cholesterol ) ."
94275,lower,O,3272.0,"Furthermore , in animals fed on olive oil in the absence of added cholesterol , plasma LDL - cholesterol concentrations were lower ( P < 0.05 ) and the extent of atherosclerotic lesions was reduced ( P < 0.001 for both regions of the aorta ) compared with animals fed on coconut oil ( with no added cholesterol ) ."
94276,(,O,3272.0,"Furthermore , in animals fed on olive oil in the absence of added cholesterol , plasma LDL - cholesterol concentrations were lower ( P < 0.05 ) and the extent of atherosclerotic lesions was reduced ( P < 0.001 for both regions of the aorta ) compared with animals fed on coconut oil ( with no added cholesterol ) ."
94277,P,O,3272.0,"Furthermore , in animals fed on olive oil in the absence of added cholesterol , plasma LDL - cholesterol concentrations were lower ( P < 0.05 ) and the extent of atherosclerotic lesions was reduced ( P < 0.001 for both regions of the aorta ) compared with animals fed on coconut oil ( with no added cholesterol ) ."
94278,<,O,3272.0,"Furthermore , in animals fed on olive oil in the absence of added cholesterol , plasma LDL - cholesterol concentrations were lower ( P < 0.05 ) and the extent of atherosclerotic lesions was reduced ( P < 0.001 for both regions of the aorta ) compared with animals fed on coconut oil ( with no added cholesterol ) ."
94279,0.05,O,3272.0,"Furthermore , in animals fed on olive oil in the absence of added cholesterol , plasma LDL - cholesterol concentrations were lower ( P < 0.05 ) and the extent of atherosclerotic lesions was reduced ( P < 0.001 for both regions of the aorta ) compared with animals fed on coconut oil ( with no added cholesterol ) ."
94280,),O,3272.0,"Furthermore , in animals fed on olive oil in the absence of added cholesterol , plasma LDL - cholesterol concentrations were lower ( P < 0.05 ) and the extent of atherosclerotic lesions was reduced ( P < 0.001 for both regions of the aorta ) compared with animals fed on coconut oil ( with no added cholesterol ) ."
94281,and,O,3272.0,"Furthermore , in animals fed on olive oil in the absence of added cholesterol , plasma LDL - cholesterol concentrations were lower ( P < 0.05 ) and the extent of atherosclerotic lesions was reduced ( P < 0.001 for both regions of the aorta ) compared with animals fed on coconut oil ( with no added cholesterol ) ."
94282,the,O,3272.0,"Furthermore , in animals fed on olive oil in the absence of added cholesterol , plasma LDL - cholesterol concentrations were lower ( P < 0.05 ) and the extent of atherosclerotic lesions was reduced ( P < 0.001 for both regions of the aorta ) compared with animals fed on coconut oil ( with no added cholesterol ) ."
94283,extent,O,3272.0,"Furthermore , in animals fed on olive oil in the absence of added cholesterol , plasma LDL - cholesterol concentrations were lower ( P < 0.05 ) and the extent of atherosclerotic lesions was reduced ( P < 0.001 for both regions of the aorta ) compared with animals fed on coconut oil ( with no added cholesterol ) ."
94284,of,O,3272.0,"Furthermore , in animals fed on olive oil in the absence of added cholesterol , plasma LDL - cholesterol concentrations were lower ( P < 0.05 ) and the extent of atherosclerotic lesions was reduced ( P < 0.001 for both regions of the aorta ) compared with animals fed on coconut oil ( with no added cholesterol ) ."
94285,atherosclerotic,O,3272.0,"Furthermore , in animals fed on olive oil in the absence of added cholesterol , plasma LDL - cholesterol concentrations were lower ( P < 0.05 ) and the extent of atherosclerotic lesions was reduced ( P < 0.001 for both regions of the aorta ) compared with animals fed on coconut oil ( with no added cholesterol ) ."
94286,lesions,O,3272.0,"Furthermore , in animals fed on olive oil in the absence of added cholesterol , plasma LDL - cholesterol concentrations were lower ( P < 0.05 ) and the extent of atherosclerotic lesions was reduced ( P < 0.001 for both regions of the aorta ) compared with animals fed on coconut oil ( with no added cholesterol ) ."
94287,was,O,3272.0,"Furthermore , in animals fed on olive oil in the absence of added cholesterol , plasma LDL - cholesterol concentrations were lower ( P < 0.05 ) and the extent of atherosclerotic lesions was reduced ( P < 0.001 for both regions of the aorta ) compared with animals fed on coconut oil ( with no added cholesterol ) ."
94288,reduced,O,3272.0,"Furthermore , in animals fed on olive oil in the absence of added cholesterol , plasma LDL - cholesterol concentrations were lower ( P < 0.05 ) and the extent of atherosclerotic lesions was reduced ( P < 0.001 for both regions of the aorta ) compared with animals fed on coconut oil ( with no added cholesterol ) ."
94289,(,O,3272.0,"Furthermore , in animals fed on olive oil in the absence of added cholesterol , plasma LDL - cholesterol concentrations were lower ( P < 0.05 ) and the extent of atherosclerotic lesions was reduced ( P < 0.001 for both regions of the aorta ) compared with animals fed on coconut oil ( with no added cholesterol ) ."
94290,P,O,3272.0,"Furthermore , in animals fed on olive oil in the absence of added cholesterol , plasma LDL - cholesterol concentrations were lower ( P < 0.05 ) and the extent of atherosclerotic lesions was reduced ( P < 0.001 for both regions of the aorta ) compared with animals fed on coconut oil ( with no added cholesterol ) ."
94291,<,O,3272.0,"Furthermore , in animals fed on olive oil in the absence of added cholesterol , plasma LDL - cholesterol concentrations were lower ( P < 0.05 ) and the extent of atherosclerotic lesions was reduced ( P < 0.001 for both regions of the aorta ) compared with animals fed on coconut oil ( with no added cholesterol ) ."
94292,0.001,O,3272.0,"Furthermore , in animals fed on olive oil in the absence of added cholesterol , plasma LDL - cholesterol concentrations were lower ( P < 0.05 ) and the extent of atherosclerotic lesions was reduced ( P < 0.001 for both regions of the aorta ) compared with animals fed on coconut oil ( with no added cholesterol ) ."
94293,for,O,3272.0,"Furthermore , in animals fed on olive oil in the absence of added cholesterol , plasma LDL - cholesterol concentrations were lower ( P < 0.05 ) and the extent of atherosclerotic lesions was reduced ( P < 0.001 for both regions of the aorta ) compared with animals fed on coconut oil ( with no added cholesterol ) ."
94294,both,O,3272.0,"Furthermore , in animals fed on olive oil in the absence of added cholesterol , plasma LDL - cholesterol concentrations were lower ( P < 0.05 ) and the extent of atherosclerotic lesions was reduced ( P < 0.001 for both regions of the aorta ) compared with animals fed on coconut oil ( with no added cholesterol ) ."
94295,regions,O,3272.0,"Furthermore , in animals fed on olive oil in the absence of added cholesterol , plasma LDL - cholesterol concentrations were lower ( P < 0.05 ) and the extent of atherosclerotic lesions was reduced ( P < 0.001 for both regions of the aorta ) compared with animals fed on coconut oil ( with no added cholesterol ) ."
94296,of,O,3272.0,"Furthermore , in animals fed on olive oil in the absence of added cholesterol , plasma LDL - cholesterol concentrations were lower ( P < 0.05 ) and the extent of atherosclerotic lesions was reduced ( P < 0.001 for both regions of the aorta ) compared with animals fed on coconut oil ( with no added cholesterol ) ."
94297,the,O,3272.0,"Furthermore , in animals fed on olive oil in the absence of added cholesterol , plasma LDL - cholesterol concentrations were lower ( P < 0.05 ) and the extent of atherosclerotic lesions was reduced ( P < 0.001 for both regions of the aorta ) compared with animals fed on coconut oil ( with no added cholesterol ) ."
94298,aorta,O,3272.0,"Furthermore , in animals fed on olive oil in the absence of added cholesterol , plasma LDL - cholesterol concentrations were lower ( P < 0.05 ) and the extent of atherosclerotic lesions was reduced ( P < 0.001 for both regions of the aorta ) compared with animals fed on coconut oil ( with no added cholesterol ) ."
94299,),O,3272.0,"Furthermore , in animals fed on olive oil in the absence of added cholesterol , plasma LDL - cholesterol concentrations were lower ( P < 0.05 ) and the extent of atherosclerotic lesions was reduced ( P < 0.001 for both regions of the aorta ) compared with animals fed on coconut oil ( with no added cholesterol ) ."
94300,compared,O,3272.0,"Furthermore , in animals fed on olive oil in the absence of added cholesterol , plasma LDL - cholesterol concentrations were lower ( P < 0.05 ) and the extent of atherosclerotic lesions was reduced ( P < 0.001 for both regions of the aorta ) compared with animals fed on coconut oil ( with no added cholesterol ) ."
94301,with,O,3272.0,"Furthermore , in animals fed on olive oil in the absence of added cholesterol , plasma LDL - cholesterol concentrations were lower ( P < 0.05 ) and the extent of atherosclerotic lesions was reduced ( P < 0.001 for both regions of the aorta ) compared with animals fed on coconut oil ( with no added cholesterol ) ."
94302,animals,O,3272.0,"Furthermore , in animals fed on olive oil in the absence of added cholesterol , plasma LDL - cholesterol concentrations were lower ( P < 0.05 ) and the extent of atherosclerotic lesions was reduced ( P < 0.001 for both regions of the aorta ) compared with animals fed on coconut oil ( with no added cholesterol ) ."
94303,fed,O,3272.0,"Furthermore , in animals fed on olive oil in the absence of added cholesterol , plasma LDL - cholesterol concentrations were lower ( P < 0.05 ) and the extent of atherosclerotic lesions was reduced ( P < 0.001 for both regions of the aorta ) compared with animals fed on coconut oil ( with no added cholesterol ) ."
94304,on,O,3272.0,"Furthermore , in animals fed on olive oil in the absence of added cholesterol , plasma LDL - cholesterol concentrations were lower ( P < 0.05 ) and the extent of atherosclerotic lesions was reduced ( P < 0.001 for both regions of the aorta ) compared with animals fed on coconut oil ( with no added cholesterol ) ."
94305,coconut,B-AG.01.f,3272.0,"Furthermore , in animals fed on olive oil in the absence of added cholesterol , plasma LDL - cholesterol concentrations were lower ( P < 0.05 ) and the extent of atherosclerotic lesions was reduced ( P < 0.001 for both regions of the aorta ) compared with animals fed on coconut oil ( with no added cholesterol ) ."
94306,oil,I-AG.01.f,3272.0,"Furthermore , in animals fed on olive oil in the absence of added cholesterol , plasma LDL - cholesterol concentrations were lower ( P < 0.05 ) and the extent of atherosclerotic lesions was reduced ( P < 0.001 for both regions of the aorta ) compared with animals fed on coconut oil ( with no added cholesterol ) ."
94307,(,O,3272.0,"Furthermore , in animals fed on olive oil in the absence of added cholesterol , plasma LDL - cholesterol concentrations were lower ( P < 0.05 ) and the extent of atherosclerotic lesions was reduced ( P < 0.001 for both regions of the aorta ) compared with animals fed on coconut oil ( with no added cholesterol ) ."
94308,with,O,3272.0,"Furthermore , in animals fed on olive oil in the absence of added cholesterol , plasma LDL - cholesterol concentrations were lower ( P < 0.05 ) and the extent of atherosclerotic lesions was reduced ( P < 0.001 for both regions of the aorta ) compared with animals fed on coconut oil ( with no added cholesterol ) ."
94309,no,O,3272.0,"Furthermore , in animals fed on olive oil in the absence of added cholesterol , plasma LDL - cholesterol concentrations were lower ( P < 0.05 ) and the extent of atherosclerotic lesions was reduced ( P < 0.001 for both regions of the aorta ) compared with animals fed on coconut oil ( with no added cholesterol ) ."
94310,added,O,3272.0,"Furthermore , in animals fed on olive oil in the absence of added cholesterol , plasma LDL - cholesterol concentrations were lower ( P < 0.05 ) and the extent of atherosclerotic lesions was reduced ( P < 0.001 for both regions of the aorta ) compared with animals fed on coconut oil ( with no added cholesterol ) ."
94311,cholesterol,O,3272.0,"Furthermore , in animals fed on olive oil in the absence of added cholesterol , plasma LDL - cholesterol concentrations were lower ( P < 0.05 ) and the extent of atherosclerotic lesions was reduced ( P < 0.001 for both regions of the aorta ) compared with animals fed on coconut oil ( with no added cholesterol ) ."
94312,),O,3272.0,"Furthermore , in animals fed on olive oil in the absence of added cholesterol , plasma LDL - cholesterol concentrations were lower ( P < 0.05 ) and the extent of atherosclerotic lesions was reduced ( P < 0.001 for both regions of the aorta ) compared with animals fed on coconut oil ( with no added cholesterol ) ."
94313,.,O,3272.0,"Furthermore , in animals fed on olive oil in the absence of added cholesterol , plasma LDL - cholesterol concentrations were lower ( P < 0.05 ) and the extent of atherosclerotic lesions was reduced ( P < 0.001 for both regions of the aorta ) compared with animals fed on coconut oil ( with no added cholesterol ) ."
94314,In,O,3273.0,"In a second study , animals were fed on the atherogenic diet for 10 weeks , transferred to diets containing either coconut oil ( 150 g / kg diet ) or olive oil ( 150 g / kg diet ) without added cholesterol and monitored for up to 16 weeks ."
94315,a,O,3273.0,"In a second study , animals were fed on the atherogenic diet for 10 weeks , transferred to diets containing either coconut oil ( 150 g / kg diet ) or olive oil ( 150 g / kg diet ) without added cholesterol and monitored for up to 16 weeks ."
94316,second,O,3273.0,"In a second study , animals were fed on the atherogenic diet for 10 weeks , transferred to diets containing either coconut oil ( 150 g / kg diet ) or olive oil ( 150 g / kg diet ) without added cholesterol and monitored for up to 16 weeks ."
94317,study,O,3273.0,"In a second study , animals were fed on the atherogenic diet for 10 weeks , transferred to diets containing either coconut oil ( 150 g / kg diet ) or olive oil ( 150 g / kg diet ) without added cholesterol and monitored for up to 16 weeks ."
94318,",",O,3273.0,"In a second study , animals were fed on the atherogenic diet for 10 weeks , transferred to diets containing either coconut oil ( 150 g / kg diet ) or olive oil ( 150 g / kg diet ) without added cholesterol and monitored for up to 16 weeks ."
94319,animals,O,3273.0,"In a second study , animals were fed on the atherogenic diet for 10 weeks , transferred to diets containing either coconut oil ( 150 g / kg diet ) or olive oil ( 150 g / kg diet ) without added cholesterol and monitored for up to 16 weeks ."
94320,were,O,3273.0,"In a second study , animals were fed on the atherogenic diet for 10 weeks , transferred to diets containing either coconut oil ( 150 g / kg diet ) or olive oil ( 150 g / kg diet ) without added cholesterol and monitored for up to 16 weeks ."
94321,fed,O,3273.0,"In a second study , animals were fed on the atherogenic diet for 10 weeks , transferred to diets containing either coconut oil ( 150 g / kg diet ) or olive oil ( 150 g / kg diet ) without added cholesterol and monitored for up to 16 weeks ."
94322,on,O,3273.0,"In a second study , animals were fed on the atherogenic diet for 10 weeks , transferred to diets containing either coconut oil ( 150 g / kg diet ) or olive oil ( 150 g / kg diet ) without added cholesterol and monitored for up to 16 weeks ."
94323,the,O,3273.0,"In a second study , animals were fed on the atherogenic diet for 10 weeks , transferred to diets containing either coconut oil ( 150 g / kg diet ) or olive oil ( 150 g / kg diet ) without added cholesterol and monitored for up to 16 weeks ."
94324,atherogenic,O,3273.0,"In a second study , animals were fed on the atherogenic diet for 10 weeks , transferred to diets containing either coconut oil ( 150 g / kg diet ) or olive oil ( 150 g / kg diet ) without added cholesterol and monitored for up to 16 weeks ."
94325,diet,O,3273.0,"In a second study , animals were fed on the atherogenic diet for 10 weeks , transferred to diets containing either coconut oil ( 150 g / kg diet ) or olive oil ( 150 g / kg diet ) without added cholesterol and monitored for up to 16 weeks ."
94326,for,O,3273.0,"In a second study , animals were fed on the atherogenic diet for 10 weeks , transferred to diets containing either coconut oil ( 150 g / kg diet ) or olive oil ( 150 g / kg diet ) without added cholesterol and monitored for up to 16 weeks ."
94327,10,O,3273.0,"In a second study , animals were fed on the atherogenic diet for 10 weeks , transferred to diets containing either coconut oil ( 150 g / kg diet ) or olive oil ( 150 g / kg diet ) without added cholesterol and monitored for up to 16 weeks ."
94328,weeks,O,3273.0,"In a second study , animals were fed on the atherogenic diet for 10 weeks , transferred to diets containing either coconut oil ( 150 g / kg diet ) or olive oil ( 150 g / kg diet ) without added cholesterol and monitored for up to 16 weeks ."
94329,",",O,3273.0,"In a second study , animals were fed on the atherogenic diet for 10 weeks , transferred to diets containing either coconut oil ( 150 g / kg diet ) or olive oil ( 150 g / kg diet ) without added cholesterol and monitored for up to 16 weeks ."
94330,transferred,O,3273.0,"In a second study , animals were fed on the atherogenic diet for 10 weeks , transferred to diets containing either coconut oil ( 150 g / kg diet ) or olive oil ( 150 g / kg diet ) without added cholesterol and monitored for up to 16 weeks ."
94331,to,O,3273.0,"In a second study , animals were fed on the atherogenic diet for 10 weeks , transferred to diets containing either coconut oil ( 150 g / kg diet ) or olive oil ( 150 g / kg diet ) without added cholesterol and monitored for up to 16 weeks ."
94332,diets,O,3273.0,"In a second study , animals were fed on the atherogenic diet for 10 weeks , transferred to diets containing either coconut oil ( 150 g / kg diet ) or olive oil ( 150 g / kg diet ) without added cholesterol and monitored for up to 16 weeks ."
94333,containing,O,3273.0,"In a second study , animals were fed on the atherogenic diet for 10 weeks , transferred to diets containing either coconut oil ( 150 g / kg diet ) or olive oil ( 150 g / kg diet ) without added cholesterol and monitored for up to 16 weeks ."
94334,either,O,3273.0,"In a second study , animals were fed on the atherogenic diet for 10 weeks , transferred to diets containing either coconut oil ( 150 g / kg diet ) or olive oil ( 150 g / kg diet ) without added cholesterol and monitored for up to 16 weeks ."
94335,coconut,B-AG.01.f,3273.0,"In a second study , animals were fed on the atherogenic diet for 10 weeks , transferred to diets containing either coconut oil ( 150 g / kg diet ) or olive oil ( 150 g / kg diet ) without added cholesterol and monitored for up to 16 weeks ."
94336,oil,I-AG.01.f,3273.0,"In a second study , animals were fed on the atherogenic diet for 10 weeks , transferred to diets containing either coconut oil ( 150 g / kg diet ) or olive oil ( 150 g / kg diet ) without added cholesterol and monitored for up to 16 weeks ."
94337,(,O,3273.0,"In a second study , animals were fed on the atherogenic diet for 10 weeks , transferred to diets containing either coconut oil ( 150 g / kg diet ) or olive oil ( 150 g / kg diet ) without added cholesterol and monitored for up to 16 weeks ."
94338,150,O,3273.0,"In a second study , animals were fed on the atherogenic diet for 10 weeks , transferred to diets containing either coconut oil ( 150 g / kg diet ) or olive oil ( 150 g / kg diet ) without added cholesterol and monitored for up to 16 weeks ."
94339,g,O,3273.0,"In a second study , animals were fed on the atherogenic diet for 10 weeks , transferred to diets containing either coconut oil ( 150 g / kg diet ) or olive oil ( 150 g / kg diet ) without added cholesterol and monitored for up to 16 weeks ."
94340,/,O,3273.0,"In a second study , animals were fed on the atherogenic diet for 10 weeks , transferred to diets containing either coconut oil ( 150 g / kg diet ) or olive oil ( 150 g / kg diet ) without added cholesterol and monitored for up to 16 weeks ."
94341,kg,O,3273.0,"In a second study , animals were fed on the atherogenic diet for 10 weeks , transferred to diets containing either coconut oil ( 150 g / kg diet ) or olive oil ( 150 g / kg diet ) without added cholesterol and monitored for up to 16 weeks ."
94342,diet,O,3273.0,"In a second study , animals were fed on the atherogenic diet for 10 weeks , transferred to diets containing either coconut oil ( 150 g / kg diet ) or olive oil ( 150 g / kg diet ) without added cholesterol and monitored for up to 16 weeks ."
94343,),O,3273.0,"In a second study , animals were fed on the atherogenic diet for 10 weeks , transferred to diets containing either coconut oil ( 150 g / kg diet ) or olive oil ( 150 g / kg diet ) without added cholesterol and monitored for up to 16 weeks ."
94344,or,O,3273.0,"In a second study , animals were fed on the atherogenic diet for 10 weeks , transferred to diets containing either coconut oil ( 150 g / kg diet ) or olive oil ( 150 g / kg diet ) without added cholesterol and monitored for up to 16 weeks ."
94345,olive,B-AG.01.f,3273.0,"In a second study , animals were fed on the atherogenic diet for 10 weeks , transferred to diets containing either coconut oil ( 150 g / kg diet ) or olive oil ( 150 g / kg diet ) without added cholesterol and monitored for up to 16 weeks ."
94346,oil,I-AG.01.f,3273.0,"In a second study , animals were fed on the atherogenic diet for 10 weeks , transferred to diets containing either coconut oil ( 150 g / kg diet ) or olive oil ( 150 g / kg diet ) without added cholesterol and monitored for up to 16 weeks ."
94347,(,O,3273.0,"In a second study , animals were fed on the atherogenic diet for 10 weeks , transferred to diets containing either coconut oil ( 150 g / kg diet ) or olive oil ( 150 g / kg diet ) without added cholesterol and monitored for up to 16 weeks ."
94348,150,O,3273.0,"In a second study , animals were fed on the atherogenic diet for 10 weeks , transferred to diets containing either coconut oil ( 150 g / kg diet ) or olive oil ( 150 g / kg diet ) without added cholesterol and monitored for up to 16 weeks ."
94349,g,O,3273.0,"In a second study , animals were fed on the atherogenic diet for 10 weeks , transferred to diets containing either coconut oil ( 150 g / kg diet ) or olive oil ( 150 g / kg diet ) without added cholesterol and monitored for up to 16 weeks ."
94350,/,O,3273.0,"In a second study , animals were fed on the atherogenic diet for 10 weeks , transferred to diets containing either coconut oil ( 150 g / kg diet ) or olive oil ( 150 g / kg diet ) without added cholesterol and monitored for up to 16 weeks ."
94351,kg,O,3273.0,"In a second study , animals were fed on the atherogenic diet for 10 weeks , transferred to diets containing either coconut oil ( 150 g / kg diet ) or olive oil ( 150 g / kg diet ) without added cholesterol and monitored for up to 16 weeks ."
94352,diet,O,3273.0,"In a second study , animals were fed on the atherogenic diet for 10 weeks , transferred to diets containing either coconut oil ( 150 g / kg diet ) or olive oil ( 150 g / kg diet ) without added cholesterol and monitored for up to 16 weeks ."
94353,),O,3273.0,"In a second study , animals were fed on the atherogenic diet for 10 weeks , transferred to diets containing either coconut oil ( 150 g / kg diet ) or olive oil ( 150 g / kg diet ) without added cholesterol and monitored for up to 16 weeks ."
94354,without,O,3273.0,"In a second study , animals were fed on the atherogenic diet for 10 weeks , transferred to diets containing either coconut oil ( 150 g / kg diet ) or olive oil ( 150 g / kg diet ) without added cholesterol and monitored for up to 16 weeks ."
94355,added,O,3273.0,"In a second study , animals were fed on the atherogenic diet for 10 weeks , transferred to diets containing either coconut oil ( 150 g / kg diet ) or olive oil ( 150 g / kg diet ) without added cholesterol and monitored for up to 16 weeks ."
94356,cholesterol,O,3273.0,"In a second study , animals were fed on the atherogenic diet for 10 weeks , transferred to diets containing either coconut oil ( 150 g / kg diet ) or olive oil ( 150 g / kg diet ) without added cholesterol and monitored for up to 16 weeks ."
94357,and,O,3273.0,"In a second study , animals were fed on the atherogenic diet for 10 weeks , transferred to diets containing either coconut oil ( 150 g / kg diet ) or olive oil ( 150 g / kg diet ) without added cholesterol and monitored for up to 16 weeks ."
94358,monitored,O,3273.0,"In a second study , animals were fed on the atherogenic diet for 10 weeks , transferred to diets containing either coconut oil ( 150 g / kg diet ) or olive oil ( 150 g / kg diet ) without added cholesterol and monitored for up to 16 weeks ."
94359,for,O,3273.0,"In a second study , animals were fed on the atherogenic diet for 10 weeks , transferred to diets containing either coconut oil ( 150 g / kg diet ) or olive oil ( 150 g / kg diet ) without added cholesterol and monitored for up to 16 weeks ."
94360,up,O,3273.0,"In a second study , animals were fed on the atherogenic diet for 10 weeks , transferred to diets containing either coconut oil ( 150 g / kg diet ) or olive oil ( 150 g / kg diet ) without added cholesterol and monitored for up to 16 weeks ."
94361,to,O,3273.0,"In a second study , animals were fed on the atherogenic diet for 10 weeks , transferred to diets containing either coconut oil ( 150 g / kg diet ) or olive oil ( 150 g / kg diet ) without added cholesterol and monitored for up to 16 weeks ."
94362,16,O,3273.0,"In a second study , animals were fed on the atherogenic diet for 10 weeks , transferred to diets containing either coconut oil ( 150 g / kg diet ) or olive oil ( 150 g / kg diet ) without added cholesterol and monitored for up to 16 weeks ."
94363,weeks,O,3273.0,"In a second study , animals were fed on the atherogenic diet for 10 weeks , transferred to diets containing either coconut oil ( 150 g / kg diet ) or olive oil ( 150 g / kg diet ) without added cholesterol and monitored for up to 16 weeks ."
94364,.,O,3273.0,"In a second study , animals were fed on the atherogenic diet for 10 weeks , transferred to diets containing either coconut oil ( 150 g / kg diet ) or olive oil ( 150 g / kg diet ) without added cholesterol and monitored for up to 16 weeks ."
94365,In,O,3274.0,"In the ascending aorta , lesion size doubled in animals fed on coconut oil but stabilized in those fed on olive oil ."
94366,the,O,3274.0,"In the ascending aorta , lesion size doubled in animals fed on coconut oil but stabilized in those fed on olive oil ."
94367,ascending,O,3274.0,"In the ascending aorta , lesion size doubled in animals fed on coconut oil but stabilized in those fed on olive oil ."
94368,aorta,O,3274.0,"In the ascending aorta , lesion size doubled in animals fed on coconut oil but stabilized in those fed on olive oil ."
94369,",",O,3274.0,"In the ascending aorta , lesion size doubled in animals fed on coconut oil but stabilized in those fed on olive oil ."
94370,lesion,O,3274.0,"In the ascending aorta , lesion size doubled in animals fed on coconut oil but stabilized in those fed on olive oil ."
94371,size,O,3274.0,"In the ascending aorta , lesion size doubled in animals fed on coconut oil but stabilized in those fed on olive oil ."
94372,doubled,O,3274.0,"In the ascending aorta , lesion size doubled in animals fed on coconut oil but stabilized in those fed on olive oil ."
94373,in,O,3274.0,"In the ascending aorta , lesion size doubled in animals fed on coconut oil but stabilized in those fed on olive oil ."
94374,animals,O,3274.0,"In the ascending aorta , lesion size doubled in animals fed on coconut oil but stabilized in those fed on olive oil ."
94375,fed,O,3274.0,"In the ascending aorta , lesion size doubled in animals fed on coconut oil but stabilized in those fed on olive oil ."
94376,on,O,3274.0,"In the ascending aorta , lesion size doubled in animals fed on coconut oil but stabilized in those fed on olive oil ."
94377,coconut,B-AG.01.f,3274.0,"In the ascending aorta , lesion size doubled in animals fed on coconut oil but stabilized in those fed on olive oil ."
94378,oil,I-AG.01.f,3274.0,"In the ascending aorta , lesion size doubled in animals fed on coconut oil but stabilized in those fed on olive oil ."
94379,but,O,3274.0,"In the ascending aorta , lesion size doubled in animals fed on coconut oil but stabilized in those fed on olive oil ."
94380,stabilized,O,3274.0,"In the ascending aorta , lesion size doubled in animals fed on coconut oil but stabilized in those fed on olive oil ."
94381,in,O,3274.0,"In the ascending aorta , lesion size doubled in animals fed on coconut oil but stabilized in those fed on olive oil ."
94382,those,O,3274.0,"In the ascending aorta , lesion size doubled in animals fed on coconut oil but stabilized in those fed on olive oil ."
94383,fed,O,3274.0,"In the ascending aorta , lesion size doubled in animals fed on coconut oil but stabilized in those fed on olive oil ."
94384,on,O,3274.0,"In the ascending aorta , lesion size doubled in animals fed on coconut oil but stabilized in those fed on olive oil ."
94385,olive,B-AG.01.f,3274.0,"In the ascending aorta , lesion size doubled in animals fed on coconut oil but stabilized in those fed on olive oil ."
94386,oil,I-AG.01.f,3274.0,"In the ascending aorta , lesion size doubled in animals fed on coconut oil but stabilized in those fed on olive oil ."
94387,.,O,3274.0,"In the ascending aorta , lesion size doubled in animals fed on coconut oil but stabilized in those fed on olive oil ."
94388,In,O,3275.0,"In the aortic arch , lesion size decreased linearly ( P < 0.05 , P < 0.001 for coconut oil and olive oil respectively ) with the greatest reduction being seen in the olive - oil - fed animals ( P < 0.05 ) ."
94389,the,O,3275.0,"In the aortic arch , lesion size decreased linearly ( P < 0.05 , P < 0.001 for coconut oil and olive oil respectively ) with the greatest reduction being seen in the olive - oil - fed animals ( P < 0.05 ) ."
94390,aortic,O,3275.0,"In the aortic arch , lesion size decreased linearly ( P < 0.05 , P < 0.001 for coconut oil and olive oil respectively ) with the greatest reduction being seen in the olive - oil - fed animals ( P < 0.05 ) ."
94391,arch,O,3275.0,"In the aortic arch , lesion size decreased linearly ( P < 0.05 , P < 0.001 for coconut oil and olive oil respectively ) with the greatest reduction being seen in the olive - oil - fed animals ( P < 0.05 ) ."
94392,",",O,3275.0,"In the aortic arch , lesion size decreased linearly ( P < 0.05 , P < 0.001 for coconut oil and olive oil respectively ) with the greatest reduction being seen in the olive - oil - fed animals ( P < 0.05 ) ."
94393,lesion,O,3275.0,"In the aortic arch , lesion size decreased linearly ( P < 0.05 , P < 0.001 for coconut oil and olive oil respectively ) with the greatest reduction being seen in the olive - oil - fed animals ( P < 0.05 ) ."
94394,size,O,3275.0,"In the aortic arch , lesion size decreased linearly ( P < 0.05 , P < 0.001 for coconut oil and olive oil respectively ) with the greatest reduction being seen in the olive - oil - fed animals ( P < 0.05 ) ."
94395,decreased,O,3275.0,"In the aortic arch , lesion size decreased linearly ( P < 0.05 , P < 0.001 for coconut oil and olive oil respectively ) with the greatest reduction being seen in the olive - oil - fed animals ( P < 0.05 ) ."
94396,linearly,O,3275.0,"In the aortic arch , lesion size decreased linearly ( P < 0.05 , P < 0.001 for coconut oil and olive oil respectively ) with the greatest reduction being seen in the olive - oil - fed animals ( P < 0.05 ) ."
94397,(,O,3275.0,"In the aortic arch , lesion size decreased linearly ( P < 0.05 , P < 0.001 for coconut oil and olive oil respectively ) with the greatest reduction being seen in the olive - oil - fed animals ( P < 0.05 ) ."
94398,P,O,3275.0,"In the aortic arch , lesion size decreased linearly ( P < 0.05 , P < 0.001 for coconut oil and olive oil respectively ) with the greatest reduction being seen in the olive - oil - fed animals ( P < 0.05 ) ."
94399,<,O,3275.0,"In the aortic arch , lesion size decreased linearly ( P < 0.05 , P < 0.001 for coconut oil and olive oil respectively ) with the greatest reduction being seen in the olive - oil - fed animals ( P < 0.05 ) ."
94400,0.05,O,3275.0,"In the aortic arch , lesion size decreased linearly ( P < 0.05 , P < 0.001 for coconut oil and olive oil respectively ) with the greatest reduction being seen in the olive - oil - fed animals ( P < 0.05 ) ."
94401,",",O,3275.0,"In the aortic arch , lesion size decreased linearly ( P < 0.05 , P < 0.001 for coconut oil and olive oil respectively ) with the greatest reduction being seen in the olive - oil - fed animals ( P < 0.05 ) ."
94402,P,O,3275.0,"In the aortic arch , lesion size decreased linearly ( P < 0.05 , P < 0.001 for coconut oil and olive oil respectively ) with the greatest reduction being seen in the olive - oil - fed animals ( P < 0.05 ) ."
94403,<,O,3275.0,"In the aortic arch , lesion size decreased linearly ( P < 0.05 , P < 0.001 for coconut oil and olive oil respectively ) with the greatest reduction being seen in the olive - oil - fed animals ( P < 0.05 ) ."
94404,0.001,O,3275.0,"In the aortic arch , lesion size decreased linearly ( P < 0.05 , P < 0.001 for coconut oil and olive oil respectively ) with the greatest reduction being seen in the olive - oil - fed animals ( P < 0.05 ) ."
94405,for,O,3275.0,"In the aortic arch , lesion size decreased linearly ( P < 0.05 , P < 0.001 for coconut oil and olive oil respectively ) with the greatest reduction being seen in the olive - oil - fed animals ( P < 0.05 ) ."
94406,coconut,B-AG.01.f,3275.0,"In the aortic arch , lesion size decreased linearly ( P < 0.05 , P < 0.001 for coconut oil and olive oil respectively ) with the greatest reduction being seen in the olive - oil - fed animals ( P < 0.05 ) ."
94407,oil,I-AG.01.f,3275.0,"In the aortic arch , lesion size decreased linearly ( P < 0.05 , P < 0.001 for coconut oil and olive oil respectively ) with the greatest reduction being seen in the olive - oil - fed animals ( P < 0.05 ) ."
94408,and,O,3275.0,"In the aortic arch , lesion size decreased linearly ( P < 0.05 , P < 0.001 for coconut oil and olive oil respectively ) with the greatest reduction being seen in the olive - oil - fed animals ( P < 0.05 ) ."
94409,olive,B-AG.01.f,3275.0,"In the aortic arch , lesion size decreased linearly ( P < 0.05 , P < 0.001 for coconut oil and olive oil respectively ) with the greatest reduction being seen in the olive - oil - fed animals ( P < 0.05 ) ."
94410,oil,I-AG.01.f,3275.0,"In the aortic arch , lesion size decreased linearly ( P < 0.05 , P < 0.001 for coconut oil and olive oil respectively ) with the greatest reduction being seen in the olive - oil - fed animals ( P < 0.05 ) ."
94411,respectively,O,3275.0,"In the aortic arch , lesion size decreased linearly ( P < 0.05 , P < 0.001 for coconut oil and olive oil respectively ) with the greatest reduction being seen in the olive - oil - fed animals ( P < 0.05 ) ."
94412,),O,3275.0,"In the aortic arch , lesion size decreased linearly ( P < 0.05 , P < 0.001 for coconut oil and olive oil respectively ) with the greatest reduction being seen in the olive - oil - fed animals ( P < 0.05 ) ."
94413,with,O,3275.0,"In the aortic arch , lesion size decreased linearly ( P < 0.05 , P < 0.001 for coconut oil and olive oil respectively ) with the greatest reduction being seen in the olive - oil - fed animals ( P < 0.05 ) ."
94414,the,O,3275.0,"In the aortic arch , lesion size decreased linearly ( P < 0.05 , P < 0.001 for coconut oil and olive oil respectively ) with the greatest reduction being seen in the olive - oil - fed animals ( P < 0.05 ) ."
94415,greatest,O,3275.0,"In the aortic arch , lesion size decreased linearly ( P < 0.05 , P < 0.001 for coconut oil and olive oil respectively ) with the greatest reduction being seen in the olive - oil - fed animals ( P < 0.05 ) ."
94416,reduction,O,3275.0,"In the aortic arch , lesion size decreased linearly ( P < 0.05 , P < 0.001 for coconut oil and olive oil respectively ) with the greatest reduction being seen in the olive - oil - fed animals ( P < 0.05 ) ."
94417,being,O,3275.0,"In the aortic arch , lesion size decreased linearly ( P < 0.05 , P < 0.001 for coconut oil and olive oil respectively ) with the greatest reduction being seen in the olive - oil - fed animals ( P < 0.05 ) ."
94418,seen,O,3275.0,"In the aortic arch , lesion size decreased linearly ( P < 0.05 , P < 0.001 for coconut oil and olive oil respectively ) with the greatest reduction being seen in the olive - oil - fed animals ( P < 0.05 ) ."
94419,in,O,3275.0,"In the aortic arch , lesion size decreased linearly ( P < 0.05 , P < 0.001 for coconut oil and olive oil respectively ) with the greatest reduction being seen in the olive - oil - fed animals ( P < 0.05 ) ."
94420,the,O,3275.0,"In the aortic arch , lesion size decreased linearly ( P < 0.05 , P < 0.001 for coconut oil and olive oil respectively ) with the greatest reduction being seen in the olive - oil - fed animals ( P < 0.05 ) ."
94421,olive,O,3275.0,"In the aortic arch , lesion size decreased linearly ( P < 0.05 , P < 0.001 for coconut oil and olive oil respectively ) with the greatest reduction being seen in the olive - oil - fed animals ( P < 0.05 ) ."
94422,-,O,3275.0,"In the aortic arch , lesion size decreased linearly ( P < 0.05 , P < 0.001 for coconut oil and olive oil respectively ) with the greatest reduction being seen in the olive - oil - fed animals ( P < 0.05 ) ."
94423,oil,O,3275.0,"In the aortic arch , lesion size decreased linearly ( P < 0.05 , P < 0.001 for coconut oil and olive oil respectively ) with the greatest reduction being seen in the olive - oil - fed animals ( P < 0.05 ) ."
94424,-,O,3275.0,"In the aortic arch , lesion size decreased linearly ( P < 0.05 , P < 0.001 for coconut oil and olive oil respectively ) with the greatest reduction being seen in the olive - oil - fed animals ( P < 0.05 ) ."
94425,fed,O,3275.0,"In the aortic arch , lesion size decreased linearly ( P < 0.05 , P < 0.001 for coconut oil and olive oil respectively ) with the greatest reduction being seen in the olive - oil - fed animals ( P < 0.05 ) ."
94426,animals,O,3275.0,"In the aortic arch , lesion size decreased linearly ( P < 0.05 , P < 0.001 for coconut oil and olive oil respectively ) with the greatest reduction being seen in the olive - oil - fed animals ( P < 0.05 ) ."
94427,(,O,3275.0,"In the aortic arch , lesion size decreased linearly ( P < 0.05 , P < 0.001 for coconut oil and olive oil respectively ) with the greatest reduction being seen in the olive - oil - fed animals ( P < 0.05 ) ."
94428,P,O,3275.0,"In the aortic arch , lesion size decreased linearly ( P < 0.05 , P < 0.001 for coconut oil and olive oil respectively ) with the greatest reduction being seen in the olive - oil - fed animals ( P < 0.05 ) ."
94429,<,O,3275.0,"In the aortic arch , lesion size decreased linearly ( P < 0.05 , P < 0.001 for coconut oil and olive oil respectively ) with the greatest reduction being seen in the olive - oil - fed animals ( P < 0.05 ) ."
94430,0.05,O,3275.0,"In the aortic arch , lesion size decreased linearly ( P < 0.05 , P < 0.001 for coconut oil and olive oil respectively ) with the greatest reduction being seen in the olive - oil - fed animals ( P < 0.05 ) ."
94431,),O,3275.0,"In the aortic arch , lesion size decreased linearly ( P < 0.05 , P < 0.001 for coconut oil and olive oil respectively ) with the greatest reduction being seen in the olive - oil - fed animals ( P < 0.05 ) ."
94432,.,O,3275.0,"In the aortic arch , lesion size decreased linearly ( P < 0.05 , P < 0.001 for coconut oil and olive oil respectively ) with the greatest reduction being seen in the olive - oil - fed animals ( P < 0.05 ) ."
94433,Again,O,3276.0,"Again , progression and regression of atherosclerosis appeared to reflect the relative concentrations of LDL - cholesterol and HDL - cholesterol in the plasma ."
94434,",",O,3276.0,"Again , progression and regression of atherosclerosis appeared to reflect the relative concentrations of LDL - cholesterol and HDL - cholesterol in the plasma ."
94435,progression,O,3276.0,"Again , progression and regression of atherosclerosis appeared to reflect the relative concentrations of LDL - cholesterol and HDL - cholesterol in the plasma ."
94436,and,O,3276.0,"Again , progression and regression of atherosclerosis appeared to reflect the relative concentrations of LDL - cholesterol and HDL - cholesterol in the plasma ."
94437,regression,O,3276.0,"Again , progression and regression of atherosclerosis appeared to reflect the relative concentrations of LDL - cholesterol and HDL - cholesterol in the plasma ."
94438,of,O,3276.0,"Again , progression and regression of atherosclerosis appeared to reflect the relative concentrations of LDL - cholesterol and HDL - cholesterol in the plasma ."
94439,atherosclerosis,O,3276.0,"Again , progression and regression of atherosclerosis appeared to reflect the relative concentrations of LDL - cholesterol and HDL - cholesterol in the plasma ."
94440,appeared,O,3276.0,"Again , progression and regression of atherosclerosis appeared to reflect the relative concentrations of LDL - cholesterol and HDL - cholesterol in the plasma ."
94441,to,O,3276.0,"Again , progression and regression of atherosclerosis appeared to reflect the relative concentrations of LDL - cholesterol and HDL - cholesterol in the plasma ."
94442,reflect,O,3276.0,"Again , progression and regression of atherosclerosis appeared to reflect the relative concentrations of LDL - cholesterol and HDL - cholesterol in the plasma ."
94443,the,O,3276.0,"Again , progression and regression of atherosclerosis appeared to reflect the relative concentrations of LDL - cholesterol and HDL - cholesterol in the plasma ."
94444,relative,O,3276.0,"Again , progression and regression of atherosclerosis appeared to reflect the relative concentrations of LDL - cholesterol and HDL - cholesterol in the plasma ."
94445,concentrations,O,3276.0,"Again , progression and regression of atherosclerosis appeared to reflect the relative concentrations of LDL - cholesterol and HDL - cholesterol in the plasma ."
94446,of,O,3276.0,"Again , progression and regression of atherosclerosis appeared to reflect the relative concentrations of LDL - cholesterol and HDL - cholesterol in the plasma ."
94447,LDL,O,3276.0,"Again , progression and regression of atherosclerosis appeared to reflect the relative concentrations of LDL - cholesterol and HDL - cholesterol in the plasma ."
94448,-,O,3276.0,"Again , progression and regression of atherosclerosis appeared to reflect the relative concentrations of LDL - cholesterol and HDL - cholesterol in the plasma ."
94449,cholesterol,O,3276.0,"Again , progression and regression of atherosclerosis appeared to reflect the relative concentrations of LDL - cholesterol and HDL - cholesterol in the plasma ."
94450,and,O,3276.0,"Again , progression and regression of atherosclerosis appeared to reflect the relative concentrations of LDL - cholesterol and HDL - cholesterol in the plasma ."
94451,HDL,O,3276.0,"Again , progression and regression of atherosclerosis appeared to reflect the relative concentrations of LDL - cholesterol and HDL - cholesterol in the plasma ."
94452,-,O,3276.0,"Again , progression and regression of atherosclerosis appeared to reflect the relative concentrations of LDL - cholesterol and HDL - cholesterol in the plasma ."
94453,cholesterol,O,3276.0,"Again , progression and regression of atherosclerosis appeared to reflect the relative concentrations of LDL - cholesterol and HDL - cholesterol in the plasma ."
94454,in,O,3276.0,"Again , progression and regression of atherosclerosis appeared to reflect the relative concentrations of LDL - cholesterol and HDL - cholesterol in the plasma ."
94455,the,O,3276.0,"Again , progression and regression of atherosclerosis appeared to reflect the relative concentrations of LDL - cholesterol and HDL - cholesterol in the plasma ."
94456,plasma,O,3276.0,"Again , progression and regression of atherosclerosis appeared to reflect the relative concentrations of LDL - cholesterol and HDL - cholesterol in the plasma ."
94457,.,O,3276.0,"Again , progression and regression of atherosclerosis appeared to reflect the relative concentrations of LDL - cholesterol and HDL - cholesterol in the plasma ."
94458,We,O,3277.0,We conclude that the male Golden Syrian hamster represents a useful model of dietary induced regression as well as progression of atherosclerosis .
94459,conclude,O,3277.0,We conclude that the male Golden Syrian hamster represents a useful model of dietary induced regression as well as progression of atherosclerosis .
94460,that,O,3277.0,We conclude that the male Golden Syrian hamster represents a useful model of dietary induced regression as well as progression of atherosclerosis .
94461,the,O,3277.0,We conclude that the male Golden Syrian hamster represents a useful model of dietary induced regression as well as progression of atherosclerosis .
94462,male,O,3277.0,We conclude that the male Golden Syrian hamster represents a useful model of dietary induced regression as well as progression of atherosclerosis .
94463,Golden,O,3277.0,We conclude that the male Golden Syrian hamster represents a useful model of dietary induced regression as well as progression of atherosclerosis .
94464,Syrian,O,3277.0,We conclude that the male Golden Syrian hamster represents a useful model of dietary induced regression as well as progression of atherosclerosis .
94465,hamster,O,3277.0,We conclude that the male Golden Syrian hamster represents a useful model of dietary induced regression as well as progression of atherosclerosis .
94466,represents,O,3277.0,We conclude that the male Golden Syrian hamster represents a useful model of dietary induced regression as well as progression of atherosclerosis .
94467,a,O,3277.0,We conclude that the male Golden Syrian hamster represents a useful model of dietary induced regression as well as progression of atherosclerosis .
94468,useful,O,3277.0,We conclude that the male Golden Syrian hamster represents a useful model of dietary induced regression as well as progression of atherosclerosis .
94469,model,O,3277.0,We conclude that the male Golden Syrian hamster represents a useful model of dietary induced regression as well as progression of atherosclerosis .
94470,of,O,3277.0,We conclude that the male Golden Syrian hamster represents a useful model of dietary induced regression as well as progression of atherosclerosis .
94471,dietary,O,3277.0,We conclude that the male Golden Syrian hamster represents a useful model of dietary induced regression as well as progression of atherosclerosis .
94472,induced,O,3277.0,We conclude that the male Golden Syrian hamster represents a useful model of dietary induced regression as well as progression of atherosclerosis .
94473,regression,O,3277.0,We conclude that the male Golden Syrian hamster represents a useful model of dietary induced regression as well as progression of atherosclerosis .
94474,as,O,3277.0,We conclude that the male Golden Syrian hamster represents a useful model of dietary induced regression as well as progression of atherosclerosis .
94475,well,O,3277.0,We conclude that the male Golden Syrian hamster represents a useful model of dietary induced regression as well as progression of atherosclerosis .
94476,as,O,3277.0,We conclude that the male Golden Syrian hamster represents a useful model of dietary induced regression as well as progression of atherosclerosis .
94477,progression,O,3277.0,We conclude that the male Golden Syrian hamster represents a useful model of dietary induced regression as well as progression of atherosclerosis .
94478,of,O,3277.0,We conclude that the male Golden Syrian hamster represents a useful model of dietary induced regression as well as progression of atherosclerosis .
94479,atherosclerosis,O,3277.0,We conclude that the male Golden Syrian hamster represents a useful model of dietary induced regression as well as progression of atherosclerosis .
94480,.,O,3277.0,We conclude that the male Golden Syrian hamster represents a useful model of dietary induced regression as well as progression of atherosclerosis .
94481,Self,O,3278.0,"Self - monitoring of plasma triglycerides ( TG ) may be a very useful tool to monitor , on a daily basis , the TG responses to different nutrients , particularly carbohydrates ( CHO ) and fat , whose influence on postprandial TG levels is not very well known ."
94482,-,O,3278.0,"Self - monitoring of plasma triglycerides ( TG ) may be a very useful tool to monitor , on a daily basis , the TG responses to different nutrients , particularly carbohydrates ( CHO ) and fat , whose influence on postprandial TG levels is not very well known ."
94483,monitoring,O,3278.0,"Self - monitoring of plasma triglycerides ( TG ) may be a very useful tool to monitor , on a daily basis , the TG responses to different nutrients , particularly carbohydrates ( CHO ) and fat , whose influence on postprandial TG levels is not very well known ."
94484,of,O,3278.0,"Self - monitoring of plasma triglycerides ( TG ) may be a very useful tool to monitor , on a daily basis , the TG responses to different nutrients , particularly carbohydrates ( CHO ) and fat , whose influence on postprandial TG levels is not very well known ."
94485,plasma,O,3278.0,"Self - monitoring of plasma triglycerides ( TG ) may be a very useful tool to monitor , on a daily basis , the TG responses to different nutrients , particularly carbohydrates ( CHO ) and fat , whose influence on postprandial TG levels is not very well known ."
94486,triglycerides,O,3278.0,"Self - monitoring of plasma triglycerides ( TG ) may be a very useful tool to monitor , on a daily basis , the TG responses to different nutrients , particularly carbohydrates ( CHO ) and fat , whose influence on postprandial TG levels is not very well known ."
94487,(,O,3278.0,"Self - monitoring of plasma triglycerides ( TG ) may be a very useful tool to monitor , on a daily basis , the TG responses to different nutrients , particularly carbohydrates ( CHO ) and fat , whose influence on postprandial TG levels is not very well known ."
94488,TG,O,3278.0,"Self - monitoring of plasma triglycerides ( TG ) may be a very useful tool to monitor , on a daily basis , the TG responses to different nutrients , particularly carbohydrates ( CHO ) and fat , whose influence on postprandial TG levels is not very well known ."
94489,),O,3278.0,"Self - monitoring of plasma triglycerides ( TG ) may be a very useful tool to monitor , on a daily basis , the TG responses to different nutrients , particularly carbohydrates ( CHO ) and fat , whose influence on postprandial TG levels is not very well known ."
94490,may,O,3278.0,"Self - monitoring of plasma triglycerides ( TG ) may be a very useful tool to monitor , on a daily basis , the TG responses to different nutrients , particularly carbohydrates ( CHO ) and fat , whose influence on postprandial TG levels is not very well known ."
94491,be,O,3278.0,"Self - monitoring of plasma triglycerides ( TG ) may be a very useful tool to monitor , on a daily basis , the TG responses to different nutrients , particularly carbohydrates ( CHO ) and fat , whose influence on postprandial TG levels is not very well known ."
94492,a,O,3278.0,"Self - monitoring of plasma triglycerides ( TG ) may be a very useful tool to monitor , on a daily basis , the TG responses to different nutrients , particularly carbohydrates ( CHO ) and fat , whose influence on postprandial TG levels is not very well known ."
94493,very,O,3278.0,"Self - monitoring of plasma triglycerides ( TG ) may be a very useful tool to monitor , on a daily basis , the TG responses to different nutrients , particularly carbohydrates ( CHO ) and fat , whose influence on postprandial TG levels is not very well known ."
94494,useful,O,3278.0,"Self - monitoring of plasma triglycerides ( TG ) may be a very useful tool to monitor , on a daily basis , the TG responses to different nutrients , particularly carbohydrates ( CHO ) and fat , whose influence on postprandial TG levels is not very well known ."
94495,tool,O,3278.0,"Self - monitoring of plasma triglycerides ( TG ) may be a very useful tool to monitor , on a daily basis , the TG responses to different nutrients , particularly carbohydrates ( CHO ) and fat , whose influence on postprandial TG levels is not very well known ."
94496,to,O,3278.0,"Self - monitoring of plasma triglycerides ( TG ) may be a very useful tool to monitor , on a daily basis , the TG responses to different nutrients , particularly carbohydrates ( CHO ) and fat , whose influence on postprandial TG levels is not very well known ."
94497,monitor,O,3278.0,"Self - monitoring of plasma triglycerides ( TG ) may be a very useful tool to monitor , on a daily basis , the TG responses to different nutrients , particularly carbohydrates ( CHO ) and fat , whose influence on postprandial TG levels is not very well known ."
94498,",",O,3278.0,"Self - monitoring of plasma triglycerides ( TG ) may be a very useful tool to monitor , on a daily basis , the TG responses to different nutrients , particularly carbohydrates ( CHO ) and fat , whose influence on postprandial TG levels is not very well known ."
94499,on,O,3278.0,"Self - monitoring of plasma triglycerides ( TG ) may be a very useful tool to monitor , on a daily basis , the TG responses to different nutrients , particularly carbohydrates ( CHO ) and fat , whose influence on postprandial TG levels is not very well known ."
94500,a,O,3278.0,"Self - monitoring of plasma triglycerides ( TG ) may be a very useful tool to monitor , on a daily basis , the TG responses to different nutrients , particularly carbohydrates ( CHO ) and fat , whose influence on postprandial TG levels is not very well known ."
94501,daily,O,3278.0,"Self - monitoring of plasma triglycerides ( TG ) may be a very useful tool to monitor , on a daily basis , the TG responses to different nutrients , particularly carbohydrates ( CHO ) and fat , whose influence on postprandial TG levels is not very well known ."
94502,basis,O,3278.0,"Self - monitoring of plasma triglycerides ( TG ) may be a very useful tool to monitor , on a daily basis , the TG responses to different nutrients , particularly carbohydrates ( CHO ) and fat , whose influence on postprandial TG levels is not very well known ."
94503,",",O,3278.0,"Self - monitoring of plasma triglycerides ( TG ) may be a very useful tool to monitor , on a daily basis , the TG responses to different nutrients , particularly carbohydrates ( CHO ) and fat , whose influence on postprandial TG levels is not very well known ."
94504,the,O,3278.0,"Self - monitoring of plasma triglycerides ( TG ) may be a very useful tool to monitor , on a daily basis , the TG responses to different nutrients , particularly carbohydrates ( CHO ) and fat , whose influence on postprandial TG levels is not very well known ."
94505,TG,O,3278.0,"Self - monitoring of plasma triglycerides ( TG ) may be a very useful tool to monitor , on a daily basis , the TG responses to different nutrients , particularly carbohydrates ( CHO ) and fat , whose influence on postprandial TG levels is not very well known ."
94506,responses,O,3278.0,"Self - monitoring of plasma triglycerides ( TG ) may be a very useful tool to monitor , on a daily basis , the TG responses to different nutrients , particularly carbohydrates ( CHO ) and fat , whose influence on postprandial TG levels is not very well known ."
94507,to,O,3278.0,"Self - monitoring of plasma triglycerides ( TG ) may be a very useful tool to monitor , on a daily basis , the TG responses to different nutrients , particularly carbohydrates ( CHO ) and fat , whose influence on postprandial TG levels is not very well known ."
94508,different,O,3278.0,"Self - monitoring of plasma triglycerides ( TG ) may be a very useful tool to monitor , on a daily basis , the TG responses to different nutrients , particularly carbohydrates ( CHO ) and fat , whose influence on postprandial TG levels is not very well known ."
94509,nutrients,O,3278.0,"Self - monitoring of plasma triglycerides ( TG ) may be a very useful tool to monitor , on a daily basis , the TG responses to different nutrients , particularly carbohydrates ( CHO ) and fat , whose influence on postprandial TG levels is not very well known ."
94510,",",O,3278.0,"Self - monitoring of plasma triglycerides ( TG ) may be a very useful tool to monitor , on a daily basis , the TG responses to different nutrients , particularly carbohydrates ( CHO ) and fat , whose influence on postprandial TG levels is not very well known ."
94511,particularly,O,3278.0,"Self - monitoring of plasma triglycerides ( TG ) may be a very useful tool to monitor , on a daily basis , the TG responses to different nutrients , particularly carbohydrates ( CHO ) and fat , whose influence on postprandial TG levels is not very well known ."
94512,carbohydrates,O,3278.0,"Self - monitoring of plasma triglycerides ( TG ) may be a very useful tool to monitor , on a daily basis , the TG responses to different nutrients , particularly carbohydrates ( CHO ) and fat , whose influence on postprandial TG levels is not very well known ."
94513,(,O,3278.0,"Self - monitoring of plasma triglycerides ( TG ) may be a very useful tool to monitor , on a daily basis , the TG responses to different nutrients , particularly carbohydrates ( CHO ) and fat , whose influence on postprandial TG levels is not very well known ."
94514,CHO,O,3278.0,"Self - monitoring of plasma triglycerides ( TG ) may be a very useful tool to monitor , on a daily basis , the TG responses to different nutrients , particularly carbohydrates ( CHO ) and fat , whose influence on postprandial TG levels is not very well known ."
94515,),O,3278.0,"Self - monitoring of plasma triglycerides ( TG ) may be a very useful tool to monitor , on a daily basis , the TG responses to different nutrients , particularly carbohydrates ( CHO ) and fat , whose influence on postprandial TG levels is not very well known ."
94516,and,O,3278.0,"Self - monitoring of plasma triglycerides ( TG ) may be a very useful tool to monitor , on a daily basis , the TG responses to different nutrients , particularly carbohydrates ( CHO ) and fat , whose influence on postprandial TG levels is not very well known ."
94517,fat,O,3278.0,"Self - monitoring of plasma triglycerides ( TG ) may be a very useful tool to monitor , on a daily basis , the TG responses to different nutrients , particularly carbohydrates ( CHO ) and fat , whose influence on postprandial TG levels is not very well known ."
94518,",",O,3278.0,"Self - monitoring of plasma triglycerides ( TG ) may be a very useful tool to monitor , on a daily basis , the TG responses to different nutrients , particularly carbohydrates ( CHO ) and fat , whose influence on postprandial TG levels is not very well known ."
94519,whose,O,3278.0,"Self - monitoring of plasma triglycerides ( TG ) may be a very useful tool to monitor , on a daily basis , the TG responses to different nutrients , particularly carbohydrates ( CHO ) and fat , whose influence on postprandial TG levels is not very well known ."
94520,influence,O,3278.0,"Self - monitoring of plasma triglycerides ( TG ) may be a very useful tool to monitor , on a daily basis , the TG responses to different nutrients , particularly carbohydrates ( CHO ) and fat , whose influence on postprandial TG levels is not very well known ."
94521,on,O,3278.0,"Self - monitoring of plasma triglycerides ( TG ) may be a very useful tool to monitor , on a daily basis , the TG responses to different nutrients , particularly carbohydrates ( CHO ) and fat , whose influence on postprandial TG levels is not very well known ."
94522,postprandial,O,3278.0,"Self - monitoring of plasma triglycerides ( TG ) may be a very useful tool to monitor , on a daily basis , the TG responses to different nutrients , particularly carbohydrates ( CHO ) and fat , whose influence on postprandial TG levels is not very well known ."
94523,TG,O,3278.0,"Self - monitoring of plasma triglycerides ( TG ) may be a very useful tool to monitor , on a daily basis , the TG responses to different nutrients , particularly carbohydrates ( CHO ) and fat , whose influence on postprandial TG levels is not very well known ."
94524,levels,O,3278.0,"Self - monitoring of plasma triglycerides ( TG ) may be a very useful tool to monitor , on a daily basis , the TG responses to different nutrients , particularly carbohydrates ( CHO ) and fat , whose influence on postprandial TG levels is not very well known ."
94525,is,O,3278.0,"Self - monitoring of plasma triglycerides ( TG ) may be a very useful tool to monitor , on a daily basis , the TG responses to different nutrients , particularly carbohydrates ( CHO ) and fat , whose influence on postprandial TG levels is not very well known ."
94526,not,O,3278.0,"Self - monitoring of plasma triglycerides ( TG ) may be a very useful tool to monitor , on a daily basis , the TG responses to different nutrients , particularly carbohydrates ( CHO ) and fat , whose influence on postprandial TG levels is not very well known ."
94527,very,O,3278.0,"Self - monitoring of plasma triglycerides ( TG ) may be a very useful tool to monitor , on a daily basis , the TG responses to different nutrients , particularly carbohydrates ( CHO ) and fat , whose influence on postprandial TG levels is not very well known ."
94528,well,O,3278.0,"Self - monitoring of plasma triglycerides ( TG ) may be a very useful tool to monitor , on a daily basis , the TG responses to different nutrients , particularly carbohydrates ( CHO ) and fat , whose influence on postprandial TG levels is not very well known ."
94529,known,O,3278.0,"Self - monitoring of plasma triglycerides ( TG ) may be a very useful tool to monitor , on a daily basis , the TG responses to different nutrients , particularly carbohydrates ( CHO ) and fat , whose influence on postprandial TG levels is not very well known ."
94530,.,O,3278.0,"Self - monitoring of plasma triglycerides ( TG ) may be a very useful tool to monitor , on a daily basis , the TG responses to different nutrients , particularly carbohydrates ( CHO ) and fat , whose influence on postprandial TG levels is not very well known ."
94531,Therefore,O,3279.0,"Therefore , the aim of the present study was to evaluate the TG response of hypertriglyceridemic patients to a similar amount of calories deriving from different sources of CHO and fat ."
94532,",",O,3279.0,"Therefore , the aim of the present study was to evaluate the TG response of hypertriglyceridemic patients to a similar amount of calories deriving from different sources of CHO and fat ."
94533,the,O,3279.0,"Therefore , the aim of the present study was to evaluate the TG response of hypertriglyceridemic patients to a similar amount of calories deriving from different sources of CHO and fat ."
94534,aim,O,3279.0,"Therefore , the aim of the present study was to evaluate the TG response of hypertriglyceridemic patients to a similar amount of calories deriving from different sources of CHO and fat ."
94535,of,O,3279.0,"Therefore , the aim of the present study was to evaluate the TG response of hypertriglyceridemic patients to a similar amount of calories deriving from different sources of CHO and fat ."
94536,the,O,3279.0,"Therefore , the aim of the present study was to evaluate the TG response of hypertriglyceridemic patients to a similar amount of calories deriving from different sources of CHO and fat ."
94537,present,O,3279.0,"Therefore , the aim of the present study was to evaluate the TG response of hypertriglyceridemic patients to a similar amount of calories deriving from different sources of CHO and fat ."
94538,study,O,3279.0,"Therefore , the aim of the present study was to evaluate the TG response of hypertriglyceridemic patients to a similar amount of calories deriving from different sources of CHO and fat ."
94539,was,O,3279.0,"Therefore , the aim of the present study was to evaluate the TG response of hypertriglyceridemic patients to a similar amount of calories deriving from different sources of CHO and fat ."
94540,to,O,3279.0,"Therefore , the aim of the present study was to evaluate the TG response of hypertriglyceridemic patients to a similar amount of calories deriving from different sources of CHO and fat ."
94541,evaluate,O,3279.0,"Therefore , the aim of the present study was to evaluate the TG response of hypertriglyceridemic patients to a similar amount of calories deriving from different sources of CHO and fat ."
94542,the,O,3279.0,"Therefore , the aim of the present study was to evaluate the TG response of hypertriglyceridemic patients to a similar amount of calories deriving from different sources of CHO and fat ."
94543,TG,O,3279.0,"Therefore , the aim of the present study was to evaluate the TG response of hypertriglyceridemic patients to a similar amount of calories deriving from different sources of CHO and fat ."
94544,response,O,3279.0,"Therefore , the aim of the present study was to evaluate the TG response of hypertriglyceridemic patients to a similar amount of calories deriving from different sources of CHO and fat ."
94545,of,O,3279.0,"Therefore , the aim of the present study was to evaluate the TG response of hypertriglyceridemic patients to a similar amount of calories deriving from different sources of CHO and fat ."
94546,hypertriglyceridemic,O,3279.0,"Therefore , the aim of the present study was to evaluate the TG response of hypertriglyceridemic patients to a similar amount of calories deriving from different sources of CHO and fat ."
94547,patients,O,3279.0,"Therefore , the aim of the present study was to evaluate the TG response of hypertriglyceridemic patients to a similar amount of calories deriving from different sources of CHO and fat ."
94548,to,O,3279.0,"Therefore , the aim of the present study was to evaluate the TG response of hypertriglyceridemic patients to a similar amount of calories deriving from different sources of CHO and fat ."
94549,a,O,3279.0,"Therefore , the aim of the present study was to evaluate the TG response of hypertriglyceridemic patients to a similar amount of calories deriving from different sources of CHO and fat ."
94550,similar,O,3279.0,"Therefore , the aim of the present study was to evaluate the TG response of hypertriglyceridemic patients to a similar amount of calories deriving from different sources of CHO and fat ."
94551,amount,O,3279.0,"Therefore , the aim of the present study was to evaluate the TG response of hypertriglyceridemic patients to a similar amount of calories deriving from different sources of CHO and fat ."
94552,of,O,3279.0,"Therefore , the aim of the present study was to evaluate the TG response of hypertriglyceridemic patients to a similar amount of calories deriving from different sources of CHO and fat ."
94553,calories,O,3279.0,"Therefore , the aim of the present study was to evaluate the TG response of hypertriglyceridemic patients to a similar amount of calories deriving from different sources of CHO and fat ."
94554,deriving,O,3279.0,"Therefore , the aim of the present study was to evaluate the TG response of hypertriglyceridemic patients to a similar amount of calories deriving from different sources of CHO and fat ."
94555,from,O,3279.0,"Therefore , the aim of the present study was to evaluate the TG response of hypertriglyceridemic patients to a similar amount of calories deriving from different sources of CHO and fat ."
94556,different,O,3279.0,"Therefore , the aim of the present study was to evaluate the TG response of hypertriglyceridemic patients to a similar amount of calories deriving from different sources of CHO and fat ."
94557,sources,O,3279.0,"Therefore , the aim of the present study was to evaluate the TG response of hypertriglyceridemic patients to a similar amount of calories deriving from different sources of CHO and fat ."
94558,of,O,3279.0,"Therefore , the aim of the present study was to evaluate the TG response of hypertriglyceridemic patients to a similar amount of calories deriving from different sources of CHO and fat ."
94559,CHO,O,3279.0,"Therefore , the aim of the present study was to evaluate the TG response of hypertriglyceridemic patients to a similar amount of calories deriving from different sources of CHO and fat ."
94560,and,O,3279.0,"Therefore , the aim of the present study was to evaluate the TG response of hypertriglyceridemic patients to a similar amount of calories deriving from different sources of CHO and fat ."
94561,fat,O,3279.0,"Therefore , the aim of the present study was to evaluate the TG response of hypertriglyceridemic patients to a similar amount of calories deriving from different sources of CHO and fat ."
94562,.,O,3279.0,"Therefore , the aim of the present study was to evaluate the TG response of hypertriglyceridemic patients to a similar amount of calories deriving from different sources of CHO and fat ."
94563,Thirty,O,3280.0,Thirty - nine hypertriglyceridemic patients were randomly assigned to 1 of 2 experimental groups .
94564,-,O,3280.0,Thirty - nine hypertriglyceridemic patients were randomly assigned to 1 of 2 experimental groups .
94565,nine,O,3280.0,Thirty - nine hypertriglyceridemic patients were randomly assigned to 1 of 2 experimental groups .
94566,hypertriglyceridemic,O,3280.0,Thirty - nine hypertriglyceridemic patients were randomly assigned to 1 of 2 experimental groups .
94567,patients,O,3280.0,Thirty - nine hypertriglyceridemic patients were randomly assigned to 1 of 2 experimental groups .
94568,were,O,3280.0,Thirty - nine hypertriglyceridemic patients were randomly assigned to 1 of 2 experimental groups .
94569,randomly,O,3280.0,Thirty - nine hypertriglyceridemic patients were randomly assigned to 1 of 2 experimental groups .
94570,assigned,O,3280.0,Thirty - nine hypertriglyceridemic patients were randomly assigned to 1 of 2 experimental groups .
94571,to,O,3280.0,Thirty - nine hypertriglyceridemic patients were randomly assigned to 1 of 2 experimental groups .
94572,1,O,3280.0,Thirty - nine hypertriglyceridemic patients were randomly assigned to 1 of 2 experimental groups .
94573,of,O,3280.0,Thirty - nine hypertriglyceridemic patients were randomly assigned to 1 of 2 experimental groups .
94574,2,O,3280.0,Thirty - nine hypertriglyceridemic patients were randomly assigned to 1 of 2 experimental groups .
94575,experimental,O,3280.0,Thirty - nine hypertriglyceridemic patients were randomly assigned to 1 of 2 experimental groups .
94576,groups,O,3280.0,Thirty - nine hypertriglyceridemic patients were randomly assigned to 1 of 2 experimental groups .
94577,.,O,3280.0,Thirty - nine hypertriglyceridemic patients were randomly assigned to 1 of 2 experimental groups .
94578,In,O,3281.0,"In 1 group ( the fat group ) , patients were given a standard meal plus a fat supplement of 300 kcal derived from different types of fat ( butter , sunflower margarine , olive oil ) for dinner , once a week for 3 weeks ."
94579,1,O,3281.0,"In 1 group ( the fat group ) , patients were given a standard meal plus a fat supplement of 300 kcal derived from different types of fat ( butter , sunflower margarine , olive oil ) for dinner , once a week for 3 weeks ."
94580,group,O,3281.0,"In 1 group ( the fat group ) , patients were given a standard meal plus a fat supplement of 300 kcal derived from different types of fat ( butter , sunflower margarine , olive oil ) for dinner , once a week for 3 weeks ."
94581,(,O,3281.0,"In 1 group ( the fat group ) , patients were given a standard meal plus a fat supplement of 300 kcal derived from different types of fat ( butter , sunflower margarine , olive oil ) for dinner , once a week for 3 weeks ."
94582,the,O,3281.0,"In 1 group ( the fat group ) , patients were given a standard meal plus a fat supplement of 300 kcal derived from different types of fat ( butter , sunflower margarine , olive oil ) for dinner , once a week for 3 weeks ."
94583,fat,O,3281.0,"In 1 group ( the fat group ) , patients were given a standard meal plus a fat supplement of 300 kcal derived from different types of fat ( butter , sunflower margarine , olive oil ) for dinner , once a week for 3 weeks ."
94584,group,O,3281.0,"In 1 group ( the fat group ) , patients were given a standard meal plus a fat supplement of 300 kcal derived from different types of fat ( butter , sunflower margarine , olive oil ) for dinner , once a week for 3 weeks ."
94585,),O,3281.0,"In 1 group ( the fat group ) , patients were given a standard meal plus a fat supplement of 300 kcal derived from different types of fat ( butter , sunflower margarine , olive oil ) for dinner , once a week for 3 weeks ."
94586,",",O,3281.0,"In 1 group ( the fat group ) , patients were given a standard meal plus a fat supplement of 300 kcal derived from different types of fat ( butter , sunflower margarine , olive oil ) for dinner , once a week for 3 weeks ."
94587,patients,O,3281.0,"In 1 group ( the fat group ) , patients were given a standard meal plus a fat supplement of 300 kcal derived from different types of fat ( butter , sunflower margarine , olive oil ) for dinner , once a week for 3 weeks ."
94588,were,O,3281.0,"In 1 group ( the fat group ) , patients were given a standard meal plus a fat supplement of 300 kcal derived from different types of fat ( butter , sunflower margarine , olive oil ) for dinner , once a week for 3 weeks ."
94589,given,O,3281.0,"In 1 group ( the fat group ) , patients were given a standard meal plus a fat supplement of 300 kcal derived from different types of fat ( butter , sunflower margarine , olive oil ) for dinner , once a week for 3 weeks ."
94590,a,O,3281.0,"In 1 group ( the fat group ) , patients were given a standard meal plus a fat supplement of 300 kcal derived from different types of fat ( butter , sunflower margarine , olive oil ) for dinner , once a week for 3 weeks ."
94591,standard,O,3281.0,"In 1 group ( the fat group ) , patients were given a standard meal plus a fat supplement of 300 kcal derived from different types of fat ( butter , sunflower margarine , olive oil ) for dinner , once a week for 3 weeks ."
94592,meal,O,3281.0,"In 1 group ( the fat group ) , patients were given a standard meal plus a fat supplement of 300 kcal derived from different types of fat ( butter , sunflower margarine , olive oil ) for dinner , once a week for 3 weeks ."
94593,plus,O,3281.0,"In 1 group ( the fat group ) , patients were given a standard meal plus a fat supplement of 300 kcal derived from different types of fat ( butter , sunflower margarine , olive oil ) for dinner , once a week for 3 weeks ."
94594,a,O,3281.0,"In 1 group ( the fat group ) , patients were given a standard meal plus a fat supplement of 300 kcal derived from different types of fat ( butter , sunflower margarine , olive oil ) for dinner , once a week for 3 weeks ."
94595,fat,O,3281.0,"In 1 group ( the fat group ) , patients were given a standard meal plus a fat supplement of 300 kcal derived from different types of fat ( butter , sunflower margarine , olive oil ) for dinner , once a week for 3 weeks ."
94596,supplement,O,3281.0,"In 1 group ( the fat group ) , patients were given a standard meal plus a fat supplement of 300 kcal derived from different types of fat ( butter , sunflower margarine , olive oil ) for dinner , once a week for 3 weeks ."
94597,of,O,3281.0,"In 1 group ( the fat group ) , patients were given a standard meal plus a fat supplement of 300 kcal derived from different types of fat ( butter , sunflower margarine , olive oil ) for dinner , once a week for 3 weeks ."
94598,300,O,3281.0,"In 1 group ( the fat group ) , patients were given a standard meal plus a fat supplement of 300 kcal derived from different types of fat ( butter , sunflower margarine , olive oil ) for dinner , once a week for 3 weeks ."
94599,kcal,O,3281.0,"In 1 group ( the fat group ) , patients were given a standard meal plus a fat supplement of 300 kcal derived from different types of fat ( butter , sunflower margarine , olive oil ) for dinner , once a week for 3 weeks ."
94600,derived,O,3281.0,"In 1 group ( the fat group ) , patients were given a standard meal plus a fat supplement of 300 kcal derived from different types of fat ( butter , sunflower margarine , olive oil ) for dinner , once a week for 3 weeks ."
94601,from,O,3281.0,"In 1 group ( the fat group ) , patients were given a standard meal plus a fat supplement of 300 kcal derived from different types of fat ( butter , sunflower margarine , olive oil ) for dinner , once a week for 3 weeks ."
94602,different,O,3281.0,"In 1 group ( the fat group ) , patients were given a standard meal plus a fat supplement of 300 kcal derived from different types of fat ( butter , sunflower margarine , olive oil ) for dinner , once a week for 3 weeks ."
94603,types,O,3281.0,"In 1 group ( the fat group ) , patients were given a standard meal plus a fat supplement of 300 kcal derived from different types of fat ( butter , sunflower margarine , olive oil ) for dinner , once a week for 3 weeks ."
94604,of,O,3281.0,"In 1 group ( the fat group ) , patients were given a standard meal plus a fat supplement of 300 kcal derived from different types of fat ( butter , sunflower margarine , olive oil ) for dinner , once a week for 3 weeks ."
94605,fat,O,3281.0,"In 1 group ( the fat group ) , patients were given a standard meal plus a fat supplement of 300 kcal derived from different types of fat ( butter , sunflower margarine , olive oil ) for dinner , once a week for 3 weeks ."
94606,(,O,3281.0,"In 1 group ( the fat group ) , patients were given a standard meal plus a fat supplement of 300 kcal derived from different types of fat ( butter , sunflower margarine , olive oil ) for dinner , once a week for 3 weeks ."
94607,butter,B-AG.01.e.01,3281.0,"In 1 group ( the fat group ) , patients were given a standard meal plus a fat supplement of 300 kcal derived from different types of fat ( butter , sunflower margarine , olive oil ) for dinner , once a week for 3 weeks ."
94608,",",O,3281.0,"In 1 group ( the fat group ) , patients were given a standard meal plus a fat supplement of 300 kcal derived from different types of fat ( butter , sunflower margarine , olive oil ) for dinner , once a week for 3 weeks ."
94609,sunflower,B-AG.01.f,3281.0,"In 1 group ( the fat group ) , patients were given a standard meal plus a fat supplement of 300 kcal derived from different types of fat ( butter , sunflower margarine , olive oil ) for dinner , once a week for 3 weeks ."
94610,margarine,I-AG.01.f,3281.0,"In 1 group ( the fat group ) , patients were given a standard meal plus a fat supplement of 300 kcal derived from different types of fat ( butter , sunflower margarine , olive oil ) for dinner , once a week for 3 weeks ."
94611,",",O,3281.0,"In 1 group ( the fat group ) , patients were given a standard meal plus a fat supplement of 300 kcal derived from different types of fat ( butter , sunflower margarine , olive oil ) for dinner , once a week for 3 weeks ."
94612,olive,B-AG.01.f,3281.0,"In 1 group ( the fat group ) , patients were given a standard meal plus a fat supplement of 300 kcal derived from different types of fat ( butter , sunflower margarine , olive oil ) for dinner , once a week for 3 weeks ."
94613,oil,I-AG.01.f,3281.0,"In 1 group ( the fat group ) , patients were given a standard meal plus a fat supplement of 300 kcal derived from different types of fat ( butter , sunflower margarine , olive oil ) for dinner , once a week for 3 weeks ."
94614,),O,3281.0,"In 1 group ( the fat group ) , patients were given a standard meal plus a fat supplement of 300 kcal derived from different types of fat ( butter , sunflower margarine , olive oil ) for dinner , once a week for 3 weeks ."
94615,for,O,3281.0,"In 1 group ( the fat group ) , patients were given a standard meal plus a fat supplement of 300 kcal derived from different types of fat ( butter , sunflower margarine , olive oil ) for dinner , once a week for 3 weeks ."
94616,dinner,O,3281.0,"In 1 group ( the fat group ) , patients were given a standard meal plus a fat supplement of 300 kcal derived from different types of fat ( butter , sunflower margarine , olive oil ) for dinner , once a week for 3 weeks ."
94617,",",O,3281.0,"In 1 group ( the fat group ) , patients were given a standard meal plus a fat supplement of 300 kcal derived from different types of fat ( butter , sunflower margarine , olive oil ) for dinner , once a week for 3 weeks ."
94618,once,O,3281.0,"In 1 group ( the fat group ) , patients were given a standard meal plus a fat supplement of 300 kcal derived from different types of fat ( butter , sunflower margarine , olive oil ) for dinner , once a week for 3 weeks ."
94619,a,O,3281.0,"In 1 group ( the fat group ) , patients were given a standard meal plus a fat supplement of 300 kcal derived from different types of fat ( butter , sunflower margarine , olive oil ) for dinner , once a week for 3 weeks ."
94620,week,O,3281.0,"In 1 group ( the fat group ) , patients were given a standard meal plus a fat supplement of 300 kcal derived from different types of fat ( butter , sunflower margarine , olive oil ) for dinner , once a week for 3 weeks ."
94621,for,O,3281.0,"In 1 group ( the fat group ) , patients were given a standard meal plus a fat supplement of 300 kcal derived from different types of fat ( butter , sunflower margarine , olive oil ) for dinner , once a week for 3 weeks ."
94622,3,O,3281.0,"In 1 group ( the fat group ) , patients were given a standard meal plus a fat supplement of 300 kcal derived from different types of fat ( butter , sunflower margarine , olive oil ) for dinner , once a week for 3 weeks ."
94623,weeks,O,3281.0,"In 1 group ( the fat group ) , patients were given a standard meal plus a fat supplement of 300 kcal derived from different types of fat ( butter , sunflower margarine , olive oil ) for dinner , once a week for 3 weeks ."
94624,.,O,3281.0,"In 1 group ( the fat group ) , patients were given a standard meal plus a fat supplement of 300 kcal derived from different types of fat ( butter , sunflower margarine , olive oil ) for dinner , once a week for 3 weeks ."
94625,In,O,3282.0,"In the other group ( the CHO group ) , patients consumed the same standard meal plus a supplement of 300 kcal derived from different types of CHO ( bread , coke , fruit ) ."
94626,the,O,3282.0,"In the other group ( the CHO group ) , patients consumed the same standard meal plus a supplement of 300 kcal derived from different types of CHO ( bread , coke , fruit ) ."
94627,other,O,3282.0,"In the other group ( the CHO group ) , patients consumed the same standard meal plus a supplement of 300 kcal derived from different types of CHO ( bread , coke , fruit ) ."
94628,group,O,3282.0,"In the other group ( the CHO group ) , patients consumed the same standard meal plus a supplement of 300 kcal derived from different types of CHO ( bread , coke , fruit ) ."
94629,(,O,3282.0,"In the other group ( the CHO group ) , patients consumed the same standard meal plus a supplement of 300 kcal derived from different types of CHO ( bread , coke , fruit ) ."
94630,the,O,3282.0,"In the other group ( the CHO group ) , patients consumed the same standard meal plus a supplement of 300 kcal derived from different types of CHO ( bread , coke , fruit ) ."
94631,CHO,O,3282.0,"In the other group ( the CHO group ) , patients consumed the same standard meal plus a supplement of 300 kcal derived from different types of CHO ( bread , coke , fruit ) ."
94632,group,O,3282.0,"In the other group ( the CHO group ) , patients consumed the same standard meal plus a supplement of 300 kcal derived from different types of CHO ( bread , coke , fruit ) ."
94633,),O,3282.0,"In the other group ( the CHO group ) , patients consumed the same standard meal plus a supplement of 300 kcal derived from different types of CHO ( bread , coke , fruit ) ."
94634,",",O,3282.0,"In the other group ( the CHO group ) , patients consumed the same standard meal plus a supplement of 300 kcal derived from different types of CHO ( bread , coke , fruit ) ."
94635,patients,O,3282.0,"In the other group ( the CHO group ) , patients consumed the same standard meal plus a supplement of 300 kcal derived from different types of CHO ( bread , coke , fruit ) ."
94636,consumed,O,3282.0,"In the other group ( the CHO group ) , patients consumed the same standard meal plus a supplement of 300 kcal derived from different types of CHO ( bread , coke , fruit ) ."
94637,the,O,3282.0,"In the other group ( the CHO group ) , patients consumed the same standard meal plus a supplement of 300 kcal derived from different types of CHO ( bread , coke , fruit ) ."
94638,same,O,3282.0,"In the other group ( the CHO group ) , patients consumed the same standard meal plus a supplement of 300 kcal derived from different types of CHO ( bread , coke , fruit ) ."
94639,standard,O,3282.0,"In the other group ( the CHO group ) , patients consumed the same standard meal plus a supplement of 300 kcal derived from different types of CHO ( bread , coke , fruit ) ."
94640,meal,O,3282.0,"In the other group ( the CHO group ) , patients consumed the same standard meal plus a supplement of 300 kcal derived from different types of CHO ( bread , coke , fruit ) ."
94641,plus,O,3282.0,"In the other group ( the CHO group ) , patients consumed the same standard meal plus a supplement of 300 kcal derived from different types of CHO ( bread , coke , fruit ) ."
94642,a,O,3282.0,"In the other group ( the CHO group ) , patients consumed the same standard meal plus a supplement of 300 kcal derived from different types of CHO ( bread , coke , fruit ) ."
94643,supplement,O,3282.0,"In the other group ( the CHO group ) , patients consumed the same standard meal plus a supplement of 300 kcal derived from different types of CHO ( bread , coke , fruit ) ."
94644,of,O,3282.0,"In the other group ( the CHO group ) , patients consumed the same standard meal plus a supplement of 300 kcal derived from different types of CHO ( bread , coke , fruit ) ."
94645,300,O,3282.0,"In the other group ( the CHO group ) , patients consumed the same standard meal plus a supplement of 300 kcal derived from different types of CHO ( bread , coke , fruit ) ."
94646,kcal,O,3282.0,"In the other group ( the CHO group ) , patients consumed the same standard meal plus a supplement of 300 kcal derived from different types of CHO ( bread , coke , fruit ) ."
94647,derived,O,3282.0,"In the other group ( the CHO group ) , patients consumed the same standard meal plus a supplement of 300 kcal derived from different types of CHO ( bread , coke , fruit ) ."
94648,from,O,3282.0,"In the other group ( the CHO group ) , patients consumed the same standard meal plus a supplement of 300 kcal derived from different types of CHO ( bread , coke , fruit ) ."
94649,different,O,3282.0,"In the other group ( the CHO group ) , patients consumed the same standard meal plus a supplement of 300 kcal derived from different types of CHO ( bread , coke , fruit ) ."
94650,types,O,3282.0,"In the other group ( the CHO group ) , patients consumed the same standard meal plus a supplement of 300 kcal derived from different types of CHO ( bread , coke , fruit ) ."
94651,of,O,3282.0,"In the other group ( the CHO group ) , patients consumed the same standard meal plus a supplement of 300 kcal derived from different types of CHO ( bread , coke , fruit ) ."
94652,CHO,O,3282.0,"In the other group ( the CHO group ) , patients consumed the same standard meal plus a supplement of 300 kcal derived from different types of CHO ( bread , coke , fruit ) ."
94653,(,O,3282.0,"In the other group ( the CHO group ) , patients consumed the same standard meal plus a supplement of 300 kcal derived from different types of CHO ( bread , coke , fruit ) ."
94654,bread,B-AG.01.n.11,3282.0,"In the other group ( the CHO group ) , patients consumed the same standard meal plus a supplement of 300 kcal derived from different types of CHO ( bread , coke , fruit ) ."
94655,",",O,3282.0,"In the other group ( the CHO group ) , patients consumed the same standard meal plus a supplement of 300 kcal derived from different types of CHO ( bread , coke , fruit ) ."
94656,coke,B-AG.01.aa,3282.0,"In the other group ( the CHO group ) , patients consumed the same standard meal plus a supplement of 300 kcal derived from different types of CHO ( bread , coke , fruit ) ."
94657,",",O,3282.0,"In the other group ( the CHO group ) , patients consumed the same standard meal plus a supplement of 300 kcal derived from different types of CHO ( bread , coke , fruit ) ."
94658,fruit,B-AG.01.h.01,3282.0,"In the other group ( the CHO group ) , patients consumed the same standard meal plus a supplement of 300 kcal derived from different types of CHO ( bread , coke , fruit ) ."
94659,),O,3282.0,"In the other group ( the CHO group ) , patients consumed the same standard meal plus a supplement of 300 kcal derived from different types of CHO ( bread , coke , fruit ) ."
94660,.,O,3282.0,"In the other group ( the CHO group ) , patients consumed the same standard meal plus a supplement of 300 kcal derived from different types of CHO ( bread , coke , fruit ) ."
94661,In,O,3283.0,"In both groups , patients measured their plasma TG before and 3 hours after each meal by Accutrend GCT ( ROCHE , Mannheim , Germany ) ."
94662,both,O,3283.0,"In both groups , patients measured their plasma TG before and 3 hours after each meal by Accutrend GCT ( ROCHE , Mannheim , Germany ) ."
94663,groups,O,3283.0,"In both groups , patients measured their plasma TG before and 3 hours after each meal by Accutrend GCT ( ROCHE , Mannheim , Germany ) ."
94664,",",O,3283.0,"In both groups , patients measured their plasma TG before and 3 hours after each meal by Accutrend GCT ( ROCHE , Mannheim , Germany ) ."
94665,patients,O,3283.0,"In both groups , patients measured their plasma TG before and 3 hours after each meal by Accutrend GCT ( ROCHE , Mannheim , Germany ) ."
94666,measured,O,3283.0,"In both groups , patients measured their plasma TG before and 3 hours after each meal by Accutrend GCT ( ROCHE , Mannheim , Germany ) ."
94667,their,O,3283.0,"In both groups , patients measured their plasma TG before and 3 hours after each meal by Accutrend GCT ( ROCHE , Mannheim , Germany ) ."
94668,plasma,O,3283.0,"In both groups , patients measured their plasma TG before and 3 hours after each meal by Accutrend GCT ( ROCHE , Mannheim , Germany ) ."
94669,TG,O,3283.0,"In both groups , patients measured their plasma TG before and 3 hours after each meal by Accutrend GCT ( ROCHE , Mannheim , Germany ) ."
94670,before,O,3283.0,"In both groups , patients measured their plasma TG before and 3 hours after each meal by Accutrend GCT ( ROCHE , Mannheim , Germany ) ."
94671,and,O,3283.0,"In both groups , patients measured their plasma TG before and 3 hours after each meal by Accutrend GCT ( ROCHE , Mannheim , Germany ) ."
94672,3,O,3283.0,"In both groups , patients measured their plasma TG before and 3 hours after each meal by Accutrend GCT ( ROCHE , Mannheim , Germany ) ."
94673,hours,O,3283.0,"In both groups , patients measured their plasma TG before and 3 hours after each meal by Accutrend GCT ( ROCHE , Mannheim , Germany ) ."
94674,after,O,3283.0,"In both groups , patients measured their plasma TG before and 3 hours after each meal by Accutrend GCT ( ROCHE , Mannheim , Germany ) ."
94675,each,O,3283.0,"In both groups , patients measured their plasma TG before and 3 hours after each meal by Accutrend GCT ( ROCHE , Mannheim , Germany ) ."
94676,meal,O,3283.0,"In both groups , patients measured their plasma TG before and 3 hours after each meal by Accutrend GCT ( ROCHE , Mannheim , Germany ) ."
94677,by,O,3283.0,"In both groups , patients measured their plasma TG before and 3 hours after each meal by Accutrend GCT ( ROCHE , Mannheim , Germany ) ."
94678,Accutrend,O,3283.0,"In both groups , patients measured their plasma TG before and 3 hours after each meal by Accutrend GCT ( ROCHE , Mannheim , Germany ) ."
94679,GCT,O,3283.0,"In both groups , patients measured their plasma TG before and 3 hours after each meal by Accutrend GCT ( ROCHE , Mannheim , Germany ) ."
94680,(,O,3283.0,"In both groups , patients measured their plasma TG before and 3 hours after each meal by Accutrend GCT ( ROCHE , Mannheim , Germany ) ."
94681,ROCHE,O,3283.0,"In both groups , patients measured their plasma TG before and 3 hours after each meal by Accutrend GCT ( ROCHE , Mannheim , Germany ) ."
94682,",",O,3283.0,"In both groups , patients measured their plasma TG before and 3 hours after each meal by Accutrend GCT ( ROCHE , Mannheim , Germany ) ."
94683,Mannheim,O,3283.0,"In both groups , patients measured their plasma TG before and 3 hours after each meal by Accutrend GCT ( ROCHE , Mannheim , Germany ) ."
94684,",",O,3283.0,"In both groups , patients measured their plasma TG before and 3 hours after each meal by Accutrend GCT ( ROCHE , Mannheim , Germany ) ."
94685,Germany,O,3283.0,"In both groups , patients measured their plasma TG before and 3 hours after each meal by Accutrend GCT ( ROCHE , Mannheim , Germany ) ."
94686,),O,3283.0,"In both groups , patients measured their plasma TG before and 3 hours after each meal by Accutrend GCT ( ROCHE , Mannheim , Germany ) ."
94687,.,O,3283.0,"In both groups , patients measured their plasma TG before and 3 hours after each meal by Accutrend GCT ( ROCHE , Mannheim , Germany ) ."
94688,A,O,3284.0,A subgroup of patients ( n = 18 ) also performed TG determinations 2 hours after the test meals .
94689,subgroup,O,3284.0,A subgroup of patients ( n = 18 ) also performed TG determinations 2 hours after the test meals .
94690,of,O,3284.0,A subgroup of patients ( n = 18 ) also performed TG determinations 2 hours after the test meals .
94691,patients,O,3284.0,A subgroup of patients ( n = 18 ) also performed TG determinations 2 hours after the test meals .
94692,(,O,3284.0,A subgroup of patients ( n = 18 ) also performed TG determinations 2 hours after the test meals .
94693,n,O,3284.0,A subgroup of patients ( n = 18 ) also performed TG determinations 2 hours after the test meals .
94694,=,O,3284.0,A subgroup of patients ( n = 18 ) also performed TG determinations 2 hours after the test meals .
94695,18,O,3284.0,A subgroup of patients ( n = 18 ) also performed TG determinations 2 hours after the test meals .
94696,),O,3284.0,A subgroup of patients ( n = 18 ) also performed TG determinations 2 hours after the test meals .
94697,also,O,3284.0,A subgroup of patients ( n = 18 ) also performed TG determinations 2 hours after the test meals .
94698,performed,O,3284.0,A subgroup of patients ( n = 18 ) also performed TG determinations 2 hours after the test meals .
94699,TG,O,3284.0,A subgroup of patients ( n = 18 ) also performed TG determinations 2 hours after the test meals .
94700,determinations,O,3284.0,A subgroup of patients ( n = 18 ) also performed TG determinations 2 hours after the test meals .
94701,2,O,3284.0,A subgroup of patients ( n = 18 ) also performed TG determinations 2 hours after the test meals .
94702,hours,O,3284.0,A subgroup of patients ( n = 18 ) also performed TG determinations 2 hours after the test meals .
94703,after,O,3284.0,A subgroup of patients ( n = 18 ) also performed TG determinations 2 hours after the test meals .
94704,the,O,3284.0,A subgroup of patients ( n = 18 ) also performed TG determinations 2 hours after the test meals .
94705,test,O,3284.0,A subgroup of patients ( n = 18 ) also performed TG determinations 2 hours after the test meals .
94706,meals,O,3284.0,A subgroup of patients ( n = 18 ) also performed TG determinations 2 hours after the test meals .
94707,.,O,3284.0,A subgroup of patients ( n = 18 ) also performed TG determinations 2 hours after the test meals .
94708,The,O,3285.0,"The 3 - hour TG increments were not significantly different between the different test meals ( f = 0.671 ; P = .52 ) ; instead , the TG increments induced by fat supplements were significantly higher than those induced by the CHO supplements ( f = 14.31 ; P = .0001 ) ."
94709,3,O,3285.0,"The 3 - hour TG increments were not significantly different between the different test meals ( f = 0.671 ; P = .52 ) ; instead , the TG increments induced by fat supplements were significantly higher than those induced by the CHO supplements ( f = 14.31 ; P = .0001 ) ."
94710,-,O,3285.0,"The 3 - hour TG increments were not significantly different between the different test meals ( f = 0.671 ; P = .52 ) ; instead , the TG increments induced by fat supplements were significantly higher than those induced by the CHO supplements ( f = 14.31 ; P = .0001 ) ."
94711,hour,O,3285.0,"The 3 - hour TG increments were not significantly different between the different test meals ( f = 0.671 ; P = .52 ) ; instead , the TG increments induced by fat supplements were significantly higher than those induced by the CHO supplements ( f = 14.31 ; P = .0001 ) ."
94712,TG,O,3285.0,"The 3 - hour TG increments were not significantly different between the different test meals ( f = 0.671 ; P = .52 ) ; instead , the TG increments induced by fat supplements were significantly higher than those induced by the CHO supplements ( f = 14.31 ; P = .0001 ) ."
94713,increments,O,3285.0,"The 3 - hour TG increments were not significantly different between the different test meals ( f = 0.671 ; P = .52 ) ; instead , the TG increments induced by fat supplements were significantly higher than those induced by the CHO supplements ( f = 14.31 ; P = .0001 ) ."
94714,were,O,3285.0,"The 3 - hour TG increments were not significantly different between the different test meals ( f = 0.671 ; P = .52 ) ; instead , the TG increments induced by fat supplements were significantly higher than those induced by the CHO supplements ( f = 14.31 ; P = .0001 ) ."
94715,not,O,3285.0,"The 3 - hour TG increments were not significantly different between the different test meals ( f = 0.671 ; P = .52 ) ; instead , the TG increments induced by fat supplements were significantly higher than those induced by the CHO supplements ( f = 14.31 ; P = .0001 ) ."
94716,significantly,O,3285.0,"The 3 - hour TG increments were not significantly different between the different test meals ( f = 0.671 ; P = .52 ) ; instead , the TG increments induced by fat supplements were significantly higher than those induced by the CHO supplements ( f = 14.31 ; P = .0001 ) ."
94717,different,O,3285.0,"The 3 - hour TG increments were not significantly different between the different test meals ( f = 0.671 ; P = .52 ) ; instead , the TG increments induced by fat supplements were significantly higher than those induced by the CHO supplements ( f = 14.31 ; P = .0001 ) ."
94718,between,O,3285.0,"The 3 - hour TG increments were not significantly different between the different test meals ( f = 0.671 ; P = .52 ) ; instead , the TG increments induced by fat supplements were significantly higher than those induced by the CHO supplements ( f = 14.31 ; P = .0001 ) ."
94719,the,O,3285.0,"The 3 - hour TG increments were not significantly different between the different test meals ( f = 0.671 ; P = .52 ) ; instead , the TG increments induced by fat supplements were significantly higher than those induced by the CHO supplements ( f = 14.31 ; P = .0001 ) ."
94720,different,O,3285.0,"The 3 - hour TG increments were not significantly different between the different test meals ( f = 0.671 ; P = .52 ) ; instead , the TG increments induced by fat supplements were significantly higher than those induced by the CHO supplements ( f = 14.31 ; P = .0001 ) ."
94721,test,O,3285.0,"The 3 - hour TG increments were not significantly different between the different test meals ( f = 0.671 ; P = .52 ) ; instead , the TG increments induced by fat supplements were significantly higher than those induced by the CHO supplements ( f = 14.31 ; P = .0001 ) ."
94722,meals,O,3285.0,"The 3 - hour TG increments were not significantly different between the different test meals ( f = 0.671 ; P = .52 ) ; instead , the TG increments induced by fat supplements were significantly higher than those induced by the CHO supplements ( f = 14.31 ; P = .0001 ) ."
94723,(,O,3285.0,"The 3 - hour TG increments were not significantly different between the different test meals ( f = 0.671 ; P = .52 ) ; instead , the TG increments induced by fat supplements were significantly higher than those induced by the CHO supplements ( f = 14.31 ; P = .0001 ) ."
94724,f,O,3285.0,"The 3 - hour TG increments were not significantly different between the different test meals ( f = 0.671 ; P = .52 ) ; instead , the TG increments induced by fat supplements were significantly higher than those induced by the CHO supplements ( f = 14.31 ; P = .0001 ) ."
94725,=,O,3285.0,"The 3 - hour TG increments were not significantly different between the different test meals ( f = 0.671 ; P = .52 ) ; instead , the TG increments induced by fat supplements were significantly higher than those induced by the CHO supplements ( f = 14.31 ; P = .0001 ) ."
94726,0.671,O,3285.0,"The 3 - hour TG increments were not significantly different between the different test meals ( f = 0.671 ; P = .52 ) ; instead , the TG increments induced by fat supplements were significantly higher than those induced by the CHO supplements ( f = 14.31 ; P = .0001 ) ."
94727,;,O,3285.0,"The 3 - hour TG increments were not significantly different between the different test meals ( f = 0.671 ; P = .52 ) ; instead , the TG increments induced by fat supplements were significantly higher than those induced by the CHO supplements ( f = 14.31 ; P = .0001 ) ."
94728,P,O,3285.0,"The 3 - hour TG increments were not significantly different between the different test meals ( f = 0.671 ; P = .52 ) ; instead , the TG increments induced by fat supplements were significantly higher than those induced by the CHO supplements ( f = 14.31 ; P = .0001 ) ."
94729,=,O,3285.0,"The 3 - hour TG increments were not significantly different between the different test meals ( f = 0.671 ; P = .52 ) ; instead , the TG increments induced by fat supplements were significantly higher than those induced by the CHO supplements ( f = 14.31 ; P = .0001 ) ."
94730,.52,O,3285.0,"The 3 - hour TG increments were not significantly different between the different test meals ( f = 0.671 ; P = .52 ) ; instead , the TG increments induced by fat supplements were significantly higher than those induced by the CHO supplements ( f = 14.31 ; P = .0001 ) ."
94731,),O,3285.0,"The 3 - hour TG increments were not significantly different between the different test meals ( f = 0.671 ; P = .52 ) ; instead , the TG increments induced by fat supplements were significantly higher than those induced by the CHO supplements ( f = 14.31 ; P = .0001 ) ."
94732,;,O,3285.0,"The 3 - hour TG increments were not significantly different between the different test meals ( f = 0.671 ; P = .52 ) ; instead , the TG increments induced by fat supplements were significantly higher than those induced by the CHO supplements ( f = 14.31 ; P = .0001 ) ."
94733,instead,O,3285.0,"The 3 - hour TG increments were not significantly different between the different test meals ( f = 0.671 ; P = .52 ) ; instead , the TG increments induced by fat supplements were significantly higher than those induced by the CHO supplements ( f = 14.31 ; P = .0001 ) ."
94734,",",O,3285.0,"The 3 - hour TG increments were not significantly different between the different test meals ( f = 0.671 ; P = .52 ) ; instead , the TG increments induced by fat supplements were significantly higher than those induced by the CHO supplements ( f = 14.31 ; P = .0001 ) ."
94735,the,O,3285.0,"The 3 - hour TG increments were not significantly different between the different test meals ( f = 0.671 ; P = .52 ) ; instead , the TG increments induced by fat supplements were significantly higher than those induced by the CHO supplements ( f = 14.31 ; P = .0001 ) ."
94736,TG,O,3285.0,"The 3 - hour TG increments were not significantly different between the different test meals ( f = 0.671 ; P = .52 ) ; instead , the TG increments induced by fat supplements were significantly higher than those induced by the CHO supplements ( f = 14.31 ; P = .0001 ) ."
94737,increments,O,3285.0,"The 3 - hour TG increments were not significantly different between the different test meals ( f = 0.671 ; P = .52 ) ; instead , the TG increments induced by fat supplements were significantly higher than those induced by the CHO supplements ( f = 14.31 ; P = .0001 ) ."
94738,induced,O,3285.0,"The 3 - hour TG increments were not significantly different between the different test meals ( f = 0.671 ; P = .52 ) ; instead , the TG increments induced by fat supplements were significantly higher than those induced by the CHO supplements ( f = 14.31 ; P = .0001 ) ."
94739,by,O,3285.0,"The 3 - hour TG increments were not significantly different between the different test meals ( f = 0.671 ; P = .52 ) ; instead , the TG increments induced by fat supplements were significantly higher than those induced by the CHO supplements ( f = 14.31 ; P = .0001 ) ."
94740,fat,O,3285.0,"The 3 - hour TG increments were not significantly different between the different test meals ( f = 0.671 ; P = .52 ) ; instead , the TG increments induced by fat supplements were significantly higher than those induced by the CHO supplements ( f = 14.31 ; P = .0001 ) ."
94741,supplements,O,3285.0,"The 3 - hour TG increments were not significantly different between the different test meals ( f = 0.671 ; P = .52 ) ; instead , the TG increments induced by fat supplements were significantly higher than those induced by the CHO supplements ( f = 14.31 ; P = .0001 ) ."
94742,were,O,3285.0,"The 3 - hour TG increments were not significantly different between the different test meals ( f = 0.671 ; P = .52 ) ; instead , the TG increments induced by fat supplements were significantly higher than those induced by the CHO supplements ( f = 14.31 ; P = .0001 ) ."
94743,significantly,O,3285.0,"The 3 - hour TG increments were not significantly different between the different test meals ( f = 0.671 ; P = .52 ) ; instead , the TG increments induced by fat supplements were significantly higher than those induced by the CHO supplements ( f = 14.31 ; P = .0001 ) ."
94744,higher,O,3285.0,"The 3 - hour TG increments were not significantly different between the different test meals ( f = 0.671 ; P = .52 ) ; instead , the TG increments induced by fat supplements were significantly higher than those induced by the CHO supplements ( f = 14.31 ; P = .0001 ) ."
94745,than,O,3285.0,"The 3 - hour TG increments were not significantly different between the different test meals ( f = 0.671 ; P = .52 ) ; instead , the TG increments induced by fat supplements were significantly higher than those induced by the CHO supplements ( f = 14.31 ; P = .0001 ) ."
94746,those,O,3285.0,"The 3 - hour TG increments were not significantly different between the different test meals ( f = 0.671 ; P = .52 ) ; instead , the TG increments induced by fat supplements were significantly higher than those induced by the CHO supplements ( f = 14.31 ; P = .0001 ) ."
94747,induced,O,3285.0,"The 3 - hour TG increments were not significantly different between the different test meals ( f = 0.671 ; P = .52 ) ; instead , the TG increments induced by fat supplements were significantly higher than those induced by the CHO supplements ( f = 14.31 ; P = .0001 ) ."
94748,by,O,3285.0,"The 3 - hour TG increments were not significantly different between the different test meals ( f = 0.671 ; P = .52 ) ; instead , the TG increments induced by fat supplements were significantly higher than those induced by the CHO supplements ( f = 14.31 ; P = .0001 ) ."
94749,the,O,3285.0,"The 3 - hour TG increments were not significantly different between the different test meals ( f = 0.671 ; P = .52 ) ; instead , the TG increments induced by fat supplements were significantly higher than those induced by the CHO supplements ( f = 14.31 ; P = .0001 ) ."
94750,CHO,O,3285.0,"The 3 - hour TG increments were not significantly different between the different test meals ( f = 0.671 ; P = .52 ) ; instead , the TG increments induced by fat supplements were significantly higher than those induced by the CHO supplements ( f = 14.31 ; P = .0001 ) ."
94751,supplements,O,3285.0,"The 3 - hour TG increments were not significantly different between the different test meals ( f = 0.671 ; P = .52 ) ; instead , the TG increments induced by fat supplements were significantly higher than those induced by the CHO supplements ( f = 14.31 ; P = .0001 ) ."
94752,(,O,3285.0,"The 3 - hour TG increments were not significantly different between the different test meals ( f = 0.671 ; P = .52 ) ; instead , the TG increments induced by fat supplements were significantly higher than those induced by the CHO supplements ( f = 14.31 ; P = .0001 ) ."
94753,f,O,3285.0,"The 3 - hour TG increments were not significantly different between the different test meals ( f = 0.671 ; P = .52 ) ; instead , the TG increments induced by fat supplements were significantly higher than those induced by the CHO supplements ( f = 14.31 ; P = .0001 ) ."
94754,=,O,3285.0,"The 3 - hour TG increments were not significantly different between the different test meals ( f = 0.671 ; P = .52 ) ; instead , the TG increments induced by fat supplements were significantly higher than those induced by the CHO supplements ( f = 14.31 ; P = .0001 ) ."
94755,14.31,O,3285.0,"The 3 - hour TG increments were not significantly different between the different test meals ( f = 0.671 ; P = .52 ) ; instead , the TG increments induced by fat supplements were significantly higher than those induced by the CHO supplements ( f = 14.31 ; P = .0001 ) ."
94756,;,O,3285.0,"The 3 - hour TG increments were not significantly different between the different test meals ( f = 0.671 ; P = .52 ) ; instead , the TG increments induced by fat supplements were significantly higher than those induced by the CHO supplements ( f = 14.31 ; P = .0001 ) ."
94757,P,O,3285.0,"The 3 - hour TG increments were not significantly different between the different test meals ( f = 0.671 ; P = .52 ) ; instead , the TG increments induced by fat supplements were significantly higher than those induced by the CHO supplements ( f = 14.31 ; P = .0001 ) ."
94758,=,O,3285.0,"The 3 - hour TG increments were not significantly different between the different test meals ( f = 0.671 ; P = .52 ) ; instead , the TG increments induced by fat supplements were significantly higher than those induced by the CHO supplements ( f = 14.31 ; P = .0001 ) ."
94759,.0001,O,3285.0,"The 3 - hour TG increments were not significantly different between the different test meals ( f = 0.671 ; P = .52 ) ; instead , the TG increments induced by fat supplements were significantly higher than those induced by the CHO supplements ( f = 14.31 ; P = .0001 ) ."
94760,),O,3285.0,"The 3 - hour TG increments were not significantly different between the different test meals ( f = 0.671 ; P = .52 ) ; instead , the TG increments induced by fat supplements were significantly higher than those induced by the CHO supplements ( f = 14.31 ; P = .0001 ) ."
94761,.,O,3285.0,"The 3 - hour TG increments were not significantly different between the different test meals ( f = 0.671 ; P = .52 ) ; instead , the TG increments induced by fat supplements were significantly higher than those induced by the CHO supplements ( f = 14.31 ; P = .0001 ) ."
94762,Similar,O,3286.0,Similar results were also obtained 2 hours after the test meals .
94763,results,O,3286.0,Similar results were also obtained 2 hours after the test meals .
94764,were,O,3286.0,Similar results were also obtained 2 hours after the test meals .
94765,also,O,3286.0,Similar results were also obtained 2 hours after the test meals .
94766,obtained,O,3286.0,Similar results were also obtained 2 hours after the test meals .
94767,2,O,3286.0,Similar results were also obtained 2 hours after the test meals .
94768,hours,O,3286.0,Similar results were also obtained 2 hours after the test meals .
94769,after,O,3286.0,Similar results were also obtained 2 hours after the test meals .
94770,the,O,3286.0,Similar results were also obtained 2 hours after the test meals .
94771,test,O,3286.0,Similar results were also obtained 2 hours after the test meals .
94772,meals,O,3286.0,Similar results were also obtained 2 hours after the test meals .
94773,.,O,3286.0,Similar results were also obtained 2 hours after the test meals .
94774,In,O,3287.0,"In conclusion , this study shows that the 2- and 3 - hour TG responses to fat are higher compared with that induced by carbohydrate ."
94775,conclusion,O,3287.0,"In conclusion , this study shows that the 2- and 3 - hour TG responses to fat are higher compared with that induced by carbohydrate ."
94776,",",O,3287.0,"In conclusion , this study shows that the 2- and 3 - hour TG responses to fat are higher compared with that induced by carbohydrate ."
94777,this,O,3287.0,"In conclusion , this study shows that the 2- and 3 - hour TG responses to fat are higher compared with that induced by carbohydrate ."
94778,study,O,3287.0,"In conclusion , this study shows that the 2- and 3 - hour TG responses to fat are higher compared with that induced by carbohydrate ."
94779,shows,O,3287.0,"In conclusion , this study shows that the 2- and 3 - hour TG responses to fat are higher compared with that induced by carbohydrate ."
94780,that,O,3287.0,"In conclusion , this study shows that the 2- and 3 - hour TG responses to fat are higher compared with that induced by carbohydrate ."
94781,the,O,3287.0,"In conclusion , this study shows that the 2- and 3 - hour TG responses to fat are higher compared with that induced by carbohydrate ."
94782,2-,O,3287.0,"In conclusion , this study shows that the 2- and 3 - hour TG responses to fat are higher compared with that induced by carbohydrate ."
94783,and,O,3287.0,"In conclusion , this study shows that the 2- and 3 - hour TG responses to fat are higher compared with that induced by carbohydrate ."
94784,3,O,3287.0,"In conclusion , this study shows that the 2- and 3 - hour TG responses to fat are higher compared with that induced by carbohydrate ."
94785,-,O,3287.0,"In conclusion , this study shows that the 2- and 3 - hour TG responses to fat are higher compared with that induced by carbohydrate ."
94786,hour,O,3287.0,"In conclusion , this study shows that the 2- and 3 - hour TG responses to fat are higher compared with that induced by carbohydrate ."
94787,TG,O,3287.0,"In conclusion , this study shows that the 2- and 3 - hour TG responses to fat are higher compared with that induced by carbohydrate ."
94788,responses,O,3287.0,"In conclusion , this study shows that the 2- and 3 - hour TG responses to fat are higher compared with that induced by carbohydrate ."
94789,to,O,3287.0,"In conclusion , this study shows that the 2- and 3 - hour TG responses to fat are higher compared with that induced by carbohydrate ."
94790,fat,O,3287.0,"In conclusion , this study shows that the 2- and 3 - hour TG responses to fat are higher compared with that induced by carbohydrate ."
94791,are,O,3287.0,"In conclusion , this study shows that the 2- and 3 - hour TG responses to fat are higher compared with that induced by carbohydrate ."
94792,higher,O,3287.0,"In conclusion , this study shows that the 2- and 3 - hour TG responses to fat are higher compared with that induced by carbohydrate ."
94793,compared,O,3287.0,"In conclusion , this study shows that the 2- and 3 - hour TG responses to fat are higher compared with that induced by carbohydrate ."
94794,with,O,3287.0,"In conclusion , this study shows that the 2- and 3 - hour TG responses to fat are higher compared with that induced by carbohydrate ."
94795,that,O,3287.0,"In conclusion , this study shows that the 2- and 3 - hour TG responses to fat are higher compared with that induced by carbohydrate ."
94796,induced,O,3287.0,"In conclusion , this study shows that the 2- and 3 - hour TG responses to fat are higher compared with that induced by carbohydrate ."
94797,by,O,3287.0,"In conclusion , this study shows that the 2- and 3 - hour TG responses to fat are higher compared with that induced by carbohydrate ."
94798,carbohydrate,O,3287.0,"In conclusion , this study shows that the 2- and 3 - hour TG responses to fat are higher compared with that induced by carbohydrate ."
94799,.,O,3287.0,"In conclusion , this study shows that the 2- and 3 - hour TG responses to fat are higher compared with that induced by carbohydrate ."
94800,This,O,3288.0,"This point , especially if confirmed by experiments with more frequent after meal measurements and of longer duration , should be taken into account in defining the best dietary approach to lower plasma TG levels throughout the whole day ."
94801,point,O,3288.0,"This point , especially if confirmed by experiments with more frequent after meal measurements and of longer duration , should be taken into account in defining the best dietary approach to lower plasma TG levels throughout the whole day ."
94802,",",O,3288.0,"This point , especially if confirmed by experiments with more frequent after meal measurements and of longer duration , should be taken into account in defining the best dietary approach to lower plasma TG levels throughout the whole day ."
94803,especially,O,3288.0,"This point , especially if confirmed by experiments with more frequent after meal measurements and of longer duration , should be taken into account in defining the best dietary approach to lower plasma TG levels throughout the whole day ."
94804,if,O,3288.0,"This point , especially if confirmed by experiments with more frequent after meal measurements and of longer duration , should be taken into account in defining the best dietary approach to lower plasma TG levels throughout the whole day ."
94805,confirmed,O,3288.0,"This point , especially if confirmed by experiments with more frequent after meal measurements and of longer duration , should be taken into account in defining the best dietary approach to lower plasma TG levels throughout the whole day ."
94806,by,O,3288.0,"This point , especially if confirmed by experiments with more frequent after meal measurements and of longer duration , should be taken into account in defining the best dietary approach to lower plasma TG levels throughout the whole day ."
94807,experiments,O,3288.0,"This point , especially if confirmed by experiments with more frequent after meal measurements and of longer duration , should be taken into account in defining the best dietary approach to lower plasma TG levels throughout the whole day ."
94808,with,O,3288.0,"This point , especially if confirmed by experiments with more frequent after meal measurements and of longer duration , should be taken into account in defining the best dietary approach to lower plasma TG levels throughout the whole day ."
94809,more,O,3288.0,"This point , especially if confirmed by experiments with more frequent after meal measurements and of longer duration , should be taken into account in defining the best dietary approach to lower plasma TG levels throughout the whole day ."
94810,frequent,O,3288.0,"This point , especially if confirmed by experiments with more frequent after meal measurements and of longer duration , should be taken into account in defining the best dietary approach to lower plasma TG levels throughout the whole day ."
94811,after,O,3288.0,"This point , especially if confirmed by experiments with more frequent after meal measurements and of longer duration , should be taken into account in defining the best dietary approach to lower plasma TG levels throughout the whole day ."
94812,meal,O,3288.0,"This point , especially if confirmed by experiments with more frequent after meal measurements and of longer duration , should be taken into account in defining the best dietary approach to lower plasma TG levels throughout the whole day ."
94813,measurements,O,3288.0,"This point , especially if confirmed by experiments with more frequent after meal measurements and of longer duration , should be taken into account in defining the best dietary approach to lower plasma TG levels throughout the whole day ."
94814,and,O,3288.0,"This point , especially if confirmed by experiments with more frequent after meal measurements and of longer duration , should be taken into account in defining the best dietary approach to lower plasma TG levels throughout the whole day ."
94815,of,O,3288.0,"This point , especially if confirmed by experiments with more frequent after meal measurements and of longer duration , should be taken into account in defining the best dietary approach to lower plasma TG levels throughout the whole day ."
94816,longer,O,3288.0,"This point , especially if confirmed by experiments with more frequent after meal measurements and of longer duration , should be taken into account in defining the best dietary approach to lower plasma TG levels throughout the whole day ."
94817,duration,O,3288.0,"This point , especially if confirmed by experiments with more frequent after meal measurements and of longer duration , should be taken into account in defining the best dietary approach to lower plasma TG levels throughout the whole day ."
94818,",",O,3288.0,"This point , especially if confirmed by experiments with more frequent after meal measurements and of longer duration , should be taken into account in defining the best dietary approach to lower plasma TG levels throughout the whole day ."
94819,should,O,3288.0,"This point , especially if confirmed by experiments with more frequent after meal measurements and of longer duration , should be taken into account in defining the best dietary approach to lower plasma TG levels throughout the whole day ."
94820,be,O,3288.0,"This point , especially if confirmed by experiments with more frequent after meal measurements and of longer duration , should be taken into account in defining the best dietary approach to lower plasma TG levels throughout the whole day ."
94821,taken,O,3288.0,"This point , especially if confirmed by experiments with more frequent after meal measurements and of longer duration , should be taken into account in defining the best dietary approach to lower plasma TG levels throughout the whole day ."
94822,into,O,3288.0,"This point , especially if confirmed by experiments with more frequent after meal measurements and of longer duration , should be taken into account in defining the best dietary approach to lower plasma TG levels throughout the whole day ."
94823,account,O,3288.0,"This point , especially if confirmed by experiments with more frequent after meal measurements and of longer duration , should be taken into account in defining the best dietary approach to lower plasma TG levels throughout the whole day ."
94824,in,O,3288.0,"This point , especially if confirmed by experiments with more frequent after meal measurements and of longer duration , should be taken into account in defining the best dietary approach to lower plasma TG levels throughout the whole day ."
94825,defining,O,3288.0,"This point , especially if confirmed by experiments with more frequent after meal measurements and of longer duration , should be taken into account in defining the best dietary approach to lower plasma TG levels throughout the whole day ."
94826,the,O,3288.0,"This point , especially if confirmed by experiments with more frequent after meal measurements and of longer duration , should be taken into account in defining the best dietary approach to lower plasma TG levels throughout the whole day ."
94827,best,O,3288.0,"This point , especially if confirmed by experiments with more frequent after meal measurements and of longer duration , should be taken into account in defining the best dietary approach to lower plasma TG levels throughout the whole day ."
94828,dietary,O,3288.0,"This point , especially if confirmed by experiments with more frequent after meal measurements and of longer duration , should be taken into account in defining the best dietary approach to lower plasma TG levels throughout the whole day ."
94829,approach,O,3288.0,"This point , especially if confirmed by experiments with more frequent after meal measurements and of longer duration , should be taken into account in defining the best dietary approach to lower plasma TG levels throughout the whole day ."
94830,to,O,3288.0,"This point , especially if confirmed by experiments with more frequent after meal measurements and of longer duration , should be taken into account in defining the best dietary approach to lower plasma TG levels throughout the whole day ."
94831,lower,O,3288.0,"This point , especially if confirmed by experiments with more frequent after meal measurements and of longer duration , should be taken into account in defining the best dietary approach to lower plasma TG levels throughout the whole day ."
94832,plasma,O,3288.0,"This point , especially if confirmed by experiments with more frequent after meal measurements and of longer duration , should be taken into account in defining the best dietary approach to lower plasma TG levels throughout the whole day ."
94833,TG,O,3288.0,"This point , especially if confirmed by experiments with more frequent after meal measurements and of longer duration , should be taken into account in defining the best dietary approach to lower plasma TG levels throughout the whole day ."
94834,levels,O,3288.0,"This point , especially if confirmed by experiments with more frequent after meal measurements and of longer duration , should be taken into account in defining the best dietary approach to lower plasma TG levels throughout the whole day ."
94835,throughout,O,3288.0,"This point , especially if confirmed by experiments with more frequent after meal measurements and of longer duration , should be taken into account in defining the best dietary approach to lower plasma TG levels throughout the whole day ."
94836,the,O,3288.0,"This point , especially if confirmed by experiments with more frequent after meal measurements and of longer duration , should be taken into account in defining the best dietary approach to lower plasma TG levels throughout the whole day ."
94837,whole,O,3288.0,"This point , especially if confirmed by experiments with more frequent after meal measurements and of longer duration , should be taken into account in defining the best dietary approach to lower plasma TG levels throughout the whole day ."
94838,day,O,3288.0,"This point , especially if confirmed by experiments with more frequent after meal measurements and of longer duration , should be taken into account in defining the best dietary approach to lower plasma TG levels throughout the whole day ."
94839,.,O,3288.0,"This point , especially if confirmed by experiments with more frequent after meal measurements and of longer duration , should be taken into account in defining the best dietary approach to lower plasma TG levels throughout the whole day ."
94840,In,O,3289.0,"In this review of the scientific literature on the relationship between vegetable and fruit consumption and risk of cancer , results from 206 human epidemiologic studies and 22 animal studies are summarized ."
94841,this,O,3289.0,"In this review of the scientific literature on the relationship between vegetable and fruit consumption and risk of cancer , results from 206 human epidemiologic studies and 22 animal studies are summarized ."
94842,review,O,3289.0,"In this review of the scientific literature on the relationship between vegetable and fruit consumption and risk of cancer , results from 206 human epidemiologic studies and 22 animal studies are summarized ."
94843,of,O,3289.0,"In this review of the scientific literature on the relationship between vegetable and fruit consumption and risk of cancer , results from 206 human epidemiologic studies and 22 animal studies are summarized ."
94844,the,O,3289.0,"In this review of the scientific literature on the relationship between vegetable and fruit consumption and risk of cancer , results from 206 human epidemiologic studies and 22 animal studies are summarized ."
94845,scientific,O,3289.0,"In this review of the scientific literature on the relationship between vegetable and fruit consumption and risk of cancer , results from 206 human epidemiologic studies and 22 animal studies are summarized ."
94846,literature,O,3289.0,"In this review of the scientific literature on the relationship between vegetable and fruit consumption and risk of cancer , results from 206 human epidemiologic studies and 22 animal studies are summarized ."
94847,on,O,3289.0,"In this review of the scientific literature on the relationship between vegetable and fruit consumption and risk of cancer , results from 206 human epidemiologic studies and 22 animal studies are summarized ."
94848,the,O,3289.0,"In this review of the scientific literature on the relationship between vegetable and fruit consumption and risk of cancer , results from 206 human epidemiologic studies and 22 animal studies are summarized ."
94849,relationship,O,3289.0,"In this review of the scientific literature on the relationship between vegetable and fruit consumption and risk of cancer , results from 206 human epidemiologic studies and 22 animal studies are summarized ."
94850,between,O,3289.0,"In this review of the scientific literature on the relationship between vegetable and fruit consumption and risk of cancer , results from 206 human epidemiologic studies and 22 animal studies are summarized ."
94851,vegetable,B-AG.01.h,3289.0,"In this review of the scientific literature on the relationship between vegetable and fruit consumption and risk of cancer , results from 206 human epidemiologic studies and 22 animal studies are summarized ."
94852,and,I-AG.01.h,3289.0,"In this review of the scientific literature on the relationship between vegetable and fruit consumption and risk of cancer , results from 206 human epidemiologic studies and 22 animal studies are summarized ."
94853,fruit,I-AG.01.h,3289.0,"In this review of the scientific literature on the relationship between vegetable and fruit consumption and risk of cancer , results from 206 human epidemiologic studies and 22 animal studies are summarized ."
94854,consumption,B-X,3289.0,"In this review of the scientific literature on the relationship between vegetable and fruit consumption and risk of cancer , results from 206 human epidemiologic studies and 22 animal studies are summarized ."
94855,and,O,3289.0,"In this review of the scientific literature on the relationship between vegetable and fruit consumption and risk of cancer , results from 206 human epidemiologic studies and 22 animal studies are summarized ."
94856,risk,O,3289.0,"In this review of the scientific literature on the relationship between vegetable and fruit consumption and risk of cancer , results from 206 human epidemiologic studies and 22 animal studies are summarized ."
94857,of,O,3289.0,"In this review of the scientific literature on the relationship between vegetable and fruit consumption and risk of cancer , results from 206 human epidemiologic studies and 22 animal studies are summarized ."
94858,cancer,O,3289.0,"In this review of the scientific literature on the relationship between vegetable and fruit consumption and risk of cancer , results from 206 human epidemiologic studies and 22 animal studies are summarized ."
94859,",",O,3289.0,"In this review of the scientific literature on the relationship between vegetable and fruit consumption and risk of cancer , results from 206 human epidemiologic studies and 22 animal studies are summarized ."
94860,results,O,3289.0,"In this review of the scientific literature on the relationship between vegetable and fruit consumption and risk of cancer , results from 206 human epidemiologic studies and 22 animal studies are summarized ."
94861,from,O,3289.0,"In this review of the scientific literature on the relationship between vegetable and fruit consumption and risk of cancer , results from 206 human epidemiologic studies and 22 animal studies are summarized ."
94862,206,O,3289.0,"In this review of the scientific literature on the relationship between vegetable and fruit consumption and risk of cancer , results from 206 human epidemiologic studies and 22 animal studies are summarized ."
94863,human,O,3289.0,"In this review of the scientific literature on the relationship between vegetable and fruit consumption and risk of cancer , results from 206 human epidemiologic studies and 22 animal studies are summarized ."
94864,epidemiologic,O,3289.0,"In this review of the scientific literature on the relationship between vegetable and fruit consumption and risk of cancer , results from 206 human epidemiologic studies and 22 animal studies are summarized ."
94865,studies,O,3289.0,"In this review of the scientific literature on the relationship between vegetable and fruit consumption and risk of cancer , results from 206 human epidemiologic studies and 22 animal studies are summarized ."
94866,and,O,3289.0,"In this review of the scientific literature on the relationship between vegetable and fruit consumption and risk of cancer , results from 206 human epidemiologic studies and 22 animal studies are summarized ."
94867,22,O,3289.0,"In this review of the scientific literature on the relationship between vegetable and fruit consumption and risk of cancer , results from 206 human epidemiologic studies and 22 animal studies are summarized ."
94868,animal,O,3289.0,"In this review of the scientific literature on the relationship between vegetable and fruit consumption and risk of cancer , results from 206 human epidemiologic studies and 22 animal studies are summarized ."
94869,studies,O,3289.0,"In this review of the scientific literature on the relationship between vegetable and fruit consumption and risk of cancer , results from 206 human epidemiologic studies and 22 animal studies are summarized ."
94870,are,O,3289.0,"In this review of the scientific literature on the relationship between vegetable and fruit consumption and risk of cancer , results from 206 human epidemiologic studies and 22 animal studies are summarized ."
94871,summarized,O,3289.0,"In this review of the scientific literature on the relationship between vegetable and fruit consumption and risk of cancer , results from 206 human epidemiologic studies and 22 animal studies are summarized ."
94872,.,O,3289.0,"In this review of the scientific literature on the relationship between vegetable and fruit consumption and risk of cancer , results from 206 human epidemiologic studies and 22 animal studies are summarized ."
94873,The,O,3290.0,"The evidence for a protective effect of greater vegetable and fruit consumption is consistent for cancers of the stomach , esophagus , lung , oral cavity and pharynx , endometrium , pancreas , and colon ."
94874,evidence,O,3290.0,"The evidence for a protective effect of greater vegetable and fruit consumption is consistent for cancers of the stomach , esophagus , lung , oral cavity and pharynx , endometrium , pancreas , and colon ."
94875,for,O,3290.0,"The evidence for a protective effect of greater vegetable and fruit consumption is consistent for cancers of the stomach , esophagus , lung , oral cavity and pharynx , endometrium , pancreas , and colon ."
94876,a,O,3290.0,"The evidence for a protective effect of greater vegetable and fruit consumption is consistent for cancers of the stomach , esophagus , lung , oral cavity and pharynx , endometrium , pancreas , and colon ."
94877,protective,O,3290.0,"The evidence for a protective effect of greater vegetable and fruit consumption is consistent for cancers of the stomach , esophagus , lung , oral cavity and pharynx , endometrium , pancreas , and colon ."
94878,effect,O,3290.0,"The evidence for a protective effect of greater vegetable and fruit consumption is consistent for cancers of the stomach , esophagus , lung , oral cavity and pharynx , endometrium , pancreas , and colon ."
94879,of,O,3290.0,"The evidence for a protective effect of greater vegetable and fruit consumption is consistent for cancers of the stomach , esophagus , lung , oral cavity and pharynx , endometrium , pancreas , and colon ."
94880,greater,O,3290.0,"The evidence for a protective effect of greater vegetable and fruit consumption is consistent for cancers of the stomach , esophagus , lung , oral cavity and pharynx , endometrium , pancreas , and colon ."
94881,vegetable,B-AG.01.h,3290.0,"The evidence for a protective effect of greater vegetable and fruit consumption is consistent for cancers of the stomach , esophagus , lung , oral cavity and pharynx , endometrium , pancreas , and colon ."
94882,and,I-AG.01.h,3290.0,"The evidence for a protective effect of greater vegetable and fruit consumption is consistent for cancers of the stomach , esophagus , lung , oral cavity and pharynx , endometrium , pancreas , and colon ."
94883,fruit,I-AG.01.h,3290.0,"The evidence for a protective effect of greater vegetable and fruit consumption is consistent for cancers of the stomach , esophagus , lung , oral cavity and pharynx , endometrium , pancreas , and colon ."
94884,consumption,B-X,3290.0,"The evidence for a protective effect of greater vegetable and fruit consumption is consistent for cancers of the stomach , esophagus , lung , oral cavity and pharynx , endometrium , pancreas , and colon ."
94885,is,O,3290.0,"The evidence for a protective effect of greater vegetable and fruit consumption is consistent for cancers of the stomach , esophagus , lung , oral cavity and pharynx , endometrium , pancreas , and colon ."
94886,consistent,O,3290.0,"The evidence for a protective effect of greater vegetable and fruit consumption is consistent for cancers of the stomach , esophagus , lung , oral cavity and pharynx , endometrium , pancreas , and colon ."
94887,for,O,3290.0,"The evidence for a protective effect of greater vegetable and fruit consumption is consistent for cancers of the stomach , esophagus , lung , oral cavity and pharynx , endometrium , pancreas , and colon ."
94888,cancers,O,3290.0,"The evidence for a protective effect of greater vegetable and fruit consumption is consistent for cancers of the stomach , esophagus , lung , oral cavity and pharynx , endometrium , pancreas , and colon ."
94889,of,O,3290.0,"The evidence for a protective effect of greater vegetable and fruit consumption is consistent for cancers of the stomach , esophagus , lung , oral cavity and pharynx , endometrium , pancreas , and colon ."
94890,the,O,3290.0,"The evidence for a protective effect of greater vegetable and fruit consumption is consistent for cancers of the stomach , esophagus , lung , oral cavity and pharynx , endometrium , pancreas , and colon ."
94891,stomach,O,3290.0,"The evidence for a protective effect of greater vegetable and fruit consumption is consistent for cancers of the stomach , esophagus , lung , oral cavity and pharynx , endometrium , pancreas , and colon ."
94892,",",O,3290.0,"The evidence for a protective effect of greater vegetable and fruit consumption is consistent for cancers of the stomach , esophagus , lung , oral cavity and pharynx , endometrium , pancreas , and colon ."
94893,esophagus,O,3290.0,"The evidence for a protective effect of greater vegetable and fruit consumption is consistent for cancers of the stomach , esophagus , lung , oral cavity and pharynx , endometrium , pancreas , and colon ."
94894,",",O,3290.0,"The evidence for a protective effect of greater vegetable and fruit consumption is consistent for cancers of the stomach , esophagus , lung , oral cavity and pharynx , endometrium , pancreas , and colon ."
94895,lung,O,3290.0,"The evidence for a protective effect of greater vegetable and fruit consumption is consistent for cancers of the stomach , esophagus , lung , oral cavity and pharynx , endometrium , pancreas , and colon ."
94896,",",O,3290.0,"The evidence for a protective effect of greater vegetable and fruit consumption is consistent for cancers of the stomach , esophagus , lung , oral cavity and pharynx , endometrium , pancreas , and colon ."
94897,oral,O,3290.0,"The evidence for a protective effect of greater vegetable and fruit consumption is consistent for cancers of the stomach , esophagus , lung , oral cavity and pharynx , endometrium , pancreas , and colon ."
94898,cavity,O,3290.0,"The evidence for a protective effect of greater vegetable and fruit consumption is consistent for cancers of the stomach , esophagus , lung , oral cavity and pharynx , endometrium , pancreas , and colon ."
94899,and,O,3290.0,"The evidence for a protective effect of greater vegetable and fruit consumption is consistent for cancers of the stomach , esophagus , lung , oral cavity and pharynx , endometrium , pancreas , and colon ."
94900,pharynx,O,3290.0,"The evidence for a protective effect of greater vegetable and fruit consumption is consistent for cancers of the stomach , esophagus , lung , oral cavity and pharynx , endometrium , pancreas , and colon ."
94901,",",O,3290.0,"The evidence for a protective effect of greater vegetable and fruit consumption is consistent for cancers of the stomach , esophagus , lung , oral cavity and pharynx , endometrium , pancreas , and colon ."
94902,endometrium,O,3290.0,"The evidence for a protective effect of greater vegetable and fruit consumption is consistent for cancers of the stomach , esophagus , lung , oral cavity and pharynx , endometrium , pancreas , and colon ."
94903,",",O,3290.0,"The evidence for a protective effect of greater vegetable and fruit consumption is consistent for cancers of the stomach , esophagus , lung , oral cavity and pharynx , endometrium , pancreas , and colon ."
94904,pancreas,O,3290.0,"The evidence for a protective effect of greater vegetable and fruit consumption is consistent for cancers of the stomach , esophagus , lung , oral cavity and pharynx , endometrium , pancreas , and colon ."
94905,",",O,3290.0,"The evidence for a protective effect of greater vegetable and fruit consumption is consistent for cancers of the stomach , esophagus , lung , oral cavity and pharynx , endometrium , pancreas , and colon ."
94906,and,O,3290.0,"The evidence for a protective effect of greater vegetable and fruit consumption is consistent for cancers of the stomach , esophagus , lung , oral cavity and pharynx , endometrium , pancreas , and colon ."
94907,colon,O,3290.0,"The evidence for a protective effect of greater vegetable and fruit consumption is consistent for cancers of the stomach , esophagus , lung , oral cavity and pharynx , endometrium , pancreas , and colon ."
94908,.,O,3290.0,"The evidence for a protective effect of greater vegetable and fruit consumption is consistent for cancers of the stomach , esophagus , lung , oral cavity and pharynx , endometrium , pancreas , and colon ."
94909,The,O,3291.0,"The types of vegetables or fruit that most often appear to be protective against cancer are raw vegetables , followed by allium vegetables , carrots , green vegetables , cruciferous vegetables , and tomatoes ."
94910,types,O,3291.0,"The types of vegetables or fruit that most often appear to be protective against cancer are raw vegetables , followed by allium vegetables , carrots , green vegetables , cruciferous vegetables , and tomatoes ."
94911,of,O,3291.0,"The types of vegetables or fruit that most often appear to be protective against cancer are raw vegetables , followed by allium vegetables , carrots , green vegetables , cruciferous vegetables , and tomatoes ."
94912,vegetables,B-AG.01.h.02,3291.0,"The types of vegetables or fruit that most often appear to be protective against cancer are raw vegetables , followed by allium vegetables , carrots , green vegetables , cruciferous vegetables , and tomatoes ."
94913,or,O,3291.0,"The types of vegetables or fruit that most often appear to be protective against cancer are raw vegetables , followed by allium vegetables , carrots , green vegetables , cruciferous vegetables , and tomatoes ."
94914,fruit,B-AG.01.h.01,3291.0,"The types of vegetables or fruit that most often appear to be protective against cancer are raw vegetables , followed by allium vegetables , carrots , green vegetables , cruciferous vegetables , and tomatoes ."
94915,that,O,3291.0,"The types of vegetables or fruit that most often appear to be protective against cancer are raw vegetables , followed by allium vegetables , carrots , green vegetables , cruciferous vegetables , and tomatoes ."
94916,most,O,3291.0,"The types of vegetables or fruit that most often appear to be protective against cancer are raw vegetables , followed by allium vegetables , carrots , green vegetables , cruciferous vegetables , and tomatoes ."
94917,often,O,3291.0,"The types of vegetables or fruit that most often appear to be protective against cancer are raw vegetables , followed by allium vegetables , carrots , green vegetables , cruciferous vegetables , and tomatoes ."
94918,appear,O,3291.0,"The types of vegetables or fruit that most often appear to be protective against cancer are raw vegetables , followed by allium vegetables , carrots , green vegetables , cruciferous vegetables , and tomatoes ."
94919,to,O,3291.0,"The types of vegetables or fruit that most often appear to be protective against cancer are raw vegetables , followed by allium vegetables , carrots , green vegetables , cruciferous vegetables , and tomatoes ."
94920,be,O,3291.0,"The types of vegetables or fruit that most often appear to be protective against cancer are raw vegetables , followed by allium vegetables , carrots , green vegetables , cruciferous vegetables , and tomatoes ."
94921,protective,O,3291.0,"The types of vegetables or fruit that most often appear to be protective against cancer are raw vegetables , followed by allium vegetables , carrots , green vegetables , cruciferous vegetables , and tomatoes ."
94922,against,O,3291.0,"The types of vegetables or fruit that most often appear to be protective against cancer are raw vegetables , followed by allium vegetables , carrots , green vegetables , cruciferous vegetables , and tomatoes ."
94923,cancer,O,3291.0,"The types of vegetables or fruit that most often appear to be protective against cancer are raw vegetables , followed by allium vegetables , carrots , green vegetables , cruciferous vegetables , and tomatoes ."
94924,are,O,3291.0,"The types of vegetables or fruit that most often appear to be protective against cancer are raw vegetables , followed by allium vegetables , carrots , green vegetables , cruciferous vegetables , and tomatoes ."
94925,raw,O,3291.0,"The types of vegetables or fruit that most often appear to be protective against cancer are raw vegetables , followed by allium vegetables , carrots , green vegetables , cruciferous vegetables , and tomatoes ."
94926,vegetables,B-AG.01.h.02,3291.0,"The types of vegetables or fruit that most often appear to be protective against cancer are raw vegetables , followed by allium vegetables , carrots , green vegetables , cruciferous vegetables , and tomatoes ."
94927,",",O,3291.0,"The types of vegetables or fruit that most often appear to be protective against cancer are raw vegetables , followed by allium vegetables , carrots , green vegetables , cruciferous vegetables , and tomatoes ."
94928,followed,O,3291.0,"The types of vegetables or fruit that most often appear to be protective against cancer are raw vegetables , followed by allium vegetables , carrots , green vegetables , cruciferous vegetables , and tomatoes ."
94929,by,O,3291.0,"The types of vegetables or fruit that most often appear to be protective against cancer are raw vegetables , followed by allium vegetables , carrots , green vegetables , cruciferous vegetables , and tomatoes ."
94930,allium,B-AG.01.h.02.e,3291.0,"The types of vegetables or fruit that most often appear to be protective against cancer are raw vegetables , followed by allium vegetables , carrots , green vegetables , cruciferous vegetables , and tomatoes ."
94931,vegetables,I-AG.01.h.02.e,3291.0,"The types of vegetables or fruit that most often appear to be protective against cancer are raw vegetables , followed by allium vegetables , carrots , green vegetables , cruciferous vegetables , and tomatoes ."
94932,",",O,3291.0,"The types of vegetables or fruit that most often appear to be protective against cancer are raw vegetables , followed by allium vegetables , carrots , green vegetables , cruciferous vegetables , and tomatoes ."
94933,carrots,B-AG.01.h.02.a,3291.0,"The types of vegetables or fruit that most often appear to be protective against cancer are raw vegetables , followed by allium vegetables , carrots , green vegetables , cruciferous vegetables , and tomatoes ."
94934,",",O,3291.0,"The types of vegetables or fruit that most often appear to be protective against cancer are raw vegetables , followed by allium vegetables , carrots , green vegetables , cruciferous vegetables , and tomatoes ."
94935,green,B-AG.01.h.02,3291.0,"The types of vegetables or fruit that most often appear to be protective against cancer are raw vegetables , followed by allium vegetables , carrots , green vegetables , cruciferous vegetables , and tomatoes ."
94936,vegetables,I-AG.01.h.02,3291.0,"The types of vegetables or fruit that most often appear to be protective against cancer are raw vegetables , followed by allium vegetables , carrots , green vegetables , cruciferous vegetables , and tomatoes ."
94937,",",O,3291.0,"The types of vegetables or fruit that most often appear to be protective against cancer are raw vegetables , followed by allium vegetables , carrots , green vegetables , cruciferous vegetables , and tomatoes ."
94938,cruciferous,B-AG.01.h.02.d,3291.0,"The types of vegetables or fruit that most often appear to be protective against cancer are raw vegetables , followed by allium vegetables , carrots , green vegetables , cruciferous vegetables , and tomatoes ."
94939,vegetables,I-AG.01.h.02.d,3291.0,"The types of vegetables or fruit that most often appear to be protective against cancer are raw vegetables , followed by allium vegetables , carrots , green vegetables , cruciferous vegetables , and tomatoes ."
94940,",",O,3291.0,"The types of vegetables or fruit that most often appear to be protective against cancer are raw vegetables , followed by allium vegetables , carrots , green vegetables , cruciferous vegetables , and tomatoes ."
94941,and,O,3291.0,"The types of vegetables or fruit that most often appear to be protective against cancer are raw vegetables , followed by allium vegetables , carrots , green vegetables , cruciferous vegetables , and tomatoes ."
94942,tomatoes,B-AG.01.h.02.f,3291.0,"The types of vegetables or fruit that most often appear to be protective against cancer are raw vegetables , followed by allium vegetables , carrots , green vegetables , cruciferous vegetables , and tomatoes ."
94943,.,O,3291.0,"The types of vegetables or fruit that most often appear to be protective against cancer are raw vegetables , followed by allium vegetables , carrots , green vegetables , cruciferous vegetables , and tomatoes ."
94944,Substances,O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
94945,present,O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
94946,in,O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
94947,vegetables,B-AG.01.h.02,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
94948,and,O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
94949,fruit,B-AG.01.h.01,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
94950,that,O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
94951,may,O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
94952,help,O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
94953,protect,O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
94954,against,O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
94955,cancer,O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
94956,",",O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
94957,and,O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
94958,their,O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
94959,mechanisms,O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
94960,",",O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
94961,are,O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
94962,also,O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
94963,briefly,O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
94964,reviewed,O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
94965,;,O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
94966,these,O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
94967,include,O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
94968,dithiolthiones,O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
94969,",",O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
94970,isothiocyanates,O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
94971,",",O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
94972,indole-3,O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
94973,-,O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
94974,carbinol,O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
94975,",",O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
94976,allium,O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
94977,compounds,O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
94978,",",O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
94979,isoflavones,O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
94980,",",O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
94981,protease,O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
94982,inhibitors,O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
94983,",",O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
94984,saponins,O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
94985,",",O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
94986,phytosterols,O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
94987,",",O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
94988,inositol,O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
94989,hexaphosphate,O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
94990,",",O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
94991,vitamin,O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
94992,C,O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
94993,",",O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
94994,D,O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
94995,-,O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
94996,limonene,O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
94997,",",O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
94998,lutein,O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
94999,",",O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
95000,folic,O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
95001,acid,O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
95002,",",O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
95003,beta,O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
95004,carotene,O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
95005,",",O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
95006,lycopene,O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
95007,",",O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
95008,selenium,O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
95009,",",O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
95010,vitamin,O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
95011,E,O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
95012,",",O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
95013,flavonoids,O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
95014,",",O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
95015,and,O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
95016,dietary,O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
95017,fiber,O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
95018,.,O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
95019,Current,O,3293.0,"Current US vegetable and fruit intake , which averages about 3.4 servings per day , is discussed , as are possible noncancer - related effects of increased vegetable and fruit consumption , including benefits against cardiovascular disease , diabetes , stroke , obesity , diverticulosis , and cataracts ."
95020,US,O,3293.0,"Current US vegetable and fruit intake , which averages about 3.4 servings per day , is discussed , as are possible noncancer - related effects of increased vegetable and fruit consumption , including benefits against cardiovascular disease , diabetes , stroke , obesity , diverticulosis , and cataracts ."
95021,vegetable,B-AG.01.h,3293.0,"Current US vegetable and fruit intake , which averages about 3.4 servings per day , is discussed , as are possible noncancer - related effects of increased vegetable and fruit consumption , including benefits against cardiovascular disease , diabetes , stroke , obesity , diverticulosis , and cataracts ."
95022,and,I-AG.01.h,3293.0,"Current US vegetable and fruit intake , which averages about 3.4 servings per day , is discussed , as are possible noncancer - related effects of increased vegetable and fruit consumption , including benefits against cardiovascular disease , diabetes , stroke , obesity , diverticulosis , and cataracts ."
95023,fruit,I-AG.01.h,3293.0,"Current US vegetable and fruit intake , which averages about 3.4 servings per day , is discussed , as are possible noncancer - related effects of increased vegetable and fruit consumption , including benefits against cardiovascular disease , diabetes , stroke , obesity , diverticulosis , and cataracts ."
95024,intake,B-X,3293.0,"Current US vegetable and fruit intake , which averages about 3.4 servings per day , is discussed , as are possible noncancer - related effects of increased vegetable and fruit consumption , including benefits against cardiovascular disease , diabetes , stroke , obesity , diverticulosis , and cataracts ."
95025,",",O,3293.0,"Current US vegetable and fruit intake , which averages about 3.4 servings per day , is discussed , as are possible noncancer - related effects of increased vegetable and fruit consumption , including benefits against cardiovascular disease , diabetes , stroke , obesity , diverticulosis , and cataracts ."
95026,which,O,3293.0,"Current US vegetable and fruit intake , which averages about 3.4 servings per day , is discussed , as are possible noncancer - related effects of increased vegetable and fruit consumption , including benefits against cardiovascular disease , diabetes , stroke , obesity , diverticulosis , and cataracts ."
95027,averages,O,3293.0,"Current US vegetable and fruit intake , which averages about 3.4 servings per day , is discussed , as are possible noncancer - related effects of increased vegetable and fruit consumption , including benefits against cardiovascular disease , diabetes , stroke , obesity , diverticulosis , and cataracts ."
95028,about,O,3293.0,"Current US vegetable and fruit intake , which averages about 3.4 servings per day , is discussed , as are possible noncancer - related effects of increased vegetable and fruit consumption , including benefits against cardiovascular disease , diabetes , stroke , obesity , diverticulosis , and cataracts ."
95029,3.4,O,3293.0,"Current US vegetable and fruit intake , which averages about 3.4 servings per day , is discussed , as are possible noncancer - related effects of increased vegetable and fruit consumption , including benefits against cardiovascular disease , diabetes , stroke , obesity , diverticulosis , and cataracts ."
95030,servings,O,3293.0,"Current US vegetable and fruit intake , which averages about 3.4 servings per day , is discussed , as are possible noncancer - related effects of increased vegetable and fruit consumption , including benefits against cardiovascular disease , diabetes , stroke , obesity , diverticulosis , and cataracts ."
95031,per,O,3293.0,"Current US vegetable and fruit intake , which averages about 3.4 servings per day , is discussed , as are possible noncancer - related effects of increased vegetable and fruit consumption , including benefits against cardiovascular disease , diabetes , stroke , obesity , diverticulosis , and cataracts ."
95032,day,O,3293.0,"Current US vegetable and fruit intake , which averages about 3.4 servings per day , is discussed , as are possible noncancer - related effects of increased vegetable and fruit consumption , including benefits against cardiovascular disease , diabetes , stroke , obesity , diverticulosis , and cataracts ."
95033,",",O,3293.0,"Current US vegetable and fruit intake , which averages about 3.4 servings per day , is discussed , as are possible noncancer - related effects of increased vegetable and fruit consumption , including benefits against cardiovascular disease , diabetes , stroke , obesity , diverticulosis , and cataracts ."
95034,is,O,3293.0,"Current US vegetable and fruit intake , which averages about 3.4 servings per day , is discussed , as are possible noncancer - related effects of increased vegetable and fruit consumption , including benefits against cardiovascular disease , diabetes , stroke , obesity , diverticulosis , and cataracts ."
95035,discussed,O,3293.0,"Current US vegetable and fruit intake , which averages about 3.4 servings per day , is discussed , as are possible noncancer - related effects of increased vegetable and fruit consumption , including benefits against cardiovascular disease , diabetes , stroke , obesity , diverticulosis , and cataracts ."
95036,",",O,3293.0,"Current US vegetable and fruit intake , which averages about 3.4 servings per day , is discussed , as are possible noncancer - related effects of increased vegetable and fruit consumption , including benefits against cardiovascular disease , diabetes , stroke , obesity , diverticulosis , and cataracts ."
95037,as,O,3293.0,"Current US vegetable and fruit intake , which averages about 3.4 servings per day , is discussed , as are possible noncancer - related effects of increased vegetable and fruit consumption , including benefits against cardiovascular disease , diabetes , stroke , obesity , diverticulosis , and cataracts ."
95038,are,O,3293.0,"Current US vegetable and fruit intake , which averages about 3.4 servings per day , is discussed , as are possible noncancer - related effects of increased vegetable and fruit consumption , including benefits against cardiovascular disease , diabetes , stroke , obesity , diverticulosis , and cataracts ."
95039,possible,O,3293.0,"Current US vegetable and fruit intake , which averages about 3.4 servings per day , is discussed , as are possible noncancer - related effects of increased vegetable and fruit consumption , including benefits against cardiovascular disease , diabetes , stroke , obesity , diverticulosis , and cataracts ."
95040,noncancer,O,3293.0,"Current US vegetable and fruit intake , which averages about 3.4 servings per day , is discussed , as are possible noncancer - related effects of increased vegetable and fruit consumption , including benefits against cardiovascular disease , diabetes , stroke , obesity , diverticulosis , and cataracts ."
95041,-,O,3293.0,"Current US vegetable and fruit intake , which averages about 3.4 servings per day , is discussed , as are possible noncancer - related effects of increased vegetable and fruit consumption , including benefits against cardiovascular disease , diabetes , stroke , obesity , diverticulosis , and cataracts ."
95042,related,O,3293.0,"Current US vegetable and fruit intake , which averages about 3.4 servings per day , is discussed , as are possible noncancer - related effects of increased vegetable and fruit consumption , including benefits against cardiovascular disease , diabetes , stroke , obesity , diverticulosis , and cataracts ."
95043,effects,O,3293.0,"Current US vegetable and fruit intake , which averages about 3.4 servings per day , is discussed , as are possible noncancer - related effects of increased vegetable and fruit consumption , including benefits against cardiovascular disease , diabetes , stroke , obesity , diverticulosis , and cataracts ."
95044,of,O,3293.0,"Current US vegetable and fruit intake , which averages about 3.4 servings per day , is discussed , as are possible noncancer - related effects of increased vegetable and fruit consumption , including benefits against cardiovascular disease , diabetes , stroke , obesity , diverticulosis , and cataracts ."
95045,increased,O,3293.0,"Current US vegetable and fruit intake , which averages about 3.4 servings per day , is discussed , as are possible noncancer - related effects of increased vegetable and fruit consumption , including benefits against cardiovascular disease , diabetes , stroke , obesity , diverticulosis , and cataracts ."
95046,vegetable,B-AG.01.h,3293.0,"Current US vegetable and fruit intake , which averages about 3.4 servings per day , is discussed , as are possible noncancer - related effects of increased vegetable and fruit consumption , including benefits against cardiovascular disease , diabetes , stroke , obesity , diverticulosis , and cataracts ."
95047,and,I-AG.01.h,3293.0,"Current US vegetable and fruit intake , which averages about 3.4 servings per day , is discussed , as are possible noncancer - related effects of increased vegetable and fruit consumption , including benefits against cardiovascular disease , diabetes , stroke , obesity , diverticulosis , and cataracts ."
95048,fruit,I-AG.01.h,3293.0,"Current US vegetable and fruit intake , which averages about 3.4 servings per day , is discussed , as are possible noncancer - related effects of increased vegetable and fruit consumption , including benefits against cardiovascular disease , diabetes , stroke , obesity , diverticulosis , and cataracts ."
95049,consumption,B-X,3293.0,"Current US vegetable and fruit intake , which averages about 3.4 servings per day , is discussed , as are possible noncancer - related effects of increased vegetable and fruit consumption , including benefits against cardiovascular disease , diabetes , stroke , obesity , diverticulosis , and cataracts ."
95050,",",O,3293.0,"Current US vegetable and fruit intake , which averages about 3.4 servings per day , is discussed , as are possible noncancer - related effects of increased vegetable and fruit consumption , including benefits against cardiovascular disease , diabetes , stroke , obesity , diverticulosis , and cataracts ."
95051,including,O,3293.0,"Current US vegetable and fruit intake , which averages about 3.4 servings per day , is discussed , as are possible noncancer - related effects of increased vegetable and fruit consumption , including benefits against cardiovascular disease , diabetes , stroke , obesity , diverticulosis , and cataracts ."
95052,benefits,O,3293.0,"Current US vegetable and fruit intake , which averages about 3.4 servings per day , is discussed , as are possible noncancer - related effects of increased vegetable and fruit consumption , including benefits against cardiovascular disease , diabetes , stroke , obesity , diverticulosis , and cataracts ."
95053,against,O,3293.0,"Current US vegetable and fruit intake , which averages about 3.4 servings per day , is discussed , as are possible noncancer - related effects of increased vegetable and fruit consumption , including benefits against cardiovascular disease , diabetes , stroke , obesity , diverticulosis , and cataracts ."
95054,cardiovascular,O,3293.0,"Current US vegetable and fruit intake , which averages about 3.4 servings per day , is discussed , as are possible noncancer - related effects of increased vegetable and fruit consumption , including benefits against cardiovascular disease , diabetes , stroke , obesity , diverticulosis , and cataracts ."
95055,disease,O,3293.0,"Current US vegetable and fruit intake , which averages about 3.4 servings per day , is discussed , as are possible noncancer - related effects of increased vegetable and fruit consumption , including benefits against cardiovascular disease , diabetes , stroke , obesity , diverticulosis , and cataracts ."
95056,",",O,3293.0,"Current US vegetable and fruit intake , which averages about 3.4 servings per day , is discussed , as are possible noncancer - related effects of increased vegetable and fruit consumption , including benefits against cardiovascular disease , diabetes , stroke , obesity , diverticulosis , and cataracts ."
95057,diabetes,O,3293.0,"Current US vegetable and fruit intake , which averages about 3.4 servings per day , is discussed , as are possible noncancer - related effects of increased vegetable and fruit consumption , including benefits against cardiovascular disease , diabetes , stroke , obesity , diverticulosis , and cataracts ."
95058,",",O,3293.0,"Current US vegetable and fruit intake , which averages about 3.4 servings per day , is discussed , as are possible noncancer - related effects of increased vegetable and fruit consumption , including benefits against cardiovascular disease , diabetes , stroke , obesity , diverticulosis , and cataracts ."
95059,stroke,O,3293.0,"Current US vegetable and fruit intake , which averages about 3.4 servings per day , is discussed , as are possible noncancer - related effects of increased vegetable and fruit consumption , including benefits against cardiovascular disease , diabetes , stroke , obesity , diverticulosis , and cataracts ."
95060,",",O,3293.0,"Current US vegetable and fruit intake , which averages about 3.4 servings per day , is discussed , as are possible noncancer - related effects of increased vegetable and fruit consumption , including benefits against cardiovascular disease , diabetes , stroke , obesity , diverticulosis , and cataracts ."
95061,obesity,O,3293.0,"Current US vegetable and fruit intake , which averages about 3.4 servings per day , is discussed , as are possible noncancer - related effects of increased vegetable and fruit consumption , including benefits against cardiovascular disease , diabetes , stroke , obesity , diverticulosis , and cataracts ."
95062,",",O,3293.0,"Current US vegetable and fruit intake , which averages about 3.4 servings per day , is discussed , as are possible noncancer - related effects of increased vegetable and fruit consumption , including benefits against cardiovascular disease , diabetes , stroke , obesity , diverticulosis , and cataracts ."
95063,diverticulosis,O,3293.0,"Current US vegetable and fruit intake , which averages about 3.4 servings per day , is discussed , as are possible noncancer - related effects of increased vegetable and fruit consumption , including benefits against cardiovascular disease , diabetes , stroke , obesity , diverticulosis , and cataracts ."
95064,",",O,3293.0,"Current US vegetable and fruit intake , which averages about 3.4 servings per day , is discussed , as are possible noncancer - related effects of increased vegetable and fruit consumption , including benefits against cardiovascular disease , diabetes , stroke , obesity , diverticulosis , and cataracts ."
95065,and,O,3293.0,"Current US vegetable and fruit intake , which averages about 3.4 servings per day , is discussed , as are possible noncancer - related effects of increased vegetable and fruit consumption , including benefits against cardiovascular disease , diabetes , stroke , obesity , diverticulosis , and cataracts ."
95066,cataracts,O,3293.0,"Current US vegetable and fruit intake , which averages about 3.4 servings per day , is discussed , as are possible noncancer - related effects of increased vegetable and fruit consumption , including benefits against cardiovascular disease , diabetes , stroke , obesity , diverticulosis , and cataracts ."
95067,.,O,3293.0,"Current US vegetable and fruit intake , which averages about 3.4 servings per day , is discussed , as are possible noncancer - related effects of increased vegetable and fruit consumption , including benefits against cardiovascular disease , diabetes , stroke , obesity , diverticulosis , and cataracts ."
95068,Suggestions,O,3294.0,Suggestions for dietitians to use in counseling persons toward increasing vegetable and fruit intake are presented .
95069,for,O,3294.0,Suggestions for dietitians to use in counseling persons toward increasing vegetable and fruit intake are presented .
95070,dietitians,O,3294.0,Suggestions for dietitians to use in counseling persons toward increasing vegetable and fruit intake are presented .
95071,to,O,3294.0,Suggestions for dietitians to use in counseling persons toward increasing vegetable and fruit intake are presented .
95072,use,O,3294.0,Suggestions for dietitians to use in counseling persons toward increasing vegetable and fruit intake are presented .
95073,in,O,3294.0,Suggestions for dietitians to use in counseling persons toward increasing vegetable and fruit intake are presented .
95074,counseling,O,3294.0,Suggestions for dietitians to use in counseling persons toward increasing vegetable and fruit intake are presented .
95075,persons,O,3294.0,Suggestions for dietitians to use in counseling persons toward increasing vegetable and fruit intake are presented .
95076,toward,O,3294.0,Suggestions for dietitians to use in counseling persons toward increasing vegetable and fruit intake are presented .
95077,increasing,O,3294.0,Suggestions for dietitians to use in counseling persons toward increasing vegetable and fruit intake are presented .
95078,vegetable,B-AG.01.h,3294.0,Suggestions for dietitians to use in counseling persons toward increasing vegetable and fruit intake are presented .
95079,and,I-AG.01.h,3294.0,Suggestions for dietitians to use in counseling persons toward increasing vegetable and fruit intake are presented .
95080,fruit,I-AG.01.h,3294.0,Suggestions for dietitians to use in counseling persons toward increasing vegetable and fruit intake are presented .
95081,intake,B-X,3294.0,Suggestions for dietitians to use in counseling persons toward increasing vegetable and fruit intake are presented .
95082,are,O,3294.0,Suggestions for dietitians to use in counseling persons toward increasing vegetable and fruit intake are presented .
95083,presented,O,3294.0,Suggestions for dietitians to use in counseling persons toward increasing vegetable and fruit intake are presented .
95084,.,O,3294.0,Suggestions for dietitians to use in counseling persons toward increasing vegetable and fruit intake are presented .
95085,Public,O,3295.0,Public awareness and misunderstandings of lactose intolerance are at an all - time high .
95086,awareness,O,3295.0,Public awareness and misunderstandings of lactose intolerance are at an all - time high .
95087,and,O,3295.0,Public awareness and misunderstandings of lactose intolerance are at an all - time high .
95088,misunderstandings,O,3295.0,Public awareness and misunderstandings of lactose intolerance are at an all - time high .
95089,of,O,3295.0,Public awareness and misunderstandings of lactose intolerance are at an all - time high .
95090,lactose,O,3295.0,Public awareness and misunderstandings of lactose intolerance are at an all - time high .
95091,intolerance,O,3295.0,Public awareness and misunderstandings of lactose intolerance are at an all - time high .
95092,are,O,3295.0,Public awareness and misunderstandings of lactose intolerance are at an all - time high .
95093,at,O,3295.0,Public awareness and misunderstandings of lactose intolerance are at an all - time high .
95094,an,O,3295.0,Public awareness and misunderstandings of lactose intolerance are at an all - time high .
95095,all,O,3295.0,Public awareness and misunderstandings of lactose intolerance are at an all - time high .
95096,-,O,3295.0,Public awareness and misunderstandings of lactose intolerance are at an all - time high .
95097,time,O,3295.0,Public awareness and misunderstandings of lactose intolerance are at an all - time high .
95098,high,O,3295.0,Public awareness and misunderstandings of lactose intolerance are at an all - time high .
95099,.,O,3295.0,Public awareness and misunderstandings of lactose intolerance are at an all - time high .
95100,Many,O,3296.0,Many people erroneously believe they are lactose intolerant or develop gastrointestinal symptoms after intake of lactose .
95101,people,O,3296.0,Many people erroneously believe they are lactose intolerant or develop gastrointestinal symptoms after intake of lactose .
95102,erroneously,O,3296.0,Many people erroneously believe they are lactose intolerant or develop gastrointestinal symptoms after intake of lactose .
95103,believe,O,3296.0,Many people erroneously believe they are lactose intolerant or develop gastrointestinal symptoms after intake of lactose .
95104,they,O,3296.0,Many people erroneously believe they are lactose intolerant or develop gastrointestinal symptoms after intake of lactose .
95105,are,O,3296.0,Many people erroneously believe they are lactose intolerant or develop gastrointestinal symptoms after intake of lactose .
95106,lactose,O,3296.0,Many people erroneously believe they are lactose intolerant or develop gastrointestinal symptoms after intake of lactose .
95107,intolerant,O,3296.0,Many people erroneously believe they are lactose intolerant or develop gastrointestinal symptoms after intake of lactose .
95108,or,O,3296.0,Many people erroneously believe they are lactose intolerant or develop gastrointestinal symptoms after intake of lactose .
95109,develop,O,3296.0,Many people erroneously believe they are lactose intolerant or develop gastrointestinal symptoms after intake of lactose .
95110,gastrointestinal,O,3296.0,Many people erroneously believe they are lactose intolerant or develop gastrointestinal symptoms after intake of lactose .
95111,symptoms,O,3296.0,Many people erroneously believe they are lactose intolerant or develop gastrointestinal symptoms after intake of lactose .
95112,after,O,3296.0,Many people erroneously believe they are lactose intolerant or develop gastrointestinal symptoms after intake of lactose .
95113,intake,O,3296.0,Many people erroneously believe they are lactose intolerant or develop gastrointestinal symptoms after intake of lactose .
95114,of,O,3296.0,Many people erroneously believe they are lactose intolerant or develop gastrointestinal symptoms after intake of lactose .
95115,lactose,O,3296.0,Many people erroneously believe they are lactose intolerant or develop gastrointestinal symptoms after intake of lactose .
95116,.,O,3296.0,Many people erroneously believe they are lactose intolerant or develop gastrointestinal symptoms after intake of lactose .
95117,Consequently,O,3297.0,"Consequently , lactose - containing foods such as milk and other dairy foods may be eliminated unnecessarily from the diet ."
95118,",",O,3297.0,"Consequently , lactose - containing foods such as milk and other dairy foods may be eliminated unnecessarily from the diet ."
95119,lactose,B-AG.01.e,3297.0,"Consequently , lactose - containing foods such as milk and other dairy foods may be eliminated unnecessarily from the diet ."
95120,-,I-AG.01.e,3297.0,"Consequently , lactose - containing foods such as milk and other dairy foods may be eliminated unnecessarily from the diet ."
95121,containing,I-AG.01.e,3297.0,"Consequently , lactose - containing foods such as milk and other dairy foods may be eliminated unnecessarily from the diet ."
95122,foods,I-AG.01.e,3297.0,"Consequently , lactose - containing foods such as milk and other dairy foods may be eliminated unnecessarily from the diet ."
95123,such,O,3297.0,"Consequently , lactose - containing foods such as milk and other dairy foods may be eliminated unnecessarily from the diet ."
95124,as,O,3297.0,"Consequently , lactose - containing foods such as milk and other dairy foods may be eliminated unnecessarily from the diet ."
95125,milk,B-AG.01.e,3297.0,"Consequently , lactose - containing foods such as milk and other dairy foods may be eliminated unnecessarily from the diet ."
95126,and,O,3297.0,"Consequently , lactose - containing foods such as milk and other dairy foods may be eliminated unnecessarily from the diet ."
95127,other,O,3297.0,"Consequently , lactose - containing foods such as milk and other dairy foods may be eliminated unnecessarily from the diet ."
95128,dairy,B-AG.01.e,3297.0,"Consequently , lactose - containing foods such as milk and other dairy foods may be eliminated unnecessarily from the diet ."
95129,foods,I-AG.01.e,3297.0,"Consequently , lactose - containing foods such as milk and other dairy foods may be eliminated unnecessarily from the diet ."
95130,may,O,3297.0,"Consequently , lactose - containing foods such as milk and other dairy foods may be eliminated unnecessarily from the diet ."
95131,be,O,3297.0,"Consequently , lactose - containing foods such as milk and other dairy foods may be eliminated unnecessarily from the diet ."
95132,eliminated,O,3297.0,"Consequently , lactose - containing foods such as milk and other dairy foods may be eliminated unnecessarily from the diet ."
95133,unnecessarily,O,3297.0,"Consequently , lactose - containing foods such as milk and other dairy foods may be eliminated unnecessarily from the diet ."
95134,from,O,3297.0,"Consequently , lactose - containing foods such as milk and other dairy foods may be eliminated unnecessarily from the diet ."
95135,the,O,3297.0,"Consequently , lactose - containing foods such as milk and other dairy foods may be eliminated unnecessarily from the diet ."
95136,diet,O,3297.0,"Consequently , lactose - containing foods such as milk and other dairy foods may be eliminated unnecessarily from the diet ."
95137,.,O,3297.0,"Consequently , lactose - containing foods such as milk and other dairy foods may be eliminated unnecessarily from the diet ."
95138,Because,O,3298.0,"Because these foods are a major source of calcium , low intake of them can compromise calcium nutriture ."
95139,these,O,3298.0,"Because these foods are a major source of calcium , low intake of them can compromise calcium nutriture ."
95140,foods,O,3298.0,"Because these foods are a major source of calcium , low intake of them can compromise calcium nutriture ."
95141,are,O,3298.0,"Because these foods are a major source of calcium , low intake of them can compromise calcium nutriture ."
95142,a,O,3298.0,"Because these foods are a major source of calcium , low intake of them can compromise calcium nutriture ."
95143,major,O,3298.0,"Because these foods are a major source of calcium , low intake of them can compromise calcium nutriture ."
95144,source,O,3298.0,"Because these foods are a major source of calcium , low intake of them can compromise calcium nutriture ."
95145,of,O,3298.0,"Because these foods are a major source of calcium , low intake of them can compromise calcium nutriture ."
95146,calcium,O,3298.0,"Because these foods are a major source of calcium , low intake of them can compromise calcium nutriture ."
95147,",",O,3298.0,"Because these foods are a major source of calcium , low intake of them can compromise calcium nutriture ."
95148,low,O,3298.0,"Because these foods are a major source of calcium , low intake of them can compromise calcium nutriture ."
95149,intake,O,3298.0,"Because these foods are a major source of calcium , low intake of them can compromise calcium nutriture ."
95150,of,O,3298.0,"Because these foods are a major source of calcium , low intake of them can compromise calcium nutriture ."
95151,them,O,3298.0,"Because these foods are a major source of calcium , low intake of them can compromise calcium nutriture ."
95152,can,O,3298.0,"Because these foods are a major source of calcium , low intake of them can compromise calcium nutriture ."
95153,compromise,O,3298.0,"Because these foods are a major source of calcium , low intake of them can compromise calcium nutriture ."
95154,calcium,O,3298.0,"Because these foods are a major source of calcium , low intake of them can compromise calcium nutriture ."
95155,nutriture,O,3298.0,"Because these foods are a major source of calcium , low intake of them can compromise calcium nutriture ."
95156,.,O,3298.0,"Because these foods are a major source of calcium , low intake of them can compromise calcium nutriture ."
95157,This,O,3299.0,"This , in turn , can increase the risk of major chronic diseases such as osteoporosis ( porous bones ) and hypertension ."
95158,",",O,3299.0,"This , in turn , can increase the risk of major chronic diseases such as osteoporosis ( porous bones ) and hypertension ."
95159,in,O,3299.0,"This , in turn , can increase the risk of major chronic diseases such as osteoporosis ( porous bones ) and hypertension ."
95160,turn,O,3299.0,"This , in turn , can increase the risk of major chronic diseases such as osteoporosis ( porous bones ) and hypertension ."
95161,",",O,3299.0,"This , in turn , can increase the risk of major chronic diseases such as osteoporosis ( porous bones ) and hypertension ."
95162,can,O,3299.0,"This , in turn , can increase the risk of major chronic diseases such as osteoporosis ( porous bones ) and hypertension ."
95163,increase,O,3299.0,"This , in turn , can increase the risk of major chronic diseases such as osteoporosis ( porous bones ) and hypertension ."
95164,the,O,3299.0,"This , in turn , can increase the risk of major chronic diseases such as osteoporosis ( porous bones ) and hypertension ."
95165,risk,O,3299.0,"This , in turn , can increase the risk of major chronic diseases such as osteoporosis ( porous bones ) and hypertension ."
95166,of,O,3299.0,"This , in turn , can increase the risk of major chronic diseases such as osteoporosis ( porous bones ) and hypertension ."
95167,major,O,3299.0,"This , in turn , can increase the risk of major chronic diseases such as osteoporosis ( porous bones ) and hypertension ."
95168,chronic,O,3299.0,"This , in turn , can increase the risk of major chronic diseases such as osteoporosis ( porous bones ) and hypertension ."
95169,diseases,O,3299.0,"This , in turn , can increase the risk of major chronic diseases such as osteoporosis ( porous bones ) and hypertension ."
95170,such,O,3299.0,"This , in turn , can increase the risk of major chronic diseases such as osteoporosis ( porous bones ) and hypertension ."
95171,as,O,3299.0,"This , in turn , can increase the risk of major chronic diseases such as osteoporosis ( porous bones ) and hypertension ."
95172,osteoporosis,O,3299.0,"This , in turn , can increase the risk of major chronic diseases such as osteoporosis ( porous bones ) and hypertension ."
95173,(,O,3299.0,"This , in turn , can increase the risk of major chronic diseases such as osteoporosis ( porous bones ) and hypertension ."
95174,porous,O,3299.0,"This , in turn , can increase the risk of major chronic diseases such as osteoporosis ( porous bones ) and hypertension ."
95175,bones,O,3299.0,"This , in turn , can increase the risk of major chronic diseases such as osteoporosis ( porous bones ) and hypertension ."
95176,),O,3299.0,"This , in turn , can increase the risk of major chronic diseases such as osteoporosis ( porous bones ) and hypertension ."
95177,and,O,3299.0,"This , in turn , can increase the risk of major chronic diseases such as osteoporosis ( porous bones ) and hypertension ."
95178,hypertension,O,3299.0,"This , in turn , can increase the risk of major chronic diseases such as osteoporosis ( porous bones ) and hypertension ."
95179,.,O,3299.0,"This , in turn , can increase the risk of major chronic diseases such as osteoporosis ( porous bones ) and hypertension ."
95180,This,O,3300.0,This review is intended to help dietetics professionals alleviate clients ' fears about lactose intolerance and recommend dietary strategies to improve tolerance to lactose .
95181,review,O,3300.0,This review is intended to help dietetics professionals alleviate clients ' fears about lactose intolerance and recommend dietary strategies to improve tolerance to lactose .
95182,is,O,3300.0,This review is intended to help dietetics professionals alleviate clients ' fears about lactose intolerance and recommend dietary strategies to improve tolerance to lactose .
95183,intended,O,3300.0,This review is intended to help dietetics professionals alleviate clients ' fears about lactose intolerance and recommend dietary strategies to improve tolerance to lactose .
95184,to,O,3300.0,This review is intended to help dietetics professionals alleviate clients ' fears about lactose intolerance and recommend dietary strategies to improve tolerance to lactose .
95185,help,O,3300.0,This review is intended to help dietetics professionals alleviate clients ' fears about lactose intolerance and recommend dietary strategies to improve tolerance to lactose .
95186,dietetics,O,3300.0,This review is intended to help dietetics professionals alleviate clients ' fears about lactose intolerance and recommend dietary strategies to improve tolerance to lactose .
95187,professionals,O,3300.0,This review is intended to help dietetics professionals alleviate clients ' fears about lactose intolerance and recommend dietary strategies to improve tolerance to lactose .
95188,alleviate,O,3300.0,This review is intended to help dietetics professionals alleviate clients ' fears about lactose intolerance and recommend dietary strategies to improve tolerance to lactose .
95189,clients,O,3300.0,This review is intended to help dietetics professionals alleviate clients ' fears about lactose intolerance and recommend dietary strategies to improve tolerance to lactose .
95190,',O,3300.0,This review is intended to help dietetics professionals alleviate clients ' fears about lactose intolerance and recommend dietary strategies to improve tolerance to lactose .
95191,fears,O,3300.0,This review is intended to help dietetics professionals alleviate clients ' fears about lactose intolerance and recommend dietary strategies to improve tolerance to lactose .
95192,about,O,3300.0,This review is intended to help dietetics professionals alleviate clients ' fears about lactose intolerance and recommend dietary strategies to improve tolerance to lactose .
95193,lactose,O,3300.0,This review is intended to help dietetics professionals alleviate clients ' fears about lactose intolerance and recommend dietary strategies to improve tolerance to lactose .
95194,intolerance,O,3300.0,This review is intended to help dietetics professionals alleviate clients ' fears about lactose intolerance and recommend dietary strategies to improve tolerance to lactose .
95195,and,O,3300.0,This review is intended to help dietetics professionals alleviate clients ' fears about lactose intolerance and recommend dietary strategies to improve tolerance to lactose .
95196,recommend,O,3300.0,This review is intended to help dietetics professionals alleviate clients ' fears about lactose intolerance and recommend dietary strategies to improve tolerance to lactose .
95197,dietary,O,3300.0,This review is intended to help dietetics professionals alleviate clients ' fears about lactose intolerance and recommend dietary strategies to improve tolerance to lactose .
95198,strategies,O,3300.0,This review is intended to help dietetics professionals alleviate clients ' fears about lactose intolerance and recommend dietary strategies to improve tolerance to lactose .
95199,to,O,3300.0,This review is intended to help dietetics professionals alleviate clients ' fears about lactose intolerance and recommend dietary strategies to improve tolerance to lactose .
95200,improve,O,3300.0,This review is intended to help dietetics professionals alleviate clients ' fears about lactose intolerance and recommend dietary strategies to improve tolerance to lactose .
95201,tolerance,O,3300.0,This review is intended to help dietetics professionals alleviate clients ' fears about lactose intolerance and recommend dietary strategies to improve tolerance to lactose .
95202,to,O,3300.0,This review is intended to help dietetics professionals alleviate clients ' fears about lactose intolerance and recommend dietary strategies to improve tolerance to lactose .
95203,lactose,O,3300.0,This review is intended to help dietetics professionals alleviate clients ' fears about lactose intolerance and recommend dietary strategies to improve tolerance to lactose .
95204,.,O,3300.0,This review is intended to help dietetics professionals alleviate clients ' fears about lactose intolerance and recommend dietary strategies to improve tolerance to lactose .
95205,Scientific,O,3301.0,Scientific findings indicate that the prevalence of lactose intolerance is grossly overestimated .
95206,findings,O,3301.0,Scientific findings indicate that the prevalence of lactose intolerance is grossly overestimated .
95207,indicate,O,3301.0,Scientific findings indicate that the prevalence of lactose intolerance is grossly overestimated .
95208,that,O,3301.0,Scientific findings indicate that the prevalence of lactose intolerance is grossly overestimated .
95209,the,O,3301.0,Scientific findings indicate that the prevalence of lactose intolerance is grossly overestimated .
95210,prevalence,O,3301.0,Scientific findings indicate that the prevalence of lactose intolerance is grossly overestimated .
95211,of,O,3301.0,Scientific findings indicate that the prevalence of lactose intolerance is grossly overestimated .
95212,lactose,O,3301.0,Scientific findings indicate that the prevalence of lactose intolerance is grossly overestimated .
95213,intolerance,O,3301.0,Scientific findings indicate that the prevalence of lactose intolerance is grossly overestimated .
95214,is,O,3301.0,Scientific findings indicate that the prevalence of lactose intolerance is grossly overestimated .
95215,grossly,O,3301.0,Scientific findings indicate that the prevalence of lactose intolerance is grossly overestimated .
95216,overestimated,O,3301.0,Scientific findings indicate that the prevalence of lactose intolerance is grossly overestimated .
95217,.,O,3301.0,Scientific findings indicate that the prevalence of lactose intolerance is grossly overestimated .
95218,Other,O,3302.0,Other physiologic and psychologic factors can contribute to gastrointestinal symptoms that mimic lactose intolerance .
95219,physiologic,O,3302.0,Other physiologic and psychologic factors can contribute to gastrointestinal symptoms that mimic lactose intolerance .
95220,and,O,3302.0,Other physiologic and psychologic factors can contribute to gastrointestinal symptoms that mimic lactose intolerance .
95221,psychologic,O,3302.0,Other physiologic and psychologic factors can contribute to gastrointestinal symptoms that mimic lactose intolerance .
95222,factors,O,3302.0,Other physiologic and psychologic factors can contribute to gastrointestinal symptoms that mimic lactose intolerance .
95223,can,O,3302.0,Other physiologic and psychologic factors can contribute to gastrointestinal symptoms that mimic lactose intolerance .
95224,contribute,O,3302.0,Other physiologic and psychologic factors can contribute to gastrointestinal symptoms that mimic lactose intolerance .
95225,to,O,3302.0,Other physiologic and psychologic factors can contribute to gastrointestinal symptoms that mimic lactose intolerance .
95226,gastrointestinal,O,3302.0,Other physiologic and psychologic factors can contribute to gastrointestinal symptoms that mimic lactose intolerance .
95227,symptoms,O,3302.0,Other physiologic and psychologic factors can contribute to gastrointestinal symptoms that mimic lactose intolerance .
95228,that,O,3302.0,Other physiologic and psychologic factors can contribute to gastrointestinal symptoms that mimic lactose intolerance .
95229,mimic,O,3302.0,Other physiologic and psychologic factors can contribute to gastrointestinal symptoms that mimic lactose intolerance .
95230,lactose,O,3302.0,Other physiologic and psychologic factors can contribute to gastrointestinal symptoms that mimic lactose intolerance .
95231,intolerance,O,3302.0,Other physiologic and psychologic factors can contribute to gastrointestinal symptoms that mimic lactose intolerance .
95232,.,O,3302.0,Other physiologic and psychologic factors can contribute to gastrointestinal symptoms that mimic lactose intolerance .
95233,Scientific,O,3303.0,Scientific findings also indicate that people with laboratory - confirmed low levels of the enzyme lactase can consume 1 serving of milk with a meal or 2 servings of milk per day in divided doses at breakfast and dinner without experiencing symptoms .
95234,findings,O,3303.0,Scientific findings also indicate that people with laboratory - confirmed low levels of the enzyme lactase can consume 1 serving of milk with a meal or 2 servings of milk per day in divided doses at breakfast and dinner without experiencing symptoms .
95235,also,O,3303.0,Scientific findings also indicate that people with laboratory - confirmed low levels of the enzyme lactase can consume 1 serving of milk with a meal or 2 servings of milk per day in divided doses at breakfast and dinner without experiencing symptoms .
95236,indicate,O,3303.0,Scientific findings also indicate that people with laboratory - confirmed low levels of the enzyme lactase can consume 1 serving of milk with a meal or 2 servings of milk per day in divided doses at breakfast and dinner without experiencing symptoms .
95237,that,O,3303.0,Scientific findings also indicate that people with laboratory - confirmed low levels of the enzyme lactase can consume 1 serving of milk with a meal or 2 servings of milk per day in divided doses at breakfast and dinner without experiencing symptoms .
95238,people,O,3303.0,Scientific findings also indicate that people with laboratory - confirmed low levels of the enzyme lactase can consume 1 serving of milk with a meal or 2 servings of milk per day in divided doses at breakfast and dinner without experiencing symptoms .
95239,with,O,3303.0,Scientific findings also indicate that people with laboratory - confirmed low levels of the enzyme lactase can consume 1 serving of milk with a meal or 2 servings of milk per day in divided doses at breakfast and dinner without experiencing symptoms .
95240,laboratory,O,3303.0,Scientific findings also indicate that people with laboratory - confirmed low levels of the enzyme lactase can consume 1 serving of milk with a meal or 2 servings of milk per day in divided doses at breakfast and dinner without experiencing symptoms .
95241,-,O,3303.0,Scientific findings also indicate that people with laboratory - confirmed low levels of the enzyme lactase can consume 1 serving of milk with a meal or 2 servings of milk per day in divided doses at breakfast and dinner without experiencing symptoms .
95242,confirmed,O,3303.0,Scientific findings also indicate that people with laboratory - confirmed low levels of the enzyme lactase can consume 1 serving of milk with a meal or 2 servings of milk per day in divided doses at breakfast and dinner without experiencing symptoms .
95243,low,O,3303.0,Scientific findings also indicate that people with laboratory - confirmed low levels of the enzyme lactase can consume 1 serving of milk with a meal or 2 servings of milk per day in divided doses at breakfast and dinner without experiencing symptoms .
95244,levels,O,3303.0,Scientific findings also indicate that people with laboratory - confirmed low levels of the enzyme lactase can consume 1 serving of milk with a meal or 2 servings of milk per day in divided doses at breakfast and dinner without experiencing symptoms .
95245,of,O,3303.0,Scientific findings also indicate that people with laboratory - confirmed low levels of the enzyme lactase can consume 1 serving of milk with a meal or 2 servings of milk per day in divided doses at breakfast and dinner without experiencing symptoms .
95246,the,O,3303.0,Scientific findings also indicate that people with laboratory - confirmed low levels of the enzyme lactase can consume 1 serving of milk with a meal or 2 servings of milk per day in divided doses at breakfast and dinner without experiencing symptoms .
95247,enzyme,O,3303.0,Scientific findings also indicate that people with laboratory - confirmed low levels of the enzyme lactase can consume 1 serving of milk with a meal or 2 servings of milk per day in divided doses at breakfast and dinner without experiencing symptoms .
95248,lactase,O,3303.0,Scientific findings also indicate that people with laboratory - confirmed low levels of the enzyme lactase can consume 1 serving of milk with a meal or 2 servings of milk per day in divided doses at breakfast and dinner without experiencing symptoms .
95249,can,O,3303.0,Scientific findings also indicate that people with laboratory - confirmed low levels of the enzyme lactase can consume 1 serving of milk with a meal or 2 servings of milk per day in divided doses at breakfast and dinner without experiencing symptoms .
95250,consume,O,3303.0,Scientific findings also indicate that people with laboratory - confirmed low levels of the enzyme lactase can consume 1 serving of milk with a meal or 2 servings of milk per day in divided doses at breakfast and dinner without experiencing symptoms .
95251,1,O,3303.0,Scientific findings also indicate that people with laboratory - confirmed low levels of the enzyme lactase can consume 1 serving of milk with a meal or 2 servings of milk per day in divided doses at breakfast and dinner without experiencing symptoms .
95252,serving,O,3303.0,Scientific findings also indicate that people with laboratory - confirmed low levels of the enzyme lactase can consume 1 serving of milk with a meal or 2 servings of milk per day in divided doses at breakfast and dinner without experiencing symptoms .
95253,of,O,3303.0,Scientific findings also indicate that people with laboratory - confirmed low levels of the enzyme lactase can consume 1 serving of milk with a meal or 2 servings of milk per day in divided doses at breakfast and dinner without experiencing symptoms .
95254,milk,B-AG.01.e,3303.0,Scientific findings also indicate that people with laboratory - confirmed low levels of the enzyme lactase can consume 1 serving of milk with a meal or 2 servings of milk per day in divided doses at breakfast and dinner without experiencing symptoms .
95255,with,O,3303.0,Scientific findings also indicate that people with laboratory - confirmed low levels of the enzyme lactase can consume 1 serving of milk with a meal or 2 servings of milk per day in divided doses at breakfast and dinner without experiencing symptoms .
95256,a,O,3303.0,Scientific findings also indicate that people with laboratory - confirmed low levels of the enzyme lactase can consume 1 serving of milk with a meal or 2 servings of milk per day in divided doses at breakfast and dinner without experiencing symptoms .
95257,meal,O,3303.0,Scientific findings also indicate that people with laboratory - confirmed low levels of the enzyme lactase can consume 1 serving of milk with a meal or 2 servings of milk per day in divided doses at breakfast and dinner without experiencing symptoms .
95258,or,O,3303.0,Scientific findings also indicate that people with laboratory - confirmed low levels of the enzyme lactase can consume 1 serving of milk with a meal or 2 servings of milk per day in divided doses at breakfast and dinner without experiencing symptoms .
95259,2,O,3303.0,Scientific findings also indicate that people with laboratory - confirmed low levels of the enzyme lactase can consume 1 serving of milk with a meal or 2 servings of milk per day in divided doses at breakfast and dinner without experiencing symptoms .
95260,servings,O,3303.0,Scientific findings also indicate that people with laboratory - confirmed low levels of the enzyme lactase can consume 1 serving of milk with a meal or 2 servings of milk per day in divided doses at breakfast and dinner without experiencing symptoms .
95261,of,O,3303.0,Scientific findings also indicate that people with laboratory - confirmed low levels of the enzyme lactase can consume 1 serving of milk with a meal or 2 servings of milk per day in divided doses at breakfast and dinner without experiencing symptoms .
95262,milk,B-AG.01.e,3303.0,Scientific findings also indicate that people with laboratory - confirmed low levels of the enzyme lactase can consume 1 serving of milk with a meal or 2 servings of milk per day in divided doses at breakfast and dinner without experiencing symptoms .
95263,per,O,3303.0,Scientific findings also indicate that people with laboratory - confirmed low levels of the enzyme lactase can consume 1 serving of milk with a meal or 2 servings of milk per day in divided doses at breakfast and dinner without experiencing symptoms .
95264,day,O,3303.0,Scientific findings also indicate that people with laboratory - confirmed low levels of the enzyme lactase can consume 1 serving of milk with a meal or 2 servings of milk per day in divided doses at breakfast and dinner without experiencing symptoms .
95265,in,O,3303.0,Scientific findings also indicate that people with laboratory - confirmed low levels of the enzyme lactase can consume 1 serving of milk with a meal or 2 servings of milk per day in divided doses at breakfast and dinner without experiencing symptoms .
95266,divided,O,3303.0,Scientific findings also indicate that people with laboratory - confirmed low levels of the enzyme lactase can consume 1 serving of milk with a meal or 2 servings of milk per day in divided doses at breakfast and dinner without experiencing symptoms .
95267,doses,O,3303.0,Scientific findings also indicate that people with laboratory - confirmed low levels of the enzyme lactase can consume 1 serving of milk with a meal or 2 servings of milk per day in divided doses at breakfast and dinner without experiencing symptoms .
95268,at,O,3303.0,Scientific findings also indicate that people with laboratory - confirmed low levels of the enzyme lactase can consume 1 serving of milk with a meal or 2 servings of milk per day in divided doses at breakfast and dinner without experiencing symptoms .
95269,breakfast,O,3303.0,Scientific findings also indicate that people with laboratory - confirmed low levels of the enzyme lactase can consume 1 serving of milk with a meal or 2 servings of milk per day in divided doses at breakfast and dinner without experiencing symptoms .
95270,and,O,3303.0,Scientific findings also indicate that people with laboratory - confirmed low levels of the enzyme lactase can consume 1 serving of milk with a meal or 2 servings of milk per day in divided doses at breakfast and dinner without experiencing symptoms .
95271,dinner,O,3303.0,Scientific findings also indicate that people with laboratory - confirmed low levels of the enzyme lactase can consume 1 serving of milk with a meal or 2 servings of milk per day in divided doses at breakfast and dinner without experiencing symptoms .
95272,without,O,3303.0,Scientific findings also indicate that people with laboratory - confirmed low levels of the enzyme lactase can consume 1 serving of milk with a meal or 2 servings of milk per day in divided doses at breakfast and dinner without experiencing symptoms .
95273,experiencing,O,3303.0,Scientific findings also indicate that people with laboratory - confirmed low levels of the enzyme lactase can consume 1 serving of milk with a meal or 2 servings of milk per day in divided doses at breakfast and dinner without experiencing symptoms .
95274,symptoms,O,3303.0,Scientific findings also indicate that people with laboratory - confirmed low levels of the enzyme lactase can consume 1 serving of milk with a meal or 2 servings of milk per day in divided doses at breakfast and dinner without experiencing symptoms .
95275,.,O,3303.0,Scientific findings also indicate that people with laboratory - confirmed low levels of the enzyme lactase can consume 1 serving of milk with a meal or 2 servings of milk per day in divided doses at breakfast and dinner without experiencing symptoms .
95276,Several,O,3304.0,Several dietary strategies are available to help lactose maldigesters include milk and other dairy foods in their diet without experiencing symptoms .
95277,dietary,O,3304.0,Several dietary strategies are available to help lactose maldigesters include milk and other dairy foods in their diet without experiencing symptoms .
95278,strategies,O,3304.0,Several dietary strategies are available to help lactose maldigesters include milk and other dairy foods in their diet without experiencing symptoms .
95279,are,O,3304.0,Several dietary strategies are available to help lactose maldigesters include milk and other dairy foods in their diet without experiencing symptoms .
95280,available,O,3304.0,Several dietary strategies are available to help lactose maldigesters include milk and other dairy foods in their diet without experiencing symptoms .
95281,to,O,3304.0,Several dietary strategies are available to help lactose maldigesters include milk and other dairy foods in their diet without experiencing symptoms .
95282,help,O,3304.0,Several dietary strategies are available to help lactose maldigesters include milk and other dairy foods in their diet without experiencing symptoms .
95283,lactose,O,3304.0,Several dietary strategies are available to help lactose maldigesters include milk and other dairy foods in their diet without experiencing symptoms .
95284,maldigesters,O,3304.0,Several dietary strategies are available to help lactose maldigesters include milk and other dairy foods in their diet without experiencing symptoms .
95285,include,O,3304.0,Several dietary strategies are available to help lactose maldigesters include milk and other dairy foods in their diet without experiencing symptoms .
95286,milk,B-AG.01.e,3304.0,Several dietary strategies are available to help lactose maldigesters include milk and other dairy foods in their diet without experiencing symptoms .
95287,and,O,3304.0,Several dietary strategies are available to help lactose maldigesters include milk and other dairy foods in their diet without experiencing symptoms .
95288,other,O,3304.0,Several dietary strategies are available to help lactose maldigesters include milk and other dairy foods in their diet without experiencing symptoms .
95289,dairy,B-AG.01.e,3304.0,Several dietary strategies are available to help lactose maldigesters include milk and other dairy foods in their diet without experiencing symptoms .
95290,foods,I-AG.01.e,3304.0,Several dietary strategies are available to help lactose maldigesters include milk and other dairy foods in their diet without experiencing symptoms .
95291,in,O,3304.0,Several dietary strategies are available to help lactose maldigesters include milk and other dairy foods in their diet without experiencing symptoms .
95292,their,O,3304.0,Several dietary strategies are available to help lactose maldigesters include milk and other dairy foods in their diet without experiencing symptoms .
95293,diet,O,3304.0,Several dietary strategies are available to help lactose maldigesters include milk and other dairy foods in their diet without experiencing symptoms .
95294,without,O,3304.0,Several dietary strategies are available to help lactose maldigesters include milk and other dairy foods in their diet without experiencing symptoms .
95295,experiencing,O,3304.0,Several dietary strategies are available to help lactose maldigesters include milk and other dairy foods in their diet without experiencing symptoms .
95296,symptoms,O,3304.0,Several dietary strategies are available to help lactose maldigesters include milk and other dairy foods in their diet without experiencing symptoms .
95297,.,O,3304.0,Several dietary strategies are available to help lactose maldigesters include milk and other dairy foods in their diet without experiencing symptoms .
95298,Skin,O,3305.0,"Skin prick tests ( SPT ) with various celery , carrot and potato preparations ( raw , cooked , cooking water of each vegetable and allergen extracts ) as well as specific IgE determinations by RAST to celery mix , celeriac ( or root celery ) , stick celery and heated celery extracts were performed in 70 patients with positive prick or intracutaneous tests to birch and/or mugwort pollens and celery ( extract and/or raw ) ."
95299,prick,O,3305.0,"Skin prick tests ( SPT ) with various celery , carrot and potato preparations ( raw , cooked , cooking water of each vegetable and allergen extracts ) as well as specific IgE determinations by RAST to celery mix , celeriac ( or root celery ) , stick celery and heated celery extracts were performed in 70 patients with positive prick or intracutaneous tests to birch and/or mugwort pollens and celery ( extract and/or raw ) ."
95300,tests,O,3305.0,"Skin prick tests ( SPT ) with various celery , carrot and potato preparations ( raw , cooked , cooking water of each vegetable and allergen extracts ) as well as specific IgE determinations by RAST to celery mix , celeriac ( or root celery ) , stick celery and heated celery extracts were performed in 70 patients with positive prick or intracutaneous tests to birch and/or mugwort pollens and celery ( extract and/or raw ) ."
95301,(,O,3305.0,"Skin prick tests ( SPT ) with various celery , carrot and potato preparations ( raw , cooked , cooking water of each vegetable and allergen extracts ) as well as specific IgE determinations by RAST to celery mix , celeriac ( or root celery ) , stick celery and heated celery extracts were performed in 70 patients with positive prick or intracutaneous tests to birch and/or mugwort pollens and celery ( extract and/or raw ) ."
95302,SPT,O,3305.0,"Skin prick tests ( SPT ) with various celery , carrot and potato preparations ( raw , cooked , cooking water of each vegetable and allergen extracts ) as well as specific IgE determinations by RAST to celery mix , celeriac ( or root celery ) , stick celery and heated celery extracts were performed in 70 patients with positive prick or intracutaneous tests to birch and/or mugwort pollens and celery ( extract and/or raw ) ."
95303,),O,3305.0,"Skin prick tests ( SPT ) with various celery , carrot and potato preparations ( raw , cooked , cooking water of each vegetable and allergen extracts ) as well as specific IgE determinations by RAST to celery mix , celeriac ( or root celery ) , stick celery and heated celery extracts were performed in 70 patients with positive prick or intracutaneous tests to birch and/or mugwort pollens and celery ( extract and/or raw ) ."
95304,with,O,3305.0,"Skin prick tests ( SPT ) with various celery , carrot and potato preparations ( raw , cooked , cooking water of each vegetable and allergen extracts ) as well as specific IgE determinations by RAST to celery mix , celeriac ( or root celery ) , stick celery and heated celery extracts were performed in 70 patients with positive prick or intracutaneous tests to birch and/or mugwort pollens and celery ( extract and/or raw ) ."
95305,various,O,3305.0,"Skin prick tests ( SPT ) with various celery , carrot and potato preparations ( raw , cooked , cooking water of each vegetable and allergen extracts ) as well as specific IgE determinations by RAST to celery mix , celeriac ( or root celery ) , stick celery and heated celery extracts were performed in 70 patients with positive prick or intracutaneous tests to birch and/or mugwort pollens and celery ( extract and/or raw ) ."
95306,celery,B-AG.01.h.02.b,3305.0,"Skin prick tests ( SPT ) with various celery , carrot and potato preparations ( raw , cooked , cooking water of each vegetable and allergen extracts ) as well as specific IgE determinations by RAST to celery mix , celeriac ( or root celery ) , stick celery and heated celery extracts were performed in 70 patients with positive prick or intracutaneous tests to birch and/or mugwort pollens and celery ( extract and/or raw ) ."
95307,",",O,3305.0,"Skin prick tests ( SPT ) with various celery , carrot and potato preparations ( raw , cooked , cooking water of each vegetable and allergen extracts ) as well as specific IgE determinations by RAST to celery mix , celeriac ( or root celery ) , stick celery and heated celery extracts were performed in 70 patients with positive prick or intracutaneous tests to birch and/or mugwort pollens and celery ( extract and/or raw ) ."
95308,carrot,B-AG.01.h.02.a,3305.0,"Skin prick tests ( SPT ) with various celery , carrot and potato preparations ( raw , cooked , cooking water of each vegetable and allergen extracts ) as well as specific IgE determinations by RAST to celery mix , celeriac ( or root celery ) , stick celery and heated celery extracts were performed in 70 patients with positive prick or intracutaneous tests to birch and/or mugwort pollens and celery ( extract and/or raw ) ."
95309,and,O,3305.0,"Skin prick tests ( SPT ) with various celery , carrot and potato preparations ( raw , cooked , cooking water of each vegetable and allergen extracts ) as well as specific IgE determinations by RAST to celery mix , celeriac ( or root celery ) , stick celery and heated celery extracts were performed in 70 patients with positive prick or intracutaneous tests to birch and/or mugwort pollens and celery ( extract and/or raw ) ."
95310,potato,B-AG.01.h.02.a,3305.0,"Skin prick tests ( SPT ) with various celery , carrot and potato preparations ( raw , cooked , cooking water of each vegetable and allergen extracts ) as well as specific IgE determinations by RAST to celery mix , celeriac ( or root celery ) , stick celery and heated celery extracts were performed in 70 patients with positive prick or intracutaneous tests to birch and/or mugwort pollens and celery ( extract and/or raw ) ."
95311,preparations,O,3305.0,"Skin prick tests ( SPT ) with various celery , carrot and potato preparations ( raw , cooked , cooking water of each vegetable and allergen extracts ) as well as specific IgE determinations by RAST to celery mix , celeriac ( or root celery ) , stick celery and heated celery extracts were performed in 70 patients with positive prick or intracutaneous tests to birch and/or mugwort pollens and celery ( extract and/or raw ) ."
95312,(,O,3305.0,"Skin prick tests ( SPT ) with various celery , carrot and potato preparations ( raw , cooked , cooking water of each vegetable and allergen extracts ) as well as specific IgE determinations by RAST to celery mix , celeriac ( or root celery ) , stick celery and heated celery extracts were performed in 70 patients with positive prick or intracutaneous tests to birch and/or mugwort pollens and celery ( extract and/or raw ) ."
95313,raw,O,3305.0,"Skin prick tests ( SPT ) with various celery , carrot and potato preparations ( raw , cooked , cooking water of each vegetable and allergen extracts ) as well as specific IgE determinations by RAST to celery mix , celeriac ( or root celery ) , stick celery and heated celery extracts were performed in 70 patients with positive prick or intracutaneous tests to birch and/or mugwort pollens and celery ( extract and/or raw ) ."
95314,",",O,3305.0,"Skin prick tests ( SPT ) with various celery , carrot and potato preparations ( raw , cooked , cooking water of each vegetable and allergen extracts ) as well as specific IgE determinations by RAST to celery mix , celeriac ( or root celery ) , stick celery and heated celery extracts were performed in 70 patients with positive prick or intracutaneous tests to birch and/or mugwort pollens and celery ( extract and/or raw ) ."
95315,cooked,O,3305.0,"Skin prick tests ( SPT ) with various celery , carrot and potato preparations ( raw , cooked , cooking water of each vegetable and allergen extracts ) as well as specific IgE determinations by RAST to celery mix , celeriac ( or root celery ) , stick celery and heated celery extracts were performed in 70 patients with positive prick or intracutaneous tests to birch and/or mugwort pollens and celery ( extract and/or raw ) ."
95316,",",O,3305.0,"Skin prick tests ( SPT ) with various celery , carrot and potato preparations ( raw , cooked , cooking water of each vegetable and allergen extracts ) as well as specific IgE determinations by RAST to celery mix , celeriac ( or root celery ) , stick celery and heated celery extracts were performed in 70 patients with positive prick or intracutaneous tests to birch and/or mugwort pollens and celery ( extract and/or raw ) ."
95317,cooking,O,3305.0,"Skin prick tests ( SPT ) with various celery , carrot and potato preparations ( raw , cooked , cooking water of each vegetable and allergen extracts ) as well as specific IgE determinations by RAST to celery mix , celeriac ( or root celery ) , stick celery and heated celery extracts were performed in 70 patients with positive prick or intracutaneous tests to birch and/or mugwort pollens and celery ( extract and/or raw ) ."
95318,water,O,3305.0,"Skin prick tests ( SPT ) with various celery , carrot and potato preparations ( raw , cooked , cooking water of each vegetable and allergen extracts ) as well as specific IgE determinations by RAST to celery mix , celeriac ( or root celery ) , stick celery and heated celery extracts were performed in 70 patients with positive prick or intracutaneous tests to birch and/or mugwort pollens and celery ( extract and/or raw ) ."
95319,of,O,3305.0,"Skin prick tests ( SPT ) with various celery , carrot and potato preparations ( raw , cooked , cooking water of each vegetable and allergen extracts ) as well as specific IgE determinations by RAST to celery mix , celeriac ( or root celery ) , stick celery and heated celery extracts were performed in 70 patients with positive prick or intracutaneous tests to birch and/or mugwort pollens and celery ( extract and/or raw ) ."
95320,each,O,3305.0,"Skin prick tests ( SPT ) with various celery , carrot and potato preparations ( raw , cooked , cooking water of each vegetable and allergen extracts ) as well as specific IgE determinations by RAST to celery mix , celeriac ( or root celery ) , stick celery and heated celery extracts were performed in 70 patients with positive prick or intracutaneous tests to birch and/or mugwort pollens and celery ( extract and/or raw ) ."
95321,vegetable,B-AG.01.h.02,3305.0,"Skin prick tests ( SPT ) with various celery , carrot and potato preparations ( raw , cooked , cooking water of each vegetable and allergen extracts ) as well as specific IgE determinations by RAST to celery mix , celeriac ( or root celery ) , stick celery and heated celery extracts were performed in 70 patients with positive prick or intracutaneous tests to birch and/or mugwort pollens and celery ( extract and/or raw ) ."
95322,and,O,3305.0,"Skin prick tests ( SPT ) with various celery , carrot and potato preparations ( raw , cooked , cooking water of each vegetable and allergen extracts ) as well as specific IgE determinations by RAST to celery mix , celeriac ( or root celery ) , stick celery and heated celery extracts were performed in 70 patients with positive prick or intracutaneous tests to birch and/or mugwort pollens and celery ( extract and/or raw ) ."
95323,allergen,O,3305.0,"Skin prick tests ( SPT ) with various celery , carrot and potato preparations ( raw , cooked , cooking water of each vegetable and allergen extracts ) as well as specific IgE determinations by RAST to celery mix , celeriac ( or root celery ) , stick celery and heated celery extracts were performed in 70 patients with positive prick or intracutaneous tests to birch and/or mugwort pollens and celery ( extract and/or raw ) ."
95324,extracts,O,3305.0,"Skin prick tests ( SPT ) with various celery , carrot and potato preparations ( raw , cooked , cooking water of each vegetable and allergen extracts ) as well as specific IgE determinations by RAST to celery mix , celeriac ( or root celery ) , stick celery and heated celery extracts were performed in 70 patients with positive prick or intracutaneous tests to birch and/or mugwort pollens and celery ( extract and/or raw ) ."
95325,),O,3305.0,"Skin prick tests ( SPT ) with various celery , carrot and potato preparations ( raw , cooked , cooking water of each vegetable and allergen extracts ) as well as specific IgE determinations by RAST to celery mix , celeriac ( or root celery ) , stick celery and heated celery extracts were performed in 70 patients with positive prick or intracutaneous tests to birch and/or mugwort pollens and celery ( extract and/or raw ) ."
95326,as,O,3305.0,"Skin prick tests ( SPT ) with various celery , carrot and potato preparations ( raw , cooked , cooking water of each vegetable and allergen extracts ) as well as specific IgE determinations by RAST to celery mix , celeriac ( or root celery ) , stick celery and heated celery extracts were performed in 70 patients with positive prick or intracutaneous tests to birch and/or mugwort pollens and celery ( extract and/or raw ) ."
95327,well,O,3305.0,"Skin prick tests ( SPT ) with various celery , carrot and potato preparations ( raw , cooked , cooking water of each vegetable and allergen extracts ) as well as specific IgE determinations by RAST to celery mix , celeriac ( or root celery ) , stick celery and heated celery extracts were performed in 70 patients with positive prick or intracutaneous tests to birch and/or mugwort pollens and celery ( extract and/or raw ) ."
95328,as,O,3305.0,"Skin prick tests ( SPT ) with various celery , carrot and potato preparations ( raw , cooked , cooking water of each vegetable and allergen extracts ) as well as specific IgE determinations by RAST to celery mix , celeriac ( or root celery ) , stick celery and heated celery extracts were performed in 70 patients with positive prick or intracutaneous tests to birch and/or mugwort pollens and celery ( extract and/or raw ) ."
95329,specific,O,3305.0,"Skin prick tests ( SPT ) with various celery , carrot and potato preparations ( raw , cooked , cooking water of each vegetable and allergen extracts ) as well as specific IgE determinations by RAST to celery mix , celeriac ( or root celery ) , stick celery and heated celery extracts were performed in 70 patients with positive prick or intracutaneous tests to birch and/or mugwort pollens and celery ( extract and/or raw ) ."
95330,IgE,O,3305.0,"Skin prick tests ( SPT ) with various celery , carrot and potato preparations ( raw , cooked , cooking water of each vegetable and allergen extracts ) as well as specific IgE determinations by RAST to celery mix , celeriac ( or root celery ) , stick celery and heated celery extracts were performed in 70 patients with positive prick or intracutaneous tests to birch and/or mugwort pollens and celery ( extract and/or raw ) ."
95331,determinations,O,3305.0,"Skin prick tests ( SPT ) with various celery , carrot and potato preparations ( raw , cooked , cooking water of each vegetable and allergen extracts ) as well as specific IgE determinations by RAST to celery mix , celeriac ( or root celery ) , stick celery and heated celery extracts were performed in 70 patients with positive prick or intracutaneous tests to birch and/or mugwort pollens and celery ( extract and/or raw ) ."
95332,by,O,3305.0,"Skin prick tests ( SPT ) with various celery , carrot and potato preparations ( raw , cooked , cooking water of each vegetable and allergen extracts ) as well as specific IgE determinations by RAST to celery mix , celeriac ( or root celery ) , stick celery and heated celery extracts were performed in 70 patients with positive prick or intracutaneous tests to birch and/or mugwort pollens and celery ( extract and/or raw ) ."
95333,RAST,O,3305.0,"Skin prick tests ( SPT ) with various celery , carrot and potato preparations ( raw , cooked , cooking water of each vegetable and allergen extracts ) as well as specific IgE determinations by RAST to celery mix , celeriac ( or root celery ) , stick celery and heated celery extracts were performed in 70 patients with positive prick or intracutaneous tests to birch and/or mugwort pollens and celery ( extract and/or raw ) ."
95334,to,O,3305.0,"Skin prick tests ( SPT ) with various celery , carrot and potato preparations ( raw , cooked , cooking water of each vegetable and allergen extracts ) as well as specific IgE determinations by RAST to celery mix , celeriac ( or root celery ) , stick celery and heated celery extracts were performed in 70 patients with positive prick or intracutaneous tests to birch and/or mugwort pollens and celery ( extract and/or raw ) ."
95335,celery,B-AG.01.h.02.b,3305.0,"Skin prick tests ( SPT ) with various celery , carrot and potato preparations ( raw , cooked , cooking water of each vegetable and allergen extracts ) as well as specific IgE determinations by RAST to celery mix , celeriac ( or root celery ) , stick celery and heated celery extracts were performed in 70 patients with positive prick or intracutaneous tests to birch and/or mugwort pollens and celery ( extract and/or raw ) ."
95336,mix,O,3305.0,"Skin prick tests ( SPT ) with various celery , carrot and potato preparations ( raw , cooked , cooking water of each vegetable and allergen extracts ) as well as specific IgE determinations by RAST to celery mix , celeriac ( or root celery ) , stick celery and heated celery extracts were performed in 70 patients with positive prick or intracutaneous tests to birch and/or mugwort pollens and celery ( extract and/or raw ) ."
95337,",",O,3305.0,"Skin prick tests ( SPT ) with various celery , carrot and potato preparations ( raw , cooked , cooking water of each vegetable and allergen extracts ) as well as specific IgE determinations by RAST to celery mix , celeriac ( or root celery ) , stick celery and heated celery extracts were performed in 70 patients with positive prick or intracutaneous tests to birch and/or mugwort pollens and celery ( extract and/or raw ) ."
95338,celeriac,B-AG.01.h.02.a,3305.0,"Skin prick tests ( SPT ) with various celery , carrot and potato preparations ( raw , cooked , cooking water of each vegetable and allergen extracts ) as well as specific IgE determinations by RAST to celery mix , celeriac ( or root celery ) , stick celery and heated celery extracts were performed in 70 patients with positive prick or intracutaneous tests to birch and/or mugwort pollens and celery ( extract and/or raw ) ."
95339,(,O,3305.0,"Skin prick tests ( SPT ) with various celery , carrot and potato preparations ( raw , cooked , cooking water of each vegetable and allergen extracts ) as well as specific IgE determinations by RAST to celery mix , celeriac ( or root celery ) , stick celery and heated celery extracts were performed in 70 patients with positive prick or intracutaneous tests to birch and/or mugwort pollens and celery ( extract and/or raw ) ."
95340,or,O,3305.0,"Skin prick tests ( SPT ) with various celery , carrot and potato preparations ( raw , cooked , cooking water of each vegetable and allergen extracts ) as well as specific IgE determinations by RAST to celery mix , celeriac ( or root celery ) , stick celery and heated celery extracts were performed in 70 patients with positive prick or intracutaneous tests to birch and/or mugwort pollens and celery ( extract and/or raw ) ."
95341,root,B-AG.01.h.02.a,3305.0,"Skin prick tests ( SPT ) with various celery , carrot and potato preparations ( raw , cooked , cooking water of each vegetable and allergen extracts ) as well as specific IgE determinations by RAST to celery mix , celeriac ( or root celery ) , stick celery and heated celery extracts were performed in 70 patients with positive prick or intracutaneous tests to birch and/or mugwort pollens and celery ( extract and/or raw ) ."
95342,celery,I-AG.01.h.02.a,3305.0,"Skin prick tests ( SPT ) with various celery , carrot and potato preparations ( raw , cooked , cooking water of each vegetable and allergen extracts ) as well as specific IgE determinations by RAST to celery mix , celeriac ( or root celery ) , stick celery and heated celery extracts were performed in 70 patients with positive prick or intracutaneous tests to birch and/or mugwort pollens and celery ( extract and/or raw ) ."
95343,),O,3305.0,"Skin prick tests ( SPT ) with various celery , carrot and potato preparations ( raw , cooked , cooking water of each vegetable and allergen extracts ) as well as specific IgE determinations by RAST to celery mix , celeriac ( or root celery ) , stick celery and heated celery extracts were performed in 70 patients with positive prick or intracutaneous tests to birch and/or mugwort pollens and celery ( extract and/or raw ) ."
95344,",",O,3305.0,"Skin prick tests ( SPT ) with various celery , carrot and potato preparations ( raw , cooked , cooking water of each vegetable and allergen extracts ) as well as specific IgE determinations by RAST to celery mix , celeriac ( or root celery ) , stick celery and heated celery extracts were performed in 70 patients with positive prick or intracutaneous tests to birch and/or mugwort pollens and celery ( extract and/or raw ) ."
95345,stick,O,3305.0,"Skin prick tests ( SPT ) with various celery , carrot and potato preparations ( raw , cooked , cooking water of each vegetable and allergen extracts ) as well as specific IgE determinations by RAST to celery mix , celeriac ( or root celery ) , stick celery and heated celery extracts were performed in 70 patients with positive prick or intracutaneous tests to birch and/or mugwort pollens and celery ( extract and/or raw ) ."
95346,celery,B-AG.01.h.02.b,3305.0,"Skin prick tests ( SPT ) with various celery , carrot and potato preparations ( raw , cooked , cooking water of each vegetable and allergen extracts ) as well as specific IgE determinations by RAST to celery mix , celeriac ( or root celery ) , stick celery and heated celery extracts were performed in 70 patients with positive prick or intracutaneous tests to birch and/or mugwort pollens and celery ( extract and/or raw ) ."
95347,and,O,3305.0,"Skin prick tests ( SPT ) with various celery , carrot and potato preparations ( raw , cooked , cooking water of each vegetable and allergen extracts ) as well as specific IgE determinations by RAST to celery mix , celeriac ( or root celery ) , stick celery and heated celery extracts were performed in 70 patients with positive prick or intracutaneous tests to birch and/or mugwort pollens and celery ( extract and/or raw ) ."
95348,heated,O,3305.0,"Skin prick tests ( SPT ) with various celery , carrot and potato preparations ( raw , cooked , cooking water of each vegetable and allergen extracts ) as well as specific IgE determinations by RAST to celery mix , celeriac ( or root celery ) , stick celery and heated celery extracts were performed in 70 patients with positive prick or intracutaneous tests to birch and/or mugwort pollens and celery ( extract and/or raw ) ."
95349,celery,O,3305.0,"Skin prick tests ( SPT ) with various celery , carrot and potato preparations ( raw , cooked , cooking water of each vegetable and allergen extracts ) as well as specific IgE determinations by RAST to celery mix , celeriac ( or root celery ) , stick celery and heated celery extracts were performed in 70 patients with positive prick or intracutaneous tests to birch and/or mugwort pollens and celery ( extract and/or raw ) ."
95350,extracts,O,3305.0,"Skin prick tests ( SPT ) with various celery , carrot and potato preparations ( raw , cooked , cooking water of each vegetable and allergen extracts ) as well as specific IgE determinations by RAST to celery mix , celeriac ( or root celery ) , stick celery and heated celery extracts were performed in 70 patients with positive prick or intracutaneous tests to birch and/or mugwort pollens and celery ( extract and/or raw ) ."
95351,were,O,3305.0,"Skin prick tests ( SPT ) with various celery , carrot and potato preparations ( raw , cooked , cooking water of each vegetable and allergen extracts ) as well as specific IgE determinations by RAST to celery mix , celeriac ( or root celery ) , stick celery and heated celery extracts were performed in 70 patients with positive prick or intracutaneous tests to birch and/or mugwort pollens and celery ( extract and/or raw ) ."
95352,performed,O,3305.0,"Skin prick tests ( SPT ) with various celery , carrot and potato preparations ( raw , cooked , cooking water of each vegetable and allergen extracts ) as well as specific IgE determinations by RAST to celery mix , celeriac ( or root celery ) , stick celery and heated celery extracts were performed in 70 patients with positive prick or intracutaneous tests to birch and/or mugwort pollens and celery ( extract and/or raw ) ."
95353,in,O,3305.0,"Skin prick tests ( SPT ) with various celery , carrot and potato preparations ( raw , cooked , cooking water of each vegetable and allergen extracts ) as well as specific IgE determinations by RAST to celery mix , celeriac ( or root celery ) , stick celery and heated celery extracts were performed in 70 patients with positive prick or intracutaneous tests to birch and/or mugwort pollens and celery ( extract and/or raw ) ."
95354,70,O,3305.0,"Skin prick tests ( SPT ) with various celery , carrot and potato preparations ( raw , cooked , cooking water of each vegetable and allergen extracts ) as well as specific IgE determinations by RAST to celery mix , celeriac ( or root celery ) , stick celery and heated celery extracts were performed in 70 patients with positive prick or intracutaneous tests to birch and/or mugwort pollens and celery ( extract and/or raw ) ."
95355,patients,O,3305.0,"Skin prick tests ( SPT ) with various celery , carrot and potato preparations ( raw , cooked , cooking water of each vegetable and allergen extracts ) as well as specific IgE determinations by RAST to celery mix , celeriac ( or root celery ) , stick celery and heated celery extracts were performed in 70 patients with positive prick or intracutaneous tests to birch and/or mugwort pollens and celery ( extract and/or raw ) ."
95356,with,O,3305.0,"Skin prick tests ( SPT ) with various celery , carrot and potato preparations ( raw , cooked , cooking water of each vegetable and allergen extracts ) as well as specific IgE determinations by RAST to celery mix , celeriac ( or root celery ) , stick celery and heated celery extracts were performed in 70 patients with positive prick or intracutaneous tests to birch and/or mugwort pollens and celery ( extract and/or raw ) ."
95357,positive,O,3305.0,"Skin prick tests ( SPT ) with various celery , carrot and potato preparations ( raw , cooked , cooking water of each vegetable and allergen extracts ) as well as specific IgE determinations by RAST to celery mix , celeriac ( or root celery ) , stick celery and heated celery extracts were performed in 70 patients with positive prick or intracutaneous tests to birch and/or mugwort pollens and celery ( extract and/or raw ) ."
95358,prick,O,3305.0,"Skin prick tests ( SPT ) with various celery , carrot and potato preparations ( raw , cooked , cooking water of each vegetable and allergen extracts ) as well as specific IgE determinations by RAST to celery mix , celeriac ( or root celery ) , stick celery and heated celery extracts were performed in 70 patients with positive prick or intracutaneous tests to birch and/or mugwort pollens and celery ( extract and/or raw ) ."
95359,or,O,3305.0,"Skin prick tests ( SPT ) with various celery , carrot and potato preparations ( raw , cooked , cooking water of each vegetable and allergen extracts ) as well as specific IgE determinations by RAST to celery mix , celeriac ( or root celery ) , stick celery and heated celery extracts were performed in 70 patients with positive prick or intracutaneous tests to birch and/or mugwort pollens and celery ( extract and/or raw ) ."
95360,intracutaneous,O,3305.0,"Skin prick tests ( SPT ) with various celery , carrot and potato preparations ( raw , cooked , cooking water of each vegetable and allergen extracts ) as well as specific IgE determinations by RAST to celery mix , celeriac ( or root celery ) , stick celery and heated celery extracts were performed in 70 patients with positive prick or intracutaneous tests to birch and/or mugwort pollens and celery ( extract and/or raw ) ."
95361,tests,O,3305.0,"Skin prick tests ( SPT ) with various celery , carrot and potato preparations ( raw , cooked , cooking water of each vegetable and allergen extracts ) as well as specific IgE determinations by RAST to celery mix , celeriac ( or root celery ) , stick celery and heated celery extracts were performed in 70 patients with positive prick or intracutaneous tests to birch and/or mugwort pollens and celery ( extract and/or raw ) ."
95362,to,O,3305.0,"Skin prick tests ( SPT ) with various celery , carrot and potato preparations ( raw , cooked , cooking water of each vegetable and allergen extracts ) as well as specific IgE determinations by RAST to celery mix , celeriac ( or root celery ) , stick celery and heated celery extracts were performed in 70 patients with positive prick or intracutaneous tests to birch and/or mugwort pollens and celery ( extract and/or raw ) ."
95363,birch,O,3305.0,"Skin prick tests ( SPT ) with various celery , carrot and potato preparations ( raw , cooked , cooking water of each vegetable and allergen extracts ) as well as specific IgE determinations by RAST to celery mix , celeriac ( or root celery ) , stick celery and heated celery extracts were performed in 70 patients with positive prick or intracutaneous tests to birch and/or mugwort pollens and celery ( extract and/or raw ) ."
95364,and/or,O,3305.0,"Skin prick tests ( SPT ) with various celery , carrot and potato preparations ( raw , cooked , cooking water of each vegetable and allergen extracts ) as well as specific IgE determinations by RAST to celery mix , celeriac ( or root celery ) , stick celery and heated celery extracts were performed in 70 patients with positive prick or intracutaneous tests to birch and/or mugwort pollens and celery ( extract and/or raw ) ."
95365,mugwort,O,3305.0,"Skin prick tests ( SPT ) with various celery , carrot and potato preparations ( raw , cooked , cooking water of each vegetable and allergen extracts ) as well as specific IgE determinations by RAST to celery mix , celeriac ( or root celery ) , stick celery and heated celery extracts were performed in 70 patients with positive prick or intracutaneous tests to birch and/or mugwort pollens and celery ( extract and/or raw ) ."
95366,pollens,O,3305.0,"Skin prick tests ( SPT ) with various celery , carrot and potato preparations ( raw , cooked , cooking water of each vegetable and allergen extracts ) as well as specific IgE determinations by RAST to celery mix , celeriac ( or root celery ) , stick celery and heated celery extracts were performed in 70 patients with positive prick or intracutaneous tests to birch and/or mugwort pollens and celery ( extract and/or raw ) ."
95367,and,O,3305.0,"Skin prick tests ( SPT ) with various celery , carrot and potato preparations ( raw , cooked , cooking water of each vegetable and allergen extracts ) as well as specific IgE determinations by RAST to celery mix , celeriac ( or root celery ) , stick celery and heated celery extracts were performed in 70 patients with positive prick or intracutaneous tests to birch and/or mugwort pollens and celery ( extract and/or raw ) ."
95368,celery,O,3305.0,"Skin prick tests ( SPT ) with various celery , carrot and potato preparations ( raw , cooked , cooking water of each vegetable and allergen extracts ) as well as specific IgE determinations by RAST to celery mix , celeriac ( or root celery ) , stick celery and heated celery extracts were performed in 70 patients with positive prick or intracutaneous tests to birch and/or mugwort pollens and celery ( extract and/or raw ) ."
95369,(,O,3305.0,"Skin prick tests ( SPT ) with various celery , carrot and potato preparations ( raw , cooked , cooking water of each vegetable and allergen extracts ) as well as specific IgE determinations by RAST to celery mix , celeriac ( or root celery ) , stick celery and heated celery extracts were performed in 70 patients with positive prick or intracutaneous tests to birch and/or mugwort pollens and celery ( extract and/or raw ) ."
95370,extract,O,3305.0,"Skin prick tests ( SPT ) with various celery , carrot and potato preparations ( raw , cooked , cooking water of each vegetable and allergen extracts ) as well as specific IgE determinations by RAST to celery mix , celeriac ( or root celery ) , stick celery and heated celery extracts were performed in 70 patients with positive prick or intracutaneous tests to birch and/or mugwort pollens and celery ( extract and/or raw ) ."
95371,and/or,O,3305.0,"Skin prick tests ( SPT ) with various celery , carrot and potato preparations ( raw , cooked , cooking water of each vegetable and allergen extracts ) as well as specific IgE determinations by RAST to celery mix , celeriac ( or root celery ) , stick celery and heated celery extracts were performed in 70 patients with positive prick or intracutaneous tests to birch and/or mugwort pollens and celery ( extract and/or raw ) ."
95372,raw,O,3305.0,"Skin prick tests ( SPT ) with various celery , carrot and potato preparations ( raw , cooked , cooking water of each vegetable and allergen extracts ) as well as specific IgE determinations by RAST to celery mix , celeriac ( or root celery ) , stick celery and heated celery extracts were performed in 70 patients with positive prick or intracutaneous tests to birch and/or mugwort pollens and celery ( extract and/or raw ) ."
95373,),O,3305.0,"Skin prick tests ( SPT ) with various celery , carrot and potato preparations ( raw , cooked , cooking water of each vegetable and allergen extracts ) as well as specific IgE determinations by RAST to celery mix , celeriac ( or root celery ) , stick celery and heated celery extracts were performed in 70 patients with positive prick or intracutaneous tests to birch and/or mugwort pollens and celery ( extract and/or raw ) ."
95374,.,O,3305.0,"Skin prick tests ( SPT ) with various celery , carrot and potato preparations ( raw , cooked , cooking water of each vegetable and allergen extracts ) as well as specific IgE determinations by RAST to celery mix , celeriac ( or root celery ) , stick celery and heated celery extracts were performed in 70 patients with positive prick or intracutaneous tests to birch and/or mugwort pollens and celery ( extract and/or raw ) ."
95375,94,O,3306.0,"94 % of the patients showed positive prick tests to raw celeriac , 36 % to cooked celeriac and 8/13 to cooking water ."
95376,%,O,3306.0,"94 % of the patients showed positive prick tests to raw celeriac , 36 % to cooked celeriac and 8/13 to cooking water ."
95377,of,O,3306.0,"94 % of the patients showed positive prick tests to raw celeriac , 36 % to cooked celeriac and 8/13 to cooking water ."
95378,the,O,3306.0,"94 % of the patients showed positive prick tests to raw celeriac , 36 % to cooked celeriac and 8/13 to cooking water ."
95379,patients,O,3306.0,"94 % of the patients showed positive prick tests to raw celeriac , 36 % to cooked celeriac and 8/13 to cooking water ."
95380,showed,O,3306.0,"94 % of the patients showed positive prick tests to raw celeriac , 36 % to cooked celeriac and 8/13 to cooking water ."
95381,positive,O,3306.0,"94 % of the patients showed positive prick tests to raw celeriac , 36 % to cooked celeriac and 8/13 to cooking water ."
95382,prick,O,3306.0,"94 % of the patients showed positive prick tests to raw celeriac , 36 % to cooked celeriac and 8/13 to cooking water ."
95383,tests,O,3306.0,"94 % of the patients showed positive prick tests to raw celeriac , 36 % to cooked celeriac and 8/13 to cooking water ."
95384,to,O,3306.0,"94 % of the patients showed positive prick tests to raw celeriac , 36 % to cooked celeriac and 8/13 to cooking water ."
95385,raw,O,3306.0,"94 % of the patients showed positive prick tests to raw celeriac , 36 % to cooked celeriac and 8/13 to cooking water ."
95386,celeriac,B-AG.01.h.02.a,3306.0,"94 % of the patients showed positive prick tests to raw celeriac , 36 % to cooked celeriac and 8/13 to cooking water ."
95387,",",O,3306.0,"94 % of the patients showed positive prick tests to raw celeriac , 36 % to cooked celeriac and 8/13 to cooking water ."
95388,36,O,3306.0,"94 % of the patients showed positive prick tests to raw celeriac , 36 % to cooked celeriac and 8/13 to cooking water ."
95389,%,O,3306.0,"94 % of the patients showed positive prick tests to raw celeriac , 36 % to cooked celeriac and 8/13 to cooking water ."
95390,to,O,3306.0,"94 % of the patients showed positive prick tests to raw celeriac , 36 % to cooked celeriac and 8/13 to cooking water ."
95391,cooked,O,3306.0,"94 % of the patients showed positive prick tests to raw celeriac , 36 % to cooked celeriac and 8/13 to cooking water ."
95392,celeriac,B-AG.01.h.02.b,3306.0,"94 % of the patients showed positive prick tests to raw celeriac , 36 % to cooked celeriac and 8/13 to cooking water ."
95393,and,O,3306.0,"94 % of the patients showed positive prick tests to raw celeriac , 36 % to cooked celeriac and 8/13 to cooking water ."
95394,8/13,O,3306.0,"94 % of the patients showed positive prick tests to raw celeriac , 36 % to cooked celeriac and 8/13 to cooking water ."
95395,to,O,3306.0,"94 % of the patients showed positive prick tests to raw celeriac , 36 % to cooked celeriac and 8/13 to cooking water ."
95396,cooking,B-AG.01.z,3306.0,"94 % of the patients showed positive prick tests to raw celeriac , 36 % to cooked celeriac and 8/13 to cooking water ."
95397,water,I-AG.01.z,3306.0,"94 % of the patients showed positive prick tests to raw celeriac , 36 % to cooked celeriac and 8/13 to cooking water ."
95398,.,O,3306.0,"94 % of the patients showed positive prick tests to raw celeriac , 36 % to cooked celeriac and 8/13 to cooking water ."
95399,Celery,O,3307.0,Celery - birch positive patients ( n = 13 ) showed negative or low RASTs to heated celery extracts and to stick celery .
95400,-,O,3307.0,Celery - birch positive patients ( n = 13 ) showed negative or low RASTs to heated celery extracts and to stick celery .
95401,birch,O,3307.0,Celery - birch positive patients ( n = 13 ) showed negative or low RASTs to heated celery extracts and to stick celery .
95402,positive,O,3307.0,Celery - birch positive patients ( n = 13 ) showed negative or low RASTs to heated celery extracts and to stick celery .
95403,patients,O,3307.0,Celery - birch positive patients ( n = 13 ) showed negative or low RASTs to heated celery extracts and to stick celery .
95404,(,O,3307.0,Celery - birch positive patients ( n = 13 ) showed negative or low RASTs to heated celery extracts and to stick celery .
95405,n,O,3307.0,Celery - birch positive patients ( n = 13 ) showed negative or low RASTs to heated celery extracts and to stick celery .
95406,=,O,3307.0,Celery - birch positive patients ( n = 13 ) showed negative or low RASTs to heated celery extracts and to stick celery .
95407,13,O,3307.0,Celery - birch positive patients ( n = 13 ) showed negative or low RASTs to heated celery extracts and to stick celery .
95408,),O,3307.0,Celery - birch positive patients ( n = 13 ) showed negative or low RASTs to heated celery extracts and to stick celery .
95409,showed,O,3307.0,Celery - birch positive patients ( n = 13 ) showed negative or low RASTs to heated celery extracts and to stick celery .
95410,negative,O,3307.0,Celery - birch positive patients ( n = 13 ) showed negative or low RASTs to heated celery extracts and to stick celery .
95411,or,O,3307.0,Celery - birch positive patients ( n = 13 ) showed negative or low RASTs to heated celery extracts and to stick celery .
95412,low,O,3307.0,Celery - birch positive patients ( n = 13 ) showed negative or low RASTs to heated celery extracts and to stick celery .
95413,RASTs,O,3307.0,Celery - birch positive patients ( n = 13 ) showed negative or low RASTs to heated celery extracts and to stick celery .
95414,to,O,3307.0,Celery - birch positive patients ( n = 13 ) showed negative or low RASTs to heated celery extracts and to stick celery .
95415,heated,O,3307.0,Celery - birch positive patients ( n = 13 ) showed negative or low RASTs to heated celery extracts and to stick celery .
95416,celery,O,3307.0,Celery - birch positive patients ( n = 13 ) showed negative or low RASTs to heated celery extracts and to stick celery .
95417,extracts,O,3307.0,Celery - birch positive patients ( n = 13 ) showed negative or low RASTs to heated celery extracts and to stick celery .
95418,and,O,3307.0,Celery - birch positive patients ( n = 13 ) showed negative or low RASTs to heated celery extracts and to stick celery .
95419,to,O,3307.0,Celery - birch positive patients ( n = 13 ) showed negative or low RASTs to heated celery extracts and to stick celery .
95420,stick,B-AG.01.h.02.b,3307.0,Celery - birch positive patients ( n = 13 ) showed negative or low RASTs to heated celery extracts and to stick celery .
95421,celery,I-AG.01.h.02.b,3307.0,Celery - birch positive patients ( n = 13 ) showed negative or low RASTs to heated celery extracts and to stick celery .
95422,.,O,3307.0,Celery - birch positive patients ( n = 13 ) showed negative or low RASTs to heated celery extracts and to stick celery .
95423,By,O,3308.0,"By contrast , in the celery - mugwort sensitive patients ( n = 6 ) the celery RASTs with heated celery extracts remained clearly positive and high RAST values to stick celery could be found ."
95424,contrast,O,3308.0,"By contrast , in the celery - mugwort sensitive patients ( n = 6 ) the celery RASTs with heated celery extracts remained clearly positive and high RAST values to stick celery could be found ."
95425,",",O,3308.0,"By contrast , in the celery - mugwort sensitive patients ( n = 6 ) the celery RASTs with heated celery extracts remained clearly positive and high RAST values to stick celery could be found ."
95426,in,O,3308.0,"By contrast , in the celery - mugwort sensitive patients ( n = 6 ) the celery RASTs with heated celery extracts remained clearly positive and high RAST values to stick celery could be found ."
95427,the,O,3308.0,"By contrast , in the celery - mugwort sensitive patients ( n = 6 ) the celery RASTs with heated celery extracts remained clearly positive and high RAST values to stick celery could be found ."
95428,celery,O,3308.0,"By contrast , in the celery - mugwort sensitive patients ( n = 6 ) the celery RASTs with heated celery extracts remained clearly positive and high RAST values to stick celery could be found ."
95429,-,O,3308.0,"By contrast , in the celery - mugwort sensitive patients ( n = 6 ) the celery RASTs with heated celery extracts remained clearly positive and high RAST values to stick celery could be found ."
95430,mugwort,O,3308.0,"By contrast , in the celery - mugwort sensitive patients ( n = 6 ) the celery RASTs with heated celery extracts remained clearly positive and high RAST values to stick celery could be found ."
95431,sensitive,O,3308.0,"By contrast , in the celery - mugwort sensitive patients ( n = 6 ) the celery RASTs with heated celery extracts remained clearly positive and high RAST values to stick celery could be found ."
95432,patients,O,3308.0,"By contrast , in the celery - mugwort sensitive patients ( n = 6 ) the celery RASTs with heated celery extracts remained clearly positive and high RAST values to stick celery could be found ."
95433,(,O,3308.0,"By contrast , in the celery - mugwort sensitive patients ( n = 6 ) the celery RASTs with heated celery extracts remained clearly positive and high RAST values to stick celery could be found ."
95434,n,O,3308.0,"By contrast , in the celery - mugwort sensitive patients ( n = 6 ) the celery RASTs with heated celery extracts remained clearly positive and high RAST values to stick celery could be found ."
95435,=,O,3308.0,"By contrast , in the celery - mugwort sensitive patients ( n = 6 ) the celery RASTs with heated celery extracts remained clearly positive and high RAST values to stick celery could be found ."
95436,6,O,3308.0,"By contrast , in the celery - mugwort sensitive patients ( n = 6 ) the celery RASTs with heated celery extracts remained clearly positive and high RAST values to stick celery could be found ."
95437,),O,3308.0,"By contrast , in the celery - mugwort sensitive patients ( n = 6 ) the celery RASTs with heated celery extracts remained clearly positive and high RAST values to stick celery could be found ."
95438,the,O,3308.0,"By contrast , in the celery - mugwort sensitive patients ( n = 6 ) the celery RASTs with heated celery extracts remained clearly positive and high RAST values to stick celery could be found ."
95439,celery,B-AG.01.h.02.b,3308.0,"By contrast , in the celery - mugwort sensitive patients ( n = 6 ) the celery RASTs with heated celery extracts remained clearly positive and high RAST values to stick celery could be found ."
95440,RASTs,O,3308.0,"By contrast , in the celery - mugwort sensitive patients ( n = 6 ) the celery RASTs with heated celery extracts remained clearly positive and high RAST values to stick celery could be found ."
95441,with,O,3308.0,"By contrast , in the celery - mugwort sensitive patients ( n = 6 ) the celery RASTs with heated celery extracts remained clearly positive and high RAST values to stick celery could be found ."
95442,heated,O,3308.0,"By contrast , in the celery - mugwort sensitive patients ( n = 6 ) the celery RASTs with heated celery extracts remained clearly positive and high RAST values to stick celery could be found ."
95443,celery,O,3308.0,"By contrast , in the celery - mugwort sensitive patients ( n = 6 ) the celery RASTs with heated celery extracts remained clearly positive and high RAST values to stick celery could be found ."
95444,extracts,O,3308.0,"By contrast , in the celery - mugwort sensitive patients ( n = 6 ) the celery RASTs with heated celery extracts remained clearly positive and high RAST values to stick celery could be found ."
95445,remained,O,3308.0,"By contrast , in the celery - mugwort sensitive patients ( n = 6 ) the celery RASTs with heated celery extracts remained clearly positive and high RAST values to stick celery could be found ."
95446,clearly,O,3308.0,"By contrast , in the celery - mugwort sensitive patients ( n = 6 ) the celery RASTs with heated celery extracts remained clearly positive and high RAST values to stick celery could be found ."
95447,positive,O,3308.0,"By contrast , in the celery - mugwort sensitive patients ( n = 6 ) the celery RASTs with heated celery extracts remained clearly positive and high RAST values to stick celery could be found ."
95448,and,O,3308.0,"By contrast , in the celery - mugwort sensitive patients ( n = 6 ) the celery RASTs with heated celery extracts remained clearly positive and high RAST values to stick celery could be found ."
95449,high,O,3308.0,"By contrast , in the celery - mugwort sensitive patients ( n = 6 ) the celery RASTs with heated celery extracts remained clearly positive and high RAST values to stick celery could be found ."
95450,RAST,O,3308.0,"By contrast , in the celery - mugwort sensitive patients ( n = 6 ) the celery RASTs with heated celery extracts remained clearly positive and high RAST values to stick celery could be found ."
95451,values,O,3308.0,"By contrast , in the celery - mugwort sensitive patients ( n = 6 ) the celery RASTs with heated celery extracts remained clearly positive and high RAST values to stick celery could be found ."
95452,to,O,3308.0,"By contrast , in the celery - mugwort sensitive patients ( n = 6 ) the celery RASTs with heated celery extracts remained clearly positive and high RAST values to stick celery could be found ."
95453,stick,B-AG.01.h.02.b,3308.0,"By contrast , in the celery - mugwort sensitive patients ( n = 6 ) the celery RASTs with heated celery extracts remained clearly positive and high RAST values to stick celery could be found ."
95454,celery,I-AG.01.h.02.b,3308.0,"By contrast , in the celery - mugwort sensitive patients ( n = 6 ) the celery RASTs with heated celery extracts remained clearly positive and high RAST values to stick celery could be found ."
95455,could,O,3308.0,"By contrast , in the celery - mugwort sensitive patients ( n = 6 ) the celery RASTs with heated celery extracts remained clearly positive and high RAST values to stick celery could be found ."
95456,be,O,3308.0,"By contrast , in the celery - mugwort sensitive patients ( n = 6 ) the celery RASTs with heated celery extracts remained clearly positive and high RAST values to stick celery could be found ."
95457,found,O,3308.0,"By contrast , in the celery - mugwort sensitive patients ( n = 6 ) the celery RASTs with heated celery extracts remained clearly positive and high RAST values to stick celery could be found ."
95458,.,O,3308.0,"By contrast , in the celery - mugwort sensitive patients ( n = 6 ) the celery RASTs with heated celery extracts remained clearly positive and high RAST values to stick celery could be found ."
95459,Celery,O,3309.0,Celery - birch - mugwort - association ( n = 22 ) favoured more positive results with relatively high values of RAST to celeriac .
95460,-,O,3309.0,Celery - birch - mugwort - association ( n = 22 ) favoured more positive results with relatively high values of RAST to celeriac .
95461,birch,O,3309.0,Celery - birch - mugwort - association ( n = 22 ) favoured more positive results with relatively high values of RAST to celeriac .
95462,-,O,3309.0,Celery - birch - mugwort - association ( n = 22 ) favoured more positive results with relatively high values of RAST to celeriac .
95463,mugwort,O,3309.0,Celery - birch - mugwort - association ( n = 22 ) favoured more positive results with relatively high values of RAST to celeriac .
95464,-,O,3309.0,Celery - birch - mugwort - association ( n = 22 ) favoured more positive results with relatively high values of RAST to celeriac .
95465,association,O,3309.0,Celery - birch - mugwort - association ( n = 22 ) favoured more positive results with relatively high values of RAST to celeriac .
95466,(,O,3309.0,Celery - birch - mugwort - association ( n = 22 ) favoured more positive results with relatively high values of RAST to celeriac .
95467,n,O,3309.0,Celery - birch - mugwort - association ( n = 22 ) favoured more positive results with relatively high values of RAST to celeriac .
95468,=,O,3309.0,Celery - birch - mugwort - association ( n = 22 ) favoured more positive results with relatively high values of RAST to celeriac .
95469,22,O,3309.0,Celery - birch - mugwort - association ( n = 22 ) favoured more positive results with relatively high values of RAST to celeriac .
95470,),O,3309.0,Celery - birch - mugwort - association ( n = 22 ) favoured more positive results with relatively high values of RAST to celeriac .
95471,favoured,O,3309.0,Celery - birch - mugwort - association ( n = 22 ) favoured more positive results with relatively high values of RAST to celeriac .
95472,more,O,3309.0,Celery - birch - mugwort - association ( n = 22 ) favoured more positive results with relatively high values of RAST to celeriac .
95473,positive,O,3309.0,Celery - birch - mugwort - association ( n = 22 ) favoured more positive results with relatively high values of RAST to celeriac .
95474,results,O,3309.0,Celery - birch - mugwort - association ( n = 22 ) favoured more positive results with relatively high values of RAST to celeriac .
95475,with,O,3309.0,Celery - birch - mugwort - association ( n = 22 ) favoured more positive results with relatively high values of RAST to celeriac .
95476,relatively,O,3309.0,Celery - birch - mugwort - association ( n = 22 ) favoured more positive results with relatively high values of RAST to celeriac .
95477,high,O,3309.0,Celery - birch - mugwort - association ( n = 22 ) favoured more positive results with relatively high values of RAST to celeriac .
95478,values,O,3309.0,Celery - birch - mugwort - association ( n = 22 ) favoured more positive results with relatively high values of RAST to celeriac .
95479,of,O,3309.0,Celery - birch - mugwort - association ( n = 22 ) favoured more positive results with relatively high values of RAST to celeriac .
95480,RAST,O,3309.0,Celery - birch - mugwort - association ( n = 22 ) favoured more positive results with relatively high values of RAST to celeriac .
95481,to,O,3309.0,Celery - birch - mugwort - association ( n = 22 ) favoured more positive results with relatively high values of RAST to celeriac .
95482,celeriac,B-AG.01.h.02.a,3309.0,Celery - birch - mugwort - association ( n = 22 ) favoured more positive results with relatively high values of RAST to celeriac .
95483,.,O,3309.0,Celery - birch - mugwort - association ( n = 22 ) favoured more positive results with relatively high values of RAST to celeriac .
95484,The,O,3310.0,"The results of homologous and heterologous RAST inhibition experiments with birch , mugwort , unheated and heated celery ( 100 degrees C ) carried out in nine celery - RAST positive sera are also discussed ."
95485,results,O,3310.0,"The results of homologous and heterologous RAST inhibition experiments with birch , mugwort , unheated and heated celery ( 100 degrees C ) carried out in nine celery - RAST positive sera are also discussed ."
95486,of,O,3310.0,"The results of homologous and heterologous RAST inhibition experiments with birch , mugwort , unheated and heated celery ( 100 degrees C ) carried out in nine celery - RAST positive sera are also discussed ."
95487,homologous,O,3310.0,"The results of homologous and heterologous RAST inhibition experiments with birch , mugwort , unheated and heated celery ( 100 degrees C ) carried out in nine celery - RAST positive sera are also discussed ."
95488,and,O,3310.0,"The results of homologous and heterologous RAST inhibition experiments with birch , mugwort , unheated and heated celery ( 100 degrees C ) carried out in nine celery - RAST positive sera are also discussed ."
95489,heterologous,O,3310.0,"The results of homologous and heterologous RAST inhibition experiments with birch , mugwort , unheated and heated celery ( 100 degrees C ) carried out in nine celery - RAST positive sera are also discussed ."
95490,RAST,O,3310.0,"The results of homologous and heterologous RAST inhibition experiments with birch , mugwort , unheated and heated celery ( 100 degrees C ) carried out in nine celery - RAST positive sera are also discussed ."
95491,inhibition,O,3310.0,"The results of homologous and heterologous RAST inhibition experiments with birch , mugwort , unheated and heated celery ( 100 degrees C ) carried out in nine celery - RAST positive sera are also discussed ."
95492,experiments,O,3310.0,"The results of homologous and heterologous RAST inhibition experiments with birch , mugwort , unheated and heated celery ( 100 degrees C ) carried out in nine celery - RAST positive sera are also discussed ."
95493,with,O,3310.0,"The results of homologous and heterologous RAST inhibition experiments with birch , mugwort , unheated and heated celery ( 100 degrees C ) carried out in nine celery - RAST positive sera are also discussed ."
95494,birch,O,3310.0,"The results of homologous and heterologous RAST inhibition experiments with birch , mugwort , unheated and heated celery ( 100 degrees C ) carried out in nine celery - RAST positive sera are also discussed ."
95495,",",O,3310.0,"The results of homologous and heterologous RAST inhibition experiments with birch , mugwort , unheated and heated celery ( 100 degrees C ) carried out in nine celery - RAST positive sera are also discussed ."
95496,mugwort,O,3310.0,"The results of homologous and heterologous RAST inhibition experiments with birch , mugwort , unheated and heated celery ( 100 degrees C ) carried out in nine celery - RAST positive sera are also discussed ."
95497,",",O,3310.0,"The results of homologous and heterologous RAST inhibition experiments with birch , mugwort , unheated and heated celery ( 100 degrees C ) carried out in nine celery - RAST positive sera are also discussed ."
95498,unheated,O,3310.0,"The results of homologous and heterologous RAST inhibition experiments with birch , mugwort , unheated and heated celery ( 100 degrees C ) carried out in nine celery - RAST positive sera are also discussed ."
95499,and,O,3310.0,"The results of homologous and heterologous RAST inhibition experiments with birch , mugwort , unheated and heated celery ( 100 degrees C ) carried out in nine celery - RAST positive sera are also discussed ."
95500,heated,O,3310.0,"The results of homologous and heterologous RAST inhibition experiments with birch , mugwort , unheated and heated celery ( 100 degrees C ) carried out in nine celery - RAST positive sera are also discussed ."
95501,celery,B-AG.01.h.02.b,3310.0,"The results of homologous and heterologous RAST inhibition experiments with birch , mugwort , unheated and heated celery ( 100 degrees C ) carried out in nine celery - RAST positive sera are also discussed ."
95502,(,O,3310.0,"The results of homologous and heterologous RAST inhibition experiments with birch , mugwort , unheated and heated celery ( 100 degrees C ) carried out in nine celery - RAST positive sera are also discussed ."
95503,100,O,3310.0,"The results of homologous and heterologous RAST inhibition experiments with birch , mugwort , unheated and heated celery ( 100 degrees C ) carried out in nine celery - RAST positive sera are also discussed ."
95504,degrees,O,3310.0,"The results of homologous and heterologous RAST inhibition experiments with birch , mugwort , unheated and heated celery ( 100 degrees C ) carried out in nine celery - RAST positive sera are also discussed ."
95505,C,O,3310.0,"The results of homologous and heterologous RAST inhibition experiments with birch , mugwort , unheated and heated celery ( 100 degrees C ) carried out in nine celery - RAST positive sera are also discussed ."
95506,),O,3310.0,"The results of homologous and heterologous RAST inhibition experiments with birch , mugwort , unheated and heated celery ( 100 degrees C ) carried out in nine celery - RAST positive sera are also discussed ."
95507,carried,O,3310.0,"The results of homologous and heterologous RAST inhibition experiments with birch , mugwort , unheated and heated celery ( 100 degrees C ) carried out in nine celery - RAST positive sera are also discussed ."
95508,out,O,3310.0,"The results of homologous and heterologous RAST inhibition experiments with birch , mugwort , unheated and heated celery ( 100 degrees C ) carried out in nine celery - RAST positive sera are also discussed ."
95509,in,O,3310.0,"The results of homologous and heterologous RAST inhibition experiments with birch , mugwort , unheated and heated celery ( 100 degrees C ) carried out in nine celery - RAST positive sera are also discussed ."
95510,nine,O,3310.0,"The results of homologous and heterologous RAST inhibition experiments with birch , mugwort , unheated and heated celery ( 100 degrees C ) carried out in nine celery - RAST positive sera are also discussed ."
95511,celery,O,3310.0,"The results of homologous and heterologous RAST inhibition experiments with birch , mugwort , unheated and heated celery ( 100 degrees C ) carried out in nine celery - RAST positive sera are also discussed ."
95512,-,O,3310.0,"The results of homologous and heterologous RAST inhibition experiments with birch , mugwort , unheated and heated celery ( 100 degrees C ) carried out in nine celery - RAST positive sera are also discussed ."
95513,RAST,O,3310.0,"The results of homologous and heterologous RAST inhibition experiments with birch , mugwort , unheated and heated celery ( 100 degrees C ) carried out in nine celery - RAST positive sera are also discussed ."
95514,positive,O,3310.0,"The results of homologous and heterologous RAST inhibition experiments with birch , mugwort , unheated and heated celery ( 100 degrees C ) carried out in nine celery - RAST positive sera are also discussed ."
95515,sera,O,3310.0,"The results of homologous and heterologous RAST inhibition experiments with birch , mugwort , unheated and heated celery ( 100 degrees C ) carried out in nine celery - RAST positive sera are also discussed ."
95516,are,O,3310.0,"The results of homologous and heterologous RAST inhibition experiments with birch , mugwort , unheated and heated celery ( 100 degrees C ) carried out in nine celery - RAST positive sera are also discussed ."
95517,also,O,3310.0,"The results of homologous and heterologous RAST inhibition experiments with birch , mugwort , unheated and heated celery ( 100 degrees C ) carried out in nine celery - RAST positive sera are also discussed ."
95518,discussed,O,3310.0,"The results of homologous and heterologous RAST inhibition experiments with birch , mugwort , unheated and heated celery ( 100 degrees C ) carried out in nine celery - RAST positive sera are also discussed ."
95519,.,O,3310.0,"The results of homologous and heterologous RAST inhibition experiments with birch , mugwort , unheated and heated celery ( 100 degrees C ) carried out in nine celery - RAST positive sera are also discussed ."
95520,In,O,3311.0,"In a previous European prospective investigation into cancer and nutrition ( EPIC ) analysis , we found an inverse association between total intake of vegetables , onion and garlic , and risk of intestinal gastric cancer ( GC ) and between citrus fruit and risk of cardia GC ."
95521,a,O,3311.0,"In a previous European prospective investigation into cancer and nutrition ( EPIC ) analysis , we found an inverse association between total intake of vegetables , onion and garlic , and risk of intestinal gastric cancer ( GC ) and between citrus fruit and risk of cardia GC ."
95522,previous,O,3311.0,"In a previous European prospective investigation into cancer and nutrition ( EPIC ) analysis , we found an inverse association between total intake of vegetables , onion and garlic , and risk of intestinal gastric cancer ( GC ) and between citrus fruit and risk of cardia GC ."
95523,European,O,3311.0,"In a previous European prospective investigation into cancer and nutrition ( EPIC ) analysis , we found an inverse association between total intake of vegetables , onion and garlic , and risk of intestinal gastric cancer ( GC ) and between citrus fruit and risk of cardia GC ."
95524,prospective,O,3311.0,"In a previous European prospective investigation into cancer and nutrition ( EPIC ) analysis , we found an inverse association between total intake of vegetables , onion and garlic , and risk of intestinal gastric cancer ( GC ) and between citrus fruit and risk of cardia GC ."
95525,investigation,O,3311.0,"In a previous European prospective investigation into cancer and nutrition ( EPIC ) analysis , we found an inverse association between total intake of vegetables , onion and garlic , and risk of intestinal gastric cancer ( GC ) and between citrus fruit and risk of cardia GC ."
95526,into,O,3311.0,"In a previous European prospective investigation into cancer and nutrition ( EPIC ) analysis , we found an inverse association between total intake of vegetables , onion and garlic , and risk of intestinal gastric cancer ( GC ) and between citrus fruit and risk of cardia GC ."
95527,cancer,O,3311.0,"In a previous European prospective investigation into cancer and nutrition ( EPIC ) analysis , we found an inverse association between total intake of vegetables , onion and garlic , and risk of intestinal gastric cancer ( GC ) and between citrus fruit and risk of cardia GC ."
95528,and,O,3311.0,"In a previous European prospective investigation into cancer and nutrition ( EPIC ) analysis , we found an inverse association between total intake of vegetables , onion and garlic , and risk of intestinal gastric cancer ( GC ) and between citrus fruit and risk of cardia GC ."
95529,nutrition,O,3311.0,"In a previous European prospective investigation into cancer and nutrition ( EPIC ) analysis , we found an inverse association between total intake of vegetables , onion and garlic , and risk of intestinal gastric cancer ( GC ) and between citrus fruit and risk of cardia GC ."
95530,(,O,3311.0,"In a previous European prospective investigation into cancer and nutrition ( EPIC ) analysis , we found an inverse association between total intake of vegetables , onion and garlic , and risk of intestinal gastric cancer ( GC ) and between citrus fruit and risk of cardia GC ."
95531,EPIC,O,3311.0,"In a previous European prospective investigation into cancer and nutrition ( EPIC ) analysis , we found an inverse association between total intake of vegetables , onion and garlic , and risk of intestinal gastric cancer ( GC ) and between citrus fruit and risk of cardia GC ."
95532,),O,3311.0,"In a previous European prospective investigation into cancer and nutrition ( EPIC ) analysis , we found an inverse association between total intake of vegetables , onion and garlic , and risk of intestinal gastric cancer ( GC ) and between citrus fruit and risk of cardia GC ."
95533,analysis,O,3311.0,"In a previous European prospective investigation into cancer and nutrition ( EPIC ) analysis , we found an inverse association between total intake of vegetables , onion and garlic , and risk of intestinal gastric cancer ( GC ) and between citrus fruit and risk of cardia GC ."
95534,",",O,3311.0,"In a previous European prospective investigation into cancer and nutrition ( EPIC ) analysis , we found an inverse association between total intake of vegetables , onion and garlic , and risk of intestinal gastric cancer ( GC ) and between citrus fruit and risk of cardia GC ."
95535,we,O,3311.0,"In a previous European prospective investigation into cancer and nutrition ( EPIC ) analysis , we found an inverse association between total intake of vegetables , onion and garlic , and risk of intestinal gastric cancer ( GC ) and between citrus fruit and risk of cardia GC ."
95536,found,O,3311.0,"In a previous European prospective investigation into cancer and nutrition ( EPIC ) analysis , we found an inverse association between total intake of vegetables , onion and garlic , and risk of intestinal gastric cancer ( GC ) and between citrus fruit and risk of cardia GC ."
95537,an,O,3311.0,"In a previous European prospective investigation into cancer and nutrition ( EPIC ) analysis , we found an inverse association between total intake of vegetables , onion and garlic , and risk of intestinal gastric cancer ( GC ) and between citrus fruit and risk of cardia GC ."
95538,inverse,O,3311.0,"In a previous European prospective investigation into cancer and nutrition ( EPIC ) analysis , we found an inverse association between total intake of vegetables , onion and garlic , and risk of intestinal gastric cancer ( GC ) and between citrus fruit and risk of cardia GC ."
95539,association,O,3311.0,"In a previous European prospective investigation into cancer and nutrition ( EPIC ) analysis , we found an inverse association between total intake of vegetables , onion and garlic , and risk of intestinal gastric cancer ( GC ) and between citrus fruit and risk of cardia GC ."
95540,between,O,3311.0,"In a previous European prospective investigation into cancer and nutrition ( EPIC ) analysis , we found an inverse association between total intake of vegetables , onion and garlic , and risk of intestinal gastric cancer ( GC ) and between citrus fruit and risk of cardia GC ."
95541,total,O,3311.0,"In a previous European prospective investigation into cancer and nutrition ( EPIC ) analysis , we found an inverse association between total intake of vegetables , onion and garlic , and risk of intestinal gastric cancer ( GC ) and between citrus fruit and risk of cardia GC ."
95542,intake,O,3311.0,"In a previous European prospective investigation into cancer and nutrition ( EPIC ) analysis , we found an inverse association between total intake of vegetables , onion and garlic , and risk of intestinal gastric cancer ( GC ) and between citrus fruit and risk of cardia GC ."
95543,of,O,3311.0,"In a previous European prospective investigation into cancer and nutrition ( EPIC ) analysis , we found an inverse association between total intake of vegetables , onion and garlic , and risk of intestinal gastric cancer ( GC ) and between citrus fruit and risk of cardia GC ."
95544,vegetables,B-AG.01.h.02,3311.0,"In a previous European prospective investigation into cancer and nutrition ( EPIC ) analysis , we found an inverse association between total intake of vegetables , onion and garlic , and risk of intestinal gastric cancer ( GC ) and between citrus fruit and risk of cardia GC ."
95545,",",O,3311.0,"In a previous European prospective investigation into cancer and nutrition ( EPIC ) analysis , we found an inverse association between total intake of vegetables , onion and garlic , and risk of intestinal gastric cancer ( GC ) and between citrus fruit and risk of cardia GC ."
95546,onion,B-AG.01.h.02.e,3311.0,"In a previous European prospective investigation into cancer and nutrition ( EPIC ) analysis , we found an inverse association between total intake of vegetables , onion and garlic , and risk of intestinal gastric cancer ( GC ) and between citrus fruit and risk of cardia GC ."
95547,and,O,3311.0,"In a previous European prospective investigation into cancer and nutrition ( EPIC ) analysis , we found an inverse association between total intake of vegetables , onion and garlic , and risk of intestinal gastric cancer ( GC ) and between citrus fruit and risk of cardia GC ."
95548,garlic,B-AG.01.h.02.e,3311.0,"In a previous European prospective investigation into cancer and nutrition ( EPIC ) analysis , we found an inverse association between total intake of vegetables , onion and garlic , and risk of intestinal gastric cancer ( GC ) and between citrus fruit and risk of cardia GC ."
95549,",",O,3311.0,"In a previous European prospective investigation into cancer and nutrition ( EPIC ) analysis , we found an inverse association between total intake of vegetables , onion and garlic , and risk of intestinal gastric cancer ( GC ) and between citrus fruit and risk of cardia GC ."
95550,and,O,3311.0,"In a previous European prospective investigation into cancer and nutrition ( EPIC ) analysis , we found an inverse association between total intake of vegetables , onion and garlic , and risk of intestinal gastric cancer ( GC ) and between citrus fruit and risk of cardia GC ."
95551,risk,O,3311.0,"In a previous European prospective investigation into cancer and nutrition ( EPIC ) analysis , we found an inverse association between total intake of vegetables , onion and garlic , and risk of intestinal gastric cancer ( GC ) and between citrus fruit and risk of cardia GC ."
95552,of,O,3311.0,"In a previous European prospective investigation into cancer and nutrition ( EPIC ) analysis , we found an inverse association between total intake of vegetables , onion and garlic , and risk of intestinal gastric cancer ( GC ) and between citrus fruit and risk of cardia GC ."
95553,intestinal,O,3311.0,"In a previous European prospective investigation into cancer and nutrition ( EPIC ) analysis , we found an inverse association between total intake of vegetables , onion and garlic , and risk of intestinal gastric cancer ( GC ) and between citrus fruit and risk of cardia GC ."
95554,gastric,O,3311.0,"In a previous European prospective investigation into cancer and nutrition ( EPIC ) analysis , we found an inverse association between total intake of vegetables , onion and garlic , and risk of intestinal gastric cancer ( GC ) and between citrus fruit and risk of cardia GC ."
95555,cancer,O,3311.0,"In a previous European prospective investigation into cancer and nutrition ( EPIC ) analysis , we found an inverse association between total intake of vegetables , onion and garlic , and risk of intestinal gastric cancer ( GC ) and between citrus fruit and risk of cardia GC ."
95556,(,O,3311.0,"In a previous European prospective investigation into cancer and nutrition ( EPIC ) analysis , we found an inverse association between total intake of vegetables , onion and garlic , and risk of intestinal gastric cancer ( GC ) and between citrus fruit and risk of cardia GC ."
95557,GC,O,3311.0,"In a previous European prospective investigation into cancer and nutrition ( EPIC ) analysis , we found an inverse association between total intake of vegetables , onion and garlic , and risk of intestinal gastric cancer ( GC ) and between citrus fruit and risk of cardia GC ."
95558,),O,3311.0,"In a previous European prospective investigation into cancer and nutrition ( EPIC ) analysis , we found an inverse association between total intake of vegetables , onion and garlic , and risk of intestinal gastric cancer ( GC ) and between citrus fruit and risk of cardia GC ."
95559,and,O,3311.0,"In a previous European prospective investigation into cancer and nutrition ( EPIC ) analysis , we found an inverse association between total intake of vegetables , onion and garlic , and risk of intestinal gastric cancer ( GC ) and between citrus fruit and risk of cardia GC ."
95560,between,O,3311.0,"In a previous European prospective investigation into cancer and nutrition ( EPIC ) analysis , we found an inverse association between total intake of vegetables , onion and garlic , and risk of intestinal gastric cancer ( GC ) and between citrus fruit and risk of cardia GC ."
95561,citrus,B-AG.01.h.01.a,3311.0,"In a previous European prospective investigation into cancer and nutrition ( EPIC ) analysis , we found an inverse association between total intake of vegetables , onion and garlic , and risk of intestinal gastric cancer ( GC ) and between citrus fruit and risk of cardia GC ."
95562,fruit,I-AG.01.h.01.a,3311.0,"In a previous European prospective investigation into cancer and nutrition ( EPIC ) analysis , we found an inverse association between total intake of vegetables , onion and garlic , and risk of intestinal gastric cancer ( GC ) and between citrus fruit and risk of cardia GC ."
95563,and,O,3311.0,"In a previous European prospective investigation into cancer and nutrition ( EPIC ) analysis , we found an inverse association between total intake of vegetables , onion and garlic , and risk of intestinal gastric cancer ( GC ) and between citrus fruit and risk of cardia GC ."
95564,risk,O,3311.0,"In a previous European prospective investigation into cancer and nutrition ( EPIC ) analysis , we found an inverse association between total intake of vegetables , onion and garlic , and risk of intestinal gastric cancer ( GC ) and between citrus fruit and risk of cardia GC ."
95565,of,O,3311.0,"In a previous European prospective investigation into cancer and nutrition ( EPIC ) analysis , we found an inverse association between total intake of vegetables , onion and garlic , and risk of intestinal gastric cancer ( GC ) and between citrus fruit and risk of cardia GC ."
95566,cardia,O,3311.0,"In a previous European prospective investigation into cancer and nutrition ( EPIC ) analysis , we found an inverse association between total intake of vegetables , onion and garlic , and risk of intestinal gastric cancer ( GC ) and between citrus fruit and risk of cardia GC ."
95567,GC,O,3311.0,"In a previous European prospective investigation into cancer and nutrition ( EPIC ) analysis , we found an inverse association between total intake of vegetables , onion and garlic , and risk of intestinal gastric cancer ( GC ) and between citrus fruit and risk of cardia GC ."
95568,.,O,3311.0,"In a previous European prospective investigation into cancer and nutrition ( EPIC ) analysis , we found an inverse association between total intake of vegetables , onion and garlic , and risk of intestinal gastric cancer ( GC ) and between citrus fruit and risk of cardia GC ."
95569,The,O,3312.0,"The aim of this study is to reanalyze the effect of fruit and vegetables ( F&V ) , based on a longer follow - up and twice the number of GC cases ."
95570,aim,O,3312.0,"The aim of this study is to reanalyze the effect of fruit and vegetables ( F&V ) , based on a longer follow - up and twice the number of GC cases ."
95571,of,O,3312.0,"The aim of this study is to reanalyze the effect of fruit and vegetables ( F&V ) , based on a longer follow - up and twice the number of GC cases ."
95572,this,O,3312.0,"The aim of this study is to reanalyze the effect of fruit and vegetables ( F&V ) , based on a longer follow - up and twice the number of GC cases ."
95573,study,O,3312.0,"The aim of this study is to reanalyze the effect of fruit and vegetables ( F&V ) , based on a longer follow - up and twice the number of GC cases ."
95574,is,O,3312.0,"The aim of this study is to reanalyze the effect of fruit and vegetables ( F&V ) , based on a longer follow - up and twice the number of GC cases ."
95575,to,O,3312.0,"The aim of this study is to reanalyze the effect of fruit and vegetables ( F&V ) , based on a longer follow - up and twice the number of GC cases ."
95576,reanalyze,O,3312.0,"The aim of this study is to reanalyze the effect of fruit and vegetables ( F&V ) , based on a longer follow - up and twice the number of GC cases ."
95577,the,O,3312.0,"The aim of this study is to reanalyze the effect of fruit and vegetables ( F&V ) , based on a longer follow - up and twice the number of GC cases ."
95578,effect,O,3312.0,"The aim of this study is to reanalyze the effect of fruit and vegetables ( F&V ) , based on a longer follow - up and twice the number of GC cases ."
95579,of,O,3312.0,"The aim of this study is to reanalyze the effect of fruit and vegetables ( F&V ) , based on a longer follow - up and twice the number of GC cases ."
95580,fruit,B-AG.01.h.01,3312.0,"The aim of this study is to reanalyze the effect of fruit and vegetables ( F&V ) , based on a longer follow - up and twice the number of GC cases ."
95581,and,O,3312.0,"The aim of this study is to reanalyze the effect of fruit and vegetables ( F&V ) , based on a longer follow - up and twice the number of GC cases ."
95582,vegetables,B-AG.01.h.02,3312.0,"The aim of this study is to reanalyze the effect of fruit and vegetables ( F&V ) , based on a longer follow - up and twice the number of GC cases ."
95583,(,O,3312.0,"The aim of this study is to reanalyze the effect of fruit and vegetables ( F&V ) , based on a longer follow - up and twice the number of GC cases ."
95584,F&V,O,3312.0,"The aim of this study is to reanalyze the effect of fruit and vegetables ( F&V ) , based on a longer follow - up and twice the number of GC cases ."
95585,),O,3312.0,"The aim of this study is to reanalyze the effect of fruit and vegetables ( F&V ) , based on a longer follow - up and twice the number of GC cases ."
95586,",",O,3312.0,"The aim of this study is to reanalyze the effect of fruit and vegetables ( F&V ) , based on a longer follow - up and twice the number of GC cases ."
95587,based,O,3312.0,"The aim of this study is to reanalyze the effect of fruit and vegetables ( F&V ) , based on a longer follow - up and twice the number of GC cases ."
95588,on,O,3312.0,"The aim of this study is to reanalyze the effect of fruit and vegetables ( F&V ) , based on a longer follow - up and twice the number of GC cases ."
95589,a,O,3312.0,"The aim of this study is to reanalyze the effect of fruit and vegetables ( F&V ) , based on a longer follow - up and twice the number of GC cases ."
95590,longer,O,3312.0,"The aim of this study is to reanalyze the effect of fruit and vegetables ( F&V ) , based on a longer follow - up and twice the number of GC cases ."
95591,follow,O,3312.0,"The aim of this study is to reanalyze the effect of fruit and vegetables ( F&V ) , based on a longer follow - up and twice the number of GC cases ."
95592,-,O,3312.0,"The aim of this study is to reanalyze the effect of fruit and vegetables ( F&V ) , based on a longer follow - up and twice the number of GC cases ."
95593,up,O,3312.0,"The aim of this study is to reanalyze the effect of fruit and vegetables ( F&V ) , based on a longer follow - up and twice the number of GC cases ."
95594,and,O,3312.0,"The aim of this study is to reanalyze the effect of fruit and vegetables ( F&V ) , based on a longer follow - up and twice the number of GC cases ."
95595,twice,O,3312.0,"The aim of this study is to reanalyze the effect of fruit and vegetables ( F&V ) , based on a longer follow - up and twice the number of GC cases ."
95596,the,O,3312.0,"The aim of this study is to reanalyze the effect of fruit and vegetables ( F&V ) , based on a longer follow - up and twice the number of GC cases ."
95597,number,O,3312.0,"The aim of this study is to reanalyze the effect of fruit and vegetables ( F&V ) , based on a longer follow - up and twice the number of GC cases ."
95598,of,O,3312.0,"The aim of this study is to reanalyze the effect of fruit and vegetables ( F&V ) , based on a longer follow - up and twice the number of GC cases ."
95599,GC,O,3312.0,"The aim of this study is to reanalyze the effect of fruit and vegetables ( F&V ) , based on a longer follow - up and twice the number of GC cases ."
95600,cases,O,3312.0,"The aim of this study is to reanalyze the effect of fruit and vegetables ( F&V ) , based on a longer follow - up and twice the number of GC cases ."
95601,.,O,3312.0,"The aim of this study is to reanalyze the effect of fruit and vegetables ( F&V ) , based on a longer follow - up and twice the number of GC cases ."
95602,Subjects,O,3313.0,"Subjects are 477,312 men and women mostly aged 35 to 70 years participating in the EPIC cohort , including 683 gastric adenocarcinomas with 11 years of follow - up ."
95603,are,O,3313.0,"Subjects are 477,312 men and women mostly aged 35 to 70 years participating in the EPIC cohort , including 683 gastric adenocarcinomas with 11 years of follow - up ."
95604,"477,312",O,3313.0,"Subjects are 477,312 men and women mostly aged 35 to 70 years participating in the EPIC cohort , including 683 gastric adenocarcinomas with 11 years of follow - up ."
95605,men,O,3313.0,"Subjects are 477,312 men and women mostly aged 35 to 70 years participating in the EPIC cohort , including 683 gastric adenocarcinomas with 11 years of follow - up ."
95606,and,O,3313.0,"Subjects are 477,312 men and women mostly aged 35 to 70 years participating in the EPIC cohort , including 683 gastric adenocarcinomas with 11 years of follow - up ."
95607,women,O,3313.0,"Subjects are 477,312 men and women mostly aged 35 to 70 years participating in the EPIC cohort , including 683 gastric adenocarcinomas with 11 years of follow - up ."
95608,mostly,O,3313.0,"Subjects are 477,312 men and women mostly aged 35 to 70 years participating in the EPIC cohort , including 683 gastric adenocarcinomas with 11 years of follow - up ."
95609,aged,O,3313.0,"Subjects are 477,312 men and women mostly aged 35 to 70 years participating in the EPIC cohort , including 683 gastric adenocarcinomas with 11 years of follow - up ."
95610,35,O,3313.0,"Subjects are 477,312 men and women mostly aged 35 to 70 years participating in the EPIC cohort , including 683 gastric adenocarcinomas with 11 years of follow - up ."
95611,to,O,3313.0,"Subjects are 477,312 men and women mostly aged 35 to 70 years participating in the EPIC cohort , including 683 gastric adenocarcinomas with 11 years of follow - up ."
95612,70,O,3313.0,"Subjects are 477,312 men and women mostly aged 35 to 70 years participating in the EPIC cohort , including 683 gastric adenocarcinomas with 11 years of follow - up ."
95613,years,O,3313.0,"Subjects are 477,312 men and women mostly aged 35 to 70 years participating in the EPIC cohort , including 683 gastric adenocarcinomas with 11 years of follow - up ."
95614,participating,O,3313.0,"Subjects are 477,312 men and women mostly aged 35 to 70 years participating in the EPIC cohort , including 683 gastric adenocarcinomas with 11 years of follow - up ."
95615,in,O,3313.0,"Subjects are 477,312 men and women mostly aged 35 to 70 years participating in the EPIC cohort , including 683 gastric adenocarcinomas with 11 years of follow - up ."
95616,the,O,3313.0,"Subjects are 477,312 men and women mostly aged 35 to 70 years participating in the EPIC cohort , including 683 gastric adenocarcinomas with 11 years of follow - up ."
95617,EPIC,O,3313.0,"Subjects are 477,312 men and women mostly aged 35 to 70 years participating in the EPIC cohort , including 683 gastric adenocarcinomas with 11 years of follow - up ."
95618,cohort,O,3313.0,"Subjects are 477,312 men and women mostly aged 35 to 70 years participating in the EPIC cohort , including 683 gastric adenocarcinomas with 11 years of follow - up ."
95619,",",O,3313.0,"Subjects are 477,312 men and women mostly aged 35 to 70 years participating in the EPIC cohort , including 683 gastric adenocarcinomas with 11 years of follow - up ."
95620,including,O,3313.0,"Subjects are 477,312 men and women mostly aged 35 to 70 years participating in the EPIC cohort , including 683 gastric adenocarcinomas with 11 years of follow - up ."
95621,683,O,3313.0,"Subjects are 477,312 men and women mostly aged 35 to 70 years participating in the EPIC cohort , including 683 gastric adenocarcinomas with 11 years of follow - up ."
95622,gastric,O,3313.0,"Subjects are 477,312 men and women mostly aged 35 to 70 years participating in the EPIC cohort , including 683 gastric adenocarcinomas with 11 years of follow - up ."
95623,adenocarcinomas,O,3313.0,"Subjects are 477,312 men and women mostly aged 35 to 70 years participating in the EPIC cohort , including 683 gastric adenocarcinomas with 11 years of follow - up ."
95624,with,O,3313.0,"Subjects are 477,312 men and women mostly aged 35 to 70 years participating in the EPIC cohort , including 683 gastric adenocarcinomas with 11 years of follow - up ."
95625,11,O,3313.0,"Subjects are 477,312 men and women mostly aged 35 to 70 years participating in the EPIC cohort , including 683 gastric adenocarcinomas with 11 years of follow - up ."
95626,years,O,3313.0,"Subjects are 477,312 men and women mostly aged 35 to 70 years participating in the EPIC cohort , including 683 gastric adenocarcinomas with 11 years of follow - up ."
95627,of,O,3313.0,"Subjects are 477,312 men and women mostly aged 35 to 70 years participating in the EPIC cohort , including 683 gastric adenocarcinomas with 11 years of follow - up ."
95628,follow,O,3313.0,"Subjects are 477,312 men and women mostly aged 35 to 70 years participating in the EPIC cohort , including 683 gastric adenocarcinomas with 11 years of follow - up ."
95629,-,O,3313.0,"Subjects are 477,312 men and women mostly aged 35 to 70 years participating in the EPIC cohort , including 683 gastric adenocarcinomas with 11 years of follow - up ."
95630,up,O,3313.0,"Subjects are 477,312 men and women mostly aged 35 to 70 years participating in the EPIC cohort , including 683 gastric adenocarcinomas with 11 years of follow - up ."
95631,.,O,3313.0,"Subjects are 477,312 men and women mostly aged 35 to 70 years participating in the EPIC cohort , including 683 gastric adenocarcinomas with 11 years of follow - up ."
95632,Information,O,3314.0,Information on diet and lifestyle was collected at baseline .
95633,on,O,3314.0,Information on diet and lifestyle was collected at baseline .
95634,diet,O,3314.0,Information on diet and lifestyle was collected at baseline .
95635,and,O,3314.0,Information on diet and lifestyle was collected at baseline .
95636,lifestyle,O,3314.0,Information on diet and lifestyle was collected at baseline .
95637,was,O,3314.0,Information on diet and lifestyle was collected at baseline .
95638,collected,O,3314.0,Information on diet and lifestyle was collected at baseline .
95639,at,O,3314.0,Information on diet and lifestyle was collected at baseline .
95640,baseline,O,3314.0,Information on diet and lifestyle was collected at baseline .
95641,.,O,3314.0,Information on diet and lifestyle was collected at baseline .
95642,A,O,3315.0,A calibration study in a subsample was used to correct for dietary measurement errors .
95643,calibration,O,3315.0,A calibration study in a subsample was used to correct for dietary measurement errors .
95644,study,O,3315.0,A calibration study in a subsample was used to correct for dietary measurement errors .
95645,in,O,3315.0,A calibration study in a subsample was used to correct for dietary measurement errors .
95646,a,O,3315.0,A calibration study in a subsample was used to correct for dietary measurement errors .
95647,subsample,O,3315.0,A calibration study in a subsample was used to correct for dietary measurement errors .
95648,was,O,3315.0,A calibration study in a subsample was used to correct for dietary measurement errors .
95649,used,O,3315.0,A calibration study in a subsample was used to correct for dietary measurement errors .
95650,to,O,3315.0,A calibration study in a subsample was used to correct for dietary measurement errors .
95651,correct,O,3315.0,A calibration study in a subsample was used to correct for dietary measurement errors .
95652,for,O,3315.0,A calibration study in a subsample was used to correct for dietary measurement errors .
95653,dietary,O,3315.0,A calibration study in a subsample was used to correct for dietary measurement errors .
95654,measurement,O,3315.0,A calibration study in a subsample was used to correct for dietary measurement errors .
95655,errors,O,3315.0,A calibration study in a subsample was used to correct for dietary measurement errors .
95656,.,O,3315.0,A calibration study in a subsample was used to correct for dietary measurement errors .
95657,When,O,3316.0,"When comparing the highest vs. lowest quintile of intake , we found an inverse association between total intake of V&F and GC risk [ hazard ratio ( HR ) 0.77 ; 95 % confidence interval ( CI ) 0.57 - 1.04 ; p for trend 0.02 ] , between fresh fruit and risk of the diffuse type ( HR 0.59 ; 95 % CI 0.36 - 0.97 ; p for trend 0.03 ) and an inverse association between citrus fruit and risk of cardia cancer ( HR 0.61 ; 95 % CI 0.38 - 1.00 , p for trend 0.01 ) ."
95658,comparing,O,3316.0,"When comparing the highest vs. lowest quintile of intake , we found an inverse association between total intake of V&F and GC risk [ hazard ratio ( HR ) 0.77 ; 95 % confidence interval ( CI ) 0.57 - 1.04 ; p for trend 0.02 ] , between fresh fruit and risk of the diffuse type ( HR 0.59 ; 95 % CI 0.36 - 0.97 ; p for trend 0.03 ) and an inverse association between citrus fruit and risk of cardia cancer ( HR 0.61 ; 95 % CI 0.38 - 1.00 , p for trend 0.01 ) ."
95659,the,O,3316.0,"When comparing the highest vs. lowest quintile of intake , we found an inverse association between total intake of V&F and GC risk [ hazard ratio ( HR ) 0.77 ; 95 % confidence interval ( CI ) 0.57 - 1.04 ; p for trend 0.02 ] , between fresh fruit and risk of the diffuse type ( HR 0.59 ; 95 % CI 0.36 - 0.97 ; p for trend 0.03 ) and an inverse association between citrus fruit and risk of cardia cancer ( HR 0.61 ; 95 % CI 0.38 - 1.00 , p for trend 0.01 ) ."
95660,highest,O,3316.0,"When comparing the highest vs. lowest quintile of intake , we found an inverse association between total intake of V&F and GC risk [ hazard ratio ( HR ) 0.77 ; 95 % confidence interval ( CI ) 0.57 - 1.04 ; p for trend 0.02 ] , between fresh fruit and risk of the diffuse type ( HR 0.59 ; 95 % CI 0.36 - 0.97 ; p for trend 0.03 ) and an inverse association between citrus fruit and risk of cardia cancer ( HR 0.61 ; 95 % CI 0.38 - 1.00 , p for trend 0.01 ) ."
95661,vs.,O,3316.0,"When comparing the highest vs. lowest quintile of intake , we found an inverse association between total intake of V&F and GC risk [ hazard ratio ( HR ) 0.77 ; 95 % confidence interval ( CI ) 0.57 - 1.04 ; p for trend 0.02 ] , between fresh fruit and risk of the diffuse type ( HR 0.59 ; 95 % CI 0.36 - 0.97 ; p for trend 0.03 ) and an inverse association between citrus fruit and risk of cardia cancer ( HR 0.61 ; 95 % CI 0.38 - 1.00 , p for trend 0.01 ) ."
95662,lowest,O,3316.0,"When comparing the highest vs. lowest quintile of intake , we found an inverse association between total intake of V&F and GC risk [ hazard ratio ( HR ) 0.77 ; 95 % confidence interval ( CI ) 0.57 - 1.04 ; p for trend 0.02 ] , between fresh fruit and risk of the diffuse type ( HR 0.59 ; 95 % CI 0.36 - 0.97 ; p for trend 0.03 ) and an inverse association between citrus fruit and risk of cardia cancer ( HR 0.61 ; 95 % CI 0.38 - 1.00 , p for trend 0.01 ) ."
95663,quintile,O,3316.0,"When comparing the highest vs. lowest quintile of intake , we found an inverse association between total intake of V&F and GC risk [ hazard ratio ( HR ) 0.77 ; 95 % confidence interval ( CI ) 0.57 - 1.04 ; p for trend 0.02 ] , between fresh fruit and risk of the diffuse type ( HR 0.59 ; 95 % CI 0.36 - 0.97 ; p for trend 0.03 ) and an inverse association between citrus fruit and risk of cardia cancer ( HR 0.61 ; 95 % CI 0.38 - 1.00 , p for trend 0.01 ) ."
95664,of,O,3316.0,"When comparing the highest vs. lowest quintile of intake , we found an inverse association between total intake of V&F and GC risk [ hazard ratio ( HR ) 0.77 ; 95 % confidence interval ( CI ) 0.57 - 1.04 ; p for trend 0.02 ] , between fresh fruit and risk of the diffuse type ( HR 0.59 ; 95 % CI 0.36 - 0.97 ; p for trend 0.03 ) and an inverse association between citrus fruit and risk of cardia cancer ( HR 0.61 ; 95 % CI 0.38 - 1.00 , p for trend 0.01 ) ."
95665,intake,O,3316.0,"When comparing the highest vs. lowest quintile of intake , we found an inverse association between total intake of V&F and GC risk [ hazard ratio ( HR ) 0.77 ; 95 % confidence interval ( CI ) 0.57 - 1.04 ; p for trend 0.02 ] , between fresh fruit and risk of the diffuse type ( HR 0.59 ; 95 % CI 0.36 - 0.97 ; p for trend 0.03 ) and an inverse association between citrus fruit and risk of cardia cancer ( HR 0.61 ; 95 % CI 0.38 - 1.00 , p for trend 0.01 ) ."
95666,",",O,3316.0,"When comparing the highest vs. lowest quintile of intake , we found an inverse association between total intake of V&F and GC risk [ hazard ratio ( HR ) 0.77 ; 95 % confidence interval ( CI ) 0.57 - 1.04 ; p for trend 0.02 ] , between fresh fruit and risk of the diffuse type ( HR 0.59 ; 95 % CI 0.36 - 0.97 ; p for trend 0.03 ) and an inverse association between citrus fruit and risk of cardia cancer ( HR 0.61 ; 95 % CI 0.38 - 1.00 , p for trend 0.01 ) ."
95667,we,O,3316.0,"When comparing the highest vs. lowest quintile of intake , we found an inverse association between total intake of V&F and GC risk [ hazard ratio ( HR ) 0.77 ; 95 % confidence interval ( CI ) 0.57 - 1.04 ; p for trend 0.02 ] , between fresh fruit and risk of the diffuse type ( HR 0.59 ; 95 % CI 0.36 - 0.97 ; p for trend 0.03 ) and an inverse association between citrus fruit and risk of cardia cancer ( HR 0.61 ; 95 % CI 0.38 - 1.00 , p for trend 0.01 ) ."
95668,found,O,3316.0,"When comparing the highest vs. lowest quintile of intake , we found an inverse association between total intake of V&F and GC risk [ hazard ratio ( HR ) 0.77 ; 95 % confidence interval ( CI ) 0.57 - 1.04 ; p for trend 0.02 ] , between fresh fruit and risk of the diffuse type ( HR 0.59 ; 95 % CI 0.36 - 0.97 ; p for trend 0.03 ) and an inverse association between citrus fruit and risk of cardia cancer ( HR 0.61 ; 95 % CI 0.38 - 1.00 , p for trend 0.01 ) ."
95669,an,O,3316.0,"When comparing the highest vs. lowest quintile of intake , we found an inverse association between total intake of V&F and GC risk [ hazard ratio ( HR ) 0.77 ; 95 % confidence interval ( CI ) 0.57 - 1.04 ; p for trend 0.02 ] , between fresh fruit and risk of the diffuse type ( HR 0.59 ; 95 % CI 0.36 - 0.97 ; p for trend 0.03 ) and an inverse association between citrus fruit and risk of cardia cancer ( HR 0.61 ; 95 % CI 0.38 - 1.00 , p for trend 0.01 ) ."
95670,inverse,O,3316.0,"When comparing the highest vs. lowest quintile of intake , we found an inverse association between total intake of V&F and GC risk [ hazard ratio ( HR ) 0.77 ; 95 % confidence interval ( CI ) 0.57 - 1.04 ; p for trend 0.02 ] , between fresh fruit and risk of the diffuse type ( HR 0.59 ; 95 % CI 0.36 - 0.97 ; p for trend 0.03 ) and an inverse association between citrus fruit and risk of cardia cancer ( HR 0.61 ; 95 % CI 0.38 - 1.00 , p for trend 0.01 ) ."
95671,association,O,3316.0,"When comparing the highest vs. lowest quintile of intake , we found an inverse association between total intake of V&F and GC risk [ hazard ratio ( HR ) 0.77 ; 95 % confidence interval ( CI ) 0.57 - 1.04 ; p for trend 0.02 ] , between fresh fruit and risk of the diffuse type ( HR 0.59 ; 95 % CI 0.36 - 0.97 ; p for trend 0.03 ) and an inverse association between citrus fruit and risk of cardia cancer ( HR 0.61 ; 95 % CI 0.38 - 1.00 , p for trend 0.01 ) ."
95672,between,O,3316.0,"When comparing the highest vs. lowest quintile of intake , we found an inverse association between total intake of V&F and GC risk [ hazard ratio ( HR ) 0.77 ; 95 % confidence interval ( CI ) 0.57 - 1.04 ; p for trend 0.02 ] , between fresh fruit and risk of the diffuse type ( HR 0.59 ; 95 % CI 0.36 - 0.97 ; p for trend 0.03 ) and an inverse association between citrus fruit and risk of cardia cancer ( HR 0.61 ; 95 % CI 0.38 - 1.00 , p for trend 0.01 ) ."
95673,total,O,3316.0,"When comparing the highest vs. lowest quintile of intake , we found an inverse association between total intake of V&F and GC risk [ hazard ratio ( HR ) 0.77 ; 95 % confidence interval ( CI ) 0.57 - 1.04 ; p for trend 0.02 ] , between fresh fruit and risk of the diffuse type ( HR 0.59 ; 95 % CI 0.36 - 0.97 ; p for trend 0.03 ) and an inverse association between citrus fruit and risk of cardia cancer ( HR 0.61 ; 95 % CI 0.38 - 1.00 , p for trend 0.01 ) ."
95674,intake,O,3316.0,"When comparing the highest vs. lowest quintile of intake , we found an inverse association between total intake of V&F and GC risk [ hazard ratio ( HR ) 0.77 ; 95 % confidence interval ( CI ) 0.57 - 1.04 ; p for trend 0.02 ] , between fresh fruit and risk of the diffuse type ( HR 0.59 ; 95 % CI 0.36 - 0.97 ; p for trend 0.03 ) and an inverse association between citrus fruit and risk of cardia cancer ( HR 0.61 ; 95 % CI 0.38 - 1.00 , p for trend 0.01 ) ."
95675,of,O,3316.0,"When comparing the highest vs. lowest quintile of intake , we found an inverse association between total intake of V&F and GC risk [ hazard ratio ( HR ) 0.77 ; 95 % confidence interval ( CI ) 0.57 - 1.04 ; p for trend 0.02 ] , between fresh fruit and risk of the diffuse type ( HR 0.59 ; 95 % CI 0.36 - 0.97 ; p for trend 0.03 ) and an inverse association between citrus fruit and risk of cardia cancer ( HR 0.61 ; 95 % CI 0.38 - 1.00 , p for trend 0.01 ) ."
95676,V&F,O,3316.0,"When comparing the highest vs. lowest quintile of intake , we found an inverse association between total intake of V&F and GC risk [ hazard ratio ( HR ) 0.77 ; 95 % confidence interval ( CI ) 0.57 - 1.04 ; p for trend 0.02 ] , between fresh fruit and risk of the diffuse type ( HR 0.59 ; 95 % CI 0.36 - 0.97 ; p for trend 0.03 ) and an inverse association between citrus fruit and risk of cardia cancer ( HR 0.61 ; 95 % CI 0.38 - 1.00 , p for trend 0.01 ) ."
95677,and,O,3316.0,"When comparing the highest vs. lowest quintile of intake , we found an inverse association between total intake of V&F and GC risk [ hazard ratio ( HR ) 0.77 ; 95 % confidence interval ( CI ) 0.57 - 1.04 ; p for trend 0.02 ] , between fresh fruit and risk of the diffuse type ( HR 0.59 ; 95 % CI 0.36 - 0.97 ; p for trend 0.03 ) and an inverse association between citrus fruit and risk of cardia cancer ( HR 0.61 ; 95 % CI 0.38 - 1.00 , p for trend 0.01 ) ."
95678,GC,O,3316.0,"When comparing the highest vs. lowest quintile of intake , we found an inverse association between total intake of V&F and GC risk [ hazard ratio ( HR ) 0.77 ; 95 % confidence interval ( CI ) 0.57 - 1.04 ; p for trend 0.02 ] , between fresh fruit and risk of the diffuse type ( HR 0.59 ; 95 % CI 0.36 - 0.97 ; p for trend 0.03 ) and an inverse association between citrus fruit and risk of cardia cancer ( HR 0.61 ; 95 % CI 0.38 - 1.00 , p for trend 0.01 ) ."
95679,risk,O,3316.0,"When comparing the highest vs. lowest quintile of intake , we found an inverse association between total intake of V&F and GC risk [ hazard ratio ( HR ) 0.77 ; 95 % confidence interval ( CI ) 0.57 - 1.04 ; p for trend 0.02 ] , between fresh fruit and risk of the diffuse type ( HR 0.59 ; 95 % CI 0.36 - 0.97 ; p for trend 0.03 ) and an inverse association between citrus fruit and risk of cardia cancer ( HR 0.61 ; 95 % CI 0.38 - 1.00 , p for trend 0.01 ) ."
95680,[,O,3316.0,"When comparing the highest vs. lowest quintile of intake , we found an inverse association between total intake of V&F and GC risk [ hazard ratio ( HR ) 0.77 ; 95 % confidence interval ( CI ) 0.57 - 1.04 ; p for trend 0.02 ] , between fresh fruit and risk of the diffuse type ( HR 0.59 ; 95 % CI 0.36 - 0.97 ; p for trend 0.03 ) and an inverse association between citrus fruit and risk of cardia cancer ( HR 0.61 ; 95 % CI 0.38 - 1.00 , p for trend 0.01 ) ."
95681,hazard,O,3316.0,"When comparing the highest vs. lowest quintile of intake , we found an inverse association between total intake of V&F and GC risk [ hazard ratio ( HR ) 0.77 ; 95 % confidence interval ( CI ) 0.57 - 1.04 ; p for trend 0.02 ] , between fresh fruit and risk of the diffuse type ( HR 0.59 ; 95 % CI 0.36 - 0.97 ; p for trend 0.03 ) and an inverse association between citrus fruit and risk of cardia cancer ( HR 0.61 ; 95 % CI 0.38 - 1.00 , p for trend 0.01 ) ."
95682,ratio,O,3316.0,"When comparing the highest vs. lowest quintile of intake , we found an inverse association between total intake of V&F and GC risk [ hazard ratio ( HR ) 0.77 ; 95 % confidence interval ( CI ) 0.57 - 1.04 ; p for trend 0.02 ] , between fresh fruit and risk of the diffuse type ( HR 0.59 ; 95 % CI 0.36 - 0.97 ; p for trend 0.03 ) and an inverse association between citrus fruit and risk of cardia cancer ( HR 0.61 ; 95 % CI 0.38 - 1.00 , p for trend 0.01 ) ."
95683,(,O,3316.0,"When comparing the highest vs. lowest quintile of intake , we found an inverse association between total intake of V&F and GC risk [ hazard ratio ( HR ) 0.77 ; 95 % confidence interval ( CI ) 0.57 - 1.04 ; p for trend 0.02 ] , between fresh fruit and risk of the diffuse type ( HR 0.59 ; 95 % CI 0.36 - 0.97 ; p for trend 0.03 ) and an inverse association between citrus fruit and risk of cardia cancer ( HR 0.61 ; 95 % CI 0.38 - 1.00 , p for trend 0.01 ) ."
95684,HR,O,3316.0,"When comparing the highest vs. lowest quintile of intake , we found an inverse association between total intake of V&F and GC risk [ hazard ratio ( HR ) 0.77 ; 95 % confidence interval ( CI ) 0.57 - 1.04 ; p for trend 0.02 ] , between fresh fruit and risk of the diffuse type ( HR 0.59 ; 95 % CI 0.36 - 0.97 ; p for trend 0.03 ) and an inverse association between citrus fruit and risk of cardia cancer ( HR 0.61 ; 95 % CI 0.38 - 1.00 , p for trend 0.01 ) ."
95685,),O,3316.0,"When comparing the highest vs. lowest quintile of intake , we found an inverse association between total intake of V&F and GC risk [ hazard ratio ( HR ) 0.77 ; 95 % confidence interval ( CI ) 0.57 - 1.04 ; p for trend 0.02 ] , between fresh fruit and risk of the diffuse type ( HR 0.59 ; 95 % CI 0.36 - 0.97 ; p for trend 0.03 ) and an inverse association between citrus fruit and risk of cardia cancer ( HR 0.61 ; 95 % CI 0.38 - 1.00 , p for trend 0.01 ) ."
95686,0.77,O,3316.0,"When comparing the highest vs. lowest quintile of intake , we found an inverse association between total intake of V&F and GC risk [ hazard ratio ( HR ) 0.77 ; 95 % confidence interval ( CI ) 0.57 - 1.04 ; p for trend 0.02 ] , between fresh fruit and risk of the diffuse type ( HR 0.59 ; 95 % CI 0.36 - 0.97 ; p for trend 0.03 ) and an inverse association between citrus fruit and risk of cardia cancer ( HR 0.61 ; 95 % CI 0.38 - 1.00 , p for trend 0.01 ) ."
95687,;,O,3316.0,"When comparing the highest vs. lowest quintile of intake , we found an inverse association between total intake of V&F and GC risk [ hazard ratio ( HR ) 0.77 ; 95 % confidence interval ( CI ) 0.57 - 1.04 ; p for trend 0.02 ] , between fresh fruit and risk of the diffuse type ( HR 0.59 ; 95 % CI 0.36 - 0.97 ; p for trend 0.03 ) and an inverse association between citrus fruit and risk of cardia cancer ( HR 0.61 ; 95 % CI 0.38 - 1.00 , p for trend 0.01 ) ."
95688,95,O,3316.0,"When comparing the highest vs. lowest quintile of intake , we found an inverse association between total intake of V&F and GC risk [ hazard ratio ( HR ) 0.77 ; 95 % confidence interval ( CI ) 0.57 - 1.04 ; p for trend 0.02 ] , between fresh fruit and risk of the diffuse type ( HR 0.59 ; 95 % CI 0.36 - 0.97 ; p for trend 0.03 ) and an inverse association between citrus fruit and risk of cardia cancer ( HR 0.61 ; 95 % CI 0.38 - 1.00 , p for trend 0.01 ) ."
95689,%,O,3316.0,"When comparing the highest vs. lowest quintile of intake , we found an inverse association between total intake of V&F and GC risk [ hazard ratio ( HR ) 0.77 ; 95 % confidence interval ( CI ) 0.57 - 1.04 ; p for trend 0.02 ] , between fresh fruit and risk of the diffuse type ( HR 0.59 ; 95 % CI 0.36 - 0.97 ; p for trend 0.03 ) and an inverse association between citrus fruit and risk of cardia cancer ( HR 0.61 ; 95 % CI 0.38 - 1.00 , p for trend 0.01 ) ."
95690,confidence,O,3316.0,"When comparing the highest vs. lowest quintile of intake , we found an inverse association between total intake of V&F and GC risk [ hazard ratio ( HR ) 0.77 ; 95 % confidence interval ( CI ) 0.57 - 1.04 ; p for trend 0.02 ] , between fresh fruit and risk of the diffuse type ( HR 0.59 ; 95 % CI 0.36 - 0.97 ; p for trend 0.03 ) and an inverse association between citrus fruit and risk of cardia cancer ( HR 0.61 ; 95 % CI 0.38 - 1.00 , p for trend 0.01 ) ."
95691,interval,O,3316.0,"When comparing the highest vs. lowest quintile of intake , we found an inverse association between total intake of V&F and GC risk [ hazard ratio ( HR ) 0.77 ; 95 % confidence interval ( CI ) 0.57 - 1.04 ; p for trend 0.02 ] , between fresh fruit and risk of the diffuse type ( HR 0.59 ; 95 % CI 0.36 - 0.97 ; p for trend 0.03 ) and an inverse association between citrus fruit and risk of cardia cancer ( HR 0.61 ; 95 % CI 0.38 - 1.00 , p for trend 0.01 ) ."
95692,(,O,3316.0,"When comparing the highest vs. lowest quintile of intake , we found an inverse association between total intake of V&F and GC risk [ hazard ratio ( HR ) 0.77 ; 95 % confidence interval ( CI ) 0.57 - 1.04 ; p for trend 0.02 ] , between fresh fruit and risk of the diffuse type ( HR 0.59 ; 95 % CI 0.36 - 0.97 ; p for trend 0.03 ) and an inverse association between citrus fruit and risk of cardia cancer ( HR 0.61 ; 95 % CI 0.38 - 1.00 , p for trend 0.01 ) ."
95693,CI,O,3316.0,"When comparing the highest vs. lowest quintile of intake , we found an inverse association between total intake of V&F and GC risk [ hazard ratio ( HR ) 0.77 ; 95 % confidence interval ( CI ) 0.57 - 1.04 ; p for trend 0.02 ] , between fresh fruit and risk of the diffuse type ( HR 0.59 ; 95 % CI 0.36 - 0.97 ; p for trend 0.03 ) and an inverse association between citrus fruit and risk of cardia cancer ( HR 0.61 ; 95 % CI 0.38 - 1.00 , p for trend 0.01 ) ."
95694,),O,3316.0,"When comparing the highest vs. lowest quintile of intake , we found an inverse association between total intake of V&F and GC risk [ hazard ratio ( HR ) 0.77 ; 95 % confidence interval ( CI ) 0.57 - 1.04 ; p for trend 0.02 ] , between fresh fruit and risk of the diffuse type ( HR 0.59 ; 95 % CI 0.36 - 0.97 ; p for trend 0.03 ) and an inverse association between citrus fruit and risk of cardia cancer ( HR 0.61 ; 95 % CI 0.38 - 1.00 , p for trend 0.01 ) ."
95695,0.57,O,3316.0,"When comparing the highest vs. lowest quintile of intake , we found an inverse association between total intake of V&F and GC risk [ hazard ratio ( HR ) 0.77 ; 95 % confidence interval ( CI ) 0.57 - 1.04 ; p for trend 0.02 ] , between fresh fruit and risk of the diffuse type ( HR 0.59 ; 95 % CI 0.36 - 0.97 ; p for trend 0.03 ) and an inverse association between citrus fruit and risk of cardia cancer ( HR 0.61 ; 95 % CI 0.38 - 1.00 , p for trend 0.01 ) ."
95696,-,O,3316.0,"When comparing the highest vs. lowest quintile of intake , we found an inverse association between total intake of V&F and GC risk [ hazard ratio ( HR ) 0.77 ; 95 % confidence interval ( CI ) 0.57 - 1.04 ; p for trend 0.02 ] , between fresh fruit and risk of the diffuse type ( HR 0.59 ; 95 % CI 0.36 - 0.97 ; p for trend 0.03 ) and an inverse association between citrus fruit and risk of cardia cancer ( HR 0.61 ; 95 % CI 0.38 - 1.00 , p for trend 0.01 ) ."
95697,1.04,O,3316.0,"When comparing the highest vs. lowest quintile of intake , we found an inverse association between total intake of V&F and GC risk [ hazard ratio ( HR ) 0.77 ; 95 % confidence interval ( CI ) 0.57 - 1.04 ; p for trend 0.02 ] , between fresh fruit and risk of the diffuse type ( HR 0.59 ; 95 % CI 0.36 - 0.97 ; p for trend 0.03 ) and an inverse association between citrus fruit and risk of cardia cancer ( HR 0.61 ; 95 % CI 0.38 - 1.00 , p for trend 0.01 ) ."
95698,;,O,3316.0,"When comparing the highest vs. lowest quintile of intake , we found an inverse association between total intake of V&F and GC risk [ hazard ratio ( HR ) 0.77 ; 95 % confidence interval ( CI ) 0.57 - 1.04 ; p for trend 0.02 ] , between fresh fruit and risk of the diffuse type ( HR 0.59 ; 95 % CI 0.36 - 0.97 ; p for trend 0.03 ) and an inverse association between citrus fruit and risk of cardia cancer ( HR 0.61 ; 95 % CI 0.38 - 1.00 , p for trend 0.01 ) ."
95699,p,O,3316.0,"When comparing the highest vs. lowest quintile of intake , we found an inverse association between total intake of V&F and GC risk [ hazard ratio ( HR ) 0.77 ; 95 % confidence interval ( CI ) 0.57 - 1.04 ; p for trend 0.02 ] , between fresh fruit and risk of the diffuse type ( HR 0.59 ; 95 % CI 0.36 - 0.97 ; p for trend 0.03 ) and an inverse association between citrus fruit and risk of cardia cancer ( HR 0.61 ; 95 % CI 0.38 - 1.00 , p for trend 0.01 ) ."
95700,for,O,3316.0,"When comparing the highest vs. lowest quintile of intake , we found an inverse association between total intake of V&F and GC risk [ hazard ratio ( HR ) 0.77 ; 95 % confidence interval ( CI ) 0.57 - 1.04 ; p for trend 0.02 ] , between fresh fruit and risk of the diffuse type ( HR 0.59 ; 95 % CI 0.36 - 0.97 ; p for trend 0.03 ) and an inverse association between citrus fruit and risk of cardia cancer ( HR 0.61 ; 95 % CI 0.38 - 1.00 , p for trend 0.01 ) ."
95701,trend,O,3316.0,"When comparing the highest vs. lowest quintile of intake , we found an inverse association between total intake of V&F and GC risk [ hazard ratio ( HR ) 0.77 ; 95 % confidence interval ( CI ) 0.57 - 1.04 ; p for trend 0.02 ] , between fresh fruit and risk of the diffuse type ( HR 0.59 ; 95 % CI 0.36 - 0.97 ; p for trend 0.03 ) and an inverse association between citrus fruit and risk of cardia cancer ( HR 0.61 ; 95 % CI 0.38 - 1.00 , p for trend 0.01 ) ."
95702,0.02,O,3316.0,"When comparing the highest vs. lowest quintile of intake , we found an inverse association between total intake of V&F and GC risk [ hazard ratio ( HR ) 0.77 ; 95 % confidence interval ( CI ) 0.57 - 1.04 ; p for trend 0.02 ] , between fresh fruit and risk of the diffuse type ( HR 0.59 ; 95 % CI 0.36 - 0.97 ; p for trend 0.03 ) and an inverse association between citrus fruit and risk of cardia cancer ( HR 0.61 ; 95 % CI 0.38 - 1.00 , p for trend 0.01 ) ."
95703,],O,3316.0,"When comparing the highest vs. lowest quintile of intake , we found an inverse association between total intake of V&F and GC risk [ hazard ratio ( HR ) 0.77 ; 95 % confidence interval ( CI ) 0.57 - 1.04 ; p for trend 0.02 ] , between fresh fruit and risk of the diffuse type ( HR 0.59 ; 95 % CI 0.36 - 0.97 ; p for trend 0.03 ) and an inverse association between citrus fruit and risk of cardia cancer ( HR 0.61 ; 95 % CI 0.38 - 1.00 , p for trend 0.01 ) ."
95704,",",O,3316.0,"When comparing the highest vs. lowest quintile of intake , we found an inverse association between total intake of V&F and GC risk [ hazard ratio ( HR ) 0.77 ; 95 % confidence interval ( CI ) 0.57 - 1.04 ; p for trend 0.02 ] , between fresh fruit and risk of the diffuse type ( HR 0.59 ; 95 % CI 0.36 - 0.97 ; p for trend 0.03 ) and an inverse association between citrus fruit and risk of cardia cancer ( HR 0.61 ; 95 % CI 0.38 - 1.00 , p for trend 0.01 ) ."
95705,between,O,3316.0,"When comparing the highest vs. lowest quintile of intake , we found an inverse association between total intake of V&F and GC risk [ hazard ratio ( HR ) 0.77 ; 95 % confidence interval ( CI ) 0.57 - 1.04 ; p for trend 0.02 ] , between fresh fruit and risk of the diffuse type ( HR 0.59 ; 95 % CI 0.36 - 0.97 ; p for trend 0.03 ) and an inverse association between citrus fruit and risk of cardia cancer ( HR 0.61 ; 95 % CI 0.38 - 1.00 , p for trend 0.01 ) ."
95706,fresh,O,3316.0,"When comparing the highest vs. lowest quintile of intake , we found an inverse association between total intake of V&F and GC risk [ hazard ratio ( HR ) 0.77 ; 95 % confidence interval ( CI ) 0.57 - 1.04 ; p for trend 0.02 ] , between fresh fruit and risk of the diffuse type ( HR 0.59 ; 95 % CI 0.36 - 0.97 ; p for trend 0.03 ) and an inverse association between citrus fruit and risk of cardia cancer ( HR 0.61 ; 95 % CI 0.38 - 1.00 , p for trend 0.01 ) ."
95707,fruit,B-AG.01.h.01,3316.0,"When comparing the highest vs. lowest quintile of intake , we found an inverse association between total intake of V&F and GC risk [ hazard ratio ( HR ) 0.77 ; 95 % confidence interval ( CI ) 0.57 - 1.04 ; p for trend 0.02 ] , between fresh fruit and risk of the diffuse type ( HR 0.59 ; 95 % CI 0.36 - 0.97 ; p for trend 0.03 ) and an inverse association between citrus fruit and risk of cardia cancer ( HR 0.61 ; 95 % CI 0.38 - 1.00 , p for trend 0.01 ) ."
95708,and,O,3316.0,"When comparing the highest vs. lowest quintile of intake , we found an inverse association between total intake of V&F and GC risk [ hazard ratio ( HR ) 0.77 ; 95 % confidence interval ( CI ) 0.57 - 1.04 ; p for trend 0.02 ] , between fresh fruit and risk of the diffuse type ( HR 0.59 ; 95 % CI 0.36 - 0.97 ; p for trend 0.03 ) and an inverse association between citrus fruit and risk of cardia cancer ( HR 0.61 ; 95 % CI 0.38 - 1.00 , p for trend 0.01 ) ."
95709,risk,O,3316.0,"When comparing the highest vs. lowest quintile of intake , we found an inverse association between total intake of V&F and GC risk [ hazard ratio ( HR ) 0.77 ; 95 % confidence interval ( CI ) 0.57 - 1.04 ; p for trend 0.02 ] , between fresh fruit and risk of the diffuse type ( HR 0.59 ; 95 % CI 0.36 - 0.97 ; p for trend 0.03 ) and an inverse association between citrus fruit and risk of cardia cancer ( HR 0.61 ; 95 % CI 0.38 - 1.00 , p for trend 0.01 ) ."
95710,of,O,3316.0,"When comparing the highest vs. lowest quintile of intake , we found an inverse association between total intake of V&F and GC risk [ hazard ratio ( HR ) 0.77 ; 95 % confidence interval ( CI ) 0.57 - 1.04 ; p for trend 0.02 ] , between fresh fruit and risk of the diffuse type ( HR 0.59 ; 95 % CI 0.36 - 0.97 ; p for trend 0.03 ) and an inverse association between citrus fruit and risk of cardia cancer ( HR 0.61 ; 95 % CI 0.38 - 1.00 , p for trend 0.01 ) ."
95711,the,O,3316.0,"When comparing the highest vs. lowest quintile of intake , we found an inverse association between total intake of V&F and GC risk [ hazard ratio ( HR ) 0.77 ; 95 % confidence interval ( CI ) 0.57 - 1.04 ; p for trend 0.02 ] , between fresh fruit and risk of the diffuse type ( HR 0.59 ; 95 % CI 0.36 - 0.97 ; p for trend 0.03 ) and an inverse association between citrus fruit and risk of cardia cancer ( HR 0.61 ; 95 % CI 0.38 - 1.00 , p for trend 0.01 ) ."
95712,diffuse,O,3316.0,"When comparing the highest vs. lowest quintile of intake , we found an inverse association between total intake of V&F and GC risk [ hazard ratio ( HR ) 0.77 ; 95 % confidence interval ( CI ) 0.57 - 1.04 ; p for trend 0.02 ] , between fresh fruit and risk of the diffuse type ( HR 0.59 ; 95 % CI 0.36 - 0.97 ; p for trend 0.03 ) and an inverse association between citrus fruit and risk of cardia cancer ( HR 0.61 ; 95 % CI 0.38 - 1.00 , p for trend 0.01 ) ."
95713,type,O,3316.0,"When comparing the highest vs. lowest quintile of intake , we found an inverse association between total intake of V&F and GC risk [ hazard ratio ( HR ) 0.77 ; 95 % confidence interval ( CI ) 0.57 - 1.04 ; p for trend 0.02 ] , between fresh fruit and risk of the diffuse type ( HR 0.59 ; 95 % CI 0.36 - 0.97 ; p for trend 0.03 ) and an inverse association between citrus fruit and risk of cardia cancer ( HR 0.61 ; 95 % CI 0.38 - 1.00 , p for trend 0.01 ) ."
95714,(,O,3316.0,"When comparing the highest vs. lowest quintile of intake , we found an inverse association between total intake of V&F and GC risk [ hazard ratio ( HR ) 0.77 ; 95 % confidence interval ( CI ) 0.57 - 1.04 ; p for trend 0.02 ] , between fresh fruit and risk of the diffuse type ( HR 0.59 ; 95 % CI 0.36 - 0.97 ; p for trend 0.03 ) and an inverse association between citrus fruit and risk of cardia cancer ( HR 0.61 ; 95 % CI 0.38 - 1.00 , p for trend 0.01 ) ."
95715,HR,O,3316.0,"When comparing the highest vs. lowest quintile of intake , we found an inverse association between total intake of V&F and GC risk [ hazard ratio ( HR ) 0.77 ; 95 % confidence interval ( CI ) 0.57 - 1.04 ; p for trend 0.02 ] , between fresh fruit and risk of the diffuse type ( HR 0.59 ; 95 % CI 0.36 - 0.97 ; p for trend 0.03 ) and an inverse association between citrus fruit and risk of cardia cancer ( HR 0.61 ; 95 % CI 0.38 - 1.00 , p for trend 0.01 ) ."
95716,0.59,O,3316.0,"When comparing the highest vs. lowest quintile of intake , we found an inverse association between total intake of V&F and GC risk [ hazard ratio ( HR ) 0.77 ; 95 % confidence interval ( CI ) 0.57 - 1.04 ; p for trend 0.02 ] , between fresh fruit and risk of the diffuse type ( HR 0.59 ; 95 % CI 0.36 - 0.97 ; p for trend 0.03 ) and an inverse association between citrus fruit and risk of cardia cancer ( HR 0.61 ; 95 % CI 0.38 - 1.00 , p for trend 0.01 ) ."
95717,;,O,3316.0,"When comparing the highest vs. lowest quintile of intake , we found an inverse association between total intake of V&F and GC risk [ hazard ratio ( HR ) 0.77 ; 95 % confidence interval ( CI ) 0.57 - 1.04 ; p for trend 0.02 ] , between fresh fruit and risk of the diffuse type ( HR 0.59 ; 95 % CI 0.36 - 0.97 ; p for trend 0.03 ) and an inverse association between citrus fruit and risk of cardia cancer ( HR 0.61 ; 95 % CI 0.38 - 1.00 , p for trend 0.01 ) ."
95718,95,O,3316.0,"When comparing the highest vs. lowest quintile of intake , we found an inverse association between total intake of V&F and GC risk [ hazard ratio ( HR ) 0.77 ; 95 % confidence interval ( CI ) 0.57 - 1.04 ; p for trend 0.02 ] , between fresh fruit and risk of the diffuse type ( HR 0.59 ; 95 % CI 0.36 - 0.97 ; p for trend 0.03 ) and an inverse association between citrus fruit and risk of cardia cancer ( HR 0.61 ; 95 % CI 0.38 - 1.00 , p for trend 0.01 ) ."
95719,%,O,3316.0,"When comparing the highest vs. lowest quintile of intake , we found an inverse association between total intake of V&F and GC risk [ hazard ratio ( HR ) 0.77 ; 95 % confidence interval ( CI ) 0.57 - 1.04 ; p for trend 0.02 ] , between fresh fruit and risk of the diffuse type ( HR 0.59 ; 95 % CI 0.36 - 0.97 ; p for trend 0.03 ) and an inverse association between citrus fruit and risk of cardia cancer ( HR 0.61 ; 95 % CI 0.38 - 1.00 , p for trend 0.01 ) ."
95720,CI,O,3316.0,"When comparing the highest vs. lowest quintile of intake , we found an inverse association between total intake of V&F and GC risk [ hazard ratio ( HR ) 0.77 ; 95 % confidence interval ( CI ) 0.57 - 1.04 ; p for trend 0.02 ] , between fresh fruit and risk of the diffuse type ( HR 0.59 ; 95 % CI 0.36 - 0.97 ; p for trend 0.03 ) and an inverse association between citrus fruit and risk of cardia cancer ( HR 0.61 ; 95 % CI 0.38 - 1.00 , p for trend 0.01 ) ."
95721,0.36,O,3316.0,"When comparing the highest vs. lowest quintile of intake , we found an inverse association between total intake of V&F and GC risk [ hazard ratio ( HR ) 0.77 ; 95 % confidence interval ( CI ) 0.57 - 1.04 ; p for trend 0.02 ] , between fresh fruit and risk of the diffuse type ( HR 0.59 ; 95 % CI 0.36 - 0.97 ; p for trend 0.03 ) and an inverse association between citrus fruit and risk of cardia cancer ( HR 0.61 ; 95 % CI 0.38 - 1.00 , p for trend 0.01 ) ."
95722,-,O,3316.0,"When comparing the highest vs. lowest quintile of intake , we found an inverse association between total intake of V&F and GC risk [ hazard ratio ( HR ) 0.77 ; 95 % confidence interval ( CI ) 0.57 - 1.04 ; p for trend 0.02 ] , between fresh fruit and risk of the diffuse type ( HR 0.59 ; 95 % CI 0.36 - 0.97 ; p for trend 0.03 ) and an inverse association between citrus fruit and risk of cardia cancer ( HR 0.61 ; 95 % CI 0.38 - 1.00 , p for trend 0.01 ) ."
95723,0.97,O,3316.0,"When comparing the highest vs. lowest quintile of intake , we found an inverse association between total intake of V&F and GC risk [ hazard ratio ( HR ) 0.77 ; 95 % confidence interval ( CI ) 0.57 - 1.04 ; p for trend 0.02 ] , between fresh fruit and risk of the diffuse type ( HR 0.59 ; 95 % CI 0.36 - 0.97 ; p for trend 0.03 ) and an inverse association between citrus fruit and risk of cardia cancer ( HR 0.61 ; 95 % CI 0.38 - 1.00 , p for trend 0.01 ) ."
95724,;,O,3316.0,"When comparing the highest vs. lowest quintile of intake , we found an inverse association between total intake of V&F and GC risk [ hazard ratio ( HR ) 0.77 ; 95 % confidence interval ( CI ) 0.57 - 1.04 ; p for trend 0.02 ] , between fresh fruit and risk of the diffuse type ( HR 0.59 ; 95 % CI 0.36 - 0.97 ; p for trend 0.03 ) and an inverse association between citrus fruit and risk of cardia cancer ( HR 0.61 ; 95 % CI 0.38 - 1.00 , p for trend 0.01 ) ."
95725,p,O,3316.0,"When comparing the highest vs. lowest quintile of intake , we found an inverse association between total intake of V&F and GC risk [ hazard ratio ( HR ) 0.77 ; 95 % confidence interval ( CI ) 0.57 - 1.04 ; p for trend 0.02 ] , between fresh fruit and risk of the diffuse type ( HR 0.59 ; 95 % CI 0.36 - 0.97 ; p for trend 0.03 ) and an inverse association between citrus fruit and risk of cardia cancer ( HR 0.61 ; 95 % CI 0.38 - 1.00 , p for trend 0.01 ) ."
95726,for,O,3316.0,"When comparing the highest vs. lowest quintile of intake , we found an inverse association between total intake of V&F and GC risk [ hazard ratio ( HR ) 0.77 ; 95 % confidence interval ( CI ) 0.57 - 1.04 ; p for trend 0.02 ] , between fresh fruit and risk of the diffuse type ( HR 0.59 ; 95 % CI 0.36 - 0.97 ; p for trend 0.03 ) and an inverse association between citrus fruit and risk of cardia cancer ( HR 0.61 ; 95 % CI 0.38 - 1.00 , p for trend 0.01 ) ."
95727,trend,O,3316.0,"When comparing the highest vs. lowest quintile of intake , we found an inverse association between total intake of V&F and GC risk [ hazard ratio ( HR ) 0.77 ; 95 % confidence interval ( CI ) 0.57 - 1.04 ; p for trend 0.02 ] , between fresh fruit and risk of the diffuse type ( HR 0.59 ; 95 % CI 0.36 - 0.97 ; p for trend 0.03 ) and an inverse association between citrus fruit and risk of cardia cancer ( HR 0.61 ; 95 % CI 0.38 - 1.00 , p for trend 0.01 ) ."
95728,0.03,O,3316.0,"When comparing the highest vs. lowest quintile of intake , we found an inverse association between total intake of V&F and GC risk [ hazard ratio ( HR ) 0.77 ; 95 % confidence interval ( CI ) 0.57 - 1.04 ; p for trend 0.02 ] , between fresh fruit and risk of the diffuse type ( HR 0.59 ; 95 % CI 0.36 - 0.97 ; p for trend 0.03 ) and an inverse association between citrus fruit and risk of cardia cancer ( HR 0.61 ; 95 % CI 0.38 - 1.00 , p for trend 0.01 ) ."
95729,),O,3316.0,"When comparing the highest vs. lowest quintile of intake , we found an inverse association between total intake of V&F and GC risk [ hazard ratio ( HR ) 0.77 ; 95 % confidence interval ( CI ) 0.57 - 1.04 ; p for trend 0.02 ] , between fresh fruit and risk of the diffuse type ( HR 0.59 ; 95 % CI 0.36 - 0.97 ; p for trend 0.03 ) and an inverse association between citrus fruit and risk of cardia cancer ( HR 0.61 ; 95 % CI 0.38 - 1.00 , p for trend 0.01 ) ."
95730,and,O,3316.0,"When comparing the highest vs. lowest quintile of intake , we found an inverse association between total intake of V&F and GC risk [ hazard ratio ( HR ) 0.77 ; 95 % confidence interval ( CI ) 0.57 - 1.04 ; p for trend 0.02 ] , between fresh fruit and risk of the diffuse type ( HR 0.59 ; 95 % CI 0.36 - 0.97 ; p for trend 0.03 ) and an inverse association between citrus fruit and risk of cardia cancer ( HR 0.61 ; 95 % CI 0.38 - 1.00 , p for trend 0.01 ) ."
95731,an,O,3316.0,"When comparing the highest vs. lowest quintile of intake , we found an inverse association between total intake of V&F and GC risk [ hazard ratio ( HR ) 0.77 ; 95 % confidence interval ( CI ) 0.57 - 1.04 ; p for trend 0.02 ] , between fresh fruit and risk of the diffuse type ( HR 0.59 ; 95 % CI 0.36 - 0.97 ; p for trend 0.03 ) and an inverse association between citrus fruit and risk of cardia cancer ( HR 0.61 ; 95 % CI 0.38 - 1.00 , p for trend 0.01 ) ."
95732,inverse,O,3316.0,"When comparing the highest vs. lowest quintile of intake , we found an inverse association between total intake of V&F and GC risk [ hazard ratio ( HR ) 0.77 ; 95 % confidence interval ( CI ) 0.57 - 1.04 ; p for trend 0.02 ] , between fresh fruit and risk of the diffuse type ( HR 0.59 ; 95 % CI 0.36 - 0.97 ; p for trend 0.03 ) and an inverse association between citrus fruit and risk of cardia cancer ( HR 0.61 ; 95 % CI 0.38 - 1.00 , p for trend 0.01 ) ."
95733,association,O,3316.0,"When comparing the highest vs. lowest quintile of intake , we found an inverse association between total intake of V&F and GC risk [ hazard ratio ( HR ) 0.77 ; 95 % confidence interval ( CI ) 0.57 - 1.04 ; p for trend 0.02 ] , between fresh fruit and risk of the diffuse type ( HR 0.59 ; 95 % CI 0.36 - 0.97 ; p for trend 0.03 ) and an inverse association between citrus fruit and risk of cardia cancer ( HR 0.61 ; 95 % CI 0.38 - 1.00 , p for trend 0.01 ) ."
95734,between,O,3316.0,"When comparing the highest vs. lowest quintile of intake , we found an inverse association between total intake of V&F and GC risk [ hazard ratio ( HR ) 0.77 ; 95 % confidence interval ( CI ) 0.57 - 1.04 ; p for trend 0.02 ] , between fresh fruit and risk of the diffuse type ( HR 0.59 ; 95 % CI 0.36 - 0.97 ; p for trend 0.03 ) and an inverse association between citrus fruit and risk of cardia cancer ( HR 0.61 ; 95 % CI 0.38 - 1.00 , p for trend 0.01 ) ."
95735,citrus,B-AG.01.h.01.a,3316.0,"When comparing the highest vs. lowest quintile of intake , we found an inverse association between total intake of V&F and GC risk [ hazard ratio ( HR ) 0.77 ; 95 % confidence interval ( CI ) 0.57 - 1.04 ; p for trend 0.02 ] , between fresh fruit and risk of the diffuse type ( HR 0.59 ; 95 % CI 0.36 - 0.97 ; p for trend 0.03 ) and an inverse association between citrus fruit and risk of cardia cancer ( HR 0.61 ; 95 % CI 0.38 - 1.00 , p for trend 0.01 ) ."
95736,fruit,I-AG.01.h.01.a,3316.0,"When comparing the highest vs. lowest quintile of intake , we found an inverse association between total intake of V&F and GC risk [ hazard ratio ( HR ) 0.77 ; 95 % confidence interval ( CI ) 0.57 - 1.04 ; p for trend 0.02 ] , between fresh fruit and risk of the diffuse type ( HR 0.59 ; 95 % CI 0.36 - 0.97 ; p for trend 0.03 ) and an inverse association between citrus fruit and risk of cardia cancer ( HR 0.61 ; 95 % CI 0.38 - 1.00 , p for trend 0.01 ) ."
95737,and,O,3316.0,"When comparing the highest vs. lowest quintile of intake , we found an inverse association between total intake of V&F and GC risk [ hazard ratio ( HR ) 0.77 ; 95 % confidence interval ( CI ) 0.57 - 1.04 ; p for trend 0.02 ] , between fresh fruit and risk of the diffuse type ( HR 0.59 ; 95 % CI 0.36 - 0.97 ; p for trend 0.03 ) and an inverse association between citrus fruit and risk of cardia cancer ( HR 0.61 ; 95 % CI 0.38 - 1.00 , p for trend 0.01 ) ."
95738,risk,O,3316.0,"When comparing the highest vs. lowest quintile of intake , we found an inverse association between total intake of V&F and GC risk [ hazard ratio ( HR ) 0.77 ; 95 % confidence interval ( CI ) 0.57 - 1.04 ; p for trend 0.02 ] , between fresh fruit and risk of the diffuse type ( HR 0.59 ; 95 % CI 0.36 - 0.97 ; p for trend 0.03 ) and an inverse association between citrus fruit and risk of cardia cancer ( HR 0.61 ; 95 % CI 0.38 - 1.00 , p for trend 0.01 ) ."
95739,of,O,3316.0,"When comparing the highest vs. lowest quintile of intake , we found an inverse association between total intake of V&F and GC risk [ hazard ratio ( HR ) 0.77 ; 95 % confidence interval ( CI ) 0.57 - 1.04 ; p for trend 0.02 ] , between fresh fruit and risk of the diffuse type ( HR 0.59 ; 95 % CI 0.36 - 0.97 ; p for trend 0.03 ) and an inverse association between citrus fruit and risk of cardia cancer ( HR 0.61 ; 95 % CI 0.38 - 1.00 , p for trend 0.01 ) ."
95740,cardia,O,3316.0,"When comparing the highest vs. lowest quintile of intake , we found an inverse association between total intake of V&F and GC risk [ hazard ratio ( HR ) 0.77 ; 95 % confidence interval ( CI ) 0.57 - 1.04 ; p for trend 0.02 ] , between fresh fruit and risk of the diffuse type ( HR 0.59 ; 95 % CI 0.36 - 0.97 ; p for trend 0.03 ) and an inverse association between citrus fruit and risk of cardia cancer ( HR 0.61 ; 95 % CI 0.38 - 1.00 , p for trend 0.01 ) ."
95741,cancer,O,3316.0,"When comparing the highest vs. lowest quintile of intake , we found an inverse association between total intake of V&F and GC risk [ hazard ratio ( HR ) 0.77 ; 95 % confidence interval ( CI ) 0.57 - 1.04 ; p for trend 0.02 ] , between fresh fruit and risk of the diffuse type ( HR 0.59 ; 95 % CI 0.36 - 0.97 ; p for trend 0.03 ) and an inverse association between citrus fruit and risk of cardia cancer ( HR 0.61 ; 95 % CI 0.38 - 1.00 , p for trend 0.01 ) ."
95742,(,O,3316.0,"When comparing the highest vs. lowest quintile of intake , we found an inverse association between total intake of V&F and GC risk [ hazard ratio ( HR ) 0.77 ; 95 % confidence interval ( CI ) 0.57 - 1.04 ; p for trend 0.02 ] , between fresh fruit and risk of the diffuse type ( HR 0.59 ; 95 % CI 0.36 - 0.97 ; p for trend 0.03 ) and an inverse association between citrus fruit and risk of cardia cancer ( HR 0.61 ; 95 % CI 0.38 - 1.00 , p for trend 0.01 ) ."
95743,HR,O,3316.0,"When comparing the highest vs. lowest quintile of intake , we found an inverse association between total intake of V&F and GC risk [ hazard ratio ( HR ) 0.77 ; 95 % confidence interval ( CI ) 0.57 - 1.04 ; p for trend 0.02 ] , between fresh fruit and risk of the diffuse type ( HR 0.59 ; 95 % CI 0.36 - 0.97 ; p for trend 0.03 ) and an inverse association between citrus fruit and risk of cardia cancer ( HR 0.61 ; 95 % CI 0.38 - 1.00 , p for trend 0.01 ) ."
95744,0.61,O,3316.0,"When comparing the highest vs. lowest quintile of intake , we found an inverse association between total intake of V&F and GC risk [ hazard ratio ( HR ) 0.77 ; 95 % confidence interval ( CI ) 0.57 - 1.04 ; p for trend 0.02 ] , between fresh fruit and risk of the diffuse type ( HR 0.59 ; 95 % CI 0.36 - 0.97 ; p for trend 0.03 ) and an inverse association between citrus fruit and risk of cardia cancer ( HR 0.61 ; 95 % CI 0.38 - 1.00 , p for trend 0.01 ) ."
95745,;,O,3316.0,"When comparing the highest vs. lowest quintile of intake , we found an inverse association between total intake of V&F and GC risk [ hazard ratio ( HR ) 0.77 ; 95 % confidence interval ( CI ) 0.57 - 1.04 ; p for trend 0.02 ] , between fresh fruit and risk of the diffuse type ( HR 0.59 ; 95 % CI 0.36 - 0.97 ; p for trend 0.03 ) and an inverse association between citrus fruit and risk of cardia cancer ( HR 0.61 ; 95 % CI 0.38 - 1.00 , p for trend 0.01 ) ."
95746,95,O,3316.0,"When comparing the highest vs. lowest quintile of intake , we found an inverse association between total intake of V&F and GC risk [ hazard ratio ( HR ) 0.77 ; 95 % confidence interval ( CI ) 0.57 - 1.04 ; p for trend 0.02 ] , between fresh fruit and risk of the diffuse type ( HR 0.59 ; 95 % CI 0.36 - 0.97 ; p for trend 0.03 ) and an inverse association between citrus fruit and risk of cardia cancer ( HR 0.61 ; 95 % CI 0.38 - 1.00 , p for trend 0.01 ) ."
95747,%,O,3316.0,"When comparing the highest vs. lowest quintile of intake , we found an inverse association between total intake of V&F and GC risk [ hazard ratio ( HR ) 0.77 ; 95 % confidence interval ( CI ) 0.57 - 1.04 ; p for trend 0.02 ] , between fresh fruit and risk of the diffuse type ( HR 0.59 ; 95 % CI 0.36 - 0.97 ; p for trend 0.03 ) and an inverse association between citrus fruit and risk of cardia cancer ( HR 0.61 ; 95 % CI 0.38 - 1.00 , p for trend 0.01 ) ."
95748,CI,O,3316.0,"When comparing the highest vs. lowest quintile of intake , we found an inverse association between total intake of V&F and GC risk [ hazard ratio ( HR ) 0.77 ; 95 % confidence interval ( CI ) 0.57 - 1.04 ; p for trend 0.02 ] , between fresh fruit and risk of the diffuse type ( HR 0.59 ; 95 % CI 0.36 - 0.97 ; p for trend 0.03 ) and an inverse association between citrus fruit and risk of cardia cancer ( HR 0.61 ; 95 % CI 0.38 - 1.00 , p for trend 0.01 ) ."
95749,0.38,O,3316.0,"When comparing the highest vs. lowest quintile of intake , we found an inverse association between total intake of V&F and GC risk [ hazard ratio ( HR ) 0.77 ; 95 % confidence interval ( CI ) 0.57 - 1.04 ; p for trend 0.02 ] , between fresh fruit and risk of the diffuse type ( HR 0.59 ; 95 % CI 0.36 - 0.97 ; p for trend 0.03 ) and an inverse association between citrus fruit and risk of cardia cancer ( HR 0.61 ; 95 % CI 0.38 - 1.00 , p for trend 0.01 ) ."
95750,-,O,3316.0,"When comparing the highest vs. lowest quintile of intake , we found an inverse association between total intake of V&F and GC risk [ hazard ratio ( HR ) 0.77 ; 95 % confidence interval ( CI ) 0.57 - 1.04 ; p for trend 0.02 ] , between fresh fruit and risk of the diffuse type ( HR 0.59 ; 95 % CI 0.36 - 0.97 ; p for trend 0.03 ) and an inverse association between citrus fruit and risk of cardia cancer ( HR 0.61 ; 95 % CI 0.38 - 1.00 , p for trend 0.01 ) ."
95751,1.00,O,3316.0,"When comparing the highest vs. lowest quintile of intake , we found an inverse association between total intake of V&F and GC risk [ hazard ratio ( HR ) 0.77 ; 95 % confidence interval ( CI ) 0.57 - 1.04 ; p for trend 0.02 ] , between fresh fruit and risk of the diffuse type ( HR 0.59 ; 95 % CI 0.36 - 0.97 ; p for trend 0.03 ) and an inverse association between citrus fruit and risk of cardia cancer ( HR 0.61 ; 95 % CI 0.38 - 1.00 , p for trend 0.01 ) ."
95752,",",O,3316.0,"When comparing the highest vs. lowest quintile of intake , we found an inverse association between total intake of V&F and GC risk [ hazard ratio ( HR ) 0.77 ; 95 % confidence interval ( CI ) 0.57 - 1.04 ; p for trend 0.02 ] , between fresh fruit and risk of the diffuse type ( HR 0.59 ; 95 % CI 0.36 - 0.97 ; p for trend 0.03 ) and an inverse association between citrus fruit and risk of cardia cancer ( HR 0.61 ; 95 % CI 0.38 - 1.00 , p for trend 0.01 ) ."
95753,p,O,3316.0,"When comparing the highest vs. lowest quintile of intake , we found an inverse association between total intake of V&F and GC risk [ hazard ratio ( HR ) 0.77 ; 95 % confidence interval ( CI ) 0.57 - 1.04 ; p for trend 0.02 ] , between fresh fruit and risk of the diffuse type ( HR 0.59 ; 95 % CI 0.36 - 0.97 ; p for trend 0.03 ) and an inverse association between citrus fruit and risk of cardia cancer ( HR 0.61 ; 95 % CI 0.38 - 1.00 , p for trend 0.01 ) ."
95754,for,O,3316.0,"When comparing the highest vs. lowest quintile of intake , we found an inverse association between total intake of V&F and GC risk [ hazard ratio ( HR ) 0.77 ; 95 % confidence interval ( CI ) 0.57 - 1.04 ; p for trend 0.02 ] , between fresh fruit and risk of the diffuse type ( HR 0.59 ; 95 % CI 0.36 - 0.97 ; p for trend 0.03 ) and an inverse association between citrus fruit and risk of cardia cancer ( HR 0.61 ; 95 % CI 0.38 - 1.00 , p for trend 0.01 ) ."
95755,trend,O,3316.0,"When comparing the highest vs. lowest quintile of intake , we found an inverse association between total intake of V&F and GC risk [ hazard ratio ( HR ) 0.77 ; 95 % confidence interval ( CI ) 0.57 - 1.04 ; p for trend 0.02 ] , between fresh fruit and risk of the diffuse type ( HR 0.59 ; 95 % CI 0.36 - 0.97 ; p for trend 0.03 ) and an inverse association between citrus fruit and risk of cardia cancer ( HR 0.61 ; 95 % CI 0.38 - 1.00 , p for trend 0.01 ) ."
95756,0.01,O,3316.0,"When comparing the highest vs. lowest quintile of intake , we found an inverse association between total intake of V&F and GC risk [ hazard ratio ( HR ) 0.77 ; 95 % confidence interval ( CI ) 0.57 - 1.04 ; p for trend 0.02 ] , between fresh fruit and risk of the diffuse type ( HR 0.59 ; 95 % CI 0.36 - 0.97 ; p for trend 0.03 ) and an inverse association between citrus fruit and risk of cardia cancer ( HR 0.61 ; 95 % CI 0.38 - 1.00 , p for trend 0.01 ) ."
95757,),O,3316.0,"When comparing the highest vs. lowest quintile of intake , we found an inverse association between total intake of V&F and GC risk [ hazard ratio ( HR ) 0.77 ; 95 % confidence interval ( CI ) 0.57 - 1.04 ; p for trend 0.02 ] , between fresh fruit and risk of the diffuse type ( HR 0.59 ; 95 % CI 0.36 - 0.97 ; p for trend 0.03 ) and an inverse association between citrus fruit and risk of cardia cancer ( HR 0.61 ; 95 % CI 0.38 - 1.00 , p for trend 0.01 ) ."
95758,.,O,3316.0,"When comparing the highest vs. lowest quintile of intake , we found an inverse association between total intake of V&F and GC risk [ hazard ratio ( HR ) 0.77 ; 95 % confidence interval ( CI ) 0.57 - 1.04 ; p for trend 0.02 ] , between fresh fruit and risk of the diffuse type ( HR 0.59 ; 95 % CI 0.36 - 0.97 ; p for trend 0.03 ) and an inverse association between citrus fruit and risk of cardia cancer ( HR 0.61 ; 95 % CI 0.38 - 1.00 , p for trend 0.01 ) ."
95759,Although,O,3317.0,"Although calibration revealed somewhat stronger inverse associations , none of the risks reached statistical significance ."
95760,calibration,O,3317.0,"Although calibration revealed somewhat stronger inverse associations , none of the risks reached statistical significance ."
95761,revealed,O,3317.0,"Although calibration revealed somewhat stronger inverse associations , none of the risks reached statistical significance ."
95762,somewhat,O,3317.0,"Although calibration revealed somewhat stronger inverse associations , none of the risks reached statistical significance ."
95763,stronger,O,3317.0,"Although calibration revealed somewhat stronger inverse associations , none of the risks reached statistical significance ."
95764,inverse,O,3317.0,"Although calibration revealed somewhat stronger inverse associations , none of the risks reached statistical significance ."
95765,associations,O,3317.0,"Although calibration revealed somewhat stronger inverse associations , none of the risks reached statistical significance ."
95766,",",O,3317.0,"Although calibration revealed somewhat stronger inverse associations , none of the risks reached statistical significance ."
95767,none,O,3317.0,"Although calibration revealed somewhat stronger inverse associations , none of the risks reached statistical significance ."
95768,of,O,3317.0,"Although calibration revealed somewhat stronger inverse associations , none of the risks reached statistical significance ."
95769,the,O,3317.0,"Although calibration revealed somewhat stronger inverse associations , none of the risks reached statistical significance ."
95770,risks,O,3317.0,"Although calibration revealed somewhat stronger inverse associations , none of the risks reached statistical significance ."
95771,reached,O,3317.0,"Although calibration revealed somewhat stronger inverse associations , none of the risks reached statistical significance ."
95772,statistical,O,3317.0,"Although calibration revealed somewhat stronger inverse associations , none of the risks reached statistical significance ."
95773,significance,O,3317.0,"Although calibration revealed somewhat stronger inverse associations , none of the risks reached statistical significance ."
95774,.,O,3317.0,"Although calibration revealed somewhat stronger inverse associations , none of the risks reached statistical significance ."
95775,There,O,3318.0,There was no association between total or specific vegetables intake and GC risk .
95776,was,O,3318.0,There was no association between total or specific vegetables intake and GC risk .
95777,no,O,3318.0,There was no association between total or specific vegetables intake and GC risk .
95778,association,O,3318.0,There was no association between total or specific vegetables intake and GC risk .
95779,between,O,3318.0,There was no association between total or specific vegetables intake and GC risk .
95780,total,O,3318.0,There was no association between total or specific vegetables intake and GC risk .
95781,or,O,3318.0,There was no association between total or specific vegetables intake and GC risk .
95782,specific,O,3318.0,There was no association between total or specific vegetables intake and GC risk .
95783,vegetables,B-AG.01.h.02,3318.0,There was no association between total or specific vegetables intake and GC risk .
95784,intake,B-X,3318.0,There was no association between total or specific vegetables intake and GC risk .
95785,and,O,3318.0,There was no association between total or specific vegetables intake and GC risk .
95786,GC,O,3318.0,There was no association between total or specific vegetables intake and GC risk .
95787,risk,O,3318.0,There was no association between total or specific vegetables intake and GC risk .
95788,.,O,3318.0,There was no association between total or specific vegetables intake and GC risk .
95789,The,O,3319.0,The inverse association between fresh fruit and citrus fruits and risk of GC seems to be restricted to smokers and the Northern European countries .
95790,inverse,O,3319.0,The inverse association between fresh fruit and citrus fruits and risk of GC seems to be restricted to smokers and the Northern European countries .
95791,association,O,3319.0,The inverse association between fresh fruit and citrus fruits and risk of GC seems to be restricted to smokers and the Northern European countries .
95792,between,O,3319.0,The inverse association between fresh fruit and citrus fruits and risk of GC seems to be restricted to smokers and the Northern European countries .
95793,fresh,O,3319.0,The inverse association between fresh fruit and citrus fruits and risk of GC seems to be restricted to smokers and the Northern European countries .
95794,fruit,B-AG.01.h.01,3319.0,The inverse association between fresh fruit and citrus fruits and risk of GC seems to be restricted to smokers and the Northern European countries .
95795,and,O,3319.0,The inverse association between fresh fruit and citrus fruits and risk of GC seems to be restricted to smokers and the Northern European countries .
95796,citrus,B-AG.01.h.01.a,3319.0,The inverse association between fresh fruit and citrus fruits and risk of GC seems to be restricted to smokers and the Northern European countries .
95797,fruits,I-AG.01.h.01.a,3319.0,The inverse association between fresh fruit and citrus fruits and risk of GC seems to be restricted to smokers and the Northern European countries .
95798,and,O,3319.0,The inverse association between fresh fruit and citrus fruits and risk of GC seems to be restricted to smokers and the Northern European countries .
95799,risk,O,3319.0,The inverse association between fresh fruit and citrus fruits and risk of GC seems to be restricted to smokers and the Northern European countries .
95800,of,O,3319.0,The inverse association between fresh fruit and citrus fruits and risk of GC seems to be restricted to smokers and the Northern European countries .
95801,GC,O,3319.0,The inverse association between fresh fruit and citrus fruits and risk of GC seems to be restricted to smokers and the Northern European countries .
95802,seems,O,3319.0,The inverse association between fresh fruit and citrus fruits and risk of GC seems to be restricted to smokers and the Northern European countries .
95803,to,O,3319.0,The inverse association between fresh fruit and citrus fruits and risk of GC seems to be restricted to smokers and the Northern European countries .
95804,be,O,3319.0,The inverse association between fresh fruit and citrus fruits and risk of GC seems to be restricted to smokers and the Northern European countries .
95805,restricted,O,3319.0,The inverse association between fresh fruit and citrus fruits and risk of GC seems to be restricted to smokers and the Northern European countries .
95806,to,O,3319.0,The inverse association between fresh fruit and citrus fruits and risk of GC seems to be restricted to smokers and the Northern European countries .
95807,smokers,O,3319.0,The inverse association between fresh fruit and citrus fruits and risk of GC seems to be restricted to smokers and the Northern European countries .
95808,and,O,3319.0,The inverse association between fresh fruit and citrus fruits and risk of GC seems to be restricted to smokers and the Northern European countries .
95809,the,O,3319.0,The inverse association between fresh fruit and citrus fruits and risk of GC seems to be restricted to smokers and the Northern European countries .
95810,Northern,O,3319.0,The inverse association between fresh fruit and citrus fruits and risk of GC seems to be restricted to smokers and the Northern European countries .
95811,European,O,3319.0,The inverse association between fresh fruit and citrus fruits and risk of GC seems to be restricted to smokers and the Northern European countries .
95812,countries,O,3319.0,The inverse association between fresh fruit and citrus fruits and risk of GC seems to be restricted to smokers and the Northern European countries .
95813,.,O,3319.0,The inverse association between fresh fruit and citrus fruits and risk of GC seems to be restricted to smokers and the Northern European countries .
95814,Fresh,O,3320.0,"Fresh fruit and citrus fruit consumption may protect against diffuse and cardia GC , respectively ."
95815,fruit,B-AG.01.h.01,3320.0,"Fresh fruit and citrus fruit consumption may protect against diffuse and cardia GC , respectively ."
95816,and,O,3320.0,"Fresh fruit and citrus fruit consumption may protect against diffuse and cardia GC , respectively ."
95817,citrus,B-AG.01.h.01.a,3320.0,"Fresh fruit and citrus fruit consumption may protect against diffuse and cardia GC , respectively ."
95818,fruit,I-AG.01.h.01.a,3320.0,"Fresh fruit and citrus fruit consumption may protect against diffuse and cardia GC , respectively ."
95819,consumption,B-X,3320.0,"Fresh fruit and citrus fruit consumption may protect against diffuse and cardia GC , respectively ."
95820,may,O,3320.0,"Fresh fruit and citrus fruit consumption may protect against diffuse and cardia GC , respectively ."
95821,protect,O,3320.0,"Fresh fruit and citrus fruit consumption may protect against diffuse and cardia GC , respectively ."
95822,against,O,3320.0,"Fresh fruit and citrus fruit consumption may protect against diffuse and cardia GC , respectively ."
95823,diffuse,O,3320.0,"Fresh fruit and citrus fruit consumption may protect against diffuse and cardia GC , respectively ."
95824,and,O,3320.0,"Fresh fruit and citrus fruit consumption may protect against diffuse and cardia GC , respectively ."
95825,cardia,O,3320.0,"Fresh fruit and citrus fruit consumption may protect against diffuse and cardia GC , respectively ."
95826,GC,O,3320.0,"Fresh fruit and citrus fruit consumption may protect against diffuse and cardia GC , respectively ."
95827,",",O,3320.0,"Fresh fruit and citrus fruit consumption may protect against diffuse and cardia GC , respectively ."
95828,respectively,O,3320.0,"Fresh fruit and citrus fruit consumption may protect against diffuse and cardia GC , respectively ."
95829,.,O,3320.0,"Fresh fruit and citrus fruit consumption may protect against diffuse and cardia GC , respectively ."
95830,Gluten,O,3321.0,"Gluten proteins in wheat , rye and barley cause celiac disease , an autoimmune disorder of the small intestine , which affects approximately 1 % of the world population ."
95831,proteins,O,3321.0,"Gluten proteins in wheat , rye and barley cause celiac disease , an autoimmune disorder of the small intestine , which affects approximately 1 % of the world population ."
95832,in,O,3321.0,"Gluten proteins in wheat , rye and barley cause celiac disease , an autoimmune disorder of the small intestine , which affects approximately 1 % of the world population ."
95833,wheat,B-AG.01.i,3321.0,"Gluten proteins in wheat , rye and barley cause celiac disease , an autoimmune disorder of the small intestine , which affects approximately 1 % of the world population ."
95834,",",O,3321.0,"Gluten proteins in wheat , rye and barley cause celiac disease , an autoimmune disorder of the small intestine , which affects approximately 1 % of the world population ."
95835,rye,B-AG.01.i,3321.0,"Gluten proteins in wheat , rye and barley cause celiac disease , an autoimmune disorder of the small intestine , which affects approximately 1 % of the world population ."
95836,and,O,3321.0,"Gluten proteins in wheat , rye and barley cause celiac disease , an autoimmune disorder of the small intestine , which affects approximately 1 % of the world population ."
95837,barley,B-AG.01.i,3321.0,"Gluten proteins in wheat , rye and barley cause celiac disease , an autoimmune disorder of the small intestine , which affects approximately 1 % of the world population ."
95838,cause,O,3321.0,"Gluten proteins in wheat , rye and barley cause celiac disease , an autoimmune disorder of the small intestine , which affects approximately 1 % of the world population ."
95839,celiac,O,3321.0,"Gluten proteins in wheat , rye and barley cause celiac disease , an autoimmune disorder of the small intestine , which affects approximately 1 % of the world population ."
95840,disease,O,3321.0,"Gluten proteins in wheat , rye and barley cause celiac disease , an autoimmune disorder of the small intestine , which affects approximately 1 % of the world population ."
95841,",",O,3321.0,"Gluten proteins in wheat , rye and barley cause celiac disease , an autoimmune disorder of the small intestine , which affects approximately 1 % of the world population ."
95842,an,O,3321.0,"Gluten proteins in wheat , rye and barley cause celiac disease , an autoimmune disorder of the small intestine , which affects approximately 1 % of the world population ."
95843,autoimmune,O,3321.0,"Gluten proteins in wheat , rye and barley cause celiac disease , an autoimmune disorder of the small intestine , which affects approximately 1 % of the world population ."
95844,disorder,O,3321.0,"Gluten proteins in wheat , rye and barley cause celiac disease , an autoimmune disorder of the small intestine , which affects approximately 1 % of the world population ."
95845,of,O,3321.0,"Gluten proteins in wheat , rye and barley cause celiac disease , an autoimmune disorder of the small intestine , which affects approximately 1 % of the world population ."
95846,the,O,3321.0,"Gluten proteins in wheat , rye and barley cause celiac disease , an autoimmune disorder of the small intestine , which affects approximately 1 % of the world population ."
95847,small,O,3321.0,"Gluten proteins in wheat , rye and barley cause celiac disease , an autoimmune disorder of the small intestine , which affects approximately 1 % of the world population ."
95848,intestine,O,3321.0,"Gluten proteins in wheat , rye and barley cause celiac disease , an autoimmune disorder of the small intestine , which affects approximately 1 % of the world population ."
95849,",",O,3321.0,"Gluten proteins in wheat , rye and barley cause celiac disease , an autoimmune disorder of the small intestine , which affects approximately 1 % of the world population ."
95850,which,O,3321.0,"Gluten proteins in wheat , rye and barley cause celiac disease , an autoimmune disorder of the small intestine , which affects approximately 1 % of the world population ."
95851,affects,O,3321.0,"Gluten proteins in wheat , rye and barley cause celiac disease , an autoimmune disorder of the small intestine , which affects approximately 1 % of the world population ."
95852,approximately,O,3321.0,"Gluten proteins in wheat , rye and barley cause celiac disease , an autoimmune disorder of the small intestine , which affects approximately 1 % of the world population ."
95853,1,O,3321.0,"Gluten proteins in wheat , rye and barley cause celiac disease , an autoimmune disorder of the small intestine , which affects approximately 1 % of the world population ."
95854,%,O,3321.0,"Gluten proteins in wheat , rye and barley cause celiac disease , an autoimmune disorder of the small intestine , which affects approximately 1 % of the world population ."
95855,of,O,3321.0,"Gluten proteins in wheat , rye and barley cause celiac disease , an autoimmune disorder of the small intestine , which affects approximately 1 % of the world population ."
95856,the,O,3321.0,"Gluten proteins in wheat , rye and barley cause celiac disease , an autoimmune disorder of the small intestine , which affects approximately 1 % of the world population ."
95857,world,O,3321.0,"Gluten proteins in wheat , rye and barley cause celiac disease , an autoimmune disorder of the small intestine , which affects approximately 1 % of the world population ."
95858,population,O,3321.0,"Gluten proteins in wheat , rye and barley cause celiac disease , an autoimmune disorder of the small intestine , which affects approximately 1 % of the world population ."
95859,.,O,3321.0,"Gluten proteins in wheat , rye and barley cause celiac disease , an autoimmune disorder of the small intestine , which affects approximately 1 % of the world population ."
95860,Gluten,O,3322.0,Gluten is comprised of prolamin and glutelin .
95861,is,O,3322.0,Gluten is comprised of prolamin and glutelin .
95862,comprised,O,3322.0,Gluten is comprised of prolamin and glutelin .
95863,of,O,3322.0,Gluten is comprised of prolamin and glutelin .
95864,prolamin,O,3322.0,Gluten is comprised of prolamin and glutelin .
95865,and,O,3322.0,Gluten is comprised of prolamin and glutelin .
95866,glutelin,O,3322.0,Gluten is comprised of prolamin and glutelin .
95867,.,O,3322.0,Gluten is comprised of prolamin and glutelin .
95868,Since,O,3323.0,"Since avoidance of dietary gluten is the only option for celiac patients , a sensitive gluten detection and quantitation method is warranted ."
95869,avoidance,O,3323.0,"Since avoidance of dietary gluten is the only option for celiac patients , a sensitive gluten detection and quantitation method is warranted ."
95870,of,O,3323.0,"Since avoidance of dietary gluten is the only option for celiac patients , a sensitive gluten detection and quantitation method is warranted ."
95871,dietary,O,3323.0,"Since avoidance of dietary gluten is the only option for celiac patients , a sensitive gluten detection and quantitation method is warranted ."
95872,gluten,O,3323.0,"Since avoidance of dietary gluten is the only option for celiac patients , a sensitive gluten detection and quantitation method is warranted ."
95873,is,O,3323.0,"Since avoidance of dietary gluten is the only option for celiac patients , a sensitive gluten detection and quantitation method is warranted ."
95874,the,O,3323.0,"Since avoidance of dietary gluten is the only option for celiac patients , a sensitive gluten detection and quantitation method is warranted ."
95875,only,O,3323.0,"Since avoidance of dietary gluten is the only option for celiac patients , a sensitive gluten detection and quantitation method is warranted ."
95876,option,O,3323.0,"Since avoidance of dietary gluten is the only option for celiac patients , a sensitive gluten detection and quantitation method is warranted ."
95877,for,O,3323.0,"Since avoidance of dietary gluten is the only option for celiac patients , a sensitive gluten detection and quantitation method is warranted ."
95878,celiac,O,3323.0,"Since avoidance of dietary gluten is the only option for celiac patients , a sensitive gluten detection and quantitation method is warranted ."
95879,patients,O,3323.0,"Since avoidance of dietary gluten is the only option for celiac patients , a sensitive gluten detection and quantitation method is warranted ."
95880,",",O,3323.0,"Since avoidance of dietary gluten is the only option for celiac patients , a sensitive gluten detection and quantitation method is warranted ."
95881,a,O,3323.0,"Since avoidance of dietary gluten is the only option for celiac patients , a sensitive gluten detection and quantitation method is warranted ."
95882,sensitive,O,3323.0,"Since avoidance of dietary gluten is the only option for celiac patients , a sensitive gluten detection and quantitation method is warranted ."
95883,gluten,O,3323.0,"Since avoidance of dietary gluten is the only option for celiac patients , a sensitive gluten detection and quantitation method is warranted ."
95884,detection,O,3323.0,"Since avoidance of dietary gluten is the only option for celiac patients , a sensitive gluten detection and quantitation method is warranted ."
95885,and,O,3323.0,"Since avoidance of dietary gluten is the only option for celiac patients , a sensitive gluten detection and quantitation method is warranted ."
95886,quantitation,O,3323.0,"Since avoidance of dietary gluten is the only option for celiac patients , a sensitive gluten detection and quantitation method is warranted ."
95887,method,O,3323.0,"Since avoidance of dietary gluten is the only option for celiac patients , a sensitive gluten detection and quantitation method is warranted ."
95888,is,O,3323.0,"Since avoidance of dietary gluten is the only option for celiac patients , a sensitive gluten detection and quantitation method is warranted ."
95889,warranted,O,3323.0,"Since avoidance of dietary gluten is the only option for celiac patients , a sensitive gluten detection and quantitation method is warranted ."
95890,.,O,3323.0,"Since avoidance of dietary gluten is the only option for celiac patients , a sensitive gluten detection and quantitation method is warranted ."
95891,Most,O,3324.0,"Most regulatory agencies have set a threshold of 20 ppm gluten in foods labeled gluten - free , based on the currently available ELISA methods ."
95892,regulatory,O,3324.0,"Most regulatory agencies have set a threshold of 20 ppm gluten in foods labeled gluten - free , based on the currently available ELISA methods ."
95893,agencies,O,3324.0,"Most regulatory agencies have set a threshold of 20 ppm gluten in foods labeled gluten - free , based on the currently available ELISA methods ."
95894,have,O,3324.0,"Most regulatory agencies have set a threshold of 20 ppm gluten in foods labeled gluten - free , based on the currently available ELISA methods ."
95895,set,O,3324.0,"Most regulatory agencies have set a threshold of 20 ppm gluten in foods labeled gluten - free , based on the currently available ELISA methods ."
95896,a,O,3324.0,"Most regulatory agencies have set a threshold of 20 ppm gluten in foods labeled gluten - free , based on the currently available ELISA methods ."
95897,threshold,O,3324.0,"Most regulatory agencies have set a threshold of 20 ppm gluten in foods labeled gluten - free , based on the currently available ELISA methods ."
95898,of,O,3324.0,"Most regulatory agencies have set a threshold of 20 ppm gluten in foods labeled gluten - free , based on the currently available ELISA methods ."
95899,20,O,3324.0,"Most regulatory agencies have set a threshold of 20 ppm gluten in foods labeled gluten - free , based on the currently available ELISA methods ."
95900,ppm,O,3324.0,"Most regulatory agencies have set a threshold of 20 ppm gluten in foods labeled gluten - free , based on the currently available ELISA methods ."
95901,gluten,O,3324.0,"Most regulatory agencies have set a threshold of 20 ppm gluten in foods labeled gluten - free , based on the currently available ELISA methods ."
95902,in,O,3324.0,"Most regulatory agencies have set a threshold of 20 ppm gluten in foods labeled gluten - free , based on the currently available ELISA methods ."
95903,foods,O,3324.0,"Most regulatory agencies have set a threshold of 20 ppm gluten in foods labeled gluten - free , based on the currently available ELISA methods ."
95904,labeled,O,3324.0,"Most regulatory agencies have set a threshold of 20 ppm gluten in foods labeled gluten - free , based on the currently available ELISA methods ."
95905,gluten,O,3324.0,"Most regulatory agencies have set a threshold of 20 ppm gluten in foods labeled gluten - free , based on the currently available ELISA methods ."
95906,-,O,3324.0,"Most regulatory agencies have set a threshold of 20 ppm gluten in foods labeled gluten - free , based on the currently available ELISA methods ."
95907,free,O,3324.0,"Most regulatory agencies have set a threshold of 20 ppm gluten in foods labeled gluten - free , based on the currently available ELISA methods ."
95908,",",O,3324.0,"Most regulatory agencies have set a threshold of 20 ppm gluten in foods labeled gluten - free , based on the currently available ELISA methods ."
95909,based,O,3324.0,"Most regulatory agencies have set a threshold of 20 ppm gluten in foods labeled gluten - free , based on the currently available ELISA methods ."
95910,on,O,3324.0,"Most regulatory agencies have set a threshold of 20 ppm gluten in foods labeled gluten - free , based on the currently available ELISA methods ."
95911,the,O,3324.0,"Most regulatory agencies have set a threshold of 20 ppm gluten in foods labeled gluten - free , based on the currently available ELISA methods ."
95912,currently,O,3324.0,"Most regulatory agencies have set a threshold of 20 ppm gluten in foods labeled gluten - free , based on the currently available ELISA methods ."
95913,available,O,3324.0,"Most regulatory agencies have set a threshold of 20 ppm gluten in foods labeled gluten - free , based on the currently available ELISA methods ."
95914,ELISA,O,3324.0,"Most regulatory agencies have set a threshold of 20 ppm gluten in foods labeled gluten - free , based on the currently available ELISA methods ."
95915,methods,O,3324.0,"Most regulatory agencies have set a threshold of 20 ppm gluten in foods labeled gluten - free , based on the currently available ELISA methods ."
95916,.,O,3324.0,"Most regulatory agencies have set a threshold of 20 ppm gluten in foods labeled gluten - free , based on the currently available ELISA methods ."
95917,However,O,3325.0,"However , these methods may exhibit differences in gluten quantitation from different gluten - containing grains ."
95918,",",O,3325.0,"However , these methods may exhibit differences in gluten quantitation from different gluten - containing grains ."
95919,these,O,3325.0,"However , these methods may exhibit differences in gluten quantitation from different gluten - containing grains ."
95920,methods,O,3325.0,"However , these methods may exhibit differences in gluten quantitation from different gluten - containing grains ."
95921,may,O,3325.0,"However , these methods may exhibit differences in gluten quantitation from different gluten - containing grains ."
95922,exhibit,O,3325.0,"However , these methods may exhibit differences in gluten quantitation from different gluten - containing grains ."
95923,differences,O,3325.0,"However , these methods may exhibit differences in gluten quantitation from different gluten - containing grains ."
95924,in,O,3325.0,"However , these methods may exhibit differences in gluten quantitation from different gluten - containing grains ."
95925,gluten,O,3325.0,"However , these methods may exhibit differences in gluten quantitation from different gluten - containing grains ."
95926,quantitation,O,3325.0,"However , these methods may exhibit differences in gluten quantitation from different gluten - containing grains ."
95927,from,O,3325.0,"However , these methods may exhibit differences in gluten quantitation from different gluten - containing grains ."
95928,different,O,3325.0,"However , these methods may exhibit differences in gluten quantitation from different gluten - containing grains ."
95929,gluten,B-AG.01.i,3325.0,"However , these methods may exhibit differences in gluten quantitation from different gluten - containing grains ."
95930,-,I-AG.01.i,3325.0,"However , these methods may exhibit differences in gluten quantitation from different gluten - containing grains ."
95931,containing,I-AG.01.i,3325.0,"However , these methods may exhibit differences in gluten quantitation from different gluten - containing grains ."
95932,grains,I-AG.01.i,3325.0,"However , these methods may exhibit differences in gluten quantitation from different gluten - containing grains ."
95933,.,O,3325.0,"However , these methods may exhibit differences in gluten quantitation from different gluten - containing grains ."
95934,In,O,3326.0,"In this study , prolamin and glutelin fractions were isolated from wheat , rye , barley , oats and corn ."
95935,this,O,3326.0,"In this study , prolamin and glutelin fractions were isolated from wheat , rye , barley , oats and corn ."
95936,study,O,3326.0,"In this study , prolamin and glutelin fractions were isolated from wheat , rye , barley , oats and corn ."
95937,",",O,3326.0,"In this study , prolamin and glutelin fractions were isolated from wheat , rye , barley , oats and corn ."
95938,prolamin,O,3326.0,"In this study , prolamin and glutelin fractions were isolated from wheat , rye , barley , oats and corn ."
95939,and,O,3326.0,"In this study , prolamin and glutelin fractions were isolated from wheat , rye , barley , oats and corn ."
95940,glutelin,O,3326.0,"In this study , prolamin and glutelin fractions were isolated from wheat , rye , barley , oats and corn ."
95941,fractions,O,3326.0,"In this study , prolamin and glutelin fractions were isolated from wheat , rye , barley , oats and corn ."
95942,were,O,3326.0,"In this study , prolamin and glutelin fractions were isolated from wheat , rye , barley , oats and corn ."
95943,isolated,O,3326.0,"In this study , prolamin and glutelin fractions were isolated from wheat , rye , barley , oats and corn ."
95944,from,O,3326.0,"In this study , prolamin and glutelin fractions were isolated from wheat , rye , barley , oats and corn ."
95945,wheat,B-AG.01.i,3326.0,"In this study , prolamin and glutelin fractions were isolated from wheat , rye , barley , oats and corn ."
95946,",",O,3326.0,"In this study , prolamin and glutelin fractions were isolated from wheat , rye , barley , oats and corn ."
95947,rye,B-AG.01.i,3326.0,"In this study , prolamin and glutelin fractions were isolated from wheat , rye , barley , oats and corn ."
95948,",",O,3326.0,"In this study , prolamin and glutelin fractions were isolated from wheat , rye , barley , oats and corn ."
95949,barley,B-AG.01.i,3326.0,"In this study , prolamin and glutelin fractions were isolated from wheat , rye , barley , oats and corn ."
95950,",",O,3326.0,"In this study , prolamin and glutelin fractions were isolated from wheat , rye , barley , oats and corn ."
95951,oats,B-AG.01.i,3326.0,"In this study , prolamin and glutelin fractions were isolated from wheat , rye , barley , oats and corn ."
95952,and,O,3326.0,"In this study , prolamin and glutelin fractions were isolated from wheat , rye , barley , oats and corn ."
95953,corn,B-AG.01.i,3326.0,"In this study , prolamin and glutelin fractions were isolated from wheat , rye , barley , oats and corn ."
95954,.,O,3326.0,"In this study , prolamin and glutelin fractions were isolated from wheat , rye , barley , oats and corn ."
95955,Intact,O,3327.0,Intact and pepsin - trypsin ( PT)-digested prolamin and glutelin fractions were used to assess their immunoreactivity and gluten recovery by three sandwich and two competitive ELISA kits .
95956,and,O,3327.0,Intact and pepsin - trypsin ( PT)-digested prolamin and glutelin fractions were used to assess their immunoreactivity and gluten recovery by three sandwich and two competitive ELISA kits .
95957,pepsin,O,3327.0,Intact and pepsin - trypsin ( PT)-digested prolamin and glutelin fractions were used to assess their immunoreactivity and gluten recovery by three sandwich and two competitive ELISA kits .
95958,-,O,3327.0,Intact and pepsin - trypsin ( PT)-digested prolamin and glutelin fractions were used to assess their immunoreactivity and gluten recovery by three sandwich and two competitive ELISA kits .
95959,trypsin,O,3327.0,Intact and pepsin - trypsin ( PT)-digested prolamin and glutelin fractions were used to assess their immunoreactivity and gluten recovery by three sandwich and two competitive ELISA kits .
95960,(,O,3327.0,Intact and pepsin - trypsin ( PT)-digested prolamin and glutelin fractions were used to assess their immunoreactivity and gluten recovery by three sandwich and two competitive ELISA kits .
95961,PT)-digested,O,3327.0,Intact and pepsin - trypsin ( PT)-digested prolamin and glutelin fractions were used to assess their immunoreactivity and gluten recovery by three sandwich and two competitive ELISA kits .
95962,prolamin,O,3327.0,Intact and pepsin - trypsin ( PT)-digested prolamin and glutelin fractions were used to assess their immunoreactivity and gluten recovery by three sandwich and two competitive ELISA kits .
95963,and,O,3327.0,Intact and pepsin - trypsin ( PT)-digested prolamin and glutelin fractions were used to assess their immunoreactivity and gluten recovery by three sandwich and two competitive ELISA kits .
95964,glutelin,O,3327.0,Intact and pepsin - trypsin ( PT)-digested prolamin and glutelin fractions were used to assess their immunoreactivity and gluten recovery by three sandwich and two competitive ELISA kits .
95965,fractions,O,3327.0,Intact and pepsin - trypsin ( PT)-digested prolamin and glutelin fractions were used to assess their immunoreactivity and gluten recovery by three sandwich and two competitive ELISA kits .
95966,were,O,3327.0,Intact and pepsin - trypsin ( PT)-digested prolamin and glutelin fractions were used to assess their immunoreactivity and gluten recovery by three sandwich and two competitive ELISA kits .
95967,used,O,3327.0,Intact and pepsin - trypsin ( PT)-digested prolamin and glutelin fractions were used to assess their immunoreactivity and gluten recovery by three sandwich and two competitive ELISA kits .
95968,to,O,3327.0,Intact and pepsin - trypsin ( PT)-digested prolamin and glutelin fractions were used to assess their immunoreactivity and gluten recovery by three sandwich and two competitive ELISA kits .
95969,assess,O,3327.0,Intact and pepsin - trypsin ( PT)-digested prolamin and glutelin fractions were used to assess their immunoreactivity and gluten recovery by three sandwich and two competitive ELISA kits .
95970,their,O,3327.0,Intact and pepsin - trypsin ( PT)-digested prolamin and glutelin fractions were used to assess their immunoreactivity and gluten recovery by three sandwich and two competitive ELISA kits .
95971,immunoreactivity,O,3327.0,Intact and pepsin - trypsin ( PT)-digested prolamin and glutelin fractions were used to assess their immunoreactivity and gluten recovery by three sandwich and two competitive ELISA kits .
95972,and,O,3327.0,Intact and pepsin - trypsin ( PT)-digested prolamin and glutelin fractions were used to assess their immunoreactivity and gluten recovery by three sandwich and two competitive ELISA kits .
95973,gluten,O,3327.0,Intact and pepsin - trypsin ( PT)-digested prolamin and glutelin fractions were used to assess their immunoreactivity and gluten recovery by three sandwich and two competitive ELISA kits .
95974,recovery,O,3327.0,Intact and pepsin - trypsin ( PT)-digested prolamin and glutelin fractions were used to assess their immunoreactivity and gluten recovery by three sandwich and two competitive ELISA kits .
95975,by,O,3327.0,Intact and pepsin - trypsin ( PT)-digested prolamin and glutelin fractions were used to assess their immunoreactivity and gluten recovery by three sandwich and two competitive ELISA kits .
95976,three,O,3327.0,Intact and pepsin - trypsin ( PT)-digested prolamin and glutelin fractions were used to assess their immunoreactivity and gluten recovery by three sandwich and two competitive ELISA kits .
95977,sandwich,O,3327.0,Intact and pepsin - trypsin ( PT)-digested prolamin and glutelin fractions were used to assess their immunoreactivity and gluten recovery by three sandwich and two competitive ELISA kits .
95978,and,O,3327.0,Intact and pepsin - trypsin ( PT)-digested prolamin and glutelin fractions were used to assess their immunoreactivity and gluten recovery by three sandwich and two competitive ELISA kits .
95979,two,O,3327.0,Intact and pepsin - trypsin ( PT)-digested prolamin and glutelin fractions were used to assess their immunoreactivity and gluten recovery by three sandwich and two competitive ELISA kits .
95980,competitive,O,3327.0,Intact and pepsin - trypsin ( PT)-digested prolamin and glutelin fractions were used to assess their immunoreactivity and gluten recovery by three sandwich and two competitive ELISA kits .
95981,ELISA,O,3327.0,Intact and pepsin - trypsin ( PT)-digested prolamin and glutelin fractions were used to assess their immunoreactivity and gluten recovery by three sandwich and two competitive ELISA kits .
95982,kits,O,3327.0,Intact and pepsin - trypsin ( PT)-digested prolamin and glutelin fractions were used to assess their immunoreactivity and gluten recovery by three sandwich and two competitive ELISA kits .
95983,.,O,3327.0,Intact and pepsin - trypsin ( PT)-digested prolamin and glutelin fractions were used to assess their immunoreactivity and gluten recovery by three sandwich and two competitive ELISA kits .
95984,The,O,3328.0,The Western blots revealed varied affinity of ELISA antibodies to gluten - containing grain proteins and no reactivity to oat and corn proteins .
95985,Western,O,3328.0,The Western blots revealed varied affinity of ELISA antibodies to gluten - containing grain proteins and no reactivity to oat and corn proteins .
95986,blots,O,3328.0,The Western blots revealed varied affinity of ELISA antibodies to gluten - containing grain proteins and no reactivity to oat and corn proteins .
95987,revealed,O,3328.0,The Western blots revealed varied affinity of ELISA antibodies to gluten - containing grain proteins and no reactivity to oat and corn proteins .
95988,varied,O,3328.0,The Western blots revealed varied affinity of ELISA antibodies to gluten - containing grain proteins and no reactivity to oat and corn proteins .
95989,affinity,O,3328.0,The Western blots revealed varied affinity of ELISA antibodies to gluten - containing grain proteins and no reactivity to oat and corn proteins .
95990,of,O,3328.0,The Western blots revealed varied affinity of ELISA antibodies to gluten - containing grain proteins and no reactivity to oat and corn proteins .
95991,ELISA,O,3328.0,The Western blots revealed varied affinity of ELISA antibodies to gluten - containing grain proteins and no reactivity to oat and corn proteins .
95992,antibodies,O,3328.0,The Western blots revealed varied affinity of ELISA antibodies to gluten - containing grain proteins and no reactivity to oat and corn proteins .
95993,to,O,3328.0,The Western blots revealed varied affinity of ELISA antibodies to gluten - containing grain proteins and no reactivity to oat and corn proteins .
95994,gluten,O,3328.0,The Western blots revealed varied affinity of ELISA antibodies to gluten - containing grain proteins and no reactivity to oat and corn proteins .
95995,-,O,3328.0,The Western blots revealed varied affinity of ELISA antibodies to gluten - containing grain proteins and no reactivity to oat and corn proteins .
95996,containing,O,3328.0,The Western blots revealed varied affinity of ELISA antibodies to gluten - containing grain proteins and no reactivity to oat and corn proteins .
95997,grain,O,3328.0,The Western blots revealed varied affinity of ELISA antibodies to gluten - containing grain proteins and no reactivity to oat and corn proteins .
95998,proteins,O,3328.0,The Western blots revealed varied affinity of ELISA antibodies to gluten - containing grain proteins and no reactivity to oat and corn proteins .
95999,and,O,3328.0,The Western blots revealed varied affinity of ELISA antibodies to gluten - containing grain proteins and no reactivity to oat and corn proteins .
96000,no,O,3328.0,The Western blots revealed varied affinity of ELISA antibodies to gluten - containing grain proteins and no reactivity to oat and corn proteins .
96001,reactivity,O,3328.0,The Western blots revealed varied affinity of ELISA antibodies to gluten - containing grain proteins and no reactivity to oat and corn proteins .
96002,to,O,3328.0,The Western blots revealed varied affinity of ELISA antibodies to gluten - containing grain proteins and no reactivity to oat and corn proteins .
96003,oat,O,3328.0,The Western blots revealed varied affinity of ELISA antibodies to gluten - containing grain proteins and no reactivity to oat and corn proteins .
96004,and,O,3328.0,The Western blots revealed varied affinity of ELISA antibodies to gluten - containing grain proteins and no reactivity to oat and corn proteins .
96005,corn,O,3328.0,The Western blots revealed varied affinity of ELISA antibodies to gluten - containing grain proteins and no reactivity to oat and corn proteins .
96006,proteins,O,3328.0,The Western blots revealed varied affinity of ELISA antibodies to gluten - containing grain proteins and no reactivity to oat and corn proteins .
96007,.,O,3328.0,The Western blots revealed varied affinity of ELISA antibodies to gluten - containing grain proteins and no reactivity to oat and corn proteins .
96008,ELISA,O,3329.0,ELISA results showed considerable variation in gluten recoveries from both intact and PT - digested gluten fractions among different kits .
96009,results,O,3329.0,ELISA results showed considerable variation in gluten recoveries from both intact and PT - digested gluten fractions among different kits .
96010,showed,O,3329.0,ELISA results showed considerable variation in gluten recoveries from both intact and PT - digested gluten fractions among different kits .
96011,considerable,O,3329.0,ELISA results showed considerable variation in gluten recoveries from both intact and PT - digested gluten fractions among different kits .
96012,variation,O,3329.0,ELISA results showed considerable variation in gluten recoveries from both intact and PT - digested gluten fractions among different kits .
96013,in,O,3329.0,ELISA results showed considerable variation in gluten recoveries from both intact and PT - digested gluten fractions among different kits .
96014,gluten,O,3329.0,ELISA results showed considerable variation in gluten recoveries from both intact and PT - digested gluten fractions among different kits .
96015,recoveries,O,3329.0,ELISA results showed considerable variation in gluten recoveries from both intact and PT - digested gluten fractions among different kits .
96016,from,O,3329.0,ELISA results showed considerable variation in gluten recoveries from both intact and PT - digested gluten fractions among different kits .
96017,both,O,3329.0,ELISA results showed considerable variation in gluten recoveries from both intact and PT - digested gluten fractions among different kits .
96018,intact,O,3329.0,ELISA results showed considerable variation in gluten recoveries from both intact and PT - digested gluten fractions among different kits .
96019,and,O,3329.0,ELISA results showed considerable variation in gluten recoveries from both intact and PT - digested gluten fractions among different kits .
96020,PT,O,3329.0,ELISA results showed considerable variation in gluten recoveries from both intact and PT - digested gluten fractions among different kits .
96021,-,O,3329.0,ELISA results showed considerable variation in gluten recoveries from both intact and PT - digested gluten fractions among different kits .
96022,digested,O,3329.0,ELISA results showed considerable variation in gluten recoveries from both intact and PT - digested gluten fractions among different kits .
96023,gluten,O,3329.0,ELISA results showed considerable variation in gluten recoveries from both intact and PT - digested gluten fractions among different kits .
96024,fractions,O,3329.0,ELISA results showed considerable variation in gluten recoveries from both intact and PT - digested gluten fractions among different kits .
96025,among,O,3329.0,ELISA results showed considerable variation in gluten recoveries from both intact and PT - digested gluten fractions among different kits .
96026,different,O,3329.0,ELISA results showed considerable variation in gluten recoveries from both intact and PT - digested gluten fractions among different kits .
96027,kits,O,3329.0,ELISA results showed considerable variation in gluten recoveries from both intact and PT - digested gluten fractions among different kits .
96028,.,O,3329.0,ELISA results showed considerable variation in gluten recoveries from both intact and PT - digested gluten fractions among different kits .
96029,Prolamin,O,3330.0,Prolamin fractions showed higher gluten recovery compared to their respective glutelin fractions .
96030,fractions,O,3330.0,Prolamin fractions showed higher gluten recovery compared to their respective glutelin fractions .
96031,showed,O,3330.0,Prolamin fractions showed higher gluten recovery compared to their respective glutelin fractions .
96032,higher,O,3330.0,Prolamin fractions showed higher gluten recovery compared to their respective glutelin fractions .
96033,gluten,O,3330.0,Prolamin fractions showed higher gluten recovery compared to their respective glutelin fractions .
96034,recovery,O,3330.0,Prolamin fractions showed higher gluten recovery compared to their respective glutelin fractions .
96035,compared,O,3330.0,Prolamin fractions showed higher gluten recovery compared to their respective glutelin fractions .
96036,to,O,3330.0,Prolamin fractions showed higher gluten recovery compared to their respective glutelin fractions .
96037,their,O,3330.0,Prolamin fractions showed higher gluten recovery compared to their respective glutelin fractions .
96038,respective,O,3330.0,Prolamin fractions showed higher gluten recovery compared to their respective glutelin fractions .
96039,glutelin,O,3330.0,Prolamin fractions showed higher gluten recovery compared to their respective glutelin fractions .
96040,fractions,O,3330.0,Prolamin fractions showed higher gluten recovery compared to their respective glutelin fractions .
96041,.,O,3330.0,Prolamin fractions showed higher gluten recovery compared to their respective glutelin fractions .
96042,Among,O,3331.0,"Among prolamins , barley exhibited higher recovery compared to wheat and rye with most of the ELISA kits used ."
96043,prolamins,O,3331.0,"Among prolamins , barley exhibited higher recovery compared to wheat and rye with most of the ELISA kits used ."
96044,",",O,3331.0,"Among prolamins , barley exhibited higher recovery compared to wheat and rye with most of the ELISA kits used ."
96045,barley,B-AG.01.i,3331.0,"Among prolamins , barley exhibited higher recovery compared to wheat and rye with most of the ELISA kits used ."
96046,exhibited,O,3331.0,"Among prolamins , barley exhibited higher recovery compared to wheat and rye with most of the ELISA kits used ."
96047,higher,O,3331.0,"Among prolamins , barley exhibited higher recovery compared to wheat and rye with most of the ELISA kits used ."
96048,recovery,O,3331.0,"Among prolamins , barley exhibited higher recovery compared to wheat and rye with most of the ELISA kits used ."
96049,compared,O,3331.0,"Among prolamins , barley exhibited higher recovery compared to wheat and rye with most of the ELISA kits used ."
96050,to,O,3331.0,"Among prolamins , barley exhibited higher recovery compared to wheat and rye with most of the ELISA kits used ."
96051,wheat,B-AG.01.i,3331.0,"Among prolamins , barley exhibited higher recovery compared to wheat and rye with most of the ELISA kits used ."
96052,and,O,3331.0,"Among prolamins , barley exhibited higher recovery compared to wheat and rye with most of the ELISA kits used ."
96053,rye,B-AG.01.i,3331.0,"Among prolamins , barley exhibited higher recovery compared to wheat and rye with most of the ELISA kits used ."
96054,with,O,3331.0,"Among prolamins , barley exhibited higher recovery compared to wheat and rye with most of the ELISA kits used ."
96055,most,O,3331.0,"Among prolamins , barley exhibited higher recovery compared to wheat and rye with most of the ELISA kits used ."
96056,of,O,3331.0,"Among prolamins , barley exhibited higher recovery compared to wheat and rye with most of the ELISA kits used ."
96057,the,O,3331.0,"Among prolamins , barley exhibited higher recovery compared to wheat and rye with most of the ELISA kits used ."
96058,ELISA,O,3331.0,"Among prolamins , barley exhibited higher recovery compared to wheat and rye with most of the ELISA kits used ."
96059,kits,O,3331.0,"Among prolamins , barley exhibited higher recovery compared to wheat and rye with most of the ELISA kits used ."
96060,used,O,3331.0,"Among prolamins , barley exhibited higher recovery compared to wheat and rye with most of the ELISA kits used ."
96061,.,O,3331.0,"Among prolamins , barley exhibited higher recovery compared to wheat and rye with most of the ELISA kits used ."
96062,Hydrolysis,O,3332.0,Hydrolysis resulted in reduced gluten recovery of most gluten fractions .
96063,resulted,O,3332.0,Hydrolysis resulted in reduced gluten recovery of most gluten fractions .
96064,in,O,3332.0,Hydrolysis resulted in reduced gluten recovery of most gluten fractions .
96065,reduced,O,3332.0,Hydrolysis resulted in reduced gluten recovery of most gluten fractions .
96066,gluten,O,3332.0,Hydrolysis resulted in reduced gluten recovery of most gluten fractions .
96067,recovery,O,3332.0,Hydrolysis resulted in reduced gluten recovery of most gluten fractions .
96068,of,O,3332.0,Hydrolysis resulted in reduced gluten recovery of most gluten fractions .
96069,most,O,3332.0,Hydrolysis resulted in reduced gluten recovery of most gluten fractions .
96070,gluten,O,3332.0,Hydrolysis resulted in reduced gluten recovery of most gluten fractions .
96071,fractions,O,3332.0,Hydrolysis resulted in reduced gluten recovery of most gluten fractions .
96072,.,O,3332.0,Hydrolysis resulted in reduced gluten recovery of most gluten fractions .
96073,These,O,3333.0,"These results suggest that the suitability of ELISA for accurate gluten quantitation is dependent upon various factors , such as grain source , antibody specificity , gluten proteins and the level of their hydrolysis in foods ."
96074,results,O,3333.0,"These results suggest that the suitability of ELISA for accurate gluten quantitation is dependent upon various factors , such as grain source , antibody specificity , gluten proteins and the level of their hydrolysis in foods ."
96075,suggest,O,3333.0,"These results suggest that the suitability of ELISA for accurate gluten quantitation is dependent upon various factors , such as grain source , antibody specificity , gluten proteins and the level of their hydrolysis in foods ."
96076,that,O,3333.0,"These results suggest that the suitability of ELISA for accurate gluten quantitation is dependent upon various factors , such as grain source , antibody specificity , gluten proteins and the level of their hydrolysis in foods ."
96077,the,O,3333.0,"These results suggest that the suitability of ELISA for accurate gluten quantitation is dependent upon various factors , such as grain source , antibody specificity , gluten proteins and the level of their hydrolysis in foods ."
96078,suitability,O,3333.0,"These results suggest that the suitability of ELISA for accurate gluten quantitation is dependent upon various factors , such as grain source , antibody specificity , gluten proteins and the level of their hydrolysis in foods ."
96079,of,O,3333.0,"These results suggest that the suitability of ELISA for accurate gluten quantitation is dependent upon various factors , such as grain source , antibody specificity , gluten proteins and the level of their hydrolysis in foods ."
96080,ELISA,O,3333.0,"These results suggest that the suitability of ELISA for accurate gluten quantitation is dependent upon various factors , such as grain source , antibody specificity , gluten proteins and the level of their hydrolysis in foods ."
96081,for,O,3333.0,"These results suggest that the suitability of ELISA for accurate gluten quantitation is dependent upon various factors , such as grain source , antibody specificity , gluten proteins and the level of their hydrolysis in foods ."
96082,accurate,O,3333.0,"These results suggest that the suitability of ELISA for accurate gluten quantitation is dependent upon various factors , such as grain source , antibody specificity , gluten proteins and the level of their hydrolysis in foods ."
96083,gluten,O,3333.0,"These results suggest that the suitability of ELISA for accurate gluten quantitation is dependent upon various factors , such as grain source , antibody specificity , gluten proteins and the level of their hydrolysis in foods ."
96084,quantitation,O,3333.0,"These results suggest that the suitability of ELISA for accurate gluten quantitation is dependent upon various factors , such as grain source , antibody specificity , gluten proteins and the level of their hydrolysis in foods ."
96085,is,O,3333.0,"These results suggest that the suitability of ELISA for accurate gluten quantitation is dependent upon various factors , such as grain source , antibody specificity , gluten proteins and the level of their hydrolysis in foods ."
96086,dependent,O,3333.0,"These results suggest that the suitability of ELISA for accurate gluten quantitation is dependent upon various factors , such as grain source , antibody specificity , gluten proteins and the level of their hydrolysis in foods ."
96087,upon,O,3333.0,"These results suggest that the suitability of ELISA for accurate gluten quantitation is dependent upon various factors , such as grain source , antibody specificity , gluten proteins and the level of their hydrolysis in foods ."
96088,various,O,3333.0,"These results suggest that the suitability of ELISA for accurate gluten quantitation is dependent upon various factors , such as grain source , antibody specificity , gluten proteins and the level of their hydrolysis in foods ."
96089,factors,O,3333.0,"These results suggest that the suitability of ELISA for accurate gluten quantitation is dependent upon various factors , such as grain source , antibody specificity , gluten proteins and the level of their hydrolysis in foods ."
96090,",",O,3333.0,"These results suggest that the suitability of ELISA for accurate gluten quantitation is dependent upon various factors , such as grain source , antibody specificity , gluten proteins and the level of their hydrolysis in foods ."
96091,such,O,3333.0,"These results suggest that the suitability of ELISA for accurate gluten quantitation is dependent upon various factors , such as grain source , antibody specificity , gluten proteins and the level of their hydrolysis in foods ."
96092,as,O,3333.0,"These results suggest that the suitability of ELISA for accurate gluten quantitation is dependent upon various factors , such as grain source , antibody specificity , gluten proteins and the level of their hydrolysis in foods ."
96093,grain,B-AG.01.i,3333.0,"These results suggest that the suitability of ELISA for accurate gluten quantitation is dependent upon various factors , such as grain source , antibody specificity , gluten proteins and the level of their hydrolysis in foods ."
96094,source,O,3333.0,"These results suggest that the suitability of ELISA for accurate gluten quantitation is dependent upon various factors , such as grain source , antibody specificity , gluten proteins and the level of their hydrolysis in foods ."
96095,",",O,3333.0,"These results suggest that the suitability of ELISA for accurate gluten quantitation is dependent upon various factors , such as grain source , antibody specificity , gluten proteins and the level of their hydrolysis in foods ."
96096,antibody,O,3333.0,"These results suggest that the suitability of ELISA for accurate gluten quantitation is dependent upon various factors , such as grain source , antibody specificity , gluten proteins and the level of their hydrolysis in foods ."
96097,specificity,O,3333.0,"These results suggest that the suitability of ELISA for accurate gluten quantitation is dependent upon various factors , such as grain source , antibody specificity , gluten proteins and the level of their hydrolysis in foods ."
96098,",",O,3333.0,"These results suggest that the suitability of ELISA for accurate gluten quantitation is dependent upon various factors , such as grain source , antibody specificity , gluten proteins and the level of their hydrolysis in foods ."
96099,gluten,O,3333.0,"These results suggest that the suitability of ELISA for accurate gluten quantitation is dependent upon various factors , such as grain source , antibody specificity , gluten proteins and the level of their hydrolysis in foods ."
96100,proteins,O,3333.0,"These results suggest that the suitability of ELISA for accurate gluten quantitation is dependent upon various factors , such as grain source , antibody specificity , gluten proteins and the level of their hydrolysis in foods ."
96101,and,O,3333.0,"These results suggest that the suitability of ELISA for accurate gluten quantitation is dependent upon various factors , such as grain source , antibody specificity , gluten proteins and the level of their hydrolysis in foods ."
96102,the,O,3333.0,"These results suggest that the suitability of ELISA for accurate gluten quantitation is dependent upon various factors , such as grain source , antibody specificity , gluten proteins and the level of their hydrolysis in foods ."
96103,level,O,3333.0,"These results suggest that the suitability of ELISA for accurate gluten quantitation is dependent upon various factors , such as grain source , antibody specificity , gluten proteins and the level of their hydrolysis in foods ."
96104,of,O,3333.0,"These results suggest that the suitability of ELISA for accurate gluten quantitation is dependent upon various factors , such as grain source , antibody specificity , gluten proteins and the level of their hydrolysis in foods ."
96105,their,O,3333.0,"These results suggest that the suitability of ELISA for accurate gluten quantitation is dependent upon various factors , such as grain source , antibody specificity , gluten proteins and the level of their hydrolysis in foods ."
96106,hydrolysis,O,3333.0,"These results suggest that the suitability of ELISA for accurate gluten quantitation is dependent upon various factors , such as grain source , antibody specificity , gluten proteins and the level of their hydrolysis in foods ."
96107,in,O,3333.0,"These results suggest that the suitability of ELISA for accurate gluten quantitation is dependent upon various factors , such as grain source , antibody specificity , gluten proteins and the level of their hydrolysis in foods ."
96108,foods,O,3333.0,"These results suggest that the suitability of ELISA for accurate gluten quantitation is dependent upon various factors , such as grain source , antibody specificity , gluten proteins and the level of their hydrolysis in foods ."
96109,.,O,3333.0,"These results suggest that the suitability of ELISA for accurate gluten quantitation is dependent upon various factors , such as grain source , antibody specificity , gluten proteins and the level of their hydrolysis in foods ."
96110,The,O,3334.0,"The knowledge of uranium concentration , in the products entering the human diet is of extreme importance because of their chemical hazard to health ."
96111,knowledge,O,3334.0,"The knowledge of uranium concentration , in the products entering the human diet is of extreme importance because of their chemical hazard to health ."
96112,of,O,3334.0,"The knowledge of uranium concentration , in the products entering the human diet is of extreme importance because of their chemical hazard to health ."
96113,uranium,O,3334.0,"The knowledge of uranium concentration , in the products entering the human diet is of extreme importance because of their chemical hazard to health ."
96114,concentration,O,3334.0,"The knowledge of uranium concentration , in the products entering the human diet is of extreme importance because of their chemical hazard to health ."
96115,",",O,3334.0,"The knowledge of uranium concentration , in the products entering the human diet is of extreme importance because of their chemical hazard to health ."
96116,in,O,3334.0,"The knowledge of uranium concentration , in the products entering the human diet is of extreme importance because of their chemical hazard to health ."
96117,the,O,3334.0,"The knowledge of uranium concentration , in the products entering the human diet is of extreme importance because of their chemical hazard to health ."
96118,products,O,3334.0,"The knowledge of uranium concentration , in the products entering the human diet is of extreme importance because of their chemical hazard to health ."
96119,entering,O,3334.0,"The knowledge of uranium concentration , in the products entering the human diet is of extreme importance because of their chemical hazard to health ."
96120,the,O,3334.0,"The knowledge of uranium concentration , in the products entering the human diet is of extreme importance because of their chemical hazard to health ."
96121,human,O,3334.0,"The knowledge of uranium concentration , in the products entering the human diet is of extreme importance because of their chemical hazard to health ."
96122,diet,O,3334.0,"The knowledge of uranium concentration , in the products entering the human diet is of extreme importance because of their chemical hazard to health ."
96123,is,O,3334.0,"The knowledge of uranium concentration , in the products entering the human diet is of extreme importance because of their chemical hazard to health ."
96124,of,O,3334.0,"The knowledge of uranium concentration , in the products entering the human diet is of extreme importance because of their chemical hazard to health ."
96125,extreme,O,3334.0,"The knowledge of uranium concentration , in the products entering the human diet is of extreme importance because of their chemical hazard to health ."
96126,importance,O,3334.0,"The knowledge of uranium concentration , in the products entering the human diet is of extreme importance because of their chemical hazard to health ."
96127,because,O,3334.0,"The knowledge of uranium concentration , in the products entering the human diet is of extreme importance because of their chemical hazard to health ."
96128,of,O,3334.0,"The knowledge of uranium concentration , in the products entering the human diet is of extreme importance because of their chemical hazard to health ."
96129,their,O,3334.0,"The knowledge of uranium concentration , in the products entering the human diet is of extreme importance because of their chemical hazard to health ."
96130,chemical,O,3334.0,"The knowledge of uranium concentration , in the products entering the human diet is of extreme importance because of their chemical hazard to health ."
96131,hazard,O,3334.0,"The knowledge of uranium concentration , in the products entering the human diet is of extreme importance because of their chemical hazard to health ."
96132,to,O,3334.0,"The knowledge of uranium concentration , in the products entering the human diet is of extreme importance because of their chemical hazard to health ."
96133,health,O,3334.0,"The knowledge of uranium concentration , in the products entering the human diet is of extreme importance because of their chemical hazard to health ."
96134,.,O,3334.0,"The knowledge of uranium concentration , in the products entering the human diet is of extreme importance because of their chemical hazard to health ."
96135,Controlled,O,3335.0,"Controlled field experiments with potatoes , beans and lettuce ( Solanum tuberosum L. , Phaseolus vulgaris L. and Lactuca sativa L. ) were carried out in a contaminated soil used by local farmers located near a closed Portuguese uranium mine ( Cunha Baixa , Mangualde ) ."
96136,field,O,3335.0,"Controlled field experiments with potatoes , beans and lettuce ( Solanum tuberosum L. , Phaseolus vulgaris L. and Lactuca sativa L. ) were carried out in a contaminated soil used by local farmers located near a closed Portuguese uranium mine ( Cunha Baixa , Mangualde ) ."
96137,experiments,O,3335.0,"Controlled field experiments with potatoes , beans and lettuce ( Solanum tuberosum L. , Phaseolus vulgaris L. and Lactuca sativa L. ) were carried out in a contaminated soil used by local farmers located near a closed Portuguese uranium mine ( Cunha Baixa , Mangualde ) ."
96138,with,O,3335.0,"Controlled field experiments with potatoes , beans and lettuce ( Solanum tuberosum L. , Phaseolus vulgaris L. and Lactuca sativa L. ) were carried out in a contaminated soil used by local farmers located near a closed Portuguese uranium mine ( Cunha Baixa , Mangualde ) ."
96139,potatoes,B-AG.01.h.02.a,3335.0,"Controlled field experiments with potatoes , beans and lettuce ( Solanum tuberosum L. , Phaseolus vulgaris L. and Lactuca sativa L. ) were carried out in a contaminated soil used by local farmers located near a closed Portuguese uranium mine ( Cunha Baixa , Mangualde ) ."
96140,",",O,3335.0,"Controlled field experiments with potatoes , beans and lettuce ( Solanum tuberosum L. , Phaseolus vulgaris L. and Lactuca sativa L. ) were carried out in a contaminated soil used by local farmers located near a closed Portuguese uranium mine ( Cunha Baixa , Mangualde ) ."
96141,beans,B-AG.01.h.02.g,3335.0,"Controlled field experiments with potatoes , beans and lettuce ( Solanum tuberosum L. , Phaseolus vulgaris L. and Lactuca sativa L. ) were carried out in a contaminated soil used by local farmers located near a closed Portuguese uranium mine ( Cunha Baixa , Mangualde ) ."
96142,and,O,3335.0,"Controlled field experiments with potatoes , beans and lettuce ( Solanum tuberosum L. , Phaseolus vulgaris L. and Lactuca sativa L. ) were carried out in a contaminated soil used by local farmers located near a closed Portuguese uranium mine ( Cunha Baixa , Mangualde ) ."
96143,lettuce,B-AG.01.h.02.c,3335.0,"Controlled field experiments with potatoes , beans and lettuce ( Solanum tuberosum L. , Phaseolus vulgaris L. and Lactuca sativa L. ) were carried out in a contaminated soil used by local farmers located near a closed Portuguese uranium mine ( Cunha Baixa , Mangualde ) ."
96144,(,O,3335.0,"Controlled field experiments with potatoes , beans and lettuce ( Solanum tuberosum L. , Phaseolus vulgaris L. and Lactuca sativa L. ) were carried out in a contaminated soil used by local farmers located near a closed Portuguese uranium mine ( Cunha Baixa , Mangualde ) ."
96145,Solanum,O,3335.0,"Controlled field experiments with potatoes , beans and lettuce ( Solanum tuberosum L. , Phaseolus vulgaris L. and Lactuca sativa L. ) were carried out in a contaminated soil used by local farmers located near a closed Portuguese uranium mine ( Cunha Baixa , Mangualde ) ."
96146,tuberosum,O,3335.0,"Controlled field experiments with potatoes , beans and lettuce ( Solanum tuberosum L. , Phaseolus vulgaris L. and Lactuca sativa L. ) were carried out in a contaminated soil used by local farmers located near a closed Portuguese uranium mine ( Cunha Baixa , Mangualde ) ."
96147,L.,O,3335.0,"Controlled field experiments with potatoes , beans and lettuce ( Solanum tuberosum L. , Phaseolus vulgaris L. and Lactuca sativa L. ) were carried out in a contaminated soil used by local farmers located near a closed Portuguese uranium mine ( Cunha Baixa , Mangualde ) ."
96148,",",O,3335.0,"Controlled field experiments with potatoes , beans and lettuce ( Solanum tuberosum L. , Phaseolus vulgaris L. and Lactuca sativa L. ) were carried out in a contaminated soil used by local farmers located near a closed Portuguese uranium mine ( Cunha Baixa , Mangualde ) ."
96149,Phaseolus,O,3335.0,"Controlled field experiments with potatoes , beans and lettuce ( Solanum tuberosum L. , Phaseolus vulgaris L. and Lactuca sativa L. ) were carried out in a contaminated soil used by local farmers located near a closed Portuguese uranium mine ( Cunha Baixa , Mangualde ) ."
96150,vulgaris,O,3335.0,"Controlled field experiments with potatoes , beans and lettuce ( Solanum tuberosum L. , Phaseolus vulgaris L. and Lactuca sativa L. ) were carried out in a contaminated soil used by local farmers located near a closed Portuguese uranium mine ( Cunha Baixa , Mangualde ) ."
96151,L.,O,3335.0,"Controlled field experiments with potatoes , beans and lettuce ( Solanum tuberosum L. , Phaseolus vulgaris L. and Lactuca sativa L. ) were carried out in a contaminated soil used by local farmers located near a closed Portuguese uranium mine ( Cunha Baixa , Mangualde ) ."
96152,and,O,3335.0,"Controlled field experiments with potatoes , beans and lettuce ( Solanum tuberosum L. , Phaseolus vulgaris L. and Lactuca sativa L. ) were carried out in a contaminated soil used by local farmers located near a closed Portuguese uranium mine ( Cunha Baixa , Mangualde ) ."
96153,Lactuca,O,3335.0,"Controlled field experiments with potatoes , beans and lettuce ( Solanum tuberosum L. , Phaseolus vulgaris L. and Lactuca sativa L. ) were carried out in a contaminated soil used by local farmers located near a closed Portuguese uranium mine ( Cunha Baixa , Mangualde ) ."
96154,sativa,O,3335.0,"Controlled field experiments with potatoes , beans and lettuce ( Solanum tuberosum L. , Phaseolus vulgaris L. and Lactuca sativa L. ) were carried out in a contaminated soil used by local farmers located near a closed Portuguese uranium mine ( Cunha Baixa , Mangualde ) ."
96155,L.,O,3335.0,"Controlled field experiments with potatoes , beans and lettuce ( Solanum tuberosum L. , Phaseolus vulgaris L. and Lactuca sativa L. ) were carried out in a contaminated soil used by local farmers located near a closed Portuguese uranium mine ( Cunha Baixa , Mangualde ) ."
96156,),O,3335.0,"Controlled field experiments with potatoes , beans and lettuce ( Solanum tuberosum L. , Phaseolus vulgaris L. and Lactuca sativa L. ) were carried out in a contaminated soil used by local farmers located near a closed Portuguese uranium mine ( Cunha Baixa , Mangualde ) ."
96157,were,O,3335.0,"Controlled field experiments with potatoes , beans and lettuce ( Solanum tuberosum L. , Phaseolus vulgaris L. and Lactuca sativa L. ) were carried out in a contaminated soil used by local farmers located near a closed Portuguese uranium mine ( Cunha Baixa , Mangualde ) ."
96158,carried,O,3335.0,"Controlled field experiments with potatoes , beans and lettuce ( Solanum tuberosum L. , Phaseolus vulgaris L. and Lactuca sativa L. ) were carried out in a contaminated soil used by local farmers located near a closed Portuguese uranium mine ( Cunha Baixa , Mangualde ) ."
96159,out,O,3335.0,"Controlled field experiments with potatoes , beans and lettuce ( Solanum tuberosum L. , Phaseolus vulgaris L. and Lactuca sativa L. ) were carried out in a contaminated soil used by local farmers located near a closed Portuguese uranium mine ( Cunha Baixa , Mangualde ) ."
96160,in,O,3335.0,"Controlled field experiments with potatoes , beans and lettuce ( Solanum tuberosum L. , Phaseolus vulgaris L. and Lactuca sativa L. ) were carried out in a contaminated soil used by local farmers located near a closed Portuguese uranium mine ( Cunha Baixa , Mangualde ) ."
96161,a,O,3335.0,"Controlled field experiments with potatoes , beans and lettuce ( Solanum tuberosum L. , Phaseolus vulgaris L. and Lactuca sativa L. ) were carried out in a contaminated soil used by local farmers located near a closed Portuguese uranium mine ( Cunha Baixa , Mangualde ) ."
96162,contaminated,O,3335.0,"Controlled field experiments with potatoes , beans and lettuce ( Solanum tuberosum L. , Phaseolus vulgaris L. and Lactuca sativa L. ) were carried out in a contaminated soil used by local farmers located near a closed Portuguese uranium mine ( Cunha Baixa , Mangualde ) ."
96163,soil,O,3335.0,"Controlled field experiments with potatoes , beans and lettuce ( Solanum tuberosum L. , Phaseolus vulgaris L. and Lactuca sativa L. ) were carried out in a contaminated soil used by local farmers located near a closed Portuguese uranium mine ( Cunha Baixa , Mangualde ) ."
96164,used,O,3335.0,"Controlled field experiments with potatoes , beans and lettuce ( Solanum tuberosum L. , Phaseolus vulgaris L. and Lactuca sativa L. ) were carried out in a contaminated soil used by local farmers located near a closed Portuguese uranium mine ( Cunha Baixa , Mangualde ) ."
96165,by,O,3335.0,"Controlled field experiments with potatoes , beans and lettuce ( Solanum tuberosum L. , Phaseolus vulgaris L. and Lactuca sativa L. ) were carried out in a contaminated soil used by local farmers located near a closed Portuguese uranium mine ( Cunha Baixa , Mangualde ) ."
96166,local,O,3335.0,"Controlled field experiments with potatoes , beans and lettuce ( Solanum tuberosum L. , Phaseolus vulgaris L. and Lactuca sativa L. ) were carried out in a contaminated soil used by local farmers located near a closed Portuguese uranium mine ( Cunha Baixa , Mangualde ) ."
96167,farmers,O,3335.0,"Controlled field experiments with potatoes , beans and lettuce ( Solanum tuberosum L. , Phaseolus vulgaris L. and Lactuca sativa L. ) were carried out in a contaminated soil used by local farmers located near a closed Portuguese uranium mine ( Cunha Baixa , Mangualde ) ."
96168,located,O,3335.0,"Controlled field experiments with potatoes , beans and lettuce ( Solanum tuberosum L. , Phaseolus vulgaris L. and Lactuca sativa L. ) were carried out in a contaminated soil used by local farmers located near a closed Portuguese uranium mine ( Cunha Baixa , Mangualde ) ."
96169,near,O,3335.0,"Controlled field experiments with potatoes , beans and lettuce ( Solanum tuberosum L. , Phaseolus vulgaris L. and Lactuca sativa L. ) were carried out in a contaminated soil used by local farmers located near a closed Portuguese uranium mine ( Cunha Baixa , Mangualde ) ."
96170,a,O,3335.0,"Controlled field experiments with potatoes , beans and lettuce ( Solanum tuberosum L. , Phaseolus vulgaris L. and Lactuca sativa L. ) were carried out in a contaminated soil used by local farmers located near a closed Portuguese uranium mine ( Cunha Baixa , Mangualde ) ."
96171,closed,O,3335.0,"Controlled field experiments with potatoes , beans and lettuce ( Solanum tuberosum L. , Phaseolus vulgaris L. and Lactuca sativa L. ) were carried out in a contaminated soil used by local farmers located near a closed Portuguese uranium mine ( Cunha Baixa , Mangualde ) ."
96172,Portuguese,O,3335.0,"Controlled field experiments with potatoes , beans and lettuce ( Solanum tuberosum L. , Phaseolus vulgaris L. and Lactuca sativa L. ) were carried out in a contaminated soil used by local farmers located near a closed Portuguese uranium mine ( Cunha Baixa , Mangualde ) ."
96173,uranium,O,3335.0,"Controlled field experiments with potatoes , beans and lettuce ( Solanum tuberosum L. , Phaseolus vulgaris L. and Lactuca sativa L. ) were carried out in a contaminated soil used by local farmers located near a closed Portuguese uranium mine ( Cunha Baixa , Mangualde ) ."
96174,mine,O,3335.0,"Controlled field experiments with potatoes , beans and lettuce ( Solanum tuberosum L. , Phaseolus vulgaris L. and Lactuca sativa L. ) were carried out in a contaminated soil used by local farmers located near a closed Portuguese uranium mine ( Cunha Baixa , Mangualde ) ."
96175,(,O,3335.0,"Controlled field experiments with potatoes , beans and lettuce ( Solanum tuberosum L. , Phaseolus vulgaris L. and Lactuca sativa L. ) were carried out in a contaminated soil used by local farmers located near a closed Portuguese uranium mine ( Cunha Baixa , Mangualde ) ."
96176,Cunha,O,3335.0,"Controlled field experiments with potatoes , beans and lettuce ( Solanum tuberosum L. , Phaseolus vulgaris L. and Lactuca sativa L. ) were carried out in a contaminated soil used by local farmers located near a closed Portuguese uranium mine ( Cunha Baixa , Mangualde ) ."
96177,Baixa,O,3335.0,"Controlled field experiments with potatoes , beans and lettuce ( Solanum tuberosum L. , Phaseolus vulgaris L. and Lactuca sativa L. ) were carried out in a contaminated soil used by local farmers located near a closed Portuguese uranium mine ( Cunha Baixa , Mangualde ) ."
96178,",",O,3335.0,"Controlled field experiments with potatoes , beans and lettuce ( Solanum tuberosum L. , Phaseolus vulgaris L. and Lactuca sativa L. ) were carried out in a contaminated soil used by local farmers located near a closed Portuguese uranium mine ( Cunha Baixa , Mangualde ) ."
96179,Mangualde,O,3335.0,"Controlled field experiments with potatoes , beans and lettuce ( Solanum tuberosum L. , Phaseolus vulgaris L. and Lactuca sativa L. ) were carried out in a contaminated soil used by local farmers located near a closed Portuguese uranium mine ( Cunha Baixa , Mangualde ) ."
96180,),O,3335.0,"Controlled field experiments with potatoes , beans and lettuce ( Solanum tuberosum L. , Phaseolus vulgaris L. and Lactuca sativa L. ) were carried out in a contaminated soil used by local farmers located near a closed Portuguese uranium mine ( Cunha Baixa , Mangualde ) ."
96181,.,O,3335.0,"Controlled field experiments with potatoes , beans and lettuce ( Solanum tuberosum L. , Phaseolus vulgaris L. and Lactuca sativa L. ) were carried out in a contaminated soil used by local farmers located near a closed Portuguese uranium mine ( Cunha Baixa , Mangualde ) ."
96182,The,O,3336.0,"The soil with high average uranium levels ( 64 - 252 mg / kg ) was divided in two plots , and irrigated with non - contaminated and uranium - contaminated water ( < 20 and > 900 microg / L ) ."
96183,soil,O,3336.0,"The soil with high average uranium levels ( 64 - 252 mg / kg ) was divided in two plots , and irrigated with non - contaminated and uranium - contaminated water ( < 20 and > 900 microg / L ) ."
96184,with,O,3336.0,"The soil with high average uranium levels ( 64 - 252 mg / kg ) was divided in two plots , and irrigated with non - contaminated and uranium - contaminated water ( < 20 and > 900 microg / L ) ."
96185,high,O,3336.0,"The soil with high average uranium levels ( 64 - 252 mg / kg ) was divided in two plots , and irrigated with non - contaminated and uranium - contaminated water ( < 20 and > 900 microg / L ) ."
96186,average,O,3336.0,"The soil with high average uranium levels ( 64 - 252 mg / kg ) was divided in two plots , and irrigated with non - contaminated and uranium - contaminated water ( < 20 and > 900 microg / L ) ."
96187,uranium,O,3336.0,"The soil with high average uranium levels ( 64 - 252 mg / kg ) was divided in two plots , and irrigated with non - contaminated and uranium - contaminated water ( < 20 and > 900 microg / L ) ."
96188,levels,O,3336.0,"The soil with high average uranium levels ( 64 - 252 mg / kg ) was divided in two plots , and irrigated with non - contaminated and uranium - contaminated water ( < 20 and > 900 microg / L ) ."
96189,(,O,3336.0,"The soil with high average uranium levels ( 64 - 252 mg / kg ) was divided in two plots , and irrigated with non - contaminated and uranium - contaminated water ( < 20 and > 900 microg / L ) ."
96190,64,O,3336.0,"The soil with high average uranium levels ( 64 - 252 mg / kg ) was divided in two plots , and irrigated with non - contaminated and uranium - contaminated water ( < 20 and > 900 microg / L ) ."
96191,-,O,3336.0,"The soil with high average uranium levels ( 64 - 252 mg / kg ) was divided in two plots , and irrigated with non - contaminated and uranium - contaminated water ( < 20 and > 900 microg / L ) ."
96192,252,O,3336.0,"The soil with high average uranium levels ( 64 - 252 mg / kg ) was divided in two plots , and irrigated with non - contaminated and uranium - contaminated water ( < 20 and > 900 microg / L ) ."
96193,mg,O,3336.0,"The soil with high average uranium levels ( 64 - 252 mg / kg ) was divided in two plots , and irrigated with non - contaminated and uranium - contaminated water ( < 20 and > 900 microg / L ) ."
96194,/,O,3336.0,"The soil with high average uranium levels ( 64 - 252 mg / kg ) was divided in two plots , and irrigated with non - contaminated and uranium - contaminated water ( < 20 and > 900 microg / L ) ."
96195,kg,O,3336.0,"The soil with high average uranium levels ( 64 - 252 mg / kg ) was divided in two plots , and irrigated with non - contaminated and uranium - contaminated water ( < 20 and > 900 microg / L ) ."
96196,),O,3336.0,"The soil with high average uranium levels ( 64 - 252 mg / kg ) was divided in two plots , and irrigated with non - contaminated and uranium - contaminated water ( < 20 and > 900 microg / L ) ."
96197,was,O,3336.0,"The soil with high average uranium levels ( 64 - 252 mg / kg ) was divided in two plots , and irrigated with non - contaminated and uranium - contaminated water ( < 20 and > 900 microg / L ) ."
96198,divided,O,3336.0,"The soil with high average uranium levels ( 64 - 252 mg / kg ) was divided in two plots , and irrigated with non - contaminated and uranium - contaminated water ( < 20 and > 900 microg / L ) ."
96199,in,O,3336.0,"The soil with high average uranium levels ( 64 - 252 mg / kg ) was divided in two plots , and irrigated with non - contaminated and uranium - contaminated water ( < 20 and > 900 microg / L ) ."
96200,two,O,3336.0,"The soil with high average uranium levels ( 64 - 252 mg / kg ) was divided in two plots , and irrigated with non - contaminated and uranium - contaminated water ( < 20 and > 900 microg / L ) ."
96201,plots,O,3336.0,"The soil with high average uranium levels ( 64 - 252 mg / kg ) was divided in two plots , and irrigated with non - contaminated and uranium - contaminated water ( < 20 and > 900 microg / L ) ."
96202,",",O,3336.0,"The soil with high average uranium levels ( 64 - 252 mg / kg ) was divided in two plots , and irrigated with non - contaminated and uranium - contaminated water ( < 20 and > 900 microg / L ) ."
96203,and,O,3336.0,"The soil with high average uranium levels ( 64 - 252 mg / kg ) was divided in two plots , and irrigated with non - contaminated and uranium - contaminated water ( < 20 and > 900 microg / L ) ."
96204,irrigated,O,3336.0,"The soil with high average uranium levels ( 64 - 252 mg / kg ) was divided in two plots , and irrigated with non - contaminated and uranium - contaminated water ( < 20 and > 900 microg / L ) ."
96205,with,O,3336.0,"The soil with high average uranium levels ( 64 - 252 mg / kg ) was divided in two plots , and irrigated with non - contaminated and uranium - contaminated water ( < 20 and > 900 microg / L ) ."
96206,non,O,3336.0,"The soil with high average uranium levels ( 64 - 252 mg / kg ) was divided in two plots , and irrigated with non - contaminated and uranium - contaminated water ( < 20 and > 900 microg / L ) ."
96207,-,O,3336.0,"The soil with high average uranium levels ( 64 - 252 mg / kg ) was divided in two plots , and irrigated with non - contaminated and uranium - contaminated water ( < 20 and > 900 microg / L ) ."
96208,contaminated,O,3336.0,"The soil with high average uranium levels ( 64 - 252 mg / kg ) was divided in two plots , and irrigated with non - contaminated and uranium - contaminated water ( < 20 and > 900 microg / L ) ."
96209,and,O,3336.0,"The soil with high average uranium levels ( 64 - 252 mg / kg ) was divided in two plots , and irrigated with non - contaminated and uranium - contaminated water ( < 20 and > 900 microg / L ) ."
96210,uranium,O,3336.0,"The soil with high average uranium levels ( 64 - 252 mg / kg ) was divided in two plots , and irrigated with non - contaminated and uranium - contaminated water ( < 20 and > 900 microg / L ) ."
96211,-,O,3336.0,"The soil with high average uranium levels ( 64 - 252 mg / kg ) was divided in two plots , and irrigated with non - contaminated and uranium - contaminated water ( < 20 and > 900 microg / L ) ."
96212,contaminated,O,3336.0,"The soil with high average uranium levels ( 64 - 252 mg / kg ) was divided in two plots , and irrigated with non - contaminated and uranium - contaminated water ( < 20 and > 900 microg / L ) ."
96213,water,O,3336.0,"The soil with high average uranium levels ( 64 - 252 mg / kg ) was divided in two plots , and irrigated with non - contaminated and uranium - contaminated water ( < 20 and > 900 microg / L ) ."
96214,(,O,3336.0,"The soil with high average uranium levels ( 64 - 252 mg / kg ) was divided in two plots , and irrigated with non - contaminated and uranium - contaminated water ( < 20 and > 900 microg / L ) ."
96215,<,O,3336.0,"The soil with high average uranium levels ( 64 - 252 mg / kg ) was divided in two plots , and irrigated with non - contaminated and uranium - contaminated water ( < 20 and > 900 microg / L ) ."
96216,20,O,3336.0,"The soil with high average uranium levels ( 64 - 252 mg / kg ) was divided in two plots , and irrigated with non - contaminated and uranium - contaminated water ( < 20 and > 900 microg / L ) ."
96217,and,O,3336.0,"The soil with high average uranium levels ( 64 - 252 mg / kg ) was divided in two plots , and irrigated with non - contaminated and uranium - contaminated water ( < 20 and > 900 microg / L ) ."
96218,>,O,3336.0,"The soil with high average uranium levels ( 64 - 252 mg / kg ) was divided in two plots , and irrigated with non - contaminated and uranium - contaminated water ( < 20 and > 900 microg / L ) ."
96219,900,O,3336.0,"The soil with high average uranium levels ( 64 - 252 mg / kg ) was divided in two plots , and irrigated with non - contaminated and uranium - contaminated water ( < 20 and > 900 microg / L ) ."
96220,microg,O,3336.0,"The soil with high average uranium levels ( 64 - 252 mg / kg ) was divided in two plots , and irrigated with non - contaminated and uranium - contaminated water ( < 20 and > 900 microg / L ) ."
96221,/,O,3336.0,"The soil with high average uranium levels ( 64 - 252 mg / kg ) was divided in two plots , and irrigated with non - contaminated and uranium - contaminated water ( < 20 and > 900 microg / L ) ."
96222,L,O,3336.0,"The soil with high average uranium levels ( 64 - 252 mg / kg ) was divided in two plots , and irrigated with non - contaminated and uranium - contaminated water ( < 20 and > 900 microg / L ) ."
96223,),O,3336.0,"The soil with high average uranium levels ( 64 - 252 mg / kg ) was divided in two plots , and irrigated with non - contaminated and uranium - contaminated water ( < 20 and > 900 microg / L ) ."
96224,.,O,3336.0,"The soil with high average uranium levels ( 64 - 252 mg / kg ) was divided in two plots , and irrigated with non - contaminated and uranium - contaminated water ( < 20 and > 900 microg / L ) ."
96225,Uranium,O,3337.0,Uranium maximum average concentration in the edible vegetables parts ( mg / kg fresh weight ) ranged in the following order : lettuce ( 234 microg / kg ) > green bean ( 30 microg / kg ) > potatoes without peel ( 4 microg / kg ) .
96226,maximum,O,3337.0,Uranium maximum average concentration in the edible vegetables parts ( mg / kg fresh weight ) ranged in the following order : lettuce ( 234 microg / kg ) > green bean ( 30 microg / kg ) > potatoes without peel ( 4 microg / kg ) .
96227,average,O,3337.0,Uranium maximum average concentration in the edible vegetables parts ( mg / kg fresh weight ) ranged in the following order : lettuce ( 234 microg / kg ) > green bean ( 30 microg / kg ) > potatoes without peel ( 4 microg / kg ) .
96228,concentration,O,3337.0,Uranium maximum average concentration in the edible vegetables parts ( mg / kg fresh weight ) ranged in the following order : lettuce ( 234 microg / kg ) > green bean ( 30 microg / kg ) > potatoes without peel ( 4 microg / kg ) .
96229,in,O,3337.0,Uranium maximum average concentration in the edible vegetables parts ( mg / kg fresh weight ) ranged in the following order : lettuce ( 234 microg / kg ) > green bean ( 30 microg / kg ) > potatoes without peel ( 4 microg / kg ) .
96230,the,O,3337.0,Uranium maximum average concentration in the edible vegetables parts ( mg / kg fresh weight ) ranged in the following order : lettuce ( 234 microg / kg ) > green bean ( 30 microg / kg ) > potatoes without peel ( 4 microg / kg ) .
96231,edible,O,3337.0,Uranium maximum average concentration in the edible vegetables parts ( mg / kg fresh weight ) ranged in the following order : lettuce ( 234 microg / kg ) > green bean ( 30 microg / kg ) > potatoes without peel ( 4 microg / kg ) .
96232,vegetables,O,3337.0,Uranium maximum average concentration in the edible vegetables parts ( mg / kg fresh weight ) ranged in the following order : lettuce ( 234 microg / kg ) > green bean ( 30 microg / kg ) > potatoes without peel ( 4 microg / kg ) .
96233,parts,O,3337.0,Uranium maximum average concentration in the edible vegetables parts ( mg / kg fresh weight ) ranged in the following order : lettuce ( 234 microg / kg ) > green bean ( 30 microg / kg ) > potatoes without peel ( 4 microg / kg ) .
96234,(,O,3337.0,Uranium maximum average concentration in the edible vegetables parts ( mg / kg fresh weight ) ranged in the following order : lettuce ( 234 microg / kg ) > green bean ( 30 microg / kg ) > potatoes without peel ( 4 microg / kg ) .
96235,mg,O,3337.0,Uranium maximum average concentration in the edible vegetables parts ( mg / kg fresh weight ) ranged in the following order : lettuce ( 234 microg / kg ) > green bean ( 30 microg / kg ) > potatoes without peel ( 4 microg / kg ) .
96236,/,O,3337.0,Uranium maximum average concentration in the edible vegetables parts ( mg / kg fresh weight ) ranged in the following order : lettuce ( 234 microg / kg ) > green bean ( 30 microg / kg ) > potatoes without peel ( 4 microg / kg ) .
96237,kg,O,3337.0,Uranium maximum average concentration in the edible vegetables parts ( mg / kg fresh weight ) ranged in the following order : lettuce ( 234 microg / kg ) > green bean ( 30 microg / kg ) > potatoes without peel ( 4 microg / kg ) .
96238,fresh,O,3337.0,Uranium maximum average concentration in the edible vegetables parts ( mg / kg fresh weight ) ranged in the following order : lettuce ( 234 microg / kg ) > green bean ( 30 microg / kg ) > potatoes without peel ( 4 microg / kg ) .
96239,weight,O,3337.0,Uranium maximum average concentration in the edible vegetables parts ( mg / kg fresh weight ) ranged in the following order : lettuce ( 234 microg / kg ) > green bean ( 30 microg / kg ) > potatoes without peel ( 4 microg / kg ) .
96240,),O,3337.0,Uranium maximum average concentration in the edible vegetables parts ( mg / kg fresh weight ) ranged in the following order : lettuce ( 234 microg / kg ) > green bean ( 30 microg / kg ) > potatoes without peel ( 4 microg / kg ) .
96241,ranged,O,3337.0,Uranium maximum average concentration in the edible vegetables parts ( mg / kg fresh weight ) ranged in the following order : lettuce ( 234 microg / kg ) > green bean ( 30 microg / kg ) > potatoes without peel ( 4 microg / kg ) .
96242,in,O,3337.0,Uranium maximum average concentration in the edible vegetables parts ( mg / kg fresh weight ) ranged in the following order : lettuce ( 234 microg / kg ) > green bean ( 30 microg / kg ) > potatoes without peel ( 4 microg / kg ) .
96243,the,O,3337.0,Uranium maximum average concentration in the edible vegetables parts ( mg / kg fresh weight ) ranged in the following order : lettuce ( 234 microg / kg ) > green bean ( 30 microg / kg ) > potatoes without peel ( 4 microg / kg ) .
96244,following,O,3337.0,Uranium maximum average concentration in the edible vegetables parts ( mg / kg fresh weight ) ranged in the following order : lettuce ( 234 microg / kg ) > green bean ( 30 microg / kg ) > potatoes without peel ( 4 microg / kg ) .
96245,order,O,3337.0,Uranium maximum average concentration in the edible vegetables parts ( mg / kg fresh weight ) ranged in the following order : lettuce ( 234 microg / kg ) > green bean ( 30 microg / kg ) > potatoes without peel ( 4 microg / kg ) .
96246,:,O,3337.0,Uranium maximum average concentration in the edible vegetables parts ( mg / kg fresh weight ) ranged in the following order : lettuce ( 234 microg / kg ) > green bean ( 30 microg / kg ) > potatoes without peel ( 4 microg / kg ) .
96247,lettuce,B-AG.01.h.02.c,3337.0,Uranium maximum average concentration in the edible vegetables parts ( mg / kg fresh weight ) ranged in the following order : lettuce ( 234 microg / kg ) > green bean ( 30 microg / kg ) > potatoes without peel ( 4 microg / kg ) .
96248,(,O,3337.0,Uranium maximum average concentration in the edible vegetables parts ( mg / kg fresh weight ) ranged in the following order : lettuce ( 234 microg / kg ) > green bean ( 30 microg / kg ) > potatoes without peel ( 4 microg / kg ) .
96249,234,O,3337.0,Uranium maximum average concentration in the edible vegetables parts ( mg / kg fresh weight ) ranged in the following order : lettuce ( 234 microg / kg ) > green bean ( 30 microg / kg ) > potatoes without peel ( 4 microg / kg ) .
96250,microg,O,3337.0,Uranium maximum average concentration in the edible vegetables parts ( mg / kg fresh weight ) ranged in the following order : lettuce ( 234 microg / kg ) > green bean ( 30 microg / kg ) > potatoes without peel ( 4 microg / kg ) .
96251,/,O,3337.0,Uranium maximum average concentration in the edible vegetables parts ( mg / kg fresh weight ) ranged in the following order : lettuce ( 234 microg / kg ) > green bean ( 30 microg / kg ) > potatoes without peel ( 4 microg / kg ) .
96252,kg,O,3337.0,Uranium maximum average concentration in the edible vegetables parts ( mg / kg fresh weight ) ranged in the following order : lettuce ( 234 microg / kg ) > green bean ( 30 microg / kg ) > potatoes without peel ( 4 microg / kg ) .
96253,),O,3337.0,Uranium maximum average concentration in the edible vegetables parts ( mg / kg fresh weight ) ranged in the following order : lettuce ( 234 microg / kg ) > green bean ( 30 microg / kg ) > potatoes without peel ( 4 microg / kg ) .
96254,>,O,3337.0,Uranium maximum average concentration in the edible vegetables parts ( mg / kg fresh weight ) ranged in the following order : lettuce ( 234 microg / kg ) > green bean ( 30 microg / kg ) > potatoes without peel ( 4 microg / kg ) .
96255,green,B-AG.01.h.02.g,3337.0,Uranium maximum average concentration in the edible vegetables parts ( mg / kg fresh weight ) ranged in the following order : lettuce ( 234 microg / kg ) > green bean ( 30 microg / kg ) > potatoes without peel ( 4 microg / kg ) .
96256,bean,I-AG.01.h.02.g,3337.0,Uranium maximum average concentration in the edible vegetables parts ( mg / kg fresh weight ) ranged in the following order : lettuce ( 234 microg / kg ) > green bean ( 30 microg / kg ) > potatoes without peel ( 4 microg / kg ) .
96257,(,O,3337.0,Uranium maximum average concentration in the edible vegetables parts ( mg / kg fresh weight ) ranged in the following order : lettuce ( 234 microg / kg ) > green bean ( 30 microg / kg ) > potatoes without peel ( 4 microg / kg ) .
96258,30,O,3337.0,Uranium maximum average concentration in the edible vegetables parts ( mg / kg fresh weight ) ranged in the following order : lettuce ( 234 microg / kg ) > green bean ( 30 microg / kg ) > potatoes without peel ( 4 microg / kg ) .
96259,microg,O,3337.0,Uranium maximum average concentration in the edible vegetables parts ( mg / kg fresh weight ) ranged in the following order : lettuce ( 234 microg / kg ) > green bean ( 30 microg / kg ) > potatoes without peel ( 4 microg / kg ) .
96260,/,O,3337.0,Uranium maximum average concentration in the edible vegetables parts ( mg / kg fresh weight ) ranged in the following order : lettuce ( 234 microg / kg ) > green bean ( 30 microg / kg ) > potatoes without peel ( 4 microg / kg ) .
96261,kg,O,3337.0,Uranium maximum average concentration in the edible vegetables parts ( mg / kg fresh weight ) ranged in the following order : lettuce ( 234 microg / kg ) > green bean ( 30 microg / kg ) > potatoes without peel ( 4 microg / kg ) .
96262,),O,3337.0,Uranium maximum average concentration in the edible vegetables parts ( mg / kg fresh weight ) ranged in the following order : lettuce ( 234 microg / kg ) > green bean ( 30 microg / kg ) > potatoes without peel ( 4 microg / kg ) .
96263,>,O,3337.0,Uranium maximum average concentration in the edible vegetables parts ( mg / kg fresh weight ) ranged in the following order : lettuce ( 234 microg / kg ) > green bean ( 30 microg / kg ) > potatoes without peel ( 4 microg / kg ) .
96264,potatoes,B-AG.01.h.02.a,3337.0,Uranium maximum average concentration in the edible vegetables parts ( mg / kg fresh weight ) ranged in the following order : lettuce ( 234 microg / kg ) > green bean ( 30 microg / kg ) > potatoes without peel ( 4 microg / kg ) .
96265,without,I-AG.01.h.02.a,3337.0,Uranium maximum average concentration in the edible vegetables parts ( mg / kg fresh weight ) ranged in the following order : lettuce ( 234 microg / kg ) > green bean ( 30 microg / kg ) > potatoes without peel ( 4 microg / kg ) .
96266,peel,I-AG.01.h.02.a,3337.0,Uranium maximum average concentration in the edible vegetables parts ( mg / kg fresh weight ) ranged in the following order : lettuce ( 234 microg / kg ) > green bean ( 30 microg / kg ) > potatoes without peel ( 4 microg / kg ) .
96267,(,O,3337.0,Uranium maximum average concentration in the edible vegetables parts ( mg / kg fresh weight ) ranged in the following order : lettuce ( 234 microg / kg ) > green bean ( 30 microg / kg ) > potatoes without peel ( 4 microg / kg ) .
96268,4,O,3337.0,Uranium maximum average concentration in the edible vegetables parts ( mg / kg fresh weight ) ranged in the following order : lettuce ( 234 microg / kg ) > green bean ( 30 microg / kg ) > potatoes without peel ( 4 microg / kg ) .
96269,microg,O,3337.0,Uranium maximum average concentration in the edible vegetables parts ( mg / kg fresh weight ) ranged in the following order : lettuce ( 234 microg / kg ) > green bean ( 30 microg / kg ) > potatoes without peel ( 4 microg / kg ) .
96270,/,O,3337.0,Uranium maximum average concentration in the edible vegetables parts ( mg / kg fresh weight ) ranged in the following order : lettuce ( 234 microg / kg ) > green bean ( 30 microg / kg ) > potatoes without peel ( 4 microg / kg ) .
96271,kg,O,3337.0,Uranium maximum average concentration in the edible vegetables parts ( mg / kg fresh weight ) ranged in the following order : lettuce ( 234 microg / kg ) > green bean ( 30 microg / kg ) > potatoes without peel ( 4 microg / kg ) .
96272,),O,3337.0,Uranium maximum average concentration in the edible vegetables parts ( mg / kg fresh weight ) ranged in the following order : lettuce ( 234 microg / kg ) > green bean ( 30 microg / kg ) > potatoes without peel ( 4 microg / kg ) .
96273,.,O,3337.0,Uranium maximum average concentration in the edible vegetables parts ( mg / kg fresh weight ) ranged in the following order : lettuce ( 234 microg / kg ) > green bean ( 30 microg / kg ) > potatoes without peel ( 4 microg / kg ) .
96274,Although,O,3338.0,"Although uranium in soil , irrigation water and vegetables was high , the assessment of the health risk based on hazard quotient indicates that consumption of these vegetables does not represent potential adverse ( no carcinogenic ) effects for a local inhabitant during lifetime ."
96275,uranium,O,3338.0,"Although uranium in soil , irrigation water and vegetables was high , the assessment of the health risk based on hazard quotient indicates that consumption of these vegetables does not represent potential adverse ( no carcinogenic ) effects for a local inhabitant during lifetime ."
96276,in,O,3338.0,"Although uranium in soil , irrigation water and vegetables was high , the assessment of the health risk based on hazard quotient indicates that consumption of these vegetables does not represent potential adverse ( no carcinogenic ) effects for a local inhabitant during lifetime ."
96277,soil,O,3338.0,"Although uranium in soil , irrigation water and vegetables was high , the assessment of the health risk based on hazard quotient indicates that consumption of these vegetables does not represent potential adverse ( no carcinogenic ) effects for a local inhabitant during lifetime ."
96278,",",O,3338.0,"Although uranium in soil , irrigation water and vegetables was high , the assessment of the health risk based on hazard quotient indicates that consumption of these vegetables does not represent potential adverse ( no carcinogenic ) effects for a local inhabitant during lifetime ."
96279,irrigation,O,3338.0,"Although uranium in soil , irrigation water and vegetables was high , the assessment of the health risk based on hazard quotient indicates that consumption of these vegetables does not represent potential adverse ( no carcinogenic ) effects for a local inhabitant during lifetime ."
96280,water,O,3338.0,"Although uranium in soil , irrigation water and vegetables was high , the assessment of the health risk based on hazard quotient indicates that consumption of these vegetables does not represent potential adverse ( no carcinogenic ) effects for a local inhabitant during lifetime ."
96281,and,O,3338.0,"Although uranium in soil , irrigation water and vegetables was high , the assessment of the health risk based on hazard quotient indicates that consumption of these vegetables does not represent potential adverse ( no carcinogenic ) effects for a local inhabitant during lifetime ."
96282,vegetables,B-AG.01.h.02,3338.0,"Although uranium in soil , irrigation water and vegetables was high , the assessment of the health risk based on hazard quotient indicates that consumption of these vegetables does not represent potential adverse ( no carcinogenic ) effects for a local inhabitant during lifetime ."
96283,was,O,3338.0,"Although uranium in soil , irrigation water and vegetables was high , the assessment of the health risk based on hazard quotient indicates that consumption of these vegetables does not represent potential adverse ( no carcinogenic ) effects for a local inhabitant during lifetime ."
96284,high,O,3338.0,"Although uranium in soil , irrigation water and vegetables was high , the assessment of the health risk based on hazard quotient indicates that consumption of these vegetables does not represent potential adverse ( no carcinogenic ) effects for a local inhabitant during lifetime ."
96285,",",O,3338.0,"Although uranium in soil , irrigation water and vegetables was high , the assessment of the health risk based on hazard quotient indicates that consumption of these vegetables does not represent potential adverse ( no carcinogenic ) effects for a local inhabitant during lifetime ."
96286,the,O,3338.0,"Although uranium in soil , irrigation water and vegetables was high , the assessment of the health risk based on hazard quotient indicates that consumption of these vegetables does not represent potential adverse ( no carcinogenic ) effects for a local inhabitant during lifetime ."
96287,assessment,O,3338.0,"Although uranium in soil , irrigation water and vegetables was high , the assessment of the health risk based on hazard quotient indicates that consumption of these vegetables does not represent potential adverse ( no carcinogenic ) effects for a local inhabitant during lifetime ."
96288,of,O,3338.0,"Although uranium in soil , irrigation water and vegetables was high , the assessment of the health risk based on hazard quotient indicates that consumption of these vegetables does not represent potential adverse ( no carcinogenic ) effects for a local inhabitant during lifetime ."
96289,the,O,3338.0,"Although uranium in soil , irrigation water and vegetables was high , the assessment of the health risk based on hazard quotient indicates that consumption of these vegetables does not represent potential adverse ( no carcinogenic ) effects for a local inhabitant during lifetime ."
96290,health,O,3338.0,"Although uranium in soil , irrigation water and vegetables was high , the assessment of the health risk based on hazard quotient indicates that consumption of these vegetables does not represent potential adverse ( no carcinogenic ) effects for a local inhabitant during lifetime ."
96291,risk,O,3338.0,"Although uranium in soil , irrigation water and vegetables was high , the assessment of the health risk based on hazard quotient indicates that consumption of these vegetables does not represent potential adverse ( no carcinogenic ) effects for a local inhabitant during lifetime ."
96292,based,O,3338.0,"Although uranium in soil , irrigation water and vegetables was high , the assessment of the health risk based on hazard quotient indicates that consumption of these vegetables does not represent potential adverse ( no carcinogenic ) effects for a local inhabitant during lifetime ."
96293,on,O,3338.0,"Although uranium in soil , irrigation water and vegetables was high , the assessment of the health risk based on hazard quotient indicates that consumption of these vegetables does not represent potential adverse ( no carcinogenic ) effects for a local inhabitant during lifetime ."
96294,hazard,O,3338.0,"Although uranium in soil , irrigation water and vegetables was high , the assessment of the health risk based on hazard quotient indicates that consumption of these vegetables does not represent potential adverse ( no carcinogenic ) effects for a local inhabitant during lifetime ."
96295,quotient,O,3338.0,"Although uranium in soil , irrigation water and vegetables was high , the assessment of the health risk based on hazard quotient indicates that consumption of these vegetables does not represent potential adverse ( no carcinogenic ) effects for a local inhabitant during lifetime ."
96296,indicates,O,3338.0,"Although uranium in soil , irrigation water and vegetables was high , the assessment of the health risk based on hazard quotient indicates that consumption of these vegetables does not represent potential adverse ( no carcinogenic ) effects for a local inhabitant during lifetime ."
96297,that,O,3338.0,"Although uranium in soil , irrigation water and vegetables was high , the assessment of the health risk based on hazard quotient indicates that consumption of these vegetables does not represent potential adverse ( no carcinogenic ) effects for a local inhabitant during lifetime ."
96298,consumption,O,3338.0,"Although uranium in soil , irrigation water and vegetables was high , the assessment of the health risk based on hazard quotient indicates that consumption of these vegetables does not represent potential adverse ( no carcinogenic ) effects for a local inhabitant during lifetime ."
96299,of,O,3338.0,"Although uranium in soil , irrigation water and vegetables was high , the assessment of the health risk based on hazard quotient indicates that consumption of these vegetables does not represent potential adverse ( no carcinogenic ) effects for a local inhabitant during lifetime ."
96300,these,O,3338.0,"Although uranium in soil , irrigation water and vegetables was high , the assessment of the health risk based on hazard quotient indicates that consumption of these vegetables does not represent potential adverse ( no carcinogenic ) effects for a local inhabitant during lifetime ."
96301,vegetables,B-AG.01.h.02,3338.0,"Although uranium in soil , irrigation water and vegetables was high , the assessment of the health risk based on hazard quotient indicates that consumption of these vegetables does not represent potential adverse ( no carcinogenic ) effects for a local inhabitant during lifetime ."
96302,does,O,3338.0,"Although uranium in soil , irrigation water and vegetables was high , the assessment of the health risk based on hazard quotient indicates that consumption of these vegetables does not represent potential adverse ( no carcinogenic ) effects for a local inhabitant during lifetime ."
96303,not,O,3338.0,"Although uranium in soil , irrigation water and vegetables was high , the assessment of the health risk based on hazard quotient indicates that consumption of these vegetables does not represent potential adverse ( no carcinogenic ) effects for a local inhabitant during lifetime ."
96304,represent,O,3338.0,"Although uranium in soil , irrigation water and vegetables was high , the assessment of the health risk based on hazard quotient indicates that consumption of these vegetables does not represent potential adverse ( no carcinogenic ) effects for a local inhabitant during lifetime ."
96305,potential,O,3338.0,"Although uranium in soil , irrigation water and vegetables was high , the assessment of the health risk based on hazard quotient indicates that consumption of these vegetables does not represent potential adverse ( no carcinogenic ) effects for a local inhabitant during lifetime ."
96306,adverse,O,3338.0,"Although uranium in soil , irrigation water and vegetables was high , the assessment of the health risk based on hazard quotient indicates that consumption of these vegetables does not represent potential adverse ( no carcinogenic ) effects for a local inhabitant during lifetime ."
96307,(,O,3338.0,"Although uranium in soil , irrigation water and vegetables was high , the assessment of the health risk based on hazard quotient indicates that consumption of these vegetables does not represent potential adverse ( no carcinogenic ) effects for a local inhabitant during lifetime ."
96308,no,O,3338.0,"Although uranium in soil , irrigation water and vegetables was high , the assessment of the health risk based on hazard quotient indicates that consumption of these vegetables does not represent potential adverse ( no carcinogenic ) effects for a local inhabitant during lifetime ."
96309,carcinogenic,O,3338.0,"Although uranium in soil , irrigation water and vegetables was high , the assessment of the health risk based on hazard quotient indicates that consumption of these vegetables does not represent potential adverse ( no carcinogenic ) effects for a local inhabitant during lifetime ."
96310,),O,3338.0,"Although uranium in soil , irrigation water and vegetables was high , the assessment of the health risk based on hazard quotient indicates that consumption of these vegetables does not represent potential adverse ( no carcinogenic ) effects for a local inhabitant during lifetime ."
96311,effects,O,3338.0,"Although uranium in soil , irrigation water and vegetables was high , the assessment of the health risk based on hazard quotient indicates that consumption of these vegetables does not represent potential adverse ( no carcinogenic ) effects for a local inhabitant during lifetime ."
96312,for,O,3338.0,"Although uranium in soil , irrigation water and vegetables was high , the assessment of the health risk based on hazard quotient indicates that consumption of these vegetables does not represent potential adverse ( no carcinogenic ) effects for a local inhabitant during lifetime ."
96313,a,O,3338.0,"Although uranium in soil , irrigation water and vegetables was high , the assessment of the health risk based on hazard quotient indicates that consumption of these vegetables does not represent potential adverse ( no carcinogenic ) effects for a local inhabitant during lifetime ."
96314,local,O,3338.0,"Although uranium in soil , irrigation water and vegetables was high , the assessment of the health risk based on hazard quotient indicates that consumption of these vegetables does not represent potential adverse ( no carcinogenic ) effects for a local inhabitant during lifetime ."
96315,inhabitant,O,3338.0,"Although uranium in soil , irrigation water and vegetables was high , the assessment of the health risk based on hazard quotient indicates that consumption of these vegetables does not represent potential adverse ( no carcinogenic ) effects for a local inhabitant during lifetime ."
96316,during,O,3338.0,"Although uranium in soil , irrigation water and vegetables was high , the assessment of the health risk based on hazard quotient indicates that consumption of these vegetables does not represent potential adverse ( no carcinogenic ) effects for a local inhabitant during lifetime ."
96317,lifetime,O,3338.0,"Although uranium in soil , irrigation water and vegetables was high , the assessment of the health risk based on hazard quotient indicates that consumption of these vegetables does not represent potential adverse ( no carcinogenic ) effects for a local inhabitant during lifetime ."
96318,.,O,3338.0,"Although uranium in soil , irrigation water and vegetables was high , the assessment of the health risk based on hazard quotient indicates that consumption of these vegetables does not represent potential adverse ( no carcinogenic ) effects for a local inhabitant during lifetime ."
96319,Observational,O,3339.0,Observational studies provide evidence that a higher intake of protein from plant - based foods and certain animal - based foods is associated with a lower risk for type 2 diabetes .
96320,studies,O,3339.0,Observational studies provide evidence that a higher intake of protein from plant - based foods and certain animal - based foods is associated with a lower risk for type 2 diabetes .
96321,provide,O,3339.0,Observational studies provide evidence that a higher intake of protein from plant - based foods and certain animal - based foods is associated with a lower risk for type 2 diabetes .
96322,evidence,O,3339.0,Observational studies provide evidence that a higher intake of protein from plant - based foods and certain animal - based foods is associated with a lower risk for type 2 diabetes .
96323,that,O,3339.0,Observational studies provide evidence that a higher intake of protein from plant - based foods and certain animal - based foods is associated with a lower risk for type 2 diabetes .
96324,a,O,3339.0,Observational studies provide evidence that a higher intake of protein from plant - based foods and certain animal - based foods is associated with a lower risk for type 2 diabetes .
96325,higher,O,3339.0,Observational studies provide evidence that a higher intake of protein from plant - based foods and certain animal - based foods is associated with a lower risk for type 2 diabetes .
96326,intake,O,3339.0,Observational studies provide evidence that a higher intake of protein from plant - based foods and certain animal - based foods is associated with a lower risk for type 2 diabetes .
96327,of,O,3339.0,Observational studies provide evidence that a higher intake of protein from plant - based foods and certain animal - based foods is associated with a lower risk for type 2 diabetes .
96328,protein,O,3339.0,Observational studies provide evidence that a higher intake of protein from plant - based foods and certain animal - based foods is associated with a lower risk for type 2 diabetes .
96329,from,O,3339.0,Observational studies provide evidence that a higher intake of protein from plant - based foods and certain animal - based foods is associated with a lower risk for type 2 diabetes .
96330,plant,B-AG.01,3339.0,Observational studies provide evidence that a higher intake of protein from plant - based foods and certain animal - based foods is associated with a lower risk for type 2 diabetes .
96331,-,I-AG.01,3339.0,Observational studies provide evidence that a higher intake of protein from plant - based foods and certain animal - based foods is associated with a lower risk for type 2 diabetes .
96332,based,I-AG.01,3339.0,Observational studies provide evidence that a higher intake of protein from plant - based foods and certain animal - based foods is associated with a lower risk for type 2 diabetes .
96333,foods,I-AG.01,3339.0,Observational studies provide evidence that a higher intake of protein from plant - based foods and certain animal - based foods is associated with a lower risk for type 2 diabetes .
96334,and,O,3339.0,Observational studies provide evidence that a higher intake of protein from plant - based foods and certain animal - based foods is associated with a lower risk for type 2 diabetes .
96335,certain,O,3339.0,Observational studies provide evidence that a higher intake of protein from plant - based foods and certain animal - based foods is associated with a lower risk for type 2 diabetes .
96336,animal,B-AG.01,3339.0,Observational studies provide evidence that a higher intake of protein from plant - based foods and certain animal - based foods is associated with a lower risk for type 2 diabetes .
96337,-,I-AG.01,3339.0,Observational studies provide evidence that a higher intake of protein from plant - based foods and certain animal - based foods is associated with a lower risk for type 2 diabetes .
96338,based,I-AG.01,3339.0,Observational studies provide evidence that a higher intake of protein from plant - based foods and certain animal - based foods is associated with a lower risk for type 2 diabetes .
96339,foods,I-AG.01,3339.0,Observational studies provide evidence that a higher intake of protein from plant - based foods and certain animal - based foods is associated with a lower risk for type 2 diabetes .
96340,is,O,3339.0,Observational studies provide evidence that a higher intake of protein from plant - based foods and certain animal - based foods is associated with a lower risk for type 2 diabetes .
96341,associated,O,3339.0,Observational studies provide evidence that a higher intake of protein from plant - based foods and certain animal - based foods is associated with a lower risk for type 2 diabetes .
96342,with,O,3339.0,Observational studies provide evidence that a higher intake of protein from plant - based foods and certain animal - based foods is associated with a lower risk for type 2 diabetes .
96343,a,O,3339.0,Observational studies provide evidence that a higher intake of protein from plant - based foods and certain animal - based foods is associated with a lower risk for type 2 diabetes .
96344,lower,O,3339.0,Observational studies provide evidence that a higher intake of protein from plant - based foods and certain animal - based foods is associated with a lower risk for type 2 diabetes .
96345,risk,O,3339.0,Observational studies provide evidence that a higher intake of protein from plant - based foods and certain animal - based foods is associated with a lower risk for type 2 diabetes .
96346,for,O,3339.0,Observational studies provide evidence that a higher intake of protein from plant - based foods and certain animal - based foods is associated with a lower risk for type 2 diabetes .
96347,type,O,3339.0,Observational studies provide evidence that a higher intake of protein from plant - based foods and certain animal - based foods is associated with a lower risk for type 2 diabetes .
96348,2,O,3339.0,Observational studies provide evidence that a higher intake of protein from plant - based foods and certain animal - based foods is associated with a lower risk for type 2 diabetes .
96349,diabetes,O,3339.0,Observational studies provide evidence that a higher intake of protein from plant - based foods and certain animal - based foods is associated with a lower risk for type 2 diabetes .
96350,.,O,3339.0,Observational studies provide evidence that a higher intake of protein from plant - based foods and certain animal - based foods is associated with a lower risk for type 2 diabetes .
96351,However,O,3340.0,"However , there are few distinguishable differences between the glucoregulatory qualities of the proteins in plant - based foods , and it is likely their numerous non - protein components ( e.g. , fibers and phytochemicals ) that drive the relationship with type 2 diabetes risk reduction ."
96352,",",O,3340.0,"However , there are few distinguishable differences between the glucoregulatory qualities of the proteins in plant - based foods , and it is likely their numerous non - protein components ( e.g. , fibers and phytochemicals ) that drive the relationship with type 2 diabetes risk reduction ."
96353,there,O,3340.0,"However , there are few distinguishable differences between the glucoregulatory qualities of the proteins in plant - based foods , and it is likely their numerous non - protein components ( e.g. , fibers and phytochemicals ) that drive the relationship with type 2 diabetes risk reduction ."
96354,are,O,3340.0,"However , there are few distinguishable differences between the glucoregulatory qualities of the proteins in plant - based foods , and it is likely their numerous non - protein components ( e.g. , fibers and phytochemicals ) that drive the relationship with type 2 diabetes risk reduction ."
96355,few,O,3340.0,"However , there are few distinguishable differences between the glucoregulatory qualities of the proteins in plant - based foods , and it is likely their numerous non - protein components ( e.g. , fibers and phytochemicals ) that drive the relationship with type 2 diabetes risk reduction ."
96356,distinguishable,O,3340.0,"However , there are few distinguishable differences between the glucoregulatory qualities of the proteins in plant - based foods , and it is likely their numerous non - protein components ( e.g. , fibers and phytochemicals ) that drive the relationship with type 2 diabetes risk reduction ."
96357,differences,O,3340.0,"However , there are few distinguishable differences between the glucoregulatory qualities of the proteins in plant - based foods , and it is likely their numerous non - protein components ( e.g. , fibers and phytochemicals ) that drive the relationship with type 2 diabetes risk reduction ."
96358,between,O,3340.0,"However , there are few distinguishable differences between the glucoregulatory qualities of the proteins in plant - based foods , and it is likely their numerous non - protein components ( e.g. , fibers and phytochemicals ) that drive the relationship with type 2 diabetes risk reduction ."
96359,the,O,3340.0,"However , there are few distinguishable differences between the glucoregulatory qualities of the proteins in plant - based foods , and it is likely their numerous non - protein components ( e.g. , fibers and phytochemicals ) that drive the relationship with type 2 diabetes risk reduction ."
96360,glucoregulatory,O,3340.0,"However , there are few distinguishable differences between the glucoregulatory qualities of the proteins in plant - based foods , and it is likely their numerous non - protein components ( e.g. , fibers and phytochemicals ) that drive the relationship with type 2 diabetes risk reduction ."
96361,qualities,O,3340.0,"However , there are few distinguishable differences between the glucoregulatory qualities of the proteins in plant - based foods , and it is likely their numerous non - protein components ( e.g. , fibers and phytochemicals ) that drive the relationship with type 2 diabetes risk reduction ."
96362,of,O,3340.0,"However , there are few distinguishable differences between the glucoregulatory qualities of the proteins in plant - based foods , and it is likely their numerous non - protein components ( e.g. , fibers and phytochemicals ) that drive the relationship with type 2 diabetes risk reduction ."
96363,the,O,3340.0,"However , there are few distinguishable differences between the glucoregulatory qualities of the proteins in plant - based foods , and it is likely their numerous non - protein components ( e.g. , fibers and phytochemicals ) that drive the relationship with type 2 diabetes risk reduction ."
96364,proteins,O,3340.0,"However , there are few distinguishable differences between the glucoregulatory qualities of the proteins in plant - based foods , and it is likely their numerous non - protein components ( e.g. , fibers and phytochemicals ) that drive the relationship with type 2 diabetes risk reduction ."
96365,in,O,3340.0,"However , there are few distinguishable differences between the glucoregulatory qualities of the proteins in plant - based foods , and it is likely their numerous non - protein components ( e.g. , fibers and phytochemicals ) that drive the relationship with type 2 diabetes risk reduction ."
96366,plant,B-AG.01,3340.0,"However , there are few distinguishable differences between the glucoregulatory qualities of the proteins in plant - based foods , and it is likely their numerous non - protein components ( e.g. , fibers and phytochemicals ) that drive the relationship with type 2 diabetes risk reduction ."
96367,-,I-AG.01,3340.0,"However , there are few distinguishable differences between the glucoregulatory qualities of the proteins in plant - based foods , and it is likely their numerous non - protein components ( e.g. , fibers and phytochemicals ) that drive the relationship with type 2 diabetes risk reduction ."
96368,based,I-AG.01,3340.0,"However , there are few distinguishable differences between the glucoregulatory qualities of the proteins in plant - based foods , and it is likely their numerous non - protein components ( e.g. , fibers and phytochemicals ) that drive the relationship with type 2 diabetes risk reduction ."
96369,foods,I-AG.01,3340.0,"However , there are few distinguishable differences between the glucoregulatory qualities of the proteins in plant - based foods , and it is likely their numerous non - protein components ( e.g. , fibers and phytochemicals ) that drive the relationship with type 2 diabetes risk reduction ."
96370,",",O,3340.0,"However , there are few distinguishable differences between the glucoregulatory qualities of the proteins in plant - based foods , and it is likely their numerous non - protein components ( e.g. , fibers and phytochemicals ) that drive the relationship with type 2 diabetes risk reduction ."
96371,and,O,3340.0,"However , there are few distinguishable differences between the glucoregulatory qualities of the proteins in plant - based foods , and it is likely their numerous non - protein components ( e.g. , fibers and phytochemicals ) that drive the relationship with type 2 diabetes risk reduction ."
96372,it,O,3340.0,"However , there are few distinguishable differences between the glucoregulatory qualities of the proteins in plant - based foods , and it is likely their numerous non - protein components ( e.g. , fibers and phytochemicals ) that drive the relationship with type 2 diabetes risk reduction ."
96373,is,O,3340.0,"However , there are few distinguishable differences between the glucoregulatory qualities of the proteins in plant - based foods , and it is likely their numerous non - protein components ( e.g. , fibers and phytochemicals ) that drive the relationship with type 2 diabetes risk reduction ."
96374,likely,O,3340.0,"However , there are few distinguishable differences between the glucoregulatory qualities of the proteins in plant - based foods , and it is likely their numerous non - protein components ( e.g. , fibers and phytochemicals ) that drive the relationship with type 2 diabetes risk reduction ."
96375,their,O,3340.0,"However , there are few distinguishable differences between the glucoregulatory qualities of the proteins in plant - based foods , and it is likely their numerous non - protein components ( e.g. , fibers and phytochemicals ) that drive the relationship with type 2 diabetes risk reduction ."
96376,numerous,O,3340.0,"However , there are few distinguishable differences between the glucoregulatory qualities of the proteins in plant - based foods , and it is likely their numerous non - protein components ( e.g. , fibers and phytochemicals ) that drive the relationship with type 2 diabetes risk reduction ."
96377,non,O,3340.0,"However , there are few distinguishable differences between the glucoregulatory qualities of the proteins in plant - based foods , and it is likely their numerous non - protein components ( e.g. , fibers and phytochemicals ) that drive the relationship with type 2 diabetes risk reduction ."
96378,-,O,3340.0,"However , there are few distinguishable differences between the glucoregulatory qualities of the proteins in plant - based foods , and it is likely their numerous non - protein components ( e.g. , fibers and phytochemicals ) that drive the relationship with type 2 diabetes risk reduction ."
96379,protein,O,3340.0,"However , there are few distinguishable differences between the glucoregulatory qualities of the proteins in plant - based foods , and it is likely their numerous non - protein components ( e.g. , fibers and phytochemicals ) that drive the relationship with type 2 diabetes risk reduction ."
96380,components,O,3340.0,"However , there are few distinguishable differences between the glucoregulatory qualities of the proteins in plant - based foods , and it is likely their numerous non - protein components ( e.g. , fibers and phytochemicals ) that drive the relationship with type 2 diabetes risk reduction ."
96381,(,O,3340.0,"However , there are few distinguishable differences between the glucoregulatory qualities of the proteins in plant - based foods , and it is likely their numerous non - protein components ( e.g. , fibers and phytochemicals ) that drive the relationship with type 2 diabetes risk reduction ."
96382,e.g.,O,3340.0,"However , there are few distinguishable differences between the glucoregulatory qualities of the proteins in plant - based foods , and it is likely their numerous non - protein components ( e.g. , fibers and phytochemicals ) that drive the relationship with type 2 diabetes risk reduction ."
96383,",",O,3340.0,"However , there are few distinguishable differences between the glucoregulatory qualities of the proteins in plant - based foods , and it is likely their numerous non - protein components ( e.g. , fibers and phytochemicals ) that drive the relationship with type 2 diabetes risk reduction ."
96384,fibers,O,3340.0,"However , there are few distinguishable differences between the glucoregulatory qualities of the proteins in plant - based foods , and it is likely their numerous non - protein components ( e.g. , fibers and phytochemicals ) that drive the relationship with type 2 diabetes risk reduction ."
96385,and,O,3340.0,"However , there are few distinguishable differences between the glucoregulatory qualities of the proteins in plant - based foods , and it is likely their numerous non - protein components ( e.g. , fibers and phytochemicals ) that drive the relationship with type 2 diabetes risk reduction ."
96386,phytochemicals,O,3340.0,"However , there are few distinguishable differences between the glucoregulatory qualities of the proteins in plant - based foods , and it is likely their numerous non - protein components ( e.g. , fibers and phytochemicals ) that drive the relationship with type 2 diabetes risk reduction ."
96387,),O,3340.0,"However , there are few distinguishable differences between the glucoregulatory qualities of the proteins in plant - based foods , and it is likely their numerous non - protein components ( e.g. , fibers and phytochemicals ) that drive the relationship with type 2 diabetes risk reduction ."
96388,that,O,3340.0,"However , there are few distinguishable differences between the glucoregulatory qualities of the proteins in plant - based foods , and it is likely their numerous non - protein components ( e.g. , fibers and phytochemicals ) that drive the relationship with type 2 diabetes risk reduction ."
96389,drive,O,3340.0,"However , there are few distinguishable differences between the glucoregulatory qualities of the proteins in plant - based foods , and it is likely their numerous non - protein components ( e.g. , fibers and phytochemicals ) that drive the relationship with type 2 diabetes risk reduction ."
96390,the,O,3340.0,"However , there are few distinguishable differences between the glucoregulatory qualities of the proteins in plant - based foods , and it is likely their numerous non - protein components ( e.g. , fibers and phytochemicals ) that drive the relationship with type 2 diabetes risk reduction ."
96391,relationship,O,3340.0,"However , there are few distinguishable differences between the glucoregulatory qualities of the proteins in plant - based foods , and it is likely their numerous non - protein components ( e.g. , fibers and phytochemicals ) that drive the relationship with type 2 diabetes risk reduction ."
96392,with,O,3340.0,"However , there are few distinguishable differences between the glucoregulatory qualities of the proteins in plant - based foods , and it is likely their numerous non - protein components ( e.g. , fibers and phytochemicals ) that drive the relationship with type 2 diabetes risk reduction ."
96393,type,O,3340.0,"However , there are few distinguishable differences between the glucoregulatory qualities of the proteins in plant - based foods , and it is likely their numerous non - protein components ( e.g. , fibers and phytochemicals ) that drive the relationship with type 2 diabetes risk reduction ."
96394,2,O,3340.0,"However , there are few distinguishable differences between the glucoregulatory qualities of the proteins in plant - based foods , and it is likely their numerous non - protein components ( e.g. , fibers and phytochemicals ) that drive the relationship with type 2 diabetes risk reduction ."
96395,diabetes,O,3340.0,"However , there are few distinguishable differences between the glucoregulatory qualities of the proteins in plant - based foods , and it is likely their numerous non - protein components ( e.g. , fibers and phytochemicals ) that drive the relationship with type 2 diabetes risk reduction ."
96396,risk,O,3340.0,"However , there are few distinguishable differences between the glucoregulatory qualities of the proteins in plant - based foods , and it is likely their numerous non - protein components ( e.g. , fibers and phytochemicals ) that drive the relationship with type 2 diabetes risk reduction ."
96397,reduction,O,3340.0,"However , there are few distinguishable differences between the glucoregulatory qualities of the proteins in plant - based foods , and it is likely their numerous non - protein components ( e.g. , fibers and phytochemicals ) that drive the relationship with type 2 diabetes risk reduction ."
96398,.,O,3340.0,"However , there are few distinguishable differences between the glucoregulatory qualities of the proteins in plant - based foods , and it is likely their numerous non - protein components ( e.g. , fibers and phytochemicals ) that drive the relationship with type 2 diabetes risk reduction ."
96399,Conversely,O,3341.0,"Conversely , the glucoregulatory qualities of the proteins in animal - based foods are extremely divergent , with a higher intake of certain animal - based protein foods showing negative effects , and others showing neutral or positive effects on type 2 diabetes risk ."
96400,",",O,3341.0,"Conversely , the glucoregulatory qualities of the proteins in animal - based foods are extremely divergent , with a higher intake of certain animal - based protein foods showing negative effects , and others showing neutral or positive effects on type 2 diabetes risk ."
96401,the,O,3341.0,"Conversely , the glucoregulatory qualities of the proteins in animal - based foods are extremely divergent , with a higher intake of certain animal - based protein foods showing negative effects , and others showing neutral or positive effects on type 2 diabetes risk ."
96402,glucoregulatory,O,3341.0,"Conversely , the glucoregulatory qualities of the proteins in animal - based foods are extremely divergent , with a higher intake of certain animal - based protein foods showing negative effects , and others showing neutral or positive effects on type 2 diabetes risk ."
96403,qualities,O,3341.0,"Conversely , the glucoregulatory qualities of the proteins in animal - based foods are extremely divergent , with a higher intake of certain animal - based protein foods showing negative effects , and others showing neutral or positive effects on type 2 diabetes risk ."
96404,of,O,3341.0,"Conversely , the glucoregulatory qualities of the proteins in animal - based foods are extremely divergent , with a higher intake of certain animal - based protein foods showing negative effects , and others showing neutral or positive effects on type 2 diabetes risk ."
96405,the,O,3341.0,"Conversely , the glucoregulatory qualities of the proteins in animal - based foods are extremely divergent , with a higher intake of certain animal - based protein foods showing negative effects , and others showing neutral or positive effects on type 2 diabetes risk ."
96406,proteins,O,3341.0,"Conversely , the glucoregulatory qualities of the proteins in animal - based foods are extremely divergent , with a higher intake of certain animal - based protein foods showing negative effects , and others showing neutral or positive effects on type 2 diabetes risk ."
96407,in,O,3341.0,"Conversely , the glucoregulatory qualities of the proteins in animal - based foods are extremely divergent , with a higher intake of certain animal - based protein foods showing negative effects , and others showing neutral or positive effects on type 2 diabetes risk ."
96408,animal,B-AG.01,3341.0,"Conversely , the glucoregulatory qualities of the proteins in animal - based foods are extremely divergent , with a higher intake of certain animal - based protein foods showing negative effects , and others showing neutral or positive effects on type 2 diabetes risk ."
96409,-,I-AG.01,3341.0,"Conversely , the glucoregulatory qualities of the proteins in animal - based foods are extremely divergent , with a higher intake of certain animal - based protein foods showing negative effects , and others showing neutral or positive effects on type 2 diabetes risk ."
96410,based,I-AG.01,3341.0,"Conversely , the glucoregulatory qualities of the proteins in animal - based foods are extremely divergent , with a higher intake of certain animal - based protein foods showing negative effects , and others showing neutral or positive effects on type 2 diabetes risk ."
96411,foods,I-AG.01,3341.0,"Conversely , the glucoregulatory qualities of the proteins in animal - based foods are extremely divergent , with a higher intake of certain animal - based protein foods showing negative effects , and others showing neutral or positive effects on type 2 diabetes risk ."
96412,are,O,3341.0,"Conversely , the glucoregulatory qualities of the proteins in animal - based foods are extremely divergent , with a higher intake of certain animal - based protein foods showing negative effects , and others showing neutral or positive effects on type 2 diabetes risk ."
96413,extremely,O,3341.0,"Conversely , the glucoregulatory qualities of the proteins in animal - based foods are extremely divergent , with a higher intake of certain animal - based protein foods showing negative effects , and others showing neutral or positive effects on type 2 diabetes risk ."
96414,divergent,O,3341.0,"Conversely , the glucoregulatory qualities of the proteins in animal - based foods are extremely divergent , with a higher intake of certain animal - based protein foods showing negative effects , and others showing neutral or positive effects on type 2 diabetes risk ."
96415,",",O,3341.0,"Conversely , the glucoregulatory qualities of the proteins in animal - based foods are extremely divergent , with a higher intake of certain animal - based protein foods showing negative effects , and others showing neutral or positive effects on type 2 diabetes risk ."
96416,with,O,3341.0,"Conversely , the glucoregulatory qualities of the proteins in animal - based foods are extremely divergent , with a higher intake of certain animal - based protein foods showing negative effects , and others showing neutral or positive effects on type 2 diabetes risk ."
96417,a,O,3341.0,"Conversely , the glucoregulatory qualities of the proteins in animal - based foods are extremely divergent , with a higher intake of certain animal - based protein foods showing negative effects , and others showing neutral or positive effects on type 2 diabetes risk ."
96418,higher,O,3341.0,"Conversely , the glucoregulatory qualities of the proteins in animal - based foods are extremely divergent , with a higher intake of certain animal - based protein foods showing negative effects , and others showing neutral or positive effects on type 2 diabetes risk ."
96419,intake,O,3341.0,"Conversely , the glucoregulatory qualities of the proteins in animal - based foods are extremely divergent , with a higher intake of certain animal - based protein foods showing negative effects , and others showing neutral or positive effects on type 2 diabetes risk ."
96420,of,O,3341.0,"Conversely , the glucoregulatory qualities of the proteins in animal - based foods are extremely divergent , with a higher intake of certain animal - based protein foods showing negative effects , and others showing neutral or positive effects on type 2 diabetes risk ."
96421,certain,O,3341.0,"Conversely , the glucoregulatory qualities of the proteins in animal - based foods are extremely divergent , with a higher intake of certain animal - based protein foods showing negative effects , and others showing neutral or positive effects on type 2 diabetes risk ."
96422,animal,B-AG.01,3341.0,"Conversely , the glucoregulatory qualities of the proteins in animal - based foods are extremely divergent , with a higher intake of certain animal - based protein foods showing negative effects , and others showing neutral or positive effects on type 2 diabetes risk ."
96423,-,I-AG.01,3341.0,"Conversely , the glucoregulatory qualities of the proteins in animal - based foods are extremely divergent , with a higher intake of certain animal - based protein foods showing negative effects , and others showing neutral or positive effects on type 2 diabetes risk ."
96424,based,I-AG.01,3341.0,"Conversely , the glucoregulatory qualities of the proteins in animal - based foods are extremely divergent , with a higher intake of certain animal - based protein foods showing negative effects , and others showing neutral or positive effects on type 2 diabetes risk ."
96425,protein,I-AG.01,3341.0,"Conversely , the glucoregulatory qualities of the proteins in animal - based foods are extremely divergent , with a higher intake of certain animal - based protein foods showing negative effects , and others showing neutral or positive effects on type 2 diabetes risk ."
96426,foods,I-AG.01,3341.0,"Conversely , the glucoregulatory qualities of the proteins in animal - based foods are extremely divergent , with a higher intake of certain animal - based protein foods showing negative effects , and others showing neutral or positive effects on type 2 diabetes risk ."
96427,showing,O,3341.0,"Conversely , the glucoregulatory qualities of the proteins in animal - based foods are extremely divergent , with a higher intake of certain animal - based protein foods showing negative effects , and others showing neutral or positive effects on type 2 diabetes risk ."
96428,negative,O,3341.0,"Conversely , the glucoregulatory qualities of the proteins in animal - based foods are extremely divergent , with a higher intake of certain animal - based protein foods showing negative effects , and others showing neutral or positive effects on type 2 diabetes risk ."
96429,effects,O,3341.0,"Conversely , the glucoregulatory qualities of the proteins in animal - based foods are extremely divergent , with a higher intake of certain animal - based protein foods showing negative effects , and others showing neutral or positive effects on type 2 diabetes risk ."
96430,",",O,3341.0,"Conversely , the glucoregulatory qualities of the proteins in animal - based foods are extremely divergent , with a higher intake of certain animal - based protein foods showing negative effects , and others showing neutral or positive effects on type 2 diabetes risk ."
96431,and,O,3341.0,"Conversely , the glucoregulatory qualities of the proteins in animal - based foods are extremely divergent , with a higher intake of certain animal - based protein foods showing negative effects , and others showing neutral or positive effects on type 2 diabetes risk ."
96432,others,O,3341.0,"Conversely , the glucoregulatory qualities of the proteins in animal - based foods are extremely divergent , with a higher intake of certain animal - based protein foods showing negative effects , and others showing neutral or positive effects on type 2 diabetes risk ."
96433,showing,O,3341.0,"Conversely , the glucoregulatory qualities of the proteins in animal - based foods are extremely divergent , with a higher intake of certain animal - based protein foods showing negative effects , and others showing neutral or positive effects on type 2 diabetes risk ."
96434,neutral,O,3341.0,"Conversely , the glucoregulatory qualities of the proteins in animal - based foods are extremely divergent , with a higher intake of certain animal - based protein foods showing negative effects , and others showing neutral or positive effects on type 2 diabetes risk ."
96435,or,O,3341.0,"Conversely , the glucoregulatory qualities of the proteins in animal - based foods are extremely divergent , with a higher intake of certain animal - based protein foods showing negative effects , and others showing neutral or positive effects on type 2 diabetes risk ."
96436,positive,O,3341.0,"Conversely , the glucoregulatory qualities of the proteins in animal - based foods are extremely divergent , with a higher intake of certain animal - based protein foods showing negative effects , and others showing neutral or positive effects on type 2 diabetes risk ."
96437,effects,O,3341.0,"Conversely , the glucoregulatory qualities of the proteins in animal - based foods are extremely divergent , with a higher intake of certain animal - based protein foods showing negative effects , and others showing neutral or positive effects on type 2 diabetes risk ."
96438,on,O,3341.0,"Conversely , the glucoregulatory qualities of the proteins in animal - based foods are extremely divergent , with a higher intake of certain animal - based protein foods showing negative effects , and others showing neutral or positive effects on type 2 diabetes risk ."
96439,type,O,3341.0,"Conversely , the glucoregulatory qualities of the proteins in animal - based foods are extremely divergent , with a higher intake of certain animal - based protein foods showing negative effects , and others showing neutral or positive effects on type 2 diabetes risk ."
96440,2,O,3341.0,"Conversely , the glucoregulatory qualities of the proteins in animal - based foods are extremely divergent , with a higher intake of certain animal - based protein foods showing negative effects , and others showing neutral or positive effects on type 2 diabetes risk ."
96441,diabetes,O,3341.0,"Conversely , the glucoregulatory qualities of the proteins in animal - based foods are extremely divergent , with a higher intake of certain animal - based protein foods showing negative effects , and others showing neutral or positive effects on type 2 diabetes risk ."
96442,risk,O,3341.0,"Conversely , the glucoregulatory qualities of the proteins in animal - based foods are extremely divergent , with a higher intake of certain animal - based protein foods showing negative effects , and others showing neutral or positive effects on type 2 diabetes risk ."
96443,.,O,3341.0,"Conversely , the glucoregulatory qualities of the proteins in animal - based foods are extremely divergent , with a higher intake of certain animal - based protein foods showing negative effects , and others showing neutral or positive effects on type 2 diabetes risk ."
96444,Among,O,3342.0,"Among the various types of animal - based protein foods , a higher intake of dairy products ( such as milk , yogurt , cheese and whey protein ) consistently shows a beneficial relationship with glucose regulation and/or type 2 diabetes risk reduction ."
96445,the,O,3342.0,"Among the various types of animal - based protein foods , a higher intake of dairy products ( such as milk , yogurt , cheese and whey protein ) consistently shows a beneficial relationship with glucose regulation and/or type 2 diabetes risk reduction ."
96446,various,O,3342.0,"Among the various types of animal - based protein foods , a higher intake of dairy products ( such as milk , yogurt , cheese and whey protein ) consistently shows a beneficial relationship with glucose regulation and/or type 2 diabetes risk reduction ."
96447,types,O,3342.0,"Among the various types of animal - based protein foods , a higher intake of dairy products ( such as milk , yogurt , cheese and whey protein ) consistently shows a beneficial relationship with glucose regulation and/or type 2 diabetes risk reduction ."
96448,of,O,3342.0,"Among the various types of animal - based protein foods , a higher intake of dairy products ( such as milk , yogurt , cheese and whey protein ) consistently shows a beneficial relationship with glucose regulation and/or type 2 diabetes risk reduction ."
96449,animal,B-AG.01,3342.0,"Among the various types of animal - based protein foods , a higher intake of dairy products ( such as milk , yogurt , cheese and whey protein ) consistently shows a beneficial relationship with glucose regulation and/or type 2 diabetes risk reduction ."
96450,-,I-AG.01,3342.0,"Among the various types of animal - based protein foods , a higher intake of dairy products ( such as milk , yogurt , cheese and whey protein ) consistently shows a beneficial relationship with glucose regulation and/or type 2 diabetes risk reduction ."
96451,based,I-AG.01,3342.0,"Among the various types of animal - based protein foods , a higher intake of dairy products ( such as milk , yogurt , cheese and whey protein ) consistently shows a beneficial relationship with glucose regulation and/or type 2 diabetes risk reduction ."
96452,protein,I-AG.01,3342.0,"Among the various types of animal - based protein foods , a higher intake of dairy products ( such as milk , yogurt , cheese and whey protein ) consistently shows a beneficial relationship with glucose regulation and/or type 2 diabetes risk reduction ."
96453,foods,I-AG.01,3342.0,"Among the various types of animal - based protein foods , a higher intake of dairy products ( such as milk , yogurt , cheese and whey protein ) consistently shows a beneficial relationship with glucose regulation and/or type 2 diabetes risk reduction ."
96454,",",O,3342.0,"Among the various types of animal - based protein foods , a higher intake of dairy products ( such as milk , yogurt , cheese and whey protein ) consistently shows a beneficial relationship with glucose regulation and/or type 2 diabetes risk reduction ."
96455,a,O,3342.0,"Among the various types of animal - based protein foods , a higher intake of dairy products ( such as milk , yogurt , cheese and whey protein ) consistently shows a beneficial relationship with glucose regulation and/or type 2 diabetes risk reduction ."
96456,higher,O,3342.0,"Among the various types of animal - based protein foods , a higher intake of dairy products ( such as milk , yogurt , cheese and whey protein ) consistently shows a beneficial relationship with glucose regulation and/or type 2 diabetes risk reduction ."
96457,intake,O,3342.0,"Among the various types of animal - based protein foods , a higher intake of dairy products ( such as milk , yogurt , cheese and whey protein ) consistently shows a beneficial relationship with glucose regulation and/or type 2 diabetes risk reduction ."
96458,of,O,3342.0,"Among the various types of animal - based protein foods , a higher intake of dairy products ( such as milk , yogurt , cheese and whey protein ) consistently shows a beneficial relationship with glucose regulation and/or type 2 diabetes risk reduction ."
96459,dairy,B-AG.01.e,3342.0,"Among the various types of animal - based protein foods , a higher intake of dairy products ( such as milk , yogurt , cheese and whey protein ) consistently shows a beneficial relationship with glucose regulation and/or type 2 diabetes risk reduction ."
96460,products,I-AG.01.e,3342.0,"Among the various types of animal - based protein foods , a higher intake of dairy products ( such as milk , yogurt , cheese and whey protein ) consistently shows a beneficial relationship with glucose regulation and/or type 2 diabetes risk reduction ."
96461,(,O,3342.0,"Among the various types of animal - based protein foods , a higher intake of dairy products ( such as milk , yogurt , cheese and whey protein ) consistently shows a beneficial relationship with glucose regulation and/or type 2 diabetes risk reduction ."
96462,such,O,3342.0,"Among the various types of animal - based protein foods , a higher intake of dairy products ( such as milk , yogurt , cheese and whey protein ) consistently shows a beneficial relationship with glucose regulation and/or type 2 diabetes risk reduction ."
96463,as,O,3342.0,"Among the various types of animal - based protein foods , a higher intake of dairy products ( such as milk , yogurt , cheese and whey protein ) consistently shows a beneficial relationship with glucose regulation and/or type 2 diabetes risk reduction ."
96464,milk,B-AG.01.e,3342.0,"Among the various types of animal - based protein foods , a higher intake of dairy products ( such as milk , yogurt , cheese and whey protein ) consistently shows a beneficial relationship with glucose regulation and/or type 2 diabetes risk reduction ."
96465,",",O,3342.0,"Among the various types of animal - based protein foods , a higher intake of dairy products ( such as milk , yogurt , cheese and whey protein ) consistently shows a beneficial relationship with glucose regulation and/or type 2 diabetes risk reduction ."
96466,yogurt,B-AG.01.e,3342.0,"Among the various types of animal - based protein foods , a higher intake of dairy products ( such as milk , yogurt , cheese and whey protein ) consistently shows a beneficial relationship with glucose regulation and/or type 2 diabetes risk reduction ."
96467,",",O,3342.0,"Among the various types of animal - based protein foods , a higher intake of dairy products ( such as milk , yogurt , cheese and whey protein ) consistently shows a beneficial relationship with glucose regulation and/or type 2 diabetes risk reduction ."
96468,cheese,B-AG.01.e.02,3342.0,"Among the various types of animal - based protein foods , a higher intake of dairy products ( such as milk , yogurt , cheese and whey protein ) consistently shows a beneficial relationship with glucose regulation and/or type 2 diabetes risk reduction ."
96469,and,O,3342.0,"Among the various types of animal - based protein foods , a higher intake of dairy products ( such as milk , yogurt , cheese and whey protein ) consistently shows a beneficial relationship with glucose regulation and/or type 2 diabetes risk reduction ."
96470,whey,O,3342.0,"Among the various types of animal - based protein foods , a higher intake of dairy products ( such as milk , yogurt , cheese and whey protein ) consistently shows a beneficial relationship with glucose regulation and/or type 2 diabetes risk reduction ."
96471,protein,O,3342.0,"Among the various types of animal - based protein foods , a higher intake of dairy products ( such as milk , yogurt , cheese and whey protein ) consistently shows a beneficial relationship with glucose regulation and/or type 2 diabetes risk reduction ."
96472,),O,3342.0,"Among the various types of animal - based protein foods , a higher intake of dairy products ( such as milk , yogurt , cheese and whey protein ) consistently shows a beneficial relationship with glucose regulation and/or type 2 diabetes risk reduction ."
96473,consistently,O,3342.0,"Among the various types of animal - based protein foods , a higher intake of dairy products ( such as milk , yogurt , cheese and whey protein ) consistently shows a beneficial relationship with glucose regulation and/or type 2 diabetes risk reduction ."
96474,shows,O,3342.0,"Among the various types of animal - based protein foods , a higher intake of dairy products ( such as milk , yogurt , cheese and whey protein ) consistently shows a beneficial relationship with glucose regulation and/or type 2 diabetes risk reduction ."
96475,a,O,3342.0,"Among the various types of animal - based protein foods , a higher intake of dairy products ( such as milk , yogurt , cheese and whey protein ) consistently shows a beneficial relationship with glucose regulation and/or type 2 diabetes risk reduction ."
96476,beneficial,O,3342.0,"Among the various types of animal - based protein foods , a higher intake of dairy products ( such as milk , yogurt , cheese and whey protein ) consistently shows a beneficial relationship with glucose regulation and/or type 2 diabetes risk reduction ."
96477,relationship,O,3342.0,"Among the various types of animal - based protein foods , a higher intake of dairy products ( such as milk , yogurt , cheese and whey protein ) consistently shows a beneficial relationship with glucose regulation and/or type 2 diabetes risk reduction ."
96478,with,O,3342.0,"Among the various types of animal - based protein foods , a higher intake of dairy products ( such as milk , yogurt , cheese and whey protein ) consistently shows a beneficial relationship with glucose regulation and/or type 2 diabetes risk reduction ."
96479,glucose,O,3342.0,"Among the various types of animal - based protein foods , a higher intake of dairy products ( such as milk , yogurt , cheese and whey protein ) consistently shows a beneficial relationship with glucose regulation and/or type 2 diabetes risk reduction ."
96480,regulation,O,3342.0,"Among the various types of animal - based protein foods , a higher intake of dairy products ( such as milk , yogurt , cheese and whey protein ) consistently shows a beneficial relationship with glucose regulation and/or type 2 diabetes risk reduction ."
96481,and/or,O,3342.0,"Among the various types of animal - based protein foods , a higher intake of dairy products ( such as milk , yogurt , cheese and whey protein ) consistently shows a beneficial relationship with glucose regulation and/or type 2 diabetes risk reduction ."
96482,type,O,3342.0,"Among the various types of animal - based protein foods , a higher intake of dairy products ( such as milk , yogurt , cheese and whey protein ) consistently shows a beneficial relationship with glucose regulation and/or type 2 diabetes risk reduction ."
96483,2,O,3342.0,"Among the various types of animal - based protein foods , a higher intake of dairy products ( such as milk , yogurt , cheese and whey protein ) consistently shows a beneficial relationship with glucose regulation and/or type 2 diabetes risk reduction ."
96484,diabetes,O,3342.0,"Among the various types of animal - based protein foods , a higher intake of dairy products ( such as milk , yogurt , cheese and whey protein ) consistently shows a beneficial relationship with glucose regulation and/or type 2 diabetes risk reduction ."
96485,risk,O,3342.0,"Among the various types of animal - based protein foods , a higher intake of dairy products ( such as milk , yogurt , cheese and whey protein ) consistently shows a beneficial relationship with glucose regulation and/or type 2 diabetes risk reduction ."
96486,reduction,O,3342.0,"Among the various types of animal - based protein foods , a higher intake of dairy products ( such as milk , yogurt , cheese and whey protein ) consistently shows a beneficial relationship with glucose regulation and/or type 2 diabetes risk reduction ."
96487,.,O,3342.0,"Among the various types of animal - based protein foods , a higher intake of dairy products ( such as milk , yogurt , cheese and whey protein ) consistently shows a beneficial relationship with glucose regulation and/or type 2 diabetes risk reduction ."
96488,Intervention,O,3343.0,Intervention studies provide evidence that dairy proteins have more potent effects on insulin and incretin secretion compared to other commonly consumed animal proteins .
96489,studies,O,3343.0,Intervention studies provide evidence that dairy proteins have more potent effects on insulin and incretin secretion compared to other commonly consumed animal proteins .
96490,provide,O,3343.0,Intervention studies provide evidence that dairy proteins have more potent effects on insulin and incretin secretion compared to other commonly consumed animal proteins .
96491,evidence,O,3343.0,Intervention studies provide evidence that dairy proteins have more potent effects on insulin and incretin secretion compared to other commonly consumed animal proteins .
96492,that,O,3343.0,Intervention studies provide evidence that dairy proteins have more potent effects on insulin and incretin secretion compared to other commonly consumed animal proteins .
96493,dairy,O,3343.0,Intervention studies provide evidence that dairy proteins have more potent effects on insulin and incretin secretion compared to other commonly consumed animal proteins .
96494,proteins,O,3343.0,Intervention studies provide evidence that dairy proteins have more potent effects on insulin and incretin secretion compared to other commonly consumed animal proteins .
96495,have,O,3343.0,Intervention studies provide evidence that dairy proteins have more potent effects on insulin and incretin secretion compared to other commonly consumed animal proteins .
96496,more,O,3343.0,Intervention studies provide evidence that dairy proteins have more potent effects on insulin and incretin secretion compared to other commonly consumed animal proteins .
96497,potent,O,3343.0,Intervention studies provide evidence that dairy proteins have more potent effects on insulin and incretin secretion compared to other commonly consumed animal proteins .
96498,effects,O,3343.0,Intervention studies provide evidence that dairy proteins have more potent effects on insulin and incretin secretion compared to other commonly consumed animal proteins .
96499,on,O,3343.0,Intervention studies provide evidence that dairy proteins have more potent effects on insulin and incretin secretion compared to other commonly consumed animal proteins .
96500,insulin,O,3343.0,Intervention studies provide evidence that dairy proteins have more potent effects on insulin and incretin secretion compared to other commonly consumed animal proteins .
96501,and,O,3343.0,Intervention studies provide evidence that dairy proteins have more potent effects on insulin and incretin secretion compared to other commonly consumed animal proteins .
96502,incretin,O,3343.0,Intervention studies provide evidence that dairy proteins have more potent effects on insulin and incretin secretion compared to other commonly consumed animal proteins .
96503,secretion,O,3343.0,Intervention studies provide evidence that dairy proteins have more potent effects on insulin and incretin secretion compared to other commonly consumed animal proteins .
96504,compared,O,3343.0,Intervention studies provide evidence that dairy proteins have more potent effects on insulin and incretin secretion compared to other commonly consumed animal proteins .
96505,to,O,3343.0,Intervention studies provide evidence that dairy proteins have more potent effects on insulin and incretin secretion compared to other commonly consumed animal proteins .
96506,other,O,3343.0,Intervention studies provide evidence that dairy proteins have more potent effects on insulin and incretin secretion compared to other commonly consumed animal proteins .
96507,commonly,O,3343.0,Intervention studies provide evidence that dairy proteins have more potent effects on insulin and incretin secretion compared to other commonly consumed animal proteins .
96508,consumed,O,3343.0,Intervention studies provide evidence that dairy proteins have more potent effects on insulin and incretin secretion compared to other commonly consumed animal proteins .
96509,animal,O,3343.0,Intervention studies provide evidence that dairy proteins have more potent effects on insulin and incretin secretion compared to other commonly consumed animal proteins .
96510,proteins,O,3343.0,Intervention studies provide evidence that dairy proteins have more potent effects on insulin and incretin secretion compared to other commonly consumed animal proteins .
96511,.,O,3343.0,Intervention studies provide evidence that dairy proteins have more potent effects on insulin and incretin secretion compared to other commonly consumed animal proteins .
96512,In,O,3344.0,"In addition to their protein components , such as insulinogenic amino acids and bioactive peptides , dairy products also contain a food matrix rich in calcium , magnesium , potassium , trans - palmitoleic fatty acids , and low - glycemic index sugars - all of which have been shown to have beneficial effects on aspects of glucose control , insulin secretion , insulin sensitivity and/or type 2 diabetes risk ."
96513,addition,O,3344.0,"In addition to their protein components , such as insulinogenic amino acids and bioactive peptides , dairy products also contain a food matrix rich in calcium , magnesium , potassium , trans - palmitoleic fatty acids , and low - glycemic index sugars - all of which have been shown to have beneficial effects on aspects of glucose control , insulin secretion , insulin sensitivity and/or type 2 diabetes risk ."
96514,to,O,3344.0,"In addition to their protein components , such as insulinogenic amino acids and bioactive peptides , dairy products also contain a food matrix rich in calcium , magnesium , potassium , trans - palmitoleic fatty acids , and low - glycemic index sugars - all of which have been shown to have beneficial effects on aspects of glucose control , insulin secretion , insulin sensitivity and/or type 2 diabetes risk ."
96515,their,O,3344.0,"In addition to their protein components , such as insulinogenic amino acids and bioactive peptides , dairy products also contain a food matrix rich in calcium , magnesium , potassium , trans - palmitoleic fatty acids , and low - glycemic index sugars - all of which have been shown to have beneficial effects on aspects of glucose control , insulin secretion , insulin sensitivity and/or type 2 diabetes risk ."
96516,protein,O,3344.0,"In addition to their protein components , such as insulinogenic amino acids and bioactive peptides , dairy products also contain a food matrix rich in calcium , magnesium , potassium , trans - palmitoleic fatty acids , and low - glycemic index sugars - all of which have been shown to have beneficial effects on aspects of glucose control , insulin secretion , insulin sensitivity and/or type 2 diabetes risk ."
96517,components,O,3344.0,"In addition to their protein components , such as insulinogenic amino acids and bioactive peptides , dairy products also contain a food matrix rich in calcium , magnesium , potassium , trans - palmitoleic fatty acids , and low - glycemic index sugars - all of which have been shown to have beneficial effects on aspects of glucose control , insulin secretion , insulin sensitivity and/or type 2 diabetes risk ."
96518,",",O,3344.0,"In addition to their protein components , such as insulinogenic amino acids and bioactive peptides , dairy products also contain a food matrix rich in calcium , magnesium , potassium , trans - palmitoleic fatty acids , and low - glycemic index sugars - all of which have been shown to have beneficial effects on aspects of glucose control , insulin secretion , insulin sensitivity and/or type 2 diabetes risk ."
96519,such,O,3344.0,"In addition to their protein components , such as insulinogenic amino acids and bioactive peptides , dairy products also contain a food matrix rich in calcium , magnesium , potassium , trans - palmitoleic fatty acids , and low - glycemic index sugars - all of which have been shown to have beneficial effects on aspects of glucose control , insulin secretion , insulin sensitivity and/or type 2 diabetes risk ."
96520,as,O,3344.0,"In addition to their protein components , such as insulinogenic amino acids and bioactive peptides , dairy products also contain a food matrix rich in calcium , magnesium , potassium , trans - palmitoleic fatty acids , and low - glycemic index sugars - all of which have been shown to have beneficial effects on aspects of glucose control , insulin secretion , insulin sensitivity and/or type 2 diabetes risk ."
96521,insulinogenic,O,3344.0,"In addition to their protein components , such as insulinogenic amino acids and bioactive peptides , dairy products also contain a food matrix rich in calcium , magnesium , potassium , trans - palmitoleic fatty acids , and low - glycemic index sugars - all of which have been shown to have beneficial effects on aspects of glucose control , insulin secretion , insulin sensitivity and/or type 2 diabetes risk ."
96522,amino,O,3344.0,"In addition to their protein components , such as insulinogenic amino acids and bioactive peptides , dairy products also contain a food matrix rich in calcium , magnesium , potassium , trans - palmitoleic fatty acids , and low - glycemic index sugars - all of which have been shown to have beneficial effects on aspects of glucose control , insulin secretion , insulin sensitivity and/or type 2 diabetes risk ."
96523,acids,O,3344.0,"In addition to their protein components , such as insulinogenic amino acids and bioactive peptides , dairy products also contain a food matrix rich in calcium , magnesium , potassium , trans - palmitoleic fatty acids , and low - glycemic index sugars - all of which have been shown to have beneficial effects on aspects of glucose control , insulin secretion , insulin sensitivity and/or type 2 diabetes risk ."
96524,and,O,3344.0,"In addition to their protein components , such as insulinogenic amino acids and bioactive peptides , dairy products also contain a food matrix rich in calcium , magnesium , potassium , trans - palmitoleic fatty acids , and low - glycemic index sugars - all of which have been shown to have beneficial effects on aspects of glucose control , insulin secretion , insulin sensitivity and/or type 2 diabetes risk ."
96525,bioactive,O,3344.0,"In addition to their protein components , such as insulinogenic amino acids and bioactive peptides , dairy products also contain a food matrix rich in calcium , magnesium , potassium , trans - palmitoleic fatty acids , and low - glycemic index sugars - all of which have been shown to have beneficial effects on aspects of glucose control , insulin secretion , insulin sensitivity and/or type 2 diabetes risk ."
96526,peptides,O,3344.0,"In addition to their protein components , such as insulinogenic amino acids and bioactive peptides , dairy products also contain a food matrix rich in calcium , magnesium , potassium , trans - palmitoleic fatty acids , and low - glycemic index sugars - all of which have been shown to have beneficial effects on aspects of glucose control , insulin secretion , insulin sensitivity and/or type 2 diabetes risk ."
96527,",",O,3344.0,"In addition to their protein components , such as insulinogenic amino acids and bioactive peptides , dairy products also contain a food matrix rich in calcium , magnesium , potassium , trans - palmitoleic fatty acids , and low - glycemic index sugars - all of which have been shown to have beneficial effects on aspects of glucose control , insulin secretion , insulin sensitivity and/or type 2 diabetes risk ."
96528,dairy,B-AG.01.e,3344.0,"In addition to their protein components , such as insulinogenic amino acids and bioactive peptides , dairy products also contain a food matrix rich in calcium , magnesium , potassium , trans - palmitoleic fatty acids , and low - glycemic index sugars - all of which have been shown to have beneficial effects on aspects of glucose control , insulin secretion , insulin sensitivity and/or type 2 diabetes risk ."
96529,products,I-AG.01.e,3344.0,"In addition to their protein components , such as insulinogenic amino acids and bioactive peptides , dairy products also contain a food matrix rich in calcium , magnesium , potassium , trans - palmitoleic fatty acids , and low - glycemic index sugars - all of which have been shown to have beneficial effects on aspects of glucose control , insulin secretion , insulin sensitivity and/or type 2 diabetes risk ."
96530,also,O,3344.0,"In addition to their protein components , such as insulinogenic amino acids and bioactive peptides , dairy products also contain a food matrix rich in calcium , magnesium , potassium , trans - palmitoleic fatty acids , and low - glycemic index sugars - all of which have been shown to have beneficial effects on aspects of glucose control , insulin secretion , insulin sensitivity and/or type 2 diabetes risk ."
96531,contain,O,3344.0,"In addition to their protein components , such as insulinogenic amino acids and bioactive peptides , dairy products also contain a food matrix rich in calcium , magnesium , potassium , trans - palmitoleic fatty acids , and low - glycemic index sugars - all of which have been shown to have beneficial effects on aspects of glucose control , insulin secretion , insulin sensitivity and/or type 2 diabetes risk ."
96532,a,O,3344.0,"In addition to their protein components , such as insulinogenic amino acids and bioactive peptides , dairy products also contain a food matrix rich in calcium , magnesium , potassium , trans - palmitoleic fatty acids , and low - glycemic index sugars - all of which have been shown to have beneficial effects on aspects of glucose control , insulin secretion , insulin sensitivity and/or type 2 diabetes risk ."
96533,food,O,3344.0,"In addition to their protein components , such as insulinogenic amino acids and bioactive peptides , dairy products also contain a food matrix rich in calcium , magnesium , potassium , trans - palmitoleic fatty acids , and low - glycemic index sugars - all of which have been shown to have beneficial effects on aspects of glucose control , insulin secretion , insulin sensitivity and/or type 2 diabetes risk ."
96534,matrix,O,3344.0,"In addition to their protein components , such as insulinogenic amino acids and bioactive peptides , dairy products also contain a food matrix rich in calcium , magnesium , potassium , trans - palmitoleic fatty acids , and low - glycemic index sugars - all of which have been shown to have beneficial effects on aspects of glucose control , insulin secretion , insulin sensitivity and/or type 2 diabetes risk ."
96535,rich,O,3344.0,"In addition to their protein components , such as insulinogenic amino acids and bioactive peptides , dairy products also contain a food matrix rich in calcium , magnesium , potassium , trans - palmitoleic fatty acids , and low - glycemic index sugars - all of which have been shown to have beneficial effects on aspects of glucose control , insulin secretion , insulin sensitivity and/or type 2 diabetes risk ."
96536,in,O,3344.0,"In addition to their protein components , such as insulinogenic amino acids and bioactive peptides , dairy products also contain a food matrix rich in calcium , magnesium , potassium , trans - palmitoleic fatty acids , and low - glycemic index sugars - all of which have been shown to have beneficial effects on aspects of glucose control , insulin secretion , insulin sensitivity and/or type 2 diabetes risk ."
96537,calcium,O,3344.0,"In addition to their protein components , such as insulinogenic amino acids and bioactive peptides , dairy products also contain a food matrix rich in calcium , magnesium , potassium , trans - palmitoleic fatty acids , and low - glycemic index sugars - all of which have been shown to have beneficial effects on aspects of glucose control , insulin secretion , insulin sensitivity and/or type 2 diabetes risk ."
96538,",",O,3344.0,"In addition to their protein components , such as insulinogenic amino acids and bioactive peptides , dairy products also contain a food matrix rich in calcium , magnesium , potassium , trans - palmitoleic fatty acids , and low - glycemic index sugars - all of which have been shown to have beneficial effects on aspects of glucose control , insulin secretion , insulin sensitivity and/or type 2 diabetes risk ."
96539,magnesium,O,3344.0,"In addition to their protein components , such as insulinogenic amino acids and bioactive peptides , dairy products also contain a food matrix rich in calcium , magnesium , potassium , trans - palmitoleic fatty acids , and low - glycemic index sugars - all of which have been shown to have beneficial effects on aspects of glucose control , insulin secretion , insulin sensitivity and/or type 2 diabetes risk ."
96540,",",O,3344.0,"In addition to their protein components , such as insulinogenic amino acids and bioactive peptides , dairy products also contain a food matrix rich in calcium , magnesium , potassium , trans - palmitoleic fatty acids , and low - glycemic index sugars - all of which have been shown to have beneficial effects on aspects of glucose control , insulin secretion , insulin sensitivity and/or type 2 diabetes risk ."
96541,potassium,O,3344.0,"In addition to their protein components , such as insulinogenic amino acids and bioactive peptides , dairy products also contain a food matrix rich in calcium , magnesium , potassium , trans - palmitoleic fatty acids , and low - glycemic index sugars - all of which have been shown to have beneficial effects on aspects of glucose control , insulin secretion , insulin sensitivity and/or type 2 diabetes risk ."
96542,",",O,3344.0,"In addition to their protein components , such as insulinogenic amino acids and bioactive peptides , dairy products also contain a food matrix rich in calcium , magnesium , potassium , trans - palmitoleic fatty acids , and low - glycemic index sugars - all of which have been shown to have beneficial effects on aspects of glucose control , insulin secretion , insulin sensitivity and/or type 2 diabetes risk ."
96543,trans,O,3344.0,"In addition to their protein components , such as insulinogenic amino acids and bioactive peptides , dairy products also contain a food matrix rich in calcium , magnesium , potassium , trans - palmitoleic fatty acids , and low - glycemic index sugars - all of which have been shown to have beneficial effects on aspects of glucose control , insulin secretion , insulin sensitivity and/or type 2 diabetes risk ."
96544,-,O,3344.0,"In addition to their protein components , such as insulinogenic amino acids and bioactive peptides , dairy products also contain a food matrix rich in calcium , magnesium , potassium , trans - palmitoleic fatty acids , and low - glycemic index sugars - all of which have been shown to have beneficial effects on aspects of glucose control , insulin secretion , insulin sensitivity and/or type 2 diabetes risk ."
96545,palmitoleic,O,3344.0,"In addition to their protein components , such as insulinogenic amino acids and bioactive peptides , dairy products also contain a food matrix rich in calcium , magnesium , potassium , trans - palmitoleic fatty acids , and low - glycemic index sugars - all of which have been shown to have beneficial effects on aspects of glucose control , insulin secretion , insulin sensitivity and/or type 2 diabetes risk ."
96546,fatty,O,3344.0,"In addition to their protein components , such as insulinogenic amino acids and bioactive peptides , dairy products also contain a food matrix rich in calcium , magnesium , potassium , trans - palmitoleic fatty acids , and low - glycemic index sugars - all of which have been shown to have beneficial effects on aspects of glucose control , insulin secretion , insulin sensitivity and/or type 2 diabetes risk ."
96547,acids,O,3344.0,"In addition to their protein components , such as insulinogenic amino acids and bioactive peptides , dairy products also contain a food matrix rich in calcium , magnesium , potassium , trans - palmitoleic fatty acids , and low - glycemic index sugars - all of which have been shown to have beneficial effects on aspects of glucose control , insulin secretion , insulin sensitivity and/or type 2 diabetes risk ."
96548,",",O,3344.0,"In addition to their protein components , such as insulinogenic amino acids and bioactive peptides , dairy products also contain a food matrix rich in calcium , magnesium , potassium , trans - palmitoleic fatty acids , and low - glycemic index sugars - all of which have been shown to have beneficial effects on aspects of glucose control , insulin secretion , insulin sensitivity and/or type 2 diabetes risk ."
96549,and,O,3344.0,"In addition to their protein components , such as insulinogenic amino acids and bioactive peptides , dairy products also contain a food matrix rich in calcium , magnesium , potassium , trans - palmitoleic fatty acids , and low - glycemic index sugars - all of which have been shown to have beneficial effects on aspects of glucose control , insulin secretion , insulin sensitivity and/or type 2 diabetes risk ."
96550,low,O,3344.0,"In addition to their protein components , such as insulinogenic amino acids and bioactive peptides , dairy products also contain a food matrix rich in calcium , magnesium , potassium , trans - palmitoleic fatty acids , and low - glycemic index sugars - all of which have been shown to have beneficial effects on aspects of glucose control , insulin secretion , insulin sensitivity and/or type 2 diabetes risk ."
96551,-,O,3344.0,"In addition to their protein components , such as insulinogenic amino acids and bioactive peptides , dairy products also contain a food matrix rich in calcium , magnesium , potassium , trans - palmitoleic fatty acids , and low - glycemic index sugars - all of which have been shown to have beneficial effects on aspects of glucose control , insulin secretion , insulin sensitivity and/or type 2 diabetes risk ."
96552,glycemic,O,3344.0,"In addition to their protein components , such as insulinogenic amino acids and bioactive peptides , dairy products also contain a food matrix rich in calcium , magnesium , potassium , trans - palmitoleic fatty acids , and low - glycemic index sugars - all of which have been shown to have beneficial effects on aspects of glucose control , insulin secretion , insulin sensitivity and/or type 2 diabetes risk ."
96553,index,O,3344.0,"In addition to their protein components , such as insulinogenic amino acids and bioactive peptides , dairy products also contain a food matrix rich in calcium , magnesium , potassium , trans - palmitoleic fatty acids , and low - glycemic index sugars - all of which have been shown to have beneficial effects on aspects of glucose control , insulin secretion , insulin sensitivity and/or type 2 diabetes risk ."
96554,sugars,O,3344.0,"In addition to their protein components , such as insulinogenic amino acids and bioactive peptides , dairy products also contain a food matrix rich in calcium , magnesium , potassium , trans - palmitoleic fatty acids , and low - glycemic index sugars - all of which have been shown to have beneficial effects on aspects of glucose control , insulin secretion , insulin sensitivity and/or type 2 diabetes risk ."
96555,-,O,3344.0,"In addition to their protein components , such as insulinogenic amino acids and bioactive peptides , dairy products also contain a food matrix rich in calcium , magnesium , potassium , trans - palmitoleic fatty acids , and low - glycemic index sugars - all of which have been shown to have beneficial effects on aspects of glucose control , insulin secretion , insulin sensitivity and/or type 2 diabetes risk ."
96556,all,O,3344.0,"In addition to their protein components , such as insulinogenic amino acids and bioactive peptides , dairy products also contain a food matrix rich in calcium , magnesium , potassium , trans - palmitoleic fatty acids , and low - glycemic index sugars - all of which have been shown to have beneficial effects on aspects of glucose control , insulin secretion , insulin sensitivity and/or type 2 diabetes risk ."
96557,of,O,3344.0,"In addition to their protein components , such as insulinogenic amino acids and bioactive peptides , dairy products also contain a food matrix rich in calcium , magnesium , potassium , trans - palmitoleic fatty acids , and low - glycemic index sugars - all of which have been shown to have beneficial effects on aspects of glucose control , insulin secretion , insulin sensitivity and/or type 2 diabetes risk ."
96558,which,O,3344.0,"In addition to their protein components , such as insulinogenic amino acids and bioactive peptides , dairy products also contain a food matrix rich in calcium , magnesium , potassium , trans - palmitoleic fatty acids , and low - glycemic index sugars - all of which have been shown to have beneficial effects on aspects of glucose control , insulin secretion , insulin sensitivity and/or type 2 diabetes risk ."
96559,have,O,3344.0,"In addition to their protein components , such as insulinogenic amino acids and bioactive peptides , dairy products also contain a food matrix rich in calcium , magnesium , potassium , trans - palmitoleic fatty acids , and low - glycemic index sugars - all of which have been shown to have beneficial effects on aspects of glucose control , insulin secretion , insulin sensitivity and/or type 2 diabetes risk ."
96560,been,O,3344.0,"In addition to their protein components , such as insulinogenic amino acids and bioactive peptides , dairy products also contain a food matrix rich in calcium , magnesium , potassium , trans - palmitoleic fatty acids , and low - glycemic index sugars - all of which have been shown to have beneficial effects on aspects of glucose control , insulin secretion , insulin sensitivity and/or type 2 diabetes risk ."
96561,shown,O,3344.0,"In addition to their protein components , such as insulinogenic amino acids and bioactive peptides , dairy products also contain a food matrix rich in calcium , magnesium , potassium , trans - palmitoleic fatty acids , and low - glycemic index sugars - all of which have been shown to have beneficial effects on aspects of glucose control , insulin secretion , insulin sensitivity and/or type 2 diabetes risk ."
96562,to,O,3344.0,"In addition to their protein components , such as insulinogenic amino acids and bioactive peptides , dairy products also contain a food matrix rich in calcium , magnesium , potassium , trans - palmitoleic fatty acids , and low - glycemic index sugars - all of which have been shown to have beneficial effects on aspects of glucose control , insulin secretion , insulin sensitivity and/or type 2 diabetes risk ."
96563,have,O,3344.0,"In addition to their protein components , such as insulinogenic amino acids and bioactive peptides , dairy products also contain a food matrix rich in calcium , magnesium , potassium , trans - palmitoleic fatty acids , and low - glycemic index sugars - all of which have been shown to have beneficial effects on aspects of glucose control , insulin secretion , insulin sensitivity and/or type 2 diabetes risk ."
96564,beneficial,O,3344.0,"In addition to their protein components , such as insulinogenic amino acids and bioactive peptides , dairy products also contain a food matrix rich in calcium , magnesium , potassium , trans - palmitoleic fatty acids , and low - glycemic index sugars - all of which have been shown to have beneficial effects on aspects of glucose control , insulin secretion , insulin sensitivity and/or type 2 diabetes risk ."
96565,effects,O,3344.0,"In addition to their protein components , such as insulinogenic amino acids and bioactive peptides , dairy products also contain a food matrix rich in calcium , magnesium , potassium , trans - palmitoleic fatty acids , and low - glycemic index sugars - all of which have been shown to have beneficial effects on aspects of glucose control , insulin secretion , insulin sensitivity and/or type 2 diabetes risk ."
96566,on,O,3344.0,"In addition to their protein components , such as insulinogenic amino acids and bioactive peptides , dairy products also contain a food matrix rich in calcium , magnesium , potassium , trans - palmitoleic fatty acids , and low - glycemic index sugars - all of which have been shown to have beneficial effects on aspects of glucose control , insulin secretion , insulin sensitivity and/or type 2 diabetes risk ."
96567,aspects,O,3344.0,"In addition to their protein components , such as insulinogenic amino acids and bioactive peptides , dairy products also contain a food matrix rich in calcium , magnesium , potassium , trans - palmitoleic fatty acids , and low - glycemic index sugars - all of which have been shown to have beneficial effects on aspects of glucose control , insulin secretion , insulin sensitivity and/or type 2 diabetes risk ."
96568,of,O,3344.0,"In addition to their protein components , such as insulinogenic amino acids and bioactive peptides , dairy products also contain a food matrix rich in calcium , magnesium , potassium , trans - palmitoleic fatty acids , and low - glycemic index sugars - all of which have been shown to have beneficial effects on aspects of glucose control , insulin secretion , insulin sensitivity and/or type 2 diabetes risk ."
96569,glucose,O,3344.0,"In addition to their protein components , such as insulinogenic amino acids and bioactive peptides , dairy products also contain a food matrix rich in calcium , magnesium , potassium , trans - palmitoleic fatty acids , and low - glycemic index sugars - all of which have been shown to have beneficial effects on aspects of glucose control , insulin secretion , insulin sensitivity and/or type 2 diabetes risk ."
96570,control,O,3344.0,"In addition to their protein components , such as insulinogenic amino acids and bioactive peptides , dairy products also contain a food matrix rich in calcium , magnesium , potassium , trans - palmitoleic fatty acids , and low - glycemic index sugars - all of which have been shown to have beneficial effects on aspects of glucose control , insulin secretion , insulin sensitivity and/or type 2 diabetes risk ."
96571,",",O,3344.0,"In addition to their protein components , such as insulinogenic amino acids and bioactive peptides , dairy products also contain a food matrix rich in calcium , magnesium , potassium , trans - palmitoleic fatty acids , and low - glycemic index sugars - all of which have been shown to have beneficial effects on aspects of glucose control , insulin secretion , insulin sensitivity and/or type 2 diabetes risk ."
96572,insulin,O,3344.0,"In addition to their protein components , such as insulinogenic amino acids and bioactive peptides , dairy products also contain a food matrix rich in calcium , magnesium , potassium , trans - palmitoleic fatty acids , and low - glycemic index sugars - all of which have been shown to have beneficial effects on aspects of glucose control , insulin secretion , insulin sensitivity and/or type 2 diabetes risk ."
96573,secretion,O,3344.0,"In addition to their protein components , such as insulinogenic amino acids and bioactive peptides , dairy products also contain a food matrix rich in calcium , magnesium , potassium , trans - palmitoleic fatty acids , and low - glycemic index sugars - all of which have been shown to have beneficial effects on aspects of glucose control , insulin secretion , insulin sensitivity and/or type 2 diabetes risk ."
96574,",",O,3344.0,"In addition to their protein components , such as insulinogenic amino acids and bioactive peptides , dairy products also contain a food matrix rich in calcium , magnesium , potassium , trans - palmitoleic fatty acids , and low - glycemic index sugars - all of which have been shown to have beneficial effects on aspects of glucose control , insulin secretion , insulin sensitivity and/or type 2 diabetes risk ."
96575,insulin,O,3344.0,"In addition to their protein components , such as insulinogenic amino acids and bioactive peptides , dairy products also contain a food matrix rich in calcium , magnesium , potassium , trans - palmitoleic fatty acids , and low - glycemic index sugars - all of which have been shown to have beneficial effects on aspects of glucose control , insulin secretion , insulin sensitivity and/or type 2 diabetes risk ."
96576,sensitivity,O,3344.0,"In addition to their protein components , such as insulinogenic amino acids and bioactive peptides , dairy products also contain a food matrix rich in calcium , magnesium , potassium , trans - palmitoleic fatty acids , and low - glycemic index sugars - all of which have been shown to have beneficial effects on aspects of glucose control , insulin secretion , insulin sensitivity and/or type 2 diabetes risk ."
96577,and/or,O,3344.0,"In addition to their protein components , such as insulinogenic amino acids and bioactive peptides , dairy products also contain a food matrix rich in calcium , magnesium , potassium , trans - palmitoleic fatty acids , and low - glycemic index sugars - all of which have been shown to have beneficial effects on aspects of glucose control , insulin secretion , insulin sensitivity and/or type 2 diabetes risk ."
96578,type,O,3344.0,"In addition to their protein components , such as insulinogenic amino acids and bioactive peptides , dairy products also contain a food matrix rich in calcium , magnesium , potassium , trans - palmitoleic fatty acids , and low - glycemic index sugars - all of which have been shown to have beneficial effects on aspects of glucose control , insulin secretion , insulin sensitivity and/or type 2 diabetes risk ."
96579,2,O,3344.0,"In addition to their protein components , such as insulinogenic amino acids and bioactive peptides , dairy products also contain a food matrix rich in calcium , magnesium , potassium , trans - palmitoleic fatty acids , and low - glycemic index sugars - all of which have been shown to have beneficial effects on aspects of glucose control , insulin secretion , insulin sensitivity and/or type 2 diabetes risk ."
96580,diabetes,O,3344.0,"In addition to their protein components , such as insulinogenic amino acids and bioactive peptides , dairy products also contain a food matrix rich in calcium , magnesium , potassium , trans - palmitoleic fatty acids , and low - glycemic index sugars - all of which have been shown to have beneficial effects on aspects of glucose control , insulin secretion , insulin sensitivity and/or type 2 diabetes risk ."
96581,risk,O,3344.0,"In addition to their protein components , such as insulinogenic amino acids and bioactive peptides , dairy products also contain a food matrix rich in calcium , magnesium , potassium , trans - palmitoleic fatty acids , and low - glycemic index sugars - all of which have been shown to have beneficial effects on aspects of glucose control , insulin secretion , insulin sensitivity and/or type 2 diabetes risk ."
96582,.,O,3344.0,"In addition to their protein components , such as insulinogenic amino acids and bioactive peptides , dairy products also contain a food matrix rich in calcium , magnesium , potassium , trans - palmitoleic fatty acids , and low - glycemic index sugars - all of which have been shown to have beneficial effects on aspects of glucose control , insulin secretion , insulin sensitivity and/or type 2 diabetes risk ."
96583,Furthermore,O,3345.0,"Furthermore , fermentation and fortification of dairy products with probiotics and vitamin D may improve a dairy product 's glucoregulatory effects ."
96584,",",O,3345.0,"Furthermore , fermentation and fortification of dairy products with probiotics and vitamin D may improve a dairy product 's glucoregulatory effects ."
96585,fermentation,O,3345.0,"Furthermore , fermentation and fortification of dairy products with probiotics and vitamin D may improve a dairy product 's glucoregulatory effects ."
96586,and,O,3345.0,"Furthermore , fermentation and fortification of dairy products with probiotics and vitamin D may improve a dairy product 's glucoregulatory effects ."
96587,fortification,O,3345.0,"Furthermore , fermentation and fortification of dairy products with probiotics and vitamin D may improve a dairy product 's glucoregulatory effects ."
96588,of,O,3345.0,"Furthermore , fermentation and fortification of dairy products with probiotics and vitamin D may improve a dairy product 's glucoregulatory effects ."
96589,dairy,B-AG.01.e,3345.0,"Furthermore , fermentation and fortification of dairy products with probiotics and vitamin D may improve a dairy product 's glucoregulatory effects ."
96590,products,I-AG.01.e,3345.0,"Furthermore , fermentation and fortification of dairy products with probiotics and vitamin D may improve a dairy product 's glucoregulatory effects ."
96591,with,O,3345.0,"Furthermore , fermentation and fortification of dairy products with probiotics and vitamin D may improve a dairy product 's glucoregulatory effects ."
96592,probiotics,O,3345.0,"Furthermore , fermentation and fortification of dairy products with probiotics and vitamin D may improve a dairy product 's glucoregulatory effects ."
96593,and,O,3345.0,"Furthermore , fermentation and fortification of dairy products with probiotics and vitamin D may improve a dairy product 's glucoregulatory effects ."
96594,vitamin,O,3345.0,"Furthermore , fermentation and fortification of dairy products with probiotics and vitamin D may improve a dairy product 's glucoregulatory effects ."
96595,D,O,3345.0,"Furthermore , fermentation and fortification of dairy products with probiotics and vitamin D may improve a dairy product 's glucoregulatory effects ."
96596,may,O,3345.0,"Furthermore , fermentation and fortification of dairy products with probiotics and vitamin D may improve a dairy product 's glucoregulatory effects ."
96597,improve,O,3345.0,"Furthermore , fermentation and fortification of dairy products with probiotics and vitamin D may improve a dairy product 's glucoregulatory effects ."
96598,a,O,3345.0,"Furthermore , fermentation and fortification of dairy products with probiotics and vitamin D may improve a dairy product 's glucoregulatory effects ."
96599,dairy,B-AG.01.e,3345.0,"Furthermore , fermentation and fortification of dairy products with probiotics and vitamin D may improve a dairy product 's glucoregulatory effects ."
96600,product,I-AG.01.e,3345.0,"Furthermore , fermentation and fortification of dairy products with probiotics and vitamin D may improve a dairy product 's glucoregulatory effects ."
96601,'s,O,3345.0,"Furthermore , fermentation and fortification of dairy products with probiotics and vitamin D may improve a dairy product 's glucoregulatory effects ."
96602,glucoregulatory,O,3345.0,"Furthermore , fermentation and fortification of dairy products with probiotics and vitamin D may improve a dairy product 's glucoregulatory effects ."
96603,effects,O,3345.0,"Furthermore , fermentation and fortification of dairy products with probiotics and vitamin D may improve a dairy product 's glucoregulatory effects ."
96604,.,O,3345.0,"Furthermore , fermentation and fortification of dairy products with probiotics and vitamin D may improve a dairy product 's glucoregulatory effects ."
96605,Epidemiologic,O,3346.0,Epidemiologic studies from numerous disparate populations reveal that individuals with the habit of daily moderate wine consumption enjoy significant reductions in all - cause and particularly cardiovascular mortality when compared with individuals who abstain or who drink alcohol to excess .
96606,studies,O,3346.0,Epidemiologic studies from numerous disparate populations reveal that individuals with the habit of daily moderate wine consumption enjoy significant reductions in all - cause and particularly cardiovascular mortality when compared with individuals who abstain or who drink alcohol to excess .
96607,from,O,3346.0,Epidemiologic studies from numerous disparate populations reveal that individuals with the habit of daily moderate wine consumption enjoy significant reductions in all - cause and particularly cardiovascular mortality when compared with individuals who abstain or who drink alcohol to excess .
96608,numerous,O,3346.0,Epidemiologic studies from numerous disparate populations reveal that individuals with the habit of daily moderate wine consumption enjoy significant reductions in all - cause and particularly cardiovascular mortality when compared with individuals who abstain or who drink alcohol to excess .
96609,disparate,O,3346.0,Epidemiologic studies from numerous disparate populations reveal that individuals with the habit of daily moderate wine consumption enjoy significant reductions in all - cause and particularly cardiovascular mortality when compared with individuals who abstain or who drink alcohol to excess .
96610,populations,O,3346.0,Epidemiologic studies from numerous disparate populations reveal that individuals with the habit of daily moderate wine consumption enjoy significant reductions in all - cause and particularly cardiovascular mortality when compared with individuals who abstain or who drink alcohol to excess .
96611,reveal,O,3346.0,Epidemiologic studies from numerous disparate populations reveal that individuals with the habit of daily moderate wine consumption enjoy significant reductions in all - cause and particularly cardiovascular mortality when compared with individuals who abstain or who drink alcohol to excess .
96612,that,O,3346.0,Epidemiologic studies from numerous disparate populations reveal that individuals with the habit of daily moderate wine consumption enjoy significant reductions in all - cause and particularly cardiovascular mortality when compared with individuals who abstain or who drink alcohol to excess .
96613,individuals,O,3346.0,Epidemiologic studies from numerous disparate populations reveal that individuals with the habit of daily moderate wine consumption enjoy significant reductions in all - cause and particularly cardiovascular mortality when compared with individuals who abstain or who drink alcohol to excess .
96614,with,O,3346.0,Epidemiologic studies from numerous disparate populations reveal that individuals with the habit of daily moderate wine consumption enjoy significant reductions in all - cause and particularly cardiovascular mortality when compared with individuals who abstain or who drink alcohol to excess .
96615,the,O,3346.0,Epidemiologic studies from numerous disparate populations reveal that individuals with the habit of daily moderate wine consumption enjoy significant reductions in all - cause and particularly cardiovascular mortality when compared with individuals who abstain or who drink alcohol to excess .
96616,habit,O,3346.0,Epidemiologic studies from numerous disparate populations reveal that individuals with the habit of daily moderate wine consumption enjoy significant reductions in all - cause and particularly cardiovascular mortality when compared with individuals who abstain or who drink alcohol to excess .
96617,of,O,3346.0,Epidemiologic studies from numerous disparate populations reveal that individuals with the habit of daily moderate wine consumption enjoy significant reductions in all - cause and particularly cardiovascular mortality when compared with individuals who abstain or who drink alcohol to excess .
96618,daily,O,3346.0,Epidemiologic studies from numerous disparate populations reveal that individuals with the habit of daily moderate wine consumption enjoy significant reductions in all - cause and particularly cardiovascular mortality when compared with individuals who abstain or who drink alcohol to excess .
96619,moderate,O,3346.0,Epidemiologic studies from numerous disparate populations reveal that individuals with the habit of daily moderate wine consumption enjoy significant reductions in all - cause and particularly cardiovascular mortality when compared with individuals who abstain or who drink alcohol to excess .
96620,wine,B-AG.01.y.01.a,3346.0,Epidemiologic studies from numerous disparate populations reveal that individuals with the habit of daily moderate wine consumption enjoy significant reductions in all - cause and particularly cardiovascular mortality when compared with individuals who abstain or who drink alcohol to excess .
96621,consumption,B-X,3346.0,Epidemiologic studies from numerous disparate populations reveal that individuals with the habit of daily moderate wine consumption enjoy significant reductions in all - cause and particularly cardiovascular mortality when compared with individuals who abstain or who drink alcohol to excess .
96622,enjoy,O,3346.0,Epidemiologic studies from numerous disparate populations reveal that individuals with the habit of daily moderate wine consumption enjoy significant reductions in all - cause and particularly cardiovascular mortality when compared with individuals who abstain or who drink alcohol to excess .
96623,significant,O,3346.0,Epidemiologic studies from numerous disparate populations reveal that individuals with the habit of daily moderate wine consumption enjoy significant reductions in all - cause and particularly cardiovascular mortality when compared with individuals who abstain or who drink alcohol to excess .
96624,reductions,O,3346.0,Epidemiologic studies from numerous disparate populations reveal that individuals with the habit of daily moderate wine consumption enjoy significant reductions in all - cause and particularly cardiovascular mortality when compared with individuals who abstain or who drink alcohol to excess .
96625,in,O,3346.0,Epidemiologic studies from numerous disparate populations reveal that individuals with the habit of daily moderate wine consumption enjoy significant reductions in all - cause and particularly cardiovascular mortality when compared with individuals who abstain or who drink alcohol to excess .
96626,all,O,3346.0,Epidemiologic studies from numerous disparate populations reveal that individuals with the habit of daily moderate wine consumption enjoy significant reductions in all - cause and particularly cardiovascular mortality when compared with individuals who abstain or who drink alcohol to excess .
96627,-,O,3346.0,Epidemiologic studies from numerous disparate populations reveal that individuals with the habit of daily moderate wine consumption enjoy significant reductions in all - cause and particularly cardiovascular mortality when compared with individuals who abstain or who drink alcohol to excess .
96628,cause,O,3346.0,Epidemiologic studies from numerous disparate populations reveal that individuals with the habit of daily moderate wine consumption enjoy significant reductions in all - cause and particularly cardiovascular mortality when compared with individuals who abstain or who drink alcohol to excess .
96629,and,O,3346.0,Epidemiologic studies from numerous disparate populations reveal that individuals with the habit of daily moderate wine consumption enjoy significant reductions in all - cause and particularly cardiovascular mortality when compared with individuals who abstain or who drink alcohol to excess .
96630,particularly,O,3346.0,Epidemiologic studies from numerous disparate populations reveal that individuals with the habit of daily moderate wine consumption enjoy significant reductions in all - cause and particularly cardiovascular mortality when compared with individuals who abstain or who drink alcohol to excess .
96631,cardiovascular,O,3346.0,Epidemiologic studies from numerous disparate populations reveal that individuals with the habit of daily moderate wine consumption enjoy significant reductions in all - cause and particularly cardiovascular mortality when compared with individuals who abstain or who drink alcohol to excess .
96632,mortality,O,3346.0,Epidemiologic studies from numerous disparate populations reveal that individuals with the habit of daily moderate wine consumption enjoy significant reductions in all - cause and particularly cardiovascular mortality when compared with individuals who abstain or who drink alcohol to excess .
96633,when,O,3346.0,Epidemiologic studies from numerous disparate populations reveal that individuals with the habit of daily moderate wine consumption enjoy significant reductions in all - cause and particularly cardiovascular mortality when compared with individuals who abstain or who drink alcohol to excess .
96634,compared,O,3346.0,Epidemiologic studies from numerous disparate populations reveal that individuals with the habit of daily moderate wine consumption enjoy significant reductions in all - cause and particularly cardiovascular mortality when compared with individuals who abstain or who drink alcohol to excess .
96635,with,O,3346.0,Epidemiologic studies from numerous disparate populations reveal that individuals with the habit of daily moderate wine consumption enjoy significant reductions in all - cause and particularly cardiovascular mortality when compared with individuals who abstain or who drink alcohol to excess .
96636,individuals,O,3346.0,Epidemiologic studies from numerous disparate populations reveal that individuals with the habit of daily moderate wine consumption enjoy significant reductions in all - cause and particularly cardiovascular mortality when compared with individuals who abstain or who drink alcohol to excess .
96637,who,O,3346.0,Epidemiologic studies from numerous disparate populations reveal that individuals with the habit of daily moderate wine consumption enjoy significant reductions in all - cause and particularly cardiovascular mortality when compared with individuals who abstain or who drink alcohol to excess .
96638,abstain,O,3346.0,Epidemiologic studies from numerous disparate populations reveal that individuals with the habit of daily moderate wine consumption enjoy significant reductions in all - cause and particularly cardiovascular mortality when compared with individuals who abstain or who drink alcohol to excess .
96639,or,O,3346.0,Epidemiologic studies from numerous disparate populations reveal that individuals with the habit of daily moderate wine consumption enjoy significant reductions in all - cause and particularly cardiovascular mortality when compared with individuals who abstain or who drink alcohol to excess .
96640,who,O,3346.0,Epidemiologic studies from numerous disparate populations reveal that individuals with the habit of daily moderate wine consumption enjoy significant reductions in all - cause and particularly cardiovascular mortality when compared with individuals who abstain or who drink alcohol to excess .
96641,drink,O,3346.0,Epidemiologic studies from numerous disparate populations reveal that individuals with the habit of daily moderate wine consumption enjoy significant reductions in all - cause and particularly cardiovascular mortality when compared with individuals who abstain or who drink alcohol to excess .
96642,alcohol,B-AG.01.y.01,3346.0,Epidemiologic studies from numerous disparate populations reveal that individuals with the habit of daily moderate wine consumption enjoy significant reductions in all - cause and particularly cardiovascular mortality when compared with individuals who abstain or who drink alcohol to excess .
96643,to,O,3346.0,Epidemiologic studies from numerous disparate populations reveal that individuals with the habit of daily moderate wine consumption enjoy significant reductions in all - cause and particularly cardiovascular mortality when compared with individuals who abstain or who drink alcohol to excess .
96644,excess,O,3346.0,Epidemiologic studies from numerous disparate populations reveal that individuals with the habit of daily moderate wine consumption enjoy significant reductions in all - cause and particularly cardiovascular mortality when compared with individuals who abstain or who drink alcohol to excess .
96645,.,O,3346.0,Epidemiologic studies from numerous disparate populations reveal that individuals with the habit of daily moderate wine consumption enjoy significant reductions in all - cause and particularly cardiovascular mortality when compared with individuals who abstain or who drink alcohol to excess .
96646,Researchers,O,3347.0,Researchers are working to explain this observation in molecular and nutritional terms .
96647,are,O,3347.0,Researchers are working to explain this observation in molecular and nutritional terms .
96648,working,O,3347.0,Researchers are working to explain this observation in molecular and nutritional terms .
96649,to,O,3347.0,Researchers are working to explain this observation in molecular and nutritional terms .
96650,explain,O,3347.0,Researchers are working to explain this observation in molecular and nutritional terms .
96651,this,O,3347.0,Researchers are working to explain this observation in molecular and nutritional terms .
96652,observation,O,3347.0,Researchers are working to explain this observation in molecular and nutritional terms .
96653,in,O,3347.0,Researchers are working to explain this observation in molecular and nutritional terms .
96654,molecular,O,3347.0,Researchers are working to explain this observation in molecular and nutritional terms .
96655,and,O,3347.0,Researchers are working to explain this observation in molecular and nutritional terms .
96656,nutritional,O,3347.0,Researchers are working to explain this observation in molecular and nutritional terms .
96657,terms,O,3347.0,Researchers are working to explain this observation in molecular and nutritional terms .
96658,.,O,3347.0,Researchers are working to explain this observation in molecular and nutritional terms .
96659,Moderate,O,3348.0,Moderate ethanol intake from any type of beverage improves lipoprotein metabolism and lowers cardiovascular mortality risk .
96660,ethanol,O,3348.0,Moderate ethanol intake from any type of beverage improves lipoprotein metabolism and lowers cardiovascular mortality risk .
96661,intake,O,3348.0,Moderate ethanol intake from any type of beverage improves lipoprotein metabolism and lowers cardiovascular mortality risk .
96662,from,O,3348.0,Moderate ethanol intake from any type of beverage improves lipoprotein metabolism and lowers cardiovascular mortality risk .
96663,any,O,3348.0,Moderate ethanol intake from any type of beverage improves lipoprotein metabolism and lowers cardiovascular mortality risk .
96664,type,O,3348.0,Moderate ethanol intake from any type of beverage improves lipoprotein metabolism and lowers cardiovascular mortality risk .
96665,of,O,3348.0,Moderate ethanol intake from any type of beverage improves lipoprotein metabolism and lowers cardiovascular mortality risk .
96666,beverage,B-AG.01.y,3348.0,Moderate ethanol intake from any type of beverage improves lipoprotein metabolism and lowers cardiovascular mortality risk .
96667,improves,O,3348.0,Moderate ethanol intake from any type of beverage improves lipoprotein metabolism and lowers cardiovascular mortality risk .
96668,lipoprotein,O,3348.0,Moderate ethanol intake from any type of beverage improves lipoprotein metabolism and lowers cardiovascular mortality risk .
96669,metabolism,O,3348.0,Moderate ethanol intake from any type of beverage improves lipoprotein metabolism and lowers cardiovascular mortality risk .
96670,and,O,3348.0,Moderate ethanol intake from any type of beverage improves lipoprotein metabolism and lowers cardiovascular mortality risk .
96671,lowers,O,3348.0,Moderate ethanol intake from any type of beverage improves lipoprotein metabolism and lowers cardiovascular mortality risk .
96672,cardiovascular,O,3348.0,Moderate ethanol intake from any type of beverage improves lipoprotein metabolism and lowers cardiovascular mortality risk .
96673,mortality,O,3348.0,Moderate ethanol intake from any type of beverage improves lipoprotein metabolism and lowers cardiovascular mortality risk .
96674,risk,O,3348.0,Moderate ethanol intake from any type of beverage improves lipoprotein metabolism and lowers cardiovascular mortality risk .
96675,.,O,3348.0,Moderate ethanol intake from any type of beverage improves lipoprotein metabolism and lowers cardiovascular mortality risk .
96676,The,O,3349.0,"The question now is whether wine , particularly red wine with its abundant content of phenolic acids and polyphenols , confers additional health benefits ."
96677,question,O,3349.0,"The question now is whether wine , particularly red wine with its abundant content of phenolic acids and polyphenols , confers additional health benefits ."
96678,now,O,3349.0,"The question now is whether wine , particularly red wine with its abundant content of phenolic acids and polyphenols , confers additional health benefits ."
96679,is,O,3349.0,"The question now is whether wine , particularly red wine with its abundant content of phenolic acids and polyphenols , confers additional health benefits ."
96680,whether,O,3349.0,"The question now is whether wine , particularly red wine with its abundant content of phenolic acids and polyphenols , confers additional health benefits ."
96681,wine,B-AG.01.y.01.a,3349.0,"The question now is whether wine , particularly red wine with its abundant content of phenolic acids and polyphenols , confers additional health benefits ."
96682,",",O,3349.0,"The question now is whether wine , particularly red wine with its abundant content of phenolic acids and polyphenols , confers additional health benefits ."
96683,particularly,O,3349.0,"The question now is whether wine , particularly red wine with its abundant content of phenolic acids and polyphenols , confers additional health benefits ."
96684,red,B-AG.01.y.01.a,3349.0,"The question now is whether wine , particularly red wine with its abundant content of phenolic acids and polyphenols , confers additional health benefits ."
96685,wine,I-AG.01.y.01.a,3349.0,"The question now is whether wine , particularly red wine with its abundant content of phenolic acids and polyphenols , confers additional health benefits ."
96686,with,O,3349.0,"The question now is whether wine , particularly red wine with its abundant content of phenolic acids and polyphenols , confers additional health benefits ."
96687,its,O,3349.0,"The question now is whether wine , particularly red wine with its abundant content of phenolic acids and polyphenols , confers additional health benefits ."
96688,abundant,O,3349.0,"The question now is whether wine , particularly red wine with its abundant content of phenolic acids and polyphenols , confers additional health benefits ."
96689,content,O,3349.0,"The question now is whether wine , particularly red wine with its abundant content of phenolic acids and polyphenols , confers additional health benefits ."
96690,of,O,3349.0,"The question now is whether wine , particularly red wine with its abundant content of phenolic acids and polyphenols , confers additional health benefits ."
96691,phenolic,O,3349.0,"The question now is whether wine , particularly red wine with its abundant content of phenolic acids and polyphenols , confers additional health benefits ."
96692,acids,O,3349.0,"The question now is whether wine , particularly red wine with its abundant content of phenolic acids and polyphenols , confers additional health benefits ."
96693,and,O,3349.0,"The question now is whether wine , particularly red wine with its abundant content of phenolic acids and polyphenols , confers additional health benefits ."
96694,polyphenols,O,3349.0,"The question now is whether wine , particularly red wine with its abundant content of phenolic acids and polyphenols , confers additional health benefits ."
96695,",",O,3349.0,"The question now is whether wine , particularly red wine with its abundant content of phenolic acids and polyphenols , confers additional health benefits ."
96696,confers,O,3349.0,"The question now is whether wine , particularly red wine with its abundant content of phenolic acids and polyphenols , confers additional health benefits ."
96697,additional,O,3349.0,"The question now is whether wine , particularly red wine with its abundant content of phenolic acids and polyphenols , confers additional health benefits ."
96698,health,O,3349.0,"The question now is whether wine , particularly red wine with its abundant content of phenolic acids and polyphenols , confers additional health benefits ."
96699,benefits,O,3349.0,"The question now is whether wine , particularly red wine with its abundant content of phenolic acids and polyphenols , confers additional health benefits ."
96700,.,O,3349.0,"The question now is whether wine , particularly red wine with its abundant content of phenolic acids and polyphenols , confers additional health benefits ."
96701,Discovering,O,3350.0,"Discovering the nutritional properties of wine is a challenging task , which requires that the biological actions and bioavailability of the > 200 individual phenolic compounds be documented and interpreted within the societal factors that stratify wine consumption and the myriad effects of alcohol alone ."
96702,the,O,3350.0,"Discovering the nutritional properties of wine is a challenging task , which requires that the biological actions and bioavailability of the > 200 individual phenolic compounds be documented and interpreted within the societal factors that stratify wine consumption and the myriad effects of alcohol alone ."
96703,nutritional,O,3350.0,"Discovering the nutritional properties of wine is a challenging task , which requires that the biological actions and bioavailability of the > 200 individual phenolic compounds be documented and interpreted within the societal factors that stratify wine consumption and the myriad effects of alcohol alone ."
96704,properties,O,3350.0,"Discovering the nutritional properties of wine is a challenging task , which requires that the biological actions and bioavailability of the > 200 individual phenolic compounds be documented and interpreted within the societal factors that stratify wine consumption and the myriad effects of alcohol alone ."
96705,of,O,3350.0,"Discovering the nutritional properties of wine is a challenging task , which requires that the biological actions and bioavailability of the > 200 individual phenolic compounds be documented and interpreted within the societal factors that stratify wine consumption and the myriad effects of alcohol alone ."
96706,wine,B-AG.01.y.01.a,3350.0,"Discovering the nutritional properties of wine is a challenging task , which requires that the biological actions and bioavailability of the > 200 individual phenolic compounds be documented and interpreted within the societal factors that stratify wine consumption and the myriad effects of alcohol alone ."
96707,is,O,3350.0,"Discovering the nutritional properties of wine is a challenging task , which requires that the biological actions and bioavailability of the > 200 individual phenolic compounds be documented and interpreted within the societal factors that stratify wine consumption and the myriad effects of alcohol alone ."
96708,a,O,3350.0,"Discovering the nutritional properties of wine is a challenging task , which requires that the biological actions and bioavailability of the > 200 individual phenolic compounds be documented and interpreted within the societal factors that stratify wine consumption and the myriad effects of alcohol alone ."
96709,challenging,O,3350.0,"Discovering the nutritional properties of wine is a challenging task , which requires that the biological actions and bioavailability of the > 200 individual phenolic compounds be documented and interpreted within the societal factors that stratify wine consumption and the myriad effects of alcohol alone ."
96710,task,O,3350.0,"Discovering the nutritional properties of wine is a challenging task , which requires that the biological actions and bioavailability of the > 200 individual phenolic compounds be documented and interpreted within the societal factors that stratify wine consumption and the myriad effects of alcohol alone ."
96711,",",O,3350.0,"Discovering the nutritional properties of wine is a challenging task , which requires that the biological actions and bioavailability of the > 200 individual phenolic compounds be documented and interpreted within the societal factors that stratify wine consumption and the myriad effects of alcohol alone ."
96712,which,O,3350.0,"Discovering the nutritional properties of wine is a challenging task , which requires that the biological actions and bioavailability of the > 200 individual phenolic compounds be documented and interpreted within the societal factors that stratify wine consumption and the myriad effects of alcohol alone ."
96713,requires,O,3350.0,"Discovering the nutritional properties of wine is a challenging task , which requires that the biological actions and bioavailability of the > 200 individual phenolic compounds be documented and interpreted within the societal factors that stratify wine consumption and the myriad effects of alcohol alone ."
96714,that,O,3350.0,"Discovering the nutritional properties of wine is a challenging task , which requires that the biological actions and bioavailability of the > 200 individual phenolic compounds be documented and interpreted within the societal factors that stratify wine consumption and the myriad effects of alcohol alone ."
96715,the,O,3350.0,"Discovering the nutritional properties of wine is a challenging task , which requires that the biological actions and bioavailability of the > 200 individual phenolic compounds be documented and interpreted within the societal factors that stratify wine consumption and the myriad effects of alcohol alone ."
96716,biological,O,3350.0,"Discovering the nutritional properties of wine is a challenging task , which requires that the biological actions and bioavailability of the > 200 individual phenolic compounds be documented and interpreted within the societal factors that stratify wine consumption and the myriad effects of alcohol alone ."
96717,actions,O,3350.0,"Discovering the nutritional properties of wine is a challenging task , which requires that the biological actions and bioavailability of the > 200 individual phenolic compounds be documented and interpreted within the societal factors that stratify wine consumption and the myriad effects of alcohol alone ."
96718,and,O,3350.0,"Discovering the nutritional properties of wine is a challenging task , which requires that the biological actions and bioavailability of the > 200 individual phenolic compounds be documented and interpreted within the societal factors that stratify wine consumption and the myriad effects of alcohol alone ."
96719,bioavailability,O,3350.0,"Discovering the nutritional properties of wine is a challenging task , which requires that the biological actions and bioavailability of the > 200 individual phenolic compounds be documented and interpreted within the societal factors that stratify wine consumption and the myriad effects of alcohol alone ."
96720,of,O,3350.0,"Discovering the nutritional properties of wine is a challenging task , which requires that the biological actions and bioavailability of the > 200 individual phenolic compounds be documented and interpreted within the societal factors that stratify wine consumption and the myriad effects of alcohol alone ."
96721,the,O,3350.0,"Discovering the nutritional properties of wine is a challenging task , which requires that the biological actions and bioavailability of the > 200 individual phenolic compounds be documented and interpreted within the societal factors that stratify wine consumption and the myriad effects of alcohol alone ."
96722,>,O,3350.0,"Discovering the nutritional properties of wine is a challenging task , which requires that the biological actions and bioavailability of the > 200 individual phenolic compounds be documented and interpreted within the societal factors that stratify wine consumption and the myriad effects of alcohol alone ."
96723,200,O,3350.0,"Discovering the nutritional properties of wine is a challenging task , which requires that the biological actions and bioavailability of the > 200 individual phenolic compounds be documented and interpreted within the societal factors that stratify wine consumption and the myriad effects of alcohol alone ."
96724,individual,O,3350.0,"Discovering the nutritional properties of wine is a challenging task , which requires that the biological actions and bioavailability of the > 200 individual phenolic compounds be documented and interpreted within the societal factors that stratify wine consumption and the myriad effects of alcohol alone ."
96725,phenolic,O,3350.0,"Discovering the nutritional properties of wine is a challenging task , which requires that the biological actions and bioavailability of the > 200 individual phenolic compounds be documented and interpreted within the societal factors that stratify wine consumption and the myriad effects of alcohol alone ."
96726,compounds,O,3350.0,"Discovering the nutritional properties of wine is a challenging task , which requires that the biological actions and bioavailability of the > 200 individual phenolic compounds be documented and interpreted within the societal factors that stratify wine consumption and the myriad effects of alcohol alone ."
96727,be,O,3350.0,"Discovering the nutritional properties of wine is a challenging task , which requires that the biological actions and bioavailability of the > 200 individual phenolic compounds be documented and interpreted within the societal factors that stratify wine consumption and the myriad effects of alcohol alone ."
96728,documented,O,3350.0,"Discovering the nutritional properties of wine is a challenging task , which requires that the biological actions and bioavailability of the > 200 individual phenolic compounds be documented and interpreted within the societal factors that stratify wine consumption and the myriad effects of alcohol alone ."
96729,and,O,3350.0,"Discovering the nutritional properties of wine is a challenging task , which requires that the biological actions and bioavailability of the > 200 individual phenolic compounds be documented and interpreted within the societal factors that stratify wine consumption and the myriad effects of alcohol alone ."
96730,interpreted,O,3350.0,"Discovering the nutritional properties of wine is a challenging task , which requires that the biological actions and bioavailability of the > 200 individual phenolic compounds be documented and interpreted within the societal factors that stratify wine consumption and the myriad effects of alcohol alone ."
96731,within,O,3350.0,"Discovering the nutritional properties of wine is a challenging task , which requires that the biological actions and bioavailability of the > 200 individual phenolic compounds be documented and interpreted within the societal factors that stratify wine consumption and the myriad effects of alcohol alone ."
96732,the,O,3350.0,"Discovering the nutritional properties of wine is a challenging task , which requires that the biological actions and bioavailability of the > 200 individual phenolic compounds be documented and interpreted within the societal factors that stratify wine consumption and the myriad effects of alcohol alone ."
96733,societal,O,3350.0,"Discovering the nutritional properties of wine is a challenging task , which requires that the biological actions and bioavailability of the > 200 individual phenolic compounds be documented and interpreted within the societal factors that stratify wine consumption and the myriad effects of alcohol alone ."
96734,factors,O,3350.0,"Discovering the nutritional properties of wine is a challenging task , which requires that the biological actions and bioavailability of the > 200 individual phenolic compounds be documented and interpreted within the societal factors that stratify wine consumption and the myriad effects of alcohol alone ."
96735,that,O,3350.0,"Discovering the nutritional properties of wine is a challenging task , which requires that the biological actions and bioavailability of the > 200 individual phenolic compounds be documented and interpreted within the societal factors that stratify wine consumption and the myriad effects of alcohol alone ."
96736,stratify,O,3350.0,"Discovering the nutritional properties of wine is a challenging task , which requires that the biological actions and bioavailability of the > 200 individual phenolic compounds be documented and interpreted within the societal factors that stratify wine consumption and the myriad effects of alcohol alone ."
96737,wine,B-AG.01.y.01.a,3350.0,"Discovering the nutritional properties of wine is a challenging task , which requires that the biological actions and bioavailability of the > 200 individual phenolic compounds be documented and interpreted within the societal factors that stratify wine consumption and the myriad effects of alcohol alone ."
96738,consumption,B-X,3350.0,"Discovering the nutritional properties of wine is a challenging task , which requires that the biological actions and bioavailability of the > 200 individual phenolic compounds be documented and interpreted within the societal factors that stratify wine consumption and the myriad effects of alcohol alone ."
96739,and,O,3350.0,"Discovering the nutritional properties of wine is a challenging task , which requires that the biological actions and bioavailability of the > 200 individual phenolic compounds be documented and interpreted within the societal factors that stratify wine consumption and the myriad effects of alcohol alone ."
96740,the,O,3350.0,"Discovering the nutritional properties of wine is a challenging task , which requires that the biological actions and bioavailability of the > 200 individual phenolic compounds be documented and interpreted within the societal factors that stratify wine consumption and the myriad effects of alcohol alone ."
96741,myriad,O,3350.0,"Discovering the nutritional properties of wine is a challenging task , which requires that the biological actions and bioavailability of the > 200 individual phenolic compounds be documented and interpreted within the societal factors that stratify wine consumption and the myriad effects of alcohol alone ."
96742,effects,O,3350.0,"Discovering the nutritional properties of wine is a challenging task , which requires that the biological actions and bioavailability of the > 200 individual phenolic compounds be documented and interpreted within the societal factors that stratify wine consumption and the myriad effects of alcohol alone ."
96743,of,O,3350.0,"Discovering the nutritional properties of wine is a challenging task , which requires that the biological actions and bioavailability of the > 200 individual phenolic compounds be documented and interpreted within the societal factors that stratify wine consumption and the myriad effects of alcohol alone ."
96744,alcohol,B-AG.01.y.01,3350.0,"Discovering the nutritional properties of wine is a challenging task , which requires that the biological actions and bioavailability of the > 200 individual phenolic compounds be documented and interpreted within the societal factors that stratify wine consumption and the myriad effects of alcohol alone ."
96745,alone,O,3350.0,"Discovering the nutritional properties of wine is a challenging task , which requires that the biological actions and bioavailability of the > 200 individual phenolic compounds be documented and interpreted within the societal factors that stratify wine consumption and the myriad effects of alcohol alone ."
96746,.,O,3350.0,"Discovering the nutritional properties of wine is a challenging task , which requires that the biological actions and bioavailability of the > 200 individual phenolic compounds be documented and interpreted within the societal factors that stratify wine consumption and the myriad effects of alcohol alone ."
96747,Further,O,3351.0,Further challenge arises because the health benefits of wine address the prevention of slowly developing diseases for which validated biomarkers are rare .
96748,challenge,O,3351.0,Further challenge arises because the health benefits of wine address the prevention of slowly developing diseases for which validated biomarkers are rare .
96749,arises,O,3351.0,Further challenge arises because the health benefits of wine address the prevention of slowly developing diseases for which validated biomarkers are rare .
96750,because,O,3351.0,Further challenge arises because the health benefits of wine address the prevention of slowly developing diseases for which validated biomarkers are rare .
96751,the,O,3351.0,Further challenge arises because the health benefits of wine address the prevention of slowly developing diseases for which validated biomarkers are rare .
96752,health,O,3351.0,Further challenge arises because the health benefits of wine address the prevention of slowly developing diseases for which validated biomarkers are rare .
96753,benefits,O,3351.0,Further challenge arises because the health benefits of wine address the prevention of slowly developing diseases for which validated biomarkers are rare .
96754,of,O,3351.0,Further challenge arises because the health benefits of wine address the prevention of slowly developing diseases for which validated biomarkers are rare .
96755,wine,B-AG.01.y.01.a,3351.0,Further challenge arises because the health benefits of wine address the prevention of slowly developing diseases for which validated biomarkers are rare .
96756,address,O,3351.0,Further challenge arises because the health benefits of wine address the prevention of slowly developing diseases for which validated biomarkers are rare .
96757,the,O,3351.0,Further challenge arises because the health benefits of wine address the prevention of slowly developing diseases for which validated biomarkers are rare .
96758,prevention,O,3351.0,Further challenge arises because the health benefits of wine address the prevention of slowly developing diseases for which validated biomarkers are rare .
96759,of,O,3351.0,Further challenge arises because the health benefits of wine address the prevention of slowly developing diseases for which validated biomarkers are rare .
96760,slowly,O,3351.0,Further challenge arises because the health benefits of wine address the prevention of slowly developing diseases for which validated biomarkers are rare .
96761,developing,O,3351.0,Further challenge arises because the health benefits of wine address the prevention of slowly developing diseases for which validated biomarkers are rare .
96762,diseases,O,3351.0,Further challenge arises because the health benefits of wine address the prevention of slowly developing diseases for which validated biomarkers are rare .
96763,for,O,3351.0,Further challenge arises because the health benefits of wine address the prevention of slowly developing diseases for which validated biomarkers are rare .
96764,which,O,3351.0,Further challenge arises because the health benefits of wine address the prevention of slowly developing diseases for which validated biomarkers are rare .
96765,validated,O,3351.0,Further challenge arises because the health benefits of wine address the prevention of slowly developing diseases for which validated biomarkers are rare .
96766,biomarkers,O,3351.0,Further challenge arises because the health benefits of wine address the prevention of slowly developing diseases for which validated biomarkers are rare .
96767,are,O,3351.0,Further challenge arises because the health benefits of wine address the prevention of slowly developing diseases for which validated biomarkers are rare .
96768,rare,O,3351.0,Further challenge arises because the health benefits of wine address the prevention of slowly developing diseases for which validated biomarkers are rare .
96769,.,O,3351.0,Further challenge arises because the health benefits of wine address the prevention of slowly developing diseases for which validated biomarkers are rare .
96770,Thus,O,3352.0,"Thus , although the benefits of the polyphenols from fruits and vegetables are increasingly accepted , consensus on wine is developing more slowly ."
96771,",",O,3352.0,"Thus , although the benefits of the polyphenols from fruits and vegetables are increasingly accepted , consensus on wine is developing more slowly ."
96772,although,O,3352.0,"Thus , although the benefits of the polyphenols from fruits and vegetables are increasingly accepted , consensus on wine is developing more slowly ."
96773,the,O,3352.0,"Thus , although the benefits of the polyphenols from fruits and vegetables are increasingly accepted , consensus on wine is developing more slowly ."
96774,benefits,O,3352.0,"Thus , although the benefits of the polyphenols from fruits and vegetables are increasingly accepted , consensus on wine is developing more slowly ."
96775,of,O,3352.0,"Thus , although the benefits of the polyphenols from fruits and vegetables are increasingly accepted , consensus on wine is developing more slowly ."
96776,the,O,3352.0,"Thus , although the benefits of the polyphenols from fruits and vegetables are increasingly accepted , consensus on wine is developing more slowly ."
96777,polyphenols,O,3352.0,"Thus , although the benefits of the polyphenols from fruits and vegetables are increasingly accepted , consensus on wine is developing more slowly ."
96778,from,O,3352.0,"Thus , although the benefits of the polyphenols from fruits and vegetables are increasingly accepted , consensus on wine is developing more slowly ."
96779,fruits,B-AG.01.h.01,3352.0,"Thus , although the benefits of the polyphenols from fruits and vegetables are increasingly accepted , consensus on wine is developing more slowly ."
96780,and,O,3352.0,"Thus , although the benefits of the polyphenols from fruits and vegetables are increasingly accepted , consensus on wine is developing more slowly ."
96781,vegetables,B-AG.01.h.02,3352.0,"Thus , although the benefits of the polyphenols from fruits and vegetables are increasingly accepted , consensus on wine is developing more slowly ."
96782,are,O,3352.0,"Thus , although the benefits of the polyphenols from fruits and vegetables are increasingly accepted , consensus on wine is developing more slowly ."
96783,increasingly,O,3352.0,"Thus , although the benefits of the polyphenols from fruits and vegetables are increasingly accepted , consensus on wine is developing more slowly ."
96784,accepted,O,3352.0,"Thus , although the benefits of the polyphenols from fruits and vegetables are increasingly accepted , consensus on wine is developing more slowly ."
96785,",",O,3352.0,"Thus , although the benefits of the polyphenols from fruits and vegetables are increasingly accepted , consensus on wine is developing more slowly ."
96786,consensus,O,3352.0,"Thus , although the benefits of the polyphenols from fruits and vegetables are increasingly accepted , consensus on wine is developing more slowly ."
96787,on,O,3352.0,"Thus , although the benefits of the polyphenols from fruits and vegetables are increasingly accepted , consensus on wine is developing more slowly ."
96788,wine,B-AG.01.y.01.a,3352.0,"Thus , although the benefits of the polyphenols from fruits and vegetables are increasingly accepted , consensus on wine is developing more slowly ."
96789,is,O,3352.0,"Thus , although the benefits of the polyphenols from fruits and vegetables are increasingly accepted , consensus on wine is developing more slowly ."
96790,developing,O,3352.0,"Thus , although the benefits of the polyphenols from fruits and vegetables are increasingly accepted , consensus on wine is developing more slowly ."
96791,more,O,3352.0,"Thus , although the benefits of the polyphenols from fruits and vegetables are increasingly accepted , consensus on wine is developing more slowly ."
96792,slowly,O,3352.0,"Thus , although the benefits of the polyphenols from fruits and vegetables are increasingly accepted , consensus on wine is developing more slowly ."
96793,.,O,3352.0,"Thus , although the benefits of the polyphenols from fruits and vegetables are increasingly accepted , consensus on wine is developing more slowly ."
96794,Scientific,O,3353.0,"Scientific research has demonstrated that the molecules present in grapes and in wine alter cellular metabolism and signaling , which is consistent mechanistically with reducing arterial disease ."
96795,research,O,3353.0,"Scientific research has demonstrated that the molecules present in grapes and in wine alter cellular metabolism and signaling , which is consistent mechanistically with reducing arterial disease ."
96796,has,O,3353.0,"Scientific research has demonstrated that the molecules present in grapes and in wine alter cellular metabolism and signaling , which is consistent mechanistically with reducing arterial disease ."
96797,demonstrated,O,3353.0,"Scientific research has demonstrated that the molecules present in grapes and in wine alter cellular metabolism and signaling , which is consistent mechanistically with reducing arterial disease ."
96798,that,O,3353.0,"Scientific research has demonstrated that the molecules present in grapes and in wine alter cellular metabolism and signaling , which is consistent mechanistically with reducing arterial disease ."
96799,the,O,3353.0,"Scientific research has demonstrated that the molecules present in grapes and in wine alter cellular metabolism and signaling , which is consistent mechanistically with reducing arterial disease ."
96800,molecules,O,3353.0,"Scientific research has demonstrated that the molecules present in grapes and in wine alter cellular metabolism and signaling , which is consistent mechanistically with reducing arterial disease ."
96801,present,O,3353.0,"Scientific research has demonstrated that the molecules present in grapes and in wine alter cellular metabolism and signaling , which is consistent mechanistically with reducing arterial disease ."
96802,in,O,3353.0,"Scientific research has demonstrated that the molecules present in grapes and in wine alter cellular metabolism and signaling , which is consistent mechanistically with reducing arterial disease ."
96803,grapes,B-AG.01.h.01.b,3353.0,"Scientific research has demonstrated that the molecules present in grapes and in wine alter cellular metabolism and signaling , which is consistent mechanistically with reducing arterial disease ."
96804,and,O,3353.0,"Scientific research has demonstrated that the molecules present in grapes and in wine alter cellular metabolism and signaling , which is consistent mechanistically with reducing arterial disease ."
96805,in,O,3353.0,"Scientific research has demonstrated that the molecules present in grapes and in wine alter cellular metabolism and signaling , which is consistent mechanistically with reducing arterial disease ."
96806,wine,B-AG.01.y.01.a,3353.0,"Scientific research has demonstrated that the molecules present in grapes and in wine alter cellular metabolism and signaling , which is consistent mechanistically with reducing arterial disease ."
96807,alter,O,3353.0,"Scientific research has demonstrated that the molecules present in grapes and in wine alter cellular metabolism and signaling , which is consistent mechanistically with reducing arterial disease ."
96808,cellular,O,3353.0,"Scientific research has demonstrated that the molecules present in grapes and in wine alter cellular metabolism and signaling , which is consistent mechanistically with reducing arterial disease ."
96809,metabolism,O,3353.0,"Scientific research has demonstrated that the molecules present in grapes and in wine alter cellular metabolism and signaling , which is consistent mechanistically with reducing arterial disease ."
96810,and,O,3353.0,"Scientific research has demonstrated that the molecules present in grapes and in wine alter cellular metabolism and signaling , which is consistent mechanistically with reducing arterial disease ."
96811,signaling,O,3353.0,"Scientific research has demonstrated that the molecules present in grapes and in wine alter cellular metabolism and signaling , which is consistent mechanistically with reducing arterial disease ."
96812,",",O,3353.0,"Scientific research has demonstrated that the molecules present in grapes and in wine alter cellular metabolism and signaling , which is consistent mechanistically with reducing arterial disease ."
96813,which,O,3353.0,"Scientific research has demonstrated that the molecules present in grapes and in wine alter cellular metabolism and signaling , which is consistent mechanistically with reducing arterial disease ."
96814,is,O,3353.0,"Scientific research has demonstrated that the molecules present in grapes and in wine alter cellular metabolism and signaling , which is consistent mechanistically with reducing arterial disease ."
96815,consistent,O,3353.0,"Scientific research has demonstrated that the molecules present in grapes and in wine alter cellular metabolism and signaling , which is consistent mechanistically with reducing arterial disease ."
96816,mechanistically,O,3353.0,"Scientific research has demonstrated that the molecules present in grapes and in wine alter cellular metabolism and signaling , which is consistent mechanistically with reducing arterial disease ."
96817,with,O,3353.0,"Scientific research has demonstrated that the molecules present in grapes and in wine alter cellular metabolism and signaling , which is consistent mechanistically with reducing arterial disease ."
96818,reducing,O,3353.0,"Scientific research has demonstrated that the molecules present in grapes and in wine alter cellular metabolism and signaling , which is consistent mechanistically with reducing arterial disease ."
96819,arterial,O,3353.0,"Scientific research has demonstrated that the molecules present in grapes and in wine alter cellular metabolism and signaling , which is consistent mechanistically with reducing arterial disease ."
96820,disease,O,3353.0,"Scientific research has demonstrated that the molecules present in grapes and in wine alter cellular metabolism and signaling , which is consistent mechanistically with reducing arterial disease ."
96821,.,O,3353.0,"Scientific research has demonstrated that the molecules present in grapes and in wine alter cellular metabolism and signaling , which is consistent mechanistically with reducing arterial disease ."
96822,Future,O,3354.0,Future research must address specific mechanisms both of alcohol and of polyphenolic action and develop biomarkers of their role in disease prevention in individuals .
96823,research,O,3354.0,Future research must address specific mechanisms both of alcohol and of polyphenolic action and develop biomarkers of their role in disease prevention in individuals .
96824,must,O,3354.0,Future research must address specific mechanisms both of alcohol and of polyphenolic action and develop biomarkers of their role in disease prevention in individuals .
96825,address,O,3354.0,Future research must address specific mechanisms both of alcohol and of polyphenolic action and develop biomarkers of their role in disease prevention in individuals .
96826,specific,O,3354.0,Future research must address specific mechanisms both of alcohol and of polyphenolic action and develop biomarkers of their role in disease prevention in individuals .
96827,mechanisms,O,3354.0,Future research must address specific mechanisms both of alcohol and of polyphenolic action and develop biomarkers of their role in disease prevention in individuals .
96828,both,O,3354.0,Future research must address specific mechanisms both of alcohol and of polyphenolic action and develop biomarkers of their role in disease prevention in individuals .
96829,of,O,3354.0,Future research must address specific mechanisms both of alcohol and of polyphenolic action and develop biomarkers of their role in disease prevention in individuals .
96830,alcohol,B-AG.01.y.01,3354.0,Future research must address specific mechanisms both of alcohol and of polyphenolic action and develop biomarkers of their role in disease prevention in individuals .
96831,and,O,3354.0,Future research must address specific mechanisms both of alcohol and of polyphenolic action and develop biomarkers of their role in disease prevention in individuals .
96832,of,O,3354.0,Future research must address specific mechanisms both of alcohol and of polyphenolic action and develop biomarkers of their role in disease prevention in individuals .
96833,polyphenolic,O,3354.0,Future research must address specific mechanisms both of alcohol and of polyphenolic action and develop biomarkers of their role in disease prevention in individuals .
96834,action,O,3354.0,Future research must address specific mechanisms both of alcohol and of polyphenolic action and develop biomarkers of their role in disease prevention in individuals .
96835,and,O,3354.0,Future research must address specific mechanisms both of alcohol and of polyphenolic action and develop biomarkers of their role in disease prevention in individuals .
96836,develop,O,3354.0,Future research must address specific mechanisms both of alcohol and of polyphenolic action and develop biomarkers of their role in disease prevention in individuals .
96837,biomarkers,O,3354.0,Future research must address specific mechanisms both of alcohol and of polyphenolic action and develop biomarkers of their role in disease prevention in individuals .
96838,of,O,3354.0,Future research must address specific mechanisms both of alcohol and of polyphenolic action and develop biomarkers of their role in disease prevention in individuals .
96839,their,O,3354.0,Future research must address specific mechanisms both of alcohol and of polyphenolic action and develop biomarkers of their role in disease prevention in individuals .
96840,role,O,3354.0,Future research must address specific mechanisms both of alcohol and of polyphenolic action and develop biomarkers of their role in disease prevention in individuals .
96841,in,O,3354.0,Future research must address specific mechanisms both of alcohol and of polyphenolic action and develop biomarkers of their role in disease prevention in individuals .
96842,disease,O,3354.0,Future research must address specific mechanisms both of alcohol and of polyphenolic action and develop biomarkers of their role in disease prevention in individuals .
96843,prevention,O,3354.0,Future research must address specific mechanisms both of alcohol and of polyphenolic action and develop biomarkers of their role in disease prevention in individuals .
96844,in,O,3354.0,Future research must address specific mechanisms both of alcohol and of polyphenolic action and develop biomarkers of their role in disease prevention in individuals .
96845,individuals,O,3354.0,Future research must address specific mechanisms both of alcohol and of polyphenolic action and develop biomarkers of their role in disease prevention in individuals .
96846,.,O,3354.0,Future research must address specific mechanisms both of alcohol and of polyphenolic action and develop biomarkers of their role in disease prevention in individuals .
96847,Probiotic,O,3355.0,"Probiotic foods , including fermented dairy ( FD ) products such as yogurt and cheese , naturally contain live microorganisms , but the relationship between the consumption of probiotic foods and health is unclear ."
96848,foods,B-AG.01,3355.0,"Probiotic foods , including fermented dairy ( FD ) products such as yogurt and cheese , naturally contain live microorganisms , but the relationship between the consumption of probiotic foods and health is unclear ."
96849,",",O,3355.0,"Probiotic foods , including fermented dairy ( FD ) products such as yogurt and cheese , naturally contain live microorganisms , but the relationship between the consumption of probiotic foods and health is unclear ."
96850,including,O,3355.0,"Probiotic foods , including fermented dairy ( FD ) products such as yogurt and cheese , naturally contain live microorganisms , but the relationship between the consumption of probiotic foods and health is unclear ."
96851,fermented,B-AG.01.e,3355.0,"Probiotic foods , including fermented dairy ( FD ) products such as yogurt and cheese , naturally contain live microorganisms , but the relationship between the consumption of probiotic foods and health is unclear ."
96852,dairy,I-AG.01.e,3355.0,"Probiotic foods , including fermented dairy ( FD ) products such as yogurt and cheese , naturally contain live microorganisms , but the relationship between the consumption of probiotic foods and health is unclear ."
96853,(,O,3355.0,"Probiotic foods , including fermented dairy ( FD ) products such as yogurt and cheese , naturally contain live microorganisms , but the relationship between the consumption of probiotic foods and health is unclear ."
96854,FD,O,3355.0,"Probiotic foods , including fermented dairy ( FD ) products such as yogurt and cheese , naturally contain live microorganisms , but the relationship between the consumption of probiotic foods and health is unclear ."
96855,),O,3355.0,"Probiotic foods , including fermented dairy ( FD ) products such as yogurt and cheese , naturally contain live microorganisms , but the relationship between the consumption of probiotic foods and health is unclear ."
96856,products,B-AG.01.e,3355.0,"Probiotic foods , including fermented dairy ( FD ) products such as yogurt and cheese , naturally contain live microorganisms , but the relationship between the consumption of probiotic foods and health is unclear ."
96857,such,O,3355.0,"Probiotic foods , including fermented dairy ( FD ) products such as yogurt and cheese , naturally contain live microorganisms , but the relationship between the consumption of probiotic foods and health is unclear ."
96858,as,O,3355.0,"Probiotic foods , including fermented dairy ( FD ) products such as yogurt and cheese , naturally contain live microorganisms , but the relationship between the consumption of probiotic foods and health is unclear ."
96859,yogurt,B-AG.01.e,3355.0,"Probiotic foods , including fermented dairy ( FD ) products such as yogurt and cheese , naturally contain live microorganisms , but the relationship between the consumption of probiotic foods and health is unclear ."
96860,and,O,3355.0,"Probiotic foods , including fermented dairy ( FD ) products such as yogurt and cheese , naturally contain live microorganisms , but the relationship between the consumption of probiotic foods and health is unclear ."
96861,cheese,B-AG.01.e.02,3355.0,"Probiotic foods , including fermented dairy ( FD ) products such as yogurt and cheese , naturally contain live microorganisms , but the relationship between the consumption of probiotic foods and health is unclear ."
96862,",",O,3355.0,"Probiotic foods , including fermented dairy ( FD ) products such as yogurt and cheese , naturally contain live microorganisms , but the relationship between the consumption of probiotic foods and health is unclear ."
96863,naturally,O,3355.0,"Probiotic foods , including fermented dairy ( FD ) products such as yogurt and cheese , naturally contain live microorganisms , but the relationship between the consumption of probiotic foods and health is unclear ."
96864,contain,O,3355.0,"Probiotic foods , including fermented dairy ( FD ) products such as yogurt and cheese , naturally contain live microorganisms , but the relationship between the consumption of probiotic foods and health is unclear ."
96865,live,O,3355.0,"Probiotic foods , including fermented dairy ( FD ) products such as yogurt and cheese , naturally contain live microorganisms , but the relationship between the consumption of probiotic foods and health is unclear ."
96866,microorganisms,O,3355.0,"Probiotic foods , including fermented dairy ( FD ) products such as yogurt and cheese , naturally contain live microorganisms , but the relationship between the consumption of probiotic foods and health is unclear ."
96867,",",O,3355.0,"Probiotic foods , including fermented dairy ( FD ) products such as yogurt and cheese , naturally contain live microorganisms , but the relationship between the consumption of probiotic foods and health is unclear ."
96868,but,O,3355.0,"Probiotic foods , including fermented dairy ( FD ) products such as yogurt and cheese , naturally contain live microorganisms , but the relationship between the consumption of probiotic foods and health is unclear ."
96869,the,O,3355.0,"Probiotic foods , including fermented dairy ( FD ) products such as yogurt and cheese , naturally contain live microorganisms , but the relationship between the consumption of probiotic foods and health is unclear ."
96870,relationship,O,3355.0,"Probiotic foods , including fermented dairy ( FD ) products such as yogurt and cheese , naturally contain live microorganisms , but the relationship between the consumption of probiotic foods and health is unclear ."
96871,between,O,3355.0,"Probiotic foods , including fermented dairy ( FD ) products such as yogurt and cheese , naturally contain live microorganisms , but the relationship between the consumption of probiotic foods and health is unclear ."
96872,the,O,3355.0,"Probiotic foods , including fermented dairy ( FD ) products such as yogurt and cheese , naturally contain live microorganisms , but the relationship between the consumption of probiotic foods and health is unclear ."
96873,consumption,O,3355.0,"Probiotic foods , including fermented dairy ( FD ) products such as yogurt and cheese , naturally contain live microorganisms , but the relationship between the consumption of probiotic foods and health is unclear ."
96874,of,O,3355.0,"Probiotic foods , including fermented dairy ( FD ) products such as yogurt and cheese , naturally contain live microorganisms , but the relationship between the consumption of probiotic foods and health is unclear ."
96875,probiotic,B-AG.01,3355.0,"Probiotic foods , including fermented dairy ( FD ) products such as yogurt and cheese , naturally contain live microorganisms , but the relationship between the consumption of probiotic foods and health is unclear ."
96876,foods,I-AG.01,3355.0,"Probiotic foods , including fermented dairy ( FD ) products such as yogurt and cheese , naturally contain live microorganisms , but the relationship between the consumption of probiotic foods and health is unclear ."
96877,and,O,3355.0,"Probiotic foods , including fermented dairy ( FD ) products such as yogurt and cheese , naturally contain live microorganisms , but the relationship between the consumption of probiotic foods and health is unclear ."
96878,health,O,3355.0,"Probiotic foods , including fermented dairy ( FD ) products such as yogurt and cheese , naturally contain live microorganisms , but the relationship between the consumption of probiotic foods and health is unclear ."
96879,is,O,3355.0,"Probiotic foods , including fermented dairy ( FD ) products such as yogurt and cheese , naturally contain live microorganisms , but the relationship between the consumption of probiotic foods and health is unclear ."
96880,unclear,O,3355.0,"Probiotic foods , including fermented dairy ( FD ) products such as yogurt and cheese , naturally contain live microorganisms , but the relationship between the consumption of probiotic foods and health is unclear ."
96881,.,O,3355.0,"Probiotic foods , including fermented dairy ( FD ) products such as yogurt and cheese , naturally contain live microorganisms , but the relationship between the consumption of probiotic foods and health is unclear ."
96882,The,O,3356.0,"The aim of the present narrative review is to integrate the available information on the relationship between the most studied FD products , which are yogurt and cheese , and cardiometabolic risk factors obtained from meta - analysis , systematic reviews of prospective cohort studies ( PCSs ) and PCSs published up to 2 November 2019 ."
96883,aim,O,3356.0,"The aim of the present narrative review is to integrate the available information on the relationship between the most studied FD products , which are yogurt and cheese , and cardiometabolic risk factors obtained from meta - analysis , systematic reviews of prospective cohort studies ( PCSs ) and PCSs published up to 2 November 2019 ."
96884,of,O,3356.0,"The aim of the present narrative review is to integrate the available information on the relationship between the most studied FD products , which are yogurt and cheese , and cardiometabolic risk factors obtained from meta - analysis , systematic reviews of prospective cohort studies ( PCSs ) and PCSs published up to 2 November 2019 ."
96885,the,O,3356.0,"The aim of the present narrative review is to integrate the available information on the relationship between the most studied FD products , which are yogurt and cheese , and cardiometabolic risk factors obtained from meta - analysis , systematic reviews of prospective cohort studies ( PCSs ) and PCSs published up to 2 November 2019 ."
96886,present,O,3356.0,"The aim of the present narrative review is to integrate the available information on the relationship between the most studied FD products , which are yogurt and cheese , and cardiometabolic risk factors obtained from meta - analysis , systematic reviews of prospective cohort studies ( PCSs ) and PCSs published up to 2 November 2019 ."
96887,narrative,O,3356.0,"The aim of the present narrative review is to integrate the available information on the relationship between the most studied FD products , which are yogurt and cheese , and cardiometabolic risk factors obtained from meta - analysis , systematic reviews of prospective cohort studies ( PCSs ) and PCSs published up to 2 November 2019 ."
96888,review,O,3356.0,"The aim of the present narrative review is to integrate the available information on the relationship between the most studied FD products , which are yogurt and cheese , and cardiometabolic risk factors obtained from meta - analysis , systematic reviews of prospective cohort studies ( PCSs ) and PCSs published up to 2 November 2019 ."
96889,is,O,3356.0,"The aim of the present narrative review is to integrate the available information on the relationship between the most studied FD products , which are yogurt and cheese , and cardiometabolic risk factors obtained from meta - analysis , systematic reviews of prospective cohort studies ( PCSs ) and PCSs published up to 2 November 2019 ."
96890,to,O,3356.0,"The aim of the present narrative review is to integrate the available information on the relationship between the most studied FD products , which are yogurt and cheese , and cardiometabolic risk factors obtained from meta - analysis , systematic reviews of prospective cohort studies ( PCSs ) and PCSs published up to 2 November 2019 ."
96891,integrate,O,3356.0,"The aim of the present narrative review is to integrate the available information on the relationship between the most studied FD products , which are yogurt and cheese , and cardiometabolic risk factors obtained from meta - analysis , systematic reviews of prospective cohort studies ( PCSs ) and PCSs published up to 2 November 2019 ."
96892,the,O,3356.0,"The aim of the present narrative review is to integrate the available information on the relationship between the most studied FD products , which are yogurt and cheese , and cardiometabolic risk factors obtained from meta - analysis , systematic reviews of prospective cohort studies ( PCSs ) and PCSs published up to 2 November 2019 ."
96893,available,O,3356.0,"The aim of the present narrative review is to integrate the available information on the relationship between the most studied FD products , which are yogurt and cheese , and cardiometabolic risk factors obtained from meta - analysis , systematic reviews of prospective cohort studies ( PCSs ) and PCSs published up to 2 November 2019 ."
96894,information,O,3356.0,"The aim of the present narrative review is to integrate the available information on the relationship between the most studied FD products , which are yogurt and cheese , and cardiometabolic risk factors obtained from meta - analysis , systematic reviews of prospective cohort studies ( PCSs ) and PCSs published up to 2 November 2019 ."
96895,on,O,3356.0,"The aim of the present narrative review is to integrate the available information on the relationship between the most studied FD products , which are yogurt and cheese , and cardiometabolic risk factors obtained from meta - analysis , systematic reviews of prospective cohort studies ( PCSs ) and PCSs published up to 2 November 2019 ."
96896,the,O,3356.0,"The aim of the present narrative review is to integrate the available information on the relationship between the most studied FD products , which are yogurt and cheese , and cardiometabolic risk factors obtained from meta - analysis , systematic reviews of prospective cohort studies ( PCSs ) and PCSs published up to 2 November 2019 ."
96897,relationship,O,3356.0,"The aim of the present narrative review is to integrate the available information on the relationship between the most studied FD products , which are yogurt and cheese , and cardiometabolic risk factors obtained from meta - analysis , systematic reviews of prospective cohort studies ( PCSs ) and PCSs published up to 2 November 2019 ."
96898,between,O,3356.0,"The aim of the present narrative review is to integrate the available information on the relationship between the most studied FD products , which are yogurt and cheese , and cardiometabolic risk factors obtained from meta - analysis , systematic reviews of prospective cohort studies ( PCSs ) and PCSs published up to 2 November 2019 ."
96899,the,O,3356.0,"The aim of the present narrative review is to integrate the available information on the relationship between the most studied FD products , which are yogurt and cheese , and cardiometabolic risk factors obtained from meta - analysis , systematic reviews of prospective cohort studies ( PCSs ) and PCSs published up to 2 November 2019 ."
96900,most,O,3356.0,"The aim of the present narrative review is to integrate the available information on the relationship between the most studied FD products , which are yogurt and cheese , and cardiometabolic risk factors obtained from meta - analysis , systematic reviews of prospective cohort studies ( PCSs ) and PCSs published up to 2 November 2019 ."
96901,studied,O,3356.0,"The aim of the present narrative review is to integrate the available information on the relationship between the most studied FD products , which are yogurt and cheese , and cardiometabolic risk factors obtained from meta - analysis , systematic reviews of prospective cohort studies ( PCSs ) and PCSs published up to 2 November 2019 ."
96902,FD,O,3356.0,"The aim of the present narrative review is to integrate the available information on the relationship between the most studied FD products , which are yogurt and cheese , and cardiometabolic risk factors obtained from meta - analysis , systematic reviews of prospective cohort studies ( PCSs ) and PCSs published up to 2 November 2019 ."
96903,products,O,3356.0,"The aim of the present narrative review is to integrate the available information on the relationship between the most studied FD products , which are yogurt and cheese , and cardiometabolic risk factors obtained from meta - analysis , systematic reviews of prospective cohort studies ( PCSs ) and PCSs published up to 2 November 2019 ."
96904,",",O,3356.0,"The aim of the present narrative review is to integrate the available information on the relationship between the most studied FD products , which are yogurt and cheese , and cardiometabolic risk factors obtained from meta - analysis , systematic reviews of prospective cohort studies ( PCSs ) and PCSs published up to 2 November 2019 ."
96905,which,O,3356.0,"The aim of the present narrative review is to integrate the available information on the relationship between the most studied FD products , which are yogurt and cheese , and cardiometabolic risk factors obtained from meta - analysis , systematic reviews of prospective cohort studies ( PCSs ) and PCSs published up to 2 November 2019 ."
96906,are,O,3356.0,"The aim of the present narrative review is to integrate the available information on the relationship between the most studied FD products , which are yogurt and cheese , and cardiometabolic risk factors obtained from meta - analysis , systematic reviews of prospective cohort studies ( PCSs ) and PCSs published up to 2 November 2019 ."
96907,yogurt,B-AG.01.e,3356.0,"The aim of the present narrative review is to integrate the available information on the relationship between the most studied FD products , which are yogurt and cheese , and cardiometabolic risk factors obtained from meta - analysis , systematic reviews of prospective cohort studies ( PCSs ) and PCSs published up to 2 November 2019 ."
96908,and,O,3356.0,"The aim of the present narrative review is to integrate the available information on the relationship between the most studied FD products , which are yogurt and cheese , and cardiometabolic risk factors obtained from meta - analysis , systematic reviews of prospective cohort studies ( PCSs ) and PCSs published up to 2 November 2019 ."
96909,cheese,B-AG.01.e.02,3356.0,"The aim of the present narrative review is to integrate the available information on the relationship between the most studied FD products , which are yogurt and cheese , and cardiometabolic risk factors obtained from meta - analysis , systematic reviews of prospective cohort studies ( PCSs ) and PCSs published up to 2 November 2019 ."
96910,",",O,3356.0,"The aim of the present narrative review is to integrate the available information on the relationship between the most studied FD products , which are yogurt and cheese , and cardiometabolic risk factors obtained from meta - analysis , systematic reviews of prospective cohort studies ( PCSs ) and PCSs published up to 2 November 2019 ."
96911,and,O,3356.0,"The aim of the present narrative review is to integrate the available information on the relationship between the most studied FD products , which are yogurt and cheese , and cardiometabolic risk factors obtained from meta - analysis , systematic reviews of prospective cohort studies ( PCSs ) and PCSs published up to 2 November 2019 ."
96912,cardiometabolic,O,3356.0,"The aim of the present narrative review is to integrate the available information on the relationship between the most studied FD products , which are yogurt and cheese , and cardiometabolic risk factors obtained from meta - analysis , systematic reviews of prospective cohort studies ( PCSs ) and PCSs published up to 2 November 2019 ."
96913,risk,O,3356.0,"The aim of the present narrative review is to integrate the available information on the relationship between the most studied FD products , which are yogurt and cheese , and cardiometabolic risk factors obtained from meta - analysis , systematic reviews of prospective cohort studies ( PCSs ) and PCSs published up to 2 November 2019 ."
96914,factors,O,3356.0,"The aim of the present narrative review is to integrate the available information on the relationship between the most studied FD products , which are yogurt and cheese , and cardiometabolic risk factors obtained from meta - analysis , systematic reviews of prospective cohort studies ( PCSs ) and PCSs published up to 2 November 2019 ."
96915,obtained,O,3356.0,"The aim of the present narrative review is to integrate the available information on the relationship between the most studied FD products , which are yogurt and cheese , and cardiometabolic risk factors obtained from meta - analysis , systematic reviews of prospective cohort studies ( PCSs ) and PCSs published up to 2 November 2019 ."
96916,from,O,3356.0,"The aim of the present narrative review is to integrate the available information on the relationship between the most studied FD products , which are yogurt and cheese , and cardiometabolic risk factors obtained from meta - analysis , systematic reviews of prospective cohort studies ( PCSs ) and PCSs published up to 2 November 2019 ."
96917,meta,O,3356.0,"The aim of the present narrative review is to integrate the available information on the relationship between the most studied FD products , which are yogurt and cheese , and cardiometabolic risk factors obtained from meta - analysis , systematic reviews of prospective cohort studies ( PCSs ) and PCSs published up to 2 November 2019 ."
96918,-,O,3356.0,"The aim of the present narrative review is to integrate the available information on the relationship between the most studied FD products , which are yogurt and cheese , and cardiometabolic risk factors obtained from meta - analysis , systematic reviews of prospective cohort studies ( PCSs ) and PCSs published up to 2 November 2019 ."
96919,analysis,O,3356.0,"The aim of the present narrative review is to integrate the available information on the relationship between the most studied FD products , which are yogurt and cheese , and cardiometabolic risk factors obtained from meta - analysis , systematic reviews of prospective cohort studies ( PCSs ) and PCSs published up to 2 November 2019 ."
96920,",",O,3356.0,"The aim of the present narrative review is to integrate the available information on the relationship between the most studied FD products , which are yogurt and cheese , and cardiometabolic risk factors obtained from meta - analysis , systematic reviews of prospective cohort studies ( PCSs ) and PCSs published up to 2 November 2019 ."
96921,systematic,O,3356.0,"The aim of the present narrative review is to integrate the available information on the relationship between the most studied FD products , which are yogurt and cheese , and cardiometabolic risk factors obtained from meta - analysis , systematic reviews of prospective cohort studies ( PCSs ) and PCSs published up to 2 November 2019 ."
96922,reviews,O,3356.0,"The aim of the present narrative review is to integrate the available information on the relationship between the most studied FD products , which are yogurt and cheese , and cardiometabolic risk factors obtained from meta - analysis , systematic reviews of prospective cohort studies ( PCSs ) and PCSs published up to 2 November 2019 ."
96923,of,O,3356.0,"The aim of the present narrative review is to integrate the available information on the relationship between the most studied FD products , which are yogurt and cheese , and cardiometabolic risk factors obtained from meta - analysis , systematic reviews of prospective cohort studies ( PCSs ) and PCSs published up to 2 November 2019 ."
96924,prospective,O,3356.0,"The aim of the present narrative review is to integrate the available information on the relationship between the most studied FD products , which are yogurt and cheese , and cardiometabolic risk factors obtained from meta - analysis , systematic reviews of prospective cohort studies ( PCSs ) and PCSs published up to 2 November 2019 ."
96925,cohort,O,3356.0,"The aim of the present narrative review is to integrate the available information on the relationship between the most studied FD products , which are yogurt and cheese , and cardiometabolic risk factors obtained from meta - analysis , systematic reviews of prospective cohort studies ( PCSs ) and PCSs published up to 2 November 2019 ."
96926,studies,O,3356.0,"The aim of the present narrative review is to integrate the available information on the relationship between the most studied FD products , which are yogurt and cheese , and cardiometabolic risk factors obtained from meta - analysis , systematic reviews of prospective cohort studies ( PCSs ) and PCSs published up to 2 November 2019 ."
96927,(,O,3356.0,"The aim of the present narrative review is to integrate the available information on the relationship between the most studied FD products , which are yogurt and cheese , and cardiometabolic risk factors obtained from meta - analysis , systematic reviews of prospective cohort studies ( PCSs ) and PCSs published up to 2 November 2019 ."
96928,PCSs,O,3356.0,"The aim of the present narrative review is to integrate the available information on the relationship between the most studied FD products , which are yogurt and cheese , and cardiometabolic risk factors obtained from meta - analysis , systematic reviews of prospective cohort studies ( PCSs ) and PCSs published up to 2 November 2019 ."
96929,),O,3356.0,"The aim of the present narrative review is to integrate the available information on the relationship between the most studied FD products , which are yogurt and cheese , and cardiometabolic risk factors obtained from meta - analysis , systematic reviews of prospective cohort studies ( PCSs ) and PCSs published up to 2 November 2019 ."
96930,and,O,3356.0,"The aim of the present narrative review is to integrate the available information on the relationship between the most studied FD products , which are yogurt and cheese , and cardiometabolic risk factors obtained from meta - analysis , systematic reviews of prospective cohort studies ( PCSs ) and PCSs published up to 2 November 2019 ."
96931,PCSs,O,3356.0,"The aim of the present narrative review is to integrate the available information on the relationship between the most studied FD products , which are yogurt and cheese , and cardiometabolic risk factors obtained from meta - analysis , systematic reviews of prospective cohort studies ( PCSs ) and PCSs published up to 2 November 2019 ."
96932,published,O,3356.0,"The aim of the present narrative review is to integrate the available information on the relationship between the most studied FD products , which are yogurt and cheese , and cardiometabolic risk factors obtained from meta - analysis , systematic reviews of prospective cohort studies ( PCSs ) and PCSs published up to 2 November 2019 ."
96933,up,O,3356.0,"The aim of the present narrative review is to integrate the available information on the relationship between the most studied FD products , which are yogurt and cheese , and cardiometabolic risk factors obtained from meta - analysis , systematic reviews of prospective cohort studies ( PCSs ) and PCSs published up to 2 November 2019 ."
96934,to,O,3356.0,"The aim of the present narrative review is to integrate the available information on the relationship between the most studied FD products , which are yogurt and cheese , and cardiometabolic risk factors obtained from meta - analysis , systematic reviews of prospective cohort studies ( PCSs ) and PCSs published up to 2 November 2019 ."
96935,2,O,3356.0,"The aim of the present narrative review is to integrate the available information on the relationship between the most studied FD products , which are yogurt and cheese , and cardiometabolic risk factors obtained from meta - analysis , systematic reviews of prospective cohort studies ( PCSs ) and PCSs published up to 2 November 2019 ."
96936,November,O,3356.0,"The aim of the present narrative review is to integrate the available information on the relationship between the most studied FD products , which are yogurt and cheese , and cardiometabolic risk factors obtained from meta - analysis , systematic reviews of prospective cohort studies ( PCSs ) and PCSs published up to 2 November 2019 ."
96937,2019,O,3356.0,"The aim of the present narrative review is to integrate the available information on the relationship between the most studied FD products , which are yogurt and cheese , and cardiometabolic risk factors obtained from meta - analysis , systematic reviews of prospective cohort studies ( PCSs ) and PCSs published up to 2 November 2019 ."
96938,.,O,3356.0,"The aim of the present narrative review is to integrate the available information on the relationship between the most studied FD products , which are yogurt and cheese , and cardiometabolic risk factors obtained from meta - analysis , systematic reviews of prospective cohort studies ( PCSs ) and PCSs published up to 2 November 2019 ."
96939,Additionally,O,3357.0,"Additionally , the effects identified by randomized controlled trials of less - studied FD products , such as kefir and kimchi , on cardiometabolic risk factors are provided ."
96940,",",O,3357.0,"Additionally , the effects identified by randomized controlled trials of less - studied FD products , such as kefir and kimchi , on cardiometabolic risk factors are provided ."
96941,the,O,3357.0,"Additionally , the effects identified by randomized controlled trials of less - studied FD products , such as kefir and kimchi , on cardiometabolic risk factors are provided ."
96942,effects,O,3357.0,"Additionally , the effects identified by randomized controlled trials of less - studied FD products , such as kefir and kimchi , on cardiometabolic risk factors are provided ."
96943,identified,O,3357.0,"Additionally , the effects identified by randomized controlled trials of less - studied FD products , such as kefir and kimchi , on cardiometabolic risk factors are provided ."
96944,by,O,3357.0,"Additionally , the effects identified by randomized controlled trials of less - studied FD products , such as kefir and kimchi , on cardiometabolic risk factors are provided ."
96945,randomized,O,3357.0,"Additionally , the effects identified by randomized controlled trials of less - studied FD products , such as kefir and kimchi , on cardiometabolic risk factors are provided ."
96946,controlled,O,3357.0,"Additionally , the effects identified by randomized controlled trials of less - studied FD products , such as kefir and kimchi , on cardiometabolic risk factors are provided ."
96947,trials,O,3357.0,"Additionally , the effects identified by randomized controlled trials of less - studied FD products , such as kefir and kimchi , on cardiometabolic risk factors are provided ."
96948,of,O,3357.0,"Additionally , the effects identified by randomized controlled trials of less - studied FD products , such as kefir and kimchi , on cardiometabolic risk factors are provided ."
96949,less,O,3357.0,"Additionally , the effects identified by randomized controlled trials of less - studied FD products , such as kefir and kimchi , on cardiometabolic risk factors are provided ."
96950,-,O,3357.0,"Additionally , the effects identified by randomized controlled trials of less - studied FD products , such as kefir and kimchi , on cardiometabolic risk factors are provided ."
96951,studied,O,3357.0,"Additionally , the effects identified by randomized controlled trials of less - studied FD products , such as kefir and kimchi , on cardiometabolic risk factors are provided ."
96952,FD,O,3357.0,"Additionally , the effects identified by randomized controlled trials of less - studied FD products , such as kefir and kimchi , on cardiometabolic risk factors are provided ."
96953,products,O,3357.0,"Additionally , the effects identified by randomized controlled trials of less - studied FD products , such as kefir and kimchi , on cardiometabolic risk factors are provided ."
96954,",",O,3357.0,"Additionally , the effects identified by randomized controlled trials of less - studied FD products , such as kefir and kimchi , on cardiometabolic risk factors are provided ."
96955,such,O,3357.0,"Additionally , the effects identified by randomized controlled trials of less - studied FD products , such as kefir and kimchi , on cardiometabolic risk factors are provided ."
96956,as,O,3357.0,"Additionally , the effects identified by randomized controlled trials of less - studied FD products , such as kefir and kimchi , on cardiometabolic risk factors are provided ."
96957,kefir,B-AG.01.e,3357.0,"Additionally , the effects identified by randomized controlled trials of less - studied FD products , such as kefir and kimchi , on cardiometabolic risk factors are provided ."
96958,and,O,3357.0,"Additionally , the effects identified by randomized controlled trials of less - studied FD products , such as kefir and kimchi , on cardiometabolic risk factors are provided ."
96959,kimchi,B-AG.01.n.09,3357.0,"Additionally , the effects identified by randomized controlled trials of less - studied FD products , such as kefir and kimchi , on cardiometabolic risk factors are provided ."
96960,",",O,3357.0,"Additionally , the effects identified by randomized controlled trials of less - studied FD products , such as kefir and kimchi , on cardiometabolic risk factors are provided ."
96961,on,O,3357.0,"Additionally , the effects identified by randomized controlled trials of less - studied FD products , such as kefir and kimchi , on cardiometabolic risk factors are provided ."
96962,cardiometabolic,O,3357.0,"Additionally , the effects identified by randomized controlled trials of less - studied FD products , such as kefir and kimchi , on cardiometabolic risk factors are provided ."
96963,risk,O,3357.0,"Additionally , the effects identified by randomized controlled trials of less - studied FD products , such as kefir and kimchi , on cardiometabolic risk factors are provided ."
96964,factors,O,3357.0,"Additionally , the effects identified by randomized controlled trials of less - studied FD products , such as kefir and kimchi , on cardiometabolic risk factors are provided ."
96965,are,O,3357.0,"Additionally , the effects identified by randomized controlled trials of less - studied FD products , such as kefir and kimchi , on cardiometabolic risk factors are provided ."
96966,provided,O,3357.0,"Additionally , the effects identified by randomized controlled trials of less - studied FD products , such as kefir and kimchi , on cardiometabolic risk factors are provided ."
96967,.,O,3357.0,"Additionally , the effects identified by randomized controlled trials of less - studied FD products , such as kefir and kimchi , on cardiometabolic risk factors are provided ."
96968,PCSs,O,3358.0,"PCSs have shown that the consumption of cheese , despite its high saturated fat content , is not associated with expected hypercholesterolemia and an increased cardiovascular risk ."
96969,have,O,3358.0,"PCSs have shown that the consumption of cheese , despite its high saturated fat content , is not associated with expected hypercholesterolemia and an increased cardiovascular risk ."
96970,shown,O,3358.0,"PCSs have shown that the consumption of cheese , despite its high saturated fat content , is not associated with expected hypercholesterolemia and an increased cardiovascular risk ."
96971,that,O,3358.0,"PCSs have shown that the consumption of cheese , despite its high saturated fat content , is not associated with expected hypercholesterolemia and an increased cardiovascular risk ."
96972,the,O,3358.0,"PCSs have shown that the consumption of cheese , despite its high saturated fat content , is not associated with expected hypercholesterolemia and an increased cardiovascular risk ."
96973,consumption,O,3358.0,"PCSs have shown that the consumption of cheese , despite its high saturated fat content , is not associated with expected hypercholesterolemia and an increased cardiovascular risk ."
96974,of,O,3358.0,"PCSs have shown that the consumption of cheese , despite its high saturated fat content , is not associated with expected hypercholesterolemia and an increased cardiovascular risk ."
96975,cheese,B-AG.01.e.02,3358.0,"PCSs have shown that the consumption of cheese , despite its high saturated fat content , is not associated with expected hypercholesterolemia and an increased cardiovascular risk ."
96976,",",O,3358.0,"PCSs have shown that the consumption of cheese , despite its high saturated fat content , is not associated with expected hypercholesterolemia and an increased cardiovascular risk ."
96977,despite,O,3358.0,"PCSs have shown that the consumption of cheese , despite its high saturated fat content , is not associated with expected hypercholesterolemia and an increased cardiovascular risk ."
96978,its,O,3358.0,"PCSs have shown that the consumption of cheese , despite its high saturated fat content , is not associated with expected hypercholesterolemia and an increased cardiovascular risk ."
96979,high,O,3358.0,"PCSs have shown that the consumption of cheese , despite its high saturated fat content , is not associated with expected hypercholesterolemia and an increased cardiovascular risk ."
96980,saturated,O,3358.0,"PCSs have shown that the consumption of cheese , despite its high saturated fat content , is not associated with expected hypercholesterolemia and an increased cardiovascular risk ."
96981,fat,O,3358.0,"PCSs have shown that the consumption of cheese , despite its high saturated fat content , is not associated with expected hypercholesterolemia and an increased cardiovascular risk ."
96982,content,O,3358.0,"PCSs have shown that the consumption of cheese , despite its high saturated fat content , is not associated with expected hypercholesterolemia and an increased cardiovascular risk ."
96983,",",O,3358.0,"PCSs have shown that the consumption of cheese , despite its high saturated fat content , is not associated with expected hypercholesterolemia and an increased cardiovascular risk ."
96984,is,O,3358.0,"PCSs have shown that the consumption of cheese , despite its high saturated fat content , is not associated with expected hypercholesterolemia and an increased cardiovascular risk ."
96985,not,O,3358.0,"PCSs have shown that the consumption of cheese , despite its high saturated fat content , is not associated with expected hypercholesterolemia and an increased cardiovascular risk ."
96986,associated,O,3358.0,"PCSs have shown that the consumption of cheese , despite its high saturated fat content , is not associated with expected hypercholesterolemia and an increased cardiovascular risk ."
96987,with,O,3358.0,"PCSs have shown that the consumption of cheese , despite its high saturated fat content , is not associated with expected hypercholesterolemia and an increased cardiovascular risk ."
96988,expected,O,3358.0,"PCSs have shown that the consumption of cheese , despite its high saturated fat content , is not associated with expected hypercholesterolemia and an increased cardiovascular risk ."
96989,hypercholesterolemia,O,3358.0,"PCSs have shown that the consumption of cheese , despite its high saturated fat content , is not associated with expected hypercholesterolemia and an increased cardiovascular risk ."
96990,and,O,3358.0,"PCSs have shown that the consumption of cheese , despite its high saturated fat content , is not associated with expected hypercholesterolemia and an increased cardiovascular risk ."
96991,an,O,3358.0,"PCSs have shown that the consumption of cheese , despite its high saturated fat content , is not associated with expected hypercholesterolemia and an increased cardiovascular risk ."
96992,increased,O,3358.0,"PCSs have shown that the consumption of cheese , despite its high saturated fat content , is not associated with expected hypercholesterolemia and an increased cardiovascular risk ."
96993,cardiovascular,O,3358.0,"PCSs have shown that the consumption of cheese , despite its high saturated fat content , is not associated with expected hypercholesterolemia and an increased cardiovascular risk ."
96994,risk,O,3358.0,"PCSs have shown that the consumption of cheese , despite its high saturated fat content , is not associated with expected hypercholesterolemia and an increased cardiovascular risk ."
96995,.,O,3358.0,"PCSs have shown that the consumption of cheese , despite its high saturated fat content , is not associated with expected hypercholesterolemia and an increased cardiovascular risk ."
96996,PCSs,O,3359.0,PCSs have revealed that the total consumption of FD appears to be associated with a lower risk of developing stroke and cardiovascular disease .
96997,have,O,3359.0,PCSs have revealed that the total consumption of FD appears to be associated with a lower risk of developing stroke and cardiovascular disease .
96998,revealed,O,3359.0,PCSs have revealed that the total consumption of FD appears to be associated with a lower risk of developing stroke and cardiovascular disease .
96999,that,O,3359.0,PCSs have revealed that the total consumption of FD appears to be associated with a lower risk of developing stroke and cardiovascular disease .
97000,the,O,3359.0,PCSs have revealed that the total consumption of FD appears to be associated with a lower risk of developing stroke and cardiovascular disease .
97001,total,O,3359.0,PCSs have revealed that the total consumption of FD appears to be associated with a lower risk of developing stroke and cardiovascular disease .
97002,consumption,O,3359.0,PCSs have revealed that the total consumption of FD appears to be associated with a lower risk of developing stroke and cardiovascular disease .
97003,of,O,3359.0,PCSs have revealed that the total consumption of FD appears to be associated with a lower risk of developing stroke and cardiovascular disease .
97004,FD,O,3359.0,PCSs have revealed that the total consumption of FD appears to be associated with a lower risk of developing stroke and cardiovascular disease .
97005,appears,O,3359.0,PCSs have revealed that the total consumption of FD appears to be associated with a lower risk of developing stroke and cardiovascular disease .
97006,to,O,3359.0,PCSs have revealed that the total consumption of FD appears to be associated with a lower risk of developing stroke and cardiovascular disease .
97007,be,O,3359.0,PCSs have revealed that the total consumption of FD appears to be associated with a lower risk of developing stroke and cardiovascular disease .
97008,associated,O,3359.0,PCSs have revealed that the total consumption of FD appears to be associated with a lower risk of developing stroke and cardiovascular disease .
97009,with,O,3359.0,PCSs have revealed that the total consumption of FD appears to be associated with a lower risk of developing stroke and cardiovascular disease .
97010,a,O,3359.0,PCSs have revealed that the total consumption of FD appears to be associated with a lower risk of developing stroke and cardiovascular disease .
97011,lower,O,3359.0,PCSs have revealed that the total consumption of FD appears to be associated with a lower risk of developing stroke and cardiovascular disease .
97012,risk,O,3359.0,PCSs have revealed that the total consumption of FD appears to be associated with a lower risk of developing stroke and cardiovascular disease .
97013,of,O,3359.0,PCSs have revealed that the total consumption of FD appears to be associated with a lower risk of developing stroke and cardiovascular disease .
97014,developing,O,3359.0,PCSs have revealed that the total consumption of FD appears to be associated with a lower risk of developing stroke and cardiovascular disease .
97015,stroke,O,3359.0,PCSs have revealed that the total consumption of FD appears to be associated with a lower risk of developing stroke and cardiovascular disease .
97016,and,O,3359.0,PCSs have revealed that the total consumption of FD appears to be associated with a lower risk of developing stroke and cardiovascular disease .
97017,cardiovascular,O,3359.0,PCSs have revealed that the total consumption of FD appears to be associated with a lower risk of developing stroke and cardiovascular disease .
97018,disease,O,3359.0,PCSs have revealed that the total consumption of FD appears to be associated with a lower risk of developing stroke and cardiovascular disease .
97019,.,O,3359.0,PCSs have revealed that the total consumption of FD appears to be associated with a lower risk of developing stroke and cardiovascular disease .
97020,The,O,3360.0,The consumption of yogurt seems to be associated with a lower risk of developing type 2 diabetes .
97021,consumption,O,3360.0,The consumption of yogurt seems to be associated with a lower risk of developing type 2 diabetes .
97022,of,O,3360.0,The consumption of yogurt seems to be associated with a lower risk of developing type 2 diabetes .
97023,yogurt,B-AG.01.e,3360.0,The consumption of yogurt seems to be associated with a lower risk of developing type 2 diabetes .
97024,seems,O,3360.0,The consumption of yogurt seems to be associated with a lower risk of developing type 2 diabetes .
97025,to,O,3360.0,The consumption of yogurt seems to be associated with a lower risk of developing type 2 diabetes .
97026,be,O,3360.0,The consumption of yogurt seems to be associated with a lower risk of developing type 2 diabetes .
97027,associated,O,3360.0,The consumption of yogurt seems to be associated with a lower risk of developing type 2 diabetes .
97028,with,O,3360.0,The consumption of yogurt seems to be associated with a lower risk of developing type 2 diabetes .
97029,a,O,3360.0,The consumption of yogurt seems to be associated with a lower risk of developing type 2 diabetes .
97030,lower,O,3360.0,The consumption of yogurt seems to be associated with a lower risk of developing type 2 diabetes .
97031,risk,O,3360.0,The consumption of yogurt seems to be associated with a lower risk of developing type 2 diabetes .
97032,of,O,3360.0,The consumption of yogurt seems to be associated with a lower risk of developing type 2 diabetes .
97033,developing,O,3360.0,The consumption of yogurt seems to be associated with a lower risk of developing type 2 diabetes .
97034,type,O,3360.0,The consumption of yogurt seems to be associated with a lower risk of developing type 2 diabetes .
97035,2,O,3360.0,The consumption of yogurt seems to be associated with a lower risk of developing type 2 diabetes .
97036,diabetes,O,3360.0,The consumption of yogurt seems to be associated with a lower risk of developing type 2 diabetes .
97037,.,O,3360.0,The consumption of yogurt seems to be associated with a lower risk of developing type 2 diabetes .
97038,There,O,3361.0,There is a lack of sufficient evidence of a protective relationship between FD or cheese consumption and metabolic syndrome .
97039,is,O,3361.0,There is a lack of sufficient evidence of a protective relationship between FD or cheese consumption and metabolic syndrome .
97040,a,O,3361.0,There is a lack of sufficient evidence of a protective relationship between FD or cheese consumption and metabolic syndrome .
97041,lack,O,3361.0,There is a lack of sufficient evidence of a protective relationship between FD or cheese consumption and metabolic syndrome .
97042,of,O,3361.0,There is a lack of sufficient evidence of a protective relationship between FD or cheese consumption and metabolic syndrome .
97043,sufficient,O,3361.0,There is a lack of sufficient evidence of a protective relationship between FD or cheese consumption and metabolic syndrome .
97044,evidence,O,3361.0,There is a lack of sufficient evidence of a protective relationship between FD or cheese consumption and metabolic syndrome .
97045,of,O,3361.0,There is a lack of sufficient evidence of a protective relationship between FD or cheese consumption and metabolic syndrome .
97046,a,O,3361.0,There is a lack of sufficient evidence of a protective relationship between FD or cheese consumption and metabolic syndrome .
97047,protective,O,3361.0,There is a lack of sufficient evidence of a protective relationship between FD or cheese consumption and metabolic syndrome .
97048,relationship,O,3361.0,There is a lack of sufficient evidence of a protective relationship between FD or cheese consumption and metabolic syndrome .
97049,between,O,3361.0,There is a lack of sufficient evidence of a protective relationship between FD or cheese consumption and metabolic syndrome .
97050,FD,O,3361.0,There is a lack of sufficient evidence of a protective relationship between FD or cheese consumption and metabolic syndrome .
97051,or,O,3361.0,There is a lack of sufficient evidence of a protective relationship between FD or cheese consumption and metabolic syndrome .
97052,cheese,B-AG.01.e.02,3361.0,There is a lack of sufficient evidence of a protective relationship between FD or cheese consumption and metabolic syndrome .
97053,consumption,B-X,3361.0,There is a lack of sufficient evidence of a protective relationship between FD or cheese consumption and metabolic syndrome .
97054,and,O,3361.0,There is a lack of sufficient evidence of a protective relationship between FD or cheese consumption and metabolic syndrome .
97055,metabolic,O,3361.0,There is a lack of sufficient evidence of a protective relationship between FD or cheese consumption and metabolic syndrome .
97056,syndrome,O,3361.0,There is a lack of sufficient evidence of a protective relationship between FD or cheese consumption and metabolic syndrome .
97057,.,O,3361.0,There is a lack of sufficient evidence of a protective relationship between FD or cheese consumption and metabolic syndrome .
97058,Moreover,O,3362.0,"Moreover , the association of FD , cheese and yogurt with hypertension needs further evidence ."
97059,",",O,3362.0,"Moreover , the association of FD , cheese and yogurt with hypertension needs further evidence ."
97060,the,O,3362.0,"Moreover , the association of FD , cheese and yogurt with hypertension needs further evidence ."
97061,association,O,3362.0,"Moreover , the association of FD , cheese and yogurt with hypertension needs further evidence ."
97062,of,O,3362.0,"Moreover , the association of FD , cheese and yogurt with hypertension needs further evidence ."
97063,FD,O,3362.0,"Moreover , the association of FD , cheese and yogurt with hypertension needs further evidence ."
97064,",",O,3362.0,"Moreover , the association of FD , cheese and yogurt with hypertension needs further evidence ."
97065,cheese,B-AG.01.e.02,3362.0,"Moreover , the association of FD , cheese and yogurt with hypertension needs further evidence ."
97066,and,O,3362.0,"Moreover , the association of FD , cheese and yogurt with hypertension needs further evidence ."
97067,yogurt,B-AG.01.e,3362.0,"Moreover , the association of FD , cheese and yogurt with hypertension needs further evidence ."
97068,with,O,3362.0,"Moreover , the association of FD , cheese and yogurt with hypertension needs further evidence ."
97069,hypertension,O,3362.0,"Moreover , the association of FD , cheese and yogurt with hypertension needs further evidence ."
97070,needs,O,3362.0,"Moreover , the association of FD , cheese and yogurt with hypertension needs further evidence ."
97071,further,O,3362.0,"Moreover , the association of FD , cheese and yogurt with hypertension needs further evidence ."
97072,evidence,O,3362.0,"Moreover , the association of FD , cheese and yogurt with hypertension needs further evidence ."
97073,.,O,3362.0,"Moreover , the association of FD , cheese and yogurt with hypertension needs further evidence ."
97074,In,O,3363.0,"In conclusion , the intake of fermented foods containing probiotics , particularly yogurt and cheese ( of an undetermined type ) , opens up new opportunities for the management of cardiometabolic risk factors ."
97075,conclusion,O,3363.0,"In conclusion , the intake of fermented foods containing probiotics , particularly yogurt and cheese ( of an undetermined type ) , opens up new opportunities for the management of cardiometabolic risk factors ."
97076,",",O,3363.0,"In conclusion , the intake of fermented foods containing probiotics , particularly yogurt and cheese ( of an undetermined type ) , opens up new opportunities for the management of cardiometabolic risk factors ."
97077,the,O,3363.0,"In conclusion , the intake of fermented foods containing probiotics , particularly yogurt and cheese ( of an undetermined type ) , opens up new opportunities for the management of cardiometabolic risk factors ."
97078,intake,O,3363.0,"In conclusion , the intake of fermented foods containing probiotics , particularly yogurt and cheese ( of an undetermined type ) , opens up new opportunities for the management of cardiometabolic risk factors ."
97079,of,O,3363.0,"In conclusion , the intake of fermented foods containing probiotics , particularly yogurt and cheese ( of an undetermined type ) , opens up new opportunities for the management of cardiometabolic risk factors ."
97080,fermented,B-AG.01,3363.0,"In conclusion , the intake of fermented foods containing probiotics , particularly yogurt and cheese ( of an undetermined type ) , opens up new opportunities for the management of cardiometabolic risk factors ."
97081,foods,I-AG.01,3363.0,"In conclusion , the intake of fermented foods containing probiotics , particularly yogurt and cheese ( of an undetermined type ) , opens up new opportunities for the management of cardiometabolic risk factors ."
97082,containing,O,3363.0,"In conclusion , the intake of fermented foods containing probiotics , particularly yogurt and cheese ( of an undetermined type ) , opens up new opportunities for the management of cardiometabolic risk factors ."
97083,probiotics,O,3363.0,"In conclusion , the intake of fermented foods containing probiotics , particularly yogurt and cheese ( of an undetermined type ) , opens up new opportunities for the management of cardiometabolic risk factors ."
97084,",",O,3363.0,"In conclusion , the intake of fermented foods containing probiotics , particularly yogurt and cheese ( of an undetermined type ) , opens up new opportunities for the management of cardiometabolic risk factors ."
97085,particularly,O,3363.0,"In conclusion , the intake of fermented foods containing probiotics , particularly yogurt and cheese ( of an undetermined type ) , opens up new opportunities for the management of cardiometabolic risk factors ."
97086,yogurt,B-AG.01.e,3363.0,"In conclusion , the intake of fermented foods containing probiotics , particularly yogurt and cheese ( of an undetermined type ) , opens up new opportunities for the management of cardiometabolic risk factors ."
97087,and,O,3363.0,"In conclusion , the intake of fermented foods containing probiotics , particularly yogurt and cheese ( of an undetermined type ) , opens up new opportunities for the management of cardiometabolic risk factors ."
97088,cheese,B-AG.01.e.02,3363.0,"In conclusion , the intake of fermented foods containing probiotics , particularly yogurt and cheese ( of an undetermined type ) , opens up new opportunities for the management of cardiometabolic risk factors ."
97089,(,O,3363.0,"In conclusion , the intake of fermented foods containing probiotics , particularly yogurt and cheese ( of an undetermined type ) , opens up new opportunities for the management of cardiometabolic risk factors ."
97090,of,O,3363.0,"In conclusion , the intake of fermented foods containing probiotics , particularly yogurt and cheese ( of an undetermined type ) , opens up new opportunities for the management of cardiometabolic risk factors ."
97091,an,O,3363.0,"In conclusion , the intake of fermented foods containing probiotics , particularly yogurt and cheese ( of an undetermined type ) , opens up new opportunities for the management of cardiometabolic risk factors ."
97092,undetermined,O,3363.0,"In conclusion , the intake of fermented foods containing probiotics , particularly yogurt and cheese ( of an undetermined type ) , opens up new opportunities for the management of cardiometabolic risk factors ."
97093,type,O,3363.0,"In conclusion , the intake of fermented foods containing probiotics , particularly yogurt and cheese ( of an undetermined type ) , opens up new opportunities for the management of cardiometabolic risk factors ."
97094,),O,3363.0,"In conclusion , the intake of fermented foods containing probiotics , particularly yogurt and cheese ( of an undetermined type ) , opens up new opportunities for the management of cardiometabolic risk factors ."
97095,",",O,3363.0,"In conclusion , the intake of fermented foods containing probiotics , particularly yogurt and cheese ( of an undetermined type ) , opens up new opportunities for the management of cardiometabolic risk factors ."
97096,opens,O,3363.0,"In conclusion , the intake of fermented foods containing probiotics , particularly yogurt and cheese ( of an undetermined type ) , opens up new opportunities for the management of cardiometabolic risk factors ."
97097,up,O,3363.0,"In conclusion , the intake of fermented foods containing probiotics , particularly yogurt and cheese ( of an undetermined type ) , opens up new opportunities for the management of cardiometabolic risk factors ."
97098,new,O,3363.0,"In conclusion , the intake of fermented foods containing probiotics , particularly yogurt and cheese ( of an undetermined type ) , opens up new opportunities for the management of cardiometabolic risk factors ."
97099,opportunities,O,3363.0,"In conclusion , the intake of fermented foods containing probiotics , particularly yogurt and cheese ( of an undetermined type ) , opens up new opportunities for the management of cardiometabolic risk factors ."
97100,for,O,3363.0,"In conclusion , the intake of fermented foods containing probiotics , particularly yogurt and cheese ( of an undetermined type ) , opens up new opportunities for the management of cardiometabolic risk factors ."
97101,the,O,3363.0,"In conclusion , the intake of fermented foods containing probiotics , particularly yogurt and cheese ( of an undetermined type ) , opens up new opportunities for the management of cardiometabolic risk factors ."
97102,management,O,3363.0,"In conclusion , the intake of fermented foods containing probiotics , particularly yogurt and cheese ( of an undetermined type ) , opens up new opportunities for the management of cardiometabolic risk factors ."
97103,of,O,3363.0,"In conclusion , the intake of fermented foods containing probiotics , particularly yogurt and cheese ( of an undetermined type ) , opens up new opportunities for the management of cardiometabolic risk factors ."
97104,cardiometabolic,O,3363.0,"In conclusion , the intake of fermented foods containing probiotics , particularly yogurt and cheese ( of an undetermined type ) , opens up new opportunities for the management of cardiometabolic risk factors ."
97105,risk,O,3363.0,"In conclusion , the intake of fermented foods containing probiotics , particularly yogurt and cheese ( of an undetermined type ) , opens up new opportunities for the management of cardiometabolic risk factors ."
97106,factors,O,3363.0,"In conclusion , the intake of fermented foods containing probiotics , particularly yogurt and cheese ( of an undetermined type ) , opens up new opportunities for the management of cardiometabolic risk factors ."
97107,.,O,3363.0,"In conclusion , the intake of fermented foods containing probiotics , particularly yogurt and cheese ( of an undetermined type ) , opens up new opportunities for the management of cardiometabolic risk factors ."
97108,Plant,O,3364.0,"Plant lectins , a unique group of proteins and glycoproteins with potent biological activity , occur in foods like wheat , corn , tomato , peanut , kidney bean , banana , pea , lentil , soybean , mushroom , rice , and potato ."
97109,lectins,O,3364.0,"Plant lectins , a unique group of proteins and glycoproteins with potent biological activity , occur in foods like wheat , corn , tomato , peanut , kidney bean , banana , pea , lentil , soybean , mushroom , rice , and potato ."
97110,",",O,3364.0,"Plant lectins , a unique group of proteins and glycoproteins with potent biological activity , occur in foods like wheat , corn , tomato , peanut , kidney bean , banana , pea , lentil , soybean , mushroom , rice , and potato ."
97111,a,O,3364.0,"Plant lectins , a unique group of proteins and glycoproteins with potent biological activity , occur in foods like wheat , corn , tomato , peanut , kidney bean , banana , pea , lentil , soybean , mushroom , rice , and potato ."
97112,unique,O,3364.0,"Plant lectins , a unique group of proteins and glycoproteins with potent biological activity , occur in foods like wheat , corn , tomato , peanut , kidney bean , banana , pea , lentil , soybean , mushroom , rice , and potato ."
97113,group,O,3364.0,"Plant lectins , a unique group of proteins and glycoproteins with potent biological activity , occur in foods like wheat , corn , tomato , peanut , kidney bean , banana , pea , lentil , soybean , mushroom , rice , and potato ."
97114,of,O,3364.0,"Plant lectins , a unique group of proteins and glycoproteins with potent biological activity , occur in foods like wheat , corn , tomato , peanut , kidney bean , banana , pea , lentil , soybean , mushroom , rice , and potato ."
97115,proteins,O,3364.0,"Plant lectins , a unique group of proteins and glycoproteins with potent biological activity , occur in foods like wheat , corn , tomato , peanut , kidney bean , banana , pea , lentil , soybean , mushroom , rice , and potato ."
97116,and,O,3364.0,"Plant lectins , a unique group of proteins and glycoproteins with potent biological activity , occur in foods like wheat , corn , tomato , peanut , kidney bean , banana , pea , lentil , soybean , mushroom , rice , and potato ."
97117,glycoproteins,O,3364.0,"Plant lectins , a unique group of proteins and glycoproteins with potent biological activity , occur in foods like wheat , corn , tomato , peanut , kidney bean , banana , pea , lentil , soybean , mushroom , rice , and potato ."
97118,with,O,3364.0,"Plant lectins , a unique group of proteins and glycoproteins with potent biological activity , occur in foods like wheat , corn , tomato , peanut , kidney bean , banana , pea , lentil , soybean , mushroom , rice , and potato ."
97119,potent,O,3364.0,"Plant lectins , a unique group of proteins and glycoproteins with potent biological activity , occur in foods like wheat , corn , tomato , peanut , kidney bean , banana , pea , lentil , soybean , mushroom , rice , and potato ."
97120,biological,O,3364.0,"Plant lectins , a unique group of proteins and glycoproteins with potent biological activity , occur in foods like wheat , corn , tomato , peanut , kidney bean , banana , pea , lentil , soybean , mushroom , rice , and potato ."
97121,activity,O,3364.0,"Plant lectins , a unique group of proteins and glycoproteins with potent biological activity , occur in foods like wheat , corn , tomato , peanut , kidney bean , banana , pea , lentil , soybean , mushroom , rice , and potato ."
97122,",",O,3364.0,"Plant lectins , a unique group of proteins and glycoproteins with potent biological activity , occur in foods like wheat , corn , tomato , peanut , kidney bean , banana , pea , lentil , soybean , mushroom , rice , and potato ."
97123,occur,O,3364.0,"Plant lectins , a unique group of proteins and glycoproteins with potent biological activity , occur in foods like wheat , corn , tomato , peanut , kidney bean , banana , pea , lentil , soybean , mushroom , rice , and potato ."
97124,in,O,3364.0,"Plant lectins , a unique group of proteins and glycoproteins with potent biological activity , occur in foods like wheat , corn , tomato , peanut , kidney bean , banana , pea , lentil , soybean , mushroom , rice , and potato ."
97125,foods,O,3364.0,"Plant lectins , a unique group of proteins and glycoproteins with potent biological activity , occur in foods like wheat , corn , tomato , peanut , kidney bean , banana , pea , lentil , soybean , mushroom , rice , and potato ."
97126,like,O,3364.0,"Plant lectins , a unique group of proteins and glycoproteins with potent biological activity , occur in foods like wheat , corn , tomato , peanut , kidney bean , banana , pea , lentil , soybean , mushroom , rice , and potato ."
97127,wheat,B-AG.01.i,3364.0,"Plant lectins , a unique group of proteins and glycoproteins with potent biological activity , occur in foods like wheat , corn , tomato , peanut , kidney bean , banana , pea , lentil , soybean , mushroom , rice , and potato ."
97128,",",O,3364.0,"Plant lectins , a unique group of proteins and glycoproteins with potent biological activity , occur in foods like wheat , corn , tomato , peanut , kidney bean , banana , pea , lentil , soybean , mushroom , rice , and potato ."
97129,corn,B-AG.01.i,3364.0,"Plant lectins , a unique group of proteins and glycoproteins with potent biological activity , occur in foods like wheat , corn , tomato , peanut , kidney bean , banana , pea , lentil , soybean , mushroom , rice , and potato ."
97130,",",O,3364.0,"Plant lectins , a unique group of proteins and glycoproteins with potent biological activity , occur in foods like wheat , corn , tomato , peanut , kidney bean , banana , pea , lentil , soybean , mushroom , rice , and potato ."
97131,tomato,B-AG.01.h.02.f,3364.0,"Plant lectins , a unique group of proteins and glycoproteins with potent biological activity , occur in foods like wheat , corn , tomato , peanut , kidney bean , banana , pea , lentil , soybean , mushroom , rice , and potato ."
97132,",",O,3364.0,"Plant lectins , a unique group of proteins and glycoproteins with potent biological activity , occur in foods like wheat , corn , tomato , peanut , kidney bean , banana , pea , lentil , soybean , mushroom , rice , and potato ."
97133,peanut,B-AG.01.h.01.f,3364.0,"Plant lectins , a unique group of proteins and glycoproteins with potent biological activity , occur in foods like wheat , corn , tomato , peanut , kidney bean , banana , pea , lentil , soybean , mushroom , rice , and potato ."
97134,",",O,3364.0,"Plant lectins , a unique group of proteins and glycoproteins with potent biological activity , occur in foods like wheat , corn , tomato , peanut , kidney bean , banana , pea , lentil , soybean , mushroom , rice , and potato ."
97135,kidney,B-AG.01.h.02.g,3364.0,"Plant lectins , a unique group of proteins and glycoproteins with potent biological activity , occur in foods like wheat , corn , tomato , peanut , kidney bean , banana , pea , lentil , soybean , mushroom , rice , and potato ."
97136,bean,I-AG.01.h.02.g,3364.0,"Plant lectins , a unique group of proteins and glycoproteins with potent biological activity , occur in foods like wheat , corn , tomato , peanut , kidney bean , banana , pea , lentil , soybean , mushroom , rice , and potato ."
97137,",",O,3364.0,"Plant lectins , a unique group of proteins and glycoproteins with potent biological activity , occur in foods like wheat , corn , tomato , peanut , kidney bean , banana , pea , lentil , soybean , mushroom , rice , and potato ."
97138,banana,B-AG.01.h.01,3364.0,"Plant lectins , a unique group of proteins and glycoproteins with potent biological activity , occur in foods like wheat , corn , tomato , peanut , kidney bean , banana , pea , lentil , soybean , mushroom , rice , and potato ."
97139,",",O,3364.0,"Plant lectins , a unique group of proteins and glycoproteins with potent biological activity , occur in foods like wheat , corn , tomato , peanut , kidney bean , banana , pea , lentil , soybean , mushroom , rice , and potato ."
97140,pea,B-AG.01.h.02.g,3364.0,"Plant lectins , a unique group of proteins and glycoproteins with potent biological activity , occur in foods like wheat , corn , tomato , peanut , kidney bean , banana , pea , lentil , soybean , mushroom , rice , and potato ."
97141,",",O,3364.0,"Plant lectins , a unique group of proteins and glycoproteins with potent biological activity , occur in foods like wheat , corn , tomato , peanut , kidney bean , banana , pea , lentil , soybean , mushroom , rice , and potato ."
97142,lentil,B-AG.01.h.02.g,3364.0,"Plant lectins , a unique group of proteins and glycoproteins with potent biological activity , occur in foods like wheat , corn , tomato , peanut , kidney bean , banana , pea , lentil , soybean , mushroom , rice , and potato ."
97143,",",O,3364.0,"Plant lectins , a unique group of proteins and glycoproteins with potent biological activity , occur in foods like wheat , corn , tomato , peanut , kidney bean , banana , pea , lentil , soybean , mushroom , rice , and potato ."
97144,soybean,B-AG.01.h.02.g,3364.0,"Plant lectins , a unique group of proteins and glycoproteins with potent biological activity , occur in foods like wheat , corn , tomato , peanut , kidney bean , banana , pea , lentil , soybean , mushroom , rice , and potato ."
97145,",",O,3364.0,"Plant lectins , a unique group of proteins and glycoproteins with potent biological activity , occur in foods like wheat , corn , tomato , peanut , kidney bean , banana , pea , lentil , soybean , mushroom , rice , and potato ."
97146,mushroom,B-AG.01.h.02.h,3364.0,"Plant lectins , a unique group of proteins and glycoproteins with potent biological activity , occur in foods like wheat , corn , tomato , peanut , kidney bean , banana , pea , lentil , soybean , mushroom , rice , and potato ."
97147,",",O,3364.0,"Plant lectins , a unique group of proteins and glycoproteins with potent biological activity , occur in foods like wheat , corn , tomato , peanut , kidney bean , banana , pea , lentil , soybean , mushroom , rice , and potato ."
97148,rice,B-AG.01.i,3364.0,"Plant lectins , a unique group of proteins and glycoproteins with potent biological activity , occur in foods like wheat , corn , tomato , peanut , kidney bean , banana , pea , lentil , soybean , mushroom , rice , and potato ."
97149,",",O,3364.0,"Plant lectins , a unique group of proteins and glycoproteins with potent biological activity , occur in foods like wheat , corn , tomato , peanut , kidney bean , banana , pea , lentil , soybean , mushroom , rice , and potato ."
97150,and,O,3364.0,"Plant lectins , a unique group of proteins and glycoproteins with potent biological activity , occur in foods like wheat , corn , tomato , peanut , kidney bean , banana , pea , lentil , soybean , mushroom , rice , and potato ."
97151,potato,B-AG.01.h.02.a,3364.0,"Plant lectins , a unique group of proteins and glycoproteins with potent biological activity , occur in foods like wheat , corn , tomato , peanut , kidney bean , banana , pea , lentil , soybean , mushroom , rice , and potato ."
97152,.,O,3364.0,"Plant lectins , a unique group of proteins and glycoproteins with potent biological activity , occur in foods like wheat , corn , tomato , peanut , kidney bean , banana , pea , lentil , soybean , mushroom , rice , and potato ."
97153,Thus,O,3365.0,"Thus , dietary intakes by humans can be significant ."
97154,",",O,3365.0,"Thus , dietary intakes by humans can be significant ."
97155,dietary,O,3365.0,"Thus , dietary intakes by humans can be significant ."
97156,intakes,O,3365.0,"Thus , dietary intakes by humans can be significant ."
97157,by,O,3365.0,"Thus , dietary intakes by humans can be significant ."
97158,humans,O,3365.0,"Thus , dietary intakes by humans can be significant ."
97159,can,O,3365.0,"Thus , dietary intakes by humans can be significant ."
97160,be,O,3365.0,"Thus , dietary intakes by humans can be significant ."
97161,significant,O,3365.0,"Thus , dietary intakes by humans can be significant ."
97162,.,O,3365.0,"Thus , dietary intakes by humans can be significant ."
97163,Many,O,3366.0,"Many lectins resist digestion , survive gut passage , and bind to gastrointestinal cells and/or enter the circulation intact , maintaining full biological activity ."
97164,lectins,O,3366.0,"Many lectins resist digestion , survive gut passage , and bind to gastrointestinal cells and/or enter the circulation intact , maintaining full biological activity ."
97165,resist,O,3366.0,"Many lectins resist digestion , survive gut passage , and bind to gastrointestinal cells and/or enter the circulation intact , maintaining full biological activity ."
97166,digestion,O,3366.0,"Many lectins resist digestion , survive gut passage , and bind to gastrointestinal cells and/or enter the circulation intact , maintaining full biological activity ."
97167,",",O,3366.0,"Many lectins resist digestion , survive gut passage , and bind to gastrointestinal cells and/or enter the circulation intact , maintaining full biological activity ."
97168,survive,O,3366.0,"Many lectins resist digestion , survive gut passage , and bind to gastrointestinal cells and/or enter the circulation intact , maintaining full biological activity ."
97169,gut,O,3366.0,"Many lectins resist digestion , survive gut passage , and bind to gastrointestinal cells and/or enter the circulation intact , maintaining full biological activity ."
97170,passage,O,3366.0,"Many lectins resist digestion , survive gut passage , and bind to gastrointestinal cells and/or enter the circulation intact , maintaining full biological activity ."
97171,",",O,3366.0,"Many lectins resist digestion , survive gut passage , and bind to gastrointestinal cells and/or enter the circulation intact , maintaining full biological activity ."
97172,and,O,3366.0,"Many lectins resist digestion , survive gut passage , and bind to gastrointestinal cells and/or enter the circulation intact , maintaining full biological activity ."
97173,bind,O,3366.0,"Many lectins resist digestion , survive gut passage , and bind to gastrointestinal cells and/or enter the circulation intact , maintaining full biological activity ."
97174,to,O,3366.0,"Many lectins resist digestion , survive gut passage , and bind to gastrointestinal cells and/or enter the circulation intact , maintaining full biological activity ."
97175,gastrointestinal,O,3366.0,"Many lectins resist digestion , survive gut passage , and bind to gastrointestinal cells and/or enter the circulation intact , maintaining full biological activity ."
97176,cells,O,3366.0,"Many lectins resist digestion , survive gut passage , and bind to gastrointestinal cells and/or enter the circulation intact , maintaining full biological activity ."
97177,and/or,O,3366.0,"Many lectins resist digestion , survive gut passage , and bind to gastrointestinal cells and/or enter the circulation intact , maintaining full biological activity ."
97178,enter,O,3366.0,"Many lectins resist digestion , survive gut passage , and bind to gastrointestinal cells and/or enter the circulation intact , maintaining full biological activity ."
97179,the,O,3366.0,"Many lectins resist digestion , survive gut passage , and bind to gastrointestinal cells and/or enter the circulation intact , maintaining full biological activity ."
97180,circulation,O,3366.0,"Many lectins resist digestion , survive gut passage , and bind to gastrointestinal cells and/or enter the circulation intact , maintaining full biological activity ."
97181,intact,O,3366.0,"Many lectins resist digestion , survive gut passage , and bind to gastrointestinal cells and/or enter the circulation intact , maintaining full biological activity ."
97182,",",O,3366.0,"Many lectins resist digestion , survive gut passage , and bind to gastrointestinal cells and/or enter the circulation intact , maintaining full biological activity ."
97183,maintaining,O,3366.0,"Many lectins resist digestion , survive gut passage , and bind to gastrointestinal cells and/or enter the circulation intact , maintaining full biological activity ."
97184,full,O,3366.0,"Many lectins resist digestion , survive gut passage , and bind to gastrointestinal cells and/or enter the circulation intact , maintaining full biological activity ."
97185,biological,O,3366.0,"Many lectins resist digestion , survive gut passage , and bind to gastrointestinal cells and/or enter the circulation intact , maintaining full biological activity ."
97186,activity,O,3366.0,"Many lectins resist digestion , survive gut passage , and bind to gastrointestinal cells and/or enter the circulation intact , maintaining full biological activity ."
97187,.,O,3366.0,"Many lectins resist digestion , survive gut passage , and bind to gastrointestinal cells and/or enter the circulation intact , maintaining full biological activity ."
97188,Several,O,3367.0,"Several lectins have been found to possess anticancer properties in vitro , in vivo , and in human case studies ; they are used as therapeutic agents , preferentially binding to cancer cell membranes or their receptors , causing cytotoxicity , apoptosis , and inhibition of tumor growth ."
97189,lectins,O,3367.0,"Several lectins have been found to possess anticancer properties in vitro , in vivo , and in human case studies ; they are used as therapeutic agents , preferentially binding to cancer cell membranes or their receptors , causing cytotoxicity , apoptosis , and inhibition of tumor growth ."
97190,have,O,3367.0,"Several lectins have been found to possess anticancer properties in vitro , in vivo , and in human case studies ; they are used as therapeutic agents , preferentially binding to cancer cell membranes or their receptors , causing cytotoxicity , apoptosis , and inhibition of tumor growth ."
97191,been,O,3367.0,"Several lectins have been found to possess anticancer properties in vitro , in vivo , and in human case studies ; they are used as therapeutic agents , preferentially binding to cancer cell membranes or their receptors , causing cytotoxicity , apoptosis , and inhibition of tumor growth ."
97192,found,O,3367.0,"Several lectins have been found to possess anticancer properties in vitro , in vivo , and in human case studies ; they are used as therapeutic agents , preferentially binding to cancer cell membranes or their receptors , causing cytotoxicity , apoptosis , and inhibition of tumor growth ."
97193,to,O,3367.0,"Several lectins have been found to possess anticancer properties in vitro , in vivo , and in human case studies ; they are used as therapeutic agents , preferentially binding to cancer cell membranes or their receptors , causing cytotoxicity , apoptosis , and inhibition of tumor growth ."
97194,possess,O,3367.0,"Several lectins have been found to possess anticancer properties in vitro , in vivo , and in human case studies ; they are used as therapeutic agents , preferentially binding to cancer cell membranes or their receptors , causing cytotoxicity , apoptosis , and inhibition of tumor growth ."
97195,anticancer,O,3367.0,"Several lectins have been found to possess anticancer properties in vitro , in vivo , and in human case studies ; they are used as therapeutic agents , preferentially binding to cancer cell membranes or their receptors , causing cytotoxicity , apoptosis , and inhibition of tumor growth ."
97196,properties,O,3367.0,"Several lectins have been found to possess anticancer properties in vitro , in vivo , and in human case studies ; they are used as therapeutic agents , preferentially binding to cancer cell membranes or their receptors , causing cytotoxicity , apoptosis , and inhibition of tumor growth ."
97197,in,O,3367.0,"Several lectins have been found to possess anticancer properties in vitro , in vivo , and in human case studies ; they are used as therapeutic agents , preferentially binding to cancer cell membranes or their receptors , causing cytotoxicity , apoptosis , and inhibition of tumor growth ."
97198,vitro,O,3367.0,"Several lectins have been found to possess anticancer properties in vitro , in vivo , and in human case studies ; they are used as therapeutic agents , preferentially binding to cancer cell membranes or their receptors , causing cytotoxicity , apoptosis , and inhibition of tumor growth ."
97199,",",O,3367.0,"Several lectins have been found to possess anticancer properties in vitro , in vivo , and in human case studies ; they are used as therapeutic agents , preferentially binding to cancer cell membranes or their receptors , causing cytotoxicity , apoptosis , and inhibition of tumor growth ."
97200,in,O,3367.0,"Several lectins have been found to possess anticancer properties in vitro , in vivo , and in human case studies ; they are used as therapeutic agents , preferentially binding to cancer cell membranes or their receptors , causing cytotoxicity , apoptosis , and inhibition of tumor growth ."
97201,vivo,O,3367.0,"Several lectins have been found to possess anticancer properties in vitro , in vivo , and in human case studies ; they are used as therapeutic agents , preferentially binding to cancer cell membranes or their receptors , causing cytotoxicity , apoptosis , and inhibition of tumor growth ."
97202,",",O,3367.0,"Several lectins have been found to possess anticancer properties in vitro , in vivo , and in human case studies ; they are used as therapeutic agents , preferentially binding to cancer cell membranes or their receptors , causing cytotoxicity , apoptosis , and inhibition of tumor growth ."
97203,and,O,3367.0,"Several lectins have been found to possess anticancer properties in vitro , in vivo , and in human case studies ; they are used as therapeutic agents , preferentially binding to cancer cell membranes or their receptors , causing cytotoxicity , apoptosis , and inhibition of tumor growth ."
97204,in,O,3367.0,"Several lectins have been found to possess anticancer properties in vitro , in vivo , and in human case studies ; they are used as therapeutic agents , preferentially binding to cancer cell membranes or their receptors , causing cytotoxicity , apoptosis , and inhibition of tumor growth ."
97205,human,O,3367.0,"Several lectins have been found to possess anticancer properties in vitro , in vivo , and in human case studies ; they are used as therapeutic agents , preferentially binding to cancer cell membranes or their receptors , causing cytotoxicity , apoptosis , and inhibition of tumor growth ."
97206,case,O,3367.0,"Several lectins have been found to possess anticancer properties in vitro , in vivo , and in human case studies ; they are used as therapeutic agents , preferentially binding to cancer cell membranes or their receptors , causing cytotoxicity , apoptosis , and inhibition of tumor growth ."
97207,studies,O,3367.0,"Several lectins have been found to possess anticancer properties in vitro , in vivo , and in human case studies ; they are used as therapeutic agents , preferentially binding to cancer cell membranes or their receptors , causing cytotoxicity , apoptosis , and inhibition of tumor growth ."
97208,;,O,3367.0,"Several lectins have been found to possess anticancer properties in vitro , in vivo , and in human case studies ; they are used as therapeutic agents , preferentially binding to cancer cell membranes or their receptors , causing cytotoxicity , apoptosis , and inhibition of tumor growth ."
97209,they,O,3367.0,"Several lectins have been found to possess anticancer properties in vitro , in vivo , and in human case studies ; they are used as therapeutic agents , preferentially binding to cancer cell membranes or their receptors , causing cytotoxicity , apoptosis , and inhibition of tumor growth ."
97210,are,O,3367.0,"Several lectins have been found to possess anticancer properties in vitro , in vivo , and in human case studies ; they are used as therapeutic agents , preferentially binding to cancer cell membranes or their receptors , causing cytotoxicity , apoptosis , and inhibition of tumor growth ."
97211,used,O,3367.0,"Several lectins have been found to possess anticancer properties in vitro , in vivo , and in human case studies ; they are used as therapeutic agents , preferentially binding to cancer cell membranes or their receptors , causing cytotoxicity , apoptosis , and inhibition of tumor growth ."
97212,as,O,3367.0,"Several lectins have been found to possess anticancer properties in vitro , in vivo , and in human case studies ; they are used as therapeutic agents , preferentially binding to cancer cell membranes or their receptors , causing cytotoxicity , apoptosis , and inhibition of tumor growth ."
97213,therapeutic,O,3367.0,"Several lectins have been found to possess anticancer properties in vitro , in vivo , and in human case studies ; they are used as therapeutic agents , preferentially binding to cancer cell membranes or their receptors , causing cytotoxicity , apoptosis , and inhibition of tumor growth ."
97214,agents,O,3367.0,"Several lectins have been found to possess anticancer properties in vitro , in vivo , and in human case studies ; they are used as therapeutic agents , preferentially binding to cancer cell membranes or their receptors , causing cytotoxicity , apoptosis , and inhibition of tumor growth ."
97215,",",O,3367.0,"Several lectins have been found to possess anticancer properties in vitro , in vivo , and in human case studies ; they are used as therapeutic agents , preferentially binding to cancer cell membranes or their receptors , causing cytotoxicity , apoptosis , and inhibition of tumor growth ."
97216,preferentially,O,3367.0,"Several lectins have been found to possess anticancer properties in vitro , in vivo , and in human case studies ; they are used as therapeutic agents , preferentially binding to cancer cell membranes or their receptors , causing cytotoxicity , apoptosis , and inhibition of tumor growth ."
97217,binding,O,3367.0,"Several lectins have been found to possess anticancer properties in vitro , in vivo , and in human case studies ; they are used as therapeutic agents , preferentially binding to cancer cell membranes or their receptors , causing cytotoxicity , apoptosis , and inhibition of tumor growth ."
97218,to,O,3367.0,"Several lectins have been found to possess anticancer properties in vitro , in vivo , and in human case studies ; they are used as therapeutic agents , preferentially binding to cancer cell membranes or their receptors , causing cytotoxicity , apoptosis , and inhibition of tumor growth ."
97219,cancer,O,3367.0,"Several lectins have been found to possess anticancer properties in vitro , in vivo , and in human case studies ; they are used as therapeutic agents , preferentially binding to cancer cell membranes or their receptors , causing cytotoxicity , apoptosis , and inhibition of tumor growth ."
97220,cell,O,3367.0,"Several lectins have been found to possess anticancer properties in vitro , in vivo , and in human case studies ; they are used as therapeutic agents , preferentially binding to cancer cell membranes or their receptors , causing cytotoxicity , apoptosis , and inhibition of tumor growth ."
97221,membranes,O,3367.0,"Several lectins have been found to possess anticancer properties in vitro , in vivo , and in human case studies ; they are used as therapeutic agents , preferentially binding to cancer cell membranes or their receptors , causing cytotoxicity , apoptosis , and inhibition of tumor growth ."
97222,or,O,3367.0,"Several lectins have been found to possess anticancer properties in vitro , in vivo , and in human case studies ; they are used as therapeutic agents , preferentially binding to cancer cell membranes or their receptors , causing cytotoxicity , apoptosis , and inhibition of tumor growth ."
97223,their,O,3367.0,"Several lectins have been found to possess anticancer properties in vitro , in vivo , and in human case studies ; they are used as therapeutic agents , preferentially binding to cancer cell membranes or their receptors , causing cytotoxicity , apoptosis , and inhibition of tumor growth ."
97224,receptors,O,3367.0,"Several lectins have been found to possess anticancer properties in vitro , in vivo , and in human case studies ; they are used as therapeutic agents , preferentially binding to cancer cell membranes or their receptors , causing cytotoxicity , apoptosis , and inhibition of tumor growth ."
97225,",",O,3367.0,"Several lectins have been found to possess anticancer properties in vitro , in vivo , and in human case studies ; they are used as therapeutic agents , preferentially binding to cancer cell membranes or their receptors , causing cytotoxicity , apoptosis , and inhibition of tumor growth ."
97226,causing,O,3367.0,"Several lectins have been found to possess anticancer properties in vitro , in vivo , and in human case studies ; they are used as therapeutic agents , preferentially binding to cancer cell membranes or their receptors , causing cytotoxicity , apoptosis , and inhibition of tumor growth ."
97227,cytotoxicity,O,3367.0,"Several lectins have been found to possess anticancer properties in vitro , in vivo , and in human case studies ; they are used as therapeutic agents , preferentially binding to cancer cell membranes or their receptors , causing cytotoxicity , apoptosis , and inhibition of tumor growth ."
97228,",",O,3367.0,"Several lectins have been found to possess anticancer properties in vitro , in vivo , and in human case studies ; they are used as therapeutic agents , preferentially binding to cancer cell membranes or their receptors , causing cytotoxicity , apoptosis , and inhibition of tumor growth ."
97229,apoptosis,O,3367.0,"Several lectins have been found to possess anticancer properties in vitro , in vivo , and in human case studies ; they are used as therapeutic agents , preferentially binding to cancer cell membranes or their receptors , causing cytotoxicity , apoptosis , and inhibition of tumor growth ."
97230,",",O,3367.0,"Several lectins have been found to possess anticancer properties in vitro , in vivo , and in human case studies ; they are used as therapeutic agents , preferentially binding to cancer cell membranes or their receptors , causing cytotoxicity , apoptosis , and inhibition of tumor growth ."
97231,and,O,3367.0,"Several lectins have been found to possess anticancer properties in vitro , in vivo , and in human case studies ; they are used as therapeutic agents , preferentially binding to cancer cell membranes or their receptors , causing cytotoxicity , apoptosis , and inhibition of tumor growth ."
97232,inhibition,O,3367.0,"Several lectins have been found to possess anticancer properties in vitro , in vivo , and in human case studies ; they are used as therapeutic agents , preferentially binding to cancer cell membranes or their receptors , causing cytotoxicity , apoptosis , and inhibition of tumor growth ."
97233,of,O,3367.0,"Several lectins have been found to possess anticancer properties in vitro , in vivo , and in human case studies ; they are used as therapeutic agents , preferentially binding to cancer cell membranes or their receptors , causing cytotoxicity , apoptosis , and inhibition of tumor growth ."
97234,tumor,O,3367.0,"Several lectins have been found to possess anticancer properties in vitro , in vivo , and in human case studies ; they are used as therapeutic agents , preferentially binding to cancer cell membranes or their receptors , causing cytotoxicity , apoptosis , and inhibition of tumor growth ."
97235,growth,O,3367.0,"Several lectins have been found to possess anticancer properties in vitro , in vivo , and in human case studies ; they are used as therapeutic agents , preferentially binding to cancer cell membranes or their receptors , causing cytotoxicity , apoptosis , and inhibition of tumor growth ."
97236,.,O,3367.0,"Several lectins have been found to possess anticancer properties in vitro , in vivo , and in human case studies ; they are used as therapeutic agents , preferentially binding to cancer cell membranes or their receptors , causing cytotoxicity , apoptosis , and inhibition of tumor growth ."
97237,These,O,3368.0,"These compounds can become internalized into cells , causing cancer cell agglutination and/or aggregation ."
97238,compounds,O,3368.0,"These compounds can become internalized into cells , causing cancer cell agglutination and/or aggregation ."
97239,can,O,3368.0,"These compounds can become internalized into cells , causing cancer cell agglutination and/or aggregation ."
97240,become,O,3368.0,"These compounds can become internalized into cells , causing cancer cell agglutination and/or aggregation ."
97241,internalized,O,3368.0,"These compounds can become internalized into cells , causing cancer cell agglutination and/or aggregation ."
97242,into,O,3368.0,"These compounds can become internalized into cells , causing cancer cell agglutination and/or aggregation ."
97243,cells,O,3368.0,"These compounds can become internalized into cells , causing cancer cell agglutination and/or aggregation ."
97244,",",O,3368.0,"These compounds can become internalized into cells , causing cancer cell agglutination and/or aggregation ."
97245,causing,O,3368.0,"These compounds can become internalized into cells , causing cancer cell agglutination and/or aggregation ."
97246,cancer,O,3368.0,"These compounds can become internalized into cells , causing cancer cell agglutination and/or aggregation ."
97247,cell,O,3368.0,"These compounds can become internalized into cells , causing cancer cell agglutination and/or aggregation ."
97248,agglutination,O,3368.0,"These compounds can become internalized into cells , causing cancer cell agglutination and/or aggregation ."
97249,and/or,O,3368.0,"These compounds can become internalized into cells , causing cancer cell agglutination and/or aggregation ."
97250,aggregation,O,3368.0,"These compounds can become internalized into cells , causing cancer cell agglutination and/or aggregation ."
97251,.,O,3368.0,"These compounds can become internalized into cells , causing cancer cell agglutination and/or aggregation ."
97252,Ingestion,O,3369.0,"Ingestion of lectins also sequesters the available body pool of polyamines , thereby thwarting cancer cell growth ."
97253,of,O,3369.0,"Ingestion of lectins also sequesters the available body pool of polyamines , thereby thwarting cancer cell growth ."
97254,lectins,O,3369.0,"Ingestion of lectins also sequesters the available body pool of polyamines , thereby thwarting cancer cell growth ."
97255,also,O,3369.0,"Ingestion of lectins also sequesters the available body pool of polyamines , thereby thwarting cancer cell growth ."
97256,sequesters,O,3369.0,"Ingestion of lectins also sequesters the available body pool of polyamines , thereby thwarting cancer cell growth ."
97257,the,O,3369.0,"Ingestion of lectins also sequesters the available body pool of polyamines , thereby thwarting cancer cell growth ."
97258,available,O,3369.0,"Ingestion of lectins also sequesters the available body pool of polyamines , thereby thwarting cancer cell growth ."
97259,body,O,3369.0,"Ingestion of lectins also sequesters the available body pool of polyamines , thereby thwarting cancer cell growth ."
97260,pool,O,3369.0,"Ingestion of lectins also sequesters the available body pool of polyamines , thereby thwarting cancer cell growth ."
97261,of,O,3369.0,"Ingestion of lectins also sequesters the available body pool of polyamines , thereby thwarting cancer cell growth ."
97262,polyamines,O,3369.0,"Ingestion of lectins also sequesters the available body pool of polyamines , thereby thwarting cancer cell growth ."
97263,",",O,3369.0,"Ingestion of lectins also sequesters the available body pool of polyamines , thereby thwarting cancer cell growth ."
97264,thereby,O,3369.0,"Ingestion of lectins also sequesters the available body pool of polyamines , thereby thwarting cancer cell growth ."
97265,thwarting,O,3369.0,"Ingestion of lectins also sequesters the available body pool of polyamines , thereby thwarting cancer cell growth ."
97266,cancer,O,3369.0,"Ingestion of lectins also sequesters the available body pool of polyamines , thereby thwarting cancer cell growth ."
97267,cell,O,3369.0,"Ingestion of lectins also sequesters the available body pool of polyamines , thereby thwarting cancer cell growth ."
97268,growth,O,3369.0,"Ingestion of lectins also sequesters the available body pool of polyamines , thereby thwarting cancer cell growth ."
97269,.,O,3369.0,"Ingestion of lectins also sequesters the available body pool of polyamines , thereby thwarting cancer cell growth ."
97270,They,O,3370.0,"They also affect the immune system by altering the production of various interleukins , or by activating certain protein kinases ."
97271,also,O,3370.0,"They also affect the immune system by altering the production of various interleukins , or by activating certain protein kinases ."
97272,affect,O,3370.0,"They also affect the immune system by altering the production of various interleukins , or by activating certain protein kinases ."
97273,the,O,3370.0,"They also affect the immune system by altering the production of various interleukins , or by activating certain protein kinases ."
97274,immune,O,3370.0,"They also affect the immune system by altering the production of various interleukins , or by activating certain protein kinases ."
97275,system,O,3370.0,"They also affect the immune system by altering the production of various interleukins , or by activating certain protein kinases ."
97276,by,O,3370.0,"They also affect the immune system by altering the production of various interleukins , or by activating certain protein kinases ."
97277,altering,O,3370.0,"They also affect the immune system by altering the production of various interleukins , or by activating certain protein kinases ."
97278,the,O,3370.0,"They also affect the immune system by altering the production of various interleukins , or by activating certain protein kinases ."
97279,production,O,3370.0,"They also affect the immune system by altering the production of various interleukins , or by activating certain protein kinases ."
97280,of,O,3370.0,"They also affect the immune system by altering the production of various interleukins , or by activating certain protein kinases ."
97281,various,O,3370.0,"They also affect the immune system by altering the production of various interleukins , or by activating certain protein kinases ."
97282,interleukins,O,3370.0,"They also affect the immune system by altering the production of various interleukins , or by activating certain protein kinases ."
97283,",",O,3370.0,"They also affect the immune system by altering the production of various interleukins , or by activating certain protein kinases ."
97284,or,O,3370.0,"They also affect the immune system by altering the production of various interleukins , or by activating certain protein kinases ."
97285,by,O,3370.0,"They also affect the immune system by altering the production of various interleukins , or by activating certain protein kinases ."
97286,activating,O,3370.0,"They also affect the immune system by altering the production of various interleukins , or by activating certain protein kinases ."
97287,certain,O,3370.0,"They also affect the immune system by altering the production of various interleukins , or by activating certain protein kinases ."
97288,protein,O,3370.0,"They also affect the immune system by altering the production of various interleukins , or by activating certain protein kinases ."
97289,kinases,O,3370.0,"They also affect the immune system by altering the production of various interleukins , or by activating certain protein kinases ."
97290,.,O,3370.0,"They also affect the immune system by altering the production of various interleukins , or by activating certain protein kinases ."
97291,Lectins,O,3371.0,Lectins can bind to ribosomes and inhibit protein synthesis .
97292,can,O,3371.0,Lectins can bind to ribosomes and inhibit protein synthesis .
97293,bind,O,3371.0,Lectins can bind to ribosomes and inhibit protein synthesis .
97294,to,O,3371.0,Lectins can bind to ribosomes and inhibit protein synthesis .
97295,ribosomes,O,3371.0,Lectins can bind to ribosomes and inhibit protein synthesis .
97296,and,O,3371.0,Lectins can bind to ribosomes and inhibit protein synthesis .
97297,inhibit,O,3371.0,Lectins can bind to ribosomes and inhibit protein synthesis .
97298,protein,O,3371.0,Lectins can bind to ribosomes and inhibit protein synthesis .
97299,synthesis,O,3371.0,Lectins can bind to ribosomes and inhibit protein synthesis .
97300,.,O,3371.0,Lectins can bind to ribosomes and inhibit protein synthesis .
97301,They,O,3372.0,"They also modify the cell cycle by inducing non - apoptotic G1 - phase accumulation mechanisms , G2 / M phase cell cycle arrest and apoptosis , and can activate the caspase cascade ."
97302,also,O,3372.0,"They also modify the cell cycle by inducing non - apoptotic G1 - phase accumulation mechanisms , G2 / M phase cell cycle arrest and apoptosis , and can activate the caspase cascade ."
97303,modify,O,3372.0,"They also modify the cell cycle by inducing non - apoptotic G1 - phase accumulation mechanisms , G2 / M phase cell cycle arrest and apoptosis , and can activate the caspase cascade ."
97304,the,O,3372.0,"They also modify the cell cycle by inducing non - apoptotic G1 - phase accumulation mechanisms , G2 / M phase cell cycle arrest and apoptosis , and can activate the caspase cascade ."
97305,cell,O,3372.0,"They also modify the cell cycle by inducing non - apoptotic G1 - phase accumulation mechanisms , G2 / M phase cell cycle arrest and apoptosis , and can activate the caspase cascade ."
97306,cycle,O,3372.0,"They also modify the cell cycle by inducing non - apoptotic G1 - phase accumulation mechanisms , G2 / M phase cell cycle arrest and apoptosis , and can activate the caspase cascade ."
97307,by,O,3372.0,"They also modify the cell cycle by inducing non - apoptotic G1 - phase accumulation mechanisms , G2 / M phase cell cycle arrest and apoptosis , and can activate the caspase cascade ."
97308,inducing,O,3372.0,"They also modify the cell cycle by inducing non - apoptotic G1 - phase accumulation mechanisms , G2 / M phase cell cycle arrest and apoptosis , and can activate the caspase cascade ."
97309,non,O,3372.0,"They also modify the cell cycle by inducing non - apoptotic G1 - phase accumulation mechanisms , G2 / M phase cell cycle arrest and apoptosis , and can activate the caspase cascade ."
97310,-,O,3372.0,"They also modify the cell cycle by inducing non - apoptotic G1 - phase accumulation mechanisms , G2 / M phase cell cycle arrest and apoptosis , and can activate the caspase cascade ."
97311,apoptotic,O,3372.0,"They also modify the cell cycle by inducing non - apoptotic G1 - phase accumulation mechanisms , G2 / M phase cell cycle arrest and apoptosis , and can activate the caspase cascade ."
97312,G1,O,3372.0,"They also modify the cell cycle by inducing non - apoptotic G1 - phase accumulation mechanisms , G2 / M phase cell cycle arrest and apoptosis , and can activate the caspase cascade ."
97313,-,O,3372.0,"They also modify the cell cycle by inducing non - apoptotic G1 - phase accumulation mechanisms , G2 / M phase cell cycle arrest and apoptosis , and can activate the caspase cascade ."
97314,phase,O,3372.0,"They also modify the cell cycle by inducing non - apoptotic G1 - phase accumulation mechanisms , G2 / M phase cell cycle arrest and apoptosis , and can activate the caspase cascade ."
97315,accumulation,O,3372.0,"They also modify the cell cycle by inducing non - apoptotic G1 - phase accumulation mechanisms , G2 / M phase cell cycle arrest and apoptosis , and can activate the caspase cascade ."
97316,mechanisms,O,3372.0,"They also modify the cell cycle by inducing non - apoptotic G1 - phase accumulation mechanisms , G2 / M phase cell cycle arrest and apoptosis , and can activate the caspase cascade ."
97317,",",O,3372.0,"They also modify the cell cycle by inducing non - apoptotic G1 - phase accumulation mechanisms , G2 / M phase cell cycle arrest and apoptosis , and can activate the caspase cascade ."
97318,G2,O,3372.0,"They also modify the cell cycle by inducing non - apoptotic G1 - phase accumulation mechanisms , G2 / M phase cell cycle arrest and apoptosis , and can activate the caspase cascade ."
97319,/,O,3372.0,"They also modify the cell cycle by inducing non - apoptotic G1 - phase accumulation mechanisms , G2 / M phase cell cycle arrest and apoptosis , and can activate the caspase cascade ."
97320,M,O,3372.0,"They also modify the cell cycle by inducing non - apoptotic G1 - phase accumulation mechanisms , G2 / M phase cell cycle arrest and apoptosis , and can activate the caspase cascade ."
97321,phase,O,3372.0,"They also modify the cell cycle by inducing non - apoptotic G1 - phase accumulation mechanisms , G2 / M phase cell cycle arrest and apoptosis , and can activate the caspase cascade ."
97322,cell,O,3372.0,"They also modify the cell cycle by inducing non - apoptotic G1 - phase accumulation mechanisms , G2 / M phase cell cycle arrest and apoptosis , and can activate the caspase cascade ."
97323,cycle,O,3372.0,"They also modify the cell cycle by inducing non - apoptotic G1 - phase accumulation mechanisms , G2 / M phase cell cycle arrest and apoptosis , and can activate the caspase cascade ."
97324,arrest,O,3372.0,"They also modify the cell cycle by inducing non - apoptotic G1 - phase accumulation mechanisms , G2 / M phase cell cycle arrest and apoptosis , and can activate the caspase cascade ."
97325,and,O,3372.0,"They also modify the cell cycle by inducing non - apoptotic G1 - phase accumulation mechanisms , G2 / M phase cell cycle arrest and apoptosis , and can activate the caspase cascade ."
97326,apoptosis,O,3372.0,"They also modify the cell cycle by inducing non - apoptotic G1 - phase accumulation mechanisms , G2 / M phase cell cycle arrest and apoptosis , and can activate the caspase cascade ."
97327,",",O,3372.0,"They also modify the cell cycle by inducing non - apoptotic G1 - phase accumulation mechanisms , G2 / M phase cell cycle arrest and apoptosis , and can activate the caspase cascade ."
97328,and,O,3372.0,"They also modify the cell cycle by inducing non - apoptotic G1 - phase accumulation mechanisms , G2 / M phase cell cycle arrest and apoptosis , and can activate the caspase cascade ."
97329,can,O,3372.0,"They also modify the cell cycle by inducing non - apoptotic G1 - phase accumulation mechanisms , G2 / M phase cell cycle arrest and apoptosis , and can activate the caspase cascade ."
97330,activate,O,3372.0,"They also modify the cell cycle by inducing non - apoptotic G1 - phase accumulation mechanisms , G2 / M phase cell cycle arrest and apoptosis , and can activate the caspase cascade ."
97331,the,O,3372.0,"They also modify the cell cycle by inducing non - apoptotic G1 - phase accumulation mechanisms , G2 / M phase cell cycle arrest and apoptosis , and can activate the caspase cascade ."
97332,caspase,O,3372.0,"They also modify the cell cycle by inducing non - apoptotic G1 - phase accumulation mechanisms , G2 / M phase cell cycle arrest and apoptosis , and can activate the caspase cascade ."
97333,cascade,O,3372.0,"They also modify the cell cycle by inducing non - apoptotic G1 - phase accumulation mechanisms , G2 / M phase cell cycle arrest and apoptosis , and can activate the caspase cascade ."
97334,.,O,3372.0,"They also modify the cell cycle by inducing non - apoptotic G1 - phase accumulation mechanisms , G2 / M phase cell cycle arrest and apoptosis , and can activate the caspase cascade ."
97335,Lectins,O,3373.0,Lectins can also downregulate telomerase activity and inhibit angiogenesis .
97336,can,O,3373.0,Lectins can also downregulate telomerase activity and inhibit angiogenesis .
97337,also,O,3373.0,Lectins can also downregulate telomerase activity and inhibit angiogenesis .
97338,downregulate,O,3373.0,Lectins can also downregulate telomerase activity and inhibit angiogenesis .
97339,telomerase,O,3373.0,Lectins can also downregulate telomerase activity and inhibit angiogenesis .
97340,activity,O,3373.0,Lectins can also downregulate telomerase activity and inhibit angiogenesis .
97341,and,O,3373.0,Lectins can also downregulate telomerase activity and inhibit angiogenesis .
97342,inhibit,O,3373.0,Lectins can also downregulate telomerase activity and inhibit angiogenesis .
97343,angiogenesis,O,3373.0,Lectins can also downregulate telomerase activity and inhibit angiogenesis .
97344,.,O,3373.0,Lectins can also downregulate telomerase activity and inhibit angiogenesis .
97345,Although,O,3374.0,"Although lectins seem to have great potential as anticancer agents , further research is still needed and should include a genomic and proteomic approach ."
97346,lectins,O,3374.0,"Although lectins seem to have great potential as anticancer agents , further research is still needed and should include a genomic and proteomic approach ."
97347,seem,O,3374.0,"Although lectins seem to have great potential as anticancer agents , further research is still needed and should include a genomic and proteomic approach ."
97348,to,O,3374.0,"Although lectins seem to have great potential as anticancer agents , further research is still needed and should include a genomic and proteomic approach ."
97349,have,O,3374.0,"Although lectins seem to have great potential as anticancer agents , further research is still needed and should include a genomic and proteomic approach ."
97350,great,O,3374.0,"Although lectins seem to have great potential as anticancer agents , further research is still needed and should include a genomic and proteomic approach ."
97351,potential,O,3374.0,"Although lectins seem to have great potential as anticancer agents , further research is still needed and should include a genomic and proteomic approach ."
97352,as,O,3374.0,"Although lectins seem to have great potential as anticancer agents , further research is still needed and should include a genomic and proteomic approach ."
97353,anticancer,O,3374.0,"Although lectins seem to have great potential as anticancer agents , further research is still needed and should include a genomic and proteomic approach ."
97354,agents,O,3374.0,"Although lectins seem to have great potential as anticancer agents , further research is still needed and should include a genomic and proteomic approach ."
97355,",",O,3374.0,"Although lectins seem to have great potential as anticancer agents , further research is still needed and should include a genomic and proteomic approach ."
97356,further,O,3374.0,"Although lectins seem to have great potential as anticancer agents , further research is still needed and should include a genomic and proteomic approach ."
97357,research,O,3374.0,"Although lectins seem to have great potential as anticancer agents , further research is still needed and should include a genomic and proteomic approach ."
97358,is,O,3374.0,"Although lectins seem to have great potential as anticancer agents , further research is still needed and should include a genomic and proteomic approach ."
97359,still,O,3374.0,"Although lectins seem to have great potential as anticancer agents , further research is still needed and should include a genomic and proteomic approach ."
97360,needed,O,3374.0,"Although lectins seem to have great potential as anticancer agents , further research is still needed and should include a genomic and proteomic approach ."
97361,and,O,3374.0,"Although lectins seem to have great potential as anticancer agents , further research is still needed and should include a genomic and proteomic approach ."
97362,should,O,3374.0,"Although lectins seem to have great potential as anticancer agents , further research is still needed and should include a genomic and proteomic approach ."
97363,include,O,3374.0,"Although lectins seem to have great potential as anticancer agents , further research is still needed and should include a genomic and proteomic approach ."
97364,a,O,3374.0,"Although lectins seem to have great potential as anticancer agents , further research is still needed and should include a genomic and proteomic approach ."
97365,genomic,O,3374.0,"Although lectins seem to have great potential as anticancer agents , further research is still needed and should include a genomic and proteomic approach ."
97366,and,O,3374.0,"Although lectins seem to have great potential as anticancer agents , further research is still needed and should include a genomic and proteomic approach ."
97367,proteomic,O,3374.0,"Although lectins seem to have great potential as anticancer agents , further research is still needed and should include a genomic and proteomic approach ."
97368,approach,O,3374.0,"Although lectins seem to have great potential as anticancer agents , further research is still needed and should include a genomic and proteomic approach ."
97369,.,O,3374.0,"Although lectins seem to have great potential as anticancer agents , further research is still needed and should include a genomic and proteomic approach ."
97370,Limited,O,3375.0,Limited data exist regarding nutrient intakes and overall dietary quality in Canadian Arctic populations .
97371,data,O,3375.0,Limited data exist regarding nutrient intakes and overall dietary quality in Canadian Arctic populations .
97372,exist,O,3375.0,Limited data exist regarding nutrient intakes and overall dietary quality in Canadian Arctic populations .
97373,regarding,O,3375.0,Limited data exist regarding nutrient intakes and overall dietary quality in Canadian Arctic populations .
97374,nutrient,O,3375.0,Limited data exist regarding nutrient intakes and overall dietary quality in Canadian Arctic populations .
97375,intakes,O,3375.0,Limited data exist regarding nutrient intakes and overall dietary quality in Canadian Arctic populations .
97376,and,O,3375.0,Limited data exist regarding nutrient intakes and overall dietary quality in Canadian Arctic populations .
97377,overall,O,3375.0,Limited data exist regarding nutrient intakes and overall dietary quality in Canadian Arctic populations .
97378,dietary,O,3375.0,Limited data exist regarding nutrient intakes and overall dietary quality in Canadian Arctic populations .
97379,quality,O,3375.0,Limited data exist regarding nutrient intakes and overall dietary quality in Canadian Arctic populations .
97380,in,O,3375.0,Limited data exist regarding nutrient intakes and overall dietary quality in Canadian Arctic populations .
97381,Canadian,O,3375.0,Limited data exist regarding nutrient intakes and overall dietary quality in Canadian Arctic populations .
97382,Arctic,O,3375.0,Limited data exist regarding nutrient intakes and overall dietary quality in Canadian Arctic populations .
97383,populations,O,3375.0,Limited data exist regarding nutrient intakes and overall dietary quality in Canadian Arctic populations .
97384,.,O,3375.0,Limited data exist regarding nutrient intakes and overall dietary quality in Canadian Arctic populations .
97385,This,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97386,cross,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97387,-,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97388,sectional,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97389,study,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97390,determined,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97391,the,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97392,frequency,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97393,of,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97394,consumption,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97395,of,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97396,traditional,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97397,meats,B-AG.01.d,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97398,(,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97399,e.g.,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97400,caribou,B-AG.01.d,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97401,",",O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97402,polar,B-AG.01.d,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97403,bear,I-AG.01.d,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97404,",",O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97405,seal,B-AG.01.d,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97406,",",O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97407,char,B-AG.01.d.07,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97408,and,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97409,whale,B-AG.01.d,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97410,),O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97411,and,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97412,non,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97413,-,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97414,traditional,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97415,store,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97416,-,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97417,bought,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97418,foods,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97419,including,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97420,non,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97421,-,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97422,traditional,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97423,meats,B-AG.01.d,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97424,(,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97425,e.g.,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97426,beef,B-AG.01.d.03,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97427,",",O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97428,pork,B-AG.01.d.05,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97429,and,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97430,chicken,B-AG.01.d.06,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97431,),O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97432,",",O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97433,grains,B-AG.01.i,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97434,",",O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97435,dairy,B-AG.01.e,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97436,",",O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97437,fruits,B-AG.01.h.01,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97438,",",O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97439,vegetables,B-AG.01.h.02,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97440,and,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97441,non,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97442,-,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97443,nutrient,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97444,dense,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97445,foods,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97446,(,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97447,NNDFs,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97448,),O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97449,(,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97450,e.g.,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97451,butter,B-AG.01.e.01,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97452,",",O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97453,chocolate,B-AG.01.n.17.a,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97454,",",O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97455,chips,B-AG.01.n,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97456,",",O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97457,candy,B-AG.01.n.17.a,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97458,and,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97459,pop,B-AG.01,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97460,),O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97461,by,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97462,Inuvialuit,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97463,adults,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97464,(,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97465,175,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97466,women,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97467,",",O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97468,mean,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97469,age,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97470,44,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97471,±,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97472,14,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97473,years,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97474,;,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97475,55,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97476,men,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97477,",",O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97478,mean,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97479,age,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97480,41,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97481,±,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97482,13,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97483,years,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97484,),O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97485,in,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97486,three,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97487,remote,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97488,communities,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97489,in,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97490,the,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97491,Northwest,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97492,Territories,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97493,.,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97494,Using,O,3377.0,"Using a validated quantitative food frequency questionnaire , frequency of consumption over a 30 - day period was determined for 141 commonly reported foods ."
97495,a,O,3377.0,"Using a validated quantitative food frequency questionnaire , frequency of consumption over a 30 - day period was determined for 141 commonly reported foods ."
97496,validated,O,3377.0,"Using a validated quantitative food frequency questionnaire , frequency of consumption over a 30 - day period was determined for 141 commonly reported foods ."
97497,quantitative,O,3377.0,"Using a validated quantitative food frequency questionnaire , frequency of consumption over a 30 - day period was determined for 141 commonly reported foods ."
97498,food,O,3377.0,"Using a validated quantitative food frequency questionnaire , frequency of consumption over a 30 - day period was determined for 141 commonly reported foods ."
97499,frequency,O,3377.0,"Using a validated quantitative food frequency questionnaire , frequency of consumption over a 30 - day period was determined for 141 commonly reported foods ."
97500,questionnaire,O,3377.0,"Using a validated quantitative food frequency questionnaire , frequency of consumption over a 30 - day period was determined for 141 commonly reported foods ."
97501,",",O,3377.0,"Using a validated quantitative food frequency questionnaire , frequency of consumption over a 30 - day period was determined for 141 commonly reported foods ."
97502,frequency,O,3377.0,"Using a validated quantitative food frequency questionnaire , frequency of consumption over a 30 - day period was determined for 141 commonly reported foods ."
97503,of,O,3377.0,"Using a validated quantitative food frequency questionnaire , frequency of consumption over a 30 - day period was determined for 141 commonly reported foods ."
97504,consumption,O,3377.0,"Using a validated quantitative food frequency questionnaire , frequency of consumption over a 30 - day period was determined for 141 commonly reported foods ."
97505,over,O,3377.0,"Using a validated quantitative food frequency questionnaire , frequency of consumption over a 30 - day period was determined for 141 commonly reported foods ."
97506,a,O,3377.0,"Using a validated quantitative food frequency questionnaire , frequency of consumption over a 30 - day period was determined for 141 commonly reported foods ."
97507,30,O,3377.0,"Using a validated quantitative food frequency questionnaire , frequency of consumption over a 30 - day period was determined for 141 commonly reported foods ."
97508,-,O,3377.0,"Using a validated quantitative food frequency questionnaire , frequency of consumption over a 30 - day period was determined for 141 commonly reported foods ."
97509,day,O,3377.0,"Using a validated quantitative food frequency questionnaire , frequency of consumption over a 30 - day period was determined for 141 commonly reported foods ."
97510,period,O,3377.0,"Using a validated quantitative food frequency questionnaire , frequency of consumption over a 30 - day period was determined for 141 commonly reported foods ."
97511,was,O,3377.0,"Using a validated quantitative food frequency questionnaire , frequency of consumption over a 30 - day period was determined for 141 commonly reported foods ."
97512,determined,O,3377.0,"Using a validated quantitative food frequency questionnaire , frequency of consumption over a 30 - day period was determined for 141 commonly reported foods ."
97513,for,O,3377.0,"Using a validated quantitative food frequency questionnaire , frequency of consumption over a 30 - day period was determined for 141 commonly reported foods ."
97514,141,O,3377.0,"Using a validated quantitative food frequency questionnaire , frequency of consumption over a 30 - day period was determined for 141 commonly reported foods ."
97515,commonly,O,3377.0,"Using a validated quantitative food frequency questionnaire , frequency of consumption over a 30 - day period was determined for 141 commonly reported foods ."
97516,reported,O,3377.0,"Using a validated quantitative food frequency questionnaire , frequency of consumption over a 30 - day period was determined for 141 commonly reported foods ."
97517,foods,O,3377.0,"Using a validated quantitative food frequency questionnaire , frequency of consumption over a 30 - day period was determined for 141 commonly reported foods ."
97518,.,O,3377.0,"Using a validated quantitative food frequency questionnaire , frequency of consumption over a 30 - day period was determined for 141 commonly reported foods ."
97519,Mean,O,3378.0,"Mean consumption of traditional meats ( 1.6 times / day ) , fruits ( 1 time / day ) and vegetables ( 0.6 times / day ) was less frequent than that of NNDFs ( 5.0 times / day ) ."
97520,consumption,O,3378.0,"Mean consumption of traditional meats ( 1.6 times / day ) , fruits ( 1 time / day ) and vegetables ( 0.6 times / day ) was less frequent than that of NNDFs ( 5.0 times / day ) ."
97521,of,O,3378.0,"Mean consumption of traditional meats ( 1.6 times / day ) , fruits ( 1 time / day ) and vegetables ( 0.6 times / day ) was less frequent than that of NNDFs ( 5.0 times / day ) ."
97522,traditional,O,3378.0,"Mean consumption of traditional meats ( 1.6 times / day ) , fruits ( 1 time / day ) and vegetables ( 0.6 times / day ) was less frequent than that of NNDFs ( 5.0 times / day ) ."
97523,meats,B-AG.01.d,3378.0,"Mean consumption of traditional meats ( 1.6 times / day ) , fruits ( 1 time / day ) and vegetables ( 0.6 times / day ) was less frequent than that of NNDFs ( 5.0 times / day ) ."
97524,(,O,3378.0,"Mean consumption of traditional meats ( 1.6 times / day ) , fruits ( 1 time / day ) and vegetables ( 0.6 times / day ) was less frequent than that of NNDFs ( 5.0 times / day ) ."
97525,1.6,O,3378.0,"Mean consumption of traditional meats ( 1.6 times / day ) , fruits ( 1 time / day ) and vegetables ( 0.6 times / day ) was less frequent than that of NNDFs ( 5.0 times / day ) ."
97526,times,O,3378.0,"Mean consumption of traditional meats ( 1.6 times / day ) , fruits ( 1 time / day ) and vegetables ( 0.6 times / day ) was less frequent than that of NNDFs ( 5.0 times / day ) ."
97527,/,O,3378.0,"Mean consumption of traditional meats ( 1.6 times / day ) , fruits ( 1 time / day ) and vegetables ( 0.6 times / day ) was less frequent than that of NNDFs ( 5.0 times / day ) ."
97528,day,O,3378.0,"Mean consumption of traditional meats ( 1.6 times / day ) , fruits ( 1 time / day ) and vegetables ( 0.6 times / day ) was less frequent than that of NNDFs ( 5.0 times / day ) ."
97529,),O,3378.0,"Mean consumption of traditional meats ( 1.6 times / day ) , fruits ( 1 time / day ) and vegetables ( 0.6 times / day ) was less frequent than that of NNDFs ( 5.0 times / day ) ."
97530,",",O,3378.0,"Mean consumption of traditional meats ( 1.6 times / day ) , fruits ( 1 time / day ) and vegetables ( 0.6 times / day ) was less frequent than that of NNDFs ( 5.0 times / day ) ."
97531,fruits,B-AG.01.h.01,3378.0,"Mean consumption of traditional meats ( 1.6 times / day ) , fruits ( 1 time / day ) and vegetables ( 0.6 times / day ) was less frequent than that of NNDFs ( 5.0 times / day ) ."
97532,(,O,3378.0,"Mean consumption of traditional meats ( 1.6 times / day ) , fruits ( 1 time / day ) and vegetables ( 0.6 times / day ) was less frequent than that of NNDFs ( 5.0 times / day ) ."
97533,1,O,3378.0,"Mean consumption of traditional meats ( 1.6 times / day ) , fruits ( 1 time / day ) and vegetables ( 0.6 times / day ) was less frequent than that of NNDFs ( 5.0 times / day ) ."
97534,time,O,3378.0,"Mean consumption of traditional meats ( 1.6 times / day ) , fruits ( 1 time / day ) and vegetables ( 0.6 times / day ) was less frequent than that of NNDFs ( 5.0 times / day ) ."
97535,/,O,3378.0,"Mean consumption of traditional meats ( 1.6 times / day ) , fruits ( 1 time / day ) and vegetables ( 0.6 times / day ) was less frequent than that of NNDFs ( 5.0 times / day ) ."
97536,day,O,3378.0,"Mean consumption of traditional meats ( 1.6 times / day ) , fruits ( 1 time / day ) and vegetables ( 0.6 times / day ) was less frequent than that of NNDFs ( 5.0 times / day ) ."
97537,),O,3378.0,"Mean consumption of traditional meats ( 1.6 times / day ) , fruits ( 1 time / day ) and vegetables ( 0.6 times / day ) was less frequent than that of NNDFs ( 5.0 times / day ) ."
97538,and,O,3378.0,"Mean consumption of traditional meats ( 1.6 times / day ) , fruits ( 1 time / day ) and vegetables ( 0.6 times / day ) was less frequent than that of NNDFs ( 5.0 times / day ) ."
97539,vegetables,B-AG.01.h.02,3378.0,"Mean consumption of traditional meats ( 1.6 times / day ) , fruits ( 1 time / day ) and vegetables ( 0.6 times / day ) was less frequent than that of NNDFs ( 5.0 times / day ) ."
97540,(,O,3378.0,"Mean consumption of traditional meats ( 1.6 times / day ) , fruits ( 1 time / day ) and vegetables ( 0.6 times / day ) was less frequent than that of NNDFs ( 5.0 times / day ) ."
97541,0.6,O,3378.0,"Mean consumption of traditional meats ( 1.6 times / day ) , fruits ( 1 time / day ) and vegetables ( 0.6 times / day ) was less frequent than that of NNDFs ( 5.0 times / day ) ."
97542,times,O,3378.0,"Mean consumption of traditional meats ( 1.6 times / day ) , fruits ( 1 time / day ) and vegetables ( 0.6 times / day ) was less frequent than that of NNDFs ( 5.0 times / day ) ."
97543,/,O,3378.0,"Mean consumption of traditional meats ( 1.6 times / day ) , fruits ( 1 time / day ) and vegetables ( 0.6 times / day ) was less frequent than that of NNDFs ( 5.0 times / day ) ."
97544,day,O,3378.0,"Mean consumption of traditional meats ( 1.6 times / day ) , fruits ( 1 time / day ) and vegetables ( 0.6 times / day ) was less frequent than that of NNDFs ( 5.0 times / day ) ."
97545,),O,3378.0,"Mean consumption of traditional meats ( 1.6 times / day ) , fruits ( 1 time / day ) and vegetables ( 0.6 times / day ) was less frequent than that of NNDFs ( 5.0 times / day ) ."
97546,was,O,3378.0,"Mean consumption of traditional meats ( 1.6 times / day ) , fruits ( 1 time / day ) and vegetables ( 0.6 times / day ) was less frequent than that of NNDFs ( 5.0 times / day ) ."
97547,less,O,3378.0,"Mean consumption of traditional meats ( 1.6 times / day ) , fruits ( 1 time / day ) and vegetables ( 0.6 times / day ) was less frequent than that of NNDFs ( 5.0 times / day ) ."
97548,frequent,O,3378.0,"Mean consumption of traditional meats ( 1.6 times / day ) , fruits ( 1 time / day ) and vegetables ( 0.6 times / day ) was less frequent than that of NNDFs ( 5.0 times / day ) ."
97549,than,O,3378.0,"Mean consumption of traditional meats ( 1.6 times / day ) , fruits ( 1 time / day ) and vegetables ( 0.6 times / day ) was less frequent than that of NNDFs ( 5.0 times / day ) ."
97550,that,O,3378.0,"Mean consumption of traditional meats ( 1.6 times / day ) , fruits ( 1 time / day ) and vegetables ( 0.6 times / day ) was less frequent than that of NNDFs ( 5.0 times / day ) ."
97551,of,O,3378.0,"Mean consumption of traditional meats ( 1.6 times / day ) , fruits ( 1 time / day ) and vegetables ( 0.6 times / day ) was less frequent than that of NNDFs ( 5.0 times / day ) ."
97552,NNDFs,O,3378.0,"Mean consumption of traditional meats ( 1.6 times / day ) , fruits ( 1 time / day ) and vegetables ( 0.6 times / day ) was less frequent than that of NNDFs ( 5.0 times / day ) ."
97553,(,O,3378.0,"Mean consumption of traditional meats ( 1.6 times / day ) , fruits ( 1 time / day ) and vegetables ( 0.6 times / day ) was less frequent than that of NNDFs ( 5.0 times / day ) ."
97554,5.0,O,3378.0,"Mean consumption of traditional meats ( 1.6 times / day ) , fruits ( 1 time / day ) and vegetables ( 0.6 times / day ) was less frequent than that of NNDFs ( 5.0 times / day ) ."
97555,times,O,3378.0,"Mean consumption of traditional meats ( 1.6 times / day ) , fruits ( 1 time / day ) and vegetables ( 0.6 times / day ) was less frequent than that of NNDFs ( 5.0 times / day ) ."
97556,/,O,3378.0,"Mean consumption of traditional meats ( 1.6 times / day ) , fruits ( 1 time / day ) and vegetables ( 0.6 times / day ) was less frequent than that of NNDFs ( 5.0 times / day ) ."
97557,day,O,3378.0,"Mean consumption of traditional meats ( 1.6 times / day ) , fruits ( 1 time / day ) and vegetables ( 0.6 times / day ) was less frequent than that of NNDFs ( 5.0 times / day ) ."
97558,),O,3378.0,"Mean consumption of traditional meats ( 1.6 times / day ) , fruits ( 1 time / day ) and vegetables ( 0.6 times / day ) was less frequent than that of NNDFs ( 5.0 times / day ) ."
97559,.,O,3378.0,"Mean consumption of traditional meats ( 1.6 times / day ) , fruits ( 1 time / day ) and vegetables ( 0.6 times / day ) was less frequent than that of NNDFs ( 5.0 times / day ) ."
97560,Nutritional,O,3379.0,Nutritional intervention strategies are needed to promote more frequent consumption of nutrient - rich foods and less frequent consumption of NNDFs in these Arctic communities .
97561,intervention,O,3379.0,Nutritional intervention strategies are needed to promote more frequent consumption of nutrient - rich foods and less frequent consumption of NNDFs in these Arctic communities .
97562,strategies,O,3379.0,Nutritional intervention strategies are needed to promote more frequent consumption of nutrient - rich foods and less frequent consumption of NNDFs in these Arctic communities .
97563,are,O,3379.0,Nutritional intervention strategies are needed to promote more frequent consumption of nutrient - rich foods and less frequent consumption of NNDFs in these Arctic communities .
97564,needed,O,3379.0,Nutritional intervention strategies are needed to promote more frequent consumption of nutrient - rich foods and less frequent consumption of NNDFs in these Arctic communities .
97565,to,O,3379.0,Nutritional intervention strategies are needed to promote more frequent consumption of nutrient - rich foods and less frequent consumption of NNDFs in these Arctic communities .
97566,promote,O,3379.0,Nutritional intervention strategies are needed to promote more frequent consumption of nutrient - rich foods and less frequent consumption of NNDFs in these Arctic communities .
97567,more,O,3379.0,Nutritional intervention strategies are needed to promote more frequent consumption of nutrient - rich foods and less frequent consumption of NNDFs in these Arctic communities .
97568,frequent,O,3379.0,Nutritional intervention strategies are needed to promote more frequent consumption of nutrient - rich foods and less frequent consumption of NNDFs in these Arctic communities .
97569,consumption,O,3379.0,Nutritional intervention strategies are needed to promote more frequent consumption of nutrient - rich foods and less frequent consumption of NNDFs in these Arctic communities .
97570,of,O,3379.0,Nutritional intervention strategies are needed to promote more frequent consumption of nutrient - rich foods and less frequent consumption of NNDFs in these Arctic communities .
97571,nutrient,O,3379.0,Nutritional intervention strategies are needed to promote more frequent consumption of nutrient - rich foods and less frequent consumption of NNDFs in these Arctic communities .
97572,-,O,3379.0,Nutritional intervention strategies are needed to promote more frequent consumption of nutrient - rich foods and less frequent consumption of NNDFs in these Arctic communities .
97573,rich,O,3379.0,Nutritional intervention strategies are needed to promote more frequent consumption of nutrient - rich foods and less frequent consumption of NNDFs in these Arctic communities .
97574,foods,O,3379.0,Nutritional intervention strategies are needed to promote more frequent consumption of nutrient - rich foods and less frequent consumption of NNDFs in these Arctic communities .
97575,and,O,3379.0,Nutritional intervention strategies are needed to promote more frequent consumption of nutrient - rich foods and less frequent consumption of NNDFs in these Arctic communities .
97576,less,O,3379.0,Nutritional intervention strategies are needed to promote more frequent consumption of nutrient - rich foods and less frequent consumption of NNDFs in these Arctic communities .
97577,frequent,O,3379.0,Nutritional intervention strategies are needed to promote more frequent consumption of nutrient - rich foods and less frequent consumption of NNDFs in these Arctic communities .
97578,consumption,O,3379.0,Nutritional intervention strategies are needed to promote more frequent consumption of nutrient - rich foods and less frequent consumption of NNDFs in these Arctic communities .
97579,of,O,3379.0,Nutritional intervention strategies are needed to promote more frequent consumption of nutrient - rich foods and less frequent consumption of NNDFs in these Arctic communities .
97580,NNDFs,O,3379.0,Nutritional intervention strategies are needed to promote more frequent consumption of nutrient - rich foods and less frequent consumption of NNDFs in these Arctic communities .
97581,in,O,3379.0,Nutritional intervention strategies are needed to promote more frequent consumption of nutrient - rich foods and less frequent consumption of NNDFs in these Arctic communities .
97582,these,O,3379.0,Nutritional intervention strategies are needed to promote more frequent consumption of nutrient - rich foods and less frequent consumption of NNDFs in these Arctic communities .
97583,Arctic,O,3379.0,Nutritional intervention strategies are needed to promote more frequent consumption of nutrient - rich foods and less frequent consumption of NNDFs in these Arctic communities .
97584,communities,O,3379.0,Nutritional intervention strategies are needed to promote more frequent consumption of nutrient - rich foods and less frequent consumption of NNDFs in these Arctic communities .
97585,.,O,3379.0,Nutritional intervention strategies are needed to promote more frequent consumption of nutrient - rich foods and less frequent consumption of NNDFs in these Arctic communities .
97586,Today,O,3380.0,"Today , tens of millions of elderly individuals worldwide suffer from dementia ."
97587,",",O,3380.0,"Today , tens of millions of elderly individuals worldwide suffer from dementia ."
97588,tens,O,3380.0,"Today , tens of millions of elderly individuals worldwide suffer from dementia ."
97589,of,O,3380.0,"Today , tens of millions of elderly individuals worldwide suffer from dementia ."
97590,millions,O,3380.0,"Today , tens of millions of elderly individuals worldwide suffer from dementia ."
97591,of,O,3380.0,"Today , tens of millions of elderly individuals worldwide suffer from dementia ."
97592,elderly,O,3380.0,"Today , tens of millions of elderly individuals worldwide suffer from dementia ."
97593,individuals,O,3380.0,"Today , tens of millions of elderly individuals worldwide suffer from dementia ."
97594,worldwide,O,3380.0,"Today , tens of millions of elderly individuals worldwide suffer from dementia ."
97595,suffer,O,3380.0,"Today , tens of millions of elderly individuals worldwide suffer from dementia ."
97596,from,O,3380.0,"Today , tens of millions of elderly individuals worldwide suffer from dementia ."
97597,dementia,O,3380.0,"Today , tens of millions of elderly individuals worldwide suffer from dementia ."
97598,.,O,3380.0,"Today , tens of millions of elderly individuals worldwide suffer from dementia ."
97599,While,O,3381.0,"While the pathogenesis of dementia is complex and incompletely understood , it may be , at least to a certain extent , the consequence of systemic vascular pathology ."
97600,the,O,3381.0,"While the pathogenesis of dementia is complex and incompletely understood , it may be , at least to a certain extent , the consequence of systemic vascular pathology ."
97601,pathogenesis,O,3381.0,"While the pathogenesis of dementia is complex and incompletely understood , it may be , at least to a certain extent , the consequence of systemic vascular pathology ."
97602,of,O,3381.0,"While the pathogenesis of dementia is complex and incompletely understood , it may be , at least to a certain extent , the consequence of systemic vascular pathology ."
97603,dementia,O,3381.0,"While the pathogenesis of dementia is complex and incompletely understood , it may be , at least to a certain extent , the consequence of systemic vascular pathology ."
97604,is,O,3381.0,"While the pathogenesis of dementia is complex and incompletely understood , it may be , at least to a certain extent , the consequence of systemic vascular pathology ."
97605,complex,O,3381.0,"While the pathogenesis of dementia is complex and incompletely understood , it may be , at least to a certain extent , the consequence of systemic vascular pathology ."
97606,and,O,3381.0,"While the pathogenesis of dementia is complex and incompletely understood , it may be , at least to a certain extent , the consequence of systemic vascular pathology ."
97607,incompletely,O,3381.0,"While the pathogenesis of dementia is complex and incompletely understood , it may be , at least to a certain extent , the consequence of systemic vascular pathology ."
97608,understood,O,3381.0,"While the pathogenesis of dementia is complex and incompletely understood , it may be , at least to a certain extent , the consequence of systemic vascular pathology ."
97609,",",O,3381.0,"While the pathogenesis of dementia is complex and incompletely understood , it may be , at least to a certain extent , the consequence of systemic vascular pathology ."
97610,it,O,3381.0,"While the pathogenesis of dementia is complex and incompletely understood , it may be , at least to a certain extent , the consequence of systemic vascular pathology ."
97611,may,O,3381.0,"While the pathogenesis of dementia is complex and incompletely understood , it may be , at least to a certain extent , the consequence of systemic vascular pathology ."
97612,be,O,3381.0,"While the pathogenesis of dementia is complex and incompletely understood , it may be , at least to a certain extent , the consequence of systemic vascular pathology ."
97613,",",O,3381.0,"While the pathogenesis of dementia is complex and incompletely understood , it may be , at least to a certain extent , the consequence of systemic vascular pathology ."
97614,at,O,3381.0,"While the pathogenesis of dementia is complex and incompletely understood , it may be , at least to a certain extent , the consequence of systemic vascular pathology ."
97615,least,O,3381.0,"While the pathogenesis of dementia is complex and incompletely understood , it may be , at least to a certain extent , the consequence of systemic vascular pathology ."
97616,to,O,3381.0,"While the pathogenesis of dementia is complex and incompletely understood , it may be , at least to a certain extent , the consequence of systemic vascular pathology ."
97617,a,O,3381.0,"While the pathogenesis of dementia is complex and incompletely understood , it may be , at least to a certain extent , the consequence of systemic vascular pathology ."
97618,certain,O,3381.0,"While the pathogenesis of dementia is complex and incompletely understood , it may be , at least to a certain extent , the consequence of systemic vascular pathology ."
97619,extent,O,3381.0,"While the pathogenesis of dementia is complex and incompletely understood , it may be , at least to a certain extent , the consequence of systemic vascular pathology ."
97620,",",O,3381.0,"While the pathogenesis of dementia is complex and incompletely understood , it may be , at least to a certain extent , the consequence of systemic vascular pathology ."
97621,the,O,3381.0,"While the pathogenesis of dementia is complex and incompletely understood , it may be , at least to a certain extent , the consequence of systemic vascular pathology ."
97622,consequence,O,3381.0,"While the pathogenesis of dementia is complex and incompletely understood , it may be , at least to a certain extent , the consequence of systemic vascular pathology ."
97623,of,O,3381.0,"While the pathogenesis of dementia is complex and incompletely understood , it may be , at least to a certain extent , the consequence of systemic vascular pathology ."
97624,systemic,O,3381.0,"While the pathogenesis of dementia is complex and incompletely understood , it may be , at least to a certain extent , the consequence of systemic vascular pathology ."
97625,vascular,O,3381.0,"While the pathogenesis of dementia is complex and incompletely understood , it may be , at least to a certain extent , the consequence of systemic vascular pathology ."
97626,pathology,O,3381.0,"While the pathogenesis of dementia is complex and incompletely understood , it may be , at least to a certain extent , the consequence of systemic vascular pathology ."
97627,.,O,3381.0,"While the pathogenesis of dementia is complex and incompletely understood , it may be , at least to a certain extent , the consequence of systemic vascular pathology ."
97628,The,O,3382.0,The metabolic syndrome and its individual components induce a proinflammatory state that damages blood vessels .
97629,metabolic,O,3382.0,The metabolic syndrome and its individual components induce a proinflammatory state that damages blood vessels .
97630,syndrome,O,3382.0,The metabolic syndrome and its individual components induce a proinflammatory state that damages blood vessels .
97631,and,O,3382.0,The metabolic syndrome and its individual components induce a proinflammatory state that damages blood vessels .
97632,its,O,3382.0,The metabolic syndrome and its individual components induce a proinflammatory state that damages blood vessels .
97633,individual,O,3382.0,The metabolic syndrome and its individual components induce a proinflammatory state that damages blood vessels .
97634,components,O,3382.0,The metabolic syndrome and its individual components induce a proinflammatory state that damages blood vessels .
97635,induce,O,3382.0,The metabolic syndrome and its individual components induce a proinflammatory state that damages blood vessels .
97636,a,O,3382.0,The metabolic syndrome and its individual components induce a proinflammatory state that damages blood vessels .
97637,proinflammatory,O,3382.0,The metabolic syndrome and its individual components induce a proinflammatory state that damages blood vessels .
97638,state,O,3382.0,The metabolic syndrome and its individual components induce a proinflammatory state that damages blood vessels .
97639,that,O,3382.0,The metabolic syndrome and its individual components induce a proinflammatory state that damages blood vessels .
97640,damages,O,3382.0,The metabolic syndrome and its individual components induce a proinflammatory state that damages blood vessels .
97641,blood,O,3382.0,The metabolic syndrome and its individual components induce a proinflammatory state that damages blood vessels .
97642,vessels,O,3382.0,The metabolic syndrome and its individual components induce a proinflammatory state that damages blood vessels .
97643,.,O,3382.0,The metabolic syndrome and its individual components induce a proinflammatory state that damages blood vessels .
97644,This,O,3383.0,This condition of chronic inflammation may damage the vasculature of the brain or be directly neurotoxic .
97645,condition,O,3383.0,This condition of chronic inflammation may damage the vasculature of the brain or be directly neurotoxic .
97646,of,O,3383.0,This condition of chronic inflammation may damage the vasculature of the brain or be directly neurotoxic .
97647,chronic,O,3383.0,This condition of chronic inflammation may damage the vasculature of the brain or be directly neurotoxic .
97648,inflammation,O,3383.0,This condition of chronic inflammation may damage the vasculature of the brain or be directly neurotoxic .
97649,may,O,3383.0,This condition of chronic inflammation may damage the vasculature of the brain or be directly neurotoxic .
97650,damage,O,3383.0,This condition of chronic inflammation may damage the vasculature of the brain or be directly neurotoxic .
97651,the,O,3383.0,This condition of chronic inflammation may damage the vasculature of the brain or be directly neurotoxic .
97652,vasculature,O,3383.0,This condition of chronic inflammation may damage the vasculature of the brain or be directly neurotoxic .
97653,of,O,3383.0,This condition of chronic inflammation may damage the vasculature of the brain or be directly neurotoxic .
97654,the,O,3383.0,This condition of chronic inflammation may damage the vasculature of the brain or be directly neurotoxic .
97655,brain,O,3383.0,This condition of chronic inflammation may damage the vasculature of the brain or be directly neurotoxic .
97656,or,O,3383.0,This condition of chronic inflammation may damage the vasculature of the brain or be directly neurotoxic .
97657,be,O,3383.0,This condition of chronic inflammation may damage the vasculature of the brain or be directly neurotoxic .
97658,directly,O,3383.0,This condition of chronic inflammation may damage the vasculature of the brain or be directly neurotoxic .
97659,neurotoxic,O,3383.0,This condition of chronic inflammation may damage the vasculature of the brain or be directly neurotoxic .
97660,.,O,3383.0,This condition of chronic inflammation may damage the vasculature of the brain or be directly neurotoxic .
97661,Associations,O,3384.0,"Associations have been established between the metabolic syndrome , its constituents and dementia ."
97662,have,O,3384.0,"Associations have been established between the metabolic syndrome , its constituents and dementia ."
97663,been,O,3384.0,"Associations have been established between the metabolic syndrome , its constituents and dementia ."
97664,established,O,3384.0,"Associations have been established between the metabolic syndrome , its constituents and dementia ."
97665,between,O,3384.0,"Associations have been established between the metabolic syndrome , its constituents and dementia ."
97666,the,O,3384.0,"Associations have been established between the metabolic syndrome , its constituents and dementia ."
97667,metabolic,O,3384.0,"Associations have been established between the metabolic syndrome , its constituents and dementia ."
97668,syndrome,O,3384.0,"Associations have been established between the metabolic syndrome , its constituents and dementia ."
97669,",",O,3384.0,"Associations have been established between the metabolic syndrome , its constituents and dementia ."
97670,its,O,3384.0,"Associations have been established between the metabolic syndrome , its constituents and dementia ."
97671,constituents,O,3384.0,"Associations have been established between the metabolic syndrome , its constituents and dementia ."
97672,and,O,3384.0,"Associations have been established between the metabolic syndrome , its constituents and dementia ."
97673,dementia,O,3384.0,"Associations have been established between the metabolic syndrome , its constituents and dementia ."
97674,.,O,3384.0,"Associations have been established between the metabolic syndrome , its constituents and dementia ."
97675,A,O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
97676,relationship,O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
97677,has,O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
97678,also,O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
97679,been,O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
97680,observed,O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
97681,between,O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
97682,certain,O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
97683,dietary,O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
97684,factors,O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
97685,",",O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
97686,such,O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
97687,as,O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
97688,constituents,O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
97689,of,O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
97690,the,O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
97691,',O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
97692,Mediterranean,O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
97693,diet,O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
97694,',O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
97695,",",O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
97696,and,O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
97697,the,O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
97698,metabolic,O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
97699,syndrome,O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
97700,;,O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
97701,similar,O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
97702,associations,O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
97703,have,O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
97704,been,O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
97705,noted,O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
97706,between,O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
97707,these,O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
97708,dietary,O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
97709,factors,O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
97710,and,O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
97711,dementia,O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
97712,.,O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
97713,Fruit,B-AG.01.ab,3386.0,Fruit juices and extracts are under investigation as treatments for cognitive impairment .
97714,juices,I-AG.01.ab,3386.0,Fruit juices and extracts are under investigation as treatments for cognitive impairment .
97715,and,O,3386.0,Fruit juices and extracts are under investigation as treatments for cognitive impairment .
97716,extracts,O,3386.0,Fruit juices and extracts are under investigation as treatments for cognitive impairment .
97717,are,O,3386.0,Fruit juices and extracts are under investigation as treatments for cognitive impairment .
97718,under,O,3386.0,Fruit juices and extracts are under investigation as treatments for cognitive impairment .
97719,investigation,O,3386.0,Fruit juices and extracts are under investigation as treatments for cognitive impairment .
97720,as,O,3386.0,Fruit juices and extracts are under investigation as treatments for cognitive impairment .
97721,treatments,O,3386.0,Fruit juices and extracts are under investigation as treatments for cognitive impairment .
97722,for,O,3386.0,Fruit juices and extracts are under investigation as treatments for cognitive impairment .
97723,cognitive,O,3386.0,Fruit juices and extracts are under investigation as treatments for cognitive impairment .
97724,impairment,O,3386.0,Fruit juices and extracts are under investigation as treatments for cognitive impairment .
97725,.,O,3386.0,Fruit juices and extracts are under investigation as treatments for cognitive impairment .
97726,Blueberry,B-AG.01.ab,3387.0,"Blueberry , strawberry , blackberry , grape and plum juices or extracts have been successfully tested in cognitively impaired rodents ."
97727,",",I-AG.01.ab,3387.0,"Blueberry , strawberry , blackberry , grape and plum juices or extracts have been successfully tested in cognitively impaired rodents ."
97728,strawberry,I-AG.01.ab,3387.0,"Blueberry , strawberry , blackberry , grape and plum juices or extracts have been successfully tested in cognitively impaired rodents ."
97729,",",I-AG.01.ab,3387.0,"Blueberry , strawberry , blackberry , grape and plum juices or extracts have been successfully tested in cognitively impaired rodents ."
97730,blackberry,I-AG.01.ab,3387.0,"Blueberry , strawberry , blackberry , grape and plum juices or extracts have been successfully tested in cognitively impaired rodents ."
97731,",",I-AG.01.ab,3387.0,"Blueberry , strawberry , blackberry , grape and plum juices or extracts have been successfully tested in cognitively impaired rodents ."
97732,grape,I-AG.01.ab,3387.0,"Blueberry , strawberry , blackberry , grape and plum juices or extracts have been successfully tested in cognitively impaired rodents ."
97733,and,I-AG.01.ab,3387.0,"Blueberry , strawberry , blackberry , grape and plum juices or extracts have been successfully tested in cognitively impaired rodents ."
97734,plum,I-AG.01.ab,3387.0,"Blueberry , strawberry , blackberry , grape and plum juices or extracts have been successfully tested in cognitively impaired rodents ."
97735,juices,I-AG.01.ab,3387.0,"Blueberry , strawberry , blackberry , grape and plum juices or extracts have been successfully tested in cognitively impaired rodents ."
97736,or,O,3387.0,"Blueberry , strawberry , blackberry , grape and plum juices or extracts have been successfully tested in cognitively impaired rodents ."
97737,extracts,O,3387.0,"Blueberry , strawberry , blackberry , grape and plum juices or extracts have been successfully tested in cognitively impaired rodents ."
97738,have,O,3387.0,"Blueberry , strawberry , blackberry , grape and plum juices or extracts have been successfully tested in cognitively impaired rodents ."
97739,been,O,3387.0,"Blueberry , strawberry , blackberry , grape and plum juices or extracts have been successfully tested in cognitively impaired rodents ."
97740,successfully,O,3387.0,"Blueberry , strawberry , blackberry , grape and plum juices or extracts have been successfully tested in cognitively impaired rodents ."
97741,tested,O,3387.0,"Blueberry , strawberry , blackberry , grape and plum juices or extracts have been successfully tested in cognitively impaired rodents ."
97742,in,O,3387.0,"Blueberry , strawberry , blackberry , grape and plum juices or extracts have been successfully tested in cognitively impaired rodents ."
97743,cognitively,O,3387.0,"Blueberry , strawberry , blackberry , grape and plum juices or extracts have been successfully tested in cognitively impaired rodents ."
97744,impaired,O,3387.0,"Blueberry , strawberry , blackberry , grape and plum juices or extracts have been successfully tested in cognitively impaired rodents ."
97745,rodents,O,3387.0,"Blueberry , strawberry , blackberry , grape and plum juices or extracts have been successfully tested in cognitively impaired rodents ."
97746,.,O,3387.0,"Blueberry , strawberry , blackberry , grape and plum juices or extracts have been successfully tested in cognitively impaired rodents ."
97747,Published,O,3388.0,Published trials of the benefits of grape and blueberry juice in the treatment of small numbers of cognitively impaired persons have recently appeared .
97748,trials,O,3388.0,Published trials of the benefits of grape and blueberry juice in the treatment of small numbers of cognitively impaired persons have recently appeared .
97749,of,O,3388.0,Published trials of the benefits of grape and blueberry juice in the treatment of small numbers of cognitively impaired persons have recently appeared .
97750,the,O,3388.0,Published trials of the benefits of grape and blueberry juice in the treatment of small numbers of cognitively impaired persons have recently appeared .
97751,benefits,O,3388.0,Published trials of the benefits of grape and blueberry juice in the treatment of small numbers of cognitively impaired persons have recently appeared .
97752,of,O,3388.0,Published trials of the benefits of grape and blueberry juice in the treatment of small numbers of cognitively impaired persons have recently appeared .
97753,grape,B-AG.01.ab,3388.0,Published trials of the benefits of grape and blueberry juice in the treatment of small numbers of cognitively impaired persons have recently appeared .
97754,and,I-AG.01.ab,3388.0,Published trials of the benefits of grape and blueberry juice in the treatment of small numbers of cognitively impaired persons have recently appeared .
97755,blueberry,I-AG.01.ab,3388.0,Published trials of the benefits of grape and blueberry juice in the treatment of small numbers of cognitively impaired persons have recently appeared .
97756,juice,I-AG.01.ab,3388.0,Published trials of the benefits of grape and blueberry juice in the treatment of small numbers of cognitively impaired persons have recently appeared .
97757,in,O,3388.0,Published trials of the benefits of grape and blueberry juice in the treatment of small numbers of cognitively impaired persons have recently appeared .
97758,the,O,3388.0,Published trials of the benefits of grape and blueberry juice in the treatment of small numbers of cognitively impaired persons have recently appeared .
97759,treatment,O,3388.0,Published trials of the benefits of grape and blueberry juice in the treatment of small numbers of cognitively impaired persons have recently appeared .
97760,of,O,3388.0,Published trials of the benefits of grape and blueberry juice in the treatment of small numbers of cognitively impaired persons have recently appeared .
97761,small,O,3388.0,Published trials of the benefits of grape and blueberry juice in the treatment of small numbers of cognitively impaired persons have recently appeared .
97762,numbers,O,3388.0,Published trials of the benefits of grape and blueberry juice in the treatment of small numbers of cognitively impaired persons have recently appeared .
97763,of,O,3388.0,Published trials of the benefits of grape and blueberry juice in the treatment of small numbers of cognitively impaired persons have recently appeared .
97764,cognitively,O,3388.0,Published trials of the benefits of grape and blueberry juice in the treatment of small numbers of cognitively impaired persons have recently appeared .
97765,impaired,O,3388.0,Published trials of the benefits of grape and blueberry juice in the treatment of small numbers of cognitively impaired persons have recently appeared .
97766,persons,O,3388.0,Published trials of the benefits of grape and blueberry juice in the treatment of small numbers of cognitively impaired persons have recently appeared .
97767,have,O,3388.0,Published trials of the benefits of grape and blueberry juice in the treatment of small numbers of cognitively impaired persons have recently appeared .
97768,recently,O,3388.0,Published trials of the benefits of grape and blueberry juice in the treatment of small numbers of cognitively impaired persons have recently appeared .
97769,appeared,O,3388.0,Published trials of the benefits of grape and blueberry juice in the treatment of small numbers of cognitively impaired persons have recently appeared .
97770,.,O,3388.0,Published trials of the benefits of grape and blueberry juice in the treatment of small numbers of cognitively impaired persons have recently appeared .
97771,The,O,3389.0,The benefits of fruit products are thought to be a result of its polyphenol content .
97772,benefits,O,3389.0,The benefits of fruit products are thought to be a result of its polyphenol content .
97773,of,O,3389.0,The benefits of fruit products are thought to be a result of its polyphenol content .
97774,fruit,B-AG.01.n.08,3389.0,The benefits of fruit products are thought to be a result of its polyphenol content .
97775,products,I-AG.01.n.08,3389.0,The benefits of fruit products are thought to be a result of its polyphenol content .
97776,are,O,3389.0,The benefits of fruit products are thought to be a result of its polyphenol content .
97777,thought,O,3389.0,The benefits of fruit products are thought to be a result of its polyphenol content .
97778,to,O,3389.0,The benefits of fruit products are thought to be a result of its polyphenol content .
97779,be,O,3389.0,The benefits of fruit products are thought to be a result of its polyphenol content .
97780,a,O,3389.0,The benefits of fruit products are thought to be a result of its polyphenol content .
97781,result,O,3389.0,The benefits of fruit products are thought to be a result of its polyphenol content .
97782,of,O,3389.0,The benefits of fruit products are thought to be a result of its polyphenol content .
97783,its,O,3389.0,The benefits of fruit products are thought to be a result of its polyphenol content .
97784,polyphenol,O,3389.0,The benefits of fruit products are thought to be a result of its polyphenol content .
97785,content,O,3389.0,The benefits of fruit products are thought to be a result of its polyphenol content .
97786,.,O,3389.0,The benefits of fruit products are thought to be a result of its polyphenol content .
97787,A,O,3390.0,"A grape polyphenol found in grapes , resveratrol , now being studied in humans , and one in grapes and blueberries , pterostilbene , have been found to improve cognition in rodents ."
97788,grape,O,3390.0,"A grape polyphenol found in grapes , resveratrol , now being studied in humans , and one in grapes and blueberries , pterostilbene , have been found to improve cognition in rodents ."
97789,polyphenol,O,3390.0,"A grape polyphenol found in grapes , resveratrol , now being studied in humans , and one in grapes and blueberries , pterostilbene , have been found to improve cognition in rodents ."
97790,found,O,3390.0,"A grape polyphenol found in grapes , resveratrol , now being studied in humans , and one in grapes and blueberries , pterostilbene , have been found to improve cognition in rodents ."
97791,in,O,3390.0,"A grape polyphenol found in grapes , resveratrol , now being studied in humans , and one in grapes and blueberries , pterostilbene , have been found to improve cognition in rodents ."
97792,grapes,B-AG.01.h.01.b,3390.0,"A grape polyphenol found in grapes , resveratrol , now being studied in humans , and one in grapes and blueberries , pterostilbene , have been found to improve cognition in rodents ."
97793,",",O,3390.0,"A grape polyphenol found in grapes , resveratrol , now being studied in humans , and one in grapes and blueberries , pterostilbene , have been found to improve cognition in rodents ."
97794,resveratrol,O,3390.0,"A grape polyphenol found in grapes , resveratrol , now being studied in humans , and one in grapes and blueberries , pterostilbene , have been found to improve cognition in rodents ."
97795,",",O,3390.0,"A grape polyphenol found in grapes , resveratrol , now being studied in humans , and one in grapes and blueberries , pterostilbene , have been found to improve cognition in rodents ."
97796,now,O,3390.0,"A grape polyphenol found in grapes , resveratrol , now being studied in humans , and one in grapes and blueberries , pterostilbene , have been found to improve cognition in rodents ."
97797,being,O,3390.0,"A grape polyphenol found in grapes , resveratrol , now being studied in humans , and one in grapes and blueberries , pterostilbene , have been found to improve cognition in rodents ."
97798,studied,O,3390.0,"A grape polyphenol found in grapes , resveratrol , now being studied in humans , and one in grapes and blueberries , pterostilbene , have been found to improve cognition in rodents ."
97799,in,O,3390.0,"A grape polyphenol found in grapes , resveratrol , now being studied in humans , and one in grapes and blueberries , pterostilbene , have been found to improve cognition in rodents ."
97800,humans,O,3390.0,"A grape polyphenol found in grapes , resveratrol , now being studied in humans , and one in grapes and blueberries , pterostilbene , have been found to improve cognition in rodents ."
97801,",",O,3390.0,"A grape polyphenol found in grapes , resveratrol , now being studied in humans , and one in grapes and blueberries , pterostilbene , have been found to improve cognition in rodents ."
97802,and,O,3390.0,"A grape polyphenol found in grapes , resveratrol , now being studied in humans , and one in grapes and blueberries , pterostilbene , have been found to improve cognition in rodents ."
97803,one,O,3390.0,"A grape polyphenol found in grapes , resveratrol , now being studied in humans , and one in grapes and blueberries , pterostilbene , have been found to improve cognition in rodents ."
97804,in,O,3390.0,"A grape polyphenol found in grapes , resveratrol , now being studied in humans , and one in grapes and blueberries , pterostilbene , have been found to improve cognition in rodents ."
97805,grapes,B-AG.01.h.01.b,3390.0,"A grape polyphenol found in grapes , resveratrol , now being studied in humans , and one in grapes and blueberries , pterostilbene , have been found to improve cognition in rodents ."
97806,and,O,3390.0,"A grape polyphenol found in grapes , resveratrol , now being studied in humans , and one in grapes and blueberries , pterostilbene , have been found to improve cognition in rodents ."
97807,blueberries,B-AG.01.h.01.b,3390.0,"A grape polyphenol found in grapes , resveratrol , now being studied in humans , and one in grapes and blueberries , pterostilbene , have been found to improve cognition in rodents ."
97808,",",O,3390.0,"A grape polyphenol found in grapes , resveratrol , now being studied in humans , and one in grapes and blueberries , pterostilbene , have been found to improve cognition in rodents ."
97809,pterostilbene,O,3390.0,"A grape polyphenol found in grapes , resveratrol , now being studied in humans , and one in grapes and blueberries , pterostilbene , have been found to improve cognition in rodents ."
97810,",",O,3390.0,"A grape polyphenol found in grapes , resveratrol , now being studied in humans , and one in grapes and blueberries , pterostilbene , have been found to improve cognition in rodents ."
97811,have,O,3390.0,"A grape polyphenol found in grapes , resveratrol , now being studied in humans , and one in grapes and blueberries , pterostilbene , have been found to improve cognition in rodents ."
97812,been,O,3390.0,"A grape polyphenol found in grapes , resveratrol , now being studied in humans , and one in grapes and blueberries , pterostilbene , have been found to improve cognition in rodents ."
97813,found,O,3390.0,"A grape polyphenol found in grapes , resveratrol , now being studied in humans , and one in grapes and blueberries , pterostilbene , have been found to improve cognition in rodents ."
97814,to,O,3390.0,"A grape polyphenol found in grapes , resveratrol , now being studied in humans , and one in grapes and blueberries , pterostilbene , have been found to improve cognition in rodents ."
97815,improve,O,3390.0,"A grape polyphenol found in grapes , resveratrol , now being studied in humans , and one in grapes and blueberries , pterostilbene , have been found to improve cognition in rodents ."
97816,cognition,O,3390.0,"A grape polyphenol found in grapes , resveratrol , now being studied in humans , and one in grapes and blueberries , pterostilbene , have been found to improve cognition in rodents ."
97817,in,O,3390.0,"A grape polyphenol found in grapes , resveratrol , now being studied in humans , and one in grapes and blueberries , pterostilbene , have been found to improve cognition in rodents ."
97818,rodents,O,3390.0,"A grape polyphenol found in grapes , resveratrol , now being studied in humans , and one in grapes and blueberries , pterostilbene , have been found to improve cognition in rodents ."
97819,.,O,3390.0,"A grape polyphenol found in grapes , resveratrol , now being studied in humans , and one in grapes and blueberries , pterostilbene , have been found to improve cognition in rodents ."
97820,In,O,3391.0,"In the design of future human trials , one ought to consider the poor bioavailability of these products , the possible need to initiate the experimental therapy long before the onset of symptoms , and currently limited knowledge about the appropriate form ( e.g. juice , powder or individual polyphenol ) of treatment ."
97821,the,O,3391.0,"In the design of future human trials , one ought to consider the poor bioavailability of these products , the possible need to initiate the experimental therapy long before the onset of symptoms , and currently limited knowledge about the appropriate form ( e.g. juice , powder or individual polyphenol ) of treatment ."
97822,design,O,3391.0,"In the design of future human trials , one ought to consider the poor bioavailability of these products , the possible need to initiate the experimental therapy long before the onset of symptoms , and currently limited knowledge about the appropriate form ( e.g. juice , powder or individual polyphenol ) of treatment ."
97823,of,O,3391.0,"In the design of future human trials , one ought to consider the poor bioavailability of these products , the possible need to initiate the experimental therapy long before the onset of symptoms , and currently limited knowledge about the appropriate form ( e.g. juice , powder or individual polyphenol ) of treatment ."
97824,future,O,3391.0,"In the design of future human trials , one ought to consider the poor bioavailability of these products , the possible need to initiate the experimental therapy long before the onset of symptoms , and currently limited knowledge about the appropriate form ( e.g. juice , powder or individual polyphenol ) of treatment ."
97825,human,O,3391.0,"In the design of future human trials , one ought to consider the poor bioavailability of these products , the possible need to initiate the experimental therapy long before the onset of symptoms , and currently limited knowledge about the appropriate form ( e.g. juice , powder or individual polyphenol ) of treatment ."
97826,trials,O,3391.0,"In the design of future human trials , one ought to consider the poor bioavailability of these products , the possible need to initiate the experimental therapy long before the onset of symptoms , and currently limited knowledge about the appropriate form ( e.g. juice , powder or individual polyphenol ) of treatment ."
97827,",",O,3391.0,"In the design of future human trials , one ought to consider the poor bioavailability of these products , the possible need to initiate the experimental therapy long before the onset of symptoms , and currently limited knowledge about the appropriate form ( e.g. juice , powder or individual polyphenol ) of treatment ."
97828,one,O,3391.0,"In the design of future human trials , one ought to consider the poor bioavailability of these products , the possible need to initiate the experimental therapy long before the onset of symptoms , and currently limited knowledge about the appropriate form ( e.g. juice , powder or individual polyphenol ) of treatment ."
97829,ought,O,3391.0,"In the design of future human trials , one ought to consider the poor bioavailability of these products , the possible need to initiate the experimental therapy long before the onset of symptoms , and currently limited knowledge about the appropriate form ( e.g. juice , powder or individual polyphenol ) of treatment ."
97830,to,O,3391.0,"In the design of future human trials , one ought to consider the poor bioavailability of these products , the possible need to initiate the experimental therapy long before the onset of symptoms , and currently limited knowledge about the appropriate form ( e.g. juice , powder or individual polyphenol ) of treatment ."
97831,consider,O,3391.0,"In the design of future human trials , one ought to consider the poor bioavailability of these products , the possible need to initiate the experimental therapy long before the onset of symptoms , and currently limited knowledge about the appropriate form ( e.g. juice , powder or individual polyphenol ) of treatment ."
97832,the,O,3391.0,"In the design of future human trials , one ought to consider the poor bioavailability of these products , the possible need to initiate the experimental therapy long before the onset of symptoms , and currently limited knowledge about the appropriate form ( e.g. juice , powder or individual polyphenol ) of treatment ."
97833,poor,O,3391.0,"In the design of future human trials , one ought to consider the poor bioavailability of these products , the possible need to initiate the experimental therapy long before the onset of symptoms , and currently limited knowledge about the appropriate form ( e.g. juice , powder or individual polyphenol ) of treatment ."
97834,bioavailability,O,3391.0,"In the design of future human trials , one ought to consider the poor bioavailability of these products , the possible need to initiate the experimental therapy long before the onset of symptoms , and currently limited knowledge about the appropriate form ( e.g. juice , powder or individual polyphenol ) of treatment ."
97835,of,O,3391.0,"In the design of future human trials , one ought to consider the poor bioavailability of these products , the possible need to initiate the experimental therapy long before the onset of symptoms , and currently limited knowledge about the appropriate form ( e.g. juice , powder or individual polyphenol ) of treatment ."
97836,these,O,3391.0,"In the design of future human trials , one ought to consider the poor bioavailability of these products , the possible need to initiate the experimental therapy long before the onset of symptoms , and currently limited knowledge about the appropriate form ( e.g. juice , powder or individual polyphenol ) of treatment ."
97837,products,O,3391.0,"In the design of future human trials , one ought to consider the poor bioavailability of these products , the possible need to initiate the experimental therapy long before the onset of symptoms , and currently limited knowledge about the appropriate form ( e.g. juice , powder or individual polyphenol ) of treatment ."
97838,",",O,3391.0,"In the design of future human trials , one ought to consider the poor bioavailability of these products , the possible need to initiate the experimental therapy long before the onset of symptoms , and currently limited knowledge about the appropriate form ( e.g. juice , powder or individual polyphenol ) of treatment ."
97839,the,O,3391.0,"In the design of future human trials , one ought to consider the poor bioavailability of these products , the possible need to initiate the experimental therapy long before the onset of symptoms , and currently limited knowledge about the appropriate form ( e.g. juice , powder or individual polyphenol ) of treatment ."
97840,possible,O,3391.0,"In the design of future human trials , one ought to consider the poor bioavailability of these products , the possible need to initiate the experimental therapy long before the onset of symptoms , and currently limited knowledge about the appropriate form ( e.g. juice , powder or individual polyphenol ) of treatment ."
97841,need,O,3391.0,"In the design of future human trials , one ought to consider the poor bioavailability of these products , the possible need to initiate the experimental therapy long before the onset of symptoms , and currently limited knowledge about the appropriate form ( e.g. juice , powder or individual polyphenol ) of treatment ."
97842,to,O,3391.0,"In the design of future human trials , one ought to consider the poor bioavailability of these products , the possible need to initiate the experimental therapy long before the onset of symptoms , and currently limited knowledge about the appropriate form ( e.g. juice , powder or individual polyphenol ) of treatment ."
97843,initiate,O,3391.0,"In the design of future human trials , one ought to consider the poor bioavailability of these products , the possible need to initiate the experimental therapy long before the onset of symptoms , and currently limited knowledge about the appropriate form ( e.g. juice , powder or individual polyphenol ) of treatment ."
97844,the,O,3391.0,"In the design of future human trials , one ought to consider the poor bioavailability of these products , the possible need to initiate the experimental therapy long before the onset of symptoms , and currently limited knowledge about the appropriate form ( e.g. juice , powder or individual polyphenol ) of treatment ."
97845,experimental,O,3391.0,"In the design of future human trials , one ought to consider the poor bioavailability of these products , the possible need to initiate the experimental therapy long before the onset of symptoms , and currently limited knowledge about the appropriate form ( e.g. juice , powder or individual polyphenol ) of treatment ."
97846,therapy,O,3391.0,"In the design of future human trials , one ought to consider the poor bioavailability of these products , the possible need to initiate the experimental therapy long before the onset of symptoms , and currently limited knowledge about the appropriate form ( e.g. juice , powder or individual polyphenol ) of treatment ."
97847,long,O,3391.0,"In the design of future human trials , one ought to consider the poor bioavailability of these products , the possible need to initiate the experimental therapy long before the onset of symptoms , and currently limited knowledge about the appropriate form ( e.g. juice , powder or individual polyphenol ) of treatment ."
97848,before,O,3391.0,"In the design of future human trials , one ought to consider the poor bioavailability of these products , the possible need to initiate the experimental therapy long before the onset of symptoms , and currently limited knowledge about the appropriate form ( e.g. juice , powder or individual polyphenol ) of treatment ."
97849,the,O,3391.0,"In the design of future human trials , one ought to consider the poor bioavailability of these products , the possible need to initiate the experimental therapy long before the onset of symptoms , and currently limited knowledge about the appropriate form ( e.g. juice , powder or individual polyphenol ) of treatment ."
97850,onset,O,3391.0,"In the design of future human trials , one ought to consider the poor bioavailability of these products , the possible need to initiate the experimental therapy long before the onset of symptoms , and currently limited knowledge about the appropriate form ( e.g. juice , powder or individual polyphenol ) of treatment ."
97851,of,O,3391.0,"In the design of future human trials , one ought to consider the poor bioavailability of these products , the possible need to initiate the experimental therapy long before the onset of symptoms , and currently limited knowledge about the appropriate form ( e.g. juice , powder or individual polyphenol ) of treatment ."
97852,symptoms,O,3391.0,"In the design of future human trials , one ought to consider the poor bioavailability of these products , the possible need to initiate the experimental therapy long before the onset of symptoms , and currently limited knowledge about the appropriate form ( e.g. juice , powder or individual polyphenol ) of treatment ."
97853,",",O,3391.0,"In the design of future human trials , one ought to consider the poor bioavailability of these products , the possible need to initiate the experimental therapy long before the onset of symptoms , and currently limited knowledge about the appropriate form ( e.g. juice , powder or individual polyphenol ) of treatment ."
97854,and,O,3391.0,"In the design of future human trials , one ought to consider the poor bioavailability of these products , the possible need to initiate the experimental therapy long before the onset of symptoms , and currently limited knowledge about the appropriate form ( e.g. juice , powder or individual polyphenol ) of treatment ."
97855,currently,O,3391.0,"In the design of future human trials , one ought to consider the poor bioavailability of these products , the possible need to initiate the experimental therapy long before the onset of symptoms , and currently limited knowledge about the appropriate form ( e.g. juice , powder or individual polyphenol ) of treatment ."
97856,limited,O,3391.0,"In the design of future human trials , one ought to consider the poor bioavailability of these products , the possible need to initiate the experimental therapy long before the onset of symptoms , and currently limited knowledge about the appropriate form ( e.g. juice , powder or individual polyphenol ) of treatment ."
97857,knowledge,O,3391.0,"In the design of future human trials , one ought to consider the poor bioavailability of these products , the possible need to initiate the experimental therapy long before the onset of symptoms , and currently limited knowledge about the appropriate form ( e.g. juice , powder or individual polyphenol ) of treatment ."
97858,about,O,3391.0,"In the design of future human trials , one ought to consider the poor bioavailability of these products , the possible need to initiate the experimental therapy long before the onset of symptoms , and currently limited knowledge about the appropriate form ( e.g. juice , powder or individual polyphenol ) of treatment ."
97859,the,O,3391.0,"In the design of future human trials , one ought to consider the poor bioavailability of these products , the possible need to initiate the experimental therapy long before the onset of symptoms , and currently limited knowledge about the appropriate form ( e.g. juice , powder or individual polyphenol ) of treatment ."
97860,appropriate,O,3391.0,"In the design of future human trials , one ought to consider the poor bioavailability of these products , the possible need to initiate the experimental therapy long before the onset of symptoms , and currently limited knowledge about the appropriate form ( e.g. juice , powder or individual polyphenol ) of treatment ."
97861,form,O,3391.0,"In the design of future human trials , one ought to consider the poor bioavailability of these products , the possible need to initiate the experimental therapy long before the onset of symptoms , and currently limited knowledge about the appropriate form ( e.g. juice , powder or individual polyphenol ) of treatment ."
97862,(,O,3391.0,"In the design of future human trials , one ought to consider the poor bioavailability of these products , the possible need to initiate the experimental therapy long before the onset of symptoms , and currently limited knowledge about the appropriate form ( e.g. juice , powder or individual polyphenol ) of treatment ."
97863,e.g.,O,3391.0,"In the design of future human trials , one ought to consider the poor bioavailability of these products , the possible need to initiate the experimental therapy long before the onset of symptoms , and currently limited knowledge about the appropriate form ( e.g. juice , powder or individual polyphenol ) of treatment ."
97864,juice,B-AG.01.ab,3391.0,"In the design of future human trials , one ought to consider the poor bioavailability of these products , the possible need to initiate the experimental therapy long before the onset of symptoms , and currently limited knowledge about the appropriate form ( e.g. juice , powder or individual polyphenol ) of treatment ."
97865,",",O,3391.0,"In the design of future human trials , one ought to consider the poor bioavailability of these products , the possible need to initiate the experimental therapy long before the onset of symptoms , and currently limited knowledge about the appropriate form ( e.g. juice , powder or individual polyphenol ) of treatment ."
97866,powder,O,3391.0,"In the design of future human trials , one ought to consider the poor bioavailability of these products , the possible need to initiate the experimental therapy long before the onset of symptoms , and currently limited knowledge about the appropriate form ( e.g. juice , powder or individual polyphenol ) of treatment ."
97867,or,O,3391.0,"In the design of future human trials , one ought to consider the poor bioavailability of these products , the possible need to initiate the experimental therapy long before the onset of symptoms , and currently limited knowledge about the appropriate form ( e.g. juice , powder or individual polyphenol ) of treatment ."
97868,individual,O,3391.0,"In the design of future human trials , one ought to consider the poor bioavailability of these products , the possible need to initiate the experimental therapy long before the onset of symptoms , and currently limited knowledge about the appropriate form ( e.g. juice , powder or individual polyphenol ) of treatment ."
97869,polyphenol,O,3391.0,"In the design of future human trials , one ought to consider the poor bioavailability of these products , the possible need to initiate the experimental therapy long before the onset of symptoms , and currently limited knowledge about the appropriate form ( e.g. juice , powder or individual polyphenol ) of treatment ."
97870,),O,3391.0,"In the design of future human trials , one ought to consider the poor bioavailability of these products , the possible need to initiate the experimental therapy long before the onset of symptoms , and currently limited knowledge about the appropriate form ( e.g. juice , powder or individual polyphenol ) of treatment ."
97871,of,O,3391.0,"In the design of future human trials , one ought to consider the poor bioavailability of these products , the possible need to initiate the experimental therapy long before the onset of symptoms , and currently limited knowledge about the appropriate form ( e.g. juice , powder or individual polyphenol ) of treatment ."
97872,treatment,O,3391.0,"In the design of future human trials , one ought to consider the poor bioavailability of these products , the possible need to initiate the experimental therapy long before the onset of symptoms , and currently limited knowledge about the appropriate form ( e.g. juice , powder or individual polyphenol ) of treatment ."
97873,.,O,3391.0,"In the design of future human trials , one ought to consider the poor bioavailability of these products , the possible need to initiate the experimental therapy long before the onset of symptoms , and currently limited knowledge about the appropriate form ( e.g. juice , powder or individual polyphenol ) of treatment ."
97874,Among,O,3392.0,"Among adult patients with bronchial asthma and/or allergic rhinitis undergoing allergological investigation with skin test , nasal provocation test and RAST , 1129 answered a questionaire regarding food sensitivity ( FS ) ."
97875,adult,O,3392.0,"Among adult patients with bronchial asthma and/or allergic rhinitis undergoing allergological investigation with skin test , nasal provocation test and RAST , 1129 answered a questionaire regarding food sensitivity ( FS ) ."
97876,patients,O,3392.0,"Among adult patients with bronchial asthma and/or allergic rhinitis undergoing allergological investigation with skin test , nasal provocation test and RAST , 1129 answered a questionaire regarding food sensitivity ( FS ) ."
97877,with,O,3392.0,"Among adult patients with bronchial asthma and/or allergic rhinitis undergoing allergological investigation with skin test , nasal provocation test and RAST , 1129 answered a questionaire regarding food sensitivity ( FS ) ."
97878,bronchial,O,3392.0,"Among adult patients with bronchial asthma and/or allergic rhinitis undergoing allergological investigation with skin test , nasal provocation test and RAST , 1129 answered a questionaire regarding food sensitivity ( FS ) ."
97879,asthma,O,3392.0,"Among adult patients with bronchial asthma and/or allergic rhinitis undergoing allergological investigation with skin test , nasal provocation test and RAST , 1129 answered a questionaire regarding food sensitivity ( FS ) ."
97880,and/or,O,3392.0,"Among adult patients with bronchial asthma and/or allergic rhinitis undergoing allergological investigation with skin test , nasal provocation test and RAST , 1129 answered a questionaire regarding food sensitivity ( FS ) ."
97881,allergic,O,3392.0,"Among adult patients with bronchial asthma and/or allergic rhinitis undergoing allergological investigation with skin test , nasal provocation test and RAST , 1129 answered a questionaire regarding food sensitivity ( FS ) ."
97882,rhinitis,O,3392.0,"Among adult patients with bronchial asthma and/or allergic rhinitis undergoing allergological investigation with skin test , nasal provocation test and RAST , 1129 answered a questionaire regarding food sensitivity ( FS ) ."
97883,undergoing,O,3392.0,"Among adult patients with bronchial asthma and/or allergic rhinitis undergoing allergological investigation with skin test , nasal provocation test and RAST , 1129 answered a questionaire regarding food sensitivity ( FS ) ."
97884,allergological,O,3392.0,"Among adult patients with bronchial asthma and/or allergic rhinitis undergoing allergological investigation with skin test , nasal provocation test and RAST , 1129 answered a questionaire regarding food sensitivity ( FS ) ."
97885,investigation,O,3392.0,"Among adult patients with bronchial asthma and/or allergic rhinitis undergoing allergological investigation with skin test , nasal provocation test and RAST , 1129 answered a questionaire regarding food sensitivity ( FS ) ."
97886,with,O,3392.0,"Among adult patients with bronchial asthma and/or allergic rhinitis undergoing allergological investigation with skin test , nasal provocation test and RAST , 1129 answered a questionaire regarding food sensitivity ( FS ) ."
97887,skin,O,3392.0,"Among adult patients with bronchial asthma and/or allergic rhinitis undergoing allergological investigation with skin test , nasal provocation test and RAST , 1129 answered a questionaire regarding food sensitivity ( FS ) ."
97888,test,O,3392.0,"Among adult patients with bronchial asthma and/or allergic rhinitis undergoing allergological investigation with skin test , nasal provocation test and RAST , 1129 answered a questionaire regarding food sensitivity ( FS ) ."
97889,",",O,3392.0,"Among adult patients with bronchial asthma and/or allergic rhinitis undergoing allergological investigation with skin test , nasal provocation test and RAST , 1129 answered a questionaire regarding food sensitivity ( FS ) ."
97890,nasal,O,3392.0,"Among adult patients with bronchial asthma and/or allergic rhinitis undergoing allergological investigation with skin test , nasal provocation test and RAST , 1129 answered a questionaire regarding food sensitivity ( FS ) ."
97891,provocation,O,3392.0,"Among adult patients with bronchial asthma and/or allergic rhinitis undergoing allergological investigation with skin test , nasal provocation test and RAST , 1129 answered a questionaire regarding food sensitivity ( FS ) ."
97892,test,O,3392.0,"Among adult patients with bronchial asthma and/or allergic rhinitis undergoing allergological investigation with skin test , nasal provocation test and RAST , 1129 answered a questionaire regarding food sensitivity ( FS ) ."
97893,and,O,3392.0,"Among adult patients with bronchial asthma and/or allergic rhinitis undergoing allergological investigation with skin test , nasal provocation test and RAST , 1129 answered a questionaire regarding food sensitivity ( FS ) ."
97894,RAST,O,3392.0,"Among adult patients with bronchial asthma and/or allergic rhinitis undergoing allergological investigation with skin test , nasal provocation test and RAST , 1129 answered a questionaire regarding food sensitivity ( FS ) ."
97895,",",O,3392.0,"Among adult patients with bronchial asthma and/or allergic rhinitis undergoing allergological investigation with skin test , nasal provocation test and RAST , 1129 answered a questionaire regarding food sensitivity ( FS ) ."
97896,1129,O,3392.0,"Among adult patients with bronchial asthma and/or allergic rhinitis undergoing allergological investigation with skin test , nasal provocation test and RAST , 1129 answered a questionaire regarding food sensitivity ( FS ) ."
97897,answered,O,3392.0,"Among adult patients with bronchial asthma and/or allergic rhinitis undergoing allergological investigation with skin test , nasal provocation test and RAST , 1129 answered a questionaire regarding food sensitivity ( FS ) ."
97898,a,O,3392.0,"Among adult patients with bronchial asthma and/or allergic rhinitis undergoing allergological investigation with skin test , nasal provocation test and RAST , 1129 answered a questionaire regarding food sensitivity ( FS ) ."
97899,questionaire,O,3392.0,"Among adult patients with bronchial asthma and/or allergic rhinitis undergoing allergological investigation with skin test , nasal provocation test and RAST , 1129 answered a questionaire regarding food sensitivity ( FS ) ."
97900,regarding,O,3392.0,"Among adult patients with bronchial asthma and/or allergic rhinitis undergoing allergological investigation with skin test , nasal provocation test and RAST , 1129 answered a questionaire regarding food sensitivity ( FS ) ."
97901,food,O,3392.0,"Among adult patients with bronchial asthma and/or allergic rhinitis undergoing allergological investigation with skin test , nasal provocation test and RAST , 1129 answered a questionaire regarding food sensitivity ( FS ) ."
97902,sensitivity,O,3392.0,"Among adult patients with bronchial asthma and/or allergic rhinitis undergoing allergological investigation with skin test , nasal provocation test and RAST , 1129 answered a questionaire regarding food sensitivity ( FS ) ."
97903,(,O,3392.0,"Among adult patients with bronchial asthma and/or allergic rhinitis undergoing allergological investigation with skin test , nasal provocation test and RAST , 1129 answered a questionaire regarding food sensitivity ( FS ) ."
97904,FS,O,3392.0,"Among adult patients with bronchial asthma and/or allergic rhinitis undergoing allergological investigation with skin test , nasal provocation test and RAST , 1129 answered a questionaire regarding food sensitivity ( FS ) ."
97905,),O,3392.0,"Among adult patients with bronchial asthma and/or allergic rhinitis undergoing allergological investigation with skin test , nasal provocation test and RAST , 1129 answered a questionaire regarding food sensitivity ( FS ) ."
97906,.,O,3392.0,"Among adult patients with bronchial asthma and/or allergic rhinitis undergoing allergological investigation with skin test , nasal provocation test and RAST , 1129 answered a questionaire regarding food sensitivity ( FS ) ."
97907,276,O,3393.0,"276 ( 24 % ) of the patients reported some kind of allergic symptoms on eating or handling various foods , of which hazel nut , apple and shell fish were the most often named ."
97908,(,O,3393.0,"276 ( 24 % ) of the patients reported some kind of allergic symptoms on eating or handling various foods , of which hazel nut , apple and shell fish were the most often named ."
97909,24,O,3393.0,"276 ( 24 % ) of the patients reported some kind of allergic symptoms on eating or handling various foods , of which hazel nut , apple and shell fish were the most often named ."
97910,%,O,3393.0,"276 ( 24 % ) of the patients reported some kind of allergic symptoms on eating or handling various foods , of which hazel nut , apple and shell fish were the most often named ."
97911,),O,3393.0,"276 ( 24 % ) of the patients reported some kind of allergic symptoms on eating or handling various foods , of which hazel nut , apple and shell fish were the most often named ."
97912,of,O,3393.0,"276 ( 24 % ) of the patients reported some kind of allergic symptoms on eating or handling various foods , of which hazel nut , apple and shell fish were the most often named ."
97913,the,O,3393.0,"276 ( 24 % ) of the patients reported some kind of allergic symptoms on eating or handling various foods , of which hazel nut , apple and shell fish were the most often named ."
97914,patients,O,3393.0,"276 ( 24 % ) of the patients reported some kind of allergic symptoms on eating or handling various foods , of which hazel nut , apple and shell fish were the most often named ."
97915,reported,O,3393.0,"276 ( 24 % ) of the patients reported some kind of allergic symptoms on eating or handling various foods , of which hazel nut , apple and shell fish were the most often named ."
97916,some,O,3393.0,"276 ( 24 % ) of the patients reported some kind of allergic symptoms on eating or handling various foods , of which hazel nut , apple and shell fish were the most often named ."
97917,kind,O,3393.0,"276 ( 24 % ) of the patients reported some kind of allergic symptoms on eating or handling various foods , of which hazel nut , apple and shell fish were the most often named ."
97918,of,O,3393.0,"276 ( 24 % ) of the patients reported some kind of allergic symptoms on eating or handling various foods , of which hazel nut , apple and shell fish were the most often named ."
97919,allergic,O,3393.0,"276 ( 24 % ) of the patients reported some kind of allergic symptoms on eating or handling various foods , of which hazel nut , apple and shell fish were the most often named ."
97920,symptoms,O,3393.0,"276 ( 24 % ) of the patients reported some kind of allergic symptoms on eating or handling various foods , of which hazel nut , apple and shell fish were the most often named ."
97921,on,O,3393.0,"276 ( 24 % ) of the patients reported some kind of allergic symptoms on eating or handling various foods , of which hazel nut , apple and shell fish were the most often named ."
97922,eating,O,3393.0,"276 ( 24 % ) of the patients reported some kind of allergic symptoms on eating or handling various foods , of which hazel nut , apple and shell fish were the most often named ."
97923,or,O,3393.0,"276 ( 24 % ) of the patients reported some kind of allergic symptoms on eating or handling various foods , of which hazel nut , apple and shell fish were the most often named ."
97924,handling,O,3393.0,"276 ( 24 % ) of the patients reported some kind of allergic symptoms on eating or handling various foods , of which hazel nut , apple and shell fish were the most often named ."
97925,various,O,3393.0,"276 ( 24 % ) of the patients reported some kind of allergic symptoms on eating or handling various foods , of which hazel nut , apple and shell fish were the most often named ."
97926,foods,O,3393.0,"276 ( 24 % ) of the patients reported some kind of allergic symptoms on eating or handling various foods , of which hazel nut , apple and shell fish were the most often named ."
97927,",",O,3393.0,"276 ( 24 % ) of the patients reported some kind of allergic symptoms on eating or handling various foods , of which hazel nut , apple and shell fish were the most often named ."
97928,of,O,3393.0,"276 ( 24 % ) of the patients reported some kind of allergic symptoms on eating or handling various foods , of which hazel nut , apple and shell fish were the most often named ."
97929,which,O,3393.0,"276 ( 24 % ) of the patients reported some kind of allergic symptoms on eating or handling various foods , of which hazel nut , apple and shell fish were the most often named ."
97930,hazel,B-AG.01.h.01.f,3393.0,"276 ( 24 % ) of the patients reported some kind of allergic symptoms on eating or handling various foods , of which hazel nut , apple and shell fish were the most often named ."
97931,nut,I-AG.01.h.01.f,3393.0,"276 ( 24 % ) of the patients reported some kind of allergic symptoms on eating or handling various foods , of which hazel nut , apple and shell fish were the most often named ."
97932,",",O,3393.0,"276 ( 24 % ) of the patients reported some kind of allergic symptoms on eating or handling various foods , of which hazel nut , apple and shell fish were the most often named ."
97933,apple,B-AG.01.h.01.c,3393.0,"276 ( 24 % ) of the patients reported some kind of allergic symptoms on eating or handling various foods , of which hazel nut , apple and shell fish were the most often named ."
97934,and,O,3393.0,"276 ( 24 % ) of the patients reported some kind of allergic symptoms on eating or handling various foods , of which hazel nut , apple and shell fish were the most often named ."
97935,shell,B-AG.01.d.07,3393.0,"276 ( 24 % ) of the patients reported some kind of allergic symptoms on eating or handling various foods , of which hazel nut , apple and shell fish were the most often named ."
97936,fish,I-AG.01.d.07,3393.0,"276 ( 24 % ) of the patients reported some kind of allergic symptoms on eating or handling various foods , of which hazel nut , apple and shell fish were the most often named ."
97937,were,O,3393.0,"276 ( 24 % ) of the patients reported some kind of allergic symptoms on eating or handling various foods , of which hazel nut , apple and shell fish were the most often named ."
97938,the,O,3393.0,"276 ( 24 % ) of the patients reported some kind of allergic symptoms on eating or handling various foods , of which hazel nut , apple and shell fish were the most often named ."
97939,most,O,3393.0,"276 ( 24 % ) of the patients reported some kind of allergic symptoms on eating or handling various foods , of which hazel nut , apple and shell fish were the most often named ."
97940,often,O,3393.0,"276 ( 24 % ) of the patients reported some kind of allergic symptoms on eating or handling various foods , of which hazel nut , apple and shell fish were the most often named ."
97941,named,O,3393.0,"276 ( 24 % ) of the patients reported some kind of allergic symptoms on eating or handling various foods , of which hazel nut , apple and shell fish were the most often named ."
97942,.,O,3393.0,"276 ( 24 % ) of the patients reported some kind of allergic symptoms on eating or handling various foods , of which hazel nut , apple and shell fish were the most often named ."
97943,Females,O,3394.0,Females reported FS more often than males .
97944,reported,O,3394.0,Females reported FS more often than males .
97945,FS,O,3394.0,Females reported FS more often than males .
97946,more,O,3394.0,Females reported FS more often than males .
97947,often,O,3394.0,Females reported FS more often than males .
97948,than,O,3394.0,Females reported FS more often than males .
97949,males,O,3394.0,Females reported FS more often than males .
97950,.,O,3394.0,Females reported FS more often than males .
97951,A,O,3395.0,"A correlation was found between birch pollen allergy and FS with nuts , apple , peach , cherry , pear , plum , carrot and new potato ."
97952,correlation,O,3395.0,"A correlation was found between birch pollen allergy and FS with nuts , apple , peach , cherry , pear , plum , carrot and new potato ."
97953,was,O,3395.0,"A correlation was found between birch pollen allergy and FS with nuts , apple , peach , cherry , pear , plum , carrot and new potato ."
97954,found,O,3395.0,"A correlation was found between birch pollen allergy and FS with nuts , apple , peach , cherry , pear , plum , carrot and new potato ."
97955,between,O,3395.0,"A correlation was found between birch pollen allergy and FS with nuts , apple , peach , cherry , pear , plum , carrot and new potato ."
97956,birch,O,3395.0,"A correlation was found between birch pollen allergy and FS with nuts , apple , peach , cherry , pear , plum , carrot and new potato ."
97957,pollen,O,3395.0,"A correlation was found between birch pollen allergy and FS with nuts , apple , peach , cherry , pear , plum , carrot and new potato ."
97958,allergy,O,3395.0,"A correlation was found between birch pollen allergy and FS with nuts , apple , peach , cherry , pear , plum , carrot and new potato ."
97959,and,O,3395.0,"A correlation was found between birch pollen allergy and FS with nuts , apple , peach , cherry , pear , plum , carrot and new potato ."
97960,FS,O,3395.0,"A correlation was found between birch pollen allergy and FS with nuts , apple , peach , cherry , pear , plum , carrot and new potato ."
97961,with,O,3395.0,"A correlation was found between birch pollen allergy and FS with nuts , apple , peach , cherry , pear , plum , carrot and new potato ."
97962,nuts,B-AG.01.h.01.f,3395.0,"A correlation was found between birch pollen allergy and FS with nuts , apple , peach , cherry , pear , plum , carrot and new potato ."
97963,",",O,3395.0,"A correlation was found between birch pollen allergy and FS with nuts , apple , peach , cherry , pear , plum , carrot and new potato ."
97964,apple,B-AG.01.h.01.c,3395.0,"A correlation was found between birch pollen allergy and FS with nuts , apple , peach , cherry , pear , plum , carrot and new potato ."
97965,",",O,3395.0,"A correlation was found between birch pollen allergy and FS with nuts , apple , peach , cherry , pear , plum , carrot and new potato ."
97966,peach,B-AG.01.h.01.e,3395.0,"A correlation was found between birch pollen allergy and FS with nuts , apple , peach , cherry , pear , plum , carrot and new potato ."
97967,",",O,3395.0,"A correlation was found between birch pollen allergy and FS with nuts , apple , peach , cherry , pear , plum , carrot and new potato ."
97968,cherry,B-AG.01.h.01.e,3395.0,"A correlation was found between birch pollen allergy and FS with nuts , apple , peach , cherry , pear , plum , carrot and new potato ."
97969,",",O,3395.0,"A correlation was found between birch pollen allergy and FS with nuts , apple , peach , cherry , pear , plum , carrot and new potato ."
97970,pear,B-AG.01.h.01.d,3395.0,"A correlation was found between birch pollen allergy and FS with nuts , apple , peach , cherry , pear , plum , carrot and new potato ."
97971,",",O,3395.0,"A correlation was found between birch pollen allergy and FS with nuts , apple , peach , cherry , pear , plum , carrot and new potato ."
97972,plum,B-AG.01.h.01.e,3395.0,"A correlation was found between birch pollen allergy and FS with nuts , apple , peach , cherry , pear , plum , carrot and new potato ."
97973,",",O,3395.0,"A correlation was found between birch pollen allergy and FS with nuts , apple , peach , cherry , pear , plum , carrot and new potato ."
97974,carrot,B-AG.01.h.02.a,3395.0,"A correlation was found between birch pollen allergy and FS with nuts , apple , peach , cherry , pear , plum , carrot and new potato ."
97975,and,O,3395.0,"A correlation was found between birch pollen allergy and FS with nuts , apple , peach , cherry , pear , plum , carrot and new potato ."
97976,new,O,3395.0,"A correlation was found between birch pollen allergy and FS with nuts , apple , peach , cherry , pear , plum , carrot and new potato ."
97977,potato,B-AG.01.h.02.a,3395.0,"A correlation was found between birch pollen allergy and FS with nuts , apple , peach , cherry , pear , plum , carrot and new potato ."
97978,.,O,3395.0,"A correlation was found between birch pollen allergy and FS with nuts , apple , peach , cherry , pear , plum , carrot and new potato ."
97979,The,O,3396.0,"The higher the degree of birch pollen allergy , according to skin test , RAST or provocation test , the higher the frequency of FS ."
97980,higher,O,3396.0,"The higher the degree of birch pollen allergy , according to skin test , RAST or provocation test , the higher the frequency of FS ."
97981,the,O,3396.0,"The higher the degree of birch pollen allergy , according to skin test , RAST or provocation test , the higher the frequency of FS ."
97982,degree,O,3396.0,"The higher the degree of birch pollen allergy , according to skin test , RAST or provocation test , the higher the frequency of FS ."
97983,of,O,3396.0,"The higher the degree of birch pollen allergy , according to skin test , RAST or provocation test , the higher the frequency of FS ."
97984,birch,O,3396.0,"The higher the degree of birch pollen allergy , according to skin test , RAST or provocation test , the higher the frequency of FS ."
97985,pollen,O,3396.0,"The higher the degree of birch pollen allergy , according to skin test , RAST or provocation test , the higher the frequency of FS ."
97986,allergy,O,3396.0,"The higher the degree of birch pollen allergy , according to skin test , RAST or provocation test , the higher the frequency of FS ."
97987,",",O,3396.0,"The higher the degree of birch pollen allergy , according to skin test , RAST or provocation test , the higher the frequency of FS ."
97988,according,O,3396.0,"The higher the degree of birch pollen allergy , according to skin test , RAST or provocation test , the higher the frequency of FS ."
97989,to,O,3396.0,"The higher the degree of birch pollen allergy , according to skin test , RAST or provocation test , the higher the frequency of FS ."
97990,skin,O,3396.0,"The higher the degree of birch pollen allergy , according to skin test , RAST or provocation test , the higher the frequency of FS ."
97991,test,O,3396.0,"The higher the degree of birch pollen allergy , according to skin test , RAST or provocation test , the higher the frequency of FS ."
97992,",",O,3396.0,"The higher the degree of birch pollen allergy , according to skin test , RAST or provocation test , the higher the frequency of FS ."
97993,RAST,O,3396.0,"The higher the degree of birch pollen allergy , according to skin test , RAST or provocation test , the higher the frequency of FS ."
97994,or,O,3396.0,"The higher the degree of birch pollen allergy , according to skin test , RAST or provocation test , the higher the frequency of FS ."
97995,provocation,O,3396.0,"The higher the degree of birch pollen allergy , according to skin test , RAST or provocation test , the higher the frequency of FS ."
97996,test,O,3396.0,"The higher the degree of birch pollen allergy , according to skin test , RAST or provocation test , the higher the frequency of FS ."
97997,",",O,3396.0,"The higher the degree of birch pollen allergy , according to skin test , RAST or provocation test , the higher the frequency of FS ."
97998,the,O,3396.0,"The higher the degree of birch pollen allergy , according to skin test , RAST or provocation test , the higher the frequency of FS ."
97999,higher,O,3396.0,"The higher the degree of birch pollen allergy , according to skin test , RAST or provocation test , the higher the frequency of FS ."
98000,the,O,3396.0,"The higher the degree of birch pollen allergy , according to skin test , RAST or provocation test , the higher the frequency of FS ."
98001,frequency,O,3396.0,"The higher the degree of birch pollen allergy , according to skin test , RAST or provocation test , the higher the frequency of FS ."
98002,of,O,3396.0,"The higher the degree of birch pollen allergy , according to skin test , RAST or provocation test , the higher the frequency of FS ."
98003,FS,O,3396.0,"The higher the degree of birch pollen allergy , according to skin test , RAST or provocation test , the higher the frequency of FS ."
98004,.,O,3396.0,"The higher the degree of birch pollen allergy , according to skin test , RAST or provocation test , the higher the frequency of FS ."
98005,A,O,3397.0,"A correlation was found too between acetylsalicylic acid intolerance and FS with some foods , e.g. nuts , strawberry , almond , green pepper , hip , chocolate , egg , cabbage , milk and wine ."
98006,correlation,O,3397.0,"A correlation was found too between acetylsalicylic acid intolerance and FS with some foods , e.g. nuts , strawberry , almond , green pepper , hip , chocolate , egg , cabbage , milk and wine ."
98007,was,O,3397.0,"A correlation was found too between acetylsalicylic acid intolerance and FS with some foods , e.g. nuts , strawberry , almond , green pepper , hip , chocolate , egg , cabbage , milk and wine ."
98008,found,O,3397.0,"A correlation was found too between acetylsalicylic acid intolerance and FS with some foods , e.g. nuts , strawberry , almond , green pepper , hip , chocolate , egg , cabbage , milk and wine ."
98009,too,O,3397.0,"A correlation was found too between acetylsalicylic acid intolerance and FS with some foods , e.g. nuts , strawberry , almond , green pepper , hip , chocolate , egg , cabbage , milk and wine ."
98010,between,O,3397.0,"A correlation was found too between acetylsalicylic acid intolerance and FS with some foods , e.g. nuts , strawberry , almond , green pepper , hip , chocolate , egg , cabbage , milk and wine ."
98011,acetylsalicylic,O,3397.0,"A correlation was found too between acetylsalicylic acid intolerance and FS with some foods , e.g. nuts , strawberry , almond , green pepper , hip , chocolate , egg , cabbage , milk and wine ."
98012,acid,O,3397.0,"A correlation was found too between acetylsalicylic acid intolerance and FS with some foods , e.g. nuts , strawberry , almond , green pepper , hip , chocolate , egg , cabbage , milk and wine ."
98013,intolerance,O,3397.0,"A correlation was found too between acetylsalicylic acid intolerance and FS with some foods , e.g. nuts , strawberry , almond , green pepper , hip , chocolate , egg , cabbage , milk and wine ."
98014,and,O,3397.0,"A correlation was found too between acetylsalicylic acid intolerance and FS with some foods , e.g. nuts , strawberry , almond , green pepper , hip , chocolate , egg , cabbage , milk and wine ."
98015,FS,O,3397.0,"A correlation was found too between acetylsalicylic acid intolerance and FS with some foods , e.g. nuts , strawberry , almond , green pepper , hip , chocolate , egg , cabbage , milk and wine ."
98016,with,O,3397.0,"A correlation was found too between acetylsalicylic acid intolerance and FS with some foods , e.g. nuts , strawberry , almond , green pepper , hip , chocolate , egg , cabbage , milk and wine ."
98017,some,O,3397.0,"A correlation was found too between acetylsalicylic acid intolerance and FS with some foods , e.g. nuts , strawberry , almond , green pepper , hip , chocolate , egg , cabbage , milk and wine ."
98018,foods,O,3397.0,"A correlation was found too between acetylsalicylic acid intolerance and FS with some foods , e.g. nuts , strawberry , almond , green pepper , hip , chocolate , egg , cabbage , milk and wine ."
98019,",",O,3397.0,"A correlation was found too between acetylsalicylic acid intolerance and FS with some foods , e.g. nuts , strawberry , almond , green pepper , hip , chocolate , egg , cabbage , milk and wine ."
98020,e.g.,O,3397.0,"A correlation was found too between acetylsalicylic acid intolerance and FS with some foods , e.g. nuts , strawberry , almond , green pepper , hip , chocolate , egg , cabbage , milk and wine ."
98021,nuts,B-AG.01.h.01.f,3397.0,"A correlation was found too between acetylsalicylic acid intolerance and FS with some foods , e.g. nuts , strawberry , almond , green pepper , hip , chocolate , egg , cabbage , milk and wine ."
98022,",",O,3397.0,"A correlation was found too between acetylsalicylic acid intolerance and FS with some foods , e.g. nuts , strawberry , almond , green pepper , hip , chocolate , egg , cabbage , milk and wine ."
98023,strawberry,B-AG.01.h.01.b,3397.0,"A correlation was found too between acetylsalicylic acid intolerance and FS with some foods , e.g. nuts , strawberry , almond , green pepper , hip , chocolate , egg , cabbage , milk and wine ."
98024,",",O,3397.0,"A correlation was found too between acetylsalicylic acid intolerance and FS with some foods , e.g. nuts , strawberry , almond , green pepper , hip , chocolate , egg , cabbage , milk and wine ."
98025,almond,B-AG.01.h.01.f,3397.0,"A correlation was found too between acetylsalicylic acid intolerance and FS with some foods , e.g. nuts , strawberry , almond , green pepper , hip , chocolate , egg , cabbage , milk and wine ."
98026,",",O,3397.0,"A correlation was found too between acetylsalicylic acid intolerance and FS with some foods , e.g. nuts , strawberry , almond , green pepper , hip , chocolate , egg , cabbage , milk and wine ."
98027,green,B-AG.01.h.02.f,3397.0,"A correlation was found too between acetylsalicylic acid intolerance and FS with some foods , e.g. nuts , strawberry , almond , green pepper , hip , chocolate , egg , cabbage , milk and wine ."
98028,pepper,I-AG.01.h.02.f,3397.0,"A correlation was found too between acetylsalicylic acid intolerance and FS with some foods , e.g. nuts , strawberry , almond , green pepper , hip , chocolate , egg , cabbage , milk and wine ."
98029,",",O,3397.0,"A correlation was found too between acetylsalicylic acid intolerance and FS with some foods , e.g. nuts , strawberry , almond , green pepper , hip , chocolate , egg , cabbage , milk and wine ."
98030,hip,B-AG.01.ac,3397.0,"A correlation was found too between acetylsalicylic acid intolerance and FS with some foods , e.g. nuts , strawberry , almond , green pepper , hip , chocolate , egg , cabbage , milk and wine ."
98031,",",O,3397.0,"A correlation was found too between acetylsalicylic acid intolerance and FS with some foods , e.g. nuts , strawberry , almond , green pepper , hip , chocolate , egg , cabbage , milk and wine ."
98032,chocolate,B-AG.01.n.17.a,3397.0,"A correlation was found too between acetylsalicylic acid intolerance and FS with some foods , e.g. nuts , strawberry , almond , green pepper , hip , chocolate , egg , cabbage , milk and wine ."
98033,",",O,3397.0,"A correlation was found too between acetylsalicylic acid intolerance and FS with some foods , e.g. nuts , strawberry , almond , green pepper , hip , chocolate , egg , cabbage , milk and wine ."
98034,egg,B-AG.01.g,3397.0,"A correlation was found too between acetylsalicylic acid intolerance and FS with some foods , e.g. nuts , strawberry , almond , green pepper , hip , chocolate , egg , cabbage , milk and wine ."
98035,",",O,3397.0,"A correlation was found too between acetylsalicylic acid intolerance and FS with some foods , e.g. nuts , strawberry , almond , green pepper , hip , chocolate , egg , cabbage , milk and wine ."
98036,cabbage,B-AG.01.h.02.d,3397.0,"A correlation was found too between acetylsalicylic acid intolerance and FS with some foods , e.g. nuts , strawberry , almond , green pepper , hip , chocolate , egg , cabbage , milk and wine ."
98037,",",O,3397.0,"A correlation was found too between acetylsalicylic acid intolerance and FS with some foods , e.g. nuts , strawberry , almond , green pepper , hip , chocolate , egg , cabbage , milk and wine ."
98038,milk,B-AG.01.e,3397.0,"A correlation was found too between acetylsalicylic acid intolerance and FS with some foods , e.g. nuts , strawberry , almond , green pepper , hip , chocolate , egg , cabbage , milk and wine ."
98039,and,O,3397.0,"A correlation was found too between acetylsalicylic acid intolerance and FS with some foods , e.g. nuts , strawberry , almond , green pepper , hip , chocolate , egg , cabbage , milk and wine ."
98040,wine,B-AG.01.y.01.a,3397.0,"A correlation was found too between acetylsalicylic acid intolerance and FS with some foods , e.g. nuts , strawberry , almond , green pepper , hip , chocolate , egg , cabbage , milk and wine ."
98041,.,O,3397.0,"A correlation was found too between acetylsalicylic acid intolerance and FS with some foods , e.g. nuts , strawberry , almond , green pepper , hip , chocolate , egg , cabbage , milk and wine ."
98042,The,O,3398.0,"The connection between birch pollen allergy and FS is probably explained by the structural relationship between birch pollen allergen and some allergens of the foodstuffs , whereas the high incidence of FS in acetylsalicylic acid - intolerant patients is probably explained by additives in foods as well as salicylates or benzoates naturally occurring in some food ."
98043,connection,O,3398.0,"The connection between birch pollen allergy and FS is probably explained by the structural relationship between birch pollen allergen and some allergens of the foodstuffs , whereas the high incidence of FS in acetylsalicylic acid - intolerant patients is probably explained by additives in foods as well as salicylates or benzoates naturally occurring in some food ."
98044,between,O,3398.0,"The connection between birch pollen allergy and FS is probably explained by the structural relationship between birch pollen allergen and some allergens of the foodstuffs , whereas the high incidence of FS in acetylsalicylic acid - intolerant patients is probably explained by additives in foods as well as salicylates or benzoates naturally occurring in some food ."
98045,birch,O,3398.0,"The connection between birch pollen allergy and FS is probably explained by the structural relationship between birch pollen allergen and some allergens of the foodstuffs , whereas the high incidence of FS in acetylsalicylic acid - intolerant patients is probably explained by additives in foods as well as salicylates or benzoates naturally occurring in some food ."
98046,pollen,O,3398.0,"The connection between birch pollen allergy and FS is probably explained by the structural relationship between birch pollen allergen and some allergens of the foodstuffs , whereas the high incidence of FS in acetylsalicylic acid - intolerant patients is probably explained by additives in foods as well as salicylates or benzoates naturally occurring in some food ."
98047,allergy,O,3398.0,"The connection between birch pollen allergy and FS is probably explained by the structural relationship between birch pollen allergen and some allergens of the foodstuffs , whereas the high incidence of FS in acetylsalicylic acid - intolerant patients is probably explained by additives in foods as well as salicylates or benzoates naturally occurring in some food ."
98048,and,O,3398.0,"The connection between birch pollen allergy and FS is probably explained by the structural relationship between birch pollen allergen and some allergens of the foodstuffs , whereas the high incidence of FS in acetylsalicylic acid - intolerant patients is probably explained by additives in foods as well as salicylates or benzoates naturally occurring in some food ."
98049,FS,O,3398.0,"The connection between birch pollen allergy and FS is probably explained by the structural relationship between birch pollen allergen and some allergens of the foodstuffs , whereas the high incidence of FS in acetylsalicylic acid - intolerant patients is probably explained by additives in foods as well as salicylates or benzoates naturally occurring in some food ."
98050,is,O,3398.0,"The connection between birch pollen allergy and FS is probably explained by the structural relationship between birch pollen allergen and some allergens of the foodstuffs , whereas the high incidence of FS in acetylsalicylic acid - intolerant patients is probably explained by additives in foods as well as salicylates or benzoates naturally occurring in some food ."
98051,probably,O,3398.0,"The connection between birch pollen allergy and FS is probably explained by the structural relationship between birch pollen allergen and some allergens of the foodstuffs , whereas the high incidence of FS in acetylsalicylic acid - intolerant patients is probably explained by additives in foods as well as salicylates or benzoates naturally occurring in some food ."
98052,explained,O,3398.0,"The connection between birch pollen allergy and FS is probably explained by the structural relationship between birch pollen allergen and some allergens of the foodstuffs , whereas the high incidence of FS in acetylsalicylic acid - intolerant patients is probably explained by additives in foods as well as salicylates or benzoates naturally occurring in some food ."
98053,by,O,3398.0,"The connection between birch pollen allergy and FS is probably explained by the structural relationship between birch pollen allergen and some allergens of the foodstuffs , whereas the high incidence of FS in acetylsalicylic acid - intolerant patients is probably explained by additives in foods as well as salicylates or benzoates naturally occurring in some food ."
98054,the,O,3398.0,"The connection between birch pollen allergy and FS is probably explained by the structural relationship between birch pollen allergen and some allergens of the foodstuffs , whereas the high incidence of FS in acetylsalicylic acid - intolerant patients is probably explained by additives in foods as well as salicylates or benzoates naturally occurring in some food ."
98055,structural,O,3398.0,"The connection between birch pollen allergy and FS is probably explained by the structural relationship between birch pollen allergen and some allergens of the foodstuffs , whereas the high incidence of FS in acetylsalicylic acid - intolerant patients is probably explained by additives in foods as well as salicylates or benzoates naturally occurring in some food ."
98056,relationship,O,3398.0,"The connection between birch pollen allergy and FS is probably explained by the structural relationship between birch pollen allergen and some allergens of the foodstuffs , whereas the high incidence of FS in acetylsalicylic acid - intolerant patients is probably explained by additives in foods as well as salicylates or benzoates naturally occurring in some food ."
98057,between,O,3398.0,"The connection between birch pollen allergy and FS is probably explained by the structural relationship between birch pollen allergen and some allergens of the foodstuffs , whereas the high incidence of FS in acetylsalicylic acid - intolerant patients is probably explained by additives in foods as well as salicylates or benzoates naturally occurring in some food ."
98058,birch,O,3398.0,"The connection between birch pollen allergy and FS is probably explained by the structural relationship between birch pollen allergen and some allergens of the foodstuffs , whereas the high incidence of FS in acetylsalicylic acid - intolerant patients is probably explained by additives in foods as well as salicylates or benzoates naturally occurring in some food ."
98059,pollen,O,3398.0,"The connection between birch pollen allergy and FS is probably explained by the structural relationship between birch pollen allergen and some allergens of the foodstuffs , whereas the high incidence of FS in acetylsalicylic acid - intolerant patients is probably explained by additives in foods as well as salicylates or benzoates naturally occurring in some food ."
98060,allergen,O,3398.0,"The connection between birch pollen allergy and FS is probably explained by the structural relationship between birch pollen allergen and some allergens of the foodstuffs , whereas the high incidence of FS in acetylsalicylic acid - intolerant patients is probably explained by additives in foods as well as salicylates or benzoates naturally occurring in some food ."
98061,and,O,3398.0,"The connection between birch pollen allergy and FS is probably explained by the structural relationship between birch pollen allergen and some allergens of the foodstuffs , whereas the high incidence of FS in acetylsalicylic acid - intolerant patients is probably explained by additives in foods as well as salicylates or benzoates naturally occurring in some food ."
98062,some,O,3398.0,"The connection between birch pollen allergy and FS is probably explained by the structural relationship between birch pollen allergen and some allergens of the foodstuffs , whereas the high incidence of FS in acetylsalicylic acid - intolerant patients is probably explained by additives in foods as well as salicylates or benzoates naturally occurring in some food ."
98063,allergens,O,3398.0,"The connection between birch pollen allergy and FS is probably explained by the structural relationship between birch pollen allergen and some allergens of the foodstuffs , whereas the high incidence of FS in acetylsalicylic acid - intolerant patients is probably explained by additives in foods as well as salicylates or benzoates naturally occurring in some food ."
98064,of,O,3398.0,"The connection between birch pollen allergy and FS is probably explained by the structural relationship between birch pollen allergen and some allergens of the foodstuffs , whereas the high incidence of FS in acetylsalicylic acid - intolerant patients is probably explained by additives in foods as well as salicylates or benzoates naturally occurring in some food ."
98065,the,O,3398.0,"The connection between birch pollen allergy and FS is probably explained by the structural relationship between birch pollen allergen and some allergens of the foodstuffs , whereas the high incidence of FS in acetylsalicylic acid - intolerant patients is probably explained by additives in foods as well as salicylates or benzoates naturally occurring in some food ."
98066,foodstuffs,O,3398.0,"The connection between birch pollen allergy and FS is probably explained by the structural relationship between birch pollen allergen and some allergens of the foodstuffs , whereas the high incidence of FS in acetylsalicylic acid - intolerant patients is probably explained by additives in foods as well as salicylates or benzoates naturally occurring in some food ."
98067,",",O,3398.0,"The connection between birch pollen allergy and FS is probably explained by the structural relationship between birch pollen allergen and some allergens of the foodstuffs , whereas the high incidence of FS in acetylsalicylic acid - intolerant patients is probably explained by additives in foods as well as salicylates or benzoates naturally occurring in some food ."
98068,whereas,O,3398.0,"The connection between birch pollen allergy and FS is probably explained by the structural relationship between birch pollen allergen and some allergens of the foodstuffs , whereas the high incidence of FS in acetylsalicylic acid - intolerant patients is probably explained by additives in foods as well as salicylates or benzoates naturally occurring in some food ."
98069,the,O,3398.0,"The connection between birch pollen allergy and FS is probably explained by the structural relationship between birch pollen allergen and some allergens of the foodstuffs , whereas the high incidence of FS in acetylsalicylic acid - intolerant patients is probably explained by additives in foods as well as salicylates or benzoates naturally occurring in some food ."
98070,high,O,3398.0,"The connection between birch pollen allergy and FS is probably explained by the structural relationship between birch pollen allergen and some allergens of the foodstuffs , whereas the high incidence of FS in acetylsalicylic acid - intolerant patients is probably explained by additives in foods as well as salicylates or benzoates naturally occurring in some food ."
98071,incidence,O,3398.0,"The connection between birch pollen allergy and FS is probably explained by the structural relationship between birch pollen allergen and some allergens of the foodstuffs , whereas the high incidence of FS in acetylsalicylic acid - intolerant patients is probably explained by additives in foods as well as salicylates or benzoates naturally occurring in some food ."
98072,of,O,3398.0,"The connection between birch pollen allergy and FS is probably explained by the structural relationship between birch pollen allergen and some allergens of the foodstuffs , whereas the high incidence of FS in acetylsalicylic acid - intolerant patients is probably explained by additives in foods as well as salicylates or benzoates naturally occurring in some food ."
98073,FS,O,3398.0,"The connection between birch pollen allergy and FS is probably explained by the structural relationship between birch pollen allergen and some allergens of the foodstuffs , whereas the high incidence of FS in acetylsalicylic acid - intolerant patients is probably explained by additives in foods as well as salicylates or benzoates naturally occurring in some food ."
98074,in,O,3398.0,"The connection between birch pollen allergy and FS is probably explained by the structural relationship between birch pollen allergen and some allergens of the foodstuffs , whereas the high incidence of FS in acetylsalicylic acid - intolerant patients is probably explained by additives in foods as well as salicylates or benzoates naturally occurring in some food ."
98075,acetylsalicylic,O,3398.0,"The connection between birch pollen allergy and FS is probably explained by the structural relationship between birch pollen allergen and some allergens of the foodstuffs , whereas the high incidence of FS in acetylsalicylic acid - intolerant patients is probably explained by additives in foods as well as salicylates or benzoates naturally occurring in some food ."
98076,acid,O,3398.0,"The connection between birch pollen allergy and FS is probably explained by the structural relationship between birch pollen allergen and some allergens of the foodstuffs , whereas the high incidence of FS in acetylsalicylic acid - intolerant patients is probably explained by additives in foods as well as salicylates or benzoates naturally occurring in some food ."
98077,-,O,3398.0,"The connection between birch pollen allergy and FS is probably explained by the structural relationship between birch pollen allergen and some allergens of the foodstuffs , whereas the high incidence of FS in acetylsalicylic acid - intolerant patients is probably explained by additives in foods as well as salicylates or benzoates naturally occurring in some food ."
98078,intolerant,O,3398.0,"The connection between birch pollen allergy and FS is probably explained by the structural relationship between birch pollen allergen and some allergens of the foodstuffs , whereas the high incidence of FS in acetylsalicylic acid - intolerant patients is probably explained by additives in foods as well as salicylates or benzoates naturally occurring in some food ."
98079,patients,O,3398.0,"The connection between birch pollen allergy and FS is probably explained by the structural relationship between birch pollen allergen and some allergens of the foodstuffs , whereas the high incidence of FS in acetylsalicylic acid - intolerant patients is probably explained by additives in foods as well as salicylates or benzoates naturally occurring in some food ."
98080,is,O,3398.0,"The connection between birch pollen allergy and FS is probably explained by the structural relationship between birch pollen allergen and some allergens of the foodstuffs , whereas the high incidence of FS in acetylsalicylic acid - intolerant patients is probably explained by additives in foods as well as salicylates or benzoates naturally occurring in some food ."
98081,probably,O,3398.0,"The connection between birch pollen allergy and FS is probably explained by the structural relationship between birch pollen allergen and some allergens of the foodstuffs , whereas the high incidence of FS in acetylsalicylic acid - intolerant patients is probably explained by additives in foods as well as salicylates or benzoates naturally occurring in some food ."
98082,explained,O,3398.0,"The connection between birch pollen allergy and FS is probably explained by the structural relationship between birch pollen allergen and some allergens of the foodstuffs , whereas the high incidence of FS in acetylsalicylic acid - intolerant patients is probably explained by additives in foods as well as salicylates or benzoates naturally occurring in some food ."
98083,by,O,3398.0,"The connection between birch pollen allergy and FS is probably explained by the structural relationship between birch pollen allergen and some allergens of the foodstuffs , whereas the high incidence of FS in acetylsalicylic acid - intolerant patients is probably explained by additives in foods as well as salicylates or benzoates naturally occurring in some food ."
98084,additives,O,3398.0,"The connection between birch pollen allergy and FS is probably explained by the structural relationship between birch pollen allergen and some allergens of the foodstuffs , whereas the high incidence of FS in acetylsalicylic acid - intolerant patients is probably explained by additives in foods as well as salicylates or benzoates naturally occurring in some food ."
98085,in,O,3398.0,"The connection between birch pollen allergy and FS is probably explained by the structural relationship between birch pollen allergen and some allergens of the foodstuffs , whereas the high incidence of FS in acetylsalicylic acid - intolerant patients is probably explained by additives in foods as well as salicylates or benzoates naturally occurring in some food ."
98086,foods,O,3398.0,"The connection between birch pollen allergy and FS is probably explained by the structural relationship between birch pollen allergen and some allergens of the foodstuffs , whereas the high incidence of FS in acetylsalicylic acid - intolerant patients is probably explained by additives in foods as well as salicylates or benzoates naturally occurring in some food ."
98087,as,O,3398.0,"The connection between birch pollen allergy and FS is probably explained by the structural relationship between birch pollen allergen and some allergens of the foodstuffs , whereas the high incidence of FS in acetylsalicylic acid - intolerant patients is probably explained by additives in foods as well as salicylates or benzoates naturally occurring in some food ."
98088,well,O,3398.0,"The connection between birch pollen allergy and FS is probably explained by the structural relationship between birch pollen allergen and some allergens of the foodstuffs , whereas the high incidence of FS in acetylsalicylic acid - intolerant patients is probably explained by additives in foods as well as salicylates or benzoates naturally occurring in some food ."
98089,as,O,3398.0,"The connection between birch pollen allergy and FS is probably explained by the structural relationship between birch pollen allergen and some allergens of the foodstuffs , whereas the high incidence of FS in acetylsalicylic acid - intolerant patients is probably explained by additives in foods as well as salicylates or benzoates naturally occurring in some food ."
98090,salicylates,O,3398.0,"The connection between birch pollen allergy and FS is probably explained by the structural relationship between birch pollen allergen and some allergens of the foodstuffs , whereas the high incidence of FS in acetylsalicylic acid - intolerant patients is probably explained by additives in foods as well as salicylates or benzoates naturally occurring in some food ."
98091,or,O,3398.0,"The connection between birch pollen allergy and FS is probably explained by the structural relationship between birch pollen allergen and some allergens of the foodstuffs , whereas the high incidence of FS in acetylsalicylic acid - intolerant patients is probably explained by additives in foods as well as salicylates or benzoates naturally occurring in some food ."
98092,benzoates,O,3398.0,"The connection between birch pollen allergy and FS is probably explained by the structural relationship between birch pollen allergen and some allergens of the foodstuffs , whereas the high incidence of FS in acetylsalicylic acid - intolerant patients is probably explained by additives in foods as well as salicylates or benzoates naturally occurring in some food ."
98093,naturally,O,3398.0,"The connection between birch pollen allergy and FS is probably explained by the structural relationship between birch pollen allergen and some allergens of the foodstuffs , whereas the high incidence of FS in acetylsalicylic acid - intolerant patients is probably explained by additives in foods as well as salicylates or benzoates naturally occurring in some food ."
98094,occurring,O,3398.0,"The connection between birch pollen allergy and FS is probably explained by the structural relationship between birch pollen allergen and some allergens of the foodstuffs , whereas the high incidence of FS in acetylsalicylic acid - intolerant patients is probably explained by additives in foods as well as salicylates or benzoates naturally occurring in some food ."
98095,in,O,3398.0,"The connection between birch pollen allergy and FS is probably explained by the structural relationship between birch pollen allergen and some allergens of the foodstuffs , whereas the high incidence of FS in acetylsalicylic acid - intolerant patients is probably explained by additives in foods as well as salicylates or benzoates naturally occurring in some food ."
98096,some,O,3398.0,"The connection between birch pollen allergy and FS is probably explained by the structural relationship between birch pollen allergen and some allergens of the foodstuffs , whereas the high incidence of FS in acetylsalicylic acid - intolerant patients is probably explained by additives in foods as well as salicylates or benzoates naturally occurring in some food ."
98097,food,O,3398.0,"The connection between birch pollen allergy and FS is probably explained by the structural relationship between birch pollen allergen and some allergens of the foodstuffs , whereas the high incidence of FS in acetylsalicylic acid - intolerant patients is probably explained by additives in foods as well as salicylates or benzoates naturally occurring in some food ."
98098,.,O,3398.0,"The connection between birch pollen allergy and FS is probably explained by the structural relationship between birch pollen allergen and some allergens of the foodstuffs , whereas the high incidence of FS in acetylsalicylic acid - intolerant patients is probably explained by additives in foods as well as salicylates or benzoates naturally occurring in some food ."
98099,Avoidance,O,3399.0,"Avoidance of saturated fat and cholesterol by 1,210 Mexican Americans and 866 non - Hispanic whites was assessed as part of a population - based survey of diabetes and cardiovascular risk factors ."
98100,of,O,3399.0,"Avoidance of saturated fat and cholesterol by 1,210 Mexican Americans and 866 non - Hispanic whites was assessed as part of a population - based survey of diabetes and cardiovascular risk factors ."
98101,saturated,O,3399.0,"Avoidance of saturated fat and cholesterol by 1,210 Mexican Americans and 866 non - Hispanic whites was assessed as part of a population - based survey of diabetes and cardiovascular risk factors ."
98102,fat,O,3399.0,"Avoidance of saturated fat and cholesterol by 1,210 Mexican Americans and 866 non - Hispanic whites was assessed as part of a population - based survey of diabetes and cardiovascular risk factors ."
98103,and,O,3399.0,"Avoidance of saturated fat and cholesterol by 1,210 Mexican Americans and 866 non - Hispanic whites was assessed as part of a population - based survey of diabetes and cardiovascular risk factors ."
98104,cholesterol,O,3399.0,"Avoidance of saturated fat and cholesterol by 1,210 Mexican Americans and 866 non - Hispanic whites was assessed as part of a population - based survey of diabetes and cardiovascular risk factors ."
98105,by,O,3399.0,"Avoidance of saturated fat and cholesterol by 1,210 Mexican Americans and 866 non - Hispanic whites was assessed as part of a population - based survey of diabetes and cardiovascular risk factors ."
98106,"1,210",O,3399.0,"Avoidance of saturated fat and cholesterol by 1,210 Mexican Americans and 866 non - Hispanic whites was assessed as part of a population - based survey of diabetes and cardiovascular risk factors ."
98107,Mexican,O,3399.0,"Avoidance of saturated fat and cholesterol by 1,210 Mexican Americans and 866 non - Hispanic whites was assessed as part of a population - based survey of diabetes and cardiovascular risk factors ."
98108,Americans,O,3399.0,"Avoidance of saturated fat and cholesterol by 1,210 Mexican Americans and 866 non - Hispanic whites was assessed as part of a population - based survey of diabetes and cardiovascular risk factors ."
98109,and,O,3399.0,"Avoidance of saturated fat and cholesterol by 1,210 Mexican Americans and 866 non - Hispanic whites was assessed as part of a population - based survey of diabetes and cardiovascular risk factors ."
98110,866,O,3399.0,"Avoidance of saturated fat and cholesterol by 1,210 Mexican Americans and 866 non - Hispanic whites was assessed as part of a population - based survey of diabetes and cardiovascular risk factors ."
98111,non,O,3399.0,"Avoidance of saturated fat and cholesterol by 1,210 Mexican Americans and 866 non - Hispanic whites was assessed as part of a population - based survey of diabetes and cardiovascular risk factors ."
98112,-,O,3399.0,"Avoidance of saturated fat and cholesterol by 1,210 Mexican Americans and 866 non - Hispanic whites was assessed as part of a population - based survey of diabetes and cardiovascular risk factors ."
98113,Hispanic,O,3399.0,"Avoidance of saturated fat and cholesterol by 1,210 Mexican Americans and 866 non - Hispanic whites was assessed as part of a population - based survey of diabetes and cardiovascular risk factors ."
98114,whites,O,3399.0,"Avoidance of saturated fat and cholesterol by 1,210 Mexican Americans and 866 non - Hispanic whites was assessed as part of a population - based survey of diabetes and cardiovascular risk factors ."
98115,was,O,3399.0,"Avoidance of saturated fat and cholesterol by 1,210 Mexican Americans and 866 non - Hispanic whites was assessed as part of a population - based survey of diabetes and cardiovascular risk factors ."
98116,assessed,O,3399.0,"Avoidance of saturated fat and cholesterol by 1,210 Mexican Americans and 866 non - Hispanic whites was assessed as part of a population - based survey of diabetes and cardiovascular risk factors ."
98117,as,O,3399.0,"Avoidance of saturated fat and cholesterol by 1,210 Mexican Americans and 866 non - Hispanic whites was assessed as part of a population - based survey of diabetes and cardiovascular risk factors ."
98118,part,O,3399.0,"Avoidance of saturated fat and cholesterol by 1,210 Mexican Americans and 866 non - Hispanic whites was assessed as part of a population - based survey of diabetes and cardiovascular risk factors ."
98119,of,O,3399.0,"Avoidance of saturated fat and cholesterol by 1,210 Mexican Americans and 866 non - Hispanic whites was assessed as part of a population - based survey of diabetes and cardiovascular risk factors ."
98120,a,O,3399.0,"Avoidance of saturated fat and cholesterol by 1,210 Mexican Americans and 866 non - Hispanic whites was assessed as part of a population - based survey of diabetes and cardiovascular risk factors ."
98121,population,O,3399.0,"Avoidance of saturated fat and cholesterol by 1,210 Mexican Americans and 866 non - Hispanic whites was assessed as part of a population - based survey of diabetes and cardiovascular risk factors ."
98122,-,O,3399.0,"Avoidance of saturated fat and cholesterol by 1,210 Mexican Americans and 866 non - Hispanic whites was assessed as part of a population - based survey of diabetes and cardiovascular risk factors ."
98123,based,O,3399.0,"Avoidance of saturated fat and cholesterol by 1,210 Mexican Americans and 866 non - Hispanic whites was assessed as part of a population - based survey of diabetes and cardiovascular risk factors ."
98124,survey,O,3399.0,"Avoidance of saturated fat and cholesterol by 1,210 Mexican Americans and 866 non - Hispanic whites was assessed as part of a population - based survey of diabetes and cardiovascular risk factors ."
98125,of,O,3399.0,"Avoidance of saturated fat and cholesterol by 1,210 Mexican Americans and 866 non - Hispanic whites was assessed as part of a population - based survey of diabetes and cardiovascular risk factors ."
98126,diabetes,O,3399.0,"Avoidance of saturated fat and cholesterol by 1,210 Mexican Americans and 866 non - Hispanic whites was assessed as part of a population - based survey of diabetes and cardiovascular risk factors ."
98127,and,O,3399.0,"Avoidance of saturated fat and cholesterol by 1,210 Mexican Americans and 866 non - Hispanic whites was assessed as part of a population - based survey of diabetes and cardiovascular risk factors ."
98128,cardiovascular,O,3399.0,"Avoidance of saturated fat and cholesterol by 1,210 Mexican Americans and 866 non - Hispanic whites was assessed as part of a population - based survey of diabetes and cardiovascular risk factors ."
98129,risk,O,3399.0,"Avoidance of saturated fat and cholesterol by 1,210 Mexican Americans and 866 non - Hispanic whites was assessed as part of a population - based survey of diabetes and cardiovascular risk factors ."
98130,factors,O,3399.0,"Avoidance of saturated fat and cholesterol by 1,210 Mexican Americans and 866 non - Hispanic whites was assessed as part of a population - based survey of diabetes and cardiovascular risk factors ."
98131,.,O,3399.0,"Avoidance of saturated fat and cholesterol by 1,210 Mexican Americans and 866 non - Hispanic whites was assessed as part of a population - based survey of diabetes and cardiovascular risk factors ."
98132,Participants,O,3400.0,"Participants ranged in age from 25 to 64 years and resided in three socioeconomically distinct neighborhoods of San Antonio , TX : low income , middle income , and upper income ."
98133,ranged,O,3400.0,"Participants ranged in age from 25 to 64 years and resided in three socioeconomically distinct neighborhoods of San Antonio , TX : low income , middle income , and upper income ."
98134,in,O,3400.0,"Participants ranged in age from 25 to 64 years and resided in three socioeconomically distinct neighborhoods of San Antonio , TX : low income , middle income , and upper income ."
98135,age,O,3400.0,"Participants ranged in age from 25 to 64 years and resided in three socioeconomically distinct neighborhoods of San Antonio , TX : low income , middle income , and upper income ."
98136,from,O,3400.0,"Participants ranged in age from 25 to 64 years and resided in three socioeconomically distinct neighborhoods of San Antonio , TX : low income , middle income , and upper income ."
98137,25,O,3400.0,"Participants ranged in age from 25 to 64 years and resided in three socioeconomically distinct neighborhoods of San Antonio , TX : low income , middle income , and upper income ."
98138,to,O,3400.0,"Participants ranged in age from 25 to 64 years and resided in three socioeconomically distinct neighborhoods of San Antonio , TX : low income , middle income , and upper income ."
98139,64,O,3400.0,"Participants ranged in age from 25 to 64 years and resided in three socioeconomically distinct neighborhoods of San Antonio , TX : low income , middle income , and upper income ."
98140,years,O,3400.0,"Participants ranged in age from 25 to 64 years and resided in three socioeconomically distinct neighborhoods of San Antonio , TX : low income , middle income , and upper income ."
98141,and,O,3400.0,"Participants ranged in age from 25 to 64 years and resided in three socioeconomically distinct neighborhoods of San Antonio , TX : low income , middle income , and upper income ."
98142,resided,O,3400.0,"Participants ranged in age from 25 to 64 years and resided in three socioeconomically distinct neighborhoods of San Antonio , TX : low income , middle income , and upper income ."
98143,in,O,3400.0,"Participants ranged in age from 25 to 64 years and resided in three socioeconomically distinct neighborhoods of San Antonio , TX : low income , middle income , and upper income ."
98144,three,O,3400.0,"Participants ranged in age from 25 to 64 years and resided in three socioeconomically distinct neighborhoods of San Antonio , TX : low income , middle income , and upper income ."
98145,socioeconomically,O,3400.0,"Participants ranged in age from 25 to 64 years and resided in three socioeconomically distinct neighborhoods of San Antonio , TX : low income , middle income , and upper income ."
98146,distinct,O,3400.0,"Participants ranged in age from 25 to 64 years and resided in three socioeconomically distinct neighborhoods of San Antonio , TX : low income , middle income , and upper income ."
98147,neighborhoods,O,3400.0,"Participants ranged in age from 25 to 64 years and resided in three socioeconomically distinct neighborhoods of San Antonio , TX : low income , middle income , and upper income ."
98148,of,O,3400.0,"Participants ranged in age from 25 to 64 years and resided in three socioeconomically distinct neighborhoods of San Antonio , TX : low income , middle income , and upper income ."
98149,San,O,3400.0,"Participants ranged in age from 25 to 64 years and resided in three socioeconomically distinct neighborhoods of San Antonio , TX : low income , middle income , and upper income ."
98150,Antonio,O,3400.0,"Participants ranged in age from 25 to 64 years and resided in three socioeconomically distinct neighborhoods of San Antonio , TX : low income , middle income , and upper income ."
98151,",",O,3400.0,"Participants ranged in age from 25 to 64 years and resided in three socioeconomically distinct neighborhoods of San Antonio , TX : low income , middle income , and upper income ."
98152,TX,O,3400.0,"Participants ranged in age from 25 to 64 years and resided in three socioeconomically distinct neighborhoods of San Antonio , TX : low income , middle income , and upper income ."
98153,:,O,3400.0,"Participants ranged in age from 25 to 64 years and resided in three socioeconomically distinct neighborhoods of San Antonio , TX : low income , middle income , and upper income ."
98154,low,O,3400.0,"Participants ranged in age from 25 to 64 years and resided in three socioeconomically distinct neighborhoods of San Antonio , TX : low income , middle income , and upper income ."
98155,income,O,3400.0,"Participants ranged in age from 25 to 64 years and resided in three socioeconomically distinct neighborhoods of San Antonio , TX : low income , middle income , and upper income ."
98156,",",O,3400.0,"Participants ranged in age from 25 to 64 years and resided in three socioeconomically distinct neighborhoods of San Antonio , TX : low income , middle income , and upper income ."
98157,middle,O,3400.0,"Participants ranged in age from 25 to 64 years and resided in three socioeconomically distinct neighborhoods of San Antonio , TX : low income , middle income , and upper income ."
98158,income,O,3400.0,"Participants ranged in age from 25 to 64 years and resided in three socioeconomically distinct neighborhoods of San Antonio , TX : low income , middle income , and upper income ."
98159,",",O,3400.0,"Participants ranged in age from 25 to 64 years and resided in three socioeconomically distinct neighborhoods of San Antonio , TX : low income , middle income , and upper income ."
98160,and,O,3400.0,"Participants ranged in age from 25 to 64 years and resided in three socioeconomically distinct neighborhoods of San Antonio , TX : low income , middle income , and upper income ."
98161,upper,O,3400.0,"Participants ranged in age from 25 to 64 years and resided in three socioeconomically distinct neighborhoods of San Antonio , TX : low income , middle income , and upper income ."
98162,income,O,3400.0,"Participants ranged in age from 25 to 64 years and resided in three socioeconomically distinct neighborhoods of San Antonio , TX : low income , middle income , and upper income ."
98163,.,O,3400.0,"Participants ranged in age from 25 to 64 years and resided in three socioeconomically distinct neighborhoods of San Antonio , TX : low income , middle income , and upper income ."
98164,A,O,3401.0,A scale was constructed to assess the degree to which individuals avoided six dietary sources of saturated fat and cholesterol .
98165,scale,O,3401.0,A scale was constructed to assess the degree to which individuals avoided six dietary sources of saturated fat and cholesterol .
98166,was,O,3401.0,A scale was constructed to assess the degree to which individuals avoided six dietary sources of saturated fat and cholesterol .
98167,constructed,O,3401.0,A scale was constructed to assess the degree to which individuals avoided six dietary sources of saturated fat and cholesterol .
98168,to,O,3401.0,A scale was constructed to assess the degree to which individuals avoided six dietary sources of saturated fat and cholesterol .
98169,assess,O,3401.0,A scale was constructed to assess the degree to which individuals avoided six dietary sources of saturated fat and cholesterol .
98170,the,O,3401.0,A scale was constructed to assess the degree to which individuals avoided six dietary sources of saturated fat and cholesterol .
98171,degree,O,3401.0,A scale was constructed to assess the degree to which individuals avoided six dietary sources of saturated fat and cholesterol .
98172,to,O,3401.0,A scale was constructed to assess the degree to which individuals avoided six dietary sources of saturated fat and cholesterol .
98173,which,O,3401.0,A scale was constructed to assess the degree to which individuals avoided six dietary sources of saturated fat and cholesterol .
98174,individuals,O,3401.0,A scale was constructed to assess the degree to which individuals avoided six dietary sources of saturated fat and cholesterol .
98175,avoided,O,3401.0,A scale was constructed to assess the degree to which individuals avoided six dietary sources of saturated fat and cholesterol .
98176,six,O,3401.0,A scale was constructed to assess the degree to which individuals avoided six dietary sources of saturated fat and cholesterol .
98177,dietary,O,3401.0,A scale was constructed to assess the degree to which individuals avoided six dietary sources of saturated fat and cholesterol .
98178,sources,O,3401.0,A scale was constructed to assess the degree to which individuals avoided six dietary sources of saturated fat and cholesterol .
98179,of,O,3401.0,A scale was constructed to assess the degree to which individuals avoided six dietary sources of saturated fat and cholesterol .
98180,saturated,O,3401.0,A scale was constructed to assess the degree to which individuals avoided six dietary sources of saturated fat and cholesterol .
98181,fat,O,3401.0,A scale was constructed to assess the degree to which individuals avoided six dietary sources of saturated fat and cholesterol .
98182,and,O,3401.0,A scale was constructed to assess the degree to which individuals avoided six dietary sources of saturated fat and cholesterol .
98183,cholesterol,O,3401.0,A scale was constructed to assess the degree to which individuals avoided six dietary sources of saturated fat and cholesterol .
98184,.,O,3401.0,A scale was constructed to assess the degree to which individuals avoided six dietary sources of saturated fat and cholesterol .
98185,Women,O,3402.0,"Women of both ethnic groups were found to avoid saturated fat and cholesterol to a greater degree than men , scoring higher on five of the six components of the scale ."
98186,of,O,3402.0,"Women of both ethnic groups were found to avoid saturated fat and cholesterol to a greater degree than men , scoring higher on five of the six components of the scale ."
98187,both,O,3402.0,"Women of both ethnic groups were found to avoid saturated fat and cholesterol to a greater degree than men , scoring higher on five of the six components of the scale ."
98188,ethnic,O,3402.0,"Women of both ethnic groups were found to avoid saturated fat and cholesterol to a greater degree than men , scoring higher on five of the six components of the scale ."
98189,groups,O,3402.0,"Women of both ethnic groups were found to avoid saturated fat and cholesterol to a greater degree than men , scoring higher on five of the six components of the scale ."
98190,were,O,3402.0,"Women of both ethnic groups were found to avoid saturated fat and cholesterol to a greater degree than men , scoring higher on five of the six components of the scale ."
98191,found,O,3402.0,"Women of both ethnic groups were found to avoid saturated fat and cholesterol to a greater degree than men , scoring higher on five of the six components of the scale ."
98192,to,O,3402.0,"Women of both ethnic groups were found to avoid saturated fat and cholesterol to a greater degree than men , scoring higher on five of the six components of the scale ."
98193,avoid,O,3402.0,"Women of both ethnic groups were found to avoid saturated fat and cholesterol to a greater degree than men , scoring higher on five of the six components of the scale ."
98194,saturated,O,3402.0,"Women of both ethnic groups were found to avoid saturated fat and cholesterol to a greater degree than men , scoring higher on five of the six components of the scale ."
98195,fat,O,3402.0,"Women of both ethnic groups were found to avoid saturated fat and cholesterol to a greater degree than men , scoring higher on five of the six components of the scale ."
98196,and,O,3402.0,"Women of both ethnic groups were found to avoid saturated fat and cholesterol to a greater degree than men , scoring higher on five of the six components of the scale ."
98197,cholesterol,O,3402.0,"Women of both ethnic groups were found to avoid saturated fat and cholesterol to a greater degree than men , scoring higher on five of the six components of the scale ."
98198,to,O,3402.0,"Women of both ethnic groups were found to avoid saturated fat and cholesterol to a greater degree than men , scoring higher on five of the six components of the scale ."
98199,a,O,3402.0,"Women of both ethnic groups were found to avoid saturated fat and cholesterol to a greater degree than men , scoring higher on five of the six components of the scale ."
98200,greater,O,3402.0,"Women of both ethnic groups were found to avoid saturated fat and cholesterol to a greater degree than men , scoring higher on five of the six components of the scale ."
98201,degree,O,3402.0,"Women of both ethnic groups were found to avoid saturated fat and cholesterol to a greater degree than men , scoring higher on five of the six components of the scale ."
98202,than,O,3402.0,"Women of both ethnic groups were found to avoid saturated fat and cholesterol to a greater degree than men , scoring higher on five of the six components of the scale ."
98203,men,O,3402.0,"Women of both ethnic groups were found to avoid saturated fat and cholesterol to a greater degree than men , scoring higher on five of the six components of the scale ."
98204,",",O,3402.0,"Women of both ethnic groups were found to avoid saturated fat and cholesterol to a greater degree than men , scoring higher on five of the six components of the scale ."
98205,scoring,O,3402.0,"Women of both ethnic groups were found to avoid saturated fat and cholesterol to a greater degree than men , scoring higher on five of the six components of the scale ."
98206,higher,O,3402.0,"Women of both ethnic groups were found to avoid saturated fat and cholesterol to a greater degree than men , scoring higher on five of the six components of the scale ."
98207,on,O,3402.0,"Women of both ethnic groups were found to avoid saturated fat and cholesterol to a greater degree than men , scoring higher on five of the six components of the scale ."
98208,five,O,3402.0,"Women of both ethnic groups were found to avoid saturated fat and cholesterol to a greater degree than men , scoring higher on five of the six components of the scale ."
98209,of,O,3402.0,"Women of both ethnic groups were found to avoid saturated fat and cholesterol to a greater degree than men , scoring higher on five of the six components of the scale ."
98210,the,O,3402.0,"Women of both ethnic groups were found to avoid saturated fat and cholesterol to a greater degree than men , scoring higher on five of the six components of the scale ."
98211,six,O,3402.0,"Women of both ethnic groups were found to avoid saturated fat and cholesterol to a greater degree than men , scoring higher on five of the six components of the scale ."
98212,components,O,3402.0,"Women of both ethnic groups were found to avoid saturated fat and cholesterol to a greater degree than men , scoring higher on five of the six components of the scale ."
98213,of,O,3402.0,"Women of both ethnic groups were found to avoid saturated fat and cholesterol to a greater degree than men , scoring higher on five of the six components of the scale ."
98214,the,O,3402.0,"Women of both ethnic groups were found to avoid saturated fat and cholesterol to a greater degree than men , scoring higher on five of the six components of the scale ."
98215,scale,O,3402.0,"Women of both ethnic groups were found to avoid saturated fat and cholesterol to a greater degree than men , scoring higher on five of the six components of the scale ."
98216,.,O,3402.0,"Women of both ethnic groups were found to avoid saturated fat and cholesterol to a greater degree than men , scoring higher on five of the six components of the scale ."
98217,Saturated,O,3403.0,Saturated fat / cholesterol avoidance increased significantly with increased socioeconomic status in both ethnic groups .
98218,fat,O,3403.0,Saturated fat / cholesterol avoidance increased significantly with increased socioeconomic status in both ethnic groups .
98219,/,O,3403.0,Saturated fat / cholesterol avoidance increased significantly with increased socioeconomic status in both ethnic groups .
98220,cholesterol,O,3403.0,Saturated fat / cholesterol avoidance increased significantly with increased socioeconomic status in both ethnic groups .
98221,avoidance,O,3403.0,Saturated fat / cholesterol avoidance increased significantly with increased socioeconomic status in both ethnic groups .
98222,increased,O,3403.0,Saturated fat / cholesterol avoidance increased significantly with increased socioeconomic status in both ethnic groups .
98223,significantly,O,3403.0,Saturated fat / cholesterol avoidance increased significantly with increased socioeconomic status in both ethnic groups .
98224,with,O,3403.0,Saturated fat / cholesterol avoidance increased significantly with increased socioeconomic status in both ethnic groups .
98225,increased,O,3403.0,Saturated fat / cholesterol avoidance increased significantly with increased socioeconomic status in both ethnic groups .
98226,socioeconomic,O,3403.0,Saturated fat / cholesterol avoidance increased significantly with increased socioeconomic status in both ethnic groups .
98227,status,O,3403.0,Saturated fat / cholesterol avoidance increased significantly with increased socioeconomic status in both ethnic groups .
98228,in,O,3403.0,Saturated fat / cholesterol avoidance increased significantly with increased socioeconomic status in both ethnic groups .
98229,both,O,3403.0,Saturated fat / cholesterol avoidance increased significantly with increased socioeconomic status in both ethnic groups .
98230,ethnic,O,3403.0,Saturated fat / cholesterol avoidance increased significantly with increased socioeconomic status in both ethnic groups .
98231,groups,O,3403.0,Saturated fat / cholesterol avoidance increased significantly with increased socioeconomic status in both ethnic groups .
98232,.,O,3403.0,Saturated fat / cholesterol avoidance increased significantly with increased socioeconomic status in both ethnic groups .
98233,Although,O,3404.0,"Although there were no ethnic differences in overall saturated fat / cholesterol avoidance , more non - Hispanic whites recognized milk , eggs , and visible fat on meat as food sources to avoid ."
98234,there,O,3404.0,"Although there were no ethnic differences in overall saturated fat / cholesterol avoidance , more non - Hispanic whites recognized milk , eggs , and visible fat on meat as food sources to avoid ."
98235,were,O,3404.0,"Although there were no ethnic differences in overall saturated fat / cholesterol avoidance , more non - Hispanic whites recognized milk , eggs , and visible fat on meat as food sources to avoid ."
98236,no,O,3404.0,"Although there were no ethnic differences in overall saturated fat / cholesterol avoidance , more non - Hispanic whites recognized milk , eggs , and visible fat on meat as food sources to avoid ."
98237,ethnic,O,3404.0,"Although there were no ethnic differences in overall saturated fat / cholesterol avoidance , more non - Hispanic whites recognized milk , eggs , and visible fat on meat as food sources to avoid ."
98238,differences,O,3404.0,"Although there were no ethnic differences in overall saturated fat / cholesterol avoidance , more non - Hispanic whites recognized milk , eggs , and visible fat on meat as food sources to avoid ."
98239,in,O,3404.0,"Although there were no ethnic differences in overall saturated fat / cholesterol avoidance , more non - Hispanic whites recognized milk , eggs , and visible fat on meat as food sources to avoid ."
98240,overall,O,3404.0,"Although there were no ethnic differences in overall saturated fat / cholesterol avoidance , more non - Hispanic whites recognized milk , eggs , and visible fat on meat as food sources to avoid ."
98241,saturated,O,3404.0,"Although there were no ethnic differences in overall saturated fat / cholesterol avoidance , more non - Hispanic whites recognized milk , eggs , and visible fat on meat as food sources to avoid ."
98242,fat,O,3404.0,"Although there were no ethnic differences in overall saturated fat / cholesterol avoidance , more non - Hispanic whites recognized milk , eggs , and visible fat on meat as food sources to avoid ."
98243,/,O,3404.0,"Although there were no ethnic differences in overall saturated fat / cholesterol avoidance , more non - Hispanic whites recognized milk , eggs , and visible fat on meat as food sources to avoid ."
98244,cholesterol,O,3404.0,"Although there were no ethnic differences in overall saturated fat / cholesterol avoidance , more non - Hispanic whites recognized milk , eggs , and visible fat on meat as food sources to avoid ."
98245,avoidance,O,3404.0,"Although there were no ethnic differences in overall saturated fat / cholesterol avoidance , more non - Hispanic whites recognized milk , eggs , and visible fat on meat as food sources to avoid ."
98246,",",O,3404.0,"Although there were no ethnic differences in overall saturated fat / cholesterol avoidance , more non - Hispanic whites recognized milk , eggs , and visible fat on meat as food sources to avoid ."
98247,more,O,3404.0,"Although there were no ethnic differences in overall saturated fat / cholesterol avoidance , more non - Hispanic whites recognized milk , eggs , and visible fat on meat as food sources to avoid ."
98248,non,O,3404.0,"Although there were no ethnic differences in overall saturated fat / cholesterol avoidance , more non - Hispanic whites recognized milk , eggs , and visible fat on meat as food sources to avoid ."
98249,-,O,3404.0,"Although there were no ethnic differences in overall saturated fat / cholesterol avoidance , more non - Hispanic whites recognized milk , eggs , and visible fat on meat as food sources to avoid ."
98250,Hispanic,O,3404.0,"Although there were no ethnic differences in overall saturated fat / cholesterol avoidance , more non - Hispanic whites recognized milk , eggs , and visible fat on meat as food sources to avoid ."
98251,whites,O,3404.0,"Although there were no ethnic differences in overall saturated fat / cholesterol avoidance , more non - Hispanic whites recognized milk , eggs , and visible fat on meat as food sources to avoid ."
98252,recognized,O,3404.0,"Although there were no ethnic differences in overall saturated fat / cholesterol avoidance , more non - Hispanic whites recognized milk , eggs , and visible fat on meat as food sources to avoid ."
98253,milk,B-AG.01.e,3404.0,"Although there were no ethnic differences in overall saturated fat / cholesterol avoidance , more non - Hispanic whites recognized milk , eggs , and visible fat on meat as food sources to avoid ."
98254,",",O,3404.0,"Although there were no ethnic differences in overall saturated fat / cholesterol avoidance , more non - Hispanic whites recognized milk , eggs , and visible fat on meat as food sources to avoid ."
98255,eggs,B-AG.01.g,3404.0,"Although there were no ethnic differences in overall saturated fat / cholesterol avoidance , more non - Hispanic whites recognized milk , eggs , and visible fat on meat as food sources to avoid ."
98256,",",O,3404.0,"Although there were no ethnic differences in overall saturated fat / cholesterol avoidance , more non - Hispanic whites recognized milk , eggs , and visible fat on meat as food sources to avoid ."
98257,and,O,3404.0,"Although there were no ethnic differences in overall saturated fat / cholesterol avoidance , more non - Hispanic whites recognized milk , eggs , and visible fat on meat as food sources to avoid ."
98258,visible,O,3404.0,"Although there were no ethnic differences in overall saturated fat / cholesterol avoidance , more non - Hispanic whites recognized milk , eggs , and visible fat on meat as food sources to avoid ."
98259,fat,B-AG.01.f,3404.0,"Although there were no ethnic differences in overall saturated fat / cholesterol avoidance , more non - Hispanic whites recognized milk , eggs , and visible fat on meat as food sources to avoid ."
98260,on,I-AG.01.f,3404.0,"Although there were no ethnic differences in overall saturated fat / cholesterol avoidance , more non - Hispanic whites recognized milk , eggs , and visible fat on meat as food sources to avoid ."
98261,meat,I-AG.01.f,3404.0,"Although there were no ethnic differences in overall saturated fat / cholesterol avoidance , more non - Hispanic whites recognized milk , eggs , and visible fat on meat as food sources to avoid ."
98262,as,O,3404.0,"Although there were no ethnic differences in overall saturated fat / cholesterol avoidance , more non - Hispanic whites recognized milk , eggs , and visible fat on meat as food sources to avoid ."
98263,food,O,3404.0,"Although there were no ethnic differences in overall saturated fat / cholesterol avoidance , more non - Hispanic whites recognized milk , eggs , and visible fat on meat as food sources to avoid ."
98264,sources,O,3404.0,"Although there were no ethnic differences in overall saturated fat / cholesterol avoidance , more non - Hispanic whites recognized milk , eggs , and visible fat on meat as food sources to avoid ."
98265,to,O,3404.0,"Although there were no ethnic differences in overall saturated fat / cholesterol avoidance , more non - Hispanic whites recognized milk , eggs , and visible fat on meat as food sources to avoid ."
98266,avoid,O,3404.0,"Although there were no ethnic differences in overall saturated fat / cholesterol avoidance , more non - Hispanic whites recognized milk , eggs , and visible fat on meat as food sources to avoid ."
98267,.,O,3404.0,"Although there were no ethnic differences in overall saturated fat / cholesterol avoidance , more non - Hispanic whites recognized milk , eggs , and visible fat on meat as food sources to avoid ."
98268,The,O,3405.0,The scale described in this paper provides useful information about the specific food components recognized as dietary sources of saturated fat and cholesterol and helps identify those population groups that would benefit from nutrition education programs .
98269,scale,O,3405.0,The scale described in this paper provides useful information about the specific food components recognized as dietary sources of saturated fat and cholesterol and helps identify those population groups that would benefit from nutrition education programs .
98270,described,O,3405.0,The scale described in this paper provides useful information about the specific food components recognized as dietary sources of saturated fat and cholesterol and helps identify those population groups that would benefit from nutrition education programs .
98271,in,O,3405.0,The scale described in this paper provides useful information about the specific food components recognized as dietary sources of saturated fat and cholesterol and helps identify those population groups that would benefit from nutrition education programs .
98272,this,O,3405.0,The scale described in this paper provides useful information about the specific food components recognized as dietary sources of saturated fat and cholesterol and helps identify those population groups that would benefit from nutrition education programs .
98273,paper,O,3405.0,The scale described in this paper provides useful information about the specific food components recognized as dietary sources of saturated fat and cholesterol and helps identify those population groups that would benefit from nutrition education programs .
98274,provides,O,3405.0,The scale described in this paper provides useful information about the specific food components recognized as dietary sources of saturated fat and cholesterol and helps identify those population groups that would benefit from nutrition education programs .
98275,useful,O,3405.0,The scale described in this paper provides useful information about the specific food components recognized as dietary sources of saturated fat and cholesterol and helps identify those population groups that would benefit from nutrition education programs .
98276,information,O,3405.0,The scale described in this paper provides useful information about the specific food components recognized as dietary sources of saturated fat and cholesterol and helps identify those population groups that would benefit from nutrition education programs .
98277,about,O,3405.0,The scale described in this paper provides useful information about the specific food components recognized as dietary sources of saturated fat and cholesterol and helps identify those population groups that would benefit from nutrition education programs .
98278,the,O,3405.0,The scale described in this paper provides useful information about the specific food components recognized as dietary sources of saturated fat and cholesterol and helps identify those population groups that would benefit from nutrition education programs .
98279,specific,O,3405.0,The scale described in this paper provides useful information about the specific food components recognized as dietary sources of saturated fat and cholesterol and helps identify those population groups that would benefit from nutrition education programs .
98280,food,O,3405.0,The scale described in this paper provides useful information about the specific food components recognized as dietary sources of saturated fat and cholesterol and helps identify those population groups that would benefit from nutrition education programs .
98281,components,O,3405.0,The scale described in this paper provides useful information about the specific food components recognized as dietary sources of saturated fat and cholesterol and helps identify those population groups that would benefit from nutrition education programs .
98282,recognized,O,3405.0,The scale described in this paper provides useful information about the specific food components recognized as dietary sources of saturated fat and cholesterol and helps identify those population groups that would benefit from nutrition education programs .
98283,as,O,3405.0,The scale described in this paper provides useful information about the specific food components recognized as dietary sources of saturated fat and cholesterol and helps identify those population groups that would benefit from nutrition education programs .
98284,dietary,O,3405.0,The scale described in this paper provides useful information about the specific food components recognized as dietary sources of saturated fat and cholesterol and helps identify those population groups that would benefit from nutrition education programs .
98285,sources,O,3405.0,The scale described in this paper provides useful information about the specific food components recognized as dietary sources of saturated fat and cholesterol and helps identify those population groups that would benefit from nutrition education programs .
98286,of,O,3405.0,The scale described in this paper provides useful information about the specific food components recognized as dietary sources of saturated fat and cholesterol and helps identify those population groups that would benefit from nutrition education programs .
98287,saturated,O,3405.0,The scale described in this paper provides useful information about the specific food components recognized as dietary sources of saturated fat and cholesterol and helps identify those population groups that would benefit from nutrition education programs .
98288,fat,O,3405.0,The scale described in this paper provides useful information about the specific food components recognized as dietary sources of saturated fat and cholesterol and helps identify those population groups that would benefit from nutrition education programs .
98289,and,O,3405.0,The scale described in this paper provides useful information about the specific food components recognized as dietary sources of saturated fat and cholesterol and helps identify those population groups that would benefit from nutrition education programs .
98290,cholesterol,O,3405.0,The scale described in this paper provides useful information about the specific food components recognized as dietary sources of saturated fat and cholesterol and helps identify those population groups that would benefit from nutrition education programs .
98291,and,O,3405.0,The scale described in this paper provides useful information about the specific food components recognized as dietary sources of saturated fat and cholesterol and helps identify those population groups that would benefit from nutrition education programs .
98292,helps,O,3405.0,The scale described in this paper provides useful information about the specific food components recognized as dietary sources of saturated fat and cholesterol and helps identify those population groups that would benefit from nutrition education programs .
98293,identify,O,3405.0,The scale described in this paper provides useful information about the specific food components recognized as dietary sources of saturated fat and cholesterol and helps identify those population groups that would benefit from nutrition education programs .
98294,those,O,3405.0,The scale described in this paper provides useful information about the specific food components recognized as dietary sources of saturated fat and cholesterol and helps identify those population groups that would benefit from nutrition education programs .
98295,population,O,3405.0,The scale described in this paper provides useful information about the specific food components recognized as dietary sources of saturated fat and cholesterol and helps identify those population groups that would benefit from nutrition education programs .
98296,groups,O,3405.0,The scale described in this paper provides useful information about the specific food components recognized as dietary sources of saturated fat and cholesterol and helps identify those population groups that would benefit from nutrition education programs .
98297,that,O,3405.0,The scale described in this paper provides useful information about the specific food components recognized as dietary sources of saturated fat and cholesterol and helps identify those population groups that would benefit from nutrition education programs .
98298,would,O,3405.0,The scale described in this paper provides useful information about the specific food components recognized as dietary sources of saturated fat and cholesterol and helps identify those population groups that would benefit from nutrition education programs .
98299,benefit,O,3405.0,The scale described in this paper provides useful information about the specific food components recognized as dietary sources of saturated fat and cholesterol and helps identify those population groups that would benefit from nutrition education programs .
98300,from,O,3405.0,The scale described in this paper provides useful information about the specific food components recognized as dietary sources of saturated fat and cholesterol and helps identify those population groups that would benefit from nutrition education programs .
98301,nutrition,O,3405.0,The scale described in this paper provides useful information about the specific food components recognized as dietary sources of saturated fat and cholesterol and helps identify those population groups that would benefit from nutrition education programs .
98302,education,O,3405.0,The scale described in this paper provides useful information about the specific food components recognized as dietary sources of saturated fat and cholesterol and helps identify those population groups that would benefit from nutrition education programs .
98303,programs,O,3405.0,The scale described in this paper provides useful information about the specific food components recognized as dietary sources of saturated fat and cholesterol and helps identify those population groups that would benefit from nutrition education programs .
98304,.,O,3405.0,The scale described in this paper provides useful information about the specific food components recognized as dietary sources of saturated fat and cholesterol and helps identify those population groups that would benefit from nutrition education programs .
98305,Because,O,3406.0,"Because of its simplicity and ease of administration , the scale may be a useful tool in epidemiological research ."
98306,of,O,3406.0,"Because of its simplicity and ease of administration , the scale may be a useful tool in epidemiological research ."
98307,its,O,3406.0,"Because of its simplicity and ease of administration , the scale may be a useful tool in epidemiological research ."
98308,simplicity,O,3406.0,"Because of its simplicity and ease of administration , the scale may be a useful tool in epidemiological research ."
98309,and,O,3406.0,"Because of its simplicity and ease of administration , the scale may be a useful tool in epidemiological research ."
98310,ease,O,3406.0,"Because of its simplicity and ease of administration , the scale may be a useful tool in epidemiological research ."
98311,of,O,3406.0,"Because of its simplicity and ease of administration , the scale may be a useful tool in epidemiological research ."
98312,administration,O,3406.0,"Because of its simplicity and ease of administration , the scale may be a useful tool in epidemiological research ."
98313,",",O,3406.0,"Because of its simplicity and ease of administration , the scale may be a useful tool in epidemiological research ."
98314,the,O,3406.0,"Because of its simplicity and ease of administration , the scale may be a useful tool in epidemiological research ."
98315,scale,O,3406.0,"Because of its simplicity and ease of administration , the scale may be a useful tool in epidemiological research ."
98316,may,O,3406.0,"Because of its simplicity and ease of administration , the scale may be a useful tool in epidemiological research ."
98317,be,O,3406.0,"Because of its simplicity and ease of administration , the scale may be a useful tool in epidemiological research ."
98318,a,O,3406.0,"Because of its simplicity and ease of administration , the scale may be a useful tool in epidemiological research ."
98319,useful,O,3406.0,"Because of its simplicity and ease of administration , the scale may be a useful tool in epidemiological research ."
98320,tool,O,3406.0,"Because of its simplicity and ease of administration , the scale may be a useful tool in epidemiological research ."
98321,in,O,3406.0,"Because of its simplicity and ease of administration , the scale may be a useful tool in epidemiological research ."
98322,epidemiological,O,3406.0,"Because of its simplicity and ease of administration , the scale may be a useful tool in epidemiological research ."
98323,research,O,3406.0,"Because of its simplicity and ease of administration , the scale may be a useful tool in epidemiological research ."
98324,.,O,3406.0,"Because of its simplicity and ease of administration , the scale may be a useful tool in epidemiological research ."
98325,The,O,3407.0,The impact of coffee and green tea consumption on upper aerodigestive tract ( UADT ) cancer risk has not been established .
98326,impact,O,3407.0,The impact of coffee and green tea consumption on upper aerodigestive tract ( UADT ) cancer risk has not been established .
98327,of,O,3407.0,The impact of coffee and green tea consumption on upper aerodigestive tract ( UADT ) cancer risk has not been established .
98328,coffee,B-AG.01.ad,3407.0,The impact of coffee and green tea consumption on upper aerodigestive tract ( UADT ) cancer risk has not been established .
98329,and,O,3407.0,The impact of coffee and green tea consumption on upper aerodigestive tract ( UADT ) cancer risk has not been established .
98330,green,B-AG.01.ac,3407.0,The impact of coffee and green tea consumption on upper aerodigestive tract ( UADT ) cancer risk has not been established .
98331,tea,I-AG.01.ac,3407.0,The impact of coffee and green tea consumption on upper aerodigestive tract ( UADT ) cancer risk has not been established .
98332,consumption,B-X,3407.0,The impact of coffee and green tea consumption on upper aerodigestive tract ( UADT ) cancer risk has not been established .
98333,on,O,3407.0,The impact of coffee and green tea consumption on upper aerodigestive tract ( UADT ) cancer risk has not been established .
98334,upper,O,3407.0,The impact of coffee and green tea consumption on upper aerodigestive tract ( UADT ) cancer risk has not been established .
98335,aerodigestive,O,3407.0,The impact of coffee and green tea consumption on upper aerodigestive tract ( UADT ) cancer risk has not been established .
98336,tract,O,3407.0,The impact of coffee and green tea consumption on upper aerodigestive tract ( UADT ) cancer risk has not been established .
98337,(,O,3407.0,The impact of coffee and green tea consumption on upper aerodigestive tract ( UADT ) cancer risk has not been established .
98338,UADT,O,3407.0,The impact of coffee and green tea consumption on upper aerodigestive tract ( UADT ) cancer risk has not been established .
98339,),O,3407.0,The impact of coffee and green tea consumption on upper aerodigestive tract ( UADT ) cancer risk has not been established .
98340,cancer,O,3407.0,The impact of coffee and green tea consumption on upper aerodigestive tract ( UADT ) cancer risk has not been established .
98341,risk,O,3407.0,The impact of coffee and green tea consumption on upper aerodigestive tract ( UADT ) cancer risk has not been established .
98342,has,O,3407.0,The impact of coffee and green tea consumption on upper aerodigestive tract ( UADT ) cancer risk has not been established .
98343,not,O,3407.0,The impact of coffee and green tea consumption on upper aerodigestive tract ( UADT ) cancer risk has not been established .
98344,been,O,3407.0,The impact of coffee and green tea consumption on upper aerodigestive tract ( UADT ) cancer risk has not been established .
98345,established,O,3407.0,The impact of coffee and green tea consumption on upper aerodigestive tract ( UADT ) cancer risk has not been established .
98346,.,O,3407.0,The impact of coffee and green tea consumption on upper aerodigestive tract ( UADT ) cancer risk has not been established .
98347,Evaluation,O,3408.0,Evaluation of the possible anticarcinogenic properties of their ingredients is confounded by the potential increase in risk owing to the high temperatures at which these beverages are generally consumed .
98348,of,O,3408.0,Evaluation of the possible anticarcinogenic properties of their ingredients is confounded by the potential increase in risk owing to the high temperatures at which these beverages are generally consumed .
98349,the,O,3408.0,Evaluation of the possible anticarcinogenic properties of their ingredients is confounded by the potential increase in risk owing to the high temperatures at which these beverages are generally consumed .
98350,possible,O,3408.0,Evaluation of the possible anticarcinogenic properties of their ingredients is confounded by the potential increase in risk owing to the high temperatures at which these beverages are generally consumed .
98351,anticarcinogenic,O,3408.0,Evaluation of the possible anticarcinogenic properties of their ingredients is confounded by the potential increase in risk owing to the high temperatures at which these beverages are generally consumed .
98352,properties,O,3408.0,Evaluation of the possible anticarcinogenic properties of their ingredients is confounded by the potential increase in risk owing to the high temperatures at which these beverages are generally consumed .
98353,of,O,3408.0,Evaluation of the possible anticarcinogenic properties of their ingredients is confounded by the potential increase in risk owing to the high temperatures at which these beverages are generally consumed .
98354,their,O,3408.0,Evaluation of the possible anticarcinogenic properties of their ingredients is confounded by the potential increase in risk owing to the high temperatures at which these beverages are generally consumed .
98355,ingredients,O,3408.0,Evaluation of the possible anticarcinogenic properties of their ingredients is confounded by the potential increase in risk owing to the high temperatures at which these beverages are generally consumed .
98356,is,O,3408.0,Evaluation of the possible anticarcinogenic properties of their ingredients is confounded by the potential increase in risk owing to the high temperatures at which these beverages are generally consumed .
98357,confounded,O,3408.0,Evaluation of the possible anticarcinogenic properties of their ingredients is confounded by the potential increase in risk owing to the high temperatures at which these beverages are generally consumed .
98358,by,O,3408.0,Evaluation of the possible anticarcinogenic properties of their ingredients is confounded by the potential increase in risk owing to the high temperatures at which these beverages are generally consumed .
98359,the,O,3408.0,Evaluation of the possible anticarcinogenic properties of their ingredients is confounded by the potential increase in risk owing to the high temperatures at which these beverages are generally consumed .
98360,potential,O,3408.0,Evaluation of the possible anticarcinogenic properties of their ingredients is confounded by the potential increase in risk owing to the high temperatures at which these beverages are generally consumed .
98361,increase,O,3408.0,Evaluation of the possible anticarcinogenic properties of their ingredients is confounded by the potential increase in risk owing to the high temperatures at which these beverages are generally consumed .
98362,in,O,3408.0,Evaluation of the possible anticarcinogenic properties of their ingredients is confounded by the potential increase in risk owing to the high temperatures at which these beverages are generally consumed .
98363,risk,O,3408.0,Evaluation of the possible anticarcinogenic properties of their ingredients is confounded by the potential increase in risk owing to the high temperatures at which these beverages are generally consumed .
98364,owing,O,3408.0,Evaluation of the possible anticarcinogenic properties of their ingredients is confounded by the potential increase in risk owing to the high temperatures at which these beverages are generally consumed .
98365,to,O,3408.0,Evaluation of the possible anticarcinogenic properties of their ingredients is confounded by the potential increase in risk owing to the high temperatures at which these beverages are generally consumed .
98366,the,O,3408.0,Evaluation of the possible anticarcinogenic properties of their ingredients is confounded by the potential increase in risk owing to the high temperatures at which these beverages are generally consumed .
98367,high,O,3408.0,Evaluation of the possible anticarcinogenic properties of their ingredients is confounded by the potential increase in risk owing to the high temperatures at which these beverages are generally consumed .
98368,temperatures,O,3408.0,Evaluation of the possible anticarcinogenic properties of their ingredients is confounded by the potential increase in risk owing to the high temperatures at which these beverages are generally consumed .
98369,at,O,3408.0,Evaluation of the possible anticarcinogenic properties of their ingredients is confounded by the potential increase in risk owing to the high temperatures at which these beverages are generally consumed .
98370,which,O,3408.0,Evaluation of the possible anticarcinogenic properties of their ingredients is confounded by the potential increase in risk owing to the high temperatures at which these beverages are generally consumed .
98371,these,O,3408.0,Evaluation of the possible anticarcinogenic properties of their ingredients is confounded by the potential increase in risk owing to the high temperatures at which these beverages are generally consumed .
98372,beverages,B-AG.01.y,3408.0,Evaluation of the possible anticarcinogenic properties of their ingredients is confounded by the potential increase in risk owing to the high temperatures at which these beverages are generally consumed .
98373,are,O,3408.0,Evaluation of the possible anticarcinogenic properties of their ingredients is confounded by the potential increase in risk owing to the high temperatures at which these beverages are generally consumed .
98374,generally,O,3408.0,Evaluation of the possible anticarcinogenic properties of their ingredients is confounded by the potential increase in risk owing to the high temperatures at which these beverages are generally consumed .
98375,consumed,O,3408.0,Evaluation of the possible anticarcinogenic properties of their ingredients is confounded by the potential increase in risk owing to the high temperatures at which these beverages are generally consumed .
98376,.,O,3408.0,Evaluation of the possible anticarcinogenic properties of their ingredients is confounded by the potential increase in risk owing to the high temperatures at which these beverages are generally consumed .
98377,We,O,3409.0,We conducted a case - control study to evaluate the association between coffee and tea consumption and the risk of UADT cancer .
98378,conducted,O,3409.0,We conducted a case - control study to evaluate the association between coffee and tea consumption and the risk of UADT cancer .
98379,a,O,3409.0,We conducted a case - control study to evaluate the association between coffee and tea consumption and the risk of UADT cancer .
98380,case,O,3409.0,We conducted a case - control study to evaluate the association between coffee and tea consumption and the risk of UADT cancer .
98381,-,O,3409.0,We conducted a case - control study to evaluate the association between coffee and tea consumption and the risk of UADT cancer .
98382,control,O,3409.0,We conducted a case - control study to evaluate the association between coffee and tea consumption and the risk of UADT cancer .
98383,study,O,3409.0,We conducted a case - control study to evaluate the association between coffee and tea consumption and the risk of UADT cancer .
98384,to,O,3409.0,We conducted a case - control study to evaluate the association between coffee and tea consumption and the risk of UADT cancer .
98385,evaluate,O,3409.0,We conducted a case - control study to evaluate the association between coffee and tea consumption and the risk of UADT cancer .
98386,the,O,3409.0,We conducted a case - control study to evaluate the association between coffee and tea consumption and the risk of UADT cancer .
98387,association,O,3409.0,We conducted a case - control study to evaluate the association between coffee and tea consumption and the risk of UADT cancer .
98388,between,O,3409.0,We conducted a case - control study to evaluate the association between coffee and tea consumption and the risk of UADT cancer .
98389,coffee,B-AG.01.ad,3409.0,We conducted a case - control study to evaluate the association between coffee and tea consumption and the risk of UADT cancer .
98390,and,O,3409.0,We conducted a case - control study to evaluate the association between coffee and tea consumption and the risk of UADT cancer .
98391,tea,B-AG.01.ac,3409.0,We conducted a case - control study to evaluate the association between coffee and tea consumption and the risk of UADT cancer .
98392,consumption,B-X,3409.0,We conducted a case - control study to evaluate the association between coffee and tea consumption and the risk of UADT cancer .
98393,and,O,3409.0,We conducted a case - control study to evaluate the association between coffee and tea consumption and the risk of UADT cancer .
98394,the,O,3409.0,We conducted a case - control study to evaluate the association between coffee and tea consumption and the risk of UADT cancer .
98395,risk,O,3409.0,We conducted a case - control study to evaluate the association between coffee and tea consumption and the risk of UADT cancer .
98396,of,O,3409.0,We conducted a case - control study to evaluate the association between coffee and tea consumption and the risk of UADT cancer .
98397,UADT,O,3409.0,We conducted a case - control study to evaluate the association between coffee and tea consumption and the risk of UADT cancer .
98398,cancer,O,3409.0,We conducted a case - control study to evaluate the association between coffee and tea consumption and the risk of UADT cancer .
98399,.,O,3409.0,We conducted a case - control study to evaluate the association between coffee and tea consumption and the risk of UADT cancer .
98400,The,O,3410.0,"The study enrolled 961 patients with UADT cancer and 2,883 noncancer outpatients who visited Aichi Cancer Center between 2001 and 2005 ."
98401,study,O,3410.0,"The study enrolled 961 patients with UADT cancer and 2,883 noncancer outpatients who visited Aichi Cancer Center between 2001 and 2005 ."
98402,enrolled,O,3410.0,"The study enrolled 961 patients with UADT cancer and 2,883 noncancer outpatients who visited Aichi Cancer Center between 2001 and 2005 ."
98403,961,O,3410.0,"The study enrolled 961 patients with UADT cancer and 2,883 noncancer outpatients who visited Aichi Cancer Center between 2001 and 2005 ."
98404,patients,O,3410.0,"The study enrolled 961 patients with UADT cancer and 2,883 noncancer outpatients who visited Aichi Cancer Center between 2001 and 2005 ."
98405,with,O,3410.0,"The study enrolled 961 patients with UADT cancer and 2,883 noncancer outpatients who visited Aichi Cancer Center between 2001 and 2005 ."
98406,UADT,O,3410.0,"The study enrolled 961 patients with UADT cancer and 2,883 noncancer outpatients who visited Aichi Cancer Center between 2001 and 2005 ."
98407,cancer,O,3410.0,"The study enrolled 961 patients with UADT cancer and 2,883 noncancer outpatients who visited Aichi Cancer Center between 2001 and 2005 ."
98408,and,O,3410.0,"The study enrolled 961 patients with UADT cancer and 2,883 noncancer outpatients who visited Aichi Cancer Center between 2001 and 2005 ."
98409,"2,883",O,3410.0,"The study enrolled 961 patients with UADT cancer and 2,883 noncancer outpatients who visited Aichi Cancer Center between 2001 and 2005 ."
98410,noncancer,O,3410.0,"The study enrolled 961 patients with UADT cancer and 2,883 noncancer outpatients who visited Aichi Cancer Center between 2001 and 2005 ."
98411,outpatients,O,3410.0,"The study enrolled 961 patients with UADT cancer and 2,883 noncancer outpatients who visited Aichi Cancer Center between 2001 and 2005 ."
98412,who,O,3410.0,"The study enrolled 961 patients with UADT cancer and 2,883 noncancer outpatients who visited Aichi Cancer Center between 2001 and 2005 ."
98413,visited,O,3410.0,"The study enrolled 961 patients with UADT cancer and 2,883 noncancer outpatients who visited Aichi Cancer Center between 2001 and 2005 ."
98414,Aichi,O,3410.0,"The study enrolled 961 patients with UADT cancer and 2,883 noncancer outpatients who visited Aichi Cancer Center between 2001 and 2005 ."
98415,Cancer,O,3410.0,"The study enrolled 961 patients with UADT cancer and 2,883 noncancer outpatients who visited Aichi Cancer Center between 2001 and 2005 ."
98416,Center,O,3410.0,"The study enrolled 961 patients with UADT cancer and 2,883 noncancer outpatients who visited Aichi Cancer Center between 2001 and 2005 ."
98417,between,O,3410.0,"The study enrolled 961 patients with UADT cancer and 2,883 noncancer outpatients who visited Aichi Cancer Center between 2001 and 2005 ."
98418,2001,O,3410.0,"The study enrolled 961 patients with UADT cancer and 2,883 noncancer outpatients who visited Aichi Cancer Center between 2001 and 2005 ."
98419,and,O,3410.0,"The study enrolled 961 patients with UADT cancer and 2,883 noncancer outpatients who visited Aichi Cancer Center between 2001 and 2005 ."
98420,2005,O,3410.0,"The study enrolled 961 patients with UADT cancer and 2,883 noncancer outpatients who visited Aichi Cancer Center between 2001 and 2005 ."
98421,.,O,3410.0,"The study enrolled 961 patients with UADT cancer and 2,883 noncancer outpatients who visited Aichi Cancer Center between 2001 and 2005 ."
98422,Information,O,3411.0,Information on coffee and green tea consumption and other lifestyle factors was collected via a self - administered questionnaire .
98423,on,O,3411.0,Information on coffee and green tea consumption and other lifestyle factors was collected via a self - administered questionnaire .
98424,coffee,B-AG.01.ad,3411.0,Information on coffee and green tea consumption and other lifestyle factors was collected via a self - administered questionnaire .
98425,and,O,3411.0,Information on coffee and green tea consumption and other lifestyle factors was collected via a self - administered questionnaire .
98426,green,B-AG.01.ac,3411.0,Information on coffee and green tea consumption and other lifestyle factors was collected via a self - administered questionnaire .
98427,tea,I-AG.01.ac,3411.0,Information on coffee and green tea consumption and other lifestyle factors was collected via a self - administered questionnaire .
98428,consumption,B-X,3411.0,Information on coffee and green tea consumption and other lifestyle factors was collected via a self - administered questionnaire .
98429,and,O,3411.0,Information on coffee and green tea consumption and other lifestyle factors was collected via a self - administered questionnaire .
98430,other,O,3411.0,Information on coffee and green tea consumption and other lifestyle factors was collected via a self - administered questionnaire .
98431,lifestyle,O,3411.0,Information on coffee and green tea consumption and other lifestyle factors was collected via a self - administered questionnaire .
98432,factors,O,3411.0,Information on coffee and green tea consumption and other lifestyle factors was collected via a self - administered questionnaire .
98433,was,O,3411.0,Information on coffee and green tea consumption and other lifestyle factors was collected via a self - administered questionnaire .
98434,collected,O,3411.0,Information on coffee and green tea consumption and other lifestyle factors was collected via a self - administered questionnaire .
98435,via,O,3411.0,Information on coffee and green tea consumption and other lifestyle factors was collected via a self - administered questionnaire .
98436,a,O,3411.0,Information on coffee and green tea consumption and other lifestyle factors was collected via a self - administered questionnaire .
98437,self,O,3411.0,Information on coffee and green tea consumption and other lifestyle factors was collected via a self - administered questionnaire .
98438,-,O,3411.0,Information on coffee and green tea consumption and other lifestyle factors was collected via a self - administered questionnaire .
98439,administered,O,3411.0,Information on coffee and green tea consumption and other lifestyle factors was collected via a self - administered questionnaire .
98440,questionnaire,O,3411.0,Information on coffee and green tea consumption and other lifestyle factors was collected via a self - administered questionnaire .
98441,.,O,3411.0,Information on coffee and green tea consumption and other lifestyle factors was collected via a self - administered questionnaire .
98442,Consumption,O,3412.0,"Consumption of three or more cups of coffee per day had a significant inverse association with UADT cancer [ odds ratio ( OR ) 0.73 , 95 % confidence interval ( CI ) 0.55 - 0.96 ] ."
98443,of,O,3412.0,"Consumption of three or more cups of coffee per day had a significant inverse association with UADT cancer [ odds ratio ( OR ) 0.73 , 95 % confidence interval ( CI ) 0.55 - 0.96 ] ."
98444,three,O,3412.0,"Consumption of three or more cups of coffee per day had a significant inverse association with UADT cancer [ odds ratio ( OR ) 0.73 , 95 % confidence interval ( CI ) 0.55 - 0.96 ] ."
98445,or,O,3412.0,"Consumption of three or more cups of coffee per day had a significant inverse association with UADT cancer [ odds ratio ( OR ) 0.73 , 95 % confidence interval ( CI ) 0.55 - 0.96 ] ."
98446,more,O,3412.0,"Consumption of three or more cups of coffee per day had a significant inverse association with UADT cancer [ odds ratio ( OR ) 0.73 , 95 % confidence interval ( CI ) 0.55 - 0.96 ] ."
98447,cups,O,3412.0,"Consumption of three or more cups of coffee per day had a significant inverse association with UADT cancer [ odds ratio ( OR ) 0.73 , 95 % confidence interval ( CI ) 0.55 - 0.96 ] ."
98448,of,O,3412.0,"Consumption of three or more cups of coffee per day had a significant inverse association with UADT cancer [ odds ratio ( OR ) 0.73 , 95 % confidence interval ( CI ) 0.55 - 0.96 ] ."
98449,coffee,B-AG.01.ad,3412.0,"Consumption of three or more cups of coffee per day had a significant inverse association with UADT cancer [ odds ratio ( OR ) 0.73 , 95 % confidence interval ( CI ) 0.55 - 0.96 ] ."
98450,per,O,3412.0,"Consumption of three or more cups of coffee per day had a significant inverse association with UADT cancer [ odds ratio ( OR ) 0.73 , 95 % confidence interval ( CI ) 0.55 - 0.96 ] ."
98451,day,O,3412.0,"Consumption of three or more cups of coffee per day had a significant inverse association with UADT cancer [ odds ratio ( OR ) 0.73 , 95 % confidence interval ( CI ) 0.55 - 0.96 ] ."
98452,had,O,3412.0,"Consumption of three or more cups of coffee per day had a significant inverse association with UADT cancer [ odds ratio ( OR ) 0.73 , 95 % confidence interval ( CI ) 0.55 - 0.96 ] ."
98453,a,O,3412.0,"Consumption of three or more cups of coffee per day had a significant inverse association with UADT cancer [ odds ratio ( OR ) 0.73 , 95 % confidence interval ( CI ) 0.55 - 0.96 ] ."
98454,significant,O,3412.0,"Consumption of three or more cups of coffee per day had a significant inverse association with UADT cancer [ odds ratio ( OR ) 0.73 , 95 % confidence interval ( CI ) 0.55 - 0.96 ] ."
98455,inverse,O,3412.0,"Consumption of three or more cups of coffee per day had a significant inverse association with UADT cancer [ odds ratio ( OR ) 0.73 , 95 % confidence interval ( CI ) 0.55 - 0.96 ] ."
98456,association,O,3412.0,"Consumption of three or more cups of coffee per day had a significant inverse association with UADT cancer [ odds ratio ( OR ) 0.73 , 95 % confidence interval ( CI ) 0.55 - 0.96 ] ."
98457,with,O,3412.0,"Consumption of three or more cups of coffee per day had a significant inverse association with UADT cancer [ odds ratio ( OR ) 0.73 , 95 % confidence interval ( CI ) 0.55 - 0.96 ] ."
98458,UADT,O,3412.0,"Consumption of three or more cups of coffee per day had a significant inverse association with UADT cancer [ odds ratio ( OR ) 0.73 , 95 % confidence interval ( CI ) 0.55 - 0.96 ] ."
98459,cancer,O,3412.0,"Consumption of three or more cups of coffee per day had a significant inverse association with UADT cancer [ odds ratio ( OR ) 0.73 , 95 % confidence interval ( CI ) 0.55 - 0.96 ] ."
98460,[,O,3412.0,"Consumption of three or more cups of coffee per day had a significant inverse association with UADT cancer [ odds ratio ( OR ) 0.73 , 95 % confidence interval ( CI ) 0.55 - 0.96 ] ."
98461,odds,O,3412.0,"Consumption of three or more cups of coffee per day had a significant inverse association with UADT cancer [ odds ratio ( OR ) 0.73 , 95 % confidence interval ( CI ) 0.55 - 0.96 ] ."
98462,ratio,O,3412.0,"Consumption of three or more cups of coffee per day had a significant inverse association with UADT cancer [ odds ratio ( OR ) 0.73 , 95 % confidence interval ( CI ) 0.55 - 0.96 ] ."
98463,(,O,3412.0,"Consumption of three or more cups of coffee per day had a significant inverse association with UADT cancer [ odds ratio ( OR ) 0.73 , 95 % confidence interval ( CI ) 0.55 - 0.96 ] ."
98464,OR,O,3412.0,"Consumption of three or more cups of coffee per day had a significant inverse association with UADT cancer [ odds ratio ( OR ) 0.73 , 95 % confidence interval ( CI ) 0.55 - 0.96 ] ."
98465,),O,3412.0,"Consumption of three or more cups of coffee per day had a significant inverse association with UADT cancer [ odds ratio ( OR ) 0.73 , 95 % confidence interval ( CI ) 0.55 - 0.96 ] ."
98466,0.73,O,3412.0,"Consumption of three or more cups of coffee per day had a significant inverse association with UADT cancer [ odds ratio ( OR ) 0.73 , 95 % confidence interval ( CI ) 0.55 - 0.96 ] ."
98467,",",O,3412.0,"Consumption of three or more cups of coffee per day had a significant inverse association with UADT cancer [ odds ratio ( OR ) 0.73 , 95 % confidence interval ( CI ) 0.55 - 0.96 ] ."
98468,95,O,3412.0,"Consumption of three or more cups of coffee per day had a significant inverse association with UADT cancer [ odds ratio ( OR ) 0.73 , 95 % confidence interval ( CI ) 0.55 - 0.96 ] ."
98469,%,O,3412.0,"Consumption of three or more cups of coffee per day had a significant inverse association with UADT cancer [ odds ratio ( OR ) 0.73 , 95 % confidence interval ( CI ) 0.55 - 0.96 ] ."
98470,confidence,O,3412.0,"Consumption of three or more cups of coffee per day had a significant inverse association with UADT cancer [ odds ratio ( OR ) 0.73 , 95 % confidence interval ( CI ) 0.55 - 0.96 ] ."
98471,interval,O,3412.0,"Consumption of three or more cups of coffee per day had a significant inverse association with UADT cancer [ odds ratio ( OR ) 0.73 , 95 % confidence interval ( CI ) 0.55 - 0.96 ] ."
98472,(,O,3412.0,"Consumption of three or more cups of coffee per day had a significant inverse association with UADT cancer [ odds ratio ( OR ) 0.73 , 95 % confidence interval ( CI ) 0.55 - 0.96 ] ."
98473,CI,O,3412.0,"Consumption of three or more cups of coffee per day had a significant inverse association with UADT cancer [ odds ratio ( OR ) 0.73 , 95 % confidence interval ( CI ) 0.55 - 0.96 ] ."
98474,),O,3412.0,"Consumption of three or more cups of coffee per day had a significant inverse association with UADT cancer [ odds ratio ( OR ) 0.73 , 95 % confidence interval ( CI ) 0.55 - 0.96 ] ."
98475,0.55,O,3412.0,"Consumption of three or more cups of coffee per day had a significant inverse association with UADT cancer [ odds ratio ( OR ) 0.73 , 95 % confidence interval ( CI ) 0.55 - 0.96 ] ."
98476,-,O,3412.0,"Consumption of three or more cups of coffee per day had a significant inverse association with UADT cancer [ odds ratio ( OR ) 0.73 , 95 % confidence interval ( CI ) 0.55 - 0.96 ] ."
98477,0.96,O,3412.0,"Consumption of three or more cups of coffee per day had a significant inverse association with UADT cancer [ odds ratio ( OR ) 0.73 , 95 % confidence interval ( CI ) 0.55 - 0.96 ] ."
98478,],O,3412.0,"Consumption of three or more cups of coffee per day had a significant inverse association with UADT cancer [ odds ratio ( OR ) 0.73 , 95 % confidence interval ( CI ) 0.55 - 0.96 ] ."
98479,.,O,3412.0,"Consumption of three or more cups of coffee per day had a significant inverse association with UADT cancer [ odds ratio ( OR ) 0.73 , 95 % confidence interval ( CI ) 0.55 - 0.96 ] ."
98480,In,O,3413.0,"In contrast , consumption of three or more cups of green tea per day had a significant positive association with UADT cancer ( OR 1.39 , 95 % CI 1.13 - 1.70 ) ."
98481,contrast,O,3413.0,"In contrast , consumption of three or more cups of green tea per day had a significant positive association with UADT cancer ( OR 1.39 , 95 % CI 1.13 - 1.70 ) ."
98482,",",O,3413.0,"In contrast , consumption of three or more cups of green tea per day had a significant positive association with UADT cancer ( OR 1.39 , 95 % CI 1.13 - 1.70 ) ."
98483,consumption,O,3413.0,"In contrast , consumption of three or more cups of green tea per day had a significant positive association with UADT cancer ( OR 1.39 , 95 % CI 1.13 - 1.70 ) ."
98484,of,O,3413.0,"In contrast , consumption of three or more cups of green tea per day had a significant positive association with UADT cancer ( OR 1.39 , 95 % CI 1.13 - 1.70 ) ."
98485,three,O,3413.0,"In contrast , consumption of three or more cups of green tea per day had a significant positive association with UADT cancer ( OR 1.39 , 95 % CI 1.13 - 1.70 ) ."
98486,or,O,3413.0,"In contrast , consumption of three or more cups of green tea per day had a significant positive association with UADT cancer ( OR 1.39 , 95 % CI 1.13 - 1.70 ) ."
98487,more,O,3413.0,"In contrast , consumption of three or more cups of green tea per day had a significant positive association with UADT cancer ( OR 1.39 , 95 % CI 1.13 - 1.70 ) ."
98488,cups,O,3413.0,"In contrast , consumption of three or more cups of green tea per day had a significant positive association with UADT cancer ( OR 1.39 , 95 % CI 1.13 - 1.70 ) ."
98489,of,O,3413.0,"In contrast , consumption of three or more cups of green tea per day had a significant positive association with UADT cancer ( OR 1.39 , 95 % CI 1.13 - 1.70 ) ."
98490,green,B-AG.01.ac,3413.0,"In contrast , consumption of three or more cups of green tea per day had a significant positive association with UADT cancer ( OR 1.39 , 95 % CI 1.13 - 1.70 ) ."
98491,tea,I-AG.01.ac,3413.0,"In contrast , consumption of three or more cups of green tea per day had a significant positive association with UADT cancer ( OR 1.39 , 95 % CI 1.13 - 1.70 ) ."
98492,per,O,3413.0,"In contrast , consumption of three or more cups of green tea per day had a significant positive association with UADT cancer ( OR 1.39 , 95 % CI 1.13 - 1.70 ) ."
98493,day,O,3413.0,"In contrast , consumption of three or more cups of green tea per day had a significant positive association with UADT cancer ( OR 1.39 , 95 % CI 1.13 - 1.70 ) ."
98494,had,O,3413.0,"In contrast , consumption of three or more cups of green tea per day had a significant positive association with UADT cancer ( OR 1.39 , 95 % CI 1.13 - 1.70 ) ."
98495,a,O,3413.0,"In contrast , consumption of three or more cups of green tea per day had a significant positive association with UADT cancer ( OR 1.39 , 95 % CI 1.13 - 1.70 ) ."
98496,significant,O,3413.0,"In contrast , consumption of three or more cups of green tea per day had a significant positive association with UADT cancer ( OR 1.39 , 95 % CI 1.13 - 1.70 ) ."
98497,positive,O,3413.0,"In contrast , consumption of three or more cups of green tea per day had a significant positive association with UADT cancer ( OR 1.39 , 95 % CI 1.13 - 1.70 ) ."
98498,association,O,3413.0,"In contrast , consumption of three or more cups of green tea per day had a significant positive association with UADT cancer ( OR 1.39 , 95 % CI 1.13 - 1.70 ) ."
98499,with,O,3413.0,"In contrast , consumption of three or more cups of green tea per day had a significant positive association with UADT cancer ( OR 1.39 , 95 % CI 1.13 - 1.70 ) ."
98500,UADT,O,3413.0,"In contrast , consumption of three or more cups of green tea per day had a significant positive association with UADT cancer ( OR 1.39 , 95 % CI 1.13 - 1.70 ) ."
98501,cancer,O,3413.0,"In contrast , consumption of three or more cups of green tea per day had a significant positive association with UADT cancer ( OR 1.39 , 95 % CI 1.13 - 1.70 ) ."
98502,(,O,3413.0,"In contrast , consumption of three or more cups of green tea per day had a significant positive association with UADT cancer ( OR 1.39 , 95 % CI 1.13 - 1.70 ) ."
98503,OR,O,3413.0,"In contrast , consumption of three or more cups of green tea per day had a significant positive association with UADT cancer ( OR 1.39 , 95 % CI 1.13 - 1.70 ) ."
98504,1.39,O,3413.0,"In contrast , consumption of three or more cups of green tea per day had a significant positive association with UADT cancer ( OR 1.39 , 95 % CI 1.13 - 1.70 ) ."
98505,",",O,3413.0,"In contrast , consumption of three or more cups of green tea per day had a significant positive association with UADT cancer ( OR 1.39 , 95 % CI 1.13 - 1.70 ) ."
98506,95,O,3413.0,"In contrast , consumption of three or more cups of green tea per day had a significant positive association with UADT cancer ( OR 1.39 , 95 % CI 1.13 - 1.70 ) ."
98507,%,O,3413.0,"In contrast , consumption of three or more cups of green tea per day had a significant positive association with UADT cancer ( OR 1.39 , 95 % CI 1.13 - 1.70 ) ."
98508,CI,O,3413.0,"In contrast , consumption of three or more cups of green tea per day had a significant positive association with UADT cancer ( OR 1.39 , 95 % CI 1.13 - 1.70 ) ."
98509,1.13,O,3413.0,"In contrast , consumption of three or more cups of green tea per day had a significant positive association with UADT cancer ( OR 1.39 , 95 % CI 1.13 - 1.70 ) ."
98510,-,O,3413.0,"In contrast , consumption of three or more cups of green tea per day had a significant positive association with UADT cancer ( OR 1.39 , 95 % CI 1.13 - 1.70 ) ."
98511,1.70,O,3413.0,"In contrast , consumption of three or more cups of green tea per day had a significant positive association with UADT cancer ( OR 1.39 , 95 % CI 1.13 - 1.70 ) ."
98512,),O,3413.0,"In contrast , consumption of three or more cups of green tea per day had a significant positive association with UADT cancer ( OR 1.39 , 95 % CI 1.13 - 1.70 ) ."
98513,.,O,3413.0,"In contrast , consumption of three or more cups of green tea per day had a significant positive association with UADT cancer ( OR 1.39 , 95 % CI 1.13 - 1.70 ) ."
98514,These,O,3414.0,These associations were evident for head and neck cancer but not for esophageal cancer .
98515,associations,O,3414.0,These associations were evident for head and neck cancer but not for esophageal cancer .
98516,were,O,3414.0,These associations were evident for head and neck cancer but not for esophageal cancer .
98517,evident,O,3414.0,These associations were evident for head and neck cancer but not for esophageal cancer .
98518,for,O,3414.0,These associations were evident for head and neck cancer but not for esophageal cancer .
98519,head,O,3414.0,These associations were evident for head and neck cancer but not for esophageal cancer .
98520,and,O,3414.0,These associations were evident for head and neck cancer but not for esophageal cancer .
98521,neck,O,3414.0,These associations were evident for head and neck cancer but not for esophageal cancer .
98522,cancer,O,3414.0,These associations were evident for head and neck cancer but not for esophageal cancer .
98523,but,O,3414.0,These associations were evident for head and neck cancer but not for esophageal cancer .
98524,not,O,3414.0,These associations were evident for head and neck cancer but not for esophageal cancer .
98525,for,O,3414.0,These associations were evident for head and neck cancer but not for esophageal cancer .
98526,esophageal,O,3414.0,These associations were evident for head and neck cancer but not for esophageal cancer .
98527,cancer,O,3414.0,These associations were evident for head and neck cancer but not for esophageal cancer .
98528,.,O,3414.0,These associations were evident for head and neck cancer but not for esophageal cancer .
98529,The,O,3415.0,The association of coffee consumption with head and neck cancer was observed only among never smokers and alcohol drinkers .
98530,association,O,3415.0,The association of coffee consumption with head and neck cancer was observed only among never smokers and alcohol drinkers .
98531,of,O,3415.0,The association of coffee consumption with head and neck cancer was observed only among never smokers and alcohol drinkers .
98532,coffee,B-AG.01.ad,3415.0,The association of coffee consumption with head and neck cancer was observed only among never smokers and alcohol drinkers .
98533,consumption,B-X,3415.0,The association of coffee consumption with head and neck cancer was observed only among never smokers and alcohol drinkers .
98534,with,O,3415.0,The association of coffee consumption with head and neck cancer was observed only among never smokers and alcohol drinkers .
98535,head,O,3415.0,The association of coffee consumption with head and neck cancer was observed only among never smokers and alcohol drinkers .
98536,and,O,3415.0,The association of coffee consumption with head and neck cancer was observed only among never smokers and alcohol drinkers .
98537,neck,O,3415.0,The association of coffee consumption with head and neck cancer was observed only among never smokers and alcohol drinkers .
98538,cancer,O,3415.0,The association of coffee consumption with head and neck cancer was observed only among never smokers and alcohol drinkers .
98539,was,O,3415.0,The association of coffee consumption with head and neck cancer was observed only among never smokers and alcohol drinkers .
98540,observed,O,3415.0,The association of coffee consumption with head and neck cancer was observed only among never smokers and alcohol drinkers .
98541,only,O,3415.0,The association of coffee consumption with head and neck cancer was observed only among never smokers and alcohol drinkers .
98542,among,O,3415.0,The association of coffee consumption with head and neck cancer was observed only among never smokers and alcohol drinkers .
98543,never,O,3415.0,The association of coffee consumption with head and neck cancer was observed only among never smokers and alcohol drinkers .
98544,smokers,O,3415.0,The association of coffee consumption with head and neck cancer was observed only among never smokers and alcohol drinkers .
98545,and,O,3415.0,The association of coffee consumption with head and neck cancer was observed only among never smokers and alcohol drinkers .
98546,alcohol,O,3415.0,The association of coffee consumption with head and neck cancer was observed only among never smokers and alcohol drinkers .
98547,drinkers,O,3415.0,The association of coffee consumption with head and neck cancer was observed only among never smokers and alcohol drinkers .
98548,.,O,3415.0,The association of coffee consumption with head and neck cancer was observed only among never smokers and alcohol drinkers .
98549,Similarly,O,3416.0,"Similarly , the association of green tea consumption was observed among never smokers and never alcohol drinkers ."
98550,",",O,3416.0,"Similarly , the association of green tea consumption was observed among never smokers and never alcohol drinkers ."
98551,the,O,3416.0,"Similarly , the association of green tea consumption was observed among never smokers and never alcohol drinkers ."
98552,association,O,3416.0,"Similarly , the association of green tea consumption was observed among never smokers and never alcohol drinkers ."
98553,of,O,3416.0,"Similarly , the association of green tea consumption was observed among never smokers and never alcohol drinkers ."
98554,green,B-AG.01.ac,3416.0,"Similarly , the association of green tea consumption was observed among never smokers and never alcohol drinkers ."
98555,tea,I-AG.01.ac,3416.0,"Similarly , the association of green tea consumption was observed among never smokers and never alcohol drinkers ."
98556,consumption,B-X,3416.0,"Similarly , the association of green tea consumption was observed among never smokers and never alcohol drinkers ."
98557,was,O,3416.0,"Similarly , the association of green tea consumption was observed among never smokers and never alcohol drinkers ."
98558,observed,O,3416.0,"Similarly , the association of green tea consumption was observed among never smokers and never alcohol drinkers ."
98559,among,O,3416.0,"Similarly , the association of green tea consumption was observed among never smokers and never alcohol drinkers ."
98560,never,O,3416.0,"Similarly , the association of green tea consumption was observed among never smokers and never alcohol drinkers ."
98561,smokers,O,3416.0,"Similarly , the association of green tea consumption was observed among never smokers and never alcohol drinkers ."
98562,and,O,3416.0,"Similarly , the association of green tea consumption was observed among never smokers and never alcohol drinkers ."
98563,never,O,3416.0,"Similarly , the association of green tea consumption was observed among never smokers and never alcohol drinkers ."
98564,alcohol,O,3416.0,"Similarly , the association of green tea consumption was observed among never smokers and never alcohol drinkers ."
98565,drinkers,O,3416.0,"Similarly , the association of green tea consumption was observed among never smokers and never alcohol drinkers ."
98566,.,O,3416.0,"Similarly , the association of green tea consumption was observed among never smokers and never alcohol drinkers ."
98567,No,O,3417.0,No change in these associations was seen on stratification by each confounding factors .
98568,change,O,3417.0,No change in these associations was seen on stratification by each confounding factors .
98569,in,O,3417.0,No change in these associations was seen on stratification by each confounding factors .
98570,these,O,3417.0,No change in these associations was seen on stratification by each confounding factors .
98571,associations,O,3417.0,No change in these associations was seen on stratification by each confounding factors .
98572,was,O,3417.0,No change in these associations was seen on stratification by each confounding factors .
98573,seen,O,3417.0,No change in these associations was seen on stratification by each confounding factors .
98574,on,O,3417.0,No change in these associations was seen on stratification by each confounding factors .
98575,stratification,O,3417.0,No change in these associations was seen on stratification by each confounding factors .
98576,by,O,3417.0,No change in these associations was seen on stratification by each confounding factors .
98577,each,O,3417.0,No change in these associations was seen on stratification by each confounding factors .
98578,confounding,O,3417.0,No change in these associations was seen on stratification by each confounding factors .
98579,factors,O,3417.0,No change in these associations was seen on stratification by each confounding factors .
98580,.,O,3417.0,No change in these associations was seen on stratification by each confounding factors .
98581,These,O,3418.0,"These findings suggest that consumption of coffee might be associated with a decreased risk of UADT cancer , whereas that of green tea might be associated with an increased risk ."
98582,findings,O,3418.0,"These findings suggest that consumption of coffee might be associated with a decreased risk of UADT cancer , whereas that of green tea might be associated with an increased risk ."
98583,suggest,O,3418.0,"These findings suggest that consumption of coffee might be associated with a decreased risk of UADT cancer , whereas that of green tea might be associated with an increased risk ."
98584,that,O,3418.0,"These findings suggest that consumption of coffee might be associated with a decreased risk of UADT cancer , whereas that of green tea might be associated with an increased risk ."
98585,consumption,O,3418.0,"These findings suggest that consumption of coffee might be associated with a decreased risk of UADT cancer , whereas that of green tea might be associated with an increased risk ."
98586,of,O,3418.0,"These findings suggest that consumption of coffee might be associated with a decreased risk of UADT cancer , whereas that of green tea might be associated with an increased risk ."
98587,coffee,B-AG.01.ad,3418.0,"These findings suggest that consumption of coffee might be associated with a decreased risk of UADT cancer , whereas that of green tea might be associated with an increased risk ."
98588,might,O,3418.0,"These findings suggest that consumption of coffee might be associated with a decreased risk of UADT cancer , whereas that of green tea might be associated with an increased risk ."
98589,be,O,3418.0,"These findings suggest that consumption of coffee might be associated with a decreased risk of UADT cancer , whereas that of green tea might be associated with an increased risk ."
98590,associated,O,3418.0,"These findings suggest that consumption of coffee might be associated with a decreased risk of UADT cancer , whereas that of green tea might be associated with an increased risk ."
98591,with,O,3418.0,"These findings suggest that consumption of coffee might be associated with a decreased risk of UADT cancer , whereas that of green tea might be associated with an increased risk ."
98592,a,O,3418.0,"These findings suggest that consumption of coffee might be associated with a decreased risk of UADT cancer , whereas that of green tea might be associated with an increased risk ."
98593,decreased,O,3418.0,"These findings suggest that consumption of coffee might be associated with a decreased risk of UADT cancer , whereas that of green tea might be associated with an increased risk ."
98594,risk,O,3418.0,"These findings suggest that consumption of coffee might be associated with a decreased risk of UADT cancer , whereas that of green tea might be associated with an increased risk ."
98595,of,O,3418.0,"These findings suggest that consumption of coffee might be associated with a decreased risk of UADT cancer , whereas that of green tea might be associated with an increased risk ."
98596,UADT,O,3418.0,"These findings suggest that consumption of coffee might be associated with a decreased risk of UADT cancer , whereas that of green tea might be associated with an increased risk ."
98597,cancer,O,3418.0,"These findings suggest that consumption of coffee might be associated with a decreased risk of UADT cancer , whereas that of green tea might be associated with an increased risk ."
98598,",",O,3418.0,"These findings suggest that consumption of coffee might be associated with a decreased risk of UADT cancer , whereas that of green tea might be associated with an increased risk ."
98599,whereas,O,3418.0,"These findings suggest that consumption of coffee might be associated with a decreased risk of UADT cancer , whereas that of green tea might be associated with an increased risk ."
98600,that,O,3418.0,"These findings suggest that consumption of coffee might be associated with a decreased risk of UADT cancer , whereas that of green tea might be associated with an increased risk ."
98601,of,O,3418.0,"These findings suggest that consumption of coffee might be associated with a decreased risk of UADT cancer , whereas that of green tea might be associated with an increased risk ."
98602,green,B-AG.01.ac,3418.0,"These findings suggest that consumption of coffee might be associated with a decreased risk of UADT cancer , whereas that of green tea might be associated with an increased risk ."
98603,tea,I-AG.01.ac,3418.0,"These findings suggest that consumption of coffee might be associated with a decreased risk of UADT cancer , whereas that of green tea might be associated with an increased risk ."
98604,might,O,3418.0,"These findings suggest that consumption of coffee might be associated with a decreased risk of UADT cancer , whereas that of green tea might be associated with an increased risk ."
98605,be,O,3418.0,"These findings suggest that consumption of coffee might be associated with a decreased risk of UADT cancer , whereas that of green tea might be associated with an increased risk ."
98606,associated,O,3418.0,"These findings suggest that consumption of coffee might be associated with a decreased risk of UADT cancer , whereas that of green tea might be associated with an increased risk ."
98607,with,O,3418.0,"These findings suggest that consumption of coffee might be associated with a decreased risk of UADT cancer , whereas that of green tea might be associated with an increased risk ."
98608,an,O,3418.0,"These findings suggest that consumption of coffee might be associated with a decreased risk of UADT cancer , whereas that of green tea might be associated with an increased risk ."
98609,increased,O,3418.0,"These findings suggest that consumption of coffee might be associated with a decreased risk of UADT cancer , whereas that of green tea might be associated with an increased risk ."
98610,risk,O,3418.0,"These findings suggest that consumption of coffee might be associated with a decreased risk of UADT cancer , whereas that of green tea might be associated with an increased risk ."
98611,.,O,3418.0,"These findings suggest that consumption of coffee might be associated with a decreased risk of UADT cancer , whereas that of green tea might be associated with an increased risk ."
98612,Food,O,3419.0,Food sources of nutrients in Mexican children are not well known .
98613,sources,O,3419.0,Food sources of nutrients in Mexican children are not well known .
98614,of,O,3419.0,Food sources of nutrients in Mexican children are not well known .
98615,nutrients,O,3419.0,Food sources of nutrients in Mexican children are not well known .
98616,in,O,3419.0,Food sources of nutrients in Mexican children are not well known .
98617,Mexican,O,3419.0,Food sources of nutrients in Mexican children are not well known .
98618,children,O,3419.0,Food sources of nutrients in Mexican children are not well known .
98619,are,O,3419.0,Food sources of nutrients in Mexican children are not well known .
98620,not,O,3419.0,Food sources of nutrients in Mexican children are not well known .
98621,well,O,3419.0,Food sources of nutrients in Mexican children are not well known .
98622,known,O,3419.0,Food sources of nutrients in Mexican children are not well known .
98623,.,O,3419.0,Food sources of nutrients in Mexican children are not well known .
98624,To,O,3420.0,"To fill the knowledge gap , dietary intake was assessed in 2057 children using a 24 - hour dietary recall ."
98625,fill,O,3420.0,"To fill the knowledge gap , dietary intake was assessed in 2057 children using a 24 - hour dietary recall ."
98626,the,O,3420.0,"To fill the knowledge gap , dietary intake was assessed in 2057 children using a 24 - hour dietary recall ."
98627,knowledge,O,3420.0,"To fill the knowledge gap , dietary intake was assessed in 2057 children using a 24 - hour dietary recall ."
98628,gap,O,3420.0,"To fill the knowledge gap , dietary intake was assessed in 2057 children using a 24 - hour dietary recall ."
98629,",",O,3420.0,"To fill the knowledge gap , dietary intake was assessed in 2057 children using a 24 - hour dietary recall ."
98630,dietary,O,3420.0,"To fill the knowledge gap , dietary intake was assessed in 2057 children using a 24 - hour dietary recall ."
98631,intake,O,3420.0,"To fill the knowledge gap , dietary intake was assessed in 2057 children using a 24 - hour dietary recall ."
98632,was,O,3420.0,"To fill the knowledge gap , dietary intake was assessed in 2057 children using a 24 - hour dietary recall ."
98633,assessed,O,3420.0,"To fill the knowledge gap , dietary intake was assessed in 2057 children using a 24 - hour dietary recall ."
98634,in,O,3420.0,"To fill the knowledge gap , dietary intake was assessed in 2057 children using a 24 - hour dietary recall ."
98635,2057,O,3420.0,"To fill the knowledge gap , dietary intake was assessed in 2057 children using a 24 - hour dietary recall ."
98636,children,O,3420.0,"To fill the knowledge gap , dietary intake was assessed in 2057 children using a 24 - hour dietary recall ."
98637,using,O,3420.0,"To fill the knowledge gap , dietary intake was assessed in 2057 children using a 24 - hour dietary recall ."
98638,a,O,3420.0,"To fill the knowledge gap , dietary intake was assessed in 2057 children using a 24 - hour dietary recall ."
98639,24,O,3420.0,"To fill the knowledge gap , dietary intake was assessed in 2057 children using a 24 - hour dietary recall ."
98640,-,O,3420.0,"To fill the knowledge gap , dietary intake was assessed in 2057 children using a 24 - hour dietary recall ."
98641,hour,O,3420.0,"To fill the knowledge gap , dietary intake was assessed in 2057 children using a 24 - hour dietary recall ."
98642,dietary,O,3420.0,"To fill the knowledge gap , dietary intake was assessed in 2057 children using a 24 - hour dietary recall ."
98643,recall,O,3420.0,"To fill the knowledge gap , dietary intake was assessed in 2057 children using a 24 - hour dietary recall ."
98644,.,O,3420.0,"To fill the knowledge gap , dietary intake was assessed in 2057 children using a 24 - hour dietary recall ."
98645,All,O,3421.0,All reported foods and beverages were assigned to one of 76 food groups .
98646,reported,O,3421.0,All reported foods and beverages were assigned to one of 76 food groups .
98647,foods,O,3421.0,All reported foods and beverages were assigned to one of 76 food groups .
98648,and,O,3421.0,All reported foods and beverages were assigned to one of 76 food groups .
98649,beverages,B-AG.01.y,3421.0,All reported foods and beverages were assigned to one of 76 food groups .
98650,were,O,3421.0,All reported foods and beverages were assigned to one of 76 food groups .
98651,assigned,O,3421.0,All reported foods and beverages were assigned to one of 76 food groups .
98652,to,O,3421.0,All reported foods and beverages were assigned to one of 76 food groups .
98653,one,O,3421.0,All reported foods and beverages were assigned to one of 76 food groups .
98654,of,O,3421.0,All reported foods and beverages were assigned to one of 76 food groups .
98655,76,O,3421.0,All reported foods and beverages were assigned to one of 76 food groups .
98656,food,O,3421.0,All reported foods and beverages were assigned to one of 76 food groups .
98657,groups,O,3421.0,All reported foods and beverages were assigned to one of 76 food groups .
98658,.,O,3421.0,All reported foods and beverages were assigned to one of 76 food groups .
98659,Percent,O,3422.0,"Percent contribution of each food group to nutrient intake was estimated for four age groups : 0 - 5.9 , 6 - 11.9 , 12 - 23.9 , and 24 - 47.9 months ."
98660,contribution,O,3422.0,"Percent contribution of each food group to nutrient intake was estimated for four age groups : 0 - 5.9 , 6 - 11.9 , 12 - 23.9 , and 24 - 47.9 months ."
98661,of,O,3422.0,"Percent contribution of each food group to nutrient intake was estimated for four age groups : 0 - 5.9 , 6 - 11.9 , 12 - 23.9 , and 24 - 47.9 months ."
98662,each,O,3422.0,"Percent contribution of each food group to nutrient intake was estimated for four age groups : 0 - 5.9 , 6 - 11.9 , 12 - 23.9 , and 24 - 47.9 months ."
98663,food,O,3422.0,"Percent contribution of each food group to nutrient intake was estimated for four age groups : 0 - 5.9 , 6 - 11.9 , 12 - 23.9 , and 24 - 47.9 months ."
98664,group,O,3422.0,"Percent contribution of each food group to nutrient intake was estimated for four age groups : 0 - 5.9 , 6 - 11.9 , 12 - 23.9 , and 24 - 47.9 months ."
98665,to,O,3422.0,"Percent contribution of each food group to nutrient intake was estimated for four age groups : 0 - 5.9 , 6 - 11.9 , 12 - 23.9 , and 24 - 47.9 months ."
98666,nutrient,O,3422.0,"Percent contribution of each food group to nutrient intake was estimated for four age groups : 0 - 5.9 , 6 - 11.9 , 12 - 23.9 , and 24 - 47.9 months ."
98667,intake,O,3422.0,"Percent contribution of each food group to nutrient intake was estimated for four age groups : 0 - 5.9 , 6 - 11.9 , 12 - 23.9 , and 24 - 47.9 months ."
98668,was,O,3422.0,"Percent contribution of each food group to nutrient intake was estimated for four age groups : 0 - 5.9 , 6 - 11.9 , 12 - 23.9 , and 24 - 47.9 months ."
98669,estimated,O,3422.0,"Percent contribution of each food group to nutrient intake was estimated for four age groups : 0 - 5.9 , 6 - 11.9 , 12 - 23.9 , and 24 - 47.9 months ."
98670,for,O,3422.0,"Percent contribution of each food group to nutrient intake was estimated for four age groups : 0 - 5.9 , 6 - 11.9 , 12 - 23.9 , and 24 - 47.9 months ."
98671,four,O,3422.0,"Percent contribution of each food group to nutrient intake was estimated for four age groups : 0 - 5.9 , 6 - 11.9 , 12 - 23.9 , and 24 - 47.9 months ."
98672,age,O,3422.0,"Percent contribution of each food group to nutrient intake was estimated for four age groups : 0 - 5.9 , 6 - 11.9 , 12 - 23.9 , and 24 - 47.9 months ."
98673,groups,O,3422.0,"Percent contribution of each food group to nutrient intake was estimated for four age groups : 0 - 5.9 , 6 - 11.9 , 12 - 23.9 , and 24 - 47.9 months ."
98674,:,O,3422.0,"Percent contribution of each food group to nutrient intake was estimated for four age groups : 0 - 5.9 , 6 - 11.9 , 12 - 23.9 , and 24 - 47.9 months ."
98675,0,O,3422.0,"Percent contribution of each food group to nutrient intake was estimated for four age groups : 0 - 5.9 , 6 - 11.9 , 12 - 23.9 , and 24 - 47.9 months ."
98676,-,O,3422.0,"Percent contribution of each food group to nutrient intake was estimated for four age groups : 0 - 5.9 , 6 - 11.9 , 12 - 23.9 , and 24 - 47.9 months ."
98677,5.9,O,3422.0,"Percent contribution of each food group to nutrient intake was estimated for four age groups : 0 - 5.9 , 6 - 11.9 , 12 - 23.9 , and 24 - 47.9 months ."
98678,",",O,3422.0,"Percent contribution of each food group to nutrient intake was estimated for four age groups : 0 - 5.9 , 6 - 11.9 , 12 - 23.9 , and 24 - 47.9 months ."
98679,6,O,3422.0,"Percent contribution of each food group to nutrient intake was estimated for four age groups : 0 - 5.9 , 6 - 11.9 , 12 - 23.9 , and 24 - 47.9 months ."
98680,-,O,3422.0,"Percent contribution of each food group to nutrient intake was estimated for four age groups : 0 - 5.9 , 6 - 11.9 , 12 - 23.9 , and 24 - 47.9 months ."
98681,11.9,O,3422.0,"Percent contribution of each food group to nutrient intake was estimated for four age groups : 0 - 5.9 , 6 - 11.9 , 12 - 23.9 , and 24 - 47.9 months ."
98682,",",O,3422.0,"Percent contribution of each food group to nutrient intake was estimated for four age groups : 0 - 5.9 , 6 - 11.9 , 12 - 23.9 , and 24 - 47.9 months ."
98683,12,O,3422.0,"Percent contribution of each food group to nutrient intake was estimated for four age groups : 0 - 5.9 , 6 - 11.9 , 12 - 23.9 , and 24 - 47.9 months ."
98684,-,O,3422.0,"Percent contribution of each food group to nutrient intake was estimated for four age groups : 0 - 5.9 , 6 - 11.9 , 12 - 23.9 , and 24 - 47.9 months ."
98685,23.9,O,3422.0,"Percent contribution of each food group to nutrient intake was estimated for four age groups : 0 - 5.9 , 6 - 11.9 , 12 - 23.9 , and 24 - 47.9 months ."
98686,",",O,3422.0,"Percent contribution of each food group to nutrient intake was estimated for four age groups : 0 - 5.9 , 6 - 11.9 , 12 - 23.9 , and 24 - 47.9 months ."
98687,and,O,3422.0,"Percent contribution of each food group to nutrient intake was estimated for four age groups : 0 - 5.9 , 6 - 11.9 , 12 - 23.9 , and 24 - 47.9 months ."
98688,24,O,3422.0,"Percent contribution of each food group to nutrient intake was estimated for four age groups : 0 - 5.9 , 6 - 11.9 , 12 - 23.9 , and 24 - 47.9 months ."
98689,-,O,3422.0,"Percent contribution of each food group to nutrient intake was estimated for four age groups : 0 - 5.9 , 6 - 11.9 , 12 - 23.9 , and 24 - 47.9 months ."
98690,47.9,O,3422.0,"Percent contribution of each food group to nutrient intake was estimated for four age groups : 0 - 5.9 , 6 - 11.9 , 12 - 23.9 , and 24 - 47.9 months ."
98691,months,O,3422.0,"Percent contribution of each food group to nutrient intake was estimated for four age groups : 0 - 5.9 , 6 - 11.9 , 12 - 23.9 , and 24 - 47.9 months ."
98692,.,O,3422.0,"Percent contribution of each food group to nutrient intake was estimated for four age groups : 0 - 5.9 , 6 - 11.9 , 12 - 23.9 , and 24 - 47.9 months ."
98693,Breast,B-AG.01,3423.0,"Breast milk , infant formula , and cow 's milk were the top sources of energy and nutrients , especially in younger groups ."
98694,milk,I-AG.01,3423.0,"Breast milk , infant formula , and cow 's milk were the top sources of energy and nutrients , especially in younger groups ."
98695,",",O,3423.0,"Breast milk , infant formula , and cow 's milk were the top sources of energy and nutrients , especially in younger groups ."
98696,infant,B-AG.01,3423.0,"Breast milk , infant formula , and cow 's milk were the top sources of energy and nutrients , especially in younger groups ."
98697,formula,I-AG.01,3423.0,"Breast milk , infant formula , and cow 's milk were the top sources of energy and nutrients , especially in younger groups ."
98698,",",O,3423.0,"Breast milk , infant formula , and cow 's milk were the top sources of energy and nutrients , especially in younger groups ."
98699,and,O,3423.0,"Breast milk , infant formula , and cow 's milk were the top sources of energy and nutrients , especially in younger groups ."
98700,cow,B-AG.01.e,3423.0,"Breast milk , infant formula , and cow 's milk were the top sources of energy and nutrients , especially in younger groups ."
98701,'s,I-AG.01.e,3423.0,"Breast milk , infant formula , and cow 's milk were the top sources of energy and nutrients , especially in younger groups ."
98702,milk,I-AG.01.e,3423.0,"Breast milk , infant formula , and cow 's milk were the top sources of energy and nutrients , especially in younger groups ."
98703,were,O,3423.0,"Breast milk , infant formula , and cow 's milk were the top sources of energy and nutrients , especially in younger groups ."
98704,the,O,3423.0,"Breast milk , infant formula , and cow 's milk were the top sources of energy and nutrients , especially in younger groups ."
98705,top,O,3423.0,"Breast milk , infant formula , and cow 's milk were the top sources of energy and nutrients , especially in younger groups ."
98706,sources,O,3423.0,"Breast milk , infant formula , and cow 's milk were the top sources of energy and nutrients , especially in younger groups ."
98707,of,O,3423.0,"Breast milk , infant formula , and cow 's milk were the top sources of energy and nutrients , especially in younger groups ."
98708,energy,O,3423.0,"Breast milk , infant formula , and cow 's milk were the top sources of energy and nutrients , especially in younger groups ."
98709,and,O,3423.0,"Breast milk , infant formula , and cow 's milk were the top sources of energy and nutrients , especially in younger groups ."
98710,nutrients,O,3423.0,"Breast milk , infant formula , and cow 's milk were the top sources of energy and nutrients , especially in younger groups ."
98711,",",O,3423.0,"Breast milk , infant formula , and cow 's milk were the top sources of energy and nutrients , especially in younger groups ."
98712,especially,O,3423.0,"Breast milk , infant formula , and cow 's milk were the top sources of energy and nutrients , especially in younger groups ."
98713,in,O,3423.0,"Breast milk , infant formula , and cow 's milk were the top sources of energy and nutrients , especially in younger groups ."
98714,younger,O,3423.0,"Breast milk , infant formula , and cow 's milk were the top sources of energy and nutrients , especially in younger groups ."
98715,groups,O,3423.0,"Breast milk , infant formula , and cow 's milk were the top sources of energy and nutrients , especially in younger groups ."
98716,.,O,3423.0,"Breast milk , infant formula , and cow 's milk were the top sources of energy and nutrients , especially in younger groups ."
98717,Among,O,3424.0,"Among infants aged 6 - 11.9 months , the top food sources of energy included soups and stews , cookies , fruit , tortillas , eggs and egg dishes , and traditional beverages ."
98718,infants,O,3424.0,"Among infants aged 6 - 11.9 months , the top food sources of energy included soups and stews , cookies , fruit , tortillas , eggs and egg dishes , and traditional beverages ."
98719,aged,O,3424.0,"Among infants aged 6 - 11.9 months , the top food sources of energy included soups and stews , cookies , fruit , tortillas , eggs and egg dishes , and traditional beverages ."
98720,6,O,3424.0,"Among infants aged 6 - 11.9 months , the top food sources of energy included soups and stews , cookies , fruit , tortillas , eggs and egg dishes , and traditional beverages ."
98721,-,O,3424.0,"Among infants aged 6 - 11.9 months , the top food sources of energy included soups and stews , cookies , fruit , tortillas , eggs and egg dishes , and traditional beverages ."
98722,11.9,O,3424.0,"Among infants aged 6 - 11.9 months , the top food sources of energy included soups and stews , cookies , fruit , tortillas , eggs and egg dishes , and traditional beverages ."
98723,months,O,3424.0,"Among infants aged 6 - 11.9 months , the top food sources of energy included soups and stews , cookies , fruit , tortillas , eggs and egg dishes , and traditional beverages ."
98724,",",O,3424.0,"Among infants aged 6 - 11.9 months , the top food sources of energy included soups and stews , cookies , fruit , tortillas , eggs and egg dishes , and traditional beverages ."
98725,the,O,3424.0,"Among infants aged 6 - 11.9 months , the top food sources of energy included soups and stews , cookies , fruit , tortillas , eggs and egg dishes , and traditional beverages ."
98726,top,O,3424.0,"Among infants aged 6 - 11.9 months , the top food sources of energy included soups and stews , cookies , fruit , tortillas , eggs and egg dishes , and traditional beverages ."
98727,food,O,3424.0,"Among infants aged 6 - 11.9 months , the top food sources of energy included soups and stews , cookies , fruit , tortillas , eggs and egg dishes , and traditional beverages ."
98728,sources,O,3424.0,"Among infants aged 6 - 11.9 months , the top food sources of energy included soups and stews , cookies , fruit , tortillas , eggs and egg dishes , and traditional beverages ."
98729,of,O,3424.0,"Among infants aged 6 - 11.9 months , the top food sources of energy included soups and stews , cookies , fruit , tortillas , eggs and egg dishes , and traditional beverages ."
98730,energy,O,3424.0,"Among infants aged 6 - 11.9 months , the top food sources of energy included soups and stews , cookies , fruit , tortillas , eggs and egg dishes , and traditional beverages ."
98731,included,O,3424.0,"Among infants aged 6 - 11.9 months , the top food sources of energy included soups and stews , cookies , fruit , tortillas , eggs and egg dishes , and traditional beverages ."
98732,soups,B-AG.01.n.02,3424.0,"Among infants aged 6 - 11.9 months , the top food sources of energy included soups and stews , cookies , fruit , tortillas , eggs and egg dishes , and traditional beverages ."
98733,and,O,3424.0,"Among infants aged 6 - 11.9 months , the top food sources of energy included soups and stews , cookies , fruit , tortillas , eggs and egg dishes , and traditional beverages ."
98734,stews,B-AG.01.n,3424.0,"Among infants aged 6 - 11.9 months , the top food sources of energy included soups and stews , cookies , fruit , tortillas , eggs and egg dishes , and traditional beverages ."
98735,",",O,3424.0,"Among infants aged 6 - 11.9 months , the top food sources of energy included soups and stews , cookies , fruit , tortillas , eggs and egg dishes , and traditional beverages ."
98736,cookies,B-AG.01.n.14,3424.0,"Among infants aged 6 - 11.9 months , the top food sources of energy included soups and stews , cookies , fruit , tortillas , eggs and egg dishes , and traditional beverages ."
98737,",",O,3424.0,"Among infants aged 6 - 11.9 months , the top food sources of energy included soups and stews , cookies , fruit , tortillas , eggs and egg dishes , and traditional beverages ."
98738,fruit,B-AG.01.h.01,3424.0,"Among infants aged 6 - 11.9 months , the top food sources of energy included soups and stews , cookies , fruit , tortillas , eggs and egg dishes , and traditional beverages ."
98739,",",O,3424.0,"Among infants aged 6 - 11.9 months , the top food sources of energy included soups and stews , cookies , fruit , tortillas , eggs and egg dishes , and traditional beverages ."
98740,tortillas,B-AG.01.n.12,3424.0,"Among infants aged 6 - 11.9 months , the top food sources of energy included soups and stews , cookies , fruit , tortillas , eggs and egg dishes , and traditional beverages ."
98741,",",O,3424.0,"Among infants aged 6 - 11.9 months , the top food sources of energy included soups and stews , cookies , fruit , tortillas , eggs and egg dishes , and traditional beverages ."
98742,eggs,B-AG.01.g,3424.0,"Among infants aged 6 - 11.9 months , the top food sources of energy included soups and stews , cookies , fruit , tortillas , eggs and egg dishes , and traditional beverages ."
98743,and,O,3424.0,"Among infants aged 6 - 11.9 months , the top food sources of energy included soups and stews , cookies , fruit , tortillas , eggs and egg dishes , and traditional beverages ."
98744,egg,B-AG.01.n.16,3424.0,"Among infants aged 6 - 11.9 months , the top food sources of energy included soups and stews , cookies , fruit , tortillas , eggs and egg dishes , and traditional beverages ."
98745,dishes,I-AG.01.n.16,3424.0,"Among infants aged 6 - 11.9 months , the top food sources of energy included soups and stews , cookies , fruit , tortillas , eggs and egg dishes , and traditional beverages ."
98746,",",O,3424.0,"Among infants aged 6 - 11.9 months , the top food sources of energy included soups and stews , cookies , fruit , tortillas , eggs and egg dishes , and traditional beverages ."
98747,and,O,3424.0,"Among infants aged 6 - 11.9 months , the top food sources of energy included soups and stews , cookies , fruit , tortillas , eggs and egg dishes , and traditional beverages ."
98748,traditional,O,3424.0,"Among infants aged 6 - 11.9 months , the top food sources of energy included soups and stews , cookies , fruit , tortillas , eggs and egg dishes , and traditional beverages ."
98749,beverages,B-AG.01.y,3424.0,"Among infants aged 6 - 11.9 months , the top food sources of energy included soups and stews , cookies , fruit , tortillas , eggs and egg dishes , and traditional beverages ."
98750,.,O,3424.0,"Among infants aged 6 - 11.9 months , the top food sources of energy included soups and stews , cookies , fruit , tortillas , eggs and egg dishes , and traditional beverages ."
98751,The,O,3425.0,"The same foods plus sweetened breads , dried beans , and sandwiches and tortas were consumed as the top sources of energy among toddlers and young children ."
98752,same,O,3425.0,"The same foods plus sweetened breads , dried beans , and sandwiches and tortas were consumed as the top sources of energy among toddlers and young children ."
98753,foods,O,3425.0,"The same foods plus sweetened breads , dried beans , and sandwiches and tortas were consumed as the top sources of energy among toddlers and young children ."
98754,plus,O,3425.0,"The same foods plus sweetened breads , dried beans , and sandwiches and tortas were consumed as the top sources of energy among toddlers and young children ."
98755,sweetened,B-AG.01.n.17.a,3425.0,"The same foods plus sweetened breads , dried beans , and sandwiches and tortas were consumed as the top sources of energy among toddlers and young children ."
98756,breads,I-AG.01.n.17.a,3425.0,"The same foods plus sweetened breads , dried beans , and sandwiches and tortas were consumed as the top sources of energy among toddlers and young children ."
98757,",",O,3425.0,"The same foods plus sweetened breads , dried beans , and sandwiches and tortas were consumed as the top sources of energy among toddlers and young children ."
98758,dried,B-AG.01.h.02.g,3425.0,"The same foods plus sweetened breads , dried beans , and sandwiches and tortas were consumed as the top sources of energy among toddlers and young children ."
98759,beans,I-AG.01.h.02.g,3425.0,"The same foods plus sweetened breads , dried beans , and sandwiches and tortas were consumed as the top sources of energy among toddlers and young children ."
98760,",",O,3425.0,"The same foods plus sweetened breads , dried beans , and sandwiches and tortas were consumed as the top sources of energy among toddlers and young children ."
98761,and,O,3425.0,"The same foods plus sweetened breads , dried beans , and sandwiches and tortas were consumed as the top sources of energy among toddlers and young children ."
98762,sandwiches,B-AG.01.n.11,3425.0,"The same foods plus sweetened breads , dried beans , and sandwiches and tortas were consumed as the top sources of energy among toddlers and young children ."
98763,and,O,3425.0,"The same foods plus sweetened breads , dried beans , and sandwiches and tortas were consumed as the top sources of energy among toddlers and young children ."
98764,tortas,B-AG.01.n.13,3425.0,"The same foods plus sweetened breads , dried beans , and sandwiches and tortas were consumed as the top sources of energy among toddlers and young children ."
98765,were,O,3425.0,"The same foods plus sweetened breads , dried beans , and sandwiches and tortas were consumed as the top sources of energy among toddlers and young children ."
98766,consumed,O,3425.0,"The same foods plus sweetened breads , dried beans , and sandwiches and tortas were consumed as the top sources of energy among toddlers and young children ."
98767,as,O,3425.0,"The same foods plus sweetened breads , dried beans , and sandwiches and tortas were consumed as the top sources of energy among toddlers and young children ."
98768,the,O,3425.0,"The same foods plus sweetened breads , dried beans , and sandwiches and tortas were consumed as the top sources of energy among toddlers and young children ."
98769,top,O,3425.0,"The same foods plus sweetened breads , dried beans , and sandwiches and tortas were consumed as the top sources of energy among toddlers and young children ."
98770,sources,O,3425.0,"The same foods plus sweetened breads , dried beans , and sandwiches and tortas were consumed as the top sources of energy among toddlers and young children ."
98771,of,O,3425.0,"The same foods plus sweetened breads , dried beans , and sandwiches and tortas were consumed as the top sources of energy among toddlers and young children ."
98772,energy,O,3425.0,"The same foods plus sweetened breads , dried beans , and sandwiches and tortas were consumed as the top sources of energy among toddlers and young children ."
98773,among,O,3425.0,"The same foods plus sweetened breads , dried beans , and sandwiches and tortas were consumed as the top sources of energy among toddlers and young children ."
98774,toddlers,O,3425.0,"The same foods plus sweetened breads , dried beans , and sandwiches and tortas were consumed as the top sources of energy among toddlers and young children ."
98775,and,O,3425.0,"The same foods plus sweetened breads , dried beans , and sandwiches and tortas were consumed as the top sources of energy among toddlers and young children ."
98776,young,O,3425.0,"The same foods plus sweetened breads , dried beans , and sandwiches and tortas were consumed as the top sources of energy among toddlers and young children ."
98777,children,O,3425.0,"The same foods plus sweetened breads , dried beans , and sandwiches and tortas were consumed as the top sources of energy among toddlers and young children ."
98778,.,O,3425.0,"The same foods plus sweetened breads , dried beans , and sandwiches and tortas were consumed as the top sources of energy among toddlers and young children ."
98779,Milk,B-AG.01.e,3426.0,"Milk , soups , and stews were the top contributors for all nutrients and tortillas , eggs , and egg dishes were among the top contributors for iron and zinc ."
98780,",",O,3426.0,"Milk , soups , and stews were the top contributors for all nutrients and tortillas , eggs , and egg dishes were among the top contributors for iron and zinc ."
98781,soups,B-AG.01.n.02,3426.0,"Milk , soups , and stews were the top contributors for all nutrients and tortillas , eggs , and egg dishes were among the top contributors for iron and zinc ."
98782,",",O,3426.0,"Milk , soups , and stews were the top contributors for all nutrients and tortillas , eggs , and egg dishes were among the top contributors for iron and zinc ."
98783,and,O,3426.0,"Milk , soups , and stews were the top contributors for all nutrients and tortillas , eggs , and egg dishes were among the top contributors for iron and zinc ."
98784,stews,B-AG.01.n,3426.0,"Milk , soups , and stews were the top contributors for all nutrients and tortillas , eggs , and egg dishes were among the top contributors for iron and zinc ."
98785,were,O,3426.0,"Milk , soups , and stews were the top contributors for all nutrients and tortillas , eggs , and egg dishes were among the top contributors for iron and zinc ."
98786,the,O,3426.0,"Milk , soups , and stews were the top contributors for all nutrients and tortillas , eggs , and egg dishes were among the top contributors for iron and zinc ."
98787,top,O,3426.0,"Milk , soups , and stews were the top contributors for all nutrients and tortillas , eggs , and egg dishes were among the top contributors for iron and zinc ."
98788,contributors,O,3426.0,"Milk , soups , and stews were the top contributors for all nutrients and tortillas , eggs , and egg dishes were among the top contributors for iron and zinc ."
98789,for,O,3426.0,"Milk , soups , and stews were the top contributors for all nutrients and tortillas , eggs , and egg dishes were among the top contributors for iron and zinc ."
98790,all,O,3426.0,"Milk , soups , and stews were the top contributors for all nutrients and tortillas , eggs , and egg dishes were among the top contributors for iron and zinc ."
98791,nutrients,O,3426.0,"Milk , soups , and stews were the top contributors for all nutrients and tortillas , eggs , and egg dishes were among the top contributors for iron and zinc ."
98792,and,O,3426.0,"Milk , soups , and stews were the top contributors for all nutrients and tortillas , eggs , and egg dishes were among the top contributors for iron and zinc ."
98793,tortillas,B-AG.01.n.12,3426.0,"Milk , soups , and stews were the top contributors for all nutrients and tortillas , eggs , and egg dishes were among the top contributors for iron and zinc ."
98794,",",O,3426.0,"Milk , soups , and stews were the top contributors for all nutrients and tortillas , eggs , and egg dishes were among the top contributors for iron and zinc ."
98795,eggs,B-AG.01.g,3426.0,"Milk , soups , and stews were the top contributors for all nutrients and tortillas , eggs , and egg dishes were among the top contributors for iron and zinc ."
98796,",",O,3426.0,"Milk , soups , and stews were the top contributors for all nutrients and tortillas , eggs , and egg dishes were among the top contributors for iron and zinc ."
98797,and,O,3426.0,"Milk , soups , and stews were the top contributors for all nutrients and tortillas , eggs , and egg dishes were among the top contributors for iron and zinc ."
98798,egg,B-AG.01.n.16,3426.0,"Milk , soups , and stews were the top contributors for all nutrients and tortillas , eggs , and egg dishes were among the top contributors for iron and zinc ."
98799,dishes,I-AG.01.n.16,3426.0,"Milk , soups , and stews were the top contributors for all nutrients and tortillas , eggs , and egg dishes were among the top contributors for iron and zinc ."
98800,were,O,3426.0,"Milk , soups , and stews were the top contributors for all nutrients and tortillas , eggs , and egg dishes were among the top contributors for iron and zinc ."
98801,among,O,3426.0,"Milk , soups , and stews were the top contributors for all nutrients and tortillas , eggs , and egg dishes were among the top contributors for iron and zinc ."
98802,the,O,3426.0,"Milk , soups , and stews were the top contributors for all nutrients and tortillas , eggs , and egg dishes were among the top contributors for iron and zinc ."
98803,top,O,3426.0,"Milk , soups , and stews were the top contributors for all nutrients and tortillas , eggs , and egg dishes were among the top contributors for iron and zinc ."
98804,contributors,O,3426.0,"Milk , soups , and stews were the top contributors for all nutrients and tortillas , eggs , and egg dishes were among the top contributors for iron and zinc ."
98805,for,O,3426.0,"Milk , soups , and stews were the top contributors for all nutrients and tortillas , eggs , and egg dishes were among the top contributors for iron and zinc ."
98806,iron,O,3426.0,"Milk , soups , and stews were the top contributors for all nutrients and tortillas , eggs , and egg dishes were among the top contributors for iron and zinc ."
98807,and,O,3426.0,"Milk , soups , and stews were the top contributors for all nutrients and tortillas , eggs , and egg dishes were among the top contributors for iron and zinc ."
98808,zinc,O,3426.0,"Milk , soups , and stews were the top contributors for all nutrients and tortillas , eggs , and egg dishes were among the top contributors for iron and zinc ."
98809,.,O,3426.0,"Milk , soups , and stews were the top contributors for all nutrients and tortillas , eggs , and egg dishes were among the top contributors for iron and zinc ."
98810,This,O,3427.0,"This study showed that low nutrient - dense cookies , sweetened breads , and traditional beverages were among the core foods consumed early in life in Mexico ."
98811,study,O,3427.0,"This study showed that low nutrient - dense cookies , sweetened breads , and traditional beverages were among the core foods consumed early in life in Mexico ."
98812,showed,O,3427.0,"This study showed that low nutrient - dense cookies , sweetened breads , and traditional beverages were among the core foods consumed early in life in Mexico ."
98813,that,O,3427.0,"This study showed that low nutrient - dense cookies , sweetened breads , and traditional beverages were among the core foods consumed early in life in Mexico ."
98814,low,O,3427.0,"This study showed that low nutrient - dense cookies , sweetened breads , and traditional beverages were among the core foods consumed early in life in Mexico ."
98815,nutrient,O,3427.0,"This study showed that low nutrient - dense cookies , sweetened breads , and traditional beverages were among the core foods consumed early in life in Mexico ."
98816,-,O,3427.0,"This study showed that low nutrient - dense cookies , sweetened breads , and traditional beverages were among the core foods consumed early in life in Mexico ."
98817,dense,O,3427.0,"This study showed that low nutrient - dense cookies , sweetened breads , and traditional beverages were among the core foods consumed early in life in Mexico ."
98818,cookies,B-AG.01.n.14,3427.0,"This study showed that low nutrient - dense cookies , sweetened breads , and traditional beverages were among the core foods consumed early in life in Mexico ."
98819,",",O,3427.0,"This study showed that low nutrient - dense cookies , sweetened breads , and traditional beverages were among the core foods consumed early in life in Mexico ."
98820,sweetened,B-AG.01.n.17.a,3427.0,"This study showed that low nutrient - dense cookies , sweetened breads , and traditional beverages were among the core foods consumed early in life in Mexico ."
98821,breads,I-AG.01.n.17.a,3427.0,"This study showed that low nutrient - dense cookies , sweetened breads , and traditional beverages were among the core foods consumed early in life in Mexico ."
98822,",",O,3427.0,"This study showed that low nutrient - dense cookies , sweetened breads , and traditional beverages were among the core foods consumed early in life in Mexico ."
98823,and,O,3427.0,"This study showed that low nutrient - dense cookies , sweetened breads , and traditional beverages were among the core foods consumed early in life in Mexico ."
98824,traditional,O,3427.0,"This study showed that low nutrient - dense cookies , sweetened breads , and traditional beverages were among the core foods consumed early in life in Mexico ."
98825,beverages,B-AG.01.y,3427.0,"This study showed that low nutrient - dense cookies , sweetened breads , and traditional beverages were among the core foods consumed early in life in Mexico ."
98826,were,O,3427.0,"This study showed that low nutrient - dense cookies , sweetened breads , and traditional beverages were among the core foods consumed early in life in Mexico ."
98827,among,O,3427.0,"This study showed that low nutrient - dense cookies , sweetened breads , and traditional beverages were among the core foods consumed early in life in Mexico ."
98828,the,O,3427.0,"This study showed that low nutrient - dense cookies , sweetened breads , and traditional beverages were among the core foods consumed early in life in Mexico ."
98829,core,O,3427.0,"This study showed that low nutrient - dense cookies , sweetened breads , and traditional beverages were among the core foods consumed early in life in Mexico ."
98830,foods,O,3427.0,"This study showed that low nutrient - dense cookies , sweetened breads , and traditional beverages were among the core foods consumed early in life in Mexico ."
98831,consumed,O,3427.0,"This study showed that low nutrient - dense cookies , sweetened breads , and traditional beverages were among the core foods consumed early in life in Mexico ."
98832,early,O,3427.0,"This study showed that low nutrient - dense cookies , sweetened breads , and traditional beverages were among the core foods consumed early in life in Mexico ."
98833,in,O,3427.0,"This study showed that low nutrient - dense cookies , sweetened breads , and traditional beverages were among the core foods consumed early in life in Mexico ."
98834,life,O,3427.0,"This study showed that low nutrient - dense cookies , sweetened breads , and traditional beverages were among the core foods consumed early in life in Mexico ."
98835,in,O,3427.0,"This study showed that low nutrient - dense cookies , sweetened breads , and traditional beverages were among the core foods consumed early in life in Mexico ."
98836,Mexico,O,3427.0,"This study showed that low nutrient - dense cookies , sweetened breads , and traditional beverages were among the core foods consumed early in life in Mexico ."
98837,.,O,3427.0,"This study showed that low nutrient - dense cookies , sweetened breads , and traditional beverages were among the core foods consumed early in life in Mexico ."
98838,This,O,3428.0,This compromises the intake of more nutritious foods such as vegetables and fortified cereals and increases the risk of obesity .
98839,compromises,O,3428.0,This compromises the intake of more nutritious foods such as vegetables and fortified cereals and increases the risk of obesity .
98840,the,O,3428.0,This compromises the intake of more nutritious foods such as vegetables and fortified cereals and increases the risk of obesity .
98841,intake,O,3428.0,This compromises the intake of more nutritious foods such as vegetables and fortified cereals and increases the risk of obesity .
98842,of,O,3428.0,This compromises the intake of more nutritious foods such as vegetables and fortified cereals and increases the risk of obesity .
98843,more,O,3428.0,This compromises the intake of more nutritious foods such as vegetables and fortified cereals and increases the risk of obesity .
98844,nutritious,O,3428.0,This compromises the intake of more nutritious foods such as vegetables and fortified cereals and increases the risk of obesity .
98845,foods,O,3428.0,This compromises the intake of more nutritious foods such as vegetables and fortified cereals and increases the risk of obesity .
98846,such,O,3428.0,This compromises the intake of more nutritious foods such as vegetables and fortified cereals and increases the risk of obesity .
98847,as,O,3428.0,This compromises the intake of more nutritious foods such as vegetables and fortified cereals and increases the risk of obesity .
98848,vegetables,B-AG.01.h.02,3428.0,This compromises the intake of more nutritious foods such as vegetables and fortified cereals and increases the risk of obesity .
98849,and,O,3428.0,This compromises the intake of more nutritious foods such as vegetables and fortified cereals and increases the risk of obesity .
98850,fortified,O,3428.0,This compromises the intake of more nutritious foods such as vegetables and fortified cereals and increases the risk of obesity .
98851,cereals,B-AG.01.i,3428.0,This compromises the intake of more nutritious foods such as vegetables and fortified cereals and increases the risk of obesity .
98852,and,O,3428.0,This compromises the intake of more nutritious foods such as vegetables and fortified cereals and increases the risk of obesity .
98853,increases,O,3428.0,This compromises the intake of more nutritious foods such as vegetables and fortified cereals and increases the risk of obesity .
98854,the,O,3428.0,This compromises the intake of more nutritious foods such as vegetables and fortified cereals and increases the risk of obesity .
98855,risk,O,3428.0,This compromises the intake of more nutritious foods such as vegetables and fortified cereals and increases the risk of obesity .
98856,of,O,3428.0,This compromises the intake of more nutritious foods such as vegetables and fortified cereals and increases the risk of obesity .
98857,obesity,O,3428.0,This compromises the intake of more nutritious foods such as vegetables and fortified cereals and increases the risk of obesity .
98858,.,O,3428.0,This compromises the intake of more nutritious foods such as vegetables and fortified cereals and increases the risk of obesity .
98859,In,O,3429.0,"In veal calves , the major portion of digestible energy intake originates from milk replacer ( MR ) , with lactose and fat contributing approximately 45 and 35 % , respectively ."
98860,veal,O,3429.0,"In veal calves , the major portion of digestible energy intake originates from milk replacer ( MR ) , with lactose and fat contributing approximately 45 and 35 % , respectively ."
98861,calves,O,3429.0,"In veal calves , the major portion of digestible energy intake originates from milk replacer ( MR ) , with lactose and fat contributing approximately 45 and 35 % , respectively ."
98862,",",O,3429.0,"In veal calves , the major portion of digestible energy intake originates from milk replacer ( MR ) , with lactose and fat contributing approximately 45 and 35 % , respectively ."
98863,the,O,3429.0,"In veal calves , the major portion of digestible energy intake originates from milk replacer ( MR ) , with lactose and fat contributing approximately 45 and 35 % , respectively ."
98864,major,O,3429.0,"In veal calves , the major portion of digestible energy intake originates from milk replacer ( MR ) , with lactose and fat contributing approximately 45 and 35 % , respectively ."
98865,portion,O,3429.0,"In veal calves , the major portion of digestible energy intake originates from milk replacer ( MR ) , with lactose and fat contributing approximately 45 and 35 % , respectively ."
98866,of,O,3429.0,"In veal calves , the major portion of digestible energy intake originates from milk replacer ( MR ) , with lactose and fat contributing approximately 45 and 35 % , respectively ."
98867,digestible,O,3429.0,"In veal calves , the major portion of digestible energy intake originates from milk replacer ( MR ) , with lactose and fat contributing approximately 45 and 35 % , respectively ."
98868,energy,O,3429.0,"In veal calves , the major portion of digestible energy intake originates from milk replacer ( MR ) , with lactose and fat contributing approximately 45 and 35 % , respectively ."
98869,intake,O,3429.0,"In veal calves , the major portion of digestible energy intake originates from milk replacer ( MR ) , with lactose and fat contributing approximately 45 and 35 % , respectively ."
98870,originates,O,3429.0,"In veal calves , the major portion of digestible energy intake originates from milk replacer ( MR ) , with lactose and fat contributing approximately 45 and 35 % , respectively ."
98871,from,O,3429.0,"In veal calves , the major portion of digestible energy intake originates from milk replacer ( MR ) , with lactose and fat contributing approximately 45 and 35 % , respectively ."
98872,milk,O,3429.0,"In veal calves , the major portion of digestible energy intake originates from milk replacer ( MR ) , with lactose and fat contributing approximately 45 and 35 % , respectively ."
98873,replacer,O,3429.0,"In veal calves , the major portion of digestible energy intake originates from milk replacer ( MR ) , with lactose and fat contributing approximately 45 and 35 % , respectively ."
98874,(,O,3429.0,"In veal calves , the major portion of digestible energy intake originates from milk replacer ( MR ) , with lactose and fat contributing approximately 45 and 35 % , respectively ."
98875,MR,O,3429.0,"In veal calves , the major portion of digestible energy intake originates from milk replacer ( MR ) , with lactose and fat contributing approximately 45 and 35 % , respectively ."
98876,),O,3429.0,"In veal calves , the major portion of digestible energy intake originates from milk replacer ( MR ) , with lactose and fat contributing approximately 45 and 35 % , respectively ."
98877,",",O,3429.0,"In veal calves , the major portion of digestible energy intake originates from milk replacer ( MR ) , with lactose and fat contributing approximately 45 and 35 % , respectively ."
98878,with,O,3429.0,"In veal calves , the major portion of digestible energy intake originates from milk replacer ( MR ) , with lactose and fat contributing approximately 45 and 35 % , respectively ."
98879,lactose,O,3429.0,"In veal calves , the major portion of digestible energy intake originates from milk replacer ( MR ) , with lactose and fat contributing approximately 45 and 35 % , respectively ."
98880,and,O,3429.0,"In veal calves , the major portion of digestible energy intake originates from milk replacer ( MR ) , with lactose and fat contributing approximately 45 and 35 % , respectively ."
98881,fat,O,3429.0,"In veal calves , the major portion of digestible energy intake originates from milk replacer ( MR ) , with lactose and fat contributing approximately 45 and 35 % , respectively ."
98882,contributing,O,3429.0,"In veal calves , the major portion of digestible energy intake originates from milk replacer ( MR ) , with lactose and fat contributing approximately 45 and 35 % , respectively ."
98883,approximately,O,3429.0,"In veal calves , the major portion of digestible energy intake originates from milk replacer ( MR ) , with lactose and fat contributing approximately 45 and 35 % , respectively ."
98884,45,O,3429.0,"In veal calves , the major portion of digestible energy intake originates from milk replacer ( MR ) , with lactose and fat contributing approximately 45 and 35 % , respectively ."
98885,and,O,3429.0,"In veal calves , the major portion of digestible energy intake originates from milk replacer ( MR ) , with lactose and fat contributing approximately 45 and 35 % , respectively ."
98886,35,O,3429.0,"In veal calves , the major portion of digestible energy intake originates from milk replacer ( MR ) , with lactose and fat contributing approximately 45 and 35 % , respectively ."
98887,%,O,3429.0,"In veal calves , the major portion of digestible energy intake originates from milk replacer ( MR ) , with lactose and fat contributing approximately 45 and 35 % , respectively ."
98888,",",O,3429.0,"In veal calves , the major portion of digestible energy intake originates from milk replacer ( MR ) , with lactose and fat contributing approximately 45 and 35 % , respectively ."
98889,respectively,O,3429.0,"In veal calves , the major portion of digestible energy intake originates from milk replacer ( MR ) , with lactose and fat contributing approximately 45 and 35 % , respectively ."
98890,.,O,3429.0,"In veal calves , the major portion of digestible energy intake originates from milk replacer ( MR ) , with lactose and fat contributing approximately 45 and 35 % , respectively ."
98891,In,O,3430.0,"In veal calves older than 4 mo , prolonged high intakes of MR may lead to problems with glucose homeostasis and insulin sensitivity , ultimately resulting in sustained insulin resistance , hepatic steatosis , and impaired animal performance ."
98892,veal,O,3430.0,"In veal calves older than 4 mo , prolonged high intakes of MR may lead to problems with glucose homeostasis and insulin sensitivity , ultimately resulting in sustained insulin resistance , hepatic steatosis , and impaired animal performance ."
98893,calves,O,3430.0,"In veal calves older than 4 mo , prolonged high intakes of MR may lead to problems with glucose homeostasis and insulin sensitivity , ultimately resulting in sustained insulin resistance , hepatic steatosis , and impaired animal performance ."
98894,older,O,3430.0,"In veal calves older than 4 mo , prolonged high intakes of MR may lead to problems with glucose homeostasis and insulin sensitivity , ultimately resulting in sustained insulin resistance , hepatic steatosis , and impaired animal performance ."
98895,than,O,3430.0,"In veal calves older than 4 mo , prolonged high intakes of MR may lead to problems with glucose homeostasis and insulin sensitivity , ultimately resulting in sustained insulin resistance , hepatic steatosis , and impaired animal performance ."
98896,4,O,3430.0,"In veal calves older than 4 mo , prolonged high intakes of MR may lead to problems with glucose homeostasis and insulin sensitivity , ultimately resulting in sustained insulin resistance , hepatic steatosis , and impaired animal performance ."
98897,mo,O,3430.0,"In veal calves older than 4 mo , prolonged high intakes of MR may lead to problems with glucose homeostasis and insulin sensitivity , ultimately resulting in sustained insulin resistance , hepatic steatosis , and impaired animal performance ."
98898,",",O,3430.0,"In veal calves older than 4 mo , prolonged high intakes of MR may lead to problems with glucose homeostasis and insulin sensitivity , ultimately resulting in sustained insulin resistance , hepatic steatosis , and impaired animal performance ."
98899,prolonged,O,3430.0,"In veal calves older than 4 mo , prolonged high intakes of MR may lead to problems with glucose homeostasis and insulin sensitivity , ultimately resulting in sustained insulin resistance , hepatic steatosis , and impaired animal performance ."
98900,high,O,3430.0,"In veal calves older than 4 mo , prolonged high intakes of MR may lead to problems with glucose homeostasis and insulin sensitivity , ultimately resulting in sustained insulin resistance , hepatic steatosis , and impaired animal performance ."
98901,intakes,O,3430.0,"In veal calves older than 4 mo , prolonged high intakes of MR may lead to problems with glucose homeostasis and insulin sensitivity , ultimately resulting in sustained insulin resistance , hepatic steatosis , and impaired animal performance ."
98902,of,O,3430.0,"In veal calves older than 4 mo , prolonged high intakes of MR may lead to problems with glucose homeostasis and insulin sensitivity , ultimately resulting in sustained insulin resistance , hepatic steatosis , and impaired animal performance ."
98903,MR,O,3430.0,"In veal calves older than 4 mo , prolonged high intakes of MR may lead to problems with glucose homeostasis and insulin sensitivity , ultimately resulting in sustained insulin resistance , hepatic steatosis , and impaired animal performance ."
98904,may,O,3430.0,"In veal calves older than 4 mo , prolonged high intakes of MR may lead to problems with glucose homeostasis and insulin sensitivity , ultimately resulting in sustained insulin resistance , hepatic steatosis , and impaired animal performance ."
98905,lead,O,3430.0,"In veal calves older than 4 mo , prolonged high intakes of MR may lead to problems with glucose homeostasis and insulin sensitivity , ultimately resulting in sustained insulin resistance , hepatic steatosis , and impaired animal performance ."
98906,to,O,3430.0,"In veal calves older than 4 mo , prolonged high intakes of MR may lead to problems with glucose homeostasis and insulin sensitivity , ultimately resulting in sustained insulin resistance , hepatic steatosis , and impaired animal performance ."
98907,problems,O,3430.0,"In veal calves older than 4 mo , prolonged high intakes of MR may lead to problems with glucose homeostasis and insulin sensitivity , ultimately resulting in sustained insulin resistance , hepatic steatosis , and impaired animal performance ."
98908,with,O,3430.0,"In veal calves older than 4 mo , prolonged high intakes of MR may lead to problems with glucose homeostasis and insulin sensitivity , ultimately resulting in sustained insulin resistance , hepatic steatosis , and impaired animal performance ."
98909,glucose,O,3430.0,"In veal calves older than 4 mo , prolonged high intakes of MR may lead to problems with glucose homeostasis and insulin sensitivity , ultimately resulting in sustained insulin resistance , hepatic steatosis , and impaired animal performance ."
98910,homeostasis,O,3430.0,"In veal calves older than 4 mo , prolonged high intakes of MR may lead to problems with glucose homeostasis and insulin sensitivity , ultimately resulting in sustained insulin resistance , hepatic steatosis , and impaired animal performance ."
98911,and,O,3430.0,"In veal calves older than 4 mo , prolonged high intakes of MR may lead to problems with glucose homeostasis and insulin sensitivity , ultimately resulting in sustained insulin resistance , hepatic steatosis , and impaired animal performance ."
98912,insulin,O,3430.0,"In veal calves older than 4 mo , prolonged high intakes of MR may lead to problems with glucose homeostasis and insulin sensitivity , ultimately resulting in sustained insulin resistance , hepatic steatosis , and impaired animal performance ."
98913,sensitivity,O,3430.0,"In veal calves older than 4 mo , prolonged high intakes of MR may lead to problems with glucose homeostasis and insulin sensitivity , ultimately resulting in sustained insulin resistance , hepatic steatosis , and impaired animal performance ."
98914,",",O,3430.0,"In veal calves older than 4 mo , prolonged high intakes of MR may lead to problems with glucose homeostasis and insulin sensitivity , ultimately resulting in sustained insulin resistance , hepatic steatosis , and impaired animal performance ."
98915,ultimately,O,3430.0,"In veal calves older than 4 mo , prolonged high intakes of MR may lead to problems with glucose homeostasis and insulin sensitivity , ultimately resulting in sustained insulin resistance , hepatic steatosis , and impaired animal performance ."
98916,resulting,O,3430.0,"In veal calves older than 4 mo , prolonged high intakes of MR may lead to problems with glucose homeostasis and insulin sensitivity , ultimately resulting in sustained insulin resistance , hepatic steatosis , and impaired animal performance ."
98917,in,O,3430.0,"In veal calves older than 4 mo , prolonged high intakes of MR may lead to problems with glucose homeostasis and insulin sensitivity , ultimately resulting in sustained insulin resistance , hepatic steatosis , and impaired animal performance ."
98918,sustained,O,3430.0,"In veal calves older than 4 mo , prolonged high intakes of MR may lead to problems with glucose homeostasis and insulin sensitivity , ultimately resulting in sustained insulin resistance , hepatic steatosis , and impaired animal performance ."
98919,insulin,O,3430.0,"In veal calves older than 4 mo , prolonged high intakes of MR may lead to problems with glucose homeostasis and insulin sensitivity , ultimately resulting in sustained insulin resistance , hepatic steatosis , and impaired animal performance ."
98920,resistance,O,3430.0,"In veal calves older than 4 mo , prolonged high intakes of MR may lead to problems with glucose homeostasis and insulin sensitivity , ultimately resulting in sustained insulin resistance , hepatic steatosis , and impaired animal performance ."
98921,",",O,3430.0,"In veal calves older than 4 mo , prolonged high intakes of MR may lead to problems with glucose homeostasis and insulin sensitivity , ultimately resulting in sustained insulin resistance , hepatic steatosis , and impaired animal performance ."
98922,hepatic,O,3430.0,"In veal calves older than 4 mo , prolonged high intakes of MR may lead to problems with glucose homeostasis and insulin sensitivity , ultimately resulting in sustained insulin resistance , hepatic steatosis , and impaired animal performance ."
98923,steatosis,O,3430.0,"In veal calves older than 4 mo , prolonged high intakes of MR may lead to problems with glucose homeostasis and insulin sensitivity , ultimately resulting in sustained insulin resistance , hepatic steatosis , and impaired animal performance ."
98924,",",O,3430.0,"In veal calves older than 4 mo , prolonged high intakes of MR may lead to problems with glucose homeostasis and insulin sensitivity , ultimately resulting in sustained insulin resistance , hepatic steatosis , and impaired animal performance ."
98925,and,O,3430.0,"In veal calves older than 4 mo , prolonged high intakes of MR may lead to problems with glucose homeostasis and insulin sensitivity , ultimately resulting in sustained insulin resistance , hepatic steatosis , and impaired animal performance ."
98926,impaired,O,3430.0,"In veal calves older than 4 mo , prolonged high intakes of MR may lead to problems with glucose homeostasis and insulin sensitivity , ultimately resulting in sustained insulin resistance , hepatic steatosis , and impaired animal performance ."
98927,animal,O,3430.0,"In veal calves older than 4 mo , prolonged high intakes of MR may lead to problems with glucose homeostasis and insulin sensitivity , ultimately resulting in sustained insulin resistance , hepatic steatosis , and impaired animal performance ."
98928,performance,O,3430.0,"In veal calves older than 4 mo , prolonged high intakes of MR may lead to problems with glucose homeostasis and insulin sensitivity , ultimately resulting in sustained insulin resistance , hepatic steatosis , and impaired animal performance ."
98929,.,O,3430.0,"In veal calves older than 4 mo , prolonged high intakes of MR may lead to problems with glucose homeostasis and insulin sensitivity , ultimately resulting in sustained insulin resistance , hepatic steatosis , and impaired animal performance ."
98930,The,O,3431.0,The contribution of each of the dietary energy sources ( lactose and fat ) to deteriorated glucose homeostasis and insulin resistance is currently unknown .
98931,contribution,O,3431.0,The contribution of each of the dietary energy sources ( lactose and fat ) to deteriorated glucose homeostasis and insulin resistance is currently unknown .
98932,of,O,3431.0,The contribution of each of the dietary energy sources ( lactose and fat ) to deteriorated glucose homeostasis and insulin resistance is currently unknown .
98933,each,O,3431.0,The contribution of each of the dietary energy sources ( lactose and fat ) to deteriorated glucose homeostasis and insulin resistance is currently unknown .
98934,of,O,3431.0,The contribution of each of the dietary energy sources ( lactose and fat ) to deteriorated glucose homeostasis and insulin resistance is currently unknown .
98935,the,O,3431.0,The contribution of each of the dietary energy sources ( lactose and fat ) to deteriorated glucose homeostasis and insulin resistance is currently unknown .
98936,dietary,O,3431.0,The contribution of each of the dietary energy sources ( lactose and fat ) to deteriorated glucose homeostasis and insulin resistance is currently unknown .
98937,energy,O,3431.0,The contribution of each of the dietary energy sources ( lactose and fat ) to deteriorated glucose homeostasis and insulin resistance is currently unknown .
98938,sources,O,3431.0,The contribution of each of the dietary energy sources ( lactose and fat ) to deteriorated glucose homeostasis and insulin resistance is currently unknown .
98939,(,O,3431.0,The contribution of each of the dietary energy sources ( lactose and fat ) to deteriorated glucose homeostasis and insulin resistance is currently unknown .
98940,lactose,O,3431.0,The contribution of each of the dietary energy sources ( lactose and fat ) to deteriorated glucose homeostasis and insulin resistance is currently unknown .
98941,and,O,3431.0,The contribution of each of the dietary energy sources ( lactose and fat ) to deteriorated glucose homeostasis and insulin resistance is currently unknown .
98942,fat,O,3431.0,The contribution of each of the dietary energy sources ( lactose and fat ) to deteriorated glucose homeostasis and insulin resistance is currently unknown .
98943,),O,3431.0,The contribution of each of the dietary energy sources ( lactose and fat ) to deteriorated glucose homeostasis and insulin resistance is currently unknown .
98944,to,O,3431.0,The contribution of each of the dietary energy sources ( lactose and fat ) to deteriorated glucose homeostasis and insulin resistance is currently unknown .
98945,deteriorated,O,3431.0,The contribution of each of the dietary energy sources ( lactose and fat ) to deteriorated glucose homeostasis and insulin resistance is currently unknown .
98946,glucose,O,3431.0,The contribution of each of the dietary energy sources ( lactose and fat ) to deteriorated glucose homeostasis and insulin resistance is currently unknown .
98947,homeostasis,O,3431.0,The contribution of each of the dietary energy sources ( lactose and fat ) to deteriorated glucose homeostasis and insulin resistance is currently unknown .
98948,and,O,3431.0,The contribution of each of the dietary energy sources ( lactose and fat ) to deteriorated glucose homeostasis and insulin resistance is currently unknown .
98949,insulin,O,3431.0,The contribution of each of the dietary energy sources ( lactose and fat ) to deteriorated glucose homeostasis and insulin resistance is currently unknown .
98950,resistance,O,3431.0,The contribution of each of the dietary energy sources ( lactose and fat ) to deteriorated glucose homeostasis and insulin resistance is currently unknown .
98951,is,O,3431.0,The contribution of each of the dietary energy sources ( lactose and fat ) to deteriorated glucose homeostasis and insulin resistance is currently unknown .
98952,currently,O,3431.0,The contribution of each of the dietary energy sources ( lactose and fat ) to deteriorated glucose homeostasis and insulin resistance is currently unknown .
98953,unknown,O,3431.0,The contribution of each of the dietary energy sources ( lactose and fat ) to deteriorated glucose homeostasis and insulin resistance is currently unknown .
98954,.,O,3431.0,The contribution of each of the dietary energy sources ( lactose and fat ) to deteriorated glucose homeostasis and insulin resistance is currently unknown .
98955,Therefore,O,3432.0,"Therefore , an experiment was designed to compare the effects of a high - lactose and a high - fat MR on glucose homeostasis and insulin sensitivity in veal calves ."
98956,",",O,3432.0,"Therefore , an experiment was designed to compare the effects of a high - lactose and a high - fat MR on glucose homeostasis and insulin sensitivity in veal calves ."
98957,an,O,3432.0,"Therefore , an experiment was designed to compare the effects of a high - lactose and a high - fat MR on glucose homeostasis and insulin sensitivity in veal calves ."
98958,experiment,O,3432.0,"Therefore , an experiment was designed to compare the effects of a high - lactose and a high - fat MR on glucose homeostasis and insulin sensitivity in veal calves ."
98959,was,O,3432.0,"Therefore , an experiment was designed to compare the effects of a high - lactose and a high - fat MR on glucose homeostasis and insulin sensitivity in veal calves ."
98960,designed,O,3432.0,"Therefore , an experiment was designed to compare the effects of a high - lactose and a high - fat MR on glucose homeostasis and insulin sensitivity in veal calves ."
98961,to,O,3432.0,"Therefore , an experiment was designed to compare the effects of a high - lactose and a high - fat MR on glucose homeostasis and insulin sensitivity in veal calves ."
98962,compare,O,3432.0,"Therefore , an experiment was designed to compare the effects of a high - lactose and a high - fat MR on glucose homeostasis and insulin sensitivity in veal calves ."
98963,the,O,3432.0,"Therefore , an experiment was designed to compare the effects of a high - lactose and a high - fat MR on glucose homeostasis and insulin sensitivity in veal calves ."
98964,effects,O,3432.0,"Therefore , an experiment was designed to compare the effects of a high - lactose and a high - fat MR on glucose homeostasis and insulin sensitivity in veal calves ."
98965,of,O,3432.0,"Therefore , an experiment was designed to compare the effects of a high - lactose and a high - fat MR on glucose homeostasis and insulin sensitivity in veal calves ."
98966,a,O,3432.0,"Therefore , an experiment was designed to compare the effects of a high - lactose and a high - fat MR on glucose homeostasis and insulin sensitivity in veal calves ."
98967,high,O,3432.0,"Therefore , an experiment was designed to compare the effects of a high - lactose and a high - fat MR on glucose homeostasis and insulin sensitivity in veal calves ."
98968,-,O,3432.0,"Therefore , an experiment was designed to compare the effects of a high - lactose and a high - fat MR on glucose homeostasis and insulin sensitivity in veal calves ."
98969,lactose,O,3432.0,"Therefore , an experiment was designed to compare the effects of a high - lactose and a high - fat MR on glucose homeostasis and insulin sensitivity in veal calves ."
98970,and,O,3432.0,"Therefore , an experiment was designed to compare the effects of a high - lactose and a high - fat MR on glucose homeostasis and insulin sensitivity in veal calves ."
98971,a,O,3432.0,"Therefore , an experiment was designed to compare the effects of a high - lactose and a high - fat MR on glucose homeostasis and insulin sensitivity in veal calves ."
98972,high,O,3432.0,"Therefore , an experiment was designed to compare the effects of a high - lactose and a high - fat MR on glucose homeostasis and insulin sensitivity in veal calves ."
98973,-,O,3432.0,"Therefore , an experiment was designed to compare the effects of a high - lactose and a high - fat MR on glucose homeostasis and insulin sensitivity in veal calves ."
98974,fat,O,3432.0,"Therefore , an experiment was designed to compare the effects of a high - lactose and a high - fat MR on glucose homeostasis and insulin sensitivity in veal calves ."
98975,MR,O,3432.0,"Therefore , an experiment was designed to compare the effects of a high - lactose and a high - fat MR on glucose homeostasis and insulin sensitivity in veal calves ."
98976,on,O,3432.0,"Therefore , an experiment was designed to compare the effects of a high - lactose and a high - fat MR on glucose homeostasis and insulin sensitivity in veal calves ."
98977,glucose,O,3432.0,"Therefore , an experiment was designed to compare the effects of a high - lactose and a high - fat MR on glucose homeostasis and insulin sensitivity in veal calves ."
98978,homeostasis,O,3432.0,"Therefore , an experiment was designed to compare the effects of a high - lactose and a high - fat MR on glucose homeostasis and insulin sensitivity in veal calves ."
98979,and,O,3432.0,"Therefore , an experiment was designed to compare the effects of a high - lactose and a high - fat MR on glucose homeostasis and insulin sensitivity in veal calves ."
98980,insulin,O,3432.0,"Therefore , an experiment was designed to compare the effects of a high - lactose and a high - fat MR on glucose homeostasis and insulin sensitivity in veal calves ."
98981,sensitivity,O,3432.0,"Therefore , an experiment was designed to compare the effects of a high - lactose and a high - fat MR on glucose homeostasis and insulin sensitivity in veal calves ."
98982,in,O,3432.0,"Therefore , an experiment was designed to compare the effects of a high - lactose and a high - fat MR on glucose homeostasis and insulin sensitivity in veal calves ."
98983,veal,O,3432.0,"Therefore , an experiment was designed to compare the effects of a high - lactose and a high - fat MR on glucose homeostasis and insulin sensitivity in veal calves ."
98984,calves,O,3432.0,"Therefore , an experiment was designed to compare the effects of a high - lactose and a high - fat MR on glucose homeostasis and insulin sensitivity in veal calves ."
98985,.,O,3432.0,"Therefore , an experiment was designed to compare the effects of a high - lactose and a high - fat MR on glucose homeostasis and insulin sensitivity in veal calves ."
98986,Sixteen,O,3433.0,Sixteen male Holstein - Friesian calves ( 120±2.8 kg of BW ) were assigned to either a high - lactose ( HL ) or a high - fat ( HF ) MR for 13 consecutive weeks .
98987,male,O,3433.0,Sixteen male Holstein - Friesian calves ( 120±2.8 kg of BW ) were assigned to either a high - lactose ( HL ) or a high - fat ( HF ) MR for 13 consecutive weeks .
98988,Holstein,O,3433.0,Sixteen male Holstein - Friesian calves ( 120±2.8 kg of BW ) were assigned to either a high - lactose ( HL ) or a high - fat ( HF ) MR for 13 consecutive weeks .
98989,-,O,3433.0,Sixteen male Holstein - Friesian calves ( 120±2.8 kg of BW ) were assigned to either a high - lactose ( HL ) or a high - fat ( HF ) MR for 13 consecutive weeks .
98990,Friesian,O,3433.0,Sixteen male Holstein - Friesian calves ( 120±2.8 kg of BW ) were assigned to either a high - lactose ( HL ) or a high - fat ( HF ) MR for 13 consecutive weeks .
98991,calves,O,3433.0,Sixteen male Holstein - Friesian calves ( 120±2.8 kg of BW ) were assigned to either a high - lactose ( HL ) or a high - fat ( HF ) MR for 13 consecutive weeks .
98992,(,O,3433.0,Sixteen male Holstein - Friesian calves ( 120±2.8 kg of BW ) were assigned to either a high - lactose ( HL ) or a high - fat ( HF ) MR for 13 consecutive weeks .
98993,120±2.8,O,3433.0,Sixteen male Holstein - Friesian calves ( 120±2.8 kg of BW ) were assigned to either a high - lactose ( HL ) or a high - fat ( HF ) MR for 13 consecutive weeks .
98994,kg,O,3433.0,Sixteen male Holstein - Friesian calves ( 120±2.8 kg of BW ) were assigned to either a high - lactose ( HL ) or a high - fat ( HF ) MR for 13 consecutive weeks .
98995,of,O,3433.0,Sixteen male Holstein - Friesian calves ( 120±2.8 kg of BW ) were assigned to either a high - lactose ( HL ) or a high - fat ( HF ) MR for 13 consecutive weeks .
98996,BW,O,3433.0,Sixteen male Holstein - Friesian calves ( 120±2.8 kg of BW ) were assigned to either a high - lactose ( HL ) or a high - fat ( HF ) MR for 13 consecutive weeks .
98997,),O,3433.0,Sixteen male Holstein - Friesian calves ( 120±2.8 kg of BW ) were assigned to either a high - lactose ( HL ) or a high - fat ( HF ) MR for 13 consecutive weeks .
98998,were,O,3433.0,Sixteen male Holstein - Friesian calves ( 120±2.8 kg of BW ) were assigned to either a high - lactose ( HL ) or a high - fat ( HF ) MR for 13 consecutive weeks .
98999,assigned,O,3433.0,Sixteen male Holstein - Friesian calves ( 120±2.8 kg of BW ) were assigned to either a high - lactose ( HL ) or a high - fat ( HF ) MR for 13 consecutive weeks .
99000,to,O,3433.0,Sixteen male Holstein - Friesian calves ( 120±2.8 kg of BW ) were assigned to either a high - lactose ( HL ) or a high - fat ( HF ) MR for 13 consecutive weeks .
99001,either,O,3433.0,Sixteen male Holstein - Friesian calves ( 120±2.8 kg of BW ) were assigned to either a high - lactose ( HL ) or a high - fat ( HF ) MR for 13 consecutive weeks .
99002,a,O,3433.0,Sixteen male Holstein - Friesian calves ( 120±2.8 kg of BW ) were assigned to either a high - lactose ( HL ) or a high - fat ( HF ) MR for 13 consecutive weeks .
99003,high,O,3433.0,Sixteen male Holstein - Friesian calves ( 120±2.8 kg of BW ) were assigned to either a high - lactose ( HL ) or a high - fat ( HF ) MR for 13 consecutive weeks .
99004,-,O,3433.0,Sixteen male Holstein - Friesian calves ( 120±2.8 kg of BW ) were assigned to either a high - lactose ( HL ) or a high - fat ( HF ) MR for 13 consecutive weeks .
99005,lactose,O,3433.0,Sixteen male Holstein - Friesian calves ( 120±2.8 kg of BW ) were assigned to either a high - lactose ( HL ) or a high - fat ( HF ) MR for 13 consecutive weeks .
99006,(,O,3433.0,Sixteen male Holstein - Friesian calves ( 120±2.8 kg of BW ) were assigned to either a high - lactose ( HL ) or a high - fat ( HF ) MR for 13 consecutive weeks .
99007,HL,O,3433.0,Sixteen male Holstein - Friesian calves ( 120±2.8 kg of BW ) were assigned to either a high - lactose ( HL ) or a high - fat ( HF ) MR for 13 consecutive weeks .
99008,),O,3433.0,Sixteen male Holstein - Friesian calves ( 120±2.8 kg of BW ) were assigned to either a high - lactose ( HL ) or a high - fat ( HF ) MR for 13 consecutive weeks .
99009,or,O,3433.0,Sixteen male Holstein - Friesian calves ( 120±2.8 kg of BW ) were assigned to either a high - lactose ( HL ) or a high - fat ( HF ) MR for 13 consecutive weeks .
99010,a,O,3433.0,Sixteen male Holstein - Friesian calves ( 120±2.8 kg of BW ) were assigned to either a high - lactose ( HL ) or a high - fat ( HF ) MR for 13 consecutive weeks .
99011,high,O,3433.0,Sixteen male Holstein - Friesian calves ( 120±2.8 kg of BW ) were assigned to either a high - lactose ( HL ) or a high - fat ( HF ) MR for 13 consecutive weeks .
99012,-,O,3433.0,Sixteen male Holstein - Friesian calves ( 120±2.8 kg of BW ) were assigned to either a high - lactose ( HL ) or a high - fat ( HF ) MR for 13 consecutive weeks .
99013,fat,O,3433.0,Sixteen male Holstein - Friesian calves ( 120±2.8 kg of BW ) were assigned to either a high - lactose ( HL ) or a high - fat ( HF ) MR for 13 consecutive weeks .
99014,(,O,3433.0,Sixteen male Holstein - Friesian calves ( 120±2.8 kg of BW ) were assigned to either a high - lactose ( HL ) or a high - fat ( HF ) MR for 13 consecutive weeks .
99015,HF,O,3433.0,Sixteen male Holstein - Friesian calves ( 120±2.8 kg of BW ) were assigned to either a high - lactose ( HL ) or a high - fat ( HF ) MR for 13 consecutive weeks .
99016,),O,3433.0,Sixteen male Holstein - Friesian calves ( 120±2.8 kg of BW ) were assigned to either a high - lactose ( HL ) or a high - fat ( HF ) MR for 13 consecutive weeks .
99017,MR,O,3433.0,Sixteen male Holstein - Friesian calves ( 120±2.8 kg of BW ) were assigned to either a high - lactose ( HL ) or a high - fat ( HF ) MR for 13 consecutive weeks .
99018,for,O,3433.0,Sixteen male Holstein - Friesian calves ( 120±2.8 kg of BW ) were assigned to either a high - lactose ( HL ) or a high - fat ( HF ) MR for 13 consecutive weeks .
99019,13,O,3433.0,Sixteen male Holstein - Friesian calves ( 120±2.8 kg of BW ) were assigned to either a high - lactose ( HL ) or a high - fat ( HF ) MR for 13 consecutive weeks .
99020,consecutive,O,3433.0,Sixteen male Holstein - Friesian calves ( 120±2.8 kg of BW ) were assigned to either a high - lactose ( HL ) or a high - fat ( HF ) MR for 13 consecutive weeks .
99021,weeks,O,3433.0,Sixteen male Holstein - Friesian calves ( 120±2.8 kg of BW ) were assigned to either a high - lactose ( HL ) or a high - fat ( HF ) MR for 13 consecutive weeks .
99022,.,O,3433.0,Sixteen male Holstein - Friesian calves ( 120±2.8 kg of BW ) were assigned to either a high - lactose ( HL ) or a high - fat ( HF ) MR for 13 consecutive weeks .
99023,After,O,3434.0,"After at least 7 wk of adaptation , whole - body insulin sensitivity and insulin secretion were assessed by euglycemic - hyperinsulinemic and hyperglycemic clamps , respectively ."
99024,at,O,3434.0,"After at least 7 wk of adaptation , whole - body insulin sensitivity and insulin secretion were assessed by euglycemic - hyperinsulinemic and hyperglycemic clamps , respectively ."
99025,least,O,3434.0,"After at least 7 wk of adaptation , whole - body insulin sensitivity and insulin secretion were assessed by euglycemic - hyperinsulinemic and hyperglycemic clamps , respectively ."
99026,7,O,3434.0,"After at least 7 wk of adaptation , whole - body insulin sensitivity and insulin secretion were assessed by euglycemic - hyperinsulinemic and hyperglycemic clamps , respectively ."
99027,wk,O,3434.0,"After at least 7 wk of adaptation , whole - body insulin sensitivity and insulin secretion were assessed by euglycemic - hyperinsulinemic and hyperglycemic clamps , respectively ."
99028,of,O,3434.0,"After at least 7 wk of adaptation , whole - body insulin sensitivity and insulin secretion were assessed by euglycemic - hyperinsulinemic and hyperglycemic clamps , respectively ."
99029,adaptation,O,3434.0,"After at least 7 wk of adaptation , whole - body insulin sensitivity and insulin secretion were assessed by euglycemic - hyperinsulinemic and hyperglycemic clamps , respectively ."
99030,",",O,3434.0,"After at least 7 wk of adaptation , whole - body insulin sensitivity and insulin secretion were assessed by euglycemic - hyperinsulinemic and hyperglycemic clamps , respectively ."
99031,whole,O,3434.0,"After at least 7 wk of adaptation , whole - body insulin sensitivity and insulin secretion were assessed by euglycemic - hyperinsulinemic and hyperglycemic clamps , respectively ."
99032,-,O,3434.0,"After at least 7 wk of adaptation , whole - body insulin sensitivity and insulin secretion were assessed by euglycemic - hyperinsulinemic and hyperglycemic clamps , respectively ."
99033,body,O,3434.0,"After at least 7 wk of adaptation , whole - body insulin sensitivity and insulin secretion were assessed by euglycemic - hyperinsulinemic and hyperglycemic clamps , respectively ."
99034,insulin,O,3434.0,"After at least 7 wk of adaptation , whole - body insulin sensitivity and insulin secretion were assessed by euglycemic - hyperinsulinemic and hyperglycemic clamps , respectively ."
99035,sensitivity,O,3434.0,"After at least 7 wk of adaptation , whole - body insulin sensitivity and insulin secretion were assessed by euglycemic - hyperinsulinemic and hyperglycemic clamps , respectively ."
99036,and,O,3434.0,"After at least 7 wk of adaptation , whole - body insulin sensitivity and insulin secretion were assessed by euglycemic - hyperinsulinemic and hyperglycemic clamps , respectively ."
99037,insulin,O,3434.0,"After at least 7 wk of adaptation , whole - body insulin sensitivity and insulin secretion were assessed by euglycemic - hyperinsulinemic and hyperglycemic clamps , respectively ."
99038,secretion,O,3434.0,"After at least 7 wk of adaptation , whole - body insulin sensitivity and insulin secretion were assessed by euglycemic - hyperinsulinemic and hyperglycemic clamps , respectively ."
99039,were,O,3434.0,"After at least 7 wk of adaptation , whole - body insulin sensitivity and insulin secretion were assessed by euglycemic - hyperinsulinemic and hyperglycemic clamps , respectively ."
99040,assessed,O,3434.0,"After at least 7 wk of adaptation , whole - body insulin sensitivity and insulin secretion were assessed by euglycemic - hyperinsulinemic and hyperglycemic clamps , respectively ."
99041,by,O,3434.0,"After at least 7 wk of adaptation , whole - body insulin sensitivity and insulin secretion were assessed by euglycemic - hyperinsulinemic and hyperglycemic clamps , respectively ."
99042,euglycemic,O,3434.0,"After at least 7 wk of adaptation , whole - body insulin sensitivity and insulin secretion were assessed by euglycemic - hyperinsulinemic and hyperglycemic clamps , respectively ."
99043,-,O,3434.0,"After at least 7 wk of adaptation , whole - body insulin sensitivity and insulin secretion were assessed by euglycemic - hyperinsulinemic and hyperglycemic clamps , respectively ."
99044,hyperinsulinemic,O,3434.0,"After at least 7 wk of adaptation , whole - body insulin sensitivity and insulin secretion were assessed by euglycemic - hyperinsulinemic and hyperglycemic clamps , respectively ."
99045,and,O,3434.0,"After at least 7 wk of adaptation , whole - body insulin sensitivity and insulin secretion were assessed by euglycemic - hyperinsulinemic and hyperglycemic clamps , respectively ."
99046,hyperglycemic,O,3434.0,"After at least 7 wk of adaptation , whole - body insulin sensitivity and insulin secretion were assessed by euglycemic - hyperinsulinemic and hyperglycemic clamps , respectively ."
99047,clamps,O,3434.0,"After at least 7 wk of adaptation , whole - body insulin sensitivity and insulin secretion were assessed by euglycemic - hyperinsulinemic and hyperglycemic clamps , respectively ."
99048,",",O,3434.0,"After at least 7 wk of adaptation , whole - body insulin sensitivity and insulin secretion were assessed by euglycemic - hyperinsulinemic and hyperglycemic clamps , respectively ."
99049,respectively,O,3434.0,"After at least 7 wk of adaptation , whole - body insulin sensitivity and insulin secretion were assessed by euglycemic - hyperinsulinemic and hyperglycemic clamps , respectively ."
99050,.,O,3434.0,"After at least 7 wk of adaptation , whole - body insulin sensitivity and insulin secretion were assessed by euglycemic - hyperinsulinemic and hyperglycemic clamps , respectively ."
99051,Postprandial,O,3435.0,"Postprandial blood samples were collected to assess glucose , insulin , and triglyceride responses to feeding , and 24 - h urine was collected to quantify urinary glucose excretion ."
99052,blood,O,3435.0,"Postprandial blood samples were collected to assess glucose , insulin , and triglyceride responses to feeding , and 24 - h urine was collected to quantify urinary glucose excretion ."
99053,samples,O,3435.0,"Postprandial blood samples were collected to assess glucose , insulin , and triglyceride responses to feeding , and 24 - h urine was collected to quantify urinary glucose excretion ."
99054,were,O,3435.0,"Postprandial blood samples were collected to assess glucose , insulin , and triglyceride responses to feeding , and 24 - h urine was collected to quantify urinary glucose excretion ."
99055,collected,O,3435.0,"Postprandial blood samples were collected to assess glucose , insulin , and triglyceride responses to feeding , and 24 - h urine was collected to quantify urinary glucose excretion ."
99056,to,O,3435.0,"Postprandial blood samples were collected to assess glucose , insulin , and triglyceride responses to feeding , and 24 - h urine was collected to quantify urinary glucose excretion ."
99057,assess,O,3435.0,"Postprandial blood samples were collected to assess glucose , insulin , and triglyceride responses to feeding , and 24 - h urine was collected to quantify urinary glucose excretion ."
99058,glucose,O,3435.0,"Postprandial blood samples were collected to assess glucose , insulin , and triglyceride responses to feeding , and 24 - h urine was collected to quantify urinary glucose excretion ."
99059,",",O,3435.0,"Postprandial blood samples were collected to assess glucose , insulin , and triglyceride responses to feeding , and 24 - h urine was collected to quantify urinary glucose excretion ."
99060,insulin,O,3435.0,"Postprandial blood samples were collected to assess glucose , insulin , and triglyceride responses to feeding , and 24 - h urine was collected to quantify urinary glucose excretion ."
99061,",",O,3435.0,"Postprandial blood samples were collected to assess glucose , insulin , and triglyceride responses to feeding , and 24 - h urine was collected to quantify urinary glucose excretion ."
99062,and,O,3435.0,"Postprandial blood samples were collected to assess glucose , insulin , and triglyceride responses to feeding , and 24 - h urine was collected to quantify urinary glucose excretion ."
99063,triglyceride,O,3435.0,"Postprandial blood samples were collected to assess glucose , insulin , and triglyceride responses to feeding , and 24 - h urine was collected to quantify urinary glucose excretion ."
99064,responses,O,3435.0,"Postprandial blood samples were collected to assess glucose , insulin , and triglyceride responses to feeding , and 24 - h urine was collected to quantify urinary glucose excretion ."
99065,to,O,3435.0,"Postprandial blood samples were collected to assess glucose , insulin , and triglyceride responses to feeding , and 24 - h urine was collected to quantify urinary glucose excretion ."
99066,feeding,O,3435.0,"Postprandial blood samples were collected to assess glucose , insulin , and triglyceride responses to feeding , and 24 - h urine was collected to quantify urinary glucose excretion ."
99067,",",O,3435.0,"Postprandial blood samples were collected to assess glucose , insulin , and triglyceride responses to feeding , and 24 - h urine was collected to quantify urinary glucose excretion ."
99068,and,O,3435.0,"Postprandial blood samples were collected to assess glucose , insulin , and triglyceride responses to feeding , and 24 - h urine was collected to quantify urinary glucose excretion ."
99069,24,O,3435.0,"Postprandial blood samples were collected to assess glucose , insulin , and triglyceride responses to feeding , and 24 - h urine was collected to quantify urinary glucose excretion ."
99070,-,O,3435.0,"Postprandial blood samples were collected to assess glucose , insulin , and triglyceride responses to feeding , and 24 - h urine was collected to quantify urinary glucose excretion ."
99071,h,O,3435.0,"Postprandial blood samples were collected to assess glucose , insulin , and triglyceride responses to feeding , and 24 - h urine was collected to quantify urinary glucose excretion ."
99072,urine,O,3435.0,"Postprandial blood samples were collected to assess glucose , insulin , and triglyceride responses to feeding , and 24 - h urine was collected to quantify urinary glucose excretion ."
99073,was,O,3435.0,"Postprandial blood samples were collected to assess glucose , insulin , and triglyceride responses to feeding , and 24 - h urine was collected to quantify urinary glucose excretion ."
99074,collected,O,3435.0,"Postprandial blood samples were collected to assess glucose , insulin , and triglyceride responses to feeding , and 24 - h urine was collected to quantify urinary glucose excretion ."
99075,to,O,3435.0,"Postprandial blood samples were collected to assess glucose , insulin , and triglyceride responses to feeding , and 24 - h urine was collected to quantify urinary glucose excretion ."
99076,quantify,O,3435.0,"Postprandial blood samples were collected to assess glucose , insulin , and triglyceride responses to feeding , and 24 - h urine was collected to quantify urinary glucose excretion ."
99077,urinary,O,3435.0,"Postprandial blood samples were collected to assess glucose , insulin , and triglyceride responses to feeding , and 24 - h urine was collected to quantify urinary glucose excretion ."
99078,glucose,O,3435.0,"Postprandial blood samples were collected to assess glucose , insulin , and triglyceride responses to feeding , and 24 - h urine was collected to quantify urinary glucose excretion ."
99079,excretion,O,3435.0,"Postprandial blood samples were collected to assess glucose , insulin , and triglyceride responses to feeding , and 24 - h urine was collected to quantify urinary glucose excretion ."
99080,.,O,3435.0,"Postprandial blood samples were collected to assess glucose , insulin , and triglyceride responses to feeding , and 24 - h urine was collected to quantify urinary glucose excretion ."
99081,At,O,3436.0,"At the end of the trial , liver and muscle biopsies were taken to assess triglyceride contents in these tissues ."
99082,the,O,3436.0,"At the end of the trial , liver and muscle biopsies were taken to assess triglyceride contents in these tissues ."
99083,end,O,3436.0,"At the end of the trial , liver and muscle biopsies were taken to assess triglyceride contents in these tissues ."
99084,of,O,3436.0,"At the end of the trial , liver and muscle biopsies were taken to assess triglyceride contents in these tissues ."
99085,the,O,3436.0,"At the end of the trial , liver and muscle biopsies were taken to assess triglyceride contents in these tissues ."
99086,trial,O,3436.0,"At the end of the trial , liver and muscle biopsies were taken to assess triglyceride contents in these tissues ."
99087,",",O,3436.0,"At the end of the trial , liver and muscle biopsies were taken to assess triglyceride contents in these tissues ."
99088,liver,O,3436.0,"At the end of the trial , liver and muscle biopsies were taken to assess triglyceride contents in these tissues ."
99089,and,O,3436.0,"At the end of the trial , liver and muscle biopsies were taken to assess triglyceride contents in these tissues ."
99090,muscle,O,3436.0,"At the end of the trial , liver and muscle biopsies were taken to assess triglyceride contents in these tissues ."
99091,biopsies,O,3436.0,"At the end of the trial , liver and muscle biopsies were taken to assess triglyceride contents in these tissues ."
99092,were,O,3436.0,"At the end of the trial , liver and muscle biopsies were taken to assess triglyceride contents in these tissues ."
99093,taken,O,3436.0,"At the end of the trial , liver and muscle biopsies were taken to assess triglyceride contents in these tissues ."
99094,to,O,3436.0,"At the end of the trial , liver and muscle biopsies were taken to assess triglyceride contents in these tissues ."
99095,assess,O,3436.0,"At the end of the trial , liver and muscle biopsies were taken to assess triglyceride contents in these tissues ."
99096,triglyceride,O,3436.0,"At the end of the trial , liver and muscle biopsies were taken to assess triglyceride contents in these tissues ."
99097,contents,O,3436.0,"At the end of the trial , liver and muscle biopsies were taken to assess triglyceride contents in these tissues ."
99098,in,O,3436.0,"At the end of the trial , liver and muscle biopsies were taken to assess triglyceride contents in these tissues ."
99099,these,O,3436.0,"At the end of the trial , liver and muscle biopsies were taken to assess triglyceride contents in these tissues ."
99100,tissues,O,3436.0,"At the end of the trial , liver and muscle biopsies were taken to assess triglyceride contents in these tissues ."
99101,.,O,3436.0,"At the end of the trial , liver and muscle biopsies were taken to assess triglyceride contents in these tissues ."
99102,Long,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99103,-,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99104,term,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99105,exposure,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99106,of,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99107,calves,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99108,to,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99109,HF,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99110,or,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99111,HL,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99112,MR,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99113,did,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99114,not,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99115,affect,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99116,whole,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99117,-,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99118,body,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99119,insulin,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99120,sensitivity,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99121,(,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99122,averaging,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99123,4.2±0.5×10,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99124,During,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99125,the,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99126,periparturient,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99127,phase,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99128,",",O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99129,cows,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99130,are,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99131,typically,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99132,in,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99133,an,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99134,inflammation,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99135,-,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99136,like,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99137,condition,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99138,",",O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99139,and,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99140,it,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99141,has,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99142,been,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99143,suggested,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99144,that,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99145,inflammation,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99146,associated,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99147,with,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99148,the,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99149,development,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99150,of,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99151,stress,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99152,of,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99153,the,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99154,endoplasmic,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99155,reticulum,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99156,(,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99157,ER,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99158,),O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99159,in,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99160,the,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99161,liver,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99162,contributes,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99163,to,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99164,the,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99165,development,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99166,of,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99167,fatty,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99168,liver,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99169,syndrome,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99170,and,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99171,ketosis,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99172,.,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99173,In,O,3438.0,"In the present study , we investigated the hypothesis that feeding grape seed and grape marc meal extract ( GSGME ) as a plant extract rich in flavonoids attenuates inflammation and ER stress in the liver of dairy cows ."
99174,the,O,3438.0,"In the present study , we investigated the hypothesis that feeding grape seed and grape marc meal extract ( GSGME ) as a plant extract rich in flavonoids attenuates inflammation and ER stress in the liver of dairy cows ."
99175,present,O,3438.0,"In the present study , we investigated the hypothesis that feeding grape seed and grape marc meal extract ( GSGME ) as a plant extract rich in flavonoids attenuates inflammation and ER stress in the liver of dairy cows ."
99176,study,O,3438.0,"In the present study , we investigated the hypothesis that feeding grape seed and grape marc meal extract ( GSGME ) as a plant extract rich in flavonoids attenuates inflammation and ER stress in the liver of dairy cows ."
99177,",",O,3438.0,"In the present study , we investigated the hypothesis that feeding grape seed and grape marc meal extract ( GSGME ) as a plant extract rich in flavonoids attenuates inflammation and ER stress in the liver of dairy cows ."
99178,we,O,3438.0,"In the present study , we investigated the hypothesis that feeding grape seed and grape marc meal extract ( GSGME ) as a plant extract rich in flavonoids attenuates inflammation and ER stress in the liver of dairy cows ."
99179,investigated,O,3438.0,"In the present study , we investigated the hypothesis that feeding grape seed and grape marc meal extract ( GSGME ) as a plant extract rich in flavonoids attenuates inflammation and ER stress in the liver of dairy cows ."
99180,the,O,3438.0,"In the present study , we investigated the hypothesis that feeding grape seed and grape marc meal extract ( GSGME ) as a plant extract rich in flavonoids attenuates inflammation and ER stress in the liver of dairy cows ."
99181,hypothesis,O,3438.0,"In the present study , we investigated the hypothesis that feeding grape seed and grape marc meal extract ( GSGME ) as a plant extract rich in flavonoids attenuates inflammation and ER stress in the liver of dairy cows ."
99182,that,O,3438.0,"In the present study , we investigated the hypothesis that feeding grape seed and grape marc meal extract ( GSGME ) as a plant extract rich in flavonoids attenuates inflammation and ER stress in the liver of dairy cows ."
99183,feeding,O,3438.0,"In the present study , we investigated the hypothesis that feeding grape seed and grape marc meal extract ( GSGME ) as a plant extract rich in flavonoids attenuates inflammation and ER stress in the liver of dairy cows ."
99184,grape,O,3438.0,"In the present study , we investigated the hypothesis that feeding grape seed and grape marc meal extract ( GSGME ) as a plant extract rich in flavonoids attenuates inflammation and ER stress in the liver of dairy cows ."
99185,seed,O,3438.0,"In the present study , we investigated the hypothesis that feeding grape seed and grape marc meal extract ( GSGME ) as a plant extract rich in flavonoids attenuates inflammation and ER stress in the liver of dairy cows ."
99186,and,O,3438.0,"In the present study , we investigated the hypothesis that feeding grape seed and grape marc meal extract ( GSGME ) as a plant extract rich in flavonoids attenuates inflammation and ER stress in the liver of dairy cows ."
99187,grape,O,3438.0,"In the present study , we investigated the hypothesis that feeding grape seed and grape marc meal extract ( GSGME ) as a plant extract rich in flavonoids attenuates inflammation and ER stress in the liver of dairy cows ."
99188,marc,O,3438.0,"In the present study , we investigated the hypothesis that feeding grape seed and grape marc meal extract ( GSGME ) as a plant extract rich in flavonoids attenuates inflammation and ER stress in the liver of dairy cows ."
99189,meal,O,3438.0,"In the present study , we investigated the hypothesis that feeding grape seed and grape marc meal extract ( GSGME ) as a plant extract rich in flavonoids attenuates inflammation and ER stress in the liver of dairy cows ."
99190,extract,O,3438.0,"In the present study , we investigated the hypothesis that feeding grape seed and grape marc meal extract ( GSGME ) as a plant extract rich in flavonoids attenuates inflammation and ER stress in the liver of dairy cows ."
99191,(,O,3438.0,"In the present study , we investigated the hypothesis that feeding grape seed and grape marc meal extract ( GSGME ) as a plant extract rich in flavonoids attenuates inflammation and ER stress in the liver of dairy cows ."
99192,GSGME,O,3438.0,"In the present study , we investigated the hypothesis that feeding grape seed and grape marc meal extract ( GSGME ) as a plant extract rich in flavonoids attenuates inflammation and ER stress in the liver of dairy cows ."
99193,),O,3438.0,"In the present study , we investigated the hypothesis that feeding grape seed and grape marc meal extract ( GSGME ) as a plant extract rich in flavonoids attenuates inflammation and ER stress in the liver of dairy cows ."
99194,as,O,3438.0,"In the present study , we investigated the hypothesis that feeding grape seed and grape marc meal extract ( GSGME ) as a plant extract rich in flavonoids attenuates inflammation and ER stress in the liver of dairy cows ."
99195,a,O,3438.0,"In the present study , we investigated the hypothesis that feeding grape seed and grape marc meal extract ( GSGME ) as a plant extract rich in flavonoids attenuates inflammation and ER stress in the liver of dairy cows ."
99196,plant,O,3438.0,"In the present study , we investigated the hypothesis that feeding grape seed and grape marc meal extract ( GSGME ) as a plant extract rich in flavonoids attenuates inflammation and ER stress in the liver of dairy cows ."
99197,extract,O,3438.0,"In the present study , we investigated the hypothesis that feeding grape seed and grape marc meal extract ( GSGME ) as a plant extract rich in flavonoids attenuates inflammation and ER stress in the liver of dairy cows ."
99198,rich,O,3438.0,"In the present study , we investigated the hypothesis that feeding grape seed and grape marc meal extract ( GSGME ) as a plant extract rich in flavonoids attenuates inflammation and ER stress in the liver of dairy cows ."
99199,in,O,3438.0,"In the present study , we investigated the hypothesis that feeding grape seed and grape marc meal extract ( GSGME ) as a plant extract rich in flavonoids attenuates inflammation and ER stress in the liver of dairy cows ."
99200,flavonoids,O,3438.0,"In the present study , we investigated the hypothesis that feeding grape seed and grape marc meal extract ( GSGME ) as a plant extract rich in flavonoids attenuates inflammation and ER stress in the liver of dairy cows ."
99201,attenuates,O,3438.0,"In the present study , we investigated the hypothesis that feeding grape seed and grape marc meal extract ( GSGME ) as a plant extract rich in flavonoids attenuates inflammation and ER stress in the liver of dairy cows ."
99202,inflammation,O,3438.0,"In the present study , we investigated the hypothesis that feeding grape seed and grape marc meal extract ( GSGME ) as a plant extract rich in flavonoids attenuates inflammation and ER stress in the liver of dairy cows ."
99203,and,O,3438.0,"In the present study , we investigated the hypothesis that feeding grape seed and grape marc meal extract ( GSGME ) as a plant extract rich in flavonoids attenuates inflammation and ER stress in the liver of dairy cows ."
99204,ER,O,3438.0,"In the present study , we investigated the hypothesis that feeding grape seed and grape marc meal extract ( GSGME ) as a plant extract rich in flavonoids attenuates inflammation and ER stress in the liver of dairy cows ."
99205,stress,O,3438.0,"In the present study , we investigated the hypothesis that feeding grape seed and grape marc meal extract ( GSGME ) as a plant extract rich in flavonoids attenuates inflammation and ER stress in the liver of dairy cows ."
99206,in,O,3438.0,"In the present study , we investigated the hypothesis that feeding grape seed and grape marc meal extract ( GSGME ) as a plant extract rich in flavonoids attenuates inflammation and ER stress in the liver of dairy cows ."
99207,the,O,3438.0,"In the present study , we investigated the hypothesis that feeding grape seed and grape marc meal extract ( GSGME ) as a plant extract rich in flavonoids attenuates inflammation and ER stress in the liver of dairy cows ."
99208,liver,O,3438.0,"In the present study , we investigated the hypothesis that feeding grape seed and grape marc meal extract ( GSGME ) as a plant extract rich in flavonoids attenuates inflammation and ER stress in the liver of dairy cows ."
99209,of,O,3438.0,"In the present study , we investigated the hypothesis that feeding grape seed and grape marc meal extract ( GSGME ) as a plant extract rich in flavonoids attenuates inflammation and ER stress in the liver of dairy cows ."
99210,dairy,O,3438.0,"In the present study , we investigated the hypothesis that feeding grape seed and grape marc meal extract ( GSGME ) as a plant extract rich in flavonoids attenuates inflammation and ER stress in the liver of dairy cows ."
99211,cows,O,3438.0,"In the present study , we investigated the hypothesis that feeding grape seed and grape marc meal extract ( GSGME ) as a plant extract rich in flavonoids attenuates inflammation and ER stress in the liver of dairy cows ."
99212,.,O,3438.0,"In the present study , we investigated the hypothesis that feeding grape seed and grape marc meal extract ( GSGME ) as a plant extract rich in flavonoids attenuates inflammation and ER stress in the liver of dairy cows ."
99213,Two,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99214,groups,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99215,of,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99216,cows,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99217,received,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99218,either,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99219,a,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99220,total,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99221,mixed,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99222,ration,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99223,as,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99224,a,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99225,control,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99226,diet,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99227,or,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99228,the,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99229,same,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99230,total,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99231,mixed,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99232,ration,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99233,supplemented,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99234,with,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99235,1,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99236,%,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99237,of,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99238,GSGME,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99239,over,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99240,the,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99241,period,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99242,from,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99243,wk,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99244,3,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99245,prepartum,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99246,to,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99247,wk,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99248,9,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99249,postpartum,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99250,.,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99251,Dry,O,3440.0,Dry matter intake during wk 3 to 9 postpartum was not different between the 2 groups .
99252,matter,O,3440.0,Dry matter intake during wk 3 to 9 postpartum was not different between the 2 groups .
99253,intake,O,3440.0,Dry matter intake during wk 3 to 9 postpartum was not different between the 2 groups .
99254,during,O,3440.0,Dry matter intake during wk 3 to 9 postpartum was not different between the 2 groups .
99255,wk,O,3440.0,Dry matter intake during wk 3 to 9 postpartum was not different between the 2 groups .
99256,3,O,3440.0,Dry matter intake during wk 3 to 9 postpartum was not different between the 2 groups .
99257,to,O,3440.0,Dry matter intake during wk 3 to 9 postpartum was not different between the 2 groups .
99258,9,O,3440.0,Dry matter intake during wk 3 to 9 postpartum was not different between the 2 groups .
99259,postpartum,O,3440.0,Dry matter intake during wk 3 to 9 postpartum was not different between the 2 groups .
99260,was,O,3440.0,Dry matter intake during wk 3 to 9 postpartum was not different between the 2 groups .
99261,not,O,3440.0,Dry matter intake during wk 3 to 9 postpartum was not different between the 2 groups .
99262,different,O,3440.0,Dry matter intake during wk 3 to 9 postpartum was not different between the 2 groups .
99263,between,O,3440.0,Dry matter intake during wk 3 to 9 postpartum was not different between the 2 groups .
99264,the,O,3440.0,Dry matter intake during wk 3 to 9 postpartum was not different between the 2 groups .
99265,2,O,3440.0,Dry matter intake during wk 3 to 9 postpartum was not different between the 2 groups .
99266,groups,O,3440.0,Dry matter intake during wk 3 to 9 postpartum was not different between the 2 groups .
99267,.,O,3440.0,Dry matter intake during wk 3 to 9 postpartum was not different between the 2 groups .
99268,However,O,3441.0,"However , the cows fed the diet supplemented with GSGME had an increased milk yield and an increased daily milk protein yield ."
99269,",",O,3441.0,"However , the cows fed the diet supplemented with GSGME had an increased milk yield and an increased daily milk protein yield ."
99270,the,O,3441.0,"However , the cows fed the diet supplemented with GSGME had an increased milk yield and an increased daily milk protein yield ."
99271,cows,O,3441.0,"However , the cows fed the diet supplemented with GSGME had an increased milk yield and an increased daily milk protein yield ."
99272,fed,O,3441.0,"However , the cows fed the diet supplemented with GSGME had an increased milk yield and an increased daily milk protein yield ."
99273,the,O,3441.0,"However , the cows fed the diet supplemented with GSGME had an increased milk yield and an increased daily milk protein yield ."
99274,diet,O,3441.0,"However , the cows fed the diet supplemented with GSGME had an increased milk yield and an increased daily milk protein yield ."
99275,supplemented,O,3441.0,"However , the cows fed the diet supplemented with GSGME had an increased milk yield and an increased daily milk protein yield ."
99276,with,O,3441.0,"However , the cows fed the diet supplemented with GSGME had an increased milk yield and an increased daily milk protein yield ."
99277,GSGME,O,3441.0,"However , the cows fed the diet supplemented with GSGME had an increased milk yield and an increased daily milk protein yield ."
99278,had,O,3441.0,"However , the cows fed the diet supplemented with GSGME had an increased milk yield and an increased daily milk protein yield ."
99279,an,O,3441.0,"However , the cows fed the diet supplemented with GSGME had an increased milk yield and an increased daily milk protein yield ."
99280,increased,O,3441.0,"However , the cows fed the diet supplemented with GSGME had an increased milk yield and an increased daily milk protein yield ."
99281,milk,O,3441.0,"However , the cows fed the diet supplemented with GSGME had an increased milk yield and an increased daily milk protein yield ."
99282,yield,O,3441.0,"However , the cows fed the diet supplemented with GSGME had an increased milk yield and an increased daily milk protein yield ."
99283,and,O,3441.0,"However , the cows fed the diet supplemented with GSGME had an increased milk yield and an increased daily milk protein yield ."
99284,an,O,3441.0,"However , the cows fed the diet supplemented with GSGME had an increased milk yield and an increased daily milk protein yield ."
99285,increased,O,3441.0,"However , the cows fed the diet supplemented with GSGME had an increased milk yield and an increased daily milk protein yield ."
99286,daily,O,3441.0,"However , the cows fed the diet supplemented with GSGME had an increased milk yield and an increased daily milk protein yield ."
99287,milk,O,3441.0,"However , the cows fed the diet supplemented with GSGME had an increased milk yield and an increased daily milk protein yield ."
99288,protein,O,3441.0,"However , the cows fed the diet supplemented with GSGME had an increased milk yield and an increased daily milk protein yield ."
99289,yield,O,3441.0,"However , the cows fed the diet supplemented with GSGME had an increased milk yield and an increased daily milk protein yield ."
99290,.,O,3441.0,"However , the cows fed the diet supplemented with GSGME had an increased milk yield and an increased daily milk protein yield ."
99291,Cows,O,3442.0,"Cows supplemented with GSGME moreover had a significantly reduced mRNA abundancy of fibroblast growth factor ( FGF ) 21 , a stress hormone induced by various stress conditions , in the liver in wk 1 and 3 postpartum ."
99292,supplemented,O,3442.0,"Cows supplemented with GSGME moreover had a significantly reduced mRNA abundancy of fibroblast growth factor ( FGF ) 21 , a stress hormone induced by various stress conditions , in the liver in wk 1 and 3 postpartum ."
99293,with,O,3442.0,"Cows supplemented with GSGME moreover had a significantly reduced mRNA abundancy of fibroblast growth factor ( FGF ) 21 , a stress hormone induced by various stress conditions , in the liver in wk 1 and 3 postpartum ."
99294,GSGME,O,3442.0,"Cows supplemented with GSGME moreover had a significantly reduced mRNA abundancy of fibroblast growth factor ( FGF ) 21 , a stress hormone induced by various stress conditions , in the liver in wk 1 and 3 postpartum ."
99295,moreover,O,3442.0,"Cows supplemented with GSGME moreover had a significantly reduced mRNA abundancy of fibroblast growth factor ( FGF ) 21 , a stress hormone induced by various stress conditions , in the liver in wk 1 and 3 postpartum ."
99296,had,O,3442.0,"Cows supplemented with GSGME moreover had a significantly reduced mRNA abundancy of fibroblast growth factor ( FGF ) 21 , a stress hormone induced by various stress conditions , in the liver in wk 1 and 3 postpartum ."
99297,a,O,3442.0,"Cows supplemented with GSGME moreover had a significantly reduced mRNA abundancy of fibroblast growth factor ( FGF ) 21 , a stress hormone induced by various stress conditions , in the liver in wk 1 and 3 postpartum ."
99298,significantly,O,3442.0,"Cows supplemented with GSGME moreover had a significantly reduced mRNA abundancy of fibroblast growth factor ( FGF ) 21 , a stress hormone induced by various stress conditions , in the liver in wk 1 and 3 postpartum ."
99299,reduced,O,3442.0,"Cows supplemented with GSGME moreover had a significantly reduced mRNA abundancy of fibroblast growth factor ( FGF ) 21 , a stress hormone induced by various stress conditions , in the liver in wk 1 and 3 postpartum ."
99300,mRNA,O,3442.0,"Cows supplemented with GSGME moreover had a significantly reduced mRNA abundancy of fibroblast growth factor ( FGF ) 21 , a stress hormone induced by various stress conditions , in the liver in wk 1 and 3 postpartum ."
99301,abundancy,O,3442.0,"Cows supplemented with GSGME moreover had a significantly reduced mRNA abundancy of fibroblast growth factor ( FGF ) 21 , a stress hormone induced by various stress conditions , in the liver in wk 1 and 3 postpartum ."
99302,of,O,3442.0,"Cows supplemented with GSGME moreover had a significantly reduced mRNA abundancy of fibroblast growth factor ( FGF ) 21 , a stress hormone induced by various stress conditions , in the liver in wk 1 and 3 postpartum ."
99303,fibroblast,O,3442.0,"Cows supplemented with GSGME moreover had a significantly reduced mRNA abundancy of fibroblast growth factor ( FGF ) 21 , a stress hormone induced by various stress conditions , in the liver in wk 1 and 3 postpartum ."
99304,growth,O,3442.0,"Cows supplemented with GSGME moreover had a significantly reduced mRNA abundancy of fibroblast growth factor ( FGF ) 21 , a stress hormone induced by various stress conditions , in the liver in wk 1 and 3 postpartum ."
99305,factor,O,3442.0,"Cows supplemented with GSGME moreover had a significantly reduced mRNA abundancy of fibroblast growth factor ( FGF ) 21 , a stress hormone induced by various stress conditions , in the liver in wk 1 and 3 postpartum ."
99306,(,O,3442.0,"Cows supplemented with GSGME moreover had a significantly reduced mRNA abundancy of fibroblast growth factor ( FGF ) 21 , a stress hormone induced by various stress conditions , in the liver in wk 1 and 3 postpartum ."
99307,FGF,O,3442.0,"Cows supplemented with GSGME moreover had a significantly reduced mRNA abundancy of fibroblast growth factor ( FGF ) 21 , a stress hormone induced by various stress conditions , in the liver in wk 1 and 3 postpartum ."
99308,),O,3442.0,"Cows supplemented with GSGME moreover had a significantly reduced mRNA abundancy of fibroblast growth factor ( FGF ) 21 , a stress hormone induced by various stress conditions , in the liver in wk 1 and 3 postpartum ."
99309,21,O,3442.0,"Cows supplemented with GSGME moreover had a significantly reduced mRNA abundancy of fibroblast growth factor ( FGF ) 21 , a stress hormone induced by various stress conditions , in the liver in wk 1 and 3 postpartum ."
99310,",",O,3442.0,"Cows supplemented with GSGME moreover had a significantly reduced mRNA abundancy of fibroblast growth factor ( FGF ) 21 , a stress hormone induced by various stress conditions , in the liver in wk 1 and 3 postpartum ."
99311,a,O,3442.0,"Cows supplemented with GSGME moreover had a significantly reduced mRNA abundancy of fibroblast growth factor ( FGF ) 21 , a stress hormone induced by various stress conditions , in the liver in wk 1 and 3 postpartum ."
99312,stress,O,3442.0,"Cows supplemented with GSGME moreover had a significantly reduced mRNA abundancy of fibroblast growth factor ( FGF ) 21 , a stress hormone induced by various stress conditions , in the liver in wk 1 and 3 postpartum ."
99313,hormone,O,3442.0,"Cows supplemented with GSGME moreover had a significantly reduced mRNA abundancy of fibroblast growth factor ( FGF ) 21 , a stress hormone induced by various stress conditions , in the liver in wk 1 and 3 postpartum ."
99314,induced,O,3442.0,"Cows supplemented with GSGME moreover had a significantly reduced mRNA abundancy of fibroblast growth factor ( FGF ) 21 , a stress hormone induced by various stress conditions , in the liver in wk 1 and 3 postpartum ."
99315,by,O,3442.0,"Cows supplemented with GSGME moreover had a significantly reduced mRNA abundancy of fibroblast growth factor ( FGF ) 21 , a stress hormone induced by various stress conditions , in the liver in wk 1 and 3 postpartum ."
99316,various,O,3442.0,"Cows supplemented with GSGME moreover had a significantly reduced mRNA abundancy of fibroblast growth factor ( FGF ) 21 , a stress hormone induced by various stress conditions , in the liver in wk 1 and 3 postpartum ."
99317,stress,O,3442.0,"Cows supplemented with GSGME moreover had a significantly reduced mRNA abundancy of fibroblast growth factor ( FGF ) 21 , a stress hormone induced by various stress conditions , in the liver in wk 1 and 3 postpartum ."
99318,conditions,O,3442.0,"Cows supplemented with GSGME moreover had a significantly reduced mRNA abundancy of fibroblast growth factor ( FGF ) 21 , a stress hormone induced by various stress conditions , in the liver in wk 1 and 3 postpartum ."
99319,",",O,3442.0,"Cows supplemented with GSGME moreover had a significantly reduced mRNA abundancy of fibroblast growth factor ( FGF ) 21 , a stress hormone induced by various stress conditions , in the liver in wk 1 and 3 postpartum ."
99320,in,O,3442.0,"Cows supplemented with GSGME moreover had a significantly reduced mRNA abundancy of fibroblast growth factor ( FGF ) 21 , a stress hormone induced by various stress conditions , in the liver in wk 1 and 3 postpartum ."
99321,the,O,3442.0,"Cows supplemented with GSGME moreover had a significantly reduced mRNA abundancy of fibroblast growth factor ( FGF ) 21 , a stress hormone induced by various stress conditions , in the liver in wk 1 and 3 postpartum ."
99322,liver,O,3442.0,"Cows supplemented with GSGME moreover had a significantly reduced mRNA abundancy of fibroblast growth factor ( FGF ) 21 , a stress hormone induced by various stress conditions , in the liver in wk 1 and 3 postpartum ."
99323,in,O,3442.0,"Cows supplemented with GSGME moreover had a significantly reduced mRNA abundancy of fibroblast growth factor ( FGF ) 21 , a stress hormone induced by various stress conditions , in the liver in wk 1 and 3 postpartum ."
99324,wk,O,3442.0,"Cows supplemented with GSGME moreover had a significantly reduced mRNA abundancy of fibroblast growth factor ( FGF ) 21 , a stress hormone induced by various stress conditions , in the liver in wk 1 and 3 postpartum ."
99325,1,O,3442.0,"Cows supplemented with GSGME moreover had a significantly reduced mRNA abundancy of fibroblast growth factor ( FGF ) 21 , a stress hormone induced by various stress conditions , in the liver in wk 1 and 3 postpartum ."
99326,and,O,3442.0,"Cows supplemented with GSGME moreover had a significantly reduced mRNA abundancy of fibroblast growth factor ( FGF ) 21 , a stress hormone induced by various stress conditions , in the liver in wk 1 and 3 postpartum ."
99327,3,O,3442.0,"Cows supplemented with GSGME moreover had a significantly reduced mRNA abundancy of fibroblast growth factor ( FGF ) 21 , a stress hormone induced by various stress conditions , in the liver in wk 1 and 3 postpartum ."
99328,postpartum,O,3442.0,"Cows supplemented with GSGME moreover had a significantly reduced mRNA abundancy of fibroblast growth factor ( FGF ) 21 , a stress hormone induced by various stress conditions , in the liver in wk 1 and 3 postpartum ."
99329,.,O,3442.0,"Cows supplemented with GSGME moreover had a significantly reduced mRNA abundancy of fibroblast growth factor ( FGF ) 21 , a stress hormone induced by various stress conditions , in the liver in wk 1 and 3 postpartum ."
99330,In,O,3443.0,"In contrast , mRNA abundances of a total of 3 genes involved in inflammation and 14 genes involved in ER stress response , as well as concentrations of triacylglycerols and cholesterol , in liver samples of wk 1 and 3 postpartum did not differ between the 2 groups ."
99331,contrast,O,3443.0,"In contrast , mRNA abundances of a total of 3 genes involved in inflammation and 14 genes involved in ER stress response , as well as concentrations of triacylglycerols and cholesterol , in liver samples of wk 1 and 3 postpartum did not differ between the 2 groups ."
99332,",",O,3443.0,"In contrast , mRNA abundances of a total of 3 genes involved in inflammation and 14 genes involved in ER stress response , as well as concentrations of triacylglycerols and cholesterol , in liver samples of wk 1 and 3 postpartum did not differ between the 2 groups ."
99333,mRNA,O,3443.0,"In contrast , mRNA abundances of a total of 3 genes involved in inflammation and 14 genes involved in ER stress response , as well as concentrations of triacylglycerols and cholesterol , in liver samples of wk 1 and 3 postpartum did not differ between the 2 groups ."
99334,abundances,O,3443.0,"In contrast , mRNA abundances of a total of 3 genes involved in inflammation and 14 genes involved in ER stress response , as well as concentrations of triacylglycerols and cholesterol , in liver samples of wk 1 and 3 postpartum did not differ between the 2 groups ."
99335,of,O,3443.0,"In contrast , mRNA abundances of a total of 3 genes involved in inflammation and 14 genes involved in ER stress response , as well as concentrations of triacylglycerols and cholesterol , in liver samples of wk 1 and 3 postpartum did not differ between the 2 groups ."
99336,a,O,3443.0,"In contrast , mRNA abundances of a total of 3 genes involved in inflammation and 14 genes involved in ER stress response , as well as concentrations of triacylglycerols and cholesterol , in liver samples of wk 1 and 3 postpartum did not differ between the 2 groups ."
99337,total,O,3443.0,"In contrast , mRNA abundances of a total of 3 genes involved in inflammation and 14 genes involved in ER stress response , as well as concentrations of triacylglycerols and cholesterol , in liver samples of wk 1 and 3 postpartum did not differ between the 2 groups ."
99338,of,O,3443.0,"In contrast , mRNA abundances of a total of 3 genes involved in inflammation and 14 genes involved in ER stress response , as well as concentrations of triacylglycerols and cholesterol , in liver samples of wk 1 and 3 postpartum did not differ between the 2 groups ."
99339,3,O,3443.0,"In contrast , mRNA abundances of a total of 3 genes involved in inflammation and 14 genes involved in ER stress response , as well as concentrations of triacylglycerols and cholesterol , in liver samples of wk 1 and 3 postpartum did not differ between the 2 groups ."
99340,genes,O,3443.0,"In contrast , mRNA abundances of a total of 3 genes involved in inflammation and 14 genes involved in ER stress response , as well as concentrations of triacylglycerols and cholesterol , in liver samples of wk 1 and 3 postpartum did not differ between the 2 groups ."
99341,involved,O,3443.0,"In contrast , mRNA abundances of a total of 3 genes involved in inflammation and 14 genes involved in ER stress response , as well as concentrations of triacylglycerols and cholesterol , in liver samples of wk 1 and 3 postpartum did not differ between the 2 groups ."
99342,in,O,3443.0,"In contrast , mRNA abundances of a total of 3 genes involved in inflammation and 14 genes involved in ER stress response , as well as concentrations of triacylglycerols and cholesterol , in liver samples of wk 1 and 3 postpartum did not differ between the 2 groups ."
99343,inflammation,O,3443.0,"In contrast , mRNA abundances of a total of 3 genes involved in inflammation and 14 genes involved in ER stress response , as well as concentrations of triacylglycerols and cholesterol , in liver samples of wk 1 and 3 postpartum did not differ between the 2 groups ."
99344,and,O,3443.0,"In contrast , mRNA abundances of a total of 3 genes involved in inflammation and 14 genes involved in ER stress response , as well as concentrations of triacylglycerols and cholesterol , in liver samples of wk 1 and 3 postpartum did not differ between the 2 groups ."
99345,14,O,3443.0,"In contrast , mRNA abundances of a total of 3 genes involved in inflammation and 14 genes involved in ER stress response , as well as concentrations of triacylglycerols and cholesterol , in liver samples of wk 1 and 3 postpartum did not differ between the 2 groups ."
99346,genes,O,3443.0,"In contrast , mRNA abundances of a total of 3 genes involved in inflammation and 14 genes involved in ER stress response , as well as concentrations of triacylglycerols and cholesterol , in liver samples of wk 1 and 3 postpartum did not differ between the 2 groups ."
99347,involved,O,3443.0,"In contrast , mRNA abundances of a total of 3 genes involved in inflammation and 14 genes involved in ER stress response , as well as concentrations of triacylglycerols and cholesterol , in liver samples of wk 1 and 3 postpartum did not differ between the 2 groups ."
99348,in,O,3443.0,"In contrast , mRNA abundances of a total of 3 genes involved in inflammation and 14 genes involved in ER stress response , as well as concentrations of triacylglycerols and cholesterol , in liver samples of wk 1 and 3 postpartum did not differ between the 2 groups ."
99349,ER,O,3443.0,"In contrast , mRNA abundances of a total of 3 genes involved in inflammation and 14 genes involved in ER stress response , as well as concentrations of triacylglycerols and cholesterol , in liver samples of wk 1 and 3 postpartum did not differ between the 2 groups ."
99350,stress,O,3443.0,"In contrast , mRNA abundances of a total of 3 genes involved in inflammation and 14 genes involved in ER stress response , as well as concentrations of triacylglycerols and cholesterol , in liver samples of wk 1 and 3 postpartum did not differ between the 2 groups ."
99351,response,O,3443.0,"In contrast , mRNA abundances of a total of 3 genes involved in inflammation and 14 genes involved in ER stress response , as well as concentrations of triacylglycerols and cholesterol , in liver samples of wk 1 and 3 postpartum did not differ between the 2 groups ."
99352,",",O,3443.0,"In contrast , mRNA abundances of a total of 3 genes involved in inflammation and 14 genes involved in ER stress response , as well as concentrations of triacylglycerols and cholesterol , in liver samples of wk 1 and 3 postpartum did not differ between the 2 groups ."
99353,as,O,3443.0,"In contrast , mRNA abundances of a total of 3 genes involved in inflammation and 14 genes involved in ER stress response , as well as concentrations of triacylglycerols and cholesterol , in liver samples of wk 1 and 3 postpartum did not differ between the 2 groups ."
99354,well,O,3443.0,"In contrast , mRNA abundances of a total of 3 genes involved in inflammation and 14 genes involved in ER stress response , as well as concentrations of triacylglycerols and cholesterol , in liver samples of wk 1 and 3 postpartum did not differ between the 2 groups ."
99355,as,O,3443.0,"In contrast , mRNA abundances of a total of 3 genes involved in inflammation and 14 genes involved in ER stress response , as well as concentrations of triacylglycerols and cholesterol , in liver samples of wk 1 and 3 postpartum did not differ between the 2 groups ."
99356,concentrations,O,3443.0,"In contrast , mRNA abundances of a total of 3 genes involved in inflammation and 14 genes involved in ER stress response , as well as concentrations of triacylglycerols and cholesterol , in liver samples of wk 1 and 3 postpartum did not differ between the 2 groups ."
99357,of,O,3443.0,"In contrast , mRNA abundances of a total of 3 genes involved in inflammation and 14 genes involved in ER stress response , as well as concentrations of triacylglycerols and cholesterol , in liver samples of wk 1 and 3 postpartum did not differ between the 2 groups ."
99358,triacylglycerols,O,3443.0,"In contrast , mRNA abundances of a total of 3 genes involved in inflammation and 14 genes involved in ER stress response , as well as concentrations of triacylglycerols and cholesterol , in liver samples of wk 1 and 3 postpartum did not differ between the 2 groups ."
99359,and,O,3443.0,"In contrast , mRNA abundances of a total of 3 genes involved in inflammation and 14 genes involved in ER stress response , as well as concentrations of triacylglycerols and cholesterol , in liver samples of wk 1 and 3 postpartum did not differ between the 2 groups ."
99360,cholesterol,O,3443.0,"In contrast , mRNA abundances of a total of 3 genes involved in inflammation and 14 genes involved in ER stress response , as well as concentrations of triacylglycerols and cholesterol , in liver samples of wk 1 and 3 postpartum did not differ between the 2 groups ."
99361,",",O,3443.0,"In contrast , mRNA abundances of a total of 3 genes involved in inflammation and 14 genes involved in ER stress response , as well as concentrations of triacylglycerols and cholesterol , in liver samples of wk 1 and 3 postpartum did not differ between the 2 groups ."
99362,in,O,3443.0,"In contrast , mRNA abundances of a total of 3 genes involved in inflammation and 14 genes involved in ER stress response , as well as concentrations of triacylglycerols and cholesterol , in liver samples of wk 1 and 3 postpartum did not differ between the 2 groups ."
99363,liver,O,3443.0,"In contrast , mRNA abundances of a total of 3 genes involved in inflammation and 14 genes involved in ER stress response , as well as concentrations of triacylglycerols and cholesterol , in liver samples of wk 1 and 3 postpartum did not differ between the 2 groups ."
99364,samples,O,3443.0,"In contrast , mRNA abundances of a total of 3 genes involved in inflammation and 14 genes involved in ER stress response , as well as concentrations of triacylglycerols and cholesterol , in liver samples of wk 1 and 3 postpartum did not differ between the 2 groups ."
99365,of,O,3443.0,"In contrast , mRNA abundances of a total of 3 genes involved in inflammation and 14 genes involved in ER stress response , as well as concentrations of triacylglycerols and cholesterol , in liver samples of wk 1 and 3 postpartum did not differ between the 2 groups ."
99366,wk,O,3443.0,"In contrast , mRNA abundances of a total of 3 genes involved in inflammation and 14 genes involved in ER stress response , as well as concentrations of triacylglycerols and cholesterol , in liver samples of wk 1 and 3 postpartum did not differ between the 2 groups ."
99367,1,O,3443.0,"In contrast , mRNA abundances of a total of 3 genes involved in inflammation and 14 genes involved in ER stress response , as well as concentrations of triacylglycerols and cholesterol , in liver samples of wk 1 and 3 postpartum did not differ between the 2 groups ."
99368,and,O,3443.0,"In contrast , mRNA abundances of a total of 3 genes involved in inflammation and 14 genes involved in ER stress response , as well as concentrations of triacylglycerols and cholesterol , in liver samples of wk 1 and 3 postpartum did not differ between the 2 groups ."
99369,3,O,3443.0,"In contrast , mRNA abundances of a total of 3 genes involved in inflammation and 14 genes involved in ER stress response , as well as concentrations of triacylglycerols and cholesterol , in liver samples of wk 1 and 3 postpartum did not differ between the 2 groups ."
99370,postpartum,O,3443.0,"In contrast , mRNA abundances of a total of 3 genes involved in inflammation and 14 genes involved in ER stress response , as well as concentrations of triacylglycerols and cholesterol , in liver samples of wk 1 and 3 postpartum did not differ between the 2 groups ."
99371,did,O,3443.0,"In contrast , mRNA abundances of a total of 3 genes involved in inflammation and 14 genes involved in ER stress response , as well as concentrations of triacylglycerols and cholesterol , in liver samples of wk 1 and 3 postpartum did not differ between the 2 groups ."
99372,not,O,3443.0,"In contrast , mRNA abundances of a total of 3 genes involved in inflammation and 14 genes involved in ER stress response , as well as concentrations of triacylglycerols and cholesterol , in liver samples of wk 1 and 3 postpartum did not differ between the 2 groups ."
99373,differ,O,3443.0,"In contrast , mRNA abundances of a total of 3 genes involved in inflammation and 14 genes involved in ER stress response , as well as concentrations of triacylglycerols and cholesterol , in liver samples of wk 1 and 3 postpartum did not differ between the 2 groups ."
99374,between,O,3443.0,"In contrast , mRNA abundances of a total of 3 genes involved in inflammation and 14 genes involved in ER stress response , as well as concentrations of triacylglycerols and cholesterol , in liver samples of wk 1 and 3 postpartum did not differ between the 2 groups ."
99375,the,O,3443.0,"In contrast , mRNA abundances of a total of 3 genes involved in inflammation and 14 genes involved in ER stress response , as well as concentrations of triacylglycerols and cholesterol , in liver samples of wk 1 and 3 postpartum did not differ between the 2 groups ."
99376,2,O,3443.0,"In contrast , mRNA abundances of a total of 3 genes involved in inflammation and 14 genes involved in ER stress response , as well as concentrations of triacylglycerols and cholesterol , in liver samples of wk 1 and 3 postpartum did not differ between the 2 groups ."
99377,groups,O,3443.0,"In contrast , mRNA abundances of a total of 3 genes involved in inflammation and 14 genes involved in ER stress response , as well as concentrations of triacylglycerols and cholesterol , in liver samples of wk 1 and 3 postpartum did not differ between the 2 groups ."
99378,.,O,3443.0,"In contrast , mRNA abundances of a total of 3 genes involved in inflammation and 14 genes involved in ER stress response , as well as concentrations of triacylglycerols and cholesterol , in liver samples of wk 1 and 3 postpartum did not differ between the 2 groups ."
99379,Overall,O,3444.0,"Overall , this study shows that supplementation of GSGME did not influence inflammation or ER stress in the liver but increased milk yield , an effect that could be due to effects on ruminal metabolism ."
99380,",",O,3444.0,"Overall , this study shows that supplementation of GSGME did not influence inflammation or ER stress in the liver but increased milk yield , an effect that could be due to effects on ruminal metabolism ."
99381,this,O,3444.0,"Overall , this study shows that supplementation of GSGME did not influence inflammation or ER stress in the liver but increased milk yield , an effect that could be due to effects on ruminal metabolism ."
99382,study,O,3444.0,"Overall , this study shows that supplementation of GSGME did not influence inflammation or ER stress in the liver but increased milk yield , an effect that could be due to effects on ruminal metabolism ."
99383,shows,O,3444.0,"Overall , this study shows that supplementation of GSGME did not influence inflammation or ER stress in the liver but increased milk yield , an effect that could be due to effects on ruminal metabolism ."
99384,that,O,3444.0,"Overall , this study shows that supplementation of GSGME did not influence inflammation or ER stress in the liver but increased milk yield , an effect that could be due to effects on ruminal metabolism ."
99385,supplementation,O,3444.0,"Overall , this study shows that supplementation of GSGME did not influence inflammation or ER stress in the liver but increased milk yield , an effect that could be due to effects on ruminal metabolism ."
99386,of,O,3444.0,"Overall , this study shows that supplementation of GSGME did not influence inflammation or ER stress in the liver but increased milk yield , an effect that could be due to effects on ruminal metabolism ."
99387,GSGME,O,3444.0,"Overall , this study shows that supplementation of GSGME did not influence inflammation or ER stress in the liver but increased milk yield , an effect that could be due to effects on ruminal metabolism ."
99388,did,O,3444.0,"Overall , this study shows that supplementation of GSGME did not influence inflammation or ER stress in the liver but increased milk yield , an effect that could be due to effects on ruminal metabolism ."
99389,not,O,3444.0,"Overall , this study shows that supplementation of GSGME did not influence inflammation or ER stress in the liver but increased milk yield , an effect that could be due to effects on ruminal metabolism ."
99390,influence,O,3444.0,"Overall , this study shows that supplementation of GSGME did not influence inflammation or ER stress in the liver but increased milk yield , an effect that could be due to effects on ruminal metabolism ."
99391,inflammation,O,3444.0,"Overall , this study shows that supplementation of GSGME did not influence inflammation or ER stress in the liver but increased milk yield , an effect that could be due to effects on ruminal metabolism ."
99392,or,O,3444.0,"Overall , this study shows that supplementation of GSGME did not influence inflammation or ER stress in the liver but increased milk yield , an effect that could be due to effects on ruminal metabolism ."
99393,ER,O,3444.0,"Overall , this study shows that supplementation of GSGME did not influence inflammation or ER stress in the liver but increased milk yield , an effect that could be due to effects on ruminal metabolism ."
99394,stress,O,3444.0,"Overall , this study shows that supplementation of GSGME did not influence inflammation or ER stress in the liver but increased milk yield , an effect that could be due to effects on ruminal metabolism ."
99395,in,O,3444.0,"Overall , this study shows that supplementation of GSGME did not influence inflammation or ER stress in the liver but increased milk yield , an effect that could be due to effects on ruminal metabolism ."
99396,the,O,3444.0,"Overall , this study shows that supplementation of GSGME did not influence inflammation or ER stress in the liver but increased milk yield , an effect that could be due to effects on ruminal metabolism ."
99397,liver,O,3444.0,"Overall , this study shows that supplementation of GSGME did not influence inflammation or ER stress in the liver but increased milk yield , an effect that could be due to effects on ruminal metabolism ."
99398,but,O,3444.0,"Overall , this study shows that supplementation of GSGME did not influence inflammation or ER stress in the liver but increased milk yield , an effect that could be due to effects on ruminal metabolism ."
99399,increased,O,3444.0,"Overall , this study shows that supplementation of GSGME did not influence inflammation or ER stress in the liver but increased milk yield , an effect that could be due to effects on ruminal metabolism ."
99400,milk,O,3444.0,"Overall , this study shows that supplementation of GSGME did not influence inflammation or ER stress in the liver but increased milk yield , an effect that could be due to effects on ruminal metabolism ."
99401,yield,O,3444.0,"Overall , this study shows that supplementation of GSGME did not influence inflammation or ER stress in the liver but increased milk yield , an effect that could be due to effects on ruminal metabolism ."
99402,",",O,3444.0,"Overall , this study shows that supplementation of GSGME did not influence inflammation or ER stress in the liver but increased milk yield , an effect that could be due to effects on ruminal metabolism ."
99403,an,O,3444.0,"Overall , this study shows that supplementation of GSGME did not influence inflammation or ER stress in the liver but increased milk yield , an effect that could be due to effects on ruminal metabolism ."
99404,effect,O,3444.0,"Overall , this study shows that supplementation of GSGME did not influence inflammation or ER stress in the liver but increased milk yield , an effect that could be due to effects on ruminal metabolism ."
99405,that,O,3444.0,"Overall , this study shows that supplementation of GSGME did not influence inflammation or ER stress in the liver but increased milk yield , an effect that could be due to effects on ruminal metabolism ."
99406,could,O,3444.0,"Overall , this study shows that supplementation of GSGME did not influence inflammation or ER stress in the liver but increased milk yield , an effect that could be due to effects on ruminal metabolism ."
99407,be,O,3444.0,"Overall , this study shows that supplementation of GSGME did not influence inflammation or ER stress in the liver but increased milk yield , an effect that could be due to effects on ruminal metabolism ."
99408,due,O,3444.0,"Overall , this study shows that supplementation of GSGME did not influence inflammation or ER stress in the liver but increased milk yield , an effect that could be due to effects on ruminal metabolism ."
99409,to,O,3444.0,"Overall , this study shows that supplementation of GSGME did not influence inflammation or ER stress in the liver but increased milk yield , an effect that could be due to effects on ruminal metabolism ."
99410,effects,O,3444.0,"Overall , this study shows that supplementation of GSGME did not influence inflammation or ER stress in the liver but increased milk yield , an effect that could be due to effects on ruminal metabolism ."
99411,on,O,3444.0,"Overall , this study shows that supplementation of GSGME did not influence inflammation or ER stress in the liver but increased milk yield , an effect that could be due to effects on ruminal metabolism ."
99412,ruminal,O,3444.0,"Overall , this study shows that supplementation of GSGME did not influence inflammation or ER stress in the liver but increased milk yield , an effect that could be due to effects on ruminal metabolism ."
99413,metabolism,O,3444.0,"Overall , this study shows that supplementation of GSGME did not influence inflammation or ER stress in the liver but increased milk yield , an effect that could be due to effects on ruminal metabolism ."
99414,.,O,3444.0,"Overall , this study shows that supplementation of GSGME did not influence inflammation or ER stress in the liver but increased milk yield , an effect that could be due to effects on ruminal metabolism ."
99415,Neutrophil,O,3445.0,Neutrophil function and the severity and incidence of mastitis in dairy cows is related to the intake of many antioxidant nutrients .
99416,function,O,3445.0,Neutrophil function and the severity and incidence of mastitis in dairy cows is related to the intake of many antioxidant nutrients .
99417,and,O,3445.0,Neutrophil function and the severity and incidence of mastitis in dairy cows is related to the intake of many antioxidant nutrients .
99418,the,O,3445.0,Neutrophil function and the severity and incidence of mastitis in dairy cows is related to the intake of many antioxidant nutrients .
99419,severity,O,3445.0,Neutrophil function and the severity and incidence of mastitis in dairy cows is related to the intake of many antioxidant nutrients .
99420,and,O,3445.0,Neutrophil function and the severity and incidence of mastitis in dairy cows is related to the intake of many antioxidant nutrients .
99421,incidence,O,3445.0,Neutrophil function and the severity and incidence of mastitis in dairy cows is related to the intake of many antioxidant nutrients .
99422,of,O,3445.0,Neutrophil function and the severity and incidence of mastitis in dairy cows is related to the intake of many antioxidant nutrients .
99423,mastitis,O,3445.0,Neutrophil function and the severity and incidence of mastitis in dairy cows is related to the intake of many antioxidant nutrients .
99424,in,O,3445.0,Neutrophil function and the severity and incidence of mastitis in dairy cows is related to the intake of many antioxidant nutrients .
99425,dairy,O,3445.0,Neutrophil function and the severity and incidence of mastitis in dairy cows is related to the intake of many antioxidant nutrients .
99426,cows,O,3445.0,Neutrophil function and the severity and incidence of mastitis in dairy cows is related to the intake of many antioxidant nutrients .
99427,is,O,3445.0,Neutrophil function and the severity and incidence of mastitis in dairy cows is related to the intake of many antioxidant nutrients .
99428,related,O,3445.0,Neutrophil function and the severity and incidence of mastitis in dairy cows is related to the intake of many antioxidant nutrients .
99429,to,O,3445.0,Neutrophil function and the severity and incidence of mastitis in dairy cows is related to the intake of many antioxidant nutrients .
99430,the,O,3445.0,Neutrophil function and the severity and incidence of mastitis in dairy cows is related to the intake of many antioxidant nutrients .
99431,intake,O,3445.0,Neutrophil function and the severity and incidence of mastitis in dairy cows is related to the intake of many antioxidant nutrients .
99432,of,O,3445.0,Neutrophil function and the severity and incidence of mastitis in dairy cows is related to the intake of many antioxidant nutrients .
99433,many,O,3445.0,Neutrophil function and the severity and incidence of mastitis in dairy cows is related to the intake of many antioxidant nutrients .
99434,antioxidant,O,3445.0,Neutrophil function and the severity and incidence of mastitis in dairy cows is related to the intake of many antioxidant nutrients .
99435,nutrients,O,3445.0,Neutrophil function and the severity and incidence of mastitis in dairy cows is related to the intake of many antioxidant nutrients .
99436,.,O,3445.0,Neutrophil function and the severity and incidence of mastitis in dairy cows is related to the intake of many antioxidant nutrients .
99437,Because,O,3446.0,"Because vitamin C is the major water - soluble antioxidant in mammals , we examined the effect of dietary vitamin C on neutrophil function and responses to intramammary infusion of lipopolysaccahride ( LPS ) in periparturient dairy cows ."
99438,vitamin,O,3446.0,"Because vitamin C is the major water - soluble antioxidant in mammals , we examined the effect of dietary vitamin C on neutrophil function and responses to intramammary infusion of lipopolysaccahride ( LPS ) in periparturient dairy cows ."
99439,C,O,3446.0,"Because vitamin C is the major water - soluble antioxidant in mammals , we examined the effect of dietary vitamin C on neutrophil function and responses to intramammary infusion of lipopolysaccahride ( LPS ) in periparturient dairy cows ."
99440,is,O,3446.0,"Because vitamin C is the major water - soluble antioxidant in mammals , we examined the effect of dietary vitamin C on neutrophil function and responses to intramammary infusion of lipopolysaccahride ( LPS ) in periparturient dairy cows ."
99441,the,O,3446.0,"Because vitamin C is the major water - soluble antioxidant in mammals , we examined the effect of dietary vitamin C on neutrophil function and responses to intramammary infusion of lipopolysaccahride ( LPS ) in periparturient dairy cows ."
99442,major,O,3446.0,"Because vitamin C is the major water - soluble antioxidant in mammals , we examined the effect of dietary vitamin C on neutrophil function and responses to intramammary infusion of lipopolysaccahride ( LPS ) in periparturient dairy cows ."
99443,water,O,3446.0,"Because vitamin C is the major water - soluble antioxidant in mammals , we examined the effect of dietary vitamin C on neutrophil function and responses to intramammary infusion of lipopolysaccahride ( LPS ) in periparturient dairy cows ."
99444,-,O,3446.0,"Because vitamin C is the major water - soluble antioxidant in mammals , we examined the effect of dietary vitamin C on neutrophil function and responses to intramammary infusion of lipopolysaccahride ( LPS ) in periparturient dairy cows ."
99445,soluble,O,3446.0,"Because vitamin C is the major water - soluble antioxidant in mammals , we examined the effect of dietary vitamin C on neutrophil function and responses to intramammary infusion of lipopolysaccahride ( LPS ) in periparturient dairy cows ."
99446,antioxidant,O,3446.0,"Because vitamin C is the major water - soluble antioxidant in mammals , we examined the effect of dietary vitamin C on neutrophil function and responses to intramammary infusion of lipopolysaccahride ( LPS ) in periparturient dairy cows ."
99447,in,O,3446.0,"Because vitamin C is the major water - soluble antioxidant in mammals , we examined the effect of dietary vitamin C on neutrophil function and responses to intramammary infusion of lipopolysaccahride ( LPS ) in periparturient dairy cows ."
99448,mammals,O,3446.0,"Because vitamin C is the major water - soluble antioxidant in mammals , we examined the effect of dietary vitamin C on neutrophil function and responses to intramammary infusion of lipopolysaccahride ( LPS ) in periparturient dairy cows ."
99449,",",O,3446.0,"Because vitamin C is the major water - soluble antioxidant in mammals , we examined the effect of dietary vitamin C on neutrophil function and responses to intramammary infusion of lipopolysaccahride ( LPS ) in periparturient dairy cows ."
99450,we,O,3446.0,"Because vitamin C is the major water - soluble antioxidant in mammals , we examined the effect of dietary vitamin C on neutrophil function and responses to intramammary infusion of lipopolysaccahride ( LPS ) in periparturient dairy cows ."
99451,examined,O,3446.0,"Because vitamin C is the major water - soluble antioxidant in mammals , we examined the effect of dietary vitamin C on neutrophil function and responses to intramammary infusion of lipopolysaccahride ( LPS ) in periparturient dairy cows ."
99452,the,O,3446.0,"Because vitamin C is the major water - soluble antioxidant in mammals , we examined the effect of dietary vitamin C on neutrophil function and responses to intramammary infusion of lipopolysaccahride ( LPS ) in periparturient dairy cows ."
99453,effect,O,3446.0,"Because vitamin C is the major water - soluble antioxidant in mammals , we examined the effect of dietary vitamin C on neutrophil function and responses to intramammary infusion of lipopolysaccahride ( LPS ) in periparturient dairy cows ."
99454,of,O,3446.0,"Because vitamin C is the major water - soluble antioxidant in mammals , we examined the effect of dietary vitamin C on neutrophil function and responses to intramammary infusion of lipopolysaccahride ( LPS ) in periparturient dairy cows ."
99455,dietary,O,3446.0,"Because vitamin C is the major water - soluble antioxidant in mammals , we examined the effect of dietary vitamin C on neutrophil function and responses to intramammary infusion of lipopolysaccahride ( LPS ) in periparturient dairy cows ."
99456,vitamin,O,3446.0,"Because vitamin C is the major water - soluble antioxidant in mammals , we examined the effect of dietary vitamin C on neutrophil function and responses to intramammary infusion of lipopolysaccahride ( LPS ) in periparturient dairy cows ."
99457,C,O,3446.0,"Because vitamin C is the major water - soluble antioxidant in mammals , we examined the effect of dietary vitamin C on neutrophil function and responses to intramammary infusion of lipopolysaccahride ( LPS ) in periparturient dairy cows ."
99458,on,O,3446.0,"Because vitamin C is the major water - soluble antioxidant in mammals , we examined the effect of dietary vitamin C on neutrophil function and responses to intramammary infusion of lipopolysaccahride ( LPS ) in periparturient dairy cows ."
99459,neutrophil,O,3446.0,"Because vitamin C is the major water - soluble antioxidant in mammals , we examined the effect of dietary vitamin C on neutrophil function and responses to intramammary infusion of lipopolysaccahride ( LPS ) in periparturient dairy cows ."
99460,function,O,3446.0,"Because vitamin C is the major water - soluble antioxidant in mammals , we examined the effect of dietary vitamin C on neutrophil function and responses to intramammary infusion of lipopolysaccahride ( LPS ) in periparturient dairy cows ."
99461,and,O,3446.0,"Because vitamin C is the major water - soluble antioxidant in mammals , we examined the effect of dietary vitamin C on neutrophil function and responses to intramammary infusion of lipopolysaccahride ( LPS ) in periparturient dairy cows ."
99462,responses,O,3446.0,"Because vitamin C is the major water - soluble antioxidant in mammals , we examined the effect of dietary vitamin C on neutrophil function and responses to intramammary infusion of lipopolysaccahride ( LPS ) in periparturient dairy cows ."
99463,to,O,3446.0,"Because vitamin C is the major water - soluble antioxidant in mammals , we examined the effect of dietary vitamin C on neutrophil function and responses to intramammary infusion of lipopolysaccahride ( LPS ) in periparturient dairy cows ."
99464,intramammary,O,3446.0,"Because vitamin C is the major water - soluble antioxidant in mammals , we examined the effect of dietary vitamin C on neutrophil function and responses to intramammary infusion of lipopolysaccahride ( LPS ) in periparturient dairy cows ."
99465,infusion,O,3446.0,"Because vitamin C is the major water - soluble antioxidant in mammals , we examined the effect of dietary vitamin C on neutrophil function and responses to intramammary infusion of lipopolysaccahride ( LPS ) in periparturient dairy cows ."
99466,of,O,3446.0,"Because vitamin C is the major water - soluble antioxidant in mammals , we examined the effect of dietary vitamin C on neutrophil function and responses to intramammary infusion of lipopolysaccahride ( LPS ) in periparturient dairy cows ."
99467,lipopolysaccahride,O,3446.0,"Because vitamin C is the major water - soluble antioxidant in mammals , we examined the effect of dietary vitamin C on neutrophil function and responses to intramammary infusion of lipopolysaccahride ( LPS ) in periparturient dairy cows ."
99468,(,O,3446.0,"Because vitamin C is the major water - soluble antioxidant in mammals , we examined the effect of dietary vitamin C on neutrophil function and responses to intramammary infusion of lipopolysaccahride ( LPS ) in periparturient dairy cows ."
99469,LPS,O,3446.0,"Because vitamin C is the major water - soluble antioxidant in mammals , we examined the effect of dietary vitamin C on neutrophil function and responses to intramammary infusion of lipopolysaccahride ( LPS ) in periparturient dairy cows ."
99470,),O,3446.0,"Because vitamin C is the major water - soluble antioxidant in mammals , we examined the effect of dietary vitamin C on neutrophil function and responses to intramammary infusion of lipopolysaccahride ( LPS ) in periparturient dairy cows ."
99471,in,O,3446.0,"Because vitamin C is the major water - soluble antioxidant in mammals , we examined the effect of dietary vitamin C on neutrophil function and responses to intramammary infusion of lipopolysaccahride ( LPS ) in periparturient dairy cows ."
99472,periparturient,O,3446.0,"Because vitamin C is the major water - soluble antioxidant in mammals , we examined the effect of dietary vitamin C on neutrophil function and responses to intramammary infusion of lipopolysaccahride ( LPS ) in periparturient dairy cows ."
99473,dairy,O,3446.0,"Because vitamin C is the major water - soluble antioxidant in mammals , we examined the effect of dietary vitamin C on neutrophil function and responses to intramammary infusion of lipopolysaccahride ( LPS ) in periparturient dairy cows ."
99474,cows,O,3446.0,"Because vitamin C is the major water - soluble antioxidant in mammals , we examined the effect of dietary vitamin C on neutrophil function and responses to intramammary infusion of lipopolysaccahride ( LPS ) in periparturient dairy cows ."
99475,.,O,3446.0,"Because vitamin C is the major water - soluble antioxidant in mammals , we examined the effect of dietary vitamin C on neutrophil function and responses to intramammary infusion of lipopolysaccahride ( LPS ) in periparturient dairy cows ."
99476,At,O,3447.0,"At 2 wk before anticipated calving , Holstein cows were fed diets that provided 0 ( 16 cows ) or 30 ( 15 cows ) g / d of supplemental vitamin C ( phosphorylated ascorbic acid ) ."
99477,2,O,3447.0,"At 2 wk before anticipated calving , Holstein cows were fed diets that provided 0 ( 16 cows ) or 30 ( 15 cows ) g / d of supplemental vitamin C ( phosphorylated ascorbic acid ) ."
99478,wk,O,3447.0,"At 2 wk before anticipated calving , Holstein cows were fed diets that provided 0 ( 16 cows ) or 30 ( 15 cows ) g / d of supplemental vitamin C ( phosphorylated ascorbic acid ) ."
99479,before,O,3447.0,"At 2 wk before anticipated calving , Holstein cows were fed diets that provided 0 ( 16 cows ) or 30 ( 15 cows ) g / d of supplemental vitamin C ( phosphorylated ascorbic acid ) ."
99480,anticipated,O,3447.0,"At 2 wk before anticipated calving , Holstein cows were fed diets that provided 0 ( 16 cows ) or 30 ( 15 cows ) g / d of supplemental vitamin C ( phosphorylated ascorbic acid ) ."
99481,calving,O,3447.0,"At 2 wk before anticipated calving , Holstein cows were fed diets that provided 0 ( 16 cows ) or 30 ( 15 cows ) g / d of supplemental vitamin C ( phosphorylated ascorbic acid ) ."
99482,",",O,3447.0,"At 2 wk before anticipated calving , Holstein cows were fed diets that provided 0 ( 16 cows ) or 30 ( 15 cows ) g / d of supplemental vitamin C ( phosphorylated ascorbic acid ) ."
99483,Holstein,O,3447.0,"At 2 wk before anticipated calving , Holstein cows were fed diets that provided 0 ( 16 cows ) or 30 ( 15 cows ) g / d of supplemental vitamin C ( phosphorylated ascorbic acid ) ."
99484,cows,O,3447.0,"At 2 wk before anticipated calving , Holstein cows were fed diets that provided 0 ( 16 cows ) or 30 ( 15 cows ) g / d of supplemental vitamin C ( phosphorylated ascorbic acid ) ."
99485,were,O,3447.0,"At 2 wk before anticipated calving , Holstein cows were fed diets that provided 0 ( 16 cows ) or 30 ( 15 cows ) g / d of supplemental vitamin C ( phosphorylated ascorbic acid ) ."
99486,fed,O,3447.0,"At 2 wk before anticipated calving , Holstein cows were fed diets that provided 0 ( 16 cows ) or 30 ( 15 cows ) g / d of supplemental vitamin C ( phosphorylated ascorbic acid ) ."
99487,diets,O,3447.0,"At 2 wk before anticipated calving , Holstein cows were fed diets that provided 0 ( 16 cows ) or 30 ( 15 cows ) g / d of supplemental vitamin C ( phosphorylated ascorbic acid ) ."
99488,that,O,3447.0,"At 2 wk before anticipated calving , Holstein cows were fed diets that provided 0 ( 16 cows ) or 30 ( 15 cows ) g / d of supplemental vitamin C ( phosphorylated ascorbic acid ) ."
99489,provided,O,3447.0,"At 2 wk before anticipated calving , Holstein cows were fed diets that provided 0 ( 16 cows ) or 30 ( 15 cows ) g / d of supplemental vitamin C ( phosphorylated ascorbic acid ) ."
99490,0,O,3447.0,"At 2 wk before anticipated calving , Holstein cows were fed diets that provided 0 ( 16 cows ) or 30 ( 15 cows ) g / d of supplemental vitamin C ( phosphorylated ascorbic acid ) ."
99491,(,O,3447.0,"At 2 wk before anticipated calving , Holstein cows were fed diets that provided 0 ( 16 cows ) or 30 ( 15 cows ) g / d of supplemental vitamin C ( phosphorylated ascorbic acid ) ."
99492,16,O,3447.0,"At 2 wk before anticipated calving , Holstein cows were fed diets that provided 0 ( 16 cows ) or 30 ( 15 cows ) g / d of supplemental vitamin C ( phosphorylated ascorbic acid ) ."
99493,cows,O,3447.0,"At 2 wk before anticipated calving , Holstein cows were fed diets that provided 0 ( 16 cows ) or 30 ( 15 cows ) g / d of supplemental vitamin C ( phosphorylated ascorbic acid ) ."
99494,),O,3447.0,"At 2 wk before anticipated calving , Holstein cows were fed diets that provided 0 ( 16 cows ) or 30 ( 15 cows ) g / d of supplemental vitamin C ( phosphorylated ascorbic acid ) ."
99495,or,O,3447.0,"At 2 wk before anticipated calving , Holstein cows were fed diets that provided 0 ( 16 cows ) or 30 ( 15 cows ) g / d of supplemental vitamin C ( phosphorylated ascorbic acid ) ."
99496,30,O,3447.0,"At 2 wk before anticipated calving , Holstein cows were fed diets that provided 0 ( 16 cows ) or 30 ( 15 cows ) g / d of supplemental vitamin C ( phosphorylated ascorbic acid ) ."
99497,(,O,3447.0,"At 2 wk before anticipated calving , Holstein cows were fed diets that provided 0 ( 16 cows ) or 30 ( 15 cows ) g / d of supplemental vitamin C ( phosphorylated ascorbic acid ) ."
99498,15,O,3447.0,"At 2 wk before anticipated calving , Holstein cows were fed diets that provided 0 ( 16 cows ) or 30 ( 15 cows ) g / d of supplemental vitamin C ( phosphorylated ascorbic acid ) ."
99499,cows,O,3447.0,"At 2 wk before anticipated calving , Holstein cows were fed diets that provided 0 ( 16 cows ) or 30 ( 15 cows ) g / d of supplemental vitamin C ( phosphorylated ascorbic acid ) ."
99500,),O,3447.0,"At 2 wk before anticipated calving , Holstein cows were fed diets that provided 0 ( 16 cows ) or 30 ( 15 cows ) g / d of supplemental vitamin C ( phosphorylated ascorbic acid ) ."
99501,g,O,3447.0,"At 2 wk before anticipated calving , Holstein cows were fed diets that provided 0 ( 16 cows ) or 30 ( 15 cows ) g / d of supplemental vitamin C ( phosphorylated ascorbic acid ) ."
99502,/,O,3447.0,"At 2 wk before anticipated calving , Holstein cows were fed diets that provided 0 ( 16 cows ) or 30 ( 15 cows ) g / d of supplemental vitamin C ( phosphorylated ascorbic acid ) ."
99503,d,O,3447.0,"At 2 wk before anticipated calving , Holstein cows were fed diets that provided 0 ( 16 cows ) or 30 ( 15 cows ) g / d of supplemental vitamin C ( phosphorylated ascorbic acid ) ."
99504,of,O,3447.0,"At 2 wk before anticipated calving , Holstein cows were fed diets that provided 0 ( 16 cows ) or 30 ( 15 cows ) g / d of supplemental vitamin C ( phosphorylated ascorbic acid ) ."
99505,supplemental,O,3447.0,"At 2 wk before anticipated calving , Holstein cows were fed diets that provided 0 ( 16 cows ) or 30 ( 15 cows ) g / d of supplemental vitamin C ( phosphorylated ascorbic acid ) ."
99506,vitamin,O,3447.0,"At 2 wk before anticipated calving , Holstein cows were fed diets that provided 0 ( 16 cows ) or 30 ( 15 cows ) g / d of supplemental vitamin C ( phosphorylated ascorbic acid ) ."
99507,C,O,3447.0,"At 2 wk before anticipated calving , Holstein cows were fed diets that provided 0 ( 16 cows ) or 30 ( 15 cows ) g / d of supplemental vitamin C ( phosphorylated ascorbic acid ) ."
99508,(,O,3447.0,"At 2 wk before anticipated calving , Holstein cows were fed diets that provided 0 ( 16 cows ) or 30 ( 15 cows ) g / d of supplemental vitamin C ( phosphorylated ascorbic acid ) ."
99509,phosphorylated,O,3447.0,"At 2 wk before anticipated calving , Holstein cows were fed diets that provided 0 ( 16 cows ) or 30 ( 15 cows ) g / d of supplemental vitamin C ( phosphorylated ascorbic acid ) ."
99510,ascorbic,O,3447.0,"At 2 wk before anticipated calving , Holstein cows were fed diets that provided 0 ( 16 cows ) or 30 ( 15 cows ) g / d of supplemental vitamin C ( phosphorylated ascorbic acid ) ."
99511,acid,O,3447.0,"At 2 wk before anticipated calving , Holstein cows were fed diets that provided 0 ( 16 cows ) or 30 ( 15 cows ) g / d of supplemental vitamin C ( phosphorylated ascorbic acid ) ."
99512,),O,3447.0,"At 2 wk before anticipated calving , Holstein cows were fed diets that provided 0 ( 16 cows ) or 30 ( 15 cows ) g / d of supplemental vitamin C ( phosphorylated ascorbic acid ) ."
99513,.,O,3447.0,"At 2 wk before anticipated calving , Holstein cows were fed diets that provided 0 ( 16 cows ) or 30 ( 15 cows ) g / d of supplemental vitamin C ( phosphorylated ascorbic acid ) ."
99514,Treatments,O,3448.0,"Treatments continued until 7 d after cows received an infusion of 10 microg of LPS into one quarter of the mammary gland ( on average , this occurred 32 d postcalving ) ."
99515,continued,O,3448.0,"Treatments continued until 7 d after cows received an infusion of 10 microg of LPS into one quarter of the mammary gland ( on average , this occurred 32 d postcalving ) ."
99516,until,O,3448.0,"Treatments continued until 7 d after cows received an infusion of 10 microg of LPS into one quarter of the mammary gland ( on average , this occurred 32 d postcalving ) ."
99517,7,O,3448.0,"Treatments continued until 7 d after cows received an infusion of 10 microg of LPS into one quarter of the mammary gland ( on average , this occurred 32 d postcalving ) ."
99518,d,O,3448.0,"Treatments continued until 7 d after cows received an infusion of 10 microg of LPS into one quarter of the mammary gland ( on average , this occurred 32 d postcalving ) ."
99519,after,O,3448.0,"Treatments continued until 7 d after cows received an infusion of 10 microg of LPS into one quarter of the mammary gland ( on average , this occurred 32 d postcalving ) ."
99520,cows,O,3448.0,"Treatments continued until 7 d after cows received an infusion of 10 microg of LPS into one quarter of the mammary gland ( on average , this occurred 32 d postcalving ) ."
99521,received,O,3448.0,"Treatments continued until 7 d after cows received an infusion of 10 microg of LPS into one quarter of the mammary gland ( on average , this occurred 32 d postcalving ) ."
99522,an,O,3448.0,"Treatments continued until 7 d after cows received an infusion of 10 microg of LPS into one quarter of the mammary gland ( on average , this occurred 32 d postcalving ) ."
99523,infusion,O,3448.0,"Treatments continued until 7 d after cows received an infusion of 10 microg of LPS into one quarter of the mammary gland ( on average , this occurred 32 d postcalving ) ."
99524,of,O,3448.0,"Treatments continued until 7 d after cows received an infusion of 10 microg of LPS into one quarter of the mammary gland ( on average , this occurred 32 d postcalving ) ."
99525,10,O,3448.0,"Treatments continued until 7 d after cows received an infusion of 10 microg of LPS into one quarter of the mammary gland ( on average , this occurred 32 d postcalving ) ."
99526,microg,O,3448.0,"Treatments continued until 7 d after cows received an infusion of 10 microg of LPS into one quarter of the mammary gland ( on average , this occurred 32 d postcalving ) ."
99527,of,O,3448.0,"Treatments continued until 7 d after cows received an infusion of 10 microg of LPS into one quarter of the mammary gland ( on average , this occurred 32 d postcalving ) ."
99528,LPS,O,3448.0,"Treatments continued until 7 d after cows received an infusion of 10 microg of LPS into one quarter of the mammary gland ( on average , this occurred 32 d postcalving ) ."
99529,into,O,3448.0,"Treatments continued until 7 d after cows received an infusion of 10 microg of LPS into one quarter of the mammary gland ( on average , this occurred 32 d postcalving ) ."
99530,one,O,3448.0,"Treatments continued until 7 d after cows received an infusion of 10 microg of LPS into one quarter of the mammary gland ( on average , this occurred 32 d postcalving ) ."
99531,quarter,O,3448.0,"Treatments continued until 7 d after cows received an infusion of 10 microg of LPS into one quarter of the mammary gland ( on average , this occurred 32 d postcalving ) ."
99532,of,O,3448.0,"Treatments continued until 7 d after cows received an infusion of 10 microg of LPS into one quarter of the mammary gland ( on average , this occurred 32 d postcalving ) ."
99533,the,O,3448.0,"Treatments continued until 7 d after cows received an infusion of 10 microg of LPS into one quarter of the mammary gland ( on average , this occurred 32 d postcalving ) ."
99534,mammary,O,3448.0,"Treatments continued until 7 d after cows received an infusion of 10 microg of LPS into one quarter of the mammary gland ( on average , this occurred 32 d postcalving ) ."
99535,gland,O,3448.0,"Treatments continued until 7 d after cows received an infusion of 10 microg of LPS into one quarter of the mammary gland ( on average , this occurred 32 d postcalving ) ."
99536,(,O,3448.0,"Treatments continued until 7 d after cows received an infusion of 10 microg of LPS into one quarter of the mammary gland ( on average , this occurred 32 d postcalving ) ."
99537,on,O,3448.0,"Treatments continued until 7 d after cows received an infusion of 10 microg of LPS into one quarter of the mammary gland ( on average , this occurred 32 d postcalving ) ."
99538,average,O,3448.0,"Treatments continued until 7 d after cows received an infusion of 10 microg of LPS into one quarter of the mammary gland ( on average , this occurred 32 d postcalving ) ."
99539,",",O,3448.0,"Treatments continued until 7 d after cows received an infusion of 10 microg of LPS into one quarter of the mammary gland ( on average , this occurred 32 d postcalving ) ."
99540,this,O,3448.0,"Treatments continued until 7 d after cows received an infusion of 10 microg of LPS into one quarter of the mammary gland ( on average , this occurred 32 d postcalving ) ."
99541,occurred,O,3448.0,"Treatments continued until 7 d after cows received an infusion of 10 microg of LPS into one quarter of the mammary gland ( on average , this occurred 32 d postcalving ) ."
99542,32,O,3448.0,"Treatments continued until 7 d after cows received an infusion of 10 microg of LPS into one quarter of the mammary gland ( on average , this occurred 32 d postcalving ) ."
99543,d,O,3448.0,"Treatments continued until 7 d after cows received an infusion of 10 microg of LPS into one quarter of the mammary gland ( on average , this occurred 32 d postcalving ) ."
99544,postcalving,O,3448.0,"Treatments continued until 7 d after cows received an infusion of 10 microg of LPS into one quarter of the mammary gland ( on average , this occurred 32 d postcalving ) ."
99545,),O,3448.0,"Treatments continued until 7 d after cows received an infusion of 10 microg of LPS into one quarter of the mammary gland ( on average , this occurred 32 d postcalving ) ."
99546,.,O,3448.0,"Treatments continued until 7 d after cows received an infusion of 10 microg of LPS into one quarter of the mammary gland ( on average , this occurred 32 d postcalving ) ."
99547,Supplementation,O,3449.0,"Supplementation of vitamin C increased plasma concentrations of vitamin C at calving , but no differences were observed in samples taken 24 h postinfusion ."
99548,of,O,3449.0,"Supplementation of vitamin C increased plasma concentrations of vitamin C at calving , but no differences were observed in samples taken 24 h postinfusion ."
99549,vitamin,O,3449.0,"Supplementation of vitamin C increased plasma concentrations of vitamin C at calving , but no differences were observed in samples taken 24 h postinfusion ."
99550,C,O,3449.0,"Supplementation of vitamin C increased plasma concentrations of vitamin C at calving , but no differences were observed in samples taken 24 h postinfusion ."
99551,increased,O,3449.0,"Supplementation of vitamin C increased plasma concentrations of vitamin C at calving , but no differences were observed in samples taken 24 h postinfusion ."
99552,plasma,O,3449.0,"Supplementation of vitamin C increased plasma concentrations of vitamin C at calving , but no differences were observed in samples taken 24 h postinfusion ."
99553,concentrations,O,3449.0,"Supplementation of vitamin C increased plasma concentrations of vitamin C at calving , but no differences were observed in samples taken 24 h postinfusion ."
99554,of,O,3449.0,"Supplementation of vitamin C increased plasma concentrations of vitamin C at calving , but no differences were observed in samples taken 24 h postinfusion ."
99555,vitamin,O,3449.0,"Supplementation of vitamin C increased plasma concentrations of vitamin C at calving , but no differences were observed in samples taken 24 h postinfusion ."
99556,C,O,3449.0,"Supplementation of vitamin C increased plasma concentrations of vitamin C at calving , but no differences were observed in samples taken 24 h postinfusion ."
99557,at,O,3449.0,"Supplementation of vitamin C increased plasma concentrations of vitamin C at calving , but no differences were observed in samples taken 24 h postinfusion ."
99558,calving,O,3449.0,"Supplementation of vitamin C increased plasma concentrations of vitamin C at calving , but no differences were observed in samples taken 24 h postinfusion ."
99559,",",O,3449.0,"Supplementation of vitamin C increased plasma concentrations of vitamin C at calving , but no differences were observed in samples taken 24 h postinfusion ."
99560,but,O,3449.0,"Supplementation of vitamin C increased plasma concentrations of vitamin C at calving , but no differences were observed in samples taken 24 h postinfusion ."
99561,no,O,3449.0,"Supplementation of vitamin C increased plasma concentrations of vitamin C at calving , but no differences were observed in samples taken 24 h postinfusion ."
99562,differences,O,3449.0,"Supplementation of vitamin C increased plasma concentrations of vitamin C at calving , but no differences were observed in samples taken 24 h postinfusion ."
99563,were,O,3449.0,"Supplementation of vitamin C increased plasma concentrations of vitamin C at calving , but no differences were observed in samples taken 24 h postinfusion ."
99564,observed,O,3449.0,"Supplementation of vitamin C increased plasma concentrations of vitamin C at calving , but no differences were observed in samples taken 24 h postinfusion ."
99565,in,O,3449.0,"Supplementation of vitamin C increased plasma concentrations of vitamin C at calving , but no differences were observed in samples taken 24 h postinfusion ."
99566,samples,O,3449.0,"Supplementation of vitamin C increased plasma concentrations of vitamin C at calving , but no differences were observed in samples taken 24 h postinfusion ."
99567,taken,O,3449.0,"Supplementation of vitamin C increased plasma concentrations of vitamin C at calving , but no differences were observed in samples taken 24 h postinfusion ."
99568,24,O,3449.0,"Supplementation of vitamin C increased plasma concentrations of vitamin C at calving , but no differences were observed in samples taken 24 h postinfusion ."
99569,h,O,3449.0,"Supplementation of vitamin C increased plasma concentrations of vitamin C at calving , but no differences were observed in samples taken 24 h postinfusion ."
99570,postinfusion,O,3449.0,"Supplementation of vitamin C increased plasma concentrations of vitamin C at calving , but no differences were observed in samples taken 24 h postinfusion ."
99571,.,O,3449.0,"Supplementation of vitamin C increased plasma concentrations of vitamin C at calving , but no differences were observed in samples taken 24 h postinfusion ."
99572,Concentrations,O,3450.0,"Concentrations of vitamin C in milk ( 24 h postinfusion ) and in neutrophils ( calving and 24 h postinfusion ) were not affected by treatment , but vitamin C concentrations in neutrophils isolated from milk were about 3 times greater than concentrations in blood neutrophils ."
99573,of,O,3450.0,"Concentrations of vitamin C in milk ( 24 h postinfusion ) and in neutrophils ( calving and 24 h postinfusion ) were not affected by treatment , but vitamin C concentrations in neutrophils isolated from milk were about 3 times greater than concentrations in blood neutrophils ."
99574,vitamin,O,3450.0,"Concentrations of vitamin C in milk ( 24 h postinfusion ) and in neutrophils ( calving and 24 h postinfusion ) were not affected by treatment , but vitamin C concentrations in neutrophils isolated from milk were about 3 times greater than concentrations in blood neutrophils ."
99575,C,O,3450.0,"Concentrations of vitamin C in milk ( 24 h postinfusion ) and in neutrophils ( calving and 24 h postinfusion ) were not affected by treatment , but vitamin C concentrations in neutrophils isolated from milk were about 3 times greater than concentrations in blood neutrophils ."
99576,in,O,3450.0,"Concentrations of vitamin C in milk ( 24 h postinfusion ) and in neutrophils ( calving and 24 h postinfusion ) were not affected by treatment , but vitamin C concentrations in neutrophils isolated from milk were about 3 times greater than concentrations in blood neutrophils ."
99577,milk,B-AG.01.e,3450.0,"Concentrations of vitamin C in milk ( 24 h postinfusion ) and in neutrophils ( calving and 24 h postinfusion ) were not affected by treatment , but vitamin C concentrations in neutrophils isolated from milk were about 3 times greater than concentrations in blood neutrophils ."
99578,(,O,3450.0,"Concentrations of vitamin C in milk ( 24 h postinfusion ) and in neutrophils ( calving and 24 h postinfusion ) were not affected by treatment , but vitamin C concentrations in neutrophils isolated from milk were about 3 times greater than concentrations in blood neutrophils ."
99579,24,O,3450.0,"Concentrations of vitamin C in milk ( 24 h postinfusion ) and in neutrophils ( calving and 24 h postinfusion ) were not affected by treatment , but vitamin C concentrations in neutrophils isolated from milk were about 3 times greater than concentrations in blood neutrophils ."
99580,h,O,3450.0,"Concentrations of vitamin C in milk ( 24 h postinfusion ) and in neutrophils ( calving and 24 h postinfusion ) were not affected by treatment , but vitamin C concentrations in neutrophils isolated from milk were about 3 times greater than concentrations in blood neutrophils ."
99581,postinfusion,O,3450.0,"Concentrations of vitamin C in milk ( 24 h postinfusion ) and in neutrophils ( calving and 24 h postinfusion ) were not affected by treatment , but vitamin C concentrations in neutrophils isolated from milk were about 3 times greater than concentrations in blood neutrophils ."
99582,),O,3450.0,"Concentrations of vitamin C in milk ( 24 h postinfusion ) and in neutrophils ( calving and 24 h postinfusion ) were not affected by treatment , but vitamin C concentrations in neutrophils isolated from milk were about 3 times greater than concentrations in blood neutrophils ."
99583,and,O,3450.0,"Concentrations of vitamin C in milk ( 24 h postinfusion ) and in neutrophils ( calving and 24 h postinfusion ) were not affected by treatment , but vitamin C concentrations in neutrophils isolated from milk were about 3 times greater than concentrations in blood neutrophils ."
99584,in,O,3450.0,"Concentrations of vitamin C in milk ( 24 h postinfusion ) and in neutrophils ( calving and 24 h postinfusion ) were not affected by treatment , but vitamin C concentrations in neutrophils isolated from milk were about 3 times greater than concentrations in blood neutrophils ."
99585,neutrophils,O,3450.0,"Concentrations of vitamin C in milk ( 24 h postinfusion ) and in neutrophils ( calving and 24 h postinfusion ) were not affected by treatment , but vitamin C concentrations in neutrophils isolated from milk were about 3 times greater than concentrations in blood neutrophils ."
99586,(,O,3450.0,"Concentrations of vitamin C in milk ( 24 h postinfusion ) and in neutrophils ( calving and 24 h postinfusion ) were not affected by treatment , but vitamin C concentrations in neutrophils isolated from milk were about 3 times greater than concentrations in blood neutrophils ."
99587,calving,O,3450.0,"Concentrations of vitamin C in milk ( 24 h postinfusion ) and in neutrophils ( calving and 24 h postinfusion ) were not affected by treatment , but vitamin C concentrations in neutrophils isolated from milk were about 3 times greater than concentrations in blood neutrophils ."
99588,and,O,3450.0,"Concentrations of vitamin C in milk ( 24 h postinfusion ) and in neutrophils ( calving and 24 h postinfusion ) were not affected by treatment , but vitamin C concentrations in neutrophils isolated from milk were about 3 times greater than concentrations in blood neutrophils ."
99589,24,O,3450.0,"Concentrations of vitamin C in milk ( 24 h postinfusion ) and in neutrophils ( calving and 24 h postinfusion ) were not affected by treatment , but vitamin C concentrations in neutrophils isolated from milk were about 3 times greater than concentrations in blood neutrophils ."
99590,h,O,3450.0,"Concentrations of vitamin C in milk ( 24 h postinfusion ) and in neutrophils ( calving and 24 h postinfusion ) were not affected by treatment , but vitamin C concentrations in neutrophils isolated from milk were about 3 times greater than concentrations in blood neutrophils ."
99591,postinfusion,O,3450.0,"Concentrations of vitamin C in milk ( 24 h postinfusion ) and in neutrophils ( calving and 24 h postinfusion ) were not affected by treatment , but vitamin C concentrations in neutrophils isolated from milk were about 3 times greater than concentrations in blood neutrophils ."
99592,),O,3450.0,"Concentrations of vitamin C in milk ( 24 h postinfusion ) and in neutrophils ( calving and 24 h postinfusion ) were not affected by treatment , but vitamin C concentrations in neutrophils isolated from milk were about 3 times greater than concentrations in blood neutrophils ."
99593,were,O,3450.0,"Concentrations of vitamin C in milk ( 24 h postinfusion ) and in neutrophils ( calving and 24 h postinfusion ) were not affected by treatment , but vitamin C concentrations in neutrophils isolated from milk were about 3 times greater than concentrations in blood neutrophils ."
99594,not,O,3450.0,"Concentrations of vitamin C in milk ( 24 h postinfusion ) and in neutrophils ( calving and 24 h postinfusion ) were not affected by treatment , but vitamin C concentrations in neutrophils isolated from milk were about 3 times greater than concentrations in blood neutrophils ."
99595,affected,O,3450.0,"Concentrations of vitamin C in milk ( 24 h postinfusion ) and in neutrophils ( calving and 24 h postinfusion ) were not affected by treatment , but vitamin C concentrations in neutrophils isolated from milk were about 3 times greater than concentrations in blood neutrophils ."
99596,by,O,3450.0,"Concentrations of vitamin C in milk ( 24 h postinfusion ) and in neutrophils ( calving and 24 h postinfusion ) were not affected by treatment , but vitamin C concentrations in neutrophils isolated from milk were about 3 times greater than concentrations in blood neutrophils ."
99597,treatment,O,3450.0,"Concentrations of vitamin C in milk ( 24 h postinfusion ) and in neutrophils ( calving and 24 h postinfusion ) were not affected by treatment , but vitamin C concentrations in neutrophils isolated from milk were about 3 times greater than concentrations in blood neutrophils ."
99598,",",O,3450.0,"Concentrations of vitamin C in milk ( 24 h postinfusion ) and in neutrophils ( calving and 24 h postinfusion ) were not affected by treatment , but vitamin C concentrations in neutrophils isolated from milk were about 3 times greater than concentrations in blood neutrophils ."
99599,but,O,3450.0,"Concentrations of vitamin C in milk ( 24 h postinfusion ) and in neutrophils ( calving and 24 h postinfusion ) were not affected by treatment , but vitamin C concentrations in neutrophils isolated from milk were about 3 times greater than concentrations in blood neutrophils ."
99600,vitamin,O,3450.0,"Concentrations of vitamin C in milk ( 24 h postinfusion ) and in neutrophils ( calving and 24 h postinfusion ) were not affected by treatment , but vitamin C concentrations in neutrophils isolated from milk were about 3 times greater than concentrations in blood neutrophils ."
99601,C,O,3450.0,"Concentrations of vitamin C in milk ( 24 h postinfusion ) and in neutrophils ( calving and 24 h postinfusion ) were not affected by treatment , but vitamin C concentrations in neutrophils isolated from milk were about 3 times greater than concentrations in blood neutrophils ."
99602,concentrations,O,3450.0,"Concentrations of vitamin C in milk ( 24 h postinfusion ) and in neutrophils ( calving and 24 h postinfusion ) were not affected by treatment , but vitamin C concentrations in neutrophils isolated from milk were about 3 times greater than concentrations in blood neutrophils ."
99603,in,O,3450.0,"Concentrations of vitamin C in milk ( 24 h postinfusion ) and in neutrophils ( calving and 24 h postinfusion ) were not affected by treatment , but vitamin C concentrations in neutrophils isolated from milk were about 3 times greater than concentrations in blood neutrophils ."
99604,neutrophils,O,3450.0,"Concentrations of vitamin C in milk ( 24 h postinfusion ) and in neutrophils ( calving and 24 h postinfusion ) were not affected by treatment , but vitamin C concentrations in neutrophils isolated from milk were about 3 times greater than concentrations in blood neutrophils ."
99605,isolated,O,3450.0,"Concentrations of vitamin C in milk ( 24 h postinfusion ) and in neutrophils ( calving and 24 h postinfusion ) were not affected by treatment , but vitamin C concentrations in neutrophils isolated from milk were about 3 times greater than concentrations in blood neutrophils ."
99606,from,O,3450.0,"Concentrations of vitamin C in milk ( 24 h postinfusion ) and in neutrophils ( calving and 24 h postinfusion ) were not affected by treatment , but vitamin C concentrations in neutrophils isolated from milk were about 3 times greater than concentrations in blood neutrophils ."
99607,milk,B-AG.01.e,3450.0,"Concentrations of vitamin C in milk ( 24 h postinfusion ) and in neutrophils ( calving and 24 h postinfusion ) were not affected by treatment , but vitamin C concentrations in neutrophils isolated from milk were about 3 times greater than concentrations in blood neutrophils ."
99608,were,O,3450.0,"Concentrations of vitamin C in milk ( 24 h postinfusion ) and in neutrophils ( calving and 24 h postinfusion ) were not affected by treatment , but vitamin C concentrations in neutrophils isolated from milk were about 3 times greater than concentrations in blood neutrophils ."
99609,about,O,3450.0,"Concentrations of vitamin C in milk ( 24 h postinfusion ) and in neutrophils ( calving and 24 h postinfusion ) were not affected by treatment , but vitamin C concentrations in neutrophils isolated from milk were about 3 times greater than concentrations in blood neutrophils ."
99610,3,O,3450.0,"Concentrations of vitamin C in milk ( 24 h postinfusion ) and in neutrophils ( calving and 24 h postinfusion ) were not affected by treatment , but vitamin C concentrations in neutrophils isolated from milk were about 3 times greater than concentrations in blood neutrophils ."
99611,times,O,3450.0,"Concentrations of vitamin C in milk ( 24 h postinfusion ) and in neutrophils ( calving and 24 h postinfusion ) were not affected by treatment , but vitamin C concentrations in neutrophils isolated from milk were about 3 times greater than concentrations in blood neutrophils ."
99612,greater,O,3450.0,"Concentrations of vitamin C in milk ( 24 h postinfusion ) and in neutrophils ( calving and 24 h postinfusion ) were not affected by treatment , but vitamin C concentrations in neutrophils isolated from milk were about 3 times greater than concentrations in blood neutrophils ."
99613,than,O,3450.0,"Concentrations of vitamin C in milk ( 24 h postinfusion ) and in neutrophils ( calving and 24 h postinfusion ) were not affected by treatment , but vitamin C concentrations in neutrophils isolated from milk were about 3 times greater than concentrations in blood neutrophils ."
99614,concentrations,O,3450.0,"Concentrations of vitamin C in milk ( 24 h postinfusion ) and in neutrophils ( calving and 24 h postinfusion ) were not affected by treatment , but vitamin C concentrations in neutrophils isolated from milk were about 3 times greater than concentrations in blood neutrophils ."
99615,in,O,3450.0,"Concentrations of vitamin C in milk ( 24 h postinfusion ) and in neutrophils ( calving and 24 h postinfusion ) were not affected by treatment , but vitamin C concentrations in neutrophils isolated from milk were about 3 times greater than concentrations in blood neutrophils ."
99616,blood,O,3450.0,"Concentrations of vitamin C in milk ( 24 h postinfusion ) and in neutrophils ( calving and 24 h postinfusion ) were not affected by treatment , but vitamin C concentrations in neutrophils isolated from milk were about 3 times greater than concentrations in blood neutrophils ."
99617,neutrophils,O,3450.0,"Concentrations of vitamin C in milk ( 24 h postinfusion ) and in neutrophils ( calving and 24 h postinfusion ) were not affected by treatment , but vitamin C concentrations in neutrophils isolated from milk were about 3 times greater than concentrations in blood neutrophils ."
99618,.,O,3450.0,"Concentrations of vitamin C in milk ( 24 h postinfusion ) and in neutrophils ( calving and 24 h postinfusion ) were not affected by treatment , but vitamin C concentrations in neutrophils isolated from milk were about 3 times greater than concentrations in blood neutrophils ."
99619,The,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99620,LPS,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99621,infusion,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99622,did,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99623,not,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99624,alter,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99625,concentrations,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99626,of,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99627,vitamin,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99628,C,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99629,in,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99630,plasma,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99631,or,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99632,milk,B-AG.01.e,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99633,",",O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99634,suggesting,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99635,that,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99636,the,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99637,LPS,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99638,model,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99639,did,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99640,not,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99641,produce,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99642,the,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99643,same,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99644,effects,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99645,as,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99646,a,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99647,bacterial,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99648,infection,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99649,of,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99650,the,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99651,mammary,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99652,gland,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99653,with,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99654,respect,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99655,to,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99656,antioxidant,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99657,effects,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99658,.,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99659,Supplemental,O,3452.0,Supplemental vitamin C had no effect on neutrophil phagocytosis or bacterial kill .
99660,vitamin,O,3452.0,Supplemental vitamin C had no effect on neutrophil phagocytosis or bacterial kill .
99661,C,O,3452.0,Supplemental vitamin C had no effect on neutrophil phagocytosis or bacterial kill .
99662,had,O,3452.0,Supplemental vitamin C had no effect on neutrophil phagocytosis or bacterial kill .
99663,no,O,3452.0,Supplemental vitamin C had no effect on neutrophil phagocytosis or bacterial kill .
99664,effect,O,3452.0,Supplemental vitamin C had no effect on neutrophil phagocytosis or bacterial kill .
99665,on,O,3452.0,Supplemental vitamin C had no effect on neutrophil phagocytosis or bacterial kill .
99666,neutrophil,O,3452.0,Supplemental vitamin C had no effect on neutrophil phagocytosis or bacterial kill .
99667,phagocytosis,O,3452.0,Supplemental vitamin C had no effect on neutrophil phagocytosis or bacterial kill .
99668,or,O,3452.0,Supplemental vitamin C had no effect on neutrophil phagocytosis or bacterial kill .
99669,bacterial,O,3452.0,Supplemental vitamin C had no effect on neutrophil phagocytosis or bacterial kill .
99670,kill,O,3452.0,Supplemental vitamin C had no effect on neutrophil phagocytosis or bacterial kill .
99671,.,O,3452.0,Supplemental vitamin C had no effect on neutrophil phagocytosis or bacterial kill .
99672,Dietary,O,3453.0,Dietary vitamin C reduced the milk somatic cell count but did not affect the febrile response or milk production following LPS infusion .
99673,vitamin,O,3453.0,Dietary vitamin C reduced the milk somatic cell count but did not affect the febrile response or milk production following LPS infusion .
99674,C,O,3453.0,Dietary vitamin C reduced the milk somatic cell count but did not affect the febrile response or milk production following LPS infusion .
99675,reduced,O,3453.0,Dietary vitamin C reduced the milk somatic cell count but did not affect the febrile response or milk production following LPS infusion .
99676,the,O,3453.0,Dietary vitamin C reduced the milk somatic cell count but did not affect the febrile response or milk production following LPS infusion .
99677,milk,O,3453.0,Dietary vitamin C reduced the milk somatic cell count but did not affect the febrile response or milk production following LPS infusion .
99678,somatic,O,3453.0,Dietary vitamin C reduced the milk somatic cell count but did not affect the febrile response or milk production following LPS infusion .
99679,cell,O,3453.0,Dietary vitamin C reduced the milk somatic cell count but did not affect the febrile response or milk production following LPS infusion .
99680,count,O,3453.0,Dietary vitamin C reduced the milk somatic cell count but did not affect the febrile response or milk production following LPS infusion .
99681,but,O,3453.0,Dietary vitamin C reduced the milk somatic cell count but did not affect the febrile response or milk production following LPS infusion .
99682,did,O,3453.0,Dietary vitamin C reduced the milk somatic cell count but did not affect the febrile response or milk production following LPS infusion .
99683,not,O,3453.0,Dietary vitamin C reduced the milk somatic cell count but did not affect the febrile response or milk production following LPS infusion .
99684,affect,O,3453.0,Dietary vitamin C reduced the milk somatic cell count but did not affect the febrile response or milk production following LPS infusion .
99685,the,O,3453.0,Dietary vitamin C reduced the milk somatic cell count but did not affect the febrile response or milk production following LPS infusion .
99686,febrile,O,3453.0,Dietary vitamin C reduced the milk somatic cell count but did not affect the febrile response or milk production following LPS infusion .
99687,response,O,3453.0,Dietary vitamin C reduced the milk somatic cell count but did not affect the febrile response or milk production following LPS infusion .
99688,or,O,3453.0,Dietary vitamin C reduced the milk somatic cell count but did not affect the febrile response or milk production following LPS infusion .
99689,milk,O,3453.0,Dietary vitamin C reduced the milk somatic cell count but did not affect the febrile response or milk production following LPS infusion .
99690,production,O,3453.0,Dietary vitamin C reduced the milk somatic cell count but did not affect the febrile response or milk production following LPS infusion .
99691,following,O,3453.0,Dietary vitamin C reduced the milk somatic cell count but did not affect the febrile response or milk production following LPS infusion .
99692,LPS,O,3453.0,Dietary vitamin C reduced the milk somatic cell count but did not affect the febrile response or milk production following LPS infusion .
99693,infusion,O,3453.0,Dietary vitamin C reduced the milk somatic cell count but did not affect the febrile response or milk production following LPS infusion .
99694,.,O,3453.0,Dietary vitamin C reduced the milk somatic cell count but did not affect the febrile response or milk production following LPS infusion .
99695,Celiac,O,3454.0,"Celiac disease is an autoimmune disease that affects the villi of the small intestine causing abdominal pain , gas , diarrhea , or bad absorption due to gluten intolerance ."
99696,disease,O,3454.0,"Celiac disease is an autoimmune disease that affects the villi of the small intestine causing abdominal pain , gas , diarrhea , or bad absorption due to gluten intolerance ."
99697,is,O,3454.0,"Celiac disease is an autoimmune disease that affects the villi of the small intestine causing abdominal pain , gas , diarrhea , or bad absorption due to gluten intolerance ."
99698,an,O,3454.0,"Celiac disease is an autoimmune disease that affects the villi of the small intestine causing abdominal pain , gas , diarrhea , or bad absorption due to gluten intolerance ."
99699,autoimmune,O,3454.0,"Celiac disease is an autoimmune disease that affects the villi of the small intestine causing abdominal pain , gas , diarrhea , or bad absorption due to gluten intolerance ."
99700,disease,O,3454.0,"Celiac disease is an autoimmune disease that affects the villi of the small intestine causing abdominal pain , gas , diarrhea , or bad absorption due to gluten intolerance ."
99701,that,O,3454.0,"Celiac disease is an autoimmune disease that affects the villi of the small intestine causing abdominal pain , gas , diarrhea , or bad absorption due to gluten intolerance ."
99702,affects,O,3454.0,"Celiac disease is an autoimmune disease that affects the villi of the small intestine causing abdominal pain , gas , diarrhea , or bad absorption due to gluten intolerance ."
99703,the,O,3454.0,"Celiac disease is an autoimmune disease that affects the villi of the small intestine causing abdominal pain , gas , diarrhea , or bad absorption due to gluten intolerance ."
99704,villi,O,3454.0,"Celiac disease is an autoimmune disease that affects the villi of the small intestine causing abdominal pain , gas , diarrhea , or bad absorption due to gluten intolerance ."
99705,of,O,3454.0,"Celiac disease is an autoimmune disease that affects the villi of the small intestine causing abdominal pain , gas , diarrhea , or bad absorption due to gluten intolerance ."
99706,the,O,3454.0,"Celiac disease is an autoimmune disease that affects the villi of the small intestine causing abdominal pain , gas , diarrhea , or bad absorption due to gluten intolerance ."
99707,small,O,3454.0,"Celiac disease is an autoimmune disease that affects the villi of the small intestine causing abdominal pain , gas , diarrhea , or bad absorption due to gluten intolerance ."
99708,intestine,O,3454.0,"Celiac disease is an autoimmune disease that affects the villi of the small intestine causing abdominal pain , gas , diarrhea , or bad absorption due to gluten intolerance ."
99709,causing,O,3454.0,"Celiac disease is an autoimmune disease that affects the villi of the small intestine causing abdominal pain , gas , diarrhea , or bad absorption due to gluten intolerance ."
99710,abdominal,O,3454.0,"Celiac disease is an autoimmune disease that affects the villi of the small intestine causing abdominal pain , gas , diarrhea , or bad absorption due to gluten intolerance ."
99711,pain,O,3454.0,"Celiac disease is an autoimmune disease that affects the villi of the small intestine causing abdominal pain , gas , diarrhea , or bad absorption due to gluten intolerance ."
99712,",",O,3454.0,"Celiac disease is an autoimmune disease that affects the villi of the small intestine causing abdominal pain , gas , diarrhea , or bad absorption due to gluten intolerance ."
99713,gas,O,3454.0,"Celiac disease is an autoimmune disease that affects the villi of the small intestine causing abdominal pain , gas , diarrhea , or bad absorption due to gluten intolerance ."
99714,",",O,3454.0,"Celiac disease is an autoimmune disease that affects the villi of the small intestine causing abdominal pain , gas , diarrhea , or bad absorption due to gluten intolerance ."
99715,diarrhea,O,3454.0,"Celiac disease is an autoimmune disease that affects the villi of the small intestine causing abdominal pain , gas , diarrhea , or bad absorption due to gluten intolerance ."
99716,",",O,3454.0,"Celiac disease is an autoimmune disease that affects the villi of the small intestine causing abdominal pain , gas , diarrhea , or bad absorption due to gluten intolerance ."
99717,or,O,3454.0,"Celiac disease is an autoimmune disease that affects the villi of the small intestine causing abdominal pain , gas , diarrhea , or bad absorption due to gluten intolerance ."
99718,bad,O,3454.0,"Celiac disease is an autoimmune disease that affects the villi of the small intestine causing abdominal pain , gas , diarrhea , or bad absorption due to gluten intolerance ."
99719,absorption,O,3454.0,"Celiac disease is an autoimmune disease that affects the villi of the small intestine causing abdominal pain , gas , diarrhea , or bad absorption due to gluten intolerance ."
99720,due,O,3454.0,"Celiac disease is an autoimmune disease that affects the villi of the small intestine causing abdominal pain , gas , diarrhea , or bad absorption due to gluten intolerance ."
99721,to,O,3454.0,"Celiac disease is an autoimmune disease that affects the villi of the small intestine causing abdominal pain , gas , diarrhea , or bad absorption due to gluten intolerance ."
99722,gluten,O,3454.0,"Celiac disease is an autoimmune disease that affects the villi of the small intestine causing abdominal pain , gas , diarrhea , or bad absorption due to gluten intolerance ."
99723,intolerance,O,3454.0,"Celiac disease is an autoimmune disease that affects the villi of the small intestine causing abdominal pain , gas , diarrhea , or bad absorption due to gluten intolerance ."
99724,.,O,3454.0,"Celiac disease is an autoimmune disease that affects the villi of the small intestine causing abdominal pain , gas , diarrhea , or bad absorption due to gluten intolerance ."
99725,The,O,3455.0,"The only treatment for this disease consists of a lifelong gluten free diet ; this is , celiac people can not consume products containing gluten , such as wheat , barley , and rye , but they can use rice and corn ."
99726,only,O,3455.0,"The only treatment for this disease consists of a lifelong gluten free diet ; this is , celiac people can not consume products containing gluten , such as wheat , barley , and rye , but they can use rice and corn ."
99727,treatment,O,3455.0,"The only treatment for this disease consists of a lifelong gluten free diet ; this is , celiac people can not consume products containing gluten , such as wheat , barley , and rye , but they can use rice and corn ."
99728,for,O,3455.0,"The only treatment for this disease consists of a lifelong gluten free diet ; this is , celiac people can not consume products containing gluten , such as wheat , barley , and rye , but they can use rice and corn ."
99729,this,O,3455.0,"The only treatment for this disease consists of a lifelong gluten free diet ; this is , celiac people can not consume products containing gluten , such as wheat , barley , and rye , but they can use rice and corn ."
99730,disease,O,3455.0,"The only treatment for this disease consists of a lifelong gluten free diet ; this is , celiac people can not consume products containing gluten , such as wheat , barley , and rye , but they can use rice and corn ."
99731,consists,O,3455.0,"The only treatment for this disease consists of a lifelong gluten free diet ; this is , celiac people can not consume products containing gluten , such as wheat , barley , and rye , but they can use rice and corn ."
99732,of,O,3455.0,"The only treatment for this disease consists of a lifelong gluten free diet ; this is , celiac people can not consume products containing gluten , such as wheat , barley , and rye , but they can use rice and corn ."
99733,a,O,3455.0,"The only treatment for this disease consists of a lifelong gluten free diet ; this is , celiac people can not consume products containing gluten , such as wheat , barley , and rye , but they can use rice and corn ."
99734,lifelong,O,3455.0,"The only treatment for this disease consists of a lifelong gluten free diet ; this is , celiac people can not consume products containing gluten , such as wheat , barley , and rye , but they can use rice and corn ."
99735,gluten,O,3455.0,"The only treatment for this disease consists of a lifelong gluten free diet ; this is , celiac people can not consume products containing gluten , such as wheat , barley , and rye , but they can use rice and corn ."
99736,free,O,3455.0,"The only treatment for this disease consists of a lifelong gluten free diet ; this is , celiac people can not consume products containing gluten , such as wheat , barley , and rye , but they can use rice and corn ."
99737,diet,O,3455.0,"The only treatment for this disease consists of a lifelong gluten free diet ; this is , celiac people can not consume products containing gluten , such as wheat , barley , and rye , but they can use rice and corn ."
99738,;,O,3455.0,"The only treatment for this disease consists of a lifelong gluten free diet ; this is , celiac people can not consume products containing gluten , such as wheat , barley , and rye , but they can use rice and corn ."
99739,this,O,3455.0,"The only treatment for this disease consists of a lifelong gluten free diet ; this is , celiac people can not consume products containing gluten , such as wheat , barley , and rye , but they can use rice and corn ."
99740,is,O,3455.0,"The only treatment for this disease consists of a lifelong gluten free diet ; this is , celiac people can not consume products containing gluten , such as wheat , barley , and rye , but they can use rice and corn ."
99741,",",O,3455.0,"The only treatment for this disease consists of a lifelong gluten free diet ; this is , celiac people can not consume products containing gluten , such as wheat , barley , and rye , but they can use rice and corn ."
99742,celiac,O,3455.0,"The only treatment for this disease consists of a lifelong gluten free diet ; this is , celiac people can not consume products containing gluten , such as wheat , barley , and rye , but they can use rice and corn ."
99743,people,O,3455.0,"The only treatment for this disease consists of a lifelong gluten free diet ; this is , celiac people can not consume products containing gluten , such as wheat , barley , and rye , but they can use rice and corn ."
99744,can,O,3455.0,"The only treatment for this disease consists of a lifelong gluten free diet ; this is , celiac people can not consume products containing gluten , such as wheat , barley , and rye , but they can use rice and corn ."
99745,not,O,3455.0,"The only treatment for this disease consists of a lifelong gluten free diet ; this is , celiac people can not consume products containing gluten , such as wheat , barley , and rye , but they can use rice and corn ."
99746,consume,O,3455.0,"The only treatment for this disease consists of a lifelong gluten free diet ; this is , celiac people can not consume products containing gluten , such as wheat , barley , and rye , but they can use rice and corn ."
99747,products,O,3455.0,"The only treatment for this disease consists of a lifelong gluten free diet ; this is , celiac people can not consume products containing gluten , such as wheat , barley , and rye , but they can use rice and corn ."
99748,containing,O,3455.0,"The only treatment for this disease consists of a lifelong gluten free diet ; this is , celiac people can not consume products containing gluten , such as wheat , barley , and rye , but they can use rice and corn ."
99749,gluten,O,3455.0,"The only treatment for this disease consists of a lifelong gluten free diet ; this is , celiac people can not consume products containing gluten , such as wheat , barley , and rye , but they can use rice and corn ."
99750,",",O,3455.0,"The only treatment for this disease consists of a lifelong gluten free diet ; this is , celiac people can not consume products containing gluten , such as wheat , barley , and rye , but they can use rice and corn ."
99751,such,O,3455.0,"The only treatment for this disease consists of a lifelong gluten free diet ; this is , celiac people can not consume products containing gluten , such as wheat , barley , and rye , but they can use rice and corn ."
99752,as,O,3455.0,"The only treatment for this disease consists of a lifelong gluten free diet ; this is , celiac people can not consume products containing gluten , such as wheat , barley , and rye , but they can use rice and corn ."
99753,wheat,B-AG.01.i,3455.0,"The only treatment for this disease consists of a lifelong gluten free diet ; this is , celiac people can not consume products containing gluten , such as wheat , barley , and rye , but they can use rice and corn ."
99754,",",O,3455.0,"The only treatment for this disease consists of a lifelong gluten free diet ; this is , celiac people can not consume products containing gluten , such as wheat , barley , and rye , but they can use rice and corn ."
99755,barley,B-AG.01.i,3455.0,"The only treatment for this disease consists of a lifelong gluten free diet ; this is , celiac people can not consume products containing gluten , such as wheat , barley , and rye , but they can use rice and corn ."
99756,",",O,3455.0,"The only treatment for this disease consists of a lifelong gluten free diet ; this is , celiac people can not consume products containing gluten , such as wheat , barley , and rye , but they can use rice and corn ."
99757,and,O,3455.0,"The only treatment for this disease consists of a lifelong gluten free diet ; this is , celiac people can not consume products containing gluten , such as wheat , barley , and rye , but they can use rice and corn ."
99758,rye,B-AG.01.i,3455.0,"The only treatment for this disease consists of a lifelong gluten free diet ; this is , celiac people can not consume products containing gluten , such as wheat , barley , and rye , but they can use rice and corn ."
99759,",",O,3455.0,"The only treatment for this disease consists of a lifelong gluten free diet ; this is , celiac people can not consume products containing gluten , such as wheat , barley , and rye , but they can use rice and corn ."
99760,but,O,3455.0,"The only treatment for this disease consists of a lifelong gluten free diet ; this is , celiac people can not consume products containing gluten , such as wheat , barley , and rye , but they can use rice and corn ."
99761,they,O,3455.0,"The only treatment for this disease consists of a lifelong gluten free diet ; this is , celiac people can not consume products containing gluten , such as wheat , barley , and rye , but they can use rice and corn ."
99762,can,O,3455.0,"The only treatment for this disease consists of a lifelong gluten free diet ; this is , celiac people can not consume products containing gluten , such as wheat , barley , and rye , but they can use rice and corn ."
99763,use,O,3455.0,"The only treatment for this disease consists of a lifelong gluten free diet ; this is , celiac people can not consume products containing gluten , such as wheat , barley , and rye , but they can use rice and corn ."
99764,rice,B-AG.01.i,3455.0,"The only treatment for this disease consists of a lifelong gluten free diet ; this is , celiac people can not consume products containing gluten , such as wheat , barley , and rye , but they can use rice and corn ."
99765,and,O,3455.0,"The only treatment for this disease consists of a lifelong gluten free diet ; this is , celiac people can not consume products containing gluten , such as wheat , barley , and rye , but they can use rice and corn ."
99766,corn,B-AG.01.i,3455.0,"The only treatment for this disease consists of a lifelong gluten free diet ; this is , celiac people can not consume products containing gluten , such as wheat , barley , and rye , but they can use rice and corn ."
99767,.,O,3455.0,"The only treatment for this disease consists of a lifelong gluten free diet ; this is , celiac people can not consume products containing gluten , such as wheat , barley , and rye , but they can use rice and corn ."
99768,Thus,O,3456.0,"Thus , rice flour is mainly used for the manufacturing of the basic products of this population ."
99769,",",O,3456.0,"Thus , rice flour is mainly used for the manufacturing of the basic products of this population ."
99770,rice,B-AG.01.k,3456.0,"Thus , rice flour is mainly used for the manufacturing of the basic products of this population ."
99771,flour,I-AG.01.k,3456.0,"Thus , rice flour is mainly used for the manufacturing of the basic products of this population ."
99772,is,O,3456.0,"Thus , rice flour is mainly used for the manufacturing of the basic products of this population ."
99773,mainly,O,3456.0,"Thus , rice flour is mainly used for the manufacturing of the basic products of this population ."
99774,used,O,3456.0,"Thus , rice flour is mainly used for the manufacturing of the basic products of this population ."
99775,for,O,3456.0,"Thus , rice flour is mainly used for the manufacturing of the basic products of this population ."
99776,the,O,3456.0,"Thus , rice flour is mainly used for the manufacturing of the basic products of this population ."
99777,manufacturing,O,3456.0,"Thus , rice flour is mainly used for the manufacturing of the basic products of this population ."
99778,of,O,3456.0,"Thus , rice flour is mainly used for the manufacturing of the basic products of this population ."
99779,the,O,3456.0,"Thus , rice flour is mainly used for the manufacturing of the basic products of this population ."
99780,basic,O,3456.0,"Thus , rice flour is mainly used for the manufacturing of the basic products of this population ."
99781,products,O,3456.0,"Thus , rice flour is mainly used for the manufacturing of the basic products of this population ."
99782,of,O,3456.0,"Thus , rice flour is mainly used for the manufacturing of the basic products of this population ."
99783,this,O,3456.0,"Thus , rice flour is mainly used for the manufacturing of the basic products of this population ."
99784,population,O,3456.0,"Thus , rice flour is mainly used for the manufacturing of the basic products of this population ."
99785,.,O,3456.0,"Thus , rice flour is mainly used for the manufacturing of the basic products of this population ."
99786,Unfortunately,O,3457.0,"Unfortunately , rice can contain high contents of total ( t - As ) and inorganic ( i - As ) arsenic ."
99787,",",O,3457.0,"Unfortunately , rice can contain high contents of total ( t - As ) and inorganic ( i - As ) arsenic ."
99788,rice,B-AG.01.i,3457.0,"Unfortunately , rice can contain high contents of total ( t - As ) and inorganic ( i - As ) arsenic ."
99789,can,O,3457.0,"Unfortunately , rice can contain high contents of total ( t - As ) and inorganic ( i - As ) arsenic ."
99790,contain,O,3457.0,"Unfortunately , rice can contain high contents of total ( t - As ) and inorganic ( i - As ) arsenic ."
99791,high,O,3457.0,"Unfortunately , rice can contain high contents of total ( t - As ) and inorganic ( i - As ) arsenic ."
99792,contents,O,3457.0,"Unfortunately , rice can contain high contents of total ( t - As ) and inorganic ( i - As ) arsenic ."
99793,of,O,3457.0,"Unfortunately , rice can contain high contents of total ( t - As ) and inorganic ( i - As ) arsenic ."
99794,total,O,3457.0,"Unfortunately , rice can contain high contents of total ( t - As ) and inorganic ( i - As ) arsenic ."
99795,(,O,3457.0,"Unfortunately , rice can contain high contents of total ( t - As ) and inorganic ( i - As ) arsenic ."
99796,t,O,3457.0,"Unfortunately , rice can contain high contents of total ( t - As ) and inorganic ( i - As ) arsenic ."
99797,-,O,3457.0,"Unfortunately , rice can contain high contents of total ( t - As ) and inorganic ( i - As ) arsenic ."
99798,As,O,3457.0,"Unfortunately , rice can contain high contents of total ( t - As ) and inorganic ( i - As ) arsenic ."
99799,),O,3457.0,"Unfortunately , rice can contain high contents of total ( t - As ) and inorganic ( i - As ) arsenic ."
99800,and,O,3457.0,"Unfortunately , rice can contain high contents of total ( t - As ) and inorganic ( i - As ) arsenic ."
99801,inorganic,O,3457.0,"Unfortunately , rice can contain high contents of total ( t - As ) and inorganic ( i - As ) arsenic ."
99802,(,O,3457.0,"Unfortunately , rice can contain high contents of total ( t - As ) and inorganic ( i - As ) arsenic ."
99803,i,O,3457.0,"Unfortunately , rice can contain high contents of total ( t - As ) and inorganic ( i - As ) arsenic ."
99804,-,O,3457.0,"Unfortunately , rice can contain high contents of total ( t - As ) and inorganic ( i - As ) arsenic ."
99805,As,O,3457.0,"Unfortunately , rice can contain high contents of total ( t - As ) and inorganic ( i - As ) arsenic ."
99806,),O,3457.0,"Unfortunately , rice can contain high contents of total ( t - As ) and inorganic ( i - As ) arsenic ."
99807,arsenic,O,3457.0,"Unfortunately , rice can contain high contents of total ( t - As ) and inorganic ( i - As ) arsenic ."
99808,.,O,3457.0,"Unfortunately , rice can contain high contents of total ( t - As ) and inorganic ( i - As ) arsenic ."
99809,The,O,3458.0,The current study demonstrated that products for celiac children with a high percentage of rice contained high concentrations of arsenic ( 256 and 128 μg kg⁻¹ ) .
99810,current,O,3458.0,The current study demonstrated that products for celiac children with a high percentage of rice contained high concentrations of arsenic ( 256 and 128 μg kg⁻¹ ) .
99811,study,O,3458.0,The current study demonstrated that products for celiac children with a high percentage of rice contained high concentrations of arsenic ( 256 and 128 μg kg⁻¹ ) .
99812,demonstrated,O,3458.0,The current study demonstrated that products for celiac children with a high percentage of rice contained high concentrations of arsenic ( 256 and 128 μg kg⁻¹ ) .
99813,that,O,3458.0,The current study demonstrated that products for celiac children with a high percentage of rice contained high concentrations of arsenic ( 256 and 128 μg kg⁻¹ ) .
99814,products,O,3458.0,The current study demonstrated that products for celiac children with a high percentage of rice contained high concentrations of arsenic ( 256 and 128 μg kg⁻¹ ) .
99815,for,O,3458.0,The current study demonstrated that products for celiac children with a high percentage of rice contained high concentrations of arsenic ( 256 and 128 μg kg⁻¹ ) .
99816,celiac,O,3458.0,The current study demonstrated that products for celiac children with a high percentage of rice contained high concentrations of arsenic ( 256 and 128 μg kg⁻¹ ) .
99817,children,O,3458.0,The current study demonstrated that products for celiac children with a high percentage of rice contained high concentrations of arsenic ( 256 and 128 μg kg⁻¹ ) .
99818,with,O,3458.0,The current study demonstrated that products for celiac children with a high percentage of rice contained high concentrations of arsenic ( 256 and 128 μg kg⁻¹ ) .
99819,a,O,3458.0,The current study demonstrated that products for celiac children with a high percentage of rice contained high concentrations of arsenic ( 256 and 128 μg kg⁻¹ ) .
99820,high,O,3458.0,The current study demonstrated that products for celiac children with a high percentage of rice contained high concentrations of arsenic ( 256 and 128 μg kg⁻¹ ) .
99821,percentage,O,3458.0,The current study demonstrated that products for celiac children with a high percentage of rice contained high concentrations of arsenic ( 256 and 128 μg kg⁻¹ ) .
99822,of,O,3458.0,The current study demonstrated that products for celiac children with a high percentage of rice contained high concentrations of arsenic ( 256 and 128 μg kg⁻¹ ) .
99823,rice,B-AG.01.i,3458.0,The current study demonstrated that products for celiac children with a high percentage of rice contained high concentrations of arsenic ( 256 and 128 μg kg⁻¹ ) .
99824,contained,O,3458.0,The current study demonstrated that products for celiac children with a high percentage of rice contained high concentrations of arsenic ( 256 and 128 μg kg⁻¹ ) .
99825,high,O,3458.0,The current study demonstrated that products for celiac children with a high percentage of rice contained high concentrations of arsenic ( 256 and 128 μg kg⁻¹ ) .
99826,concentrations,O,3458.0,The current study demonstrated that products for celiac children with a high percentage of rice contained high concentrations of arsenic ( 256 and 128 μg kg⁻¹ ) .
99827,of,O,3458.0,The current study demonstrated that products for celiac children with a high percentage of rice contained high concentrations of arsenic ( 256 and 128 μg kg⁻¹ ) .
99828,arsenic,O,3458.0,The current study demonstrated that products for celiac children with a high percentage of rice contained high concentrations of arsenic ( 256 and 128 μg kg⁻¹ ) .
99829,(,O,3458.0,The current study demonstrated that products for celiac children with a high percentage of rice contained high concentrations of arsenic ( 256 and 128 μg kg⁻¹ ) .
99830,256,O,3458.0,The current study demonstrated that products for celiac children with a high percentage of rice contained high concentrations of arsenic ( 256 and 128 μg kg⁻¹ ) .
99831,and,O,3458.0,The current study demonstrated that products for celiac children with a high percentage of rice contained high concentrations of arsenic ( 256 and 128 μg kg⁻¹ ) .
99832,128,O,3458.0,The current study demonstrated that products for celiac children with a high percentage of rice contained high concentrations of arsenic ( 256 and 128 μg kg⁻¹ ) .
99833,μg,O,3458.0,The current study demonstrated that products for celiac children with a high percentage of rice contained high concentrations of arsenic ( 256 and 128 μg kg⁻¹ ) .
99834,kg⁻¹,O,3458.0,The current study demonstrated that products for celiac children with a high percentage of rice contained high concentrations of arsenic ( 256 and 128 μg kg⁻¹ ) .
99835,),O,3458.0,The current study demonstrated that products for celiac children with a high percentage of rice contained high concentrations of arsenic ( 256 and 128 μg kg⁻¹ ) .
99836,.,O,3458.0,The current study demonstrated that products for celiac children with a high percentage of rice contained high concentrations of arsenic ( 256 and 128 μg kg⁻¹ ) .
99837,The,O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99838,daily,O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99839,intake,O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99840,of,O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99841,i,O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99842,-,O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99843,As,O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99844,ranged,O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99845,from,O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99846,0.61,O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99847,to,O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99848,0.78,O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99849,μg,O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99850,kg⁻¹,O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99851,body,O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99852,weight,O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99853,(,O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99854,bw,O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99855,),O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99856,in,O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99857,children,O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99858,up,O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99859,to,O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99860,5,O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99861,y,O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99862,of,O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99863,age,O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99864,;,O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99865,these,O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99866,values,O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99867,were,O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99868,below,O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99869,the,O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99870,maximum,O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99871,value,O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99872,established,O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99873,by,O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99874,the,O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99875,EFSA,O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99876,Panel,O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99877,(,O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99878,8.0,O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99879,μg,O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99880,kg⁻¹,O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99881,bw,O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99882,per,O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99883,day,O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99884,),O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99885,",",O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99886,but,O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99887,it,O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99888,should,O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99889,be,O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99890,considered,O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99891,typical,O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99892,of,O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99893,populations,O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99894,with,O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99895,a,O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99896,high,O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99897,exposure,O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99898,to,O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99899,this,O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99900,pollutant,O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99901,.,O,3459.0,"The daily intake of i - As ranged from 0.61 to 0.78 μg kg⁻¹ body weight ( bw ) in children up to 5 y of age ; these values were below the maximum value established by the EFSA Panel ( 8.0 μg kg⁻¹ bw per day ) , but it should be considered typical of populations with a high exposure to this pollutant ."
99902,Finally,O,3460.0,"Finally , legislation is needed to improve the labeling of these special rice - based foods for celiac children ; label should include information about percentage , geographical origin , and cultivar of the used rice ."
99903,",",O,3460.0,"Finally , legislation is needed to improve the labeling of these special rice - based foods for celiac children ; label should include information about percentage , geographical origin , and cultivar of the used rice ."
99904,legislation,O,3460.0,"Finally , legislation is needed to improve the labeling of these special rice - based foods for celiac children ; label should include information about percentage , geographical origin , and cultivar of the used rice ."
99905,is,O,3460.0,"Finally , legislation is needed to improve the labeling of these special rice - based foods for celiac children ; label should include information about percentage , geographical origin , and cultivar of the used rice ."
99906,needed,O,3460.0,"Finally , legislation is needed to improve the labeling of these special rice - based foods for celiac children ; label should include information about percentage , geographical origin , and cultivar of the used rice ."
99907,to,O,3460.0,"Finally , legislation is needed to improve the labeling of these special rice - based foods for celiac children ; label should include information about percentage , geographical origin , and cultivar of the used rice ."
99908,improve,O,3460.0,"Finally , legislation is needed to improve the labeling of these special rice - based foods for celiac children ; label should include information about percentage , geographical origin , and cultivar of the used rice ."
99909,the,O,3460.0,"Finally , legislation is needed to improve the labeling of these special rice - based foods for celiac children ; label should include information about percentage , geographical origin , and cultivar of the used rice ."
99910,labeling,O,3460.0,"Finally , legislation is needed to improve the labeling of these special rice - based foods for celiac children ; label should include information about percentage , geographical origin , and cultivar of the used rice ."
99911,of,O,3460.0,"Finally , legislation is needed to improve the labeling of these special rice - based foods for celiac children ; label should include information about percentage , geographical origin , and cultivar of the used rice ."
99912,these,O,3460.0,"Finally , legislation is needed to improve the labeling of these special rice - based foods for celiac children ; label should include information about percentage , geographical origin , and cultivar of the used rice ."
99913,special,O,3460.0,"Finally , legislation is needed to improve the labeling of these special rice - based foods for celiac children ; label should include information about percentage , geographical origin , and cultivar of the used rice ."
99914,rice,B-AG.01,3460.0,"Finally , legislation is needed to improve the labeling of these special rice - based foods for celiac children ; label should include information about percentage , geographical origin , and cultivar of the used rice ."
99915,-,I-AG.01,3460.0,"Finally , legislation is needed to improve the labeling of these special rice - based foods for celiac children ; label should include information about percentage , geographical origin , and cultivar of the used rice ."
99916,based,I-AG.01,3460.0,"Finally , legislation is needed to improve the labeling of these special rice - based foods for celiac children ; label should include information about percentage , geographical origin , and cultivar of the used rice ."
99917,foods,I-AG.01,3460.0,"Finally , legislation is needed to improve the labeling of these special rice - based foods for celiac children ; label should include information about percentage , geographical origin , and cultivar of the used rice ."
99918,for,O,3460.0,"Finally , legislation is needed to improve the labeling of these special rice - based foods for celiac children ; label should include information about percentage , geographical origin , and cultivar of the used rice ."
99919,celiac,O,3460.0,"Finally , legislation is needed to improve the labeling of these special rice - based foods for celiac children ; label should include information about percentage , geographical origin , and cultivar of the used rice ."
99920,children,O,3460.0,"Finally , legislation is needed to improve the labeling of these special rice - based foods for celiac children ; label should include information about percentage , geographical origin , and cultivar of the used rice ."
99921,;,O,3460.0,"Finally , legislation is needed to improve the labeling of these special rice - based foods for celiac children ; label should include information about percentage , geographical origin , and cultivar of the used rice ."
99922,label,O,3460.0,"Finally , legislation is needed to improve the labeling of these special rice - based foods for celiac children ; label should include information about percentage , geographical origin , and cultivar of the used rice ."
99923,should,O,3460.0,"Finally , legislation is needed to improve the labeling of these special rice - based foods for celiac children ; label should include information about percentage , geographical origin , and cultivar of the used rice ."
99924,include,O,3460.0,"Finally , legislation is needed to improve the labeling of these special rice - based foods for celiac children ; label should include information about percentage , geographical origin , and cultivar of the used rice ."
99925,information,O,3460.0,"Finally , legislation is needed to improve the labeling of these special rice - based foods for celiac children ; label should include information about percentage , geographical origin , and cultivar of the used rice ."
99926,about,O,3460.0,"Finally , legislation is needed to improve the labeling of these special rice - based foods for celiac children ; label should include information about percentage , geographical origin , and cultivar of the used rice ."
99927,percentage,O,3460.0,"Finally , legislation is needed to improve the labeling of these special rice - based foods for celiac children ; label should include information about percentage , geographical origin , and cultivar of the used rice ."
99928,",",O,3460.0,"Finally , legislation is needed to improve the labeling of these special rice - based foods for celiac children ; label should include information about percentage , geographical origin , and cultivar of the used rice ."
99929,geographical,O,3460.0,"Finally , legislation is needed to improve the labeling of these special rice - based foods for celiac children ; label should include information about percentage , geographical origin , and cultivar of the used rice ."
99930,origin,O,3460.0,"Finally , legislation is needed to improve the labeling of these special rice - based foods for celiac children ; label should include information about percentage , geographical origin , and cultivar of the used rice ."
99931,",",O,3460.0,"Finally , legislation is needed to improve the labeling of these special rice - based foods for celiac children ; label should include information about percentage , geographical origin , and cultivar of the used rice ."
99932,and,O,3460.0,"Finally , legislation is needed to improve the labeling of these special rice - based foods for celiac children ; label should include information about percentage , geographical origin , and cultivar of the used rice ."
99933,cultivar,O,3460.0,"Finally , legislation is needed to improve the labeling of these special rice - based foods for celiac children ; label should include information about percentage , geographical origin , and cultivar of the used rice ."
99934,of,O,3460.0,"Finally , legislation is needed to improve the labeling of these special rice - based foods for celiac children ; label should include information about percentage , geographical origin , and cultivar of the used rice ."
99935,the,O,3460.0,"Finally , legislation is needed to improve the labeling of these special rice - based foods for celiac children ; label should include information about percentage , geographical origin , and cultivar of the used rice ."
99936,used,O,3460.0,"Finally , legislation is needed to improve the labeling of these special rice - based foods for celiac children ; label should include information about percentage , geographical origin , and cultivar of the used rice ."
99937,rice,B-AG.01.i,3460.0,"Finally , legislation is needed to improve the labeling of these special rice - based foods for celiac children ; label should include information about percentage , geographical origin , and cultivar of the used rice ."
99938,.,O,3460.0,"Finally , legislation is needed to improve the labeling of these special rice - based foods for celiac children ; label should include information about percentage , geographical origin , and cultivar of the used rice ."
99939,Consumption,O,3461.0,Consumption of olive oil within the Mediterranean diet has been long known to have many health benefits .
99940,of,O,3461.0,Consumption of olive oil within the Mediterranean diet has been long known to have many health benefits .
99941,olive,B-AG.01.f,3461.0,Consumption of olive oil within the Mediterranean diet has been long known to have many health benefits .
99942,oil,I-AG.01.f,3461.0,Consumption of olive oil within the Mediterranean diet has been long known to have many health benefits .
99943,within,O,3461.0,Consumption of olive oil within the Mediterranean diet has been long known to have many health benefits .
99944,the,O,3461.0,Consumption of olive oil within the Mediterranean diet has been long known to have many health benefits .
99945,Mediterranean,O,3461.0,Consumption of olive oil within the Mediterranean diet has been long known to have many health benefits .
99946,diet,O,3461.0,Consumption of olive oil within the Mediterranean diet has been long known to have many health benefits .
99947,has,O,3461.0,Consumption of olive oil within the Mediterranean diet has been long known to have many health benefits .
99948,been,O,3461.0,Consumption of olive oil within the Mediterranean diet has been long known to have many health benefits .
99949,long,O,3461.0,Consumption of olive oil within the Mediterranean diet has been long known to have many health benefits .
99950,known,O,3461.0,Consumption of olive oil within the Mediterranean diet has been long known to have many health benefits .
99951,to,O,3461.0,Consumption of olive oil within the Mediterranean diet has been long known to have many health benefits .
99952,have,O,3461.0,Consumption of olive oil within the Mediterranean diet has been long known to have many health benefits .
99953,many,O,3461.0,Consumption of olive oil within the Mediterranean diet has been long known to have many health benefits .
99954,health,O,3461.0,Consumption of olive oil within the Mediterranean diet has been long known to have many health benefits .
99955,benefits,O,3461.0,Consumption of olive oil within the Mediterranean diet has been long known to have many health benefits .
99956,.,O,3461.0,Consumption of olive oil within the Mediterranean diet has been long known to have many health benefits .
99957,However,O,3462.0,"However , only over the last decade has epidemiological research confirmed its protective role against developing several chronic diseases ."
99958,",",O,3462.0,"However , only over the last decade has epidemiological research confirmed its protective role against developing several chronic diseases ."
99959,only,O,3462.0,"However , only over the last decade has epidemiological research confirmed its protective role against developing several chronic diseases ."
99960,over,O,3462.0,"However , only over the last decade has epidemiological research confirmed its protective role against developing several chronic diseases ."
99961,the,O,3462.0,"However , only over the last decade has epidemiological research confirmed its protective role against developing several chronic diseases ."
99962,last,O,3462.0,"However , only over the last decade has epidemiological research confirmed its protective role against developing several chronic diseases ."
99963,decade,O,3462.0,"However , only over the last decade has epidemiological research confirmed its protective role against developing several chronic diseases ."
99964,has,O,3462.0,"However , only over the last decade has epidemiological research confirmed its protective role against developing several chronic diseases ."
99965,epidemiological,O,3462.0,"However , only over the last decade has epidemiological research confirmed its protective role against developing several chronic diseases ."
99966,research,O,3462.0,"However , only over the last decade has epidemiological research confirmed its protective role against developing several chronic diseases ."
99967,confirmed,O,3462.0,"However , only over the last decade has epidemiological research confirmed its protective role against developing several chronic diseases ."
99968,its,O,3462.0,"However , only over the last decade has epidemiological research confirmed its protective role against developing several chronic diseases ."
99969,protective,O,3462.0,"However , only over the last decade has epidemiological research confirmed its protective role against developing several chronic diseases ."
99970,role,O,3462.0,"However , only over the last decade has epidemiological research confirmed its protective role against developing several chronic diseases ."
99971,against,O,3462.0,"However , only over the last decade has epidemiological research confirmed its protective role against developing several chronic diseases ."
99972,developing,O,3462.0,"However , only over the last decade has epidemiological research confirmed its protective role against developing several chronic diseases ."
99973,several,O,3462.0,"However , only over the last decade has epidemiological research confirmed its protective role against developing several chronic diseases ."
99974,chronic,O,3462.0,"However , only over the last decade has epidemiological research confirmed its protective role against developing several chronic diseases ."
99975,diseases,O,3462.0,"However , only over the last decade has epidemiological research confirmed its protective role against developing several chronic diseases ."
99976,.,O,3462.0,"However , only over the last decade has epidemiological research confirmed its protective role against developing several chronic diseases ."
99977,The,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
99978,objective,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
99979,of,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
99980,this,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
99981,review,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
99982,was,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
99983,to,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
99984,give,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
99985,an,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
99986,overview,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
99987,of,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
99988,the,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
99989,state,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
99990,of,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
99991,art,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
99992,epidemiological,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
99993,evidence,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
99994,concerning,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
99995,the,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
99996,relationship,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
99997,between,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
99998,olive,B-AG.01.f,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
99999,oil,I-AG.01.f,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100000,and,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100001,key,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100002,public,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100003,health,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100004,outcomes,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100005,including,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100006,mortality,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100007,",",O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100008,CVD,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100009,",",O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100010,diabetes,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100011,",",O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100012,metabolic,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100013,syndrome,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100014,(,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100015,MetS,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100016,),O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100017,",",O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100018,obesity,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100019,and,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100020,cancer,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100021,",",O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100022,with,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100023,a,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100024,particular,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100025,focus,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100026,on,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100027,recent,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100028,results,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100029,from,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100030,cohort,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100031,studies,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100032,and,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100033,dietary,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100034,intervention,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100035,trials,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100036,.,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100037,Recent,O,3464.0,Recent epidemiological research has shown that regular consumption of olive oil is associated with increased longevity .
100038,epidemiological,O,3464.0,Recent epidemiological research has shown that regular consumption of olive oil is associated with increased longevity .
100039,research,O,3464.0,Recent epidemiological research has shown that regular consumption of olive oil is associated with increased longevity .
100040,has,O,3464.0,Recent epidemiological research has shown that regular consumption of olive oil is associated with increased longevity .
100041,shown,O,3464.0,Recent epidemiological research has shown that regular consumption of olive oil is associated with increased longevity .
100042,that,O,3464.0,Recent epidemiological research has shown that regular consumption of olive oil is associated with increased longevity .
100043,regular,O,3464.0,Recent epidemiological research has shown that regular consumption of olive oil is associated with increased longevity .
100044,consumption,O,3464.0,Recent epidemiological research has shown that regular consumption of olive oil is associated with increased longevity .
100045,of,O,3464.0,Recent epidemiological research has shown that regular consumption of olive oil is associated with increased longevity .
100046,olive,B-AG.01.f,3464.0,Recent epidemiological research has shown that regular consumption of olive oil is associated with increased longevity .
100047,oil,I-AG.01.f,3464.0,Recent epidemiological research has shown that regular consumption of olive oil is associated with increased longevity .
100048,is,O,3464.0,Recent epidemiological research has shown that regular consumption of olive oil is associated with increased longevity .
100049,associated,O,3464.0,Recent epidemiological research has shown that regular consumption of olive oil is associated with increased longevity .
100050,with,O,3464.0,Recent epidemiological research has shown that regular consumption of olive oil is associated with increased longevity .
100051,increased,O,3464.0,Recent epidemiological research has shown that regular consumption of olive oil is associated with increased longevity .
100052,longevity,O,3464.0,Recent epidemiological research has shown that regular consumption of olive oil is associated with increased longevity .
100053,.,O,3464.0,Recent epidemiological research has shown that regular consumption of olive oil is associated with increased longevity .
100054,This,O,3465.0,This benefit is partly due to the olive oil 's unequivocal cardio - protective role .
100055,benefit,O,3465.0,This benefit is partly due to the olive oil 's unequivocal cardio - protective role .
100056,is,O,3465.0,This benefit is partly due to the olive oil 's unequivocal cardio - protective role .
100057,partly,O,3465.0,This benefit is partly due to the olive oil 's unequivocal cardio - protective role .
100058,due,O,3465.0,This benefit is partly due to the olive oil 's unequivocal cardio - protective role .
100059,to,O,3465.0,This benefit is partly due to the olive oil 's unequivocal cardio - protective role .
100060,the,O,3465.0,This benefit is partly due to the olive oil 's unequivocal cardio - protective role .
100061,olive,O,3465.0,This benefit is partly due to the olive oil 's unequivocal cardio - protective role .
100062,oil,O,3465.0,This benefit is partly due to the olive oil 's unequivocal cardio - protective role .
100063,'s,O,3465.0,This benefit is partly due to the olive oil 's unequivocal cardio - protective role .
100064,unequivocal,O,3465.0,This benefit is partly due to the olive oil 's unequivocal cardio - protective role .
100065,cardio,O,3465.0,This benefit is partly due to the olive oil 's unequivocal cardio - protective role .
100066,-,O,3465.0,This benefit is partly due to the olive oil 's unequivocal cardio - protective role .
100067,protective,O,3465.0,This benefit is partly due to the olive oil 's unequivocal cardio - protective role .
100068,role,O,3465.0,This benefit is partly due to the olive oil 's unequivocal cardio - protective role .
100069,.,O,3465.0,This benefit is partly due to the olive oil 's unequivocal cardio - protective role .
100070,There,O,3466.0,"There is converging evidence on the benefits of olive oil for preventing several CVD risk factors , including diabetes , MetS and obesity ."
100071,is,O,3466.0,"There is converging evidence on the benefits of olive oil for preventing several CVD risk factors , including diabetes , MetS and obesity ."
100072,converging,O,3466.0,"There is converging evidence on the benefits of olive oil for preventing several CVD risk factors , including diabetes , MetS and obesity ."
100073,evidence,O,3466.0,"There is converging evidence on the benefits of olive oil for preventing several CVD risk factors , including diabetes , MetS and obesity ."
100074,on,O,3466.0,"There is converging evidence on the benefits of olive oil for preventing several CVD risk factors , including diabetes , MetS and obesity ."
100075,the,O,3466.0,"There is converging evidence on the benefits of olive oil for preventing several CVD risk factors , including diabetes , MetS and obesity ."
100076,benefits,O,3466.0,"There is converging evidence on the benefits of olive oil for preventing several CVD risk factors , including diabetes , MetS and obesity ."
100077,of,O,3466.0,"There is converging evidence on the benefits of olive oil for preventing several CVD risk factors , including diabetes , MetS and obesity ."
100078,olive,B-AG.01.f,3466.0,"There is converging evidence on the benefits of olive oil for preventing several CVD risk factors , including diabetes , MetS and obesity ."
100079,oil,I-AG.01.f,3466.0,"There is converging evidence on the benefits of olive oil for preventing several CVD risk factors , including diabetes , MetS and obesity ."
100080,for,O,3466.0,"There is converging evidence on the benefits of olive oil for preventing several CVD risk factors , including diabetes , MetS and obesity ."
100081,preventing,O,3466.0,"There is converging evidence on the benefits of olive oil for preventing several CVD risk factors , including diabetes , MetS and obesity ."
100082,several,O,3466.0,"There is converging evidence on the benefits of olive oil for preventing several CVD risk factors , including diabetes , MetS and obesity ."
100083,CVD,O,3466.0,"There is converging evidence on the benefits of olive oil for preventing several CVD risk factors , including diabetes , MetS and obesity ."
100084,risk,O,3466.0,"There is converging evidence on the benefits of olive oil for preventing several CVD risk factors , including diabetes , MetS and obesity ."
100085,factors,O,3466.0,"There is converging evidence on the benefits of olive oil for preventing several CVD risk factors , including diabetes , MetS and obesity ."
100086,",",O,3466.0,"There is converging evidence on the benefits of olive oil for preventing several CVD risk factors , including diabetes , MetS and obesity ."
100087,including,O,3466.0,"There is converging evidence on the benefits of olive oil for preventing several CVD risk factors , including diabetes , MetS and obesity ."
100088,diabetes,O,3466.0,"There is converging evidence on the benefits of olive oil for preventing several CVD risk factors , including diabetes , MetS and obesity ."
100089,",",O,3466.0,"There is converging evidence on the benefits of olive oil for preventing several CVD risk factors , including diabetes , MetS and obesity ."
100090,MetS,O,3466.0,"There is converging evidence on the benefits of olive oil for preventing several CVD risk factors , including diabetes , MetS and obesity ."
100091,and,O,3466.0,"There is converging evidence on the benefits of olive oil for preventing several CVD risk factors , including diabetes , MetS and obesity ."
100092,obesity,O,3466.0,"There is converging evidence on the benefits of olive oil for preventing several CVD risk factors , including diabetes , MetS and obesity ."
100093,.,O,3466.0,"There is converging evidence on the benefits of olive oil for preventing several CVD risk factors , including diabetes , MetS and obesity ."
100094,Olive,B-AG.01.f,3467.0,"Olive oil is also implicated in preventing certain cancers , with the most promising findings for breast and digestive tract cancers , although the data are still not entirely consistent and mainly from case - control studies ."
100095,oil,I-AG.01.f,3467.0,"Olive oil is also implicated in preventing certain cancers , with the most promising findings for breast and digestive tract cancers , although the data are still not entirely consistent and mainly from case - control studies ."
100096,is,O,3467.0,"Olive oil is also implicated in preventing certain cancers , with the most promising findings for breast and digestive tract cancers , although the data are still not entirely consistent and mainly from case - control studies ."
100097,also,O,3467.0,"Olive oil is also implicated in preventing certain cancers , with the most promising findings for breast and digestive tract cancers , although the data are still not entirely consistent and mainly from case - control studies ."
100098,implicated,O,3467.0,"Olive oil is also implicated in preventing certain cancers , with the most promising findings for breast and digestive tract cancers , although the data are still not entirely consistent and mainly from case - control studies ."
100099,in,O,3467.0,"Olive oil is also implicated in preventing certain cancers , with the most promising findings for breast and digestive tract cancers , although the data are still not entirely consistent and mainly from case - control studies ."
100100,preventing,O,3467.0,"Olive oil is also implicated in preventing certain cancers , with the most promising findings for breast and digestive tract cancers , although the data are still not entirely consistent and mainly from case - control studies ."
100101,certain,O,3467.0,"Olive oil is also implicated in preventing certain cancers , with the most promising findings for breast and digestive tract cancers , although the data are still not entirely consistent and mainly from case - control studies ."
100102,cancers,O,3467.0,"Olive oil is also implicated in preventing certain cancers , with the most promising findings for breast and digestive tract cancers , although the data are still not entirely consistent and mainly from case - control studies ."
100103,",",O,3467.0,"Olive oil is also implicated in preventing certain cancers , with the most promising findings for breast and digestive tract cancers , although the data are still not entirely consistent and mainly from case - control studies ."
100104,with,O,3467.0,"Olive oil is also implicated in preventing certain cancers , with the most promising findings for breast and digestive tract cancers , although the data are still not entirely consistent and mainly from case - control studies ."
100105,the,O,3467.0,"Olive oil is also implicated in preventing certain cancers , with the most promising findings for breast and digestive tract cancers , although the data are still not entirely consistent and mainly from case - control studies ."
100106,most,O,3467.0,"Olive oil is also implicated in preventing certain cancers , with the most promising findings for breast and digestive tract cancers , although the data are still not entirely consistent and mainly from case - control studies ."
100107,promising,O,3467.0,"Olive oil is also implicated in preventing certain cancers , with the most promising findings for breast and digestive tract cancers , although the data are still not entirely consistent and mainly from case - control studies ."
100108,findings,O,3467.0,"Olive oil is also implicated in preventing certain cancers , with the most promising findings for breast and digestive tract cancers , although the data are still not entirely consistent and mainly from case - control studies ."
100109,for,O,3467.0,"Olive oil is also implicated in preventing certain cancers , with the most promising findings for breast and digestive tract cancers , although the data are still not entirely consistent and mainly from case - control studies ."
100110,breast,O,3467.0,"Olive oil is also implicated in preventing certain cancers , with the most promising findings for breast and digestive tract cancers , although the data are still not entirely consistent and mainly from case - control studies ."
100111,and,O,3467.0,"Olive oil is also implicated in preventing certain cancers , with the most promising findings for breast and digestive tract cancers , although the data are still not entirely consistent and mainly from case - control studies ."
100112,digestive,O,3467.0,"Olive oil is also implicated in preventing certain cancers , with the most promising findings for breast and digestive tract cancers , although the data are still not entirely consistent and mainly from case - control studies ."
100113,tract,O,3467.0,"Olive oil is also implicated in preventing certain cancers , with the most promising findings for breast and digestive tract cancers , although the data are still not entirely consistent and mainly from case - control studies ."
100114,cancers,O,3467.0,"Olive oil is also implicated in preventing certain cancers , with the most promising findings for breast and digestive tract cancers , although the data are still not entirely consistent and mainly from case - control studies ."
100115,",",O,3467.0,"Olive oil is also implicated in preventing certain cancers , with the most promising findings for breast and digestive tract cancers , although the data are still not entirely consistent and mainly from case - control studies ."
100116,although,O,3467.0,"Olive oil is also implicated in preventing certain cancers , with the most promising findings for breast and digestive tract cancers , although the data are still not entirely consistent and mainly from case - control studies ."
100117,the,O,3467.0,"Olive oil is also implicated in preventing certain cancers , with the most promising findings for breast and digestive tract cancers , although the data are still not entirely consistent and mainly from case - control studies ."
100118,data,O,3467.0,"Olive oil is also implicated in preventing certain cancers , with the most promising findings for breast and digestive tract cancers , although the data are still not entirely consistent and mainly from case - control studies ."
100119,are,O,3467.0,"Olive oil is also implicated in preventing certain cancers , with the most promising findings for breast and digestive tract cancers , although the data are still not entirely consistent and mainly from case - control studies ."
100120,still,O,3467.0,"Olive oil is also implicated in preventing certain cancers , with the most promising findings for breast and digestive tract cancers , although the data are still not entirely consistent and mainly from case - control studies ."
100121,not,O,3467.0,"Olive oil is also implicated in preventing certain cancers , with the most promising findings for breast and digestive tract cancers , although the data are still not entirely consistent and mainly from case - control studies ."
100122,entirely,O,3467.0,"Olive oil is also implicated in preventing certain cancers , with the most promising findings for breast and digestive tract cancers , although the data are still not entirely consistent and mainly from case - control studies ."
100123,consistent,O,3467.0,"Olive oil is also implicated in preventing certain cancers , with the most promising findings for breast and digestive tract cancers , although the data are still not entirely consistent and mainly from case - control studies ."
100124,and,O,3467.0,"Olive oil is also implicated in preventing certain cancers , with the most promising findings for breast and digestive tract cancers , although the data are still not entirely consistent and mainly from case - control studies ."
100125,mainly,O,3467.0,"Olive oil is also implicated in preventing certain cancers , with the most promising findings for breast and digestive tract cancers , although the data are still not entirely consistent and mainly from case - control studies ."
100126,from,O,3467.0,"Olive oil is also implicated in preventing certain cancers , with the most promising findings for breast and digestive tract cancers , although the data are still not entirely consistent and mainly from case - control studies ."
100127,case,O,3467.0,"Olive oil is also implicated in preventing certain cancers , with the most promising findings for breast and digestive tract cancers , although the data are still not entirely consistent and mainly from case - control studies ."
100128,-,O,3467.0,"Olive oil is also implicated in preventing certain cancers , with the most promising findings for breast and digestive tract cancers , although the data are still not entirely consistent and mainly from case - control studies ."
100129,control,O,3467.0,"Olive oil is also implicated in preventing certain cancers , with the most promising findings for breast and digestive tract cancers , although the data are still not entirely consistent and mainly from case - control studies ."
100130,studies,O,3467.0,"Olive oil is also implicated in preventing certain cancers , with the most promising findings for breast and digestive tract cancers , although the data are still not entirely consistent and mainly from case - control studies ."
100131,.,O,3467.0,"Olive oil is also implicated in preventing certain cancers , with the most promising findings for breast and digestive tract cancers , although the data are still not entirely consistent and mainly from case - control studies ."
100132,These,O,3468.0,"These health benefits are supported by strong mechanistic evidence from experimental studies , demonstrating that specific components of olive oil have antihypertensive , antithrombotic , antioxidant , antiinflammatory and anticarcinogenic action ."
100133,health,O,3468.0,"These health benefits are supported by strong mechanistic evidence from experimental studies , demonstrating that specific components of olive oil have antihypertensive , antithrombotic , antioxidant , antiinflammatory and anticarcinogenic action ."
100134,benefits,O,3468.0,"These health benefits are supported by strong mechanistic evidence from experimental studies , demonstrating that specific components of olive oil have antihypertensive , antithrombotic , antioxidant , antiinflammatory and anticarcinogenic action ."
100135,are,O,3468.0,"These health benefits are supported by strong mechanistic evidence from experimental studies , demonstrating that specific components of olive oil have antihypertensive , antithrombotic , antioxidant , antiinflammatory and anticarcinogenic action ."
100136,supported,O,3468.0,"These health benefits are supported by strong mechanistic evidence from experimental studies , demonstrating that specific components of olive oil have antihypertensive , antithrombotic , antioxidant , antiinflammatory and anticarcinogenic action ."
100137,by,O,3468.0,"These health benefits are supported by strong mechanistic evidence from experimental studies , demonstrating that specific components of olive oil have antihypertensive , antithrombotic , antioxidant , antiinflammatory and anticarcinogenic action ."
100138,strong,O,3468.0,"These health benefits are supported by strong mechanistic evidence from experimental studies , demonstrating that specific components of olive oil have antihypertensive , antithrombotic , antioxidant , antiinflammatory and anticarcinogenic action ."
100139,mechanistic,O,3468.0,"These health benefits are supported by strong mechanistic evidence from experimental studies , demonstrating that specific components of olive oil have antihypertensive , antithrombotic , antioxidant , antiinflammatory and anticarcinogenic action ."
100140,evidence,O,3468.0,"These health benefits are supported by strong mechanistic evidence from experimental studies , demonstrating that specific components of olive oil have antihypertensive , antithrombotic , antioxidant , antiinflammatory and anticarcinogenic action ."
100141,from,O,3468.0,"These health benefits are supported by strong mechanistic evidence from experimental studies , demonstrating that specific components of olive oil have antihypertensive , antithrombotic , antioxidant , antiinflammatory and anticarcinogenic action ."
100142,experimental,O,3468.0,"These health benefits are supported by strong mechanistic evidence from experimental studies , demonstrating that specific components of olive oil have antihypertensive , antithrombotic , antioxidant , antiinflammatory and anticarcinogenic action ."
100143,studies,O,3468.0,"These health benefits are supported by strong mechanistic evidence from experimental studies , demonstrating that specific components of olive oil have antihypertensive , antithrombotic , antioxidant , antiinflammatory and anticarcinogenic action ."
100144,",",O,3468.0,"These health benefits are supported by strong mechanistic evidence from experimental studies , demonstrating that specific components of olive oil have antihypertensive , antithrombotic , antioxidant , antiinflammatory and anticarcinogenic action ."
100145,demonstrating,O,3468.0,"These health benefits are supported by strong mechanistic evidence from experimental studies , demonstrating that specific components of olive oil have antihypertensive , antithrombotic , antioxidant , antiinflammatory and anticarcinogenic action ."
100146,that,O,3468.0,"These health benefits are supported by strong mechanistic evidence from experimental studies , demonstrating that specific components of olive oil have antihypertensive , antithrombotic , antioxidant , antiinflammatory and anticarcinogenic action ."
100147,specific,O,3468.0,"These health benefits are supported by strong mechanistic evidence from experimental studies , demonstrating that specific components of olive oil have antihypertensive , antithrombotic , antioxidant , antiinflammatory and anticarcinogenic action ."
100148,components,O,3468.0,"These health benefits are supported by strong mechanistic evidence from experimental studies , demonstrating that specific components of olive oil have antihypertensive , antithrombotic , antioxidant , antiinflammatory and anticarcinogenic action ."
100149,of,O,3468.0,"These health benefits are supported by strong mechanistic evidence from experimental studies , demonstrating that specific components of olive oil have antihypertensive , antithrombotic , antioxidant , antiinflammatory and anticarcinogenic action ."
100150,olive,B-AG.01.f,3468.0,"These health benefits are supported by strong mechanistic evidence from experimental studies , demonstrating that specific components of olive oil have antihypertensive , antithrombotic , antioxidant , antiinflammatory and anticarcinogenic action ."
100151,oil,I-AG.01.f,3468.0,"These health benefits are supported by strong mechanistic evidence from experimental studies , demonstrating that specific components of olive oil have antihypertensive , antithrombotic , antioxidant , antiinflammatory and anticarcinogenic action ."
100152,have,O,3468.0,"These health benefits are supported by strong mechanistic evidence from experimental studies , demonstrating that specific components of olive oil have antihypertensive , antithrombotic , antioxidant , antiinflammatory and anticarcinogenic action ."
100153,antihypertensive,O,3468.0,"These health benefits are supported by strong mechanistic evidence from experimental studies , demonstrating that specific components of olive oil have antihypertensive , antithrombotic , antioxidant , antiinflammatory and anticarcinogenic action ."
100154,",",O,3468.0,"These health benefits are supported by strong mechanistic evidence from experimental studies , demonstrating that specific components of olive oil have antihypertensive , antithrombotic , antioxidant , antiinflammatory and anticarcinogenic action ."
100155,antithrombotic,O,3468.0,"These health benefits are supported by strong mechanistic evidence from experimental studies , demonstrating that specific components of olive oil have antihypertensive , antithrombotic , antioxidant , antiinflammatory and anticarcinogenic action ."
100156,",",O,3468.0,"These health benefits are supported by strong mechanistic evidence from experimental studies , demonstrating that specific components of olive oil have antihypertensive , antithrombotic , antioxidant , antiinflammatory and anticarcinogenic action ."
100157,antioxidant,O,3468.0,"These health benefits are supported by strong mechanistic evidence from experimental studies , demonstrating that specific components of olive oil have antihypertensive , antithrombotic , antioxidant , antiinflammatory and anticarcinogenic action ."
100158,",",O,3468.0,"These health benefits are supported by strong mechanistic evidence from experimental studies , demonstrating that specific components of olive oil have antihypertensive , antithrombotic , antioxidant , antiinflammatory and anticarcinogenic action ."
100159,antiinflammatory,O,3468.0,"These health benefits are supported by strong mechanistic evidence from experimental studies , demonstrating that specific components of olive oil have antihypertensive , antithrombotic , antioxidant , antiinflammatory and anticarcinogenic action ."
100160,and,O,3468.0,"These health benefits are supported by strong mechanistic evidence from experimental studies , demonstrating that specific components of olive oil have antihypertensive , antithrombotic , antioxidant , antiinflammatory and anticarcinogenic action ."
100161,anticarcinogenic,O,3468.0,"These health benefits are supported by strong mechanistic evidence from experimental studies , demonstrating that specific components of olive oil have antihypertensive , antithrombotic , antioxidant , antiinflammatory and anticarcinogenic action ."
100162,action,O,3468.0,"These health benefits are supported by strong mechanistic evidence from experimental studies , demonstrating that specific components of olive oil have antihypertensive , antithrombotic , antioxidant , antiinflammatory and anticarcinogenic action ."
100163,.,O,3468.0,"These health benefits are supported by strong mechanistic evidence from experimental studies , demonstrating that specific components of olive oil have antihypertensive , antithrombotic , antioxidant , antiinflammatory and anticarcinogenic action ."
100164,Despite,O,3469.0,"Despite the accumulating epidemiological research , there is still a lack of consistent results from high - quality studies for many health outcomes ( i.e. certain cancers and metabolism - related disorders ) ."
100165,the,O,3469.0,"Despite the accumulating epidemiological research , there is still a lack of consistent results from high - quality studies for many health outcomes ( i.e. certain cancers and metabolism - related disorders ) ."
100166,accumulating,O,3469.0,"Despite the accumulating epidemiological research , there is still a lack of consistent results from high - quality studies for many health outcomes ( i.e. certain cancers and metabolism - related disorders ) ."
100167,epidemiological,O,3469.0,"Despite the accumulating epidemiological research , there is still a lack of consistent results from high - quality studies for many health outcomes ( i.e. certain cancers and metabolism - related disorders ) ."
100168,research,O,3469.0,"Despite the accumulating epidemiological research , there is still a lack of consistent results from high - quality studies for many health outcomes ( i.e. certain cancers and metabolism - related disorders ) ."
100169,",",O,3469.0,"Despite the accumulating epidemiological research , there is still a lack of consistent results from high - quality studies for many health outcomes ( i.e. certain cancers and metabolism - related disorders ) ."
100170,there,O,3469.0,"Despite the accumulating epidemiological research , there is still a lack of consistent results from high - quality studies for many health outcomes ( i.e. certain cancers and metabolism - related disorders ) ."
100171,is,O,3469.0,"Despite the accumulating epidemiological research , there is still a lack of consistent results from high - quality studies for many health outcomes ( i.e. certain cancers and metabolism - related disorders ) ."
100172,still,O,3469.0,"Despite the accumulating epidemiological research , there is still a lack of consistent results from high - quality studies for many health outcomes ( i.e. certain cancers and metabolism - related disorders ) ."
100173,a,O,3469.0,"Despite the accumulating epidemiological research , there is still a lack of consistent results from high - quality studies for many health outcomes ( i.e. certain cancers and metabolism - related disorders ) ."
100174,lack,O,3469.0,"Despite the accumulating epidemiological research , there is still a lack of consistent results from high - quality studies for many health outcomes ( i.e. certain cancers and metabolism - related disorders ) ."
100175,of,O,3469.0,"Despite the accumulating epidemiological research , there is still a lack of consistent results from high - quality studies for many health outcomes ( i.e. certain cancers and metabolism - related disorders ) ."
100176,consistent,O,3469.0,"Despite the accumulating epidemiological research , there is still a lack of consistent results from high - quality studies for many health outcomes ( i.e. certain cancers and metabolism - related disorders ) ."
100177,results,O,3469.0,"Despite the accumulating epidemiological research , there is still a lack of consistent results from high - quality studies for many health outcomes ( i.e. certain cancers and metabolism - related disorders ) ."
100178,from,O,3469.0,"Despite the accumulating epidemiological research , there is still a lack of consistent results from high - quality studies for many health outcomes ( i.e. certain cancers and metabolism - related disorders ) ."
100179,high,O,3469.0,"Despite the accumulating epidemiological research , there is still a lack of consistent results from high - quality studies for many health outcomes ( i.e. certain cancers and metabolism - related disorders ) ."
100180,-,O,3469.0,"Despite the accumulating epidemiological research , there is still a lack of consistent results from high - quality studies for many health outcomes ( i.e. certain cancers and metabolism - related disorders ) ."
100181,quality,O,3469.0,"Despite the accumulating epidemiological research , there is still a lack of consistent results from high - quality studies for many health outcomes ( i.e. certain cancers and metabolism - related disorders ) ."
100182,studies,O,3469.0,"Despite the accumulating epidemiological research , there is still a lack of consistent results from high - quality studies for many health outcomes ( i.e. certain cancers and metabolism - related disorders ) ."
100183,for,O,3469.0,"Despite the accumulating epidemiological research , there is still a lack of consistent results from high - quality studies for many health outcomes ( i.e. certain cancers and metabolism - related disorders ) ."
100184,many,O,3469.0,"Despite the accumulating epidemiological research , there is still a lack of consistent results from high - quality studies for many health outcomes ( i.e. certain cancers and metabolism - related disorders ) ."
100185,health,O,3469.0,"Despite the accumulating epidemiological research , there is still a lack of consistent results from high - quality studies for many health outcomes ( i.e. certain cancers and metabolism - related disorders ) ."
100186,outcomes,O,3469.0,"Despite the accumulating epidemiological research , there is still a lack of consistent results from high - quality studies for many health outcomes ( i.e. certain cancers and metabolism - related disorders ) ."
100187,(,O,3469.0,"Despite the accumulating epidemiological research , there is still a lack of consistent results from high - quality studies for many health outcomes ( i.e. certain cancers and metabolism - related disorders ) ."
100188,i.e.,O,3469.0,"Despite the accumulating epidemiological research , there is still a lack of consistent results from high - quality studies for many health outcomes ( i.e. certain cancers and metabolism - related disorders ) ."
100189,certain,O,3469.0,"Despite the accumulating epidemiological research , there is still a lack of consistent results from high - quality studies for many health outcomes ( i.e. certain cancers and metabolism - related disorders ) ."
100190,cancers,O,3469.0,"Despite the accumulating epidemiological research , there is still a lack of consistent results from high - quality studies for many health outcomes ( i.e. certain cancers and metabolism - related disorders ) ."
100191,and,O,3469.0,"Despite the accumulating epidemiological research , there is still a lack of consistent results from high - quality studies for many health outcomes ( i.e. certain cancers and metabolism - related disorders ) ."
100192,metabolism,O,3469.0,"Despite the accumulating epidemiological research , there is still a lack of consistent results from high - quality studies for many health outcomes ( i.e. certain cancers and metabolism - related disorders ) ."
100193,-,O,3469.0,"Despite the accumulating epidemiological research , there is still a lack of consistent results from high - quality studies for many health outcomes ( i.e. certain cancers and metabolism - related disorders ) ."
100194,related,O,3469.0,"Despite the accumulating epidemiological research , there is still a lack of consistent results from high - quality studies for many health outcomes ( i.e. certain cancers and metabolism - related disorders ) ."
100195,disorders,O,3469.0,"Despite the accumulating epidemiological research , there is still a lack of consistent results from high - quality studies for many health outcomes ( i.e. certain cancers and metabolism - related disorders ) ."
100196,),O,3469.0,"Despite the accumulating epidemiological research , there is still a lack of consistent results from high - quality studies for many health outcomes ( i.e. certain cancers and metabolism - related disorders ) ."
100197,.,O,3469.0,"Despite the accumulating epidemiological research , there is still a lack of consistent results from high - quality studies for many health outcomes ( i.e. certain cancers and metabolism - related disorders ) ."
100198,Further,O,3470.0,"Further research is mandatory , above all from prospective studies and randomised dietary intervention trials when feasible , to confirm some of the still potential health benefits ."
100199,research,O,3470.0,"Further research is mandatory , above all from prospective studies and randomised dietary intervention trials when feasible , to confirm some of the still potential health benefits ."
100200,is,O,3470.0,"Further research is mandatory , above all from prospective studies and randomised dietary intervention trials when feasible , to confirm some of the still potential health benefits ."
100201,mandatory,O,3470.0,"Further research is mandatory , above all from prospective studies and randomised dietary intervention trials when feasible , to confirm some of the still potential health benefits ."
100202,",",O,3470.0,"Further research is mandatory , above all from prospective studies and randomised dietary intervention trials when feasible , to confirm some of the still potential health benefits ."
100203,above,O,3470.0,"Further research is mandatory , above all from prospective studies and randomised dietary intervention trials when feasible , to confirm some of the still potential health benefits ."
100204,all,O,3470.0,"Further research is mandatory , above all from prospective studies and randomised dietary intervention trials when feasible , to confirm some of the still potential health benefits ."
100205,from,O,3470.0,"Further research is mandatory , above all from prospective studies and randomised dietary intervention trials when feasible , to confirm some of the still potential health benefits ."
100206,prospective,O,3470.0,"Further research is mandatory , above all from prospective studies and randomised dietary intervention trials when feasible , to confirm some of the still potential health benefits ."
100207,studies,O,3470.0,"Further research is mandatory , above all from prospective studies and randomised dietary intervention trials when feasible , to confirm some of the still potential health benefits ."
100208,and,O,3470.0,"Further research is mandatory , above all from prospective studies and randomised dietary intervention trials when feasible , to confirm some of the still potential health benefits ."
100209,randomised,O,3470.0,"Further research is mandatory , above all from prospective studies and randomised dietary intervention trials when feasible , to confirm some of the still potential health benefits ."
100210,dietary,O,3470.0,"Further research is mandatory , above all from prospective studies and randomised dietary intervention trials when feasible , to confirm some of the still potential health benefits ."
100211,intervention,O,3470.0,"Further research is mandatory , above all from prospective studies and randomised dietary intervention trials when feasible , to confirm some of the still potential health benefits ."
100212,trials,O,3470.0,"Further research is mandatory , above all from prospective studies and randomised dietary intervention trials when feasible , to confirm some of the still potential health benefits ."
100213,when,O,3470.0,"Further research is mandatory , above all from prospective studies and randomised dietary intervention trials when feasible , to confirm some of the still potential health benefits ."
100214,feasible,O,3470.0,"Further research is mandatory , above all from prospective studies and randomised dietary intervention trials when feasible , to confirm some of the still potential health benefits ."
100215,",",O,3470.0,"Further research is mandatory , above all from prospective studies and randomised dietary intervention trials when feasible , to confirm some of the still potential health benefits ."
100216,to,O,3470.0,"Further research is mandatory , above all from prospective studies and randomised dietary intervention trials when feasible , to confirm some of the still potential health benefits ."
100217,confirm,O,3470.0,"Further research is mandatory , above all from prospective studies and randomised dietary intervention trials when feasible , to confirm some of the still potential health benefits ."
100218,some,O,3470.0,"Further research is mandatory , above all from prospective studies and randomised dietary intervention trials when feasible , to confirm some of the still potential health benefits ."
100219,of,O,3470.0,"Further research is mandatory , above all from prospective studies and randomised dietary intervention trials when feasible , to confirm some of the still potential health benefits ."
100220,the,O,3470.0,"Further research is mandatory , above all from prospective studies and randomised dietary intervention trials when feasible , to confirm some of the still potential health benefits ."
100221,still,O,3470.0,"Further research is mandatory , above all from prospective studies and randomised dietary intervention trials when feasible , to confirm some of the still potential health benefits ."
100222,potential,O,3470.0,"Further research is mandatory , above all from prospective studies and randomised dietary intervention trials when feasible , to confirm some of the still potential health benefits ."
100223,health,O,3470.0,"Further research is mandatory , above all from prospective studies and randomised dietary intervention trials when feasible , to confirm some of the still potential health benefits ."
100224,benefits,O,3470.0,"Further research is mandatory , above all from prospective studies and randomised dietary intervention trials when feasible , to confirm some of the still potential health benefits ."
100225,.,O,3470.0,"Further research is mandatory , above all from prospective studies and randomised dietary intervention trials when feasible , to confirm some of the still potential health benefits ."
100226,Colorectal,O,3471.0,Colorectal cancer is the second leading cause of cancer death in Australia .
100227,cancer,O,3471.0,Colorectal cancer is the second leading cause of cancer death in Australia .
100228,is,O,3471.0,Colorectal cancer is the second leading cause of cancer death in Australia .
100229,the,O,3471.0,Colorectal cancer is the second leading cause of cancer death in Australia .
100230,second,O,3471.0,Colorectal cancer is the second leading cause of cancer death in Australia .
100231,leading,O,3471.0,Colorectal cancer is the second leading cause of cancer death in Australia .
100232,cause,O,3471.0,Colorectal cancer is the second leading cause of cancer death in Australia .
100233,of,O,3471.0,Colorectal cancer is the second leading cause of cancer death in Australia .
100234,cancer,O,3471.0,Colorectal cancer is the second leading cause of cancer death in Australia .
100235,death,O,3471.0,Colorectal cancer is the second leading cause of cancer death in Australia .
100236,in,O,3471.0,Colorectal cancer is the second leading cause of cancer death in Australia .
100237,Australia,O,3471.0,Colorectal cancer is the second leading cause of cancer death in Australia .
100238,.,O,3471.0,Colorectal cancer is the second leading cause of cancer death in Australia .
100239,Nutrition,O,3472.0,"Nutrition , particularly intake of vegetables and certain plant components , has been reported to have a major role in cancer risk reduction ."
100240,",",O,3472.0,"Nutrition , particularly intake of vegetables and certain plant components , has been reported to have a major role in cancer risk reduction ."
100241,particularly,O,3472.0,"Nutrition , particularly intake of vegetables and certain plant components , has been reported to have a major role in cancer risk reduction ."
100242,intake,O,3472.0,"Nutrition , particularly intake of vegetables and certain plant components , has been reported to have a major role in cancer risk reduction ."
100243,of,O,3472.0,"Nutrition , particularly intake of vegetables and certain plant components , has been reported to have a major role in cancer risk reduction ."
100244,vegetables,B-AG.01.h.02,3472.0,"Nutrition , particularly intake of vegetables and certain plant components , has been reported to have a major role in cancer risk reduction ."
100245,and,O,3472.0,"Nutrition , particularly intake of vegetables and certain plant components , has been reported to have a major role in cancer risk reduction ."
100246,certain,O,3472.0,"Nutrition , particularly intake of vegetables and certain plant components , has been reported to have a major role in cancer risk reduction ."
100247,plant,O,3472.0,"Nutrition , particularly intake of vegetables and certain plant components , has been reported to have a major role in cancer risk reduction ."
100248,components,O,3472.0,"Nutrition , particularly intake of vegetables and certain plant components , has been reported to have a major role in cancer risk reduction ."
100249,",",O,3472.0,"Nutrition , particularly intake of vegetables and certain plant components , has been reported to have a major role in cancer risk reduction ."
100250,has,O,3472.0,"Nutrition , particularly intake of vegetables and certain plant components , has been reported to have a major role in cancer risk reduction ."
100251,been,O,3472.0,"Nutrition , particularly intake of vegetables and certain plant components , has been reported to have a major role in cancer risk reduction ."
100252,reported,O,3472.0,"Nutrition , particularly intake of vegetables and certain plant components , has been reported to have a major role in cancer risk reduction ."
100253,to,O,3472.0,"Nutrition , particularly intake of vegetables and certain plant components , has been reported to have a major role in cancer risk reduction ."
100254,have,O,3472.0,"Nutrition , particularly intake of vegetables and certain plant components , has been reported to have a major role in cancer risk reduction ."
100255,a,O,3472.0,"Nutrition , particularly intake of vegetables and certain plant components , has been reported to have a major role in cancer risk reduction ."
100256,major,O,3472.0,"Nutrition , particularly intake of vegetables and certain plant components , has been reported to have a major role in cancer risk reduction ."
100257,role,O,3472.0,"Nutrition , particularly intake of vegetables and certain plant components , has been reported to have a major role in cancer risk reduction ."
100258,in,O,3472.0,"Nutrition , particularly intake of vegetables and certain plant components , has been reported to have a major role in cancer risk reduction ."
100259,cancer,O,3472.0,"Nutrition , particularly intake of vegetables and certain plant components , has been reported to have a major role in cancer risk reduction ."
100260,risk,O,3472.0,"Nutrition , particularly intake of vegetables and certain plant components , has been reported to have a major role in cancer risk reduction ."
100261,reduction,O,3472.0,"Nutrition , particularly intake of vegetables and certain plant components , has been reported to have a major role in cancer risk reduction ."
100262,.,O,3472.0,"Nutrition , particularly intake of vegetables and certain plant components , has been reported to have a major role in cancer risk reduction ."
100263,Recently,O,3473.0,"Recently , there has been a growing research interest in rosemary , a common household plant grown in many parts of the world ."
100264,",",O,3473.0,"Recently , there has been a growing research interest in rosemary , a common household plant grown in many parts of the world ."
100265,there,O,3473.0,"Recently , there has been a growing research interest in rosemary , a common household plant grown in many parts of the world ."
100266,has,O,3473.0,"Recently , there has been a growing research interest in rosemary , a common household plant grown in many parts of the world ."
100267,been,O,3473.0,"Recently , there has been a growing research interest in rosemary , a common household plant grown in many parts of the world ."
100268,a,O,3473.0,"Recently , there has been a growing research interest in rosemary , a common household plant grown in many parts of the world ."
100269,growing,O,3473.0,"Recently , there has been a growing research interest in rosemary , a common household plant grown in many parts of the world ."
100270,research,O,3473.0,"Recently , there has been a growing research interest in rosemary , a common household plant grown in many parts of the world ."
100271,interest,O,3473.0,"Recently , there has been a growing research interest in rosemary , a common household plant grown in many parts of the world ."
100272,in,O,3473.0,"Recently , there has been a growing research interest in rosemary , a common household plant grown in many parts of the world ."
100273,rosemary,B-AG.01.h.02.i,3473.0,"Recently , there has been a growing research interest in rosemary , a common household plant grown in many parts of the world ."
100274,",",O,3473.0,"Recently , there has been a growing research interest in rosemary , a common household plant grown in many parts of the world ."
100275,a,O,3473.0,"Recently , there has been a growing research interest in rosemary , a common household plant grown in many parts of the world ."
100276,common,O,3473.0,"Recently , there has been a growing research interest in rosemary , a common household plant grown in many parts of the world ."
100277,household,O,3473.0,"Recently , there has been a growing research interest in rosemary , a common household plant grown in many parts of the world ."
100278,plant,O,3473.0,"Recently , there has been a growing research interest in rosemary , a common household plant grown in many parts of the world ."
100279,grown,O,3473.0,"Recently , there has been a growing research interest in rosemary , a common household plant grown in many parts of the world ."
100280,in,O,3473.0,"Recently , there has been a growing research interest in rosemary , a common household plant grown in many parts of the world ."
100281,many,O,3473.0,"Recently , there has been a growing research interest in rosemary , a common household plant grown in many parts of the world ."
100282,parts,O,3473.0,"Recently , there has been a growing research interest in rosemary , a common household plant grown in many parts of the world ."
100283,of,O,3473.0,"Recently , there has been a growing research interest in rosemary , a common household plant grown in many parts of the world ."
100284,the,O,3473.0,"Recently , there has been a growing research interest in rosemary , a common household plant grown in many parts of the world ."
100285,world,O,3473.0,"Recently , there has been a growing research interest in rosemary , a common household plant grown in many parts of the world ."
100286,.,O,3473.0,"Recently , there has been a growing research interest in rosemary , a common household plant grown in many parts of the world ."
100287,This,O,3474.0,"This study aims to review scientific evidence from all studies , published from 1996 to March 2010 that examined the protective effects of rosemary on colorectal cancer and other types of cancer ."
100288,study,O,3474.0,"This study aims to review scientific evidence from all studies , published from 1996 to March 2010 that examined the protective effects of rosemary on colorectal cancer and other types of cancer ."
100289,aims,O,3474.0,"This study aims to review scientific evidence from all studies , published from 1996 to March 2010 that examined the protective effects of rosemary on colorectal cancer and other types of cancer ."
100290,to,O,3474.0,"This study aims to review scientific evidence from all studies , published from 1996 to March 2010 that examined the protective effects of rosemary on colorectal cancer and other types of cancer ."
100291,review,O,3474.0,"This study aims to review scientific evidence from all studies , published from 1996 to March 2010 that examined the protective effects of rosemary on colorectal cancer and other types of cancer ."
100292,scientific,O,3474.0,"This study aims to review scientific evidence from all studies , published from 1996 to March 2010 that examined the protective effects of rosemary on colorectal cancer and other types of cancer ."
100293,evidence,O,3474.0,"This study aims to review scientific evidence from all studies , published from 1996 to March 2010 that examined the protective effects of rosemary on colorectal cancer and other types of cancer ."
100294,from,O,3474.0,"This study aims to review scientific evidence from all studies , published from 1996 to March 2010 that examined the protective effects of rosemary on colorectal cancer and other types of cancer ."
100295,all,O,3474.0,"This study aims to review scientific evidence from all studies , published from 1996 to March 2010 that examined the protective effects of rosemary on colorectal cancer and other types of cancer ."
100296,studies,O,3474.0,"This study aims to review scientific evidence from all studies , published from 1996 to March 2010 that examined the protective effects of rosemary on colorectal cancer and other types of cancer ."
100297,",",O,3474.0,"This study aims to review scientific evidence from all studies , published from 1996 to March 2010 that examined the protective effects of rosemary on colorectal cancer and other types of cancer ."
100298,published,O,3474.0,"This study aims to review scientific evidence from all studies , published from 1996 to March 2010 that examined the protective effects of rosemary on colorectal cancer and other types of cancer ."
100299,from,O,3474.0,"This study aims to review scientific evidence from all studies , published from 1996 to March 2010 that examined the protective effects of rosemary on colorectal cancer and other types of cancer ."
100300,1996,O,3474.0,"This study aims to review scientific evidence from all studies , published from 1996 to March 2010 that examined the protective effects of rosemary on colorectal cancer and other types of cancer ."
100301,to,O,3474.0,"This study aims to review scientific evidence from all studies , published from 1996 to March 2010 that examined the protective effects of rosemary on colorectal cancer and other types of cancer ."
100302,March,O,3474.0,"This study aims to review scientific evidence from all studies , published from 1996 to March 2010 that examined the protective effects of rosemary on colorectal cancer and other types of cancer ."
100303,2010,O,3474.0,"This study aims to review scientific evidence from all studies , published from 1996 to March 2010 that examined the protective effects of rosemary on colorectal cancer and other types of cancer ."
100304,that,O,3474.0,"This study aims to review scientific evidence from all studies , published from 1996 to March 2010 that examined the protective effects of rosemary on colorectal cancer and other types of cancer ."
100305,examined,O,3474.0,"This study aims to review scientific evidence from all studies , published from 1996 to March 2010 that examined the protective effects of rosemary on colorectal cancer and other types of cancer ."
100306,the,O,3474.0,"This study aims to review scientific evidence from all studies , published from 1996 to March 2010 that examined the protective effects of rosemary on colorectal cancer and other types of cancer ."
100307,protective,O,3474.0,"This study aims to review scientific evidence from all studies , published from 1996 to March 2010 that examined the protective effects of rosemary on colorectal cancer and other types of cancer ."
100308,effects,O,3474.0,"This study aims to review scientific evidence from all studies , published from 1996 to March 2010 that examined the protective effects of rosemary on colorectal cancer and other types of cancer ."
100309,of,O,3474.0,"This study aims to review scientific evidence from all studies , published from 1996 to March 2010 that examined the protective effects of rosemary on colorectal cancer and other types of cancer ."
100310,rosemary,B-AG.01.h.02.i,3474.0,"This study aims to review scientific evidence from all studies , published from 1996 to March 2010 that examined the protective effects of rosemary on colorectal cancer and other types of cancer ."
100311,on,O,3474.0,"This study aims to review scientific evidence from all studies , published from 1996 to March 2010 that examined the protective effects of rosemary on colorectal cancer and other types of cancer ."
100312,colorectal,O,3474.0,"This study aims to review scientific evidence from all studies , published from 1996 to March 2010 that examined the protective effects of rosemary on colorectal cancer and other types of cancer ."
100313,cancer,O,3474.0,"This study aims to review scientific evidence from all studies , published from 1996 to March 2010 that examined the protective effects of rosemary on colorectal cancer and other types of cancer ."
100314,and,O,3474.0,"This study aims to review scientific evidence from all studies , published from 1996 to March 2010 that examined the protective effects of rosemary on colorectal cancer and other types of cancer ."
100315,other,O,3474.0,"This study aims to review scientific evidence from all studies , published from 1996 to March 2010 that examined the protective effects of rosemary on colorectal cancer and other types of cancer ."
100316,types,O,3474.0,"This study aims to review scientific evidence from all studies , published from 1996 to March 2010 that examined the protective effects of rosemary on colorectal cancer and other types of cancer ."
100317,of,O,3474.0,"This study aims to review scientific evidence from all studies , published from 1996 to March 2010 that examined the protective effects of rosemary on colorectal cancer and other types of cancer ."
100318,cancer,O,3474.0,"This study aims to review scientific evidence from all studies , published from 1996 to March 2010 that examined the protective effects of rosemary on colorectal cancer and other types of cancer ."
100319,.,O,3474.0,"This study aims to review scientific evidence from all studies , published from 1996 to March 2010 that examined the protective effects of rosemary on colorectal cancer and other types of cancer ."
100320,Literature,O,3475.0,"Literature evidence from animal and cell culture studies demonstrates the anticancer potential of rosemary extract , carnosol , carnosic acid , ursolic acid , and rosmarinic acid ."
100321,evidence,O,3475.0,"Literature evidence from animal and cell culture studies demonstrates the anticancer potential of rosemary extract , carnosol , carnosic acid , ursolic acid , and rosmarinic acid ."
100322,from,O,3475.0,"Literature evidence from animal and cell culture studies demonstrates the anticancer potential of rosemary extract , carnosol , carnosic acid , ursolic acid , and rosmarinic acid ."
100323,animal,O,3475.0,"Literature evidence from animal and cell culture studies demonstrates the anticancer potential of rosemary extract , carnosol , carnosic acid , ursolic acid , and rosmarinic acid ."
100324,and,O,3475.0,"Literature evidence from animal and cell culture studies demonstrates the anticancer potential of rosemary extract , carnosol , carnosic acid , ursolic acid , and rosmarinic acid ."
100325,cell,O,3475.0,"Literature evidence from animal and cell culture studies demonstrates the anticancer potential of rosemary extract , carnosol , carnosic acid , ursolic acid , and rosmarinic acid ."
100326,culture,O,3475.0,"Literature evidence from animal and cell culture studies demonstrates the anticancer potential of rosemary extract , carnosol , carnosic acid , ursolic acid , and rosmarinic acid ."
100327,studies,O,3475.0,"Literature evidence from animal and cell culture studies demonstrates the anticancer potential of rosemary extract , carnosol , carnosic acid , ursolic acid , and rosmarinic acid ."
100328,demonstrates,O,3475.0,"Literature evidence from animal and cell culture studies demonstrates the anticancer potential of rosemary extract , carnosol , carnosic acid , ursolic acid , and rosmarinic acid ."
100329,the,O,3475.0,"Literature evidence from animal and cell culture studies demonstrates the anticancer potential of rosemary extract , carnosol , carnosic acid , ursolic acid , and rosmarinic acid ."
100330,anticancer,O,3475.0,"Literature evidence from animal and cell culture studies demonstrates the anticancer potential of rosemary extract , carnosol , carnosic acid , ursolic acid , and rosmarinic acid ."
100331,potential,O,3475.0,"Literature evidence from animal and cell culture studies demonstrates the anticancer potential of rosemary extract , carnosol , carnosic acid , ursolic acid , and rosmarinic acid ."
100332,of,O,3475.0,"Literature evidence from animal and cell culture studies demonstrates the anticancer potential of rosemary extract , carnosol , carnosic acid , ursolic acid , and rosmarinic acid ."
100333,rosemary,O,3475.0,"Literature evidence from animal and cell culture studies demonstrates the anticancer potential of rosemary extract , carnosol , carnosic acid , ursolic acid , and rosmarinic acid ."
100334,extract,O,3475.0,"Literature evidence from animal and cell culture studies demonstrates the anticancer potential of rosemary extract , carnosol , carnosic acid , ursolic acid , and rosmarinic acid ."
100335,",",O,3475.0,"Literature evidence from animal and cell culture studies demonstrates the anticancer potential of rosemary extract , carnosol , carnosic acid , ursolic acid , and rosmarinic acid ."
100336,carnosol,O,3475.0,"Literature evidence from animal and cell culture studies demonstrates the anticancer potential of rosemary extract , carnosol , carnosic acid , ursolic acid , and rosmarinic acid ."
100337,",",O,3475.0,"Literature evidence from animal and cell culture studies demonstrates the anticancer potential of rosemary extract , carnosol , carnosic acid , ursolic acid , and rosmarinic acid ."
100338,carnosic,O,3475.0,"Literature evidence from animal and cell culture studies demonstrates the anticancer potential of rosemary extract , carnosol , carnosic acid , ursolic acid , and rosmarinic acid ."
100339,acid,O,3475.0,"Literature evidence from animal and cell culture studies demonstrates the anticancer potential of rosemary extract , carnosol , carnosic acid , ursolic acid , and rosmarinic acid ."
100340,",",O,3475.0,"Literature evidence from animal and cell culture studies demonstrates the anticancer potential of rosemary extract , carnosol , carnosic acid , ursolic acid , and rosmarinic acid ."
100341,ursolic,O,3475.0,"Literature evidence from animal and cell culture studies demonstrates the anticancer potential of rosemary extract , carnosol , carnosic acid , ursolic acid , and rosmarinic acid ."
100342,acid,O,3475.0,"Literature evidence from animal and cell culture studies demonstrates the anticancer potential of rosemary extract , carnosol , carnosic acid , ursolic acid , and rosmarinic acid ."
100343,",",O,3475.0,"Literature evidence from animal and cell culture studies demonstrates the anticancer potential of rosemary extract , carnosol , carnosic acid , ursolic acid , and rosmarinic acid ."
100344,and,O,3475.0,"Literature evidence from animal and cell culture studies demonstrates the anticancer potential of rosemary extract , carnosol , carnosic acid , ursolic acid , and rosmarinic acid ."
100345,rosmarinic,O,3475.0,"Literature evidence from animal and cell culture studies demonstrates the anticancer potential of rosemary extract , carnosol , carnosic acid , ursolic acid , and rosmarinic acid ."
100346,acid,O,3475.0,"Literature evidence from animal and cell culture studies demonstrates the anticancer potential of rosemary extract , carnosol , carnosic acid , ursolic acid , and rosmarinic acid ."
100347,.,O,3475.0,"Literature evidence from animal and cell culture studies demonstrates the anticancer potential of rosemary extract , carnosol , carnosic acid , ursolic acid , and rosmarinic acid ."
100348,No,O,3476.0,No evidence for other rosemary constituents was found .
100349,evidence,O,3476.0,No evidence for other rosemary constituents was found .
100350,for,O,3476.0,No evidence for other rosemary constituents was found .
100351,other,O,3476.0,No evidence for other rosemary constituents was found .
100352,rosemary,B-AG.01.h.02.i,3476.0,No evidence for other rosemary constituents was found .
100353,constituents,O,3476.0,No evidence for other rosemary constituents was found .
100354,was,O,3476.0,No evidence for other rosemary constituents was found .
100355,found,O,3476.0,No evidence for other rosemary constituents was found .
100356,.,O,3476.0,No evidence for other rosemary constituents was found .
100357,The,O,3477.0,"The reported anticancer properties were found to arise through the molecular changes in the multiple - stage process of cancer development , which are dose related and not tissue or species specific ."
100358,reported,O,3477.0,"The reported anticancer properties were found to arise through the molecular changes in the multiple - stage process of cancer development , which are dose related and not tissue or species specific ."
100359,anticancer,O,3477.0,"The reported anticancer properties were found to arise through the molecular changes in the multiple - stage process of cancer development , which are dose related and not tissue or species specific ."
100360,properties,O,3477.0,"The reported anticancer properties were found to arise through the molecular changes in the multiple - stage process of cancer development , which are dose related and not tissue or species specific ."
100361,were,O,3477.0,"The reported anticancer properties were found to arise through the molecular changes in the multiple - stage process of cancer development , which are dose related and not tissue or species specific ."
100362,found,O,3477.0,"The reported anticancer properties were found to arise through the molecular changes in the multiple - stage process of cancer development , which are dose related and not tissue or species specific ."
100363,to,O,3477.0,"The reported anticancer properties were found to arise through the molecular changes in the multiple - stage process of cancer development , which are dose related and not tissue or species specific ."
100364,arise,O,3477.0,"The reported anticancer properties were found to arise through the molecular changes in the multiple - stage process of cancer development , which are dose related and not tissue or species specific ."
100365,through,O,3477.0,"The reported anticancer properties were found to arise through the molecular changes in the multiple - stage process of cancer development , which are dose related and not tissue or species specific ."
100366,the,O,3477.0,"The reported anticancer properties were found to arise through the molecular changes in the multiple - stage process of cancer development , which are dose related and not tissue or species specific ."
100367,molecular,O,3477.0,"The reported anticancer properties were found to arise through the molecular changes in the multiple - stage process of cancer development , which are dose related and not tissue or species specific ."
100368,changes,O,3477.0,"The reported anticancer properties were found to arise through the molecular changes in the multiple - stage process of cancer development , which are dose related and not tissue or species specific ."
100369,in,O,3477.0,"The reported anticancer properties were found to arise through the molecular changes in the multiple - stage process of cancer development , which are dose related and not tissue or species specific ."
100370,the,O,3477.0,"The reported anticancer properties were found to arise through the molecular changes in the multiple - stage process of cancer development , which are dose related and not tissue or species specific ."
100371,multiple,O,3477.0,"The reported anticancer properties were found to arise through the molecular changes in the multiple - stage process of cancer development , which are dose related and not tissue or species specific ."
100372,-,O,3477.0,"The reported anticancer properties were found to arise through the molecular changes in the multiple - stage process of cancer development , which are dose related and not tissue or species specific ."
100373,stage,O,3477.0,"The reported anticancer properties were found to arise through the molecular changes in the multiple - stage process of cancer development , which are dose related and not tissue or species specific ."
100374,process,O,3477.0,"The reported anticancer properties were found to arise through the molecular changes in the multiple - stage process of cancer development , which are dose related and not tissue or species specific ."
100375,of,O,3477.0,"The reported anticancer properties were found to arise through the molecular changes in the multiple - stage process of cancer development , which are dose related and not tissue or species specific ."
100376,cancer,O,3477.0,"The reported anticancer properties were found to arise through the molecular changes in the multiple - stage process of cancer development , which are dose related and not tissue or species specific ."
100377,development,O,3477.0,"The reported anticancer properties were found to arise through the molecular changes in the multiple - stage process of cancer development , which are dose related and not tissue or species specific ."
100378,",",O,3477.0,"The reported anticancer properties were found to arise through the molecular changes in the multiple - stage process of cancer development , which are dose related and not tissue or species specific ."
100379,which,O,3477.0,"The reported anticancer properties were found to arise through the molecular changes in the multiple - stage process of cancer development , which are dose related and not tissue or species specific ."
100380,are,O,3477.0,"The reported anticancer properties were found to arise through the molecular changes in the multiple - stage process of cancer development , which are dose related and not tissue or species specific ."
100381,dose,O,3477.0,"The reported anticancer properties were found to arise through the molecular changes in the multiple - stage process of cancer development , which are dose related and not tissue or species specific ."
100382,related,O,3477.0,"The reported anticancer properties were found to arise through the molecular changes in the multiple - stage process of cancer development , which are dose related and not tissue or species specific ."
100383,and,O,3477.0,"The reported anticancer properties were found to arise through the molecular changes in the multiple - stage process of cancer development , which are dose related and not tissue or species specific ."
100384,not,O,3477.0,"The reported anticancer properties were found to arise through the molecular changes in the multiple - stage process of cancer development , which are dose related and not tissue or species specific ."
100385,tissue,O,3477.0,"The reported anticancer properties were found to arise through the molecular changes in the multiple - stage process of cancer development , which are dose related and not tissue or species specific ."
100386,or,O,3477.0,"The reported anticancer properties were found to arise through the molecular changes in the multiple - stage process of cancer development , which are dose related and not tissue or species specific ."
100387,species,O,3477.0,"The reported anticancer properties were found to arise through the molecular changes in the multiple - stage process of cancer development , which are dose related and not tissue or species specific ."
100388,specific,O,3477.0,"The reported anticancer properties were found to arise through the molecular changes in the multiple - stage process of cancer development , which are dose related and not tissue or species specific ."
100389,.,O,3477.0,"The reported anticancer properties were found to arise through the molecular changes in the multiple - stage process of cancer development , which are dose related and not tissue or species specific ."
100390,This,O,3478.0,"This is evidenced by the ability of rosemary to suppress the development of tumors in several organs including the colon , breast , liver , stomach , as well as melanoma and leukemia cells ."
100391,is,O,3478.0,"This is evidenced by the ability of rosemary to suppress the development of tumors in several organs including the colon , breast , liver , stomach , as well as melanoma and leukemia cells ."
100392,evidenced,O,3478.0,"This is evidenced by the ability of rosemary to suppress the development of tumors in several organs including the colon , breast , liver , stomach , as well as melanoma and leukemia cells ."
100393,by,O,3478.0,"This is evidenced by the ability of rosemary to suppress the development of tumors in several organs including the colon , breast , liver , stomach , as well as melanoma and leukemia cells ."
100394,the,O,3478.0,"This is evidenced by the ability of rosemary to suppress the development of tumors in several organs including the colon , breast , liver , stomach , as well as melanoma and leukemia cells ."
100395,ability,O,3478.0,"This is evidenced by the ability of rosemary to suppress the development of tumors in several organs including the colon , breast , liver , stomach , as well as melanoma and leukemia cells ."
100396,of,O,3478.0,"This is evidenced by the ability of rosemary to suppress the development of tumors in several organs including the colon , breast , liver , stomach , as well as melanoma and leukemia cells ."
100397,rosemary,B-AG.01.h.02.i,3478.0,"This is evidenced by the ability of rosemary to suppress the development of tumors in several organs including the colon , breast , liver , stomach , as well as melanoma and leukemia cells ."
100398,to,O,3478.0,"This is evidenced by the ability of rosemary to suppress the development of tumors in several organs including the colon , breast , liver , stomach , as well as melanoma and leukemia cells ."
100399,suppress,O,3478.0,"This is evidenced by the ability of rosemary to suppress the development of tumors in several organs including the colon , breast , liver , stomach , as well as melanoma and leukemia cells ."
100400,the,O,3478.0,"This is evidenced by the ability of rosemary to suppress the development of tumors in several organs including the colon , breast , liver , stomach , as well as melanoma and leukemia cells ."
100401,development,O,3478.0,"This is evidenced by the ability of rosemary to suppress the development of tumors in several organs including the colon , breast , liver , stomach , as well as melanoma and leukemia cells ."
100402,of,O,3478.0,"This is evidenced by the ability of rosemary to suppress the development of tumors in several organs including the colon , breast , liver , stomach , as well as melanoma and leukemia cells ."
100403,tumors,O,3478.0,"This is evidenced by the ability of rosemary to suppress the development of tumors in several organs including the colon , breast , liver , stomach , as well as melanoma and leukemia cells ."
100404,in,O,3478.0,"This is evidenced by the ability of rosemary to suppress the development of tumors in several organs including the colon , breast , liver , stomach , as well as melanoma and leukemia cells ."
100405,several,O,3478.0,"This is evidenced by the ability of rosemary to suppress the development of tumors in several organs including the colon , breast , liver , stomach , as well as melanoma and leukemia cells ."
100406,organs,O,3478.0,"This is evidenced by the ability of rosemary to suppress the development of tumors in several organs including the colon , breast , liver , stomach , as well as melanoma and leukemia cells ."
100407,including,O,3478.0,"This is evidenced by the ability of rosemary to suppress the development of tumors in several organs including the colon , breast , liver , stomach , as well as melanoma and leukemia cells ."
100408,the,O,3478.0,"This is evidenced by the ability of rosemary to suppress the development of tumors in several organs including the colon , breast , liver , stomach , as well as melanoma and leukemia cells ."
100409,colon,O,3478.0,"This is evidenced by the ability of rosemary to suppress the development of tumors in several organs including the colon , breast , liver , stomach , as well as melanoma and leukemia cells ."
100410,",",O,3478.0,"This is evidenced by the ability of rosemary to suppress the development of tumors in several organs including the colon , breast , liver , stomach , as well as melanoma and leukemia cells ."
100411,breast,O,3478.0,"This is evidenced by the ability of rosemary to suppress the development of tumors in several organs including the colon , breast , liver , stomach , as well as melanoma and leukemia cells ."
100412,",",O,3478.0,"This is evidenced by the ability of rosemary to suppress the development of tumors in several organs including the colon , breast , liver , stomach , as well as melanoma and leukemia cells ."
100413,liver,O,3478.0,"This is evidenced by the ability of rosemary to suppress the development of tumors in several organs including the colon , breast , liver , stomach , as well as melanoma and leukemia cells ."
100414,",",O,3478.0,"This is evidenced by the ability of rosemary to suppress the development of tumors in several organs including the colon , breast , liver , stomach , as well as melanoma and leukemia cells ."
100415,stomach,O,3478.0,"This is evidenced by the ability of rosemary to suppress the development of tumors in several organs including the colon , breast , liver , stomach , as well as melanoma and leukemia cells ."
100416,",",O,3478.0,"This is evidenced by the ability of rosemary to suppress the development of tumors in several organs including the colon , breast , liver , stomach , as well as melanoma and leukemia cells ."
100417,as,O,3478.0,"This is evidenced by the ability of rosemary to suppress the development of tumors in several organs including the colon , breast , liver , stomach , as well as melanoma and leukemia cells ."
100418,well,O,3478.0,"This is evidenced by the ability of rosemary to suppress the development of tumors in several organs including the colon , breast , liver , stomach , as well as melanoma and leukemia cells ."
100419,as,O,3478.0,"This is evidenced by the ability of rosemary to suppress the development of tumors in several organs including the colon , breast , liver , stomach , as well as melanoma and leukemia cells ."
100420,melanoma,O,3478.0,"This is evidenced by the ability of rosemary to suppress the development of tumors in several organs including the colon , breast , liver , stomach , as well as melanoma and leukemia cells ."
100421,and,O,3478.0,"This is evidenced by the ability of rosemary to suppress the development of tumors in several organs including the colon , breast , liver , stomach , as well as melanoma and leukemia cells ."
100422,leukemia,O,3478.0,"This is evidenced by the ability of rosemary to suppress the development of tumors in several organs including the colon , breast , liver , stomach , as well as melanoma and leukemia cells ."
100423,cells,O,3478.0,"This is evidenced by the ability of rosemary to suppress the development of tumors in several organs including the colon , breast , liver , stomach , as well as melanoma and leukemia cells ."
100424,.,O,3478.0,"This is evidenced by the ability of rosemary to suppress the development of tumors in several organs including the colon , breast , liver , stomach , as well as melanoma and leukemia cells ."
100425,The,O,3479.0,The results suggested that the different molecular targets modulated by rosemary and its active constituents are useful indicators of success in clinical cancer chemo - prevention trials .
100426,results,O,3479.0,The results suggested that the different molecular targets modulated by rosemary and its active constituents are useful indicators of success in clinical cancer chemo - prevention trials .
100427,suggested,O,3479.0,The results suggested that the different molecular targets modulated by rosemary and its active constituents are useful indicators of success in clinical cancer chemo - prevention trials .
100428,that,O,3479.0,The results suggested that the different molecular targets modulated by rosemary and its active constituents are useful indicators of success in clinical cancer chemo - prevention trials .
100429,the,O,3479.0,The results suggested that the different molecular targets modulated by rosemary and its active constituents are useful indicators of success in clinical cancer chemo - prevention trials .
100430,different,O,3479.0,The results suggested that the different molecular targets modulated by rosemary and its active constituents are useful indicators of success in clinical cancer chemo - prevention trials .
100431,molecular,O,3479.0,The results suggested that the different molecular targets modulated by rosemary and its active constituents are useful indicators of success in clinical cancer chemo - prevention trials .
100432,targets,O,3479.0,The results suggested that the different molecular targets modulated by rosemary and its active constituents are useful indicators of success in clinical cancer chemo - prevention trials .
100433,modulated,O,3479.0,The results suggested that the different molecular targets modulated by rosemary and its active constituents are useful indicators of success in clinical cancer chemo - prevention trials .
100434,by,O,3479.0,The results suggested that the different molecular targets modulated by rosemary and its active constituents are useful indicators of success in clinical cancer chemo - prevention trials .
100435,rosemary,B-AG.01.h.02.i,3479.0,The results suggested that the different molecular targets modulated by rosemary and its active constituents are useful indicators of success in clinical cancer chemo - prevention trials .
100436,and,O,3479.0,The results suggested that the different molecular targets modulated by rosemary and its active constituents are useful indicators of success in clinical cancer chemo - prevention trials .
100437,its,O,3479.0,The results suggested that the different molecular targets modulated by rosemary and its active constituents are useful indicators of success in clinical cancer chemo - prevention trials .
100438,active,O,3479.0,The results suggested that the different molecular targets modulated by rosemary and its active constituents are useful indicators of success in clinical cancer chemo - prevention trials .
100439,constituents,O,3479.0,The results suggested that the different molecular targets modulated by rosemary and its active constituents are useful indicators of success in clinical cancer chemo - prevention trials .
100440,are,O,3479.0,The results suggested that the different molecular targets modulated by rosemary and its active constituents are useful indicators of success in clinical cancer chemo - prevention trials .
100441,useful,O,3479.0,The results suggested that the different molecular targets modulated by rosemary and its active constituents are useful indicators of success in clinical cancer chemo - prevention trials .
100442,indicators,O,3479.0,The results suggested that the different molecular targets modulated by rosemary and its active constituents are useful indicators of success in clinical cancer chemo - prevention trials .
100443,of,O,3479.0,The results suggested that the different molecular targets modulated by rosemary and its active constituents are useful indicators of success in clinical cancer chemo - prevention trials .
100444,success,O,3479.0,The results suggested that the different molecular targets modulated by rosemary and its active constituents are useful indicators of success in clinical cancer chemo - prevention trials .
100445,in,O,3479.0,The results suggested that the different molecular targets modulated by rosemary and its active constituents are useful indicators of success in clinical cancer chemo - prevention trials .
100446,clinical,O,3479.0,The results suggested that the different molecular targets modulated by rosemary and its active constituents are useful indicators of success in clinical cancer chemo - prevention trials .
100447,cancer,O,3479.0,The results suggested that the different molecular targets modulated by rosemary and its active constituents are useful indicators of success in clinical cancer chemo - prevention trials .
100448,chemo,O,3479.0,The results suggested that the different molecular targets modulated by rosemary and its active constituents are useful indicators of success in clinical cancer chemo - prevention trials .
100449,-,O,3479.0,The results suggested that the different molecular targets modulated by rosemary and its active constituents are useful indicators of success in clinical cancer chemo - prevention trials .
100450,prevention,O,3479.0,The results suggested that the different molecular targets modulated by rosemary and its active constituents are useful indicators of success in clinical cancer chemo - prevention trials .
100451,trials,O,3479.0,The results suggested that the different molecular targets modulated by rosemary and its active constituents are useful indicators of success in clinical cancer chemo - prevention trials .
100452,.,O,3479.0,The results suggested that the different molecular targets modulated by rosemary and its active constituents are useful indicators of success in clinical cancer chemo - prevention trials .
100453,Food,O,3480.0,Food allergy and allergen management are important global public health issues .
100454,allergy,O,3480.0,Food allergy and allergen management are important global public health issues .
100455,and,O,3480.0,Food allergy and allergen management are important global public health issues .
100456,allergen,O,3480.0,Food allergy and allergen management are important global public health issues .
100457,management,O,3480.0,Food allergy and allergen management are important global public health issues .
100458,are,O,3480.0,Food allergy and allergen management are important global public health issues .
100459,important,O,3480.0,Food allergy and allergen management are important global public health issues .
100460,global,O,3480.0,Food allergy and allergen management are important global public health issues .
100461,public,O,3480.0,Food allergy and allergen management are important global public health issues .
100462,health,O,3480.0,Food allergy and allergen management are important global public health issues .
100463,issues,O,3480.0,Food allergy and allergen management are important global public health issues .
100464,.,O,3480.0,Food allergy and allergen management are important global public health issues .
100465,In,O,3481.0,"In 2011 , the first iteration of our allergen threshold database ( ATDB ) was established based on individual NOAELs and LOAELs from oral food challenge in roughly 1750 allergic individuals ."
100466,2011,O,3481.0,"In 2011 , the first iteration of our allergen threshold database ( ATDB ) was established based on individual NOAELs and LOAELs from oral food challenge in roughly 1750 allergic individuals ."
100467,",",O,3481.0,"In 2011 , the first iteration of our allergen threshold database ( ATDB ) was established based on individual NOAELs and LOAELs from oral food challenge in roughly 1750 allergic individuals ."
100468,the,O,3481.0,"In 2011 , the first iteration of our allergen threshold database ( ATDB ) was established based on individual NOAELs and LOAELs from oral food challenge in roughly 1750 allergic individuals ."
100469,first,O,3481.0,"In 2011 , the first iteration of our allergen threshold database ( ATDB ) was established based on individual NOAELs and LOAELs from oral food challenge in roughly 1750 allergic individuals ."
100470,iteration,O,3481.0,"In 2011 , the first iteration of our allergen threshold database ( ATDB ) was established based on individual NOAELs and LOAELs from oral food challenge in roughly 1750 allergic individuals ."
100471,of,O,3481.0,"In 2011 , the first iteration of our allergen threshold database ( ATDB ) was established based on individual NOAELs and LOAELs from oral food challenge in roughly 1750 allergic individuals ."
100472,our,O,3481.0,"In 2011 , the first iteration of our allergen threshold database ( ATDB ) was established based on individual NOAELs and LOAELs from oral food challenge in roughly 1750 allergic individuals ."
100473,allergen,O,3481.0,"In 2011 , the first iteration of our allergen threshold database ( ATDB ) was established based on individual NOAELs and LOAELs from oral food challenge in roughly 1750 allergic individuals ."
100474,threshold,O,3481.0,"In 2011 , the first iteration of our allergen threshold database ( ATDB ) was established based on individual NOAELs and LOAELs from oral food challenge in roughly 1750 allergic individuals ."
100475,database,O,3481.0,"In 2011 , the first iteration of our allergen threshold database ( ATDB ) was established based on individual NOAELs and LOAELs from oral food challenge in roughly 1750 allergic individuals ."
100476,(,O,3481.0,"In 2011 , the first iteration of our allergen threshold database ( ATDB ) was established based on individual NOAELs and LOAELs from oral food challenge in roughly 1750 allergic individuals ."
100477,ATDB,O,3481.0,"In 2011 , the first iteration of our allergen threshold database ( ATDB ) was established based on individual NOAELs and LOAELs from oral food challenge in roughly 1750 allergic individuals ."
100478,),O,3481.0,"In 2011 , the first iteration of our allergen threshold database ( ATDB ) was established based on individual NOAELs and LOAELs from oral food challenge in roughly 1750 allergic individuals ."
100479,was,O,3481.0,"In 2011 , the first iteration of our allergen threshold database ( ATDB ) was established based on individual NOAELs and LOAELs from oral food challenge in roughly 1750 allergic individuals ."
100480,established,O,3481.0,"In 2011 , the first iteration of our allergen threshold database ( ATDB ) was established based on individual NOAELs and LOAELs from oral food challenge in roughly 1750 allergic individuals ."
100481,based,O,3481.0,"In 2011 , the first iteration of our allergen threshold database ( ATDB ) was established based on individual NOAELs and LOAELs from oral food challenge in roughly 1750 allergic individuals ."
100482,on,O,3481.0,"In 2011 , the first iteration of our allergen threshold database ( ATDB ) was established based on individual NOAELs and LOAELs from oral food challenge in roughly 1750 allergic individuals ."
100483,individual,O,3481.0,"In 2011 , the first iteration of our allergen threshold database ( ATDB ) was established based on individual NOAELs and LOAELs from oral food challenge in roughly 1750 allergic individuals ."
100484,NOAELs,O,3481.0,"In 2011 , the first iteration of our allergen threshold database ( ATDB ) was established based on individual NOAELs and LOAELs from oral food challenge in roughly 1750 allergic individuals ."
100485,and,O,3481.0,"In 2011 , the first iteration of our allergen threshold database ( ATDB ) was established based on individual NOAELs and LOAELs from oral food challenge in roughly 1750 allergic individuals ."
100486,LOAELs,O,3481.0,"In 2011 , the first iteration of our allergen threshold database ( ATDB ) was established based on individual NOAELs and LOAELs from oral food challenge in roughly 1750 allergic individuals ."
100487,from,O,3481.0,"In 2011 , the first iteration of our allergen threshold database ( ATDB ) was established based on individual NOAELs and LOAELs from oral food challenge in roughly 1750 allergic individuals ."
100488,oral,O,3481.0,"In 2011 , the first iteration of our allergen threshold database ( ATDB ) was established based on individual NOAELs and LOAELs from oral food challenge in roughly 1750 allergic individuals ."
100489,food,O,3481.0,"In 2011 , the first iteration of our allergen threshold database ( ATDB ) was established based on individual NOAELs and LOAELs from oral food challenge in roughly 1750 allergic individuals ."
100490,challenge,O,3481.0,"In 2011 , the first iteration of our allergen threshold database ( ATDB ) was established based on individual NOAELs and LOAELs from oral food challenge in roughly 1750 allergic individuals ."
100491,in,O,3481.0,"In 2011 , the first iteration of our allergen threshold database ( ATDB ) was established based on individual NOAELs and LOAELs from oral food challenge in roughly 1750 allergic individuals ."
100492,roughly,O,3481.0,"In 2011 , the first iteration of our allergen threshold database ( ATDB ) was established based on individual NOAELs and LOAELs from oral food challenge in roughly 1750 allergic individuals ."
100493,1750,O,3481.0,"In 2011 , the first iteration of our allergen threshold database ( ATDB ) was established based on individual NOAELs and LOAELs from oral food challenge in roughly 1750 allergic individuals ."
100494,allergic,O,3481.0,"In 2011 , the first iteration of our allergen threshold database ( ATDB ) was established based on individual NOAELs and LOAELs from oral food challenge in roughly 1750 allergic individuals ."
100495,individuals,O,3481.0,"In 2011 , the first iteration of our allergen threshold database ( ATDB ) was established based on individual NOAELs and LOAELs from oral food challenge in roughly 1750 allergic individuals ."
100496,.,O,3481.0,"In 2011 , the first iteration of our allergen threshold database ( ATDB ) was established based on individual NOAELs and LOAELs from oral food challenge in roughly 1750 allergic individuals ."
100497,Population,O,3482.0,Population minimal eliciting dose ( EDp ) distributions based on this dataset were published for 11 allergenic foods in 2014 .
100498,minimal,O,3482.0,Population minimal eliciting dose ( EDp ) distributions based on this dataset were published for 11 allergenic foods in 2014 .
100499,eliciting,O,3482.0,Population minimal eliciting dose ( EDp ) distributions based on this dataset were published for 11 allergenic foods in 2014 .
100500,dose,O,3482.0,Population minimal eliciting dose ( EDp ) distributions based on this dataset were published for 11 allergenic foods in 2014 .
100501,(,O,3482.0,Population minimal eliciting dose ( EDp ) distributions based on this dataset were published for 11 allergenic foods in 2014 .
100502,EDp,O,3482.0,Population minimal eliciting dose ( EDp ) distributions based on this dataset were published for 11 allergenic foods in 2014 .
100503,),O,3482.0,Population minimal eliciting dose ( EDp ) distributions based on this dataset were published for 11 allergenic foods in 2014 .
100504,distributions,O,3482.0,Population minimal eliciting dose ( EDp ) distributions based on this dataset were published for 11 allergenic foods in 2014 .
100505,based,O,3482.0,Population minimal eliciting dose ( EDp ) distributions based on this dataset were published for 11 allergenic foods in 2014 .
100506,on,O,3482.0,Population minimal eliciting dose ( EDp ) distributions based on this dataset were published for 11 allergenic foods in 2014 .
100507,this,O,3482.0,Population minimal eliciting dose ( EDp ) distributions based on this dataset were published for 11 allergenic foods in 2014 .
100508,dataset,O,3482.0,Population minimal eliciting dose ( EDp ) distributions based on this dataset were published for 11 allergenic foods in 2014 .
100509,were,O,3482.0,Population minimal eliciting dose ( EDp ) distributions based on this dataset were published for 11 allergenic foods in 2014 .
100510,published,O,3482.0,Population minimal eliciting dose ( EDp ) distributions based on this dataset were published for 11 allergenic foods in 2014 .
100511,for,O,3482.0,Population minimal eliciting dose ( EDp ) distributions based on this dataset were published for 11 allergenic foods in 2014 .
100512,11,O,3482.0,Population minimal eliciting dose ( EDp ) distributions based on this dataset were published for 11 allergenic foods in 2014 .
100513,allergenic,B-AG.01,3482.0,Population minimal eliciting dose ( EDp ) distributions based on this dataset were published for 11 allergenic foods in 2014 .
100514,foods,I-AG.01,3482.0,Population minimal eliciting dose ( EDp ) distributions based on this dataset were published for 11 allergenic foods in 2014 .
100515,in,O,3482.0,Population minimal eliciting dose ( EDp ) distributions based on this dataset were published for 11 allergenic foods in 2014 .
100516,2014,O,3482.0,Population minimal eliciting dose ( EDp ) distributions based on this dataset were published for 11 allergenic foods in 2014 .
100517,.,O,3482.0,Population minimal eliciting dose ( EDp ) distributions based on this dataset were published for 11 allergenic foods in 2014 .
100518,Systematic,O,3483.0,Systematic data collection has continued ( 2011 - 2018 ) and the dataset now contains over 3400 data points .
100519,data,O,3483.0,Systematic data collection has continued ( 2011 - 2018 ) and the dataset now contains over 3400 data points .
100520,collection,O,3483.0,Systematic data collection has continued ( 2011 - 2018 ) and the dataset now contains over 3400 data points .
100521,has,O,3483.0,Systematic data collection has continued ( 2011 - 2018 ) and the dataset now contains over 3400 data points .
100522,continued,O,3483.0,Systematic data collection has continued ( 2011 - 2018 ) and the dataset now contains over 3400 data points .
100523,(,O,3483.0,Systematic data collection has continued ( 2011 - 2018 ) and the dataset now contains over 3400 data points .
100524,2011,O,3483.0,Systematic data collection has continued ( 2011 - 2018 ) and the dataset now contains over 3400 data points .
100525,-,O,3483.0,Systematic data collection has continued ( 2011 - 2018 ) and the dataset now contains over 3400 data points .
100526,2018,O,3483.0,Systematic data collection has continued ( 2011 - 2018 ) and the dataset now contains over 3400 data points .
100527,),O,3483.0,Systematic data collection has continued ( 2011 - 2018 ) and the dataset now contains over 3400 data points .
100528,and,O,3483.0,Systematic data collection has continued ( 2011 - 2018 ) and the dataset now contains over 3400 data points .
100529,the,O,3483.0,Systematic data collection has continued ( 2011 - 2018 ) and the dataset now contains over 3400 data points .
100530,dataset,O,3483.0,Systematic data collection has continued ( 2011 - 2018 ) and the dataset now contains over 3400 data points .
100531,now,O,3483.0,Systematic data collection has continued ( 2011 - 2018 ) and the dataset now contains over 3400 data points .
100532,contains,O,3483.0,Systematic data collection has continued ( 2011 - 2018 ) and the dataset now contains over 3400 data points .
100533,over,O,3483.0,Systematic data collection has continued ( 2011 - 2018 ) and the dataset now contains over 3400 data points .
100534,3400,O,3483.0,Systematic data collection has continued ( 2011 - 2018 ) and the dataset now contains over 3400 data points .
100535,data,O,3483.0,Systematic data collection has continued ( 2011 - 2018 ) and the dataset now contains over 3400 data points .
100536,points,O,3483.0,Systematic data collection has continued ( 2011 - 2018 ) and the dataset now contains over 3400 data points .
100537,.,O,3483.0,Systematic data collection has continued ( 2011 - 2018 ) and the dataset now contains over 3400 data points .
100538,The,O,3484.0,The current study provides new and updated EDp values for 14 allergenic foods and incorporates a newly developed Stacked Model Averaging statistical method for interval - censored data .
100539,current,O,3484.0,The current study provides new and updated EDp values for 14 allergenic foods and incorporates a newly developed Stacked Model Averaging statistical method for interval - censored data .
100540,study,O,3484.0,The current study provides new and updated EDp values for 14 allergenic foods and incorporates a newly developed Stacked Model Averaging statistical method for interval - censored data .
100541,provides,O,3484.0,The current study provides new and updated EDp values for 14 allergenic foods and incorporates a newly developed Stacked Model Averaging statistical method for interval - censored data .
100542,new,O,3484.0,The current study provides new and updated EDp values for 14 allergenic foods and incorporates a newly developed Stacked Model Averaging statistical method for interval - censored data .
100543,and,O,3484.0,The current study provides new and updated EDp values for 14 allergenic foods and incorporates a newly developed Stacked Model Averaging statistical method for interval - censored data .
100544,updated,O,3484.0,The current study provides new and updated EDp values for 14 allergenic foods and incorporates a newly developed Stacked Model Averaging statistical method for interval - censored data .
100545,EDp,O,3484.0,The current study provides new and updated EDp values for 14 allergenic foods and incorporates a newly developed Stacked Model Averaging statistical method for interval - censored data .
100546,values,O,3484.0,The current study provides new and updated EDp values for 14 allergenic foods and incorporates a newly developed Stacked Model Averaging statistical method for interval - censored data .
100547,for,O,3484.0,The current study provides new and updated EDp values for 14 allergenic foods and incorporates a newly developed Stacked Model Averaging statistical method for interval - censored data .
100548,14,O,3484.0,The current study provides new and updated EDp values for 14 allergenic foods and incorporates a newly developed Stacked Model Averaging statistical method for interval - censored data .
100549,allergenic,B-AG.01,3484.0,The current study provides new and updated EDp values for 14 allergenic foods and incorporates a newly developed Stacked Model Averaging statistical method for interval - censored data .
100550,foods,I-AG.01,3484.0,The current study provides new and updated EDp values for 14 allergenic foods and incorporates a newly developed Stacked Model Averaging statistical method for interval - censored data .
100551,and,O,3484.0,The current study provides new and updated EDp values for 14 allergenic foods and incorporates a newly developed Stacked Model Averaging statistical method for interval - censored data .
100552,incorporates,O,3484.0,The current study provides new and updated EDp values for 14 allergenic foods and incorporates a newly developed Stacked Model Averaging statistical method for interval - censored data .
100553,a,O,3484.0,The current study provides new and updated EDp values for 14 allergenic foods and incorporates a newly developed Stacked Model Averaging statistical method for interval - censored data .
100554,newly,O,3484.0,The current study provides new and updated EDp values for 14 allergenic foods and incorporates a newly developed Stacked Model Averaging statistical method for interval - censored data .
100555,developed,O,3484.0,The current study provides new and updated EDp values for 14 allergenic foods and incorporates a newly developed Stacked Model Averaging statistical method for interval - censored data .
100556,Stacked,O,3484.0,The current study provides new and updated EDp values for 14 allergenic foods and incorporates a newly developed Stacked Model Averaging statistical method for interval - censored data .
100557,Model,O,3484.0,The current study provides new and updated EDp values for 14 allergenic foods and incorporates a newly developed Stacked Model Averaging statistical method for interval - censored data .
100558,Averaging,O,3484.0,The current study provides new and updated EDp values for 14 allergenic foods and incorporates a newly developed Stacked Model Averaging statistical method for interval - censored data .
100559,statistical,O,3484.0,The current study provides new and updated EDp values for 14 allergenic foods and incorporates a newly developed Stacked Model Averaging statistical method for interval - censored data .
100560,method,O,3484.0,The current study provides new and updated EDp values for 14 allergenic foods and incorporates a newly developed Stacked Model Averaging statistical method for interval - censored data .
100561,for,O,3484.0,The current study provides new and updated EDp values for 14 allergenic foods and incorporates a newly developed Stacked Model Averaging statistical method for interval - censored data .
100562,interval,O,3484.0,The current study provides new and updated EDp values for 14 allergenic foods and incorporates a newly developed Stacked Model Averaging statistical method for interval - censored data .
100563,-,O,3484.0,The current study provides new and updated EDp values for 14 allergenic foods and incorporates a newly developed Stacked Model Averaging statistical method for interval - censored data .
100564,censored,O,3484.0,The current study provides new and updated EDp values for 14 allergenic foods and incorporates a newly developed Stacked Model Averaging statistical method for interval - censored data .
100565,data,O,3484.0,The current study provides new and updated EDp values for 14 allergenic foods and incorporates a newly developed Stacked Model Averaging statistical method for interval - censored data .
100566,.,O,3484.0,The current study provides new and updated EDp values for 14 allergenic foods and incorporates a newly developed Stacked Model Averaging statistical method for interval - censored data .
100567,ED01,O,3485.0,"ED01 and ED05 values , the doses at which 1 % , and respectively 5 % , of the respective allergic population would be predicted to experience any objective allergic reaction were determined ."
100568,and,O,3485.0,"ED01 and ED05 values , the doses at which 1 % , and respectively 5 % , of the respective allergic population would be predicted to experience any objective allergic reaction were determined ."
100569,ED05,O,3485.0,"ED01 and ED05 values , the doses at which 1 % , and respectively 5 % , of the respective allergic population would be predicted to experience any objective allergic reaction were determined ."
100570,values,O,3485.0,"ED01 and ED05 values , the doses at which 1 % , and respectively 5 % , of the respective allergic population would be predicted to experience any objective allergic reaction were determined ."
100571,",",O,3485.0,"ED01 and ED05 values , the doses at which 1 % , and respectively 5 % , of the respective allergic population would be predicted to experience any objective allergic reaction were determined ."
100572,the,O,3485.0,"ED01 and ED05 values , the doses at which 1 % , and respectively 5 % , of the respective allergic population would be predicted to experience any objective allergic reaction were determined ."
100573,doses,O,3485.0,"ED01 and ED05 values , the doses at which 1 % , and respectively 5 % , of the respective allergic population would be predicted to experience any objective allergic reaction were determined ."
100574,at,O,3485.0,"ED01 and ED05 values , the doses at which 1 % , and respectively 5 % , of the respective allergic population would be predicted to experience any objective allergic reaction were determined ."
100575,which,O,3485.0,"ED01 and ED05 values , the doses at which 1 % , and respectively 5 % , of the respective allergic population would be predicted to experience any objective allergic reaction were determined ."
100576,1,O,3485.0,"ED01 and ED05 values , the doses at which 1 % , and respectively 5 % , of the respective allergic population would be predicted to experience any objective allergic reaction were determined ."
100577,%,O,3485.0,"ED01 and ED05 values , the doses at which 1 % , and respectively 5 % , of the respective allergic population would be predicted to experience any objective allergic reaction were determined ."
100578,",",O,3485.0,"ED01 and ED05 values , the doses at which 1 % , and respectively 5 % , of the respective allergic population would be predicted to experience any objective allergic reaction were determined ."
100579,and,O,3485.0,"ED01 and ED05 values , the doses at which 1 % , and respectively 5 % , of the respective allergic population would be predicted to experience any objective allergic reaction were determined ."
100580,respectively,O,3485.0,"ED01 and ED05 values , the doses at which 1 % , and respectively 5 % , of the respective allergic population would be predicted to experience any objective allergic reaction were determined ."
100581,5,O,3485.0,"ED01 and ED05 values , the doses at which 1 % , and respectively 5 % , of the respective allergic population would be predicted to experience any objective allergic reaction were determined ."
100582,%,O,3485.0,"ED01 and ED05 values , the doses at which 1 % , and respectively 5 % , of the respective allergic population would be predicted to experience any objective allergic reaction were determined ."
100583,",",O,3485.0,"ED01 and ED05 values , the doses at which 1 % , and respectively 5 % , of the respective allergic population would be predicted to experience any objective allergic reaction were determined ."
100584,of,O,3485.0,"ED01 and ED05 values , the doses at which 1 % , and respectively 5 % , of the respective allergic population would be predicted to experience any objective allergic reaction were determined ."
100585,the,O,3485.0,"ED01 and ED05 values , the doses at which 1 % , and respectively 5 % , of the respective allergic population would be predicted to experience any objective allergic reaction were determined ."
100586,respective,O,3485.0,"ED01 and ED05 values , the doses at which 1 % , and respectively 5 % , of the respective allergic population would be predicted to experience any objective allergic reaction were determined ."
100587,allergic,O,3485.0,"ED01 and ED05 values , the doses at which 1 % , and respectively 5 % , of the respective allergic population would be predicted to experience any objective allergic reaction were determined ."
100588,population,O,3485.0,"ED01 and ED05 values , the doses at which 1 % , and respectively 5 % , of the respective allergic population would be predicted to experience any objective allergic reaction were determined ."
100589,would,O,3485.0,"ED01 and ED05 values , the doses at which 1 % , and respectively 5 % , of the respective allergic population would be predicted to experience any objective allergic reaction were determined ."
100590,be,O,3485.0,"ED01 and ED05 values , the doses at which 1 % , and respectively 5 % , of the respective allergic population would be predicted to experience any objective allergic reaction were determined ."
100591,predicted,O,3485.0,"ED01 and ED05 values , the doses at which 1 % , and respectively 5 % , of the respective allergic population would be predicted to experience any objective allergic reaction were determined ."
100592,to,O,3485.0,"ED01 and ED05 values , the doses at which 1 % , and respectively 5 % , of the respective allergic population would be predicted to experience any objective allergic reaction were determined ."
100593,experience,O,3485.0,"ED01 and ED05 values , the doses at which 1 % , and respectively 5 % , of the respective allergic population would be predicted to experience any objective allergic reaction were determined ."
100594,any,O,3485.0,"ED01 and ED05 values , the doses at which 1 % , and respectively 5 % , of the respective allergic population would be predicted to experience any objective allergic reaction were determined ."
100595,objective,O,3485.0,"ED01 and ED05 values , the doses at which 1 % , and respectively 5 % , of the respective allergic population would be predicted to experience any objective allergic reaction were determined ."
100596,allergic,O,3485.0,"ED01 and ED05 values , the doses at which 1 % , and respectively 5 % , of the respective allergic population would be predicted to experience any objective allergic reaction were determined ."
100597,reaction,O,3485.0,"ED01 and ED05 values , the doses at which 1 % , and respectively 5 % , of the respective allergic population would be predicted to experience any objective allergic reaction were determined ."
100598,were,O,3485.0,"ED01 and ED05 values , the doses at which 1 % , and respectively 5 % , of the respective allergic population would be predicted to experience any objective allergic reaction were determined ."
100599,determined,O,3485.0,"ED01 and ED05 values , the doses at which 1 % , and respectively 5 % , of the respective allergic population would be predicted to experience any objective allergic reaction were determined ."
100600,.,O,3485.0,"ED01 and ED05 values , the doses at which 1 % , and respectively 5 % , of the respective allergic population would be predicted to experience any objective allergic reaction were determined ."
100601,The,O,3486.0,"The 14 allergenic foods were cashew , celery , egg , fish , hazelnut , lupine , milk , mustard , peanut , sesame , shrimp ( for crustacean shellfish ) , soy , walnut , and wheat ."
100602,14,O,3486.0,"The 14 allergenic foods were cashew , celery , egg , fish , hazelnut , lupine , milk , mustard , peanut , sesame , shrimp ( for crustacean shellfish ) , soy , walnut , and wheat ."
100603,allergenic,O,3486.0,"The 14 allergenic foods were cashew , celery , egg , fish , hazelnut , lupine , milk , mustard , peanut , sesame , shrimp ( for crustacean shellfish ) , soy , walnut , and wheat ."
100604,foods,O,3486.0,"The 14 allergenic foods were cashew , celery , egg , fish , hazelnut , lupine , milk , mustard , peanut , sesame , shrimp ( for crustacean shellfish ) , soy , walnut , and wheat ."
100605,were,O,3486.0,"The 14 allergenic foods were cashew , celery , egg , fish , hazelnut , lupine , milk , mustard , peanut , sesame , shrimp ( for crustacean shellfish ) , soy , walnut , and wheat ."
100606,cashew,B-AG.01.h.01.f,3486.0,"The 14 allergenic foods were cashew , celery , egg , fish , hazelnut , lupine , milk , mustard , peanut , sesame , shrimp ( for crustacean shellfish ) , soy , walnut , and wheat ."
100607,",",O,3486.0,"The 14 allergenic foods were cashew , celery , egg , fish , hazelnut , lupine , milk , mustard , peanut , sesame , shrimp ( for crustacean shellfish ) , soy , walnut , and wheat ."
100608,celery,B-AG.01.h.02.b,3486.0,"The 14 allergenic foods were cashew , celery , egg , fish , hazelnut , lupine , milk , mustard , peanut , sesame , shrimp ( for crustacean shellfish ) , soy , walnut , and wheat ."
100609,",",O,3486.0,"The 14 allergenic foods were cashew , celery , egg , fish , hazelnut , lupine , milk , mustard , peanut , sesame , shrimp ( for crustacean shellfish ) , soy , walnut , and wheat ."
100610,egg,B-AG.01.g,3486.0,"The 14 allergenic foods were cashew , celery , egg , fish , hazelnut , lupine , milk , mustard , peanut , sesame , shrimp ( for crustacean shellfish ) , soy , walnut , and wheat ."
100611,",",O,3486.0,"The 14 allergenic foods were cashew , celery , egg , fish , hazelnut , lupine , milk , mustard , peanut , sesame , shrimp ( for crustacean shellfish ) , soy , walnut , and wheat ."
100612,fish,B-AG.01.d.07,3486.0,"The 14 allergenic foods were cashew , celery , egg , fish , hazelnut , lupine , milk , mustard , peanut , sesame , shrimp ( for crustacean shellfish ) , soy , walnut , and wheat ."
100613,",",O,3486.0,"The 14 allergenic foods were cashew , celery , egg , fish , hazelnut , lupine , milk , mustard , peanut , sesame , shrimp ( for crustacean shellfish ) , soy , walnut , and wheat ."
100614,hazelnut,B-AG.01.h.01.f,3486.0,"The 14 allergenic foods were cashew , celery , egg , fish , hazelnut , lupine , milk , mustard , peanut , sesame , shrimp ( for crustacean shellfish ) , soy , walnut , and wheat ."
100615,",",O,3486.0,"The 14 allergenic foods were cashew , celery , egg , fish , hazelnut , lupine , milk , mustard , peanut , sesame , shrimp ( for crustacean shellfish ) , soy , walnut , and wheat ."
100616,lupine,B-AG.01.h.02.g,3486.0,"The 14 allergenic foods were cashew , celery , egg , fish , hazelnut , lupine , milk , mustard , peanut , sesame , shrimp ( for crustacean shellfish ) , soy , walnut , and wheat ."
100617,",",O,3486.0,"The 14 allergenic foods were cashew , celery , egg , fish , hazelnut , lupine , milk , mustard , peanut , sesame , shrimp ( for crustacean shellfish ) , soy , walnut , and wheat ."
100618,milk,B-AG.01.e,3486.0,"The 14 allergenic foods were cashew , celery , egg , fish , hazelnut , lupine , milk , mustard , peanut , sesame , shrimp ( for crustacean shellfish ) , soy , walnut , and wheat ."
100619,",",O,3486.0,"The 14 allergenic foods were cashew , celery , egg , fish , hazelnut , lupine , milk , mustard , peanut , sesame , shrimp ( for crustacean shellfish ) , soy , walnut , and wheat ."
100620,mustard,B-AG.01.l.03,3486.0,"The 14 allergenic foods were cashew , celery , egg , fish , hazelnut , lupine , milk , mustard , peanut , sesame , shrimp ( for crustacean shellfish ) , soy , walnut , and wheat ."
100621,",",O,3486.0,"The 14 allergenic foods were cashew , celery , egg , fish , hazelnut , lupine , milk , mustard , peanut , sesame , shrimp ( for crustacean shellfish ) , soy , walnut , and wheat ."
100622,peanut,B-AG.01.h.01.f,3486.0,"The 14 allergenic foods were cashew , celery , egg , fish , hazelnut , lupine , milk , mustard , peanut , sesame , shrimp ( for crustacean shellfish ) , soy , walnut , and wheat ."
100623,",",O,3486.0,"The 14 allergenic foods were cashew , celery , egg , fish , hazelnut , lupine , milk , mustard , peanut , sesame , shrimp ( for crustacean shellfish ) , soy , walnut , and wheat ."
100624,sesame,B-AG.01,3486.0,"The 14 allergenic foods were cashew , celery , egg , fish , hazelnut , lupine , milk , mustard , peanut , sesame , shrimp ( for crustacean shellfish ) , soy , walnut , and wheat ."
100625,",",O,3486.0,"The 14 allergenic foods were cashew , celery , egg , fish , hazelnut , lupine , milk , mustard , peanut , sesame , shrimp ( for crustacean shellfish ) , soy , walnut , and wheat ."
100626,shrimp,B-AG.01.d.07,3486.0,"The 14 allergenic foods were cashew , celery , egg , fish , hazelnut , lupine , milk , mustard , peanut , sesame , shrimp ( for crustacean shellfish ) , soy , walnut , and wheat ."
100627,(,O,3486.0,"The 14 allergenic foods were cashew , celery , egg , fish , hazelnut , lupine , milk , mustard , peanut , sesame , shrimp ( for crustacean shellfish ) , soy , walnut , and wheat ."
100628,for,O,3486.0,"The 14 allergenic foods were cashew , celery , egg , fish , hazelnut , lupine , milk , mustard , peanut , sesame , shrimp ( for crustacean shellfish ) , soy , walnut , and wheat ."
100629,crustacean,O,3486.0,"The 14 allergenic foods were cashew , celery , egg , fish , hazelnut , lupine , milk , mustard , peanut , sesame , shrimp ( for crustacean shellfish ) , soy , walnut , and wheat ."
100630,shellfish,O,3486.0,"The 14 allergenic foods were cashew , celery , egg , fish , hazelnut , lupine , milk , mustard , peanut , sesame , shrimp ( for crustacean shellfish ) , soy , walnut , and wheat ."
100631,),O,3486.0,"The 14 allergenic foods were cashew , celery , egg , fish , hazelnut , lupine , milk , mustard , peanut , sesame , shrimp ( for crustacean shellfish ) , soy , walnut , and wheat ."
100632,",",O,3486.0,"The 14 allergenic foods were cashew , celery , egg , fish , hazelnut , lupine , milk , mustard , peanut , sesame , shrimp ( for crustacean shellfish ) , soy , walnut , and wheat ."
100633,soy,B-AG.01.h.02.g,3486.0,"The 14 allergenic foods were cashew , celery , egg , fish , hazelnut , lupine , milk , mustard , peanut , sesame , shrimp ( for crustacean shellfish ) , soy , walnut , and wheat ."
100634,",",O,3486.0,"The 14 allergenic foods were cashew , celery , egg , fish , hazelnut , lupine , milk , mustard , peanut , sesame , shrimp ( for crustacean shellfish ) , soy , walnut , and wheat ."
100635,walnut,B-AG.01.h.01.f,3486.0,"The 14 allergenic foods were cashew , celery , egg , fish , hazelnut , lupine , milk , mustard , peanut , sesame , shrimp ( for crustacean shellfish ) , soy , walnut , and wheat ."
100636,",",O,3486.0,"The 14 allergenic foods were cashew , celery , egg , fish , hazelnut , lupine , milk , mustard , peanut , sesame , shrimp ( for crustacean shellfish ) , soy , walnut , and wheat ."
100637,and,O,3486.0,"The 14 allergenic foods were cashew , celery , egg , fish , hazelnut , lupine , milk , mustard , peanut , sesame , shrimp ( for crustacean shellfish ) , soy , walnut , and wheat ."
100638,wheat,B-AG.01.i,3486.0,"The 14 allergenic foods were cashew , celery , egg , fish , hazelnut , lupine , milk , mustard , peanut , sesame , shrimp ( for crustacean shellfish ) , soy , walnut , and wheat ."
100639,.,O,3486.0,"The 14 allergenic foods were cashew , celery , egg , fish , hazelnut , lupine , milk , mustard , peanut , sesame , shrimp ( for crustacean shellfish ) , soy , walnut , and wheat ."
100640,Updated,O,3487.0,Updated ED01 estimates ranged between 0.03   mg for walnut protein and 26.2   mg for shrimp protein .
100641,ED01,O,3487.0,Updated ED01 estimates ranged between 0.03   mg for walnut protein and 26.2   mg for shrimp protein .
100642,estimates,O,3487.0,Updated ED01 estimates ranged between 0.03   mg for walnut protein and 26.2   mg for shrimp protein .
100643,ranged,O,3487.0,Updated ED01 estimates ranged between 0.03   mg for walnut protein and 26.2   mg for shrimp protein .
100644,between,O,3487.0,Updated ED01 estimates ranged between 0.03   mg for walnut protein and 26.2   mg for shrimp protein .
100645,0.03,O,3487.0,Updated ED01 estimates ranged between 0.03   mg for walnut protein and 26.2   mg for shrimp protein .
100646, ,O,3487.0,Updated ED01 estimates ranged between 0.03   mg for walnut protein and 26.2   mg for shrimp protein .
100647,mg,O,3487.0,Updated ED01 estimates ranged between 0.03   mg for walnut protein and 26.2   mg for shrimp protein .
100648,for,O,3487.0,Updated ED01 estimates ranged between 0.03   mg for walnut protein and 26.2   mg for shrimp protein .
100649,walnut,O,3487.0,Updated ED01 estimates ranged between 0.03   mg for walnut protein and 26.2   mg for shrimp protein .
100650,protein,O,3487.0,Updated ED01 estimates ranged between 0.03   mg for walnut protein and 26.2   mg for shrimp protein .
100651,and,O,3487.0,Updated ED01 estimates ranged between 0.03   mg for walnut protein and 26.2   mg for shrimp protein .
100652,26.2,O,3487.0,Updated ED01 estimates ranged between 0.03   mg for walnut protein and 26.2   mg for shrimp protein .
100653, ,O,3487.0,Updated ED01 estimates ranged between 0.03   mg for walnut protein and 26.2   mg for shrimp protein .
100654,mg,O,3487.0,Updated ED01 estimates ranged between 0.03   mg for walnut protein and 26.2   mg for shrimp protein .
100655,for,O,3487.0,Updated ED01 estimates ranged between 0.03   mg for walnut protein and 26.2   mg for shrimp protein .
100656,shrimp,O,3487.0,Updated ED01 estimates ranged between 0.03   mg for walnut protein and 26.2   mg for shrimp protein .
100657,protein,O,3487.0,Updated ED01 estimates ranged between 0.03   mg for walnut protein and 26.2   mg for shrimp protein .
100658,.,O,3487.0,Updated ED01 estimates ranged between 0.03   mg for walnut protein and 26.2   mg for shrimp protein .
100659,ED05,O,3488.0,ED05 estimates ranged between 0.4   mg for mustard protein and 280   mg for shrimp protein .
100660,estimates,O,3488.0,ED05 estimates ranged between 0.4   mg for mustard protein and 280   mg for shrimp protein .
100661,ranged,O,3488.0,ED05 estimates ranged between 0.4   mg for mustard protein and 280   mg for shrimp protein .
100662,between,O,3488.0,ED05 estimates ranged between 0.4   mg for mustard protein and 280   mg for shrimp protein .
100663,0.4,O,3488.0,ED05 estimates ranged between 0.4   mg for mustard protein and 280   mg for shrimp protein .
100664, ,O,3488.0,ED05 estimates ranged between 0.4   mg for mustard protein and 280   mg for shrimp protein .
100665,mg,O,3488.0,ED05 estimates ranged between 0.4   mg for mustard protein and 280   mg for shrimp protein .
100666,for,O,3488.0,ED05 estimates ranged between 0.4   mg for mustard protein and 280   mg for shrimp protein .
100667,mustard,O,3488.0,ED05 estimates ranged between 0.4   mg for mustard protein and 280   mg for shrimp protein .
100668,protein,O,3488.0,ED05 estimates ranged between 0.4   mg for mustard protein and 280   mg for shrimp protein .
100669,and,O,3488.0,ED05 estimates ranged between 0.4   mg for mustard protein and 280   mg for shrimp protein .
100670,280,O,3488.0,ED05 estimates ranged between 0.4   mg for mustard protein and 280   mg for shrimp protein .
100671, ,O,3488.0,ED05 estimates ranged between 0.4   mg for mustard protein and 280   mg for shrimp protein .
100672,mg,O,3488.0,ED05 estimates ranged between 0.4   mg for mustard protein and 280   mg for shrimp protein .
100673,for,O,3488.0,ED05 estimates ranged between 0.4   mg for mustard protein and 280   mg for shrimp protein .
100674,shrimp,O,3488.0,ED05 estimates ranged between 0.4   mg for mustard protein and 280   mg for shrimp protein .
100675,protein,O,3488.0,ED05 estimates ranged between 0.4   mg for mustard protein and 280   mg for shrimp protein .
100676,.,O,3488.0,ED05 estimates ranged between 0.4   mg for mustard protein and 280   mg for shrimp protein .
100677,The,O,3489.0,The ED01 and ED05 values presented here are valuable in the risk assessment and subsequent risk management of allergenic foods .
100678,ED01,O,3489.0,The ED01 and ED05 values presented here are valuable in the risk assessment and subsequent risk management of allergenic foods .
100679,and,O,3489.0,The ED01 and ED05 values presented here are valuable in the risk assessment and subsequent risk management of allergenic foods .
100680,ED05,O,3489.0,The ED01 and ED05 values presented here are valuable in the risk assessment and subsequent risk management of allergenic foods .
100681,values,O,3489.0,The ED01 and ED05 values presented here are valuable in the risk assessment and subsequent risk management of allergenic foods .
100682,presented,O,3489.0,The ED01 and ED05 values presented here are valuable in the risk assessment and subsequent risk management of allergenic foods .
100683,here,O,3489.0,The ED01 and ED05 values presented here are valuable in the risk assessment and subsequent risk management of allergenic foods .
100684,are,O,3489.0,The ED01 and ED05 values presented here are valuable in the risk assessment and subsequent risk management of allergenic foods .
100685,valuable,O,3489.0,The ED01 and ED05 values presented here are valuable in the risk assessment and subsequent risk management of allergenic foods .
100686,in,O,3489.0,The ED01 and ED05 values presented here are valuable in the risk assessment and subsequent risk management of allergenic foods .
100687,the,O,3489.0,The ED01 and ED05 values presented here are valuable in the risk assessment and subsequent risk management of allergenic foods .
100688,risk,O,3489.0,The ED01 and ED05 values presented here are valuable in the risk assessment and subsequent risk management of allergenic foods .
100689,assessment,O,3489.0,The ED01 and ED05 values presented here are valuable in the risk assessment and subsequent risk management of allergenic foods .
100690,and,O,3489.0,The ED01 and ED05 values presented here are valuable in the risk assessment and subsequent risk management of allergenic foods .
100691,subsequent,O,3489.0,The ED01 and ED05 values presented here are valuable in the risk assessment and subsequent risk management of allergenic foods .
100692,risk,O,3489.0,The ED01 and ED05 values presented here are valuable in the risk assessment and subsequent risk management of allergenic foods .
100693,management,O,3489.0,The ED01 and ED05 values presented here are valuable in the risk assessment and subsequent risk management of allergenic foods .
100694,of,O,3489.0,The ED01 and ED05 values presented here are valuable in the risk assessment and subsequent risk management of allergenic foods .
100695,allergenic,B-AG.01,3489.0,The ED01 and ED05 values presented here are valuable in the risk assessment and subsequent risk management of allergenic foods .
100696,foods,I-AG.01,3489.0,The ED01 and ED05 values presented here are valuable in the risk assessment and subsequent risk management of allergenic foods .
100697,.,O,3489.0,The ED01 and ED05 values presented here are valuable in the risk assessment and subsequent risk management of allergenic foods .
100698,The,O,3490.0,The association between intake of different dairy products and the risk of stroke remains unclear .
100699,association,O,3490.0,The association between intake of different dairy products and the risk of stroke remains unclear .
100700,between,O,3490.0,The association between intake of different dairy products and the risk of stroke remains unclear .
100701,intake,O,3490.0,The association between intake of different dairy products and the risk of stroke remains unclear .
100702,of,O,3490.0,The association between intake of different dairy products and the risk of stroke remains unclear .
100703,different,O,3490.0,The association between intake of different dairy products and the risk of stroke remains unclear .
100704,dairy,B-AG.01.e,3490.0,The association between intake of different dairy products and the risk of stroke remains unclear .
100705,products,I-AG.01.e,3490.0,The association between intake of different dairy products and the risk of stroke remains unclear .
100706,and,O,3490.0,The association between intake of different dairy products and the risk of stroke remains unclear .
100707,the,O,3490.0,The association between intake of different dairy products and the risk of stroke remains unclear .
100708,risk,O,3490.0,The association between intake of different dairy products and the risk of stroke remains unclear .
100709,of,O,3490.0,The association between intake of different dairy products and the risk of stroke remains unclear .
100710,stroke,O,3490.0,The association between intake of different dairy products and the risk of stroke remains unclear .
100711,remains,O,3490.0,The association between intake of different dairy products and the risk of stroke remains unclear .
100712,unclear,O,3490.0,The association between intake of different dairy products and the risk of stroke remains unclear .
100713,.,O,3490.0,The association between intake of different dairy products and the risk of stroke remains unclear .
100714,We,O,3491.0,We therefore investigated substitutions between dairy product subgroups and risk of stroke .
100715,therefore,O,3491.0,We therefore investigated substitutions between dairy product subgroups and risk of stroke .
100716,investigated,O,3491.0,We therefore investigated substitutions between dairy product subgroups and risk of stroke .
100717,substitutions,O,3491.0,We therefore investigated substitutions between dairy product subgroups and risk of stroke .
100718,between,O,3491.0,We therefore investigated substitutions between dairy product subgroups and risk of stroke .
100719,dairy,O,3491.0,We therefore investigated substitutions between dairy product subgroups and risk of stroke .
100720,product,O,3491.0,We therefore investigated substitutions between dairy product subgroups and risk of stroke .
100721,subgroups,O,3491.0,We therefore investigated substitutions between dairy product subgroups and risk of stroke .
100722,and,O,3491.0,We therefore investigated substitutions between dairy product subgroups and risk of stroke .
100723,risk,O,3491.0,We therefore investigated substitutions between dairy product subgroups and risk of stroke .
100724,of,O,3491.0,We therefore investigated substitutions between dairy product subgroups and risk of stroke .
100725,stroke,O,3491.0,We therefore investigated substitutions between dairy product subgroups and risk of stroke .
100726,.,O,3491.0,We therefore investigated substitutions between dairy product subgroups and risk of stroke .
100727,We,O,3492.0,We included 36 886 Dutch men and women .
100728,included,O,3492.0,We included 36 886 Dutch men and women .
100729,36,O,3492.0,We included 36 886 Dutch men and women .
100730,886,O,3492.0,We included 36 886 Dutch men and women .
100731,Dutch,O,3492.0,We included 36 886 Dutch men and women .
100732,men,O,3492.0,We included 36 886 Dutch men and women .
100733,and,O,3492.0,We included 36 886 Dutch men and women .
100734,women,O,3492.0,We included 36 886 Dutch men and women .
100735,.,O,3492.0,We included 36 886 Dutch men and women .
100736,Information,O,3493.0,Information about dairy product intake was collected through a FFQ .
100737,about,O,3493.0,Information about dairy product intake was collected through a FFQ .
100738,dairy,B-AG.01.e,3493.0,Information about dairy product intake was collected through a FFQ .
100739,product,I-AG.01.e,3493.0,Information about dairy product intake was collected through a FFQ .
100740,intake,B-X,3493.0,Information about dairy product intake was collected through a FFQ .
100741,was,O,3493.0,Information about dairy product intake was collected through a FFQ .
100742,collected,O,3493.0,Information about dairy product intake was collected through a FFQ .
100743,through,O,3493.0,Information about dairy product intake was collected through a FFQ .
100744,a,O,3493.0,Information about dairy product intake was collected through a FFQ .
100745,FFQ,O,3493.0,Information about dairy product intake was collected through a FFQ .
100746,.,O,3493.0,Information about dairy product intake was collected through a FFQ .
100747,Dairy,B-AG.01.e,3494.0,"Dairy products were grouped as low - fat milk , whole - fat milk , buttermilk , low - fat yogurt , whole - fat yogurt , cheese and butter ."
100748,products,I-AG.01.e,3494.0,"Dairy products were grouped as low - fat milk , whole - fat milk , buttermilk , low - fat yogurt , whole - fat yogurt , cheese and butter ."
100749,were,O,3494.0,"Dairy products were grouped as low - fat milk , whole - fat milk , buttermilk , low - fat yogurt , whole - fat yogurt , cheese and butter ."
100750,grouped,O,3494.0,"Dairy products were grouped as low - fat milk , whole - fat milk , buttermilk , low - fat yogurt , whole - fat yogurt , cheese and butter ."
100751,as,O,3494.0,"Dairy products were grouped as low - fat milk , whole - fat milk , buttermilk , low - fat yogurt , whole - fat yogurt , cheese and butter ."
100752,low,B-AG.01.e,3494.0,"Dairy products were grouped as low - fat milk , whole - fat milk , buttermilk , low - fat yogurt , whole - fat yogurt , cheese and butter ."
100753,-,I-AG.01.e,3494.0,"Dairy products were grouped as low - fat milk , whole - fat milk , buttermilk , low - fat yogurt , whole - fat yogurt , cheese and butter ."
100754,fat,I-AG.01.e,3494.0,"Dairy products were grouped as low - fat milk , whole - fat milk , buttermilk , low - fat yogurt , whole - fat yogurt , cheese and butter ."
100755,milk,I-AG.01.e,3494.0,"Dairy products were grouped as low - fat milk , whole - fat milk , buttermilk , low - fat yogurt , whole - fat yogurt , cheese and butter ."
100756,",",O,3494.0,"Dairy products were grouped as low - fat milk , whole - fat milk , buttermilk , low - fat yogurt , whole - fat yogurt , cheese and butter ."
100757,whole,B-AG.01.e,3494.0,"Dairy products were grouped as low - fat milk , whole - fat milk , buttermilk , low - fat yogurt , whole - fat yogurt , cheese and butter ."
100758,-,I-AG.01.e,3494.0,"Dairy products were grouped as low - fat milk , whole - fat milk , buttermilk , low - fat yogurt , whole - fat yogurt , cheese and butter ."
100759,fat,I-AG.01.e,3494.0,"Dairy products were grouped as low - fat milk , whole - fat milk , buttermilk , low - fat yogurt , whole - fat yogurt , cheese and butter ."
100760,milk,I-AG.01.e,3494.0,"Dairy products were grouped as low - fat milk , whole - fat milk , buttermilk , low - fat yogurt , whole - fat yogurt , cheese and butter ."
100761,",",O,3494.0,"Dairy products were grouped as low - fat milk , whole - fat milk , buttermilk , low - fat yogurt , whole - fat yogurt , cheese and butter ."
100762,buttermilk,B-AG.01.e,3494.0,"Dairy products were grouped as low - fat milk , whole - fat milk , buttermilk , low - fat yogurt , whole - fat yogurt , cheese and butter ."
100763,",",O,3494.0,"Dairy products were grouped as low - fat milk , whole - fat milk , buttermilk , low - fat yogurt , whole - fat yogurt , cheese and butter ."
100764,low,B-AG.01.e,3494.0,"Dairy products were grouped as low - fat milk , whole - fat milk , buttermilk , low - fat yogurt , whole - fat yogurt , cheese and butter ."
100765,-,I-AG.01.e,3494.0,"Dairy products were grouped as low - fat milk , whole - fat milk , buttermilk , low - fat yogurt , whole - fat yogurt , cheese and butter ."
100766,fat,I-AG.01.e,3494.0,"Dairy products were grouped as low - fat milk , whole - fat milk , buttermilk , low - fat yogurt , whole - fat yogurt , cheese and butter ."
100767,yogurt,I-AG.01.e,3494.0,"Dairy products were grouped as low - fat milk , whole - fat milk , buttermilk , low - fat yogurt , whole - fat yogurt , cheese and butter ."
100768,",",O,3494.0,"Dairy products were grouped as low - fat milk , whole - fat milk , buttermilk , low - fat yogurt , whole - fat yogurt , cheese and butter ."
100769,whole,B-AG.01.e,3494.0,"Dairy products were grouped as low - fat milk , whole - fat milk , buttermilk , low - fat yogurt , whole - fat yogurt , cheese and butter ."
100770,-,I-AG.01.e,3494.0,"Dairy products were grouped as low - fat milk , whole - fat milk , buttermilk , low - fat yogurt , whole - fat yogurt , cheese and butter ."
100771,fat,I-AG.01.e,3494.0,"Dairy products were grouped as low - fat milk , whole - fat milk , buttermilk , low - fat yogurt , whole - fat yogurt , cheese and butter ."
100772,yogurt,I-AG.01.e,3494.0,"Dairy products were grouped as low - fat milk , whole - fat milk , buttermilk , low - fat yogurt , whole - fat yogurt , cheese and butter ."
100773,",",O,3494.0,"Dairy products were grouped as low - fat milk , whole - fat milk , buttermilk , low - fat yogurt , whole - fat yogurt , cheese and butter ."
100774,cheese,B-AG.01.e.02,3494.0,"Dairy products were grouped as low - fat milk , whole - fat milk , buttermilk , low - fat yogurt , whole - fat yogurt , cheese and butter ."
100775,and,O,3494.0,"Dairy products were grouped as low - fat milk , whole - fat milk , buttermilk , low - fat yogurt , whole - fat yogurt , cheese and butter ."
100776,butter,B-AG.01.e.01,3494.0,"Dairy products were grouped as low - fat milk , whole - fat milk , buttermilk , low - fat yogurt , whole - fat yogurt , cheese and butter ."
100777,.,O,3494.0,"Dairy products were grouped as low - fat milk , whole - fat milk , buttermilk , low - fat yogurt , whole - fat yogurt , cheese and butter ."
100778,Incident,O,3495.0,Incident stroke cases were identified in national registers .
100779,stroke,O,3495.0,Incident stroke cases were identified in national registers .
100780,cases,O,3495.0,Incident stroke cases were identified in national registers .
100781,were,O,3495.0,Incident stroke cases were identified in national registers .
100782,identified,O,3495.0,Incident stroke cases were identified in national registers .
100783,in,O,3495.0,Incident stroke cases were identified in national registers .
100784,national,O,3495.0,Incident stroke cases were identified in national registers .
100785,registers,O,3495.0,Incident stroke cases were identified in national registers .
100786,.,O,3495.0,Incident stroke cases were identified in national registers .
100787,We,O,3496.0,We used Cox proportional hazards regression to calculate associations for substitutions between dairy products with the rate of stroke .
100788,used,O,3496.0,We used Cox proportional hazards regression to calculate associations for substitutions between dairy products with the rate of stroke .
100789,Cox,O,3496.0,We used Cox proportional hazards regression to calculate associations for substitutions between dairy products with the rate of stroke .
100790,proportional,O,3496.0,We used Cox proportional hazards regression to calculate associations for substitutions between dairy products with the rate of stroke .
100791,hazards,O,3496.0,We used Cox proportional hazards regression to calculate associations for substitutions between dairy products with the rate of stroke .
100792,regression,O,3496.0,We used Cox proportional hazards regression to calculate associations for substitutions between dairy products with the rate of stroke .
100793,to,O,3496.0,We used Cox proportional hazards regression to calculate associations for substitutions between dairy products with the rate of stroke .
100794,calculate,O,3496.0,We used Cox proportional hazards regression to calculate associations for substitutions between dairy products with the rate of stroke .
100795,associations,O,3496.0,We used Cox proportional hazards regression to calculate associations for substitutions between dairy products with the rate of stroke .
100796,for,O,3496.0,We used Cox proportional hazards regression to calculate associations for substitutions between dairy products with the rate of stroke .
100797,substitutions,O,3496.0,We used Cox proportional hazards regression to calculate associations for substitutions between dairy products with the rate of stroke .
100798,between,O,3496.0,We used Cox proportional hazards regression to calculate associations for substitutions between dairy products with the rate of stroke .
100799,dairy,B-AG.01.e,3496.0,We used Cox proportional hazards regression to calculate associations for substitutions between dairy products with the rate of stroke .
100800,products,I-AG.01.e,3496.0,We used Cox proportional hazards regression to calculate associations for substitutions between dairy products with the rate of stroke .
100801,with,O,3496.0,We used Cox proportional hazards regression to calculate associations for substitutions between dairy products with the rate of stroke .
100802,the,O,3496.0,We used Cox proportional hazards regression to calculate associations for substitutions between dairy products with the rate of stroke .
100803,rate,O,3496.0,We used Cox proportional hazards regression to calculate associations for substitutions between dairy products with the rate of stroke .
100804,of,O,3496.0,We used Cox proportional hazards regression to calculate associations for substitutions between dairy products with the rate of stroke .
100805,stroke,O,3496.0,We used Cox proportional hazards regression to calculate associations for substitutions between dairy products with the rate of stroke .
100806,.,O,3496.0,We used Cox proportional hazards regression to calculate associations for substitutions between dairy products with the rate of stroke .
100807,During,O,3497.0,During a median follow - up of 15·2 years we identified 884 stroke cases ( 503 ischaemic and 244 haemorrhagic ) .
100808,a,O,3497.0,During a median follow - up of 15·2 years we identified 884 stroke cases ( 503 ischaemic and 244 haemorrhagic ) .
100809,median,O,3497.0,During a median follow - up of 15·2 years we identified 884 stroke cases ( 503 ischaemic and 244 haemorrhagic ) .
100810,follow,O,3497.0,During a median follow - up of 15·2 years we identified 884 stroke cases ( 503 ischaemic and 244 haemorrhagic ) .
100811,-,O,3497.0,During a median follow - up of 15·2 years we identified 884 stroke cases ( 503 ischaemic and 244 haemorrhagic ) .
100812,up,O,3497.0,During a median follow - up of 15·2 years we identified 884 stroke cases ( 503 ischaemic and 244 haemorrhagic ) .
100813,of,O,3497.0,During a median follow - up of 15·2 years we identified 884 stroke cases ( 503 ischaemic and 244 haemorrhagic ) .
100814,15·2,O,3497.0,During a median follow - up of 15·2 years we identified 884 stroke cases ( 503 ischaemic and 244 haemorrhagic ) .
100815,years,O,3497.0,During a median follow - up of 15·2 years we identified 884 stroke cases ( 503 ischaemic and 244 haemorrhagic ) .
100816,we,O,3497.0,During a median follow - up of 15·2 years we identified 884 stroke cases ( 503 ischaemic and 244 haemorrhagic ) .
100817,identified,O,3497.0,During a median follow - up of 15·2 years we identified 884 stroke cases ( 503 ischaemic and 244 haemorrhagic ) .
100818,884,O,3497.0,During a median follow - up of 15·2 years we identified 884 stroke cases ( 503 ischaemic and 244 haemorrhagic ) .
100819,stroke,O,3497.0,During a median follow - up of 15·2 years we identified 884 stroke cases ( 503 ischaemic and 244 haemorrhagic ) .
100820,cases,O,3497.0,During a median follow - up of 15·2 years we identified 884 stroke cases ( 503 ischaemic and 244 haemorrhagic ) .
100821,(,O,3497.0,During a median follow - up of 15·2 years we identified 884 stroke cases ( 503 ischaemic and 244 haemorrhagic ) .
100822,503,O,3497.0,During a median follow - up of 15·2 years we identified 884 stroke cases ( 503 ischaemic and 244 haemorrhagic ) .
100823,ischaemic,O,3497.0,During a median follow - up of 15·2 years we identified 884 stroke cases ( 503 ischaemic and 244 haemorrhagic ) .
100824,and,O,3497.0,During a median follow - up of 15·2 years we identified 884 stroke cases ( 503 ischaemic and 244 haemorrhagic ) .
100825,244,O,3497.0,During a median follow - up of 15·2 years we identified 884 stroke cases ( 503 ischaemic and 244 haemorrhagic ) .
100826,haemorrhagic,O,3497.0,During a median follow - up of 15·2 years we identified 884 stroke cases ( 503 ischaemic and 244 haemorrhagic ) .
100827,),O,3497.0,During a median follow - up of 15·2 years we identified 884 stroke cases ( 503 ischaemic and 244 haemorrhagic ) .
100828,.,O,3497.0,During a median follow - up of 15·2 years we identified 884 stroke cases ( 503 ischaemic and 244 haemorrhagic ) .
100829,Median,O,3498.0,"Median intake of total dairy products was four servings / d. Low - fat yogurt substituted for whole - fat yogurt was associated with a higher rate of ischaemic stroke ( hazard ratio ( HR ) = 2·58 ( 95 % CI 1·11 , 5·97)/serving per d ) ."
100830,intake,O,3498.0,"Median intake of total dairy products was four servings / d. Low - fat yogurt substituted for whole - fat yogurt was associated with a higher rate of ischaemic stroke ( hazard ratio ( HR ) = 2·58 ( 95 % CI 1·11 , 5·97)/serving per d ) ."
100831,of,O,3498.0,"Median intake of total dairy products was four servings / d. Low - fat yogurt substituted for whole - fat yogurt was associated with a higher rate of ischaemic stroke ( hazard ratio ( HR ) = 2·58 ( 95 % CI 1·11 , 5·97)/serving per d ) ."
100832,total,O,3498.0,"Median intake of total dairy products was four servings / d. Low - fat yogurt substituted for whole - fat yogurt was associated with a higher rate of ischaemic stroke ( hazard ratio ( HR ) = 2·58 ( 95 % CI 1·11 , 5·97)/serving per d ) ."
100833,dairy,B-AG.01.e,3498.0,"Median intake of total dairy products was four servings / d. Low - fat yogurt substituted for whole - fat yogurt was associated with a higher rate of ischaemic stroke ( hazard ratio ( HR ) = 2·58 ( 95 % CI 1·11 , 5·97)/serving per d ) ."
100834,products,I-AG.01.e,3498.0,"Median intake of total dairy products was four servings / d. Low - fat yogurt substituted for whole - fat yogurt was associated with a higher rate of ischaemic stroke ( hazard ratio ( HR ) = 2·58 ( 95 % CI 1·11 , 5·97)/serving per d ) ."
100835,was,O,3498.0,"Median intake of total dairy products was four servings / d. Low - fat yogurt substituted for whole - fat yogurt was associated with a higher rate of ischaemic stroke ( hazard ratio ( HR ) = 2·58 ( 95 % CI 1·11 , 5·97)/serving per d ) ."
100836,four,O,3498.0,"Median intake of total dairy products was four servings / d. Low - fat yogurt substituted for whole - fat yogurt was associated with a higher rate of ischaemic stroke ( hazard ratio ( HR ) = 2·58 ( 95 % CI 1·11 , 5·97)/serving per d ) ."
100837,servings,O,3498.0,"Median intake of total dairy products was four servings / d. Low - fat yogurt substituted for whole - fat yogurt was associated with a higher rate of ischaemic stroke ( hazard ratio ( HR ) = 2·58 ( 95 % CI 1·11 , 5·97)/serving per d ) ."
100838,/,O,3498.0,"Median intake of total dairy products was four servings / d. Low - fat yogurt substituted for whole - fat yogurt was associated with a higher rate of ischaemic stroke ( hazard ratio ( HR ) = 2·58 ( 95 % CI 1·11 , 5·97)/serving per d ) ."
100839,d.,O,3498.0,"Median intake of total dairy products was four servings / d. Low - fat yogurt substituted for whole - fat yogurt was associated with a higher rate of ischaemic stroke ( hazard ratio ( HR ) = 2·58 ( 95 % CI 1·11 , 5·97)/serving per d ) ."
100840,Low,B-AG.01.e,3498.0,"Median intake of total dairy products was four servings / d. Low - fat yogurt substituted for whole - fat yogurt was associated with a higher rate of ischaemic stroke ( hazard ratio ( HR ) = 2·58 ( 95 % CI 1·11 , 5·97)/serving per d ) ."
100841,-,I-AG.01.e,3498.0,"Median intake of total dairy products was four servings / d. Low - fat yogurt substituted for whole - fat yogurt was associated with a higher rate of ischaemic stroke ( hazard ratio ( HR ) = 2·58 ( 95 % CI 1·11 , 5·97)/serving per d ) ."
100842,fat,I-AG.01.e,3498.0,"Median intake of total dairy products was four servings / d. Low - fat yogurt substituted for whole - fat yogurt was associated with a higher rate of ischaemic stroke ( hazard ratio ( HR ) = 2·58 ( 95 % CI 1·11 , 5·97)/serving per d ) ."
100843,yogurt,I-AG.01.e,3498.0,"Median intake of total dairy products was four servings / d. Low - fat yogurt substituted for whole - fat yogurt was associated with a higher rate of ischaemic stroke ( hazard ratio ( HR ) = 2·58 ( 95 % CI 1·11 , 5·97)/serving per d ) ."
100844,substituted,O,3498.0,"Median intake of total dairy products was four servings / d. Low - fat yogurt substituted for whole - fat yogurt was associated with a higher rate of ischaemic stroke ( hazard ratio ( HR ) = 2·58 ( 95 % CI 1·11 , 5·97)/serving per d ) ."
100845,for,O,3498.0,"Median intake of total dairy products was four servings / d. Low - fat yogurt substituted for whole - fat yogurt was associated with a higher rate of ischaemic stroke ( hazard ratio ( HR ) = 2·58 ( 95 % CI 1·11 , 5·97)/serving per d ) ."
100846,whole,B-AG.01.e,3498.0,"Median intake of total dairy products was four servings / d. Low - fat yogurt substituted for whole - fat yogurt was associated with a higher rate of ischaemic stroke ( hazard ratio ( HR ) = 2·58 ( 95 % CI 1·11 , 5·97)/serving per d ) ."
100847,-,I-AG.01.e,3498.0,"Median intake of total dairy products was four servings / d. Low - fat yogurt substituted for whole - fat yogurt was associated with a higher rate of ischaemic stroke ( hazard ratio ( HR ) = 2·58 ( 95 % CI 1·11 , 5·97)/serving per d ) ."
100848,fat,I-AG.01.e,3498.0,"Median intake of total dairy products was four servings / d. Low - fat yogurt substituted for whole - fat yogurt was associated with a higher rate of ischaemic stroke ( hazard ratio ( HR ) = 2·58 ( 95 % CI 1·11 , 5·97)/serving per d ) ."
100849,yogurt,I-AG.01.e,3498.0,"Median intake of total dairy products was four servings / d. Low - fat yogurt substituted for whole - fat yogurt was associated with a higher rate of ischaemic stroke ( hazard ratio ( HR ) = 2·58 ( 95 % CI 1·11 , 5·97)/serving per d ) ."
100850,was,O,3498.0,"Median intake of total dairy products was four servings / d. Low - fat yogurt substituted for whole - fat yogurt was associated with a higher rate of ischaemic stroke ( hazard ratio ( HR ) = 2·58 ( 95 % CI 1·11 , 5·97)/serving per d ) ."
100851,associated,O,3498.0,"Median intake of total dairy products was four servings / d. Low - fat yogurt substituted for whole - fat yogurt was associated with a higher rate of ischaemic stroke ( hazard ratio ( HR ) = 2·58 ( 95 % CI 1·11 , 5·97)/serving per d ) ."
100852,with,O,3498.0,"Median intake of total dairy products was four servings / d. Low - fat yogurt substituted for whole - fat yogurt was associated with a higher rate of ischaemic stroke ( hazard ratio ( HR ) = 2·58 ( 95 % CI 1·11 , 5·97)/serving per d ) ."
100853,a,O,3498.0,"Median intake of total dairy products was four servings / d. Low - fat yogurt substituted for whole - fat yogurt was associated with a higher rate of ischaemic stroke ( hazard ratio ( HR ) = 2·58 ( 95 % CI 1·11 , 5·97)/serving per d ) ."
100854,higher,O,3498.0,"Median intake of total dairy products was four servings / d. Low - fat yogurt substituted for whole - fat yogurt was associated with a higher rate of ischaemic stroke ( hazard ratio ( HR ) = 2·58 ( 95 % CI 1·11 , 5·97)/serving per d ) ."
100855,rate,O,3498.0,"Median intake of total dairy products was four servings / d. Low - fat yogurt substituted for whole - fat yogurt was associated with a higher rate of ischaemic stroke ( hazard ratio ( HR ) = 2·58 ( 95 % CI 1·11 , 5·97)/serving per d ) ."
100856,of,O,3498.0,"Median intake of total dairy products was four servings / d. Low - fat yogurt substituted for whole - fat yogurt was associated with a higher rate of ischaemic stroke ( hazard ratio ( HR ) = 2·58 ( 95 % CI 1·11 , 5·97)/serving per d ) ."
100857,ischaemic,O,3498.0,"Median intake of total dairy products was four servings / d. Low - fat yogurt substituted for whole - fat yogurt was associated with a higher rate of ischaemic stroke ( hazard ratio ( HR ) = 2·58 ( 95 % CI 1·11 , 5·97)/serving per d ) ."
100858,stroke,O,3498.0,"Median intake of total dairy products was four servings / d. Low - fat yogurt substituted for whole - fat yogurt was associated with a higher rate of ischaemic stroke ( hazard ratio ( HR ) = 2·58 ( 95 % CI 1·11 , 5·97)/serving per d ) ."
100859,(,O,3498.0,"Median intake of total dairy products was four servings / d. Low - fat yogurt substituted for whole - fat yogurt was associated with a higher rate of ischaemic stroke ( hazard ratio ( HR ) = 2·58 ( 95 % CI 1·11 , 5·97)/serving per d ) ."
100860,hazard,O,3498.0,"Median intake of total dairy products was four servings / d. Low - fat yogurt substituted for whole - fat yogurt was associated with a higher rate of ischaemic stroke ( hazard ratio ( HR ) = 2·58 ( 95 % CI 1·11 , 5·97)/serving per d ) ."
100861,ratio,O,3498.0,"Median intake of total dairy products was four servings / d. Low - fat yogurt substituted for whole - fat yogurt was associated with a higher rate of ischaemic stroke ( hazard ratio ( HR ) = 2·58 ( 95 % CI 1·11 , 5·97)/serving per d ) ."
100862,(,O,3498.0,"Median intake of total dairy products was four servings / d. Low - fat yogurt substituted for whole - fat yogurt was associated with a higher rate of ischaemic stroke ( hazard ratio ( HR ) = 2·58 ( 95 % CI 1·11 , 5·97)/serving per d ) ."
100863,HR,O,3498.0,"Median intake of total dairy products was four servings / d. Low - fat yogurt substituted for whole - fat yogurt was associated with a higher rate of ischaemic stroke ( hazard ratio ( HR ) = 2·58 ( 95 % CI 1·11 , 5·97)/serving per d ) ."
100864,),O,3498.0,"Median intake of total dairy products was four servings / d. Low - fat yogurt substituted for whole - fat yogurt was associated with a higher rate of ischaemic stroke ( hazard ratio ( HR ) = 2·58 ( 95 % CI 1·11 , 5·97)/serving per d ) ."
100865,=,O,3498.0,"Median intake of total dairy products was four servings / d. Low - fat yogurt substituted for whole - fat yogurt was associated with a higher rate of ischaemic stroke ( hazard ratio ( HR ) = 2·58 ( 95 % CI 1·11 , 5·97)/serving per d ) ."
100866,2·58,O,3498.0,"Median intake of total dairy products was four servings / d. Low - fat yogurt substituted for whole - fat yogurt was associated with a higher rate of ischaemic stroke ( hazard ratio ( HR ) = 2·58 ( 95 % CI 1·11 , 5·97)/serving per d ) ."
100867,(,O,3498.0,"Median intake of total dairy products was four servings / d. Low - fat yogurt substituted for whole - fat yogurt was associated with a higher rate of ischaemic stroke ( hazard ratio ( HR ) = 2·58 ( 95 % CI 1·11 , 5·97)/serving per d ) ."
100868,95,O,3498.0,"Median intake of total dairy products was four servings / d. Low - fat yogurt substituted for whole - fat yogurt was associated with a higher rate of ischaemic stroke ( hazard ratio ( HR ) = 2·58 ( 95 % CI 1·11 , 5·97)/serving per d ) ."
100869,%,O,3498.0,"Median intake of total dairy products was four servings / d. Low - fat yogurt substituted for whole - fat yogurt was associated with a higher rate of ischaemic stroke ( hazard ratio ( HR ) = 2·58 ( 95 % CI 1·11 , 5·97)/serving per d ) ."
100870,CI,O,3498.0,"Median intake of total dairy products was four servings / d. Low - fat yogurt substituted for whole - fat yogurt was associated with a higher rate of ischaemic stroke ( hazard ratio ( HR ) = 2·58 ( 95 % CI 1·11 , 5·97)/serving per d ) ."
100871,1·11,O,3498.0,"Median intake of total dairy products was four servings / d. Low - fat yogurt substituted for whole - fat yogurt was associated with a higher rate of ischaemic stroke ( hazard ratio ( HR ) = 2·58 ( 95 % CI 1·11 , 5·97)/serving per d ) ."
100872,",",O,3498.0,"Median intake of total dairy products was four servings / d. Low - fat yogurt substituted for whole - fat yogurt was associated with a higher rate of ischaemic stroke ( hazard ratio ( HR ) = 2·58 ( 95 % CI 1·11 , 5·97)/serving per d ) ."
100873,5·97)/serving,O,3498.0,"Median intake of total dairy products was four servings / d. Low - fat yogurt substituted for whole - fat yogurt was associated with a higher rate of ischaemic stroke ( hazard ratio ( HR ) = 2·58 ( 95 % CI 1·11 , 5·97)/serving per d ) ."
100874,per,O,3498.0,"Median intake of total dairy products was four servings / d. Low - fat yogurt substituted for whole - fat yogurt was associated with a higher rate of ischaemic stroke ( hazard ratio ( HR ) = 2·58 ( 95 % CI 1·11 , 5·97)/serving per d ) ."
100875,d,O,3498.0,"Median intake of total dairy products was four servings / d. Low - fat yogurt substituted for whole - fat yogurt was associated with a higher rate of ischaemic stroke ( hazard ratio ( HR ) = 2·58 ( 95 % CI 1·11 , 5·97)/serving per d ) ."
100876,),O,3498.0,"Median intake of total dairy products was four servings / d. Low - fat yogurt substituted for whole - fat yogurt was associated with a higher rate of ischaemic stroke ( hazard ratio ( HR ) = 2·58 ( 95 % CI 1·11 , 5·97)/serving per d ) ."
100877,.,O,3498.0,"Median intake of total dairy products was four servings / d. Low - fat yogurt substituted for whole - fat yogurt was associated with a higher rate of ischaemic stroke ( hazard ratio ( HR ) = 2·58 ( 95 % CI 1·11 , 5·97)/serving per d ) ."
100878,Whole,B-AG.01.e,3499.0,Whole - fat yogurt as a substitution for any other subgroup was associated with a lower rate of ischaemic stroke ( HR between 0·33 and 0·36 / serving per d ) .
100879,-,I-AG.01.e,3499.0,Whole - fat yogurt as a substitution for any other subgroup was associated with a lower rate of ischaemic stroke ( HR between 0·33 and 0·36 / serving per d ) .
100880,fat,I-AG.01.e,3499.0,Whole - fat yogurt as a substitution for any other subgroup was associated with a lower rate of ischaemic stroke ( HR between 0·33 and 0·36 / serving per d ) .
100881,yogurt,I-AG.01.e,3499.0,Whole - fat yogurt as a substitution for any other subgroup was associated with a lower rate of ischaemic stroke ( HR between 0·33 and 0·36 / serving per d ) .
100882,as,O,3499.0,Whole - fat yogurt as a substitution for any other subgroup was associated with a lower rate of ischaemic stroke ( HR between 0·33 and 0·36 / serving per d ) .
100883,a,O,3499.0,Whole - fat yogurt as a substitution for any other subgroup was associated with a lower rate of ischaemic stroke ( HR between 0·33 and 0·36 / serving per d ) .
100884,substitution,O,3499.0,Whole - fat yogurt as a substitution for any other subgroup was associated with a lower rate of ischaemic stroke ( HR between 0·33 and 0·36 / serving per d ) .
100885,for,O,3499.0,Whole - fat yogurt as a substitution for any other subgroup was associated with a lower rate of ischaemic stroke ( HR between 0·33 and 0·36 / serving per d ) .
100886,any,O,3499.0,Whole - fat yogurt as a substitution for any other subgroup was associated with a lower rate of ischaemic stroke ( HR between 0·33 and 0·36 / serving per d ) .
100887,other,O,3499.0,Whole - fat yogurt as a substitution for any other subgroup was associated with a lower rate of ischaemic stroke ( HR between 0·33 and 0·36 / serving per d ) .
100888,subgroup,O,3499.0,Whole - fat yogurt as a substitution for any other subgroup was associated with a lower rate of ischaemic stroke ( HR between 0·33 and 0·36 / serving per d ) .
100889,was,O,3499.0,Whole - fat yogurt as a substitution for any other subgroup was associated with a lower rate of ischaemic stroke ( HR between 0·33 and 0·36 / serving per d ) .
100890,associated,O,3499.0,Whole - fat yogurt as a substitution for any other subgroup was associated with a lower rate of ischaemic stroke ( HR between 0·33 and 0·36 / serving per d ) .
100891,with,O,3499.0,Whole - fat yogurt as a substitution for any other subgroup was associated with a lower rate of ischaemic stroke ( HR between 0·33 and 0·36 / serving per d ) .
100892,a,O,3499.0,Whole - fat yogurt as a substitution for any other subgroup was associated with a lower rate of ischaemic stroke ( HR between 0·33 and 0·36 / serving per d ) .
100893,lower,O,3499.0,Whole - fat yogurt as a substitution for any other subgroup was associated with a lower rate of ischaemic stroke ( HR between 0·33 and 0·36 / serving per d ) .
100894,rate,O,3499.0,Whole - fat yogurt as a substitution for any other subgroup was associated with a lower rate of ischaemic stroke ( HR between 0·33 and 0·36 / serving per d ) .
100895,of,O,3499.0,Whole - fat yogurt as a substitution for any other subgroup was associated with a lower rate of ischaemic stroke ( HR between 0·33 and 0·36 / serving per d ) .
100896,ischaemic,O,3499.0,Whole - fat yogurt as a substitution for any other subgroup was associated with a lower rate of ischaemic stroke ( HR between 0·33 and 0·36 / serving per d ) .
100897,stroke,O,3499.0,Whole - fat yogurt as a substitution for any other subgroup was associated with a lower rate of ischaemic stroke ( HR between 0·33 and 0·36 / serving per d ) .
100898,(,O,3499.0,Whole - fat yogurt as a substitution for any other subgroup was associated with a lower rate of ischaemic stroke ( HR between 0·33 and 0·36 / serving per d ) .
100899,HR,O,3499.0,Whole - fat yogurt as a substitution for any other subgroup was associated with a lower rate of ischaemic stroke ( HR between 0·33 and 0·36 / serving per d ) .
100900,between,O,3499.0,Whole - fat yogurt as a substitution for any other subgroup was associated with a lower rate of ischaemic stroke ( HR between 0·33 and 0·36 / serving per d ) .
100901,0·33,O,3499.0,Whole - fat yogurt as a substitution for any other subgroup was associated with a lower rate of ischaemic stroke ( HR between 0·33 and 0·36 / serving per d ) .
100902,and,O,3499.0,Whole - fat yogurt as a substitution for any other subgroup was associated with a lower rate of ischaemic stroke ( HR between 0·33 and 0·36 / serving per d ) .
100903,0·36,O,3499.0,Whole - fat yogurt as a substitution for any other subgroup was associated with a lower rate of ischaemic stroke ( HR between 0·33 and 0·36 / serving per d ) .
100904,/,O,3499.0,Whole - fat yogurt as a substitution for any other subgroup was associated with a lower rate of ischaemic stroke ( HR between 0·33 and 0·36 / serving per d ) .
100905,serving,O,3499.0,Whole - fat yogurt as a substitution for any other subgroup was associated with a lower rate of ischaemic stroke ( HR between 0·33 and 0·36 / serving per d ) .
100906,per,O,3499.0,Whole - fat yogurt as a substitution for any other subgroup was associated with a lower rate of ischaemic stroke ( HR between 0·33 and 0·36 / serving per d ) .
100907,d,O,3499.0,Whole - fat yogurt as a substitution for any other subgroup was associated with a lower rate of ischaemic stroke ( HR between 0·33 and 0·36 / serving per d ) .
100908,),O,3499.0,Whole - fat yogurt as a substitution for any other subgroup was associated with a lower rate of ischaemic stroke ( HR between 0·33 and 0·36 / serving per d ) .
100909,.,O,3499.0,Whole - fat yogurt as a substitution for any other subgroup was associated with a lower rate of ischaemic stroke ( HR between 0·33 and 0·36 / serving per d ) .
100910,We,O,3500.0,We did not observe any associations for haemorrhagic stroke .
100911,did,O,3500.0,We did not observe any associations for haemorrhagic stroke .
100912,not,O,3500.0,We did not observe any associations for haemorrhagic stroke .
100913,observe,O,3500.0,We did not observe any associations for haemorrhagic stroke .
100914,any,O,3500.0,We did not observe any associations for haemorrhagic stroke .
100915,associations,O,3500.0,We did not observe any associations for haemorrhagic stroke .
100916,for,O,3500.0,We did not observe any associations for haemorrhagic stroke .
100917,haemorrhagic,O,3500.0,We did not observe any associations for haemorrhagic stroke .
100918,stroke,O,3500.0,We did not observe any associations for haemorrhagic stroke .
100919,.,O,3500.0,We did not observe any associations for haemorrhagic stroke .
100920,In,O,3501.0,"In conclusion , whole - fat yogurt as a substitution for low - fat yogurt , cheese , butter , buttermilk or milk , regardless of fat content , was associated with a lower rate of ischaemic stroke ."
100921,conclusion,O,3501.0,"In conclusion , whole - fat yogurt as a substitution for low - fat yogurt , cheese , butter , buttermilk or milk , regardless of fat content , was associated with a lower rate of ischaemic stroke ."
100922,",",O,3501.0,"In conclusion , whole - fat yogurt as a substitution for low - fat yogurt , cheese , butter , buttermilk or milk , regardless of fat content , was associated with a lower rate of ischaemic stroke ."
100923,whole,B-AG.01.e,3501.0,"In conclusion , whole - fat yogurt as a substitution for low - fat yogurt , cheese , butter , buttermilk or milk , regardless of fat content , was associated with a lower rate of ischaemic stroke ."
100924,-,I-AG.01.e,3501.0,"In conclusion , whole - fat yogurt as a substitution for low - fat yogurt , cheese , butter , buttermilk or milk , regardless of fat content , was associated with a lower rate of ischaemic stroke ."
100925,fat,I-AG.01.e,3501.0,"In conclusion , whole - fat yogurt as a substitution for low - fat yogurt , cheese , butter , buttermilk or milk , regardless of fat content , was associated with a lower rate of ischaemic stroke ."
100926,yogurt,I-AG.01.e,3501.0,"In conclusion , whole - fat yogurt as a substitution for low - fat yogurt , cheese , butter , buttermilk or milk , regardless of fat content , was associated with a lower rate of ischaemic stroke ."
100927,as,O,3501.0,"In conclusion , whole - fat yogurt as a substitution for low - fat yogurt , cheese , butter , buttermilk or milk , regardless of fat content , was associated with a lower rate of ischaemic stroke ."
100928,a,O,3501.0,"In conclusion , whole - fat yogurt as a substitution for low - fat yogurt , cheese , butter , buttermilk or milk , regardless of fat content , was associated with a lower rate of ischaemic stroke ."
100929,substitution,O,3501.0,"In conclusion , whole - fat yogurt as a substitution for low - fat yogurt , cheese , butter , buttermilk or milk , regardless of fat content , was associated with a lower rate of ischaemic stroke ."
100930,for,O,3501.0,"In conclusion , whole - fat yogurt as a substitution for low - fat yogurt , cheese , butter , buttermilk or milk , regardless of fat content , was associated with a lower rate of ischaemic stroke ."
100931,low,B-AG.01.e,3501.0,"In conclusion , whole - fat yogurt as a substitution for low - fat yogurt , cheese , butter , buttermilk or milk , regardless of fat content , was associated with a lower rate of ischaemic stroke ."
100932,-,I-AG.01.e,3501.0,"In conclusion , whole - fat yogurt as a substitution for low - fat yogurt , cheese , butter , buttermilk or milk , regardless of fat content , was associated with a lower rate of ischaemic stroke ."
100933,fat,I-AG.01.e,3501.0,"In conclusion , whole - fat yogurt as a substitution for low - fat yogurt , cheese , butter , buttermilk or milk , regardless of fat content , was associated with a lower rate of ischaemic stroke ."
100934,yogurt,I-AG.01.e,3501.0,"In conclusion , whole - fat yogurt as a substitution for low - fat yogurt , cheese , butter , buttermilk or milk , regardless of fat content , was associated with a lower rate of ischaemic stroke ."
100935,",",O,3501.0,"In conclusion , whole - fat yogurt as a substitution for low - fat yogurt , cheese , butter , buttermilk or milk , regardless of fat content , was associated with a lower rate of ischaemic stroke ."
100936,cheese,B-AG.01.e.02,3501.0,"In conclusion , whole - fat yogurt as a substitution for low - fat yogurt , cheese , butter , buttermilk or milk , regardless of fat content , was associated with a lower rate of ischaemic stroke ."
100937,",",O,3501.0,"In conclusion , whole - fat yogurt as a substitution for low - fat yogurt , cheese , butter , buttermilk or milk , regardless of fat content , was associated with a lower rate of ischaemic stroke ."
100938,butter,B-AG.01.e.01,3501.0,"In conclusion , whole - fat yogurt as a substitution for low - fat yogurt , cheese , butter , buttermilk or milk , regardless of fat content , was associated with a lower rate of ischaemic stroke ."
100939,",",O,3501.0,"In conclusion , whole - fat yogurt as a substitution for low - fat yogurt , cheese , butter , buttermilk or milk , regardless of fat content , was associated with a lower rate of ischaemic stroke ."
100940,buttermilk,B-AG.01.e,3501.0,"In conclusion , whole - fat yogurt as a substitution for low - fat yogurt , cheese , butter , buttermilk or milk , regardless of fat content , was associated with a lower rate of ischaemic stroke ."
100941,or,O,3501.0,"In conclusion , whole - fat yogurt as a substitution for low - fat yogurt , cheese , butter , buttermilk or milk , regardless of fat content , was associated with a lower rate of ischaemic stroke ."
100942,milk,B-AG.01.e,3501.0,"In conclusion , whole - fat yogurt as a substitution for low - fat yogurt , cheese , butter , buttermilk or milk , regardless of fat content , was associated with a lower rate of ischaemic stroke ."
100943,",",O,3501.0,"In conclusion , whole - fat yogurt as a substitution for low - fat yogurt , cheese , butter , buttermilk or milk , regardless of fat content , was associated with a lower rate of ischaemic stroke ."
100944,regardless,O,3501.0,"In conclusion , whole - fat yogurt as a substitution for low - fat yogurt , cheese , butter , buttermilk or milk , regardless of fat content , was associated with a lower rate of ischaemic stroke ."
100945,of,O,3501.0,"In conclusion , whole - fat yogurt as a substitution for low - fat yogurt , cheese , butter , buttermilk or milk , regardless of fat content , was associated with a lower rate of ischaemic stroke ."
100946,fat,O,3501.0,"In conclusion , whole - fat yogurt as a substitution for low - fat yogurt , cheese , butter , buttermilk or milk , regardless of fat content , was associated with a lower rate of ischaemic stroke ."
100947,content,O,3501.0,"In conclusion , whole - fat yogurt as a substitution for low - fat yogurt , cheese , butter , buttermilk or milk , regardless of fat content , was associated with a lower rate of ischaemic stroke ."
100948,",",O,3501.0,"In conclusion , whole - fat yogurt as a substitution for low - fat yogurt , cheese , butter , buttermilk or milk , regardless of fat content , was associated with a lower rate of ischaemic stroke ."
100949,was,O,3501.0,"In conclusion , whole - fat yogurt as a substitution for low - fat yogurt , cheese , butter , buttermilk or milk , regardless of fat content , was associated with a lower rate of ischaemic stroke ."
100950,associated,O,3501.0,"In conclusion , whole - fat yogurt as a substitution for low - fat yogurt , cheese , butter , buttermilk or milk , regardless of fat content , was associated with a lower rate of ischaemic stroke ."
100951,with,O,3501.0,"In conclusion , whole - fat yogurt as a substitution for low - fat yogurt , cheese , butter , buttermilk or milk , regardless of fat content , was associated with a lower rate of ischaemic stroke ."
100952,a,O,3501.0,"In conclusion , whole - fat yogurt as a substitution for low - fat yogurt , cheese , butter , buttermilk or milk , regardless of fat content , was associated with a lower rate of ischaemic stroke ."
100953,lower,O,3501.0,"In conclusion , whole - fat yogurt as a substitution for low - fat yogurt , cheese , butter , buttermilk or milk , regardless of fat content , was associated with a lower rate of ischaemic stroke ."
100954,rate,O,3501.0,"In conclusion , whole - fat yogurt as a substitution for low - fat yogurt , cheese , butter , buttermilk or milk , regardless of fat content , was associated with a lower rate of ischaemic stroke ."
100955,of,O,3501.0,"In conclusion , whole - fat yogurt as a substitution for low - fat yogurt , cheese , butter , buttermilk or milk , regardless of fat content , was associated with a lower rate of ischaemic stroke ."
100956,ischaemic,O,3501.0,"In conclusion , whole - fat yogurt as a substitution for low - fat yogurt , cheese , butter , buttermilk or milk , regardless of fat content , was associated with a lower rate of ischaemic stroke ."
100957,stroke,O,3501.0,"In conclusion , whole - fat yogurt as a substitution for low - fat yogurt , cheese , butter , buttermilk or milk , regardless of fat content , was associated with a lower rate of ischaemic stroke ."
100958,.,O,3501.0,"In conclusion , whole - fat yogurt as a substitution for low - fat yogurt , cheese , butter , buttermilk or milk , regardless of fat content , was associated with a lower rate of ischaemic stroke ."
100959,The,O,3502.0,The incidence and severity of hypertension are affected by nutritional status and intake of many nutrients .
100960,incidence,O,3502.0,The incidence and severity of hypertension are affected by nutritional status and intake of many nutrients .
100961,and,O,3502.0,The incidence and severity of hypertension are affected by nutritional status and intake of many nutrients .
100962,severity,O,3502.0,The incidence and severity of hypertension are affected by nutritional status and intake of many nutrients .
100963,of,O,3502.0,The incidence and severity of hypertension are affected by nutritional status and intake of many nutrients .
100964,hypertension,O,3502.0,The incidence and severity of hypertension are affected by nutritional status and intake of many nutrients .
100965,are,O,3502.0,The incidence and severity of hypertension are affected by nutritional status and intake of many nutrients .
100966,affected,O,3502.0,The incidence and severity of hypertension are affected by nutritional status and intake of many nutrients .
100967,by,O,3502.0,The incidence and severity of hypertension are affected by nutritional status and intake of many nutrients .
100968,nutritional,O,3502.0,The incidence and severity of hypertension are affected by nutritional status and intake of many nutrients .
100969,status,O,3502.0,The incidence and severity of hypertension are affected by nutritional status and intake of many nutrients .
100970,and,O,3502.0,The incidence and severity of hypertension are affected by nutritional status and intake of many nutrients .
100971,intake,O,3502.0,The incidence and severity of hypertension are affected by nutritional status and intake of many nutrients .
100972,of,O,3502.0,The incidence and severity of hypertension are affected by nutritional status and intake of many nutrients .
100973,many,O,3502.0,The incidence and severity of hypertension are affected by nutritional status and intake of many nutrients .
100974,nutrients,O,3502.0,The incidence and severity of hypertension are affected by nutritional status and intake of many nutrients .
100975,.,O,3502.0,The incidence and severity of hypertension are affected by nutritional status and intake of many nutrients .
100976,Excessive,O,3503.0,Excessive energy intake and obesity are major causes of hypertension .
100977,energy,O,3503.0,Excessive energy intake and obesity are major causes of hypertension .
100978,intake,O,3503.0,Excessive energy intake and obesity are major causes of hypertension .
100979,and,O,3503.0,Excessive energy intake and obesity are major causes of hypertension .
100980,obesity,O,3503.0,Excessive energy intake and obesity are major causes of hypertension .
100981,are,O,3503.0,Excessive energy intake and obesity are major causes of hypertension .
100982,major,O,3503.0,Excessive energy intake and obesity are major causes of hypertension .
100983,causes,O,3503.0,Excessive energy intake and obesity are major causes of hypertension .
100984,of,O,3503.0,Excessive energy intake and obesity are major causes of hypertension .
100985,hypertension,O,3503.0,Excessive energy intake and obesity are major causes of hypertension .
100986,.,O,3503.0,Excessive energy intake and obesity are major causes of hypertension .
100987,Obesity,O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
100988,is,O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
100989,associated,O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
100990,with,O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
100991,increased,O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
100992,activity,O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
100993,of,O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
100994,the,O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
100995,renin,O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
100996,-,O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
100997,angiotensin,O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
100998,-,O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
100999,aldosterone,O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
101000,and,O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
101001,sympathetic,O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
101002,nervous,O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
101003,systems,O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
101004,",",O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
101005,possibly,O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
101006,other,O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
101007,mineralcorticoid,O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
101008,activity,O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
101009,",",O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
101010,insulin,O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
101011,resistance,O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
101012,",",O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
101013,salt,O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
101014,-,O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
101015,sensitive,O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
101016,hypertension,O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
101017,and,O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
101018,excess,O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
101019,salt,B-AG.01.l.01,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
101020,intake,B-X,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
101021,",",O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
101022,and,O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
101023,reduced,O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
101024,kidney,O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
101025,function,O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
101026,.,O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
101027,High,O,3505.0,High sodium chloride intake strongly predisposes to hypertension .
101028,sodium,O,3505.0,High sodium chloride intake strongly predisposes to hypertension .
101029,chloride,O,3505.0,High sodium chloride intake strongly predisposes to hypertension .
101030,intake,O,3505.0,High sodium chloride intake strongly predisposes to hypertension .
101031,strongly,O,3505.0,High sodium chloride intake strongly predisposes to hypertension .
101032,predisposes,O,3505.0,High sodium chloride intake strongly predisposes to hypertension .
101033,to,O,3505.0,High sodium chloride intake strongly predisposes to hypertension .
101034,hypertension,O,3505.0,High sodium chloride intake strongly predisposes to hypertension .
101035,.,O,3505.0,High sodium chloride intake strongly predisposes to hypertension .
101036,Increased,O,3506.0,Increased alcohol consumption may acutely elevate blood pressure .
101037,alcohol,B-AG.01.y.01,3506.0,Increased alcohol consumption may acutely elevate blood pressure .
101038,consumption,B-X,3506.0,Increased alcohol consumption may acutely elevate blood pressure .
101039,may,O,3506.0,Increased alcohol consumption may acutely elevate blood pressure .
101040,acutely,O,3506.0,Increased alcohol consumption may acutely elevate blood pressure .
101041,elevate,O,3506.0,Increased alcohol consumption may acutely elevate blood pressure .
101042,blood,O,3506.0,Increased alcohol consumption may acutely elevate blood pressure .
101043,pressure,O,3506.0,Increased alcohol consumption may acutely elevate blood pressure .
101044,.,O,3506.0,Increased alcohol consumption may acutely elevate blood pressure .
101045,High,O,3507.0,"High intakes of potassium , polyunsaturated fatty acids , and protein , along with exercise and possibly vitamin D , may reduce blood pressure ."
101046,intakes,O,3507.0,"High intakes of potassium , polyunsaturated fatty acids , and protein , along with exercise and possibly vitamin D , may reduce blood pressure ."
101047,of,O,3507.0,"High intakes of potassium , polyunsaturated fatty acids , and protein , along with exercise and possibly vitamin D , may reduce blood pressure ."
101048,potassium,O,3507.0,"High intakes of potassium , polyunsaturated fatty acids , and protein , along with exercise and possibly vitamin D , may reduce blood pressure ."
101049,",",O,3507.0,"High intakes of potassium , polyunsaturated fatty acids , and protein , along with exercise and possibly vitamin D , may reduce blood pressure ."
101050,polyunsaturated,O,3507.0,"High intakes of potassium , polyunsaturated fatty acids , and protein , along with exercise and possibly vitamin D , may reduce blood pressure ."
101051,fatty,O,3507.0,"High intakes of potassium , polyunsaturated fatty acids , and protein , along with exercise and possibly vitamin D , may reduce blood pressure ."
101052,acids,O,3507.0,"High intakes of potassium , polyunsaturated fatty acids , and protein , along with exercise and possibly vitamin D , may reduce blood pressure ."
101053,",",O,3507.0,"High intakes of potassium , polyunsaturated fatty acids , and protein , along with exercise and possibly vitamin D , may reduce blood pressure ."
101054,and,O,3507.0,"High intakes of potassium , polyunsaturated fatty acids , and protein , along with exercise and possibly vitamin D , may reduce blood pressure ."
101055,protein,O,3507.0,"High intakes of potassium , polyunsaturated fatty acids , and protein , along with exercise and possibly vitamin D , may reduce blood pressure ."
101056,",",O,3507.0,"High intakes of potassium , polyunsaturated fatty acids , and protein , along with exercise and possibly vitamin D , may reduce blood pressure ."
101057,along,O,3507.0,"High intakes of potassium , polyunsaturated fatty acids , and protein , along with exercise and possibly vitamin D , may reduce blood pressure ."
101058,with,O,3507.0,"High intakes of potassium , polyunsaturated fatty acids , and protein , along with exercise and possibly vitamin D , may reduce blood pressure ."
101059,exercise,O,3507.0,"High intakes of potassium , polyunsaturated fatty acids , and protein , along with exercise and possibly vitamin D , may reduce blood pressure ."
101060,and,O,3507.0,"High intakes of potassium , polyunsaturated fatty acids , and protein , along with exercise and possibly vitamin D , may reduce blood pressure ."
101061,possibly,O,3507.0,"High intakes of potassium , polyunsaturated fatty acids , and protein , along with exercise and possibly vitamin D , may reduce blood pressure ."
101062,vitamin,O,3507.0,"High intakes of potassium , polyunsaturated fatty acids , and protein , along with exercise and possibly vitamin D , may reduce blood pressure ."
101063,D,O,3507.0,"High intakes of potassium , polyunsaturated fatty acids , and protein , along with exercise and possibly vitamin D , may reduce blood pressure ."
101064,",",O,3507.0,"High intakes of potassium , polyunsaturated fatty acids , and protein , along with exercise and possibly vitamin D , may reduce blood pressure ."
101065,may,O,3507.0,"High intakes of potassium , polyunsaturated fatty acids , and protein , along with exercise and possibly vitamin D , may reduce blood pressure ."
101066,reduce,O,3507.0,"High intakes of potassium , polyunsaturated fatty acids , and protein , along with exercise and possibly vitamin D , may reduce blood pressure ."
101067,blood,O,3507.0,"High intakes of potassium , polyunsaturated fatty acids , and protein , along with exercise and possibly vitamin D , may reduce blood pressure ."
101068,pressure,O,3507.0,"High intakes of potassium , polyunsaturated fatty acids , and protein , along with exercise and possibly vitamin D , may reduce blood pressure ."
101069,.,O,3507.0,"High intakes of potassium , polyunsaturated fatty acids , and protein , along with exercise and possibly vitamin D , may reduce blood pressure ."
101070,Less,O,3508.0,"Less - conclusive studies suggest that amino acids , tea , green coffee bean extract , dark chocolate , and foods high in nitrates may reduce blood pressure ."
101071,-,O,3508.0,"Less - conclusive studies suggest that amino acids , tea , green coffee bean extract , dark chocolate , and foods high in nitrates may reduce blood pressure ."
101072,conclusive,O,3508.0,"Less - conclusive studies suggest that amino acids , tea , green coffee bean extract , dark chocolate , and foods high in nitrates may reduce blood pressure ."
101073,studies,O,3508.0,"Less - conclusive studies suggest that amino acids , tea , green coffee bean extract , dark chocolate , and foods high in nitrates may reduce blood pressure ."
101074,suggest,O,3508.0,"Less - conclusive studies suggest that amino acids , tea , green coffee bean extract , dark chocolate , and foods high in nitrates may reduce blood pressure ."
101075,that,O,3508.0,"Less - conclusive studies suggest that amino acids , tea , green coffee bean extract , dark chocolate , and foods high in nitrates may reduce blood pressure ."
101076,amino,O,3508.0,"Less - conclusive studies suggest that amino acids , tea , green coffee bean extract , dark chocolate , and foods high in nitrates may reduce blood pressure ."
101077,acids,O,3508.0,"Less - conclusive studies suggest that amino acids , tea , green coffee bean extract , dark chocolate , and foods high in nitrates may reduce blood pressure ."
101078,",",O,3508.0,"Less - conclusive studies suggest that amino acids , tea , green coffee bean extract , dark chocolate , and foods high in nitrates may reduce blood pressure ."
101079,tea,B-AG.01.ac,3508.0,"Less - conclusive studies suggest that amino acids , tea , green coffee bean extract , dark chocolate , and foods high in nitrates may reduce blood pressure ."
101080,",",O,3508.0,"Less - conclusive studies suggest that amino acids , tea , green coffee bean extract , dark chocolate , and foods high in nitrates may reduce blood pressure ."
101081,green,O,3508.0,"Less - conclusive studies suggest that amino acids , tea , green coffee bean extract , dark chocolate , and foods high in nitrates may reduce blood pressure ."
101082,coffee,O,3508.0,"Less - conclusive studies suggest that amino acids , tea , green coffee bean extract , dark chocolate , and foods high in nitrates may reduce blood pressure ."
101083,bean,O,3508.0,"Less - conclusive studies suggest that amino acids , tea , green coffee bean extract , dark chocolate , and foods high in nitrates may reduce blood pressure ."
101084,extract,O,3508.0,"Less - conclusive studies suggest that amino acids , tea , green coffee bean extract , dark chocolate , and foods high in nitrates may reduce blood pressure ."
101085,",",O,3508.0,"Less - conclusive studies suggest that amino acids , tea , green coffee bean extract , dark chocolate , and foods high in nitrates may reduce blood pressure ."
101086,dark,B-AG.01.n.17.a,3508.0,"Less - conclusive studies suggest that amino acids , tea , green coffee bean extract , dark chocolate , and foods high in nitrates may reduce blood pressure ."
101087,chocolate,I-AG.01.n.17.a,3508.0,"Less - conclusive studies suggest that amino acids , tea , green coffee bean extract , dark chocolate , and foods high in nitrates may reduce blood pressure ."
101088,",",O,3508.0,"Less - conclusive studies suggest that amino acids , tea , green coffee bean extract , dark chocolate , and foods high in nitrates may reduce blood pressure ."
101089,and,O,3508.0,"Less - conclusive studies suggest that amino acids , tea , green coffee bean extract , dark chocolate , and foods high in nitrates may reduce blood pressure ."
101090,foods,O,3508.0,"Less - conclusive studies suggest that amino acids , tea , green coffee bean extract , dark chocolate , and foods high in nitrates may reduce blood pressure ."
101091,high,O,3508.0,"Less - conclusive studies suggest that amino acids , tea , green coffee bean extract , dark chocolate , and foods high in nitrates may reduce blood pressure ."
101092,in,O,3508.0,"Less - conclusive studies suggest that amino acids , tea , green coffee bean extract , dark chocolate , and foods high in nitrates may reduce blood pressure ."
101093,nitrates,O,3508.0,"Less - conclusive studies suggest that amino acids , tea , green coffee bean extract , dark chocolate , and foods high in nitrates may reduce blood pressure ."
101094,may,O,3508.0,"Less - conclusive studies suggest that amino acids , tea , green coffee bean extract , dark chocolate , and foods high in nitrates may reduce blood pressure ."
101095,reduce,O,3508.0,"Less - conclusive studies suggest that amino acids , tea , green coffee bean extract , dark chocolate , and foods high in nitrates may reduce blood pressure ."
101096,blood,O,3508.0,"Less - conclusive studies suggest that amino acids , tea , green coffee bean extract , dark chocolate , and foods high in nitrates may reduce blood pressure ."
101097,pressure,O,3508.0,"Less - conclusive studies suggest that amino acids , tea , green coffee bean extract , dark chocolate , and foods high in nitrates may reduce blood pressure ."
101098,.,O,3508.0,"Less - conclusive studies suggest that amino acids , tea , green coffee bean extract , dark chocolate , and foods high in nitrates may reduce blood pressure ."
101099,Short,O,3509.0,"Short - term studies indicate that specialized diets may prevent or ameliorate mild hypertension ; most notable are the Dietary Approaches to Stop Hypertension ( DASH ) diet , which is high in fruits , vegetables , and low - fat dairy products , and the DASH low - sodium diet ."
101100,-,O,3509.0,"Short - term studies indicate that specialized diets may prevent or ameliorate mild hypertension ; most notable are the Dietary Approaches to Stop Hypertension ( DASH ) diet , which is high in fruits , vegetables , and low - fat dairy products , and the DASH low - sodium diet ."
101101,term,O,3509.0,"Short - term studies indicate that specialized diets may prevent or ameliorate mild hypertension ; most notable are the Dietary Approaches to Stop Hypertension ( DASH ) diet , which is high in fruits , vegetables , and low - fat dairy products , and the DASH low - sodium diet ."
101102,studies,O,3509.0,"Short - term studies indicate that specialized diets may prevent or ameliorate mild hypertension ; most notable are the Dietary Approaches to Stop Hypertension ( DASH ) diet , which is high in fruits , vegetables , and low - fat dairy products , and the DASH low - sodium diet ."
101103,indicate,O,3509.0,"Short - term studies indicate that specialized diets may prevent or ameliorate mild hypertension ; most notable are the Dietary Approaches to Stop Hypertension ( DASH ) diet , which is high in fruits , vegetables , and low - fat dairy products , and the DASH low - sodium diet ."
101104,that,O,3509.0,"Short - term studies indicate that specialized diets may prevent or ameliorate mild hypertension ; most notable are the Dietary Approaches to Stop Hypertension ( DASH ) diet , which is high in fruits , vegetables , and low - fat dairy products , and the DASH low - sodium diet ."
101105,specialized,O,3509.0,"Short - term studies indicate that specialized diets may prevent or ameliorate mild hypertension ; most notable are the Dietary Approaches to Stop Hypertension ( DASH ) diet , which is high in fruits , vegetables , and low - fat dairy products , and the DASH low - sodium diet ."
101106,diets,O,3509.0,"Short - term studies indicate that specialized diets may prevent or ameliorate mild hypertension ; most notable are the Dietary Approaches to Stop Hypertension ( DASH ) diet , which is high in fruits , vegetables , and low - fat dairy products , and the DASH low - sodium diet ."
101107,may,O,3509.0,"Short - term studies indicate that specialized diets may prevent or ameliorate mild hypertension ; most notable are the Dietary Approaches to Stop Hypertension ( DASH ) diet , which is high in fruits , vegetables , and low - fat dairy products , and the DASH low - sodium diet ."
101108,prevent,O,3509.0,"Short - term studies indicate that specialized diets may prevent or ameliorate mild hypertension ; most notable are the Dietary Approaches to Stop Hypertension ( DASH ) diet , which is high in fruits , vegetables , and low - fat dairy products , and the DASH low - sodium diet ."
101109,or,O,3509.0,"Short - term studies indicate that specialized diets may prevent or ameliorate mild hypertension ; most notable are the Dietary Approaches to Stop Hypertension ( DASH ) diet , which is high in fruits , vegetables , and low - fat dairy products , and the DASH low - sodium diet ."
101110,ameliorate,O,3509.0,"Short - term studies indicate that specialized diets may prevent or ameliorate mild hypertension ; most notable are the Dietary Approaches to Stop Hypertension ( DASH ) diet , which is high in fruits , vegetables , and low - fat dairy products , and the DASH low - sodium diet ."
101111,mild,O,3509.0,"Short - term studies indicate that specialized diets may prevent or ameliorate mild hypertension ; most notable are the Dietary Approaches to Stop Hypertension ( DASH ) diet , which is high in fruits , vegetables , and low - fat dairy products , and the DASH low - sodium diet ."
101112,hypertension,O,3509.0,"Short - term studies indicate that specialized diets may prevent or ameliorate mild hypertension ; most notable are the Dietary Approaches to Stop Hypertension ( DASH ) diet , which is high in fruits , vegetables , and low - fat dairy products , and the DASH low - sodium diet ."
101113,;,O,3509.0,"Short - term studies indicate that specialized diets may prevent or ameliorate mild hypertension ; most notable are the Dietary Approaches to Stop Hypertension ( DASH ) diet , which is high in fruits , vegetables , and low - fat dairy products , and the DASH low - sodium diet ."
101114,most,O,3509.0,"Short - term studies indicate that specialized diets may prevent or ameliorate mild hypertension ; most notable are the Dietary Approaches to Stop Hypertension ( DASH ) diet , which is high in fruits , vegetables , and low - fat dairy products , and the DASH low - sodium diet ."
101115,notable,O,3509.0,"Short - term studies indicate that specialized diets may prevent or ameliorate mild hypertension ; most notable are the Dietary Approaches to Stop Hypertension ( DASH ) diet , which is high in fruits , vegetables , and low - fat dairy products , and the DASH low - sodium diet ."
101116,are,O,3509.0,"Short - term studies indicate that specialized diets may prevent or ameliorate mild hypertension ; most notable are the Dietary Approaches to Stop Hypertension ( DASH ) diet , which is high in fruits , vegetables , and low - fat dairy products , and the DASH low - sodium diet ."
101117,the,O,3509.0,"Short - term studies indicate that specialized diets may prevent or ameliorate mild hypertension ; most notable are the Dietary Approaches to Stop Hypertension ( DASH ) diet , which is high in fruits , vegetables , and low - fat dairy products , and the DASH low - sodium diet ."
101118,Dietary,O,3509.0,"Short - term studies indicate that specialized diets may prevent or ameliorate mild hypertension ; most notable are the Dietary Approaches to Stop Hypertension ( DASH ) diet , which is high in fruits , vegetables , and low - fat dairy products , and the DASH low - sodium diet ."
101119,Approaches,O,3509.0,"Short - term studies indicate that specialized diets may prevent or ameliorate mild hypertension ; most notable are the Dietary Approaches to Stop Hypertension ( DASH ) diet , which is high in fruits , vegetables , and low - fat dairy products , and the DASH low - sodium diet ."
101120,to,O,3509.0,"Short - term studies indicate that specialized diets may prevent or ameliorate mild hypertension ; most notable are the Dietary Approaches to Stop Hypertension ( DASH ) diet , which is high in fruits , vegetables , and low - fat dairy products , and the DASH low - sodium diet ."
101121,Stop,O,3509.0,"Short - term studies indicate that specialized diets may prevent or ameliorate mild hypertension ; most notable are the Dietary Approaches to Stop Hypertension ( DASH ) diet , which is high in fruits , vegetables , and low - fat dairy products , and the DASH low - sodium diet ."
101122,Hypertension,O,3509.0,"Short - term studies indicate that specialized diets may prevent or ameliorate mild hypertension ; most notable are the Dietary Approaches to Stop Hypertension ( DASH ) diet , which is high in fruits , vegetables , and low - fat dairy products , and the DASH low - sodium diet ."
101123,(,O,3509.0,"Short - term studies indicate that specialized diets may prevent or ameliorate mild hypertension ; most notable are the Dietary Approaches to Stop Hypertension ( DASH ) diet , which is high in fruits , vegetables , and low - fat dairy products , and the DASH low - sodium diet ."
101124,DASH,O,3509.0,"Short - term studies indicate that specialized diets may prevent or ameliorate mild hypertension ; most notable are the Dietary Approaches to Stop Hypertension ( DASH ) diet , which is high in fruits , vegetables , and low - fat dairy products , and the DASH low - sodium diet ."
101125,),O,3509.0,"Short - term studies indicate that specialized diets may prevent or ameliorate mild hypertension ; most notable are the Dietary Approaches to Stop Hypertension ( DASH ) diet , which is high in fruits , vegetables , and low - fat dairy products , and the DASH low - sodium diet ."
101126,diet,O,3509.0,"Short - term studies indicate that specialized diets may prevent or ameliorate mild hypertension ; most notable are the Dietary Approaches to Stop Hypertension ( DASH ) diet , which is high in fruits , vegetables , and low - fat dairy products , and the DASH low - sodium diet ."
101127,",",O,3509.0,"Short - term studies indicate that specialized diets may prevent or ameliorate mild hypertension ; most notable are the Dietary Approaches to Stop Hypertension ( DASH ) diet , which is high in fruits , vegetables , and low - fat dairy products , and the DASH low - sodium diet ."
101128,which,O,3509.0,"Short - term studies indicate that specialized diets may prevent or ameliorate mild hypertension ; most notable are the Dietary Approaches to Stop Hypertension ( DASH ) diet , which is high in fruits , vegetables , and low - fat dairy products , and the DASH low - sodium diet ."
101129,is,O,3509.0,"Short - term studies indicate that specialized diets may prevent or ameliorate mild hypertension ; most notable are the Dietary Approaches to Stop Hypertension ( DASH ) diet , which is high in fruits , vegetables , and low - fat dairy products , and the DASH low - sodium diet ."
101130,high,O,3509.0,"Short - term studies indicate that specialized diets may prevent or ameliorate mild hypertension ; most notable are the Dietary Approaches to Stop Hypertension ( DASH ) diet , which is high in fruits , vegetables , and low - fat dairy products , and the DASH low - sodium diet ."
101131,in,O,3509.0,"Short - term studies indicate that specialized diets may prevent or ameliorate mild hypertension ; most notable are the Dietary Approaches to Stop Hypertension ( DASH ) diet , which is high in fruits , vegetables , and low - fat dairy products , and the DASH low - sodium diet ."
101132,fruits,B-AG.01.h.01,3509.0,"Short - term studies indicate that specialized diets may prevent or ameliorate mild hypertension ; most notable are the Dietary Approaches to Stop Hypertension ( DASH ) diet , which is high in fruits , vegetables , and low - fat dairy products , and the DASH low - sodium diet ."
101133,",",O,3509.0,"Short - term studies indicate that specialized diets may prevent or ameliorate mild hypertension ; most notable are the Dietary Approaches to Stop Hypertension ( DASH ) diet , which is high in fruits , vegetables , and low - fat dairy products , and the DASH low - sodium diet ."
101134,vegetables,B-AG.01.h.02,3509.0,"Short - term studies indicate that specialized diets may prevent or ameliorate mild hypertension ; most notable are the Dietary Approaches to Stop Hypertension ( DASH ) diet , which is high in fruits , vegetables , and low - fat dairy products , and the DASH low - sodium diet ."
101135,",",O,3509.0,"Short - term studies indicate that specialized diets may prevent or ameliorate mild hypertension ; most notable are the Dietary Approaches to Stop Hypertension ( DASH ) diet , which is high in fruits , vegetables , and low - fat dairy products , and the DASH low - sodium diet ."
101136,and,O,3509.0,"Short - term studies indicate that specialized diets may prevent or ameliorate mild hypertension ; most notable are the Dietary Approaches to Stop Hypertension ( DASH ) diet , which is high in fruits , vegetables , and low - fat dairy products , and the DASH low - sodium diet ."
101137,low,B-AG.01.e,3509.0,"Short - term studies indicate that specialized diets may prevent or ameliorate mild hypertension ; most notable are the Dietary Approaches to Stop Hypertension ( DASH ) diet , which is high in fruits , vegetables , and low - fat dairy products , and the DASH low - sodium diet ."
101138,-,I-AG.01.e,3509.0,"Short - term studies indicate that specialized diets may prevent or ameliorate mild hypertension ; most notable are the Dietary Approaches to Stop Hypertension ( DASH ) diet , which is high in fruits , vegetables , and low - fat dairy products , and the DASH low - sodium diet ."
101139,fat,I-AG.01.e,3509.0,"Short - term studies indicate that specialized diets may prevent or ameliorate mild hypertension ; most notable are the Dietary Approaches to Stop Hypertension ( DASH ) diet , which is high in fruits , vegetables , and low - fat dairy products , and the DASH low - sodium diet ."
101140,dairy,I-AG.01.e,3509.0,"Short - term studies indicate that specialized diets may prevent or ameliorate mild hypertension ; most notable are the Dietary Approaches to Stop Hypertension ( DASH ) diet , which is high in fruits , vegetables , and low - fat dairy products , and the DASH low - sodium diet ."
101141,products,I-AG.01.e,3509.0,"Short - term studies indicate that specialized diets may prevent or ameliorate mild hypertension ; most notable are the Dietary Approaches to Stop Hypertension ( DASH ) diet , which is high in fruits , vegetables , and low - fat dairy products , and the DASH low - sodium diet ."
101142,",",O,3509.0,"Short - term studies indicate that specialized diets may prevent or ameliorate mild hypertension ; most notable are the Dietary Approaches to Stop Hypertension ( DASH ) diet , which is high in fruits , vegetables , and low - fat dairy products , and the DASH low - sodium diet ."
101143,and,O,3509.0,"Short - term studies indicate that specialized diets may prevent or ameliorate mild hypertension ; most notable are the Dietary Approaches to Stop Hypertension ( DASH ) diet , which is high in fruits , vegetables , and low - fat dairy products , and the DASH low - sodium diet ."
101144,the,O,3509.0,"Short - term studies indicate that specialized diets may prevent or ameliorate mild hypertension ; most notable are the Dietary Approaches to Stop Hypertension ( DASH ) diet , which is high in fruits , vegetables , and low - fat dairy products , and the DASH low - sodium diet ."
101145,DASH,O,3509.0,"Short - term studies indicate that specialized diets may prevent or ameliorate mild hypertension ; most notable are the Dietary Approaches to Stop Hypertension ( DASH ) diet , which is high in fruits , vegetables , and low - fat dairy products , and the DASH low - sodium diet ."
101146,low,O,3509.0,"Short - term studies indicate that specialized diets may prevent or ameliorate mild hypertension ; most notable are the Dietary Approaches to Stop Hypertension ( DASH ) diet , which is high in fruits , vegetables , and low - fat dairy products , and the DASH low - sodium diet ."
101147,-,O,3509.0,"Short - term studies indicate that specialized diets may prevent or ameliorate mild hypertension ; most notable are the Dietary Approaches to Stop Hypertension ( DASH ) diet , which is high in fruits , vegetables , and low - fat dairy products , and the DASH low - sodium diet ."
101148,sodium,O,3509.0,"Short - term studies indicate that specialized diets may prevent or ameliorate mild hypertension ; most notable are the Dietary Approaches to Stop Hypertension ( DASH ) diet , which is high in fruits , vegetables , and low - fat dairy products , and the DASH low - sodium diet ."
101149,diet,O,3509.0,"Short - term studies indicate that specialized diets may prevent or ameliorate mild hypertension ; most notable are the Dietary Approaches to Stop Hypertension ( DASH ) diet , which is high in fruits , vegetables , and low - fat dairy products , and the DASH low - sodium diet ."
101150,.,O,3509.0,"Short - term studies indicate that specialized diets may prevent or ameliorate mild hypertension ; most notable are the Dietary Approaches to Stop Hypertension ( DASH ) diet , which is high in fruits , vegetables , and low - fat dairy products , and the DASH low - sodium diet ."
101151,Long,O,3510.0,Long - term compliance to these diets remains a major concern .
101152,-,O,3510.0,Long - term compliance to these diets remains a major concern .
101153,term,O,3510.0,Long - term compliance to these diets remains a major concern .
101154,compliance,O,3510.0,Long - term compliance to these diets remains a major concern .
101155,to,O,3510.0,Long - term compliance to these diets remains a major concern .
101156,these,O,3510.0,Long - term compliance to these diets remains a major concern .
101157,diets,O,3510.0,Long - term compliance to these diets remains a major concern .
101158,remains,O,3510.0,Long - term compliance to these diets remains a major concern .
101159,a,O,3510.0,Long - term compliance to these diets remains a major concern .
101160,major,O,3510.0,Long - term compliance to these diets remains a major concern .
101161,concern,O,3510.0,Long - term compliance to these diets remains a major concern .
101162,.,O,3510.0,Long - term compliance to these diets remains a major concern .
101163,Cancer,O,3511.0,Cancer is the second leading cause of death in developed countries and poor diet and physical inactivity are major risk factors in cancer - related deaths .
101164,is,O,3511.0,Cancer is the second leading cause of death in developed countries and poor diet and physical inactivity are major risk factors in cancer - related deaths .
101165,the,O,3511.0,Cancer is the second leading cause of death in developed countries and poor diet and physical inactivity are major risk factors in cancer - related deaths .
101166,second,O,3511.0,Cancer is the second leading cause of death in developed countries and poor diet and physical inactivity are major risk factors in cancer - related deaths .
101167,leading,O,3511.0,Cancer is the second leading cause of death in developed countries and poor diet and physical inactivity are major risk factors in cancer - related deaths .
101168,cause,O,3511.0,Cancer is the second leading cause of death in developed countries and poor diet and physical inactivity are major risk factors in cancer - related deaths .
101169,of,O,3511.0,Cancer is the second leading cause of death in developed countries and poor diet and physical inactivity are major risk factors in cancer - related deaths .
101170,death,O,3511.0,Cancer is the second leading cause of death in developed countries and poor diet and physical inactivity are major risk factors in cancer - related deaths .
101171,in,O,3511.0,Cancer is the second leading cause of death in developed countries and poor diet and physical inactivity are major risk factors in cancer - related deaths .
101172,developed,O,3511.0,Cancer is the second leading cause of death in developed countries and poor diet and physical inactivity are major risk factors in cancer - related deaths .
101173,countries,O,3511.0,Cancer is the second leading cause of death in developed countries and poor diet and physical inactivity are major risk factors in cancer - related deaths .
101174,and,O,3511.0,Cancer is the second leading cause of death in developed countries and poor diet and physical inactivity are major risk factors in cancer - related deaths .
101175,poor,O,3511.0,Cancer is the second leading cause of death in developed countries and poor diet and physical inactivity are major risk factors in cancer - related deaths .
101176,diet,O,3511.0,Cancer is the second leading cause of death in developed countries and poor diet and physical inactivity are major risk factors in cancer - related deaths .
101177,and,O,3511.0,Cancer is the second leading cause of death in developed countries and poor diet and physical inactivity are major risk factors in cancer - related deaths .
101178,physical,O,3511.0,Cancer is the second leading cause of death in developed countries and poor diet and physical inactivity are major risk factors in cancer - related deaths .
101179,inactivity,O,3511.0,Cancer is the second leading cause of death in developed countries and poor diet and physical inactivity are major risk factors in cancer - related deaths .
101180,are,O,3511.0,Cancer is the second leading cause of death in developed countries and poor diet and physical inactivity are major risk factors in cancer - related deaths .
101181,major,O,3511.0,Cancer is the second leading cause of death in developed countries and poor diet and physical inactivity are major risk factors in cancer - related deaths .
101182,risk,O,3511.0,Cancer is the second leading cause of death in developed countries and poor diet and physical inactivity are major risk factors in cancer - related deaths .
101183,factors,O,3511.0,Cancer is the second leading cause of death in developed countries and poor diet and physical inactivity are major risk factors in cancer - related deaths .
101184,in,O,3511.0,Cancer is the second leading cause of death in developed countries and poor diet and physical inactivity are major risk factors in cancer - related deaths .
101185,cancer,O,3511.0,Cancer is the second leading cause of death in developed countries and poor diet and physical inactivity are major risk factors in cancer - related deaths .
101186,-,O,3511.0,Cancer is the second leading cause of death in developed countries and poor diet and physical inactivity are major risk factors in cancer - related deaths .
101187,related,O,3511.0,Cancer is the second leading cause of death in developed countries and poor diet and physical inactivity are major risk factors in cancer - related deaths .
101188,deaths,O,3511.0,Cancer is the second leading cause of death in developed countries and poor diet and physical inactivity are major risk factors in cancer - related deaths .
101189,.,O,3511.0,Cancer is the second leading cause of death in developed countries and poor diet and physical inactivity are major risk factors in cancer - related deaths .
101190,Therefore,O,3512.0,"Therefore , interventions to reduce levels of smoking , improve diet , and increase physical activity must become much higher priorities in the general population 's health and health care systems ."
101191,",",O,3512.0,"Therefore , interventions to reduce levels of smoking , improve diet , and increase physical activity must become much higher priorities in the general population 's health and health care systems ."
101192,interventions,O,3512.0,"Therefore , interventions to reduce levels of smoking , improve diet , and increase physical activity must become much higher priorities in the general population 's health and health care systems ."
101193,to,O,3512.0,"Therefore , interventions to reduce levels of smoking , improve diet , and increase physical activity must become much higher priorities in the general population 's health and health care systems ."
101194,reduce,O,3512.0,"Therefore , interventions to reduce levels of smoking , improve diet , and increase physical activity must become much higher priorities in the general population 's health and health care systems ."
101195,levels,O,3512.0,"Therefore , interventions to reduce levels of smoking , improve diet , and increase physical activity must become much higher priorities in the general population 's health and health care systems ."
101196,of,O,3512.0,"Therefore , interventions to reduce levels of smoking , improve diet , and increase physical activity must become much higher priorities in the general population 's health and health care systems ."
101197,smoking,O,3512.0,"Therefore , interventions to reduce levels of smoking , improve diet , and increase physical activity must become much higher priorities in the general population 's health and health care systems ."
101198,",",O,3512.0,"Therefore , interventions to reduce levels of smoking , improve diet , and increase physical activity must become much higher priorities in the general population 's health and health care systems ."
101199,improve,O,3512.0,"Therefore , interventions to reduce levels of smoking , improve diet , and increase physical activity must become much higher priorities in the general population 's health and health care systems ."
101200,diet,O,3512.0,"Therefore , interventions to reduce levels of smoking , improve diet , and increase physical activity must become much higher priorities in the general population 's health and health care systems ."
101201,",",O,3512.0,"Therefore , interventions to reduce levels of smoking , improve diet , and increase physical activity must become much higher priorities in the general population 's health and health care systems ."
101202,and,O,3512.0,"Therefore , interventions to reduce levels of smoking , improve diet , and increase physical activity must become much higher priorities in the general population 's health and health care systems ."
101203,increase,O,3512.0,"Therefore , interventions to reduce levels of smoking , improve diet , and increase physical activity must become much higher priorities in the general population 's health and health care systems ."
101204,physical,O,3512.0,"Therefore , interventions to reduce levels of smoking , improve diet , and increase physical activity must become much higher priorities in the general population 's health and health care systems ."
101205,activity,O,3512.0,"Therefore , interventions to reduce levels of smoking , improve diet , and increase physical activity must become much higher priorities in the general population 's health and health care systems ."
101206,must,O,3512.0,"Therefore , interventions to reduce levels of smoking , improve diet , and increase physical activity must become much higher priorities in the general population 's health and health care systems ."
101207,become,O,3512.0,"Therefore , interventions to reduce levels of smoking , improve diet , and increase physical activity must become much higher priorities in the general population 's health and health care systems ."
101208,much,O,3512.0,"Therefore , interventions to reduce levels of smoking , improve diet , and increase physical activity must become much higher priorities in the general population 's health and health care systems ."
101209,higher,O,3512.0,"Therefore , interventions to reduce levels of smoking , improve diet , and increase physical activity must become much higher priorities in the general population 's health and health care systems ."
101210,priorities,O,3512.0,"Therefore , interventions to reduce levels of smoking , improve diet , and increase physical activity must become much higher priorities in the general population 's health and health care systems ."
101211,in,O,3512.0,"Therefore , interventions to reduce levels of smoking , improve diet , and increase physical activity must become much higher priorities in the general population 's health and health care systems ."
101212,the,O,3512.0,"Therefore , interventions to reduce levels of smoking , improve diet , and increase physical activity must become much higher priorities in the general population 's health and health care systems ."
101213,general,O,3512.0,"Therefore , interventions to reduce levels of smoking , improve diet , and increase physical activity must become much higher priorities in the general population 's health and health care systems ."
101214,population,O,3512.0,"Therefore , interventions to reduce levels of smoking , improve diet , and increase physical activity must become much higher priorities in the general population 's health and health care systems ."
101215,'s,O,3512.0,"Therefore , interventions to reduce levels of smoking , improve diet , and increase physical activity must become much higher priorities in the general population 's health and health care systems ."
101216,health,O,3512.0,"Therefore , interventions to reduce levels of smoking , improve diet , and increase physical activity must become much higher priorities in the general population 's health and health care systems ."
101217,and,O,3512.0,"Therefore , interventions to reduce levels of smoking , improve diet , and increase physical activity must become much higher priorities in the general population 's health and health care systems ."
101218,health,O,3512.0,"Therefore , interventions to reduce levels of smoking , improve diet , and increase physical activity must become much higher priorities in the general population 's health and health care systems ."
101219,care,O,3512.0,"Therefore , interventions to reduce levels of smoking , improve diet , and increase physical activity must become much higher priorities in the general population 's health and health care systems ."
101220,systems,O,3512.0,"Therefore , interventions to reduce levels of smoking , improve diet , and increase physical activity must become much higher priorities in the general population 's health and health care systems ."
101221,.,O,3512.0,"Therefore , interventions to reduce levels of smoking , improve diet , and increase physical activity must become much higher priorities in the general population 's health and health care systems ."
101222,The,O,3513.0,The consumption of fruit and vegetables exerts a preventive effect towards cancer and in recent years natural dietary agents have attracted great attention in the scientific community and among the general public .
101223,consumption,O,3513.0,The consumption of fruit and vegetables exerts a preventive effect towards cancer and in recent years natural dietary agents have attracted great attention in the scientific community and among the general public .
101224,of,O,3513.0,The consumption of fruit and vegetables exerts a preventive effect towards cancer and in recent years natural dietary agents have attracted great attention in the scientific community and among the general public .
101225,fruit,B-AG.01.h.01,3513.0,The consumption of fruit and vegetables exerts a preventive effect towards cancer and in recent years natural dietary agents have attracted great attention in the scientific community and among the general public .
101226,and,O,3513.0,The consumption of fruit and vegetables exerts a preventive effect towards cancer and in recent years natural dietary agents have attracted great attention in the scientific community and among the general public .
101227,vegetables,B-AG.01.h.02,3513.0,The consumption of fruit and vegetables exerts a preventive effect towards cancer and in recent years natural dietary agents have attracted great attention in the scientific community and among the general public .
101228,exerts,O,3513.0,The consumption of fruit and vegetables exerts a preventive effect towards cancer and in recent years natural dietary agents have attracted great attention in the scientific community and among the general public .
101229,a,O,3513.0,The consumption of fruit and vegetables exerts a preventive effect towards cancer and in recent years natural dietary agents have attracted great attention in the scientific community and among the general public .
101230,preventive,O,3513.0,The consumption of fruit and vegetables exerts a preventive effect towards cancer and in recent years natural dietary agents have attracted great attention in the scientific community and among the general public .
101231,effect,O,3513.0,The consumption of fruit and vegetables exerts a preventive effect towards cancer and in recent years natural dietary agents have attracted great attention in the scientific community and among the general public .
101232,towards,O,3513.0,The consumption of fruit and vegetables exerts a preventive effect towards cancer and in recent years natural dietary agents have attracted great attention in the scientific community and among the general public .
101233,cancer,O,3513.0,The consumption of fruit and vegetables exerts a preventive effect towards cancer and in recent years natural dietary agents have attracted great attention in the scientific community and among the general public .
101234,and,O,3513.0,The consumption of fruit and vegetables exerts a preventive effect towards cancer and in recent years natural dietary agents have attracted great attention in the scientific community and among the general public .
101235,in,O,3513.0,The consumption of fruit and vegetables exerts a preventive effect towards cancer and in recent years natural dietary agents have attracted great attention in the scientific community and among the general public .
101236,recent,O,3513.0,The consumption of fruit and vegetables exerts a preventive effect towards cancer and in recent years natural dietary agents have attracted great attention in the scientific community and among the general public .
101237,years,O,3513.0,The consumption of fruit and vegetables exerts a preventive effect towards cancer and in recent years natural dietary agents have attracted great attention in the scientific community and among the general public .
101238,natural,O,3513.0,The consumption of fruit and vegetables exerts a preventive effect towards cancer and in recent years natural dietary agents have attracted great attention in the scientific community and among the general public .
101239,dietary,O,3513.0,The consumption of fruit and vegetables exerts a preventive effect towards cancer and in recent years natural dietary agents have attracted great attention in the scientific community and among the general public .
101240,agents,O,3513.0,The consumption of fruit and vegetables exerts a preventive effect towards cancer and in recent years natural dietary agents have attracted great attention in the scientific community and among the general public .
101241,have,O,3513.0,The consumption of fruit and vegetables exerts a preventive effect towards cancer and in recent years natural dietary agents have attracted great attention in the scientific community and among the general public .
101242,attracted,O,3513.0,The consumption of fruit and vegetables exerts a preventive effect towards cancer and in recent years natural dietary agents have attracted great attention in the scientific community and among the general public .
101243,great,O,3513.0,The consumption of fruit and vegetables exerts a preventive effect towards cancer and in recent years natural dietary agents have attracted great attention in the scientific community and among the general public .
101244,attention,O,3513.0,The consumption of fruit and vegetables exerts a preventive effect towards cancer and in recent years natural dietary agents have attracted great attention in the scientific community and among the general public .
101245,in,O,3513.0,The consumption of fruit and vegetables exerts a preventive effect towards cancer and in recent years natural dietary agents have attracted great attention in the scientific community and among the general public .
101246,the,O,3513.0,The consumption of fruit and vegetables exerts a preventive effect towards cancer and in recent years natural dietary agents have attracted great attention in the scientific community and among the general public .
101247,scientific,O,3513.0,The consumption of fruit and vegetables exerts a preventive effect towards cancer and in recent years natural dietary agents have attracted great attention in the scientific community and among the general public .
101248,community,O,3513.0,The consumption of fruit and vegetables exerts a preventive effect towards cancer and in recent years natural dietary agents have attracted great attention in the scientific community and among the general public .
101249,and,O,3513.0,The consumption of fruit and vegetables exerts a preventive effect towards cancer and in recent years natural dietary agents have attracted great attention in the scientific community and among the general public .
101250,among,O,3513.0,The consumption of fruit and vegetables exerts a preventive effect towards cancer and in recent years natural dietary agents have attracted great attention in the scientific community and among the general public .
101251,the,O,3513.0,The consumption of fruit and vegetables exerts a preventive effect towards cancer and in recent years natural dietary agents have attracted great attention in the scientific community and among the general public .
101252,general,O,3513.0,The consumption of fruit and vegetables exerts a preventive effect towards cancer and in recent years natural dietary agents have attracted great attention in the scientific community and among the general public .
101253,public,O,3513.0,The consumption of fruit and vegetables exerts a preventive effect towards cancer and in recent years natural dietary agents have attracted great attention in the scientific community and among the general public .
101254,.,O,3513.0,The consumption of fruit and vegetables exerts a preventive effect towards cancer and in recent years natural dietary agents have attracted great attention in the scientific community and among the general public .
101255,Foods,O,3514.0,"Foods , such as tomatoes , olive oil , broccoli , garlic , onions , berries , soy bean , honey , tea , aloe vera , grapes , rosemary , basil , chili peppers , carrots , pomegranate , and curcuma contain active components that can influence the initiation and the progression of carcinogenesis , acting on pathways implied in cell proliferation , apoptosis and metastasis ."
101256,",",O,3514.0,"Foods , such as tomatoes , olive oil , broccoli , garlic , onions , berries , soy bean , honey , tea , aloe vera , grapes , rosemary , basil , chili peppers , carrots , pomegranate , and curcuma contain active components that can influence the initiation and the progression of carcinogenesis , acting on pathways implied in cell proliferation , apoptosis and metastasis ."
101257,such,O,3514.0,"Foods , such as tomatoes , olive oil , broccoli , garlic , onions , berries , soy bean , honey , tea , aloe vera , grapes , rosemary , basil , chili peppers , carrots , pomegranate , and curcuma contain active components that can influence the initiation and the progression of carcinogenesis , acting on pathways implied in cell proliferation , apoptosis and metastasis ."
101258,as,O,3514.0,"Foods , such as tomatoes , olive oil , broccoli , garlic , onions , berries , soy bean , honey , tea , aloe vera , grapes , rosemary , basil , chili peppers , carrots , pomegranate , and curcuma contain active components that can influence the initiation and the progression of carcinogenesis , acting on pathways implied in cell proliferation , apoptosis and metastasis ."
101259,tomatoes,B-AG.01.h.02.f,3514.0,"Foods , such as tomatoes , olive oil , broccoli , garlic , onions , berries , soy bean , honey , tea , aloe vera , grapes , rosemary , basil , chili peppers , carrots , pomegranate , and curcuma contain active components that can influence the initiation and the progression of carcinogenesis , acting on pathways implied in cell proliferation , apoptosis and metastasis ."
101260,",",O,3514.0,"Foods , such as tomatoes , olive oil , broccoli , garlic , onions , berries , soy bean , honey , tea , aloe vera , grapes , rosemary , basil , chili peppers , carrots , pomegranate , and curcuma contain active components that can influence the initiation and the progression of carcinogenesis , acting on pathways implied in cell proliferation , apoptosis and metastasis ."
101261,olive,B-AG.01.f,3514.0,"Foods , such as tomatoes , olive oil , broccoli , garlic , onions , berries , soy bean , honey , tea , aloe vera , grapes , rosemary , basil , chili peppers , carrots , pomegranate , and curcuma contain active components that can influence the initiation and the progression of carcinogenesis , acting on pathways implied in cell proliferation , apoptosis and metastasis ."
101262,oil,I-AG.01.f,3514.0,"Foods , such as tomatoes , olive oil , broccoli , garlic , onions , berries , soy bean , honey , tea , aloe vera , grapes , rosemary , basil , chili peppers , carrots , pomegranate , and curcuma contain active components that can influence the initiation and the progression of carcinogenesis , acting on pathways implied in cell proliferation , apoptosis and metastasis ."
101263,",",O,3514.0,"Foods , such as tomatoes , olive oil , broccoli , garlic , onions , berries , soy bean , honey , tea , aloe vera , grapes , rosemary , basil , chili peppers , carrots , pomegranate , and curcuma contain active components that can influence the initiation and the progression of carcinogenesis , acting on pathways implied in cell proliferation , apoptosis and metastasis ."
101264,broccoli,B-AG.01.h.02.d,3514.0,"Foods , such as tomatoes , olive oil , broccoli , garlic , onions , berries , soy bean , honey , tea , aloe vera , grapes , rosemary , basil , chili peppers , carrots , pomegranate , and curcuma contain active components that can influence the initiation and the progression of carcinogenesis , acting on pathways implied in cell proliferation , apoptosis and metastasis ."
101265,",",O,3514.0,"Foods , such as tomatoes , olive oil , broccoli , garlic , onions , berries , soy bean , honey , tea , aloe vera , grapes , rosemary , basil , chili peppers , carrots , pomegranate , and curcuma contain active components that can influence the initiation and the progression of carcinogenesis , acting on pathways implied in cell proliferation , apoptosis and metastasis ."
101266,garlic,B-AG.01.h.02.e,3514.0,"Foods , such as tomatoes , olive oil , broccoli , garlic , onions , berries , soy bean , honey , tea , aloe vera , grapes , rosemary , basil , chili peppers , carrots , pomegranate , and curcuma contain active components that can influence the initiation and the progression of carcinogenesis , acting on pathways implied in cell proliferation , apoptosis and metastasis ."
101267,",",O,3514.0,"Foods , such as tomatoes , olive oil , broccoli , garlic , onions , berries , soy bean , honey , tea , aloe vera , grapes , rosemary , basil , chili peppers , carrots , pomegranate , and curcuma contain active components that can influence the initiation and the progression of carcinogenesis , acting on pathways implied in cell proliferation , apoptosis and metastasis ."
101268,onions,B-AG.01.h.02.e,3514.0,"Foods , such as tomatoes , olive oil , broccoli , garlic , onions , berries , soy bean , honey , tea , aloe vera , grapes , rosemary , basil , chili peppers , carrots , pomegranate , and curcuma contain active components that can influence the initiation and the progression of carcinogenesis , acting on pathways implied in cell proliferation , apoptosis and metastasis ."
101269,",",O,3514.0,"Foods , such as tomatoes , olive oil , broccoli , garlic , onions , berries , soy bean , honey , tea , aloe vera , grapes , rosemary , basil , chili peppers , carrots , pomegranate , and curcuma contain active components that can influence the initiation and the progression of carcinogenesis , acting on pathways implied in cell proliferation , apoptosis and metastasis ."
101270,berries,B-AG.01.h.01.b,3514.0,"Foods , such as tomatoes , olive oil , broccoli , garlic , onions , berries , soy bean , honey , tea , aloe vera , grapes , rosemary , basil , chili peppers , carrots , pomegranate , and curcuma contain active components that can influence the initiation and the progression of carcinogenesis , acting on pathways implied in cell proliferation , apoptosis and metastasis ."
101271,",",O,3514.0,"Foods , such as tomatoes , olive oil , broccoli , garlic , onions , berries , soy bean , honey , tea , aloe vera , grapes , rosemary , basil , chili peppers , carrots , pomegranate , and curcuma contain active components that can influence the initiation and the progression of carcinogenesis , acting on pathways implied in cell proliferation , apoptosis and metastasis ."
101272,soy,B-AG.01.h.02.g,3514.0,"Foods , such as tomatoes , olive oil , broccoli , garlic , onions , berries , soy bean , honey , tea , aloe vera , grapes , rosemary , basil , chili peppers , carrots , pomegranate , and curcuma contain active components that can influence the initiation and the progression of carcinogenesis , acting on pathways implied in cell proliferation , apoptosis and metastasis ."
101273,bean,I-AG.01.h.02.g,3514.0,"Foods , such as tomatoes , olive oil , broccoli , garlic , onions , berries , soy bean , honey , tea , aloe vera , grapes , rosemary , basil , chili peppers , carrots , pomegranate , and curcuma contain active components that can influence the initiation and the progression of carcinogenesis , acting on pathways implied in cell proliferation , apoptosis and metastasis ."
101274,",",O,3514.0,"Foods , such as tomatoes , olive oil , broccoli , garlic , onions , berries , soy bean , honey , tea , aloe vera , grapes , rosemary , basil , chili peppers , carrots , pomegranate , and curcuma contain active components that can influence the initiation and the progression of carcinogenesis , acting on pathways implied in cell proliferation , apoptosis and metastasis ."
101275,honey,B-AG.01.l.02,3514.0,"Foods , such as tomatoes , olive oil , broccoli , garlic , onions , berries , soy bean , honey , tea , aloe vera , grapes , rosemary , basil , chili peppers , carrots , pomegranate , and curcuma contain active components that can influence the initiation and the progression of carcinogenesis , acting on pathways implied in cell proliferation , apoptosis and metastasis ."
101276,",",O,3514.0,"Foods , such as tomatoes , olive oil , broccoli , garlic , onions , berries , soy bean , honey , tea , aloe vera , grapes , rosemary , basil , chili peppers , carrots , pomegranate , and curcuma contain active components that can influence the initiation and the progression of carcinogenesis , acting on pathways implied in cell proliferation , apoptosis and metastasis ."
101277,tea,B-AG.01.ac,3514.0,"Foods , such as tomatoes , olive oil , broccoli , garlic , onions , berries , soy bean , honey , tea , aloe vera , grapes , rosemary , basil , chili peppers , carrots , pomegranate , and curcuma contain active components that can influence the initiation and the progression of carcinogenesis , acting on pathways implied in cell proliferation , apoptosis and metastasis ."
101278,",",O,3514.0,"Foods , such as tomatoes , olive oil , broccoli , garlic , onions , berries , soy bean , honey , tea , aloe vera , grapes , rosemary , basil , chili peppers , carrots , pomegranate , and curcuma contain active components that can influence the initiation and the progression of carcinogenesis , acting on pathways implied in cell proliferation , apoptosis and metastasis ."
101279,aloe,B-AG.01,3514.0,"Foods , such as tomatoes , olive oil , broccoli , garlic , onions , berries , soy bean , honey , tea , aloe vera , grapes , rosemary , basil , chili peppers , carrots , pomegranate , and curcuma contain active components that can influence the initiation and the progression of carcinogenesis , acting on pathways implied in cell proliferation , apoptosis and metastasis ."
101280,vera,I-AG.01,3514.0,"Foods , such as tomatoes , olive oil , broccoli , garlic , onions , berries , soy bean , honey , tea , aloe vera , grapes , rosemary , basil , chili peppers , carrots , pomegranate , and curcuma contain active components that can influence the initiation and the progression of carcinogenesis , acting on pathways implied in cell proliferation , apoptosis and metastasis ."
101281,",",O,3514.0,"Foods , such as tomatoes , olive oil , broccoli , garlic , onions , berries , soy bean , honey , tea , aloe vera , grapes , rosemary , basil , chili peppers , carrots , pomegranate , and curcuma contain active components that can influence the initiation and the progression of carcinogenesis , acting on pathways implied in cell proliferation , apoptosis and metastasis ."
101282,grapes,B-AG.01.h.01.b,3514.0,"Foods , such as tomatoes , olive oil , broccoli , garlic , onions , berries , soy bean , honey , tea , aloe vera , grapes , rosemary , basil , chili peppers , carrots , pomegranate , and curcuma contain active components that can influence the initiation and the progression of carcinogenesis , acting on pathways implied in cell proliferation , apoptosis and metastasis ."
101283,",",O,3514.0,"Foods , such as tomatoes , olive oil , broccoli , garlic , onions , berries , soy bean , honey , tea , aloe vera , grapes , rosemary , basil , chili peppers , carrots , pomegranate , and curcuma contain active components that can influence the initiation and the progression of carcinogenesis , acting on pathways implied in cell proliferation , apoptosis and metastasis ."
101284,rosemary,B-AG.01.h.02.i,3514.0,"Foods , such as tomatoes , olive oil , broccoli , garlic , onions , berries , soy bean , honey , tea , aloe vera , grapes , rosemary , basil , chili peppers , carrots , pomegranate , and curcuma contain active components that can influence the initiation and the progression of carcinogenesis , acting on pathways implied in cell proliferation , apoptosis and metastasis ."
101285,",",O,3514.0,"Foods , such as tomatoes , olive oil , broccoli , garlic , onions , berries , soy bean , honey , tea , aloe vera , grapes , rosemary , basil , chili peppers , carrots , pomegranate , and curcuma contain active components that can influence the initiation and the progression of carcinogenesis , acting on pathways implied in cell proliferation , apoptosis and metastasis ."
101286,basil,B-AG.01.l.03,3514.0,"Foods , such as tomatoes , olive oil , broccoli , garlic , onions , berries , soy bean , honey , tea , aloe vera , grapes , rosemary , basil , chili peppers , carrots , pomegranate , and curcuma contain active components that can influence the initiation and the progression of carcinogenesis , acting on pathways implied in cell proliferation , apoptosis and metastasis ."
101287,",",O,3514.0,"Foods , such as tomatoes , olive oil , broccoli , garlic , onions , berries , soy bean , honey , tea , aloe vera , grapes , rosemary , basil , chili peppers , carrots , pomegranate , and curcuma contain active components that can influence the initiation and the progression of carcinogenesis , acting on pathways implied in cell proliferation , apoptosis and metastasis ."
101288,chili,B-AG.01.h.02.f,3514.0,"Foods , such as tomatoes , olive oil , broccoli , garlic , onions , berries , soy bean , honey , tea , aloe vera , grapes , rosemary , basil , chili peppers , carrots , pomegranate , and curcuma contain active components that can influence the initiation and the progression of carcinogenesis , acting on pathways implied in cell proliferation , apoptosis and metastasis ."
101289,peppers,I-AG.01.h.02.f,3514.0,"Foods , such as tomatoes , olive oil , broccoli , garlic , onions , berries , soy bean , honey , tea , aloe vera , grapes , rosemary , basil , chili peppers , carrots , pomegranate , and curcuma contain active components that can influence the initiation and the progression of carcinogenesis , acting on pathways implied in cell proliferation , apoptosis and metastasis ."
101290,",",O,3514.0,"Foods , such as tomatoes , olive oil , broccoli , garlic , onions , berries , soy bean , honey , tea , aloe vera , grapes , rosemary , basil , chili peppers , carrots , pomegranate , and curcuma contain active components that can influence the initiation and the progression of carcinogenesis , acting on pathways implied in cell proliferation , apoptosis and metastasis ."
101291,carrots,B-AG.01.h.02.a,3514.0,"Foods , such as tomatoes , olive oil , broccoli , garlic , onions , berries , soy bean , honey , tea , aloe vera , grapes , rosemary , basil , chili peppers , carrots , pomegranate , and curcuma contain active components that can influence the initiation and the progression of carcinogenesis , acting on pathways implied in cell proliferation , apoptosis and metastasis ."
101292,",",O,3514.0,"Foods , such as tomatoes , olive oil , broccoli , garlic , onions , berries , soy bean , honey , tea , aloe vera , grapes , rosemary , basil , chili peppers , carrots , pomegranate , and curcuma contain active components that can influence the initiation and the progression of carcinogenesis , acting on pathways implied in cell proliferation , apoptosis and metastasis ."
101293,pomegranate,B-AG.01.h.01,3514.0,"Foods , such as tomatoes , olive oil , broccoli , garlic , onions , berries , soy bean , honey , tea , aloe vera , grapes , rosemary , basil , chili peppers , carrots , pomegranate , and curcuma contain active components that can influence the initiation and the progression of carcinogenesis , acting on pathways implied in cell proliferation , apoptosis and metastasis ."
101294,",",O,3514.0,"Foods , such as tomatoes , olive oil , broccoli , garlic , onions , berries , soy bean , honey , tea , aloe vera , grapes , rosemary , basil , chili peppers , carrots , pomegranate , and curcuma contain active components that can influence the initiation and the progression of carcinogenesis , acting on pathways implied in cell proliferation , apoptosis and metastasis ."
101295,and,O,3514.0,"Foods , such as tomatoes , olive oil , broccoli , garlic , onions , berries , soy bean , honey , tea , aloe vera , grapes , rosemary , basil , chili peppers , carrots , pomegranate , and curcuma contain active components that can influence the initiation and the progression of carcinogenesis , acting on pathways implied in cell proliferation , apoptosis and metastasis ."
101296,curcuma,B-AG.01.l.03,3514.0,"Foods , such as tomatoes , olive oil , broccoli , garlic , onions , berries , soy bean , honey , tea , aloe vera , grapes , rosemary , basil , chili peppers , carrots , pomegranate , and curcuma contain active components that can influence the initiation and the progression of carcinogenesis , acting on pathways implied in cell proliferation , apoptosis and metastasis ."
101297,contain,O,3514.0,"Foods , such as tomatoes , olive oil , broccoli , garlic , onions , berries , soy bean , honey , tea , aloe vera , grapes , rosemary , basil , chili peppers , carrots , pomegranate , and curcuma contain active components that can influence the initiation and the progression of carcinogenesis , acting on pathways implied in cell proliferation , apoptosis and metastasis ."
101298,active,O,3514.0,"Foods , such as tomatoes , olive oil , broccoli , garlic , onions , berries , soy bean , honey , tea , aloe vera , grapes , rosemary , basil , chili peppers , carrots , pomegranate , and curcuma contain active components that can influence the initiation and the progression of carcinogenesis , acting on pathways implied in cell proliferation , apoptosis and metastasis ."
101299,components,O,3514.0,"Foods , such as tomatoes , olive oil , broccoli , garlic , onions , berries , soy bean , honey , tea , aloe vera , grapes , rosemary , basil , chili peppers , carrots , pomegranate , and curcuma contain active components that can influence the initiation and the progression of carcinogenesis , acting on pathways implied in cell proliferation , apoptosis and metastasis ."
101300,that,O,3514.0,"Foods , such as tomatoes , olive oil , broccoli , garlic , onions , berries , soy bean , honey , tea , aloe vera , grapes , rosemary , basil , chili peppers , carrots , pomegranate , and curcuma contain active components that can influence the initiation and the progression of carcinogenesis , acting on pathways implied in cell proliferation , apoptosis and metastasis ."
101301,can,O,3514.0,"Foods , such as tomatoes , olive oil , broccoli , garlic , onions , berries , soy bean , honey , tea , aloe vera , grapes , rosemary , basil , chili peppers , carrots , pomegranate , and curcuma contain active components that can influence the initiation and the progression of carcinogenesis , acting on pathways implied in cell proliferation , apoptosis and metastasis ."
101302,influence,O,3514.0,"Foods , such as tomatoes , olive oil , broccoli , garlic , onions , berries , soy bean , honey , tea , aloe vera , grapes , rosemary , basil , chili peppers , carrots , pomegranate , and curcuma contain active components that can influence the initiation and the progression of carcinogenesis , acting on pathways implied in cell proliferation , apoptosis and metastasis ."
101303,the,O,3514.0,"Foods , such as tomatoes , olive oil , broccoli , garlic , onions , berries , soy bean , honey , tea , aloe vera , grapes , rosemary , basil , chili peppers , carrots , pomegranate , and curcuma contain active components that can influence the initiation and the progression of carcinogenesis , acting on pathways implied in cell proliferation , apoptosis and metastasis ."
101304,initiation,O,3514.0,"Foods , such as tomatoes , olive oil , broccoli , garlic , onions , berries , soy bean , honey , tea , aloe vera , grapes , rosemary , basil , chili peppers , carrots , pomegranate , and curcuma contain active components that can influence the initiation and the progression of carcinogenesis , acting on pathways implied in cell proliferation , apoptosis and metastasis ."
101305,and,O,3514.0,"Foods , such as tomatoes , olive oil , broccoli , garlic , onions , berries , soy bean , honey , tea , aloe vera , grapes , rosemary , basil , chili peppers , carrots , pomegranate , and curcuma contain active components that can influence the initiation and the progression of carcinogenesis , acting on pathways implied in cell proliferation , apoptosis and metastasis ."
101306,the,O,3514.0,"Foods , such as tomatoes , olive oil , broccoli , garlic , onions , berries , soy bean , honey , tea , aloe vera , grapes , rosemary , basil , chili peppers , carrots , pomegranate , and curcuma contain active components that can influence the initiation and the progression of carcinogenesis , acting on pathways implied in cell proliferation , apoptosis and metastasis ."
101307,progression,O,3514.0,"Foods , such as tomatoes , olive oil , broccoli , garlic , onions , berries , soy bean , honey , tea , aloe vera , grapes , rosemary , basil , chili peppers , carrots , pomegranate , and curcuma contain active components that can influence the initiation and the progression of carcinogenesis , acting on pathways implied in cell proliferation , apoptosis and metastasis ."
101308,of,O,3514.0,"Foods , such as tomatoes , olive oil , broccoli , garlic , onions , berries , soy bean , honey , tea , aloe vera , grapes , rosemary , basil , chili peppers , carrots , pomegranate , and curcuma contain active components that can influence the initiation and the progression of carcinogenesis , acting on pathways implied in cell proliferation , apoptosis and metastasis ."
101309,carcinogenesis,O,3514.0,"Foods , such as tomatoes , olive oil , broccoli , garlic , onions , berries , soy bean , honey , tea , aloe vera , grapes , rosemary , basil , chili peppers , carrots , pomegranate , and curcuma contain active components that can influence the initiation and the progression of carcinogenesis , acting on pathways implied in cell proliferation , apoptosis and metastasis ."
101310,",",O,3514.0,"Foods , such as tomatoes , olive oil , broccoli , garlic , onions , berries , soy bean , honey , tea , aloe vera , grapes , rosemary , basil , chili peppers , carrots , pomegranate , and curcuma contain active components that can influence the initiation and the progression of carcinogenesis , acting on pathways implied in cell proliferation , apoptosis and metastasis ."
101311,acting,O,3514.0,"Foods , such as tomatoes , olive oil , broccoli , garlic , onions , berries , soy bean , honey , tea , aloe vera , grapes , rosemary , basil , chili peppers , carrots , pomegranate , and curcuma contain active components that can influence the initiation and the progression of carcinogenesis , acting on pathways implied in cell proliferation , apoptosis and metastasis ."
101312,on,O,3514.0,"Foods , such as tomatoes , olive oil , broccoli , garlic , onions , berries , soy bean , honey , tea , aloe vera , grapes , rosemary , basil , chili peppers , carrots , pomegranate , and curcuma contain active components that can influence the initiation and the progression of carcinogenesis , acting on pathways implied in cell proliferation , apoptosis and metastasis ."
101313,pathways,O,3514.0,"Foods , such as tomatoes , olive oil , broccoli , garlic , onions , berries , soy bean , honey , tea , aloe vera , grapes , rosemary , basil , chili peppers , carrots , pomegranate , and curcuma contain active components that can influence the initiation and the progression of carcinogenesis , acting on pathways implied in cell proliferation , apoptosis and metastasis ."
101314,implied,O,3514.0,"Foods , such as tomatoes , olive oil , broccoli , garlic , onions , berries , soy bean , honey , tea , aloe vera , grapes , rosemary , basil , chili peppers , carrots , pomegranate , and curcuma contain active components that can influence the initiation and the progression of carcinogenesis , acting on pathways implied in cell proliferation , apoptosis and metastasis ."
101315,in,O,3514.0,"Foods , such as tomatoes , olive oil , broccoli , garlic , onions , berries , soy bean , honey , tea , aloe vera , grapes , rosemary , basil , chili peppers , carrots , pomegranate , and curcuma contain active components that can influence the initiation and the progression of carcinogenesis , acting on pathways implied in cell proliferation , apoptosis and metastasis ."
101316,cell,O,3514.0,"Foods , such as tomatoes , olive oil , broccoli , garlic , onions , berries , soy bean , honey , tea , aloe vera , grapes , rosemary , basil , chili peppers , carrots , pomegranate , and curcuma contain active components that can influence the initiation and the progression of carcinogenesis , acting on pathways implied in cell proliferation , apoptosis and metastasis ."
101317,proliferation,O,3514.0,"Foods , such as tomatoes , olive oil , broccoli , garlic , onions , berries , soy bean , honey , tea , aloe vera , grapes , rosemary , basil , chili peppers , carrots , pomegranate , and curcuma contain active components that can influence the initiation and the progression of carcinogenesis , acting on pathways implied in cell proliferation , apoptosis and metastasis ."
101318,",",O,3514.0,"Foods , such as tomatoes , olive oil , broccoli , garlic , onions , berries , soy bean , honey , tea , aloe vera , grapes , rosemary , basil , chili peppers , carrots , pomegranate , and curcuma contain active components that can influence the initiation and the progression of carcinogenesis , acting on pathways implied in cell proliferation , apoptosis and metastasis ."
101319,apoptosis,O,3514.0,"Foods , such as tomatoes , olive oil , broccoli , garlic , onions , berries , soy bean , honey , tea , aloe vera , grapes , rosemary , basil , chili peppers , carrots , pomegranate , and curcuma contain active components that can influence the initiation and the progression of carcinogenesis , acting on pathways implied in cell proliferation , apoptosis and metastasis ."
101320,and,O,3514.0,"Foods , such as tomatoes , olive oil , broccoli , garlic , onions , berries , soy bean , honey , tea , aloe vera , grapes , rosemary , basil , chili peppers , carrots , pomegranate , and curcuma contain active components that can influence the initiation and the progression of carcinogenesis , acting on pathways implied in cell proliferation , apoptosis and metastasis ."
101321,metastasis,O,3514.0,"Foods , such as tomatoes , olive oil , broccoli , garlic , onions , berries , soy bean , honey , tea , aloe vera , grapes , rosemary , basil , chili peppers , carrots , pomegranate , and curcuma contain active components that can influence the initiation and the progression of carcinogenesis , acting on pathways implied in cell proliferation , apoptosis and metastasis ."
101322,.,O,3514.0,"Foods , such as tomatoes , olive oil , broccoli , garlic , onions , berries , soy bean , honey , tea , aloe vera , grapes , rosemary , basil , chili peppers , carrots , pomegranate , and curcuma contain active components that can influence the initiation and the progression of carcinogenesis , acting on pathways implied in cell proliferation , apoptosis and metastasis ."
101323,The,O,3515.0,"The present review illustrates the main foods and their active components , including their antioxidant , cytotoxic , and pro - apoptotic properties , with a particular focus on the evidence related to cancers of the digestive system ."
101324,present,O,3515.0,"The present review illustrates the main foods and their active components , including their antioxidant , cytotoxic , and pro - apoptotic properties , with a particular focus on the evidence related to cancers of the digestive system ."
101325,review,O,3515.0,"The present review illustrates the main foods and their active components , including their antioxidant , cytotoxic , and pro - apoptotic properties , with a particular focus on the evidence related to cancers of the digestive system ."
101326,illustrates,O,3515.0,"The present review illustrates the main foods and their active components , including their antioxidant , cytotoxic , and pro - apoptotic properties , with a particular focus on the evidence related to cancers of the digestive system ."
101327,the,O,3515.0,"The present review illustrates the main foods and their active components , including their antioxidant , cytotoxic , and pro - apoptotic properties , with a particular focus on the evidence related to cancers of the digestive system ."
101328,main,O,3515.0,"The present review illustrates the main foods and their active components , including their antioxidant , cytotoxic , and pro - apoptotic properties , with a particular focus on the evidence related to cancers of the digestive system ."
101329,foods,O,3515.0,"The present review illustrates the main foods and their active components , including their antioxidant , cytotoxic , and pro - apoptotic properties , with a particular focus on the evidence related to cancers of the digestive system ."
101330,and,O,3515.0,"The present review illustrates the main foods and their active components , including their antioxidant , cytotoxic , and pro - apoptotic properties , with a particular focus on the evidence related to cancers of the digestive system ."
101331,their,O,3515.0,"The present review illustrates the main foods and their active components , including their antioxidant , cytotoxic , and pro - apoptotic properties , with a particular focus on the evidence related to cancers of the digestive system ."
101332,active,O,3515.0,"The present review illustrates the main foods and their active components , including their antioxidant , cytotoxic , and pro - apoptotic properties , with a particular focus on the evidence related to cancers of the digestive system ."
101333,components,O,3515.0,"The present review illustrates the main foods and their active components , including their antioxidant , cytotoxic , and pro - apoptotic properties , with a particular focus on the evidence related to cancers of the digestive system ."
101334,",",O,3515.0,"The present review illustrates the main foods and their active components , including their antioxidant , cytotoxic , and pro - apoptotic properties , with a particular focus on the evidence related to cancers of the digestive system ."
101335,including,O,3515.0,"The present review illustrates the main foods and their active components , including their antioxidant , cytotoxic , and pro - apoptotic properties , with a particular focus on the evidence related to cancers of the digestive system ."
101336,their,O,3515.0,"The present review illustrates the main foods and their active components , including their antioxidant , cytotoxic , and pro - apoptotic properties , with a particular focus on the evidence related to cancers of the digestive system ."
101337,antioxidant,O,3515.0,"The present review illustrates the main foods and their active components , including their antioxidant , cytotoxic , and pro - apoptotic properties , with a particular focus on the evidence related to cancers of the digestive system ."
101338,",",O,3515.0,"The present review illustrates the main foods and their active components , including their antioxidant , cytotoxic , and pro - apoptotic properties , with a particular focus on the evidence related to cancers of the digestive system ."
101339,cytotoxic,O,3515.0,"The present review illustrates the main foods and their active components , including their antioxidant , cytotoxic , and pro - apoptotic properties , with a particular focus on the evidence related to cancers of the digestive system ."
101340,",",O,3515.0,"The present review illustrates the main foods and their active components , including their antioxidant , cytotoxic , and pro - apoptotic properties , with a particular focus on the evidence related to cancers of the digestive system ."
101341,and,O,3515.0,"The present review illustrates the main foods and their active components , including their antioxidant , cytotoxic , and pro - apoptotic properties , with a particular focus on the evidence related to cancers of the digestive system ."
101342,pro,O,3515.0,"The present review illustrates the main foods and their active components , including their antioxidant , cytotoxic , and pro - apoptotic properties , with a particular focus on the evidence related to cancers of the digestive system ."
101343,-,O,3515.0,"The present review illustrates the main foods and their active components , including their antioxidant , cytotoxic , and pro - apoptotic properties , with a particular focus on the evidence related to cancers of the digestive system ."
101344,apoptotic,O,3515.0,"The present review illustrates the main foods and their active components , including their antioxidant , cytotoxic , and pro - apoptotic properties , with a particular focus on the evidence related to cancers of the digestive system ."
101345,properties,O,3515.0,"The present review illustrates the main foods and their active components , including their antioxidant , cytotoxic , and pro - apoptotic properties , with a particular focus on the evidence related to cancers of the digestive system ."
101346,",",O,3515.0,"The present review illustrates the main foods and their active components , including their antioxidant , cytotoxic , and pro - apoptotic properties , with a particular focus on the evidence related to cancers of the digestive system ."
101347,with,O,3515.0,"The present review illustrates the main foods and their active components , including their antioxidant , cytotoxic , and pro - apoptotic properties , with a particular focus on the evidence related to cancers of the digestive system ."
101348,a,O,3515.0,"The present review illustrates the main foods and their active components , including their antioxidant , cytotoxic , and pro - apoptotic properties , with a particular focus on the evidence related to cancers of the digestive system ."
101349,particular,O,3515.0,"The present review illustrates the main foods and their active components , including their antioxidant , cytotoxic , and pro - apoptotic properties , with a particular focus on the evidence related to cancers of the digestive system ."
101350,focus,O,3515.0,"The present review illustrates the main foods and their active components , including their antioxidant , cytotoxic , and pro - apoptotic properties , with a particular focus on the evidence related to cancers of the digestive system ."
101351,on,O,3515.0,"The present review illustrates the main foods and their active components , including their antioxidant , cytotoxic , and pro - apoptotic properties , with a particular focus on the evidence related to cancers of the digestive system ."
101352,the,O,3515.0,"The present review illustrates the main foods and their active components , including their antioxidant , cytotoxic , and pro - apoptotic properties , with a particular focus on the evidence related to cancers of the digestive system ."
101353,evidence,O,3515.0,"The present review illustrates the main foods and their active components , including their antioxidant , cytotoxic , and pro - apoptotic properties , with a particular focus on the evidence related to cancers of the digestive system ."
101354,related,O,3515.0,"The present review illustrates the main foods and their active components , including their antioxidant , cytotoxic , and pro - apoptotic properties , with a particular focus on the evidence related to cancers of the digestive system ."
101355,to,O,3515.0,"The present review illustrates the main foods and their active components , including their antioxidant , cytotoxic , and pro - apoptotic properties , with a particular focus on the evidence related to cancers of the digestive system ."
101356,cancers,O,3515.0,"The present review illustrates the main foods and their active components , including their antioxidant , cytotoxic , and pro - apoptotic properties , with a particular focus on the evidence related to cancers of the digestive system ."
101357,of,O,3515.0,"The present review illustrates the main foods and their active components , including their antioxidant , cytotoxic , and pro - apoptotic properties , with a particular focus on the evidence related to cancers of the digestive system ."
101358,the,O,3515.0,"The present review illustrates the main foods and their active components , including their antioxidant , cytotoxic , and pro - apoptotic properties , with a particular focus on the evidence related to cancers of the digestive system ."
101359,digestive,O,3515.0,"The present review illustrates the main foods and their active components , including their antioxidant , cytotoxic , and pro - apoptotic properties , with a particular focus on the evidence related to cancers of the digestive system ."
101360,system,O,3515.0,"The present review illustrates the main foods and their active components , including their antioxidant , cytotoxic , and pro - apoptotic properties , with a particular focus on the evidence related to cancers of the digestive system ."
101361,.,O,3515.0,"The present review illustrates the main foods and their active components , including their antioxidant , cytotoxic , and pro - apoptotic properties , with a particular focus on the evidence related to cancers of the digestive system ."
101362,In,O,3516.0,"In the time period 1996 - 2004 , 697 cases with lymphoid neoplasms and 3606 controls with nonneoplastic conditions were included in a case - control study conducted in the Cancer Institute of Uruguay ."
101363,the,O,3516.0,"In the time period 1996 - 2004 , 697 cases with lymphoid neoplasms and 3606 controls with nonneoplastic conditions were included in a case - control study conducted in the Cancer Institute of Uruguay ."
101364,time,O,3516.0,"In the time period 1996 - 2004 , 697 cases with lymphoid neoplasms and 3606 controls with nonneoplastic conditions were included in a case - control study conducted in the Cancer Institute of Uruguay ."
101365,period,O,3516.0,"In the time period 1996 - 2004 , 697 cases with lymphoid neoplasms and 3606 controls with nonneoplastic conditions were included in a case - control study conducted in the Cancer Institute of Uruguay ."
101366,1996,O,3516.0,"In the time period 1996 - 2004 , 697 cases with lymphoid neoplasms and 3606 controls with nonneoplastic conditions were included in a case - control study conducted in the Cancer Institute of Uruguay ."
101367,-,O,3516.0,"In the time period 1996 - 2004 , 697 cases with lymphoid neoplasms and 3606 controls with nonneoplastic conditions were included in a case - control study conducted in the Cancer Institute of Uruguay ."
101368,2004,O,3516.0,"In the time period 1996 - 2004 , 697 cases with lymphoid neoplasms and 3606 controls with nonneoplastic conditions were included in a case - control study conducted in the Cancer Institute of Uruguay ."
101369,",",O,3516.0,"In the time period 1996 - 2004 , 697 cases with lymphoid neoplasms and 3606 controls with nonneoplastic conditions were included in a case - control study conducted in the Cancer Institute of Uruguay ."
101370,697,O,3516.0,"In the time period 1996 - 2004 , 697 cases with lymphoid neoplasms and 3606 controls with nonneoplastic conditions were included in a case - control study conducted in the Cancer Institute of Uruguay ."
101371,cases,O,3516.0,"In the time period 1996 - 2004 , 697 cases with lymphoid neoplasms and 3606 controls with nonneoplastic conditions were included in a case - control study conducted in the Cancer Institute of Uruguay ."
101372,with,O,3516.0,"In the time period 1996 - 2004 , 697 cases with lymphoid neoplasms and 3606 controls with nonneoplastic conditions were included in a case - control study conducted in the Cancer Institute of Uruguay ."
101373,lymphoid,O,3516.0,"In the time period 1996 - 2004 , 697 cases with lymphoid neoplasms and 3606 controls with nonneoplastic conditions were included in a case - control study conducted in the Cancer Institute of Uruguay ."
101374,neoplasms,O,3516.0,"In the time period 1996 - 2004 , 697 cases with lymphoid neoplasms and 3606 controls with nonneoplastic conditions were included in a case - control study conducted in the Cancer Institute of Uruguay ."
101375,and,O,3516.0,"In the time period 1996 - 2004 , 697 cases with lymphoid neoplasms and 3606 controls with nonneoplastic conditions were included in a case - control study conducted in the Cancer Institute of Uruguay ."
101376,3606,O,3516.0,"In the time period 1996 - 2004 , 697 cases with lymphoid neoplasms and 3606 controls with nonneoplastic conditions were included in a case - control study conducted in the Cancer Institute of Uruguay ."
101377,controls,O,3516.0,"In the time period 1996 - 2004 , 697 cases with lymphoid neoplasms and 3606 controls with nonneoplastic conditions were included in a case - control study conducted in the Cancer Institute of Uruguay ."
101378,with,O,3516.0,"In the time period 1996 - 2004 , 697 cases with lymphoid neoplasms and 3606 controls with nonneoplastic conditions were included in a case - control study conducted in the Cancer Institute of Uruguay ."
101379,nonneoplastic,O,3516.0,"In the time period 1996 - 2004 , 697 cases with lymphoid neoplasms and 3606 controls with nonneoplastic conditions were included in a case - control study conducted in the Cancer Institute of Uruguay ."
101380,conditions,O,3516.0,"In the time period 1996 - 2004 , 697 cases with lymphoid neoplasms and 3606 controls with nonneoplastic conditions were included in a case - control study conducted in the Cancer Institute of Uruguay ."
101381,were,O,3516.0,"In the time period 1996 - 2004 , 697 cases with lymphoid neoplasms and 3606 controls with nonneoplastic conditions were included in a case - control study conducted in the Cancer Institute of Uruguay ."
101382,included,O,3516.0,"In the time period 1996 - 2004 , 697 cases with lymphoid neoplasms and 3606 controls with nonneoplastic conditions were included in a case - control study conducted in the Cancer Institute of Uruguay ."
101383,in,O,3516.0,"In the time period 1996 - 2004 , 697 cases with lymphoid neoplasms and 3606 controls with nonneoplastic conditions were included in a case - control study conducted in the Cancer Institute of Uruguay ."
101384,a,O,3516.0,"In the time period 1996 - 2004 , 697 cases with lymphoid neoplasms and 3606 controls with nonneoplastic conditions were included in a case - control study conducted in the Cancer Institute of Uruguay ."
101385,case,O,3516.0,"In the time period 1996 - 2004 , 697 cases with lymphoid neoplasms and 3606 controls with nonneoplastic conditions were included in a case - control study conducted in the Cancer Institute of Uruguay ."
101386,-,O,3516.0,"In the time period 1996 - 2004 , 697 cases with lymphoid neoplasms and 3606 controls with nonneoplastic conditions were included in a case - control study conducted in the Cancer Institute of Uruguay ."
101387,control,O,3516.0,"In the time period 1996 - 2004 , 697 cases with lymphoid neoplasms and 3606 controls with nonneoplastic conditions were included in a case - control study conducted in the Cancer Institute of Uruguay ."
101388,study,O,3516.0,"In the time period 1996 - 2004 , 697 cases with lymphoid neoplasms and 3606 controls with nonneoplastic conditions were included in a case - control study conducted in the Cancer Institute of Uruguay ."
101389,conducted,O,3516.0,"In the time period 1996 - 2004 , 697 cases with lymphoid neoplasms and 3606 controls with nonneoplastic conditions were included in a case - control study conducted in the Cancer Institute of Uruguay ."
101390,in,O,3516.0,"In the time period 1996 - 2004 , 697 cases with lymphoid neoplasms and 3606 controls with nonneoplastic conditions were included in a case - control study conducted in the Cancer Institute of Uruguay ."
101391,the,O,3516.0,"In the time period 1996 - 2004 , 697 cases with lymphoid neoplasms and 3606 controls with nonneoplastic conditions were included in a case - control study conducted in the Cancer Institute of Uruguay ."
101392,Cancer,O,3516.0,"In the time period 1996 - 2004 , 697 cases with lymphoid neoplasms and 3606 controls with nonneoplastic conditions were included in a case - control study conducted in the Cancer Institute of Uruguay ."
101393,Institute,O,3516.0,"In the time period 1996 - 2004 , 697 cases with lymphoid neoplasms and 3606 controls with nonneoplastic conditions were included in a case - control study conducted in the Cancer Institute of Uruguay ."
101394,of,O,3516.0,"In the time period 1996 - 2004 , 697 cases with lymphoid neoplasms and 3606 controls with nonneoplastic conditions were included in a case - control study conducted in the Cancer Institute of Uruguay ."
101395,Uruguay,O,3516.0,"In the time period 1996 - 2004 , 697 cases with lymphoid neoplasms and 3606 controls with nonneoplastic conditions were included in a case - control study conducted in the Cancer Institute of Uruguay ."
101396,.,O,3516.0,"In the time period 1996 - 2004 , 697 cases with lymphoid neoplasms and 3606 controls with nonneoplastic conditions were included in a case - control study conducted in the Cancer Institute of Uruguay ."
101397,They,O,3517.0,"They were administered a routine questionnaire that included 8 sections and a food frequency questionnaire focused on intakes of total meat , red meat , salted meat , barbecued meat , processed meat , milk , total vegetables and total fruits , and alcoholic beverages ."
101398,were,O,3517.0,"They were administered a routine questionnaire that included 8 sections and a food frequency questionnaire focused on intakes of total meat , red meat , salted meat , barbecued meat , processed meat , milk , total vegetables and total fruits , and alcoholic beverages ."
101399,administered,O,3517.0,"They were administered a routine questionnaire that included 8 sections and a food frequency questionnaire focused on intakes of total meat , red meat , salted meat , barbecued meat , processed meat , milk , total vegetables and total fruits , and alcoholic beverages ."
101400,a,O,3517.0,"They were administered a routine questionnaire that included 8 sections and a food frequency questionnaire focused on intakes of total meat , red meat , salted meat , barbecued meat , processed meat , milk , total vegetables and total fruits , and alcoholic beverages ."
101401,routine,O,3517.0,"They were administered a routine questionnaire that included 8 sections and a food frequency questionnaire focused on intakes of total meat , red meat , salted meat , barbecued meat , processed meat , milk , total vegetables and total fruits , and alcoholic beverages ."
101402,questionnaire,O,3517.0,"They were administered a routine questionnaire that included 8 sections and a food frequency questionnaire focused on intakes of total meat , red meat , salted meat , barbecued meat , processed meat , milk , total vegetables and total fruits , and alcoholic beverages ."
101403,that,O,3517.0,"They were administered a routine questionnaire that included 8 sections and a food frequency questionnaire focused on intakes of total meat , red meat , salted meat , barbecued meat , processed meat , milk , total vegetables and total fruits , and alcoholic beverages ."
101404,included,O,3517.0,"They were administered a routine questionnaire that included 8 sections and a food frequency questionnaire focused on intakes of total meat , red meat , salted meat , barbecued meat , processed meat , milk , total vegetables and total fruits , and alcoholic beverages ."
101405,8,O,3517.0,"They were administered a routine questionnaire that included 8 sections and a food frequency questionnaire focused on intakes of total meat , red meat , salted meat , barbecued meat , processed meat , milk , total vegetables and total fruits , and alcoholic beverages ."
101406,sections,O,3517.0,"They were administered a routine questionnaire that included 8 sections and a food frequency questionnaire focused on intakes of total meat , red meat , salted meat , barbecued meat , processed meat , milk , total vegetables and total fruits , and alcoholic beverages ."
101407,and,O,3517.0,"They were administered a routine questionnaire that included 8 sections and a food frequency questionnaire focused on intakes of total meat , red meat , salted meat , barbecued meat , processed meat , milk , total vegetables and total fruits , and alcoholic beverages ."
101408,a,O,3517.0,"They were administered a routine questionnaire that included 8 sections and a food frequency questionnaire focused on intakes of total meat , red meat , salted meat , barbecued meat , processed meat , milk , total vegetables and total fruits , and alcoholic beverages ."
101409,food,O,3517.0,"They were administered a routine questionnaire that included 8 sections and a food frequency questionnaire focused on intakes of total meat , red meat , salted meat , barbecued meat , processed meat , milk , total vegetables and total fruits , and alcoholic beverages ."
101410,frequency,O,3517.0,"They were administered a routine questionnaire that included 8 sections and a food frequency questionnaire focused on intakes of total meat , red meat , salted meat , barbecued meat , processed meat , milk , total vegetables and total fruits , and alcoholic beverages ."
101411,questionnaire,O,3517.0,"They were administered a routine questionnaire that included 8 sections and a food frequency questionnaire focused on intakes of total meat , red meat , salted meat , barbecued meat , processed meat , milk , total vegetables and total fruits , and alcoholic beverages ."
101412,focused,O,3517.0,"They were administered a routine questionnaire that included 8 sections and a food frequency questionnaire focused on intakes of total meat , red meat , salted meat , barbecued meat , processed meat , milk , total vegetables and total fruits , and alcoholic beverages ."
101413,on,O,3517.0,"They were administered a routine questionnaire that included 8 sections and a food frequency questionnaire focused on intakes of total meat , red meat , salted meat , barbecued meat , processed meat , milk , total vegetables and total fruits , and alcoholic beverages ."
101414,intakes,O,3517.0,"They were administered a routine questionnaire that included 8 sections and a food frequency questionnaire focused on intakes of total meat , red meat , salted meat , barbecued meat , processed meat , milk , total vegetables and total fruits , and alcoholic beverages ."
101415,of,O,3517.0,"They were administered a routine questionnaire that included 8 sections and a food frequency questionnaire focused on intakes of total meat , red meat , salted meat , barbecued meat , processed meat , milk , total vegetables and total fruits , and alcoholic beverages ."
101416,total,O,3517.0,"They were administered a routine questionnaire that included 8 sections and a food frequency questionnaire focused on intakes of total meat , red meat , salted meat , barbecued meat , processed meat , milk , total vegetables and total fruits , and alcoholic beverages ."
101417,meat,B-AG.01.d,3517.0,"They were administered a routine questionnaire that included 8 sections and a food frequency questionnaire focused on intakes of total meat , red meat , salted meat , barbecued meat , processed meat , milk , total vegetables and total fruits , and alcoholic beverages ."
101418,",",O,3517.0,"They were administered a routine questionnaire that included 8 sections and a food frequency questionnaire focused on intakes of total meat , red meat , salted meat , barbecued meat , processed meat , milk , total vegetables and total fruits , and alcoholic beverages ."
101419,red,B-AG.01.d,3517.0,"They were administered a routine questionnaire that included 8 sections and a food frequency questionnaire focused on intakes of total meat , red meat , salted meat , barbecued meat , processed meat , milk , total vegetables and total fruits , and alcoholic beverages ."
101420,meat,I-AG.01.d,3517.0,"They were administered a routine questionnaire that included 8 sections and a food frequency questionnaire focused on intakes of total meat , red meat , salted meat , barbecued meat , processed meat , milk , total vegetables and total fruits , and alcoholic beverages ."
101421,",",O,3517.0,"They were administered a routine questionnaire that included 8 sections and a food frequency questionnaire focused on intakes of total meat , red meat , salted meat , barbecued meat , processed meat , milk , total vegetables and total fruits , and alcoholic beverages ."
101422,salted,B-AG.01.d,3517.0,"They were administered a routine questionnaire that included 8 sections and a food frequency questionnaire focused on intakes of total meat , red meat , salted meat , barbecued meat , processed meat , milk , total vegetables and total fruits , and alcoholic beverages ."
101423,meat,I-AG.01.d,3517.0,"They were administered a routine questionnaire that included 8 sections and a food frequency questionnaire focused on intakes of total meat , red meat , salted meat , barbecued meat , processed meat , milk , total vegetables and total fruits , and alcoholic beverages ."
101424,",",O,3517.0,"They were administered a routine questionnaire that included 8 sections and a food frequency questionnaire focused on intakes of total meat , red meat , salted meat , barbecued meat , processed meat , milk , total vegetables and total fruits , and alcoholic beverages ."
101425,barbecued,B-AG.01.n.06,3517.0,"They were administered a routine questionnaire that included 8 sections and a food frequency questionnaire focused on intakes of total meat , red meat , salted meat , barbecued meat , processed meat , milk , total vegetables and total fruits , and alcoholic beverages ."
101426,meat,I-AG.01.n.06,3517.0,"They were administered a routine questionnaire that included 8 sections and a food frequency questionnaire focused on intakes of total meat , red meat , salted meat , barbecued meat , processed meat , milk , total vegetables and total fruits , and alcoholic beverages ."
101427,",",O,3517.0,"They were administered a routine questionnaire that included 8 sections and a food frequency questionnaire focused on intakes of total meat , red meat , salted meat , barbecued meat , processed meat , milk , total vegetables and total fruits , and alcoholic beverages ."
101428,processed,B-AG.01.d,3517.0,"They were administered a routine questionnaire that included 8 sections and a food frequency questionnaire focused on intakes of total meat , red meat , salted meat , barbecued meat , processed meat , milk , total vegetables and total fruits , and alcoholic beverages ."
101429,meat,I-AG.01.d,3517.0,"They were administered a routine questionnaire that included 8 sections and a food frequency questionnaire focused on intakes of total meat , red meat , salted meat , barbecued meat , processed meat , milk , total vegetables and total fruits , and alcoholic beverages ."
101430,",",O,3517.0,"They were administered a routine questionnaire that included 8 sections and a food frequency questionnaire focused on intakes of total meat , red meat , salted meat , barbecued meat , processed meat , milk , total vegetables and total fruits , and alcoholic beverages ."
101431,milk,B-AG.01.e,3517.0,"They were administered a routine questionnaire that included 8 sections and a food frequency questionnaire focused on intakes of total meat , red meat , salted meat , barbecued meat , processed meat , milk , total vegetables and total fruits , and alcoholic beverages ."
101432,",",O,3517.0,"They were administered a routine questionnaire that included 8 sections and a food frequency questionnaire focused on intakes of total meat , red meat , salted meat , barbecued meat , processed meat , milk , total vegetables and total fruits , and alcoholic beverages ."
101433,total,O,3517.0,"They were administered a routine questionnaire that included 8 sections and a food frequency questionnaire focused on intakes of total meat , red meat , salted meat , barbecued meat , processed meat , milk , total vegetables and total fruits , and alcoholic beverages ."
101434,vegetables,B-AG.01.h.02,3517.0,"They were administered a routine questionnaire that included 8 sections and a food frequency questionnaire focused on intakes of total meat , red meat , salted meat , barbecued meat , processed meat , milk , total vegetables and total fruits , and alcoholic beverages ."
101435,and,O,3517.0,"They were administered a routine questionnaire that included 8 sections and a food frequency questionnaire focused on intakes of total meat , red meat , salted meat , barbecued meat , processed meat , milk , total vegetables and total fruits , and alcoholic beverages ."
101436,total,O,3517.0,"They were administered a routine questionnaire that included 8 sections and a food frequency questionnaire focused on intakes of total meat , red meat , salted meat , barbecued meat , processed meat , milk , total vegetables and total fruits , and alcoholic beverages ."
101437,fruits,B-AG.01.h.01,3517.0,"They were administered a routine questionnaire that included 8 sections and a food frequency questionnaire focused on intakes of total meat , red meat , salted meat , barbecued meat , processed meat , milk , total vegetables and total fruits , and alcoholic beverages ."
101438,",",O,3517.0,"They were administered a routine questionnaire that included 8 sections and a food frequency questionnaire focused on intakes of total meat , red meat , salted meat , barbecued meat , processed meat , milk , total vegetables and total fruits , and alcoholic beverages ."
101439,and,O,3517.0,"They were administered a routine questionnaire that included 8 sections and a food frequency questionnaire focused on intakes of total meat , red meat , salted meat , barbecued meat , processed meat , milk , total vegetables and total fruits , and alcoholic beverages ."
101440,alcoholic,B-AG.01.y.01,3517.0,"They were administered a routine questionnaire that included 8 sections and a food frequency questionnaire focused on intakes of total meat , red meat , salted meat , barbecued meat , processed meat , milk , total vegetables and total fruits , and alcoholic beverages ."
101441,beverages,I-AG.01.y.01,3517.0,"They were administered a routine questionnaire that included 8 sections and a food frequency questionnaire focused on intakes of total meat , red meat , salted meat , barbecued meat , processed meat , milk , total vegetables and total fruits , and alcoholic beverages ."
101442,.,O,3517.0,"They were administered a routine questionnaire that included 8 sections and a food frequency questionnaire focused on intakes of total meat , red meat , salted meat , barbecued meat , processed meat , milk , total vegetables and total fruits , and alcoholic beverages ."
101443,Lymphoid,O,3518.0,Lymphoid cancers were analyzed by multiple polytomous regression .
101444,cancers,O,3518.0,Lymphoid cancers were analyzed by multiple polytomous regression .
101445,were,O,3518.0,Lymphoid cancers were analyzed by multiple polytomous regression .
101446,analyzed,O,3518.0,Lymphoid cancers were analyzed by multiple polytomous regression .
101447,by,O,3518.0,Lymphoid cancers were analyzed by multiple polytomous regression .
101448,multiple,O,3518.0,Lymphoid cancers were analyzed by multiple polytomous regression .
101449,polytomous,O,3518.0,Lymphoid cancers were analyzed by multiple polytomous regression .
101450,regression,O,3518.0,Lymphoid cancers were analyzed by multiple polytomous regression .
101451,.,O,3518.0,Lymphoid cancers were analyzed by multiple polytomous regression .
101452,Red,B-AG.01.d,3519.0,"Red meat , salted meat , and milk were positively associated with risk of lymphoid cancers [ odds ratios ( OR ) for the highest tertile vs. the lowest one of red meat = 1.68 , 95 % confidence interval ( CI ) 1.37 - 2.08 , OR for whole milk = 2.92 , 95 % CI 2.63 - 3.63 ) ."
101453,meat,I-AG.01.d,3519.0,"Red meat , salted meat , and milk were positively associated with risk of lymphoid cancers [ odds ratios ( OR ) for the highest tertile vs. the lowest one of red meat = 1.68 , 95 % confidence interval ( CI ) 1.37 - 2.08 , OR for whole milk = 2.92 , 95 % CI 2.63 - 3.63 ) ."
101454,",",O,3519.0,"Red meat , salted meat , and milk were positively associated with risk of lymphoid cancers [ odds ratios ( OR ) for the highest tertile vs. the lowest one of red meat = 1.68 , 95 % confidence interval ( CI ) 1.37 - 2.08 , OR for whole milk = 2.92 , 95 % CI 2.63 - 3.63 ) ."
101455,salted,B-AG.01.d,3519.0,"Red meat , salted meat , and milk were positively associated with risk of lymphoid cancers [ odds ratios ( OR ) for the highest tertile vs. the lowest one of red meat = 1.68 , 95 % confidence interval ( CI ) 1.37 - 2.08 , OR for whole milk = 2.92 , 95 % CI 2.63 - 3.63 ) ."
101456,meat,I-AG.01.d,3519.0,"Red meat , salted meat , and milk were positively associated with risk of lymphoid cancers [ odds ratios ( OR ) for the highest tertile vs. the lowest one of red meat = 1.68 , 95 % confidence interval ( CI ) 1.37 - 2.08 , OR for whole milk = 2.92 , 95 % CI 2.63 - 3.63 ) ."
101457,",",O,3519.0,"Red meat , salted meat , and milk were positively associated with risk of lymphoid cancers [ odds ratios ( OR ) for the highest tertile vs. the lowest one of red meat = 1.68 , 95 % confidence interval ( CI ) 1.37 - 2.08 , OR for whole milk = 2.92 , 95 % CI 2.63 - 3.63 ) ."
101458,and,O,3519.0,"Red meat , salted meat , and milk were positively associated with risk of lymphoid cancers [ odds ratios ( OR ) for the highest tertile vs. the lowest one of red meat = 1.68 , 95 % confidence interval ( CI ) 1.37 - 2.08 , OR for whole milk = 2.92 , 95 % CI 2.63 - 3.63 ) ."
101459,milk,B-AG.01.e,3519.0,"Red meat , salted meat , and milk were positively associated with risk of lymphoid cancers [ odds ratios ( OR ) for the highest tertile vs. the lowest one of red meat = 1.68 , 95 % confidence interval ( CI ) 1.37 - 2.08 , OR for whole milk = 2.92 , 95 % CI 2.63 - 3.63 ) ."
101460,were,O,3519.0,"Red meat , salted meat , and milk were positively associated with risk of lymphoid cancers [ odds ratios ( OR ) for the highest tertile vs. the lowest one of red meat = 1.68 , 95 % confidence interval ( CI ) 1.37 - 2.08 , OR for whole milk = 2.92 , 95 % CI 2.63 - 3.63 ) ."
101461,positively,O,3519.0,"Red meat , salted meat , and milk were positively associated with risk of lymphoid cancers [ odds ratios ( OR ) for the highest tertile vs. the lowest one of red meat = 1.68 , 95 % confidence interval ( CI ) 1.37 - 2.08 , OR for whole milk = 2.92 , 95 % CI 2.63 - 3.63 ) ."
101462,associated,O,3519.0,"Red meat , salted meat , and milk were positively associated with risk of lymphoid cancers [ odds ratios ( OR ) for the highest tertile vs. the lowest one of red meat = 1.68 , 95 % confidence interval ( CI ) 1.37 - 2.08 , OR for whole milk = 2.92 , 95 % CI 2.63 - 3.63 ) ."
101463,with,O,3519.0,"Red meat , salted meat , and milk were positively associated with risk of lymphoid cancers [ odds ratios ( OR ) for the highest tertile vs. the lowest one of red meat = 1.68 , 95 % confidence interval ( CI ) 1.37 - 2.08 , OR for whole milk = 2.92 , 95 % CI 2.63 - 3.63 ) ."
101464,risk,O,3519.0,"Red meat , salted meat , and milk were positively associated with risk of lymphoid cancers [ odds ratios ( OR ) for the highest tertile vs. the lowest one of red meat = 1.68 , 95 % confidence interval ( CI ) 1.37 - 2.08 , OR for whole milk = 2.92 , 95 % CI 2.63 - 3.63 ) ."
101465,of,O,3519.0,"Red meat , salted meat , and milk were positively associated with risk of lymphoid cancers [ odds ratios ( OR ) for the highest tertile vs. the lowest one of red meat = 1.68 , 95 % confidence interval ( CI ) 1.37 - 2.08 , OR for whole milk = 2.92 , 95 % CI 2.63 - 3.63 ) ."
101466,lymphoid,O,3519.0,"Red meat , salted meat , and milk were positively associated with risk of lymphoid cancers [ odds ratios ( OR ) for the highest tertile vs. the lowest one of red meat = 1.68 , 95 % confidence interval ( CI ) 1.37 - 2.08 , OR for whole milk = 2.92 , 95 % CI 2.63 - 3.63 ) ."
101467,cancers,O,3519.0,"Red meat , salted meat , and milk were positively associated with risk of lymphoid cancers [ odds ratios ( OR ) for the highest tertile vs. the lowest one of red meat = 1.68 , 95 % confidence interval ( CI ) 1.37 - 2.08 , OR for whole milk = 2.92 , 95 % CI 2.63 - 3.63 ) ."
101468,[,O,3519.0,"Red meat , salted meat , and milk were positively associated with risk of lymphoid cancers [ odds ratios ( OR ) for the highest tertile vs. the lowest one of red meat = 1.68 , 95 % confidence interval ( CI ) 1.37 - 2.08 , OR for whole milk = 2.92 , 95 % CI 2.63 - 3.63 ) ."
101469,odds,O,3519.0,"Red meat , salted meat , and milk were positively associated with risk of lymphoid cancers [ odds ratios ( OR ) for the highest tertile vs. the lowest one of red meat = 1.68 , 95 % confidence interval ( CI ) 1.37 - 2.08 , OR for whole milk = 2.92 , 95 % CI 2.63 - 3.63 ) ."
101470,ratios,O,3519.0,"Red meat , salted meat , and milk were positively associated with risk of lymphoid cancers [ odds ratios ( OR ) for the highest tertile vs. the lowest one of red meat = 1.68 , 95 % confidence interval ( CI ) 1.37 - 2.08 , OR for whole milk = 2.92 , 95 % CI 2.63 - 3.63 ) ."
101471,(,O,3519.0,"Red meat , salted meat , and milk were positively associated with risk of lymphoid cancers [ odds ratios ( OR ) for the highest tertile vs. the lowest one of red meat = 1.68 , 95 % confidence interval ( CI ) 1.37 - 2.08 , OR for whole milk = 2.92 , 95 % CI 2.63 - 3.63 ) ."
101472,OR,O,3519.0,"Red meat , salted meat , and milk were positively associated with risk of lymphoid cancers [ odds ratios ( OR ) for the highest tertile vs. the lowest one of red meat = 1.68 , 95 % confidence interval ( CI ) 1.37 - 2.08 , OR for whole milk = 2.92 , 95 % CI 2.63 - 3.63 ) ."
101473,),O,3519.0,"Red meat , salted meat , and milk were positively associated with risk of lymphoid cancers [ odds ratios ( OR ) for the highest tertile vs. the lowest one of red meat = 1.68 , 95 % confidence interval ( CI ) 1.37 - 2.08 , OR for whole milk = 2.92 , 95 % CI 2.63 - 3.63 ) ."
101474,for,O,3519.0,"Red meat , salted meat , and milk were positively associated with risk of lymphoid cancers [ odds ratios ( OR ) for the highest tertile vs. the lowest one of red meat = 1.68 , 95 % confidence interval ( CI ) 1.37 - 2.08 , OR for whole milk = 2.92 , 95 % CI 2.63 - 3.63 ) ."
101475,the,O,3519.0,"Red meat , salted meat , and milk were positively associated with risk of lymphoid cancers [ odds ratios ( OR ) for the highest tertile vs. the lowest one of red meat = 1.68 , 95 % confidence interval ( CI ) 1.37 - 2.08 , OR for whole milk = 2.92 , 95 % CI 2.63 - 3.63 ) ."
101476,highest,O,3519.0,"Red meat , salted meat , and milk were positively associated with risk of lymphoid cancers [ odds ratios ( OR ) for the highest tertile vs. the lowest one of red meat = 1.68 , 95 % confidence interval ( CI ) 1.37 - 2.08 , OR for whole milk = 2.92 , 95 % CI 2.63 - 3.63 ) ."
101477,tertile,O,3519.0,"Red meat , salted meat , and milk were positively associated with risk of lymphoid cancers [ odds ratios ( OR ) for the highest tertile vs. the lowest one of red meat = 1.68 , 95 % confidence interval ( CI ) 1.37 - 2.08 , OR for whole milk = 2.92 , 95 % CI 2.63 - 3.63 ) ."
101478,vs.,O,3519.0,"Red meat , salted meat , and milk were positively associated with risk of lymphoid cancers [ odds ratios ( OR ) for the highest tertile vs. the lowest one of red meat = 1.68 , 95 % confidence interval ( CI ) 1.37 - 2.08 , OR for whole milk = 2.92 , 95 % CI 2.63 - 3.63 ) ."
101479,the,O,3519.0,"Red meat , salted meat , and milk were positively associated with risk of lymphoid cancers [ odds ratios ( OR ) for the highest tertile vs. the lowest one of red meat = 1.68 , 95 % confidence interval ( CI ) 1.37 - 2.08 , OR for whole milk = 2.92 , 95 % CI 2.63 - 3.63 ) ."
101480,lowest,O,3519.0,"Red meat , salted meat , and milk were positively associated with risk of lymphoid cancers [ odds ratios ( OR ) for the highest tertile vs. the lowest one of red meat = 1.68 , 95 % confidence interval ( CI ) 1.37 - 2.08 , OR for whole milk = 2.92 , 95 % CI 2.63 - 3.63 ) ."
101481,one,O,3519.0,"Red meat , salted meat , and milk were positively associated with risk of lymphoid cancers [ odds ratios ( OR ) for the highest tertile vs. the lowest one of red meat = 1.68 , 95 % confidence interval ( CI ) 1.37 - 2.08 , OR for whole milk = 2.92 , 95 % CI 2.63 - 3.63 ) ."
101482,of,O,3519.0,"Red meat , salted meat , and milk were positively associated with risk of lymphoid cancers [ odds ratios ( OR ) for the highest tertile vs. the lowest one of red meat = 1.68 , 95 % confidence interval ( CI ) 1.37 - 2.08 , OR for whole milk = 2.92 , 95 % CI 2.63 - 3.63 ) ."
101483,red,B-AG.01.d,3519.0,"Red meat , salted meat , and milk were positively associated with risk of lymphoid cancers [ odds ratios ( OR ) for the highest tertile vs. the lowest one of red meat = 1.68 , 95 % confidence interval ( CI ) 1.37 - 2.08 , OR for whole milk = 2.92 , 95 % CI 2.63 - 3.63 ) ."
101484,meat,I-AG.01.d,3519.0,"Red meat , salted meat , and milk were positively associated with risk of lymphoid cancers [ odds ratios ( OR ) for the highest tertile vs. the lowest one of red meat = 1.68 , 95 % confidence interval ( CI ) 1.37 - 2.08 , OR for whole milk = 2.92 , 95 % CI 2.63 - 3.63 ) ."
101485,=,O,3519.0,"Red meat , salted meat , and milk were positively associated with risk of lymphoid cancers [ odds ratios ( OR ) for the highest tertile vs. the lowest one of red meat = 1.68 , 95 % confidence interval ( CI ) 1.37 - 2.08 , OR for whole milk = 2.92 , 95 % CI 2.63 - 3.63 ) ."
101486,1.68,O,3519.0,"Red meat , salted meat , and milk were positively associated with risk of lymphoid cancers [ odds ratios ( OR ) for the highest tertile vs. the lowest one of red meat = 1.68 , 95 % confidence interval ( CI ) 1.37 - 2.08 , OR for whole milk = 2.92 , 95 % CI 2.63 - 3.63 ) ."
101487,",",O,3519.0,"Red meat , salted meat , and milk were positively associated with risk of lymphoid cancers [ odds ratios ( OR ) for the highest tertile vs. the lowest one of red meat = 1.68 , 95 % confidence interval ( CI ) 1.37 - 2.08 , OR for whole milk = 2.92 , 95 % CI 2.63 - 3.63 ) ."
101488,95,O,3519.0,"Red meat , salted meat , and milk were positively associated with risk of lymphoid cancers [ odds ratios ( OR ) for the highest tertile vs. the lowest one of red meat = 1.68 , 95 % confidence interval ( CI ) 1.37 - 2.08 , OR for whole milk = 2.92 , 95 % CI 2.63 - 3.63 ) ."
101489,%,O,3519.0,"Red meat , salted meat , and milk were positively associated with risk of lymphoid cancers [ odds ratios ( OR ) for the highest tertile vs. the lowest one of red meat = 1.68 , 95 % confidence interval ( CI ) 1.37 - 2.08 , OR for whole milk = 2.92 , 95 % CI 2.63 - 3.63 ) ."
101490,confidence,O,3519.0,"Red meat , salted meat , and milk were positively associated with risk of lymphoid cancers [ odds ratios ( OR ) for the highest tertile vs. the lowest one of red meat = 1.68 , 95 % confidence interval ( CI ) 1.37 - 2.08 , OR for whole milk = 2.92 , 95 % CI 2.63 - 3.63 ) ."
101491,interval,O,3519.0,"Red meat , salted meat , and milk were positively associated with risk of lymphoid cancers [ odds ratios ( OR ) for the highest tertile vs. the lowest one of red meat = 1.68 , 95 % confidence interval ( CI ) 1.37 - 2.08 , OR for whole milk = 2.92 , 95 % CI 2.63 - 3.63 ) ."
101492,(,O,3519.0,"Red meat , salted meat , and milk were positively associated with risk of lymphoid cancers [ odds ratios ( OR ) for the highest tertile vs. the lowest one of red meat = 1.68 , 95 % confidence interval ( CI ) 1.37 - 2.08 , OR for whole milk = 2.92 , 95 % CI 2.63 - 3.63 ) ."
101493,CI,O,3519.0,"Red meat , salted meat , and milk were positively associated with risk of lymphoid cancers [ odds ratios ( OR ) for the highest tertile vs. the lowest one of red meat = 1.68 , 95 % confidence interval ( CI ) 1.37 - 2.08 , OR for whole milk = 2.92 , 95 % CI 2.63 - 3.63 ) ."
101494,),O,3519.0,"Red meat , salted meat , and milk were positively associated with risk of lymphoid cancers [ odds ratios ( OR ) for the highest tertile vs. the lowest one of red meat = 1.68 , 95 % confidence interval ( CI ) 1.37 - 2.08 , OR for whole milk = 2.92 , 95 % CI 2.63 - 3.63 ) ."
101495,1.37,O,3519.0,"Red meat , salted meat , and milk were positively associated with risk of lymphoid cancers [ odds ratios ( OR ) for the highest tertile vs. the lowest one of red meat = 1.68 , 95 % confidence interval ( CI ) 1.37 - 2.08 , OR for whole milk = 2.92 , 95 % CI 2.63 - 3.63 ) ."
101496,-,O,3519.0,"Red meat , salted meat , and milk were positively associated with risk of lymphoid cancers [ odds ratios ( OR ) for the highest tertile vs. the lowest one of red meat = 1.68 , 95 % confidence interval ( CI ) 1.37 - 2.08 , OR for whole milk = 2.92 , 95 % CI 2.63 - 3.63 ) ."
101497,2.08,O,3519.0,"Red meat , salted meat , and milk were positively associated with risk of lymphoid cancers [ odds ratios ( OR ) for the highest tertile vs. the lowest one of red meat = 1.68 , 95 % confidence interval ( CI ) 1.37 - 2.08 , OR for whole milk = 2.92 , 95 % CI 2.63 - 3.63 ) ."
101498,",",O,3519.0,"Red meat , salted meat , and milk were positively associated with risk of lymphoid cancers [ odds ratios ( OR ) for the highest tertile vs. the lowest one of red meat = 1.68 , 95 % confidence interval ( CI ) 1.37 - 2.08 , OR for whole milk = 2.92 , 95 % CI 2.63 - 3.63 ) ."
101499,OR,O,3519.0,"Red meat , salted meat , and milk were positively associated with risk of lymphoid cancers [ odds ratios ( OR ) for the highest tertile vs. the lowest one of red meat = 1.68 , 95 % confidence interval ( CI ) 1.37 - 2.08 , OR for whole milk = 2.92 , 95 % CI 2.63 - 3.63 ) ."
101500,for,O,3519.0,"Red meat , salted meat , and milk were positively associated with risk of lymphoid cancers [ odds ratios ( OR ) for the highest tertile vs. the lowest one of red meat = 1.68 , 95 % confidence interval ( CI ) 1.37 - 2.08 , OR for whole milk = 2.92 , 95 % CI 2.63 - 3.63 ) ."
101501,whole,B-AG.01.e,3519.0,"Red meat , salted meat , and milk were positively associated with risk of lymphoid cancers [ odds ratios ( OR ) for the highest tertile vs. the lowest one of red meat = 1.68 , 95 % confidence interval ( CI ) 1.37 - 2.08 , OR for whole milk = 2.92 , 95 % CI 2.63 - 3.63 ) ."
101502,milk,I-AG.01.e,3519.0,"Red meat , salted meat , and milk were positively associated with risk of lymphoid cancers [ odds ratios ( OR ) for the highest tertile vs. the lowest one of red meat = 1.68 , 95 % confidence interval ( CI ) 1.37 - 2.08 , OR for whole milk = 2.92 , 95 % CI 2.63 - 3.63 ) ."
101503,=,O,3519.0,"Red meat , salted meat , and milk were positively associated with risk of lymphoid cancers [ odds ratios ( OR ) for the highest tertile vs. the lowest one of red meat = 1.68 , 95 % confidence interval ( CI ) 1.37 - 2.08 , OR for whole milk = 2.92 , 95 % CI 2.63 - 3.63 ) ."
101504,2.92,O,3519.0,"Red meat , salted meat , and milk were positively associated with risk of lymphoid cancers [ odds ratios ( OR ) for the highest tertile vs. the lowest one of red meat = 1.68 , 95 % confidence interval ( CI ) 1.37 - 2.08 , OR for whole milk = 2.92 , 95 % CI 2.63 - 3.63 ) ."
101505,",",O,3519.0,"Red meat , salted meat , and milk were positively associated with risk of lymphoid cancers [ odds ratios ( OR ) for the highest tertile vs. the lowest one of red meat = 1.68 , 95 % confidence interval ( CI ) 1.37 - 2.08 , OR for whole milk = 2.92 , 95 % CI 2.63 - 3.63 ) ."
101506,95,O,3519.0,"Red meat , salted meat , and milk were positively associated with risk of lymphoid cancers [ odds ratios ( OR ) for the highest tertile vs. the lowest one of red meat = 1.68 , 95 % confidence interval ( CI ) 1.37 - 2.08 , OR for whole milk = 2.92 , 95 % CI 2.63 - 3.63 ) ."
101507,%,O,3519.0,"Red meat , salted meat , and milk were positively associated with risk of lymphoid cancers [ odds ratios ( OR ) for the highest tertile vs. the lowest one of red meat = 1.68 , 95 % confidence interval ( CI ) 1.37 - 2.08 , OR for whole milk = 2.92 , 95 % CI 2.63 - 3.63 ) ."
101508,CI,O,3519.0,"Red meat , salted meat , and milk were positively associated with risk of lymphoid cancers [ odds ratios ( OR ) for the highest tertile vs. the lowest one of red meat = 1.68 , 95 % confidence interval ( CI ) 1.37 - 2.08 , OR for whole milk = 2.92 , 95 % CI 2.63 - 3.63 ) ."
101509,2.63,O,3519.0,"Red meat , salted meat , and milk were positively associated with risk of lymphoid cancers [ odds ratios ( OR ) for the highest tertile vs. the lowest one of red meat = 1.68 , 95 % confidence interval ( CI ) 1.37 - 2.08 , OR for whole milk = 2.92 , 95 % CI 2.63 - 3.63 ) ."
101510,-,O,3519.0,"Red meat , salted meat , and milk were positively associated with risk of lymphoid cancers [ odds ratios ( OR ) for the highest tertile vs. the lowest one of red meat = 1.68 , 95 % confidence interval ( CI ) 1.37 - 2.08 , OR for whole milk = 2.92 , 95 % CI 2.63 - 3.63 ) ."
101511,3.63,O,3519.0,"Red meat , salted meat , and milk were positively associated with risk of lymphoid cancers [ odds ratios ( OR ) for the highest tertile vs. the lowest one of red meat = 1.68 , 95 % confidence interval ( CI ) 1.37 - 2.08 , OR for whole milk = 2.92 , 95 % CI 2.63 - 3.63 ) ."
101512,),O,3519.0,"Red meat , salted meat , and milk were positively associated with risk of lymphoid cancers [ odds ratios ( OR ) for the highest tertile vs. the lowest one of red meat = 1.68 , 95 % confidence interval ( CI ) 1.37 - 2.08 , OR for whole milk = 2.92 , 95 % CI 2.63 - 3.63 ) ."
101513,.,O,3519.0,"Red meat , salted meat , and milk were positively associated with risk of lymphoid cancers [ odds ratios ( OR ) for the highest tertile vs. the lowest one of red meat = 1.68 , 95 % confidence interval ( CI ) 1.37 - 2.08 , OR for whole milk = 2.92 , 95 % CI 2.63 - 3.63 ) ."
101514,On,O,3520.0,"On the other hand , plant foods , particularly total fruits , and alcoholic beverages ( mainly red wine ) were protective ."
101515,the,O,3520.0,"On the other hand , plant foods , particularly total fruits , and alcoholic beverages ( mainly red wine ) were protective ."
101516,other,O,3520.0,"On the other hand , plant foods , particularly total fruits , and alcoholic beverages ( mainly red wine ) were protective ."
101517,hand,O,3520.0,"On the other hand , plant foods , particularly total fruits , and alcoholic beverages ( mainly red wine ) were protective ."
101518,",",O,3520.0,"On the other hand , plant foods , particularly total fruits , and alcoholic beverages ( mainly red wine ) were protective ."
101519,plant,O,3520.0,"On the other hand , plant foods , particularly total fruits , and alcoholic beverages ( mainly red wine ) were protective ."
101520,foods,O,3520.0,"On the other hand , plant foods , particularly total fruits , and alcoholic beverages ( mainly red wine ) were protective ."
101521,",",O,3520.0,"On the other hand , plant foods , particularly total fruits , and alcoholic beverages ( mainly red wine ) were protective ."
101522,particularly,O,3520.0,"On the other hand , plant foods , particularly total fruits , and alcoholic beverages ( mainly red wine ) were protective ."
101523,total,O,3520.0,"On the other hand , plant foods , particularly total fruits , and alcoholic beverages ( mainly red wine ) were protective ."
101524,fruits,B-AG.01.h.01,3520.0,"On the other hand , plant foods , particularly total fruits , and alcoholic beverages ( mainly red wine ) were protective ."
101525,",",O,3520.0,"On the other hand , plant foods , particularly total fruits , and alcoholic beverages ( mainly red wine ) were protective ."
101526,and,O,3520.0,"On the other hand , plant foods , particularly total fruits , and alcoholic beverages ( mainly red wine ) were protective ."
101527,alcoholic,B-AG.01.y.01,3520.0,"On the other hand , plant foods , particularly total fruits , and alcoholic beverages ( mainly red wine ) were protective ."
101528,beverages,I-AG.01.y.01,3520.0,"On the other hand , plant foods , particularly total fruits , and alcoholic beverages ( mainly red wine ) were protective ."
101529,(,O,3520.0,"On the other hand , plant foods , particularly total fruits , and alcoholic beverages ( mainly red wine ) were protective ."
101530,mainly,O,3520.0,"On the other hand , plant foods , particularly total fruits , and alcoholic beverages ( mainly red wine ) were protective ."
101531,red,B-AG.01.y.01.a,3520.0,"On the other hand , plant foods , particularly total fruits , and alcoholic beverages ( mainly red wine ) were protective ."
101532,wine,I-AG.01.y.01.a,3520.0,"On the other hand , plant foods , particularly total fruits , and alcoholic beverages ( mainly red wine ) were protective ."
101533,),O,3520.0,"On the other hand , plant foods , particularly total fruits , and alcoholic beverages ( mainly red wine ) were protective ."
101534,were,O,3520.0,"On the other hand , plant foods , particularly total fruits , and alcoholic beverages ( mainly red wine ) were protective ."
101535,protective,O,3520.0,"On the other hand , plant foods , particularly total fruits , and alcoholic beverages ( mainly red wine ) were protective ."
101536,.,O,3520.0,"On the other hand , plant foods , particularly total fruits , and alcoholic beverages ( mainly red wine ) were protective ."
101537,We,O,3521.0,We could conclude that these foods could play a significant role in the etiology of lymphoid malignancies .
101538,could,O,3521.0,We could conclude that these foods could play a significant role in the etiology of lymphoid malignancies .
101539,conclude,O,3521.0,We could conclude that these foods could play a significant role in the etiology of lymphoid malignancies .
101540,that,O,3521.0,We could conclude that these foods could play a significant role in the etiology of lymphoid malignancies .
101541,these,O,3521.0,We could conclude that these foods could play a significant role in the etiology of lymphoid malignancies .
101542,foods,O,3521.0,We could conclude that these foods could play a significant role in the etiology of lymphoid malignancies .
101543,could,O,3521.0,We could conclude that these foods could play a significant role in the etiology of lymphoid malignancies .
101544,play,O,3521.0,We could conclude that these foods could play a significant role in the etiology of lymphoid malignancies .
101545,a,O,3521.0,We could conclude that these foods could play a significant role in the etiology of lymphoid malignancies .
101546,significant,O,3521.0,We could conclude that these foods could play a significant role in the etiology of lymphoid malignancies .
101547,role,O,3521.0,We could conclude that these foods could play a significant role in the etiology of lymphoid malignancies .
101548,in,O,3521.0,We could conclude that these foods could play a significant role in the etiology of lymphoid malignancies .
101549,the,O,3521.0,We could conclude that these foods could play a significant role in the etiology of lymphoid malignancies .
101550,etiology,O,3521.0,We could conclude that these foods could play a significant role in the etiology of lymphoid malignancies .
101551,of,O,3521.0,We could conclude that these foods could play a significant role in the etiology of lymphoid malignancies .
101552,lymphoid,O,3521.0,We could conclude that these foods could play a significant role in the etiology of lymphoid malignancies .
101553,malignancies,O,3521.0,We could conclude that these foods could play a significant role in the etiology of lymphoid malignancies .
101554,.,O,3521.0,We could conclude that these foods could play a significant role in the etiology of lymphoid malignancies .
101555,Calcium,O,3522.0,Calcium intake is one of a number of factors that affect peak bone mass .
101556,intake,O,3522.0,Calcium intake is one of a number of factors that affect peak bone mass .
101557,is,O,3522.0,Calcium intake is one of a number of factors that affect peak bone mass .
101558,one,O,3522.0,Calcium intake is one of a number of factors that affect peak bone mass .
101559,of,O,3522.0,Calcium intake is one of a number of factors that affect peak bone mass .
101560,a,O,3522.0,Calcium intake is one of a number of factors that affect peak bone mass .
101561,number,O,3522.0,Calcium intake is one of a number of factors that affect peak bone mass .
101562,of,O,3522.0,Calcium intake is one of a number of factors that affect peak bone mass .
101563,factors,O,3522.0,Calcium intake is one of a number of factors that affect peak bone mass .
101564,that,O,3522.0,Calcium intake is one of a number of factors that affect peak bone mass .
101565,affect,O,3522.0,Calcium intake is one of a number of factors that affect peak bone mass .
101566,peak,O,3522.0,Calcium intake is one of a number of factors that affect peak bone mass .
101567,bone,O,3522.0,Calcium intake is one of a number of factors that affect peak bone mass .
101568,mass,O,3522.0,Calcium intake is one of a number of factors that affect peak bone mass .
101569,.,O,3522.0,Calcium intake is one of a number of factors that affect peak bone mass .
101570,Low,O,3523.0,Low bone mass is related to increased incidence of osteoporotic fractures .
101571,bone,O,3523.0,Low bone mass is related to increased incidence of osteoporotic fractures .
101572,mass,O,3523.0,Low bone mass is related to increased incidence of osteoporotic fractures .
101573,is,O,3523.0,Low bone mass is related to increased incidence of osteoporotic fractures .
101574,related,O,3523.0,Low bone mass is related to increased incidence of osteoporotic fractures .
101575,to,O,3523.0,Low bone mass is related to increased incidence of osteoporotic fractures .
101576,increased,O,3523.0,Low bone mass is related to increased incidence of osteoporotic fractures .
101577,incidence,O,3523.0,Low bone mass is related to increased incidence of osteoporotic fractures .
101578,of,O,3523.0,Low bone mass is related to increased incidence of osteoporotic fractures .
101579,osteoporotic,O,3523.0,Low bone mass is related to increased incidence of osteoporotic fractures .
101580,fractures,O,3523.0,Low bone mass is related to increased incidence of osteoporotic fractures .
101581,.,O,3523.0,Low bone mass is related to increased incidence of osteoporotic fractures .
101582,Data,O,3524.0,Data from the USDA 1987 - 88 Nationwide Food Consumption Survey were used to determine populations most at risk of less than optimal calcium intake and food sources of calcium intake .
101583,from,O,3524.0,Data from the USDA 1987 - 88 Nationwide Food Consumption Survey were used to determine populations most at risk of less than optimal calcium intake and food sources of calcium intake .
101584,the,O,3524.0,Data from the USDA 1987 - 88 Nationwide Food Consumption Survey were used to determine populations most at risk of less than optimal calcium intake and food sources of calcium intake .
101585,USDA,O,3524.0,Data from the USDA 1987 - 88 Nationwide Food Consumption Survey were used to determine populations most at risk of less than optimal calcium intake and food sources of calcium intake .
101586,1987,O,3524.0,Data from the USDA 1987 - 88 Nationwide Food Consumption Survey were used to determine populations most at risk of less than optimal calcium intake and food sources of calcium intake .
101587,-,O,3524.0,Data from the USDA 1987 - 88 Nationwide Food Consumption Survey were used to determine populations most at risk of less than optimal calcium intake and food sources of calcium intake .
101588,88,O,3524.0,Data from the USDA 1987 - 88 Nationwide Food Consumption Survey were used to determine populations most at risk of less than optimal calcium intake and food sources of calcium intake .
101589,Nationwide,O,3524.0,Data from the USDA 1987 - 88 Nationwide Food Consumption Survey were used to determine populations most at risk of less than optimal calcium intake and food sources of calcium intake .
101590,Food,O,3524.0,Data from the USDA 1987 - 88 Nationwide Food Consumption Survey were used to determine populations most at risk of less than optimal calcium intake and food sources of calcium intake .
101591,Consumption,O,3524.0,Data from the USDA 1987 - 88 Nationwide Food Consumption Survey were used to determine populations most at risk of less than optimal calcium intake and food sources of calcium intake .
101592,Survey,O,3524.0,Data from the USDA 1987 - 88 Nationwide Food Consumption Survey were used to determine populations most at risk of less than optimal calcium intake and food sources of calcium intake .
101593,were,O,3524.0,Data from the USDA 1987 - 88 Nationwide Food Consumption Survey were used to determine populations most at risk of less than optimal calcium intake and food sources of calcium intake .
101594,used,O,3524.0,Data from the USDA 1987 - 88 Nationwide Food Consumption Survey were used to determine populations most at risk of less than optimal calcium intake and food sources of calcium intake .
101595,to,O,3524.0,Data from the USDA 1987 - 88 Nationwide Food Consumption Survey were used to determine populations most at risk of less than optimal calcium intake and food sources of calcium intake .
101596,determine,O,3524.0,Data from the USDA 1987 - 88 Nationwide Food Consumption Survey were used to determine populations most at risk of less than optimal calcium intake and food sources of calcium intake .
101597,populations,O,3524.0,Data from the USDA 1987 - 88 Nationwide Food Consumption Survey were used to determine populations most at risk of less than optimal calcium intake and food sources of calcium intake .
101598,most,O,3524.0,Data from the USDA 1987 - 88 Nationwide Food Consumption Survey were used to determine populations most at risk of less than optimal calcium intake and food sources of calcium intake .
101599,at,O,3524.0,Data from the USDA 1987 - 88 Nationwide Food Consumption Survey were used to determine populations most at risk of less than optimal calcium intake and food sources of calcium intake .
101600,risk,O,3524.0,Data from the USDA 1987 - 88 Nationwide Food Consumption Survey were used to determine populations most at risk of less than optimal calcium intake and food sources of calcium intake .
101601,of,O,3524.0,Data from the USDA 1987 - 88 Nationwide Food Consumption Survey were used to determine populations most at risk of less than optimal calcium intake and food sources of calcium intake .
101602,less,O,3524.0,Data from the USDA 1987 - 88 Nationwide Food Consumption Survey were used to determine populations most at risk of less than optimal calcium intake and food sources of calcium intake .
101603,than,O,3524.0,Data from the USDA 1987 - 88 Nationwide Food Consumption Survey were used to determine populations most at risk of less than optimal calcium intake and food sources of calcium intake .
101604,optimal,O,3524.0,Data from the USDA 1987 - 88 Nationwide Food Consumption Survey were used to determine populations most at risk of less than optimal calcium intake and food sources of calcium intake .
101605,calcium,O,3524.0,Data from the USDA 1987 - 88 Nationwide Food Consumption Survey were used to determine populations most at risk of less than optimal calcium intake and food sources of calcium intake .
101606,intake,O,3524.0,Data from the USDA 1987 - 88 Nationwide Food Consumption Survey were used to determine populations most at risk of less than optimal calcium intake and food sources of calcium intake .
101607,and,O,3524.0,Data from the USDA 1987 - 88 Nationwide Food Consumption Survey were used to determine populations most at risk of less than optimal calcium intake and food sources of calcium intake .
101608,food,O,3524.0,Data from the USDA 1987 - 88 Nationwide Food Consumption Survey were used to determine populations most at risk of less than optimal calcium intake and food sources of calcium intake .
101609,sources,O,3524.0,Data from the USDA 1987 - 88 Nationwide Food Consumption Survey were used to determine populations most at risk of less than optimal calcium intake and food sources of calcium intake .
101610,of,O,3524.0,Data from the USDA 1987 - 88 Nationwide Food Consumption Survey were used to determine populations most at risk of less than optimal calcium intake and food sources of calcium intake .
101611,calcium,O,3524.0,Data from the USDA 1987 - 88 Nationwide Food Consumption Survey were used to determine populations most at risk of less than optimal calcium intake and food sources of calcium intake .
101612,intake,O,3524.0,Data from the USDA 1987 - 88 Nationwide Food Consumption Survey were used to determine populations most at risk of less than optimal calcium intake and food sources of calcium intake .
101613,.,O,3524.0,Data from the USDA 1987 - 88 Nationwide Food Consumption Survey were used to determine populations most at risk of less than optimal calcium intake and food sources of calcium intake .
101614,Mean,O,3525.0,"Mean per capita daily consumption of calcium for the total U.S. population was 737 mg and varied by region of the country , household income , ethnic group , sex , and age ."
101615,per,O,3525.0,"Mean per capita daily consumption of calcium for the total U.S. population was 737 mg and varied by region of the country , household income , ethnic group , sex , and age ."
101616,capita,O,3525.0,"Mean per capita daily consumption of calcium for the total U.S. population was 737 mg and varied by region of the country , household income , ethnic group , sex , and age ."
101617,daily,O,3525.0,"Mean per capita daily consumption of calcium for the total U.S. population was 737 mg and varied by region of the country , household income , ethnic group , sex , and age ."
101618,consumption,O,3525.0,"Mean per capita daily consumption of calcium for the total U.S. population was 737 mg and varied by region of the country , household income , ethnic group , sex , and age ."
101619,of,O,3525.0,"Mean per capita daily consumption of calcium for the total U.S. population was 737 mg and varied by region of the country , household income , ethnic group , sex , and age ."
101620,calcium,O,3525.0,"Mean per capita daily consumption of calcium for the total U.S. population was 737 mg and varied by region of the country , household income , ethnic group , sex , and age ."
101621,for,O,3525.0,"Mean per capita daily consumption of calcium for the total U.S. population was 737 mg and varied by region of the country , household income , ethnic group , sex , and age ."
101622,the,O,3525.0,"Mean per capita daily consumption of calcium for the total U.S. population was 737 mg and varied by region of the country , household income , ethnic group , sex , and age ."
101623,total,O,3525.0,"Mean per capita daily consumption of calcium for the total U.S. population was 737 mg and varied by region of the country , household income , ethnic group , sex , and age ."
101624,U.S.,O,3525.0,"Mean per capita daily consumption of calcium for the total U.S. population was 737 mg and varied by region of the country , household income , ethnic group , sex , and age ."
101625,population,O,3525.0,"Mean per capita daily consumption of calcium for the total U.S. population was 737 mg and varied by region of the country , household income , ethnic group , sex , and age ."
101626,was,O,3525.0,"Mean per capita daily consumption of calcium for the total U.S. population was 737 mg and varied by region of the country , household income , ethnic group , sex , and age ."
101627,737,O,3525.0,"Mean per capita daily consumption of calcium for the total U.S. population was 737 mg and varied by region of the country , household income , ethnic group , sex , and age ."
101628,mg,O,3525.0,"Mean per capita daily consumption of calcium for the total U.S. population was 737 mg and varied by region of the country , household income , ethnic group , sex , and age ."
101629,and,O,3525.0,"Mean per capita daily consumption of calcium for the total U.S. population was 737 mg and varied by region of the country , household income , ethnic group , sex , and age ."
101630,varied,O,3525.0,"Mean per capita daily consumption of calcium for the total U.S. population was 737 mg and varied by region of the country , household income , ethnic group , sex , and age ."
101631,by,O,3525.0,"Mean per capita daily consumption of calcium for the total U.S. population was 737 mg and varied by region of the country , household income , ethnic group , sex , and age ."
101632,region,O,3525.0,"Mean per capita daily consumption of calcium for the total U.S. population was 737 mg and varied by region of the country , household income , ethnic group , sex , and age ."
101633,of,O,3525.0,"Mean per capita daily consumption of calcium for the total U.S. population was 737 mg and varied by region of the country , household income , ethnic group , sex , and age ."
101634,the,O,3525.0,"Mean per capita daily consumption of calcium for the total U.S. population was 737 mg and varied by region of the country , household income , ethnic group , sex , and age ."
101635,country,O,3525.0,"Mean per capita daily consumption of calcium for the total U.S. population was 737 mg and varied by region of the country , household income , ethnic group , sex , and age ."
101636,",",O,3525.0,"Mean per capita daily consumption of calcium for the total U.S. population was 737 mg and varied by region of the country , household income , ethnic group , sex , and age ."
101637,household,O,3525.0,"Mean per capita daily consumption of calcium for the total U.S. population was 737 mg and varied by region of the country , household income , ethnic group , sex , and age ."
101638,income,O,3525.0,"Mean per capita daily consumption of calcium for the total U.S. population was 737 mg and varied by region of the country , household income , ethnic group , sex , and age ."
101639,",",O,3525.0,"Mean per capita daily consumption of calcium for the total U.S. population was 737 mg and varied by region of the country , household income , ethnic group , sex , and age ."
101640,ethnic,O,3525.0,"Mean per capita daily consumption of calcium for the total U.S. population was 737 mg and varied by region of the country , household income , ethnic group , sex , and age ."
101641,group,O,3525.0,"Mean per capita daily consumption of calcium for the total U.S. population was 737 mg and varied by region of the country , household income , ethnic group , sex , and age ."
101642,",",O,3525.0,"Mean per capita daily consumption of calcium for the total U.S. population was 737 mg and varied by region of the country , household income , ethnic group , sex , and age ."
101643,sex,O,3525.0,"Mean per capita daily consumption of calcium for the total U.S. population was 737 mg and varied by region of the country , household income , ethnic group , sex , and age ."
101644,",",O,3525.0,"Mean per capita daily consumption of calcium for the total U.S. population was 737 mg and varied by region of the country , household income , ethnic group , sex , and age ."
101645,and,O,3525.0,"Mean per capita daily consumption of calcium for the total U.S. population was 737 mg and varied by region of the country , household income , ethnic group , sex , and age ."
101646,age,O,3525.0,"Mean per capita daily consumption of calcium for the total U.S. population was 737 mg and varied by region of the country , household income , ethnic group , sex , and age ."
101647,.,O,3525.0,"Mean per capita daily consumption of calcium for the total U.S. population was 737 mg and varied by region of the country , household income , ethnic group , sex , and age ."
101648,For,O,3526.0,"For most groups of females , intake was substantially less than the RDA ."
101649,most,O,3526.0,"For most groups of females , intake was substantially less than the RDA ."
101650,groups,O,3526.0,"For most groups of females , intake was substantially less than the RDA ."
101651,of,O,3526.0,"For most groups of females , intake was substantially less than the RDA ."
101652,females,O,3526.0,"For most groups of females , intake was substantially less than the RDA ."
101653,",",O,3526.0,"For most groups of females , intake was substantially less than the RDA ."
101654,intake,O,3526.0,"For most groups of females , intake was substantially less than the RDA ."
101655,was,O,3526.0,"For most groups of females , intake was substantially less than the RDA ."
101656,substantially,O,3526.0,"For most groups of females , intake was substantially less than the RDA ."
101657,less,O,3526.0,"For most groups of females , intake was substantially less than the RDA ."
101658,than,O,3526.0,"For most groups of females , intake was substantially less than the RDA ."
101659,the,O,3526.0,"For most groups of females , intake was substantially less than the RDA ."
101660,RDA,O,3526.0,"For most groups of females , intake was substantially less than the RDA ."
101661,.,O,3526.0,"For most groups of females , intake was substantially less than the RDA ."
101662,About,O,3527.0,About 50 % of total dietary calcium was supplied by milk and milk products .
101663,50,O,3527.0,About 50 % of total dietary calcium was supplied by milk and milk products .
101664,%,O,3527.0,About 50 % of total dietary calcium was supplied by milk and milk products .
101665,of,O,3527.0,About 50 % of total dietary calcium was supplied by milk and milk products .
101666,total,O,3527.0,About 50 % of total dietary calcium was supplied by milk and milk products .
101667,dietary,O,3527.0,About 50 % of total dietary calcium was supplied by milk and milk products .
101668,calcium,O,3527.0,About 50 % of total dietary calcium was supplied by milk and milk products .
101669,was,O,3527.0,About 50 % of total dietary calcium was supplied by milk and milk products .
101670,supplied,O,3527.0,About 50 % of total dietary calcium was supplied by milk and milk products .
101671,by,O,3527.0,About 50 % of total dietary calcium was supplied by milk and milk products .
101672,milk,B-AG.01.e,3527.0,About 50 % of total dietary calcium was supplied by milk and milk products .
101673,and,O,3527.0,About 50 % of total dietary calcium was supplied by milk and milk products .
101674,milk,B-AG.01.e,3527.0,About 50 % of total dietary calcium was supplied by milk and milk products .
101675,products,I-AG.01.e,3527.0,About 50 % of total dietary calcium was supplied by milk and milk products .
101676,.,O,3527.0,About 50 % of total dietary calcium was supplied by milk and milk products .
101677,Milk,B-AG.01.e,3528.0,"Milk and cheese used as ingredients in meat , grain , and vegetable mixtures contributed another 20 % of dietary calcium ."
101678,and,O,3528.0,"Milk and cheese used as ingredients in meat , grain , and vegetable mixtures contributed another 20 % of dietary calcium ."
101679,cheese,B-AG.01.e.02,3528.0,"Milk and cheese used as ingredients in meat , grain , and vegetable mixtures contributed another 20 % of dietary calcium ."
101680,used,O,3528.0,"Milk and cheese used as ingredients in meat , grain , and vegetable mixtures contributed another 20 % of dietary calcium ."
101681,as,O,3528.0,"Milk and cheese used as ingredients in meat , grain , and vegetable mixtures contributed another 20 % of dietary calcium ."
101682,ingredients,O,3528.0,"Milk and cheese used as ingredients in meat , grain , and vegetable mixtures contributed another 20 % of dietary calcium ."
101683,in,O,3528.0,"Milk and cheese used as ingredients in meat , grain , and vegetable mixtures contributed another 20 % of dietary calcium ."
101684,meat,B-AG.01.d,3528.0,"Milk and cheese used as ingredients in meat , grain , and vegetable mixtures contributed another 20 % of dietary calcium ."
101685,",",O,3528.0,"Milk and cheese used as ingredients in meat , grain , and vegetable mixtures contributed another 20 % of dietary calcium ."
101686,grain,B-AG.01.i,3528.0,"Milk and cheese used as ingredients in meat , grain , and vegetable mixtures contributed another 20 % of dietary calcium ."
101687,",",O,3528.0,"Milk and cheese used as ingredients in meat , grain , and vegetable mixtures contributed another 20 % of dietary calcium ."
101688,and,O,3528.0,"Milk and cheese used as ingredients in meat , grain , and vegetable mixtures contributed another 20 % of dietary calcium ."
101689,vegetable,B-AG.01.h.02,3528.0,"Milk and cheese used as ingredients in meat , grain , and vegetable mixtures contributed another 20 % of dietary calcium ."
101690,mixtures,I-AG.01.h.02,3528.0,"Milk and cheese used as ingredients in meat , grain , and vegetable mixtures contributed another 20 % of dietary calcium ."
101691,contributed,O,3528.0,"Milk and cheese used as ingredients in meat , grain , and vegetable mixtures contributed another 20 % of dietary calcium ."
101692,another,O,3528.0,"Milk and cheese used as ingredients in meat , grain , and vegetable mixtures contributed another 20 % of dietary calcium ."
101693,20,O,3528.0,"Milk and cheese used as ingredients in meat , grain , and vegetable mixtures contributed another 20 % of dietary calcium ."
101694,%,O,3528.0,"Milk and cheese used as ingredients in meat , grain , and vegetable mixtures contributed another 20 % of dietary calcium ."
101695,of,O,3528.0,"Milk and cheese used as ingredients in meat , grain , and vegetable mixtures contributed another 20 % of dietary calcium ."
101696,dietary,O,3528.0,"Milk and cheese used as ingredients in meat , grain , and vegetable mixtures contributed another 20 % of dietary calcium ."
101697,calcium,O,3528.0,"Milk and cheese used as ingredients in meat , grain , and vegetable mixtures contributed another 20 % of dietary calcium ."
101698,.,O,3528.0,"Milk and cheese used as ingredients in meat , grain , and vegetable mixtures contributed another 20 % of dietary calcium ."
101699,The,O,3529.0,"The remaining 30 % of calcium was provided by grains and grain products , meat , poultry , fish , vegetables , fruits , eggs , legumes , nuts , and seeds ."
101700,remaining,O,3529.0,"The remaining 30 % of calcium was provided by grains and grain products , meat , poultry , fish , vegetables , fruits , eggs , legumes , nuts , and seeds ."
101701,30,O,3529.0,"The remaining 30 % of calcium was provided by grains and grain products , meat , poultry , fish , vegetables , fruits , eggs , legumes , nuts , and seeds ."
101702,%,O,3529.0,"The remaining 30 % of calcium was provided by grains and grain products , meat , poultry , fish , vegetables , fruits , eggs , legumes , nuts , and seeds ."
101703,of,O,3529.0,"The remaining 30 % of calcium was provided by grains and grain products , meat , poultry , fish , vegetables , fruits , eggs , legumes , nuts , and seeds ."
101704,calcium,O,3529.0,"The remaining 30 % of calcium was provided by grains and grain products , meat , poultry , fish , vegetables , fruits , eggs , legumes , nuts , and seeds ."
101705,was,O,3529.0,"The remaining 30 % of calcium was provided by grains and grain products , meat , poultry , fish , vegetables , fruits , eggs , legumes , nuts , and seeds ."
101706,provided,O,3529.0,"The remaining 30 % of calcium was provided by grains and grain products , meat , poultry , fish , vegetables , fruits , eggs , legumes , nuts , and seeds ."
101707,by,O,3529.0,"The remaining 30 % of calcium was provided by grains and grain products , meat , poultry , fish , vegetables , fruits , eggs , legumes , nuts , and seeds ."
101708,grains,B-AG.01.i,3529.0,"The remaining 30 % of calcium was provided by grains and grain products , meat , poultry , fish , vegetables , fruits , eggs , legumes , nuts , and seeds ."
101709,and,O,3529.0,"The remaining 30 % of calcium was provided by grains and grain products , meat , poultry , fish , vegetables , fruits , eggs , legumes , nuts , and seeds ."
101710,grain,B-AG.01.n.10,3529.0,"The remaining 30 % of calcium was provided by grains and grain products , meat , poultry , fish , vegetables , fruits , eggs , legumes , nuts , and seeds ."
101711,products,I-AG.01.n.10,3529.0,"The remaining 30 % of calcium was provided by grains and grain products , meat , poultry , fish , vegetables , fruits , eggs , legumes , nuts , and seeds ."
101712,",",O,3529.0,"The remaining 30 % of calcium was provided by grains and grain products , meat , poultry , fish , vegetables , fruits , eggs , legumes , nuts , and seeds ."
101713,meat,B-AG.01.d,3529.0,"The remaining 30 % of calcium was provided by grains and grain products , meat , poultry , fish , vegetables , fruits , eggs , legumes , nuts , and seeds ."
101714,",",O,3529.0,"The remaining 30 % of calcium was provided by grains and grain products , meat , poultry , fish , vegetables , fruits , eggs , legumes , nuts , and seeds ."
101715,poultry,B-AG.01.d.06,3529.0,"The remaining 30 % of calcium was provided by grains and grain products , meat , poultry , fish , vegetables , fruits , eggs , legumes , nuts , and seeds ."
101716,",",O,3529.0,"The remaining 30 % of calcium was provided by grains and grain products , meat , poultry , fish , vegetables , fruits , eggs , legumes , nuts , and seeds ."
101717,fish,B-AG.01.d.07,3529.0,"The remaining 30 % of calcium was provided by grains and grain products , meat , poultry , fish , vegetables , fruits , eggs , legumes , nuts , and seeds ."
101718,",",O,3529.0,"The remaining 30 % of calcium was provided by grains and grain products , meat , poultry , fish , vegetables , fruits , eggs , legumes , nuts , and seeds ."
101719,vegetables,B-AG.01.h.02,3529.0,"The remaining 30 % of calcium was provided by grains and grain products , meat , poultry , fish , vegetables , fruits , eggs , legumes , nuts , and seeds ."
101720,",",O,3529.0,"The remaining 30 % of calcium was provided by grains and grain products , meat , poultry , fish , vegetables , fruits , eggs , legumes , nuts , and seeds ."
101721,fruits,B-AG.01.h.01,3529.0,"The remaining 30 % of calcium was provided by grains and grain products , meat , poultry , fish , vegetables , fruits , eggs , legumes , nuts , and seeds ."
101722,",",O,3529.0,"The remaining 30 % of calcium was provided by grains and grain products , meat , poultry , fish , vegetables , fruits , eggs , legumes , nuts , and seeds ."
101723,eggs,B-AG.01.g,3529.0,"The remaining 30 % of calcium was provided by grains and grain products , meat , poultry , fish , vegetables , fruits , eggs , legumes , nuts , and seeds ."
101724,",",O,3529.0,"The remaining 30 % of calcium was provided by grains and grain products , meat , poultry , fish , vegetables , fruits , eggs , legumes , nuts , and seeds ."
101725,legumes,B-AG.01.h.02.g,3529.0,"The remaining 30 % of calcium was provided by grains and grain products , meat , poultry , fish , vegetables , fruits , eggs , legumes , nuts , and seeds ."
101726,",",O,3529.0,"The remaining 30 % of calcium was provided by grains and grain products , meat , poultry , fish , vegetables , fruits , eggs , legumes , nuts , and seeds ."
101727,nuts,B-AG.01.h.01.f,3529.0,"The remaining 30 % of calcium was provided by grains and grain products , meat , poultry , fish , vegetables , fruits , eggs , legumes , nuts , and seeds ."
101728,",",O,3529.0,"The remaining 30 % of calcium was provided by grains and grain products , meat , poultry , fish , vegetables , fruits , eggs , legumes , nuts , and seeds ."
101729,and,O,3529.0,"The remaining 30 % of calcium was provided by grains and grain products , meat , poultry , fish , vegetables , fruits , eggs , legumes , nuts , and seeds ."
101730,seeds,B-AG.01,3529.0,"The remaining 30 % of calcium was provided by grains and grain products , meat , poultry , fish , vegetables , fruits , eggs , legumes , nuts , and seeds ."
101731,.,O,3529.0,"The remaining 30 % of calcium was provided by grains and grain products , meat , poultry , fish , vegetables , fruits , eggs , legumes , nuts , and seeds ."
101732,Chocolate,O,3530.0,"Chocolate elicits unique brain activity compared to other foods , activating similar brain regions and neurobiological substrates with potentially similar psychoactive effects as substances of abuse ."
101733,elicits,O,3530.0,"Chocolate elicits unique brain activity compared to other foods , activating similar brain regions and neurobiological substrates with potentially similar psychoactive effects as substances of abuse ."
101734,unique,O,3530.0,"Chocolate elicits unique brain activity compared to other foods , activating similar brain regions and neurobiological substrates with potentially similar psychoactive effects as substances of abuse ."
101735,brain,O,3530.0,"Chocolate elicits unique brain activity compared to other foods , activating similar brain regions and neurobiological substrates with potentially similar psychoactive effects as substances of abuse ."
101736,activity,O,3530.0,"Chocolate elicits unique brain activity compared to other foods , activating similar brain regions and neurobiological substrates with potentially similar psychoactive effects as substances of abuse ."
101737,compared,O,3530.0,"Chocolate elicits unique brain activity compared to other foods , activating similar brain regions and neurobiological substrates with potentially similar psychoactive effects as substances of abuse ."
101738,to,O,3530.0,"Chocolate elicits unique brain activity compared to other foods , activating similar brain regions and neurobiological substrates with potentially similar psychoactive effects as substances of abuse ."
101739,other,O,3530.0,"Chocolate elicits unique brain activity compared to other foods , activating similar brain regions and neurobiological substrates with potentially similar psychoactive effects as substances of abuse ."
101740,foods,O,3530.0,"Chocolate elicits unique brain activity compared to other foods , activating similar brain regions and neurobiological substrates with potentially similar psychoactive effects as substances of abuse ."
101741,",",O,3530.0,"Chocolate elicits unique brain activity compared to other foods , activating similar brain regions and neurobiological substrates with potentially similar psychoactive effects as substances of abuse ."
101742,activating,O,3530.0,"Chocolate elicits unique brain activity compared to other foods , activating similar brain regions and neurobiological substrates with potentially similar psychoactive effects as substances of abuse ."
101743,similar,O,3530.0,"Chocolate elicits unique brain activity compared to other foods , activating similar brain regions and neurobiological substrates with potentially similar psychoactive effects as substances of abuse ."
101744,brain,O,3530.0,"Chocolate elicits unique brain activity compared to other foods , activating similar brain regions and neurobiological substrates with potentially similar psychoactive effects as substances of abuse ."
101745,regions,O,3530.0,"Chocolate elicits unique brain activity compared to other foods , activating similar brain regions and neurobiological substrates with potentially similar psychoactive effects as substances of abuse ."
101746,and,O,3530.0,"Chocolate elicits unique brain activity compared to other foods , activating similar brain regions and neurobiological substrates with potentially similar psychoactive effects as substances of abuse ."
101747,neurobiological,O,3530.0,"Chocolate elicits unique brain activity compared to other foods , activating similar brain regions and neurobiological substrates with potentially similar psychoactive effects as substances of abuse ."
101748,substrates,O,3530.0,"Chocolate elicits unique brain activity compared to other foods , activating similar brain regions and neurobiological substrates with potentially similar psychoactive effects as substances of abuse ."
101749,with,O,3530.0,"Chocolate elicits unique brain activity compared to other foods , activating similar brain regions and neurobiological substrates with potentially similar psychoactive effects as substances of abuse ."
101750,potentially,O,3530.0,"Chocolate elicits unique brain activity compared to other foods , activating similar brain regions and neurobiological substrates with potentially similar psychoactive effects as substances of abuse ."
101751,similar,O,3530.0,"Chocolate elicits unique brain activity compared to other foods , activating similar brain regions and neurobiological substrates with potentially similar psychoactive effects as substances of abuse ."
101752,psychoactive,O,3530.0,"Chocolate elicits unique brain activity compared to other foods , activating similar brain regions and neurobiological substrates with potentially similar psychoactive effects as substances of abuse ."
101753,effects,O,3530.0,"Chocolate elicits unique brain activity compared to other foods , activating similar brain regions and neurobiological substrates with potentially similar psychoactive effects as substances of abuse ."
101754,as,O,3530.0,"Chocolate elicits unique brain activity compared to other foods , activating similar brain regions and neurobiological substrates with potentially similar psychoactive effects as substances of abuse ."
101755,substances,O,3530.0,"Chocolate elicits unique brain activity compared to other foods , activating similar brain regions and neurobiological substrates with potentially similar psychoactive effects as substances of abuse ."
101756,of,O,3530.0,"Chocolate elicits unique brain activity compared to other foods , activating similar brain regions and neurobiological substrates with potentially similar psychoactive effects as substances of abuse ."
101757,abuse,O,3530.0,"Chocolate elicits unique brain activity compared to other foods , activating similar brain regions and neurobiological substrates with potentially similar psychoactive effects as substances of abuse ."
101758,.,O,3530.0,"Chocolate elicits unique brain activity compared to other foods , activating similar brain regions and neurobiological substrates with potentially similar psychoactive effects as substances of abuse ."
101759,We,O,3531.0,"We sought to determine the relationship between chocolate with varying combinations of its main constituents ( sugar , cocoa , and fat ) and its psychoactive effects ."
101760,sought,O,3531.0,"We sought to determine the relationship between chocolate with varying combinations of its main constituents ( sugar , cocoa , and fat ) and its psychoactive effects ."
101761,to,O,3531.0,"We sought to determine the relationship between chocolate with varying combinations of its main constituents ( sugar , cocoa , and fat ) and its psychoactive effects ."
101762,determine,O,3531.0,"We sought to determine the relationship between chocolate with varying combinations of its main constituents ( sugar , cocoa , and fat ) and its psychoactive effects ."
101763,the,O,3531.0,"We sought to determine the relationship between chocolate with varying combinations of its main constituents ( sugar , cocoa , and fat ) and its psychoactive effects ."
101764,relationship,O,3531.0,"We sought to determine the relationship between chocolate with varying combinations of its main constituents ( sugar , cocoa , and fat ) and its psychoactive effects ."
101765,between,O,3531.0,"We sought to determine the relationship between chocolate with varying combinations of its main constituents ( sugar , cocoa , and fat ) and its psychoactive effects ."
101766,chocolate,B-AG.01.n.17.a,3531.0,"We sought to determine the relationship between chocolate with varying combinations of its main constituents ( sugar , cocoa , and fat ) and its psychoactive effects ."
101767,with,O,3531.0,"We sought to determine the relationship between chocolate with varying combinations of its main constituents ( sugar , cocoa , and fat ) and its psychoactive effects ."
101768,varying,O,3531.0,"We sought to determine the relationship between chocolate with varying combinations of its main constituents ( sugar , cocoa , and fat ) and its psychoactive effects ."
101769,combinations,O,3531.0,"We sought to determine the relationship between chocolate with varying combinations of its main constituents ( sugar , cocoa , and fat ) and its psychoactive effects ."
101770,of,O,3531.0,"We sought to determine the relationship between chocolate with varying combinations of its main constituents ( sugar , cocoa , and fat ) and its psychoactive effects ."
101771,its,O,3531.0,"We sought to determine the relationship between chocolate with varying combinations of its main constituents ( sugar , cocoa , and fat ) and its psychoactive effects ."
101772,main,O,3531.0,"We sought to determine the relationship between chocolate with varying combinations of its main constituents ( sugar , cocoa , and fat ) and its psychoactive effects ."
101773,constituents,O,3531.0,"We sought to determine the relationship between chocolate with varying combinations of its main constituents ( sugar , cocoa , and fat ) and its psychoactive effects ."
101774,(,O,3531.0,"We sought to determine the relationship between chocolate with varying combinations of its main constituents ( sugar , cocoa , and fat ) and its psychoactive effects ."
101775,sugar,B-AG.01.l.02,3531.0,"We sought to determine the relationship between chocolate with varying combinations of its main constituents ( sugar , cocoa , and fat ) and its psychoactive effects ."
101776,",",O,3531.0,"We sought to determine the relationship between chocolate with varying combinations of its main constituents ( sugar , cocoa , and fat ) and its psychoactive effects ."
101777,cocoa,B-AG.01,3531.0,"We sought to determine the relationship between chocolate with varying combinations of its main constituents ( sugar , cocoa , and fat ) and its psychoactive effects ."
101778,",",O,3531.0,"We sought to determine the relationship between chocolate with varying combinations of its main constituents ( sugar , cocoa , and fat ) and its psychoactive effects ."
101779,and,O,3531.0,"We sought to determine the relationship between chocolate with varying combinations of its main constituents ( sugar , cocoa , and fat ) and its psychoactive effects ."
101780,fat,B-AG.01.f,3531.0,"We sought to determine the relationship between chocolate with varying combinations of its main constituents ( sugar , cocoa , and fat ) and its psychoactive effects ."
101781,),O,3531.0,"We sought to determine the relationship between chocolate with varying combinations of its main constituents ( sugar , cocoa , and fat ) and its psychoactive effects ."
101782,and,O,3531.0,"We sought to determine the relationship between chocolate with varying combinations of its main constituents ( sugar , cocoa , and fat ) and its psychoactive effects ."
101783,its,O,3531.0,"We sought to determine the relationship between chocolate with varying combinations of its main constituents ( sugar , cocoa , and fat ) and its psychoactive effects ."
101784,psychoactive,O,3531.0,"We sought to determine the relationship between chocolate with varying combinations of its main constituents ( sugar , cocoa , and fat ) and its psychoactive effects ."
101785,effects,O,3531.0,"We sought to determine the relationship between chocolate with varying combinations of its main constituents ( sugar , cocoa , and fat ) and its psychoactive effects ."
101786,.,O,3531.0,"We sought to determine the relationship between chocolate with varying combinations of its main constituents ( sugar , cocoa , and fat ) and its psychoactive effects ."
101787,Participants,O,3532.0,"Participants consumed 5 g of a commercially available chocolate with increasing amounts of sugar ( 90 % cocoa , 85 % cocoa , 70 % cocoa , and milk chocolates ) ."
101788,consumed,O,3532.0,"Participants consumed 5 g of a commercially available chocolate with increasing amounts of sugar ( 90 % cocoa , 85 % cocoa , 70 % cocoa , and milk chocolates ) ."
101789,5,O,3532.0,"Participants consumed 5 g of a commercially available chocolate with increasing amounts of sugar ( 90 % cocoa , 85 % cocoa , 70 % cocoa , and milk chocolates ) ."
101790,g,O,3532.0,"Participants consumed 5 g of a commercially available chocolate with increasing amounts of sugar ( 90 % cocoa , 85 % cocoa , 70 % cocoa , and milk chocolates ) ."
101791,of,O,3532.0,"Participants consumed 5 g of a commercially available chocolate with increasing amounts of sugar ( 90 % cocoa , 85 % cocoa , 70 % cocoa , and milk chocolates ) ."
101792,a,O,3532.0,"Participants consumed 5 g of a commercially available chocolate with increasing amounts of sugar ( 90 % cocoa , 85 % cocoa , 70 % cocoa , and milk chocolates ) ."
101793,commercially,O,3532.0,"Participants consumed 5 g of a commercially available chocolate with increasing amounts of sugar ( 90 % cocoa , 85 % cocoa , 70 % cocoa , and milk chocolates ) ."
101794,available,O,3532.0,"Participants consumed 5 g of a commercially available chocolate with increasing amounts of sugar ( 90 % cocoa , 85 % cocoa , 70 % cocoa , and milk chocolates ) ."
101795,chocolate,B-AG.01.n.17.a,3532.0,"Participants consumed 5 g of a commercially available chocolate with increasing amounts of sugar ( 90 % cocoa , 85 % cocoa , 70 % cocoa , and milk chocolates ) ."
101796,with,O,3532.0,"Participants consumed 5 g of a commercially available chocolate with increasing amounts of sugar ( 90 % cocoa , 85 % cocoa , 70 % cocoa , and milk chocolates ) ."
101797,increasing,O,3532.0,"Participants consumed 5 g of a commercially available chocolate with increasing amounts of sugar ( 90 % cocoa , 85 % cocoa , 70 % cocoa , and milk chocolates ) ."
101798,amounts,O,3532.0,"Participants consumed 5 g of a commercially available chocolate with increasing amounts of sugar ( 90 % cocoa , 85 % cocoa , 70 % cocoa , and milk chocolates ) ."
101799,of,O,3532.0,"Participants consumed 5 g of a commercially available chocolate with increasing amounts of sugar ( 90 % cocoa , 85 % cocoa , 70 % cocoa , and milk chocolates ) ."
101800,sugar,B-AG.01.l.02,3532.0,"Participants consumed 5 g of a commercially available chocolate with increasing amounts of sugar ( 90 % cocoa , 85 % cocoa , 70 % cocoa , and milk chocolates ) ."
101801,(,O,3532.0,"Participants consumed 5 g of a commercially available chocolate with increasing amounts of sugar ( 90 % cocoa , 85 % cocoa , 70 % cocoa , and milk chocolates ) ."
101802,90,O,3532.0,"Participants consumed 5 g of a commercially available chocolate with increasing amounts of sugar ( 90 % cocoa , 85 % cocoa , 70 % cocoa , and milk chocolates ) ."
101803,%,O,3532.0,"Participants consumed 5 g of a commercially available chocolate with increasing amounts of sugar ( 90 % cocoa , 85 % cocoa , 70 % cocoa , and milk chocolates ) ."
101804,cocoa,B-AG.01,3532.0,"Participants consumed 5 g of a commercially available chocolate with increasing amounts of sugar ( 90 % cocoa , 85 % cocoa , 70 % cocoa , and milk chocolates ) ."
101805,",",O,3532.0,"Participants consumed 5 g of a commercially available chocolate with increasing amounts of sugar ( 90 % cocoa , 85 % cocoa , 70 % cocoa , and milk chocolates ) ."
101806,85,O,3532.0,"Participants consumed 5 g of a commercially available chocolate with increasing amounts of sugar ( 90 % cocoa , 85 % cocoa , 70 % cocoa , and milk chocolates ) ."
101807,%,O,3532.0,"Participants consumed 5 g of a commercially available chocolate with increasing amounts of sugar ( 90 % cocoa , 85 % cocoa , 70 % cocoa , and milk chocolates ) ."
101808,cocoa,B-AG.01,3532.0,"Participants consumed 5 g of a commercially available chocolate with increasing amounts of sugar ( 90 % cocoa , 85 % cocoa , 70 % cocoa , and milk chocolates ) ."
101809,",",O,3532.0,"Participants consumed 5 g of a commercially available chocolate with increasing amounts of sugar ( 90 % cocoa , 85 % cocoa , 70 % cocoa , and milk chocolates ) ."
101810,70,O,3532.0,"Participants consumed 5 g of a commercially available chocolate with increasing amounts of sugar ( 90 % cocoa , 85 % cocoa , 70 % cocoa , and milk chocolates ) ."
101811,%,O,3532.0,"Participants consumed 5 g of a commercially available chocolate with increasing amounts of sugar ( 90 % cocoa , 85 % cocoa , 70 % cocoa , and milk chocolates ) ."
101812,cocoa,B-AG.01,3532.0,"Participants consumed 5 g of a commercially available chocolate with increasing amounts of sugar ( 90 % cocoa , 85 % cocoa , 70 % cocoa , and milk chocolates ) ."
101813,",",O,3532.0,"Participants consumed 5 g of a commercially available chocolate with increasing amounts of sugar ( 90 % cocoa , 85 % cocoa , 70 % cocoa , and milk chocolates ) ."
101814,and,O,3532.0,"Participants consumed 5 g of a commercially available chocolate with increasing amounts of sugar ( 90 % cocoa , 85 % cocoa , 70 % cocoa , and milk chocolates ) ."
101815,milk,B-AG.01.n.17.a,3532.0,"Participants consumed 5 g of a commercially available chocolate with increasing amounts of sugar ( 90 % cocoa , 85 % cocoa , 70 % cocoa , and milk chocolates ) ."
101816,chocolates,I-AG.01.n.17.a,3532.0,"Participants consumed 5 g of a commercially available chocolate with increasing amounts of sugar ( 90 % cocoa , 85 % cocoa , 70 % cocoa , and milk chocolates ) ."
101817,),O,3532.0,"Participants consumed 5 g of a commercially available chocolate with increasing amounts of sugar ( 90 % cocoa , 85 % cocoa , 70 % cocoa , and milk chocolates ) ."
101818,.,O,3532.0,"Participants consumed 5 g of a commercially available chocolate with increasing amounts of sugar ( 90 % cocoa , 85 % cocoa , 70 % cocoa , and milk chocolates ) ."
101819,After,O,3533.0,"After each chocolate sample , participants completed the Psychoactive Effects Questionnaire ( PEQ ) ."
101820,each,O,3533.0,"After each chocolate sample , participants completed the Psychoactive Effects Questionnaire ( PEQ ) ."
101821,chocolate,O,3533.0,"After each chocolate sample , participants completed the Psychoactive Effects Questionnaire ( PEQ ) ."
101822,sample,O,3533.0,"After each chocolate sample , participants completed the Psychoactive Effects Questionnaire ( PEQ ) ."
101823,",",O,3533.0,"After each chocolate sample , participants completed the Psychoactive Effects Questionnaire ( PEQ ) ."
101824,participants,O,3533.0,"After each chocolate sample , participants completed the Psychoactive Effects Questionnaire ( PEQ ) ."
101825,completed,O,3533.0,"After each chocolate sample , participants completed the Psychoactive Effects Questionnaire ( PEQ ) ."
101826,the,O,3533.0,"After each chocolate sample , participants completed the Psychoactive Effects Questionnaire ( PEQ ) ."
101827,Psychoactive,O,3533.0,"After each chocolate sample , participants completed the Psychoactive Effects Questionnaire ( PEQ ) ."
101828,Effects,O,3533.0,"After each chocolate sample , participants completed the Psychoactive Effects Questionnaire ( PEQ ) ."
101829,Questionnaire,O,3533.0,"After each chocolate sample , participants completed the Psychoactive Effects Questionnaire ( PEQ ) ."
101830,(,O,3533.0,"After each chocolate sample , participants completed the Psychoactive Effects Questionnaire ( PEQ ) ."
101831,PEQ,O,3533.0,"After each chocolate sample , participants completed the Psychoactive Effects Questionnaire ( PEQ ) ."
101832,),O,3533.0,"After each chocolate sample , participants completed the Psychoactive Effects Questionnaire ( PEQ ) ."
101833,.,O,3533.0,"After each chocolate sample , participants completed the Psychoactive Effects Questionnaire ( PEQ ) ."
101834,The,O,3534.0,"The PEQ consists of questions taken from the Morphine - Benzedrine Group ( MBG ) , Morphine ( M , ) and Excitement ( E ) subscales of the Addiction Research Center Inventory ."
101835,PEQ,O,3534.0,"The PEQ consists of questions taken from the Morphine - Benzedrine Group ( MBG ) , Morphine ( M , ) and Excitement ( E ) subscales of the Addiction Research Center Inventory ."
101836,consists,O,3534.0,"The PEQ consists of questions taken from the Morphine - Benzedrine Group ( MBG ) , Morphine ( M , ) and Excitement ( E ) subscales of the Addiction Research Center Inventory ."
101837,of,O,3534.0,"The PEQ consists of questions taken from the Morphine - Benzedrine Group ( MBG ) , Morphine ( M , ) and Excitement ( E ) subscales of the Addiction Research Center Inventory ."
101838,questions,O,3534.0,"The PEQ consists of questions taken from the Morphine - Benzedrine Group ( MBG ) , Morphine ( M , ) and Excitement ( E ) subscales of the Addiction Research Center Inventory ."
101839,taken,O,3534.0,"The PEQ consists of questions taken from the Morphine - Benzedrine Group ( MBG ) , Morphine ( M , ) and Excitement ( E ) subscales of the Addiction Research Center Inventory ."
101840,from,O,3534.0,"The PEQ consists of questions taken from the Morphine - Benzedrine Group ( MBG ) , Morphine ( M , ) and Excitement ( E ) subscales of the Addiction Research Center Inventory ."
101841,the,O,3534.0,"The PEQ consists of questions taken from the Morphine - Benzedrine Group ( MBG ) , Morphine ( M , ) and Excitement ( E ) subscales of the Addiction Research Center Inventory ."
101842,Morphine,O,3534.0,"The PEQ consists of questions taken from the Morphine - Benzedrine Group ( MBG ) , Morphine ( M , ) and Excitement ( E ) subscales of the Addiction Research Center Inventory ."
101843,-,O,3534.0,"The PEQ consists of questions taken from the Morphine - Benzedrine Group ( MBG ) , Morphine ( M , ) and Excitement ( E ) subscales of the Addiction Research Center Inventory ."
101844,Benzedrine,O,3534.0,"The PEQ consists of questions taken from the Morphine - Benzedrine Group ( MBG ) , Morphine ( M , ) and Excitement ( E ) subscales of the Addiction Research Center Inventory ."
101845,Group,O,3534.0,"The PEQ consists of questions taken from the Morphine - Benzedrine Group ( MBG ) , Morphine ( M , ) and Excitement ( E ) subscales of the Addiction Research Center Inventory ."
101846,(,O,3534.0,"The PEQ consists of questions taken from the Morphine - Benzedrine Group ( MBG ) , Morphine ( M , ) and Excitement ( E ) subscales of the Addiction Research Center Inventory ."
101847,MBG,O,3534.0,"The PEQ consists of questions taken from the Morphine - Benzedrine Group ( MBG ) , Morphine ( M , ) and Excitement ( E ) subscales of the Addiction Research Center Inventory ."
101848,),O,3534.0,"The PEQ consists of questions taken from the Morphine - Benzedrine Group ( MBG ) , Morphine ( M , ) and Excitement ( E ) subscales of the Addiction Research Center Inventory ."
101849,",",O,3534.0,"The PEQ consists of questions taken from the Morphine - Benzedrine Group ( MBG ) , Morphine ( M , ) and Excitement ( E ) subscales of the Addiction Research Center Inventory ."
101850,Morphine,O,3534.0,"The PEQ consists of questions taken from the Morphine - Benzedrine Group ( MBG ) , Morphine ( M , ) and Excitement ( E ) subscales of the Addiction Research Center Inventory ."
101851,(,O,3534.0,"The PEQ consists of questions taken from the Morphine - Benzedrine Group ( MBG ) , Morphine ( M , ) and Excitement ( E ) subscales of the Addiction Research Center Inventory ."
101852,M,O,3534.0,"The PEQ consists of questions taken from the Morphine - Benzedrine Group ( MBG ) , Morphine ( M , ) and Excitement ( E ) subscales of the Addiction Research Center Inventory ."
101853,",",O,3534.0,"The PEQ consists of questions taken from the Morphine - Benzedrine Group ( MBG ) , Morphine ( M , ) and Excitement ( E ) subscales of the Addiction Research Center Inventory ."
101854,),O,3534.0,"The PEQ consists of questions taken from the Morphine - Benzedrine Group ( MBG ) , Morphine ( M , ) and Excitement ( E ) subscales of the Addiction Research Center Inventory ."
101855,and,O,3534.0,"The PEQ consists of questions taken from the Morphine - Benzedrine Group ( MBG ) , Morphine ( M , ) and Excitement ( E ) subscales of the Addiction Research Center Inventory ."
101856,Excitement,O,3534.0,"The PEQ consists of questions taken from the Morphine - Benzedrine Group ( MBG ) , Morphine ( M , ) and Excitement ( E ) subscales of the Addiction Research Center Inventory ."
101857,(,O,3534.0,"The PEQ consists of questions taken from the Morphine - Benzedrine Group ( MBG ) , Morphine ( M , ) and Excitement ( E ) subscales of the Addiction Research Center Inventory ."
101858,E,O,3534.0,"The PEQ consists of questions taken from the Morphine - Benzedrine Group ( MBG ) , Morphine ( M , ) and Excitement ( E ) subscales of the Addiction Research Center Inventory ."
101859,),O,3534.0,"The PEQ consists of questions taken from the Morphine - Benzedrine Group ( MBG ) , Morphine ( M , ) and Excitement ( E ) subscales of the Addiction Research Center Inventory ."
101860,subscales,O,3534.0,"The PEQ consists of questions taken from the Morphine - Benzedrine Group ( MBG ) , Morphine ( M , ) and Excitement ( E ) subscales of the Addiction Research Center Inventory ."
101861,of,O,3534.0,"The PEQ consists of questions taken from the Morphine - Benzedrine Group ( MBG ) , Morphine ( M , ) and Excitement ( E ) subscales of the Addiction Research Center Inventory ."
101862,the,O,3534.0,"The PEQ consists of questions taken from the Morphine - Benzedrine Group ( MBG ) , Morphine ( M , ) and Excitement ( E ) subscales of the Addiction Research Center Inventory ."
101863,Addiction,O,3534.0,"The PEQ consists of questions taken from the Morphine - Benzedrine Group ( MBG ) , Morphine ( M , ) and Excitement ( E ) subscales of the Addiction Research Center Inventory ."
101864,Research,O,3534.0,"The PEQ consists of questions taken from the Morphine - Benzedrine Group ( MBG ) , Morphine ( M , ) and Excitement ( E ) subscales of the Addiction Research Center Inventory ."
101865,Center,O,3534.0,"The PEQ consists of questions taken from the Morphine - Benzedrine Group ( MBG ) , Morphine ( M , ) and Excitement ( E ) subscales of the Addiction Research Center Inventory ."
101866,Inventory,O,3534.0,"The PEQ consists of questions taken from the Morphine - Benzedrine Group ( MBG ) , Morphine ( M , ) and Excitement ( E ) subscales of the Addiction Research Center Inventory ."
101867,.,O,3534.0,"The PEQ consists of questions taken from the Morphine - Benzedrine Group ( MBG ) , Morphine ( M , ) and Excitement ( E ) subscales of the Addiction Research Center Inventory ."
101868,After,O,3535.0,"After all testing procedures , participants completed the Binge Eating Scale ( BES ) while left alone and allowed to eat as much as they wanted of each of the different chocolates ."
101869,all,O,3535.0,"After all testing procedures , participants completed the Binge Eating Scale ( BES ) while left alone and allowed to eat as much as they wanted of each of the different chocolates ."
101870,testing,O,3535.0,"After all testing procedures , participants completed the Binge Eating Scale ( BES ) while left alone and allowed to eat as much as they wanted of each of the different chocolates ."
101871,procedures,O,3535.0,"After all testing procedures , participants completed the Binge Eating Scale ( BES ) while left alone and allowed to eat as much as they wanted of each of the different chocolates ."
101872,",",O,3535.0,"After all testing procedures , participants completed the Binge Eating Scale ( BES ) while left alone and allowed to eat as much as they wanted of each of the different chocolates ."
101873,participants,O,3535.0,"After all testing procedures , participants completed the Binge Eating Scale ( BES ) while left alone and allowed to eat as much as they wanted of each of the different chocolates ."
101874,completed,O,3535.0,"After all testing procedures , participants completed the Binge Eating Scale ( BES ) while left alone and allowed to eat as much as they wanted of each of the different chocolates ."
101875,the,O,3535.0,"After all testing procedures , participants completed the Binge Eating Scale ( BES ) while left alone and allowed to eat as much as they wanted of each of the different chocolates ."
101876,Binge,O,3535.0,"After all testing procedures , participants completed the Binge Eating Scale ( BES ) while left alone and allowed to eat as much as they wanted of each of the different chocolates ."
101877,Eating,O,3535.0,"After all testing procedures , participants completed the Binge Eating Scale ( BES ) while left alone and allowed to eat as much as they wanted of each of the different chocolates ."
101878,Scale,O,3535.0,"After all testing procedures , participants completed the Binge Eating Scale ( BES ) while left alone and allowed to eat as much as they wanted of each of the different chocolates ."
101879,(,O,3535.0,"After all testing procedures , participants completed the Binge Eating Scale ( BES ) while left alone and allowed to eat as much as they wanted of each of the different chocolates ."
101880,BES,O,3535.0,"After all testing procedures , participants completed the Binge Eating Scale ( BES ) while left alone and allowed to eat as much as they wanted of each of the different chocolates ."
101881,),O,3535.0,"After all testing procedures , participants completed the Binge Eating Scale ( BES ) while left alone and allowed to eat as much as they wanted of each of the different chocolates ."
101882,while,O,3535.0,"After all testing procedures , participants completed the Binge Eating Scale ( BES ) while left alone and allowed to eat as much as they wanted of each of the different chocolates ."
101883,left,O,3535.0,"After all testing procedures , participants completed the Binge Eating Scale ( BES ) while left alone and allowed to eat as much as they wanted of each of the different chocolates ."
101884,alone,O,3535.0,"After all testing procedures , participants completed the Binge Eating Scale ( BES ) while left alone and allowed to eat as much as they wanted of each of the different chocolates ."
101885,and,O,3535.0,"After all testing procedures , participants completed the Binge Eating Scale ( BES ) while left alone and allowed to eat as much as they wanted of each of the different chocolates ."
101886,allowed,O,3535.0,"After all testing procedures , participants completed the Binge Eating Scale ( BES ) while left alone and allowed to eat as much as they wanted of each of the different chocolates ."
101887,to,O,3535.0,"After all testing procedures , participants completed the Binge Eating Scale ( BES ) while left alone and allowed to eat as much as they wanted of each of the different chocolates ."
101888,eat,O,3535.0,"After all testing procedures , participants completed the Binge Eating Scale ( BES ) while left alone and allowed to eat as much as they wanted of each of the different chocolates ."
101889,as,O,3535.0,"After all testing procedures , participants completed the Binge Eating Scale ( BES ) while left alone and allowed to eat as much as they wanted of each of the different chocolates ."
101890,much,O,3535.0,"After all testing procedures , participants completed the Binge Eating Scale ( BES ) while left alone and allowed to eat as much as they wanted of each of the different chocolates ."
101891,as,O,3535.0,"After all testing procedures , participants completed the Binge Eating Scale ( BES ) while left alone and allowed to eat as much as they wanted of each of the different chocolates ."
101892,they,O,3535.0,"After all testing procedures , participants completed the Binge Eating Scale ( BES ) while left alone and allowed to eat as much as they wanted of each of the different chocolates ."
101893,wanted,O,3535.0,"After all testing procedures , participants completed the Binge Eating Scale ( BES ) while left alone and allowed to eat as much as they wanted of each of the different chocolates ."
101894,of,O,3535.0,"After all testing procedures , participants completed the Binge Eating Scale ( BES ) while left alone and allowed to eat as much as they wanted of each of the different chocolates ."
101895,each,O,3535.0,"After all testing procedures , participants completed the Binge Eating Scale ( BES ) while left alone and allowed to eat as much as they wanted of each of the different chocolates ."
101896,of,O,3535.0,"After all testing procedures , participants completed the Binge Eating Scale ( BES ) while left alone and allowed to eat as much as they wanted of each of the different chocolates ."
101897,the,O,3535.0,"After all testing procedures , participants completed the Binge Eating Scale ( BES ) while left alone and allowed to eat as much as they wanted of each of the different chocolates ."
101898,different,O,3535.0,"After all testing procedures , participants completed the Binge Eating Scale ( BES ) while left alone and allowed to eat as much as they wanted of each of the different chocolates ."
101899,chocolates,B-AG.01.n.17.a,3535.0,"After all testing procedures , participants completed the Binge Eating Scale ( BES ) while left alone and allowed to eat as much as they wanted of each of the different chocolates ."
101900,.,O,3535.0,"After all testing procedures , participants completed the Binge Eating Scale ( BES ) while left alone and allowed to eat as much as they wanted of each of the different chocolates ."
101901,We,O,3536.0,We found a measurable psychoactive dose⁻effect relationship with each incremental increase in the chocolate 's sugar content .
101902,found,O,3536.0,We found a measurable psychoactive dose⁻effect relationship with each incremental increase in the chocolate 's sugar content .
101903,a,O,3536.0,We found a measurable psychoactive dose⁻effect relationship with each incremental increase in the chocolate 's sugar content .
101904,measurable,O,3536.0,We found a measurable psychoactive dose⁻effect relationship with each incremental increase in the chocolate 's sugar content .
101905,psychoactive,O,3536.0,We found a measurable psychoactive dose⁻effect relationship with each incremental increase in the chocolate 's sugar content .
101906,dose⁻effect,O,3536.0,We found a measurable psychoactive dose⁻effect relationship with each incremental increase in the chocolate 's sugar content .
101907,relationship,O,3536.0,We found a measurable psychoactive dose⁻effect relationship with each incremental increase in the chocolate 's sugar content .
101908,with,O,3536.0,We found a measurable psychoactive dose⁻effect relationship with each incremental increase in the chocolate 's sugar content .
101909,each,O,3536.0,We found a measurable psychoactive dose⁻effect relationship with each incremental increase in the chocolate 's sugar content .
101910,incremental,O,3536.0,We found a measurable psychoactive dose⁻effect relationship with each incremental increase in the chocolate 's sugar content .
101911,increase,O,3536.0,We found a measurable psychoactive dose⁻effect relationship with each incremental increase in the chocolate 's sugar content .
101912,in,O,3536.0,We found a measurable psychoactive dose⁻effect relationship with each incremental increase in the chocolate 's sugar content .
101913,the,O,3536.0,We found a measurable psychoactive dose⁻effect relationship with each incremental increase in the chocolate 's sugar content .
101914,chocolate,O,3536.0,We found a measurable psychoactive dose⁻effect relationship with each incremental increase in the chocolate 's sugar content .
101915,'s,O,3536.0,We found a measurable psychoactive dose⁻effect relationship with each incremental increase in the chocolate 's sugar content .
101916,sugar,O,3536.0,We found a measurable psychoactive dose⁻effect relationship with each incremental increase in the chocolate 's sugar content .
101917,content,O,3536.0,We found a measurable psychoactive dose⁻effect relationship with each incremental increase in the chocolate 's sugar content .
101918,.,O,3536.0,We found a measurable psychoactive dose⁻effect relationship with each incremental increase in the chocolate 's sugar content .
101919,The,O,3537.0,"The total number of positive responses and the number of positive responses on the E subscale began increasing after tasting the 90 % cocoa chocolate , whereas the number of positive responses on the MBG and M subscales began increasing after tasting the 85 % cocoa chocolate sample ."
101920,total,O,3537.0,"The total number of positive responses and the number of positive responses on the E subscale began increasing after tasting the 90 % cocoa chocolate , whereas the number of positive responses on the MBG and M subscales began increasing after tasting the 85 % cocoa chocolate sample ."
101921,number,O,3537.0,"The total number of positive responses and the number of positive responses on the E subscale began increasing after tasting the 90 % cocoa chocolate , whereas the number of positive responses on the MBG and M subscales began increasing after tasting the 85 % cocoa chocolate sample ."
101922,of,O,3537.0,"The total number of positive responses and the number of positive responses on the E subscale began increasing after tasting the 90 % cocoa chocolate , whereas the number of positive responses on the MBG and M subscales began increasing after tasting the 85 % cocoa chocolate sample ."
101923,positive,O,3537.0,"The total number of positive responses and the number of positive responses on the E subscale began increasing after tasting the 90 % cocoa chocolate , whereas the number of positive responses on the MBG and M subscales began increasing after tasting the 85 % cocoa chocolate sample ."
101924,responses,O,3537.0,"The total number of positive responses and the number of positive responses on the E subscale began increasing after tasting the 90 % cocoa chocolate , whereas the number of positive responses on the MBG and M subscales began increasing after tasting the 85 % cocoa chocolate sample ."
101925,and,O,3537.0,"The total number of positive responses and the number of positive responses on the E subscale began increasing after tasting the 90 % cocoa chocolate , whereas the number of positive responses on the MBG and M subscales began increasing after tasting the 85 % cocoa chocolate sample ."
101926,the,O,3537.0,"The total number of positive responses and the number of positive responses on the E subscale began increasing after tasting the 90 % cocoa chocolate , whereas the number of positive responses on the MBG and M subscales began increasing after tasting the 85 % cocoa chocolate sample ."
101927,number,O,3537.0,"The total number of positive responses and the number of positive responses on the E subscale began increasing after tasting the 90 % cocoa chocolate , whereas the number of positive responses on the MBG and M subscales began increasing after tasting the 85 % cocoa chocolate sample ."
101928,of,O,3537.0,"The total number of positive responses and the number of positive responses on the E subscale began increasing after tasting the 90 % cocoa chocolate , whereas the number of positive responses on the MBG and M subscales began increasing after tasting the 85 % cocoa chocolate sample ."
101929,positive,O,3537.0,"The total number of positive responses and the number of positive responses on the E subscale began increasing after tasting the 90 % cocoa chocolate , whereas the number of positive responses on the MBG and M subscales began increasing after tasting the 85 % cocoa chocolate sample ."
101930,responses,O,3537.0,"The total number of positive responses and the number of positive responses on the E subscale began increasing after tasting the 90 % cocoa chocolate , whereas the number of positive responses on the MBG and M subscales began increasing after tasting the 85 % cocoa chocolate sample ."
101931,on,O,3537.0,"The total number of positive responses and the number of positive responses on the E subscale began increasing after tasting the 90 % cocoa chocolate , whereas the number of positive responses on the MBG and M subscales began increasing after tasting the 85 % cocoa chocolate sample ."
101932,the,O,3537.0,"The total number of positive responses and the number of positive responses on the E subscale began increasing after tasting the 90 % cocoa chocolate , whereas the number of positive responses on the MBG and M subscales began increasing after tasting the 85 % cocoa chocolate sample ."
101933,E,O,3537.0,"The total number of positive responses and the number of positive responses on the E subscale began increasing after tasting the 90 % cocoa chocolate , whereas the number of positive responses on the MBG and M subscales began increasing after tasting the 85 % cocoa chocolate sample ."
101934,subscale,O,3537.0,"The total number of positive responses and the number of positive responses on the E subscale began increasing after tasting the 90 % cocoa chocolate , whereas the number of positive responses on the MBG and M subscales began increasing after tasting the 85 % cocoa chocolate sample ."
101935,began,O,3537.0,"The total number of positive responses and the number of positive responses on the E subscale began increasing after tasting the 90 % cocoa chocolate , whereas the number of positive responses on the MBG and M subscales began increasing after tasting the 85 % cocoa chocolate sample ."
101936,increasing,O,3537.0,"The total number of positive responses and the number of positive responses on the E subscale began increasing after tasting the 90 % cocoa chocolate , whereas the number of positive responses on the MBG and M subscales began increasing after tasting the 85 % cocoa chocolate sample ."
101937,after,O,3537.0,"The total number of positive responses and the number of positive responses on the E subscale began increasing after tasting the 90 % cocoa chocolate , whereas the number of positive responses on the MBG and M subscales began increasing after tasting the 85 % cocoa chocolate sample ."
101938,tasting,O,3537.0,"The total number of positive responses and the number of positive responses on the E subscale began increasing after tasting the 90 % cocoa chocolate , whereas the number of positive responses on the MBG and M subscales began increasing after tasting the 85 % cocoa chocolate sample ."
101939,the,O,3537.0,"The total number of positive responses and the number of positive responses on the E subscale began increasing after tasting the 90 % cocoa chocolate , whereas the number of positive responses on the MBG and M subscales began increasing after tasting the 85 % cocoa chocolate sample ."
101940,90,B-AG.01.n.17.a,3537.0,"The total number of positive responses and the number of positive responses on the E subscale began increasing after tasting the 90 % cocoa chocolate , whereas the number of positive responses on the MBG and M subscales began increasing after tasting the 85 % cocoa chocolate sample ."
101941,%,I-AG.01.n.17.a,3537.0,"The total number of positive responses and the number of positive responses on the E subscale began increasing after tasting the 90 % cocoa chocolate , whereas the number of positive responses on the MBG and M subscales began increasing after tasting the 85 % cocoa chocolate sample ."
101942,cocoa,I-AG.01.n.17.a,3537.0,"The total number of positive responses and the number of positive responses on the E subscale began increasing after tasting the 90 % cocoa chocolate , whereas the number of positive responses on the MBG and M subscales began increasing after tasting the 85 % cocoa chocolate sample ."
101943,chocolate,I-AG.01.n.17.a,3537.0,"The total number of positive responses and the number of positive responses on the E subscale began increasing after tasting the 90 % cocoa chocolate , whereas the number of positive responses on the MBG and M subscales began increasing after tasting the 85 % cocoa chocolate sample ."
101944,",",O,3537.0,"The total number of positive responses and the number of positive responses on the E subscale began increasing after tasting the 90 % cocoa chocolate , whereas the number of positive responses on the MBG and M subscales began increasing after tasting the 85 % cocoa chocolate sample ."
101945,whereas,O,3537.0,"The total number of positive responses and the number of positive responses on the E subscale began increasing after tasting the 90 % cocoa chocolate , whereas the number of positive responses on the MBG and M subscales began increasing after tasting the 85 % cocoa chocolate sample ."
101946,the,O,3537.0,"The total number of positive responses and the number of positive responses on the E subscale began increasing after tasting the 90 % cocoa chocolate , whereas the number of positive responses on the MBG and M subscales began increasing after tasting the 85 % cocoa chocolate sample ."
101947,number,O,3537.0,"The total number of positive responses and the number of positive responses on the E subscale began increasing after tasting the 90 % cocoa chocolate , whereas the number of positive responses on the MBG and M subscales began increasing after tasting the 85 % cocoa chocolate sample ."
101948,of,O,3537.0,"The total number of positive responses and the number of positive responses on the E subscale began increasing after tasting the 90 % cocoa chocolate , whereas the number of positive responses on the MBG and M subscales began increasing after tasting the 85 % cocoa chocolate sample ."
101949,positive,O,3537.0,"The total number of positive responses and the number of positive responses on the E subscale began increasing after tasting the 90 % cocoa chocolate , whereas the number of positive responses on the MBG and M subscales began increasing after tasting the 85 % cocoa chocolate sample ."
101950,responses,O,3537.0,"The total number of positive responses and the number of positive responses on the E subscale began increasing after tasting the 90 % cocoa chocolate , whereas the number of positive responses on the MBG and M subscales began increasing after tasting the 85 % cocoa chocolate sample ."
101951,on,O,3537.0,"The total number of positive responses and the number of positive responses on the E subscale began increasing after tasting the 90 % cocoa chocolate , whereas the number of positive responses on the MBG and M subscales began increasing after tasting the 85 % cocoa chocolate sample ."
101952,the,O,3537.0,"The total number of positive responses and the number of positive responses on the E subscale began increasing after tasting the 90 % cocoa chocolate , whereas the number of positive responses on the MBG and M subscales began increasing after tasting the 85 % cocoa chocolate sample ."
101953,MBG,O,3537.0,"The total number of positive responses and the number of positive responses on the E subscale began increasing after tasting the 90 % cocoa chocolate , whereas the number of positive responses on the MBG and M subscales began increasing after tasting the 85 % cocoa chocolate sample ."
101954,and,O,3537.0,"The total number of positive responses and the number of positive responses on the E subscale began increasing after tasting the 90 % cocoa chocolate , whereas the number of positive responses on the MBG and M subscales began increasing after tasting the 85 % cocoa chocolate sample ."
101955,M,O,3537.0,"The total number of positive responses and the number of positive responses on the E subscale began increasing after tasting the 90 % cocoa chocolate , whereas the number of positive responses on the MBG and M subscales began increasing after tasting the 85 % cocoa chocolate sample ."
101956,subscales,O,3537.0,"The total number of positive responses and the number of positive responses on the E subscale began increasing after tasting the 90 % cocoa chocolate , whereas the number of positive responses on the MBG and M subscales began increasing after tasting the 85 % cocoa chocolate sample ."
101957,began,O,3537.0,"The total number of positive responses and the number of positive responses on the E subscale began increasing after tasting the 90 % cocoa chocolate , whereas the number of positive responses on the MBG and M subscales began increasing after tasting the 85 % cocoa chocolate sample ."
101958,increasing,O,3537.0,"The total number of positive responses and the number of positive responses on the E subscale began increasing after tasting the 90 % cocoa chocolate , whereas the number of positive responses on the MBG and M subscales began increasing after tasting the 85 % cocoa chocolate sample ."
101959,after,O,3537.0,"The total number of positive responses and the number of positive responses on the E subscale began increasing after tasting the 90 % cocoa chocolate , whereas the number of positive responses on the MBG and M subscales began increasing after tasting the 85 % cocoa chocolate sample ."
101960,tasting,O,3537.0,"The total number of positive responses and the number of positive responses on the E subscale began increasing after tasting the 90 % cocoa chocolate , whereas the number of positive responses on the MBG and M subscales began increasing after tasting the 85 % cocoa chocolate sample ."
101961,the,O,3537.0,"The total number of positive responses and the number of positive responses on the E subscale began increasing after tasting the 90 % cocoa chocolate , whereas the number of positive responses on the MBG and M subscales began increasing after tasting the 85 % cocoa chocolate sample ."
101962,85,O,3537.0,"The total number of positive responses and the number of positive responses on the E subscale began increasing after tasting the 90 % cocoa chocolate , whereas the number of positive responses on the MBG and M subscales began increasing after tasting the 85 % cocoa chocolate sample ."
101963,%,O,3537.0,"The total number of positive responses and the number of positive responses on the E subscale began increasing after tasting the 90 % cocoa chocolate , whereas the number of positive responses on the MBG and M subscales began increasing after tasting the 85 % cocoa chocolate sample ."
101964,cocoa,O,3537.0,"The total number of positive responses and the number of positive responses on the E subscale began increasing after tasting the 90 % cocoa chocolate , whereas the number of positive responses on the MBG and M subscales began increasing after tasting the 85 % cocoa chocolate sample ."
101965,chocolate,O,3537.0,"The total number of positive responses and the number of positive responses on the E subscale began increasing after tasting the 90 % cocoa chocolate , whereas the number of positive responses on the MBG and M subscales began increasing after tasting the 85 % cocoa chocolate sample ."
101966,sample,O,3537.0,"The total number of positive responses and the number of positive responses on the E subscale began increasing after tasting the 90 % cocoa chocolate , whereas the number of positive responses on the MBG and M subscales began increasing after tasting the 85 % cocoa chocolate sample ."
101967,.,O,3537.0,"The total number of positive responses and the number of positive responses on the E subscale began increasing after tasting the 90 % cocoa chocolate , whereas the number of positive responses on the MBG and M subscales began increasing after tasting the 85 % cocoa chocolate sample ."
101968,We,O,3538.0,We did not find a correlation between BES scores and the total amount of chocolate consumed or self - reported scores on the PEQ .
101969,did,O,3538.0,We did not find a correlation between BES scores and the total amount of chocolate consumed or self - reported scores on the PEQ .
101970,not,O,3538.0,We did not find a correlation between BES scores and the total amount of chocolate consumed or self - reported scores on the PEQ .
101971,find,O,3538.0,We did not find a correlation between BES scores and the total amount of chocolate consumed or self - reported scores on the PEQ .
101972,a,O,3538.0,We did not find a correlation between BES scores and the total amount of chocolate consumed or self - reported scores on the PEQ .
101973,correlation,O,3538.0,We did not find a correlation between BES scores and the total amount of chocolate consumed or self - reported scores on the PEQ .
101974,between,O,3538.0,We did not find a correlation between BES scores and the total amount of chocolate consumed or self - reported scores on the PEQ .
101975,BES,O,3538.0,We did not find a correlation between BES scores and the total amount of chocolate consumed or self - reported scores on the PEQ .
101976,scores,O,3538.0,We did not find a correlation between BES scores and the total amount of chocolate consumed or self - reported scores on the PEQ .
101977,and,O,3538.0,We did not find a correlation between BES scores and the total amount of chocolate consumed or self - reported scores on the PEQ .
101978,the,O,3538.0,We did not find a correlation between BES scores and the total amount of chocolate consumed or self - reported scores on the PEQ .
101979,total,O,3538.0,We did not find a correlation between BES scores and the total amount of chocolate consumed or self - reported scores on the PEQ .
101980,amount,O,3538.0,We did not find a correlation between BES scores and the total amount of chocolate consumed or self - reported scores on the PEQ .
101981,of,O,3538.0,We did not find a correlation between BES scores and the total amount of chocolate consumed or self - reported scores on the PEQ .
101982,chocolate,O,3538.0,We did not find a correlation between BES scores and the total amount of chocolate consumed or self - reported scores on the PEQ .
101983,consumed,O,3538.0,We did not find a correlation between BES scores and the total amount of chocolate consumed or self - reported scores on the PEQ .
101984,or,O,3538.0,We did not find a correlation between BES scores and the total amount of chocolate consumed or self - reported scores on the PEQ .
101985,self,O,3538.0,We did not find a correlation between BES scores and the total amount of chocolate consumed or self - reported scores on the PEQ .
101986,-,O,3538.0,We did not find a correlation between BES scores and the total amount of chocolate consumed or self - reported scores on the PEQ .
101987,reported,O,3538.0,We did not find a correlation between BES scores and the total amount of chocolate consumed or self - reported scores on the PEQ .
101988,scores,O,3538.0,We did not find a correlation between BES scores and the total amount of chocolate consumed or self - reported scores on the PEQ .
101989,on,O,3538.0,We did not find a correlation between BES scores and the total amount of chocolate consumed or self - reported scores on the PEQ .
101990,the,O,3538.0,We did not find a correlation between BES scores and the total amount of chocolate consumed or self - reported scores on the PEQ .
101991,PEQ,O,3538.0,We did not find a correlation between BES scores and the total amount of chocolate consumed or self - reported scores on the PEQ .
101992,.,O,3538.0,We did not find a correlation between BES scores and the total amount of chocolate consumed or self - reported scores on the PEQ .
101993,These,O,3539.0,These results suggest that each incremental increase in chocolate 's sugar content enhances its psychoactive effects .
101994,results,O,3539.0,These results suggest that each incremental increase in chocolate 's sugar content enhances its psychoactive effects .
101995,suggest,O,3539.0,These results suggest that each incremental increase in chocolate 's sugar content enhances its psychoactive effects .
101996,that,O,3539.0,These results suggest that each incremental increase in chocolate 's sugar content enhances its psychoactive effects .
101997,each,O,3539.0,These results suggest that each incremental increase in chocolate 's sugar content enhances its psychoactive effects .
101998,incremental,O,3539.0,These results suggest that each incremental increase in chocolate 's sugar content enhances its psychoactive effects .
101999,increase,O,3539.0,These results suggest that each incremental increase in chocolate 's sugar content enhances its psychoactive effects .
102000,in,O,3539.0,These results suggest that each incremental increase in chocolate 's sugar content enhances its psychoactive effects .
102001,chocolate,O,3539.0,These results suggest that each incremental increase in chocolate 's sugar content enhances its psychoactive effects .
102002,'s,O,3539.0,These results suggest that each incremental increase in chocolate 's sugar content enhances its psychoactive effects .
102003,sugar,O,3539.0,These results suggest that each incremental increase in chocolate 's sugar content enhances its psychoactive effects .
102004,content,O,3539.0,These results suggest that each incremental increase in chocolate 's sugar content enhances its psychoactive effects .
102005,enhances,O,3539.0,These results suggest that each incremental increase in chocolate 's sugar content enhances its psychoactive effects .
102006,its,O,3539.0,These results suggest that each incremental increase in chocolate 's sugar content enhances its psychoactive effects .
102007,psychoactive,O,3539.0,These results suggest that each incremental increase in chocolate 's sugar content enhances its psychoactive effects .
102008,effects,O,3539.0,These results suggest that each incremental increase in chocolate 's sugar content enhances its psychoactive effects .
102009,.,O,3539.0,These results suggest that each incremental increase in chocolate 's sugar content enhances its psychoactive effects .
102010,These,O,3540.0,These results extend our understanding of chocolate 's appeal and unique ability to prompt an addictive - like eating response .
102011,results,O,3540.0,These results extend our understanding of chocolate 's appeal and unique ability to prompt an addictive - like eating response .
102012,extend,O,3540.0,These results extend our understanding of chocolate 's appeal and unique ability to prompt an addictive - like eating response .
102013,our,O,3540.0,These results extend our understanding of chocolate 's appeal and unique ability to prompt an addictive - like eating response .
102014,understanding,O,3540.0,These results extend our understanding of chocolate 's appeal and unique ability to prompt an addictive - like eating response .
102015,of,O,3540.0,These results extend our understanding of chocolate 's appeal and unique ability to prompt an addictive - like eating response .
102016,chocolate,O,3540.0,These results extend our understanding of chocolate 's appeal and unique ability to prompt an addictive - like eating response .
102017,'s,O,3540.0,These results extend our understanding of chocolate 's appeal and unique ability to prompt an addictive - like eating response .
102018,appeal,O,3540.0,These results extend our understanding of chocolate 's appeal and unique ability to prompt an addictive - like eating response .
102019,and,O,3540.0,These results extend our understanding of chocolate 's appeal and unique ability to prompt an addictive - like eating response .
102020,unique,O,3540.0,These results extend our understanding of chocolate 's appeal and unique ability to prompt an addictive - like eating response .
102021,ability,O,3540.0,These results extend our understanding of chocolate 's appeal and unique ability to prompt an addictive - like eating response .
102022,to,O,3540.0,These results extend our understanding of chocolate 's appeal and unique ability to prompt an addictive - like eating response .
102023,prompt,O,3540.0,These results extend our understanding of chocolate 's appeal and unique ability to prompt an addictive - like eating response .
102024,an,O,3540.0,These results extend our understanding of chocolate 's appeal and unique ability to prompt an addictive - like eating response .
102025,addictive,O,3540.0,These results extend our understanding of chocolate 's appeal and unique ability to prompt an addictive - like eating response .
102026,-,O,3540.0,These results extend our understanding of chocolate 's appeal and unique ability to prompt an addictive - like eating response .
102027,like,O,3540.0,These results extend our understanding of chocolate 's appeal and unique ability to prompt an addictive - like eating response .
102028,eating,O,3540.0,These results extend our understanding of chocolate 's appeal and unique ability to prompt an addictive - like eating response .
102029,response,O,3540.0,These results extend our understanding of chocolate 's appeal and unique ability to prompt an addictive - like eating response .
102030,.,O,3540.0,These results extend our understanding of chocolate 's appeal and unique ability to prompt an addictive - like eating response .
102031,Recent,O,3541.0,Recent reports on cocoa are appealing in that a food commonly consumed for pure pleasure might also bring tangible benefits for human health .
102032,reports,O,3541.0,Recent reports on cocoa are appealing in that a food commonly consumed for pure pleasure might also bring tangible benefits for human health .
102033,on,O,3541.0,Recent reports on cocoa are appealing in that a food commonly consumed for pure pleasure might also bring tangible benefits for human health .
102034,cocoa,B-AG.01,3541.0,Recent reports on cocoa are appealing in that a food commonly consumed for pure pleasure might also bring tangible benefits for human health .
102035,are,O,3541.0,Recent reports on cocoa are appealing in that a food commonly consumed for pure pleasure might also bring tangible benefits for human health .
102036,appealing,O,3541.0,Recent reports on cocoa are appealing in that a food commonly consumed for pure pleasure might also bring tangible benefits for human health .
102037,in,O,3541.0,Recent reports on cocoa are appealing in that a food commonly consumed for pure pleasure might also bring tangible benefits for human health .
102038,that,O,3541.0,Recent reports on cocoa are appealing in that a food commonly consumed for pure pleasure might also bring tangible benefits for human health .
102039,a,O,3541.0,Recent reports on cocoa are appealing in that a food commonly consumed for pure pleasure might also bring tangible benefits for human health .
102040,food,O,3541.0,Recent reports on cocoa are appealing in that a food commonly consumed for pure pleasure might also bring tangible benefits for human health .
102041,commonly,O,3541.0,Recent reports on cocoa are appealing in that a food commonly consumed for pure pleasure might also bring tangible benefits for human health .
102042,consumed,O,3541.0,Recent reports on cocoa are appealing in that a food commonly consumed for pure pleasure might also bring tangible benefits for human health .
102043,for,O,3541.0,Recent reports on cocoa are appealing in that a food commonly consumed for pure pleasure might also bring tangible benefits for human health .
102044,pure,O,3541.0,Recent reports on cocoa are appealing in that a food commonly consumed for pure pleasure might also bring tangible benefits for human health .
102045,pleasure,O,3541.0,Recent reports on cocoa are appealing in that a food commonly consumed for pure pleasure might also bring tangible benefits for human health .
102046,might,O,3541.0,Recent reports on cocoa are appealing in that a food commonly consumed for pure pleasure might also bring tangible benefits for human health .
102047,also,O,3541.0,Recent reports on cocoa are appealing in that a food commonly consumed for pure pleasure might also bring tangible benefits for human health .
102048,bring,O,3541.0,Recent reports on cocoa are appealing in that a food commonly consumed for pure pleasure might also bring tangible benefits for human health .
102049,tangible,O,3541.0,Recent reports on cocoa are appealing in that a food commonly consumed for pure pleasure might also bring tangible benefits for human health .
102050,benefits,O,3541.0,Recent reports on cocoa are appealing in that a food commonly consumed for pure pleasure might also bring tangible benefits for human health .
102051,for,O,3541.0,Recent reports on cocoa are appealing in that a food commonly consumed for pure pleasure might also bring tangible benefits for human health .
102052,human,O,3541.0,Recent reports on cocoa are appealing in that a food commonly consumed for pure pleasure might also bring tangible benefits for human health .
102053,health,O,3541.0,Recent reports on cocoa are appealing in that a food commonly consumed for pure pleasure might also bring tangible benefits for human health .
102054,.,O,3541.0,Recent reports on cocoa are appealing in that a food commonly consumed for pure pleasure might also bring tangible benefits for human health .
102055,Cocoa,B-AG.01,3542.0,"Cocoa consumption is correlated with reduced health risks of cardiovascular diseases , hypertension , atherosclerosis , and cancer , and the health - promoting effects of cocoa are mediated by cocoa - driven phytochemicals ."
102056,consumption,B-X,3542.0,"Cocoa consumption is correlated with reduced health risks of cardiovascular diseases , hypertension , atherosclerosis , and cancer , and the health - promoting effects of cocoa are mediated by cocoa - driven phytochemicals ."
102057,is,O,3542.0,"Cocoa consumption is correlated with reduced health risks of cardiovascular diseases , hypertension , atherosclerosis , and cancer , and the health - promoting effects of cocoa are mediated by cocoa - driven phytochemicals ."
102058,correlated,O,3542.0,"Cocoa consumption is correlated with reduced health risks of cardiovascular diseases , hypertension , atherosclerosis , and cancer , and the health - promoting effects of cocoa are mediated by cocoa - driven phytochemicals ."
102059,with,O,3542.0,"Cocoa consumption is correlated with reduced health risks of cardiovascular diseases , hypertension , atherosclerosis , and cancer , and the health - promoting effects of cocoa are mediated by cocoa - driven phytochemicals ."
102060,reduced,O,3542.0,"Cocoa consumption is correlated with reduced health risks of cardiovascular diseases , hypertension , atherosclerosis , and cancer , and the health - promoting effects of cocoa are mediated by cocoa - driven phytochemicals ."
102061,health,O,3542.0,"Cocoa consumption is correlated with reduced health risks of cardiovascular diseases , hypertension , atherosclerosis , and cancer , and the health - promoting effects of cocoa are mediated by cocoa - driven phytochemicals ."
102062,risks,O,3542.0,"Cocoa consumption is correlated with reduced health risks of cardiovascular diseases , hypertension , atherosclerosis , and cancer , and the health - promoting effects of cocoa are mediated by cocoa - driven phytochemicals ."
102063,of,O,3542.0,"Cocoa consumption is correlated with reduced health risks of cardiovascular diseases , hypertension , atherosclerosis , and cancer , and the health - promoting effects of cocoa are mediated by cocoa - driven phytochemicals ."
102064,cardiovascular,O,3542.0,"Cocoa consumption is correlated with reduced health risks of cardiovascular diseases , hypertension , atherosclerosis , and cancer , and the health - promoting effects of cocoa are mediated by cocoa - driven phytochemicals ."
102065,diseases,O,3542.0,"Cocoa consumption is correlated with reduced health risks of cardiovascular diseases , hypertension , atherosclerosis , and cancer , and the health - promoting effects of cocoa are mediated by cocoa - driven phytochemicals ."
102066,",",O,3542.0,"Cocoa consumption is correlated with reduced health risks of cardiovascular diseases , hypertension , atherosclerosis , and cancer , and the health - promoting effects of cocoa are mediated by cocoa - driven phytochemicals ."
102067,hypertension,O,3542.0,"Cocoa consumption is correlated with reduced health risks of cardiovascular diseases , hypertension , atherosclerosis , and cancer , and the health - promoting effects of cocoa are mediated by cocoa - driven phytochemicals ."
102068,",",O,3542.0,"Cocoa consumption is correlated with reduced health risks of cardiovascular diseases , hypertension , atherosclerosis , and cancer , and the health - promoting effects of cocoa are mediated by cocoa - driven phytochemicals ."
102069,atherosclerosis,O,3542.0,"Cocoa consumption is correlated with reduced health risks of cardiovascular diseases , hypertension , atherosclerosis , and cancer , and the health - promoting effects of cocoa are mediated by cocoa - driven phytochemicals ."
102070,",",O,3542.0,"Cocoa consumption is correlated with reduced health risks of cardiovascular diseases , hypertension , atherosclerosis , and cancer , and the health - promoting effects of cocoa are mediated by cocoa - driven phytochemicals ."
102071,and,O,3542.0,"Cocoa consumption is correlated with reduced health risks of cardiovascular diseases , hypertension , atherosclerosis , and cancer , and the health - promoting effects of cocoa are mediated by cocoa - driven phytochemicals ."
102072,cancer,O,3542.0,"Cocoa consumption is correlated with reduced health risks of cardiovascular diseases , hypertension , atherosclerosis , and cancer , and the health - promoting effects of cocoa are mediated by cocoa - driven phytochemicals ."
102073,",",O,3542.0,"Cocoa consumption is correlated with reduced health risks of cardiovascular diseases , hypertension , atherosclerosis , and cancer , and the health - promoting effects of cocoa are mediated by cocoa - driven phytochemicals ."
102074,and,O,3542.0,"Cocoa consumption is correlated with reduced health risks of cardiovascular diseases , hypertension , atherosclerosis , and cancer , and the health - promoting effects of cocoa are mediated by cocoa - driven phytochemicals ."
102075,the,O,3542.0,"Cocoa consumption is correlated with reduced health risks of cardiovascular diseases , hypertension , atherosclerosis , and cancer , and the health - promoting effects of cocoa are mediated by cocoa - driven phytochemicals ."
102076,health,O,3542.0,"Cocoa consumption is correlated with reduced health risks of cardiovascular diseases , hypertension , atherosclerosis , and cancer , and the health - promoting effects of cocoa are mediated by cocoa - driven phytochemicals ."
102077,-,O,3542.0,"Cocoa consumption is correlated with reduced health risks of cardiovascular diseases , hypertension , atherosclerosis , and cancer , and the health - promoting effects of cocoa are mediated by cocoa - driven phytochemicals ."
102078,promoting,O,3542.0,"Cocoa consumption is correlated with reduced health risks of cardiovascular diseases , hypertension , atherosclerosis , and cancer , and the health - promoting effects of cocoa are mediated by cocoa - driven phytochemicals ."
102079,effects,O,3542.0,"Cocoa consumption is correlated with reduced health risks of cardiovascular diseases , hypertension , atherosclerosis , and cancer , and the health - promoting effects of cocoa are mediated by cocoa - driven phytochemicals ."
102080,of,O,3542.0,"Cocoa consumption is correlated with reduced health risks of cardiovascular diseases , hypertension , atherosclerosis , and cancer , and the health - promoting effects of cocoa are mediated by cocoa - driven phytochemicals ."
102081,cocoa,B-AG.01,3542.0,"Cocoa consumption is correlated with reduced health risks of cardiovascular diseases , hypertension , atherosclerosis , and cancer , and the health - promoting effects of cocoa are mediated by cocoa - driven phytochemicals ."
102082,are,O,3542.0,"Cocoa consumption is correlated with reduced health risks of cardiovascular diseases , hypertension , atherosclerosis , and cancer , and the health - promoting effects of cocoa are mediated by cocoa - driven phytochemicals ."
102083,mediated,O,3542.0,"Cocoa consumption is correlated with reduced health risks of cardiovascular diseases , hypertension , atherosclerosis , and cancer , and the health - promoting effects of cocoa are mediated by cocoa - driven phytochemicals ."
102084,by,O,3542.0,"Cocoa consumption is correlated with reduced health risks of cardiovascular diseases , hypertension , atherosclerosis , and cancer , and the health - promoting effects of cocoa are mediated by cocoa - driven phytochemicals ."
102085,cocoa,O,3542.0,"Cocoa consumption is correlated with reduced health risks of cardiovascular diseases , hypertension , atherosclerosis , and cancer , and the health - promoting effects of cocoa are mediated by cocoa - driven phytochemicals ."
102086,-,O,3542.0,"Cocoa consumption is correlated with reduced health risks of cardiovascular diseases , hypertension , atherosclerosis , and cancer , and the health - promoting effects of cocoa are mediated by cocoa - driven phytochemicals ."
102087,driven,O,3542.0,"Cocoa consumption is correlated with reduced health risks of cardiovascular diseases , hypertension , atherosclerosis , and cancer , and the health - promoting effects of cocoa are mediated by cocoa - driven phytochemicals ."
102088,phytochemicals,O,3542.0,"Cocoa consumption is correlated with reduced health risks of cardiovascular diseases , hypertension , atherosclerosis , and cancer , and the health - promoting effects of cocoa are mediated by cocoa - driven phytochemicals ."
102089,.,O,3542.0,"Cocoa consumption is correlated with reduced health risks of cardiovascular diseases , hypertension , atherosclerosis , and cancer , and the health - promoting effects of cocoa are mediated by cocoa - driven phytochemicals ."
102090,Cocoa,B-AG.01,3543.0,"Cocoa is rich in procyanidins , theobromine , ( -)-epicatechin , catechins , and caffeine ."
102091,is,O,3543.0,"Cocoa is rich in procyanidins , theobromine , ( -)-epicatechin , catechins , and caffeine ."
102092,rich,O,3543.0,"Cocoa is rich in procyanidins , theobromine , ( -)-epicatechin , catechins , and caffeine ."
102093,in,O,3543.0,"Cocoa is rich in procyanidins , theobromine , ( -)-epicatechin , catechins , and caffeine ."
102094,procyanidins,O,3543.0,"Cocoa is rich in procyanidins , theobromine , ( -)-epicatechin , catechins , and caffeine ."
102095,",",O,3543.0,"Cocoa is rich in procyanidins , theobromine , ( -)-epicatechin , catechins , and caffeine ."
102096,theobromine,O,3543.0,"Cocoa is rich in procyanidins , theobromine , ( -)-epicatechin , catechins , and caffeine ."
102097,",",O,3543.0,"Cocoa is rich in procyanidins , theobromine , ( -)-epicatechin , catechins , and caffeine ."
102098,(,O,3543.0,"Cocoa is rich in procyanidins , theobromine , ( -)-epicatechin , catechins , and caffeine ."
102099,-)-epicatechin,O,3543.0,"Cocoa is rich in procyanidins , theobromine , ( -)-epicatechin , catechins , and caffeine ."
102100,",",O,3543.0,"Cocoa is rich in procyanidins , theobromine , ( -)-epicatechin , catechins , and caffeine ."
102101,catechins,O,3543.0,"Cocoa is rich in procyanidins , theobromine , ( -)-epicatechin , catechins , and caffeine ."
102102,",",O,3543.0,"Cocoa is rich in procyanidins , theobromine , ( -)-epicatechin , catechins , and caffeine ."
102103,and,O,3543.0,"Cocoa is rich in procyanidins , theobromine , ( -)-epicatechin , catechins , and caffeine ."
102104,caffeine,O,3543.0,"Cocoa is rich in procyanidins , theobromine , ( -)-epicatechin , catechins , and caffeine ."
102105,.,O,3543.0,"Cocoa is rich in procyanidins , theobromine , ( -)-epicatechin , catechins , and caffeine ."
102106,Among,O,3544.0,"Among the phytochemicals present in consumed cocoa , theobromine is most available in human plasma , followed by caffeine , ( -)-epicatechin , catechin , and procyanidins ."
102107,the,O,3544.0,"Among the phytochemicals present in consumed cocoa , theobromine is most available in human plasma , followed by caffeine , ( -)-epicatechin , catechin , and procyanidins ."
102108,phytochemicals,O,3544.0,"Among the phytochemicals present in consumed cocoa , theobromine is most available in human plasma , followed by caffeine , ( -)-epicatechin , catechin , and procyanidins ."
102109,present,O,3544.0,"Among the phytochemicals present in consumed cocoa , theobromine is most available in human plasma , followed by caffeine , ( -)-epicatechin , catechin , and procyanidins ."
102110,in,O,3544.0,"Among the phytochemicals present in consumed cocoa , theobromine is most available in human plasma , followed by caffeine , ( -)-epicatechin , catechin , and procyanidins ."
102111,consumed,O,3544.0,"Among the phytochemicals present in consumed cocoa , theobromine is most available in human plasma , followed by caffeine , ( -)-epicatechin , catechin , and procyanidins ."
102112,cocoa,B-AG.01,3544.0,"Among the phytochemicals present in consumed cocoa , theobromine is most available in human plasma , followed by caffeine , ( -)-epicatechin , catechin , and procyanidins ."
102113,",",O,3544.0,"Among the phytochemicals present in consumed cocoa , theobromine is most available in human plasma , followed by caffeine , ( -)-epicatechin , catechin , and procyanidins ."
102114,theobromine,O,3544.0,"Among the phytochemicals present in consumed cocoa , theobromine is most available in human plasma , followed by caffeine , ( -)-epicatechin , catechin , and procyanidins ."
102115,is,O,3544.0,"Among the phytochemicals present in consumed cocoa , theobromine is most available in human plasma , followed by caffeine , ( -)-epicatechin , catechin , and procyanidins ."
102116,most,O,3544.0,"Among the phytochemicals present in consumed cocoa , theobromine is most available in human plasma , followed by caffeine , ( -)-epicatechin , catechin , and procyanidins ."
102117,available,O,3544.0,"Among the phytochemicals present in consumed cocoa , theobromine is most available in human plasma , followed by caffeine , ( -)-epicatechin , catechin , and procyanidins ."
102118,in,O,3544.0,"Among the phytochemicals present in consumed cocoa , theobromine is most available in human plasma , followed by caffeine , ( -)-epicatechin , catechin , and procyanidins ."
102119,human,O,3544.0,"Among the phytochemicals present in consumed cocoa , theobromine is most available in human plasma , followed by caffeine , ( -)-epicatechin , catechin , and procyanidins ."
102120,plasma,O,3544.0,"Among the phytochemicals present in consumed cocoa , theobromine is most available in human plasma , followed by caffeine , ( -)-epicatechin , catechin , and procyanidins ."
102121,",",O,3544.0,"Among the phytochemicals present in consumed cocoa , theobromine is most available in human plasma , followed by caffeine , ( -)-epicatechin , catechin , and procyanidins ."
102122,followed,O,3544.0,"Among the phytochemicals present in consumed cocoa , theobromine is most available in human plasma , followed by caffeine , ( -)-epicatechin , catechin , and procyanidins ."
102123,by,O,3544.0,"Among the phytochemicals present in consumed cocoa , theobromine is most available in human plasma , followed by caffeine , ( -)-epicatechin , catechin , and procyanidins ."
102124,caffeine,O,3544.0,"Among the phytochemicals present in consumed cocoa , theobromine is most available in human plasma , followed by caffeine , ( -)-epicatechin , catechin , and procyanidins ."
102125,",",O,3544.0,"Among the phytochemicals present in consumed cocoa , theobromine is most available in human plasma , followed by caffeine , ( -)-epicatechin , catechin , and procyanidins ."
102126,(,O,3544.0,"Among the phytochemicals present in consumed cocoa , theobromine is most available in human plasma , followed by caffeine , ( -)-epicatechin , catechin , and procyanidins ."
102127,-)-epicatechin,O,3544.0,"Among the phytochemicals present in consumed cocoa , theobromine is most available in human plasma , followed by caffeine , ( -)-epicatechin , catechin , and procyanidins ."
102128,",",O,3544.0,"Among the phytochemicals present in consumed cocoa , theobromine is most available in human plasma , followed by caffeine , ( -)-epicatechin , catechin , and procyanidins ."
102129,catechin,O,3544.0,"Among the phytochemicals present in consumed cocoa , theobromine is most available in human plasma , followed by caffeine , ( -)-epicatechin , catechin , and procyanidins ."
102130,",",O,3544.0,"Among the phytochemicals present in consumed cocoa , theobromine is most available in human plasma , followed by caffeine , ( -)-epicatechin , catechin , and procyanidins ."
102131,and,O,3544.0,"Among the phytochemicals present in consumed cocoa , theobromine is most available in human plasma , followed by caffeine , ( -)-epicatechin , catechin , and procyanidins ."
102132,procyanidins,O,3544.0,"Among the phytochemicals present in consumed cocoa , theobromine is most available in human plasma , followed by caffeine , ( -)-epicatechin , catechin , and procyanidins ."
102133,.,O,3544.0,"Among the phytochemicals present in consumed cocoa , theobromine is most available in human plasma , followed by caffeine , ( -)-epicatechin , catechin , and procyanidins ."
102134,It,O,3545.0,"It has been reported that cocoa phytochemicals specifically modulate or interact with specific molecular targets linked to the pathogenesis of chronic human diseases , including cardiovascular diseases , cancer , neurodegenerative diseases , obesity , diabetes , and skin aging ."
102135,has,O,3545.0,"It has been reported that cocoa phytochemicals specifically modulate or interact with specific molecular targets linked to the pathogenesis of chronic human diseases , including cardiovascular diseases , cancer , neurodegenerative diseases , obesity , diabetes , and skin aging ."
102136,been,O,3545.0,"It has been reported that cocoa phytochemicals specifically modulate or interact with specific molecular targets linked to the pathogenesis of chronic human diseases , including cardiovascular diseases , cancer , neurodegenerative diseases , obesity , diabetes , and skin aging ."
102137,reported,O,3545.0,"It has been reported that cocoa phytochemicals specifically modulate or interact with specific molecular targets linked to the pathogenesis of chronic human diseases , including cardiovascular diseases , cancer , neurodegenerative diseases , obesity , diabetes , and skin aging ."
102138,that,O,3545.0,"It has been reported that cocoa phytochemicals specifically modulate or interact with specific molecular targets linked to the pathogenesis of chronic human diseases , including cardiovascular diseases , cancer , neurodegenerative diseases , obesity , diabetes , and skin aging ."
102139,cocoa,O,3545.0,"It has been reported that cocoa phytochemicals specifically modulate or interact with specific molecular targets linked to the pathogenesis of chronic human diseases , including cardiovascular diseases , cancer , neurodegenerative diseases , obesity , diabetes , and skin aging ."
102140,phytochemicals,O,3545.0,"It has been reported that cocoa phytochemicals specifically modulate or interact with specific molecular targets linked to the pathogenesis of chronic human diseases , including cardiovascular diseases , cancer , neurodegenerative diseases , obesity , diabetes , and skin aging ."
102141,specifically,O,3545.0,"It has been reported that cocoa phytochemicals specifically modulate or interact with specific molecular targets linked to the pathogenesis of chronic human diseases , including cardiovascular diseases , cancer , neurodegenerative diseases , obesity , diabetes , and skin aging ."
102142,modulate,O,3545.0,"It has been reported that cocoa phytochemicals specifically modulate or interact with specific molecular targets linked to the pathogenesis of chronic human diseases , including cardiovascular diseases , cancer , neurodegenerative diseases , obesity , diabetes , and skin aging ."
102143,or,O,3545.0,"It has been reported that cocoa phytochemicals specifically modulate or interact with specific molecular targets linked to the pathogenesis of chronic human diseases , including cardiovascular diseases , cancer , neurodegenerative diseases , obesity , diabetes , and skin aging ."
102144,interact,O,3545.0,"It has been reported that cocoa phytochemicals specifically modulate or interact with specific molecular targets linked to the pathogenesis of chronic human diseases , including cardiovascular diseases , cancer , neurodegenerative diseases , obesity , diabetes , and skin aging ."
102145,with,O,3545.0,"It has been reported that cocoa phytochemicals specifically modulate or interact with specific molecular targets linked to the pathogenesis of chronic human diseases , including cardiovascular diseases , cancer , neurodegenerative diseases , obesity , diabetes , and skin aging ."
102146,specific,O,3545.0,"It has been reported that cocoa phytochemicals specifically modulate or interact with specific molecular targets linked to the pathogenesis of chronic human diseases , including cardiovascular diseases , cancer , neurodegenerative diseases , obesity , diabetes , and skin aging ."
102147,molecular,O,3545.0,"It has been reported that cocoa phytochemicals specifically modulate or interact with specific molecular targets linked to the pathogenesis of chronic human diseases , including cardiovascular diseases , cancer , neurodegenerative diseases , obesity , diabetes , and skin aging ."
102148,targets,O,3545.0,"It has been reported that cocoa phytochemicals specifically modulate or interact with specific molecular targets linked to the pathogenesis of chronic human diseases , including cardiovascular diseases , cancer , neurodegenerative diseases , obesity , diabetes , and skin aging ."
102149,linked,O,3545.0,"It has been reported that cocoa phytochemicals specifically modulate or interact with specific molecular targets linked to the pathogenesis of chronic human diseases , including cardiovascular diseases , cancer , neurodegenerative diseases , obesity , diabetes , and skin aging ."
102150,to,O,3545.0,"It has been reported that cocoa phytochemicals specifically modulate or interact with specific molecular targets linked to the pathogenesis of chronic human diseases , including cardiovascular diseases , cancer , neurodegenerative diseases , obesity , diabetes , and skin aging ."
102151,the,O,3545.0,"It has been reported that cocoa phytochemicals specifically modulate or interact with specific molecular targets linked to the pathogenesis of chronic human diseases , including cardiovascular diseases , cancer , neurodegenerative diseases , obesity , diabetes , and skin aging ."
102152,pathogenesis,O,3545.0,"It has been reported that cocoa phytochemicals specifically modulate or interact with specific molecular targets linked to the pathogenesis of chronic human diseases , including cardiovascular diseases , cancer , neurodegenerative diseases , obesity , diabetes , and skin aging ."
102153,of,O,3545.0,"It has been reported that cocoa phytochemicals specifically modulate or interact with specific molecular targets linked to the pathogenesis of chronic human diseases , including cardiovascular diseases , cancer , neurodegenerative diseases , obesity , diabetes , and skin aging ."
102154,chronic,O,3545.0,"It has been reported that cocoa phytochemicals specifically modulate or interact with specific molecular targets linked to the pathogenesis of chronic human diseases , including cardiovascular diseases , cancer , neurodegenerative diseases , obesity , diabetes , and skin aging ."
102155,human,O,3545.0,"It has been reported that cocoa phytochemicals specifically modulate or interact with specific molecular targets linked to the pathogenesis of chronic human diseases , including cardiovascular diseases , cancer , neurodegenerative diseases , obesity , diabetes , and skin aging ."
102156,diseases,O,3545.0,"It has been reported that cocoa phytochemicals specifically modulate or interact with specific molecular targets linked to the pathogenesis of chronic human diseases , including cardiovascular diseases , cancer , neurodegenerative diseases , obesity , diabetes , and skin aging ."
102157,",",O,3545.0,"It has been reported that cocoa phytochemicals specifically modulate or interact with specific molecular targets linked to the pathogenesis of chronic human diseases , including cardiovascular diseases , cancer , neurodegenerative diseases , obesity , diabetes , and skin aging ."
102158,including,O,3545.0,"It has been reported that cocoa phytochemicals specifically modulate or interact with specific molecular targets linked to the pathogenesis of chronic human diseases , including cardiovascular diseases , cancer , neurodegenerative diseases , obesity , diabetes , and skin aging ."
102159,cardiovascular,O,3545.0,"It has been reported that cocoa phytochemicals specifically modulate or interact with specific molecular targets linked to the pathogenesis of chronic human diseases , including cardiovascular diseases , cancer , neurodegenerative diseases , obesity , diabetes , and skin aging ."
102160,diseases,O,3545.0,"It has been reported that cocoa phytochemicals specifically modulate or interact with specific molecular targets linked to the pathogenesis of chronic human diseases , including cardiovascular diseases , cancer , neurodegenerative diseases , obesity , diabetes , and skin aging ."
102161,",",O,3545.0,"It has been reported that cocoa phytochemicals specifically modulate or interact with specific molecular targets linked to the pathogenesis of chronic human diseases , including cardiovascular diseases , cancer , neurodegenerative diseases , obesity , diabetes , and skin aging ."
102162,cancer,O,3545.0,"It has been reported that cocoa phytochemicals specifically modulate or interact with specific molecular targets linked to the pathogenesis of chronic human diseases , including cardiovascular diseases , cancer , neurodegenerative diseases , obesity , diabetes , and skin aging ."
102163,",",O,3545.0,"It has been reported that cocoa phytochemicals specifically modulate or interact with specific molecular targets linked to the pathogenesis of chronic human diseases , including cardiovascular diseases , cancer , neurodegenerative diseases , obesity , diabetes , and skin aging ."
102164,neurodegenerative,O,3545.0,"It has been reported that cocoa phytochemicals specifically modulate or interact with specific molecular targets linked to the pathogenesis of chronic human diseases , including cardiovascular diseases , cancer , neurodegenerative diseases , obesity , diabetes , and skin aging ."
102165,diseases,O,3545.0,"It has been reported that cocoa phytochemicals specifically modulate or interact with specific molecular targets linked to the pathogenesis of chronic human diseases , including cardiovascular diseases , cancer , neurodegenerative diseases , obesity , diabetes , and skin aging ."
102166,",",O,3545.0,"It has been reported that cocoa phytochemicals specifically modulate or interact with specific molecular targets linked to the pathogenesis of chronic human diseases , including cardiovascular diseases , cancer , neurodegenerative diseases , obesity , diabetes , and skin aging ."
102167,obesity,O,3545.0,"It has been reported that cocoa phytochemicals specifically modulate or interact with specific molecular targets linked to the pathogenesis of chronic human diseases , including cardiovascular diseases , cancer , neurodegenerative diseases , obesity , diabetes , and skin aging ."
102168,",",O,3545.0,"It has been reported that cocoa phytochemicals specifically modulate or interact with specific molecular targets linked to the pathogenesis of chronic human diseases , including cardiovascular diseases , cancer , neurodegenerative diseases , obesity , diabetes , and skin aging ."
102169,diabetes,O,3545.0,"It has been reported that cocoa phytochemicals specifically modulate or interact with specific molecular targets linked to the pathogenesis of chronic human diseases , including cardiovascular diseases , cancer , neurodegenerative diseases , obesity , diabetes , and skin aging ."
102170,",",O,3545.0,"It has been reported that cocoa phytochemicals specifically modulate or interact with specific molecular targets linked to the pathogenesis of chronic human diseases , including cardiovascular diseases , cancer , neurodegenerative diseases , obesity , diabetes , and skin aging ."
102171,and,O,3545.0,"It has been reported that cocoa phytochemicals specifically modulate or interact with specific molecular targets linked to the pathogenesis of chronic human diseases , including cardiovascular diseases , cancer , neurodegenerative diseases , obesity , diabetes , and skin aging ."
102172,skin,O,3545.0,"It has been reported that cocoa phytochemicals specifically modulate or interact with specific molecular targets linked to the pathogenesis of chronic human diseases , including cardiovascular diseases , cancer , neurodegenerative diseases , obesity , diabetes , and skin aging ."
102173,aging,O,3545.0,"It has been reported that cocoa phytochemicals specifically modulate or interact with specific molecular targets linked to the pathogenesis of chronic human diseases , including cardiovascular diseases , cancer , neurodegenerative diseases , obesity , diabetes , and skin aging ."
102174,.,O,3545.0,"It has been reported that cocoa phytochemicals specifically modulate or interact with specific molecular targets linked to the pathogenesis of chronic human diseases , including cardiovascular diseases , cancer , neurodegenerative diseases , obesity , diabetes , and skin aging ."
102175,This,O,3546.0,This review summarizes comprehensive recent findings on the beneficial actions of cocoa - driven phytochemicals in molecular mechanisms of human health .
102176,review,O,3546.0,This review summarizes comprehensive recent findings on the beneficial actions of cocoa - driven phytochemicals in molecular mechanisms of human health .
102177,summarizes,O,3546.0,This review summarizes comprehensive recent findings on the beneficial actions of cocoa - driven phytochemicals in molecular mechanisms of human health .
102178,comprehensive,O,3546.0,This review summarizes comprehensive recent findings on the beneficial actions of cocoa - driven phytochemicals in molecular mechanisms of human health .
102179,recent,O,3546.0,This review summarizes comprehensive recent findings on the beneficial actions of cocoa - driven phytochemicals in molecular mechanisms of human health .
102180,findings,O,3546.0,This review summarizes comprehensive recent findings on the beneficial actions of cocoa - driven phytochemicals in molecular mechanisms of human health .
102181,on,O,3546.0,This review summarizes comprehensive recent findings on the beneficial actions of cocoa - driven phytochemicals in molecular mechanisms of human health .
102182,the,O,3546.0,This review summarizes comprehensive recent findings on the beneficial actions of cocoa - driven phytochemicals in molecular mechanisms of human health .
102183,beneficial,O,3546.0,This review summarizes comprehensive recent findings on the beneficial actions of cocoa - driven phytochemicals in molecular mechanisms of human health .
102184,actions,O,3546.0,This review summarizes comprehensive recent findings on the beneficial actions of cocoa - driven phytochemicals in molecular mechanisms of human health .
102185,of,O,3546.0,This review summarizes comprehensive recent findings on the beneficial actions of cocoa - driven phytochemicals in molecular mechanisms of human health .
102186,cocoa,O,3546.0,This review summarizes comprehensive recent findings on the beneficial actions of cocoa - driven phytochemicals in molecular mechanisms of human health .
102187,-,O,3546.0,This review summarizes comprehensive recent findings on the beneficial actions of cocoa - driven phytochemicals in molecular mechanisms of human health .
102188,driven,O,3546.0,This review summarizes comprehensive recent findings on the beneficial actions of cocoa - driven phytochemicals in molecular mechanisms of human health .
102189,phytochemicals,O,3546.0,This review summarizes comprehensive recent findings on the beneficial actions of cocoa - driven phytochemicals in molecular mechanisms of human health .
102190,in,O,3546.0,This review summarizes comprehensive recent findings on the beneficial actions of cocoa - driven phytochemicals in molecular mechanisms of human health .
102191,molecular,O,3546.0,This review summarizes comprehensive recent findings on the beneficial actions of cocoa - driven phytochemicals in molecular mechanisms of human health .
102192,mechanisms,O,3546.0,This review summarizes comprehensive recent findings on the beneficial actions of cocoa - driven phytochemicals in molecular mechanisms of human health .
102193,of,O,3546.0,This review summarizes comprehensive recent findings on the beneficial actions of cocoa - driven phytochemicals in molecular mechanisms of human health .
102194,human,O,3546.0,This review summarizes comprehensive recent findings on the beneficial actions of cocoa - driven phytochemicals in molecular mechanisms of human health .
102195,health,O,3546.0,This review summarizes comprehensive recent findings on the beneficial actions of cocoa - driven phytochemicals in molecular mechanisms of human health .
102196,.,O,3546.0,This review summarizes comprehensive recent findings on the beneficial actions of cocoa - driven phytochemicals in molecular mechanisms of human health .
102197,Fruit,O,3547.0,Fruit consumption is recommended as part of a healthy diet .
102198,consumption,B-X,3547.0,Fruit consumption is recommended as part of a healthy diet .
102199,is,O,3547.0,Fruit consumption is recommended as part of a healthy diet .
102200,recommended,O,3547.0,Fruit consumption is recommended as part of a healthy diet .
102201,as,O,3547.0,Fruit consumption is recommended as part of a healthy diet .
102202,part,O,3547.0,Fruit consumption is recommended as part of a healthy diet .
102203,of,O,3547.0,Fruit consumption is recommended as part of a healthy diet .
102204,a,O,3547.0,Fruit consumption is recommended as part of a healthy diet .
102205,healthy,O,3547.0,Fruit consumption is recommended as part of a healthy diet .
102206,diet,O,3547.0,Fruit consumption is recommended as part of a healthy diet .
102207,.,O,3547.0,Fruit consumption is recommended as part of a healthy diet .
102208,However,O,3548.0,"However , consumption of fruit in the form of juice is positively associated with type 2 diabetes risk , possibly due to resulting hyperglycemia ."
102209,",",O,3548.0,"However , consumption of fruit in the form of juice is positively associated with type 2 diabetes risk , possibly due to resulting hyperglycemia ."
102210,consumption,O,3548.0,"However , consumption of fruit in the form of juice is positively associated with type 2 diabetes risk , possibly due to resulting hyperglycemia ."
102211,of,O,3548.0,"However , consumption of fruit in the form of juice is positively associated with type 2 diabetes risk , possibly due to resulting hyperglycemia ."
102212,fruit,B-AG.01.h.01,3548.0,"However , consumption of fruit in the form of juice is positively associated with type 2 diabetes risk , possibly due to resulting hyperglycemia ."
102213,in,O,3548.0,"However , consumption of fruit in the form of juice is positively associated with type 2 diabetes risk , possibly due to resulting hyperglycemia ."
102214,the,O,3548.0,"However , consumption of fruit in the form of juice is positively associated with type 2 diabetes risk , possibly due to resulting hyperglycemia ."
102215,form,O,3548.0,"However , consumption of fruit in the form of juice is positively associated with type 2 diabetes risk , possibly due to resulting hyperglycemia ."
102216,of,O,3548.0,"However , consumption of fruit in the form of juice is positively associated with type 2 diabetes risk , possibly due to resulting hyperglycemia ."
102217,juice,B-AG.01.ab,3548.0,"However , consumption of fruit in the form of juice is positively associated with type 2 diabetes risk , possibly due to resulting hyperglycemia ."
102218,is,O,3548.0,"However , consumption of fruit in the form of juice is positively associated with type 2 diabetes risk , possibly due to resulting hyperglycemia ."
102219,positively,O,3548.0,"However , consumption of fruit in the form of juice is positively associated with type 2 diabetes risk , possibly due to resulting hyperglycemia ."
102220,associated,O,3548.0,"However , consumption of fruit in the form of juice is positively associated with type 2 diabetes risk , possibly due to resulting hyperglycemia ."
102221,with,O,3548.0,"However , consumption of fruit in the form of juice is positively associated with type 2 diabetes risk , possibly due to resulting hyperglycemia ."
102222,type,O,3548.0,"However , consumption of fruit in the form of juice is positively associated with type 2 diabetes risk , possibly due to resulting hyperglycemia ."
102223,2,O,3548.0,"However , consumption of fruit in the form of juice is positively associated with type 2 diabetes risk , possibly due to resulting hyperglycemia ."
102224,diabetes,O,3548.0,"However , consumption of fruit in the form of juice is positively associated with type 2 diabetes risk , possibly due to resulting hyperglycemia ."
102225,risk,O,3548.0,"However , consumption of fruit in the form of juice is positively associated with type 2 diabetes risk , possibly due to resulting hyperglycemia ."
102226,",",O,3548.0,"However , consumption of fruit in the form of juice is positively associated with type 2 diabetes risk , possibly due to resulting hyperglycemia ."
102227,possibly,O,3548.0,"However , consumption of fruit in the form of juice is positively associated with type 2 diabetes risk , possibly due to resulting hyperglycemia ."
102228,due,O,3548.0,"However , consumption of fruit in the form of juice is positively associated with type 2 diabetes risk , possibly due to resulting hyperglycemia ."
102229,to,O,3548.0,"However , consumption of fruit in the form of juice is positively associated with type 2 diabetes risk , possibly due to resulting hyperglycemia ."
102230,resulting,O,3548.0,"However , consumption of fruit in the form of juice is positively associated with type 2 diabetes risk , possibly due to resulting hyperglycemia ."
102231,hyperglycemia,O,3548.0,"However , consumption of fruit in the form of juice is positively associated with type 2 diabetes risk , possibly due to resulting hyperglycemia ."
102232,.,O,3548.0,"However , consumption of fruit in the form of juice is positively associated with type 2 diabetes risk , possibly due to resulting hyperglycemia ."
102233,In,O,3549.0,"In a recent study , fruit juice prepared by nutrient extraction , a process that retains the fiber component , was shown to elicit a favorable glycemic index ( GI ) , compared to eating the fruit whole , in healthy weight adults ."
102234,a,O,3549.0,"In a recent study , fruit juice prepared by nutrient extraction , a process that retains the fiber component , was shown to elicit a favorable glycemic index ( GI ) , compared to eating the fruit whole , in healthy weight adults ."
102235,recent,O,3549.0,"In a recent study , fruit juice prepared by nutrient extraction , a process that retains the fiber component , was shown to elicit a favorable glycemic index ( GI ) , compared to eating the fruit whole , in healthy weight adults ."
102236,study,O,3549.0,"In a recent study , fruit juice prepared by nutrient extraction , a process that retains the fiber component , was shown to elicit a favorable glycemic index ( GI ) , compared to eating the fruit whole , in healthy weight adults ."
102237,",",O,3549.0,"In a recent study , fruit juice prepared by nutrient extraction , a process that retains the fiber component , was shown to elicit a favorable glycemic index ( GI ) , compared to eating the fruit whole , in healthy weight adults ."
102238,fruit,B-AG.01.ab,3549.0,"In a recent study , fruit juice prepared by nutrient extraction , a process that retains the fiber component , was shown to elicit a favorable glycemic index ( GI ) , compared to eating the fruit whole , in healthy weight adults ."
102239,juice,I-AG.01.ab,3549.0,"In a recent study , fruit juice prepared by nutrient extraction , a process that retains the fiber component , was shown to elicit a favorable glycemic index ( GI ) , compared to eating the fruit whole , in healthy weight adults ."
102240,prepared,O,3549.0,"In a recent study , fruit juice prepared by nutrient extraction , a process that retains the fiber component , was shown to elicit a favorable glycemic index ( GI ) , compared to eating the fruit whole , in healthy weight adults ."
102241,by,O,3549.0,"In a recent study , fruit juice prepared by nutrient extraction , a process that retains the fiber component , was shown to elicit a favorable glycemic index ( GI ) , compared to eating the fruit whole , in healthy weight adults ."
102242,nutrient,O,3549.0,"In a recent study , fruit juice prepared by nutrient extraction , a process that retains the fiber component , was shown to elicit a favorable glycemic index ( GI ) , compared to eating the fruit whole , in healthy weight adults ."
102243,extraction,O,3549.0,"In a recent study , fruit juice prepared by nutrient extraction , a process that retains the fiber component , was shown to elicit a favorable glycemic index ( GI ) , compared to eating the fruit whole , in healthy weight adults ."
102244,",",O,3549.0,"In a recent study , fruit juice prepared by nutrient extraction , a process that retains the fiber component , was shown to elicit a favorable glycemic index ( GI ) , compared to eating the fruit whole , in healthy weight adults ."
102245,a,O,3549.0,"In a recent study , fruit juice prepared by nutrient extraction , a process that retains the fiber component , was shown to elicit a favorable glycemic index ( GI ) , compared to eating the fruit whole , in healthy weight adults ."
102246,process,O,3549.0,"In a recent study , fruit juice prepared by nutrient extraction , a process that retains the fiber component , was shown to elicit a favorable glycemic index ( GI ) , compared to eating the fruit whole , in healthy weight adults ."
102247,that,O,3549.0,"In a recent study , fruit juice prepared by nutrient extraction , a process that retains the fiber component , was shown to elicit a favorable glycemic index ( GI ) , compared to eating the fruit whole , in healthy weight adults ."
102248,retains,O,3549.0,"In a recent study , fruit juice prepared by nutrient extraction , a process that retains the fiber component , was shown to elicit a favorable glycemic index ( GI ) , compared to eating the fruit whole , in healthy weight adults ."
102249,the,O,3549.0,"In a recent study , fruit juice prepared by nutrient extraction , a process that retains the fiber component , was shown to elicit a favorable glycemic index ( GI ) , compared to eating the fruit whole , in healthy weight adults ."
102250,fiber,O,3549.0,"In a recent study , fruit juice prepared by nutrient extraction , a process that retains the fiber component , was shown to elicit a favorable glycemic index ( GI ) , compared to eating the fruit whole , in healthy weight adults ."
102251,component,O,3549.0,"In a recent study , fruit juice prepared by nutrient extraction , a process that retains the fiber component , was shown to elicit a favorable glycemic index ( GI ) , compared to eating the fruit whole , in healthy weight adults ."
102252,",",O,3549.0,"In a recent study , fruit juice prepared by nutrient extraction , a process that retains the fiber component , was shown to elicit a favorable glycemic index ( GI ) , compared to eating the fruit whole , in healthy weight adults ."
102253,was,O,3549.0,"In a recent study , fruit juice prepared by nutrient extraction , a process that retains the fiber component , was shown to elicit a favorable glycemic index ( GI ) , compared to eating the fruit whole , in healthy weight adults ."
102254,shown,O,3549.0,"In a recent study , fruit juice prepared by nutrient extraction , a process that retains the fiber component , was shown to elicit a favorable glycemic index ( GI ) , compared to eating the fruit whole , in healthy weight adults ."
102255,to,O,3549.0,"In a recent study , fruit juice prepared by nutrient extraction , a process that retains the fiber component , was shown to elicit a favorable glycemic index ( GI ) , compared to eating the fruit whole , in healthy weight adults ."
102256,elicit,O,3549.0,"In a recent study , fruit juice prepared by nutrient extraction , a process that retains the fiber component , was shown to elicit a favorable glycemic index ( GI ) , compared to eating the fruit whole , in healthy weight adults ."
102257,a,O,3549.0,"In a recent study , fruit juice prepared by nutrient extraction , a process that retains the fiber component , was shown to elicit a favorable glycemic index ( GI ) , compared to eating the fruit whole , in healthy weight adults ."
102258,favorable,O,3549.0,"In a recent study , fruit juice prepared by nutrient extraction , a process that retains the fiber component , was shown to elicit a favorable glycemic index ( GI ) , compared to eating the fruit whole , in healthy weight adults ."
102259,glycemic,O,3549.0,"In a recent study , fruit juice prepared by nutrient extraction , a process that retains the fiber component , was shown to elicit a favorable glycemic index ( GI ) , compared to eating the fruit whole , in healthy weight adults ."
102260,index,O,3549.0,"In a recent study , fruit juice prepared by nutrient extraction , a process that retains the fiber component , was shown to elicit a favorable glycemic index ( GI ) , compared to eating the fruit whole , in healthy weight adults ."
102261,(,O,3549.0,"In a recent study , fruit juice prepared by nutrient extraction , a process that retains the fiber component , was shown to elicit a favorable glycemic index ( GI ) , compared to eating the fruit whole , in healthy weight adults ."
102262,GI,O,3549.0,"In a recent study , fruit juice prepared by nutrient extraction , a process that retains the fiber component , was shown to elicit a favorable glycemic index ( GI ) , compared to eating the fruit whole , in healthy weight adults ."
102263,),O,3549.0,"In a recent study , fruit juice prepared by nutrient extraction , a process that retains the fiber component , was shown to elicit a favorable glycemic index ( GI ) , compared to eating the fruit whole , in healthy weight adults ."
102264,",",O,3549.0,"In a recent study , fruit juice prepared by nutrient extraction , a process that retains the fiber component , was shown to elicit a favorable glycemic index ( GI ) , compared to eating the fruit whole , in healthy weight adults ."
102265,compared,O,3549.0,"In a recent study , fruit juice prepared by nutrient extraction , a process that retains the fiber component , was shown to elicit a favorable glycemic index ( GI ) , compared to eating the fruit whole , in healthy weight adults ."
102266,to,O,3549.0,"In a recent study , fruit juice prepared by nutrient extraction , a process that retains the fiber component , was shown to elicit a favorable glycemic index ( GI ) , compared to eating the fruit whole , in healthy weight adults ."
102267,eating,O,3549.0,"In a recent study , fruit juice prepared by nutrient extraction , a process that retains the fiber component , was shown to elicit a favorable glycemic index ( GI ) , compared to eating the fruit whole , in healthy weight adults ."
102268,the,O,3549.0,"In a recent study , fruit juice prepared by nutrient extraction , a process that retains the fiber component , was shown to elicit a favorable glycemic index ( GI ) , compared to eating the fruit whole , in healthy weight adults ."
102269,fruit,B-AG.01.h.01,3549.0,"In a recent study , fruit juice prepared by nutrient extraction , a process that retains the fiber component , was shown to elicit a favorable glycemic index ( GI ) , compared to eating the fruit whole , in healthy weight adults ."
102270,whole,O,3549.0,"In a recent study , fruit juice prepared by nutrient extraction , a process that retains the fiber component , was shown to elicit a favorable glycemic index ( GI ) , compared to eating the fruit whole , in healthy weight adults ."
102271,",",O,3549.0,"In a recent study , fruit juice prepared by nutrient extraction , a process that retains the fiber component , was shown to elicit a favorable glycemic index ( GI ) , compared to eating the fruit whole , in healthy weight adults ."
102272,in,O,3549.0,"In a recent study , fruit juice prepared by nutrient extraction , a process that retains the fiber component , was shown to elicit a favorable glycemic index ( GI ) , compared to eating the fruit whole , in healthy weight adults ."
102273,healthy,O,3549.0,"In a recent study , fruit juice prepared by nutrient extraction , a process that retains the fiber component , was shown to elicit a favorable glycemic index ( GI ) , compared to eating the fruit whole , in healthy weight adults ."
102274,weight,O,3549.0,"In a recent study , fruit juice prepared by nutrient extraction , a process that retains the fiber component , was shown to elicit a favorable glycemic index ( GI ) , compared to eating the fruit whole , in healthy weight adults ."
102275,adults,O,3549.0,"In a recent study , fruit juice prepared by nutrient extraction , a process that retains the fiber component , was shown to elicit a favorable glycemic index ( GI ) , compared to eating the fruit whole , in healthy weight adults ."
102276,.,O,3549.0,"In a recent study , fruit juice prepared by nutrient extraction , a process that retains the fiber component , was shown to elicit a favorable glycemic index ( GI ) , compared to eating the fruit whole , in healthy weight adults ."
102277,The,O,3550.0,"The current study expanded on this to include individuals with obesity , and assessed whether the nutrient extraction of seeded fruits reduced GI in a higher disease risk group ."
102278,current,O,3550.0,"The current study expanded on this to include individuals with obesity , and assessed whether the nutrient extraction of seeded fruits reduced GI in a higher disease risk group ."
102279,study,O,3550.0,"The current study expanded on this to include individuals with obesity , and assessed whether the nutrient extraction of seeded fruits reduced GI in a higher disease risk group ."
102280,expanded,O,3550.0,"The current study expanded on this to include individuals with obesity , and assessed whether the nutrient extraction of seeded fruits reduced GI in a higher disease risk group ."
102281,on,O,3550.0,"The current study expanded on this to include individuals with obesity , and assessed whether the nutrient extraction of seeded fruits reduced GI in a higher disease risk group ."
102282,this,O,3550.0,"The current study expanded on this to include individuals with obesity , and assessed whether the nutrient extraction of seeded fruits reduced GI in a higher disease risk group ."
102283,to,O,3550.0,"The current study expanded on this to include individuals with obesity , and assessed whether the nutrient extraction of seeded fruits reduced GI in a higher disease risk group ."
102284,include,O,3550.0,"The current study expanded on this to include individuals with obesity , and assessed whether the nutrient extraction of seeded fruits reduced GI in a higher disease risk group ."
102285,individuals,O,3550.0,"The current study expanded on this to include individuals with obesity , and assessed whether the nutrient extraction of seeded fruits reduced GI in a higher disease risk group ."
102286,with,O,3550.0,"The current study expanded on this to include individuals with obesity , and assessed whether the nutrient extraction of seeded fruits reduced GI in a higher disease risk group ."
102287,obesity,O,3550.0,"The current study expanded on this to include individuals with obesity , and assessed whether the nutrient extraction of seeded fruits reduced GI in a higher disease risk group ."
102288,",",O,3550.0,"The current study expanded on this to include individuals with obesity , and assessed whether the nutrient extraction of seeded fruits reduced GI in a higher disease risk group ."
102289,and,O,3550.0,"The current study expanded on this to include individuals with obesity , and assessed whether the nutrient extraction of seeded fruits reduced GI in a higher disease risk group ."
102290,assessed,O,3550.0,"The current study expanded on this to include individuals with obesity , and assessed whether the nutrient extraction of seeded fruits reduced GI in a higher disease risk group ."
102291,whether,O,3550.0,"The current study expanded on this to include individuals with obesity , and assessed whether the nutrient extraction of seeded fruits reduced GI in a higher disease risk group ."
102292,the,O,3550.0,"The current study expanded on this to include individuals with obesity , and assessed whether the nutrient extraction of seeded fruits reduced GI in a higher disease risk group ."
102293,nutrient,O,3550.0,"The current study expanded on this to include individuals with obesity , and assessed whether the nutrient extraction of seeded fruits reduced GI in a higher disease risk group ."
102294,extraction,O,3550.0,"The current study expanded on this to include individuals with obesity , and assessed whether the nutrient extraction of seeded fruits reduced GI in a higher disease risk group ."
102295,of,O,3550.0,"The current study expanded on this to include individuals with obesity , and assessed whether the nutrient extraction of seeded fruits reduced GI in a higher disease risk group ."
102296,seeded,O,3550.0,"The current study expanded on this to include individuals with obesity , and assessed whether the nutrient extraction of seeded fruits reduced GI in a higher disease risk group ."
102297,fruits,B-AG.01.h.01,3550.0,"The current study expanded on this to include individuals with obesity , and assessed whether the nutrient extraction of seeded fruits reduced GI in a higher disease risk group ."
102298,reduced,O,3550.0,"The current study expanded on this to include individuals with obesity , and assessed whether the nutrient extraction of seeded fruits reduced GI in a higher disease risk group ."
102299,GI,O,3550.0,"The current study expanded on this to include individuals with obesity , and assessed whether the nutrient extraction of seeded fruits reduced GI in a higher disease risk group ."
102300,in,O,3550.0,"The current study expanded on this to include individuals with obesity , and assessed whether the nutrient extraction of seeded fruits reduced GI in a higher disease risk group ."
102301,a,O,3550.0,"The current study expanded on this to include individuals with obesity , and assessed whether the nutrient extraction of seeded fruits reduced GI in a higher disease risk group ."
102302,higher,O,3550.0,"The current study expanded on this to include individuals with obesity , and assessed whether the nutrient extraction of seeded fruits reduced GI in a higher disease risk group ."
102303,disease,O,3550.0,"The current study expanded on this to include individuals with obesity , and assessed whether the nutrient extraction of seeded fruits reduced GI in a higher disease risk group ."
102304,risk,O,3550.0,"The current study expanded on this to include individuals with obesity , and assessed whether the nutrient extraction of seeded fruits reduced GI in a higher disease risk group ."
102305,group,O,3550.0,"The current study expanded on this to include individuals with obesity , and assessed whether the nutrient extraction of seeded fruits reduced GI in a higher disease risk group ."
102306,.,O,3550.0,"The current study expanded on this to include individuals with obesity , and assessed whether the nutrient extraction of seeded fruits reduced GI in a higher disease risk group ."
102307,Nutrient,O,3551.0,"Nutrient extraction was shown to significantly lower GI , compared to eating fruit whole , in subjects with obesity ( raspberry / mango : 25.43 ± 18.20 vs. 44.85 ± 20.18 , Nephrolithiasis is a common medical condition influenced by multiple environmental factors , including diet ."
102308,extraction,O,3551.0,"Nutrient extraction was shown to significantly lower GI , compared to eating fruit whole , in subjects with obesity ( raspberry / mango : 25.43 ± 18.20 vs. 44.85 ± 20.18 , Nephrolithiasis is a common medical condition influenced by multiple environmental factors , including diet ."
102309,was,O,3551.0,"Nutrient extraction was shown to significantly lower GI , compared to eating fruit whole , in subjects with obesity ( raspberry / mango : 25.43 ± 18.20 vs. 44.85 ± 20.18 , Nephrolithiasis is a common medical condition influenced by multiple environmental factors , including diet ."
102310,shown,O,3551.0,"Nutrient extraction was shown to significantly lower GI , compared to eating fruit whole , in subjects with obesity ( raspberry / mango : 25.43 ± 18.20 vs. 44.85 ± 20.18 , Nephrolithiasis is a common medical condition influenced by multiple environmental factors , including diet ."
102311,to,O,3551.0,"Nutrient extraction was shown to significantly lower GI , compared to eating fruit whole , in subjects with obesity ( raspberry / mango : 25.43 ± 18.20 vs. 44.85 ± 20.18 , Nephrolithiasis is a common medical condition influenced by multiple environmental factors , including diet ."
102312,significantly,O,3551.0,"Nutrient extraction was shown to significantly lower GI , compared to eating fruit whole , in subjects with obesity ( raspberry / mango : 25.43 ± 18.20 vs. 44.85 ± 20.18 , Nephrolithiasis is a common medical condition influenced by multiple environmental factors , including diet ."
102313,lower,O,3551.0,"Nutrient extraction was shown to significantly lower GI , compared to eating fruit whole , in subjects with obesity ( raspberry / mango : 25.43 ± 18.20 vs. 44.85 ± 20.18 , Nephrolithiasis is a common medical condition influenced by multiple environmental factors , including diet ."
102314,GI,O,3551.0,"Nutrient extraction was shown to significantly lower GI , compared to eating fruit whole , in subjects with obesity ( raspberry / mango : 25.43 ± 18.20 vs. 44.85 ± 20.18 , Nephrolithiasis is a common medical condition influenced by multiple environmental factors , including diet ."
102315,",",O,3551.0,"Nutrient extraction was shown to significantly lower GI , compared to eating fruit whole , in subjects with obesity ( raspberry / mango : 25.43 ± 18.20 vs. 44.85 ± 20.18 , Nephrolithiasis is a common medical condition influenced by multiple environmental factors , including diet ."
102316,compared,O,3551.0,"Nutrient extraction was shown to significantly lower GI , compared to eating fruit whole , in subjects with obesity ( raspberry / mango : 25.43 ± 18.20 vs. 44.85 ± 20.18 , Nephrolithiasis is a common medical condition influenced by multiple environmental factors , including diet ."
102317,to,O,3551.0,"Nutrient extraction was shown to significantly lower GI , compared to eating fruit whole , in subjects with obesity ( raspberry / mango : 25.43 ± 18.20 vs. 44.85 ± 20.18 , Nephrolithiasis is a common medical condition influenced by multiple environmental factors , including diet ."
102318,eating,O,3551.0,"Nutrient extraction was shown to significantly lower GI , compared to eating fruit whole , in subjects with obesity ( raspberry / mango : 25.43 ± 18.20 vs. 44.85 ± 20.18 , Nephrolithiasis is a common medical condition influenced by multiple environmental factors , including diet ."
102319,fruit,B-AG.01.h.01,3551.0,"Nutrient extraction was shown to significantly lower GI , compared to eating fruit whole , in subjects with obesity ( raspberry / mango : 25.43 ± 18.20 vs. 44.85 ± 20.18 , Nephrolithiasis is a common medical condition influenced by multiple environmental factors , including diet ."
102320,whole,O,3551.0,"Nutrient extraction was shown to significantly lower GI , compared to eating fruit whole , in subjects with obesity ( raspberry / mango : 25.43 ± 18.20 vs. 44.85 ± 20.18 , Nephrolithiasis is a common medical condition influenced by multiple environmental factors , including diet ."
102321,",",O,3551.0,"Nutrient extraction was shown to significantly lower GI , compared to eating fruit whole , in subjects with obesity ( raspberry / mango : 25.43 ± 18.20 vs. 44.85 ± 20.18 , Nephrolithiasis is a common medical condition influenced by multiple environmental factors , including diet ."
102322,in,O,3551.0,"Nutrient extraction was shown to significantly lower GI , compared to eating fruit whole , in subjects with obesity ( raspberry / mango : 25.43 ± 18.20 vs. 44.85 ± 20.18 , Nephrolithiasis is a common medical condition influenced by multiple environmental factors , including diet ."
102323,subjects,O,3551.0,"Nutrient extraction was shown to significantly lower GI , compared to eating fruit whole , in subjects with obesity ( raspberry / mango : 25.43 ± 18.20 vs. 44.85 ± 20.18 , Nephrolithiasis is a common medical condition influenced by multiple environmental factors , including diet ."
102324,with,O,3551.0,"Nutrient extraction was shown to significantly lower GI , compared to eating fruit whole , in subjects with obesity ( raspberry / mango : 25.43 ± 18.20 vs. 44.85 ± 20.18 , Nephrolithiasis is a common medical condition influenced by multiple environmental factors , including diet ."
102325,obesity,O,3551.0,"Nutrient extraction was shown to significantly lower GI , compared to eating fruit whole , in subjects with obesity ( raspberry / mango : 25.43 ± 18.20 vs. 44.85 ± 20.18 , Nephrolithiasis is a common medical condition influenced by multiple environmental factors , including diet ."
102326,(,O,3551.0,"Nutrient extraction was shown to significantly lower GI , compared to eating fruit whole , in subjects with obesity ( raspberry / mango : 25.43 ± 18.20 vs. 44.85 ± 20.18 , Nephrolithiasis is a common medical condition influenced by multiple environmental factors , including diet ."
102327,raspberry,B-AG.01.h.01.b,3551.0,"Nutrient extraction was shown to significantly lower GI , compared to eating fruit whole , in subjects with obesity ( raspberry / mango : 25.43 ± 18.20 vs. 44.85 ± 20.18 , Nephrolithiasis is a common medical condition influenced by multiple environmental factors , including diet ."
102328,/,O,3551.0,"Nutrient extraction was shown to significantly lower GI , compared to eating fruit whole , in subjects with obesity ( raspberry / mango : 25.43 ± 18.20 vs. 44.85 ± 20.18 , Nephrolithiasis is a common medical condition influenced by multiple environmental factors , including diet ."
102329,mango,B-AG.01.h.01.e,3551.0,"Nutrient extraction was shown to significantly lower GI , compared to eating fruit whole , in subjects with obesity ( raspberry / mango : 25.43 ± 18.20 vs. 44.85 ± 20.18 , Nephrolithiasis is a common medical condition influenced by multiple environmental factors , including diet ."
102330,:,O,3551.0,"Nutrient extraction was shown to significantly lower GI , compared to eating fruit whole , in subjects with obesity ( raspberry / mango : 25.43 ± 18.20 vs. 44.85 ± 20.18 , Nephrolithiasis is a common medical condition influenced by multiple environmental factors , including diet ."
102331,25.43,O,3551.0,"Nutrient extraction was shown to significantly lower GI , compared to eating fruit whole , in subjects with obesity ( raspberry / mango : 25.43 ± 18.20 vs. 44.85 ± 20.18 , Nephrolithiasis is a common medical condition influenced by multiple environmental factors , including diet ."
102332,±,O,3551.0,"Nutrient extraction was shown to significantly lower GI , compared to eating fruit whole , in subjects with obesity ( raspberry / mango : 25.43 ± 18.20 vs. 44.85 ± 20.18 , Nephrolithiasis is a common medical condition influenced by multiple environmental factors , including diet ."
102333,18.20,O,3551.0,"Nutrient extraction was shown to significantly lower GI , compared to eating fruit whole , in subjects with obesity ( raspberry / mango : 25.43 ± 18.20 vs. 44.85 ± 20.18 , Nephrolithiasis is a common medical condition influenced by multiple environmental factors , including diet ."
102334,vs.,O,3551.0,"Nutrient extraction was shown to significantly lower GI , compared to eating fruit whole , in subjects with obesity ( raspberry / mango : 25.43 ± 18.20 vs. 44.85 ± 20.18 , Nephrolithiasis is a common medical condition influenced by multiple environmental factors , including diet ."
102335,44.85,O,3551.0,"Nutrient extraction was shown to significantly lower GI , compared to eating fruit whole , in subjects with obesity ( raspberry / mango : 25.43 ± 18.20 vs. 44.85 ± 20.18 , Nephrolithiasis is a common medical condition influenced by multiple environmental factors , including diet ."
102336,±,O,3551.0,"Nutrient extraction was shown to significantly lower GI , compared to eating fruit whole , in subjects with obesity ( raspberry / mango : 25.43 ± 18.20 vs. 44.85 ± 20.18 , Nephrolithiasis is a common medical condition influenced by multiple environmental factors , including diet ."
102337,20.18,O,3551.0,"Nutrient extraction was shown to significantly lower GI , compared to eating fruit whole , in subjects with obesity ( raspberry / mango : 25.43 ± 18.20 vs. 44.85 ± 20.18 , Nephrolithiasis is a common medical condition influenced by multiple environmental factors , including diet ."
102338,",",O,3551.0,"Nutrient extraction was shown to significantly lower GI , compared to eating fruit whole , in subjects with obesity ( raspberry / mango : 25.43 ± 18.20 vs. 44.85 ± 20.18 , Nephrolithiasis is a common medical condition influenced by multiple environmental factors , including diet ."
102339,Nephrolithiasis,O,3551.0,"Nutrient extraction was shown to significantly lower GI , compared to eating fruit whole , in subjects with obesity ( raspberry / mango : 25.43 ± 18.20 vs. 44.85 ± 20.18 , Nephrolithiasis is a common medical condition influenced by multiple environmental factors , including diet ."
102340,is,O,3551.0,"Nutrient extraction was shown to significantly lower GI , compared to eating fruit whole , in subjects with obesity ( raspberry / mango : 25.43 ± 18.20 vs. 44.85 ± 20.18 , Nephrolithiasis is a common medical condition influenced by multiple environmental factors , including diet ."
102341,a,O,3551.0,"Nutrient extraction was shown to significantly lower GI , compared to eating fruit whole , in subjects with obesity ( raspberry / mango : 25.43 ± 18.20 vs. 44.85 ± 20.18 , Nephrolithiasis is a common medical condition influenced by multiple environmental factors , including diet ."
102342,common,O,3551.0,"Nutrient extraction was shown to significantly lower GI , compared to eating fruit whole , in subjects with obesity ( raspberry / mango : 25.43 ± 18.20 vs. 44.85 ± 20.18 , Nephrolithiasis is a common medical condition influenced by multiple environmental factors , including diet ."
102343,medical,O,3551.0,"Nutrient extraction was shown to significantly lower GI , compared to eating fruit whole , in subjects with obesity ( raspberry / mango : 25.43 ± 18.20 vs. 44.85 ± 20.18 , Nephrolithiasis is a common medical condition influenced by multiple environmental factors , including diet ."
102344,condition,O,3551.0,"Nutrient extraction was shown to significantly lower GI , compared to eating fruit whole , in subjects with obesity ( raspberry / mango : 25.43 ± 18.20 vs. 44.85 ± 20.18 , Nephrolithiasis is a common medical condition influenced by multiple environmental factors , including diet ."
102345,influenced,O,3551.0,"Nutrient extraction was shown to significantly lower GI , compared to eating fruit whole , in subjects with obesity ( raspberry / mango : 25.43 ± 18.20 vs. 44.85 ± 20.18 , Nephrolithiasis is a common medical condition influenced by multiple environmental factors , including diet ."
102346,by,O,3551.0,"Nutrient extraction was shown to significantly lower GI , compared to eating fruit whole , in subjects with obesity ( raspberry / mango : 25.43 ± 18.20 vs. 44.85 ± 20.18 , Nephrolithiasis is a common medical condition influenced by multiple environmental factors , including diet ."
102347,multiple,O,3551.0,"Nutrient extraction was shown to significantly lower GI , compared to eating fruit whole , in subjects with obesity ( raspberry / mango : 25.43 ± 18.20 vs. 44.85 ± 20.18 , Nephrolithiasis is a common medical condition influenced by multiple environmental factors , including diet ."
102348,environmental,O,3551.0,"Nutrient extraction was shown to significantly lower GI , compared to eating fruit whole , in subjects with obesity ( raspberry / mango : 25.43 ± 18.20 vs. 44.85 ± 20.18 , Nephrolithiasis is a common medical condition influenced by multiple environmental factors , including diet ."
102349,factors,O,3551.0,"Nutrient extraction was shown to significantly lower GI , compared to eating fruit whole , in subjects with obesity ( raspberry / mango : 25.43 ± 18.20 vs. 44.85 ± 20.18 , Nephrolithiasis is a common medical condition influenced by multiple environmental factors , including diet ."
102350,",",O,3551.0,"Nutrient extraction was shown to significantly lower GI , compared to eating fruit whole , in subjects with obesity ( raspberry / mango : 25.43 ± 18.20 vs. 44.85 ± 20.18 , Nephrolithiasis is a common medical condition influenced by multiple environmental factors , including diet ."
102351,including,O,3551.0,"Nutrient extraction was shown to significantly lower GI , compared to eating fruit whole , in subjects with obesity ( raspberry / mango : 25.43 ± 18.20 vs. 44.85 ± 20.18 , Nephrolithiasis is a common medical condition influenced by multiple environmental factors , including diet ."
102352,diet,O,3551.0,"Nutrient extraction was shown to significantly lower GI , compared to eating fruit whole , in subjects with obesity ( raspberry / mango : 25.43 ± 18.20 vs. 44.85 ± 20.18 , Nephrolithiasis is a common medical condition influenced by multiple environmental factors , including diet ."
102353,.,O,3551.0,"Nutrient extraction was shown to significantly lower GI , compared to eating fruit whole , in subjects with obesity ( raspberry / mango : 25.43 ± 18.20 vs. 44.85 ± 20.18 , Nephrolithiasis is a common medical condition influenced by multiple environmental factors , including diet ."
102354,Since,O,3552.0,"Since nutritional habits play a relevant role in the genesis and recurrence of kidney stones disease , dietary manipulation has become a fundamental tool for the medical management of nephrolithiasis ."
102355,nutritional,O,3552.0,"Since nutritional habits play a relevant role in the genesis and recurrence of kidney stones disease , dietary manipulation has become a fundamental tool for the medical management of nephrolithiasis ."
102356,habits,O,3552.0,"Since nutritional habits play a relevant role in the genesis and recurrence of kidney stones disease , dietary manipulation has become a fundamental tool for the medical management of nephrolithiasis ."
102357,play,O,3552.0,"Since nutritional habits play a relevant role in the genesis and recurrence of kidney stones disease , dietary manipulation has become a fundamental tool for the medical management of nephrolithiasis ."
102358,a,O,3552.0,"Since nutritional habits play a relevant role in the genesis and recurrence of kidney stones disease , dietary manipulation has become a fundamental tool for the medical management of nephrolithiasis ."
102359,relevant,O,3552.0,"Since nutritional habits play a relevant role in the genesis and recurrence of kidney stones disease , dietary manipulation has become a fundamental tool for the medical management of nephrolithiasis ."
102360,role,O,3552.0,"Since nutritional habits play a relevant role in the genesis and recurrence of kidney stones disease , dietary manipulation has become a fundamental tool for the medical management of nephrolithiasis ."
102361,in,O,3552.0,"Since nutritional habits play a relevant role in the genesis and recurrence of kidney stones disease , dietary manipulation has become a fundamental tool for the medical management of nephrolithiasis ."
102362,the,O,3552.0,"Since nutritional habits play a relevant role in the genesis and recurrence of kidney stones disease , dietary manipulation has become a fundamental tool for the medical management of nephrolithiasis ."
102363,genesis,O,3552.0,"Since nutritional habits play a relevant role in the genesis and recurrence of kidney stones disease , dietary manipulation has become a fundamental tool for the medical management of nephrolithiasis ."
102364,and,O,3552.0,"Since nutritional habits play a relevant role in the genesis and recurrence of kidney stones disease , dietary manipulation has become a fundamental tool for the medical management of nephrolithiasis ."
102365,recurrence,O,3552.0,"Since nutritional habits play a relevant role in the genesis and recurrence of kidney stones disease , dietary manipulation has become a fundamental tool for the medical management of nephrolithiasis ."
102366,of,O,3552.0,"Since nutritional habits play a relevant role in the genesis and recurrence of kidney stones disease , dietary manipulation has become a fundamental tool for the medical management of nephrolithiasis ."
102367,kidney,O,3552.0,"Since nutritional habits play a relevant role in the genesis and recurrence of kidney stones disease , dietary manipulation has become a fundamental tool for the medical management of nephrolithiasis ."
102368,stones,O,3552.0,"Since nutritional habits play a relevant role in the genesis and recurrence of kidney stones disease , dietary manipulation has become a fundamental tool for the medical management of nephrolithiasis ."
102369,disease,O,3552.0,"Since nutritional habits play a relevant role in the genesis and recurrence of kidney stones disease , dietary manipulation has become a fundamental tool for the medical management of nephrolithiasis ."
102370,",",O,3552.0,"Since nutritional habits play a relevant role in the genesis and recurrence of kidney stones disease , dietary manipulation has become a fundamental tool for the medical management of nephrolithiasis ."
102371,dietary,O,3552.0,"Since nutritional habits play a relevant role in the genesis and recurrence of kidney stones disease , dietary manipulation has become a fundamental tool for the medical management of nephrolithiasis ."
102372,manipulation,O,3552.0,"Since nutritional habits play a relevant role in the genesis and recurrence of kidney stones disease , dietary manipulation has become a fundamental tool for the medical management of nephrolithiasis ."
102373,has,O,3552.0,"Since nutritional habits play a relevant role in the genesis and recurrence of kidney stones disease , dietary manipulation has become a fundamental tool for the medical management of nephrolithiasis ."
102374,become,O,3552.0,"Since nutritional habits play a relevant role in the genesis and recurrence of kidney stones disease , dietary manipulation has become a fundamental tool for the medical management of nephrolithiasis ."
102375,a,O,3552.0,"Since nutritional habits play a relevant role in the genesis and recurrence of kidney stones disease , dietary manipulation has become a fundamental tool for the medical management of nephrolithiasis ."
102376,fundamental,O,3552.0,"Since nutritional habits play a relevant role in the genesis and recurrence of kidney stones disease , dietary manipulation has become a fundamental tool for the medical management of nephrolithiasis ."
102377,tool,O,3552.0,"Since nutritional habits play a relevant role in the genesis and recurrence of kidney stones disease , dietary manipulation has become a fundamental tool for the medical management of nephrolithiasis ."
102378,for,O,3552.0,"Since nutritional habits play a relevant role in the genesis and recurrence of kidney stones disease , dietary manipulation has become a fundamental tool for the medical management of nephrolithiasis ."
102379,the,O,3552.0,"Since nutritional habits play a relevant role in the genesis and recurrence of kidney stones disease , dietary manipulation has become a fundamental tool for the medical management of nephrolithiasis ."
102380,medical,O,3552.0,"Since nutritional habits play a relevant role in the genesis and recurrence of kidney stones disease , dietary manipulation has become a fundamental tool for the medical management of nephrolithiasis ."
102381,management,O,3552.0,"Since nutritional habits play a relevant role in the genesis and recurrence of kidney stones disease , dietary manipulation has become a fundamental tool for the medical management of nephrolithiasis ."
102382,of,O,3552.0,"Since nutritional habits play a relevant role in the genesis and recurrence of kidney stones disease , dietary manipulation has become a fundamental tool for the medical management of nephrolithiasis ."
102383,nephrolithiasis,O,3552.0,"Since nutritional habits play a relevant role in the genesis and recurrence of kidney stones disease , dietary manipulation has become a fundamental tool for the medical management of nephrolithiasis ."
102384,.,O,3552.0,"Since nutritional habits play a relevant role in the genesis and recurrence of kidney stones disease , dietary manipulation has become a fundamental tool for the medical management of nephrolithiasis ."
102385,Dietary,O,3553.0,"Dietary advice aims to reduce the majority of lithogenic risk factors , reducing the supersaturation of urine , mainly for calcium oxalate , calcium phosphate , and uric acid ."
102386,advice,O,3553.0,"Dietary advice aims to reduce the majority of lithogenic risk factors , reducing the supersaturation of urine , mainly for calcium oxalate , calcium phosphate , and uric acid ."
102387,aims,O,3553.0,"Dietary advice aims to reduce the majority of lithogenic risk factors , reducing the supersaturation of urine , mainly for calcium oxalate , calcium phosphate , and uric acid ."
102388,to,O,3553.0,"Dietary advice aims to reduce the majority of lithogenic risk factors , reducing the supersaturation of urine , mainly for calcium oxalate , calcium phosphate , and uric acid ."
102389,reduce,O,3553.0,"Dietary advice aims to reduce the majority of lithogenic risk factors , reducing the supersaturation of urine , mainly for calcium oxalate , calcium phosphate , and uric acid ."
102390,the,O,3553.0,"Dietary advice aims to reduce the majority of lithogenic risk factors , reducing the supersaturation of urine , mainly for calcium oxalate , calcium phosphate , and uric acid ."
102391,majority,O,3553.0,"Dietary advice aims to reduce the majority of lithogenic risk factors , reducing the supersaturation of urine , mainly for calcium oxalate , calcium phosphate , and uric acid ."
102392,of,O,3553.0,"Dietary advice aims to reduce the majority of lithogenic risk factors , reducing the supersaturation of urine , mainly for calcium oxalate , calcium phosphate , and uric acid ."
102393,lithogenic,O,3553.0,"Dietary advice aims to reduce the majority of lithogenic risk factors , reducing the supersaturation of urine , mainly for calcium oxalate , calcium phosphate , and uric acid ."
102394,risk,O,3553.0,"Dietary advice aims to reduce the majority of lithogenic risk factors , reducing the supersaturation of urine , mainly for calcium oxalate , calcium phosphate , and uric acid ."
102395,factors,O,3553.0,"Dietary advice aims to reduce the majority of lithogenic risk factors , reducing the supersaturation of urine , mainly for calcium oxalate , calcium phosphate , and uric acid ."
102396,",",O,3553.0,"Dietary advice aims to reduce the majority of lithogenic risk factors , reducing the supersaturation of urine , mainly for calcium oxalate , calcium phosphate , and uric acid ."
102397,reducing,O,3553.0,"Dietary advice aims to reduce the majority of lithogenic risk factors , reducing the supersaturation of urine , mainly for calcium oxalate , calcium phosphate , and uric acid ."
102398,the,O,3553.0,"Dietary advice aims to reduce the majority of lithogenic risk factors , reducing the supersaturation of urine , mainly for calcium oxalate , calcium phosphate , and uric acid ."
102399,supersaturation,O,3553.0,"Dietary advice aims to reduce the majority of lithogenic risk factors , reducing the supersaturation of urine , mainly for calcium oxalate , calcium phosphate , and uric acid ."
102400,of,O,3553.0,"Dietary advice aims to reduce the majority of lithogenic risk factors , reducing the supersaturation of urine , mainly for calcium oxalate , calcium phosphate , and uric acid ."
102401,urine,O,3553.0,"Dietary advice aims to reduce the majority of lithogenic risk factors , reducing the supersaturation of urine , mainly for calcium oxalate , calcium phosphate , and uric acid ."
102402,",",O,3553.0,"Dietary advice aims to reduce the majority of lithogenic risk factors , reducing the supersaturation of urine , mainly for calcium oxalate , calcium phosphate , and uric acid ."
102403,mainly,O,3553.0,"Dietary advice aims to reduce the majority of lithogenic risk factors , reducing the supersaturation of urine , mainly for calcium oxalate , calcium phosphate , and uric acid ."
102404,for,O,3553.0,"Dietary advice aims to reduce the majority of lithogenic risk factors , reducing the supersaturation of urine , mainly for calcium oxalate , calcium phosphate , and uric acid ."
102405,calcium,O,3553.0,"Dietary advice aims to reduce the majority of lithogenic risk factors , reducing the supersaturation of urine , mainly for calcium oxalate , calcium phosphate , and uric acid ."
102406,oxalate,O,3553.0,"Dietary advice aims to reduce the majority of lithogenic risk factors , reducing the supersaturation of urine , mainly for calcium oxalate , calcium phosphate , and uric acid ."
102407,",",O,3553.0,"Dietary advice aims to reduce the majority of lithogenic risk factors , reducing the supersaturation of urine , mainly for calcium oxalate , calcium phosphate , and uric acid ."
102408,calcium,O,3553.0,"Dietary advice aims to reduce the majority of lithogenic risk factors , reducing the supersaturation of urine , mainly for calcium oxalate , calcium phosphate , and uric acid ."
102409,phosphate,O,3553.0,"Dietary advice aims to reduce the majority of lithogenic risk factors , reducing the supersaturation of urine , mainly for calcium oxalate , calcium phosphate , and uric acid ."
102410,",",O,3553.0,"Dietary advice aims to reduce the majority of lithogenic risk factors , reducing the supersaturation of urine , mainly for calcium oxalate , calcium phosphate , and uric acid ."
102411,and,O,3553.0,"Dietary advice aims to reduce the majority of lithogenic risk factors , reducing the supersaturation of urine , mainly for calcium oxalate , calcium phosphate , and uric acid ."
102412,uric,O,3553.0,"Dietary advice aims to reduce the majority of lithogenic risk factors , reducing the supersaturation of urine , mainly for calcium oxalate , calcium phosphate , and uric acid ."
102413,acid,O,3553.0,"Dietary advice aims to reduce the majority of lithogenic risk factors , reducing the supersaturation of urine , mainly for calcium oxalate , calcium phosphate , and uric acid ."
102414,.,O,3553.0,"Dietary advice aims to reduce the majority of lithogenic risk factors , reducing the supersaturation of urine , mainly for calcium oxalate , calcium phosphate , and uric acid ."
102415,For,O,3554.0,"For this purpose , current guidelines recommend increasing fluid intake , maintaining a balanced calcium intake , reducing dietary intake of sodium and animal proteins , and increasing intake of fruits and fibers ."
102416,this,O,3554.0,"For this purpose , current guidelines recommend increasing fluid intake , maintaining a balanced calcium intake , reducing dietary intake of sodium and animal proteins , and increasing intake of fruits and fibers ."
102417,purpose,O,3554.0,"For this purpose , current guidelines recommend increasing fluid intake , maintaining a balanced calcium intake , reducing dietary intake of sodium and animal proteins , and increasing intake of fruits and fibers ."
102418,",",O,3554.0,"For this purpose , current guidelines recommend increasing fluid intake , maintaining a balanced calcium intake , reducing dietary intake of sodium and animal proteins , and increasing intake of fruits and fibers ."
102419,current,O,3554.0,"For this purpose , current guidelines recommend increasing fluid intake , maintaining a balanced calcium intake , reducing dietary intake of sodium and animal proteins , and increasing intake of fruits and fibers ."
102420,guidelines,O,3554.0,"For this purpose , current guidelines recommend increasing fluid intake , maintaining a balanced calcium intake , reducing dietary intake of sodium and animal proteins , and increasing intake of fruits and fibers ."
102421,recommend,O,3554.0,"For this purpose , current guidelines recommend increasing fluid intake , maintaining a balanced calcium intake , reducing dietary intake of sodium and animal proteins , and increasing intake of fruits and fibers ."
102422,increasing,O,3554.0,"For this purpose , current guidelines recommend increasing fluid intake , maintaining a balanced calcium intake , reducing dietary intake of sodium and animal proteins , and increasing intake of fruits and fibers ."
102423,fluid,O,3554.0,"For this purpose , current guidelines recommend increasing fluid intake , maintaining a balanced calcium intake , reducing dietary intake of sodium and animal proteins , and increasing intake of fruits and fibers ."
102424,intake,O,3554.0,"For this purpose , current guidelines recommend increasing fluid intake , maintaining a balanced calcium intake , reducing dietary intake of sodium and animal proteins , and increasing intake of fruits and fibers ."
102425,",",O,3554.0,"For this purpose , current guidelines recommend increasing fluid intake , maintaining a balanced calcium intake , reducing dietary intake of sodium and animal proteins , and increasing intake of fruits and fibers ."
102426,maintaining,O,3554.0,"For this purpose , current guidelines recommend increasing fluid intake , maintaining a balanced calcium intake , reducing dietary intake of sodium and animal proteins , and increasing intake of fruits and fibers ."
102427,a,O,3554.0,"For this purpose , current guidelines recommend increasing fluid intake , maintaining a balanced calcium intake , reducing dietary intake of sodium and animal proteins , and increasing intake of fruits and fibers ."
102428,balanced,O,3554.0,"For this purpose , current guidelines recommend increasing fluid intake , maintaining a balanced calcium intake , reducing dietary intake of sodium and animal proteins , and increasing intake of fruits and fibers ."
102429,calcium,O,3554.0,"For this purpose , current guidelines recommend increasing fluid intake , maintaining a balanced calcium intake , reducing dietary intake of sodium and animal proteins , and increasing intake of fruits and fibers ."
102430,intake,O,3554.0,"For this purpose , current guidelines recommend increasing fluid intake , maintaining a balanced calcium intake , reducing dietary intake of sodium and animal proteins , and increasing intake of fruits and fibers ."
102431,",",O,3554.0,"For this purpose , current guidelines recommend increasing fluid intake , maintaining a balanced calcium intake , reducing dietary intake of sodium and animal proteins , and increasing intake of fruits and fibers ."
102432,reducing,O,3554.0,"For this purpose , current guidelines recommend increasing fluid intake , maintaining a balanced calcium intake , reducing dietary intake of sodium and animal proteins , and increasing intake of fruits and fibers ."
102433,dietary,O,3554.0,"For this purpose , current guidelines recommend increasing fluid intake , maintaining a balanced calcium intake , reducing dietary intake of sodium and animal proteins , and increasing intake of fruits and fibers ."
102434,intake,O,3554.0,"For this purpose , current guidelines recommend increasing fluid intake , maintaining a balanced calcium intake , reducing dietary intake of sodium and animal proteins , and increasing intake of fruits and fibers ."
102435,of,O,3554.0,"For this purpose , current guidelines recommend increasing fluid intake , maintaining a balanced calcium intake , reducing dietary intake of sodium and animal proteins , and increasing intake of fruits and fibers ."
102436,sodium,O,3554.0,"For this purpose , current guidelines recommend increasing fluid intake , maintaining a balanced calcium intake , reducing dietary intake of sodium and animal proteins , and increasing intake of fruits and fibers ."
102437,and,O,3554.0,"For this purpose , current guidelines recommend increasing fluid intake , maintaining a balanced calcium intake , reducing dietary intake of sodium and animal proteins , and increasing intake of fruits and fibers ."
102438,animal,O,3554.0,"For this purpose , current guidelines recommend increasing fluid intake , maintaining a balanced calcium intake , reducing dietary intake of sodium and animal proteins , and increasing intake of fruits and fibers ."
102439,proteins,O,3554.0,"For this purpose , current guidelines recommend increasing fluid intake , maintaining a balanced calcium intake , reducing dietary intake of sodium and animal proteins , and increasing intake of fruits and fibers ."
102440,",",O,3554.0,"For this purpose , current guidelines recommend increasing fluid intake , maintaining a balanced calcium intake , reducing dietary intake of sodium and animal proteins , and increasing intake of fruits and fibers ."
102441,and,O,3554.0,"For this purpose , current guidelines recommend increasing fluid intake , maintaining a balanced calcium intake , reducing dietary intake of sodium and animal proteins , and increasing intake of fruits and fibers ."
102442,increasing,O,3554.0,"For this purpose , current guidelines recommend increasing fluid intake , maintaining a balanced calcium intake , reducing dietary intake of sodium and animal proteins , and increasing intake of fruits and fibers ."
102443,intake,O,3554.0,"For this purpose , current guidelines recommend increasing fluid intake , maintaining a balanced calcium intake , reducing dietary intake of sodium and animal proteins , and increasing intake of fruits and fibers ."
102444,of,O,3554.0,"For this purpose , current guidelines recommend increasing fluid intake , maintaining a balanced calcium intake , reducing dietary intake of sodium and animal proteins , and increasing intake of fruits and fibers ."
102445,fruits,B-AG.01.h.01,3554.0,"For this purpose , current guidelines recommend increasing fluid intake , maintaining a balanced calcium intake , reducing dietary intake of sodium and animal proteins , and increasing intake of fruits and fibers ."
102446,and,O,3554.0,"For this purpose , current guidelines recommend increasing fluid intake , maintaining a balanced calcium intake , reducing dietary intake of sodium and animal proteins , and increasing intake of fruits and fibers ."
102447,fibers,O,3554.0,"For this purpose , current guidelines recommend increasing fluid intake , maintaining a balanced calcium intake , reducing dietary intake of sodium and animal proteins , and increasing intake of fruits and fibers ."
102448,.,O,3554.0,"For this purpose , current guidelines recommend increasing fluid intake , maintaining a balanced calcium intake , reducing dietary intake of sodium and animal proteins , and increasing intake of fruits and fibers ."
102449,In,O,3555.0,"In this review , we analyzed the effects of each dietary factor on nephrolithiasis incidence and recurrence rate ."
102450,this,O,3555.0,"In this review , we analyzed the effects of each dietary factor on nephrolithiasis incidence and recurrence rate ."
102451,review,O,3555.0,"In this review , we analyzed the effects of each dietary factor on nephrolithiasis incidence and recurrence rate ."
102452,",",O,3555.0,"In this review , we analyzed the effects of each dietary factor on nephrolithiasis incidence and recurrence rate ."
102453,we,O,3555.0,"In this review , we analyzed the effects of each dietary factor on nephrolithiasis incidence and recurrence rate ."
102454,analyzed,O,3555.0,"In this review , we analyzed the effects of each dietary factor on nephrolithiasis incidence and recurrence rate ."
102455,the,O,3555.0,"In this review , we analyzed the effects of each dietary factor on nephrolithiasis incidence and recurrence rate ."
102456,effects,O,3555.0,"In this review , we analyzed the effects of each dietary factor on nephrolithiasis incidence and recurrence rate ."
102457,of,O,3555.0,"In this review , we analyzed the effects of each dietary factor on nephrolithiasis incidence and recurrence rate ."
102458,each,O,3555.0,"In this review , we analyzed the effects of each dietary factor on nephrolithiasis incidence and recurrence rate ."
102459,dietary,O,3555.0,"In this review , we analyzed the effects of each dietary factor on nephrolithiasis incidence and recurrence rate ."
102460,factor,O,3555.0,"In this review , we analyzed the effects of each dietary factor on nephrolithiasis incidence and recurrence rate ."
102461,on,O,3555.0,"In this review , we analyzed the effects of each dietary factor on nephrolithiasis incidence and recurrence rate ."
102462,nephrolithiasis,O,3555.0,"In this review , we analyzed the effects of each dietary factor on nephrolithiasis incidence and recurrence rate ."
102463,incidence,O,3555.0,"In this review , we analyzed the effects of each dietary factor on nephrolithiasis incidence and recurrence rate ."
102464,and,O,3555.0,"In this review , we analyzed the effects of each dietary factor on nephrolithiasis incidence and recurrence rate ."
102465,recurrence,O,3555.0,"In this review , we analyzed the effects of each dietary factor on nephrolithiasis incidence and recurrence rate ."
102466,rate,O,3555.0,"In this review , we analyzed the effects of each dietary factor on nephrolithiasis incidence and recurrence rate ."
102467,.,O,3555.0,"In this review , we analyzed the effects of each dietary factor on nephrolithiasis incidence and recurrence rate ."
102468,Available,O,3556.0,"Available scientific evidence agrees on the harmful effects of high meat / animal protein intake and low calcium diets , whereas high content of fruits and vegetables associated with a balanced intake of low - fat dairy products carries the lowest risk for incident kidney stones ."
102469,scientific,O,3556.0,"Available scientific evidence agrees on the harmful effects of high meat / animal protein intake and low calcium diets , whereas high content of fruits and vegetables associated with a balanced intake of low - fat dairy products carries the lowest risk for incident kidney stones ."
102470,evidence,O,3556.0,"Available scientific evidence agrees on the harmful effects of high meat / animal protein intake and low calcium diets , whereas high content of fruits and vegetables associated with a balanced intake of low - fat dairy products carries the lowest risk for incident kidney stones ."
102471,agrees,O,3556.0,"Available scientific evidence agrees on the harmful effects of high meat / animal protein intake and low calcium diets , whereas high content of fruits and vegetables associated with a balanced intake of low - fat dairy products carries the lowest risk for incident kidney stones ."
102472,on,O,3556.0,"Available scientific evidence agrees on the harmful effects of high meat / animal protein intake and low calcium diets , whereas high content of fruits and vegetables associated with a balanced intake of low - fat dairy products carries the lowest risk for incident kidney stones ."
102473,the,O,3556.0,"Available scientific evidence agrees on the harmful effects of high meat / animal protein intake and low calcium diets , whereas high content of fruits and vegetables associated with a balanced intake of low - fat dairy products carries the lowest risk for incident kidney stones ."
102474,harmful,O,3556.0,"Available scientific evidence agrees on the harmful effects of high meat / animal protein intake and low calcium diets , whereas high content of fruits and vegetables associated with a balanced intake of low - fat dairy products carries the lowest risk for incident kidney stones ."
102475,effects,O,3556.0,"Available scientific evidence agrees on the harmful effects of high meat / animal protein intake and low calcium diets , whereas high content of fruits and vegetables associated with a balanced intake of low - fat dairy products carries the lowest risk for incident kidney stones ."
102476,of,O,3556.0,"Available scientific evidence agrees on the harmful effects of high meat / animal protein intake and low calcium diets , whereas high content of fruits and vegetables associated with a balanced intake of low - fat dairy products carries the lowest risk for incident kidney stones ."
102477,high,O,3556.0,"Available scientific evidence agrees on the harmful effects of high meat / animal protein intake and low calcium diets , whereas high content of fruits and vegetables associated with a balanced intake of low - fat dairy products carries the lowest risk for incident kidney stones ."
102478,meat,B-AG.01.d,3556.0,"Available scientific evidence agrees on the harmful effects of high meat / animal protein intake and low calcium diets , whereas high content of fruits and vegetables associated with a balanced intake of low - fat dairy products carries the lowest risk for incident kidney stones ."
102479,/,O,3556.0,"Available scientific evidence agrees on the harmful effects of high meat / animal protein intake and low calcium diets , whereas high content of fruits and vegetables associated with a balanced intake of low - fat dairy products carries the lowest risk for incident kidney stones ."
102480,animal,O,3556.0,"Available scientific evidence agrees on the harmful effects of high meat / animal protein intake and low calcium diets , whereas high content of fruits and vegetables associated with a balanced intake of low - fat dairy products carries the lowest risk for incident kidney stones ."
102481,protein,O,3556.0,"Available scientific evidence agrees on the harmful effects of high meat / animal protein intake and low calcium diets , whereas high content of fruits and vegetables associated with a balanced intake of low - fat dairy products carries the lowest risk for incident kidney stones ."
102482,intake,B-X,3556.0,"Available scientific evidence agrees on the harmful effects of high meat / animal protein intake and low calcium diets , whereas high content of fruits and vegetables associated with a balanced intake of low - fat dairy products carries the lowest risk for incident kidney stones ."
102483,and,O,3556.0,"Available scientific evidence agrees on the harmful effects of high meat / animal protein intake and low calcium diets , whereas high content of fruits and vegetables associated with a balanced intake of low - fat dairy products carries the lowest risk for incident kidney stones ."
102484,low,O,3556.0,"Available scientific evidence agrees on the harmful effects of high meat / animal protein intake and low calcium diets , whereas high content of fruits and vegetables associated with a balanced intake of low - fat dairy products carries the lowest risk for incident kidney stones ."
102485,calcium,O,3556.0,"Available scientific evidence agrees on the harmful effects of high meat / animal protein intake and low calcium diets , whereas high content of fruits and vegetables associated with a balanced intake of low - fat dairy products carries the lowest risk for incident kidney stones ."
102486,diets,O,3556.0,"Available scientific evidence agrees on the harmful effects of high meat / animal protein intake and low calcium diets , whereas high content of fruits and vegetables associated with a balanced intake of low - fat dairy products carries the lowest risk for incident kidney stones ."
102487,",",O,3556.0,"Available scientific evidence agrees on the harmful effects of high meat / animal protein intake and low calcium diets , whereas high content of fruits and vegetables associated with a balanced intake of low - fat dairy products carries the lowest risk for incident kidney stones ."
102488,whereas,O,3556.0,"Available scientific evidence agrees on the harmful effects of high meat / animal protein intake and low calcium diets , whereas high content of fruits and vegetables associated with a balanced intake of low - fat dairy products carries the lowest risk for incident kidney stones ."
102489,high,O,3556.0,"Available scientific evidence agrees on the harmful effects of high meat / animal protein intake and low calcium diets , whereas high content of fruits and vegetables associated with a balanced intake of low - fat dairy products carries the lowest risk for incident kidney stones ."
102490,content,O,3556.0,"Available scientific evidence agrees on the harmful effects of high meat / animal protein intake and low calcium diets , whereas high content of fruits and vegetables associated with a balanced intake of low - fat dairy products carries the lowest risk for incident kidney stones ."
102491,of,O,3556.0,"Available scientific evidence agrees on the harmful effects of high meat / animal protein intake and low calcium diets , whereas high content of fruits and vegetables associated with a balanced intake of low - fat dairy products carries the lowest risk for incident kidney stones ."
102492,fruits,B-AG.01.h.01,3556.0,"Available scientific evidence agrees on the harmful effects of high meat / animal protein intake and low calcium diets , whereas high content of fruits and vegetables associated with a balanced intake of low - fat dairy products carries the lowest risk for incident kidney stones ."
102493,and,O,3556.0,"Available scientific evidence agrees on the harmful effects of high meat / animal protein intake and low calcium diets , whereas high content of fruits and vegetables associated with a balanced intake of low - fat dairy products carries the lowest risk for incident kidney stones ."
102494,vegetables,B-AG.01.h.02,3556.0,"Available scientific evidence agrees on the harmful effects of high meat / animal protein intake and low calcium diets , whereas high content of fruits and vegetables associated with a balanced intake of low - fat dairy products carries the lowest risk for incident kidney stones ."
102495,associated,O,3556.0,"Available scientific evidence agrees on the harmful effects of high meat / animal protein intake and low calcium diets , whereas high content of fruits and vegetables associated with a balanced intake of low - fat dairy products carries the lowest risk for incident kidney stones ."
102496,with,O,3556.0,"Available scientific evidence agrees on the harmful effects of high meat / animal protein intake and low calcium diets , whereas high content of fruits and vegetables associated with a balanced intake of low - fat dairy products carries the lowest risk for incident kidney stones ."
102497,a,O,3556.0,"Available scientific evidence agrees on the harmful effects of high meat / animal protein intake and low calcium diets , whereas high content of fruits and vegetables associated with a balanced intake of low - fat dairy products carries the lowest risk for incident kidney stones ."
102498,balanced,O,3556.0,"Available scientific evidence agrees on the harmful effects of high meat / animal protein intake and low calcium diets , whereas high content of fruits and vegetables associated with a balanced intake of low - fat dairy products carries the lowest risk for incident kidney stones ."
102499,intake,O,3556.0,"Available scientific evidence agrees on the harmful effects of high meat / animal protein intake and low calcium diets , whereas high content of fruits and vegetables associated with a balanced intake of low - fat dairy products carries the lowest risk for incident kidney stones ."
102500,of,O,3556.0,"Available scientific evidence agrees on the harmful effects of high meat / animal protein intake and low calcium diets , whereas high content of fruits and vegetables associated with a balanced intake of low - fat dairy products carries the lowest risk for incident kidney stones ."
102501,low,B-AG.01.e,3556.0,"Available scientific evidence agrees on the harmful effects of high meat / animal protein intake and low calcium diets , whereas high content of fruits and vegetables associated with a balanced intake of low - fat dairy products carries the lowest risk for incident kidney stones ."
102502,-,I-AG.01.e,3556.0,"Available scientific evidence agrees on the harmful effects of high meat / animal protein intake and low calcium diets , whereas high content of fruits and vegetables associated with a balanced intake of low - fat dairy products carries the lowest risk for incident kidney stones ."
102503,fat,I-AG.01.e,3556.0,"Available scientific evidence agrees on the harmful effects of high meat / animal protein intake and low calcium diets , whereas high content of fruits and vegetables associated with a balanced intake of low - fat dairy products carries the lowest risk for incident kidney stones ."
102504,dairy,I-AG.01.e,3556.0,"Available scientific evidence agrees on the harmful effects of high meat / animal protein intake and low calcium diets , whereas high content of fruits and vegetables associated with a balanced intake of low - fat dairy products carries the lowest risk for incident kidney stones ."
102505,products,I-AG.01.e,3556.0,"Available scientific evidence agrees on the harmful effects of high meat / animal protein intake and low calcium diets , whereas high content of fruits and vegetables associated with a balanced intake of low - fat dairy products carries the lowest risk for incident kidney stones ."
102506,carries,O,3556.0,"Available scientific evidence agrees on the harmful effects of high meat / animal protein intake and low calcium diets , whereas high content of fruits and vegetables associated with a balanced intake of low - fat dairy products carries the lowest risk for incident kidney stones ."
102507,the,O,3556.0,"Available scientific evidence agrees on the harmful effects of high meat / animal protein intake and low calcium diets , whereas high content of fruits and vegetables associated with a balanced intake of low - fat dairy products carries the lowest risk for incident kidney stones ."
102508,lowest,O,3556.0,"Available scientific evidence agrees on the harmful effects of high meat / animal protein intake and low calcium diets , whereas high content of fruits and vegetables associated with a balanced intake of low - fat dairy products carries the lowest risk for incident kidney stones ."
102509,risk,O,3556.0,"Available scientific evidence agrees on the harmful effects of high meat / animal protein intake and low calcium diets , whereas high content of fruits and vegetables associated with a balanced intake of low - fat dairy products carries the lowest risk for incident kidney stones ."
102510,for,O,3556.0,"Available scientific evidence agrees on the harmful effects of high meat / animal protein intake and low calcium diets , whereas high content of fruits and vegetables associated with a balanced intake of low - fat dairy products carries the lowest risk for incident kidney stones ."
102511,incident,O,3556.0,"Available scientific evidence agrees on the harmful effects of high meat / animal protein intake and low calcium diets , whereas high content of fruits and vegetables associated with a balanced intake of low - fat dairy products carries the lowest risk for incident kidney stones ."
102512,kidney,O,3556.0,"Available scientific evidence agrees on the harmful effects of high meat / animal protein intake and low calcium diets , whereas high content of fruits and vegetables associated with a balanced intake of low - fat dairy products carries the lowest risk for incident kidney stones ."
102513,stones,O,3556.0,"Available scientific evidence agrees on the harmful effects of high meat / animal protein intake and low calcium diets , whereas high content of fruits and vegetables associated with a balanced intake of low - fat dairy products carries the lowest risk for incident kidney stones ."
102514,.,O,3556.0,"Available scientific evidence agrees on the harmful effects of high meat / animal protein intake and low calcium diets , whereas high content of fruits and vegetables associated with a balanced intake of low - fat dairy products carries the lowest risk for incident kidney stones ."
102515,Furthermore,O,3557.0,"Furthermore , a balanced vegetarian diet with dairy products seems to be the most protective diet for kidney stone patients ."
102516,",",O,3557.0,"Furthermore , a balanced vegetarian diet with dairy products seems to be the most protective diet for kidney stone patients ."
102517,a,O,3557.0,"Furthermore , a balanced vegetarian diet with dairy products seems to be the most protective diet for kidney stone patients ."
102518,balanced,O,3557.0,"Furthermore , a balanced vegetarian diet with dairy products seems to be the most protective diet for kidney stone patients ."
102519,vegetarian,O,3557.0,"Furthermore , a balanced vegetarian diet with dairy products seems to be the most protective diet for kidney stone patients ."
102520,diet,O,3557.0,"Furthermore , a balanced vegetarian diet with dairy products seems to be the most protective diet for kidney stone patients ."
102521,with,O,3557.0,"Furthermore , a balanced vegetarian diet with dairy products seems to be the most protective diet for kidney stone patients ."
102522,dairy,O,3557.0,"Furthermore , a balanced vegetarian diet with dairy products seems to be the most protective diet for kidney stone patients ."
102523,products,O,3557.0,"Furthermore , a balanced vegetarian diet with dairy products seems to be the most protective diet for kidney stone patients ."
102524,seems,O,3557.0,"Furthermore , a balanced vegetarian diet with dairy products seems to be the most protective diet for kidney stone patients ."
102525,to,O,3557.0,"Furthermore , a balanced vegetarian diet with dairy products seems to be the most protective diet for kidney stone patients ."
102526,be,O,3557.0,"Furthermore , a balanced vegetarian diet with dairy products seems to be the most protective diet for kidney stone patients ."
102527,the,O,3557.0,"Furthermore , a balanced vegetarian diet with dairy products seems to be the most protective diet for kidney stone patients ."
102528,most,O,3557.0,"Furthermore , a balanced vegetarian diet with dairy products seems to be the most protective diet for kidney stone patients ."
102529,protective,O,3557.0,"Furthermore , a balanced vegetarian diet with dairy products seems to be the most protective diet for kidney stone patients ."
102530,diet,O,3557.0,"Furthermore , a balanced vegetarian diet with dairy products seems to be the most protective diet for kidney stone patients ."
102531,for,O,3557.0,"Furthermore , a balanced vegetarian diet with dairy products seems to be the most protective diet for kidney stone patients ."
102532,kidney,O,3557.0,"Furthermore , a balanced vegetarian diet with dairy products seems to be the most protective diet for kidney stone patients ."
102533,stone,O,3557.0,"Furthermore , a balanced vegetarian diet with dairy products seems to be the most protective diet for kidney stone patients ."
102534,patients,O,3557.0,"Furthermore , a balanced vegetarian diet with dairy products seems to be the most protective diet for kidney stone patients ."
102535,.,O,3557.0,"Furthermore , a balanced vegetarian diet with dairy products seems to be the most protective diet for kidney stone patients ."
102536,Since,O,3558.0,"Since no study prospectively examined the effects of vegan diets on nephrolithiasis risk factors , more scientific work should be made to define the best diet for different kidney stone phenotypes ."
102537,no,O,3558.0,"Since no study prospectively examined the effects of vegan diets on nephrolithiasis risk factors , more scientific work should be made to define the best diet for different kidney stone phenotypes ."
102538,study,O,3558.0,"Since no study prospectively examined the effects of vegan diets on nephrolithiasis risk factors , more scientific work should be made to define the best diet for different kidney stone phenotypes ."
102539,prospectively,O,3558.0,"Since no study prospectively examined the effects of vegan diets on nephrolithiasis risk factors , more scientific work should be made to define the best diet for different kidney stone phenotypes ."
102540,examined,O,3558.0,"Since no study prospectively examined the effects of vegan diets on nephrolithiasis risk factors , more scientific work should be made to define the best diet for different kidney stone phenotypes ."
102541,the,O,3558.0,"Since no study prospectively examined the effects of vegan diets on nephrolithiasis risk factors , more scientific work should be made to define the best diet for different kidney stone phenotypes ."
102542,effects,O,3558.0,"Since no study prospectively examined the effects of vegan diets on nephrolithiasis risk factors , more scientific work should be made to define the best diet for different kidney stone phenotypes ."
102543,of,O,3558.0,"Since no study prospectively examined the effects of vegan diets on nephrolithiasis risk factors , more scientific work should be made to define the best diet for different kidney stone phenotypes ."
102544,vegan,O,3558.0,"Since no study prospectively examined the effects of vegan diets on nephrolithiasis risk factors , more scientific work should be made to define the best diet for different kidney stone phenotypes ."
102545,diets,O,3558.0,"Since no study prospectively examined the effects of vegan diets on nephrolithiasis risk factors , more scientific work should be made to define the best diet for different kidney stone phenotypes ."
102546,on,O,3558.0,"Since no study prospectively examined the effects of vegan diets on nephrolithiasis risk factors , more scientific work should be made to define the best diet for different kidney stone phenotypes ."
102547,nephrolithiasis,O,3558.0,"Since no study prospectively examined the effects of vegan diets on nephrolithiasis risk factors , more scientific work should be made to define the best diet for different kidney stone phenotypes ."
102548,risk,O,3558.0,"Since no study prospectively examined the effects of vegan diets on nephrolithiasis risk factors , more scientific work should be made to define the best diet for different kidney stone phenotypes ."
102549,factors,O,3558.0,"Since no study prospectively examined the effects of vegan diets on nephrolithiasis risk factors , more scientific work should be made to define the best diet for different kidney stone phenotypes ."
102550,",",O,3558.0,"Since no study prospectively examined the effects of vegan diets on nephrolithiasis risk factors , more scientific work should be made to define the best diet for different kidney stone phenotypes ."
102551,more,O,3558.0,"Since no study prospectively examined the effects of vegan diets on nephrolithiasis risk factors , more scientific work should be made to define the best diet for different kidney stone phenotypes ."
102552,scientific,O,3558.0,"Since no study prospectively examined the effects of vegan diets on nephrolithiasis risk factors , more scientific work should be made to define the best diet for different kidney stone phenotypes ."
102553,work,O,3558.0,"Since no study prospectively examined the effects of vegan diets on nephrolithiasis risk factors , more scientific work should be made to define the best diet for different kidney stone phenotypes ."
102554,should,O,3558.0,"Since no study prospectively examined the effects of vegan diets on nephrolithiasis risk factors , more scientific work should be made to define the best diet for different kidney stone phenotypes ."
102555,be,O,3558.0,"Since no study prospectively examined the effects of vegan diets on nephrolithiasis risk factors , more scientific work should be made to define the best diet for different kidney stone phenotypes ."
102556,made,O,3558.0,"Since no study prospectively examined the effects of vegan diets on nephrolithiasis risk factors , more scientific work should be made to define the best diet for different kidney stone phenotypes ."
102557,to,O,3558.0,"Since no study prospectively examined the effects of vegan diets on nephrolithiasis risk factors , more scientific work should be made to define the best diet for different kidney stone phenotypes ."
102558,define,O,3558.0,"Since no study prospectively examined the effects of vegan diets on nephrolithiasis risk factors , more scientific work should be made to define the best diet for different kidney stone phenotypes ."
102559,the,O,3558.0,"Since no study prospectively examined the effects of vegan diets on nephrolithiasis risk factors , more scientific work should be made to define the best diet for different kidney stone phenotypes ."
102560,best,O,3558.0,"Since no study prospectively examined the effects of vegan diets on nephrolithiasis risk factors , more scientific work should be made to define the best diet for different kidney stone phenotypes ."
102561,diet,O,3558.0,"Since no study prospectively examined the effects of vegan diets on nephrolithiasis risk factors , more scientific work should be made to define the best diet for different kidney stone phenotypes ."
102562,for,O,3558.0,"Since no study prospectively examined the effects of vegan diets on nephrolithiasis risk factors , more scientific work should be made to define the best diet for different kidney stone phenotypes ."
102563,different,O,3558.0,"Since no study prospectively examined the effects of vegan diets on nephrolithiasis risk factors , more scientific work should be made to define the best diet for different kidney stone phenotypes ."
102564,kidney,O,3558.0,"Since no study prospectively examined the effects of vegan diets on nephrolithiasis risk factors , more scientific work should be made to define the best diet for different kidney stone phenotypes ."
102565,stone,O,3558.0,"Since no study prospectively examined the effects of vegan diets on nephrolithiasis risk factors , more scientific work should be made to define the best diet for different kidney stone phenotypes ."
102566,phenotypes,O,3558.0,"Since no study prospectively examined the effects of vegan diets on nephrolithiasis risk factors , more scientific work should be made to define the best diet for different kidney stone phenotypes ."
102567,.,O,3558.0,"Since no study prospectively examined the effects of vegan diets on nephrolithiasis risk factors , more scientific work should be made to define the best diet for different kidney stone phenotypes ."
102568,High,O,3559.0,High salt intake is a major risk factor of hypertension and cardiovascular disease .
102569,salt,B-AG.01.l.01,3559.0,High salt intake is a major risk factor of hypertension and cardiovascular disease .
102570,intake,B-X,3559.0,High salt intake is a major risk factor of hypertension and cardiovascular disease .
102571,is,O,3559.0,High salt intake is a major risk factor of hypertension and cardiovascular disease .
102572,a,O,3559.0,High salt intake is a major risk factor of hypertension and cardiovascular disease .
102573,major,O,3559.0,High salt intake is a major risk factor of hypertension and cardiovascular disease .
102574,risk,O,3559.0,High salt intake is a major risk factor of hypertension and cardiovascular disease .
102575,factor,O,3559.0,High salt intake is a major risk factor of hypertension and cardiovascular disease .
102576,of,O,3559.0,High salt intake is a major risk factor of hypertension and cardiovascular disease .
102577,hypertension,O,3559.0,High salt intake is a major risk factor of hypertension and cardiovascular disease .
102578,and,O,3559.0,High salt intake is a major risk factor of hypertension and cardiovascular disease .
102579,cardiovascular,O,3559.0,High salt intake is a major risk factor of hypertension and cardiovascular disease .
102580,disease,O,3559.0,High salt intake is a major risk factor of hypertension and cardiovascular disease .
102581,.,O,3559.0,High salt intake is a major risk factor of hypertension and cardiovascular disease .
102582,Improving,O,3560.0,"Improving knowledge , attitudes , and practices ( KAP ) related to salt intake in the general population is a key component of salt reduction strategies ."
102583,knowledge,O,3560.0,"Improving knowledge , attitudes , and practices ( KAP ) related to salt intake in the general population is a key component of salt reduction strategies ."
102584,",",O,3560.0,"Improving knowledge , attitudes , and practices ( KAP ) related to salt intake in the general population is a key component of salt reduction strategies ."
102585,attitudes,O,3560.0,"Improving knowledge , attitudes , and practices ( KAP ) related to salt intake in the general population is a key component of salt reduction strategies ."
102586,",",O,3560.0,"Improving knowledge , attitudes , and practices ( KAP ) related to salt intake in the general population is a key component of salt reduction strategies ."
102587,and,O,3560.0,"Improving knowledge , attitudes , and practices ( KAP ) related to salt intake in the general population is a key component of salt reduction strategies ."
102588,practices,O,3560.0,"Improving knowledge , attitudes , and practices ( KAP ) related to salt intake in the general population is a key component of salt reduction strategies ."
102589,(,O,3560.0,"Improving knowledge , attitudes , and practices ( KAP ) related to salt intake in the general population is a key component of salt reduction strategies ."
102590,KAP,O,3560.0,"Improving knowledge , attitudes , and practices ( KAP ) related to salt intake in the general population is a key component of salt reduction strategies ."
102591,),O,3560.0,"Improving knowledge , attitudes , and practices ( KAP ) related to salt intake in the general population is a key component of salt reduction strategies ."
102592,related,O,3560.0,"Improving knowledge , attitudes , and practices ( KAP ) related to salt intake in the general population is a key component of salt reduction strategies ."
102593,to,O,3560.0,"Improving knowledge , attitudes , and practices ( KAP ) related to salt intake in the general population is a key component of salt reduction strategies ."
102594,salt,B-AG.01.l.01,3560.0,"Improving knowledge , attitudes , and practices ( KAP ) related to salt intake in the general population is a key component of salt reduction strategies ."
102595,intake,B-X,3560.0,"Improving knowledge , attitudes , and practices ( KAP ) related to salt intake in the general population is a key component of salt reduction strategies ."
102596,in,O,3560.0,"Improving knowledge , attitudes , and practices ( KAP ) related to salt intake in the general population is a key component of salt reduction strategies ."
102597,the,O,3560.0,"Improving knowledge , attitudes , and practices ( KAP ) related to salt intake in the general population is a key component of salt reduction strategies ."
102598,general,O,3560.0,"Improving knowledge , attitudes , and practices ( KAP ) related to salt intake in the general population is a key component of salt reduction strategies ."
102599,population,O,3560.0,"Improving knowledge , attitudes , and practices ( KAP ) related to salt intake in the general population is a key component of salt reduction strategies ."
102600,is,O,3560.0,"Improving knowledge , attitudes , and practices ( KAP ) related to salt intake in the general population is a key component of salt reduction strategies ."
102601,a,O,3560.0,"Improving knowledge , attitudes , and practices ( KAP ) related to salt intake in the general population is a key component of salt reduction strategies ."
102602,key,O,3560.0,"Improving knowledge , attitudes , and practices ( KAP ) related to salt intake in the general population is a key component of salt reduction strategies ."
102603,component,O,3560.0,"Improving knowledge , attitudes , and practices ( KAP ) related to salt intake in the general population is a key component of salt reduction strategies ."
102604,of,O,3560.0,"Improving knowledge , attitudes , and practices ( KAP ) related to salt intake in the general population is a key component of salt reduction strategies ."
102605,salt,B-AG.01.l.01,3560.0,"Improving knowledge , attitudes , and practices ( KAP ) related to salt intake in the general population is a key component of salt reduction strategies ."
102606,reduction,O,3560.0,"Improving knowledge , attitudes , and practices ( KAP ) related to salt intake in the general population is a key component of salt reduction strategies ."
102607,strategies,O,3560.0,"Improving knowledge , attitudes , and practices ( KAP ) related to salt intake in the general population is a key component of salt reduction strategies ."
102608,.,O,3560.0,"Improving knowledge , attitudes , and practices ( KAP ) related to salt intake in the general population is a key component of salt reduction strategies ."
102609,The,O,3561.0,The objective of this study was to describe and compare the KAP of adults related to salt in urban areas of five countries in sub - Saharan Africa .
102610,objective,O,3561.0,The objective of this study was to describe and compare the KAP of adults related to salt in urban areas of five countries in sub - Saharan Africa .
102611,of,O,3561.0,The objective of this study was to describe and compare the KAP of adults related to salt in urban areas of five countries in sub - Saharan Africa .
102612,this,O,3561.0,The objective of this study was to describe and compare the KAP of adults related to salt in urban areas of five countries in sub - Saharan Africa .
102613,study,O,3561.0,The objective of this study was to describe and compare the KAP of adults related to salt in urban areas of five countries in sub - Saharan Africa .
102614,was,O,3561.0,The objective of this study was to describe and compare the KAP of adults related to salt in urban areas of five countries in sub - Saharan Africa .
102615,to,O,3561.0,The objective of this study was to describe and compare the KAP of adults related to salt in urban areas of five countries in sub - Saharan Africa .
102616,describe,O,3561.0,The objective of this study was to describe and compare the KAP of adults related to salt in urban areas of five countries in sub - Saharan Africa .
102617,and,O,3561.0,The objective of this study was to describe and compare the KAP of adults related to salt in urban areas of five countries in sub - Saharan Africa .
102618,compare,O,3561.0,The objective of this study was to describe and compare the KAP of adults related to salt in urban areas of five countries in sub - Saharan Africa .
102619,the,O,3561.0,The objective of this study was to describe and compare the KAP of adults related to salt in urban areas of five countries in sub - Saharan Africa .
102620,KAP,O,3561.0,The objective of this study was to describe and compare the KAP of adults related to salt in urban areas of five countries in sub - Saharan Africa .
102621,of,O,3561.0,The objective of this study was to describe and compare the KAP of adults related to salt in urban areas of five countries in sub - Saharan Africa .
102622,adults,O,3561.0,The objective of this study was to describe and compare the KAP of adults related to salt in urban areas of five countries in sub - Saharan Africa .
102623,related,O,3561.0,The objective of this study was to describe and compare the KAP of adults related to salt in urban areas of five countries in sub - Saharan Africa .
102624,to,O,3561.0,The objective of this study was to describe and compare the KAP of adults related to salt in urban areas of five countries in sub - Saharan Africa .
102625,salt,B-AG.01.l.01,3561.0,The objective of this study was to describe and compare the KAP of adults related to salt in urban areas of five countries in sub - Saharan Africa .
102626,in,O,3561.0,The objective of this study was to describe and compare the KAP of adults related to salt in urban areas of five countries in sub - Saharan Africa .
102627,urban,O,3561.0,The objective of this study was to describe and compare the KAP of adults related to salt in urban areas of five countries in sub - Saharan Africa .
102628,areas,O,3561.0,The objective of this study was to describe and compare the KAP of adults related to salt in urban areas of five countries in sub - Saharan Africa .
102629,of,O,3561.0,The objective of this study was to describe and compare the KAP of adults related to salt in urban areas of five countries in sub - Saharan Africa .
102630,five,O,3561.0,The objective of this study was to describe and compare the KAP of adults related to salt in urban areas of five countries in sub - Saharan Africa .
102631,countries,O,3561.0,The objective of this study was to describe and compare the KAP of adults related to salt in urban areas of five countries in sub - Saharan Africa .
102632,in,O,3561.0,The objective of this study was to describe and compare the KAP of adults related to salt in urban areas of five countries in sub - Saharan Africa .
102633,sub,O,3561.0,The objective of this study was to describe and compare the KAP of adults related to salt in urban areas of five countries in sub - Saharan Africa .
102634,-,O,3561.0,The objective of this study was to describe and compare the KAP of adults related to salt in urban areas of five countries in sub - Saharan Africa .
102635,Saharan,O,3561.0,The objective of this study was to describe and compare the KAP of adults related to salt in urban areas of five countries in sub - Saharan Africa .
102636,Africa,O,3561.0,The objective of this study was to describe and compare the KAP of adults related to salt in urban areas of five countries in sub - Saharan Africa .
102637,.,O,3561.0,The objective of this study was to describe and compare the KAP of adults related to salt in urban areas of five countries in sub - Saharan Africa .
102638,The,O,3562.0,"The survey included 588 participants aged 25 to 65 years who were selected using convenience samples in the urban areas of Benin , Guinea , Kenya , Mozambique , and Seychelles ."
102639,survey,O,3562.0,"The survey included 588 participants aged 25 to 65 years who were selected using convenience samples in the urban areas of Benin , Guinea , Kenya , Mozambique , and Seychelles ."
102640,included,O,3562.0,"The survey included 588 participants aged 25 to 65 years who were selected using convenience samples in the urban areas of Benin , Guinea , Kenya , Mozambique , and Seychelles ."
102641,588,O,3562.0,"The survey included 588 participants aged 25 to 65 years who were selected using convenience samples in the urban areas of Benin , Guinea , Kenya , Mozambique , and Seychelles ."
102642,participants,O,3562.0,"The survey included 588 participants aged 25 to 65 years who were selected using convenience samples in the urban areas of Benin , Guinea , Kenya , Mozambique , and Seychelles ."
102643,aged,O,3562.0,"The survey included 588 participants aged 25 to 65 years who were selected using convenience samples in the urban areas of Benin , Guinea , Kenya , Mozambique , and Seychelles ."
102644,25,O,3562.0,"The survey included 588 participants aged 25 to 65 years who were selected using convenience samples in the urban areas of Benin , Guinea , Kenya , Mozambique , and Seychelles ."
102645,to,O,3562.0,"The survey included 588 participants aged 25 to 65 years who were selected using convenience samples in the urban areas of Benin , Guinea , Kenya , Mozambique , and Seychelles ."
102646,65,O,3562.0,"The survey included 588 participants aged 25 to 65 years who were selected using convenience samples in the urban areas of Benin , Guinea , Kenya , Mozambique , and Seychelles ."
102647,years,O,3562.0,"The survey included 588 participants aged 25 to 65 years who were selected using convenience samples in the urban areas of Benin , Guinea , Kenya , Mozambique , and Seychelles ."
102648,who,O,3562.0,"The survey included 588 participants aged 25 to 65 years who were selected using convenience samples in the urban areas of Benin , Guinea , Kenya , Mozambique , and Seychelles ."
102649,were,O,3562.0,"The survey included 588 participants aged 25 to 65 years who were selected using convenience samples in the urban areas of Benin , Guinea , Kenya , Mozambique , and Seychelles ."
102650,selected,O,3562.0,"The survey included 588 participants aged 25 to 65 years who were selected using convenience samples in the urban areas of Benin , Guinea , Kenya , Mozambique , and Seychelles ."
102651,using,O,3562.0,"The survey included 588 participants aged 25 to 65 years who were selected using convenience samples in the urban areas of Benin , Guinea , Kenya , Mozambique , and Seychelles ."
102652,convenience,O,3562.0,"The survey included 588 participants aged 25 to 65 years who were selected using convenience samples in the urban areas of Benin , Guinea , Kenya , Mozambique , and Seychelles ."
102653,samples,O,3562.0,"The survey included 588 participants aged 25 to 65 years who were selected using convenience samples in the urban areas of Benin , Guinea , Kenya , Mozambique , and Seychelles ."
102654,in,O,3562.0,"The survey included 588 participants aged 25 to 65 years who were selected using convenience samples in the urban areas of Benin , Guinea , Kenya , Mozambique , and Seychelles ."
102655,the,O,3562.0,"The survey included 588 participants aged 25 to 65 years who were selected using convenience samples in the urban areas of Benin , Guinea , Kenya , Mozambique , and Seychelles ."
102656,urban,O,3562.0,"The survey included 588 participants aged 25 to 65 years who were selected using convenience samples in the urban areas of Benin , Guinea , Kenya , Mozambique , and Seychelles ."
102657,areas,O,3562.0,"The survey included 588 participants aged 25 to 65 years who were selected using convenience samples in the urban areas of Benin , Guinea , Kenya , Mozambique , and Seychelles ."
102658,of,O,3562.0,"The survey included 588 participants aged 25 to 65 years who were selected using convenience samples in the urban areas of Benin , Guinea , Kenya , Mozambique , and Seychelles ."
102659,Benin,O,3562.0,"The survey included 588 participants aged 25 to 65 years who were selected using convenience samples in the urban areas of Benin , Guinea , Kenya , Mozambique , and Seychelles ."
102660,",",O,3562.0,"The survey included 588 participants aged 25 to 65 years who were selected using convenience samples in the urban areas of Benin , Guinea , Kenya , Mozambique , and Seychelles ."
102661,Guinea,O,3562.0,"The survey included 588 participants aged 25 to 65 years who were selected using convenience samples in the urban areas of Benin , Guinea , Kenya , Mozambique , and Seychelles ."
102662,",",O,3562.0,"The survey included 588 participants aged 25 to 65 years who were selected using convenience samples in the urban areas of Benin , Guinea , Kenya , Mozambique , and Seychelles ."
102663,Kenya,O,3562.0,"The survey included 588 participants aged 25 to 65 years who were selected using convenience samples in the urban areas of Benin , Guinea , Kenya , Mozambique , and Seychelles ."
102664,",",O,3562.0,"The survey included 588 participants aged 25 to 65 years who were selected using convenience samples in the urban areas of Benin , Guinea , Kenya , Mozambique , and Seychelles ."
102665,Mozambique,O,3562.0,"The survey included 588 participants aged 25 to 65 years who were selected using convenience samples in the urban areas of Benin , Guinea , Kenya , Mozambique , and Seychelles ."
102666,",",O,3562.0,"The survey included 588 participants aged 25 to 65 years who were selected using convenience samples in the urban areas of Benin , Guinea , Kenya , Mozambique , and Seychelles ."
102667,and,O,3562.0,"The survey included 588 participants aged 25 to 65 years who were selected using convenience samples in the urban areas of Benin , Guinea , Kenya , Mozambique , and Seychelles ."
102668,Seychelles,O,3562.0,"The survey included 588 participants aged 25 to 65 years who were selected using convenience samples in the urban areas of Benin , Guinea , Kenya , Mozambique , and Seychelles ."
102669,.,O,3562.0,"The survey included 588 participants aged 25 to 65 years who were selected using convenience samples in the urban areas of Benin , Guinea , Kenya , Mozambique , and Seychelles ."
102670,Socio,O,3563.0,Socio - demographic and food consumption were assessed using a structured closed - ended questionnaire administered by survey officers .
102671,-,O,3563.0,Socio - demographic and food consumption were assessed using a structured closed - ended questionnaire administered by survey officers .
102672,demographic,O,3563.0,Socio - demographic and food consumption were assessed using a structured closed - ended questionnaire administered by survey officers .
102673,and,O,3563.0,Socio - demographic and food consumption were assessed using a structured closed - ended questionnaire administered by survey officers .
102674,food,O,3563.0,Socio - demographic and food consumption were assessed using a structured closed - ended questionnaire administered by survey officers .
102675,consumption,O,3563.0,Socio - demographic and food consumption were assessed using a structured closed - ended questionnaire administered by survey officers .
102676,were,O,3563.0,Socio - demographic and food consumption were assessed using a structured closed - ended questionnaire administered by survey officers .
102677,assessed,O,3563.0,Socio - demographic and food consumption were assessed using a structured closed - ended questionnaire administered by survey officers .
102678,using,O,3563.0,Socio - demographic and food consumption were assessed using a structured closed - ended questionnaire administered by survey officers .
102679,a,O,3563.0,Socio - demographic and food consumption were assessed using a structured closed - ended questionnaire administered by survey officers .
102680,structured,O,3563.0,Socio - demographic and food consumption were assessed using a structured closed - ended questionnaire administered by survey officers .
102681,closed,O,3563.0,Socio - demographic and food consumption were assessed using a structured closed - ended questionnaire administered by survey officers .
102682,-,O,3563.0,Socio - demographic and food consumption were assessed using a structured closed - ended questionnaire administered by survey officers .
102683,ended,O,3563.0,Socio - demographic and food consumption were assessed using a structured closed - ended questionnaire administered by survey officers .
102684,questionnaire,O,3563.0,Socio - demographic and food consumption were assessed using a structured closed - ended questionnaire administered by survey officers .
102685,administered,O,3563.0,Socio - demographic and food consumption were assessed using a structured closed - ended questionnaire administered by survey officers .
102686,by,O,3563.0,Socio - demographic and food consumption were assessed using a structured closed - ended questionnaire administered by survey officers .
102687,survey,O,3563.0,Socio - demographic and food consumption were assessed using a structured closed - ended questionnaire administered by survey officers .
102688,officers,O,3563.0,Socio - demographic and food consumption were assessed using a structured closed - ended questionnaire administered by survey officers .
102689,.,O,3563.0,Socio - demographic and food consumption were assessed using a structured closed - ended questionnaire administered by survey officers .
102690,Height,O,3564.0,"Height , weight , and blood pressure were measured ."
102691,",",O,3564.0,"Height , weight , and blood pressure were measured ."
102692,weight,O,3564.0,"Height , weight , and blood pressure were measured ."
102693,",",O,3564.0,"Height , weight , and blood pressure were measured ."
102694,and,O,3564.0,"Height , weight , and blood pressure were measured ."
102695,blood,O,3564.0,"Height , weight , and blood pressure were measured ."
102696,pressure,O,3564.0,"Height , weight , and blood pressure were measured ."
102697,were,O,3564.0,"Height , weight , and blood pressure were measured ."
102698,measured,O,3564.0,"Height , weight , and blood pressure were measured ."
102699,.,O,3564.0,"Height , weight , and blood pressure were measured ."
102700,Food,O,3565.0,Food consumption varied largely between countries .
102701,consumption,O,3565.0,Food consumption varied largely between countries .
102702,varied,O,3565.0,Food consumption varied largely between countries .
102703,largely,O,3565.0,Food consumption varied largely between countries .
102704,between,O,3565.0,Food consumption varied largely between countries .
102705,countries,O,3565.0,Food consumption varied largely between countries .
102706,.,O,3565.0,Food consumption varied largely between countries .
102707,Processed,B-AG.01,3566.0,"Processed foods high in salt , such as processed meat , cheese , pizzas , and savory snacks were consumed rather infrequently in all the countries , but salt - rich foods , such as soups or bread and salty condiments , were consumed frequently in all countries ."
102708,foods,I-AG.01,3566.0,"Processed foods high in salt , such as processed meat , cheese , pizzas , and savory snacks were consumed rather infrequently in all the countries , but salt - rich foods , such as soups or bread and salty condiments , were consumed frequently in all countries ."
102709,high,I-AG.01,3566.0,"Processed foods high in salt , such as processed meat , cheese , pizzas , and savory snacks were consumed rather infrequently in all the countries , but salt - rich foods , such as soups or bread and salty condiments , were consumed frequently in all countries ."
102710,in,I-AG.01,3566.0,"Processed foods high in salt , such as processed meat , cheese , pizzas , and savory snacks were consumed rather infrequently in all the countries , but salt - rich foods , such as soups or bread and salty condiments , were consumed frequently in all countries ."
102711,salt,I-AG.01,3566.0,"Processed foods high in salt , such as processed meat , cheese , pizzas , and savory snacks were consumed rather infrequently in all the countries , but salt - rich foods , such as soups or bread and salty condiments , were consumed frequently in all countries ."
102712,",",O,3566.0,"Processed foods high in salt , such as processed meat , cheese , pizzas , and savory snacks were consumed rather infrequently in all the countries , but salt - rich foods , such as soups or bread and salty condiments , were consumed frequently in all countries ."
102713,such,O,3566.0,"Processed foods high in salt , such as processed meat , cheese , pizzas , and savory snacks were consumed rather infrequently in all the countries , but salt - rich foods , such as soups or bread and salty condiments , were consumed frequently in all countries ."
102714,as,O,3566.0,"Processed foods high in salt , such as processed meat , cheese , pizzas , and savory snacks were consumed rather infrequently in all the countries , but salt - rich foods , such as soups or bread and salty condiments , were consumed frequently in all countries ."
102715,processed,B-AG.01.d,3566.0,"Processed foods high in salt , such as processed meat , cheese , pizzas , and savory snacks were consumed rather infrequently in all the countries , but salt - rich foods , such as soups or bread and salty condiments , were consumed frequently in all countries ."
102716,meat,I-AG.01.d,3566.0,"Processed foods high in salt , such as processed meat , cheese , pizzas , and savory snacks were consumed rather infrequently in all the countries , but salt - rich foods , such as soups or bread and salty condiments , were consumed frequently in all countries ."
102717,",",O,3566.0,"Processed foods high in salt , such as processed meat , cheese , pizzas , and savory snacks were consumed rather infrequently in all the countries , but salt - rich foods , such as soups or bread and salty condiments , were consumed frequently in all countries ."
102718,cheese,B-AG.01.e.02,3566.0,"Processed foods high in salt , such as processed meat , cheese , pizzas , and savory snacks were consumed rather infrequently in all the countries , but salt - rich foods , such as soups or bread and salty condiments , were consumed frequently in all countries ."
102719,",",O,3566.0,"Processed foods high in salt , such as processed meat , cheese , pizzas , and savory snacks were consumed rather infrequently in all the countries , but salt - rich foods , such as soups or bread and salty condiments , were consumed frequently in all countries ."
102720,pizzas,B-AG.01.n,3566.0,"Processed foods high in salt , such as processed meat , cheese , pizzas , and savory snacks were consumed rather infrequently in all the countries , but salt - rich foods , such as soups or bread and salty condiments , were consumed frequently in all countries ."
102721,",",O,3566.0,"Processed foods high in salt , such as processed meat , cheese , pizzas , and savory snacks were consumed rather infrequently in all the countries , but salt - rich foods , such as soups or bread and salty condiments , were consumed frequently in all countries ."
102722,and,O,3566.0,"Processed foods high in salt , such as processed meat , cheese , pizzas , and savory snacks were consumed rather infrequently in all the countries , but salt - rich foods , such as soups or bread and salty condiments , were consumed frequently in all countries ."
102723,savory,B-AG.01,3566.0,"Processed foods high in salt , such as processed meat , cheese , pizzas , and savory snacks were consumed rather infrequently in all the countries , but salt - rich foods , such as soups or bread and salty condiments , were consumed frequently in all countries ."
102724,snacks,I-AG.01,3566.0,"Processed foods high in salt , such as processed meat , cheese , pizzas , and savory snacks were consumed rather infrequently in all the countries , but salt - rich foods , such as soups or bread and salty condiments , were consumed frequently in all countries ."
102725,were,O,3566.0,"Processed foods high in salt , such as processed meat , cheese , pizzas , and savory snacks were consumed rather infrequently in all the countries , but salt - rich foods , such as soups or bread and salty condiments , were consumed frequently in all countries ."
102726,consumed,O,3566.0,"Processed foods high in salt , such as processed meat , cheese , pizzas , and savory snacks were consumed rather infrequently in all the countries , but salt - rich foods , such as soups or bread and salty condiments , were consumed frequently in all countries ."
102727,rather,O,3566.0,"Processed foods high in salt , such as processed meat , cheese , pizzas , and savory snacks were consumed rather infrequently in all the countries , but salt - rich foods , such as soups or bread and salty condiments , were consumed frequently in all countries ."
102728,infrequently,O,3566.0,"Processed foods high in salt , such as processed meat , cheese , pizzas , and savory snacks were consumed rather infrequently in all the countries , but salt - rich foods , such as soups or bread and salty condiments , were consumed frequently in all countries ."
102729,in,O,3566.0,"Processed foods high in salt , such as processed meat , cheese , pizzas , and savory snacks were consumed rather infrequently in all the countries , but salt - rich foods , such as soups or bread and salty condiments , were consumed frequently in all countries ."
102730,all,O,3566.0,"Processed foods high in salt , such as processed meat , cheese , pizzas , and savory snacks were consumed rather infrequently in all the countries , but salt - rich foods , such as soups or bread and salty condiments , were consumed frequently in all countries ."
102731,the,O,3566.0,"Processed foods high in salt , such as processed meat , cheese , pizzas , and savory snacks were consumed rather infrequently in all the countries , but salt - rich foods , such as soups or bread and salty condiments , were consumed frequently in all countries ."
102732,countries,O,3566.0,"Processed foods high in salt , such as processed meat , cheese , pizzas , and savory snacks were consumed rather infrequently in all the countries , but salt - rich foods , such as soups or bread and salty condiments , were consumed frequently in all countries ."
102733,",",O,3566.0,"Processed foods high in salt , such as processed meat , cheese , pizzas , and savory snacks were consumed rather infrequently in all the countries , but salt - rich foods , such as soups or bread and salty condiments , were consumed frequently in all countries ."
102734,but,O,3566.0,"Processed foods high in salt , such as processed meat , cheese , pizzas , and savory snacks were consumed rather infrequently in all the countries , but salt - rich foods , such as soups or bread and salty condiments , were consumed frequently in all countries ."
102735,salt,B-AG.01,3566.0,"Processed foods high in salt , such as processed meat , cheese , pizzas , and savory snacks were consumed rather infrequently in all the countries , but salt - rich foods , such as soups or bread and salty condiments , were consumed frequently in all countries ."
102736,-,I-AG.01,3566.0,"Processed foods high in salt , such as processed meat , cheese , pizzas , and savory snacks were consumed rather infrequently in all the countries , but salt - rich foods , such as soups or bread and salty condiments , were consumed frequently in all countries ."
102737,rich,I-AG.01,3566.0,"Processed foods high in salt , such as processed meat , cheese , pizzas , and savory snacks were consumed rather infrequently in all the countries , but salt - rich foods , such as soups or bread and salty condiments , were consumed frequently in all countries ."
102738,foods,I-AG.01,3566.0,"Processed foods high in salt , such as processed meat , cheese , pizzas , and savory snacks were consumed rather infrequently in all the countries , but salt - rich foods , such as soups or bread and salty condiments , were consumed frequently in all countries ."
102739,",",O,3566.0,"Processed foods high in salt , such as processed meat , cheese , pizzas , and savory snacks were consumed rather infrequently in all the countries , but salt - rich foods , such as soups or bread and salty condiments , were consumed frequently in all countries ."
102740,such,O,3566.0,"Processed foods high in salt , such as processed meat , cheese , pizzas , and savory snacks were consumed rather infrequently in all the countries , but salt - rich foods , such as soups or bread and salty condiments , were consumed frequently in all countries ."
102741,as,O,3566.0,"Processed foods high in salt , such as processed meat , cheese , pizzas , and savory snacks were consumed rather infrequently in all the countries , but salt - rich foods , such as soups or bread and salty condiments , were consumed frequently in all countries ."
102742,soups,B-AG.01.n.02,3566.0,"Processed foods high in salt , such as processed meat , cheese , pizzas , and savory snacks were consumed rather infrequently in all the countries , but salt - rich foods , such as soups or bread and salty condiments , were consumed frequently in all countries ."
102743,or,O,3566.0,"Processed foods high in salt , such as processed meat , cheese , pizzas , and savory snacks were consumed rather infrequently in all the countries , but salt - rich foods , such as soups or bread and salty condiments , were consumed frequently in all countries ."
102744,bread,B-AG.01.n.11,3566.0,"Processed foods high in salt , such as processed meat , cheese , pizzas , and savory snacks were consumed rather infrequently in all the countries , but salt - rich foods , such as soups or bread and salty condiments , were consumed frequently in all countries ."
102745,and,O,3566.0,"Processed foods high in salt , such as processed meat , cheese , pizzas , and savory snacks were consumed rather infrequently in all the countries , but salt - rich foods , such as soups or bread and salty condiments , were consumed frequently in all countries ."
102746,salty,B-AG.01.l,3566.0,"Processed foods high in salt , such as processed meat , cheese , pizzas , and savory snacks were consumed rather infrequently in all the countries , but salt - rich foods , such as soups or bread and salty condiments , were consumed frequently in all countries ."
102747,condiments,I-AG.01.l,3566.0,"Processed foods high in salt , such as processed meat , cheese , pizzas , and savory snacks were consumed rather infrequently in all the countries , but salt - rich foods , such as soups or bread and salty condiments , were consumed frequently in all countries ."
102748,",",O,3566.0,"Processed foods high in salt , such as processed meat , cheese , pizzas , and savory snacks were consumed rather infrequently in all the countries , but salt - rich foods , such as soups or bread and salty condiments , were consumed frequently in all countries ."
102749,were,O,3566.0,"Processed foods high in salt , such as processed meat , cheese , pizzas , and savory snacks were consumed rather infrequently in all the countries , but salt - rich foods , such as soups or bread and salty condiments , were consumed frequently in all countries ."
102750,consumed,O,3566.0,"Processed foods high in salt , such as processed meat , cheese , pizzas , and savory snacks were consumed rather infrequently in all the countries , but salt - rich foods , such as soups or bread and salty condiments , were consumed frequently in all countries ."
102751,frequently,O,3566.0,"Processed foods high in salt , such as processed meat , cheese , pizzas , and savory snacks were consumed rather infrequently in all the countries , but salt - rich foods , such as soups or bread and salty condiments , were consumed frequently in all countries ."
102752,in,O,3566.0,"Processed foods high in salt , such as processed meat , cheese , pizzas , and savory snacks were consumed rather infrequently in all the countries , but salt - rich foods , such as soups or bread and salty condiments , were consumed frequently in all countries ."
102753,all,O,3566.0,"Processed foods high in salt , such as processed meat , cheese , pizzas , and savory snacks were consumed rather infrequently in all the countries , but salt - rich foods , such as soups or bread and salty condiments , were consumed frequently in all countries ."
102754,countries,O,3566.0,"Processed foods high in salt , such as processed meat , cheese , pizzas , and savory snacks were consumed rather infrequently in all the countries , but salt - rich foods , such as soups or bread and salty condiments , were consumed frequently in all countries ."
102755,.,O,3566.0,"Processed foods high in salt , such as processed meat , cheese , pizzas , and savory snacks were consumed rather infrequently in all the countries , but salt - rich foods , such as soups or bread and salty condiments , were consumed frequently in all countries ."
102756,The,O,3567.0,The majority of the participants knew that high salt intake can cause health problems ( 85 % ) and thought that it is important to limit salt intake ( 91 % ) .
102757,majority,O,3567.0,The majority of the participants knew that high salt intake can cause health problems ( 85 % ) and thought that it is important to limit salt intake ( 91 % ) .
102758,of,O,3567.0,The majority of the participants knew that high salt intake can cause health problems ( 85 % ) and thought that it is important to limit salt intake ( 91 % ) .
102759,the,O,3567.0,The majority of the participants knew that high salt intake can cause health problems ( 85 % ) and thought that it is important to limit salt intake ( 91 % ) .
102760,participants,O,3567.0,The majority of the participants knew that high salt intake can cause health problems ( 85 % ) and thought that it is important to limit salt intake ( 91 % ) .
102761,knew,O,3567.0,The majority of the participants knew that high salt intake can cause health problems ( 85 % ) and thought that it is important to limit salt intake ( 91 % ) .
102762,that,O,3567.0,The majority of the participants knew that high salt intake can cause health problems ( 85 % ) and thought that it is important to limit salt intake ( 91 % ) .
102763,high,O,3567.0,The majority of the participants knew that high salt intake can cause health problems ( 85 % ) and thought that it is important to limit salt intake ( 91 % ) .
102764,salt,B-AG.01.l.01,3567.0,The majority of the participants knew that high salt intake can cause health problems ( 85 % ) and thought that it is important to limit salt intake ( 91 % ) .
102765,intake,B-X,3567.0,The majority of the participants knew that high salt intake can cause health problems ( 85 % ) and thought that it is important to limit salt intake ( 91 % ) .
102766,can,O,3567.0,The majority of the participants knew that high salt intake can cause health problems ( 85 % ) and thought that it is important to limit salt intake ( 91 % ) .
102767,cause,O,3567.0,The majority of the participants knew that high salt intake can cause health problems ( 85 % ) and thought that it is important to limit salt intake ( 91 % ) .
102768,health,O,3567.0,The majority of the participants knew that high salt intake can cause health problems ( 85 % ) and thought that it is important to limit salt intake ( 91 % ) .
102769,problems,O,3567.0,The majority of the participants knew that high salt intake can cause health problems ( 85 % ) and thought that it is important to limit salt intake ( 91 % ) .
102770,(,O,3567.0,The majority of the participants knew that high salt intake can cause health problems ( 85 % ) and thought that it is important to limit salt intake ( 91 % ) .
102771,85,O,3567.0,The majority of the participants knew that high salt intake can cause health problems ( 85 % ) and thought that it is important to limit salt intake ( 91 % ) .
102772,%,O,3567.0,The majority of the participants knew that high salt intake can cause health problems ( 85 % ) and thought that it is important to limit salt intake ( 91 % ) .
102773,),O,3567.0,The majority of the participants knew that high salt intake can cause health problems ( 85 % ) and thought that it is important to limit salt intake ( 91 % ) .
102774,and,O,3567.0,The majority of the participants knew that high salt intake can cause health problems ( 85 % ) and thought that it is important to limit salt intake ( 91 % ) .
102775,thought,O,3567.0,The majority of the participants knew that high salt intake can cause health problems ( 85 % ) and thought that it is important to limit salt intake ( 91 % ) .
102776,that,O,3567.0,The majority of the participants knew that high salt intake can cause health problems ( 85 % ) and thought that it is important to limit salt intake ( 91 % ) .
102777,it,O,3567.0,The majority of the participants knew that high salt intake can cause health problems ( 85 % ) and thought that it is important to limit salt intake ( 91 % ) .
102778,is,O,3567.0,The majority of the participants knew that high salt intake can cause health problems ( 85 % ) and thought that it is important to limit salt intake ( 91 % ) .
102779,important,O,3567.0,The majority of the participants knew that high salt intake can cause health problems ( 85 % ) and thought that it is important to limit salt intake ( 91 % ) .
102780,to,O,3567.0,The majority of the participants knew that high salt intake can cause health problems ( 85 % ) and thought that it is important to limit salt intake ( 91 % ) .
102781,limit,O,3567.0,The majority of the participants knew that high salt intake can cause health problems ( 85 % ) and thought that it is important to limit salt intake ( 91 % ) .
102782,salt,B-AG.01.l.01,3567.0,The majority of the participants knew that high salt intake can cause health problems ( 85 % ) and thought that it is important to limit salt intake ( 91 % ) .
102783,intake,B-X,3567.0,The majority of the participants knew that high salt intake can cause health problems ( 85 % ) and thought that it is important to limit salt intake ( 91 % ) .
102784,(,O,3567.0,The majority of the participants knew that high salt intake can cause health problems ( 85 % ) and thought that it is important to limit salt intake ( 91 % ) .
102785,91,O,3567.0,The majority of the participants knew that high salt intake can cause health problems ( 85 % ) and thought that it is important to limit salt intake ( 91 % ) .
102786,%,O,3567.0,The majority of the participants knew that high salt intake can cause health problems ( 85 % ) and thought that it is important to limit salt intake ( 91 % ) .
102787,),O,3567.0,The majority of the participants knew that high salt intake can cause health problems ( 85 % ) and thought that it is important to limit salt intake ( 91 % ) .
102788,.,O,3567.0,The majority of the participants knew that high salt intake can cause health problems ( 85 % ) and thought that it is important to limit salt intake ( 91 % ) .
102789,However,O,3568.0,"However , slightly over half ( 56 % ) of the respondents regularly tried to limit their salt intake while only 8 % of the respondents thought that they consumed too much salt ."
102790,",",O,3568.0,"However , slightly over half ( 56 % ) of the respondents regularly tried to limit their salt intake while only 8 % of the respondents thought that they consumed too much salt ."
102791,slightly,O,3568.0,"However , slightly over half ( 56 % ) of the respondents regularly tried to limit their salt intake while only 8 % of the respondents thought that they consumed too much salt ."
102792,over,O,3568.0,"However , slightly over half ( 56 % ) of the respondents regularly tried to limit their salt intake while only 8 % of the respondents thought that they consumed too much salt ."
102793,half,O,3568.0,"However , slightly over half ( 56 % ) of the respondents regularly tried to limit their salt intake while only 8 % of the respondents thought that they consumed too much salt ."
102794,(,O,3568.0,"However , slightly over half ( 56 % ) of the respondents regularly tried to limit their salt intake while only 8 % of the respondents thought that they consumed too much salt ."
102795,56,O,3568.0,"However , slightly over half ( 56 % ) of the respondents regularly tried to limit their salt intake while only 8 % of the respondents thought that they consumed too much salt ."
102796,%,O,3568.0,"However , slightly over half ( 56 % ) of the respondents regularly tried to limit their salt intake while only 8 % of the respondents thought that they consumed too much salt ."
102797,),O,3568.0,"However , slightly over half ( 56 % ) of the respondents regularly tried to limit their salt intake while only 8 % of the respondents thought that they consumed too much salt ."
102798,of,O,3568.0,"However , slightly over half ( 56 % ) of the respondents regularly tried to limit their salt intake while only 8 % of the respondents thought that they consumed too much salt ."
102799,the,O,3568.0,"However , slightly over half ( 56 % ) of the respondents regularly tried to limit their salt intake while only 8 % of the respondents thought that they consumed too much salt ."
102800,respondents,O,3568.0,"However , slightly over half ( 56 % ) of the respondents regularly tried to limit their salt intake while only 8 % of the respondents thought that they consumed too much salt ."
102801,regularly,O,3568.0,"However , slightly over half ( 56 % ) of the respondents regularly tried to limit their salt intake while only 8 % of the respondents thought that they consumed too much salt ."
102802,tried,O,3568.0,"However , slightly over half ( 56 % ) of the respondents regularly tried to limit their salt intake while only 8 % of the respondents thought that they consumed too much salt ."
102803,to,O,3568.0,"However , slightly over half ( 56 % ) of the respondents regularly tried to limit their salt intake while only 8 % of the respondents thought that they consumed too much salt ."
102804,limit,O,3568.0,"However , slightly over half ( 56 % ) of the respondents regularly tried to limit their salt intake while only 8 % of the respondents thought that they consumed too much salt ."
102805,their,O,3568.0,"However , slightly over half ( 56 % ) of the respondents regularly tried to limit their salt intake while only 8 % of the respondents thought that they consumed too much salt ."
102806,salt,B-AG.01.l.01,3568.0,"However , slightly over half ( 56 % ) of the respondents regularly tried to limit their salt intake while only 8 % of the respondents thought that they consumed too much salt ."
102807,intake,B-X,3568.0,"However , slightly over half ( 56 % ) of the respondents regularly tried to limit their salt intake while only 8 % of the respondents thought that they consumed too much salt ."
102808,while,O,3568.0,"However , slightly over half ( 56 % ) of the respondents regularly tried to limit their salt intake while only 8 % of the respondents thought that they consumed too much salt ."
102809,only,O,3568.0,"However , slightly over half ( 56 % ) of the respondents regularly tried to limit their salt intake while only 8 % of the respondents thought that they consumed too much salt ."
102810,8,O,3568.0,"However , slightly over half ( 56 % ) of the respondents regularly tried to limit their salt intake while only 8 % of the respondents thought that they consumed too much salt ."
102811,%,O,3568.0,"However , slightly over half ( 56 % ) of the respondents regularly tried to limit their salt intake while only 8 % of the respondents thought that they consumed too much salt ."
102812,of,O,3568.0,"However , slightly over half ( 56 % ) of the respondents regularly tried to limit their salt intake while only 8 % of the respondents thought that they consumed too much salt ."
102813,the,O,3568.0,"However , slightly over half ( 56 % ) of the respondents regularly tried to limit their salt intake while only 8 % of the respondents thought that they consumed too much salt ."
102814,respondents,O,3568.0,"However , slightly over half ( 56 % ) of the respondents regularly tried to limit their salt intake while only 8 % of the respondents thought that they consumed too much salt ."
102815,thought,O,3568.0,"However , slightly over half ( 56 % ) of the respondents regularly tried to limit their salt intake while only 8 % of the respondents thought that they consumed too much salt ."
102816,that,O,3568.0,"However , slightly over half ( 56 % ) of the respondents regularly tried to limit their salt intake while only 8 % of the respondents thought that they consumed too much salt ."
102817,they,O,3568.0,"However , slightly over half ( 56 % ) of the respondents regularly tried to limit their salt intake while only 8 % of the respondents thought that they consumed too much salt ."
102818,consumed,O,3568.0,"However , slightly over half ( 56 % ) of the respondents regularly tried to limit their salt intake while only 8 % of the respondents thought that they consumed too much salt ."
102819,too,O,3568.0,"However , slightly over half ( 56 % ) of the respondents regularly tried to limit their salt intake while only 8 % of the respondents thought that they consumed too much salt ."
102820,much,O,3568.0,"However , slightly over half ( 56 % ) of the respondents regularly tried to limit their salt intake while only 8 % of the respondents thought that they consumed too much salt ."
102821,salt,B-AG.01.l.01,3568.0,"However , slightly over half ( 56 % ) of the respondents regularly tried to limit their salt intake while only 8 % of the respondents thought that they consumed too much salt ."
102822,.,O,3568.0,"However , slightly over half ( 56 % ) of the respondents regularly tried to limit their salt intake while only 8 % of the respondents thought that they consumed too much salt ."
102823,Salt,B-AG.01.l.01,3569.0,"Salt and salty condiments were added most of the time during cooking ( 92 % and 64 % , respectively ) but rarely at the table ( 11 % ) ."
102824,and,O,3569.0,"Salt and salty condiments were added most of the time during cooking ( 92 % and 64 % , respectively ) but rarely at the table ( 11 % ) ."
102825,salty,B-AG.01.l,3569.0,"Salt and salty condiments were added most of the time during cooking ( 92 % and 64 % , respectively ) but rarely at the table ( 11 % ) ."
102826,condiments,I-AG.01.l,3569.0,"Salt and salty condiments were added most of the time during cooking ( 92 % and 64 % , respectively ) but rarely at the table ( 11 % ) ."
102827,were,O,3569.0,"Salt and salty condiments were added most of the time during cooking ( 92 % and 64 % , respectively ) but rarely at the table ( 11 % ) ."
102828,added,O,3569.0,"Salt and salty condiments were added most of the time during cooking ( 92 % and 64 % , respectively ) but rarely at the table ( 11 % ) ."
102829,most,O,3569.0,"Salt and salty condiments were added most of the time during cooking ( 92 % and 64 % , respectively ) but rarely at the table ( 11 % ) ."
102830,of,O,3569.0,"Salt and salty condiments were added most of the time during cooking ( 92 % and 64 % , respectively ) but rarely at the table ( 11 % ) ."
102831,the,O,3569.0,"Salt and salty condiments were added most of the time during cooking ( 92 % and 64 % , respectively ) but rarely at the table ( 11 % ) ."
102832,time,O,3569.0,"Salt and salty condiments were added most of the time during cooking ( 92 % and 64 % , respectively ) but rarely at the table ( 11 % ) ."
102833,during,O,3569.0,"Salt and salty condiments were added most of the time during cooking ( 92 % and 64 % , respectively ) but rarely at the table ( 11 % ) ."
102834,cooking,O,3569.0,"Salt and salty condiments were added most of the time during cooking ( 92 % and 64 % , respectively ) but rarely at the table ( 11 % ) ."
102835,(,O,3569.0,"Salt and salty condiments were added most of the time during cooking ( 92 % and 64 % , respectively ) but rarely at the table ( 11 % ) ."
102836,92,O,3569.0,"Salt and salty condiments were added most of the time during cooking ( 92 % and 64 % , respectively ) but rarely at the table ( 11 % ) ."
102837,%,O,3569.0,"Salt and salty condiments were added most of the time during cooking ( 92 % and 64 % , respectively ) but rarely at the table ( 11 % ) ."
102838,and,O,3569.0,"Salt and salty condiments were added most of the time during cooking ( 92 % and 64 % , respectively ) but rarely at the table ( 11 % ) ."
102839,64,O,3569.0,"Salt and salty condiments were added most of the time during cooking ( 92 % and 64 % , respectively ) but rarely at the table ( 11 % ) ."
102840,%,O,3569.0,"Salt and salty condiments were added most of the time during cooking ( 92 % and 64 % , respectively ) but rarely at the table ( 11 % ) ."
102841,",",O,3569.0,"Salt and salty condiments were added most of the time during cooking ( 92 % and 64 % , respectively ) but rarely at the table ( 11 % ) ."
102842,respectively,O,3569.0,"Salt and salty condiments were added most of the time during cooking ( 92 % and 64 % , respectively ) but rarely at the table ( 11 % ) ."
102843,),O,3569.0,"Salt and salty condiments were added most of the time during cooking ( 92 % and 64 % , respectively ) but rarely at the table ( 11 % ) ."
102844,but,O,3569.0,"Salt and salty condiments were added most of the time during cooking ( 92 % and 64 % , respectively ) but rarely at the table ( 11 % ) ."
102845,rarely,O,3569.0,"Salt and salty condiments were added most of the time during cooking ( 92 % and 64 % , respectively ) but rarely at the table ( 11 % ) ."
102846,at,O,3569.0,"Salt and salty condiments were added most of the time during cooking ( 92 % and 64 % , respectively ) but rarely at the table ( 11 % ) ."
102847,the,O,3569.0,"Salt and salty condiments were added most of the time during cooking ( 92 % and 64 % , respectively ) but rarely at the table ( 11 % ) ."
102848,table,O,3569.0,"Salt and salty condiments were added most of the time during cooking ( 92 % and 64 % , respectively ) but rarely at the table ( 11 % ) ."
102849,(,O,3569.0,"Salt and salty condiments were added most of the time during cooking ( 92 % and 64 % , respectively ) but rarely at the table ( 11 % ) ."
102850,11,O,3569.0,"Salt and salty condiments were added most of the time during cooking ( 92 % and 64 % , respectively ) but rarely at the table ( 11 % ) ."
102851,%,O,3569.0,"Salt and salty condiments were added most of the time during cooking ( 92 % and 64 % , respectively ) but rarely at the table ( 11 % ) ."
102852,),O,3569.0,"Salt and salty condiments were added most of the time during cooking ( 92 % and 64 % , respectively ) but rarely at the table ( 11 % ) ."
102853,.,O,3569.0,"Salt and salty condiments were added most of the time during cooking ( 92 % and 64 % , respectively ) but rarely at the table ( 11 % ) ."
102854,These,O,3570.0,These findings support the need for education campaigns to reduce salt added during cooking and for strategies to reduce salt content in selected manufactured foods in the region .
102855,findings,O,3570.0,These findings support the need for education campaigns to reduce salt added during cooking and for strategies to reduce salt content in selected manufactured foods in the region .
102856,support,O,3570.0,These findings support the need for education campaigns to reduce salt added during cooking and for strategies to reduce salt content in selected manufactured foods in the region .
102857,the,O,3570.0,These findings support the need for education campaigns to reduce salt added during cooking and for strategies to reduce salt content in selected manufactured foods in the region .
102858,need,O,3570.0,These findings support the need for education campaigns to reduce salt added during cooking and for strategies to reduce salt content in selected manufactured foods in the region .
102859,for,O,3570.0,These findings support the need for education campaigns to reduce salt added during cooking and for strategies to reduce salt content in selected manufactured foods in the region .
102860,education,O,3570.0,These findings support the need for education campaigns to reduce salt added during cooking and for strategies to reduce salt content in selected manufactured foods in the region .
102861,campaigns,O,3570.0,These findings support the need for education campaigns to reduce salt added during cooking and for strategies to reduce salt content in selected manufactured foods in the region .
102862,to,O,3570.0,These findings support the need for education campaigns to reduce salt added during cooking and for strategies to reduce salt content in selected manufactured foods in the region .
102863,reduce,O,3570.0,These findings support the need for education campaigns to reduce salt added during cooking and for strategies to reduce salt content in selected manufactured foods in the region .
102864,salt,B-AG.01.l.01,3570.0,These findings support the need for education campaigns to reduce salt added during cooking and for strategies to reduce salt content in selected manufactured foods in the region .
102865,added,O,3570.0,These findings support the need for education campaigns to reduce salt added during cooking and for strategies to reduce salt content in selected manufactured foods in the region .
102866,during,O,3570.0,These findings support the need for education campaigns to reduce salt added during cooking and for strategies to reduce salt content in selected manufactured foods in the region .
102867,cooking,O,3570.0,These findings support the need for education campaigns to reduce salt added during cooking and for strategies to reduce salt content in selected manufactured foods in the region .
102868,and,O,3570.0,These findings support the need for education campaigns to reduce salt added during cooking and for strategies to reduce salt content in selected manufactured foods in the region .
102869,for,O,3570.0,These findings support the need for education campaigns to reduce salt added during cooking and for strategies to reduce salt content in selected manufactured foods in the region .
102870,strategies,O,3570.0,These findings support the need for education campaigns to reduce salt added during cooking and for strategies to reduce salt content in selected manufactured foods in the region .
102871,to,O,3570.0,These findings support the need for education campaigns to reduce salt added during cooking and for strategies to reduce salt content in selected manufactured foods in the region .
102872,reduce,O,3570.0,These findings support the need for education campaigns to reduce salt added during cooking and for strategies to reduce salt content in selected manufactured foods in the region .
102873,salt,B-AG.01.l.01,3570.0,These findings support the need for education campaigns to reduce salt added during cooking and for strategies to reduce salt content in selected manufactured foods in the region .
102874,content,O,3570.0,These findings support the need for education campaigns to reduce salt added during cooking and for strategies to reduce salt content in selected manufactured foods in the region .
102875,in,O,3570.0,These findings support the need for education campaigns to reduce salt added during cooking and for strategies to reduce salt content in selected manufactured foods in the region .
102876,selected,O,3570.0,These findings support the need for education campaigns to reduce salt added during cooking and for strategies to reduce salt content in selected manufactured foods in the region .
102877,manufactured,O,3570.0,These findings support the need for education campaigns to reduce salt added during cooking and for strategies to reduce salt content in selected manufactured foods in the region .
102878,foods,O,3570.0,These findings support the need for education campaigns to reduce salt added during cooking and for strategies to reduce salt content in selected manufactured foods in the region .
102879,in,O,3570.0,These findings support the need for education campaigns to reduce salt added during cooking and for strategies to reduce salt content in selected manufactured foods in the region .
102880,the,O,3570.0,These findings support the need for education campaigns to reduce salt added during cooking and for strategies to reduce salt content in selected manufactured foods in the region .
102881,region,O,3570.0,These findings support the need for education campaigns to reduce salt added during cooking and for strategies to reduce salt content in selected manufactured foods in the region .
102882,.,O,3570.0,These findings support the need for education campaigns to reduce salt added during cooking and for strategies to reduce salt content in selected manufactured foods in the region .
102883,Here,O,3571.0,"Here , we combined magnetic resonance imaging with lesion - symptom mapping in patients with chronic brain lesions to investigate brain representations of sugar and fat perception ."
102884,",",O,3571.0,"Here , we combined magnetic resonance imaging with lesion - symptom mapping in patients with chronic brain lesions to investigate brain representations of sugar and fat perception ."
102885,we,O,3571.0,"Here , we combined magnetic resonance imaging with lesion - symptom mapping in patients with chronic brain lesions to investigate brain representations of sugar and fat perception ."
102886,combined,O,3571.0,"Here , we combined magnetic resonance imaging with lesion - symptom mapping in patients with chronic brain lesions to investigate brain representations of sugar and fat perception ."
102887,magnetic,O,3571.0,"Here , we combined magnetic resonance imaging with lesion - symptom mapping in patients with chronic brain lesions to investigate brain representations of sugar and fat perception ."
102888,resonance,O,3571.0,"Here , we combined magnetic resonance imaging with lesion - symptom mapping in patients with chronic brain lesions to investigate brain representations of sugar and fat perception ."
102889,imaging,O,3571.0,"Here , we combined magnetic resonance imaging with lesion - symptom mapping in patients with chronic brain lesions to investigate brain representations of sugar and fat perception ."
102890,with,O,3571.0,"Here , we combined magnetic resonance imaging with lesion - symptom mapping in patients with chronic brain lesions to investigate brain representations of sugar and fat perception ."
102891,lesion,O,3571.0,"Here , we combined magnetic resonance imaging with lesion - symptom mapping in patients with chronic brain lesions to investigate brain representations of sugar and fat perception ."
102892,-,O,3571.0,"Here , we combined magnetic resonance imaging with lesion - symptom mapping in patients with chronic brain lesions to investigate brain representations of sugar and fat perception ."
102893,symptom,O,3571.0,"Here , we combined magnetic resonance imaging with lesion - symptom mapping in patients with chronic brain lesions to investigate brain representations of sugar and fat perception ."
102894,mapping,O,3571.0,"Here , we combined magnetic resonance imaging with lesion - symptom mapping in patients with chronic brain lesions to investigate brain representations of sugar and fat perception ."
102895,in,O,3571.0,"Here , we combined magnetic resonance imaging with lesion - symptom mapping in patients with chronic brain lesions to investigate brain representations of sugar and fat perception ."
102896,patients,O,3571.0,"Here , we combined magnetic resonance imaging with lesion - symptom mapping in patients with chronic brain lesions to investigate brain representations of sugar and fat perception ."
102897,with,O,3571.0,"Here , we combined magnetic resonance imaging with lesion - symptom mapping in patients with chronic brain lesions to investigate brain representations of sugar and fat perception ."
102898,chronic,O,3571.0,"Here , we combined magnetic resonance imaging with lesion - symptom mapping in patients with chronic brain lesions to investigate brain representations of sugar and fat perception ."
102899,brain,O,3571.0,"Here , we combined magnetic resonance imaging with lesion - symptom mapping in patients with chronic brain lesions to investigate brain representations of sugar and fat perception ."
102900,lesions,O,3571.0,"Here , we combined magnetic resonance imaging with lesion - symptom mapping in patients with chronic brain lesions to investigate brain representations of sugar and fat perception ."
102901,to,O,3571.0,"Here , we combined magnetic resonance imaging with lesion - symptom mapping in patients with chronic brain lesions to investigate brain representations of sugar and fat perception ."
102902,investigate,O,3571.0,"Here , we combined magnetic resonance imaging with lesion - symptom mapping in patients with chronic brain lesions to investigate brain representations of sugar and fat perception ."
102903,brain,O,3571.0,"Here , we combined magnetic resonance imaging with lesion - symptom mapping in patients with chronic brain lesions to investigate brain representations of sugar and fat perception ."
102904,representations,O,3571.0,"Here , we combined magnetic resonance imaging with lesion - symptom mapping in patients with chronic brain lesions to investigate brain representations of sugar and fat perception ."
102905,of,O,3571.0,"Here , we combined magnetic resonance imaging with lesion - symptom mapping in patients with chronic brain lesions to investigate brain representations of sugar and fat perception ."
102906,sugar,O,3571.0,"Here , we combined magnetic resonance imaging with lesion - symptom mapping in patients with chronic brain lesions to investigate brain representations of sugar and fat perception ."
102907,and,O,3571.0,"Here , we combined magnetic resonance imaging with lesion - symptom mapping in patients with chronic brain lesions to investigate brain representations of sugar and fat perception ."
102908,fat,O,3571.0,"Here , we combined magnetic resonance imaging with lesion - symptom mapping in patients with chronic brain lesions to investigate brain representations of sugar and fat perception ."
102909,perception,O,3571.0,"Here , we combined magnetic resonance imaging with lesion - symptom mapping in patients with chronic brain lesions to investigate brain representations of sugar and fat perception ."
102910,.,O,3571.0,"Here , we combined magnetic resonance imaging with lesion - symptom mapping in patients with chronic brain lesions to investigate brain representations of sugar and fat perception ."
102911,Patients,O,3572.0,Patients and healthy controls rated chocolate milkshakes that only differed in sugar or fat content .
102912,and,O,3572.0,Patients and healthy controls rated chocolate milkshakes that only differed in sugar or fat content .
102913,healthy,O,3572.0,Patients and healthy controls rated chocolate milkshakes that only differed in sugar or fat content .
102914,controls,O,3572.0,Patients and healthy controls rated chocolate milkshakes that only differed in sugar or fat content .
102915,rated,O,3572.0,Patients and healthy controls rated chocolate milkshakes that only differed in sugar or fat content .
102916,chocolate,B-AG.01.e,3572.0,Patients and healthy controls rated chocolate milkshakes that only differed in sugar or fat content .
102917,milkshakes,I-AG.01.e,3572.0,Patients and healthy controls rated chocolate milkshakes that only differed in sugar or fat content .
102918,that,O,3572.0,Patients and healthy controls rated chocolate milkshakes that only differed in sugar or fat content .
102919,only,O,3572.0,Patients and healthy controls rated chocolate milkshakes that only differed in sugar or fat content .
102920,differed,O,3572.0,Patients and healthy controls rated chocolate milkshakes that only differed in sugar or fat content .
102921,in,O,3572.0,Patients and healthy controls rated chocolate milkshakes that only differed in sugar or fat content .
102922,sugar,O,3572.0,Patients and healthy controls rated chocolate milkshakes that only differed in sugar or fat content .
102923,or,O,3572.0,Patients and healthy controls rated chocolate milkshakes that only differed in sugar or fat content .
102924,fat,O,3572.0,Patients and healthy controls rated chocolate milkshakes that only differed in sugar or fat content .
102925,content,O,3572.0,Patients and healthy controls rated chocolate milkshakes that only differed in sugar or fat content .
102926,.,O,3572.0,Patients and healthy controls rated chocolate milkshakes that only differed in sugar or fat content .
102927,As,O,3573.0,"As compared to controls , patients showed an impaired fat , but not sugar perception ."
102928,compared,O,3573.0,"As compared to controls , patients showed an impaired fat , but not sugar perception ."
102929,to,O,3573.0,"As compared to controls , patients showed an impaired fat , but not sugar perception ."
102930,controls,O,3573.0,"As compared to controls , patients showed an impaired fat , but not sugar perception ."
102931,",",O,3573.0,"As compared to controls , patients showed an impaired fat , but not sugar perception ."
102932,patients,O,3573.0,"As compared to controls , patients showed an impaired fat , but not sugar perception ."
102933,showed,O,3573.0,"As compared to controls , patients showed an impaired fat , but not sugar perception ."
102934,an,O,3573.0,"As compared to controls , patients showed an impaired fat , but not sugar perception ."
102935,impaired,O,3573.0,"As compared to controls , patients showed an impaired fat , but not sugar perception ."
102936,fat,O,3573.0,"As compared to controls , patients showed an impaired fat , but not sugar perception ."
102937,",",O,3573.0,"As compared to controls , patients showed an impaired fat , but not sugar perception ."
102938,but,O,3573.0,"As compared to controls , patients showed an impaired fat , but not sugar perception ."
102939,not,O,3573.0,"As compared to controls , patients showed an impaired fat , but not sugar perception ."
102940,sugar,O,3573.0,"As compared to controls , patients showed an impaired fat , but not sugar perception ."
102941,perception,O,3573.0,"As compared to controls , patients showed an impaired fat , but not sugar perception ."
102942,.,O,3573.0,"As compared to controls , patients showed an impaired fat , but not sugar perception ."
102943,Impairments,O,3574.0,"Impairments in fat perception overlapped with the anterior insula and frontal operculum , together assumed to underpin gustatory processing ."
102944,in,O,3574.0,"Impairments in fat perception overlapped with the anterior insula and frontal operculum , together assumed to underpin gustatory processing ."
102945,fat,O,3574.0,"Impairments in fat perception overlapped with the anterior insula and frontal operculum , together assumed to underpin gustatory processing ."
102946,perception,O,3574.0,"Impairments in fat perception overlapped with the anterior insula and frontal operculum , together assumed to underpin gustatory processing ."
102947,overlapped,O,3574.0,"Impairments in fat perception overlapped with the anterior insula and frontal operculum , together assumed to underpin gustatory processing ."
102948,with,O,3574.0,"Impairments in fat perception overlapped with the anterior insula and frontal operculum , together assumed to underpin gustatory processing ."
102949,the,O,3574.0,"Impairments in fat perception overlapped with the anterior insula and frontal operculum , together assumed to underpin gustatory processing ."
102950,anterior,O,3574.0,"Impairments in fat perception overlapped with the anterior insula and frontal operculum , together assumed to underpin gustatory processing ."
102951,insula,O,3574.0,"Impairments in fat perception overlapped with the anterior insula and frontal operculum , together assumed to underpin gustatory processing ."
102952,and,O,3574.0,"Impairments in fat perception overlapped with the anterior insula and frontal operculum , together assumed to underpin gustatory processing ."
102953,frontal,O,3574.0,"Impairments in fat perception overlapped with the anterior insula and frontal operculum , together assumed to underpin gustatory processing ."
102954,operculum,O,3574.0,"Impairments in fat perception overlapped with the anterior insula and frontal operculum , together assumed to underpin gustatory processing ."
102955,",",O,3574.0,"Impairments in fat perception overlapped with the anterior insula and frontal operculum , together assumed to underpin gustatory processing ."
102956,together,O,3574.0,"Impairments in fat perception overlapped with the anterior insula and frontal operculum , together assumed to underpin gustatory processing ."
102957,assumed,O,3574.0,"Impairments in fat perception overlapped with the anterior insula and frontal operculum , together assumed to underpin gustatory processing ."
102958,to,O,3574.0,"Impairments in fat perception overlapped with the anterior insula and frontal operculum , together assumed to underpin gustatory processing ."
102959,underpin,O,3574.0,"Impairments in fat perception overlapped with the anterior insula and frontal operculum , together assumed to underpin gustatory processing ."
102960,gustatory,O,3574.0,"Impairments in fat perception overlapped with the anterior insula and frontal operculum , together assumed to underpin gustatory processing ."
102961,processing,O,3574.0,"Impairments in fat perception overlapped with the anterior insula and frontal operculum , together assumed to underpin gustatory processing ."
102962,.,O,3574.0,"Impairments in fat perception overlapped with the anterior insula and frontal operculum , together assumed to underpin gustatory processing ."
102963,We,O,3575.0,We also identified the mid - dorsal insula as well as the primary and secondary somatosensory cortex - regions previously assumed to integrate oral - sensory inputs .
102964,also,O,3575.0,We also identified the mid - dorsal insula as well as the primary and secondary somatosensory cortex - regions previously assumed to integrate oral - sensory inputs .
102965,identified,O,3575.0,We also identified the mid - dorsal insula as well as the primary and secondary somatosensory cortex - regions previously assumed to integrate oral - sensory inputs .
102966,the,O,3575.0,We also identified the mid - dorsal insula as well as the primary and secondary somatosensory cortex - regions previously assumed to integrate oral - sensory inputs .
102967,mid,O,3575.0,We also identified the mid - dorsal insula as well as the primary and secondary somatosensory cortex - regions previously assumed to integrate oral - sensory inputs .
102968,-,O,3575.0,We also identified the mid - dorsal insula as well as the primary and secondary somatosensory cortex - regions previously assumed to integrate oral - sensory inputs .
102969,dorsal,O,3575.0,We also identified the mid - dorsal insula as well as the primary and secondary somatosensory cortex - regions previously assumed to integrate oral - sensory inputs .
102970,insula,O,3575.0,We also identified the mid - dorsal insula as well as the primary and secondary somatosensory cortex - regions previously assumed to integrate oral - sensory inputs .
102971,as,O,3575.0,We also identified the mid - dorsal insula as well as the primary and secondary somatosensory cortex - regions previously assumed to integrate oral - sensory inputs .
102972,well,O,3575.0,We also identified the mid - dorsal insula as well as the primary and secondary somatosensory cortex - regions previously assumed to integrate oral - sensory inputs .
102973,as,O,3575.0,We also identified the mid - dorsal insula as well as the primary and secondary somatosensory cortex - regions previously assumed to integrate oral - sensory inputs .
102974,the,O,3575.0,We also identified the mid - dorsal insula as well as the primary and secondary somatosensory cortex - regions previously assumed to integrate oral - sensory inputs .
102975,primary,O,3575.0,We also identified the mid - dorsal insula as well as the primary and secondary somatosensory cortex - regions previously assumed to integrate oral - sensory inputs .
102976,and,O,3575.0,We also identified the mid - dorsal insula as well as the primary and secondary somatosensory cortex - regions previously assumed to integrate oral - sensory inputs .
102977,secondary,O,3575.0,We also identified the mid - dorsal insula as well as the primary and secondary somatosensory cortex - regions previously assumed to integrate oral - sensory inputs .
102978,somatosensory,O,3575.0,We also identified the mid - dorsal insula as well as the primary and secondary somatosensory cortex - regions previously assumed to integrate oral - sensory inputs .
102979,cortex,O,3575.0,We also identified the mid - dorsal insula as well as the primary and secondary somatosensory cortex - regions previously assumed to integrate oral - sensory inputs .
102980,-,O,3575.0,We also identified the mid - dorsal insula as well as the primary and secondary somatosensory cortex - regions previously assumed to integrate oral - sensory inputs .
102981,regions,O,3575.0,We also identified the mid - dorsal insula as well as the primary and secondary somatosensory cortex - regions previously assumed to integrate oral - sensory inputs .
102982,previously,O,3575.0,We also identified the mid - dorsal insula as well as the primary and secondary somatosensory cortex - regions previously assumed to integrate oral - sensory inputs .
102983,assumed,O,3575.0,We also identified the mid - dorsal insula as well as the primary and secondary somatosensory cortex - regions previously assumed to integrate oral - sensory inputs .
102984,to,O,3575.0,We also identified the mid - dorsal insula as well as the primary and secondary somatosensory cortex - regions previously assumed to integrate oral - sensory inputs .
102985,integrate,O,3575.0,We also identified the mid - dorsal insula as well as the primary and secondary somatosensory cortex - regions previously assumed to integrate oral - sensory inputs .
102986,oral,O,3575.0,We also identified the mid - dorsal insula as well as the primary and secondary somatosensory cortex - regions previously assumed to integrate oral - sensory inputs .
102987,-,O,3575.0,We also identified the mid - dorsal insula as well as the primary and secondary somatosensory cortex - regions previously assumed to integrate oral - sensory inputs .
102988,sensory,O,3575.0,We also identified the mid - dorsal insula as well as the primary and secondary somatosensory cortex - regions previously assumed to integrate oral - sensory inputs .
102989,inputs,O,3575.0,We also identified the mid - dorsal insula as well as the primary and secondary somatosensory cortex - regions previously assumed to integrate oral - sensory inputs .
102990,.,O,3575.0,We also identified the mid - dorsal insula as well as the primary and secondary somatosensory cortex - regions previously assumed to integrate oral - sensory inputs .
102991,These,O,3576.0,These findings suggest that fat perception involves a specific set of brain regions that were previously reported to underpin gustatory processing and oral - sensory integration processes .
102992,findings,O,3576.0,These findings suggest that fat perception involves a specific set of brain regions that were previously reported to underpin gustatory processing and oral - sensory integration processes .
102993,suggest,O,3576.0,These findings suggest that fat perception involves a specific set of brain regions that were previously reported to underpin gustatory processing and oral - sensory integration processes .
102994,that,O,3576.0,These findings suggest that fat perception involves a specific set of brain regions that were previously reported to underpin gustatory processing and oral - sensory integration processes .
102995,fat,O,3576.0,These findings suggest that fat perception involves a specific set of brain regions that were previously reported to underpin gustatory processing and oral - sensory integration processes .
102996,perception,O,3576.0,These findings suggest that fat perception involves a specific set of brain regions that were previously reported to underpin gustatory processing and oral - sensory integration processes .
102997,involves,O,3576.0,These findings suggest that fat perception involves a specific set of brain regions that were previously reported to underpin gustatory processing and oral - sensory integration processes .
102998,a,O,3576.0,These findings suggest that fat perception involves a specific set of brain regions that were previously reported to underpin gustatory processing and oral - sensory integration processes .
102999,specific,O,3576.0,These findings suggest that fat perception involves a specific set of brain regions that were previously reported to underpin gustatory processing and oral - sensory integration processes .
103000,set,O,3576.0,These findings suggest that fat perception involves a specific set of brain regions that were previously reported to underpin gustatory processing and oral - sensory integration processes .
103001,of,O,3576.0,These findings suggest that fat perception involves a specific set of brain regions that were previously reported to underpin gustatory processing and oral - sensory integration processes .
103002,brain,O,3576.0,These findings suggest that fat perception involves a specific set of brain regions that were previously reported to underpin gustatory processing and oral - sensory integration processes .
103003,regions,O,3576.0,These findings suggest that fat perception involves a specific set of brain regions that were previously reported to underpin gustatory processing and oral - sensory integration processes .
103004,that,O,3576.0,These findings suggest that fat perception involves a specific set of brain regions that were previously reported to underpin gustatory processing and oral - sensory integration processes .
103005,were,O,3576.0,These findings suggest that fat perception involves a specific set of brain regions that were previously reported to underpin gustatory processing and oral - sensory integration processes .
103006,previously,O,3576.0,These findings suggest that fat perception involves a specific set of brain regions that were previously reported to underpin gustatory processing and oral - sensory integration processes .
103007,reported,O,3576.0,These findings suggest that fat perception involves a specific set of brain regions that were previously reported to underpin gustatory processing and oral - sensory integration processes .
103008,to,O,3576.0,These findings suggest that fat perception involves a specific set of brain regions that were previously reported to underpin gustatory processing and oral - sensory integration processes .
103009,underpin,O,3576.0,These findings suggest that fat perception involves a specific set of brain regions that were previously reported to underpin gustatory processing and oral - sensory integration processes .
103010,gustatory,O,3576.0,These findings suggest that fat perception involves a specific set of brain regions that were previously reported to underpin gustatory processing and oral - sensory integration processes .
103011,processing,O,3576.0,These findings suggest that fat perception involves a specific set of brain regions that were previously reported to underpin gustatory processing and oral - sensory integration processes .
103012,and,O,3576.0,These findings suggest that fat perception involves a specific set of brain regions that were previously reported to underpin gustatory processing and oral - sensory integration processes .
103013,oral,O,3576.0,These findings suggest that fat perception involves a specific set of brain regions that were previously reported to underpin gustatory processing and oral - sensory integration processes .
103014,-,O,3576.0,These findings suggest that fat perception involves a specific set of brain regions that were previously reported to underpin gustatory processing and oral - sensory integration processes .
103015,sensory,O,3576.0,These findings suggest that fat perception involves a specific set of brain regions that were previously reported to underpin gustatory processing and oral - sensory integration processes .
103016,integration,O,3576.0,These findings suggest that fat perception involves a specific set of brain regions that were previously reported to underpin gustatory processing and oral - sensory integration processes .
103017,processes,O,3576.0,These findings suggest that fat perception involves a specific set of brain regions that were previously reported to underpin gustatory processing and oral - sensory integration processes .
103018,.,O,3576.0,These findings suggest that fat perception involves a specific set of brain regions that were previously reported to underpin gustatory processing and oral - sensory integration processes .
103019,Dietary,O,3577.0,"Dietary intakes of B vitamins and other components involved in one - carbon metabolism , which is necessary for DNA replication , DNA repair , and regulation of gene expression , may be associated with carcinogenesis ."
103020,intakes,O,3577.0,"Dietary intakes of B vitamins and other components involved in one - carbon metabolism , which is necessary for DNA replication , DNA repair , and regulation of gene expression , may be associated with carcinogenesis ."
103021,of,O,3577.0,"Dietary intakes of B vitamins and other components involved in one - carbon metabolism , which is necessary for DNA replication , DNA repair , and regulation of gene expression , may be associated with carcinogenesis ."
103022,B,O,3577.0,"Dietary intakes of B vitamins and other components involved in one - carbon metabolism , which is necessary for DNA replication , DNA repair , and regulation of gene expression , may be associated with carcinogenesis ."
103023,vitamins,O,3577.0,"Dietary intakes of B vitamins and other components involved in one - carbon metabolism , which is necessary for DNA replication , DNA repair , and regulation of gene expression , may be associated with carcinogenesis ."
103024,and,O,3577.0,"Dietary intakes of B vitamins and other components involved in one - carbon metabolism , which is necessary for DNA replication , DNA repair , and regulation of gene expression , may be associated with carcinogenesis ."
103025,other,O,3577.0,"Dietary intakes of B vitamins and other components involved in one - carbon metabolism , which is necessary for DNA replication , DNA repair , and regulation of gene expression , may be associated with carcinogenesis ."
103026,components,O,3577.0,"Dietary intakes of B vitamins and other components involved in one - carbon metabolism , which is necessary for DNA replication , DNA repair , and regulation of gene expression , may be associated with carcinogenesis ."
103027,involved,O,3577.0,"Dietary intakes of B vitamins and other components involved in one - carbon metabolism , which is necessary for DNA replication , DNA repair , and regulation of gene expression , may be associated with carcinogenesis ."
103028,in,O,3577.0,"Dietary intakes of B vitamins and other components involved in one - carbon metabolism , which is necessary for DNA replication , DNA repair , and regulation of gene expression , may be associated with carcinogenesis ."
103029,one,O,3577.0,"Dietary intakes of B vitamins and other components involved in one - carbon metabolism , which is necessary for DNA replication , DNA repair , and regulation of gene expression , may be associated with carcinogenesis ."
103030,-,O,3577.0,"Dietary intakes of B vitamins and other components involved in one - carbon metabolism , which is necessary for DNA replication , DNA repair , and regulation of gene expression , may be associated with carcinogenesis ."
103031,carbon,O,3577.0,"Dietary intakes of B vitamins and other components involved in one - carbon metabolism , which is necessary for DNA replication , DNA repair , and regulation of gene expression , may be associated with carcinogenesis ."
103032,metabolism,O,3577.0,"Dietary intakes of B vitamins and other components involved in one - carbon metabolism , which is necessary for DNA replication , DNA repair , and regulation of gene expression , may be associated with carcinogenesis ."
103033,",",O,3577.0,"Dietary intakes of B vitamins and other components involved in one - carbon metabolism , which is necessary for DNA replication , DNA repair , and regulation of gene expression , may be associated with carcinogenesis ."
103034,which,O,3577.0,"Dietary intakes of B vitamins and other components involved in one - carbon metabolism , which is necessary for DNA replication , DNA repair , and regulation of gene expression , may be associated with carcinogenesis ."
103035,is,O,3577.0,"Dietary intakes of B vitamins and other components involved in one - carbon metabolism , which is necessary for DNA replication , DNA repair , and regulation of gene expression , may be associated with carcinogenesis ."
103036,necessary,O,3577.0,"Dietary intakes of B vitamins and other components involved in one - carbon metabolism , which is necessary for DNA replication , DNA repair , and regulation of gene expression , may be associated with carcinogenesis ."
103037,for,O,3577.0,"Dietary intakes of B vitamins and other components involved in one - carbon metabolism , which is necessary for DNA replication , DNA repair , and regulation of gene expression , may be associated with carcinogenesis ."
103038,DNA,O,3577.0,"Dietary intakes of B vitamins and other components involved in one - carbon metabolism , which is necessary for DNA replication , DNA repair , and regulation of gene expression , may be associated with carcinogenesis ."
103039,replication,O,3577.0,"Dietary intakes of B vitamins and other components involved in one - carbon metabolism , which is necessary for DNA replication , DNA repair , and regulation of gene expression , may be associated with carcinogenesis ."
103040,",",O,3577.0,"Dietary intakes of B vitamins and other components involved in one - carbon metabolism , which is necessary for DNA replication , DNA repair , and regulation of gene expression , may be associated with carcinogenesis ."
103041,DNA,O,3577.0,"Dietary intakes of B vitamins and other components involved in one - carbon metabolism , which is necessary for DNA replication , DNA repair , and regulation of gene expression , may be associated with carcinogenesis ."
103042,repair,O,3577.0,"Dietary intakes of B vitamins and other components involved in one - carbon metabolism , which is necessary for DNA replication , DNA repair , and regulation of gene expression , may be associated with carcinogenesis ."
103043,",",O,3577.0,"Dietary intakes of B vitamins and other components involved in one - carbon metabolism , which is necessary for DNA replication , DNA repair , and regulation of gene expression , may be associated with carcinogenesis ."
103044,and,O,3577.0,"Dietary intakes of B vitamins and other components involved in one - carbon metabolism , which is necessary for DNA replication , DNA repair , and regulation of gene expression , may be associated with carcinogenesis ."
103045,regulation,O,3577.0,"Dietary intakes of B vitamins and other components involved in one - carbon metabolism , which is necessary for DNA replication , DNA repair , and regulation of gene expression , may be associated with carcinogenesis ."
103046,of,O,3577.0,"Dietary intakes of B vitamins and other components involved in one - carbon metabolism , which is necessary for DNA replication , DNA repair , and regulation of gene expression , may be associated with carcinogenesis ."
103047,gene,O,3577.0,"Dietary intakes of B vitamins and other components involved in one - carbon metabolism , which is necessary for DNA replication , DNA repair , and regulation of gene expression , may be associated with carcinogenesis ."
103048,expression,O,3577.0,"Dietary intakes of B vitamins and other components involved in one - carbon metabolism , which is necessary for DNA replication , DNA repair , and regulation of gene expression , may be associated with carcinogenesis ."
103049,",",O,3577.0,"Dietary intakes of B vitamins and other components involved in one - carbon metabolism , which is necessary for DNA replication , DNA repair , and regulation of gene expression , may be associated with carcinogenesis ."
103050,may,O,3577.0,"Dietary intakes of B vitamins and other components involved in one - carbon metabolism , which is necessary for DNA replication , DNA repair , and regulation of gene expression , may be associated with carcinogenesis ."
103051,be,O,3577.0,"Dietary intakes of B vitamins and other components involved in one - carbon metabolism , which is necessary for DNA replication , DNA repair , and regulation of gene expression , may be associated with carcinogenesis ."
103052,associated,O,3577.0,"Dietary intakes of B vitamins and other components involved in one - carbon metabolism , which is necessary for DNA replication , DNA repair , and regulation of gene expression , may be associated with carcinogenesis ."
103053,with,O,3577.0,"Dietary intakes of B vitamins and other components involved in one - carbon metabolism , which is necessary for DNA replication , DNA repair , and regulation of gene expression , may be associated with carcinogenesis ."
103054,carcinogenesis,O,3577.0,"Dietary intakes of B vitamins and other components involved in one - carbon metabolism , which is necessary for DNA replication , DNA repair , and regulation of gene expression , may be associated with carcinogenesis ."
103055,.,O,3577.0,"Dietary intakes of B vitamins and other components involved in one - carbon metabolism , which is necessary for DNA replication , DNA repair , and regulation of gene expression , may be associated with carcinogenesis ."
103056,We,O,3578.0,"We investigated associations between intakes of 11 nutrients ( thiamine , riboflavin , niacin , pantothenic acid , vitamin B6 , biotin , folate , vitamin B12 , methionine , choline , and betaine ) and gastric cancer risk ."
103057,investigated,O,3578.0,"We investigated associations between intakes of 11 nutrients ( thiamine , riboflavin , niacin , pantothenic acid , vitamin B6 , biotin , folate , vitamin B12 , methionine , choline , and betaine ) and gastric cancer risk ."
103058,associations,O,3578.0,"We investigated associations between intakes of 11 nutrients ( thiamine , riboflavin , niacin , pantothenic acid , vitamin B6 , biotin , folate , vitamin B12 , methionine , choline , and betaine ) and gastric cancer risk ."
103059,between,O,3578.0,"We investigated associations between intakes of 11 nutrients ( thiamine , riboflavin , niacin , pantothenic acid , vitamin B6 , biotin , folate , vitamin B12 , methionine , choline , and betaine ) and gastric cancer risk ."
103060,intakes,O,3578.0,"We investigated associations between intakes of 11 nutrients ( thiamine , riboflavin , niacin , pantothenic acid , vitamin B6 , biotin , folate , vitamin B12 , methionine , choline , and betaine ) and gastric cancer risk ."
103061,of,O,3578.0,"We investigated associations between intakes of 11 nutrients ( thiamine , riboflavin , niacin , pantothenic acid , vitamin B6 , biotin , folate , vitamin B12 , methionine , choline , and betaine ) and gastric cancer risk ."
103062,11,O,3578.0,"We investigated associations between intakes of 11 nutrients ( thiamine , riboflavin , niacin , pantothenic acid , vitamin B6 , biotin , folate , vitamin B12 , methionine , choline , and betaine ) and gastric cancer risk ."
103063,nutrients,O,3578.0,"We investigated associations between intakes of 11 nutrients ( thiamine , riboflavin , niacin , pantothenic acid , vitamin B6 , biotin , folate , vitamin B12 , methionine , choline , and betaine ) and gastric cancer risk ."
103064,(,O,3578.0,"We investigated associations between intakes of 11 nutrients ( thiamine , riboflavin , niacin , pantothenic acid , vitamin B6 , biotin , folate , vitamin B12 , methionine , choline , and betaine ) and gastric cancer risk ."
103065,thiamine,O,3578.0,"We investigated associations between intakes of 11 nutrients ( thiamine , riboflavin , niacin , pantothenic acid , vitamin B6 , biotin , folate , vitamin B12 , methionine , choline , and betaine ) and gastric cancer risk ."
103066,",",O,3578.0,"We investigated associations between intakes of 11 nutrients ( thiamine , riboflavin , niacin , pantothenic acid , vitamin B6 , biotin , folate , vitamin B12 , methionine , choline , and betaine ) and gastric cancer risk ."
103067,riboflavin,O,3578.0,"We investigated associations between intakes of 11 nutrients ( thiamine , riboflavin , niacin , pantothenic acid , vitamin B6 , biotin , folate , vitamin B12 , methionine , choline , and betaine ) and gastric cancer risk ."
103068,",",O,3578.0,"We investigated associations between intakes of 11 nutrients ( thiamine , riboflavin , niacin , pantothenic acid , vitamin B6 , biotin , folate , vitamin B12 , methionine , choline , and betaine ) and gastric cancer risk ."
103069,niacin,O,3578.0,"We investigated associations between intakes of 11 nutrients ( thiamine , riboflavin , niacin , pantothenic acid , vitamin B6 , biotin , folate , vitamin B12 , methionine , choline , and betaine ) and gastric cancer risk ."
103070,",",O,3578.0,"We investigated associations between intakes of 11 nutrients ( thiamine , riboflavin , niacin , pantothenic acid , vitamin B6 , biotin , folate , vitamin B12 , methionine , choline , and betaine ) and gastric cancer risk ."
103071,pantothenic,O,3578.0,"We investigated associations between intakes of 11 nutrients ( thiamine , riboflavin , niacin , pantothenic acid , vitamin B6 , biotin , folate , vitamin B12 , methionine , choline , and betaine ) and gastric cancer risk ."
103072,acid,O,3578.0,"We investigated associations between intakes of 11 nutrients ( thiamine , riboflavin , niacin , pantothenic acid , vitamin B6 , biotin , folate , vitamin B12 , methionine , choline , and betaine ) and gastric cancer risk ."
103073,",",O,3578.0,"We investigated associations between intakes of 11 nutrients ( thiamine , riboflavin , niacin , pantothenic acid , vitamin B6 , biotin , folate , vitamin B12 , methionine , choline , and betaine ) and gastric cancer risk ."
103074,vitamin,O,3578.0,"We investigated associations between intakes of 11 nutrients ( thiamine , riboflavin , niacin , pantothenic acid , vitamin B6 , biotin , folate , vitamin B12 , methionine , choline , and betaine ) and gastric cancer risk ."
103075,B6,O,3578.0,"We investigated associations between intakes of 11 nutrients ( thiamine , riboflavin , niacin , pantothenic acid , vitamin B6 , biotin , folate , vitamin B12 , methionine , choline , and betaine ) and gastric cancer risk ."
103076,",",O,3578.0,"We investigated associations between intakes of 11 nutrients ( thiamine , riboflavin , niacin , pantothenic acid , vitamin B6 , biotin , folate , vitamin B12 , methionine , choline , and betaine ) and gastric cancer risk ."
103077,biotin,O,3578.0,"We investigated associations between intakes of 11 nutrients ( thiamine , riboflavin , niacin , pantothenic acid , vitamin B6 , biotin , folate , vitamin B12 , methionine , choline , and betaine ) and gastric cancer risk ."
103078,",",O,3578.0,"We investigated associations between intakes of 11 nutrients ( thiamine , riboflavin , niacin , pantothenic acid , vitamin B6 , biotin , folate , vitamin B12 , methionine , choline , and betaine ) and gastric cancer risk ."
103079,folate,O,3578.0,"We investigated associations between intakes of 11 nutrients ( thiamine , riboflavin , niacin , pantothenic acid , vitamin B6 , biotin , folate , vitamin B12 , methionine , choline , and betaine ) and gastric cancer risk ."
103080,",",O,3578.0,"We investigated associations between intakes of 11 nutrients ( thiamine , riboflavin , niacin , pantothenic acid , vitamin B6 , biotin , folate , vitamin B12 , methionine , choline , and betaine ) and gastric cancer risk ."
103081,vitamin,O,3578.0,"We investigated associations between intakes of 11 nutrients ( thiamine , riboflavin , niacin , pantothenic acid , vitamin B6 , biotin , folate , vitamin B12 , methionine , choline , and betaine ) and gastric cancer risk ."
103082,B12,O,3578.0,"We investigated associations between intakes of 11 nutrients ( thiamine , riboflavin , niacin , pantothenic acid , vitamin B6 , biotin , folate , vitamin B12 , methionine , choline , and betaine ) and gastric cancer risk ."
103083,",",O,3578.0,"We investigated associations between intakes of 11 nutrients ( thiamine , riboflavin , niacin , pantothenic acid , vitamin B6 , biotin , folate , vitamin B12 , methionine , choline , and betaine ) and gastric cancer risk ."
103084,methionine,O,3578.0,"We investigated associations between intakes of 11 nutrients ( thiamine , riboflavin , niacin , pantothenic acid , vitamin B6 , biotin , folate , vitamin B12 , methionine , choline , and betaine ) and gastric cancer risk ."
103085,",",O,3578.0,"We investigated associations between intakes of 11 nutrients ( thiamine , riboflavin , niacin , pantothenic acid , vitamin B6 , biotin , folate , vitamin B12 , methionine , choline , and betaine ) and gastric cancer risk ."
103086,choline,O,3578.0,"We investigated associations between intakes of 11 nutrients ( thiamine , riboflavin , niacin , pantothenic acid , vitamin B6 , biotin , folate , vitamin B12 , methionine , choline , and betaine ) and gastric cancer risk ."
103087,",",O,3578.0,"We investigated associations between intakes of 11 nutrients ( thiamine , riboflavin , niacin , pantothenic acid , vitamin B6 , biotin , folate , vitamin B12 , methionine , choline , and betaine ) and gastric cancer risk ."
103088,and,O,3578.0,"We investigated associations between intakes of 11 nutrients ( thiamine , riboflavin , niacin , pantothenic acid , vitamin B6 , biotin , folate , vitamin B12 , methionine , choline , and betaine ) and gastric cancer risk ."
103089,betaine,O,3578.0,"We investigated associations between intakes of 11 nutrients ( thiamine , riboflavin , niacin , pantothenic acid , vitamin B6 , biotin , folate , vitamin B12 , methionine , choline , and betaine ) and gastric cancer risk ."
103090,),O,3578.0,"We investigated associations between intakes of 11 nutrients ( thiamine , riboflavin , niacin , pantothenic acid , vitamin B6 , biotin , folate , vitamin B12 , methionine , choline , and betaine ) and gastric cancer risk ."
103091,and,O,3578.0,"We investigated associations between intakes of 11 nutrients ( thiamine , riboflavin , niacin , pantothenic acid , vitamin B6 , biotin , folate , vitamin B12 , methionine , choline , and betaine ) and gastric cancer risk ."
103092,gastric,O,3578.0,"We investigated associations between intakes of 11 nutrients ( thiamine , riboflavin , niacin , pantothenic acid , vitamin B6 , biotin , folate , vitamin B12 , methionine , choline , and betaine ) and gastric cancer risk ."
103093,cancer,O,3578.0,"We investigated associations between intakes of 11 nutrients ( thiamine , riboflavin , niacin , pantothenic acid , vitamin B6 , biotin , folate , vitamin B12 , methionine , choline , and betaine ) and gastric cancer risk ."
103094,risk,O,3578.0,"We investigated associations between intakes of 11 nutrients ( thiamine , riboflavin , niacin , pantothenic acid , vitamin B6 , biotin , folate , vitamin B12 , methionine , choline , and betaine ) and gastric cancer risk ."
103095,.,O,3578.0,"We investigated associations between intakes of 11 nutrients ( thiamine , riboflavin , niacin , pantothenic acid , vitamin B6 , biotin , folate , vitamin B12 , methionine , choline , and betaine ) and gastric cancer risk ."
103096,A,O,3579.0,"A total of 159 incident gastric cancer cases were identified from the Melbourne Collaborative Cohort Study ( N   =   41,513 ) and matched with 159 controls on year of birth , sex , and country of birth using incidence density sampling ."
103097,total,O,3579.0,"A total of 159 incident gastric cancer cases were identified from the Melbourne Collaborative Cohort Study ( N   =   41,513 ) and matched with 159 controls on year of birth , sex , and country of birth using incidence density sampling ."
103098,of,O,3579.0,"A total of 159 incident gastric cancer cases were identified from the Melbourne Collaborative Cohort Study ( N   =   41,513 ) and matched with 159 controls on year of birth , sex , and country of birth using incidence density sampling ."
103099,159,O,3579.0,"A total of 159 incident gastric cancer cases were identified from the Melbourne Collaborative Cohort Study ( N   =   41,513 ) and matched with 159 controls on year of birth , sex , and country of birth using incidence density sampling ."
103100,incident,O,3579.0,"A total of 159 incident gastric cancer cases were identified from the Melbourne Collaborative Cohort Study ( N   =   41,513 ) and matched with 159 controls on year of birth , sex , and country of birth using incidence density sampling ."
103101,gastric,O,3579.0,"A total of 159 incident gastric cancer cases were identified from the Melbourne Collaborative Cohort Study ( N   =   41,513 ) and matched with 159 controls on year of birth , sex , and country of birth using incidence density sampling ."
103102,cancer,O,3579.0,"A total of 159 incident gastric cancer cases were identified from the Melbourne Collaborative Cohort Study ( N   =   41,513 ) and matched with 159 controls on year of birth , sex , and country of birth using incidence density sampling ."
103103,cases,O,3579.0,"A total of 159 incident gastric cancer cases were identified from the Melbourne Collaborative Cohort Study ( N   =   41,513 ) and matched with 159 controls on year of birth , sex , and country of birth using incidence density sampling ."
103104,were,O,3579.0,"A total of 159 incident gastric cancer cases were identified from the Melbourne Collaborative Cohort Study ( N   =   41,513 ) and matched with 159 controls on year of birth , sex , and country of birth using incidence density sampling ."
103105,identified,O,3579.0,"A total of 159 incident gastric cancer cases were identified from the Melbourne Collaborative Cohort Study ( N   =   41,513 ) and matched with 159 controls on year of birth , sex , and country of birth using incidence density sampling ."
103106,from,O,3579.0,"A total of 159 incident gastric cancer cases were identified from the Melbourne Collaborative Cohort Study ( N   =   41,513 ) and matched with 159 controls on year of birth , sex , and country of birth using incidence density sampling ."
103107,the,O,3579.0,"A total of 159 incident gastric cancer cases were identified from the Melbourne Collaborative Cohort Study ( N   =   41,513 ) and matched with 159 controls on year of birth , sex , and country of birth using incidence density sampling ."
103108,Melbourne,O,3579.0,"A total of 159 incident gastric cancer cases were identified from the Melbourne Collaborative Cohort Study ( N   =   41,513 ) and matched with 159 controls on year of birth , sex , and country of birth using incidence density sampling ."
103109,Collaborative,O,3579.0,"A total of 159 incident gastric cancer cases were identified from the Melbourne Collaborative Cohort Study ( N   =   41,513 ) and matched with 159 controls on year of birth , sex , and country of birth using incidence density sampling ."
103110,Cohort,O,3579.0,"A total of 159 incident gastric cancer cases were identified from the Melbourne Collaborative Cohort Study ( N   =   41,513 ) and matched with 159 controls on year of birth , sex , and country of birth using incidence density sampling ."
103111,Study,O,3579.0,"A total of 159 incident gastric cancer cases were identified from the Melbourne Collaborative Cohort Study ( N   =   41,513 ) and matched with 159 controls on year of birth , sex , and country of birth using incidence density sampling ."
103112,(,O,3579.0,"A total of 159 incident gastric cancer cases were identified from the Melbourne Collaborative Cohort Study ( N   =   41,513 ) and matched with 159 controls on year of birth , sex , and country of birth using incidence density sampling ."
103113,N,O,3579.0,"A total of 159 incident gastric cancer cases were identified from the Melbourne Collaborative Cohort Study ( N   =   41,513 ) and matched with 159 controls on year of birth , sex , and country of birth using incidence density sampling ."
103114, ,O,3579.0,"A total of 159 incident gastric cancer cases were identified from the Melbourne Collaborative Cohort Study ( N   =   41,513 ) and matched with 159 controls on year of birth , sex , and country of birth using incidence density sampling ."
103115,=,O,3579.0,"A total of 159 incident gastric cancer cases were identified from the Melbourne Collaborative Cohort Study ( N   =   41,513 ) and matched with 159 controls on year of birth , sex , and country of birth using incidence density sampling ."
103116, ,O,3579.0,"A total of 159 incident gastric cancer cases were identified from the Melbourne Collaborative Cohort Study ( N   =   41,513 ) and matched with 159 controls on year of birth , sex , and country of birth using incidence density sampling ."
103117,"41,513",O,3579.0,"A total of 159 incident gastric cancer cases were identified from the Melbourne Collaborative Cohort Study ( N   =   41,513 ) and matched with 159 controls on year of birth , sex , and country of birth using incidence density sampling ."
103118,),O,3579.0,"A total of 159 incident gastric cancer cases were identified from the Melbourne Collaborative Cohort Study ( N   =   41,513 ) and matched with 159 controls on year of birth , sex , and country of birth using incidence density sampling ."
103119,and,O,3579.0,"A total of 159 incident gastric cancer cases were identified from the Melbourne Collaborative Cohort Study ( N   =   41,513 ) and matched with 159 controls on year of birth , sex , and country of birth using incidence density sampling ."
103120,matched,O,3579.0,"A total of 159 incident gastric cancer cases were identified from the Melbourne Collaborative Cohort Study ( N   =   41,513 ) and matched with 159 controls on year of birth , sex , and country of birth using incidence density sampling ."
103121,with,O,3579.0,"A total of 159 incident gastric cancer cases were identified from the Melbourne Collaborative Cohort Study ( N   =   41,513 ) and matched with 159 controls on year of birth , sex , and country of birth using incidence density sampling ."
103122,159,O,3579.0,"A total of 159 incident gastric cancer cases were identified from the Melbourne Collaborative Cohort Study ( N   =   41,513 ) and matched with 159 controls on year of birth , sex , and country of birth using incidence density sampling ."
103123,controls,O,3579.0,"A total of 159 incident gastric cancer cases were identified from the Melbourne Collaborative Cohort Study ( N   =   41,513 ) and matched with 159 controls on year of birth , sex , and country of birth using incidence density sampling ."
103124,on,O,3579.0,"A total of 159 incident gastric cancer cases were identified from the Melbourne Collaborative Cohort Study ( N   =   41,513 ) and matched with 159 controls on year of birth , sex , and country of birth using incidence density sampling ."
103125,year,O,3579.0,"A total of 159 incident gastric cancer cases were identified from the Melbourne Collaborative Cohort Study ( N   =   41,513 ) and matched with 159 controls on year of birth , sex , and country of birth using incidence density sampling ."
103126,of,O,3579.0,"A total of 159 incident gastric cancer cases were identified from the Melbourne Collaborative Cohort Study ( N   =   41,513 ) and matched with 159 controls on year of birth , sex , and country of birth using incidence density sampling ."
103127,birth,O,3579.0,"A total of 159 incident gastric cancer cases were identified from the Melbourne Collaborative Cohort Study ( N   =   41,513 ) and matched with 159 controls on year of birth , sex , and country of birth using incidence density sampling ."
103128,",",O,3579.0,"A total of 159 incident gastric cancer cases were identified from the Melbourne Collaborative Cohort Study ( N   =   41,513 ) and matched with 159 controls on year of birth , sex , and country of birth using incidence density sampling ."
103129,sex,O,3579.0,"A total of 159 incident gastric cancer cases were identified from the Melbourne Collaborative Cohort Study ( N   =   41,513 ) and matched with 159 controls on year of birth , sex , and country of birth using incidence density sampling ."
103130,",",O,3579.0,"A total of 159 incident gastric cancer cases were identified from the Melbourne Collaborative Cohort Study ( N   =   41,513 ) and matched with 159 controls on year of birth , sex , and country of birth using incidence density sampling ."
103131,and,O,3579.0,"A total of 159 incident gastric cancer cases were identified from the Melbourne Collaborative Cohort Study ( N   =   41,513 ) and matched with 159 controls on year of birth , sex , and country of birth using incidence density sampling ."
103132,country,O,3579.0,"A total of 159 incident gastric cancer cases were identified from the Melbourne Collaborative Cohort Study ( N   =   41,513 ) and matched with 159 controls on year of birth , sex , and country of birth using incidence density sampling ."
103133,of,O,3579.0,"A total of 159 incident gastric cancer cases were identified from the Melbourne Collaborative Cohort Study ( N   =   41,513 ) and matched with 159 controls on year of birth , sex , and country of birth using incidence density sampling ."
103134,birth,O,3579.0,"A total of 159 incident gastric cancer cases were identified from the Melbourne Collaborative Cohort Study ( N   =   41,513 ) and matched with 159 controls on year of birth , sex , and country of birth using incidence density sampling ."
103135,using,O,3579.0,"A total of 159 incident gastric cancer cases were identified from the Melbourne Collaborative Cohort Study ( N   =   41,513 ) and matched with 159 controls on year of birth , sex , and country of birth using incidence density sampling ."
103136,incidence,O,3579.0,"A total of 159 incident gastric cancer cases were identified from the Melbourne Collaborative Cohort Study ( N   =   41,513 ) and matched with 159 controls on year of birth , sex , and country of birth using incidence density sampling ."
103137,density,O,3579.0,"A total of 159 incident gastric cancer cases were identified from the Melbourne Collaborative Cohort Study ( N   =   41,513 ) and matched with 159 controls on year of birth , sex , and country of birth using incidence density sampling ."
103138,sampling,O,3579.0,"A total of 159 incident gastric cancer cases were identified from the Melbourne Collaborative Cohort Study ( N   =   41,513 ) and matched with 159 controls on year of birth , sex , and country of birth using incidence density sampling ."
103139,.,O,3579.0,"A total of 159 incident gastric cancer cases were identified from the Melbourne Collaborative Cohort Study ( N   =   41,513 ) and matched with 159 controls on year of birth , sex , and country of birth using incidence density sampling ."
103140,Dietary,O,3580.0,Dietary intakes of nutrients were estimated at baseline ( 1990 - 1994 ) using a 121 - item food frequency questionnaire .
103141,intakes,O,3580.0,Dietary intakes of nutrients were estimated at baseline ( 1990 - 1994 ) using a 121 - item food frequency questionnaire .
103142,of,O,3580.0,Dietary intakes of nutrients were estimated at baseline ( 1990 - 1994 ) using a 121 - item food frequency questionnaire .
103143,nutrients,O,3580.0,Dietary intakes of nutrients were estimated at baseline ( 1990 - 1994 ) using a 121 - item food frequency questionnaire .
103144,were,O,3580.0,Dietary intakes of nutrients were estimated at baseline ( 1990 - 1994 ) using a 121 - item food frequency questionnaire .
103145,estimated,O,3580.0,Dietary intakes of nutrients were estimated at baseline ( 1990 - 1994 ) using a 121 - item food frequency questionnaire .
103146,at,O,3580.0,Dietary intakes of nutrients were estimated at baseline ( 1990 - 1994 ) using a 121 - item food frequency questionnaire .
103147,baseline,O,3580.0,Dietary intakes of nutrients were estimated at baseline ( 1990 - 1994 ) using a 121 - item food frequency questionnaire .
103148,(,O,3580.0,Dietary intakes of nutrients were estimated at baseline ( 1990 - 1994 ) using a 121 - item food frequency questionnaire .
103149,1990,O,3580.0,Dietary intakes of nutrients were estimated at baseline ( 1990 - 1994 ) using a 121 - item food frequency questionnaire .
103150,-,O,3580.0,Dietary intakes of nutrients were estimated at baseline ( 1990 - 1994 ) using a 121 - item food frequency questionnaire .
103151,1994,O,3580.0,Dietary intakes of nutrients were estimated at baseline ( 1990 - 1994 ) using a 121 - item food frequency questionnaire .
103152,),O,3580.0,Dietary intakes of nutrients were estimated at baseline ( 1990 - 1994 ) using a 121 - item food frequency questionnaire .
103153,using,O,3580.0,Dietary intakes of nutrients were estimated at baseline ( 1990 - 1994 ) using a 121 - item food frequency questionnaire .
103154,a,O,3580.0,Dietary intakes of nutrients were estimated at baseline ( 1990 - 1994 ) using a 121 - item food frequency questionnaire .
103155,121,O,3580.0,Dietary intakes of nutrients were estimated at baseline ( 1990 - 1994 ) using a 121 - item food frequency questionnaire .
103156,-,O,3580.0,Dietary intakes of nutrients were estimated at baseline ( 1990 - 1994 ) using a 121 - item food frequency questionnaire .
103157,item,O,3580.0,Dietary intakes of nutrients were estimated at baseline ( 1990 - 1994 ) using a 121 - item food frequency questionnaire .
103158,food,O,3580.0,Dietary intakes of nutrients were estimated at baseline ( 1990 - 1994 ) using a 121 - item food frequency questionnaire .
103159,frequency,O,3580.0,Dietary intakes of nutrients were estimated at baseline ( 1990 - 1994 ) using a 121 - item food frequency questionnaire .
103160,questionnaire,O,3580.0,Dietary intakes of nutrients were estimated at baseline ( 1990 - 1994 ) using a 121 - item food frequency questionnaire .
103161,.,O,3580.0,Dietary intakes of nutrients were estimated at baseline ( 1990 - 1994 ) using a 121 - item food frequency questionnaire .
103162,Odds,O,3581.0,"Odds ratios ( ORs ) and 95 % confidence intervals were estimated using conditional logistic regression models adjusting for Helicobacter pylori infection , and other potential confounders ."
103163,ratios,O,3581.0,"Odds ratios ( ORs ) and 95 % confidence intervals were estimated using conditional logistic regression models adjusting for Helicobacter pylori infection , and other potential confounders ."
103164,(,O,3581.0,"Odds ratios ( ORs ) and 95 % confidence intervals were estimated using conditional logistic regression models adjusting for Helicobacter pylori infection , and other potential confounders ."
103165,ORs,O,3581.0,"Odds ratios ( ORs ) and 95 % confidence intervals were estimated using conditional logistic regression models adjusting for Helicobacter pylori infection , and other potential confounders ."
103166,),O,3581.0,"Odds ratios ( ORs ) and 95 % confidence intervals were estimated using conditional logistic regression models adjusting for Helicobacter pylori infection , and other potential confounders ."
103167,and,O,3581.0,"Odds ratios ( ORs ) and 95 % confidence intervals were estimated using conditional logistic regression models adjusting for Helicobacter pylori infection , and other potential confounders ."
103168,95,O,3581.0,"Odds ratios ( ORs ) and 95 % confidence intervals were estimated using conditional logistic regression models adjusting for Helicobacter pylori infection , and other potential confounders ."
103169,%,O,3581.0,"Odds ratios ( ORs ) and 95 % confidence intervals were estimated using conditional logistic regression models adjusting for Helicobacter pylori infection , and other potential confounders ."
103170,confidence,O,3581.0,"Odds ratios ( ORs ) and 95 % confidence intervals were estimated using conditional logistic regression models adjusting for Helicobacter pylori infection , and other potential confounders ."
103171,intervals,O,3581.0,"Odds ratios ( ORs ) and 95 % confidence intervals were estimated using conditional logistic regression models adjusting for Helicobacter pylori infection , and other potential confounders ."
103172,were,O,3581.0,"Odds ratios ( ORs ) and 95 % confidence intervals were estimated using conditional logistic regression models adjusting for Helicobacter pylori infection , and other potential confounders ."
103173,estimated,O,3581.0,"Odds ratios ( ORs ) and 95 % confidence intervals were estimated using conditional logistic regression models adjusting for Helicobacter pylori infection , and other potential confounders ."
103174,using,O,3581.0,"Odds ratios ( ORs ) and 95 % confidence intervals were estimated using conditional logistic regression models adjusting for Helicobacter pylori infection , and other potential confounders ."
103175,conditional,O,3581.0,"Odds ratios ( ORs ) and 95 % confidence intervals were estimated using conditional logistic regression models adjusting for Helicobacter pylori infection , and other potential confounders ."
103176,logistic,O,3581.0,"Odds ratios ( ORs ) and 95 % confidence intervals were estimated using conditional logistic regression models adjusting for Helicobacter pylori infection , and other potential confounders ."
103177,regression,O,3581.0,"Odds ratios ( ORs ) and 95 % confidence intervals were estimated using conditional logistic regression models adjusting for Helicobacter pylori infection , and other potential confounders ."
103178,models,O,3581.0,"Odds ratios ( ORs ) and 95 % confidence intervals were estimated using conditional logistic regression models adjusting for Helicobacter pylori infection , and other potential confounders ."
103179,adjusting,O,3581.0,"Odds ratios ( ORs ) and 95 % confidence intervals were estimated using conditional logistic regression models adjusting for Helicobacter pylori infection , and other potential confounders ."
103180,for,O,3581.0,"Odds ratios ( ORs ) and 95 % confidence intervals were estimated using conditional logistic regression models adjusting for Helicobacter pylori infection , and other potential confounders ."
103181,Helicobacter,O,3581.0,"Odds ratios ( ORs ) and 95 % confidence intervals were estimated using conditional logistic regression models adjusting for Helicobacter pylori infection , and other potential confounders ."
103182,pylori,O,3581.0,"Odds ratios ( ORs ) and 95 % confidence intervals were estimated using conditional logistic regression models adjusting for Helicobacter pylori infection , and other potential confounders ."
103183,infection,O,3581.0,"Odds ratios ( ORs ) and 95 % confidence intervals were estimated using conditional logistic regression models adjusting for Helicobacter pylori infection , and other potential confounders ."
103184,",",O,3581.0,"Odds ratios ( ORs ) and 95 % confidence intervals were estimated using conditional logistic regression models adjusting for Helicobacter pylori infection , and other potential confounders ."
103185,and,O,3581.0,"Odds ratios ( ORs ) and 95 % confidence intervals were estimated using conditional logistic regression models adjusting for Helicobacter pylori infection , and other potential confounders ."
103186,other,O,3581.0,"Odds ratios ( ORs ) and 95 % confidence intervals were estimated using conditional logistic regression models adjusting for Helicobacter pylori infection , and other potential confounders ."
103187,potential,O,3581.0,"Odds ratios ( ORs ) and 95 % confidence intervals were estimated using conditional logistic regression models adjusting for Helicobacter pylori infection , and other potential confounders ."
103188,confounders,O,3581.0,"Odds ratios ( ORs ) and 95 % confidence intervals were estimated using conditional logistic regression models adjusting for Helicobacter pylori infection , and other potential confounders ."
103189,.,O,3581.0,"Odds ratios ( ORs ) and 95 % confidence intervals were estimated using conditional logistic regression models adjusting for Helicobacter pylori infection , and other potential confounders ."
103190,We,O,3582.0,"We observed a positive association between intake of niacin and overall gastric cancer risk ( OR   =   1.33 , 95%CI : 1.01 - 1.75 per SD increment ) ."
103191,observed,O,3582.0,"We observed a positive association between intake of niacin and overall gastric cancer risk ( OR   =   1.33 , 95%CI : 1.01 - 1.75 per SD increment ) ."
103192,a,O,3582.0,"We observed a positive association between intake of niacin and overall gastric cancer risk ( OR   =   1.33 , 95%CI : 1.01 - 1.75 per SD increment ) ."
103193,positive,O,3582.0,"We observed a positive association between intake of niacin and overall gastric cancer risk ( OR   =   1.33 , 95%CI : 1.01 - 1.75 per SD increment ) ."
103194,association,O,3582.0,"We observed a positive association between intake of niacin and overall gastric cancer risk ( OR   =   1.33 , 95%CI : 1.01 - 1.75 per SD increment ) ."
103195,between,O,3582.0,"We observed a positive association between intake of niacin and overall gastric cancer risk ( OR   =   1.33 , 95%CI : 1.01 - 1.75 per SD increment ) ."
103196,intake,O,3582.0,"We observed a positive association between intake of niacin and overall gastric cancer risk ( OR   =   1.33 , 95%CI : 1.01 - 1.75 per SD increment ) ."
103197,of,O,3582.0,"We observed a positive association between intake of niacin and overall gastric cancer risk ( OR   =   1.33 , 95%CI : 1.01 - 1.75 per SD increment ) ."
103198,niacin,O,3582.0,"We observed a positive association between intake of niacin and overall gastric cancer risk ( OR   =   1.33 , 95%CI : 1.01 - 1.75 per SD increment ) ."
103199,and,O,3582.0,"We observed a positive association between intake of niacin and overall gastric cancer risk ( OR   =   1.33 , 95%CI : 1.01 - 1.75 per SD increment ) ."
103200,overall,O,3582.0,"We observed a positive association between intake of niacin and overall gastric cancer risk ( OR   =   1.33 , 95%CI : 1.01 - 1.75 per SD increment ) ."
103201,gastric,O,3582.0,"We observed a positive association between intake of niacin and overall gastric cancer risk ( OR   =   1.33 , 95%CI : 1.01 - 1.75 per SD increment ) ."
103202,cancer,O,3582.0,"We observed a positive association between intake of niacin and overall gastric cancer risk ( OR   =   1.33 , 95%CI : 1.01 - 1.75 per SD increment ) ."
103203,risk,O,3582.0,"We observed a positive association between intake of niacin and overall gastric cancer risk ( OR   =   1.33 , 95%CI : 1.01 - 1.75 per SD increment ) ."
103204,(,O,3582.0,"We observed a positive association between intake of niacin and overall gastric cancer risk ( OR   =   1.33 , 95%CI : 1.01 - 1.75 per SD increment ) ."
103205,OR,O,3582.0,"We observed a positive association between intake of niacin and overall gastric cancer risk ( OR   =   1.33 , 95%CI : 1.01 - 1.75 per SD increment ) ."
103206, ,O,3582.0,"We observed a positive association between intake of niacin and overall gastric cancer risk ( OR   =   1.33 , 95%CI : 1.01 - 1.75 per SD increment ) ."
103207,=,O,3582.0,"We observed a positive association between intake of niacin and overall gastric cancer risk ( OR   =   1.33 , 95%CI : 1.01 - 1.75 per SD increment ) ."
103208, ,O,3582.0,"We observed a positive association between intake of niacin and overall gastric cancer risk ( OR   =   1.33 , 95%CI : 1.01 - 1.75 per SD increment ) ."
103209,1.33,O,3582.0,"We observed a positive association between intake of niacin and overall gastric cancer risk ( OR   =   1.33 , 95%CI : 1.01 - 1.75 per SD increment ) ."
103210,",",O,3582.0,"We observed a positive association between intake of niacin and overall gastric cancer risk ( OR   =   1.33 , 95%CI : 1.01 - 1.75 per SD increment ) ."
103211,95%CI,O,3582.0,"We observed a positive association between intake of niacin and overall gastric cancer risk ( OR   =   1.33 , 95%CI : 1.01 - 1.75 per SD increment ) ."
103212,:,O,3582.0,"We observed a positive association between intake of niacin and overall gastric cancer risk ( OR   =   1.33 , 95%CI : 1.01 - 1.75 per SD increment ) ."
103213,1.01,O,3582.0,"We observed a positive association between intake of niacin and overall gastric cancer risk ( OR   =   1.33 , 95%CI : 1.01 - 1.75 per SD increment ) ."
103214,-,O,3582.0,"We observed a positive association between intake of niacin and overall gastric cancer risk ( OR   =   1.33 , 95%CI : 1.01 - 1.75 per SD increment ) ."
103215,1.75,O,3582.0,"We observed a positive association between intake of niacin and overall gastric cancer risk ( OR   =   1.33 , 95%CI : 1.01 - 1.75 per SD increment ) ."
103216,per,O,3582.0,"We observed a positive association between intake of niacin and overall gastric cancer risk ( OR   =   1.33 , 95%CI : 1.01 - 1.75 per SD increment ) ."
103217,SD,O,3582.0,"We observed a positive association between intake of niacin and overall gastric cancer risk ( OR   =   1.33 , 95%CI : 1.01 - 1.75 per SD increment ) ."
103218,increment,O,3582.0,"We observed a positive association between intake of niacin and overall gastric cancer risk ( OR   =   1.33 , 95%CI : 1.01 - 1.75 per SD increment ) ."
103219,),O,3582.0,"We observed a positive association between intake of niacin and overall gastric cancer risk ( OR   =   1.33 , 95%CI : 1.01 - 1.75 per SD increment ) ."
103220,.,O,3582.0,"We observed a positive association between intake of niacin and overall gastric cancer risk ( OR   =   1.33 , 95%CI : 1.01 - 1.75 per SD increment ) ."
103221,For,O,3583.0,"For thiamine , heterogeneity by subtype ( cardia and non - cardia ) was found ( P The reported milk consumption habits of 3,334 cancer patients and 1,300 comparable control subjects seen at Roswell Park Memorial Institute were studied ."
103222,thiamine,O,3583.0,"For thiamine , heterogeneity by subtype ( cardia and non - cardia ) was found ( P The reported milk consumption habits of 3,334 cancer patients and 1,300 comparable control subjects seen at Roswell Park Memorial Institute were studied ."
103223,",",O,3583.0,"For thiamine , heterogeneity by subtype ( cardia and non - cardia ) was found ( P The reported milk consumption habits of 3,334 cancer patients and 1,300 comparable control subjects seen at Roswell Park Memorial Institute were studied ."
103224,heterogeneity,O,3583.0,"For thiamine , heterogeneity by subtype ( cardia and non - cardia ) was found ( P The reported milk consumption habits of 3,334 cancer patients and 1,300 comparable control subjects seen at Roswell Park Memorial Institute were studied ."
103225,by,O,3583.0,"For thiamine , heterogeneity by subtype ( cardia and non - cardia ) was found ( P The reported milk consumption habits of 3,334 cancer patients and 1,300 comparable control subjects seen at Roswell Park Memorial Institute were studied ."
103226,subtype,O,3583.0,"For thiamine , heterogeneity by subtype ( cardia and non - cardia ) was found ( P The reported milk consumption habits of 3,334 cancer patients and 1,300 comparable control subjects seen at Roswell Park Memorial Institute were studied ."
103227,(,O,3583.0,"For thiamine , heterogeneity by subtype ( cardia and non - cardia ) was found ( P The reported milk consumption habits of 3,334 cancer patients and 1,300 comparable control subjects seen at Roswell Park Memorial Institute were studied ."
103228,cardia,O,3583.0,"For thiamine , heterogeneity by subtype ( cardia and non - cardia ) was found ( P The reported milk consumption habits of 3,334 cancer patients and 1,300 comparable control subjects seen at Roswell Park Memorial Institute were studied ."
103229,and,O,3583.0,"For thiamine , heterogeneity by subtype ( cardia and non - cardia ) was found ( P The reported milk consumption habits of 3,334 cancer patients and 1,300 comparable control subjects seen at Roswell Park Memorial Institute were studied ."
103230,non,O,3583.0,"For thiamine , heterogeneity by subtype ( cardia and non - cardia ) was found ( P The reported milk consumption habits of 3,334 cancer patients and 1,300 comparable control subjects seen at Roswell Park Memorial Institute were studied ."
103231,-,O,3583.0,"For thiamine , heterogeneity by subtype ( cardia and non - cardia ) was found ( P The reported milk consumption habits of 3,334 cancer patients and 1,300 comparable control subjects seen at Roswell Park Memorial Institute were studied ."
103232,cardia,O,3583.0,"For thiamine , heterogeneity by subtype ( cardia and non - cardia ) was found ( P The reported milk consumption habits of 3,334 cancer patients and 1,300 comparable control subjects seen at Roswell Park Memorial Institute were studied ."
103233,),O,3583.0,"For thiamine , heterogeneity by subtype ( cardia and non - cardia ) was found ( P The reported milk consumption habits of 3,334 cancer patients and 1,300 comparable control subjects seen at Roswell Park Memorial Institute were studied ."
103234,was,O,3583.0,"For thiamine , heterogeneity by subtype ( cardia and non - cardia ) was found ( P The reported milk consumption habits of 3,334 cancer patients and 1,300 comparable control subjects seen at Roswell Park Memorial Institute were studied ."
103235,found,O,3583.0,"For thiamine , heterogeneity by subtype ( cardia and non - cardia ) was found ( P The reported milk consumption habits of 3,334 cancer patients and 1,300 comparable control subjects seen at Roswell Park Memorial Institute were studied ."
103236,(,O,3583.0,"For thiamine , heterogeneity by subtype ( cardia and non - cardia ) was found ( P The reported milk consumption habits of 3,334 cancer patients and 1,300 comparable control subjects seen at Roswell Park Memorial Institute were studied ."
103237,P,O,3583.0,"For thiamine , heterogeneity by subtype ( cardia and non - cardia ) was found ( P The reported milk consumption habits of 3,334 cancer patients and 1,300 comparable control subjects seen at Roswell Park Memorial Institute were studied ."
103238,The,O,3583.0,"For thiamine , heterogeneity by subtype ( cardia and non - cardia ) was found ( P The reported milk consumption habits of 3,334 cancer patients and 1,300 comparable control subjects seen at Roswell Park Memorial Institute were studied ."
103239,reported,O,3583.0,"For thiamine , heterogeneity by subtype ( cardia and non - cardia ) was found ( P The reported milk consumption habits of 3,334 cancer patients and 1,300 comparable control subjects seen at Roswell Park Memorial Institute were studied ."
103240,milk,B-AG.01.e,3583.0,"For thiamine , heterogeneity by subtype ( cardia and non - cardia ) was found ( P The reported milk consumption habits of 3,334 cancer patients and 1,300 comparable control subjects seen at Roswell Park Memorial Institute were studied ."
103241,consumption,B-X,3583.0,"For thiamine , heterogeneity by subtype ( cardia and non - cardia ) was found ( P The reported milk consumption habits of 3,334 cancer patients and 1,300 comparable control subjects seen at Roswell Park Memorial Institute were studied ."
103242,habits,O,3583.0,"For thiamine , heterogeneity by subtype ( cardia and non - cardia ) was found ( P The reported milk consumption habits of 3,334 cancer patients and 1,300 comparable control subjects seen at Roswell Park Memorial Institute were studied ."
103243,of,O,3583.0,"For thiamine , heterogeneity by subtype ( cardia and non - cardia ) was found ( P The reported milk consumption habits of 3,334 cancer patients and 1,300 comparable control subjects seen at Roswell Park Memorial Institute were studied ."
103244,"3,334",O,3583.0,"For thiamine , heterogeneity by subtype ( cardia and non - cardia ) was found ( P The reported milk consumption habits of 3,334 cancer patients and 1,300 comparable control subjects seen at Roswell Park Memorial Institute were studied ."
103245,cancer,O,3583.0,"For thiamine , heterogeneity by subtype ( cardia and non - cardia ) was found ( P The reported milk consumption habits of 3,334 cancer patients and 1,300 comparable control subjects seen at Roswell Park Memorial Institute were studied ."
103246,patients,O,3583.0,"For thiamine , heterogeneity by subtype ( cardia and non - cardia ) was found ( P The reported milk consumption habits of 3,334 cancer patients and 1,300 comparable control subjects seen at Roswell Park Memorial Institute were studied ."
103247,and,O,3583.0,"For thiamine , heterogeneity by subtype ( cardia and non - cardia ) was found ( P The reported milk consumption habits of 3,334 cancer patients and 1,300 comparable control subjects seen at Roswell Park Memorial Institute were studied ."
103248,"1,300",O,3583.0,"For thiamine , heterogeneity by subtype ( cardia and non - cardia ) was found ( P The reported milk consumption habits of 3,334 cancer patients and 1,300 comparable control subjects seen at Roswell Park Memorial Institute were studied ."
103249,comparable,O,3583.0,"For thiamine , heterogeneity by subtype ( cardia and non - cardia ) was found ( P The reported milk consumption habits of 3,334 cancer patients and 1,300 comparable control subjects seen at Roswell Park Memorial Institute were studied ."
103250,control,O,3583.0,"For thiamine , heterogeneity by subtype ( cardia and non - cardia ) was found ( P The reported milk consumption habits of 3,334 cancer patients and 1,300 comparable control subjects seen at Roswell Park Memorial Institute were studied ."
103251,subjects,O,3583.0,"For thiamine , heterogeneity by subtype ( cardia and non - cardia ) was found ( P The reported milk consumption habits of 3,334 cancer patients and 1,300 comparable control subjects seen at Roswell Park Memorial Institute were studied ."
103252,seen,O,3583.0,"For thiamine , heterogeneity by subtype ( cardia and non - cardia ) was found ( P The reported milk consumption habits of 3,334 cancer patients and 1,300 comparable control subjects seen at Roswell Park Memorial Institute were studied ."
103253,at,O,3583.0,"For thiamine , heterogeneity by subtype ( cardia and non - cardia ) was found ( P The reported milk consumption habits of 3,334 cancer patients and 1,300 comparable control subjects seen at Roswell Park Memorial Institute were studied ."
103254,Roswell,O,3583.0,"For thiamine , heterogeneity by subtype ( cardia and non - cardia ) was found ( P The reported milk consumption habits of 3,334 cancer patients and 1,300 comparable control subjects seen at Roswell Park Memorial Institute were studied ."
103255,Park,O,3583.0,"For thiamine , heterogeneity by subtype ( cardia and non - cardia ) was found ( P The reported milk consumption habits of 3,334 cancer patients and 1,300 comparable control subjects seen at Roswell Park Memorial Institute were studied ."
103256,Memorial,O,3583.0,"For thiamine , heterogeneity by subtype ( cardia and non - cardia ) was found ( P The reported milk consumption habits of 3,334 cancer patients and 1,300 comparable control subjects seen at Roswell Park Memorial Institute were studied ."
103257,Institute,O,3583.0,"For thiamine , heterogeneity by subtype ( cardia and non - cardia ) was found ( P The reported milk consumption habits of 3,334 cancer patients and 1,300 comparable control subjects seen at Roswell Park Memorial Institute were studied ."
103258,were,O,3583.0,"For thiamine , heterogeneity by subtype ( cardia and non - cardia ) was found ( P The reported milk consumption habits of 3,334 cancer patients and 1,300 comparable control subjects seen at Roswell Park Memorial Institute were studied ."
103259,studied,O,3583.0,"For thiamine , heterogeneity by subtype ( cardia and non - cardia ) was found ( P The reported milk consumption habits of 3,334 cancer patients and 1,300 comparable control subjects seen at Roswell Park Memorial Institute were studied ."
103260,.,O,3583.0,"For thiamine , heterogeneity by subtype ( cardia and non - cardia ) was found ( P The reported milk consumption habits of 3,334 cancer patients and 1,300 comparable control subjects seen at Roswell Park Memorial Institute were studied ."
103261,The,O,3584.0,"The cancer patient group included persons diagnosed with cancers of the oral cavity , stomach , colon , rectum , lung , breast , uterus , cervix , prostate , or bladder ."
103262,cancer,O,3584.0,"The cancer patient group included persons diagnosed with cancers of the oral cavity , stomach , colon , rectum , lung , breast , uterus , cervix , prostate , or bladder ."
103263,patient,O,3584.0,"The cancer patient group included persons diagnosed with cancers of the oral cavity , stomach , colon , rectum , lung , breast , uterus , cervix , prostate , or bladder ."
103264,group,O,3584.0,"The cancer patient group included persons diagnosed with cancers of the oral cavity , stomach , colon , rectum , lung , breast , uterus , cervix , prostate , or bladder ."
103265,included,O,3584.0,"The cancer patient group included persons diagnosed with cancers of the oral cavity , stomach , colon , rectum , lung , breast , uterus , cervix , prostate , or bladder ."
103266,persons,O,3584.0,"The cancer patient group included persons diagnosed with cancers of the oral cavity , stomach , colon , rectum , lung , breast , uterus , cervix , prostate , or bladder ."
103267,diagnosed,O,3584.0,"The cancer patient group included persons diagnosed with cancers of the oral cavity , stomach , colon , rectum , lung , breast , uterus , cervix , prostate , or bladder ."
103268,with,O,3584.0,"The cancer patient group included persons diagnosed with cancers of the oral cavity , stomach , colon , rectum , lung , breast , uterus , cervix , prostate , or bladder ."
103269,cancers,O,3584.0,"The cancer patient group included persons diagnosed with cancers of the oral cavity , stomach , colon , rectum , lung , breast , uterus , cervix , prostate , or bladder ."
103270,of,O,3584.0,"The cancer patient group included persons diagnosed with cancers of the oral cavity , stomach , colon , rectum , lung , breast , uterus , cervix , prostate , or bladder ."
103271,the,O,3584.0,"The cancer patient group included persons diagnosed with cancers of the oral cavity , stomach , colon , rectum , lung , breast , uterus , cervix , prostate , or bladder ."
103272,oral,O,3584.0,"The cancer patient group included persons diagnosed with cancers of the oral cavity , stomach , colon , rectum , lung , breast , uterus , cervix , prostate , or bladder ."
103273,cavity,O,3584.0,"The cancer patient group included persons diagnosed with cancers of the oral cavity , stomach , colon , rectum , lung , breast , uterus , cervix , prostate , or bladder ."
103274,",",O,3584.0,"The cancer patient group included persons diagnosed with cancers of the oral cavity , stomach , colon , rectum , lung , breast , uterus , cervix , prostate , or bladder ."
103275,stomach,O,3584.0,"The cancer patient group included persons diagnosed with cancers of the oral cavity , stomach , colon , rectum , lung , breast , uterus , cervix , prostate , or bladder ."
103276,",",O,3584.0,"The cancer patient group included persons diagnosed with cancers of the oral cavity , stomach , colon , rectum , lung , breast , uterus , cervix , prostate , or bladder ."
103277,colon,O,3584.0,"The cancer patient group included persons diagnosed with cancers of the oral cavity , stomach , colon , rectum , lung , breast , uterus , cervix , prostate , or bladder ."
103278,",",O,3584.0,"The cancer patient group included persons diagnosed with cancers of the oral cavity , stomach , colon , rectum , lung , breast , uterus , cervix , prostate , or bladder ."
103279,rectum,O,3584.0,"The cancer patient group included persons diagnosed with cancers of the oral cavity , stomach , colon , rectum , lung , breast , uterus , cervix , prostate , or bladder ."
103280,",",O,3584.0,"The cancer patient group included persons diagnosed with cancers of the oral cavity , stomach , colon , rectum , lung , breast , uterus , cervix , prostate , or bladder ."
103281,lung,O,3584.0,"The cancer patient group included persons diagnosed with cancers of the oral cavity , stomach , colon , rectum , lung , breast , uterus , cervix , prostate , or bladder ."
103282,",",O,3584.0,"The cancer patient group included persons diagnosed with cancers of the oral cavity , stomach , colon , rectum , lung , breast , uterus , cervix , prostate , or bladder ."
103283,breast,O,3584.0,"The cancer patient group included persons diagnosed with cancers of the oral cavity , stomach , colon , rectum , lung , breast , uterus , cervix , prostate , or bladder ."
103284,",",O,3584.0,"The cancer patient group included persons diagnosed with cancers of the oral cavity , stomach , colon , rectum , lung , breast , uterus , cervix , prostate , or bladder ."
103285,uterus,O,3584.0,"The cancer patient group included persons diagnosed with cancers of the oral cavity , stomach , colon , rectum , lung , breast , uterus , cervix , prostate , or bladder ."
103286,",",O,3584.0,"The cancer patient group included persons diagnosed with cancers of the oral cavity , stomach , colon , rectum , lung , breast , uterus , cervix , prostate , or bladder ."
103287,cervix,O,3584.0,"The cancer patient group included persons diagnosed with cancers of the oral cavity , stomach , colon , rectum , lung , breast , uterus , cervix , prostate , or bladder ."
103288,",",O,3584.0,"The cancer patient group included persons diagnosed with cancers of the oral cavity , stomach , colon , rectum , lung , breast , uterus , cervix , prostate , or bladder ."
103289,prostate,O,3584.0,"The cancer patient group included persons diagnosed with cancers of the oral cavity , stomach , colon , rectum , lung , breast , uterus , cervix , prostate , or bladder ."
103290,",",O,3584.0,"The cancer patient group included persons diagnosed with cancers of the oral cavity , stomach , colon , rectum , lung , breast , uterus , cervix , prostate , or bladder ."
103291,or,O,3584.0,"The cancer patient group included persons diagnosed with cancers of the oral cavity , stomach , colon , rectum , lung , breast , uterus , cervix , prostate , or bladder ."
103292,bladder,O,3584.0,"The cancer patient group included persons diagnosed with cancers of the oral cavity , stomach , colon , rectum , lung , breast , uterus , cervix , prostate , or bladder ."
103293,.,O,3584.0,"The cancer patient group included persons diagnosed with cancers of the oral cavity , stomach , colon , rectum , lung , breast , uterus , cervix , prostate , or bladder ."
103294,Data,O,3585.0,Data were obtained by means of a standardized admissions questionnaire .
103295,were,O,3585.0,Data were obtained by means of a standardized admissions questionnaire .
103296,obtained,O,3585.0,Data were obtained by means of a standardized admissions questionnaire .
103297,by,O,3585.0,Data were obtained by means of a standardized admissions questionnaire .
103298,means,O,3585.0,Data were obtained by means of a standardized admissions questionnaire .
103299,of,O,3585.0,Data were obtained by means of a standardized admissions questionnaire .
103300,a,O,3585.0,Data were obtained by means of a standardized admissions questionnaire .
103301,standardized,O,3585.0,Data were obtained by means of a standardized admissions questionnaire .
103302,admissions,O,3585.0,Data were obtained by means of a standardized admissions questionnaire .
103303,questionnaire,O,3585.0,Data were obtained by means of a standardized admissions questionnaire .
103304,.,O,3585.0,Data were obtained by means of a standardized admissions questionnaire .
103305,As,O,3586.0,"As a group , control patients were more likely to report never drinking whole milk ; cancer patients more often reported frequent consumption of whole milk ."
103306,a,O,3586.0,"As a group , control patients were more likely to report never drinking whole milk ; cancer patients more often reported frequent consumption of whole milk ."
103307,group,O,3586.0,"As a group , control patients were more likely to report never drinking whole milk ; cancer patients more often reported frequent consumption of whole milk ."
103308,",",O,3586.0,"As a group , control patients were more likely to report never drinking whole milk ; cancer patients more often reported frequent consumption of whole milk ."
103309,control,O,3586.0,"As a group , control patients were more likely to report never drinking whole milk ; cancer patients more often reported frequent consumption of whole milk ."
103310,patients,O,3586.0,"As a group , control patients were more likely to report never drinking whole milk ; cancer patients more often reported frequent consumption of whole milk ."
103311,were,O,3586.0,"As a group , control patients were more likely to report never drinking whole milk ; cancer patients more often reported frequent consumption of whole milk ."
103312,more,O,3586.0,"As a group , control patients were more likely to report never drinking whole milk ; cancer patients more often reported frequent consumption of whole milk ."
103313,likely,O,3586.0,"As a group , control patients were more likely to report never drinking whole milk ; cancer patients more often reported frequent consumption of whole milk ."
103314,to,O,3586.0,"As a group , control patients were more likely to report never drinking whole milk ; cancer patients more often reported frequent consumption of whole milk ."
103315,report,O,3586.0,"As a group , control patients were more likely to report never drinking whole milk ; cancer patients more often reported frequent consumption of whole milk ."
103316,never,O,3586.0,"As a group , control patients were more likely to report never drinking whole milk ; cancer patients more often reported frequent consumption of whole milk ."
103317,drinking,O,3586.0,"As a group , control patients were more likely to report never drinking whole milk ; cancer patients more often reported frequent consumption of whole milk ."
103318,whole,B-AG.01.e,3586.0,"As a group , control patients were more likely to report never drinking whole milk ; cancer patients more often reported frequent consumption of whole milk ."
103319,milk,I-AG.01.e,3586.0,"As a group , control patients were more likely to report never drinking whole milk ; cancer patients more often reported frequent consumption of whole milk ."
103320,;,O,3586.0,"As a group , control patients were more likely to report never drinking whole milk ; cancer patients more often reported frequent consumption of whole milk ."
103321,cancer,O,3586.0,"As a group , control patients were more likely to report never drinking whole milk ; cancer patients more often reported frequent consumption of whole milk ."
103322,patients,O,3586.0,"As a group , control patients were more likely to report never drinking whole milk ; cancer patients more often reported frequent consumption of whole milk ."
103323,more,O,3586.0,"As a group , control patients were more likely to report never drinking whole milk ; cancer patients more often reported frequent consumption of whole milk ."
103324,often,O,3586.0,"As a group , control patients were more likely to report never drinking whole milk ; cancer patients more often reported frequent consumption of whole milk ."
103325,reported,O,3586.0,"As a group , control patients were more likely to report never drinking whole milk ; cancer patients more often reported frequent consumption of whole milk ."
103326,frequent,O,3586.0,"As a group , control patients were more likely to report never drinking whole milk ; cancer patients more often reported frequent consumption of whole milk ."
103327,consumption,O,3586.0,"As a group , control patients were more likely to report never drinking whole milk ; cancer patients more often reported frequent consumption of whole milk ."
103328,of,O,3586.0,"As a group , control patients were more likely to report never drinking whole milk ; cancer patients more often reported frequent consumption of whole milk ."
103329,whole,B-AG.01.e,3586.0,"As a group , control patients were more likely to report never drinking whole milk ; cancer patients more often reported frequent consumption of whole milk ."
103330,milk,I-AG.01.e,3586.0,"As a group , control patients were more likely to report never drinking whole milk ; cancer patients more often reported frequent consumption of whole milk ."
103331,.,O,3586.0,"As a group , control patients were more likely to report never drinking whole milk ; cancer patients more often reported frequent consumption of whole milk ."
103332,Relative,O,3587.0,"Relative risks of different patterns of milk consumption for specific cancer diagnoses , adjusted for sex , age , smoking history , education , and county of residence , were calculated with multiple logistic regression analysis ."
103333,risks,O,3587.0,"Relative risks of different patterns of milk consumption for specific cancer diagnoses , adjusted for sex , age , smoking history , education , and county of residence , were calculated with multiple logistic regression analysis ."
103334,of,O,3587.0,"Relative risks of different patterns of milk consumption for specific cancer diagnoses , adjusted for sex , age , smoking history , education , and county of residence , were calculated with multiple logistic regression analysis ."
103335,different,O,3587.0,"Relative risks of different patterns of milk consumption for specific cancer diagnoses , adjusted for sex , age , smoking history , education , and county of residence , were calculated with multiple logistic regression analysis ."
103336,patterns,O,3587.0,"Relative risks of different patterns of milk consumption for specific cancer diagnoses , adjusted for sex , age , smoking history , education , and county of residence , were calculated with multiple logistic regression analysis ."
103337,of,O,3587.0,"Relative risks of different patterns of milk consumption for specific cancer diagnoses , adjusted for sex , age , smoking history , education , and county of residence , were calculated with multiple logistic regression analysis ."
103338,milk,B-AG.01.e,3587.0,"Relative risks of different patterns of milk consumption for specific cancer diagnoses , adjusted for sex , age , smoking history , education , and county of residence , were calculated with multiple logistic regression analysis ."
103339,consumption,B-X,3587.0,"Relative risks of different patterns of milk consumption for specific cancer diagnoses , adjusted for sex , age , smoking history , education , and county of residence , were calculated with multiple logistic regression analysis ."
103340,for,O,3587.0,"Relative risks of different patterns of milk consumption for specific cancer diagnoses , adjusted for sex , age , smoking history , education , and county of residence , were calculated with multiple logistic regression analysis ."
103341,specific,O,3587.0,"Relative risks of different patterns of milk consumption for specific cancer diagnoses , adjusted for sex , age , smoking history , education , and county of residence , were calculated with multiple logistic regression analysis ."
103342,cancer,O,3587.0,"Relative risks of different patterns of milk consumption for specific cancer diagnoses , adjusted for sex , age , smoking history , education , and county of residence , were calculated with multiple logistic regression analysis ."
103343,diagnoses,O,3587.0,"Relative risks of different patterns of milk consumption for specific cancer diagnoses , adjusted for sex , age , smoking history , education , and county of residence , were calculated with multiple logistic regression analysis ."
103344,",",O,3587.0,"Relative risks of different patterns of milk consumption for specific cancer diagnoses , adjusted for sex , age , smoking history , education , and county of residence , were calculated with multiple logistic regression analysis ."
103345,adjusted,O,3587.0,"Relative risks of different patterns of milk consumption for specific cancer diagnoses , adjusted for sex , age , smoking history , education , and county of residence , were calculated with multiple logistic regression analysis ."
103346,for,O,3587.0,"Relative risks of different patterns of milk consumption for specific cancer diagnoses , adjusted for sex , age , smoking history , education , and county of residence , were calculated with multiple logistic regression analysis ."
103347,sex,O,3587.0,"Relative risks of different patterns of milk consumption for specific cancer diagnoses , adjusted for sex , age , smoking history , education , and county of residence , were calculated with multiple logistic regression analysis ."
103348,",",O,3587.0,"Relative risks of different patterns of milk consumption for specific cancer diagnoses , adjusted for sex , age , smoking history , education , and county of residence , were calculated with multiple logistic regression analysis ."
103349,age,O,3587.0,"Relative risks of different patterns of milk consumption for specific cancer diagnoses , adjusted for sex , age , smoking history , education , and county of residence , were calculated with multiple logistic regression analysis ."
103350,",",O,3587.0,"Relative risks of different patterns of milk consumption for specific cancer diagnoses , adjusted for sex , age , smoking history , education , and county of residence , were calculated with multiple logistic regression analysis ."
103351,smoking,O,3587.0,"Relative risks of different patterns of milk consumption for specific cancer diagnoses , adjusted for sex , age , smoking history , education , and county of residence , were calculated with multiple logistic regression analysis ."
103352,history,O,3587.0,"Relative risks of different patterns of milk consumption for specific cancer diagnoses , adjusted for sex , age , smoking history , education , and county of residence , were calculated with multiple logistic regression analysis ."
103353,",",O,3587.0,"Relative risks of different patterns of milk consumption for specific cancer diagnoses , adjusted for sex , age , smoking history , education , and county of residence , were calculated with multiple logistic regression analysis ."
103354,education,O,3587.0,"Relative risks of different patterns of milk consumption for specific cancer diagnoses , adjusted for sex , age , smoking history , education , and county of residence , were calculated with multiple logistic regression analysis ."
103355,",",O,3587.0,"Relative risks of different patterns of milk consumption for specific cancer diagnoses , adjusted for sex , age , smoking history , education , and county of residence , were calculated with multiple logistic regression analysis ."
103356,and,O,3587.0,"Relative risks of different patterns of milk consumption for specific cancer diagnoses , adjusted for sex , age , smoking history , education , and county of residence , were calculated with multiple logistic regression analysis ."
103357,county,O,3587.0,"Relative risks of different patterns of milk consumption for specific cancer diagnoses , adjusted for sex , age , smoking history , education , and county of residence , were calculated with multiple logistic regression analysis ."
103358,of,O,3587.0,"Relative risks of different patterns of milk consumption for specific cancer diagnoses , adjusted for sex , age , smoking history , education , and county of residence , were calculated with multiple logistic regression analysis ."
103359,residence,O,3587.0,"Relative risks of different patterns of milk consumption for specific cancer diagnoses , adjusted for sex , age , smoking history , education , and county of residence , were calculated with multiple logistic regression analysis ."
103360,",",O,3587.0,"Relative risks of different patterns of milk consumption for specific cancer diagnoses , adjusted for sex , age , smoking history , education , and county of residence , were calculated with multiple logistic regression analysis ."
103361,were,O,3587.0,"Relative risks of different patterns of milk consumption for specific cancer diagnoses , adjusted for sex , age , smoking history , education , and county of residence , were calculated with multiple logistic regression analysis ."
103362,calculated,O,3587.0,"Relative risks of different patterns of milk consumption for specific cancer diagnoses , adjusted for sex , age , smoking history , education , and county of residence , were calculated with multiple logistic regression analysis ."
103363,with,O,3587.0,"Relative risks of different patterns of milk consumption for specific cancer diagnoses , adjusted for sex , age , smoking history , education , and county of residence , were calculated with multiple logistic regression analysis ."
103364,multiple,O,3587.0,"Relative risks of different patterns of milk consumption for specific cancer diagnoses , adjusted for sex , age , smoking history , education , and county of residence , were calculated with multiple logistic regression analysis ."
103365,logistic,O,3587.0,"Relative risks of different patterns of milk consumption for specific cancer diagnoses , adjusted for sex , age , smoking history , education , and county of residence , were calculated with multiple logistic regression analysis ."
103366,regression,O,3587.0,"Relative risks of different patterns of milk consumption for specific cancer diagnoses , adjusted for sex , age , smoking history , education , and county of residence , were calculated with multiple logistic regression analysis ."
103367,analysis,O,3587.0,"Relative risks of different patterns of milk consumption for specific cancer diagnoses , adjusted for sex , age , smoking history , education , and county of residence , were calculated with multiple logistic regression analysis ."
103368,.,O,3587.0,"Relative risks of different patterns of milk consumption for specific cancer diagnoses , adjusted for sex , age , smoking history , education , and county of residence , were calculated with multiple logistic regression analysis ."
103369,Elevated,O,3588.0,"Elevated risks for frequent consumption of whole milk relative to not drinking milk were observed for cancers of the oral cavity , stomach , colon , rectum , lung , bladder , breast , and cervix ."
103370,risks,O,3588.0,"Elevated risks for frequent consumption of whole milk relative to not drinking milk were observed for cancers of the oral cavity , stomach , colon , rectum , lung , bladder , breast , and cervix ."
103371,for,O,3588.0,"Elevated risks for frequent consumption of whole milk relative to not drinking milk were observed for cancers of the oral cavity , stomach , colon , rectum , lung , bladder , breast , and cervix ."
103372,frequent,O,3588.0,"Elevated risks for frequent consumption of whole milk relative to not drinking milk were observed for cancers of the oral cavity , stomach , colon , rectum , lung , bladder , breast , and cervix ."
103373,consumption,O,3588.0,"Elevated risks for frequent consumption of whole milk relative to not drinking milk were observed for cancers of the oral cavity , stomach , colon , rectum , lung , bladder , breast , and cervix ."
103374,of,O,3588.0,"Elevated risks for frequent consumption of whole milk relative to not drinking milk were observed for cancers of the oral cavity , stomach , colon , rectum , lung , bladder , breast , and cervix ."
103375,whole,B-AG.01.e,3588.0,"Elevated risks for frequent consumption of whole milk relative to not drinking milk were observed for cancers of the oral cavity , stomach , colon , rectum , lung , bladder , breast , and cervix ."
103376,milk,I-AG.01.e,3588.0,"Elevated risks for frequent consumption of whole milk relative to not drinking milk were observed for cancers of the oral cavity , stomach , colon , rectum , lung , bladder , breast , and cervix ."
103377,relative,O,3588.0,"Elevated risks for frequent consumption of whole milk relative to not drinking milk were observed for cancers of the oral cavity , stomach , colon , rectum , lung , bladder , breast , and cervix ."
103378,to,O,3588.0,"Elevated risks for frequent consumption of whole milk relative to not drinking milk were observed for cancers of the oral cavity , stomach , colon , rectum , lung , bladder , breast , and cervix ."
103379,not,O,3588.0,"Elevated risks for frequent consumption of whole milk relative to not drinking milk were observed for cancers of the oral cavity , stomach , colon , rectum , lung , bladder , breast , and cervix ."
103380,drinking,O,3588.0,"Elevated risks for frequent consumption of whole milk relative to not drinking milk were observed for cancers of the oral cavity , stomach , colon , rectum , lung , bladder , breast , and cervix ."
103381,milk,B-AG.01.e,3588.0,"Elevated risks for frequent consumption of whole milk relative to not drinking milk were observed for cancers of the oral cavity , stomach , colon , rectum , lung , bladder , breast , and cervix ."
103382,were,O,3588.0,"Elevated risks for frequent consumption of whole milk relative to not drinking milk were observed for cancers of the oral cavity , stomach , colon , rectum , lung , bladder , breast , and cervix ."
103383,observed,O,3588.0,"Elevated risks for frequent consumption of whole milk relative to not drinking milk were observed for cancers of the oral cavity , stomach , colon , rectum , lung , bladder , breast , and cervix ."
103384,for,O,3588.0,"Elevated risks for frequent consumption of whole milk relative to not drinking milk were observed for cancers of the oral cavity , stomach , colon , rectum , lung , bladder , breast , and cervix ."
103385,cancers,O,3588.0,"Elevated risks for frequent consumption of whole milk relative to not drinking milk were observed for cancers of the oral cavity , stomach , colon , rectum , lung , bladder , breast , and cervix ."
103386,of,O,3588.0,"Elevated risks for frequent consumption of whole milk relative to not drinking milk were observed for cancers of the oral cavity , stomach , colon , rectum , lung , bladder , breast , and cervix ."
103387,the,O,3588.0,"Elevated risks for frequent consumption of whole milk relative to not drinking milk were observed for cancers of the oral cavity , stomach , colon , rectum , lung , bladder , breast , and cervix ."
103388,oral,O,3588.0,"Elevated risks for frequent consumption of whole milk relative to not drinking milk were observed for cancers of the oral cavity , stomach , colon , rectum , lung , bladder , breast , and cervix ."
103389,cavity,O,3588.0,"Elevated risks for frequent consumption of whole milk relative to not drinking milk were observed for cancers of the oral cavity , stomach , colon , rectum , lung , bladder , breast , and cervix ."
103390,",",O,3588.0,"Elevated risks for frequent consumption of whole milk relative to not drinking milk were observed for cancers of the oral cavity , stomach , colon , rectum , lung , bladder , breast , and cervix ."
103391,stomach,O,3588.0,"Elevated risks for frequent consumption of whole milk relative to not drinking milk were observed for cancers of the oral cavity , stomach , colon , rectum , lung , bladder , breast , and cervix ."
103392,",",O,3588.0,"Elevated risks for frequent consumption of whole milk relative to not drinking milk were observed for cancers of the oral cavity , stomach , colon , rectum , lung , bladder , breast , and cervix ."
103393,colon,O,3588.0,"Elevated risks for frequent consumption of whole milk relative to not drinking milk were observed for cancers of the oral cavity , stomach , colon , rectum , lung , bladder , breast , and cervix ."
103394,",",O,3588.0,"Elevated risks for frequent consumption of whole milk relative to not drinking milk were observed for cancers of the oral cavity , stomach , colon , rectum , lung , bladder , breast , and cervix ."
103395,rectum,O,3588.0,"Elevated risks for frequent consumption of whole milk relative to not drinking milk were observed for cancers of the oral cavity , stomach , colon , rectum , lung , bladder , breast , and cervix ."
103396,",",O,3588.0,"Elevated risks for frequent consumption of whole milk relative to not drinking milk were observed for cancers of the oral cavity , stomach , colon , rectum , lung , bladder , breast , and cervix ."
103397,lung,O,3588.0,"Elevated risks for frequent consumption of whole milk relative to not drinking milk were observed for cancers of the oral cavity , stomach , colon , rectum , lung , bladder , breast , and cervix ."
103398,",",O,3588.0,"Elevated risks for frequent consumption of whole milk relative to not drinking milk were observed for cancers of the oral cavity , stomach , colon , rectum , lung , bladder , breast , and cervix ."
103399,bladder,O,3588.0,"Elevated risks for frequent consumption of whole milk relative to not drinking milk were observed for cancers of the oral cavity , stomach , colon , rectum , lung , bladder , breast , and cervix ."
103400,",",O,3588.0,"Elevated risks for frequent consumption of whole milk relative to not drinking milk were observed for cancers of the oral cavity , stomach , colon , rectum , lung , bladder , breast , and cervix ."
103401,breast,O,3588.0,"Elevated risks for frequent consumption of whole milk relative to not drinking milk were observed for cancers of the oral cavity , stomach , colon , rectum , lung , bladder , breast , and cervix ."
103402,",",O,3588.0,"Elevated risks for frequent consumption of whole milk relative to not drinking milk were observed for cancers of the oral cavity , stomach , colon , rectum , lung , bladder , breast , and cervix ."
103403,and,O,3588.0,"Elevated risks for frequent consumption of whole milk relative to not drinking milk were observed for cancers of the oral cavity , stomach , colon , rectum , lung , bladder , breast , and cervix ."
103404,cervix,O,3588.0,"Elevated risks for frequent consumption of whole milk relative to not drinking milk were observed for cancers of the oral cavity , stomach , colon , rectum , lung , bladder , breast , and cervix ."
103405,.,O,3588.0,"Elevated risks for frequent consumption of whole milk relative to not drinking milk were observed for cancers of the oral cavity , stomach , colon , rectum , lung , bladder , breast , and cervix ."
103406,Reduced,O,3589.0,"Reduced risks for frequent consumption of 2 % milk relative to not drinking milk were observed for cancers of the oral cavity , stomach , rectum , lung , and cervix ."
103407,risks,O,3589.0,"Reduced risks for frequent consumption of 2 % milk relative to not drinking milk were observed for cancers of the oral cavity , stomach , rectum , lung , and cervix ."
103408,for,O,3589.0,"Reduced risks for frequent consumption of 2 % milk relative to not drinking milk were observed for cancers of the oral cavity , stomach , rectum , lung , and cervix ."
103409,frequent,O,3589.0,"Reduced risks for frequent consumption of 2 % milk relative to not drinking milk were observed for cancers of the oral cavity , stomach , rectum , lung , and cervix ."
103410,consumption,O,3589.0,"Reduced risks for frequent consumption of 2 % milk relative to not drinking milk were observed for cancers of the oral cavity , stomach , rectum , lung , and cervix ."
103411,of,O,3589.0,"Reduced risks for frequent consumption of 2 % milk relative to not drinking milk were observed for cancers of the oral cavity , stomach , rectum , lung , and cervix ."
103412,2,B-AG.01.e,3589.0,"Reduced risks for frequent consumption of 2 % milk relative to not drinking milk were observed for cancers of the oral cavity , stomach , rectum , lung , and cervix ."
103413,%,I-AG.01.e,3589.0,"Reduced risks for frequent consumption of 2 % milk relative to not drinking milk were observed for cancers of the oral cavity , stomach , rectum , lung , and cervix ."
103414,milk,I-AG.01.e,3589.0,"Reduced risks for frequent consumption of 2 % milk relative to not drinking milk were observed for cancers of the oral cavity , stomach , rectum , lung , and cervix ."
103415,relative,O,3589.0,"Reduced risks for frequent consumption of 2 % milk relative to not drinking milk were observed for cancers of the oral cavity , stomach , rectum , lung , and cervix ."
103416,to,O,3589.0,"Reduced risks for frequent consumption of 2 % milk relative to not drinking milk were observed for cancers of the oral cavity , stomach , rectum , lung , and cervix ."
103417,not,O,3589.0,"Reduced risks for frequent consumption of 2 % milk relative to not drinking milk were observed for cancers of the oral cavity , stomach , rectum , lung , and cervix ."
103418,drinking,O,3589.0,"Reduced risks for frequent consumption of 2 % milk relative to not drinking milk were observed for cancers of the oral cavity , stomach , rectum , lung , and cervix ."
103419,milk,B-AG.01.e,3589.0,"Reduced risks for frequent consumption of 2 % milk relative to not drinking milk were observed for cancers of the oral cavity , stomach , rectum , lung , and cervix ."
103420,were,O,3589.0,"Reduced risks for frequent consumption of 2 % milk relative to not drinking milk were observed for cancers of the oral cavity , stomach , rectum , lung , and cervix ."
103421,observed,O,3589.0,"Reduced risks for frequent consumption of 2 % milk relative to not drinking milk were observed for cancers of the oral cavity , stomach , rectum , lung , and cervix ."
103422,for,O,3589.0,"Reduced risks for frequent consumption of 2 % milk relative to not drinking milk were observed for cancers of the oral cavity , stomach , rectum , lung , and cervix ."
103423,cancers,O,3589.0,"Reduced risks for frequent consumption of 2 % milk relative to not drinking milk were observed for cancers of the oral cavity , stomach , rectum , lung , and cervix ."
103424,of,O,3589.0,"Reduced risks for frequent consumption of 2 % milk relative to not drinking milk were observed for cancers of the oral cavity , stomach , rectum , lung , and cervix ."
103425,the,O,3589.0,"Reduced risks for frequent consumption of 2 % milk relative to not drinking milk were observed for cancers of the oral cavity , stomach , rectum , lung , and cervix ."
103426,oral,O,3589.0,"Reduced risks for frequent consumption of 2 % milk relative to not drinking milk were observed for cancers of the oral cavity , stomach , rectum , lung , and cervix ."
103427,cavity,O,3589.0,"Reduced risks for frequent consumption of 2 % milk relative to not drinking milk were observed for cancers of the oral cavity , stomach , rectum , lung , and cervix ."
103428,",",O,3589.0,"Reduced risks for frequent consumption of 2 % milk relative to not drinking milk were observed for cancers of the oral cavity , stomach , rectum , lung , and cervix ."
103429,stomach,O,3589.0,"Reduced risks for frequent consumption of 2 % milk relative to not drinking milk were observed for cancers of the oral cavity , stomach , rectum , lung , and cervix ."
103430,",",O,3589.0,"Reduced risks for frequent consumption of 2 % milk relative to not drinking milk were observed for cancers of the oral cavity , stomach , rectum , lung , and cervix ."
103431,rectum,O,3589.0,"Reduced risks for frequent consumption of 2 % milk relative to not drinking milk were observed for cancers of the oral cavity , stomach , rectum , lung , and cervix ."
103432,",",O,3589.0,"Reduced risks for frequent consumption of 2 % milk relative to not drinking milk were observed for cancers of the oral cavity , stomach , rectum , lung , and cervix ."
103433,lung,O,3589.0,"Reduced risks for frequent consumption of 2 % milk relative to not drinking milk were observed for cancers of the oral cavity , stomach , rectum , lung , and cervix ."
103434,",",O,3589.0,"Reduced risks for frequent consumption of 2 % milk relative to not drinking milk were observed for cancers of the oral cavity , stomach , rectum , lung , and cervix ."
103435,and,O,3589.0,"Reduced risks for frequent consumption of 2 % milk relative to not drinking milk were observed for cancers of the oral cavity , stomach , rectum , lung , and cervix ."
103436,cervix,O,3589.0,"Reduced risks for frequent consumption of 2 % milk relative to not drinking milk were observed for cancers of the oral cavity , stomach , rectum , lung , and cervix ."
103437,.,O,3589.0,"Reduced risks for frequent consumption of 2 % milk relative to not drinking milk were observed for cancers of the oral cavity , stomach , rectum , lung , and cervix ."
103438,Preference,O,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103439,for,O,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103440,exclusive,O,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103441,consumption,O,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103442,of,O,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103443,reduced,B-AG.01.e,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103444,-,I-AG.01.e,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103445,fat,I-AG.01.e,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103446,milk,I-AG.01.e,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103447,was,O,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103448,linked,O,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103449,to,O,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103450,significant,O,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103451,risk,O,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103452,reduction,O,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103453,for,O,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103454,oral,O,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103455,and,O,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103456,cervical,O,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103457,cancers,O,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103458,",",O,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103459,and,O,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103460,drinking,O,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103461,only,O,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103462,whole,B-AG.01.e,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103463,milk,I-AG.01.e,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103464,was,O,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103465,linked,O,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103466,to,O,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103467,significant,O,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103468,risk,O,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103469,increases,O,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103470,for,O,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103471,cancers,O,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103472,of,O,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103473,the,O,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103474,oral,O,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103475,cavity,O,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103476,",",O,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103477,stomach,O,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103478,",",O,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103479,rectum,O,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103480,",",O,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103481,lung,O,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103482,",",O,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103483,and,O,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103484,breast,O,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103485,.,O,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103486,Some,O,3591.0,"Some associations were observed for a computed index of milk fat intake , but the overall pattern of effects was not fully explained by variations in fat content ."
103487,associations,O,3591.0,"Some associations were observed for a computed index of milk fat intake , but the overall pattern of effects was not fully explained by variations in fat content ."
103488,were,O,3591.0,"Some associations were observed for a computed index of milk fat intake , but the overall pattern of effects was not fully explained by variations in fat content ."
103489,observed,O,3591.0,"Some associations were observed for a computed index of milk fat intake , but the overall pattern of effects was not fully explained by variations in fat content ."
103490,for,O,3591.0,"Some associations were observed for a computed index of milk fat intake , but the overall pattern of effects was not fully explained by variations in fat content ."
103491,a,O,3591.0,"Some associations were observed for a computed index of milk fat intake , but the overall pattern of effects was not fully explained by variations in fat content ."
103492,computed,O,3591.0,"Some associations were observed for a computed index of milk fat intake , but the overall pattern of effects was not fully explained by variations in fat content ."
103493,index,O,3591.0,"Some associations were observed for a computed index of milk fat intake , but the overall pattern of effects was not fully explained by variations in fat content ."
103494,of,O,3591.0,"Some associations were observed for a computed index of milk fat intake , but the overall pattern of effects was not fully explained by variations in fat content ."
103495,milk,B-AG.01.e,3591.0,"Some associations were observed for a computed index of milk fat intake , but the overall pattern of effects was not fully explained by variations in fat content ."
103496,fat,I-AG.01.e,3591.0,"Some associations were observed for a computed index of milk fat intake , but the overall pattern of effects was not fully explained by variations in fat content ."
103497,intake,B-X,3591.0,"Some associations were observed for a computed index of milk fat intake , but the overall pattern of effects was not fully explained by variations in fat content ."
103498,",",O,3591.0,"Some associations were observed for a computed index of milk fat intake , but the overall pattern of effects was not fully explained by variations in fat content ."
103499,but,O,3591.0,"Some associations were observed for a computed index of milk fat intake , but the overall pattern of effects was not fully explained by variations in fat content ."
103500,the,O,3591.0,"Some associations were observed for a computed index of milk fat intake , but the overall pattern of effects was not fully explained by variations in fat content ."
103501,overall,O,3591.0,"Some associations were observed for a computed index of milk fat intake , but the overall pattern of effects was not fully explained by variations in fat content ."
103502,pattern,O,3591.0,"Some associations were observed for a computed index of milk fat intake , but the overall pattern of effects was not fully explained by variations in fat content ."
103503,of,O,3591.0,"Some associations were observed for a computed index of milk fat intake , but the overall pattern of effects was not fully explained by variations in fat content ."
103504,effects,O,3591.0,"Some associations were observed for a computed index of milk fat intake , but the overall pattern of effects was not fully explained by variations in fat content ."
103505,was,O,3591.0,"Some associations were observed for a computed index of milk fat intake , but the overall pattern of effects was not fully explained by variations in fat content ."
103506,not,O,3591.0,"Some associations were observed for a computed index of milk fat intake , but the overall pattern of effects was not fully explained by variations in fat content ."
103507,fully,O,3591.0,"Some associations were observed for a computed index of milk fat intake , but the overall pattern of effects was not fully explained by variations in fat content ."
103508,explained,O,3591.0,"Some associations were observed for a computed index of milk fat intake , but the overall pattern of effects was not fully explained by variations in fat content ."
103509,by,O,3591.0,"Some associations were observed for a computed index of milk fat intake , but the overall pattern of effects was not fully explained by variations in fat content ."
103510,variations,O,3591.0,"Some associations were observed for a computed index of milk fat intake , but the overall pattern of effects was not fully explained by variations in fat content ."
103511,in,O,3591.0,"Some associations were observed for a computed index of milk fat intake , but the overall pattern of effects was not fully explained by variations in fat content ."
103512,fat,O,3591.0,"Some associations were observed for a computed index of milk fat intake , but the overall pattern of effects was not fully explained by variations in fat content ."
103513,content,O,3591.0,"Some associations were observed for a computed index of milk fat intake , but the overall pattern of effects was not fully explained by variations in fat content ."
103514,.,O,3591.0,"Some associations were observed for a computed index of milk fat intake , but the overall pattern of effects was not fully explained by variations in fat content ."
103515,The,O,3592.0,The effects observed for some sites may be confounded by other dietary or nondietary correlates of risk .
103516,effects,O,3592.0,The effects observed for some sites may be confounded by other dietary or nondietary correlates of risk .
103517,observed,O,3592.0,The effects observed for some sites may be confounded by other dietary or nondietary correlates of risk .
103518,for,O,3592.0,The effects observed for some sites may be confounded by other dietary or nondietary correlates of risk .
103519,some,O,3592.0,The effects observed for some sites may be confounded by other dietary or nondietary correlates of risk .
103520,sites,O,3592.0,The effects observed for some sites may be confounded by other dietary or nondietary correlates of risk .
103521,may,O,3592.0,The effects observed for some sites may be confounded by other dietary or nondietary correlates of risk .
103522,be,O,3592.0,The effects observed for some sites may be confounded by other dietary or nondietary correlates of risk .
103523,confounded,O,3592.0,The effects observed for some sites may be confounded by other dietary or nondietary correlates of risk .
103524,by,O,3592.0,The effects observed for some sites may be confounded by other dietary or nondietary correlates of risk .
103525,other,O,3592.0,The effects observed for some sites may be confounded by other dietary or nondietary correlates of risk .
103526,dietary,O,3592.0,The effects observed for some sites may be confounded by other dietary or nondietary correlates of risk .
103527,or,O,3592.0,The effects observed for some sites may be confounded by other dietary or nondietary correlates of risk .
103528,nondietary,O,3592.0,The effects observed for some sites may be confounded by other dietary or nondietary correlates of risk .
103529,correlates,O,3592.0,The effects observed for some sites may be confounded by other dietary or nondietary correlates of risk .
103530,of,O,3592.0,The effects observed for some sites may be confounded by other dietary or nondietary correlates of risk .
103531,risk,O,3592.0,The effects observed for some sites may be confounded by other dietary or nondietary correlates of risk .
103532,.,O,3592.0,The effects observed for some sites may be confounded by other dietary or nondietary correlates of risk .
103533,During,O,3593.0,"During the past 20 years , many studies have focused on polyphenol compounds for their potential beneficial health effects ."
103534,the,O,3593.0,"During the past 20 years , many studies have focused on polyphenol compounds for their potential beneficial health effects ."
103535,past,O,3593.0,"During the past 20 years , many studies have focused on polyphenol compounds for their potential beneficial health effects ."
103536,20,O,3593.0,"During the past 20 years , many studies have focused on polyphenol compounds for their potential beneficial health effects ."
103537,years,O,3593.0,"During the past 20 years , many studies have focused on polyphenol compounds for their potential beneficial health effects ."
103538,",",O,3593.0,"During the past 20 years , many studies have focused on polyphenol compounds for their potential beneficial health effects ."
103539,many,O,3593.0,"During the past 20 years , many studies have focused on polyphenol compounds for their potential beneficial health effects ."
103540,studies,O,3593.0,"During the past 20 years , many studies have focused on polyphenol compounds for their potential beneficial health effects ."
103541,have,O,3593.0,"During the past 20 years , many studies have focused on polyphenol compounds for their potential beneficial health effects ."
103542,focused,O,3593.0,"During the past 20 years , many studies have focused on polyphenol compounds for their potential beneficial health effects ."
103543,on,O,3593.0,"During the past 20 years , many studies have focused on polyphenol compounds for their potential beneficial health effects ."
103544,polyphenol,O,3593.0,"During the past 20 years , many studies have focused on polyphenol compounds for their potential beneficial health effects ."
103545,compounds,O,3593.0,"During the past 20 years , many studies have focused on polyphenol compounds for their potential beneficial health effects ."
103546,for,O,3593.0,"During the past 20 years , many studies have focused on polyphenol compounds for their potential beneficial health effects ."
103547,their,O,3593.0,"During the past 20 years , many studies have focused on polyphenol compounds for their potential beneficial health effects ."
103548,potential,O,3593.0,"During the past 20 years , many studies have focused on polyphenol compounds for their potential beneficial health effects ."
103549,beneficial,O,3593.0,"During the past 20 years , many studies have focused on polyphenol compounds for their potential beneficial health effects ."
103550,health,O,3593.0,"During the past 20 years , many studies have focused on polyphenol compounds for their potential beneficial health effects ."
103551,effects,O,3593.0,"During the past 20 years , many studies have focused on polyphenol compounds for their potential beneficial health effects ."
103552,.,O,3593.0,"During the past 20 years , many studies have focused on polyphenol compounds for their potential beneficial health effects ."
103553,Flavonoids,O,3594.0,"Flavonoids represent a large class of phenolic compounds found in fruits , vegetables , nuts , grains , cocoa , tea , and other beverages ."
103554,represent,O,3594.0,"Flavonoids represent a large class of phenolic compounds found in fruits , vegetables , nuts , grains , cocoa , tea , and other beverages ."
103555,a,O,3594.0,"Flavonoids represent a large class of phenolic compounds found in fruits , vegetables , nuts , grains , cocoa , tea , and other beverages ."
103556,large,O,3594.0,"Flavonoids represent a large class of phenolic compounds found in fruits , vegetables , nuts , grains , cocoa , tea , and other beverages ."
103557,class,O,3594.0,"Flavonoids represent a large class of phenolic compounds found in fruits , vegetables , nuts , grains , cocoa , tea , and other beverages ."
103558,of,O,3594.0,"Flavonoids represent a large class of phenolic compounds found in fruits , vegetables , nuts , grains , cocoa , tea , and other beverages ."
103559,phenolic,O,3594.0,"Flavonoids represent a large class of phenolic compounds found in fruits , vegetables , nuts , grains , cocoa , tea , and other beverages ."
103560,compounds,O,3594.0,"Flavonoids represent a large class of phenolic compounds found in fruits , vegetables , nuts , grains , cocoa , tea , and other beverages ."
103561,found,O,3594.0,"Flavonoids represent a large class of phenolic compounds found in fruits , vegetables , nuts , grains , cocoa , tea , and other beverages ."
103562,in,O,3594.0,"Flavonoids represent a large class of phenolic compounds found in fruits , vegetables , nuts , grains , cocoa , tea , and other beverages ."
103563,fruits,B-AG.01.h.01,3594.0,"Flavonoids represent a large class of phenolic compounds found in fruits , vegetables , nuts , grains , cocoa , tea , and other beverages ."
103564,",",O,3594.0,"Flavonoids represent a large class of phenolic compounds found in fruits , vegetables , nuts , grains , cocoa , tea , and other beverages ."
103565,vegetables,B-AG.01.h.02,3594.0,"Flavonoids represent a large class of phenolic compounds found in fruits , vegetables , nuts , grains , cocoa , tea , and other beverages ."
103566,",",O,3594.0,"Flavonoids represent a large class of phenolic compounds found in fruits , vegetables , nuts , grains , cocoa , tea , and other beverages ."
103567,nuts,B-AG.01.h.01.f,3594.0,"Flavonoids represent a large class of phenolic compounds found in fruits , vegetables , nuts , grains , cocoa , tea , and other beverages ."
103568,",",O,3594.0,"Flavonoids represent a large class of phenolic compounds found in fruits , vegetables , nuts , grains , cocoa , tea , and other beverages ."
103569,grains,B-AG.01.i,3594.0,"Flavonoids represent a large class of phenolic compounds found in fruits , vegetables , nuts , grains , cocoa , tea , and other beverages ."
103570,",",O,3594.0,"Flavonoids represent a large class of phenolic compounds found in fruits , vegetables , nuts , grains , cocoa , tea , and other beverages ."
103571,cocoa,B-AG.01,3594.0,"Flavonoids represent a large class of phenolic compounds found in fruits , vegetables , nuts , grains , cocoa , tea , and other beverages ."
103572,",",O,3594.0,"Flavonoids represent a large class of phenolic compounds found in fruits , vegetables , nuts , grains , cocoa , tea , and other beverages ."
103573,tea,B-AG.01.ac,3594.0,"Flavonoids represent a large class of phenolic compounds found in fruits , vegetables , nuts , grains , cocoa , tea , and other beverages ."
103574,",",O,3594.0,"Flavonoids represent a large class of phenolic compounds found in fruits , vegetables , nuts , grains , cocoa , tea , and other beverages ."
103575,and,O,3594.0,"Flavonoids represent a large class of phenolic compounds found in fruits , vegetables , nuts , grains , cocoa , tea , and other beverages ."
103576,other,O,3594.0,"Flavonoids represent a large class of phenolic compounds found in fruits , vegetables , nuts , grains , cocoa , tea , and other beverages ."
103577,beverages,B-AG.01.y,3594.0,"Flavonoids represent a large class of phenolic compounds found in fruits , vegetables , nuts , grains , cocoa , tea , and other beverages ."
103578,.,O,3594.0,"Flavonoids represent a large class of phenolic compounds found in fruits , vegetables , nuts , grains , cocoa , tea , and other beverages ."
103579,Flavonoids,O,3595.0,Flavonoids have shown antioxidant and anti - inflammatory activities .
103580,have,O,3595.0,Flavonoids have shown antioxidant and anti - inflammatory activities .
103581,shown,O,3595.0,Flavonoids have shown antioxidant and anti - inflammatory activities .
103582,antioxidant,O,3595.0,Flavonoids have shown antioxidant and anti - inflammatory activities .
103583,and,O,3595.0,Flavonoids have shown antioxidant and anti - inflammatory activities .
103584,anti,O,3595.0,Flavonoids have shown antioxidant and anti - inflammatory activities .
103585,-,O,3595.0,Flavonoids have shown antioxidant and anti - inflammatory activities .
103586,inflammatory,O,3595.0,Flavonoids have shown antioxidant and anti - inflammatory activities .
103587,activities,O,3595.0,Flavonoids have shown antioxidant and anti - inflammatory activities .
103588,.,O,3595.0,Flavonoids have shown antioxidant and anti - inflammatory activities .
103589,Given,O,3596.0,"Given the putative relationship between inflammation and insulin resistance , the consumption of flavonoids or flavonoid - rich foods has been suggested to reduce the risk of diabetes by targeting inflammatory signals ."
103590,the,O,3596.0,"Given the putative relationship between inflammation and insulin resistance , the consumption of flavonoids or flavonoid - rich foods has been suggested to reduce the risk of diabetes by targeting inflammatory signals ."
103591,putative,O,3596.0,"Given the putative relationship between inflammation and insulin resistance , the consumption of flavonoids or flavonoid - rich foods has been suggested to reduce the risk of diabetes by targeting inflammatory signals ."
103592,relationship,O,3596.0,"Given the putative relationship between inflammation and insulin resistance , the consumption of flavonoids or flavonoid - rich foods has been suggested to reduce the risk of diabetes by targeting inflammatory signals ."
103593,between,O,3596.0,"Given the putative relationship between inflammation and insulin resistance , the consumption of flavonoids or flavonoid - rich foods has been suggested to reduce the risk of diabetes by targeting inflammatory signals ."
103594,inflammation,O,3596.0,"Given the putative relationship between inflammation and insulin resistance , the consumption of flavonoids or flavonoid - rich foods has been suggested to reduce the risk of diabetes by targeting inflammatory signals ."
103595,and,O,3596.0,"Given the putative relationship between inflammation and insulin resistance , the consumption of flavonoids or flavonoid - rich foods has been suggested to reduce the risk of diabetes by targeting inflammatory signals ."
103596,insulin,O,3596.0,"Given the putative relationship between inflammation and insulin resistance , the consumption of flavonoids or flavonoid - rich foods has been suggested to reduce the risk of diabetes by targeting inflammatory signals ."
103597,resistance,O,3596.0,"Given the putative relationship between inflammation and insulin resistance , the consumption of flavonoids or flavonoid - rich foods has been suggested to reduce the risk of diabetes by targeting inflammatory signals ."
103598,",",O,3596.0,"Given the putative relationship between inflammation and insulin resistance , the consumption of flavonoids or flavonoid - rich foods has been suggested to reduce the risk of diabetes by targeting inflammatory signals ."
103599,the,O,3596.0,"Given the putative relationship between inflammation and insulin resistance , the consumption of flavonoids or flavonoid - rich foods has been suggested to reduce the risk of diabetes by targeting inflammatory signals ."
103600,consumption,O,3596.0,"Given the putative relationship between inflammation and insulin resistance , the consumption of flavonoids or flavonoid - rich foods has been suggested to reduce the risk of diabetes by targeting inflammatory signals ."
103601,of,O,3596.0,"Given the putative relationship between inflammation and insulin resistance , the consumption of flavonoids or flavonoid - rich foods has been suggested to reduce the risk of diabetes by targeting inflammatory signals ."
103602,flavonoids,O,3596.0,"Given the putative relationship between inflammation and insulin resistance , the consumption of flavonoids or flavonoid - rich foods has been suggested to reduce the risk of diabetes by targeting inflammatory signals ."
103603,or,O,3596.0,"Given the putative relationship between inflammation and insulin resistance , the consumption of flavonoids or flavonoid - rich foods has been suggested to reduce the risk of diabetes by targeting inflammatory signals ."
103604,flavonoid,B-AG.01,3596.0,"Given the putative relationship between inflammation and insulin resistance , the consumption of flavonoids or flavonoid - rich foods has been suggested to reduce the risk of diabetes by targeting inflammatory signals ."
103605,-,I-AG.01,3596.0,"Given the putative relationship between inflammation and insulin resistance , the consumption of flavonoids or flavonoid - rich foods has been suggested to reduce the risk of diabetes by targeting inflammatory signals ."
103606,rich,I-AG.01,3596.0,"Given the putative relationship between inflammation and insulin resistance , the consumption of flavonoids or flavonoid - rich foods has been suggested to reduce the risk of diabetes by targeting inflammatory signals ."
103607,foods,I-AG.01,3596.0,"Given the putative relationship between inflammation and insulin resistance , the consumption of flavonoids or flavonoid - rich foods has been suggested to reduce the risk of diabetes by targeting inflammatory signals ."
103608,has,O,3596.0,"Given the putative relationship between inflammation and insulin resistance , the consumption of flavonoids or flavonoid - rich foods has been suggested to reduce the risk of diabetes by targeting inflammatory signals ."
103609,been,O,3596.0,"Given the putative relationship between inflammation and insulin resistance , the consumption of flavonoids or flavonoid - rich foods has been suggested to reduce the risk of diabetes by targeting inflammatory signals ."
103610,suggested,O,3596.0,"Given the putative relationship between inflammation and insulin resistance , the consumption of flavonoids or flavonoid - rich foods has been suggested to reduce the risk of diabetes by targeting inflammatory signals ."
103611,to,O,3596.0,"Given the putative relationship between inflammation and insulin resistance , the consumption of flavonoids or flavonoid - rich foods has been suggested to reduce the risk of diabetes by targeting inflammatory signals ."
103612,reduce,O,3596.0,"Given the putative relationship between inflammation and insulin resistance , the consumption of flavonoids or flavonoid - rich foods has been suggested to reduce the risk of diabetes by targeting inflammatory signals ."
103613,the,O,3596.0,"Given the putative relationship between inflammation and insulin resistance , the consumption of flavonoids or flavonoid - rich foods has been suggested to reduce the risk of diabetes by targeting inflammatory signals ."
103614,risk,O,3596.0,"Given the putative relationship between inflammation and insulin resistance , the consumption of flavonoids or flavonoid - rich foods has been suggested to reduce the risk of diabetes by targeting inflammatory signals ."
103615,of,O,3596.0,"Given the putative relationship between inflammation and insulin resistance , the consumption of flavonoids or flavonoid - rich foods has been suggested to reduce the risk of diabetes by targeting inflammatory signals ."
103616,diabetes,O,3596.0,"Given the putative relationship between inflammation and insulin resistance , the consumption of flavonoids or flavonoid - rich foods has been suggested to reduce the risk of diabetes by targeting inflammatory signals ."
103617,by,O,3596.0,"Given the putative relationship between inflammation and insulin resistance , the consumption of flavonoids or flavonoid - rich foods has been suggested to reduce the risk of diabetes by targeting inflammatory signals ."
103618,targeting,O,3596.0,"Given the putative relationship between inflammation and insulin resistance , the consumption of flavonoids or flavonoid - rich foods has been suggested to reduce the risk of diabetes by targeting inflammatory signals ."
103619,inflammatory,O,3596.0,"Given the putative relationship between inflammation and insulin resistance , the consumption of flavonoids or flavonoid - rich foods has been suggested to reduce the risk of diabetes by targeting inflammatory signals ."
103620,signals,O,3596.0,"Given the putative relationship between inflammation and insulin resistance , the consumption of flavonoids or flavonoid - rich foods has been suggested to reduce the risk of diabetes by targeting inflammatory signals ."
103621,.,O,3596.0,"Given the putative relationship between inflammation and insulin resistance , the consumption of flavonoids or flavonoid - rich foods has been suggested to reduce the risk of diabetes by targeting inflammatory signals ."
103622,This,O,3597.0,This is the first comprehensive review summarizing the current research progress on the inhibition of inflammation and alleviation of insulin resistance by flavonoids as well as the mechanistic link between these disorders .
103623,is,O,3597.0,This is the first comprehensive review summarizing the current research progress on the inhibition of inflammation and alleviation of insulin resistance by flavonoids as well as the mechanistic link between these disorders .
103624,the,O,3597.0,This is the first comprehensive review summarizing the current research progress on the inhibition of inflammation and alleviation of insulin resistance by flavonoids as well as the mechanistic link between these disorders .
103625,first,O,3597.0,This is the first comprehensive review summarizing the current research progress on the inhibition of inflammation and alleviation of insulin resistance by flavonoids as well as the mechanistic link between these disorders .
103626,comprehensive,O,3597.0,This is the first comprehensive review summarizing the current research progress on the inhibition of inflammation and alleviation of insulin resistance by flavonoids as well as the mechanistic link between these disorders .
103627,review,O,3597.0,This is the first comprehensive review summarizing the current research progress on the inhibition of inflammation and alleviation of insulin resistance by flavonoids as well as the mechanistic link between these disorders .
103628,summarizing,O,3597.0,This is the first comprehensive review summarizing the current research progress on the inhibition of inflammation and alleviation of insulin resistance by flavonoids as well as the mechanistic link between these disorders .
103629,the,O,3597.0,This is the first comprehensive review summarizing the current research progress on the inhibition of inflammation and alleviation of insulin resistance by flavonoids as well as the mechanistic link between these disorders .
103630,current,O,3597.0,This is the first comprehensive review summarizing the current research progress on the inhibition of inflammation and alleviation of insulin resistance by flavonoids as well as the mechanistic link between these disorders .
103631,research,O,3597.0,This is the first comprehensive review summarizing the current research progress on the inhibition of inflammation and alleviation of insulin resistance by flavonoids as well as the mechanistic link between these disorders .
103632,progress,O,3597.0,This is the first comprehensive review summarizing the current research progress on the inhibition of inflammation and alleviation of insulin resistance by flavonoids as well as the mechanistic link between these disorders .
103633,on,O,3597.0,This is the first comprehensive review summarizing the current research progress on the inhibition of inflammation and alleviation of insulin resistance by flavonoids as well as the mechanistic link between these disorders .
103634,the,O,3597.0,This is the first comprehensive review summarizing the current research progress on the inhibition of inflammation and alleviation of insulin resistance by flavonoids as well as the mechanistic link between these disorders .
103635,inhibition,O,3597.0,This is the first comprehensive review summarizing the current research progress on the inhibition of inflammation and alleviation of insulin resistance by flavonoids as well as the mechanistic link between these disorders .
103636,of,O,3597.0,This is the first comprehensive review summarizing the current research progress on the inhibition of inflammation and alleviation of insulin resistance by flavonoids as well as the mechanistic link between these disorders .
103637,inflammation,O,3597.0,This is the first comprehensive review summarizing the current research progress on the inhibition of inflammation and alleviation of insulin resistance by flavonoids as well as the mechanistic link between these disorders .
103638,and,O,3597.0,This is the first comprehensive review summarizing the current research progress on the inhibition of inflammation and alleviation of insulin resistance by flavonoids as well as the mechanistic link between these disorders .
103639,alleviation,O,3597.0,This is the first comprehensive review summarizing the current research progress on the inhibition of inflammation and alleviation of insulin resistance by flavonoids as well as the mechanistic link between these disorders .
103640,of,O,3597.0,This is the first comprehensive review summarizing the current research progress on the inhibition of inflammation and alleviation of insulin resistance by flavonoids as well as the mechanistic link between these disorders .
103641,insulin,O,3597.0,This is the first comprehensive review summarizing the current research progress on the inhibition of inflammation and alleviation of insulin resistance by flavonoids as well as the mechanistic link between these disorders .
103642,resistance,O,3597.0,This is the first comprehensive review summarizing the current research progress on the inhibition of inflammation and alleviation of insulin resistance by flavonoids as well as the mechanistic link between these disorders .
103643,by,O,3597.0,This is the first comprehensive review summarizing the current research progress on the inhibition of inflammation and alleviation of insulin resistance by flavonoids as well as the mechanistic link between these disorders .
103644,flavonoids,O,3597.0,This is the first comprehensive review summarizing the current research progress on the inhibition of inflammation and alleviation of insulin resistance by flavonoids as well as the mechanistic link between these disorders .
103645,as,O,3597.0,This is the first comprehensive review summarizing the current research progress on the inhibition of inflammation and alleviation of insulin resistance by flavonoids as well as the mechanistic link between these disorders .
103646,well,O,3597.0,This is the first comprehensive review summarizing the current research progress on the inhibition of inflammation and alleviation of insulin resistance by flavonoids as well as the mechanistic link between these disorders .
103647,as,O,3597.0,This is the first comprehensive review summarizing the current research progress on the inhibition of inflammation and alleviation of insulin resistance by flavonoids as well as the mechanistic link between these disorders .
103648,the,O,3597.0,This is the first comprehensive review summarizing the current research progress on the inhibition of inflammation and alleviation of insulin resistance by flavonoids as well as the mechanistic link between these disorders .
103649,mechanistic,O,3597.0,This is the first comprehensive review summarizing the current research progress on the inhibition of inflammation and alleviation of insulin resistance by flavonoids as well as the mechanistic link between these disorders .
103650,link,O,3597.0,This is the first comprehensive review summarizing the current research progress on the inhibition of inflammation and alleviation of insulin resistance by flavonoids as well as the mechanistic link between these disorders .
103651,between,O,3597.0,This is the first comprehensive review summarizing the current research progress on the inhibition of inflammation and alleviation of insulin resistance by flavonoids as well as the mechanistic link between these disorders .
103652,these,O,3597.0,This is the first comprehensive review summarizing the current research progress on the inhibition of inflammation and alleviation of insulin resistance by flavonoids as well as the mechanistic link between these disorders .
103653,disorders,O,3597.0,This is the first comprehensive review summarizing the current research progress on the inhibition of inflammation and alleviation of insulin resistance by flavonoids as well as the mechanistic link between these disorders .
103654,.,O,3597.0,This is the first comprehensive review summarizing the current research progress on the inhibition of inflammation and alleviation of insulin resistance by flavonoids as well as the mechanistic link between these disorders .
103655,Laboratory,O,3598.0,"Laboratory and human studies on the activities of major flavonoids ( flavones , isoflavones , flavonols , etc ."
103656,and,O,3598.0,"Laboratory and human studies on the activities of major flavonoids ( flavones , isoflavones , flavonols , etc ."
103657,human,O,3598.0,"Laboratory and human studies on the activities of major flavonoids ( flavones , isoflavones , flavonols , etc ."
103658,studies,O,3598.0,"Laboratory and human studies on the activities of major flavonoids ( flavones , isoflavones , flavonols , etc ."
103659,on,O,3598.0,"Laboratory and human studies on the activities of major flavonoids ( flavones , isoflavones , flavonols , etc ."
103660,the,O,3598.0,"Laboratory and human studies on the activities of major flavonoids ( flavones , isoflavones , flavonols , etc ."
103661,activities,O,3598.0,"Laboratory and human studies on the activities of major flavonoids ( flavones , isoflavones , flavonols , etc ."
103662,of,O,3598.0,"Laboratory and human studies on the activities of major flavonoids ( flavones , isoflavones , flavonols , etc ."
103663,major,O,3598.0,"Laboratory and human studies on the activities of major flavonoids ( flavones , isoflavones , flavonols , etc ."
103664,flavonoids,O,3598.0,"Laboratory and human studies on the activities of major flavonoids ( flavones , isoflavones , flavonols , etc ."
103665,(,O,3598.0,"Laboratory and human studies on the activities of major flavonoids ( flavones , isoflavones , flavonols , etc ."
103666,flavones,O,3598.0,"Laboratory and human studies on the activities of major flavonoids ( flavones , isoflavones , flavonols , etc ."
103667,",",O,3598.0,"Laboratory and human studies on the activities of major flavonoids ( flavones , isoflavones , flavonols , etc ."
103668,isoflavones,O,3598.0,"Laboratory and human studies on the activities of major flavonoids ( flavones , isoflavones , flavonols , etc ."
103669,",",O,3598.0,"Laboratory and human studies on the activities of major flavonoids ( flavones , isoflavones , flavonols , etc ."
103670,flavonols,O,3598.0,"Laboratory and human studies on the activities of major flavonoids ( flavones , isoflavones , flavonols , etc ."
103671,",",O,3598.0,"Laboratory and human studies on the activities of major flavonoids ( flavones , isoflavones , flavonols , etc ."
103672,etc,O,3598.0,"Laboratory and human studies on the activities of major flavonoids ( flavones , isoflavones , flavonols , etc ."
103673,.,O,3598.0,"Laboratory and human studies on the activities of major flavonoids ( flavones , isoflavones , flavonols , etc ."
103674,),O,3599.0,) are discussed .
103675,are,O,3599.0,) are discussed .
103676,discussed,O,3599.0,) are discussed .
103677,.,O,3599.0,) are discussed .
103678,Fermented,O,3600.0,Fermented foods have long been produced according to knowledge passed down from generation to generation and with no understanding of the potential role of the microorganism(s ) involved in the process .
103679,foods,B-AG.01,3600.0,Fermented foods have long been produced according to knowledge passed down from generation to generation and with no understanding of the potential role of the microorganism(s ) involved in the process .
103680,have,O,3600.0,Fermented foods have long been produced according to knowledge passed down from generation to generation and with no understanding of the potential role of the microorganism(s ) involved in the process .
103681,long,O,3600.0,Fermented foods have long been produced according to knowledge passed down from generation to generation and with no understanding of the potential role of the microorganism(s ) involved in the process .
103682,been,O,3600.0,Fermented foods have long been produced according to knowledge passed down from generation to generation and with no understanding of the potential role of the microorganism(s ) involved in the process .
103683,produced,O,3600.0,Fermented foods have long been produced according to knowledge passed down from generation to generation and with no understanding of the potential role of the microorganism(s ) involved in the process .
103684,according,O,3600.0,Fermented foods have long been produced according to knowledge passed down from generation to generation and with no understanding of the potential role of the microorganism(s ) involved in the process .
103685,to,O,3600.0,Fermented foods have long been produced according to knowledge passed down from generation to generation and with no understanding of the potential role of the microorganism(s ) involved in the process .
103686,knowledge,O,3600.0,Fermented foods have long been produced according to knowledge passed down from generation to generation and with no understanding of the potential role of the microorganism(s ) involved in the process .
103687,passed,O,3600.0,Fermented foods have long been produced according to knowledge passed down from generation to generation and with no understanding of the potential role of the microorganism(s ) involved in the process .
103688,down,O,3600.0,Fermented foods have long been produced according to knowledge passed down from generation to generation and with no understanding of the potential role of the microorganism(s ) involved in the process .
103689,from,O,3600.0,Fermented foods have long been produced according to knowledge passed down from generation to generation and with no understanding of the potential role of the microorganism(s ) involved in the process .
103690,generation,O,3600.0,Fermented foods have long been produced according to knowledge passed down from generation to generation and with no understanding of the potential role of the microorganism(s ) involved in the process .
103691,to,O,3600.0,Fermented foods have long been produced according to knowledge passed down from generation to generation and with no understanding of the potential role of the microorganism(s ) involved in the process .
103692,generation,O,3600.0,Fermented foods have long been produced according to knowledge passed down from generation to generation and with no understanding of the potential role of the microorganism(s ) involved in the process .
103693,and,O,3600.0,Fermented foods have long been produced according to knowledge passed down from generation to generation and with no understanding of the potential role of the microorganism(s ) involved in the process .
103694,with,O,3600.0,Fermented foods have long been produced according to knowledge passed down from generation to generation and with no understanding of the potential role of the microorganism(s ) involved in the process .
103695,no,O,3600.0,Fermented foods have long been produced according to knowledge passed down from generation to generation and with no understanding of the potential role of the microorganism(s ) involved in the process .
103696,understanding,O,3600.0,Fermented foods have long been produced according to knowledge passed down from generation to generation and with no understanding of the potential role of the microorganism(s ) involved in the process .
103697,of,O,3600.0,Fermented foods have long been produced according to knowledge passed down from generation to generation and with no understanding of the potential role of the microorganism(s ) involved in the process .
103698,the,O,3600.0,Fermented foods have long been produced according to knowledge passed down from generation to generation and with no understanding of the potential role of the microorganism(s ) involved in the process .
103699,potential,O,3600.0,Fermented foods have long been produced according to knowledge passed down from generation to generation and with no understanding of the potential role of the microorganism(s ) involved in the process .
103700,role,O,3600.0,Fermented foods have long been produced according to knowledge passed down from generation to generation and with no understanding of the potential role of the microorganism(s ) involved in the process .
103701,of,O,3600.0,Fermented foods have long been produced according to knowledge passed down from generation to generation and with no understanding of the potential role of the microorganism(s ) involved in the process .
103702,the,O,3600.0,Fermented foods have long been produced according to knowledge passed down from generation to generation and with no understanding of the potential role of the microorganism(s ) involved in the process .
103703,microorganism(s,O,3600.0,Fermented foods have long been produced according to knowledge passed down from generation to generation and with no understanding of the potential role of the microorganism(s ) involved in the process .
103704,),O,3600.0,Fermented foods have long been produced according to knowledge passed down from generation to generation and with no understanding of the potential role of the microorganism(s ) involved in the process .
103705,involved,O,3600.0,Fermented foods have long been produced according to knowledge passed down from generation to generation and with no understanding of the potential role of the microorganism(s ) involved in the process .
103706,in,O,3600.0,Fermented foods have long been produced according to knowledge passed down from generation to generation and with no understanding of the potential role of the microorganism(s ) involved in the process .
103707,the,O,3600.0,Fermented foods have long been produced according to knowledge passed down from generation to generation and with no understanding of the potential role of the microorganism(s ) involved in the process .
103708,process,O,3600.0,Fermented foods have long been produced according to knowledge passed down from generation to generation and with no understanding of the potential role of the microorganism(s ) involved in the process .
103709,.,O,3600.0,Fermented foods have long been produced according to knowledge passed down from generation to generation and with no understanding of the potential role of the microorganism(s ) involved in the process .
103710,However,O,3601.0,"However , the scientific and technological revolution in Western countries made fermentation turn from a household to a controlled process suitable for industrial scale production systems intended for the mass marketplace ."
103711,",",O,3601.0,"However , the scientific and technological revolution in Western countries made fermentation turn from a household to a controlled process suitable for industrial scale production systems intended for the mass marketplace ."
103712,the,O,3601.0,"However , the scientific and technological revolution in Western countries made fermentation turn from a household to a controlled process suitable for industrial scale production systems intended for the mass marketplace ."
103713,scientific,O,3601.0,"However , the scientific and technological revolution in Western countries made fermentation turn from a household to a controlled process suitable for industrial scale production systems intended for the mass marketplace ."
103714,and,O,3601.0,"However , the scientific and technological revolution in Western countries made fermentation turn from a household to a controlled process suitable for industrial scale production systems intended for the mass marketplace ."
103715,technological,O,3601.0,"However , the scientific and technological revolution in Western countries made fermentation turn from a household to a controlled process suitable for industrial scale production systems intended for the mass marketplace ."
103716,revolution,O,3601.0,"However , the scientific and technological revolution in Western countries made fermentation turn from a household to a controlled process suitable for industrial scale production systems intended for the mass marketplace ."
103717,in,O,3601.0,"However , the scientific and technological revolution in Western countries made fermentation turn from a household to a controlled process suitable for industrial scale production systems intended for the mass marketplace ."
103718,Western,O,3601.0,"However , the scientific and technological revolution in Western countries made fermentation turn from a household to a controlled process suitable for industrial scale production systems intended for the mass marketplace ."
103719,countries,O,3601.0,"However , the scientific and technological revolution in Western countries made fermentation turn from a household to a controlled process suitable for industrial scale production systems intended for the mass marketplace ."
103720,made,O,3601.0,"However , the scientific and technological revolution in Western countries made fermentation turn from a household to a controlled process suitable for industrial scale production systems intended for the mass marketplace ."
103721,fermentation,O,3601.0,"However , the scientific and technological revolution in Western countries made fermentation turn from a household to a controlled process suitable for industrial scale production systems intended for the mass marketplace ."
103722,turn,O,3601.0,"However , the scientific and technological revolution in Western countries made fermentation turn from a household to a controlled process suitable for industrial scale production systems intended for the mass marketplace ."
103723,from,O,3601.0,"However , the scientific and technological revolution in Western countries made fermentation turn from a household to a controlled process suitable for industrial scale production systems intended for the mass marketplace ."
103724,a,O,3601.0,"However , the scientific and technological revolution in Western countries made fermentation turn from a household to a controlled process suitable for industrial scale production systems intended for the mass marketplace ."
103725,household,O,3601.0,"However , the scientific and technological revolution in Western countries made fermentation turn from a household to a controlled process suitable for industrial scale production systems intended for the mass marketplace ."
103726,to,O,3601.0,"However , the scientific and technological revolution in Western countries made fermentation turn from a household to a controlled process suitable for industrial scale production systems intended for the mass marketplace ."
103727,a,O,3601.0,"However , the scientific and technological revolution in Western countries made fermentation turn from a household to a controlled process suitable for industrial scale production systems intended for the mass marketplace ."
103728,controlled,O,3601.0,"However , the scientific and technological revolution in Western countries made fermentation turn from a household to a controlled process suitable for industrial scale production systems intended for the mass marketplace ."
103729,process,O,3601.0,"However , the scientific and technological revolution in Western countries made fermentation turn from a household to a controlled process suitable for industrial scale production systems intended for the mass marketplace ."
103730,suitable,O,3601.0,"However , the scientific and technological revolution in Western countries made fermentation turn from a household to a controlled process suitable for industrial scale production systems intended for the mass marketplace ."
103731,for,O,3601.0,"However , the scientific and technological revolution in Western countries made fermentation turn from a household to a controlled process suitable for industrial scale production systems intended for the mass marketplace ."
103732,industrial,O,3601.0,"However , the scientific and technological revolution in Western countries made fermentation turn from a household to a controlled process suitable for industrial scale production systems intended for the mass marketplace ."
103733,scale,O,3601.0,"However , the scientific and technological revolution in Western countries made fermentation turn from a household to a controlled process suitable for industrial scale production systems intended for the mass marketplace ."
103734,production,O,3601.0,"However , the scientific and technological revolution in Western countries made fermentation turn from a household to a controlled process suitable for industrial scale production systems intended for the mass marketplace ."
103735,systems,O,3601.0,"However , the scientific and technological revolution in Western countries made fermentation turn from a household to a controlled process suitable for industrial scale production systems intended for the mass marketplace ."
103736,intended,O,3601.0,"However , the scientific and technological revolution in Western countries made fermentation turn from a household to a controlled process suitable for industrial scale production systems intended for the mass marketplace ."
103737,for,O,3601.0,"However , the scientific and technological revolution in Western countries made fermentation turn from a household to a controlled process suitable for industrial scale production systems intended for the mass marketplace ."
103738,the,O,3601.0,"However , the scientific and technological revolution in Western countries made fermentation turn from a household to a controlled process suitable for industrial scale production systems intended for the mass marketplace ."
103739,mass,O,3601.0,"However , the scientific and technological revolution in Western countries made fermentation turn from a household to a controlled process suitable for industrial scale production systems intended for the mass marketplace ."
103740,marketplace,O,3601.0,"However , the scientific and technological revolution in Western countries made fermentation turn from a household to a controlled process suitable for industrial scale production systems intended for the mass marketplace ."
103741,.,O,3601.0,"However , the scientific and technological revolution in Western countries made fermentation turn from a household to a controlled process suitable for industrial scale production systems intended for the mass marketplace ."
103742,The,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103743,aim,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103744,of,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103745,this,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103746,paper,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103747,is,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103748,to,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103749,provide,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103750,an,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103751,up,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103752,-,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103753,to,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103754,-,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103755,date,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103756,review,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103757,of,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103758,the,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103759,latest,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103760,studies,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103761,which,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103762,investigated,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103763,the,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103764,health,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103765,-,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103766,promoting,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103767,components,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103768,forming,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103769,upon,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103770,fermentation,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103771,of,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103772,the,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103773,main,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103774,food,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103775,matrices,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103776,",",O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103777,in,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103778,order,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103779,to,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103780,contribute,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103781,to,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103782,understanding,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103783,their,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103784,important,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103785,role,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103786,in,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103787,healthy,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103788,diets,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103789,and,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103790,relevance,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103791,in,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103792,national,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103793,dietary,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103794,recommendations,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103795,worldwide,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103796,.,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103797,Formation,O,3603.0,"Formation of antioxidant , bioactive , anti - hypertensive , anti - diabetic , and FODMAP - reducing components in fermented foods are mainly presented and discussed ."
103798,of,O,3603.0,"Formation of antioxidant , bioactive , anti - hypertensive , anti - diabetic , and FODMAP - reducing components in fermented foods are mainly presented and discussed ."
103799,antioxidant,O,3603.0,"Formation of antioxidant , bioactive , anti - hypertensive , anti - diabetic , and FODMAP - reducing components in fermented foods are mainly presented and discussed ."
103800,",",O,3603.0,"Formation of antioxidant , bioactive , anti - hypertensive , anti - diabetic , and FODMAP - reducing components in fermented foods are mainly presented and discussed ."
103801,bioactive,O,3603.0,"Formation of antioxidant , bioactive , anti - hypertensive , anti - diabetic , and FODMAP - reducing components in fermented foods are mainly presented and discussed ."
103802,",",O,3603.0,"Formation of antioxidant , bioactive , anti - hypertensive , anti - diabetic , and FODMAP - reducing components in fermented foods are mainly presented and discussed ."
103803,anti,O,3603.0,"Formation of antioxidant , bioactive , anti - hypertensive , anti - diabetic , and FODMAP - reducing components in fermented foods are mainly presented and discussed ."
103804,-,O,3603.0,"Formation of antioxidant , bioactive , anti - hypertensive , anti - diabetic , and FODMAP - reducing components in fermented foods are mainly presented and discussed ."
103805,hypertensive,O,3603.0,"Formation of antioxidant , bioactive , anti - hypertensive , anti - diabetic , and FODMAP - reducing components in fermented foods are mainly presented and discussed ."
103806,",",O,3603.0,"Formation of antioxidant , bioactive , anti - hypertensive , anti - diabetic , and FODMAP - reducing components in fermented foods are mainly presented and discussed ."
103807,anti,O,3603.0,"Formation of antioxidant , bioactive , anti - hypertensive , anti - diabetic , and FODMAP - reducing components in fermented foods are mainly presented and discussed ."
103808,-,O,3603.0,"Formation of antioxidant , bioactive , anti - hypertensive , anti - diabetic , and FODMAP - reducing components in fermented foods are mainly presented and discussed ."
103809,diabetic,O,3603.0,"Formation of antioxidant , bioactive , anti - hypertensive , anti - diabetic , and FODMAP - reducing components in fermented foods are mainly presented and discussed ."
103810,",",O,3603.0,"Formation of antioxidant , bioactive , anti - hypertensive , anti - diabetic , and FODMAP - reducing components in fermented foods are mainly presented and discussed ."
103811,and,O,3603.0,"Formation of antioxidant , bioactive , anti - hypertensive , anti - diabetic , and FODMAP - reducing components in fermented foods are mainly presented and discussed ."
103812,FODMAP,O,3603.0,"Formation of antioxidant , bioactive , anti - hypertensive , anti - diabetic , and FODMAP - reducing components in fermented foods are mainly presented and discussed ."
103813,-,O,3603.0,"Formation of antioxidant , bioactive , anti - hypertensive , anti - diabetic , and FODMAP - reducing components in fermented foods are mainly presented and discussed ."
103814,reducing,O,3603.0,"Formation of antioxidant , bioactive , anti - hypertensive , anti - diabetic , and FODMAP - reducing components in fermented foods are mainly presented and discussed ."
103815,components,O,3603.0,"Formation of antioxidant , bioactive , anti - hypertensive , anti - diabetic , and FODMAP - reducing components in fermented foods are mainly presented and discussed ."
103816,in,O,3603.0,"Formation of antioxidant , bioactive , anti - hypertensive , anti - diabetic , and FODMAP - reducing components in fermented foods are mainly presented and discussed ."
103817,fermented,O,3603.0,"Formation of antioxidant , bioactive , anti - hypertensive , anti - diabetic , and FODMAP - reducing components in fermented foods are mainly presented and discussed ."
103818,foods,O,3603.0,"Formation of antioxidant , bioactive , anti - hypertensive , anti - diabetic , and FODMAP - reducing components in fermented foods are mainly presented and discussed ."
103819,are,O,3603.0,"Formation of antioxidant , bioactive , anti - hypertensive , anti - diabetic , and FODMAP - reducing components in fermented foods are mainly presented and discussed ."
103820,mainly,O,3603.0,"Formation of antioxidant , bioactive , anti - hypertensive , anti - diabetic , and FODMAP - reducing components in fermented foods are mainly presented and discussed ."
103821,presented,O,3603.0,"Formation of antioxidant , bioactive , anti - hypertensive , anti - diabetic , and FODMAP - reducing components in fermented foods are mainly presented and discussed ."
103822,and,O,3603.0,"Formation of antioxidant , bioactive , anti - hypertensive , anti - diabetic , and FODMAP - reducing components in fermented foods are mainly presented and discussed ."
103823,discussed,O,3603.0,"Formation of antioxidant , bioactive , anti - hypertensive , anti - diabetic , and FODMAP - reducing components in fermented foods are mainly presented and discussed ."
103824,.,O,3603.0,"Formation of antioxidant , bioactive , anti - hypertensive , anti - diabetic , and FODMAP - reducing components in fermented foods are mainly presented and discussed ."
103825,Fermentation,O,3604.0,"Fermentation was found to increase antioxidant activity of milks , cereals , fruit and vegetables , meat and fish ."
103826,was,O,3604.0,"Fermentation was found to increase antioxidant activity of milks , cereals , fruit and vegetables , meat and fish ."
103827,found,O,3604.0,"Fermentation was found to increase antioxidant activity of milks , cereals , fruit and vegetables , meat and fish ."
103828,to,O,3604.0,"Fermentation was found to increase antioxidant activity of milks , cereals , fruit and vegetables , meat and fish ."
103829,increase,O,3604.0,"Fermentation was found to increase antioxidant activity of milks , cereals , fruit and vegetables , meat and fish ."
103830,antioxidant,O,3604.0,"Fermentation was found to increase antioxidant activity of milks , cereals , fruit and vegetables , meat and fish ."
103831,activity,O,3604.0,"Fermentation was found to increase antioxidant activity of milks , cereals , fruit and vegetables , meat and fish ."
103832,of,O,3604.0,"Fermentation was found to increase antioxidant activity of milks , cereals , fruit and vegetables , meat and fish ."
103833,milks,B-AG.01.e,3604.0,"Fermentation was found to increase antioxidant activity of milks , cereals , fruit and vegetables , meat and fish ."
103834,",",O,3604.0,"Fermentation was found to increase antioxidant activity of milks , cereals , fruit and vegetables , meat and fish ."
103835,cereals,B-AG.01.i,3604.0,"Fermentation was found to increase antioxidant activity of milks , cereals , fruit and vegetables , meat and fish ."
103836,",",O,3604.0,"Fermentation was found to increase antioxidant activity of milks , cereals , fruit and vegetables , meat and fish ."
103837,fruit,B-AG.01.h,3604.0,"Fermentation was found to increase antioxidant activity of milks , cereals , fruit and vegetables , meat and fish ."
103838,and,I-AG.01.h,3604.0,"Fermentation was found to increase antioxidant activity of milks , cereals , fruit and vegetables , meat and fish ."
103839,vegetables,I-AG.01.h,3604.0,"Fermentation was found to increase antioxidant activity of milks , cereals , fruit and vegetables , meat and fish ."
103840,",",O,3604.0,"Fermentation was found to increase antioxidant activity of milks , cereals , fruit and vegetables , meat and fish ."
103841,meat,B-AG.01.d,3604.0,"Fermentation was found to increase antioxidant activity of milks , cereals , fruit and vegetables , meat and fish ."
103842,and,O,3604.0,"Fermentation was found to increase antioxidant activity of milks , cereals , fruit and vegetables , meat and fish ."
103843,fish,B-AG.01.d.07,3604.0,"Fermentation was found to increase antioxidant activity of milks , cereals , fruit and vegetables , meat and fish ."
103844,.,O,3604.0,"Fermentation was found to increase antioxidant activity of milks , cereals , fruit and vegetables , meat and fish ."
103845,Anti,O,3605.0,Anti - hypertensive peptides are detected in fermented milk and cereals .
103846,-,O,3605.0,Anti - hypertensive peptides are detected in fermented milk and cereals .
103847,hypertensive,O,3605.0,Anti - hypertensive peptides are detected in fermented milk and cereals .
103848,peptides,O,3605.0,Anti - hypertensive peptides are detected in fermented milk and cereals .
103849,are,O,3605.0,Anti - hypertensive peptides are detected in fermented milk and cereals .
103850,detected,O,3605.0,Anti - hypertensive peptides are detected in fermented milk and cereals .
103851,in,O,3605.0,Anti - hypertensive peptides are detected in fermented milk and cereals .
103852,fermented,B-AG.01.e,3605.0,Anti - hypertensive peptides are detected in fermented milk and cereals .
103853,milk,I-AG.01.e,3605.0,Anti - hypertensive peptides are detected in fermented milk and cereals .
103854,and,O,3605.0,Anti - hypertensive peptides are detected in fermented milk and cereals .
103855,cereals,B-AG.01.i,3605.0,Anti - hypertensive peptides are detected in fermented milk and cereals .
103856,.,O,3605.0,Anti - hypertensive peptides are detected in fermented milk and cereals .
103857,Changes,O,3606.0,Changes in vitamin content are mainly observed in fermented milk and fruits .
103858,in,O,3606.0,Changes in vitamin content are mainly observed in fermented milk and fruits .
103859,vitamin,O,3606.0,Changes in vitamin content are mainly observed in fermented milk and fruits .
103860,content,O,3606.0,Changes in vitamin content are mainly observed in fermented milk and fruits .
103861,are,O,3606.0,Changes in vitamin content are mainly observed in fermented milk and fruits .
103862,mainly,O,3606.0,Changes in vitamin content are mainly observed in fermented milk and fruits .
103863,observed,O,3606.0,Changes in vitamin content are mainly observed in fermented milk and fruits .
103864,in,O,3606.0,Changes in vitamin content are mainly observed in fermented milk and fruits .
103865,fermented,B-AG.01.e,3606.0,Changes in vitamin content are mainly observed in fermented milk and fruits .
103866,milk,I-AG.01.e,3606.0,Changes in vitamin content are mainly observed in fermented milk and fruits .
103867,and,O,3606.0,Changes in vitamin content are mainly observed in fermented milk and fruits .
103868,fruits,B-AG.01.h.01,3606.0,Changes in vitamin content are mainly observed in fermented milk and fruits .
103869,.,O,3606.0,Changes in vitamin content are mainly observed in fermented milk and fruits .
103870,Fermented,B-AG.01.e,3607.0,Fermented milk and fruit juice were found to have probiotic activity .
103871,milk,I-AG.01.e,3607.0,Fermented milk and fruit juice were found to have probiotic activity .
103872,and,O,3607.0,Fermented milk and fruit juice were found to have probiotic activity .
103873,fruit,B-AG.01.ab,3607.0,Fermented milk and fruit juice were found to have probiotic activity .
103874,juice,I-AG.01.ab,3607.0,Fermented milk and fruit juice were found to have probiotic activity .
103875,were,O,3607.0,Fermented milk and fruit juice were found to have probiotic activity .
103876,found,O,3607.0,Fermented milk and fruit juice were found to have probiotic activity .
103877,to,O,3607.0,Fermented milk and fruit juice were found to have probiotic activity .
103878,have,O,3607.0,Fermented milk and fruit juice were found to have probiotic activity .
103879,probiotic,O,3607.0,Fermented milk and fruit juice were found to have probiotic activity .
103880,activity,O,3607.0,Fermented milk and fruit juice were found to have probiotic activity .
103881,.,O,3607.0,Fermented milk and fruit juice were found to have probiotic activity .
103882,Other,O,3608.0,"Other effects such as anti - diabetic properties , FODMAP reduction , and changes in fatty acid profile are peculiar of specific food categories ."
103883,effects,O,3608.0,"Other effects such as anti - diabetic properties , FODMAP reduction , and changes in fatty acid profile are peculiar of specific food categories ."
103884,such,O,3608.0,"Other effects such as anti - diabetic properties , FODMAP reduction , and changes in fatty acid profile are peculiar of specific food categories ."
103885,as,O,3608.0,"Other effects such as anti - diabetic properties , FODMAP reduction , and changes in fatty acid profile are peculiar of specific food categories ."
103886,anti,O,3608.0,"Other effects such as anti - diabetic properties , FODMAP reduction , and changes in fatty acid profile are peculiar of specific food categories ."
103887,-,O,3608.0,"Other effects such as anti - diabetic properties , FODMAP reduction , and changes in fatty acid profile are peculiar of specific food categories ."
103888,diabetic,O,3608.0,"Other effects such as anti - diabetic properties , FODMAP reduction , and changes in fatty acid profile are peculiar of specific food categories ."
103889,properties,O,3608.0,"Other effects such as anti - diabetic properties , FODMAP reduction , and changes in fatty acid profile are peculiar of specific food categories ."
103890,",",O,3608.0,"Other effects such as anti - diabetic properties , FODMAP reduction , and changes in fatty acid profile are peculiar of specific food categories ."
103891,FODMAP,O,3608.0,"Other effects such as anti - diabetic properties , FODMAP reduction , and changes in fatty acid profile are peculiar of specific food categories ."
103892,reduction,O,3608.0,"Other effects such as anti - diabetic properties , FODMAP reduction , and changes in fatty acid profile are peculiar of specific food categories ."
103893,",",O,3608.0,"Other effects such as anti - diabetic properties , FODMAP reduction , and changes in fatty acid profile are peculiar of specific food categories ."
103894,and,O,3608.0,"Other effects such as anti - diabetic properties , FODMAP reduction , and changes in fatty acid profile are peculiar of specific food categories ."
103895,changes,O,3608.0,"Other effects such as anti - diabetic properties , FODMAP reduction , and changes in fatty acid profile are peculiar of specific food categories ."
103896,in,O,3608.0,"Other effects such as anti - diabetic properties , FODMAP reduction , and changes in fatty acid profile are peculiar of specific food categories ."
103897,fatty,O,3608.0,"Other effects such as anti - diabetic properties , FODMAP reduction , and changes in fatty acid profile are peculiar of specific food categories ."
103898,acid,O,3608.0,"Other effects such as anti - diabetic properties , FODMAP reduction , and changes in fatty acid profile are peculiar of specific food categories ."
103899,profile,O,3608.0,"Other effects such as anti - diabetic properties , FODMAP reduction , and changes in fatty acid profile are peculiar of specific food categories ."
103900,are,O,3608.0,"Other effects such as anti - diabetic properties , FODMAP reduction , and changes in fatty acid profile are peculiar of specific food categories ."
103901,peculiar,O,3608.0,"Other effects such as anti - diabetic properties , FODMAP reduction , and changes in fatty acid profile are peculiar of specific food categories ."
103902,of,O,3608.0,"Other effects such as anti - diabetic properties , FODMAP reduction , and changes in fatty acid profile are peculiar of specific food categories ."
103903,specific,O,3608.0,"Other effects such as anti - diabetic properties , FODMAP reduction , and changes in fatty acid profile are peculiar of specific food categories ."
103904,food,O,3608.0,"Other effects such as anti - diabetic properties , FODMAP reduction , and changes in fatty acid profile are peculiar of specific food categories ."
103905,categories,O,3608.0,"Other effects such as anti - diabetic properties , FODMAP reduction , and changes in fatty acid profile are peculiar of specific food categories ."
103906,.,O,3608.0,"Other effects such as anti - diabetic properties , FODMAP reduction , and changes in fatty acid profile are peculiar of specific food categories ."
103907,Conjugated,O,3609.0,"Conjugated linoleic acid ( CLA ) is a collective term for positional and geometric isomers of octadecadienoic acid in which the double bonds are conjugated , i.e. contiguous ."
103908,linoleic,O,3609.0,"Conjugated linoleic acid ( CLA ) is a collective term for positional and geometric isomers of octadecadienoic acid in which the double bonds are conjugated , i.e. contiguous ."
103909,acid,O,3609.0,"Conjugated linoleic acid ( CLA ) is a collective term for positional and geometric isomers of octadecadienoic acid in which the double bonds are conjugated , i.e. contiguous ."
103910,(,O,3609.0,"Conjugated linoleic acid ( CLA ) is a collective term for positional and geometric isomers of octadecadienoic acid in which the double bonds are conjugated , i.e. contiguous ."
103911,CLA,O,3609.0,"Conjugated linoleic acid ( CLA ) is a collective term for positional and geometric isomers of octadecadienoic acid in which the double bonds are conjugated , i.e. contiguous ."
103912,),O,3609.0,"Conjugated linoleic acid ( CLA ) is a collective term for positional and geometric isomers of octadecadienoic acid in which the double bonds are conjugated , i.e. contiguous ."
103913,is,O,3609.0,"Conjugated linoleic acid ( CLA ) is a collective term for positional and geometric isomers of octadecadienoic acid in which the double bonds are conjugated , i.e. contiguous ."
103914,a,O,3609.0,"Conjugated linoleic acid ( CLA ) is a collective term for positional and geometric isomers of octadecadienoic acid in which the double bonds are conjugated , i.e. contiguous ."
103915,collective,O,3609.0,"Conjugated linoleic acid ( CLA ) is a collective term for positional and geometric isomers of octadecadienoic acid in which the double bonds are conjugated , i.e. contiguous ."
103916,term,O,3609.0,"Conjugated linoleic acid ( CLA ) is a collective term for positional and geometric isomers of octadecadienoic acid in which the double bonds are conjugated , i.e. contiguous ."
103917,for,O,3609.0,"Conjugated linoleic acid ( CLA ) is a collective term for positional and geometric isomers of octadecadienoic acid in which the double bonds are conjugated , i.e. contiguous ."
103918,positional,O,3609.0,"Conjugated linoleic acid ( CLA ) is a collective term for positional and geometric isomers of octadecadienoic acid in which the double bonds are conjugated , i.e. contiguous ."
103919,and,O,3609.0,"Conjugated linoleic acid ( CLA ) is a collective term for positional and geometric isomers of octadecadienoic acid in which the double bonds are conjugated , i.e. contiguous ."
103920,geometric,O,3609.0,"Conjugated linoleic acid ( CLA ) is a collective term for positional and geometric isomers of octadecadienoic acid in which the double bonds are conjugated , i.e. contiguous ."
103921,isomers,O,3609.0,"Conjugated linoleic acid ( CLA ) is a collective term for positional and geometric isomers of octadecadienoic acid in which the double bonds are conjugated , i.e. contiguous ."
103922,of,O,3609.0,"Conjugated linoleic acid ( CLA ) is a collective term for positional and geometric isomers of octadecadienoic acid in which the double bonds are conjugated , i.e. contiguous ."
103923,octadecadienoic,O,3609.0,"Conjugated linoleic acid ( CLA ) is a collective term for positional and geometric isomers of octadecadienoic acid in which the double bonds are conjugated , i.e. contiguous ."
103924,acid,O,3609.0,"Conjugated linoleic acid ( CLA ) is a collective term for positional and geometric isomers of octadecadienoic acid in which the double bonds are conjugated , i.e. contiguous ."
103925,in,O,3609.0,"Conjugated linoleic acid ( CLA ) is a collective term for positional and geometric isomers of octadecadienoic acid in which the double bonds are conjugated , i.e. contiguous ."
103926,which,O,3609.0,"Conjugated linoleic acid ( CLA ) is a collective term for positional and geometric isomers of octadecadienoic acid in which the double bonds are conjugated , i.e. contiguous ."
103927,the,O,3609.0,"Conjugated linoleic acid ( CLA ) is a collective term for positional and geometric isomers of octadecadienoic acid in which the double bonds are conjugated , i.e. contiguous ."
103928,double,O,3609.0,"Conjugated linoleic acid ( CLA ) is a collective term for positional and geometric isomers of octadecadienoic acid in which the double bonds are conjugated , i.e. contiguous ."
103929,bonds,O,3609.0,"Conjugated linoleic acid ( CLA ) is a collective term for positional and geometric isomers of octadecadienoic acid in which the double bonds are conjugated , i.e. contiguous ."
103930,are,O,3609.0,"Conjugated linoleic acid ( CLA ) is a collective term for positional and geometric isomers of octadecadienoic acid in which the double bonds are conjugated , i.e. contiguous ."
103931,conjugated,O,3609.0,"Conjugated linoleic acid ( CLA ) is a collective term for positional and geometric isomers of octadecadienoic acid in which the double bonds are conjugated , i.e. contiguous ."
103932,",",O,3609.0,"Conjugated linoleic acid ( CLA ) is a collective term for positional and geometric isomers of octadecadienoic acid in which the double bonds are conjugated , i.e. contiguous ."
103933,i.e.,O,3609.0,"Conjugated linoleic acid ( CLA ) is a collective term for positional and geometric isomers of octadecadienoic acid in which the double bonds are conjugated , i.e. contiguous ."
103934,contiguous,O,3609.0,"Conjugated linoleic acid ( CLA ) is a collective term for positional and geometric isomers of octadecadienoic acid in which the double bonds are conjugated , i.e. contiguous ."
103935,.,O,3609.0,"Conjugated linoleic acid ( CLA ) is a collective term for positional and geometric isomers of octadecadienoic acid in which the double bonds are conjugated , i.e. contiguous ."
103936,CLA,O,3610.0,CLA was identified as a component of milk and dairy products over 20 years ago .
103937,was,O,3610.0,CLA was identified as a component of milk and dairy products over 20 years ago .
103938,identified,O,3610.0,CLA was identified as a component of milk and dairy products over 20 years ago .
103939,as,O,3610.0,CLA was identified as a component of milk and dairy products over 20 years ago .
103940,a,O,3610.0,CLA was identified as a component of milk and dairy products over 20 years ago .
103941,component,O,3610.0,CLA was identified as a component of milk and dairy products over 20 years ago .
103942,of,O,3610.0,CLA was identified as a component of milk and dairy products over 20 years ago .
103943,milk,B-AG.01.e,3610.0,CLA was identified as a component of milk and dairy products over 20 years ago .
103944,and,O,3610.0,CLA was identified as a component of milk and dairy products over 20 years ago .
103945,dairy,B-AG.01.e,3610.0,CLA was identified as a component of milk and dairy products over 20 years ago .
103946,products,I-AG.01.e,3610.0,CLA was identified as a component of milk and dairy products over 20 years ago .
103947,over,O,3610.0,CLA was identified as a component of milk and dairy products over 20 years ago .
103948,20,O,3610.0,CLA was identified as a component of milk and dairy products over 20 years ago .
103949,years,O,3610.0,CLA was identified as a component of milk and dairy products over 20 years ago .
103950,ago,O,3610.0,CLA was identified as a component of milk and dairy products over 20 years ago .
103951,.,O,3610.0,CLA was identified as a component of milk and dairy products over 20 years ago .
103952,It,O,3611.0,It is formed as an intermediate in the course of the conversion of linoleic acid to oleic acid in the rumen .
103953,is,O,3611.0,It is formed as an intermediate in the course of the conversion of linoleic acid to oleic acid in the rumen .
103954,formed,O,3611.0,It is formed as an intermediate in the course of the conversion of linoleic acid to oleic acid in the rumen .
103955,as,O,3611.0,It is formed as an intermediate in the course of the conversion of linoleic acid to oleic acid in the rumen .
103956,an,O,3611.0,It is formed as an intermediate in the course of the conversion of linoleic acid to oleic acid in the rumen .
103957,intermediate,O,3611.0,It is formed as an intermediate in the course of the conversion of linoleic acid to oleic acid in the rumen .
103958,in,O,3611.0,It is formed as an intermediate in the course of the conversion of linoleic acid to oleic acid in the rumen .
103959,the,O,3611.0,It is formed as an intermediate in the course of the conversion of linoleic acid to oleic acid in the rumen .
103960,course,O,3611.0,It is formed as an intermediate in the course of the conversion of linoleic acid to oleic acid in the rumen .
103961,of,O,3611.0,It is formed as an intermediate in the course of the conversion of linoleic acid to oleic acid in the rumen .
103962,the,O,3611.0,It is formed as an intermediate in the course of the conversion of linoleic acid to oleic acid in the rumen .
103963,conversion,O,3611.0,It is formed as an intermediate in the course of the conversion of linoleic acid to oleic acid in the rumen .
103964,of,O,3611.0,It is formed as an intermediate in the course of the conversion of linoleic acid to oleic acid in the rumen .
103965,linoleic,O,3611.0,It is formed as an intermediate in the course of the conversion of linoleic acid to oleic acid in the rumen .
103966,acid,O,3611.0,It is formed as an intermediate in the course of the conversion of linoleic acid to oleic acid in the rumen .
103967,to,O,3611.0,It is formed as an intermediate in the course of the conversion of linoleic acid to oleic acid in the rumen .
103968,oleic,O,3611.0,It is formed as an intermediate in the course of the conversion of linoleic acid to oleic acid in the rumen .
103969,acid,O,3611.0,It is formed as an intermediate in the course of the conversion of linoleic acid to oleic acid in the rumen .
103970,in,O,3611.0,It is formed as an intermediate in the course of the conversion of linoleic acid to oleic acid in the rumen .
103971,the,O,3611.0,It is formed as an intermediate in the course of the conversion of linoleic acid to oleic acid in the rumen .
103972,rumen,O,3611.0,It is formed as an intermediate in the course of the conversion of linoleic acid to oleic acid in the rumen .
103973,.,O,3611.0,It is formed as an intermediate in the course of the conversion of linoleic acid to oleic acid in the rumen .
103974,The,O,3612.0,"The predominant naturally occurring isomer is the cis-9 , trans-11 modification ."
103975,predominant,O,3612.0,"The predominant naturally occurring isomer is the cis-9 , trans-11 modification ."
103976,naturally,O,3612.0,"The predominant naturally occurring isomer is the cis-9 , trans-11 modification ."
103977,occurring,O,3612.0,"The predominant naturally occurring isomer is the cis-9 , trans-11 modification ."
103978,isomer,O,3612.0,"The predominant naturally occurring isomer is the cis-9 , trans-11 modification ."
103979,is,O,3612.0,"The predominant naturally occurring isomer is the cis-9 , trans-11 modification ."
103980,the,O,3612.0,"The predominant naturally occurring isomer is the cis-9 , trans-11 modification ."
103981,cis-9,O,3612.0,"The predominant naturally occurring isomer is the cis-9 , trans-11 modification ."
103982,",",O,3612.0,"The predominant naturally occurring isomer is the cis-9 , trans-11 modification ."
103983,trans-11,O,3612.0,"The predominant naturally occurring isomer is the cis-9 , trans-11 modification ."
103984,modification,O,3612.0,"The predominant naturally occurring isomer is the cis-9 , trans-11 modification ."
103985,.,O,3612.0,"The predominant naturally occurring isomer is the cis-9 , trans-11 modification ."
103986,Treatment,O,3613.0,"Treatment of linoleic acid - rich oils such as safflower oil , soybean oil , or maize oil with base and heat will result in the formation of CLA ."
103987,of,O,3613.0,"Treatment of linoleic acid - rich oils such as safflower oil , soybean oil , or maize oil with base and heat will result in the formation of CLA ."
103988,linoleic,B-AG.01.f,3613.0,"Treatment of linoleic acid - rich oils such as safflower oil , soybean oil , or maize oil with base and heat will result in the formation of CLA ."
103989,acid,I-AG.01.f,3613.0,"Treatment of linoleic acid - rich oils such as safflower oil , soybean oil , or maize oil with base and heat will result in the formation of CLA ."
103990,-,I-AG.01.f,3613.0,"Treatment of linoleic acid - rich oils such as safflower oil , soybean oil , or maize oil with base and heat will result in the formation of CLA ."
103991,rich,I-AG.01.f,3613.0,"Treatment of linoleic acid - rich oils such as safflower oil , soybean oil , or maize oil with base and heat will result in the formation of CLA ."
103992,oils,I-AG.01.f,3613.0,"Treatment of linoleic acid - rich oils such as safflower oil , soybean oil , or maize oil with base and heat will result in the formation of CLA ."
103993,such,O,3613.0,"Treatment of linoleic acid - rich oils such as safflower oil , soybean oil , or maize oil with base and heat will result in the formation of CLA ."
103994,as,O,3613.0,"Treatment of linoleic acid - rich oils such as safflower oil , soybean oil , or maize oil with base and heat will result in the formation of CLA ."
103995,safflower,B-AG.01.f,3613.0,"Treatment of linoleic acid - rich oils such as safflower oil , soybean oil , or maize oil with base and heat will result in the formation of CLA ."
103996,oil,I-AG.01.f,3613.0,"Treatment of linoleic acid - rich oils such as safflower oil , soybean oil , or maize oil with base and heat will result in the formation of CLA ."
103997,",",O,3613.0,"Treatment of linoleic acid - rich oils such as safflower oil , soybean oil , or maize oil with base and heat will result in the formation of CLA ."
103998,soybean,B-AG.01.f,3613.0,"Treatment of linoleic acid - rich oils such as safflower oil , soybean oil , or maize oil with base and heat will result in the formation of CLA ."
103999,oil,I-AG.01.f,3613.0,"Treatment of linoleic acid - rich oils such as safflower oil , soybean oil , or maize oil with base and heat will result in the formation of CLA ."
104000,",",O,3613.0,"Treatment of linoleic acid - rich oils such as safflower oil , soybean oil , or maize oil with base and heat will result in the formation of CLA ."
104001,or,O,3613.0,"Treatment of linoleic acid - rich oils such as safflower oil , soybean oil , or maize oil with base and heat will result in the formation of CLA ."
104002,maize,B-AG.01.f,3613.0,"Treatment of linoleic acid - rich oils such as safflower oil , soybean oil , or maize oil with base and heat will result in the formation of CLA ."
104003,oil,I-AG.01.f,3613.0,"Treatment of linoleic acid - rich oils such as safflower oil , soybean oil , or maize oil with base and heat will result in the formation of CLA ."
104004,with,O,3613.0,"Treatment of linoleic acid - rich oils such as safflower oil , soybean oil , or maize oil with base and heat will result in the formation of CLA ."
104005,base,O,3613.0,"Treatment of linoleic acid - rich oils such as safflower oil , soybean oil , or maize oil with base and heat will result in the formation of CLA ."
104006,and,O,3613.0,"Treatment of linoleic acid - rich oils such as safflower oil , soybean oil , or maize oil with base and heat will result in the formation of CLA ."
104007,heat,O,3613.0,"Treatment of linoleic acid - rich oils such as safflower oil , soybean oil , or maize oil with base and heat will result in the formation of CLA ."
104008,will,O,3613.0,"Treatment of linoleic acid - rich oils such as safflower oil , soybean oil , or maize oil with base and heat will result in the formation of CLA ."
104009,result,O,3613.0,"Treatment of linoleic acid - rich oils such as safflower oil , soybean oil , or maize oil with base and heat will result in the formation of CLA ."
104010,in,O,3613.0,"Treatment of linoleic acid - rich oils such as safflower oil , soybean oil , or maize oil with base and heat will result in the formation of CLA ."
104011,the,O,3613.0,"Treatment of linoleic acid - rich oils such as safflower oil , soybean oil , or maize oil with base and heat will result in the formation of CLA ."
104012,formation,O,3613.0,"Treatment of linoleic acid - rich oils such as safflower oil , soybean oil , or maize oil with base and heat will result in the formation of CLA ."
104013,of,O,3613.0,"Treatment of linoleic acid - rich oils such as safflower oil , soybean oil , or maize oil with base and heat will result in the formation of CLA ."
104014,CLA,O,3613.0,"Treatment of linoleic acid - rich oils such as safflower oil , soybean oil , or maize oil with base and heat will result in the formation of CLA ."
104015,.,O,3613.0,"Treatment of linoleic acid - rich oils such as safflower oil , soybean oil , or maize oil with base and heat will result in the formation of CLA ."
104016,Two,O,3614.0,"Two isomers predominate in the synthetic preparation , c9,t11 and t10,c12 ."
104017,isomers,O,3614.0,"Two isomers predominate in the synthetic preparation , c9,t11 and t10,c12 ."
104018,predominate,O,3614.0,"Two isomers predominate in the synthetic preparation , c9,t11 and t10,c12 ."
104019,in,O,3614.0,"Two isomers predominate in the synthetic preparation , c9,t11 and t10,c12 ."
104020,the,O,3614.0,"Two isomers predominate in the synthetic preparation , c9,t11 and t10,c12 ."
104021,synthetic,O,3614.0,"Two isomers predominate in the synthetic preparation , c9,t11 and t10,c12 ."
104022,preparation,O,3614.0,"Two isomers predominate in the synthetic preparation , c9,t11 and t10,c12 ."
104023,",",O,3614.0,"Two isomers predominate in the synthetic preparation , c9,t11 and t10,c12 ."
104024,"c9,t11",O,3614.0,"Two isomers predominate in the synthetic preparation , c9,t11 and t10,c12 ."
104025,and,O,3614.0,"Two isomers predominate in the synthetic preparation , c9,t11 and t10,c12 ."
104026,"t10,c12",O,3614.0,"Two isomers predominate in the synthetic preparation , c9,t11 and t10,c12 ."
104027,.,O,3614.0,"Two isomers predominate in the synthetic preparation , c9,t11 and t10,c12 ."
104028,CLA,O,3615.0,"CLA has been shown to inhibit chemically - induced skin , stomach , mammary or colon tumours in mice and rats ."
104029,has,O,3615.0,"CLA has been shown to inhibit chemically - induced skin , stomach , mammary or colon tumours in mice and rats ."
104030,been,O,3615.0,"CLA has been shown to inhibit chemically - induced skin , stomach , mammary or colon tumours in mice and rats ."
104031,shown,O,3615.0,"CLA has been shown to inhibit chemically - induced skin , stomach , mammary or colon tumours in mice and rats ."
104032,to,O,3615.0,"CLA has been shown to inhibit chemically - induced skin , stomach , mammary or colon tumours in mice and rats ."
104033,inhibit,O,3615.0,"CLA has been shown to inhibit chemically - induced skin , stomach , mammary or colon tumours in mice and rats ."
104034,chemically,O,3615.0,"CLA has been shown to inhibit chemically - induced skin , stomach , mammary or colon tumours in mice and rats ."
104035,-,O,3615.0,"CLA has been shown to inhibit chemically - induced skin , stomach , mammary or colon tumours in mice and rats ."
104036,induced,O,3615.0,"CLA has been shown to inhibit chemically - induced skin , stomach , mammary or colon tumours in mice and rats ."
104037,skin,O,3615.0,"CLA has been shown to inhibit chemically - induced skin , stomach , mammary or colon tumours in mice and rats ."
104038,",",O,3615.0,"CLA has been shown to inhibit chemically - induced skin , stomach , mammary or colon tumours in mice and rats ."
104039,stomach,O,3615.0,"CLA has been shown to inhibit chemically - induced skin , stomach , mammary or colon tumours in mice and rats ."
104040,",",O,3615.0,"CLA has been shown to inhibit chemically - induced skin , stomach , mammary or colon tumours in mice and rats ."
104041,mammary,O,3615.0,"CLA has been shown to inhibit chemically - induced skin , stomach , mammary or colon tumours in mice and rats ."
104042,or,O,3615.0,"CLA has been shown to inhibit chemically - induced skin , stomach , mammary or colon tumours in mice and rats ."
104043,colon,O,3615.0,"CLA has been shown to inhibit chemically - induced skin , stomach , mammary or colon tumours in mice and rats ."
104044,tumours,O,3615.0,"CLA has been shown to inhibit chemically - induced skin , stomach , mammary or colon tumours in mice and rats ."
104045,in,O,3615.0,"CLA has been shown to inhibit chemically - induced skin , stomach , mammary or colon tumours in mice and rats ."
104046,mice,O,3615.0,"CLA has been shown to inhibit chemically - induced skin , stomach , mammary or colon tumours in mice and rats ."
104047,and,O,3615.0,"CLA has been shown to inhibit chemically - induced skin , stomach , mammary or colon tumours in mice and rats ."
104048,rats,O,3615.0,"CLA has been shown to inhibit chemically - induced skin , stomach , mammary or colon tumours in mice and rats ."
104049,.,O,3615.0,"CLA has been shown to inhibit chemically - induced skin , stomach , mammary or colon tumours in mice and rats ."
104050,The,O,3616.0,The inhibition of mammary tumours in rats is effective regardless of type of carcinogen or type or amount of dietary fat .
104051,inhibition,O,3616.0,The inhibition of mammary tumours in rats is effective regardless of type of carcinogen or type or amount of dietary fat .
104052,of,O,3616.0,The inhibition of mammary tumours in rats is effective regardless of type of carcinogen or type or amount of dietary fat .
104053,mammary,O,3616.0,The inhibition of mammary tumours in rats is effective regardless of type of carcinogen or type or amount of dietary fat .
104054,tumours,O,3616.0,The inhibition of mammary tumours in rats is effective regardless of type of carcinogen or type or amount of dietary fat .
104055,in,O,3616.0,The inhibition of mammary tumours in rats is effective regardless of type of carcinogen or type or amount of dietary fat .
104056,rats,O,3616.0,The inhibition of mammary tumours in rats is effective regardless of type of carcinogen or type or amount of dietary fat .
104057,is,O,3616.0,The inhibition of mammary tumours in rats is effective regardless of type of carcinogen or type or amount of dietary fat .
104058,effective,O,3616.0,The inhibition of mammary tumours in rats is effective regardless of type of carcinogen or type or amount of dietary fat .
104059,regardless,O,3616.0,The inhibition of mammary tumours in rats is effective regardless of type of carcinogen or type or amount of dietary fat .
104060,of,O,3616.0,The inhibition of mammary tumours in rats is effective regardless of type of carcinogen or type or amount of dietary fat .
104061,type,O,3616.0,The inhibition of mammary tumours in rats is effective regardless of type of carcinogen or type or amount of dietary fat .
104062,of,O,3616.0,The inhibition of mammary tumours in rats is effective regardless of type of carcinogen or type or amount of dietary fat .
104063,carcinogen,O,3616.0,The inhibition of mammary tumours in rats is effective regardless of type of carcinogen or type or amount of dietary fat .
104064,or,O,3616.0,The inhibition of mammary tumours in rats is effective regardless of type of carcinogen or type or amount of dietary fat .
104065,type,O,3616.0,The inhibition of mammary tumours in rats is effective regardless of type of carcinogen or type or amount of dietary fat .
104066,or,O,3616.0,The inhibition of mammary tumours in rats is effective regardless of type of carcinogen or type or amount of dietary fat .
104067,amount,O,3616.0,The inhibition of mammary tumours in rats is effective regardless of type of carcinogen or type or amount of dietary fat .
104068,of,O,3616.0,The inhibition of mammary tumours in rats is effective regardless of type of carcinogen or type or amount of dietary fat .
104069,dietary,O,3616.0,The inhibition of mammary tumours in rats is effective regardless of type of carcinogen or type or amount of dietary fat .
104070,fat,O,3616.0,The inhibition of mammary tumours in rats is effective regardless of type of carcinogen or type or amount of dietary fat .
104071,.,O,3616.0,The inhibition of mammary tumours in rats is effective regardless of type of carcinogen or type or amount of dietary fat .
104072,CLA,O,3617.0,CLA has also been shown to inhibit cholesterol - induced atherosclerosis in rabbits .
104073,has,O,3617.0,CLA has also been shown to inhibit cholesterol - induced atherosclerosis in rabbits .
104074,also,O,3617.0,CLA has also been shown to inhibit cholesterol - induced atherosclerosis in rabbits .
104075,been,O,3617.0,CLA has also been shown to inhibit cholesterol - induced atherosclerosis in rabbits .
104076,shown,O,3617.0,CLA has also been shown to inhibit cholesterol - induced atherosclerosis in rabbits .
104077,to,O,3617.0,CLA has also been shown to inhibit cholesterol - induced atherosclerosis in rabbits .
104078,inhibit,O,3617.0,CLA has also been shown to inhibit cholesterol - induced atherosclerosis in rabbits .
104079,cholesterol,O,3617.0,CLA has also been shown to inhibit cholesterol - induced atherosclerosis in rabbits .
104080,-,O,3617.0,CLA has also been shown to inhibit cholesterol - induced atherosclerosis in rabbits .
104081,induced,O,3617.0,CLA has also been shown to inhibit cholesterol - induced atherosclerosis in rabbits .
104082,atherosclerosis,O,3617.0,CLA has also been shown to inhibit cholesterol - induced atherosclerosis in rabbits .
104083,in,O,3617.0,CLA has also been shown to inhibit cholesterol - induced atherosclerosis in rabbits .
104084,rabbits,O,3617.0,CLA has also been shown to inhibit cholesterol - induced atherosclerosis in rabbits .
104085,.,O,3617.0,CLA has also been shown to inhibit cholesterol - induced atherosclerosis in rabbits .
104086,When,O,3618.0,"When young animals ( mice , pigs ) are placed on CLA - containing diets after weaning they accumulate more body protein and less fat ."
104087,young,O,3618.0,"When young animals ( mice , pigs ) are placed on CLA - containing diets after weaning they accumulate more body protein and less fat ."
104088,animals,O,3618.0,"When young animals ( mice , pigs ) are placed on CLA - containing diets after weaning they accumulate more body protein and less fat ."
104089,(,O,3618.0,"When young animals ( mice , pigs ) are placed on CLA - containing diets after weaning they accumulate more body protein and less fat ."
104090,mice,O,3618.0,"When young animals ( mice , pigs ) are placed on CLA - containing diets after weaning they accumulate more body protein and less fat ."
104091,",",O,3618.0,"When young animals ( mice , pigs ) are placed on CLA - containing diets after weaning they accumulate more body protein and less fat ."
104092,pigs,O,3618.0,"When young animals ( mice , pigs ) are placed on CLA - containing diets after weaning they accumulate more body protein and less fat ."
104093,),O,3618.0,"When young animals ( mice , pigs ) are placed on CLA - containing diets after weaning they accumulate more body protein and less fat ."
104094,are,O,3618.0,"When young animals ( mice , pigs ) are placed on CLA - containing diets after weaning they accumulate more body protein and less fat ."
104095,placed,O,3618.0,"When young animals ( mice , pigs ) are placed on CLA - containing diets after weaning they accumulate more body protein and less fat ."
104096,on,O,3618.0,"When young animals ( mice , pigs ) are placed on CLA - containing diets after weaning they accumulate more body protein and less fat ."
104097,CLA,O,3618.0,"When young animals ( mice , pigs ) are placed on CLA - containing diets after weaning they accumulate more body protein and less fat ."
104098,-,O,3618.0,"When young animals ( mice , pigs ) are placed on CLA - containing diets after weaning they accumulate more body protein and less fat ."
104099,containing,O,3618.0,"When young animals ( mice , pigs ) are placed on CLA - containing diets after weaning they accumulate more body protein and less fat ."
104100,diets,O,3618.0,"When young animals ( mice , pigs ) are placed on CLA - containing diets after weaning they accumulate more body protein and less fat ."
104101,after,O,3618.0,"When young animals ( mice , pigs ) are placed on CLA - containing diets after weaning they accumulate more body protein and less fat ."
104102,weaning,O,3618.0,"When young animals ( mice , pigs ) are placed on CLA - containing diets after weaning they accumulate more body protein and less fat ."
104103,they,O,3618.0,"When young animals ( mice , pigs ) are placed on CLA - containing diets after weaning they accumulate more body protein and less fat ."
104104,accumulate,O,3618.0,"When young animals ( mice , pigs ) are placed on CLA - containing diets after weaning they accumulate more body protein and less fat ."
104105,more,O,3618.0,"When young animals ( mice , pigs ) are placed on CLA - containing diets after weaning they accumulate more body protein and less fat ."
104106,body,O,3618.0,"When young animals ( mice , pigs ) are placed on CLA - containing diets after weaning they accumulate more body protein and less fat ."
104107,protein,O,3618.0,"When young animals ( mice , pigs ) are placed on CLA - containing diets after weaning they accumulate more body protein and less fat ."
104108,and,O,3618.0,"When young animals ( mice , pigs ) are placed on CLA - containing diets after weaning they accumulate more body protein and less fat ."
104109,less,O,3618.0,"When young animals ( mice , pigs ) are placed on CLA - containing diets after weaning they accumulate more body protein and less fat ."
104110,fat,O,3618.0,"When young animals ( mice , pigs ) are placed on CLA - containing diets after weaning they accumulate more body protein and less fat ."
104111,.,O,3618.0,"When young animals ( mice , pigs ) are placed on CLA - containing diets after weaning they accumulate more body protein and less fat ."
104112,Since,O,3619.0,Since CLA is derived from the milk of ruminant animals and is found primarily in their meat and in products derived from their milk there is a concerted world - wide effort to increase CLA content of milk by dietary means .
104113,CLA,O,3619.0,Since CLA is derived from the milk of ruminant animals and is found primarily in their meat and in products derived from their milk there is a concerted world - wide effort to increase CLA content of milk by dietary means .
104114,is,O,3619.0,Since CLA is derived from the milk of ruminant animals and is found primarily in their meat and in products derived from their milk there is a concerted world - wide effort to increase CLA content of milk by dietary means .
104115,derived,O,3619.0,Since CLA is derived from the milk of ruminant animals and is found primarily in their meat and in products derived from their milk there is a concerted world - wide effort to increase CLA content of milk by dietary means .
104116,from,O,3619.0,Since CLA is derived from the milk of ruminant animals and is found primarily in their meat and in products derived from their milk there is a concerted world - wide effort to increase CLA content of milk by dietary means .
104117,the,O,3619.0,Since CLA is derived from the milk of ruminant animals and is found primarily in their meat and in products derived from their milk there is a concerted world - wide effort to increase CLA content of milk by dietary means .
104118,milk,B-AG.01.e,3619.0,Since CLA is derived from the milk of ruminant animals and is found primarily in their meat and in products derived from their milk there is a concerted world - wide effort to increase CLA content of milk by dietary means .
104119,of,O,3619.0,Since CLA is derived from the milk of ruminant animals and is found primarily in their meat and in products derived from their milk there is a concerted world - wide effort to increase CLA content of milk by dietary means .
104120,ruminant,O,3619.0,Since CLA is derived from the milk of ruminant animals and is found primarily in their meat and in products derived from their milk there is a concerted world - wide effort to increase CLA content of milk by dietary means .
104121,animals,O,3619.0,Since CLA is derived from the milk of ruminant animals and is found primarily in their meat and in products derived from their milk there is a concerted world - wide effort to increase CLA content of milk by dietary means .
104122,and,O,3619.0,Since CLA is derived from the milk of ruminant animals and is found primarily in their meat and in products derived from their milk there is a concerted world - wide effort to increase CLA content of milk by dietary means .
104123,is,O,3619.0,Since CLA is derived from the milk of ruminant animals and is found primarily in their meat and in products derived from their milk there is a concerted world - wide effort to increase CLA content of milk by dietary means .
104124,found,O,3619.0,Since CLA is derived from the milk of ruminant animals and is found primarily in their meat and in products derived from their milk there is a concerted world - wide effort to increase CLA content of milk by dietary means .
104125,primarily,O,3619.0,Since CLA is derived from the milk of ruminant animals and is found primarily in their meat and in products derived from their milk there is a concerted world - wide effort to increase CLA content of milk by dietary means .
104126,in,O,3619.0,Since CLA is derived from the milk of ruminant animals and is found primarily in their meat and in products derived from their milk there is a concerted world - wide effort to increase CLA content of milk by dietary means .
104127,their,O,3619.0,Since CLA is derived from the milk of ruminant animals and is found primarily in their meat and in products derived from their milk there is a concerted world - wide effort to increase CLA content of milk by dietary means .
104128,meat,B-AG.01.d,3619.0,Since CLA is derived from the milk of ruminant animals and is found primarily in their meat and in products derived from their milk there is a concerted world - wide effort to increase CLA content of milk by dietary means .
104129,and,O,3619.0,Since CLA is derived from the milk of ruminant animals and is found primarily in their meat and in products derived from their milk there is a concerted world - wide effort to increase CLA content of milk by dietary means .
104130,in,O,3619.0,Since CLA is derived from the milk of ruminant animals and is found primarily in their meat and in products derived from their milk there is a concerted world - wide effort to increase CLA content of milk by dietary means .
104131,products,O,3619.0,Since CLA is derived from the milk of ruminant animals and is found primarily in their meat and in products derived from their milk there is a concerted world - wide effort to increase CLA content of milk by dietary means .
104132,derived,O,3619.0,Since CLA is derived from the milk of ruminant animals and is found primarily in their meat and in products derived from their milk there is a concerted world - wide effort to increase CLA content of milk by dietary means .
104133,from,O,3619.0,Since CLA is derived from the milk of ruminant animals and is found primarily in their meat and in products derived from their milk there is a concerted world - wide effort to increase CLA content of milk by dietary means .
104134,their,O,3619.0,Since CLA is derived from the milk of ruminant animals and is found primarily in their meat and in products derived from their milk there is a concerted world - wide effort to increase CLA content of milk by dietary means .
104135,milk,B-AG.01.e,3619.0,Since CLA is derived from the milk of ruminant animals and is found primarily in their meat and in products derived from their milk there is a concerted world - wide effort to increase CLA content of milk by dietary means .
104136,there,O,3619.0,Since CLA is derived from the milk of ruminant animals and is found primarily in their meat and in products derived from their milk there is a concerted world - wide effort to increase CLA content of milk by dietary means .
104137,is,O,3619.0,Since CLA is derived from the milk of ruminant animals and is found primarily in their meat and in products derived from their milk there is a concerted world - wide effort to increase CLA content of milk by dietary means .
104138,a,O,3619.0,Since CLA is derived from the milk of ruminant animals and is found primarily in their meat and in products derived from their milk there is a concerted world - wide effort to increase CLA content of milk by dietary means .
104139,concerted,O,3619.0,Since CLA is derived from the milk of ruminant animals and is found primarily in their meat and in products derived from their milk there is a concerted world - wide effort to increase CLA content of milk by dietary means .
104140,world,O,3619.0,Since CLA is derived from the milk of ruminant animals and is found primarily in their meat and in products derived from their milk there is a concerted world - wide effort to increase CLA content of milk by dietary means .
104141,-,O,3619.0,Since CLA is derived from the milk of ruminant animals and is found primarily in their meat and in products derived from their milk there is a concerted world - wide effort to increase CLA content of milk by dietary means .
104142,wide,O,3619.0,Since CLA is derived from the milk of ruminant animals and is found primarily in their meat and in products derived from their milk there is a concerted world - wide effort to increase CLA content of milk by dietary means .
104143,effort,O,3619.0,Since CLA is derived from the milk of ruminant animals and is found primarily in their meat and in products derived from their milk there is a concerted world - wide effort to increase CLA content of milk by dietary means .
104144,to,O,3619.0,Since CLA is derived from the milk of ruminant animals and is found primarily in their meat and in products derived from their milk there is a concerted world - wide effort to increase CLA content of milk by dietary means .
104145,increase,O,3619.0,Since CLA is derived from the milk of ruminant animals and is found primarily in their meat and in products derived from their milk there is a concerted world - wide effort to increase CLA content of milk by dietary means .
104146,CLA,O,3619.0,Since CLA is derived from the milk of ruminant animals and is found primarily in their meat and in products derived from their milk there is a concerted world - wide effort to increase CLA content of milk by dietary means .
104147,content,O,3619.0,Since CLA is derived from the milk of ruminant animals and is found primarily in their meat and in products derived from their milk there is a concerted world - wide effort to increase CLA content of milk by dietary means .
104148,of,O,3619.0,Since CLA is derived from the milk of ruminant animals and is found primarily in their meat and in products derived from their milk there is a concerted world - wide effort to increase CLA content of milk by dietary means .
104149,milk,B-AG.01.e,3619.0,Since CLA is derived from the milk of ruminant animals and is found primarily in their meat and in products derived from their milk there is a concerted world - wide effort to increase CLA content of milk by dietary means .
104150,by,O,3619.0,Since CLA is derived from the milk of ruminant animals and is found primarily in their meat and in products derived from their milk there is a concerted world - wide effort to increase CLA content of milk by dietary means .
104151,dietary,O,3619.0,Since CLA is derived from the milk of ruminant animals and is found primarily in their meat and in products derived from their milk there is a concerted world - wide effort to increase CLA content of milk by dietary means .
104152,means,O,3619.0,Since CLA is derived from the milk of ruminant animals and is found primarily in their meat and in products derived from their milk there is a concerted world - wide effort to increase CLA content of milk by dietary means .
104153,.,O,3619.0,Since CLA is derived from the milk of ruminant animals and is found primarily in their meat and in products derived from their milk there is a concerted world - wide effort to increase CLA content of milk by dietary means .
104154,Its,O,3620.0,"Its effect on growth ( less fat , more protein ) is also a subject of active research ."
104155,effect,O,3620.0,"Its effect on growth ( less fat , more protein ) is also a subject of active research ."
104156,on,O,3620.0,"Its effect on growth ( less fat , more protein ) is also a subject of active research ."
104157,growth,O,3620.0,"Its effect on growth ( less fat , more protein ) is also a subject of active research ."
104158,(,O,3620.0,"Its effect on growth ( less fat , more protein ) is also a subject of active research ."
104159,less,O,3620.0,"Its effect on growth ( less fat , more protein ) is also a subject of active research ."
104160,fat,O,3620.0,"Its effect on growth ( less fat , more protein ) is also a subject of active research ."
104161,",",O,3620.0,"Its effect on growth ( less fat , more protein ) is also a subject of active research ."
104162,more,O,3620.0,"Its effect on growth ( less fat , more protein ) is also a subject of active research ."
104163,protein,O,3620.0,"Its effect on growth ( less fat , more protein ) is also a subject of active research ."
104164,),O,3620.0,"Its effect on growth ( less fat , more protein ) is also a subject of active research ."
104165,is,O,3620.0,"Its effect on growth ( less fat , more protein ) is also a subject of active research ."
104166,also,O,3620.0,"Its effect on growth ( less fat , more protein ) is also a subject of active research ."
104167,a,O,3620.0,"Its effect on growth ( less fat , more protein ) is also a subject of active research ."
104168,subject,O,3620.0,"Its effect on growth ( less fat , more protein ) is also a subject of active research ."
104169,of,O,3620.0,"Its effect on growth ( less fat , more protein ) is also a subject of active research ."
104170,active,O,3620.0,"Its effect on growth ( less fat , more protein ) is also a subject of active research ."
104171,research,O,3620.0,"Its effect on growth ( less fat , more protein ) is also a subject of active research ."
104172,.,O,3620.0,"Its effect on growth ( less fat , more protein ) is also a subject of active research ."
104173,The,O,3621.0,The mechanisms underlying the effects of CLA are still moot .
104174,mechanisms,O,3621.0,The mechanisms underlying the effects of CLA are still moot .
104175,underlying,O,3621.0,The mechanisms underlying the effects of CLA are still moot .
104176,the,O,3621.0,The mechanisms underlying the effects of CLA are still moot .
104177,effects,O,3621.0,The mechanisms underlying the effects of CLA are still moot .
104178,of,O,3621.0,The mechanisms underlying the effects of CLA are still moot .
104179,CLA,O,3621.0,The mechanisms underlying the effects of CLA are still moot .
104180,are,O,3621.0,The mechanisms underlying the effects of CLA are still moot .
104181,still,O,3621.0,The mechanisms underlying the effects of CLA are still moot .
104182,moot,O,3621.0,The mechanisms underlying the effects of CLA are still moot .
104183,.,O,3621.0,The mechanisms underlying the effects of CLA are still moot .
104184,North,O,3622.0,North of Italy was severely hit by the COVID-19 ( Coronavirus disease 19 ) pandemic .
104185,of,O,3622.0,North of Italy was severely hit by the COVID-19 ( Coronavirus disease 19 ) pandemic .
104186,Italy,O,3622.0,North of Italy was severely hit by the COVID-19 ( Coronavirus disease 19 ) pandemic .
104187,was,O,3622.0,North of Italy was severely hit by the COVID-19 ( Coronavirus disease 19 ) pandemic .
104188,severely,O,3622.0,North of Italy was severely hit by the COVID-19 ( Coronavirus disease 19 ) pandemic .
104189,hit,O,3622.0,North of Italy was severely hit by the COVID-19 ( Coronavirus disease 19 ) pandemic .
104190,by,O,3622.0,North of Italy was severely hit by the COVID-19 ( Coronavirus disease 19 ) pandemic .
104191,the,O,3622.0,North of Italy was severely hit by the COVID-19 ( Coronavirus disease 19 ) pandemic .
104192,COVID-19,O,3622.0,North of Italy was severely hit by the COVID-19 ( Coronavirus disease 19 ) pandemic .
104193,(,O,3622.0,North of Italy was severely hit by the COVID-19 ( Coronavirus disease 19 ) pandemic .
104194,Coronavirus,O,3622.0,North of Italy was severely hit by the COVID-19 ( Coronavirus disease 19 ) pandemic .
104195,disease,O,3622.0,North of Italy was severely hit by the COVID-19 ( Coronavirus disease 19 ) pandemic .
104196,19,O,3622.0,North of Italy was severely hit by the COVID-19 ( Coronavirus disease 19 ) pandemic .
104197,),O,3622.0,North of Italy was severely hit by the COVID-19 ( Coronavirus disease 19 ) pandemic .
104198,pandemic,O,3622.0,North of Italy was severely hit by the COVID-19 ( Coronavirus disease 19 ) pandemic .
104199,.,O,3622.0,North of Italy was severely hit by the COVID-19 ( Coronavirus disease 19 ) pandemic .
104200,This,O,3623.0,"This induced the government to adopt severely restrictive measures to reduce the contagion risk , forcing most of the population to stop working and from leisure activities , and to remain at home for several weeks ."
104201,induced,O,3623.0,"This induced the government to adopt severely restrictive measures to reduce the contagion risk , forcing most of the population to stop working and from leisure activities , and to remain at home for several weeks ."
104202,the,O,3623.0,"This induced the government to adopt severely restrictive measures to reduce the contagion risk , forcing most of the population to stop working and from leisure activities , and to remain at home for several weeks ."
104203,government,O,3623.0,"This induced the government to adopt severely restrictive measures to reduce the contagion risk , forcing most of the population to stop working and from leisure activities , and to remain at home for several weeks ."
104204,to,O,3623.0,"This induced the government to adopt severely restrictive measures to reduce the contagion risk , forcing most of the population to stop working and from leisure activities , and to remain at home for several weeks ."
104205,adopt,O,3623.0,"This induced the government to adopt severely restrictive measures to reduce the contagion risk , forcing most of the population to stop working and from leisure activities , and to remain at home for several weeks ."
104206,severely,O,3623.0,"This induced the government to adopt severely restrictive measures to reduce the contagion risk , forcing most of the population to stop working and from leisure activities , and to remain at home for several weeks ."
104207,restrictive,O,3623.0,"This induced the government to adopt severely restrictive measures to reduce the contagion risk , forcing most of the population to stop working and from leisure activities , and to remain at home for several weeks ."
104208,measures,O,3623.0,"This induced the government to adopt severely restrictive measures to reduce the contagion risk , forcing most of the population to stop working and from leisure activities , and to remain at home for several weeks ."
104209,to,O,3623.0,"This induced the government to adopt severely restrictive measures to reduce the contagion risk , forcing most of the population to stop working and from leisure activities , and to remain at home for several weeks ."
104210,reduce,O,3623.0,"This induced the government to adopt severely restrictive measures to reduce the contagion risk , forcing most of the population to stop working and from leisure activities , and to remain at home for several weeks ."
104211,the,O,3623.0,"This induced the government to adopt severely restrictive measures to reduce the contagion risk , forcing most of the population to stop working and from leisure activities , and to remain at home for several weeks ."
104212,contagion,O,3623.0,"This induced the government to adopt severely restrictive measures to reduce the contagion risk , forcing most of the population to stop working and from leisure activities , and to remain at home for several weeks ."
104213,risk,O,3623.0,"This induced the government to adopt severely restrictive measures to reduce the contagion risk , forcing most of the population to stop working and from leisure activities , and to remain at home for several weeks ."
104214,",",O,3623.0,"This induced the government to adopt severely restrictive measures to reduce the contagion risk , forcing most of the population to stop working and from leisure activities , and to remain at home for several weeks ."
104215,forcing,O,3623.0,"This induced the government to adopt severely restrictive measures to reduce the contagion risk , forcing most of the population to stop working and from leisure activities , and to remain at home for several weeks ."
104216,most,O,3623.0,"This induced the government to adopt severely restrictive measures to reduce the contagion risk , forcing most of the population to stop working and from leisure activities , and to remain at home for several weeks ."
104217,of,O,3623.0,"This induced the government to adopt severely restrictive measures to reduce the contagion risk , forcing most of the population to stop working and from leisure activities , and to remain at home for several weeks ."
104218,the,O,3623.0,"This induced the government to adopt severely restrictive measures to reduce the contagion risk , forcing most of the population to stop working and from leisure activities , and to remain at home for several weeks ."
104219,population,O,3623.0,"This induced the government to adopt severely restrictive measures to reduce the contagion risk , forcing most of the population to stop working and from leisure activities , and to remain at home for several weeks ."
104220,to,O,3623.0,"This induced the government to adopt severely restrictive measures to reduce the contagion risk , forcing most of the population to stop working and from leisure activities , and to remain at home for several weeks ."
104221,stop,O,3623.0,"This induced the government to adopt severely restrictive measures to reduce the contagion risk , forcing most of the population to stop working and from leisure activities , and to remain at home for several weeks ."
104222,working,O,3623.0,"This induced the government to adopt severely restrictive measures to reduce the contagion risk , forcing most of the population to stop working and from leisure activities , and to remain at home for several weeks ."
104223,and,O,3623.0,"This induced the government to adopt severely restrictive measures to reduce the contagion risk , forcing most of the population to stop working and from leisure activities , and to remain at home for several weeks ."
104224,from,O,3623.0,"This induced the government to adopt severely restrictive measures to reduce the contagion risk , forcing most of the population to stop working and from leisure activities , and to remain at home for several weeks ."
104225,leisure,O,3623.0,"This induced the government to adopt severely restrictive measures to reduce the contagion risk , forcing most of the population to stop working and from leisure activities , and to remain at home for several weeks ."
104226,activities,O,3623.0,"This induced the government to adopt severely restrictive measures to reduce the contagion risk , forcing most of the population to stop working and from leisure activities , and to remain at home for several weeks ."
104227,",",O,3623.0,"This induced the government to adopt severely restrictive measures to reduce the contagion risk , forcing most of the population to stop working and from leisure activities , and to remain at home for several weeks ."
104228,and,O,3623.0,"This induced the government to adopt severely restrictive measures to reduce the contagion risk , forcing most of the population to stop working and from leisure activities , and to remain at home for several weeks ."
104229,to,O,3623.0,"This induced the government to adopt severely restrictive measures to reduce the contagion risk , forcing most of the population to stop working and from leisure activities , and to remain at home for several weeks ."
104230,remain,O,3623.0,"This induced the government to adopt severely restrictive measures to reduce the contagion risk , forcing most of the population to stop working and from leisure activities , and to remain at home for several weeks ."
104231,at,O,3623.0,"This induced the government to adopt severely restrictive measures to reduce the contagion risk , forcing most of the population to stop working and from leisure activities , and to remain at home for several weeks ."
104232,home,O,3623.0,"This induced the government to adopt severely restrictive measures to reduce the contagion risk , forcing most of the population to stop working and from leisure activities , and to remain at home for several weeks ."
104233,for,O,3623.0,"This induced the government to adopt severely restrictive measures to reduce the contagion risk , forcing most of the population to stop working and from leisure activities , and to remain at home for several weeks ."
104234,several,O,3623.0,"This induced the government to adopt severely restrictive measures to reduce the contagion risk , forcing most of the population to stop working and from leisure activities , and to remain at home for several weeks ."
104235,weeks,O,3623.0,"This induced the government to adopt severely restrictive measures to reduce the contagion risk , forcing most of the population to stop working and from leisure activities , and to remain at home for several weeks ."
104236,.,O,3623.0,"This induced the government to adopt severely restrictive measures to reduce the contagion risk , forcing most of the population to stop working and from leisure activities , and to remain at home for several weeks ."
104237,Our,O,3624.0,Our study aimed to evaluate the effect of COVID - related quarantine on smoking and dietary habits of a well - characterized northern Italian rural population .
104238,study,O,3624.0,Our study aimed to evaluate the effect of COVID - related quarantine on smoking and dietary habits of a well - characterized northern Italian rural population .
104239,aimed,O,3624.0,Our study aimed to evaluate the effect of COVID - related quarantine on smoking and dietary habits of a well - characterized northern Italian rural population .
104240,to,O,3624.0,Our study aimed to evaluate the effect of COVID - related quarantine on smoking and dietary habits of a well - characterized northern Italian rural population .
104241,evaluate,O,3624.0,Our study aimed to evaluate the effect of COVID - related quarantine on smoking and dietary habits of a well - characterized northern Italian rural population .
104242,the,O,3624.0,Our study aimed to evaluate the effect of COVID - related quarantine on smoking and dietary habits of a well - characterized northern Italian rural population .
104243,effect,O,3624.0,Our study aimed to evaluate the effect of COVID - related quarantine on smoking and dietary habits of a well - characterized northern Italian rural population .
104244,of,O,3624.0,Our study aimed to evaluate the effect of COVID - related quarantine on smoking and dietary habits of a well - characterized northern Italian rural population .
104245,COVID,O,3624.0,Our study aimed to evaluate the effect of COVID - related quarantine on smoking and dietary habits of a well - characterized northern Italian rural population .
104246,-,O,3624.0,Our study aimed to evaluate the effect of COVID - related quarantine on smoking and dietary habits of a well - characterized northern Italian rural population .
104247,related,O,3624.0,Our study aimed to evaluate the effect of COVID - related quarantine on smoking and dietary habits of a well - characterized northern Italian rural population .
104248,quarantine,O,3624.0,Our study aimed to evaluate the effect of COVID - related quarantine on smoking and dietary habits of a well - characterized northern Italian rural population .
104249,on,O,3624.0,Our study aimed to evaluate the effect of COVID - related quarantine on smoking and dietary habits of a well - characterized northern Italian rural population .
104250,smoking,O,3624.0,Our study aimed to evaluate the effect of COVID - related quarantine on smoking and dietary habits of a well - characterized northern Italian rural population .
104251,and,O,3624.0,Our study aimed to evaluate the effect of COVID - related quarantine on smoking and dietary habits of a well - characterized northern Italian rural population .
104252,dietary,O,3624.0,Our study aimed to evaluate the effect of COVID - related quarantine on smoking and dietary habits of a well - characterized northern Italian rural population .
104253,habits,O,3624.0,Our study aimed to evaluate the effect of COVID - related quarantine on smoking and dietary habits of a well - characterized northern Italian rural population .
104254,of,O,3624.0,Our study aimed to evaluate the effect of COVID - related quarantine on smoking and dietary habits of a well - characterized northern Italian rural population .
104255,a,O,3624.0,Our study aimed to evaluate the effect of COVID - related quarantine on smoking and dietary habits of a well - characterized northern Italian rural population .
104256,well,O,3624.0,Our study aimed to evaluate the effect of COVID - related quarantine on smoking and dietary habits of a well - characterized northern Italian rural population .
104257,-,O,3624.0,Our study aimed to evaluate the effect of COVID - related quarantine on smoking and dietary habits of a well - characterized northern Italian rural population .
104258,characterized,O,3624.0,Our study aimed to evaluate the effect of COVID - related quarantine on smoking and dietary habits of a well - characterized northern Italian rural population .
104259,northern,O,3624.0,Our study aimed to evaluate the effect of COVID - related quarantine on smoking and dietary habits of a well - characterized northern Italian rural population .
104260,Italian,O,3624.0,Our study aimed to evaluate the effect of COVID - related quarantine on smoking and dietary habits of a well - characterized northern Italian rural population .
104261,rural,O,3624.0,Our study aimed to evaluate the effect of COVID - related quarantine on smoking and dietary habits of a well - characterized northern Italian rural population .
104262,population,O,3624.0,Our study aimed to evaluate the effect of COVID - related quarantine on smoking and dietary habits of a well - characterized northern Italian rural population .
104263,.,O,3624.0,Our study aimed to evaluate the effect of COVID - related quarantine on smoking and dietary habits of a well - characterized northern Italian rural population .
104264,For,O,3625.0,"For this purpose , while lockdown restrictions were in place ( February - April 2020 ) , 359 subjects from the Brisighella Heart Study cohort underwent a phone interview about their lifestyle habit changes during COVID-19 - related quarantine ."
104265,this,O,3625.0,"For this purpose , while lockdown restrictions were in place ( February - April 2020 ) , 359 subjects from the Brisighella Heart Study cohort underwent a phone interview about their lifestyle habit changes during COVID-19 - related quarantine ."
104266,purpose,O,3625.0,"For this purpose , while lockdown restrictions were in place ( February - April 2020 ) , 359 subjects from the Brisighella Heart Study cohort underwent a phone interview about their lifestyle habit changes during COVID-19 - related quarantine ."
104267,",",O,3625.0,"For this purpose , while lockdown restrictions were in place ( February - April 2020 ) , 359 subjects from the Brisighella Heart Study cohort underwent a phone interview about their lifestyle habit changes during COVID-19 - related quarantine ."
104268,while,O,3625.0,"For this purpose , while lockdown restrictions were in place ( February - April 2020 ) , 359 subjects from the Brisighella Heart Study cohort underwent a phone interview about their lifestyle habit changes during COVID-19 - related quarantine ."
104269,lockdown,O,3625.0,"For this purpose , while lockdown restrictions were in place ( February - April 2020 ) , 359 subjects from the Brisighella Heart Study cohort underwent a phone interview about their lifestyle habit changes during COVID-19 - related quarantine ."
104270,restrictions,O,3625.0,"For this purpose , while lockdown restrictions were in place ( February - April 2020 ) , 359 subjects from the Brisighella Heart Study cohort underwent a phone interview about their lifestyle habit changes during COVID-19 - related quarantine ."
104271,were,O,3625.0,"For this purpose , while lockdown restrictions were in place ( February - April 2020 ) , 359 subjects from the Brisighella Heart Study cohort underwent a phone interview about their lifestyle habit changes during COVID-19 - related quarantine ."
104272,in,O,3625.0,"For this purpose , while lockdown restrictions were in place ( February - April 2020 ) , 359 subjects from the Brisighella Heart Study cohort underwent a phone interview about their lifestyle habit changes during COVID-19 - related quarantine ."
104273,place,O,3625.0,"For this purpose , while lockdown restrictions were in place ( February - April 2020 ) , 359 subjects from the Brisighella Heart Study cohort underwent a phone interview about their lifestyle habit changes during COVID-19 - related quarantine ."
104274,(,O,3625.0,"For this purpose , while lockdown restrictions were in place ( February - April 2020 ) , 359 subjects from the Brisighella Heart Study cohort underwent a phone interview about their lifestyle habit changes during COVID-19 - related quarantine ."
104275,February,O,3625.0,"For this purpose , while lockdown restrictions were in place ( February - April 2020 ) , 359 subjects from the Brisighella Heart Study cohort underwent a phone interview about their lifestyle habit changes during COVID-19 - related quarantine ."
104276,-,O,3625.0,"For this purpose , while lockdown restrictions were in place ( February - April 2020 ) , 359 subjects from the Brisighella Heart Study cohort underwent a phone interview about their lifestyle habit changes during COVID-19 - related quarantine ."
104277,April,O,3625.0,"For this purpose , while lockdown restrictions were in place ( February - April 2020 ) , 359 subjects from the Brisighella Heart Study cohort underwent a phone interview about their lifestyle habit changes during COVID-19 - related quarantine ."
104278,2020,O,3625.0,"For this purpose , while lockdown restrictions were in place ( February - April 2020 ) , 359 subjects from the Brisighella Heart Study cohort underwent a phone interview about their lifestyle habit changes during COVID-19 - related quarantine ."
104279,),O,3625.0,"For this purpose , while lockdown restrictions were in place ( February - April 2020 ) , 359 subjects from the Brisighella Heart Study cohort underwent a phone interview about their lifestyle habit changes during COVID-19 - related quarantine ."
104280,",",O,3625.0,"For this purpose , while lockdown restrictions were in place ( February - April 2020 ) , 359 subjects from the Brisighella Heart Study cohort underwent a phone interview about their lifestyle habit changes during COVID-19 - related quarantine ."
104281,359,O,3625.0,"For this purpose , while lockdown restrictions were in place ( February - April 2020 ) , 359 subjects from the Brisighella Heart Study cohort underwent a phone interview about their lifestyle habit changes during COVID-19 - related quarantine ."
104282,subjects,O,3625.0,"For this purpose , while lockdown restrictions were in place ( February - April 2020 ) , 359 subjects from the Brisighella Heart Study cohort underwent a phone interview about their lifestyle habit changes during COVID-19 - related quarantine ."
104283,from,O,3625.0,"For this purpose , while lockdown restrictions were in place ( February - April 2020 ) , 359 subjects from the Brisighella Heart Study cohort underwent a phone interview about their lifestyle habit changes during COVID-19 - related quarantine ."
104284,the,O,3625.0,"For this purpose , while lockdown restrictions were in place ( February - April 2020 ) , 359 subjects from the Brisighella Heart Study cohort underwent a phone interview about their lifestyle habit changes during COVID-19 - related quarantine ."
104285,Brisighella,O,3625.0,"For this purpose , while lockdown restrictions were in place ( February - April 2020 ) , 359 subjects from the Brisighella Heart Study cohort underwent a phone interview about their lifestyle habit changes during COVID-19 - related quarantine ."
104286,Heart,O,3625.0,"For this purpose , while lockdown restrictions were in place ( February - April 2020 ) , 359 subjects from the Brisighella Heart Study cohort underwent a phone interview about their lifestyle habit changes during COVID-19 - related quarantine ."
104287,Study,O,3625.0,"For this purpose , while lockdown restrictions were in place ( February - April 2020 ) , 359 subjects from the Brisighella Heart Study cohort underwent a phone interview about their lifestyle habit changes during COVID-19 - related quarantine ."
104288,cohort,O,3625.0,"For this purpose , while lockdown restrictions were in place ( February - April 2020 ) , 359 subjects from the Brisighella Heart Study cohort underwent a phone interview about their lifestyle habit changes during COVID-19 - related quarantine ."
104289,underwent,O,3625.0,"For this purpose , while lockdown restrictions were in place ( February - April 2020 ) , 359 subjects from the Brisighella Heart Study cohort underwent a phone interview about their lifestyle habit changes during COVID-19 - related quarantine ."
104290,a,O,3625.0,"For this purpose , while lockdown restrictions were in place ( February - April 2020 ) , 359 subjects from the Brisighella Heart Study cohort underwent a phone interview about their lifestyle habit changes during COVID-19 - related quarantine ."
104291,phone,O,3625.0,"For this purpose , while lockdown restrictions were in place ( February - April 2020 ) , 359 subjects from the Brisighella Heart Study cohort underwent a phone interview about their lifestyle habit changes during COVID-19 - related quarantine ."
104292,interview,O,3625.0,"For this purpose , while lockdown restrictions were in place ( February - April 2020 ) , 359 subjects from the Brisighella Heart Study cohort underwent a phone interview about their lifestyle habit changes during COVID-19 - related quarantine ."
104293,about,O,3625.0,"For this purpose , while lockdown restrictions were in place ( February - April 2020 ) , 359 subjects from the Brisighella Heart Study cohort underwent a phone interview about their lifestyle habit changes during COVID-19 - related quarantine ."
104294,their,O,3625.0,"For this purpose , while lockdown restrictions were in place ( February - April 2020 ) , 359 subjects from the Brisighella Heart Study cohort underwent a phone interview about their lifestyle habit changes during COVID-19 - related quarantine ."
104295,lifestyle,O,3625.0,"For this purpose , while lockdown restrictions were in place ( February - April 2020 ) , 359 subjects from the Brisighella Heart Study cohort underwent a phone interview about their lifestyle habit changes during COVID-19 - related quarantine ."
104296,habit,O,3625.0,"For this purpose , while lockdown restrictions were in place ( February - April 2020 ) , 359 subjects from the Brisighella Heart Study cohort underwent a phone interview about their lifestyle habit changes during COVID-19 - related quarantine ."
104297,changes,O,3625.0,"For this purpose , while lockdown restrictions were in place ( February - April 2020 ) , 359 subjects from the Brisighella Heart Study cohort underwent a phone interview about their lifestyle habit changes during COVID-19 - related quarantine ."
104298,during,O,3625.0,"For this purpose , while lockdown restrictions were in place ( February - April 2020 ) , 359 subjects from the Brisighella Heart Study cohort underwent a phone interview about their lifestyle habit changes during COVID-19 - related quarantine ."
104299,COVID-19,O,3625.0,"For this purpose , while lockdown restrictions were in place ( February - April 2020 ) , 359 subjects from the Brisighella Heart Study cohort underwent a phone interview about their lifestyle habit changes during COVID-19 - related quarantine ."
104300,-,O,3625.0,"For this purpose , while lockdown restrictions were in place ( February - April 2020 ) , 359 subjects from the Brisighella Heart Study cohort underwent a phone interview about their lifestyle habit changes during COVID-19 - related quarantine ."
104301,related,O,3625.0,"For this purpose , while lockdown restrictions were in place ( February - April 2020 ) , 359 subjects from the Brisighella Heart Study cohort underwent a phone interview about their lifestyle habit changes during COVID-19 - related quarantine ."
104302,quarantine,O,3625.0,"For this purpose , while lockdown restrictions were in place ( February - April 2020 ) , 359 subjects from the Brisighella Heart Study cohort underwent a phone interview about their lifestyle habit changes during COVID-19 - related quarantine ."
104303,.,O,3625.0,"For this purpose , while lockdown restrictions were in place ( February - April 2020 ) , 359 subjects from the Brisighella Heart Study cohort underwent a phone interview about their lifestyle habit changes during COVID-19 - related quarantine ."
104304,Quarantine,O,3626.0,Quarantine did not significantly modify smoking habit nor body mass index .
104305,did,O,3626.0,Quarantine did not significantly modify smoking habit nor body mass index .
104306,not,O,3626.0,Quarantine did not significantly modify smoking habit nor body mass index .
104307,significantly,O,3626.0,Quarantine did not significantly modify smoking habit nor body mass index .
104308,modify,O,3626.0,Quarantine did not significantly modify smoking habit nor body mass index .
104309,smoking,O,3626.0,Quarantine did not significantly modify smoking habit nor body mass index .
104310,habit,O,3626.0,Quarantine did not significantly modify smoking habit nor body mass index .
104311,nor,O,3626.0,Quarantine did not significantly modify smoking habit nor body mass index .
104312,body,O,3626.0,Quarantine did not significantly modify smoking habit nor body mass index .
104313,mass,O,3626.0,Quarantine did not significantly modify smoking habit nor body mass index .
104314,index,O,3626.0,Quarantine did not significantly modify smoking habit nor body mass index .
104315,.,O,3626.0,Quarantine did not significantly modify smoking habit nor body mass index .
104316,Subjects,O,3627.0,"Subjects significantly increased daily carbohydrates consumption , all fresh vegetables , healthy vegetable oils , milk and yogurt , alcoholic drinks , sugars and sweets , and coffee ."
104317,significantly,O,3627.0,"Subjects significantly increased daily carbohydrates consumption , all fresh vegetables , healthy vegetable oils , milk and yogurt , alcoholic drinks , sugars and sweets , and coffee ."
104318,increased,O,3627.0,"Subjects significantly increased daily carbohydrates consumption , all fresh vegetables , healthy vegetable oils , milk and yogurt , alcoholic drinks , sugars and sweets , and coffee ."
104319,daily,O,3627.0,"Subjects significantly increased daily carbohydrates consumption , all fresh vegetables , healthy vegetable oils , milk and yogurt , alcoholic drinks , sugars and sweets , and coffee ."
104320,carbohydrates,O,3627.0,"Subjects significantly increased daily carbohydrates consumption , all fresh vegetables , healthy vegetable oils , milk and yogurt , alcoholic drinks , sugars and sweets , and coffee ."
104321,consumption,O,3627.0,"Subjects significantly increased daily carbohydrates consumption , all fresh vegetables , healthy vegetable oils , milk and yogurt , alcoholic drinks , sugars and sweets , and coffee ."
104322,",",O,3627.0,"Subjects significantly increased daily carbohydrates consumption , all fresh vegetables , healthy vegetable oils , milk and yogurt , alcoholic drinks , sugars and sweets , and coffee ."
104323,all,O,3627.0,"Subjects significantly increased daily carbohydrates consumption , all fresh vegetables , healthy vegetable oils , milk and yogurt , alcoholic drinks , sugars and sweets , and coffee ."
104324,fresh,O,3627.0,"Subjects significantly increased daily carbohydrates consumption , all fresh vegetables , healthy vegetable oils , milk and yogurt , alcoholic drinks , sugars and sweets , and coffee ."
104325,vegetables,B-AG.01.h.02,3627.0,"Subjects significantly increased daily carbohydrates consumption , all fresh vegetables , healthy vegetable oils , milk and yogurt , alcoholic drinks , sugars and sweets , and coffee ."
104326,",",O,3627.0,"Subjects significantly increased daily carbohydrates consumption , all fresh vegetables , healthy vegetable oils , milk and yogurt , alcoholic drinks , sugars and sweets , and coffee ."
104327,healthy,B-AG.01.f,3627.0,"Subjects significantly increased daily carbohydrates consumption , all fresh vegetables , healthy vegetable oils , milk and yogurt , alcoholic drinks , sugars and sweets , and coffee ."
104328,vegetable,I-AG.01.f,3627.0,"Subjects significantly increased daily carbohydrates consumption , all fresh vegetables , healthy vegetable oils , milk and yogurt , alcoholic drinks , sugars and sweets , and coffee ."
104329,oils,I-AG.01.f,3627.0,"Subjects significantly increased daily carbohydrates consumption , all fresh vegetables , healthy vegetable oils , milk and yogurt , alcoholic drinks , sugars and sweets , and coffee ."
104330,",",O,3627.0,"Subjects significantly increased daily carbohydrates consumption , all fresh vegetables , healthy vegetable oils , milk and yogurt , alcoholic drinks , sugars and sweets , and coffee ."
104331,milk,B-AG.01.e,3627.0,"Subjects significantly increased daily carbohydrates consumption , all fresh vegetables , healthy vegetable oils , milk and yogurt , alcoholic drinks , sugars and sweets , and coffee ."
104332,and,O,3627.0,"Subjects significantly increased daily carbohydrates consumption , all fresh vegetables , healthy vegetable oils , milk and yogurt , alcoholic drinks , sugars and sweets , and coffee ."
104333,yogurt,B-AG.01.e,3627.0,"Subjects significantly increased daily carbohydrates consumption , all fresh vegetables , healthy vegetable oils , milk and yogurt , alcoholic drinks , sugars and sweets , and coffee ."
104334,",",O,3627.0,"Subjects significantly increased daily carbohydrates consumption , all fresh vegetables , healthy vegetable oils , milk and yogurt , alcoholic drinks , sugars and sweets , and coffee ."
104335,alcoholic,B-AG.01.y.01,3627.0,"Subjects significantly increased daily carbohydrates consumption , all fresh vegetables , healthy vegetable oils , milk and yogurt , alcoholic drinks , sugars and sweets , and coffee ."
104336,drinks,I-AG.01.y.01,3627.0,"Subjects significantly increased daily carbohydrates consumption , all fresh vegetables , healthy vegetable oils , milk and yogurt , alcoholic drinks , sugars and sweets , and coffee ."
104337,",",O,3627.0,"Subjects significantly increased daily carbohydrates consumption , all fresh vegetables , healthy vegetable oils , milk and yogurt , alcoholic drinks , sugars and sweets , and coffee ."
104338,sugars,B-AG.01.l.02,3627.0,"Subjects significantly increased daily carbohydrates consumption , all fresh vegetables , healthy vegetable oils , milk and yogurt , alcoholic drinks , sugars and sweets , and coffee ."
104339,and,O,3627.0,"Subjects significantly increased daily carbohydrates consumption , all fresh vegetables , healthy vegetable oils , milk and yogurt , alcoholic drinks , sugars and sweets , and coffee ."
104340,sweets,B-AG.01.n.17.a,3627.0,"Subjects significantly increased daily carbohydrates consumption , all fresh vegetables , healthy vegetable oils , milk and yogurt , alcoholic drinks , sugars and sweets , and coffee ."
104341,",",O,3627.0,"Subjects significantly increased daily carbohydrates consumption , all fresh vegetables , healthy vegetable oils , milk and yogurt , alcoholic drinks , sugars and sweets , and coffee ."
104342,and,O,3627.0,"Subjects significantly increased daily carbohydrates consumption , all fresh vegetables , healthy vegetable oils , milk and yogurt , alcoholic drinks , sugars and sweets , and coffee ."
104343,coffee,B-AG.01.ad,3627.0,"Subjects significantly increased daily carbohydrates consumption , all fresh vegetables , healthy vegetable oils , milk and yogurt , alcoholic drinks , sugars and sweets , and coffee ."
104344,.,O,3627.0,"Subjects significantly increased daily carbohydrates consumption , all fresh vegetables , healthy vegetable oils , milk and yogurt , alcoholic drinks , sugars and sweets , and coffee ."
104345,The,O,3628.0,"The weekly consumption of low - fat meat , cured meat other than ham , cheeses , eggs , nuts and mixed seed oils significantly increased , while the weekly intake of fish , mussels , and legumes significantly decreased during lockdown ."
104346,weekly,O,3628.0,"The weekly consumption of low - fat meat , cured meat other than ham , cheeses , eggs , nuts and mixed seed oils significantly increased , while the weekly intake of fish , mussels , and legumes significantly decreased during lockdown ."
104347,consumption,O,3628.0,"The weekly consumption of low - fat meat , cured meat other than ham , cheeses , eggs , nuts and mixed seed oils significantly increased , while the weekly intake of fish , mussels , and legumes significantly decreased during lockdown ."
104348,of,O,3628.0,"The weekly consumption of low - fat meat , cured meat other than ham , cheeses , eggs , nuts and mixed seed oils significantly increased , while the weekly intake of fish , mussels , and legumes significantly decreased during lockdown ."
104349,low,B-AG.01.d,3628.0,"The weekly consumption of low - fat meat , cured meat other than ham , cheeses , eggs , nuts and mixed seed oils significantly increased , while the weekly intake of fish , mussels , and legumes significantly decreased during lockdown ."
104350,-,I-AG.01.d,3628.0,"The weekly consumption of low - fat meat , cured meat other than ham , cheeses , eggs , nuts and mixed seed oils significantly increased , while the weekly intake of fish , mussels , and legumes significantly decreased during lockdown ."
104351,fat,I-AG.01.d,3628.0,"The weekly consumption of low - fat meat , cured meat other than ham , cheeses , eggs , nuts and mixed seed oils significantly increased , while the weekly intake of fish , mussels , and legumes significantly decreased during lockdown ."
104352,meat,I-AG.01.d,3628.0,"The weekly consumption of low - fat meat , cured meat other than ham , cheeses , eggs , nuts and mixed seed oils significantly increased , while the weekly intake of fish , mussels , and legumes significantly decreased during lockdown ."
104353,",",O,3628.0,"The weekly consumption of low - fat meat , cured meat other than ham , cheeses , eggs , nuts and mixed seed oils significantly increased , while the weekly intake of fish , mussels , and legumes significantly decreased during lockdown ."
104354,cured,B-AG.01.d,3628.0,"The weekly consumption of low - fat meat , cured meat other than ham , cheeses , eggs , nuts and mixed seed oils significantly increased , while the weekly intake of fish , mussels , and legumes significantly decreased during lockdown ."
104355,meat,I-AG.01.d,3628.0,"The weekly consumption of low - fat meat , cured meat other than ham , cheeses , eggs , nuts and mixed seed oils significantly increased , while the weekly intake of fish , mussels , and legumes significantly decreased during lockdown ."
104356,other,I-AG.01.d,3628.0,"The weekly consumption of low - fat meat , cured meat other than ham , cheeses , eggs , nuts and mixed seed oils significantly increased , while the weekly intake of fish , mussels , and legumes significantly decreased during lockdown ."
104357,than,I-AG.01.d,3628.0,"The weekly consumption of low - fat meat , cured meat other than ham , cheeses , eggs , nuts and mixed seed oils significantly increased , while the weekly intake of fish , mussels , and legumes significantly decreased during lockdown ."
104358,ham,I-AG.01.d,3628.0,"The weekly consumption of low - fat meat , cured meat other than ham , cheeses , eggs , nuts and mixed seed oils significantly increased , while the weekly intake of fish , mussels , and legumes significantly decreased during lockdown ."
104359,",",O,3628.0,"The weekly consumption of low - fat meat , cured meat other than ham , cheeses , eggs , nuts and mixed seed oils significantly increased , while the weekly intake of fish , mussels , and legumes significantly decreased during lockdown ."
104360,cheeses,B-AG.01.e.02,3628.0,"The weekly consumption of low - fat meat , cured meat other than ham , cheeses , eggs , nuts and mixed seed oils significantly increased , while the weekly intake of fish , mussels , and legumes significantly decreased during lockdown ."
104361,",",O,3628.0,"The weekly consumption of low - fat meat , cured meat other than ham , cheeses , eggs , nuts and mixed seed oils significantly increased , while the weekly intake of fish , mussels , and legumes significantly decreased during lockdown ."
104362,eggs,B-AG.01.g,3628.0,"The weekly consumption of low - fat meat , cured meat other than ham , cheeses , eggs , nuts and mixed seed oils significantly increased , while the weekly intake of fish , mussels , and legumes significantly decreased during lockdown ."
104363,",",O,3628.0,"The weekly consumption of low - fat meat , cured meat other than ham , cheeses , eggs , nuts and mixed seed oils significantly increased , while the weekly intake of fish , mussels , and legumes significantly decreased during lockdown ."
104364,nuts,B-AG.01.h.01.f,3628.0,"The weekly consumption of low - fat meat , cured meat other than ham , cheeses , eggs , nuts and mixed seed oils significantly increased , while the weekly intake of fish , mussels , and legumes significantly decreased during lockdown ."
104365,and,O,3628.0,"The weekly consumption of low - fat meat , cured meat other than ham , cheeses , eggs , nuts and mixed seed oils significantly increased , while the weekly intake of fish , mussels , and legumes significantly decreased during lockdown ."
104366,mixed,B-AG.01.f,3628.0,"The weekly consumption of low - fat meat , cured meat other than ham , cheeses , eggs , nuts and mixed seed oils significantly increased , while the weekly intake of fish , mussels , and legumes significantly decreased during lockdown ."
104367,seed,I-AG.01.f,3628.0,"The weekly consumption of low - fat meat , cured meat other than ham , cheeses , eggs , nuts and mixed seed oils significantly increased , while the weekly intake of fish , mussels , and legumes significantly decreased during lockdown ."
104368,oils,I-AG.01.f,3628.0,"The weekly consumption of low - fat meat , cured meat other than ham , cheeses , eggs , nuts and mixed seed oils significantly increased , while the weekly intake of fish , mussels , and legumes significantly decreased during lockdown ."
104369,significantly,O,3628.0,"The weekly consumption of low - fat meat , cured meat other than ham , cheeses , eggs , nuts and mixed seed oils significantly increased , while the weekly intake of fish , mussels , and legumes significantly decreased during lockdown ."
104370,increased,O,3628.0,"The weekly consumption of low - fat meat , cured meat other than ham , cheeses , eggs , nuts and mixed seed oils significantly increased , while the weekly intake of fish , mussels , and legumes significantly decreased during lockdown ."
104371,",",O,3628.0,"The weekly consumption of low - fat meat , cured meat other than ham , cheeses , eggs , nuts and mixed seed oils significantly increased , while the weekly intake of fish , mussels , and legumes significantly decreased during lockdown ."
104372,while,O,3628.0,"The weekly consumption of low - fat meat , cured meat other than ham , cheeses , eggs , nuts and mixed seed oils significantly increased , while the weekly intake of fish , mussels , and legumes significantly decreased during lockdown ."
104373,the,O,3628.0,"The weekly consumption of low - fat meat , cured meat other than ham , cheeses , eggs , nuts and mixed seed oils significantly increased , while the weekly intake of fish , mussels , and legumes significantly decreased during lockdown ."
104374,weekly,O,3628.0,"The weekly consumption of low - fat meat , cured meat other than ham , cheeses , eggs , nuts and mixed seed oils significantly increased , while the weekly intake of fish , mussels , and legumes significantly decreased during lockdown ."
104375,intake,O,3628.0,"The weekly consumption of low - fat meat , cured meat other than ham , cheeses , eggs , nuts and mixed seed oils significantly increased , while the weekly intake of fish , mussels , and legumes significantly decreased during lockdown ."
104376,of,O,3628.0,"The weekly consumption of low - fat meat , cured meat other than ham , cheeses , eggs , nuts and mixed seed oils significantly increased , while the weekly intake of fish , mussels , and legumes significantly decreased during lockdown ."
104377,fish,B-AG.01.d.07,3628.0,"The weekly consumption of low - fat meat , cured meat other than ham , cheeses , eggs , nuts and mixed seed oils significantly increased , while the weekly intake of fish , mussels , and legumes significantly decreased during lockdown ."
104378,",",O,3628.0,"The weekly consumption of low - fat meat , cured meat other than ham , cheeses , eggs , nuts and mixed seed oils significantly increased , while the weekly intake of fish , mussels , and legumes significantly decreased during lockdown ."
104379,mussels,B-AG.01.d.07,3628.0,"The weekly consumption of low - fat meat , cured meat other than ham , cheeses , eggs , nuts and mixed seed oils significantly increased , while the weekly intake of fish , mussels , and legumes significantly decreased during lockdown ."
104380,",",O,3628.0,"The weekly consumption of low - fat meat , cured meat other than ham , cheeses , eggs , nuts and mixed seed oils significantly increased , while the weekly intake of fish , mussels , and legumes significantly decreased during lockdown ."
104381,and,O,3628.0,"The weekly consumption of low - fat meat , cured meat other than ham , cheeses , eggs , nuts and mixed seed oils significantly increased , while the weekly intake of fish , mussels , and legumes significantly decreased during lockdown ."
104382,legumes,B-AG.01.h.02.g,3628.0,"The weekly consumption of low - fat meat , cured meat other than ham , cheeses , eggs , nuts and mixed seed oils significantly increased , while the weekly intake of fish , mussels , and legumes significantly decreased during lockdown ."
104383,significantly,O,3628.0,"The weekly consumption of low - fat meat , cured meat other than ham , cheeses , eggs , nuts and mixed seed oils significantly increased , while the weekly intake of fish , mussels , and legumes significantly decreased during lockdown ."
104384,decreased,O,3628.0,"The weekly consumption of low - fat meat , cured meat other than ham , cheeses , eggs , nuts and mixed seed oils significantly increased , while the weekly intake of fish , mussels , and legumes significantly decreased during lockdown ."
104385,during,O,3628.0,"The weekly consumption of low - fat meat , cured meat other than ham , cheeses , eggs , nuts and mixed seed oils significantly increased , while the weekly intake of fish , mussels , and legumes significantly decreased during lockdown ."
104386,lockdown,O,3628.0,"The weekly consumption of low - fat meat , cured meat other than ham , cheeses , eggs , nuts and mixed seed oils significantly increased , while the weekly intake of fish , mussels , and legumes significantly decreased during lockdown ."
104387,.,O,3628.0,"The weekly consumption of low - fat meat , cured meat other than ham , cheeses , eggs , nuts and mixed seed oils significantly increased , while the weekly intake of fish , mussels , and legumes significantly decreased during lockdown ."
104388,The,O,3629.0,The Dietary Quality Index was reduced from 42.4 ± 4.1 to 37.8 ± 4.7 ( Low dietary fat intake may reduce the risk of developing atherosclerosis .
104389,Dietary,O,3629.0,The Dietary Quality Index was reduced from 42.4 ± 4.1 to 37.8 ± 4.7 ( Low dietary fat intake may reduce the risk of developing atherosclerosis .
104390,Quality,O,3629.0,The Dietary Quality Index was reduced from 42.4 ± 4.1 to 37.8 ± 4.7 ( Low dietary fat intake may reduce the risk of developing atherosclerosis .
104391,Index,O,3629.0,The Dietary Quality Index was reduced from 42.4 ± 4.1 to 37.8 ± 4.7 ( Low dietary fat intake may reduce the risk of developing atherosclerosis .
104392,was,O,3629.0,The Dietary Quality Index was reduced from 42.4 ± 4.1 to 37.8 ± 4.7 ( Low dietary fat intake may reduce the risk of developing atherosclerosis .
104393,reduced,O,3629.0,The Dietary Quality Index was reduced from 42.4 ± 4.1 to 37.8 ± 4.7 ( Low dietary fat intake may reduce the risk of developing atherosclerosis .
104394,from,O,3629.0,The Dietary Quality Index was reduced from 42.4 ± 4.1 to 37.8 ± 4.7 ( Low dietary fat intake may reduce the risk of developing atherosclerosis .
104395,42.4,O,3629.0,The Dietary Quality Index was reduced from 42.4 ± 4.1 to 37.8 ± 4.7 ( Low dietary fat intake may reduce the risk of developing atherosclerosis .
104396,±,O,3629.0,The Dietary Quality Index was reduced from 42.4 ± 4.1 to 37.8 ± 4.7 ( Low dietary fat intake may reduce the risk of developing atherosclerosis .
104397,4.1,O,3629.0,The Dietary Quality Index was reduced from 42.4 ± 4.1 to 37.8 ± 4.7 ( Low dietary fat intake may reduce the risk of developing atherosclerosis .
104398,to,O,3629.0,The Dietary Quality Index was reduced from 42.4 ± 4.1 to 37.8 ± 4.7 ( Low dietary fat intake may reduce the risk of developing atherosclerosis .
104399,37.8,O,3629.0,The Dietary Quality Index was reduced from 42.4 ± 4.1 to 37.8 ± 4.7 ( Low dietary fat intake may reduce the risk of developing atherosclerosis .
104400,±,O,3629.0,The Dietary Quality Index was reduced from 42.4 ± 4.1 to 37.8 ± 4.7 ( Low dietary fat intake may reduce the risk of developing atherosclerosis .
104401,4.7,O,3629.0,The Dietary Quality Index was reduced from 42.4 ± 4.1 to 37.8 ± 4.7 ( Low dietary fat intake may reduce the risk of developing atherosclerosis .
104402,(,O,3629.0,The Dietary Quality Index was reduced from 42.4 ± 4.1 to 37.8 ± 4.7 ( Low dietary fat intake may reduce the risk of developing atherosclerosis .
104403,Low,O,3629.0,The Dietary Quality Index was reduced from 42.4 ± 4.1 to 37.8 ± 4.7 ( Low dietary fat intake may reduce the risk of developing atherosclerosis .
104404,dietary,O,3629.0,The Dietary Quality Index was reduced from 42.4 ± 4.1 to 37.8 ± 4.7 ( Low dietary fat intake may reduce the risk of developing atherosclerosis .
104405,fat,O,3629.0,The Dietary Quality Index was reduced from 42.4 ± 4.1 to 37.8 ± 4.7 ( Low dietary fat intake may reduce the risk of developing atherosclerosis .
104406,intake,O,3629.0,The Dietary Quality Index was reduced from 42.4 ± 4.1 to 37.8 ± 4.7 ( Low dietary fat intake may reduce the risk of developing atherosclerosis .
104407,may,O,3629.0,The Dietary Quality Index was reduced from 42.4 ± 4.1 to 37.8 ± 4.7 ( Low dietary fat intake may reduce the risk of developing atherosclerosis .
104408,reduce,O,3629.0,The Dietary Quality Index was reduced from 42.4 ± 4.1 to 37.8 ± 4.7 ( Low dietary fat intake may reduce the risk of developing atherosclerosis .
104409,the,O,3629.0,The Dietary Quality Index was reduced from 42.4 ± 4.1 to 37.8 ± 4.7 ( Low dietary fat intake may reduce the risk of developing atherosclerosis .
104410,risk,O,3629.0,The Dietary Quality Index was reduced from 42.4 ± 4.1 to 37.8 ± 4.7 ( Low dietary fat intake may reduce the risk of developing atherosclerosis .
104411,of,O,3629.0,The Dietary Quality Index was reduced from 42.4 ± 4.1 to 37.8 ± 4.7 ( Low dietary fat intake may reduce the risk of developing atherosclerosis .
104412,developing,O,3629.0,The Dietary Quality Index was reduced from 42.4 ± 4.1 to 37.8 ± 4.7 ( Low dietary fat intake may reduce the risk of developing atherosclerosis .
104413,atherosclerosis,O,3629.0,The Dietary Quality Index was reduced from 42.4 ± 4.1 to 37.8 ± 4.7 ( Low dietary fat intake may reduce the risk of developing atherosclerosis .
104414,.,O,3629.0,The Dietary Quality Index was reduced from 42.4 ± 4.1 to 37.8 ± 4.7 ( Low dietary fat intake may reduce the risk of developing atherosclerosis .
104415,This,O,3630.0,This study determined the feasibility of using okra gum as a fat replacer in chocolate bar cookies .
104416,study,O,3630.0,This study determined the feasibility of using okra gum as a fat replacer in chocolate bar cookies .
104417,determined,O,3630.0,This study determined the feasibility of using okra gum as a fat replacer in chocolate bar cookies .
104418,the,O,3630.0,This study determined the feasibility of using okra gum as a fat replacer in chocolate bar cookies .
104419,feasibility,O,3630.0,This study determined the feasibility of using okra gum as a fat replacer in chocolate bar cookies .
104420,of,O,3630.0,This study determined the feasibility of using okra gum as a fat replacer in chocolate bar cookies .
104421,using,O,3630.0,This study determined the feasibility of using okra gum as a fat replacer in chocolate bar cookies .
104422,okra,O,3630.0,This study determined the feasibility of using okra gum as a fat replacer in chocolate bar cookies .
104423,gum,O,3630.0,This study determined the feasibility of using okra gum as a fat replacer in chocolate bar cookies .
104424,as,O,3630.0,This study determined the feasibility of using okra gum as a fat replacer in chocolate bar cookies .
104425,a,O,3630.0,This study determined the feasibility of using okra gum as a fat replacer in chocolate bar cookies .
104426,fat,O,3630.0,This study determined the feasibility of using okra gum as a fat replacer in chocolate bar cookies .
104427,replacer,O,3630.0,This study determined the feasibility of using okra gum as a fat replacer in chocolate bar cookies .
104428,in,O,3630.0,This study determined the feasibility of using okra gum as a fat replacer in chocolate bar cookies .
104429,chocolate,B-AG.01.n.14,3630.0,This study determined the feasibility of using okra gum as a fat replacer in chocolate bar cookies .
104430,bar,I-AG.01.n.14,3630.0,This study determined the feasibility of using okra gum as a fat replacer in chocolate bar cookies .
104431,cookies,I-AG.01.n.14,3630.0,This study determined the feasibility of using okra gum as a fat replacer in chocolate bar cookies .
104432,.,O,3630.0,This study determined the feasibility of using okra gum as a fat replacer in chocolate bar cookies .
104433,Fat,B-AG.01.n.14,3631.0,"Fat - free cookies were prepared with okra gum ( OK ) or applesauce ( AP ) , replacing margarine and egg yolk in high - fat cookies ( CTL ) ."
104434,-,I-AG.01.n.14,3631.0,"Fat - free cookies were prepared with okra gum ( OK ) or applesauce ( AP ) , replacing margarine and egg yolk in high - fat cookies ( CTL ) ."
104435,free,I-AG.01.n.14,3631.0,"Fat - free cookies were prepared with okra gum ( OK ) or applesauce ( AP ) , replacing margarine and egg yolk in high - fat cookies ( CTL ) ."
104436,cookies,I-AG.01.n.14,3631.0,"Fat - free cookies were prepared with okra gum ( OK ) or applesauce ( AP ) , replacing margarine and egg yolk in high - fat cookies ( CTL ) ."
104437,were,O,3631.0,"Fat - free cookies were prepared with okra gum ( OK ) or applesauce ( AP ) , replacing margarine and egg yolk in high - fat cookies ( CTL ) ."
104438,prepared,O,3631.0,"Fat - free cookies were prepared with okra gum ( OK ) or applesauce ( AP ) , replacing margarine and egg yolk in high - fat cookies ( CTL ) ."
104439,with,O,3631.0,"Fat - free cookies were prepared with okra gum ( OK ) or applesauce ( AP ) , replacing margarine and egg yolk in high - fat cookies ( CTL ) ."
104440,okra,O,3631.0,"Fat - free cookies were prepared with okra gum ( OK ) or applesauce ( AP ) , replacing margarine and egg yolk in high - fat cookies ( CTL ) ."
104441,gum,O,3631.0,"Fat - free cookies were prepared with okra gum ( OK ) or applesauce ( AP ) , replacing margarine and egg yolk in high - fat cookies ( CTL ) ."
104442,(,O,3631.0,"Fat - free cookies were prepared with okra gum ( OK ) or applesauce ( AP ) , replacing margarine and egg yolk in high - fat cookies ( CTL ) ."
104443,OK,O,3631.0,"Fat - free cookies were prepared with okra gum ( OK ) or applesauce ( AP ) , replacing margarine and egg yolk in high - fat cookies ( CTL ) ."
104444,),O,3631.0,"Fat - free cookies were prepared with okra gum ( OK ) or applesauce ( AP ) , replacing margarine and egg yolk in high - fat cookies ( CTL ) ."
104445,or,O,3631.0,"Fat - free cookies were prepared with okra gum ( OK ) or applesauce ( AP ) , replacing margarine and egg yolk in high - fat cookies ( CTL ) ."
104446,applesauce,B-AG.01.n.08,3631.0,"Fat - free cookies were prepared with okra gum ( OK ) or applesauce ( AP ) , replacing margarine and egg yolk in high - fat cookies ( CTL ) ."
104447,(,O,3631.0,"Fat - free cookies were prepared with okra gum ( OK ) or applesauce ( AP ) , replacing margarine and egg yolk in high - fat cookies ( CTL ) ."
104448,AP,O,3631.0,"Fat - free cookies were prepared with okra gum ( OK ) or applesauce ( AP ) , replacing margarine and egg yolk in high - fat cookies ( CTL ) ."
104449,),O,3631.0,"Fat - free cookies were prepared with okra gum ( OK ) or applesauce ( AP ) , replacing margarine and egg yolk in high - fat cookies ( CTL ) ."
104450,",",O,3631.0,"Fat - free cookies were prepared with okra gum ( OK ) or applesauce ( AP ) , replacing margarine and egg yolk in high - fat cookies ( CTL ) ."
104451,replacing,O,3631.0,"Fat - free cookies were prepared with okra gum ( OK ) or applesauce ( AP ) , replacing margarine and egg yolk in high - fat cookies ( CTL ) ."
104452,margarine,B-AG.01.f,3631.0,"Fat - free cookies were prepared with okra gum ( OK ) or applesauce ( AP ) , replacing margarine and egg yolk in high - fat cookies ( CTL ) ."
104453,and,O,3631.0,"Fat - free cookies were prepared with okra gum ( OK ) or applesauce ( AP ) , replacing margarine and egg yolk in high - fat cookies ( CTL ) ."
104454,egg,B-AG.01.g,3631.0,"Fat - free cookies were prepared with okra gum ( OK ) or applesauce ( AP ) , replacing margarine and egg yolk in high - fat cookies ( CTL ) ."
104455,yolk,I-AG.01.g,3631.0,"Fat - free cookies were prepared with okra gum ( OK ) or applesauce ( AP ) , replacing margarine and egg yolk in high - fat cookies ( CTL ) ."
104456,in,O,3631.0,"Fat - free cookies were prepared with okra gum ( OK ) or applesauce ( AP ) , replacing margarine and egg yolk in high - fat cookies ( CTL ) ."
104457,high,B-AG.01.n.14,3631.0,"Fat - free cookies were prepared with okra gum ( OK ) or applesauce ( AP ) , replacing margarine and egg yolk in high - fat cookies ( CTL ) ."
104458,-,I-AG.01.n.14,3631.0,"Fat - free cookies were prepared with okra gum ( OK ) or applesauce ( AP ) , replacing margarine and egg yolk in high - fat cookies ( CTL ) ."
104459,fat,I-AG.01.n.14,3631.0,"Fat - free cookies were prepared with okra gum ( OK ) or applesauce ( AP ) , replacing margarine and egg yolk in high - fat cookies ( CTL ) ."
104460,cookies,I-AG.01.n.14,3631.0,"Fat - free cookies were prepared with okra gum ( OK ) or applesauce ( AP ) , replacing margarine and egg yolk in high - fat cookies ( CTL ) ."
104461,(,O,3631.0,"Fat - free cookies were prepared with okra gum ( OK ) or applesauce ( AP ) , replacing margarine and egg yolk in high - fat cookies ( CTL ) ."
104462,CTL,O,3631.0,"Fat - free cookies were prepared with okra gum ( OK ) or applesauce ( AP ) , replacing margarine and egg yolk in high - fat cookies ( CTL ) ."
104463,),O,3631.0,"Fat - free cookies were prepared with okra gum ( OK ) or applesauce ( AP ) , replacing margarine and egg yolk in high - fat cookies ( CTL ) ."
104464,.,O,3631.0,"Fat - free cookies were prepared with okra gum ( OK ) or applesauce ( AP ) , replacing margarine and egg yolk in high - fat cookies ( CTL ) ."
104465,The,O,3632.0,The moisture content of cookies was determined by using a drying oven .
104466,moisture,O,3632.0,The moisture content of cookies was determined by using a drying oven .
104467,content,O,3632.0,The moisture content of cookies was determined by using a drying oven .
104468,of,O,3632.0,The moisture content of cookies was determined by using a drying oven .
104469,cookies,O,3632.0,The moisture content of cookies was determined by using a drying oven .
104470,was,O,3632.0,The moisture content of cookies was determined by using a drying oven .
104471,determined,O,3632.0,The moisture content of cookies was determined by using a drying oven .
104472,by,O,3632.0,The moisture content of cookies was determined by using a drying oven .
104473,using,O,3632.0,The moisture content of cookies was determined by using a drying oven .
104474,a,O,3632.0,The moisture content of cookies was determined by using a drying oven .
104475,drying,O,3632.0,The moisture content of cookies was determined by using a drying oven .
104476,oven,O,3632.0,The moisture content of cookies was determined by using a drying oven .
104477,.,O,3632.0,The moisture content of cookies was determined by using a drying oven .
104478,The,O,3633.0,The moisture contents of fresh OK ( 28.3+/-0.4 % ) and AP ( 27.6 + 1.1 % ) cookies were higher than CTL ( 8.5+/-0.3 % ) and remained higher after 48 hours ( P<.001)(n=3 ) .
104479,moisture,O,3633.0,The moisture contents of fresh OK ( 28.3+/-0.4 % ) and AP ( 27.6 + 1.1 % ) cookies were higher than CTL ( 8.5+/-0.3 % ) and remained higher after 48 hours ( P<.001)(n=3 ) .
104480,contents,O,3633.0,The moisture contents of fresh OK ( 28.3+/-0.4 % ) and AP ( 27.6 + 1.1 % ) cookies were higher than CTL ( 8.5+/-0.3 % ) and remained higher after 48 hours ( P<.001)(n=3 ) .
104481,of,O,3633.0,The moisture contents of fresh OK ( 28.3+/-0.4 % ) and AP ( 27.6 + 1.1 % ) cookies were higher than CTL ( 8.5+/-0.3 % ) and remained higher after 48 hours ( P<.001)(n=3 ) .
104482,fresh,O,3633.0,The moisture contents of fresh OK ( 28.3+/-0.4 % ) and AP ( 27.6 + 1.1 % ) cookies were higher than CTL ( 8.5+/-0.3 % ) and remained higher after 48 hours ( P<.001)(n=3 ) .
104483,OK,O,3633.0,The moisture contents of fresh OK ( 28.3+/-0.4 % ) and AP ( 27.6 + 1.1 % ) cookies were higher than CTL ( 8.5+/-0.3 % ) and remained higher after 48 hours ( P<.001)(n=3 ) .
104484,(,O,3633.0,The moisture contents of fresh OK ( 28.3+/-0.4 % ) and AP ( 27.6 + 1.1 % ) cookies were higher than CTL ( 8.5+/-0.3 % ) and remained higher after 48 hours ( P<.001)(n=3 ) .
104485,28.3+/-0.4,O,3633.0,The moisture contents of fresh OK ( 28.3+/-0.4 % ) and AP ( 27.6 + 1.1 % ) cookies were higher than CTL ( 8.5+/-0.3 % ) and remained higher after 48 hours ( P<.001)(n=3 ) .
104486,%,O,3633.0,The moisture contents of fresh OK ( 28.3+/-0.4 % ) and AP ( 27.6 + 1.1 % ) cookies were higher than CTL ( 8.5+/-0.3 % ) and remained higher after 48 hours ( P<.001)(n=3 ) .
104487,),O,3633.0,The moisture contents of fresh OK ( 28.3+/-0.4 % ) and AP ( 27.6 + 1.1 % ) cookies were higher than CTL ( 8.5+/-0.3 % ) and remained higher after 48 hours ( P<.001)(n=3 ) .
104488,and,O,3633.0,The moisture contents of fresh OK ( 28.3+/-0.4 % ) and AP ( 27.6 + 1.1 % ) cookies were higher than CTL ( 8.5+/-0.3 % ) and remained higher after 48 hours ( P<.001)(n=3 ) .
104489,AP,O,3633.0,The moisture contents of fresh OK ( 28.3+/-0.4 % ) and AP ( 27.6 + 1.1 % ) cookies were higher than CTL ( 8.5+/-0.3 % ) and remained higher after 48 hours ( P<.001)(n=3 ) .
104490,(,O,3633.0,The moisture contents of fresh OK ( 28.3+/-0.4 % ) and AP ( 27.6 + 1.1 % ) cookies were higher than CTL ( 8.5+/-0.3 % ) and remained higher after 48 hours ( P<.001)(n=3 ) .
104491,27.6,O,3633.0,The moisture contents of fresh OK ( 28.3+/-0.4 % ) and AP ( 27.6 + 1.1 % ) cookies were higher than CTL ( 8.5+/-0.3 % ) and remained higher after 48 hours ( P<.001)(n=3 ) .
104492,+,O,3633.0,The moisture contents of fresh OK ( 28.3+/-0.4 % ) and AP ( 27.6 + 1.1 % ) cookies were higher than CTL ( 8.5+/-0.3 % ) and remained higher after 48 hours ( P<.001)(n=3 ) .
104493,1.1,O,3633.0,The moisture contents of fresh OK ( 28.3+/-0.4 % ) and AP ( 27.6 + 1.1 % ) cookies were higher than CTL ( 8.5+/-0.3 % ) and remained higher after 48 hours ( P<.001)(n=3 ) .
104494,%,O,3633.0,The moisture contents of fresh OK ( 28.3+/-0.4 % ) and AP ( 27.6 + 1.1 % ) cookies were higher than CTL ( 8.5+/-0.3 % ) and remained higher after 48 hours ( P<.001)(n=3 ) .
104495,),O,3633.0,The moisture contents of fresh OK ( 28.3+/-0.4 % ) and AP ( 27.6 + 1.1 % ) cookies were higher than CTL ( 8.5+/-0.3 % ) and remained higher after 48 hours ( P<.001)(n=3 ) .
104496,cookies,B-AG.01.n.14,3633.0,The moisture contents of fresh OK ( 28.3+/-0.4 % ) and AP ( 27.6 + 1.1 % ) cookies were higher than CTL ( 8.5+/-0.3 % ) and remained higher after 48 hours ( P<.001)(n=3 ) .
104497,were,O,3633.0,The moisture contents of fresh OK ( 28.3+/-0.4 % ) and AP ( 27.6 + 1.1 % ) cookies were higher than CTL ( 8.5+/-0.3 % ) and remained higher after 48 hours ( P<.001)(n=3 ) .
104498,higher,O,3633.0,The moisture contents of fresh OK ( 28.3+/-0.4 % ) and AP ( 27.6 + 1.1 % ) cookies were higher than CTL ( 8.5+/-0.3 % ) and remained higher after 48 hours ( P<.001)(n=3 ) .
104499,than,O,3633.0,The moisture contents of fresh OK ( 28.3+/-0.4 % ) and AP ( 27.6 + 1.1 % ) cookies were higher than CTL ( 8.5+/-0.3 % ) and remained higher after 48 hours ( P<.001)(n=3 ) .
104500,CTL,O,3633.0,The moisture contents of fresh OK ( 28.3+/-0.4 % ) and AP ( 27.6 + 1.1 % ) cookies were higher than CTL ( 8.5+/-0.3 % ) and remained higher after 48 hours ( P<.001)(n=3 ) .
104501,(,O,3633.0,The moisture contents of fresh OK ( 28.3+/-0.4 % ) and AP ( 27.6 + 1.1 % ) cookies were higher than CTL ( 8.5+/-0.3 % ) and remained higher after 48 hours ( P<.001)(n=3 ) .
104502,8.5+/-0.3,O,3633.0,The moisture contents of fresh OK ( 28.3+/-0.4 % ) and AP ( 27.6 + 1.1 % ) cookies were higher than CTL ( 8.5+/-0.3 % ) and remained higher after 48 hours ( P<.001)(n=3 ) .
104503,%,O,3633.0,The moisture contents of fresh OK ( 28.3+/-0.4 % ) and AP ( 27.6 + 1.1 % ) cookies were higher than CTL ( 8.5+/-0.3 % ) and remained higher after 48 hours ( P<.001)(n=3 ) .
104504,),O,3633.0,The moisture contents of fresh OK ( 28.3+/-0.4 % ) and AP ( 27.6 + 1.1 % ) cookies were higher than CTL ( 8.5+/-0.3 % ) and remained higher after 48 hours ( P<.001)(n=3 ) .
104505,and,O,3633.0,The moisture contents of fresh OK ( 28.3+/-0.4 % ) and AP ( 27.6 + 1.1 % ) cookies were higher than CTL ( 8.5+/-0.3 % ) and remained higher after 48 hours ( P<.001)(n=3 ) .
104506,remained,O,3633.0,The moisture contents of fresh OK ( 28.3+/-0.4 % ) and AP ( 27.6 + 1.1 % ) cookies were higher than CTL ( 8.5+/-0.3 % ) and remained higher after 48 hours ( P<.001)(n=3 ) .
104507,higher,O,3633.0,The moisture contents of fresh OK ( 28.3+/-0.4 % ) and AP ( 27.6 + 1.1 % ) cookies were higher than CTL ( 8.5+/-0.3 % ) and remained higher after 48 hours ( P<.001)(n=3 ) .
104508,after,O,3633.0,The moisture contents of fresh OK ( 28.3+/-0.4 % ) and AP ( 27.6 + 1.1 % ) cookies were higher than CTL ( 8.5+/-0.3 % ) and remained higher after 48 hours ( P<.001)(n=3 ) .
104509,48,O,3633.0,The moisture contents of fresh OK ( 28.3+/-0.4 % ) and AP ( 27.6 + 1.1 % ) cookies were higher than CTL ( 8.5+/-0.3 % ) and remained higher after 48 hours ( P<.001)(n=3 ) .
104510,hours,O,3633.0,The moisture contents of fresh OK ( 28.3+/-0.4 % ) and AP ( 27.6 + 1.1 % ) cookies were higher than CTL ( 8.5+/-0.3 % ) and remained higher after 48 hours ( P<.001)(n=3 ) .
104511,(,O,3633.0,The moisture contents of fresh OK ( 28.3+/-0.4 % ) and AP ( 27.6 + 1.1 % ) cookies were higher than CTL ( 8.5+/-0.3 % ) and remained higher after 48 hours ( P<.001)(n=3 ) .
104512,P<.001)(n=3,O,3633.0,The moisture contents of fresh OK ( 28.3+/-0.4 % ) and AP ( 27.6 + 1.1 % ) cookies were higher than CTL ( 8.5+/-0.3 % ) and remained higher after 48 hours ( P<.001)(n=3 ) .
104513,),O,3633.0,The moisture contents of fresh OK ( 28.3+/-0.4 % ) and AP ( 27.6 + 1.1 % ) cookies were higher than CTL ( 8.5+/-0.3 % ) and remained higher after 48 hours ( P<.001)(n=3 ) .
104514,.,O,3633.0,The moisture contents of fresh OK ( 28.3+/-0.4 % ) and AP ( 27.6 + 1.1 % ) cookies were higher than CTL ( 8.5+/-0.3 % ) and remained higher after 48 hours ( P<.001)(n=3 ) .
104515,Fifty,O,3634.0,Fifty - two consumers evaluated the quality of cookies using a hedonic scale .
104516,-,O,3634.0,Fifty - two consumers evaluated the quality of cookies using a hedonic scale .
104517,two,O,3634.0,Fifty - two consumers evaluated the quality of cookies using a hedonic scale .
104518,consumers,O,3634.0,Fifty - two consumers evaluated the quality of cookies using a hedonic scale .
104519,evaluated,O,3634.0,Fifty - two consumers evaluated the quality of cookies using a hedonic scale .
104520,the,O,3634.0,Fifty - two consumers evaluated the quality of cookies using a hedonic scale .
104521,quality,O,3634.0,Fifty - two consumers evaluated the quality of cookies using a hedonic scale .
104522,of,O,3634.0,Fifty - two consumers evaluated the quality of cookies using a hedonic scale .
104523,cookies,B-AG.01.n.14,3634.0,Fifty - two consumers evaluated the quality of cookies using a hedonic scale .
104524,using,O,3634.0,Fifty - two consumers evaluated the quality of cookies using a hedonic scale .
104525,a,O,3634.0,Fifty - two consumers evaluated the quality of cookies using a hedonic scale .
104526,hedonic,O,3634.0,Fifty - two consumers evaluated the quality of cookies using a hedonic scale .
104527,scale,O,3634.0,Fifty - two consumers evaluated the quality of cookies using a hedonic scale .
104528,.,O,3634.0,Fifty - two consumers evaluated the quality of cookies using a hedonic scale .
104529,Sensory,O,3635.0,"Sensory scores for color , smell , flavor , aftertaste , moistness , and overall acceptability for fresh cookies were acceptable , yet lower for flavor and aftertaste in fat - free cookies than CTL ( P<.01 ) ."
104530,scores,O,3635.0,"Sensory scores for color , smell , flavor , aftertaste , moistness , and overall acceptability for fresh cookies were acceptable , yet lower for flavor and aftertaste in fat - free cookies than CTL ( P<.01 ) ."
104531,for,O,3635.0,"Sensory scores for color , smell , flavor , aftertaste , moistness , and overall acceptability for fresh cookies were acceptable , yet lower for flavor and aftertaste in fat - free cookies than CTL ( P<.01 ) ."
104532,color,O,3635.0,"Sensory scores for color , smell , flavor , aftertaste , moistness , and overall acceptability for fresh cookies were acceptable , yet lower for flavor and aftertaste in fat - free cookies than CTL ( P<.01 ) ."
104533,",",O,3635.0,"Sensory scores for color , smell , flavor , aftertaste , moistness , and overall acceptability for fresh cookies were acceptable , yet lower for flavor and aftertaste in fat - free cookies than CTL ( P<.01 ) ."
104534,smell,O,3635.0,"Sensory scores for color , smell , flavor , aftertaste , moistness , and overall acceptability for fresh cookies were acceptable , yet lower for flavor and aftertaste in fat - free cookies than CTL ( P<.01 ) ."
104535,",",O,3635.0,"Sensory scores for color , smell , flavor , aftertaste , moistness , and overall acceptability for fresh cookies were acceptable , yet lower for flavor and aftertaste in fat - free cookies than CTL ( P<.01 ) ."
104536,flavor,O,3635.0,"Sensory scores for color , smell , flavor , aftertaste , moistness , and overall acceptability for fresh cookies were acceptable , yet lower for flavor and aftertaste in fat - free cookies than CTL ( P<.01 ) ."
104537,",",O,3635.0,"Sensory scores for color , smell , flavor , aftertaste , moistness , and overall acceptability for fresh cookies were acceptable , yet lower for flavor and aftertaste in fat - free cookies than CTL ( P<.01 ) ."
104538,aftertaste,O,3635.0,"Sensory scores for color , smell , flavor , aftertaste , moistness , and overall acceptability for fresh cookies were acceptable , yet lower for flavor and aftertaste in fat - free cookies than CTL ( P<.01 ) ."
104539,",",O,3635.0,"Sensory scores for color , smell , flavor , aftertaste , moistness , and overall acceptability for fresh cookies were acceptable , yet lower for flavor and aftertaste in fat - free cookies than CTL ( P<.01 ) ."
104540,moistness,O,3635.0,"Sensory scores for color , smell , flavor , aftertaste , moistness , and overall acceptability for fresh cookies were acceptable , yet lower for flavor and aftertaste in fat - free cookies than CTL ( P<.01 ) ."
104541,",",O,3635.0,"Sensory scores for color , smell , flavor , aftertaste , moistness , and overall acceptability for fresh cookies were acceptable , yet lower for flavor and aftertaste in fat - free cookies than CTL ( P<.01 ) ."
104542,and,O,3635.0,"Sensory scores for color , smell , flavor , aftertaste , moistness , and overall acceptability for fresh cookies were acceptable , yet lower for flavor and aftertaste in fat - free cookies than CTL ( P<.01 ) ."
104543,overall,O,3635.0,"Sensory scores for color , smell , flavor , aftertaste , moistness , and overall acceptability for fresh cookies were acceptable , yet lower for flavor and aftertaste in fat - free cookies than CTL ( P<.01 ) ."
104544,acceptability,O,3635.0,"Sensory scores for color , smell , flavor , aftertaste , moistness , and overall acceptability for fresh cookies were acceptable , yet lower for flavor and aftertaste in fat - free cookies than CTL ( P<.01 ) ."
104545,for,O,3635.0,"Sensory scores for color , smell , flavor , aftertaste , moistness , and overall acceptability for fresh cookies were acceptable , yet lower for flavor and aftertaste in fat - free cookies than CTL ( P<.01 ) ."
104546,fresh,O,3635.0,"Sensory scores for color , smell , flavor , aftertaste , moistness , and overall acceptability for fresh cookies were acceptable , yet lower for flavor and aftertaste in fat - free cookies than CTL ( P<.01 ) ."
104547,cookies,B-AG.01.n.14,3635.0,"Sensory scores for color , smell , flavor , aftertaste , moistness , and overall acceptability for fresh cookies were acceptable , yet lower for flavor and aftertaste in fat - free cookies than CTL ( P<.01 ) ."
104548,were,O,3635.0,"Sensory scores for color , smell , flavor , aftertaste , moistness , and overall acceptability for fresh cookies were acceptable , yet lower for flavor and aftertaste in fat - free cookies than CTL ( P<.01 ) ."
104549,acceptable,O,3635.0,"Sensory scores for color , smell , flavor , aftertaste , moistness , and overall acceptability for fresh cookies were acceptable , yet lower for flavor and aftertaste in fat - free cookies than CTL ( P<.01 ) ."
104550,",",O,3635.0,"Sensory scores for color , smell , flavor , aftertaste , moistness , and overall acceptability for fresh cookies were acceptable , yet lower for flavor and aftertaste in fat - free cookies than CTL ( P<.01 ) ."
104551,yet,O,3635.0,"Sensory scores for color , smell , flavor , aftertaste , moistness , and overall acceptability for fresh cookies were acceptable , yet lower for flavor and aftertaste in fat - free cookies than CTL ( P<.01 ) ."
104552,lower,O,3635.0,"Sensory scores for color , smell , flavor , aftertaste , moistness , and overall acceptability for fresh cookies were acceptable , yet lower for flavor and aftertaste in fat - free cookies than CTL ( P<.01 ) ."
104553,for,O,3635.0,"Sensory scores for color , smell , flavor , aftertaste , moistness , and overall acceptability for fresh cookies were acceptable , yet lower for flavor and aftertaste in fat - free cookies than CTL ( P<.01 ) ."
104554,flavor,O,3635.0,"Sensory scores for color , smell , flavor , aftertaste , moistness , and overall acceptability for fresh cookies were acceptable , yet lower for flavor and aftertaste in fat - free cookies than CTL ( P<.01 ) ."
104555,and,O,3635.0,"Sensory scores for color , smell , flavor , aftertaste , moistness , and overall acceptability for fresh cookies were acceptable , yet lower for flavor and aftertaste in fat - free cookies than CTL ( P<.01 ) ."
104556,aftertaste,O,3635.0,"Sensory scores for color , smell , flavor , aftertaste , moistness , and overall acceptability for fresh cookies were acceptable , yet lower for flavor and aftertaste in fat - free cookies than CTL ( P<.01 ) ."
104557,in,O,3635.0,"Sensory scores for color , smell , flavor , aftertaste , moistness , and overall acceptability for fresh cookies were acceptable , yet lower for flavor and aftertaste in fat - free cookies than CTL ( P<.01 ) ."
104558,fat,B-AG.01.n.14,3635.0,"Sensory scores for color , smell , flavor , aftertaste , moistness , and overall acceptability for fresh cookies were acceptable , yet lower for flavor and aftertaste in fat - free cookies than CTL ( P<.01 ) ."
104559,-,I-AG.01.n.14,3635.0,"Sensory scores for color , smell , flavor , aftertaste , moistness , and overall acceptability for fresh cookies were acceptable , yet lower for flavor and aftertaste in fat - free cookies than CTL ( P<.01 ) ."
104560,free,I-AG.01.n.14,3635.0,"Sensory scores for color , smell , flavor , aftertaste , moistness , and overall acceptability for fresh cookies were acceptable , yet lower for flavor and aftertaste in fat - free cookies than CTL ( P<.01 ) ."
104561,cookies,I-AG.01.n.14,3635.0,"Sensory scores for color , smell , flavor , aftertaste , moistness , and overall acceptability for fresh cookies were acceptable , yet lower for flavor and aftertaste in fat - free cookies than CTL ( P<.01 ) ."
104562,than,O,3635.0,"Sensory scores for color , smell , flavor , aftertaste , moistness , and overall acceptability for fresh cookies were acceptable , yet lower for flavor and aftertaste in fat - free cookies than CTL ( P<.01 ) ."
104563,CTL,O,3635.0,"Sensory scores for color , smell , flavor , aftertaste , moistness , and overall acceptability for fresh cookies were acceptable , yet lower for flavor and aftertaste in fat - free cookies than CTL ( P<.01 ) ."
104564,(,O,3635.0,"Sensory scores for color , smell , flavor , aftertaste , moistness , and overall acceptability for fresh cookies were acceptable , yet lower for flavor and aftertaste in fat - free cookies than CTL ( P<.01 ) ."
104565,P<.01,O,3635.0,"Sensory scores for color , smell , flavor , aftertaste , moistness , and overall acceptability for fresh cookies were acceptable , yet lower for flavor and aftertaste in fat - free cookies than CTL ( P<.01 ) ."
104566,),O,3635.0,"Sensory scores for color , smell , flavor , aftertaste , moistness , and overall acceptability for fresh cookies were acceptable , yet lower for flavor and aftertaste in fat - free cookies than CTL ( P<.01 ) ."
104567,.,O,3635.0,"Sensory scores for color , smell , flavor , aftertaste , moistness , and overall acceptability for fresh cookies were acceptable , yet lower for flavor and aftertaste in fat - free cookies than CTL ( P<.01 ) ."
104568,After,O,3636.0,"After 48 hours , moistness ratings for fat - free cookies were acceptable and higher than CTL ( P<.01 ) ."
104569,48,O,3636.0,"After 48 hours , moistness ratings for fat - free cookies were acceptable and higher than CTL ( P<.01 ) ."
104570,hours,O,3636.0,"After 48 hours , moistness ratings for fat - free cookies were acceptable and higher than CTL ( P<.01 ) ."
104571,",",O,3636.0,"After 48 hours , moistness ratings for fat - free cookies were acceptable and higher than CTL ( P<.01 ) ."
104572,moistness,O,3636.0,"After 48 hours , moistness ratings for fat - free cookies were acceptable and higher than CTL ( P<.01 ) ."
104573,ratings,O,3636.0,"After 48 hours , moistness ratings for fat - free cookies were acceptable and higher than CTL ( P<.01 ) ."
104574,for,O,3636.0,"After 48 hours , moistness ratings for fat - free cookies were acceptable and higher than CTL ( P<.01 ) ."
104575,fat,O,3636.0,"After 48 hours , moistness ratings for fat - free cookies were acceptable and higher than CTL ( P<.01 ) ."
104576,-,O,3636.0,"After 48 hours , moistness ratings for fat - free cookies were acceptable and higher than CTL ( P<.01 ) ."
104577,free,O,3636.0,"After 48 hours , moistness ratings for fat - free cookies were acceptable and higher than CTL ( P<.01 ) ."
104578,cookies,B-AG.01.n.14,3636.0,"After 48 hours , moistness ratings for fat - free cookies were acceptable and higher than CTL ( P<.01 ) ."
104579,were,O,3636.0,"After 48 hours , moistness ratings for fat - free cookies were acceptable and higher than CTL ( P<.01 ) ."
104580,acceptable,O,3636.0,"After 48 hours , moistness ratings for fat - free cookies were acceptable and higher than CTL ( P<.01 ) ."
104581,and,O,3636.0,"After 48 hours , moistness ratings for fat - free cookies were acceptable and higher than CTL ( P<.01 ) ."
104582,higher,O,3636.0,"After 48 hours , moistness ratings for fat - free cookies were acceptable and higher than CTL ( P<.01 ) ."
104583,than,O,3636.0,"After 48 hours , moistness ratings for fat - free cookies were acceptable and higher than CTL ( P<.01 ) ."
104584,CTL,O,3636.0,"After 48 hours , moistness ratings for fat - free cookies were acceptable and higher than CTL ( P<.01 ) ."
104585,(,O,3636.0,"After 48 hours , moistness ratings for fat - free cookies were acceptable and higher than CTL ( P<.01 ) ."
104586,P<.01,O,3636.0,"After 48 hours , moistness ratings for fat - free cookies were acceptable and higher than CTL ( P<.01 ) ."
104587,),O,3636.0,"After 48 hours , moistness ratings for fat - free cookies were acceptable and higher than CTL ( P<.01 ) ."
104588,.,O,3636.0,"After 48 hours , moistness ratings for fat - free cookies were acceptable and higher than CTL ( P<.01 ) ."
104589,Okra,O,3637.0,Okra gum is an acceptable fat replacer in chocolate bar cookies .
104590,gum,O,3637.0,Okra gum is an acceptable fat replacer in chocolate bar cookies .
104591,is,O,3637.0,Okra gum is an acceptable fat replacer in chocolate bar cookies .
104592,an,O,3637.0,Okra gum is an acceptable fat replacer in chocolate bar cookies .
104593,acceptable,O,3637.0,Okra gum is an acceptable fat replacer in chocolate bar cookies .
104594,fat,O,3637.0,Okra gum is an acceptable fat replacer in chocolate bar cookies .
104595,replacer,O,3637.0,Okra gum is an acceptable fat replacer in chocolate bar cookies .
104596,in,O,3637.0,Okra gum is an acceptable fat replacer in chocolate bar cookies .
104597,chocolate,B-AG.01.n.14,3637.0,Okra gum is an acceptable fat replacer in chocolate bar cookies .
104598,bar,I-AG.01.n.14,3637.0,Okra gum is an acceptable fat replacer in chocolate bar cookies .
104599,cookies,I-AG.01.n.14,3637.0,Okra gum is an acceptable fat replacer in chocolate bar cookies .
104600,.,O,3637.0,Okra gum is an acceptable fat replacer in chocolate bar cookies .
104601,The,O,3638.0,The avocado ( Av ) is a fruit that belongs to the Lauraceae family .
104602,avocado,B-AG.01.h.01.e,3638.0,The avocado ( Av ) is a fruit that belongs to the Lauraceae family .
104603,(,O,3638.0,The avocado ( Av ) is a fruit that belongs to the Lauraceae family .
104604,Av,O,3638.0,The avocado ( Av ) is a fruit that belongs to the Lauraceae family .
104605,),O,3638.0,The avocado ( Av ) is a fruit that belongs to the Lauraceae family .
104606,is,O,3638.0,The avocado ( Av ) is a fruit that belongs to the Lauraceae family .
104607,a,O,3638.0,The avocado ( Av ) is a fruit that belongs to the Lauraceae family .
104608,fruit,B-AG.01.h.01,3638.0,The avocado ( Av ) is a fruit that belongs to the Lauraceae family .
104609,that,O,3638.0,The avocado ( Av ) is a fruit that belongs to the Lauraceae family .
104610,belongs,O,3638.0,The avocado ( Av ) is a fruit that belongs to the Lauraceae family .
104611,to,O,3638.0,The avocado ( Av ) is a fruit that belongs to the Lauraceae family .
104612,the,O,3638.0,The avocado ( Av ) is a fruit that belongs to the Lauraceae family .
104613,Lauraceae,O,3638.0,The avocado ( Av ) is a fruit that belongs to the Lauraceae family .
104614,family,O,3638.0,The avocado ( Av ) is a fruit that belongs to the Lauraceae family .
104615,.,O,3638.0,The avocado ( Av ) is a fruit that belongs to the Lauraceae family .
104616,We,O,3639.0,We report 17 patients with immediate hypersensitivity to avocado .
104617,report,O,3639.0,We report 17 patients with immediate hypersensitivity to avocado .
104618,17,O,3639.0,We report 17 patients with immediate hypersensitivity to avocado .
104619,patients,O,3639.0,We report 17 patients with immediate hypersensitivity to avocado .
104620,with,O,3639.0,We report 17 patients with immediate hypersensitivity to avocado .
104621,immediate,O,3639.0,We report 17 patients with immediate hypersensitivity to avocado .
104622,hypersensitivity,O,3639.0,We report 17 patients with immediate hypersensitivity to avocado .
104623,to,O,3639.0,We report 17 patients with immediate hypersensitivity to avocado .
104624,avocado,B-AG.01.h.01.e,3639.0,We report 17 patients with immediate hypersensitivity to avocado .
104625,.,O,3639.0,We report 17 patients with immediate hypersensitivity to avocado .
104626,Clinical,O,3640.0,"Clinical manifestations in relation to avocado ingestion were as follows : systemic anaphylaxis in seven patients , angioedema / urticaria in six , vomiting in two , bronchial asthma in one , and rhinoconjunctivitis in one ."
104627,manifestations,O,3640.0,"Clinical manifestations in relation to avocado ingestion were as follows : systemic anaphylaxis in seven patients , angioedema / urticaria in six , vomiting in two , bronchial asthma in one , and rhinoconjunctivitis in one ."
104628,in,O,3640.0,"Clinical manifestations in relation to avocado ingestion were as follows : systemic anaphylaxis in seven patients , angioedema / urticaria in six , vomiting in two , bronchial asthma in one , and rhinoconjunctivitis in one ."
104629,relation,O,3640.0,"Clinical manifestations in relation to avocado ingestion were as follows : systemic anaphylaxis in seven patients , angioedema / urticaria in six , vomiting in two , bronchial asthma in one , and rhinoconjunctivitis in one ."
104630,to,O,3640.0,"Clinical manifestations in relation to avocado ingestion were as follows : systemic anaphylaxis in seven patients , angioedema / urticaria in six , vomiting in two , bronchial asthma in one , and rhinoconjunctivitis in one ."
104631,avocado,O,3640.0,"Clinical manifestations in relation to avocado ingestion were as follows : systemic anaphylaxis in seven patients , angioedema / urticaria in six , vomiting in two , bronchial asthma in one , and rhinoconjunctivitis in one ."
104632,ingestion,O,3640.0,"Clinical manifestations in relation to avocado ingestion were as follows : systemic anaphylaxis in seven patients , angioedema / urticaria in six , vomiting in two , bronchial asthma in one , and rhinoconjunctivitis in one ."
104633,were,O,3640.0,"Clinical manifestations in relation to avocado ingestion were as follows : systemic anaphylaxis in seven patients , angioedema / urticaria in six , vomiting in two , bronchial asthma in one , and rhinoconjunctivitis in one ."
104634,as,O,3640.0,"Clinical manifestations in relation to avocado ingestion were as follows : systemic anaphylaxis in seven patients , angioedema / urticaria in six , vomiting in two , bronchial asthma in one , and rhinoconjunctivitis in one ."
104635,follows,O,3640.0,"Clinical manifestations in relation to avocado ingestion were as follows : systemic anaphylaxis in seven patients , angioedema / urticaria in six , vomiting in two , bronchial asthma in one , and rhinoconjunctivitis in one ."
104636,:,O,3640.0,"Clinical manifestations in relation to avocado ingestion were as follows : systemic anaphylaxis in seven patients , angioedema / urticaria in six , vomiting in two , bronchial asthma in one , and rhinoconjunctivitis in one ."
104637,systemic,O,3640.0,"Clinical manifestations in relation to avocado ingestion were as follows : systemic anaphylaxis in seven patients , angioedema / urticaria in six , vomiting in two , bronchial asthma in one , and rhinoconjunctivitis in one ."
104638,anaphylaxis,O,3640.0,"Clinical manifestations in relation to avocado ingestion were as follows : systemic anaphylaxis in seven patients , angioedema / urticaria in six , vomiting in two , bronchial asthma in one , and rhinoconjunctivitis in one ."
104639,in,O,3640.0,"Clinical manifestations in relation to avocado ingestion were as follows : systemic anaphylaxis in seven patients , angioedema / urticaria in six , vomiting in two , bronchial asthma in one , and rhinoconjunctivitis in one ."
104640,seven,O,3640.0,"Clinical manifestations in relation to avocado ingestion were as follows : systemic anaphylaxis in seven patients , angioedema / urticaria in six , vomiting in two , bronchial asthma in one , and rhinoconjunctivitis in one ."
104641,patients,O,3640.0,"Clinical manifestations in relation to avocado ingestion were as follows : systemic anaphylaxis in seven patients , angioedema / urticaria in six , vomiting in two , bronchial asthma in one , and rhinoconjunctivitis in one ."
104642,",",O,3640.0,"Clinical manifestations in relation to avocado ingestion were as follows : systemic anaphylaxis in seven patients , angioedema / urticaria in six , vomiting in two , bronchial asthma in one , and rhinoconjunctivitis in one ."
104643,angioedema,O,3640.0,"Clinical manifestations in relation to avocado ingestion were as follows : systemic anaphylaxis in seven patients , angioedema / urticaria in six , vomiting in two , bronchial asthma in one , and rhinoconjunctivitis in one ."
104644,/,O,3640.0,"Clinical manifestations in relation to avocado ingestion were as follows : systemic anaphylaxis in seven patients , angioedema / urticaria in six , vomiting in two , bronchial asthma in one , and rhinoconjunctivitis in one ."
104645,urticaria,O,3640.0,"Clinical manifestations in relation to avocado ingestion were as follows : systemic anaphylaxis in seven patients , angioedema / urticaria in six , vomiting in two , bronchial asthma in one , and rhinoconjunctivitis in one ."
104646,in,O,3640.0,"Clinical manifestations in relation to avocado ingestion were as follows : systemic anaphylaxis in seven patients , angioedema / urticaria in six , vomiting in two , bronchial asthma in one , and rhinoconjunctivitis in one ."
104647,six,O,3640.0,"Clinical manifestations in relation to avocado ingestion were as follows : systemic anaphylaxis in seven patients , angioedema / urticaria in six , vomiting in two , bronchial asthma in one , and rhinoconjunctivitis in one ."
104648,",",O,3640.0,"Clinical manifestations in relation to avocado ingestion were as follows : systemic anaphylaxis in seven patients , angioedema / urticaria in six , vomiting in two , bronchial asthma in one , and rhinoconjunctivitis in one ."
104649,vomiting,O,3640.0,"Clinical manifestations in relation to avocado ingestion were as follows : systemic anaphylaxis in seven patients , angioedema / urticaria in six , vomiting in two , bronchial asthma in one , and rhinoconjunctivitis in one ."
104650,in,O,3640.0,"Clinical manifestations in relation to avocado ingestion were as follows : systemic anaphylaxis in seven patients , angioedema / urticaria in six , vomiting in two , bronchial asthma in one , and rhinoconjunctivitis in one ."
104651,two,O,3640.0,"Clinical manifestations in relation to avocado ingestion were as follows : systemic anaphylaxis in seven patients , angioedema / urticaria in six , vomiting in two , bronchial asthma in one , and rhinoconjunctivitis in one ."
104652,",",O,3640.0,"Clinical manifestations in relation to avocado ingestion were as follows : systemic anaphylaxis in seven patients , angioedema / urticaria in six , vomiting in two , bronchial asthma in one , and rhinoconjunctivitis in one ."
104653,bronchial,O,3640.0,"Clinical manifestations in relation to avocado ingestion were as follows : systemic anaphylaxis in seven patients , angioedema / urticaria in six , vomiting in two , bronchial asthma in one , and rhinoconjunctivitis in one ."
104654,asthma,O,3640.0,"Clinical manifestations in relation to avocado ingestion were as follows : systemic anaphylaxis in seven patients , angioedema / urticaria in six , vomiting in two , bronchial asthma in one , and rhinoconjunctivitis in one ."
104655,in,O,3640.0,"Clinical manifestations in relation to avocado ingestion were as follows : systemic anaphylaxis in seven patients , angioedema / urticaria in six , vomiting in two , bronchial asthma in one , and rhinoconjunctivitis in one ."
104656,one,O,3640.0,"Clinical manifestations in relation to avocado ingestion were as follows : systemic anaphylaxis in seven patients , angioedema / urticaria in six , vomiting in two , bronchial asthma in one , and rhinoconjunctivitis in one ."
104657,",",O,3640.0,"Clinical manifestations in relation to avocado ingestion were as follows : systemic anaphylaxis in seven patients , angioedema / urticaria in six , vomiting in two , bronchial asthma in one , and rhinoconjunctivitis in one ."
104658,and,O,3640.0,"Clinical manifestations in relation to avocado ingestion were as follows : systemic anaphylaxis in seven patients , angioedema / urticaria in six , vomiting in two , bronchial asthma in one , and rhinoconjunctivitis in one ."
104659,rhinoconjunctivitis,O,3640.0,"Clinical manifestations in relation to avocado ingestion were as follows : systemic anaphylaxis in seven patients , angioedema / urticaria in six , vomiting in two , bronchial asthma in one , and rhinoconjunctivitis in one ."
104660,in,O,3640.0,"Clinical manifestations in relation to avocado ingestion were as follows : systemic anaphylaxis in seven patients , angioedema / urticaria in six , vomiting in two , bronchial asthma in one , and rhinoconjunctivitis in one ."
104661,one,O,3640.0,"Clinical manifestations in relation to avocado ingestion were as follows : systemic anaphylaxis in seven patients , angioedema / urticaria in six , vomiting in two , bronchial asthma in one , and rhinoconjunctivitis in one ."
104662,.,O,3640.0,"Clinical manifestations in relation to avocado ingestion were as follows : systemic anaphylaxis in seven patients , angioedema / urticaria in six , vomiting in two , bronchial asthma in one , and rhinoconjunctivitis in one ."
104663,Skin,O,3641.0,Skin prick test ( SPT ) with fresh avocado was positive in all patients with the Strong avocado variety ( SAv ) and in 14 patients with the Hass avocado variety ( HAv ) .
104664,prick,O,3641.0,Skin prick test ( SPT ) with fresh avocado was positive in all patients with the Strong avocado variety ( SAv ) and in 14 patients with the Hass avocado variety ( HAv ) .
104665,test,O,3641.0,Skin prick test ( SPT ) with fresh avocado was positive in all patients with the Strong avocado variety ( SAv ) and in 14 patients with the Hass avocado variety ( HAv ) .
104666,(,O,3641.0,Skin prick test ( SPT ) with fresh avocado was positive in all patients with the Strong avocado variety ( SAv ) and in 14 patients with the Hass avocado variety ( HAv ) .
104667,SPT,O,3641.0,Skin prick test ( SPT ) with fresh avocado was positive in all patients with the Strong avocado variety ( SAv ) and in 14 patients with the Hass avocado variety ( HAv ) .
104668,),O,3641.0,Skin prick test ( SPT ) with fresh avocado was positive in all patients with the Strong avocado variety ( SAv ) and in 14 patients with the Hass avocado variety ( HAv ) .
104669,with,O,3641.0,Skin prick test ( SPT ) with fresh avocado was positive in all patients with the Strong avocado variety ( SAv ) and in 14 patients with the Hass avocado variety ( HAv ) .
104670,fresh,O,3641.0,Skin prick test ( SPT ) with fresh avocado was positive in all patients with the Strong avocado variety ( SAv ) and in 14 patients with the Hass avocado variety ( HAv ) .
104671,avocado,B-AG.01.h.01.e,3641.0,Skin prick test ( SPT ) with fresh avocado was positive in all patients with the Strong avocado variety ( SAv ) and in 14 patients with the Hass avocado variety ( HAv ) .
104672,was,O,3641.0,Skin prick test ( SPT ) with fresh avocado was positive in all patients with the Strong avocado variety ( SAv ) and in 14 patients with the Hass avocado variety ( HAv ) .
104673,positive,O,3641.0,Skin prick test ( SPT ) with fresh avocado was positive in all patients with the Strong avocado variety ( SAv ) and in 14 patients with the Hass avocado variety ( HAv ) .
104674,in,O,3641.0,Skin prick test ( SPT ) with fresh avocado was positive in all patients with the Strong avocado variety ( SAv ) and in 14 patients with the Hass avocado variety ( HAv ) .
104675,all,O,3641.0,Skin prick test ( SPT ) with fresh avocado was positive in all patients with the Strong avocado variety ( SAv ) and in 14 patients with the Hass avocado variety ( HAv ) .
104676,patients,O,3641.0,Skin prick test ( SPT ) with fresh avocado was positive in all patients with the Strong avocado variety ( SAv ) and in 14 patients with the Hass avocado variety ( HAv ) .
104677,with,O,3641.0,Skin prick test ( SPT ) with fresh avocado was positive in all patients with the Strong avocado variety ( SAv ) and in 14 patients with the Hass avocado variety ( HAv ) .
104678,the,O,3641.0,Skin prick test ( SPT ) with fresh avocado was positive in all patients with the Strong avocado variety ( SAv ) and in 14 patients with the Hass avocado variety ( HAv ) .
104679,Strong,O,3641.0,Skin prick test ( SPT ) with fresh avocado was positive in all patients with the Strong avocado variety ( SAv ) and in 14 patients with the Hass avocado variety ( HAv ) .
104680,avocado,O,3641.0,Skin prick test ( SPT ) with fresh avocado was positive in all patients with the Strong avocado variety ( SAv ) and in 14 patients with the Hass avocado variety ( HAv ) .
104681,variety,O,3641.0,Skin prick test ( SPT ) with fresh avocado was positive in all patients with the Strong avocado variety ( SAv ) and in 14 patients with the Hass avocado variety ( HAv ) .
104682,(,O,3641.0,Skin prick test ( SPT ) with fresh avocado was positive in all patients with the Strong avocado variety ( SAv ) and in 14 patients with the Hass avocado variety ( HAv ) .
104683,SAv,O,3641.0,Skin prick test ( SPT ) with fresh avocado was positive in all patients with the Strong avocado variety ( SAv ) and in 14 patients with the Hass avocado variety ( HAv ) .
104684,),O,3641.0,Skin prick test ( SPT ) with fresh avocado was positive in all patients with the Strong avocado variety ( SAv ) and in 14 patients with the Hass avocado variety ( HAv ) .
104685,and,O,3641.0,Skin prick test ( SPT ) with fresh avocado was positive in all patients with the Strong avocado variety ( SAv ) and in 14 patients with the Hass avocado variety ( HAv ) .
104686,in,O,3641.0,Skin prick test ( SPT ) with fresh avocado was positive in all patients with the Strong avocado variety ( SAv ) and in 14 patients with the Hass avocado variety ( HAv ) .
104687,14,O,3641.0,Skin prick test ( SPT ) with fresh avocado was positive in all patients with the Strong avocado variety ( SAv ) and in 14 patients with the Hass avocado variety ( HAv ) .
104688,patients,O,3641.0,Skin prick test ( SPT ) with fresh avocado was positive in all patients with the Strong avocado variety ( SAv ) and in 14 patients with the Hass avocado variety ( HAv ) .
104689,with,O,3641.0,Skin prick test ( SPT ) with fresh avocado was positive in all patients with the Strong avocado variety ( SAv ) and in 14 patients with the Hass avocado variety ( HAv ) .
104690,the,O,3641.0,Skin prick test ( SPT ) with fresh avocado was positive in all patients with the Strong avocado variety ( SAv ) and in 14 patients with the Hass avocado variety ( HAv ) .
104691,Hass,O,3641.0,Skin prick test ( SPT ) with fresh avocado was positive in all patients with the Strong avocado variety ( SAv ) and in 14 patients with the Hass avocado variety ( HAv ) .
104692,avocado,O,3641.0,Skin prick test ( SPT ) with fresh avocado was positive in all patients with the Strong avocado variety ( SAv ) and in 14 patients with the Hass avocado variety ( HAv ) .
104693,variety,O,3641.0,Skin prick test ( SPT ) with fresh avocado was positive in all patients with the Strong avocado variety ( SAv ) and in 14 patients with the Hass avocado variety ( HAv ) .
104694,(,O,3641.0,Skin prick test ( SPT ) with fresh avocado was positive in all patients with the Strong avocado variety ( SAv ) and in 14 patients with the Hass avocado variety ( HAv ) .
104695,HAv,O,3641.0,Skin prick test ( SPT ) with fresh avocado was positive in all patients with the Strong avocado variety ( SAv ) and in 14 patients with the Hass avocado variety ( HAv ) .
104696,),O,3641.0,Skin prick test ( SPT ) with fresh avocado was positive in all patients with the Strong avocado variety ( SAv ) and in 14 patients with the Hass avocado variety ( HAv ) .
104697,.,O,3641.0,Skin prick test ( SPT ) with fresh avocado was positive in all patients with the Strong avocado variety ( SAv ) and in 14 patients with the Hass avocado variety ( HAv ) .
104698,Our,O,3642.0,"Our patient - associated sensitizations were as follows : 10 to latex , eight to chestnut , eight to banana , four to kiwi , and four to walnut ."
104699,patient,O,3642.0,"Our patient - associated sensitizations were as follows : 10 to latex , eight to chestnut , eight to banana , four to kiwi , and four to walnut ."
104700,-,O,3642.0,"Our patient - associated sensitizations were as follows : 10 to latex , eight to chestnut , eight to banana , four to kiwi , and four to walnut ."
104701,associated,O,3642.0,"Our patient - associated sensitizations were as follows : 10 to latex , eight to chestnut , eight to banana , four to kiwi , and four to walnut ."
104702,sensitizations,O,3642.0,"Our patient - associated sensitizations were as follows : 10 to latex , eight to chestnut , eight to banana , four to kiwi , and four to walnut ."
104703,were,O,3642.0,"Our patient - associated sensitizations were as follows : 10 to latex , eight to chestnut , eight to banana , four to kiwi , and four to walnut ."
104704,as,O,3642.0,"Our patient - associated sensitizations were as follows : 10 to latex , eight to chestnut , eight to banana , four to kiwi , and four to walnut ."
104705,follows,O,3642.0,"Our patient - associated sensitizations were as follows : 10 to latex , eight to chestnut , eight to banana , four to kiwi , and four to walnut ."
104706,:,O,3642.0,"Our patient - associated sensitizations were as follows : 10 to latex , eight to chestnut , eight to banana , four to kiwi , and four to walnut ."
104707,10,O,3642.0,"Our patient - associated sensitizations were as follows : 10 to latex , eight to chestnut , eight to banana , four to kiwi , and four to walnut ."
104708,to,O,3642.0,"Our patient - associated sensitizations were as follows : 10 to latex , eight to chestnut , eight to banana , four to kiwi , and four to walnut ."
104709,latex,O,3642.0,"Our patient - associated sensitizations were as follows : 10 to latex , eight to chestnut , eight to banana , four to kiwi , and four to walnut ."
104710,",",O,3642.0,"Our patient - associated sensitizations were as follows : 10 to latex , eight to chestnut , eight to banana , four to kiwi , and four to walnut ."
104711,eight,O,3642.0,"Our patient - associated sensitizations were as follows : 10 to latex , eight to chestnut , eight to banana , four to kiwi , and four to walnut ."
104712,to,O,3642.0,"Our patient - associated sensitizations were as follows : 10 to latex , eight to chestnut , eight to banana , four to kiwi , and four to walnut ."
104713,chestnut,B-AG.01.h.01.f,3642.0,"Our patient - associated sensitizations were as follows : 10 to latex , eight to chestnut , eight to banana , four to kiwi , and four to walnut ."
104714,",",O,3642.0,"Our patient - associated sensitizations were as follows : 10 to latex , eight to chestnut , eight to banana , four to kiwi , and four to walnut ."
104715,eight,O,3642.0,"Our patient - associated sensitizations were as follows : 10 to latex , eight to chestnut , eight to banana , four to kiwi , and four to walnut ."
104716,to,O,3642.0,"Our patient - associated sensitizations were as follows : 10 to latex , eight to chestnut , eight to banana , four to kiwi , and four to walnut ."
104717,banana,B-AG.01.h.01,3642.0,"Our patient - associated sensitizations were as follows : 10 to latex , eight to chestnut , eight to banana , four to kiwi , and four to walnut ."
104718,",",O,3642.0,"Our patient - associated sensitizations were as follows : 10 to latex , eight to chestnut , eight to banana , four to kiwi , and four to walnut ."
104719,four,O,3642.0,"Our patient - associated sensitizations were as follows : 10 to latex , eight to chestnut , eight to banana , four to kiwi , and four to walnut ."
104720,to,O,3642.0,"Our patient - associated sensitizations were as follows : 10 to latex , eight to chestnut , eight to banana , four to kiwi , and four to walnut ."
104721,kiwi,B-AG.01.h.01,3642.0,"Our patient - associated sensitizations were as follows : 10 to latex , eight to chestnut , eight to banana , four to kiwi , and four to walnut ."
104722,",",O,3642.0,"Our patient - associated sensitizations were as follows : 10 to latex , eight to chestnut , eight to banana , four to kiwi , and four to walnut ."
104723,and,O,3642.0,"Our patient - associated sensitizations were as follows : 10 to latex , eight to chestnut , eight to banana , four to kiwi , and four to walnut ."
104724,four,O,3642.0,"Our patient - associated sensitizations were as follows : 10 to latex , eight to chestnut , eight to banana , four to kiwi , and four to walnut ."
104725,to,O,3642.0,"Our patient - associated sensitizations were as follows : 10 to latex , eight to chestnut , eight to banana , four to kiwi , and four to walnut ."
104726,walnut,B-AG.01.h.01.f,3642.0,"Our patient - associated sensitizations were as follows : 10 to latex , eight to chestnut , eight to banana , four to kiwi , and four to walnut ."
104727,.,O,3642.0,"Our patient - associated sensitizations were as follows : 10 to latex , eight to chestnut , eight to banana , four to kiwi , and four to walnut ."
104728,Avocado,O,3643.0,"Avocado - sensitized patients with latex allergy were typically middle - aged women , professionally exposed to latex , who also exhibited frequent associated sensitizations to chestnut , banana , and other fruits ."
104729,-,O,3643.0,"Avocado - sensitized patients with latex allergy were typically middle - aged women , professionally exposed to latex , who also exhibited frequent associated sensitizations to chestnut , banana , and other fruits ."
104730,sensitized,O,3643.0,"Avocado - sensitized patients with latex allergy were typically middle - aged women , professionally exposed to latex , who also exhibited frequent associated sensitizations to chestnut , banana , and other fruits ."
104731,patients,O,3643.0,"Avocado - sensitized patients with latex allergy were typically middle - aged women , professionally exposed to latex , who also exhibited frequent associated sensitizations to chestnut , banana , and other fruits ."
104732,with,O,3643.0,"Avocado - sensitized patients with latex allergy were typically middle - aged women , professionally exposed to latex , who also exhibited frequent associated sensitizations to chestnut , banana , and other fruits ."
104733,latex,O,3643.0,"Avocado - sensitized patients with latex allergy were typically middle - aged women , professionally exposed to latex , who also exhibited frequent associated sensitizations to chestnut , banana , and other fruits ."
104734,allergy,O,3643.0,"Avocado - sensitized patients with latex allergy were typically middle - aged women , professionally exposed to latex , who also exhibited frequent associated sensitizations to chestnut , banana , and other fruits ."
104735,were,O,3643.0,"Avocado - sensitized patients with latex allergy were typically middle - aged women , professionally exposed to latex , who also exhibited frequent associated sensitizations to chestnut , banana , and other fruits ."
104736,typically,O,3643.0,"Avocado - sensitized patients with latex allergy were typically middle - aged women , professionally exposed to latex , who also exhibited frequent associated sensitizations to chestnut , banana , and other fruits ."
104737,middle,O,3643.0,"Avocado - sensitized patients with latex allergy were typically middle - aged women , professionally exposed to latex , who also exhibited frequent associated sensitizations to chestnut , banana , and other fruits ."
104738,-,O,3643.0,"Avocado - sensitized patients with latex allergy were typically middle - aged women , professionally exposed to latex , who also exhibited frequent associated sensitizations to chestnut , banana , and other fruits ."
104739,aged,O,3643.0,"Avocado - sensitized patients with latex allergy were typically middle - aged women , professionally exposed to latex , who also exhibited frequent associated sensitizations to chestnut , banana , and other fruits ."
104740,women,O,3643.0,"Avocado - sensitized patients with latex allergy were typically middle - aged women , professionally exposed to latex , who also exhibited frequent associated sensitizations to chestnut , banana , and other fruits ."
104741,",",O,3643.0,"Avocado - sensitized patients with latex allergy were typically middle - aged women , professionally exposed to latex , who also exhibited frequent associated sensitizations to chestnut , banana , and other fruits ."
104742,professionally,O,3643.0,"Avocado - sensitized patients with latex allergy were typically middle - aged women , professionally exposed to latex , who also exhibited frequent associated sensitizations to chestnut , banana , and other fruits ."
104743,exposed,O,3643.0,"Avocado - sensitized patients with latex allergy were typically middle - aged women , professionally exposed to latex , who also exhibited frequent associated sensitizations to chestnut , banana , and other fruits ."
104744,to,O,3643.0,"Avocado - sensitized patients with latex allergy were typically middle - aged women , professionally exposed to latex , who also exhibited frequent associated sensitizations to chestnut , banana , and other fruits ."
104745,latex,O,3643.0,"Avocado - sensitized patients with latex allergy were typically middle - aged women , professionally exposed to latex , who also exhibited frequent associated sensitizations to chestnut , banana , and other fruits ."
104746,",",O,3643.0,"Avocado - sensitized patients with latex allergy were typically middle - aged women , professionally exposed to latex , who also exhibited frequent associated sensitizations to chestnut , banana , and other fruits ."
104747,who,O,3643.0,"Avocado - sensitized patients with latex allergy were typically middle - aged women , professionally exposed to latex , who also exhibited frequent associated sensitizations to chestnut , banana , and other fruits ."
104748,also,O,3643.0,"Avocado - sensitized patients with latex allergy were typically middle - aged women , professionally exposed to latex , who also exhibited frequent associated sensitizations to chestnut , banana , and other fruits ."
104749,exhibited,O,3643.0,"Avocado - sensitized patients with latex allergy were typically middle - aged women , professionally exposed to latex , who also exhibited frequent associated sensitizations to chestnut , banana , and other fruits ."
104750,frequent,O,3643.0,"Avocado - sensitized patients with latex allergy were typically middle - aged women , professionally exposed to latex , who also exhibited frequent associated sensitizations to chestnut , banana , and other fruits ."
104751,associated,O,3643.0,"Avocado - sensitized patients with latex allergy were typically middle - aged women , professionally exposed to latex , who also exhibited frequent associated sensitizations to chestnut , banana , and other fruits ."
104752,sensitizations,O,3643.0,"Avocado - sensitized patients with latex allergy were typically middle - aged women , professionally exposed to latex , who also exhibited frequent associated sensitizations to chestnut , banana , and other fruits ."
104753,to,O,3643.0,"Avocado - sensitized patients with latex allergy were typically middle - aged women , professionally exposed to latex , who also exhibited frequent associated sensitizations to chestnut , banana , and other fruits ."
104754,chestnut,B-AG.01.h.01.f,3643.0,"Avocado - sensitized patients with latex allergy were typically middle - aged women , professionally exposed to latex , who also exhibited frequent associated sensitizations to chestnut , banana , and other fruits ."
104755,",",O,3643.0,"Avocado - sensitized patients with latex allergy were typically middle - aged women , professionally exposed to latex , who also exhibited frequent associated sensitizations to chestnut , banana , and other fruits ."
104756,banana,B-AG.01.h.01,3643.0,"Avocado - sensitized patients with latex allergy were typically middle - aged women , professionally exposed to latex , who also exhibited frequent associated sensitizations to chestnut , banana , and other fruits ."
104757,",",O,3643.0,"Avocado - sensitized patients with latex allergy were typically middle - aged women , professionally exposed to latex , who also exhibited frequent associated sensitizations to chestnut , banana , and other fruits ."
104758,and,O,3643.0,"Avocado - sensitized patients with latex allergy were typically middle - aged women , professionally exposed to latex , who also exhibited frequent associated sensitizations to chestnut , banana , and other fruits ."
104759,other,O,3643.0,"Avocado - sensitized patients with latex allergy were typically middle - aged women , professionally exposed to latex , who also exhibited frequent associated sensitizations to chestnut , banana , and other fruits ."
104760,fruits,B-AG.01.h.01,3643.0,"Avocado - sensitized patients with latex allergy were typically middle - aged women , professionally exposed to latex , who also exhibited frequent associated sensitizations to chestnut , banana , and other fruits ."
104761,.,O,3643.0,"Avocado - sensitized patients with latex allergy were typically middle - aged women , professionally exposed to latex , who also exhibited frequent associated sensitizations to chestnut , banana , and other fruits ."
104762,Specific,O,3644.0,"Specific IgE against avocado was demonstrated in 11 of our patients , by both commercial CAP and RAST with avocado extract coupled to nitrocellulose disks ."
104763,IgE,O,3644.0,"Specific IgE against avocado was demonstrated in 11 of our patients , by both commercial CAP and RAST with avocado extract coupled to nitrocellulose disks ."
104764,against,O,3644.0,"Specific IgE against avocado was demonstrated in 11 of our patients , by both commercial CAP and RAST with avocado extract coupled to nitrocellulose disks ."
104765,avocado,B-AG.01.h.01.e,3644.0,"Specific IgE against avocado was demonstrated in 11 of our patients , by both commercial CAP and RAST with avocado extract coupled to nitrocellulose disks ."
104766,was,O,3644.0,"Specific IgE against avocado was demonstrated in 11 of our patients , by both commercial CAP and RAST with avocado extract coupled to nitrocellulose disks ."
104767,demonstrated,O,3644.0,"Specific IgE against avocado was demonstrated in 11 of our patients , by both commercial CAP and RAST with avocado extract coupled to nitrocellulose disks ."
104768,in,O,3644.0,"Specific IgE against avocado was demonstrated in 11 of our patients , by both commercial CAP and RAST with avocado extract coupled to nitrocellulose disks ."
104769,11,O,3644.0,"Specific IgE against avocado was demonstrated in 11 of our patients , by both commercial CAP and RAST with avocado extract coupled to nitrocellulose disks ."
104770,of,O,3644.0,"Specific IgE against avocado was demonstrated in 11 of our patients , by both commercial CAP and RAST with avocado extract coupled to nitrocellulose disks ."
104771,our,O,3644.0,"Specific IgE against avocado was demonstrated in 11 of our patients , by both commercial CAP and RAST with avocado extract coupled to nitrocellulose disks ."
104772,patients,O,3644.0,"Specific IgE against avocado was demonstrated in 11 of our patients , by both commercial CAP and RAST with avocado extract coupled to nitrocellulose disks ."
104773,",",O,3644.0,"Specific IgE against avocado was demonstrated in 11 of our patients , by both commercial CAP and RAST with avocado extract coupled to nitrocellulose disks ."
104774,by,O,3644.0,"Specific IgE against avocado was demonstrated in 11 of our patients , by both commercial CAP and RAST with avocado extract coupled to nitrocellulose disks ."
104775,both,O,3644.0,"Specific IgE against avocado was demonstrated in 11 of our patients , by both commercial CAP and RAST with avocado extract coupled to nitrocellulose disks ."
104776,commercial,O,3644.0,"Specific IgE against avocado was demonstrated in 11 of our patients , by both commercial CAP and RAST with avocado extract coupled to nitrocellulose disks ."
104777,CAP,O,3644.0,"Specific IgE against avocado was demonstrated in 11 of our patients , by both commercial CAP and RAST with avocado extract coupled to nitrocellulose disks ."
104778,and,O,3644.0,"Specific IgE against avocado was demonstrated in 11 of our patients , by both commercial CAP and RAST with avocado extract coupled to nitrocellulose disks ."
104779,RAST,O,3644.0,"Specific IgE against avocado was demonstrated in 11 of our patients , by both commercial CAP and RAST with avocado extract coupled to nitrocellulose disks ."
104780,with,O,3644.0,"Specific IgE against avocado was demonstrated in 11 of our patients , by both commercial CAP and RAST with avocado extract coupled to nitrocellulose disks ."
104781,avocado,O,3644.0,"Specific IgE against avocado was demonstrated in 11 of our patients , by both commercial CAP and RAST with avocado extract coupled to nitrocellulose disks ."
104782,extract,O,3644.0,"Specific IgE against avocado was demonstrated in 11 of our patients , by both commercial CAP and RAST with avocado extract coupled to nitrocellulose disks ."
104783,coupled,O,3644.0,"Specific IgE against avocado was demonstrated in 11 of our patients , by both commercial CAP and RAST with avocado extract coupled to nitrocellulose disks ."
104784,to,O,3644.0,"Specific IgE against avocado was demonstrated in 11 of our patients , by both commercial CAP and RAST with avocado extract coupled to nitrocellulose disks ."
104785,nitrocellulose,O,3644.0,"Specific IgE against avocado was demonstrated in 11 of our patients , by both commercial CAP and RAST with avocado extract coupled to nitrocellulose disks ."
104786,disks,O,3644.0,"Specific IgE against avocado was demonstrated in 11 of our patients , by both commercial CAP and RAST with avocado extract coupled to nitrocellulose disks ."
104787,.,O,3644.0,"Specific IgE against avocado was demonstrated in 11 of our patients , by both commercial CAP and RAST with avocado extract coupled to nitrocellulose disks ."
104788,Despite,O,3645.0,"Despite its lower protein content , SAv seems to be more allergenic than HAv , both in vivo and in vitro ."
104789,its,O,3645.0,"Despite its lower protein content , SAv seems to be more allergenic than HAv , both in vivo and in vitro ."
104790,lower,O,3645.0,"Despite its lower protein content , SAv seems to be more allergenic than HAv , both in vivo and in vitro ."
104791,protein,O,3645.0,"Despite its lower protein content , SAv seems to be more allergenic than HAv , both in vivo and in vitro ."
104792,content,O,3645.0,"Despite its lower protein content , SAv seems to be more allergenic than HAv , both in vivo and in vitro ."
104793,",",O,3645.0,"Despite its lower protein content , SAv seems to be more allergenic than HAv , both in vivo and in vitro ."
104794,SAv,O,3645.0,"Despite its lower protein content , SAv seems to be more allergenic than HAv , both in vivo and in vitro ."
104795,seems,O,3645.0,"Despite its lower protein content , SAv seems to be more allergenic than HAv , both in vivo and in vitro ."
104796,to,O,3645.0,"Despite its lower protein content , SAv seems to be more allergenic than HAv , both in vivo and in vitro ."
104797,be,O,3645.0,"Despite its lower protein content , SAv seems to be more allergenic than HAv , both in vivo and in vitro ."
104798,more,O,3645.0,"Despite its lower protein content , SAv seems to be more allergenic than HAv , both in vivo and in vitro ."
104799,allergenic,O,3645.0,"Despite its lower protein content , SAv seems to be more allergenic than HAv , both in vivo and in vitro ."
104800,than,O,3645.0,"Despite its lower protein content , SAv seems to be more allergenic than HAv , both in vivo and in vitro ."
104801,HAv,O,3645.0,"Despite its lower protein content , SAv seems to be more allergenic than HAv , both in vivo and in vitro ."
104802,",",O,3645.0,"Despite its lower protein content , SAv seems to be more allergenic than HAv , both in vivo and in vitro ."
104803,both,O,3645.0,"Despite its lower protein content , SAv seems to be more allergenic than HAv , both in vivo and in vitro ."
104804,in,O,3645.0,"Despite its lower protein content , SAv seems to be more allergenic than HAv , both in vivo and in vitro ."
104805,vivo,O,3645.0,"Despite its lower protein content , SAv seems to be more allergenic than HAv , both in vivo and in vitro ."
104806,and,O,3645.0,"Despite its lower protein content , SAv seems to be more allergenic than HAv , both in vivo and in vitro ."
104807,in,O,3645.0,"Despite its lower protein content , SAv seems to be more allergenic than HAv , both in vivo and in vitro ."
104808,vitro,O,3645.0,"Despite its lower protein content , SAv seems to be more allergenic than HAv , both in vivo and in vitro ."
104809,.,O,3645.0,"Despite its lower protein content , SAv seems to be more allergenic than HAv , both in vivo and in vitro ."
104810,On,O,3646.0,"On incubating a pool of sera from our patients with avocado , latex , chestnut , and banana extracts , a progressive RAST inhibition was obtained , with SAv- and chestnut - marked disks ."
104811,incubating,O,3646.0,"On incubating a pool of sera from our patients with avocado , latex , chestnut , and banana extracts , a progressive RAST inhibition was obtained , with SAv- and chestnut - marked disks ."
104812,a,O,3646.0,"On incubating a pool of sera from our patients with avocado , latex , chestnut , and banana extracts , a progressive RAST inhibition was obtained , with SAv- and chestnut - marked disks ."
104813,pool,O,3646.0,"On incubating a pool of sera from our patients with avocado , latex , chestnut , and banana extracts , a progressive RAST inhibition was obtained , with SAv- and chestnut - marked disks ."
104814,of,O,3646.0,"On incubating a pool of sera from our patients with avocado , latex , chestnut , and banana extracts , a progressive RAST inhibition was obtained , with SAv- and chestnut - marked disks ."
104815,sera,O,3646.0,"On incubating a pool of sera from our patients with avocado , latex , chestnut , and banana extracts , a progressive RAST inhibition was obtained , with SAv- and chestnut - marked disks ."
104816,from,O,3646.0,"On incubating a pool of sera from our patients with avocado , latex , chestnut , and banana extracts , a progressive RAST inhibition was obtained , with SAv- and chestnut - marked disks ."
104817,our,O,3646.0,"On incubating a pool of sera from our patients with avocado , latex , chestnut , and banana extracts , a progressive RAST inhibition was obtained , with SAv- and chestnut - marked disks ."
104818,patients,O,3646.0,"On incubating a pool of sera from our patients with avocado , latex , chestnut , and banana extracts , a progressive RAST inhibition was obtained , with SAv- and chestnut - marked disks ."
104819,with,O,3646.0,"On incubating a pool of sera from our patients with avocado , latex , chestnut , and banana extracts , a progressive RAST inhibition was obtained , with SAv- and chestnut - marked disks ."
104820,avocado,B-AG.01.h.01.e,3646.0,"On incubating a pool of sera from our patients with avocado , latex , chestnut , and banana extracts , a progressive RAST inhibition was obtained , with SAv- and chestnut - marked disks ."
104821,",",O,3646.0,"On incubating a pool of sera from our patients with avocado , latex , chestnut , and banana extracts , a progressive RAST inhibition was obtained , with SAv- and chestnut - marked disks ."
104822,latex,O,3646.0,"On incubating a pool of sera from our patients with avocado , latex , chestnut , and banana extracts , a progressive RAST inhibition was obtained , with SAv- and chestnut - marked disks ."
104823,",",O,3646.0,"On incubating a pool of sera from our patients with avocado , latex , chestnut , and banana extracts , a progressive RAST inhibition was obtained , with SAv- and chestnut - marked disks ."
104824,chestnut,B-AG.01.h.01.f,3646.0,"On incubating a pool of sera from our patients with avocado , latex , chestnut , and banana extracts , a progressive RAST inhibition was obtained , with SAv- and chestnut - marked disks ."
104825,",",O,3646.0,"On incubating a pool of sera from our patients with avocado , latex , chestnut , and banana extracts , a progressive RAST inhibition was obtained , with SAv- and chestnut - marked disks ."
104826,and,O,3646.0,"On incubating a pool of sera from our patients with avocado , latex , chestnut , and banana extracts , a progressive RAST inhibition was obtained , with SAv- and chestnut - marked disks ."
104827,banana,B-AG.01.h.01,3646.0,"On incubating a pool of sera from our patients with avocado , latex , chestnut , and banana extracts , a progressive RAST inhibition was obtained , with SAv- and chestnut - marked disks ."
104828,extracts,O,3646.0,"On incubating a pool of sera from our patients with avocado , latex , chestnut , and banana extracts , a progressive RAST inhibition was obtained , with SAv- and chestnut - marked disks ."
104829,",",O,3646.0,"On incubating a pool of sera from our patients with avocado , latex , chestnut , and banana extracts , a progressive RAST inhibition was obtained , with SAv- and chestnut - marked disks ."
104830,a,O,3646.0,"On incubating a pool of sera from our patients with avocado , latex , chestnut , and banana extracts , a progressive RAST inhibition was obtained , with SAv- and chestnut - marked disks ."
104831,progressive,O,3646.0,"On incubating a pool of sera from our patients with avocado , latex , chestnut , and banana extracts , a progressive RAST inhibition was obtained , with SAv- and chestnut - marked disks ."
104832,RAST,O,3646.0,"On incubating a pool of sera from our patients with avocado , latex , chestnut , and banana extracts , a progressive RAST inhibition was obtained , with SAv- and chestnut - marked disks ."
104833,inhibition,O,3646.0,"On incubating a pool of sera from our patients with avocado , latex , chestnut , and banana extracts , a progressive RAST inhibition was obtained , with SAv- and chestnut - marked disks ."
104834,was,O,3646.0,"On incubating a pool of sera from our patients with avocado , latex , chestnut , and banana extracts , a progressive RAST inhibition was obtained , with SAv- and chestnut - marked disks ."
104835,obtained,O,3646.0,"On incubating a pool of sera from our patients with avocado , latex , chestnut , and banana extracts , a progressive RAST inhibition was obtained , with SAv- and chestnut - marked disks ."
104836,",",O,3646.0,"On incubating a pool of sera from our patients with avocado , latex , chestnut , and banana extracts , a progressive RAST inhibition was obtained , with SAv- and chestnut - marked disks ."
104837,with,O,3646.0,"On incubating a pool of sera from our patients with avocado , latex , chestnut , and banana extracts , a progressive RAST inhibition was obtained , with SAv- and chestnut - marked disks ."
104838,SAv-,O,3646.0,"On incubating a pool of sera from our patients with avocado , latex , chestnut , and banana extracts , a progressive RAST inhibition was obtained , with SAv- and chestnut - marked disks ."
104839,and,O,3646.0,"On incubating a pool of sera from our patients with avocado , latex , chestnut , and banana extracts , a progressive RAST inhibition was obtained , with SAv- and chestnut - marked disks ."
104840,chestnut,O,3646.0,"On incubating a pool of sera from our patients with avocado , latex , chestnut , and banana extracts , a progressive RAST inhibition was obtained , with SAv- and chestnut - marked disks ."
104841,-,O,3646.0,"On incubating a pool of sera from our patients with avocado , latex , chestnut , and banana extracts , a progressive RAST inhibition was obtained , with SAv- and chestnut - marked disks ."
104842,marked,O,3646.0,"On incubating a pool of sera from our patients with avocado , latex , chestnut , and banana extracts , a progressive RAST inhibition was obtained , with SAv- and chestnut - marked disks ."
104843,disks,O,3646.0,"On incubating a pool of sera from our patients with avocado , latex , chestnut , and banana extracts , a progressive RAST inhibition was obtained , with SAv- and chestnut - marked disks ."
104844,.,O,3646.0,"On incubating a pool of sera from our patients with avocado , latex , chestnut , and banana extracts , a progressive RAST inhibition was obtained , with SAv- and chestnut - marked disks ."
104845,This,O,3647.0,This suggests the existence of common antigenic determinants among these allergens .
104846,suggests,O,3647.0,This suggests the existence of common antigenic determinants among these allergens .
104847,the,O,3647.0,This suggests the existence of common antigenic determinants among these allergens .
104848,existence,O,3647.0,This suggests the existence of common antigenic determinants among these allergens .
104849,of,O,3647.0,This suggests the existence of common antigenic determinants among these allergens .
104850,common,O,3647.0,This suggests the existence of common antigenic determinants among these allergens .
104851,antigenic,O,3647.0,This suggests the existence of common antigenic determinants among these allergens .
104852,determinants,O,3647.0,This suggests the existence of common antigenic determinants among these allergens .
104853,among,O,3647.0,This suggests the existence of common antigenic determinants among these allergens .
104854,these,O,3647.0,This suggests the existence of common antigenic determinants among these allergens .
104855,allergens,O,3647.0,This suggests the existence of common antigenic determinants among these allergens .
104856,.,O,3647.0,This suggests the existence of common antigenic determinants among these allergens .
104857,Milk,O,3648.0,"Milk chocolate is rich in both sucrose and fat , and is therefore considered unsuitable for diabetics ."
104858,chocolate,B-AG.01.n.17.a,3648.0,"Milk chocolate is rich in both sucrose and fat , and is therefore considered unsuitable for diabetics ."
104859,is,O,3648.0,"Milk chocolate is rich in both sucrose and fat , and is therefore considered unsuitable for diabetics ."
104860,rich,O,3648.0,"Milk chocolate is rich in both sucrose and fat , and is therefore considered unsuitable for diabetics ."
104861,in,O,3648.0,"Milk chocolate is rich in both sucrose and fat , and is therefore considered unsuitable for diabetics ."
104862,both,O,3648.0,"Milk chocolate is rich in both sucrose and fat , and is therefore considered unsuitable for diabetics ."
104863,sucrose,O,3648.0,"Milk chocolate is rich in both sucrose and fat , and is therefore considered unsuitable for diabetics ."
104864,and,O,3648.0,"Milk chocolate is rich in both sucrose and fat , and is therefore considered unsuitable for diabetics ."
104865,fat,O,3648.0,"Milk chocolate is rich in both sucrose and fat , and is therefore considered unsuitable for diabetics ."
104866,",",O,3648.0,"Milk chocolate is rich in both sucrose and fat , and is therefore considered unsuitable for diabetics ."
104867,and,O,3648.0,"Milk chocolate is rich in both sucrose and fat , and is therefore considered unsuitable for diabetics ."
104868,is,O,3648.0,"Milk chocolate is rich in both sucrose and fat , and is therefore considered unsuitable for diabetics ."
104869,therefore,O,3648.0,"Milk chocolate is rich in both sucrose and fat , and is therefore considered unsuitable for diabetics ."
104870,considered,O,3648.0,"Milk chocolate is rich in both sucrose and fat , and is therefore considered unsuitable for diabetics ."
104871,unsuitable,O,3648.0,"Milk chocolate is rich in both sucrose and fat , and is therefore considered unsuitable for diabetics ."
104872,for,O,3648.0,"Milk chocolate is rich in both sucrose and fat , and is therefore considered unsuitable for diabetics ."
104873,diabetics,O,3648.0,"Milk chocolate is rich in both sucrose and fat , and is therefore considered unsuitable for diabetics ."
104874,.,O,3648.0,"Milk chocolate is rich in both sucrose and fat , and is therefore considered unsuitable for diabetics ."
104875,Nevertheless,O,3649.0,Nevertheless there is little information on the metabolic effects of conventional chocolate or specialized formulations with reduced sucrose content .
104876,there,O,3649.0,Nevertheless there is little information on the metabolic effects of conventional chocolate or specialized formulations with reduced sucrose content .
104877,is,O,3649.0,Nevertheless there is little information on the metabolic effects of conventional chocolate or specialized formulations with reduced sucrose content .
104878,little,O,3649.0,Nevertheless there is little information on the metabolic effects of conventional chocolate or specialized formulations with reduced sucrose content .
104879,information,O,3649.0,Nevertheless there is little information on the metabolic effects of conventional chocolate or specialized formulations with reduced sucrose content .
104880,on,O,3649.0,Nevertheless there is little information on the metabolic effects of conventional chocolate or specialized formulations with reduced sucrose content .
104881,the,O,3649.0,Nevertheless there is little information on the metabolic effects of conventional chocolate or specialized formulations with reduced sucrose content .
104882,metabolic,O,3649.0,Nevertheless there is little information on the metabolic effects of conventional chocolate or specialized formulations with reduced sucrose content .
104883,effects,O,3649.0,Nevertheless there is little information on the metabolic effects of conventional chocolate or specialized formulations with reduced sucrose content .
104884,of,O,3649.0,Nevertheless there is little information on the metabolic effects of conventional chocolate or specialized formulations with reduced sucrose content .
104885,conventional,B-AG.01.n.17.a,3649.0,Nevertheless there is little information on the metabolic effects of conventional chocolate or specialized formulations with reduced sucrose content .
104886,chocolate,I-AG.01.n.17.a,3649.0,Nevertheless there is little information on the metabolic effects of conventional chocolate or specialized formulations with reduced sucrose content .
104887,or,O,3649.0,Nevertheless there is little information on the metabolic effects of conventional chocolate or specialized formulations with reduced sucrose content .
104888,specialized,O,3649.0,Nevertheless there is little information on the metabolic effects of conventional chocolate or specialized formulations with reduced sucrose content .
104889,formulations,O,3649.0,Nevertheless there is little information on the metabolic effects of conventional chocolate or specialized formulations with reduced sucrose content .
104890,with,O,3649.0,Nevertheless there is little information on the metabolic effects of conventional chocolate or specialized formulations with reduced sucrose content .
104891,reduced,O,3649.0,Nevertheless there is little information on the metabolic effects of conventional chocolate or specialized formulations with reduced sucrose content .
104892,sucrose,O,3649.0,Nevertheless there is little information on the metabolic effects of conventional chocolate or specialized formulations with reduced sucrose content .
104893,content,O,3649.0,Nevertheless there is little information on the metabolic effects of conventional chocolate or specialized formulations with reduced sucrose content .
104894,.,O,3649.0,Nevertheless there is little information on the metabolic effects of conventional chocolate or specialized formulations with reduced sucrose content .
104895,In,O,3650.0,In the present study six male non - insulin - dependent diabetes mellitus patients ( age range 35 - 60 years ; body - mass index less than 28 ) consumed test meals of chocolate ( 75 g ) on three separate occasions .
104896,the,O,3650.0,In the present study six male non - insulin - dependent diabetes mellitus patients ( age range 35 - 60 years ; body - mass index less than 28 ) consumed test meals of chocolate ( 75 g ) on three separate occasions .
104897,present,O,3650.0,In the present study six male non - insulin - dependent diabetes mellitus patients ( age range 35 - 60 years ; body - mass index less than 28 ) consumed test meals of chocolate ( 75 g ) on three separate occasions .
104898,study,O,3650.0,In the present study six male non - insulin - dependent diabetes mellitus patients ( age range 35 - 60 years ; body - mass index less than 28 ) consumed test meals of chocolate ( 75 g ) on three separate occasions .
104899,six,O,3650.0,In the present study six male non - insulin - dependent diabetes mellitus patients ( age range 35 - 60 years ; body - mass index less than 28 ) consumed test meals of chocolate ( 75 g ) on three separate occasions .
104900,male,O,3650.0,In the present study six male non - insulin - dependent diabetes mellitus patients ( age range 35 - 60 years ; body - mass index less than 28 ) consumed test meals of chocolate ( 75 g ) on three separate occasions .
104901,non,O,3650.0,In the present study six male non - insulin - dependent diabetes mellitus patients ( age range 35 - 60 years ; body - mass index less than 28 ) consumed test meals of chocolate ( 75 g ) on three separate occasions .
104902,-,O,3650.0,In the present study six male non - insulin - dependent diabetes mellitus patients ( age range 35 - 60 years ; body - mass index less than 28 ) consumed test meals of chocolate ( 75 g ) on three separate occasions .
104903,insulin,O,3650.0,In the present study six male non - insulin - dependent diabetes mellitus patients ( age range 35 - 60 years ; body - mass index less than 28 ) consumed test meals of chocolate ( 75 g ) on three separate occasions .
104904,-,O,3650.0,In the present study six male non - insulin - dependent diabetes mellitus patients ( age range 35 - 60 years ; body - mass index less than 28 ) consumed test meals of chocolate ( 75 g ) on three separate occasions .
104905,dependent,O,3650.0,In the present study six male non - insulin - dependent diabetes mellitus patients ( age range 35 - 60 years ; body - mass index less than 28 ) consumed test meals of chocolate ( 75 g ) on three separate occasions .
104906,diabetes,O,3650.0,In the present study six male non - insulin - dependent diabetes mellitus patients ( age range 35 - 60 years ; body - mass index less than 28 ) consumed test meals of chocolate ( 75 g ) on three separate occasions .
104907,mellitus,O,3650.0,In the present study six male non - insulin - dependent diabetes mellitus patients ( age range 35 - 60 years ; body - mass index less than 28 ) consumed test meals of chocolate ( 75 g ) on three separate occasions .
104908,patients,O,3650.0,In the present study six male non - insulin - dependent diabetes mellitus patients ( age range 35 - 60 years ; body - mass index less than 28 ) consumed test meals of chocolate ( 75 g ) on three separate occasions .
104909,(,O,3650.0,In the present study six male non - insulin - dependent diabetes mellitus patients ( age range 35 - 60 years ; body - mass index less than 28 ) consumed test meals of chocolate ( 75 g ) on three separate occasions .
104910,age,O,3650.0,In the present study six male non - insulin - dependent diabetes mellitus patients ( age range 35 - 60 years ; body - mass index less than 28 ) consumed test meals of chocolate ( 75 g ) on three separate occasions .
104911,range,O,3650.0,In the present study six male non - insulin - dependent diabetes mellitus patients ( age range 35 - 60 years ; body - mass index less than 28 ) consumed test meals of chocolate ( 75 g ) on three separate occasions .
104912,35,O,3650.0,In the present study six male non - insulin - dependent diabetes mellitus patients ( age range 35 - 60 years ; body - mass index less than 28 ) consumed test meals of chocolate ( 75 g ) on three separate occasions .
104913,-,O,3650.0,In the present study six male non - insulin - dependent diabetes mellitus patients ( age range 35 - 60 years ; body - mass index less than 28 ) consumed test meals of chocolate ( 75 g ) on three separate occasions .
104914,60,O,3650.0,In the present study six male non - insulin - dependent diabetes mellitus patients ( age range 35 - 60 years ; body - mass index less than 28 ) consumed test meals of chocolate ( 75 g ) on three separate occasions .
104915,years,O,3650.0,In the present study six male non - insulin - dependent diabetes mellitus patients ( age range 35 - 60 years ; body - mass index less than 28 ) consumed test meals of chocolate ( 75 g ) on three separate occasions .
104916,;,O,3650.0,In the present study six male non - insulin - dependent diabetes mellitus patients ( age range 35 - 60 years ; body - mass index less than 28 ) consumed test meals of chocolate ( 75 g ) on three separate occasions .
104917,body,O,3650.0,In the present study six male non - insulin - dependent diabetes mellitus patients ( age range 35 - 60 years ; body - mass index less than 28 ) consumed test meals of chocolate ( 75 g ) on three separate occasions .
104918,-,O,3650.0,In the present study six male non - insulin - dependent diabetes mellitus patients ( age range 35 - 60 years ; body - mass index less than 28 ) consumed test meals of chocolate ( 75 g ) on three separate occasions .
104919,mass,O,3650.0,In the present study six male non - insulin - dependent diabetes mellitus patients ( age range 35 - 60 years ; body - mass index less than 28 ) consumed test meals of chocolate ( 75 g ) on three separate occasions .
104920,index,O,3650.0,In the present study six male non - insulin - dependent diabetes mellitus patients ( age range 35 - 60 years ; body - mass index less than 28 ) consumed test meals of chocolate ( 75 g ) on three separate occasions .
104921,less,O,3650.0,In the present study six male non - insulin - dependent diabetes mellitus patients ( age range 35 - 60 years ; body - mass index less than 28 ) consumed test meals of chocolate ( 75 g ) on three separate occasions .
104922,than,O,3650.0,In the present study six male non - insulin - dependent diabetes mellitus patients ( age range 35 - 60 years ; body - mass index less than 28 ) consumed test meals of chocolate ( 75 g ) on three separate occasions .
104923,28,O,3650.0,In the present study six male non - insulin - dependent diabetes mellitus patients ( age range 35 - 60 years ; body - mass index less than 28 ) consumed test meals of chocolate ( 75 g ) on three separate occasions .
104924,),O,3650.0,In the present study six male non - insulin - dependent diabetes mellitus patients ( age range 35 - 60 years ; body - mass index less than 28 ) consumed test meals of chocolate ( 75 g ) on three separate occasions .
104925,consumed,O,3650.0,In the present study six male non - insulin - dependent diabetes mellitus patients ( age range 35 - 60 years ; body - mass index less than 28 ) consumed test meals of chocolate ( 75 g ) on three separate occasions .
104926,test,O,3650.0,In the present study six male non - insulin - dependent diabetes mellitus patients ( age range 35 - 60 years ; body - mass index less than 28 ) consumed test meals of chocolate ( 75 g ) on three separate occasions .
104927,meals,O,3650.0,In the present study six male non - insulin - dependent diabetes mellitus patients ( age range 35 - 60 years ; body - mass index less than 28 ) consumed test meals of chocolate ( 75 g ) on three separate occasions .
104928,of,O,3650.0,In the present study six male non - insulin - dependent diabetes mellitus patients ( age range 35 - 60 years ; body - mass index less than 28 ) consumed test meals of chocolate ( 75 g ) on three separate occasions .
104929,chocolate,B-AG.01.n.17.a,3650.0,In the present study six male non - insulin - dependent diabetes mellitus patients ( age range 35 - 60 years ; body - mass index less than 28 ) consumed test meals of chocolate ( 75 g ) on three separate occasions .
104930,(,O,3650.0,In the present study six male non - insulin - dependent diabetes mellitus patients ( age range 35 - 60 years ; body - mass index less than 28 ) consumed test meals of chocolate ( 75 g ) on three separate occasions .
104931,75,O,3650.0,In the present study six male non - insulin - dependent diabetes mellitus patients ( age range 35 - 60 years ; body - mass index less than 28 ) consumed test meals of chocolate ( 75 g ) on three separate occasions .
104932,g,O,3650.0,In the present study six male non - insulin - dependent diabetes mellitus patients ( age range 35 - 60 years ; body - mass index less than 28 ) consumed test meals of chocolate ( 75 g ) on three separate occasions .
104933,),O,3650.0,In the present study six male non - insulin - dependent diabetes mellitus patients ( age range 35 - 60 years ; body - mass index less than 28 ) consumed test meals of chocolate ( 75 g ) on three separate occasions .
104934,on,O,3650.0,In the present study six male non - insulin - dependent diabetes mellitus patients ( age range 35 - 60 years ; body - mass index less than 28 ) consumed test meals of chocolate ( 75 g ) on three separate occasions .
104935,three,O,3650.0,In the present study six male non - insulin - dependent diabetes mellitus patients ( age range 35 - 60 years ; body - mass index less than 28 ) consumed test meals of chocolate ( 75 g ) on three separate occasions .
104936,separate,O,3650.0,In the present study six male non - insulin - dependent diabetes mellitus patients ( age range 35 - 60 years ; body - mass index less than 28 ) consumed test meals of chocolate ( 75 g ) on three separate occasions .
104937,occasions,O,3650.0,In the present study six male non - insulin - dependent diabetes mellitus patients ( age range 35 - 60 years ; body - mass index less than 28 ) consumed test meals of chocolate ( 75 g ) on three separate occasions .
104938,.,O,3650.0,In the present study six male non - insulin - dependent diabetes mellitus patients ( age range 35 - 60 years ; body - mass index less than 28 ) consumed test meals of chocolate ( 75 g ) on three separate occasions .
104939,The,O,3651.0,The control chocolate contained sucrose ( 45.5 % w / w ) ; the test chocolates contained either fructose ( 45.5 % w / w ) or isomalt ( 45.1 % w / w ) .
104940,control,O,3651.0,The control chocolate contained sucrose ( 45.5 % w / w ) ; the test chocolates contained either fructose ( 45.5 % w / w ) or isomalt ( 45.1 % w / w ) .
104941,chocolate,B-AG.01.n.17.a,3651.0,The control chocolate contained sucrose ( 45.5 % w / w ) ; the test chocolates contained either fructose ( 45.5 % w / w ) or isomalt ( 45.1 % w / w ) .
104942,contained,O,3651.0,The control chocolate contained sucrose ( 45.5 % w / w ) ; the test chocolates contained either fructose ( 45.5 % w / w ) or isomalt ( 45.1 % w / w ) .
104943,sucrose,O,3651.0,The control chocolate contained sucrose ( 45.5 % w / w ) ; the test chocolates contained either fructose ( 45.5 % w / w ) or isomalt ( 45.1 % w / w ) .
104944,(,O,3651.0,The control chocolate contained sucrose ( 45.5 % w / w ) ; the test chocolates contained either fructose ( 45.5 % w / w ) or isomalt ( 45.1 % w / w ) .
104945,45.5,O,3651.0,The control chocolate contained sucrose ( 45.5 % w / w ) ; the test chocolates contained either fructose ( 45.5 % w / w ) or isomalt ( 45.1 % w / w ) .
104946,%,O,3651.0,The control chocolate contained sucrose ( 45.5 % w / w ) ; the test chocolates contained either fructose ( 45.5 % w / w ) or isomalt ( 45.1 % w / w ) .
104947,w,O,3651.0,The control chocolate contained sucrose ( 45.5 % w / w ) ; the test chocolates contained either fructose ( 45.5 % w / w ) or isomalt ( 45.1 % w / w ) .
104948,/,O,3651.0,The control chocolate contained sucrose ( 45.5 % w / w ) ; the test chocolates contained either fructose ( 45.5 % w / w ) or isomalt ( 45.1 % w / w ) .
104949,w,O,3651.0,The control chocolate contained sucrose ( 45.5 % w / w ) ; the test chocolates contained either fructose ( 45.5 % w / w ) or isomalt ( 45.1 % w / w ) .
104950,),O,3651.0,The control chocolate contained sucrose ( 45.5 % w / w ) ; the test chocolates contained either fructose ( 45.5 % w / w ) or isomalt ( 45.1 % w / w ) .
104951,;,O,3651.0,The control chocolate contained sucrose ( 45.5 % w / w ) ; the test chocolates contained either fructose ( 45.5 % w / w ) or isomalt ( 45.1 % w / w ) .
104952,the,O,3651.0,The control chocolate contained sucrose ( 45.5 % w / w ) ; the test chocolates contained either fructose ( 45.5 % w / w ) or isomalt ( 45.1 % w / w ) .
104953,test,O,3651.0,The control chocolate contained sucrose ( 45.5 % w / w ) ; the test chocolates contained either fructose ( 45.5 % w / w ) or isomalt ( 45.1 % w / w ) .
104954,chocolates,B-AG.01.n.17.a,3651.0,The control chocolate contained sucrose ( 45.5 % w / w ) ; the test chocolates contained either fructose ( 45.5 % w / w ) or isomalt ( 45.1 % w / w ) .
104955,contained,O,3651.0,The control chocolate contained sucrose ( 45.5 % w / w ) ; the test chocolates contained either fructose ( 45.5 % w / w ) or isomalt ( 45.1 % w / w ) .
104956,either,O,3651.0,The control chocolate contained sucrose ( 45.5 % w / w ) ; the test chocolates contained either fructose ( 45.5 % w / w ) or isomalt ( 45.1 % w / w ) .
104957,fructose,O,3651.0,The control chocolate contained sucrose ( 45.5 % w / w ) ; the test chocolates contained either fructose ( 45.5 % w / w ) or isomalt ( 45.1 % w / w ) .
104958,(,O,3651.0,The control chocolate contained sucrose ( 45.5 % w / w ) ; the test chocolates contained either fructose ( 45.5 % w / w ) or isomalt ( 45.1 % w / w ) .
104959,45.5,O,3651.0,The control chocolate contained sucrose ( 45.5 % w / w ) ; the test chocolates contained either fructose ( 45.5 % w / w ) or isomalt ( 45.1 % w / w ) .
104960,%,O,3651.0,The control chocolate contained sucrose ( 45.5 % w / w ) ; the test chocolates contained either fructose ( 45.5 % w / w ) or isomalt ( 45.1 % w / w ) .
104961,w,O,3651.0,The control chocolate contained sucrose ( 45.5 % w / w ) ; the test chocolates contained either fructose ( 45.5 % w / w ) or isomalt ( 45.1 % w / w ) .
104962,/,O,3651.0,The control chocolate contained sucrose ( 45.5 % w / w ) ; the test chocolates contained either fructose ( 45.5 % w / w ) or isomalt ( 45.1 % w / w ) .
104963,w,O,3651.0,The control chocolate contained sucrose ( 45.5 % w / w ) ; the test chocolates contained either fructose ( 45.5 % w / w ) or isomalt ( 45.1 % w / w ) .
104964,),O,3651.0,The control chocolate contained sucrose ( 45.5 % w / w ) ; the test chocolates contained either fructose ( 45.5 % w / w ) or isomalt ( 45.1 % w / w ) .
104965,or,O,3651.0,The control chocolate contained sucrose ( 45.5 % w / w ) ; the test chocolates contained either fructose ( 45.5 % w / w ) or isomalt ( 45.1 % w / w ) .
104966,isomalt,O,3651.0,The control chocolate contained sucrose ( 45.5 % w / w ) ; the test chocolates contained either fructose ( 45.5 % w / w ) or isomalt ( 45.1 % w / w ) .
104967,(,O,3651.0,The control chocolate contained sucrose ( 45.5 % w / w ) ; the test chocolates contained either fructose ( 45.5 % w / w ) or isomalt ( 45.1 % w / w ) .
104968,45.1,O,3651.0,The control chocolate contained sucrose ( 45.5 % w / w ) ; the test chocolates contained either fructose ( 45.5 % w / w ) or isomalt ( 45.1 % w / w ) .
104969,%,O,3651.0,The control chocolate contained sucrose ( 45.5 % w / w ) ; the test chocolates contained either fructose ( 45.5 % w / w ) or isomalt ( 45.1 % w / w ) .
104970,w,O,3651.0,The control chocolate contained sucrose ( 45.5 % w / w ) ; the test chocolates contained either fructose ( 45.5 % w / w ) or isomalt ( 45.1 % w / w ) .
104971,/,O,3651.0,The control chocolate contained sucrose ( 45.5 % w / w ) ; the test chocolates contained either fructose ( 45.5 % w / w ) or isomalt ( 45.1 % w / w ) .
104972,w,O,3651.0,The control chocolate contained sucrose ( 45.5 % w / w ) ; the test chocolates contained either fructose ( 45.5 % w / w ) or isomalt ( 45.1 % w / w ) .
104973,),O,3651.0,The control chocolate contained sucrose ( 45.5 % w / w ) ; the test chocolates contained either fructose ( 45.5 % w / w ) or isomalt ( 45.1 % w / w ) .
104974,.,O,3651.0,The control chocolate contained sucrose ( 45.5 % w / w ) ; the test chocolates contained either fructose ( 45.5 % w / w ) or isomalt ( 45.1 % w / w ) .
104975,The,O,3652.0,The latter is a sweet disaccharide alcohol which has no glycaemic effect when consumed as a pure compound .
104976,latter,O,3652.0,The latter is a sweet disaccharide alcohol which has no glycaemic effect when consumed as a pure compound .
104977,is,O,3652.0,The latter is a sweet disaccharide alcohol which has no glycaemic effect when consumed as a pure compound .
104978,a,O,3652.0,The latter is a sweet disaccharide alcohol which has no glycaemic effect when consumed as a pure compound .
104979,sweet,O,3652.0,The latter is a sweet disaccharide alcohol which has no glycaemic effect when consumed as a pure compound .
104980,disaccharide,O,3652.0,The latter is a sweet disaccharide alcohol which has no glycaemic effect when consumed as a pure compound .
104981,alcohol,O,3652.0,The latter is a sweet disaccharide alcohol which has no glycaemic effect when consumed as a pure compound .
104982,which,O,3652.0,The latter is a sweet disaccharide alcohol which has no glycaemic effect when consumed as a pure compound .
104983,has,O,3652.0,The latter is a sweet disaccharide alcohol which has no glycaemic effect when consumed as a pure compound .
104984,no,O,3652.0,The latter is a sweet disaccharide alcohol which has no glycaemic effect when consumed as a pure compound .
104985,glycaemic,O,3652.0,The latter is a sweet disaccharide alcohol which has no glycaemic effect when consumed as a pure compound .
104986,effect,O,3652.0,The latter is a sweet disaccharide alcohol which has no glycaemic effect when consumed as a pure compound .
104987,when,O,3652.0,The latter is a sweet disaccharide alcohol which has no glycaemic effect when consumed as a pure compound .
104988,consumed,O,3652.0,The latter is a sweet disaccharide alcohol which has no glycaemic effect when consumed as a pure compound .
104989,as,O,3652.0,The latter is a sweet disaccharide alcohol which has no glycaemic effect when consumed as a pure compound .
104990,a,O,3652.0,The latter is a sweet disaccharide alcohol which has no glycaemic effect when consumed as a pure compound .
104991,pure,O,3652.0,The latter is a sweet disaccharide alcohol which has no glycaemic effect when consumed as a pure compound .
104992,compound,O,3652.0,The latter is a sweet disaccharide alcohol which has no glycaemic effect when consumed as a pure compound .
104993,.,O,3652.0,The latter is a sweet disaccharide alcohol which has no glycaemic effect when consumed as a pure compound .
104994,Venous,O,3653.0,"Venous blood samples were obtained at 30 min intervals for 5 h , and analysed for glucose , insulin , lactate and triglycerides ."
104995,blood,O,3653.0,"Venous blood samples were obtained at 30 min intervals for 5 h , and analysed for glucose , insulin , lactate and triglycerides ."
104996,samples,O,3653.0,"Venous blood samples were obtained at 30 min intervals for 5 h , and analysed for glucose , insulin , lactate and triglycerides ."
104997,were,O,3653.0,"Venous blood samples were obtained at 30 min intervals for 5 h , and analysed for glucose , insulin , lactate and triglycerides ."
104998,obtained,O,3653.0,"Venous blood samples were obtained at 30 min intervals for 5 h , and analysed for glucose , insulin , lactate and triglycerides ."
104999,at,O,3653.0,"Venous blood samples were obtained at 30 min intervals for 5 h , and analysed for glucose , insulin , lactate and triglycerides ."
105000,30,O,3653.0,"Venous blood samples were obtained at 30 min intervals for 5 h , and analysed for glucose , insulin , lactate and triglycerides ."
105001,min,O,3653.0,"Venous blood samples were obtained at 30 min intervals for 5 h , and analysed for glucose , insulin , lactate and triglycerides ."
105002,intervals,O,3653.0,"Venous blood samples were obtained at 30 min intervals for 5 h , and analysed for glucose , insulin , lactate and triglycerides ."
105003,for,O,3653.0,"Venous blood samples were obtained at 30 min intervals for 5 h , and analysed for glucose , insulin , lactate and triglycerides ."
105004,5,O,3653.0,"Venous blood samples were obtained at 30 min intervals for 5 h , and analysed for glucose , insulin , lactate and triglycerides ."
105005,h,O,3653.0,"Venous blood samples were obtained at 30 min intervals for 5 h , and analysed for glucose , insulin , lactate and triglycerides ."
105006,",",O,3653.0,"Venous blood samples were obtained at 30 min intervals for 5 h , and analysed for glucose , insulin , lactate and triglycerides ."
105007,and,O,3653.0,"Venous blood samples were obtained at 30 min intervals for 5 h , and analysed for glucose , insulin , lactate and triglycerides ."
105008,analysed,O,3653.0,"Venous blood samples were obtained at 30 min intervals for 5 h , and analysed for glucose , insulin , lactate and triglycerides ."
105009,for,O,3653.0,"Venous blood samples were obtained at 30 min intervals for 5 h , and analysed for glucose , insulin , lactate and triglycerides ."
105010,glucose,O,3653.0,"Venous blood samples were obtained at 30 min intervals for 5 h , and analysed for glucose , insulin , lactate and triglycerides ."
105011,",",O,3653.0,"Venous blood samples were obtained at 30 min intervals for 5 h , and analysed for glucose , insulin , lactate and triglycerides ."
105012,insulin,O,3653.0,"Venous blood samples were obtained at 30 min intervals for 5 h , and analysed for glucose , insulin , lactate and triglycerides ."
105013,",",O,3653.0,"Venous blood samples were obtained at 30 min intervals for 5 h , and analysed for glucose , insulin , lactate and triglycerides ."
105014,lactate,O,3653.0,"Venous blood samples were obtained at 30 min intervals for 5 h , and analysed for glucose , insulin , lactate and triglycerides ."
105015,and,O,3653.0,"Venous blood samples were obtained at 30 min intervals for 5 h , and analysed for glucose , insulin , lactate and triglycerides ."
105016,triglycerides,O,3653.0,"Venous blood samples were obtained at 30 min intervals for 5 h , and analysed for glucose , insulin , lactate and triglycerides ."
105017,.,O,3653.0,"Venous blood samples were obtained at 30 min intervals for 5 h , and analysed for glucose , insulin , lactate and triglycerides ."
105018,All,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105019,three,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105020,chocolates,B-AG.01.n.17.a,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105021,provoked,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105022,a,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105023,sustained,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105024,rise,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105025,in,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105026,blood,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105027,glucose,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105028,",",O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105029,which,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105030,reached,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105031,a,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105032,maximum,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105033,at,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105034,90,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105035,min,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105036,after,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105037,ingestion,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105038,and,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105039,returned,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105040,to,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105041,baseline,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105042,values,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105043,by,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105044,5,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105045,h.,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105046,The,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105047,highest,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105048,blood,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105049,glucose,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105050,levels,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105051,occurred,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105052,after,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105053,conventional,B-AG.01.n.17.a,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105054,chocolate,I-AG.01.n.17.a,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105055,",",O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105056,and,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105057,differences,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105058,were,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105059,statistically,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105060,significant,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105061,at,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105062,60,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105063,and,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105064,90,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105065,min,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105066,(,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105067,P,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105068,less,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105069,than,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105070,0.05,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105071,),O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105072,.,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105073,The,O,3655.0,"The area under the glycaemic curve for isomalt chocolate was 36 % smaller than that for conventional chocolate ( P less than 0.05 ) , and there were differences in insulin and lactate levels , consistent with the lower glycaemic effect ."
105074,area,O,3655.0,"The area under the glycaemic curve for isomalt chocolate was 36 % smaller than that for conventional chocolate ( P less than 0.05 ) , and there were differences in insulin and lactate levels , consistent with the lower glycaemic effect ."
105075,under,O,3655.0,"The area under the glycaemic curve for isomalt chocolate was 36 % smaller than that for conventional chocolate ( P less than 0.05 ) , and there were differences in insulin and lactate levels , consistent with the lower glycaemic effect ."
105076,the,O,3655.0,"The area under the glycaemic curve for isomalt chocolate was 36 % smaller than that for conventional chocolate ( P less than 0.05 ) , and there were differences in insulin and lactate levels , consistent with the lower glycaemic effect ."
105077,glycaemic,O,3655.0,"The area under the glycaemic curve for isomalt chocolate was 36 % smaller than that for conventional chocolate ( P less than 0.05 ) , and there were differences in insulin and lactate levels , consistent with the lower glycaemic effect ."
105078,curve,O,3655.0,"The area under the glycaemic curve for isomalt chocolate was 36 % smaller than that for conventional chocolate ( P less than 0.05 ) , and there were differences in insulin and lactate levels , consistent with the lower glycaemic effect ."
105079,for,O,3655.0,"The area under the glycaemic curve for isomalt chocolate was 36 % smaller than that for conventional chocolate ( P less than 0.05 ) , and there were differences in insulin and lactate levels , consistent with the lower glycaemic effect ."
105080,isomalt,B-AG.01.n.17.a,3655.0,"The area under the glycaemic curve for isomalt chocolate was 36 % smaller than that for conventional chocolate ( P less than 0.05 ) , and there were differences in insulin and lactate levels , consistent with the lower glycaemic effect ."
105081,chocolate,I-AG.01.n.17.a,3655.0,"The area under the glycaemic curve for isomalt chocolate was 36 % smaller than that for conventional chocolate ( P less than 0.05 ) , and there were differences in insulin and lactate levels , consistent with the lower glycaemic effect ."
105082,was,O,3655.0,"The area under the glycaemic curve for isomalt chocolate was 36 % smaller than that for conventional chocolate ( P less than 0.05 ) , and there were differences in insulin and lactate levels , consistent with the lower glycaemic effect ."
105083,36,O,3655.0,"The area under the glycaemic curve for isomalt chocolate was 36 % smaller than that for conventional chocolate ( P less than 0.05 ) , and there were differences in insulin and lactate levels , consistent with the lower glycaemic effect ."
105084,%,O,3655.0,"The area under the glycaemic curve for isomalt chocolate was 36 % smaller than that for conventional chocolate ( P less than 0.05 ) , and there were differences in insulin and lactate levels , consistent with the lower glycaemic effect ."
105085,smaller,O,3655.0,"The area under the glycaemic curve for isomalt chocolate was 36 % smaller than that for conventional chocolate ( P less than 0.05 ) , and there were differences in insulin and lactate levels , consistent with the lower glycaemic effect ."
105086,than,O,3655.0,"The area under the glycaemic curve for isomalt chocolate was 36 % smaller than that for conventional chocolate ( P less than 0.05 ) , and there were differences in insulin and lactate levels , consistent with the lower glycaemic effect ."
105087,that,O,3655.0,"The area under the glycaemic curve for isomalt chocolate was 36 % smaller than that for conventional chocolate ( P less than 0.05 ) , and there were differences in insulin and lactate levels , consistent with the lower glycaemic effect ."
105088,for,O,3655.0,"The area under the glycaemic curve for isomalt chocolate was 36 % smaller than that for conventional chocolate ( P less than 0.05 ) , and there were differences in insulin and lactate levels , consistent with the lower glycaemic effect ."
105089,conventional,B-AG.01.n.17.a,3655.0,"The area under the glycaemic curve for isomalt chocolate was 36 % smaller than that for conventional chocolate ( P less than 0.05 ) , and there were differences in insulin and lactate levels , consistent with the lower glycaemic effect ."
105090,chocolate,I-AG.01.n.17.a,3655.0,"The area under the glycaemic curve for isomalt chocolate was 36 % smaller than that for conventional chocolate ( P less than 0.05 ) , and there were differences in insulin and lactate levels , consistent with the lower glycaemic effect ."
105091,(,O,3655.0,"The area under the glycaemic curve for isomalt chocolate was 36 % smaller than that for conventional chocolate ( P less than 0.05 ) , and there were differences in insulin and lactate levels , consistent with the lower glycaemic effect ."
105092,P,O,3655.0,"The area under the glycaemic curve for isomalt chocolate was 36 % smaller than that for conventional chocolate ( P less than 0.05 ) , and there were differences in insulin and lactate levels , consistent with the lower glycaemic effect ."
105093,less,O,3655.0,"The area under the glycaemic curve for isomalt chocolate was 36 % smaller than that for conventional chocolate ( P less than 0.05 ) , and there were differences in insulin and lactate levels , consistent with the lower glycaemic effect ."
105094,than,O,3655.0,"The area under the glycaemic curve for isomalt chocolate was 36 % smaller than that for conventional chocolate ( P less than 0.05 ) , and there were differences in insulin and lactate levels , consistent with the lower glycaemic effect ."
105095,0.05,O,3655.0,"The area under the glycaemic curve for isomalt chocolate was 36 % smaller than that for conventional chocolate ( P less than 0.05 ) , and there were differences in insulin and lactate levels , consistent with the lower glycaemic effect ."
105096,),O,3655.0,"The area under the glycaemic curve for isomalt chocolate was 36 % smaller than that for conventional chocolate ( P less than 0.05 ) , and there were differences in insulin and lactate levels , consistent with the lower glycaemic effect ."
105097,",",O,3655.0,"The area under the glycaemic curve for isomalt chocolate was 36 % smaller than that for conventional chocolate ( P less than 0.05 ) , and there were differences in insulin and lactate levels , consistent with the lower glycaemic effect ."
105098,and,O,3655.0,"The area under the glycaemic curve for isomalt chocolate was 36 % smaller than that for conventional chocolate ( P less than 0.05 ) , and there were differences in insulin and lactate levels , consistent with the lower glycaemic effect ."
105099,there,O,3655.0,"The area under the glycaemic curve for isomalt chocolate was 36 % smaller than that for conventional chocolate ( P less than 0.05 ) , and there were differences in insulin and lactate levels , consistent with the lower glycaemic effect ."
105100,were,O,3655.0,"The area under the glycaemic curve for isomalt chocolate was 36 % smaller than that for conventional chocolate ( P less than 0.05 ) , and there were differences in insulin and lactate levels , consistent with the lower glycaemic effect ."
105101,differences,O,3655.0,"The area under the glycaemic curve for isomalt chocolate was 36 % smaller than that for conventional chocolate ( P less than 0.05 ) , and there were differences in insulin and lactate levels , consistent with the lower glycaemic effect ."
105102,in,O,3655.0,"The area under the glycaemic curve for isomalt chocolate was 36 % smaller than that for conventional chocolate ( P less than 0.05 ) , and there were differences in insulin and lactate levels , consistent with the lower glycaemic effect ."
105103,insulin,O,3655.0,"The area under the glycaemic curve for isomalt chocolate was 36 % smaller than that for conventional chocolate ( P less than 0.05 ) , and there were differences in insulin and lactate levels , consistent with the lower glycaemic effect ."
105104,and,O,3655.0,"The area under the glycaemic curve for isomalt chocolate was 36 % smaller than that for conventional chocolate ( P less than 0.05 ) , and there were differences in insulin and lactate levels , consistent with the lower glycaemic effect ."
105105,lactate,O,3655.0,"The area under the glycaemic curve for isomalt chocolate was 36 % smaller than that for conventional chocolate ( P less than 0.05 ) , and there were differences in insulin and lactate levels , consistent with the lower glycaemic effect ."
105106,levels,O,3655.0,"The area under the glycaemic curve for isomalt chocolate was 36 % smaller than that for conventional chocolate ( P less than 0.05 ) , and there were differences in insulin and lactate levels , consistent with the lower glycaemic effect ."
105107,",",O,3655.0,"The area under the glycaemic curve for isomalt chocolate was 36 % smaller than that for conventional chocolate ( P less than 0.05 ) , and there were differences in insulin and lactate levels , consistent with the lower glycaemic effect ."
105108,consistent,O,3655.0,"The area under the glycaemic curve for isomalt chocolate was 36 % smaller than that for conventional chocolate ( P less than 0.05 ) , and there were differences in insulin and lactate levels , consistent with the lower glycaemic effect ."
105109,with,O,3655.0,"The area under the glycaemic curve for isomalt chocolate was 36 % smaller than that for conventional chocolate ( P less than 0.05 ) , and there were differences in insulin and lactate levels , consistent with the lower glycaemic effect ."
105110,the,O,3655.0,"The area under the glycaemic curve for isomalt chocolate was 36 % smaller than that for conventional chocolate ( P less than 0.05 ) , and there were differences in insulin and lactate levels , consistent with the lower glycaemic effect ."
105111,lower,O,3655.0,"The area under the glycaemic curve for isomalt chocolate was 36 % smaller than that for conventional chocolate ( P less than 0.05 ) , and there were differences in insulin and lactate levels , consistent with the lower glycaemic effect ."
105112,glycaemic,O,3655.0,"The area under the glycaemic curve for isomalt chocolate was 36 % smaller than that for conventional chocolate ( P less than 0.05 ) , and there were differences in insulin and lactate levels , consistent with the lower glycaemic effect ."
105113,effect,O,3655.0,"The area under the glycaemic curve for isomalt chocolate was 36 % smaller than that for conventional chocolate ( P less than 0.05 ) , and there were differences in insulin and lactate levels , consistent with the lower glycaemic effect ."
105114,.,O,3655.0,"The area under the glycaemic curve for isomalt chocolate was 36 % smaller than that for conventional chocolate ( P less than 0.05 ) , and there were differences in insulin and lactate levels , consistent with the lower glycaemic effect ."
105115,The,O,3656.0,The glycaemic response to the fructose - based chocolate was also lower than that to control chocolate but the difference was not significant .
105116,glycaemic,O,3656.0,The glycaemic response to the fructose - based chocolate was also lower than that to control chocolate but the difference was not significant .
105117,response,O,3656.0,The glycaemic response to the fructose - based chocolate was also lower than that to control chocolate but the difference was not significant .
105118,to,O,3656.0,The glycaemic response to the fructose - based chocolate was also lower than that to control chocolate but the difference was not significant .
105119,the,O,3656.0,The glycaemic response to the fructose - based chocolate was also lower than that to control chocolate but the difference was not significant .
105120,fructose,B-AG.01.n.17.a,3656.0,The glycaemic response to the fructose - based chocolate was also lower than that to control chocolate but the difference was not significant .
105121,-,I-AG.01.n.17.a,3656.0,The glycaemic response to the fructose - based chocolate was also lower than that to control chocolate but the difference was not significant .
105122,based,I-AG.01.n.17.a,3656.0,The glycaemic response to the fructose - based chocolate was also lower than that to control chocolate but the difference was not significant .
105123,chocolate,I-AG.01.n.17.a,3656.0,The glycaemic response to the fructose - based chocolate was also lower than that to control chocolate but the difference was not significant .
105124,was,O,3656.0,The glycaemic response to the fructose - based chocolate was also lower than that to control chocolate but the difference was not significant .
105125,also,O,3656.0,The glycaemic response to the fructose - based chocolate was also lower than that to control chocolate but the difference was not significant .
105126,lower,O,3656.0,The glycaemic response to the fructose - based chocolate was also lower than that to control chocolate but the difference was not significant .
105127,than,O,3656.0,The glycaemic response to the fructose - based chocolate was also lower than that to control chocolate but the difference was not significant .
105128,that,O,3656.0,The glycaemic response to the fructose - based chocolate was also lower than that to control chocolate but the difference was not significant .
105129,to,O,3656.0,The glycaemic response to the fructose - based chocolate was also lower than that to control chocolate but the difference was not significant .
105130,control,O,3656.0,The glycaemic response to the fructose - based chocolate was also lower than that to control chocolate but the difference was not significant .
105131,chocolate,B-AG.01.n.17.a,3656.0,The glycaemic response to the fructose - based chocolate was also lower than that to control chocolate but the difference was not significant .
105132,but,O,3656.0,The glycaemic response to the fructose - based chocolate was also lower than that to control chocolate but the difference was not significant .
105133,the,O,3656.0,The glycaemic response to the fructose - based chocolate was also lower than that to control chocolate but the difference was not significant .
105134,difference,O,3656.0,The glycaemic response to the fructose - based chocolate was also lower than that to control chocolate but the difference was not significant .
105135,was,O,3656.0,The glycaemic response to the fructose - based chocolate was also lower than that to control chocolate but the difference was not significant .
105136,not,O,3656.0,The glycaemic response to the fructose - based chocolate was also lower than that to control chocolate but the difference was not significant .
105137,significant,O,3656.0,The glycaemic response to the fructose - based chocolate was also lower than that to control chocolate but the difference was not significant .
105138,.,O,3656.0,The glycaemic response to the fructose - based chocolate was also lower than that to control chocolate but the difference was not significant .
105139,All,O,3657.0,All three chocolates led to a similar sustained rise in serum triglyceride levels .
105140,three,O,3657.0,All three chocolates led to a similar sustained rise in serum triglyceride levels .
105141,chocolates,B-AG.01.n.17.a,3657.0,All three chocolates led to a similar sustained rise in serum triglyceride levels .
105142,led,O,3657.0,All three chocolates led to a similar sustained rise in serum triglyceride levels .
105143,to,O,3657.0,All three chocolates led to a similar sustained rise in serum triglyceride levels .
105144,a,O,3657.0,All three chocolates led to a similar sustained rise in serum triglyceride levels .
105145,similar,O,3657.0,All three chocolates led to a similar sustained rise in serum triglyceride levels .
105146,sustained,O,3657.0,All three chocolates led to a similar sustained rise in serum triglyceride levels .
105147,rise,O,3657.0,All three chocolates led to a similar sustained rise in serum triglyceride levels .
105148,in,O,3657.0,All three chocolates led to a similar sustained rise in serum triglyceride levels .
105149,serum,O,3657.0,All three chocolates led to a similar sustained rise in serum triglyceride levels .
105150,triglyceride,O,3657.0,All three chocolates led to a similar sustained rise in serum triglyceride levels .
105151,levels,O,3657.0,All three chocolates led to a similar sustained rise in serum triglyceride levels .
105152,.,O,3657.0,All three chocolates led to a similar sustained rise in serum triglyceride levels .
105153,Isomalt,O,3658.0,Isomalt appears to be a palatable alternative sweetener capable of reducing the glycaemic effect of diabetic confectionary .
105154,appears,O,3658.0,Isomalt appears to be a palatable alternative sweetener capable of reducing the glycaemic effect of diabetic confectionary .
105155,to,O,3658.0,Isomalt appears to be a palatable alternative sweetener capable of reducing the glycaemic effect of diabetic confectionary .
105156,be,O,3658.0,Isomalt appears to be a palatable alternative sweetener capable of reducing the glycaemic effect of diabetic confectionary .
105157,a,O,3658.0,Isomalt appears to be a palatable alternative sweetener capable of reducing the glycaemic effect of diabetic confectionary .
105158,palatable,O,3658.0,Isomalt appears to be a palatable alternative sweetener capable of reducing the glycaemic effect of diabetic confectionary .
105159,alternative,O,3658.0,Isomalt appears to be a palatable alternative sweetener capable of reducing the glycaemic effect of diabetic confectionary .
105160,sweetener,B-AG.01.l.02,3658.0,Isomalt appears to be a palatable alternative sweetener capable of reducing the glycaemic effect of diabetic confectionary .
105161,capable,O,3658.0,Isomalt appears to be a palatable alternative sweetener capable of reducing the glycaemic effect of diabetic confectionary .
105162,of,O,3658.0,Isomalt appears to be a palatable alternative sweetener capable of reducing the glycaemic effect of diabetic confectionary .
105163,reducing,O,3658.0,Isomalt appears to be a palatable alternative sweetener capable of reducing the glycaemic effect of diabetic confectionary .
105164,the,O,3658.0,Isomalt appears to be a palatable alternative sweetener capable of reducing the glycaemic effect of diabetic confectionary .
105165,glycaemic,O,3658.0,Isomalt appears to be a palatable alternative sweetener capable of reducing the glycaemic effect of diabetic confectionary .
105166,effect,O,3658.0,Isomalt appears to be a palatable alternative sweetener capable of reducing the glycaemic effect of diabetic confectionary .
105167,of,O,3658.0,Isomalt appears to be a palatable alternative sweetener capable of reducing the glycaemic effect of diabetic confectionary .
105168,diabetic,O,3658.0,Isomalt appears to be a palatable alternative sweetener capable of reducing the glycaemic effect of diabetic confectionary .
105169,confectionary,O,3658.0,Isomalt appears to be a palatable alternative sweetener capable of reducing the glycaemic effect of diabetic confectionary .
105170,.,O,3658.0,Isomalt appears to be a palatable alternative sweetener capable of reducing the glycaemic effect of diabetic confectionary .
105171,A,O,3659.0,A lower - than - recommended potassium intake is a well - established risk factor for increased blood pressure .
105172,lower,O,3659.0,A lower - than - recommended potassium intake is a well - established risk factor for increased blood pressure .
105173,-,O,3659.0,A lower - than - recommended potassium intake is a well - established risk factor for increased blood pressure .
105174,than,O,3659.0,A lower - than - recommended potassium intake is a well - established risk factor for increased blood pressure .
105175,-,O,3659.0,A lower - than - recommended potassium intake is a well - established risk factor for increased blood pressure .
105176,recommended,O,3659.0,A lower - than - recommended potassium intake is a well - established risk factor for increased blood pressure .
105177,potassium,O,3659.0,A lower - than - recommended potassium intake is a well - established risk factor for increased blood pressure .
105178,intake,O,3659.0,A lower - than - recommended potassium intake is a well - established risk factor for increased blood pressure .
105179,is,O,3659.0,A lower - than - recommended potassium intake is a well - established risk factor for increased blood pressure .
105180,a,O,3659.0,A lower - than - recommended potassium intake is a well - established risk factor for increased blood pressure .
105181,well,O,3659.0,A lower - than - recommended potassium intake is a well - established risk factor for increased blood pressure .
105182,-,O,3659.0,A lower - than - recommended potassium intake is a well - established risk factor for increased blood pressure .
105183,established,O,3659.0,A lower - than - recommended potassium intake is a well - established risk factor for increased blood pressure .
105184,risk,O,3659.0,A lower - than - recommended potassium intake is a well - established risk factor for increased blood pressure .
105185,factor,O,3659.0,A lower - than - recommended potassium intake is a well - established risk factor for increased blood pressure .
105186,for,O,3659.0,A lower - than - recommended potassium intake is a well - established risk factor for increased blood pressure .
105187,increased,O,3659.0,A lower - than - recommended potassium intake is a well - established risk factor for increased blood pressure .
105188,blood,O,3659.0,A lower - than - recommended potassium intake is a well - established risk factor for increased blood pressure .
105189,pressure,O,3659.0,A lower - than - recommended potassium intake is a well - established risk factor for increased blood pressure .
105190,.,O,3659.0,A lower - than - recommended potassium intake is a well - established risk factor for increased blood pressure .
105191,Although,O,3660.0,"Although the Japanese diet is associated with higher sodium intake and lower potassium intake , few studies have examined the source foods quantitatively ."
105192,the,O,3660.0,"Although the Japanese diet is associated with higher sodium intake and lower potassium intake , few studies have examined the source foods quantitatively ."
105193,Japanese,O,3660.0,"Although the Japanese diet is associated with higher sodium intake and lower potassium intake , few studies have examined the source foods quantitatively ."
105194,diet,O,3660.0,"Although the Japanese diet is associated with higher sodium intake and lower potassium intake , few studies have examined the source foods quantitatively ."
105195,is,O,3660.0,"Although the Japanese diet is associated with higher sodium intake and lower potassium intake , few studies have examined the source foods quantitatively ."
105196,associated,O,3660.0,"Although the Japanese diet is associated with higher sodium intake and lower potassium intake , few studies have examined the source foods quantitatively ."
105197,with,O,3660.0,"Although the Japanese diet is associated with higher sodium intake and lower potassium intake , few studies have examined the source foods quantitatively ."
105198,higher,O,3660.0,"Although the Japanese diet is associated with higher sodium intake and lower potassium intake , few studies have examined the source foods quantitatively ."
105199,sodium,O,3660.0,"Although the Japanese diet is associated with higher sodium intake and lower potassium intake , few studies have examined the source foods quantitatively ."
105200,intake,O,3660.0,"Although the Japanese diet is associated with higher sodium intake and lower potassium intake , few studies have examined the source foods quantitatively ."
105201,and,O,3660.0,"Although the Japanese diet is associated with higher sodium intake and lower potassium intake , few studies have examined the source foods quantitatively ."
105202,lower,O,3660.0,"Although the Japanese diet is associated with higher sodium intake and lower potassium intake , few studies have examined the source foods quantitatively ."
105203,potassium,O,3660.0,"Although the Japanese diet is associated with higher sodium intake and lower potassium intake , few studies have examined the source foods quantitatively ."
105204,intake,O,3660.0,"Although the Japanese diet is associated with higher sodium intake and lower potassium intake , few studies have examined the source foods quantitatively ."
105205,",",O,3660.0,"Although the Japanese diet is associated with higher sodium intake and lower potassium intake , few studies have examined the source foods quantitatively ."
105206,few,O,3660.0,"Although the Japanese diet is associated with higher sodium intake and lower potassium intake , few studies have examined the source foods quantitatively ."
105207,studies,O,3660.0,"Although the Japanese diet is associated with higher sodium intake and lower potassium intake , few studies have examined the source foods quantitatively ."
105208,have,O,3660.0,"Although the Japanese diet is associated with higher sodium intake and lower potassium intake , few studies have examined the source foods quantitatively ."
105209,examined,O,3660.0,"Although the Japanese diet is associated with higher sodium intake and lower potassium intake , few studies have examined the source foods quantitatively ."
105210,the,O,3660.0,"Although the Japanese diet is associated with higher sodium intake and lower potassium intake , few studies have examined the source foods quantitatively ."
105211,source,O,3660.0,"Although the Japanese diet is associated with higher sodium intake and lower potassium intake , few studies have examined the source foods quantitatively ."
105212,foods,O,3660.0,"Although the Japanese diet is associated with higher sodium intake and lower potassium intake , few studies have examined the source foods quantitatively ."
105213,quantitatively,O,3660.0,"Although the Japanese diet is associated with higher sodium intake and lower potassium intake , few studies have examined the source foods quantitatively ."
105214,.,O,3660.0,"Although the Japanese diet is associated with higher sodium intake and lower potassium intake , few studies have examined the source foods quantitatively ."
105215,Studies,O,3661.0,Studies on dietary patterns in association with potassium intake will be useful to provide dietary advice to increase potassium intake .
105216,on,O,3661.0,Studies on dietary patterns in association with potassium intake will be useful to provide dietary advice to increase potassium intake .
105217,dietary,O,3661.0,Studies on dietary patterns in association with potassium intake will be useful to provide dietary advice to increase potassium intake .
105218,patterns,O,3661.0,Studies on dietary patterns in association with potassium intake will be useful to provide dietary advice to increase potassium intake .
105219,in,O,3661.0,Studies on dietary patterns in association with potassium intake will be useful to provide dietary advice to increase potassium intake .
105220,association,O,3661.0,Studies on dietary patterns in association with potassium intake will be useful to provide dietary advice to increase potassium intake .
105221,with,O,3661.0,Studies on dietary patterns in association with potassium intake will be useful to provide dietary advice to increase potassium intake .
105222,potassium,O,3661.0,Studies on dietary patterns in association with potassium intake will be useful to provide dietary advice to increase potassium intake .
105223,intake,O,3661.0,Studies on dietary patterns in association with potassium intake will be useful to provide dietary advice to increase potassium intake .
105224,will,O,3661.0,Studies on dietary patterns in association with potassium intake will be useful to provide dietary advice to increase potassium intake .
105225,be,O,3661.0,Studies on dietary patterns in association with potassium intake will be useful to provide dietary advice to increase potassium intake .
105226,useful,O,3661.0,Studies on dietary patterns in association with potassium intake will be useful to provide dietary advice to increase potassium intake .
105227,to,O,3661.0,Studies on dietary patterns in association with potassium intake will be useful to provide dietary advice to increase potassium intake .
105228,provide,O,3661.0,Studies on dietary patterns in association with potassium intake will be useful to provide dietary advice to increase potassium intake .
105229,dietary,O,3661.0,Studies on dietary patterns in association with potassium intake will be useful to provide dietary advice to increase potassium intake .
105230,advice,O,3661.0,Studies on dietary patterns in association with potassium intake will be useful to provide dietary advice to increase potassium intake .
105231,to,O,3661.0,Studies on dietary patterns in association with potassium intake will be useful to provide dietary advice to increase potassium intake .
105232,increase,O,3661.0,Studies on dietary patterns in association with potassium intake will be useful to provide dietary advice to increase potassium intake .
105233,potassium,O,3661.0,Studies on dietary patterns in association with potassium intake will be useful to provide dietary advice to increase potassium intake .
105234,intake,O,3661.0,Studies on dietary patterns in association with potassium intake will be useful to provide dietary advice to increase potassium intake .
105235,.,O,3661.0,Studies on dietary patterns in association with potassium intake will be useful to provide dietary advice to increase potassium intake .
105236,Twenty,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105237,-,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105238,four,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105239,-,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105240,hour,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105241,(,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105242,hr,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105243,),O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105244,dietary,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105245,recall,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105246,data,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105247,and,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105248,24,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105249,-,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105250,hr,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105251,urinary,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105252,potassium,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105253,excretion,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105254,data,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105255,from,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105256,Japanese,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105257,participants,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105258,(,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105259,574,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105260,men,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105261,and,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105262,571,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105263,women,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105264,),O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105265,in,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105266,the,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105267,International,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105268,Study,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105269,of,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105270,Macro,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105271,/,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105272,Micronutrients,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105273,and,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105274,Blood,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105275,Pressure,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105276,(,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105277,INTERMAP,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105278,),O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105279,were,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105280,used,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105281,to,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105282,calculate,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105283,food,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105284,sources,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105285,of,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105286,potassium,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105287,and,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105288,compare,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105289,food,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105290,consumption,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105291,patterns,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105292,among,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105293,quartiles,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105294,of,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105295,participants,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105296,categorized,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105297,according,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105298,to,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105299,24,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105300,-,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105301,hr,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105302,urinary,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105303,potassium,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105304,excretion,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105305,per,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105306,unit,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105307,of,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105308,body,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105309,weight,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105310,(,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105311,UK,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105312,/,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105313,BW,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105314,),O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105315,.,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105316,The,O,3663.0,"The average potassium intake was 2791 mg / day per participant , and the major sources were vegetables and fruits ( 1262 mg / day ) , fish ( 333 mg / day ) , coffee and tea ( 206 mg / day ) , and milk and dairy products ( 200 mg / day ) ."
105317,average,O,3663.0,"The average potassium intake was 2791 mg / day per participant , and the major sources were vegetables and fruits ( 1262 mg / day ) , fish ( 333 mg / day ) , coffee and tea ( 206 mg / day ) , and milk and dairy products ( 200 mg / day ) ."
105318,potassium,O,3663.0,"The average potassium intake was 2791 mg / day per participant , and the major sources were vegetables and fruits ( 1262 mg / day ) , fish ( 333 mg / day ) , coffee and tea ( 206 mg / day ) , and milk and dairy products ( 200 mg / day ) ."
105319,intake,O,3663.0,"The average potassium intake was 2791 mg / day per participant , and the major sources were vegetables and fruits ( 1262 mg / day ) , fish ( 333 mg / day ) , coffee and tea ( 206 mg / day ) , and milk and dairy products ( 200 mg / day ) ."
105320,was,O,3663.0,"The average potassium intake was 2791 mg / day per participant , and the major sources were vegetables and fruits ( 1262 mg / day ) , fish ( 333 mg / day ) , coffee and tea ( 206 mg / day ) , and milk and dairy products ( 200 mg / day ) ."
105321,2791,O,3663.0,"The average potassium intake was 2791 mg / day per participant , and the major sources were vegetables and fruits ( 1262 mg / day ) , fish ( 333 mg / day ) , coffee and tea ( 206 mg / day ) , and milk and dairy products ( 200 mg / day ) ."
105322,mg,O,3663.0,"The average potassium intake was 2791 mg / day per participant , and the major sources were vegetables and fruits ( 1262 mg / day ) , fish ( 333 mg / day ) , coffee and tea ( 206 mg / day ) , and milk and dairy products ( 200 mg / day ) ."
105323,/,O,3663.0,"The average potassium intake was 2791 mg / day per participant , and the major sources were vegetables and fruits ( 1262 mg / day ) , fish ( 333 mg / day ) , coffee and tea ( 206 mg / day ) , and milk and dairy products ( 200 mg / day ) ."
105324,day,O,3663.0,"The average potassium intake was 2791 mg / day per participant , and the major sources were vegetables and fruits ( 1262 mg / day ) , fish ( 333 mg / day ) , coffee and tea ( 206 mg / day ) , and milk and dairy products ( 200 mg / day ) ."
105325,per,O,3663.0,"The average potassium intake was 2791 mg / day per participant , and the major sources were vegetables and fruits ( 1262 mg / day ) , fish ( 333 mg / day ) , coffee and tea ( 206 mg / day ) , and milk and dairy products ( 200 mg / day ) ."
105326,participant,O,3663.0,"The average potassium intake was 2791 mg / day per participant , and the major sources were vegetables and fruits ( 1262 mg / day ) , fish ( 333 mg / day ) , coffee and tea ( 206 mg / day ) , and milk and dairy products ( 200 mg / day ) ."
105327,",",O,3663.0,"The average potassium intake was 2791 mg / day per participant , and the major sources were vegetables and fruits ( 1262 mg / day ) , fish ( 333 mg / day ) , coffee and tea ( 206 mg / day ) , and milk and dairy products ( 200 mg / day ) ."
105328,and,O,3663.0,"The average potassium intake was 2791 mg / day per participant , and the major sources were vegetables and fruits ( 1262 mg / day ) , fish ( 333 mg / day ) , coffee and tea ( 206 mg / day ) , and milk and dairy products ( 200 mg / day ) ."
105329,the,O,3663.0,"The average potassium intake was 2791 mg / day per participant , and the major sources were vegetables and fruits ( 1262 mg / day ) , fish ( 333 mg / day ) , coffee and tea ( 206 mg / day ) , and milk and dairy products ( 200 mg / day ) ."
105330,major,O,3663.0,"The average potassium intake was 2791 mg / day per participant , and the major sources were vegetables and fruits ( 1262 mg / day ) , fish ( 333 mg / day ) , coffee and tea ( 206 mg / day ) , and milk and dairy products ( 200 mg / day ) ."
105331,sources,O,3663.0,"The average potassium intake was 2791 mg / day per participant , and the major sources were vegetables and fruits ( 1262 mg / day ) , fish ( 333 mg / day ) , coffee and tea ( 206 mg / day ) , and milk and dairy products ( 200 mg / day ) ."
105332,were,O,3663.0,"The average potassium intake was 2791 mg / day per participant , and the major sources were vegetables and fruits ( 1262 mg / day ) , fish ( 333 mg / day ) , coffee and tea ( 206 mg / day ) , and milk and dairy products ( 200 mg / day ) ."
105333,vegetables,B-AG.01.h,3663.0,"The average potassium intake was 2791 mg / day per participant , and the major sources were vegetables and fruits ( 1262 mg / day ) , fish ( 333 mg / day ) , coffee and tea ( 206 mg / day ) , and milk and dairy products ( 200 mg / day ) ."
105334,and,I-AG.01.h,3663.0,"The average potassium intake was 2791 mg / day per participant , and the major sources were vegetables and fruits ( 1262 mg / day ) , fish ( 333 mg / day ) , coffee and tea ( 206 mg / day ) , and milk and dairy products ( 200 mg / day ) ."
105335,fruits,I-AG.01.h,3663.0,"The average potassium intake was 2791 mg / day per participant , and the major sources were vegetables and fruits ( 1262 mg / day ) , fish ( 333 mg / day ) , coffee and tea ( 206 mg / day ) , and milk and dairy products ( 200 mg / day ) ."
105336,(,O,3663.0,"The average potassium intake was 2791 mg / day per participant , and the major sources were vegetables and fruits ( 1262 mg / day ) , fish ( 333 mg / day ) , coffee and tea ( 206 mg / day ) , and milk and dairy products ( 200 mg / day ) ."
105337,1262,O,3663.0,"The average potassium intake was 2791 mg / day per participant , and the major sources were vegetables and fruits ( 1262 mg / day ) , fish ( 333 mg / day ) , coffee and tea ( 206 mg / day ) , and milk and dairy products ( 200 mg / day ) ."
105338,mg,O,3663.0,"The average potassium intake was 2791 mg / day per participant , and the major sources were vegetables and fruits ( 1262 mg / day ) , fish ( 333 mg / day ) , coffee and tea ( 206 mg / day ) , and milk and dairy products ( 200 mg / day ) ."
105339,/,O,3663.0,"The average potassium intake was 2791 mg / day per participant , and the major sources were vegetables and fruits ( 1262 mg / day ) , fish ( 333 mg / day ) , coffee and tea ( 206 mg / day ) , and milk and dairy products ( 200 mg / day ) ."
105340,day,O,3663.0,"The average potassium intake was 2791 mg / day per participant , and the major sources were vegetables and fruits ( 1262 mg / day ) , fish ( 333 mg / day ) , coffee and tea ( 206 mg / day ) , and milk and dairy products ( 200 mg / day ) ."
105341,),O,3663.0,"The average potassium intake was 2791 mg / day per participant , and the major sources were vegetables and fruits ( 1262 mg / day ) , fish ( 333 mg / day ) , coffee and tea ( 206 mg / day ) , and milk and dairy products ( 200 mg / day ) ."
105342,",",O,3663.0,"The average potassium intake was 2791 mg / day per participant , and the major sources were vegetables and fruits ( 1262 mg / day ) , fish ( 333 mg / day ) , coffee and tea ( 206 mg / day ) , and milk and dairy products ( 200 mg / day ) ."
105343,fish,B-AG.01.d.07,3663.0,"The average potassium intake was 2791 mg / day per participant , and the major sources were vegetables and fruits ( 1262 mg / day ) , fish ( 333 mg / day ) , coffee and tea ( 206 mg / day ) , and milk and dairy products ( 200 mg / day ) ."
105344,(,O,3663.0,"The average potassium intake was 2791 mg / day per participant , and the major sources were vegetables and fruits ( 1262 mg / day ) , fish ( 333 mg / day ) , coffee and tea ( 206 mg / day ) , and milk and dairy products ( 200 mg / day ) ."
105345,333,O,3663.0,"The average potassium intake was 2791 mg / day per participant , and the major sources were vegetables and fruits ( 1262 mg / day ) , fish ( 333 mg / day ) , coffee and tea ( 206 mg / day ) , and milk and dairy products ( 200 mg / day ) ."
105346,mg,O,3663.0,"The average potassium intake was 2791 mg / day per participant , and the major sources were vegetables and fruits ( 1262 mg / day ) , fish ( 333 mg / day ) , coffee and tea ( 206 mg / day ) , and milk and dairy products ( 200 mg / day ) ."
105347,/,O,3663.0,"The average potassium intake was 2791 mg / day per participant , and the major sources were vegetables and fruits ( 1262 mg / day ) , fish ( 333 mg / day ) , coffee and tea ( 206 mg / day ) , and milk and dairy products ( 200 mg / day ) ."
105348,day,O,3663.0,"The average potassium intake was 2791 mg / day per participant , and the major sources were vegetables and fruits ( 1262 mg / day ) , fish ( 333 mg / day ) , coffee and tea ( 206 mg / day ) , and milk and dairy products ( 200 mg / day ) ."
105349,),O,3663.0,"The average potassium intake was 2791 mg / day per participant , and the major sources were vegetables and fruits ( 1262 mg / day ) , fish ( 333 mg / day ) , coffee and tea ( 206 mg / day ) , and milk and dairy products ( 200 mg / day ) ."
105350,",",O,3663.0,"The average potassium intake was 2791 mg / day per participant , and the major sources were vegetables and fruits ( 1262 mg / day ) , fish ( 333 mg / day ) , coffee and tea ( 206 mg / day ) , and milk and dairy products ( 200 mg / day ) ."
105351,coffee,B-AG.01.ad,3663.0,"The average potassium intake was 2791 mg / day per participant , and the major sources were vegetables and fruits ( 1262 mg / day ) , fish ( 333 mg / day ) , coffee and tea ( 206 mg / day ) , and milk and dairy products ( 200 mg / day ) ."
105352,and,O,3663.0,"The average potassium intake was 2791 mg / day per participant , and the major sources were vegetables and fruits ( 1262 mg / day ) , fish ( 333 mg / day ) , coffee and tea ( 206 mg / day ) , and milk and dairy products ( 200 mg / day ) ."
105353,tea,B-AG.01.ac,3663.0,"The average potassium intake was 2791 mg / day per participant , and the major sources were vegetables and fruits ( 1262 mg / day ) , fish ( 333 mg / day ) , coffee and tea ( 206 mg / day ) , and milk and dairy products ( 200 mg / day ) ."
105354,(,O,3663.0,"The average potassium intake was 2791 mg / day per participant , and the major sources were vegetables and fruits ( 1262 mg / day ) , fish ( 333 mg / day ) , coffee and tea ( 206 mg / day ) , and milk and dairy products ( 200 mg / day ) ."
105355,206,O,3663.0,"The average potassium intake was 2791 mg / day per participant , and the major sources were vegetables and fruits ( 1262 mg / day ) , fish ( 333 mg / day ) , coffee and tea ( 206 mg / day ) , and milk and dairy products ( 200 mg / day ) ."
105356,mg,O,3663.0,"The average potassium intake was 2791 mg / day per participant , and the major sources were vegetables and fruits ( 1262 mg / day ) , fish ( 333 mg / day ) , coffee and tea ( 206 mg / day ) , and milk and dairy products ( 200 mg / day ) ."
105357,/,O,3663.0,"The average potassium intake was 2791 mg / day per participant , and the major sources were vegetables and fruits ( 1262 mg / day ) , fish ( 333 mg / day ) , coffee and tea ( 206 mg / day ) , and milk and dairy products ( 200 mg / day ) ."
105358,day,O,3663.0,"The average potassium intake was 2791 mg / day per participant , and the major sources were vegetables and fruits ( 1262 mg / day ) , fish ( 333 mg / day ) , coffee and tea ( 206 mg / day ) , and milk and dairy products ( 200 mg / day ) ."
105359,),O,3663.0,"The average potassium intake was 2791 mg / day per participant , and the major sources were vegetables and fruits ( 1262 mg / day ) , fish ( 333 mg / day ) , coffee and tea ( 206 mg / day ) , and milk and dairy products ( 200 mg / day ) ."
105360,",",O,3663.0,"The average potassium intake was 2791 mg / day per participant , and the major sources were vegetables and fruits ( 1262 mg / day ) , fish ( 333 mg / day ) , coffee and tea ( 206 mg / day ) , and milk and dairy products ( 200 mg / day ) ."
105361,and,O,3663.0,"The average potassium intake was 2791 mg / day per participant , and the major sources were vegetables and fruits ( 1262 mg / day ) , fish ( 333 mg / day ) , coffee and tea ( 206 mg / day ) , and milk and dairy products ( 200 mg / day ) ."
105362,milk,B-AG.01.e,3663.0,"The average potassium intake was 2791 mg / day per participant , and the major sources were vegetables and fruits ( 1262 mg / day ) , fish ( 333 mg / day ) , coffee and tea ( 206 mg / day ) , and milk and dairy products ( 200 mg / day ) ."
105363,and,O,3663.0,"The average potassium intake was 2791 mg / day per participant , and the major sources were vegetables and fruits ( 1262 mg / day ) , fish ( 333 mg / day ) , coffee and tea ( 206 mg / day ) , and milk and dairy products ( 200 mg / day ) ."
105364,dairy,B-AG.01.e,3663.0,"The average potassium intake was 2791 mg / day per participant , and the major sources were vegetables and fruits ( 1262 mg / day ) , fish ( 333 mg / day ) , coffee and tea ( 206 mg / day ) , and milk and dairy products ( 200 mg / day ) ."
105365,products,I-AG.01.e,3663.0,"The average potassium intake was 2791 mg / day per participant , and the major sources were vegetables and fruits ( 1262 mg / day ) , fish ( 333 mg / day ) , coffee and tea ( 206 mg / day ) , and milk and dairy products ( 200 mg / day ) ."
105366,(,O,3663.0,"The average potassium intake was 2791 mg / day per participant , and the major sources were vegetables and fruits ( 1262 mg / day ) , fish ( 333 mg / day ) , coffee and tea ( 206 mg / day ) , and milk and dairy products ( 200 mg / day ) ."
105367,200,O,3663.0,"The average potassium intake was 2791 mg / day per participant , and the major sources were vegetables and fruits ( 1262 mg / day ) , fish ( 333 mg / day ) , coffee and tea ( 206 mg / day ) , and milk and dairy products ( 200 mg / day ) ."
105368,mg,O,3663.0,"The average potassium intake was 2791 mg / day per participant , and the major sources were vegetables and fruits ( 1262 mg / day ) , fish ( 333 mg / day ) , coffee and tea ( 206 mg / day ) , and milk and dairy products ( 200 mg / day ) ."
105369,/,O,3663.0,"The average potassium intake was 2791 mg / day per participant , and the major sources were vegetables and fruits ( 1262 mg / day ) , fish ( 333 mg / day ) , coffee and tea ( 206 mg / day ) , and milk and dairy products ( 200 mg / day ) ."
105370,day,O,3663.0,"The average potassium intake was 2791 mg / day per participant , and the major sources were vegetables and fruits ( 1262 mg / day ) , fish ( 333 mg / day ) , coffee and tea ( 206 mg / day ) , and milk and dairy products ( 200 mg / day ) ."
105371,),O,3663.0,"The average potassium intake was 2791 mg / day per participant , and the major sources were vegetables and fruits ( 1262 mg / day ) , fish ( 333 mg / day ) , coffee and tea ( 206 mg / day ) , and milk and dairy products ( 200 mg / day ) ."
105372,.,O,3663.0,"The average potassium intake was 2791 mg / day per participant , and the major sources were vegetables and fruits ( 1262 mg / day ) , fish ( 333 mg / day ) , coffee and tea ( 206 mg / day ) , and milk and dairy products ( 200 mg / day ) ."
105373,Participants,O,3664.0,"Participants in the higher UK / BW quartile consumed significantly more vegetables and fruits , fish , and milk and dairy products , and ate less rice and noodles ."
105374,in,O,3664.0,"Participants in the higher UK / BW quartile consumed significantly more vegetables and fruits , fish , and milk and dairy products , and ate less rice and noodles ."
105375,the,O,3664.0,"Participants in the higher UK / BW quartile consumed significantly more vegetables and fruits , fish , and milk and dairy products , and ate less rice and noodles ."
105376,higher,O,3664.0,"Participants in the higher UK / BW quartile consumed significantly more vegetables and fruits , fish , and milk and dairy products , and ate less rice and noodles ."
105377,UK,O,3664.0,"Participants in the higher UK / BW quartile consumed significantly more vegetables and fruits , fish , and milk and dairy products , and ate less rice and noodles ."
105378,/,O,3664.0,"Participants in the higher UK / BW quartile consumed significantly more vegetables and fruits , fish , and milk and dairy products , and ate less rice and noodles ."
105379,BW,O,3664.0,"Participants in the higher UK / BW quartile consumed significantly more vegetables and fruits , fish , and milk and dairy products , and ate less rice and noodles ."
105380,quartile,O,3664.0,"Participants in the higher UK / BW quartile consumed significantly more vegetables and fruits , fish , and milk and dairy products , and ate less rice and noodles ."
105381,consumed,O,3664.0,"Participants in the higher UK / BW quartile consumed significantly more vegetables and fruits , fish , and milk and dairy products , and ate less rice and noodles ."
105382,significantly,O,3664.0,"Participants in the higher UK / BW quartile consumed significantly more vegetables and fruits , fish , and milk and dairy products , and ate less rice and noodles ."
105383,more,O,3664.0,"Participants in the higher UK / BW quartile consumed significantly more vegetables and fruits , fish , and milk and dairy products , and ate less rice and noodles ."
105384,vegetables,B-AG.01.h,3664.0,"Participants in the higher UK / BW quartile consumed significantly more vegetables and fruits , fish , and milk and dairy products , and ate less rice and noodles ."
105385,and,I-AG.01.h,3664.0,"Participants in the higher UK / BW quartile consumed significantly more vegetables and fruits , fish , and milk and dairy products , and ate less rice and noodles ."
105386,fruits,I-AG.01.h,3664.0,"Participants in the higher UK / BW quartile consumed significantly more vegetables and fruits , fish , and milk and dairy products , and ate less rice and noodles ."
105387,",",O,3664.0,"Participants in the higher UK / BW quartile consumed significantly more vegetables and fruits , fish , and milk and dairy products , and ate less rice and noodles ."
105388,fish,B-AG.01.d.07,3664.0,"Participants in the higher UK / BW quartile consumed significantly more vegetables and fruits , fish , and milk and dairy products , and ate less rice and noodles ."
105389,",",O,3664.0,"Participants in the higher UK / BW quartile consumed significantly more vegetables and fruits , fish , and milk and dairy products , and ate less rice and noodles ."
105390,and,O,3664.0,"Participants in the higher UK / BW quartile consumed significantly more vegetables and fruits , fish , and milk and dairy products , and ate less rice and noodles ."
105391,milk,B-AG.01.e,3664.0,"Participants in the higher UK / BW quartile consumed significantly more vegetables and fruits , fish , and milk and dairy products , and ate less rice and noodles ."
105392,and,O,3664.0,"Participants in the higher UK / BW quartile consumed significantly more vegetables and fruits , fish , and milk and dairy products , and ate less rice and noodles ."
105393,dairy,B-AG.01.e,3664.0,"Participants in the higher UK / BW quartile consumed significantly more vegetables and fruits , fish , and milk and dairy products , and ate less rice and noodles ."
105394,products,I-AG.01.e,3664.0,"Participants in the higher UK / BW quartile consumed significantly more vegetables and fruits , fish , and milk and dairy products , and ate less rice and noodles ."
105395,",",O,3664.0,"Participants in the higher UK / BW quartile consumed significantly more vegetables and fruits , fish , and milk and dairy products , and ate less rice and noodles ."
105396,and,O,3664.0,"Participants in the higher UK / BW quartile consumed significantly more vegetables and fruits , fish , and milk and dairy products , and ate less rice and noodles ."
105397,ate,O,3664.0,"Participants in the higher UK / BW quartile consumed significantly more vegetables and fruits , fish , and milk and dairy products , and ate less rice and noodles ."
105398,less,O,3664.0,"Participants in the higher UK / BW quartile consumed significantly more vegetables and fruits , fish , and milk and dairy products , and ate less rice and noodles ."
105399,rice,B-AG.01.i,3664.0,"Participants in the higher UK / BW quartile consumed significantly more vegetables and fruits , fish , and milk and dairy products , and ate less rice and noodles ."
105400,and,O,3664.0,"Participants in the higher UK / BW quartile consumed significantly more vegetables and fruits , fish , and milk and dairy products , and ate less rice and noodles ."
105401,noodles,B-AG.01.i,3664.0,"Participants in the higher UK / BW quartile consumed significantly more vegetables and fruits , fish , and milk and dairy products , and ate less rice and noodles ."
105402,.,O,3664.0,"Participants in the higher UK / BW quartile consumed significantly more vegetables and fruits , fish , and milk and dairy products , and ate less rice and noodles ."
105403,Conclusion,O,3665.0,"Conclusion : Advice to increase the intake of vegetables and fruits , fish , and milk may be useful to increase potassium intake in Japan ."
105404,:,O,3665.0,"Conclusion : Advice to increase the intake of vegetables and fruits , fish , and milk may be useful to increase potassium intake in Japan ."
105405,Advice,O,3665.0,"Conclusion : Advice to increase the intake of vegetables and fruits , fish , and milk may be useful to increase potassium intake in Japan ."
105406,to,O,3665.0,"Conclusion : Advice to increase the intake of vegetables and fruits , fish , and milk may be useful to increase potassium intake in Japan ."
105407,increase,O,3665.0,"Conclusion : Advice to increase the intake of vegetables and fruits , fish , and milk may be useful to increase potassium intake in Japan ."
105408,the,O,3665.0,"Conclusion : Advice to increase the intake of vegetables and fruits , fish , and milk may be useful to increase potassium intake in Japan ."
105409,intake,O,3665.0,"Conclusion : Advice to increase the intake of vegetables and fruits , fish , and milk may be useful to increase potassium intake in Japan ."
105410,of,O,3665.0,"Conclusion : Advice to increase the intake of vegetables and fruits , fish , and milk may be useful to increase potassium intake in Japan ."
105411,vegetables,B-AG.01.h,3665.0,"Conclusion : Advice to increase the intake of vegetables and fruits , fish , and milk may be useful to increase potassium intake in Japan ."
105412,and,I-AG.01.h,3665.0,"Conclusion : Advice to increase the intake of vegetables and fruits , fish , and milk may be useful to increase potassium intake in Japan ."
105413,fruits,I-AG.01.h,3665.0,"Conclusion : Advice to increase the intake of vegetables and fruits , fish , and milk may be useful to increase potassium intake in Japan ."
105414,",",O,3665.0,"Conclusion : Advice to increase the intake of vegetables and fruits , fish , and milk may be useful to increase potassium intake in Japan ."
105415,fish,B-AG.01.d.07,3665.0,"Conclusion : Advice to increase the intake of vegetables and fruits , fish , and milk may be useful to increase potassium intake in Japan ."
105416,",",O,3665.0,"Conclusion : Advice to increase the intake of vegetables and fruits , fish , and milk may be useful to increase potassium intake in Japan ."
105417,and,O,3665.0,"Conclusion : Advice to increase the intake of vegetables and fruits , fish , and milk may be useful to increase potassium intake in Japan ."
105418,milk,B-AG.01.e,3665.0,"Conclusion : Advice to increase the intake of vegetables and fruits , fish , and milk may be useful to increase potassium intake in Japan ."
105419,may,O,3665.0,"Conclusion : Advice to increase the intake of vegetables and fruits , fish , and milk may be useful to increase potassium intake in Japan ."
105420,be,O,3665.0,"Conclusion : Advice to increase the intake of vegetables and fruits , fish , and milk may be useful to increase potassium intake in Japan ."
105421,useful,O,3665.0,"Conclusion : Advice to increase the intake of vegetables and fruits , fish , and milk may be useful to increase potassium intake in Japan ."
105422,to,O,3665.0,"Conclusion : Advice to increase the intake of vegetables and fruits , fish , and milk may be useful to increase potassium intake in Japan ."
105423,increase,O,3665.0,"Conclusion : Advice to increase the intake of vegetables and fruits , fish , and milk may be useful to increase potassium intake in Japan ."
105424,potassium,O,3665.0,"Conclusion : Advice to increase the intake of vegetables and fruits , fish , and milk may be useful to increase potassium intake in Japan ."
105425,intake,O,3665.0,"Conclusion : Advice to increase the intake of vegetables and fruits , fish , and milk may be useful to increase potassium intake in Japan ."
105426,in,O,3665.0,"Conclusion : Advice to increase the intake of vegetables and fruits , fish , and milk may be useful to increase potassium intake in Japan ."
105427,Japan,O,3665.0,"Conclusion : Advice to increase the intake of vegetables and fruits , fish , and milk may be useful to increase potassium intake in Japan ."
105428,.,O,3665.0,"Conclusion : Advice to increase the intake of vegetables and fruits , fish , and milk may be useful to increase potassium intake in Japan ."
105429,Honey,O,3666.0,"Honey is a natural product , containing flavonoids and phenolic acids , appreciated for its therapeutic abilities since ancient times ."
105430,is,O,3666.0,"Honey is a natural product , containing flavonoids and phenolic acids , appreciated for its therapeutic abilities since ancient times ."
105431,a,O,3666.0,"Honey is a natural product , containing flavonoids and phenolic acids , appreciated for its therapeutic abilities since ancient times ."
105432,natural,O,3666.0,"Honey is a natural product , containing flavonoids and phenolic acids , appreciated for its therapeutic abilities since ancient times ."
105433,product,O,3666.0,"Honey is a natural product , containing flavonoids and phenolic acids , appreciated for its therapeutic abilities since ancient times ."
105434,",",O,3666.0,"Honey is a natural product , containing flavonoids and phenolic acids , appreciated for its therapeutic abilities since ancient times ."
105435,containing,O,3666.0,"Honey is a natural product , containing flavonoids and phenolic acids , appreciated for its therapeutic abilities since ancient times ."
105436,flavonoids,O,3666.0,"Honey is a natural product , containing flavonoids and phenolic acids , appreciated for its therapeutic abilities since ancient times ."
105437,and,O,3666.0,"Honey is a natural product , containing flavonoids and phenolic acids , appreciated for its therapeutic abilities since ancient times ."
105438,phenolic,O,3666.0,"Honey is a natural product , containing flavonoids and phenolic acids , appreciated for its therapeutic abilities since ancient times ."
105439,acids,O,3666.0,"Honey is a natural product , containing flavonoids and phenolic acids , appreciated for its therapeutic abilities since ancient times ."
105440,",",O,3666.0,"Honey is a natural product , containing flavonoids and phenolic acids , appreciated for its therapeutic abilities since ancient times ."
105441,appreciated,O,3666.0,"Honey is a natural product , containing flavonoids and phenolic acids , appreciated for its therapeutic abilities since ancient times ."
105442,for,O,3666.0,"Honey is a natural product , containing flavonoids and phenolic acids , appreciated for its therapeutic abilities since ancient times ."
105443,its,O,3666.0,"Honey is a natural product , containing flavonoids and phenolic acids , appreciated for its therapeutic abilities since ancient times ."
105444,therapeutic,O,3666.0,"Honey is a natural product , containing flavonoids and phenolic acids , appreciated for its therapeutic abilities since ancient times ."
105445,abilities,O,3666.0,"Honey is a natural product , containing flavonoids and phenolic acids , appreciated for its therapeutic abilities since ancient times ."
105446,since,O,3666.0,"Honey is a natural product , containing flavonoids and phenolic acids , appreciated for its therapeutic abilities since ancient times ."
105447,ancient,O,3666.0,"Honey is a natural product , containing flavonoids and phenolic acids , appreciated for its therapeutic abilities since ancient times ."
105448,times,O,3666.0,"Honey is a natural product , containing flavonoids and phenolic acids , appreciated for its therapeutic abilities since ancient times ."
105449,.,O,3666.0,"Honey is a natural product , containing flavonoids and phenolic acids , appreciated for its therapeutic abilities since ancient times ."
105450,Although,O,3667.0,"Although the bioactive potential is linked to the composition , that is variable depending on mainly the botanical origin , honey has antioxidant and anti - inflammatory properties ."
105451,the,O,3667.0,"Although the bioactive potential is linked to the composition , that is variable depending on mainly the botanical origin , honey has antioxidant and anti - inflammatory properties ."
105452,bioactive,O,3667.0,"Although the bioactive potential is linked to the composition , that is variable depending on mainly the botanical origin , honey has antioxidant and anti - inflammatory properties ."
105453,potential,O,3667.0,"Although the bioactive potential is linked to the composition , that is variable depending on mainly the botanical origin , honey has antioxidant and anti - inflammatory properties ."
105454,is,O,3667.0,"Although the bioactive potential is linked to the composition , that is variable depending on mainly the botanical origin , honey has antioxidant and anti - inflammatory properties ."
105455,linked,O,3667.0,"Although the bioactive potential is linked to the composition , that is variable depending on mainly the botanical origin , honey has antioxidant and anti - inflammatory properties ."
105456,to,O,3667.0,"Although the bioactive potential is linked to the composition , that is variable depending on mainly the botanical origin , honey has antioxidant and anti - inflammatory properties ."
105457,the,O,3667.0,"Although the bioactive potential is linked to the composition , that is variable depending on mainly the botanical origin , honey has antioxidant and anti - inflammatory properties ."
105458,composition,O,3667.0,"Although the bioactive potential is linked to the composition , that is variable depending on mainly the botanical origin , honey has antioxidant and anti - inflammatory properties ."
105459,",",O,3667.0,"Although the bioactive potential is linked to the composition , that is variable depending on mainly the botanical origin , honey has antioxidant and anti - inflammatory properties ."
105460,that,O,3667.0,"Although the bioactive potential is linked to the composition , that is variable depending on mainly the botanical origin , honey has antioxidant and anti - inflammatory properties ."
105461,is,O,3667.0,"Although the bioactive potential is linked to the composition , that is variable depending on mainly the botanical origin , honey has antioxidant and anti - inflammatory properties ."
105462,variable,O,3667.0,"Although the bioactive potential is linked to the composition , that is variable depending on mainly the botanical origin , honey has antioxidant and anti - inflammatory properties ."
105463,depending,O,3667.0,"Although the bioactive potential is linked to the composition , that is variable depending on mainly the botanical origin , honey has antioxidant and anti - inflammatory properties ."
105464,on,O,3667.0,"Although the bioactive potential is linked to the composition , that is variable depending on mainly the botanical origin , honey has antioxidant and anti - inflammatory properties ."
105465,mainly,O,3667.0,"Although the bioactive potential is linked to the composition , that is variable depending on mainly the botanical origin , honey has antioxidant and anti - inflammatory properties ."
105466,the,O,3667.0,"Although the bioactive potential is linked to the composition , that is variable depending on mainly the botanical origin , honey has antioxidant and anti - inflammatory properties ."
105467,botanical,O,3667.0,"Although the bioactive potential is linked to the composition , that is variable depending on mainly the botanical origin , honey has antioxidant and anti - inflammatory properties ."
105468,origin,O,3667.0,"Although the bioactive potential is linked to the composition , that is variable depending on mainly the botanical origin , honey has antioxidant and anti - inflammatory properties ."
105469,",",O,3667.0,"Although the bioactive potential is linked to the composition , that is variable depending on mainly the botanical origin , honey has antioxidant and anti - inflammatory properties ."
105470,honey,B-AG.01.l.02,3667.0,"Although the bioactive potential is linked to the composition , that is variable depending on mainly the botanical origin , honey has antioxidant and anti - inflammatory properties ."
105471,has,O,3667.0,"Although the bioactive potential is linked to the composition , that is variable depending on mainly the botanical origin , honey has antioxidant and anti - inflammatory properties ."
105472,antioxidant,O,3667.0,"Although the bioactive potential is linked to the composition , that is variable depending on mainly the botanical origin , honey has antioxidant and anti - inflammatory properties ."
105473,and,O,3667.0,"Although the bioactive potential is linked to the composition , that is variable depending on mainly the botanical origin , honey has antioxidant and anti - inflammatory properties ."
105474,anti,O,3667.0,"Although the bioactive potential is linked to the composition , that is variable depending on mainly the botanical origin , honey has antioxidant and anti - inflammatory properties ."
105475,-,O,3667.0,"Although the bioactive potential is linked to the composition , that is variable depending on mainly the botanical origin , honey has antioxidant and anti - inflammatory properties ."
105476,inflammatory,O,3667.0,"Although the bioactive potential is linked to the composition , that is variable depending on mainly the botanical origin , honey has antioxidant and anti - inflammatory properties ."
105477,properties,O,3667.0,"Although the bioactive potential is linked to the composition , that is variable depending on mainly the botanical origin , honey has antioxidant and anti - inflammatory properties ."
105478,.,O,3667.0,"Although the bioactive potential is linked to the composition , that is variable depending on mainly the botanical origin , honey has antioxidant and anti - inflammatory properties ."
105479,Therefore,O,3668.0,"Therefore , honey , administered alone or in combination with conventional therapy , might result useful in the management of chronic diseases that are commonly associated with oxidative stress and inflammation state ."
105480,",",O,3668.0,"Therefore , honey , administered alone or in combination with conventional therapy , might result useful in the management of chronic diseases that are commonly associated with oxidative stress and inflammation state ."
105481,honey,B-AG.01.l.02,3668.0,"Therefore , honey , administered alone or in combination with conventional therapy , might result useful in the management of chronic diseases that are commonly associated with oxidative stress and inflammation state ."
105482,",",O,3668.0,"Therefore , honey , administered alone or in combination with conventional therapy , might result useful in the management of chronic diseases that are commonly associated with oxidative stress and inflammation state ."
105483,administered,O,3668.0,"Therefore , honey , administered alone or in combination with conventional therapy , might result useful in the management of chronic diseases that are commonly associated with oxidative stress and inflammation state ."
105484,alone,O,3668.0,"Therefore , honey , administered alone or in combination with conventional therapy , might result useful in the management of chronic diseases that are commonly associated with oxidative stress and inflammation state ."
105485,or,O,3668.0,"Therefore , honey , administered alone or in combination with conventional therapy , might result useful in the management of chronic diseases that are commonly associated with oxidative stress and inflammation state ."
105486,in,O,3668.0,"Therefore , honey , administered alone or in combination with conventional therapy , might result useful in the management of chronic diseases that are commonly associated with oxidative stress and inflammation state ."
105487,combination,O,3668.0,"Therefore , honey , administered alone or in combination with conventional therapy , might result useful in the management of chronic diseases that are commonly associated with oxidative stress and inflammation state ."
105488,with,O,3668.0,"Therefore , honey , administered alone or in combination with conventional therapy , might result useful in the management of chronic diseases that are commonly associated with oxidative stress and inflammation state ."
105489,conventional,O,3668.0,"Therefore , honey , administered alone or in combination with conventional therapy , might result useful in the management of chronic diseases that are commonly associated with oxidative stress and inflammation state ."
105490,therapy,O,3668.0,"Therefore , honey , administered alone or in combination with conventional therapy , might result useful in the management of chronic diseases that are commonly associated with oxidative stress and inflammation state ."
105491,",",O,3668.0,"Therefore , honey , administered alone or in combination with conventional therapy , might result useful in the management of chronic diseases that are commonly associated with oxidative stress and inflammation state ."
105492,might,O,3668.0,"Therefore , honey , administered alone or in combination with conventional therapy , might result useful in the management of chronic diseases that are commonly associated with oxidative stress and inflammation state ."
105493,result,O,3668.0,"Therefore , honey , administered alone or in combination with conventional therapy , might result useful in the management of chronic diseases that are commonly associated with oxidative stress and inflammation state ."
105494,useful,O,3668.0,"Therefore , honey , administered alone or in combination with conventional therapy , might result useful in the management of chronic diseases that are commonly associated with oxidative stress and inflammation state ."
105495,in,O,3668.0,"Therefore , honey , administered alone or in combination with conventional therapy , might result useful in the management of chronic diseases that are commonly associated with oxidative stress and inflammation state ."
105496,the,O,3668.0,"Therefore , honey , administered alone or in combination with conventional therapy , might result useful in the management of chronic diseases that are commonly associated with oxidative stress and inflammation state ."
105497,management,O,3668.0,"Therefore , honey , administered alone or in combination with conventional therapy , might result useful in the management of chronic diseases that are commonly associated with oxidative stress and inflammation state ."
105498,of,O,3668.0,"Therefore , honey , administered alone or in combination with conventional therapy , might result useful in the management of chronic diseases that are commonly associated with oxidative stress and inflammation state ."
105499,chronic,O,3668.0,"Therefore , honey , administered alone or in combination with conventional therapy , might result useful in the management of chronic diseases that are commonly associated with oxidative stress and inflammation state ."
105500,diseases,O,3668.0,"Therefore , honey , administered alone or in combination with conventional therapy , might result useful in the management of chronic diseases that are commonly associated with oxidative stress and inflammation state ."
105501,that,O,3668.0,"Therefore , honey , administered alone or in combination with conventional therapy , might result useful in the management of chronic diseases that are commonly associated with oxidative stress and inflammation state ."
105502,are,O,3668.0,"Therefore , honey , administered alone or in combination with conventional therapy , might result useful in the management of chronic diseases that are commonly associated with oxidative stress and inflammation state ."
105503,commonly,O,3668.0,"Therefore , honey , administered alone or in combination with conventional therapy , might result useful in the management of chronic diseases that are commonly associated with oxidative stress and inflammation state ."
105504,associated,O,3668.0,"Therefore , honey , administered alone or in combination with conventional therapy , might result useful in the management of chronic diseases that are commonly associated with oxidative stress and inflammation state ."
105505,with,O,3668.0,"Therefore , honey , administered alone or in combination with conventional therapy , might result useful in the management of chronic diseases that are commonly associated with oxidative stress and inflammation state ."
105506,oxidative,O,3668.0,"Therefore , honey , administered alone or in combination with conventional therapy , might result useful in the management of chronic diseases that are commonly associated with oxidative stress and inflammation state ."
105507,stress,O,3668.0,"Therefore , honey , administered alone or in combination with conventional therapy , might result useful in the management of chronic diseases that are commonly associated with oxidative stress and inflammation state ."
105508,and,O,3668.0,"Therefore , honey , administered alone or in combination with conventional therapy , might result useful in the management of chronic diseases that are commonly associated with oxidative stress and inflammation state ."
105509,inflammation,O,3668.0,"Therefore , honey , administered alone or in combination with conventional therapy , might result useful in the management of chronic diseases that are commonly associated with oxidative stress and inflammation state ."
105510,state,O,3668.0,"Therefore , honey , administered alone or in combination with conventional therapy , might result useful in the management of chronic diseases that are commonly associated with oxidative stress and inflammation state ."
105511,.,O,3668.0,"Therefore , honey , administered alone or in combination with conventional therapy , might result useful in the management of chronic diseases that are commonly associated with oxidative stress and inflammation state ."
105512,Obesity,O,3669.0,Obesity is a metabolic disorder characterized by visceral adiposity .
105513,is,O,3669.0,Obesity is a metabolic disorder characterized by visceral adiposity .
105514,a,O,3669.0,Obesity is a metabolic disorder characterized by visceral adiposity .
105515,metabolic,O,3669.0,Obesity is a metabolic disorder characterized by visceral adiposity .
105516,disorder,O,3669.0,Obesity is a metabolic disorder characterized by visceral adiposity .
105517,characterized,O,3669.0,Obesity is a metabolic disorder characterized by visceral adiposity .
105518,by,O,3669.0,Obesity is a metabolic disorder characterized by visceral adiposity .
105519,visceral,O,3669.0,Obesity is a metabolic disorder characterized by visceral adiposity .
105520,adiposity,O,3669.0,Obesity is a metabolic disorder characterized by visceral adiposity .
105521,.,O,3669.0,Obesity is a metabolic disorder characterized by visceral adiposity .
105522,The,O,3670.0,"The adipose tissue becomes hypertrophic and undergoes hyperplasia , resulting in a hypoxic environment , oxidative stress and production of pro - inflammatory mediators that can be responsible for other disorders , such as metabolic syndrome and neurodegeneration ."
105523,adipose,O,3670.0,"The adipose tissue becomes hypertrophic and undergoes hyperplasia , resulting in a hypoxic environment , oxidative stress and production of pro - inflammatory mediators that can be responsible for other disorders , such as metabolic syndrome and neurodegeneration ."
105524,tissue,O,3670.0,"The adipose tissue becomes hypertrophic and undergoes hyperplasia , resulting in a hypoxic environment , oxidative stress and production of pro - inflammatory mediators that can be responsible for other disorders , such as metabolic syndrome and neurodegeneration ."
105525,becomes,O,3670.0,"The adipose tissue becomes hypertrophic and undergoes hyperplasia , resulting in a hypoxic environment , oxidative stress and production of pro - inflammatory mediators that can be responsible for other disorders , such as metabolic syndrome and neurodegeneration ."
105526,hypertrophic,O,3670.0,"The adipose tissue becomes hypertrophic and undergoes hyperplasia , resulting in a hypoxic environment , oxidative stress and production of pro - inflammatory mediators that can be responsible for other disorders , such as metabolic syndrome and neurodegeneration ."
105527,and,O,3670.0,"The adipose tissue becomes hypertrophic and undergoes hyperplasia , resulting in a hypoxic environment , oxidative stress and production of pro - inflammatory mediators that can be responsible for other disorders , such as metabolic syndrome and neurodegeneration ."
105528,undergoes,O,3670.0,"The adipose tissue becomes hypertrophic and undergoes hyperplasia , resulting in a hypoxic environment , oxidative stress and production of pro - inflammatory mediators that can be responsible for other disorders , such as metabolic syndrome and neurodegeneration ."
105529,hyperplasia,O,3670.0,"The adipose tissue becomes hypertrophic and undergoes hyperplasia , resulting in a hypoxic environment , oxidative stress and production of pro - inflammatory mediators that can be responsible for other disorders , such as metabolic syndrome and neurodegeneration ."
105530,",",O,3670.0,"The adipose tissue becomes hypertrophic and undergoes hyperplasia , resulting in a hypoxic environment , oxidative stress and production of pro - inflammatory mediators that can be responsible for other disorders , such as metabolic syndrome and neurodegeneration ."
105531,resulting,O,3670.0,"The adipose tissue becomes hypertrophic and undergoes hyperplasia , resulting in a hypoxic environment , oxidative stress and production of pro - inflammatory mediators that can be responsible for other disorders , such as metabolic syndrome and neurodegeneration ."
105532,in,O,3670.0,"The adipose tissue becomes hypertrophic and undergoes hyperplasia , resulting in a hypoxic environment , oxidative stress and production of pro - inflammatory mediators that can be responsible for other disorders , such as metabolic syndrome and neurodegeneration ."
105533,a,O,3670.0,"The adipose tissue becomes hypertrophic and undergoes hyperplasia , resulting in a hypoxic environment , oxidative stress and production of pro - inflammatory mediators that can be responsible for other disorders , such as metabolic syndrome and neurodegeneration ."
105534,hypoxic,O,3670.0,"The adipose tissue becomes hypertrophic and undergoes hyperplasia , resulting in a hypoxic environment , oxidative stress and production of pro - inflammatory mediators that can be responsible for other disorders , such as metabolic syndrome and neurodegeneration ."
105535,environment,O,3670.0,"The adipose tissue becomes hypertrophic and undergoes hyperplasia , resulting in a hypoxic environment , oxidative stress and production of pro - inflammatory mediators that can be responsible for other disorders , such as metabolic syndrome and neurodegeneration ."
105536,",",O,3670.0,"The adipose tissue becomes hypertrophic and undergoes hyperplasia , resulting in a hypoxic environment , oxidative stress and production of pro - inflammatory mediators that can be responsible for other disorders , such as metabolic syndrome and neurodegeneration ."
105537,oxidative,O,3670.0,"The adipose tissue becomes hypertrophic and undergoes hyperplasia , resulting in a hypoxic environment , oxidative stress and production of pro - inflammatory mediators that can be responsible for other disorders , such as metabolic syndrome and neurodegeneration ."
105538,stress,O,3670.0,"The adipose tissue becomes hypertrophic and undergoes hyperplasia , resulting in a hypoxic environment , oxidative stress and production of pro - inflammatory mediators that can be responsible for other disorders , such as metabolic syndrome and neurodegeneration ."
105539,and,O,3670.0,"The adipose tissue becomes hypertrophic and undergoes hyperplasia , resulting in a hypoxic environment , oxidative stress and production of pro - inflammatory mediators that can be responsible for other disorders , such as metabolic syndrome and neurodegeneration ."
105540,production,O,3670.0,"The adipose tissue becomes hypertrophic and undergoes hyperplasia , resulting in a hypoxic environment , oxidative stress and production of pro - inflammatory mediators that can be responsible for other disorders , such as metabolic syndrome and neurodegeneration ."
105541,of,O,3670.0,"The adipose tissue becomes hypertrophic and undergoes hyperplasia , resulting in a hypoxic environment , oxidative stress and production of pro - inflammatory mediators that can be responsible for other disorders , such as metabolic syndrome and neurodegeneration ."
105542,pro,O,3670.0,"The adipose tissue becomes hypertrophic and undergoes hyperplasia , resulting in a hypoxic environment , oxidative stress and production of pro - inflammatory mediators that can be responsible for other disorders , such as metabolic syndrome and neurodegeneration ."
105543,-,O,3670.0,"The adipose tissue becomes hypertrophic and undergoes hyperplasia , resulting in a hypoxic environment , oxidative stress and production of pro - inflammatory mediators that can be responsible for other disorders , such as metabolic syndrome and neurodegeneration ."
105544,inflammatory,O,3670.0,"The adipose tissue becomes hypertrophic and undergoes hyperplasia , resulting in a hypoxic environment , oxidative stress and production of pro - inflammatory mediators that can be responsible for other disorders , such as metabolic syndrome and neurodegeneration ."
105545,mediators,O,3670.0,"The adipose tissue becomes hypertrophic and undergoes hyperplasia , resulting in a hypoxic environment , oxidative stress and production of pro - inflammatory mediators that can be responsible for other disorders , such as metabolic syndrome and neurodegeneration ."
105546,that,O,3670.0,"The adipose tissue becomes hypertrophic and undergoes hyperplasia , resulting in a hypoxic environment , oxidative stress and production of pro - inflammatory mediators that can be responsible for other disorders , such as metabolic syndrome and neurodegeneration ."
105547,can,O,3670.0,"The adipose tissue becomes hypertrophic and undergoes hyperplasia , resulting in a hypoxic environment , oxidative stress and production of pro - inflammatory mediators that can be responsible for other disorders , such as metabolic syndrome and neurodegeneration ."
105548,be,O,3670.0,"The adipose tissue becomes hypertrophic and undergoes hyperplasia , resulting in a hypoxic environment , oxidative stress and production of pro - inflammatory mediators that can be responsible for other disorders , such as metabolic syndrome and neurodegeneration ."
105549,responsible,O,3670.0,"The adipose tissue becomes hypertrophic and undergoes hyperplasia , resulting in a hypoxic environment , oxidative stress and production of pro - inflammatory mediators that can be responsible for other disorders , such as metabolic syndrome and neurodegeneration ."
105550,for,O,3670.0,"The adipose tissue becomes hypertrophic and undergoes hyperplasia , resulting in a hypoxic environment , oxidative stress and production of pro - inflammatory mediators that can be responsible for other disorders , such as metabolic syndrome and neurodegeneration ."
105551,other,O,3670.0,"The adipose tissue becomes hypertrophic and undergoes hyperplasia , resulting in a hypoxic environment , oxidative stress and production of pro - inflammatory mediators that can be responsible for other disorders , such as metabolic syndrome and neurodegeneration ."
105552,disorders,O,3670.0,"The adipose tissue becomes hypertrophic and undergoes hyperplasia , resulting in a hypoxic environment , oxidative stress and production of pro - inflammatory mediators that can be responsible for other disorders , such as metabolic syndrome and neurodegeneration ."
105553,",",O,3670.0,"The adipose tissue becomes hypertrophic and undergoes hyperplasia , resulting in a hypoxic environment , oxidative stress and production of pro - inflammatory mediators that can be responsible for other disorders , such as metabolic syndrome and neurodegeneration ."
105554,such,O,3670.0,"The adipose tissue becomes hypertrophic and undergoes hyperplasia , resulting in a hypoxic environment , oxidative stress and production of pro - inflammatory mediators that can be responsible for other disorders , such as metabolic syndrome and neurodegeneration ."
105555,as,O,3670.0,"The adipose tissue becomes hypertrophic and undergoes hyperplasia , resulting in a hypoxic environment , oxidative stress and production of pro - inflammatory mediators that can be responsible for other disorders , such as metabolic syndrome and neurodegeneration ."
105556,metabolic,O,3670.0,"The adipose tissue becomes hypertrophic and undergoes hyperplasia , resulting in a hypoxic environment , oxidative stress and production of pro - inflammatory mediators that can be responsible for other disorders , such as metabolic syndrome and neurodegeneration ."
105557,syndrome,O,3670.0,"The adipose tissue becomes hypertrophic and undergoes hyperplasia , resulting in a hypoxic environment , oxidative stress and production of pro - inflammatory mediators that can be responsible for other disorders , such as metabolic syndrome and neurodegeneration ."
105558,and,O,3670.0,"The adipose tissue becomes hypertrophic and undergoes hyperplasia , resulting in a hypoxic environment , oxidative stress and production of pro - inflammatory mediators that can be responsible for other disorders , such as metabolic syndrome and neurodegeneration ."
105559,neurodegeneration,O,3670.0,"The adipose tissue becomes hypertrophic and undergoes hyperplasia , resulting in a hypoxic environment , oxidative stress and production of pro - inflammatory mediators that can be responsible for other disorders , such as metabolic syndrome and neurodegeneration ."
105560,.,O,3670.0,"The adipose tissue becomes hypertrophic and undergoes hyperplasia , resulting in a hypoxic environment , oxidative stress and production of pro - inflammatory mediators that can be responsible for other disorders , such as metabolic syndrome and neurodegeneration ."
105561,Experimental,O,3671.0,Experimental evidence from animals have shown that honey improves glycemic control and lipid profile with consequent protection from endothelial dysfunction and neurodegeneration .
105562,evidence,O,3671.0,Experimental evidence from animals have shown that honey improves glycemic control and lipid profile with consequent protection from endothelial dysfunction and neurodegeneration .
105563,from,O,3671.0,Experimental evidence from animals have shown that honey improves glycemic control and lipid profile with consequent protection from endothelial dysfunction and neurodegeneration .
105564,animals,O,3671.0,Experimental evidence from animals have shown that honey improves glycemic control and lipid profile with consequent protection from endothelial dysfunction and neurodegeneration .
105565,have,O,3671.0,Experimental evidence from animals have shown that honey improves glycemic control and lipid profile with consequent protection from endothelial dysfunction and neurodegeneration .
105566,shown,O,3671.0,Experimental evidence from animals have shown that honey improves glycemic control and lipid profile with consequent protection from endothelial dysfunction and neurodegeneration .
105567,that,O,3671.0,Experimental evidence from animals have shown that honey improves glycemic control and lipid profile with consequent protection from endothelial dysfunction and neurodegeneration .
105568,honey,B-AG.01.l.02,3671.0,Experimental evidence from animals have shown that honey improves glycemic control and lipid profile with consequent protection from endothelial dysfunction and neurodegeneration .
105569,improves,O,3671.0,Experimental evidence from animals have shown that honey improves glycemic control and lipid profile with consequent protection from endothelial dysfunction and neurodegeneration .
105570,glycemic,O,3671.0,Experimental evidence from animals have shown that honey improves glycemic control and lipid profile with consequent protection from endothelial dysfunction and neurodegeneration .
105571,control,O,3671.0,Experimental evidence from animals have shown that honey improves glycemic control and lipid profile with consequent protection from endothelial dysfunction and neurodegeneration .
105572,and,O,3671.0,Experimental evidence from animals have shown that honey improves glycemic control and lipid profile with consequent protection from endothelial dysfunction and neurodegeneration .
105573,lipid,O,3671.0,Experimental evidence from animals have shown that honey improves glycemic control and lipid profile with consequent protection from endothelial dysfunction and neurodegeneration .
105574,profile,O,3671.0,Experimental evidence from animals have shown that honey improves glycemic control and lipid profile with consequent protection from endothelial dysfunction and neurodegeneration .
105575,with,O,3671.0,Experimental evidence from animals have shown that honey improves glycemic control and lipid profile with consequent protection from endothelial dysfunction and neurodegeneration .
105576,consequent,O,3671.0,Experimental evidence from animals have shown that honey improves glycemic control and lipid profile with consequent protection from endothelial dysfunction and neurodegeneration .
105577,protection,O,3671.0,Experimental evidence from animals have shown that honey improves glycemic control and lipid profile with consequent protection from endothelial dysfunction and neurodegeneration .
105578,from,O,3671.0,Experimental evidence from animals have shown that honey improves glycemic control and lipid profile with consequent protection from endothelial dysfunction and neurodegeneration .
105579,endothelial,O,3671.0,Experimental evidence from animals have shown that honey improves glycemic control and lipid profile with consequent protection from endothelial dysfunction and neurodegeneration .
105580,dysfunction,O,3671.0,Experimental evidence from animals have shown that honey improves glycemic control and lipid profile with consequent protection from endothelial dysfunction and neurodegeneration .
105581,and,O,3671.0,Experimental evidence from animals have shown that honey improves glycemic control and lipid profile with consequent protection from endothelial dysfunction and neurodegeneration .
105582,neurodegeneration,O,3671.0,Experimental evidence from animals have shown that honey improves glycemic control and lipid profile with consequent protection from endothelial dysfunction and neurodegeneration .
105583,.,O,3671.0,Experimental evidence from animals have shown that honey improves glycemic control and lipid profile with consequent protection from endothelial dysfunction and neurodegeneration .
105584,The,O,3672.0,"The purpose of the present review is to summarize the current literature concerning the beneficial effects of honey in the management of the obesity - related dysfunctions , including neurodegeneration ."
105585,purpose,O,3672.0,"The purpose of the present review is to summarize the current literature concerning the beneficial effects of honey in the management of the obesity - related dysfunctions , including neurodegeneration ."
105586,of,O,3672.0,"The purpose of the present review is to summarize the current literature concerning the beneficial effects of honey in the management of the obesity - related dysfunctions , including neurodegeneration ."
105587,the,O,3672.0,"The purpose of the present review is to summarize the current literature concerning the beneficial effects of honey in the management of the obesity - related dysfunctions , including neurodegeneration ."
105588,present,O,3672.0,"The purpose of the present review is to summarize the current literature concerning the beneficial effects of honey in the management of the obesity - related dysfunctions , including neurodegeneration ."
105589,review,O,3672.0,"The purpose of the present review is to summarize the current literature concerning the beneficial effects of honey in the management of the obesity - related dysfunctions , including neurodegeneration ."
105590,is,O,3672.0,"The purpose of the present review is to summarize the current literature concerning the beneficial effects of honey in the management of the obesity - related dysfunctions , including neurodegeneration ."
105591,to,O,3672.0,"The purpose of the present review is to summarize the current literature concerning the beneficial effects of honey in the management of the obesity - related dysfunctions , including neurodegeneration ."
105592,summarize,O,3672.0,"The purpose of the present review is to summarize the current literature concerning the beneficial effects of honey in the management of the obesity - related dysfunctions , including neurodegeneration ."
105593,the,O,3672.0,"The purpose of the present review is to summarize the current literature concerning the beneficial effects of honey in the management of the obesity - related dysfunctions , including neurodegeneration ."
105594,current,O,3672.0,"The purpose of the present review is to summarize the current literature concerning the beneficial effects of honey in the management of the obesity - related dysfunctions , including neurodegeneration ."
105595,literature,O,3672.0,"The purpose of the present review is to summarize the current literature concerning the beneficial effects of honey in the management of the obesity - related dysfunctions , including neurodegeneration ."
105596,concerning,O,3672.0,"The purpose of the present review is to summarize the current literature concerning the beneficial effects of honey in the management of the obesity - related dysfunctions , including neurodegeneration ."
105597,the,O,3672.0,"The purpose of the present review is to summarize the current literature concerning the beneficial effects of honey in the management of the obesity - related dysfunctions , including neurodegeneration ."
105598,beneficial,O,3672.0,"The purpose of the present review is to summarize the current literature concerning the beneficial effects of honey in the management of the obesity - related dysfunctions , including neurodegeneration ."
105599,effects,O,3672.0,"The purpose of the present review is to summarize the current literature concerning the beneficial effects of honey in the management of the obesity - related dysfunctions , including neurodegeneration ."
105600,of,O,3672.0,"The purpose of the present review is to summarize the current literature concerning the beneficial effects of honey in the management of the obesity - related dysfunctions , including neurodegeneration ."
105601,honey,B-AG.01.l.02,3672.0,"The purpose of the present review is to summarize the current literature concerning the beneficial effects of honey in the management of the obesity - related dysfunctions , including neurodegeneration ."
105602,in,O,3672.0,"The purpose of the present review is to summarize the current literature concerning the beneficial effects of honey in the management of the obesity - related dysfunctions , including neurodegeneration ."
105603,the,O,3672.0,"The purpose of the present review is to summarize the current literature concerning the beneficial effects of honey in the management of the obesity - related dysfunctions , including neurodegeneration ."
105604,management,O,3672.0,"The purpose of the present review is to summarize the current literature concerning the beneficial effects of honey in the management of the obesity - related dysfunctions , including neurodegeneration ."
105605,of,O,3672.0,"The purpose of the present review is to summarize the current literature concerning the beneficial effects of honey in the management of the obesity - related dysfunctions , including neurodegeneration ."
105606,the,O,3672.0,"The purpose of the present review is to summarize the current literature concerning the beneficial effects of honey in the management of the obesity - related dysfunctions , including neurodegeneration ."
105607,obesity,O,3672.0,"The purpose of the present review is to summarize the current literature concerning the beneficial effects of honey in the management of the obesity - related dysfunctions , including neurodegeneration ."
105608,-,O,3672.0,"The purpose of the present review is to summarize the current literature concerning the beneficial effects of honey in the management of the obesity - related dysfunctions , including neurodegeneration ."
105609,related,O,3672.0,"The purpose of the present review is to summarize the current literature concerning the beneficial effects of honey in the management of the obesity - related dysfunctions , including neurodegeneration ."
105610,dysfunctions,O,3672.0,"The purpose of the present review is to summarize the current literature concerning the beneficial effects of honey in the management of the obesity - related dysfunctions , including neurodegeneration ."
105611,",",O,3672.0,"The purpose of the present review is to summarize the current literature concerning the beneficial effects of honey in the management of the obesity - related dysfunctions , including neurodegeneration ."
105612,including,O,3672.0,"The purpose of the present review is to summarize the current literature concerning the beneficial effects of honey in the management of the obesity - related dysfunctions , including neurodegeneration ."
105613,neurodegeneration,O,3672.0,"The purpose of the present review is to summarize the current literature concerning the beneficial effects of honey in the management of the obesity - related dysfunctions , including neurodegeneration ."
105614,.,O,3672.0,"The purpose of the present review is to summarize the current literature concerning the beneficial effects of honey in the management of the obesity - related dysfunctions , including neurodegeneration ."
105615,Based,O,3673.0,"Based on the key constituents of honey , the paper also highlights polyphenols to be potentially responsible for the health benefits of honey ."
105616,on,O,3673.0,"Based on the key constituents of honey , the paper also highlights polyphenols to be potentially responsible for the health benefits of honey ."
105617,the,O,3673.0,"Based on the key constituents of honey , the paper also highlights polyphenols to be potentially responsible for the health benefits of honey ."
105618,key,O,3673.0,"Based on the key constituents of honey , the paper also highlights polyphenols to be potentially responsible for the health benefits of honey ."
105619,constituents,O,3673.0,"Based on the key constituents of honey , the paper also highlights polyphenols to be potentially responsible for the health benefits of honey ."
105620,of,O,3673.0,"Based on the key constituents of honey , the paper also highlights polyphenols to be potentially responsible for the health benefits of honey ."
105621,honey,B-AG.01.l.02,3673.0,"Based on the key constituents of honey , the paper also highlights polyphenols to be potentially responsible for the health benefits of honey ."
105622,",",O,3673.0,"Based on the key constituents of honey , the paper also highlights polyphenols to be potentially responsible for the health benefits of honey ."
105623,the,O,3673.0,"Based on the key constituents of honey , the paper also highlights polyphenols to be potentially responsible for the health benefits of honey ."
105624,paper,O,3673.0,"Based on the key constituents of honey , the paper also highlights polyphenols to be potentially responsible for the health benefits of honey ."
105625,also,O,3673.0,"Based on the key constituents of honey , the paper also highlights polyphenols to be potentially responsible for the health benefits of honey ."
105626,highlights,O,3673.0,"Based on the key constituents of honey , the paper also highlights polyphenols to be potentially responsible for the health benefits of honey ."
105627,polyphenols,O,3673.0,"Based on the key constituents of honey , the paper also highlights polyphenols to be potentially responsible for the health benefits of honey ."
105628,to,O,3673.0,"Based on the key constituents of honey , the paper also highlights polyphenols to be potentially responsible for the health benefits of honey ."
105629,be,O,3673.0,"Based on the key constituents of honey , the paper also highlights polyphenols to be potentially responsible for the health benefits of honey ."
105630,potentially,O,3673.0,"Based on the key constituents of honey , the paper also highlights polyphenols to be potentially responsible for the health benefits of honey ."
105631,responsible,O,3673.0,"Based on the key constituents of honey , the paper also highlights polyphenols to be potentially responsible for the health benefits of honey ."
105632,for,O,3673.0,"Based on the key constituents of honey , the paper also highlights polyphenols to be potentially responsible for the health benefits of honey ."
105633,the,O,3673.0,"Based on the key constituents of honey , the paper also highlights polyphenols to be potentially responsible for the health benefits of honey ."
105634,health,O,3673.0,"Based on the key constituents of honey , the paper also highlights polyphenols to be potentially responsible for the health benefits of honey ."
105635,benefits,O,3673.0,"Based on the key constituents of honey , the paper also highlights polyphenols to be potentially responsible for the health benefits of honey ."
105636,of,O,3673.0,"Based on the key constituents of honey , the paper also highlights polyphenols to be potentially responsible for the health benefits of honey ."
105637,honey,B-AG.01.l.02,3673.0,"Based on the key constituents of honey , the paper also highlights polyphenols to be potentially responsible for the health benefits of honey ."
105638,.,O,3673.0,"Based on the key constituents of honey , the paper also highlights polyphenols to be potentially responsible for the health benefits of honey ."
105639,Further,O,3674.0,Further well - designed and controlled studies are necessary to validate these benefits in humans .
105640,well,O,3674.0,Further well - designed and controlled studies are necessary to validate these benefits in humans .
105641,-,O,3674.0,Further well - designed and controlled studies are necessary to validate these benefits in humans .
105642,designed,O,3674.0,Further well - designed and controlled studies are necessary to validate these benefits in humans .
105643,and,O,3674.0,Further well - designed and controlled studies are necessary to validate these benefits in humans .
105644,controlled,O,3674.0,Further well - designed and controlled studies are necessary to validate these benefits in humans .
105645,studies,O,3674.0,Further well - designed and controlled studies are necessary to validate these benefits in humans .
105646,are,O,3674.0,Further well - designed and controlled studies are necessary to validate these benefits in humans .
105647,necessary,O,3674.0,Further well - designed and controlled studies are necessary to validate these benefits in humans .
105648,to,O,3674.0,Further well - designed and controlled studies are necessary to validate these benefits in humans .
105649,validate,O,3674.0,Further well - designed and controlled studies are necessary to validate these benefits in humans .
105650,these,O,3674.0,Further well - designed and controlled studies are necessary to validate these benefits in humans .
105651,benefits,O,3674.0,Further well - designed and controlled studies are necessary to validate these benefits in humans .
105652,in,O,3674.0,Further well - designed and controlled studies are necessary to validate these benefits in humans .
105653,humans,O,3674.0,Further well - designed and controlled studies are necessary to validate these benefits in humans .
105654,.,O,3674.0,Further well - designed and controlled studies are necessary to validate these benefits in humans .
105655,The,O,3675.0,"The gluten protein of wheat triggers an immunological reaction in some gluten - sensitive people with HLA - DQ2/8 genotypes , which leads to Celiac disease ( CD ) with symptomatic damage in the small intestinal villi ."
105656,gluten,O,3675.0,"The gluten protein of wheat triggers an immunological reaction in some gluten - sensitive people with HLA - DQ2/8 genotypes , which leads to Celiac disease ( CD ) with symptomatic damage in the small intestinal villi ."
105657,protein,O,3675.0,"The gluten protein of wheat triggers an immunological reaction in some gluten - sensitive people with HLA - DQ2/8 genotypes , which leads to Celiac disease ( CD ) with symptomatic damage in the small intestinal villi ."
105658,of,O,3675.0,"The gluten protein of wheat triggers an immunological reaction in some gluten - sensitive people with HLA - DQ2/8 genotypes , which leads to Celiac disease ( CD ) with symptomatic damage in the small intestinal villi ."
105659,wheat,B-AG.01.i,3675.0,"The gluten protein of wheat triggers an immunological reaction in some gluten - sensitive people with HLA - DQ2/8 genotypes , which leads to Celiac disease ( CD ) with symptomatic damage in the small intestinal villi ."
105660,triggers,O,3675.0,"The gluten protein of wheat triggers an immunological reaction in some gluten - sensitive people with HLA - DQ2/8 genotypes , which leads to Celiac disease ( CD ) with symptomatic damage in the small intestinal villi ."
105661,an,O,3675.0,"The gluten protein of wheat triggers an immunological reaction in some gluten - sensitive people with HLA - DQ2/8 genotypes , which leads to Celiac disease ( CD ) with symptomatic damage in the small intestinal villi ."
105662,immunological,O,3675.0,"The gluten protein of wheat triggers an immunological reaction in some gluten - sensitive people with HLA - DQ2/8 genotypes , which leads to Celiac disease ( CD ) with symptomatic damage in the small intestinal villi ."
105663,reaction,O,3675.0,"The gluten protein of wheat triggers an immunological reaction in some gluten - sensitive people with HLA - DQ2/8 genotypes , which leads to Celiac disease ( CD ) with symptomatic damage in the small intestinal villi ."
105664,in,O,3675.0,"The gluten protein of wheat triggers an immunological reaction in some gluten - sensitive people with HLA - DQ2/8 genotypes , which leads to Celiac disease ( CD ) with symptomatic damage in the small intestinal villi ."
105665,some,O,3675.0,"The gluten protein of wheat triggers an immunological reaction in some gluten - sensitive people with HLA - DQ2/8 genotypes , which leads to Celiac disease ( CD ) with symptomatic damage in the small intestinal villi ."
105666,gluten,O,3675.0,"The gluten protein of wheat triggers an immunological reaction in some gluten - sensitive people with HLA - DQ2/8 genotypes , which leads to Celiac disease ( CD ) with symptomatic damage in the small intestinal villi ."
105667,-,O,3675.0,"The gluten protein of wheat triggers an immunological reaction in some gluten - sensitive people with HLA - DQ2/8 genotypes , which leads to Celiac disease ( CD ) with symptomatic damage in the small intestinal villi ."
105668,sensitive,O,3675.0,"The gluten protein of wheat triggers an immunological reaction in some gluten - sensitive people with HLA - DQ2/8 genotypes , which leads to Celiac disease ( CD ) with symptomatic damage in the small intestinal villi ."
105669,people,O,3675.0,"The gluten protein of wheat triggers an immunological reaction in some gluten - sensitive people with HLA - DQ2/8 genotypes , which leads to Celiac disease ( CD ) with symptomatic damage in the small intestinal villi ."
105670,with,O,3675.0,"The gluten protein of wheat triggers an immunological reaction in some gluten - sensitive people with HLA - DQ2/8 genotypes , which leads to Celiac disease ( CD ) with symptomatic damage in the small intestinal villi ."
105671,HLA,O,3675.0,"The gluten protein of wheat triggers an immunological reaction in some gluten - sensitive people with HLA - DQ2/8 genotypes , which leads to Celiac disease ( CD ) with symptomatic damage in the small intestinal villi ."
105672,-,O,3675.0,"The gluten protein of wheat triggers an immunological reaction in some gluten - sensitive people with HLA - DQ2/8 genotypes , which leads to Celiac disease ( CD ) with symptomatic damage in the small intestinal villi ."
105673,DQ2/8,O,3675.0,"The gluten protein of wheat triggers an immunological reaction in some gluten - sensitive people with HLA - DQ2/8 genotypes , which leads to Celiac disease ( CD ) with symptomatic damage in the small intestinal villi ."
105674,genotypes,O,3675.0,"The gluten protein of wheat triggers an immunological reaction in some gluten - sensitive people with HLA - DQ2/8 genotypes , which leads to Celiac disease ( CD ) with symptomatic damage in the small intestinal villi ."
105675,",",O,3675.0,"The gluten protein of wheat triggers an immunological reaction in some gluten - sensitive people with HLA - DQ2/8 genotypes , which leads to Celiac disease ( CD ) with symptomatic damage in the small intestinal villi ."
105676,which,O,3675.0,"The gluten protein of wheat triggers an immunological reaction in some gluten - sensitive people with HLA - DQ2/8 genotypes , which leads to Celiac disease ( CD ) with symptomatic damage in the small intestinal villi ."
105677,leads,O,3675.0,"The gluten protein of wheat triggers an immunological reaction in some gluten - sensitive people with HLA - DQ2/8 genotypes , which leads to Celiac disease ( CD ) with symptomatic damage in the small intestinal villi ."
105678,to,O,3675.0,"The gluten protein of wheat triggers an immunological reaction in some gluten - sensitive people with HLA - DQ2/8 genotypes , which leads to Celiac disease ( CD ) with symptomatic damage in the small intestinal villi ."
105679,Celiac,O,3675.0,"The gluten protein of wheat triggers an immunological reaction in some gluten - sensitive people with HLA - DQ2/8 genotypes , which leads to Celiac disease ( CD ) with symptomatic damage in the small intestinal villi ."
105680,disease,O,3675.0,"The gluten protein of wheat triggers an immunological reaction in some gluten - sensitive people with HLA - DQ2/8 genotypes , which leads to Celiac disease ( CD ) with symptomatic damage in the small intestinal villi ."
105681,(,O,3675.0,"The gluten protein of wheat triggers an immunological reaction in some gluten - sensitive people with HLA - DQ2/8 genotypes , which leads to Celiac disease ( CD ) with symptomatic damage in the small intestinal villi ."
105682,CD,O,3675.0,"The gluten protein of wheat triggers an immunological reaction in some gluten - sensitive people with HLA - DQ2/8 genotypes , which leads to Celiac disease ( CD ) with symptomatic damage in the small intestinal villi ."
105683,),O,3675.0,"The gluten protein of wheat triggers an immunological reaction in some gluten - sensitive people with HLA - DQ2/8 genotypes , which leads to Celiac disease ( CD ) with symptomatic damage in the small intestinal villi ."
105684,with,O,3675.0,"The gluten protein of wheat triggers an immunological reaction in some gluten - sensitive people with HLA - DQ2/8 genotypes , which leads to Celiac disease ( CD ) with symptomatic damage in the small intestinal villi ."
105685,symptomatic,O,3675.0,"The gluten protein of wheat triggers an immunological reaction in some gluten - sensitive people with HLA - DQ2/8 genotypes , which leads to Celiac disease ( CD ) with symptomatic damage in the small intestinal villi ."
105686,damage,O,3675.0,"The gluten protein of wheat triggers an immunological reaction in some gluten - sensitive people with HLA - DQ2/8 genotypes , which leads to Celiac disease ( CD ) with symptomatic damage in the small intestinal villi ."
105687,in,O,3675.0,"The gluten protein of wheat triggers an immunological reaction in some gluten - sensitive people with HLA - DQ2/8 genotypes , which leads to Celiac disease ( CD ) with symptomatic damage in the small intestinal villi ."
105688,the,O,3675.0,"The gluten protein of wheat triggers an immunological reaction in some gluten - sensitive people with HLA - DQ2/8 genotypes , which leads to Celiac disease ( CD ) with symptomatic damage in the small intestinal villi ."
105689,small,O,3675.0,"The gluten protein of wheat triggers an immunological reaction in some gluten - sensitive people with HLA - DQ2/8 genotypes , which leads to Celiac disease ( CD ) with symptomatic damage in the small intestinal villi ."
105690,intestinal,O,3675.0,"The gluten protein of wheat triggers an immunological reaction in some gluten - sensitive people with HLA - DQ2/8 genotypes , which leads to Celiac disease ( CD ) with symptomatic damage in the small intestinal villi ."
105691,villi,O,3675.0,"The gluten protein of wheat triggers an immunological reaction in some gluten - sensitive people with HLA - DQ2/8 genotypes , which leads to Celiac disease ( CD ) with symptomatic damage in the small intestinal villi ."
105692,.,O,3675.0,"The gluten protein of wheat triggers an immunological reaction in some gluten - sensitive people with HLA - DQ2/8 genotypes , which leads to Celiac disease ( CD ) with symptomatic damage in the small intestinal villi ."
105693,Glutenin,O,3676.0,Glutenin and gliadin are two major components of gluten that are essentially required for developing a strong protein network for providing desired viscoelasticity of dough .
105694,and,O,3676.0,Glutenin and gliadin are two major components of gluten that are essentially required for developing a strong protein network for providing desired viscoelasticity of dough .
105695,gliadin,O,3676.0,Glutenin and gliadin are two major components of gluten that are essentially required for developing a strong protein network for providing desired viscoelasticity of dough .
105696,are,O,3676.0,Glutenin and gliadin are two major components of gluten that are essentially required for developing a strong protein network for providing desired viscoelasticity of dough .
105697,two,O,3676.0,Glutenin and gliadin are two major components of gluten that are essentially required for developing a strong protein network for providing desired viscoelasticity of dough .
105698,major,O,3676.0,Glutenin and gliadin are two major components of gluten that are essentially required for developing a strong protein network for providing desired viscoelasticity of dough .
105699,components,O,3676.0,Glutenin and gliadin are two major components of gluten that are essentially required for developing a strong protein network for providing desired viscoelasticity of dough .
105700,of,O,3676.0,Glutenin and gliadin are two major components of gluten that are essentially required for developing a strong protein network for providing desired viscoelasticity of dough .
105701,gluten,O,3676.0,Glutenin and gliadin are two major components of gluten that are essentially required for developing a strong protein network for providing desired viscoelasticity of dough .
105702,that,O,3676.0,Glutenin and gliadin are two major components of gluten that are essentially required for developing a strong protein network for providing desired viscoelasticity of dough .
105703,are,O,3676.0,Glutenin and gliadin are two major components of gluten that are essentially required for developing a strong protein network for providing desired viscoelasticity of dough .
105704,essentially,O,3676.0,Glutenin and gliadin are two major components of gluten that are essentially required for developing a strong protein network for providing desired viscoelasticity of dough .
105705,required,O,3676.0,Glutenin and gliadin are two major components of gluten that are essentially required for developing a strong protein network for providing desired viscoelasticity of dough .
105706,for,O,3676.0,Glutenin and gliadin are two major components of gluten that are essentially required for developing a strong protein network for providing desired viscoelasticity of dough .
105707,developing,O,3676.0,Glutenin and gliadin are two major components of gluten that are essentially required for developing a strong protein network for providing desired viscoelasticity of dough .
105708,a,O,3676.0,Glutenin and gliadin are two major components of gluten that are essentially required for developing a strong protein network for providing desired viscoelasticity of dough .
105709,strong,O,3676.0,Glutenin and gliadin are two major components of gluten that are essentially required for developing a strong protein network for providing desired viscoelasticity of dough .
105710,protein,O,3676.0,Glutenin and gliadin are two major components of gluten that are essentially required for developing a strong protein network for providing desired viscoelasticity of dough .
105711,network,O,3676.0,Glutenin and gliadin are two major components of gluten that are essentially required for developing a strong protein network for providing desired viscoelasticity of dough .
105712,for,O,3676.0,Glutenin and gliadin are two major components of gluten that are essentially required for developing a strong protein network for providing desired viscoelasticity of dough .
105713,providing,O,3676.0,Glutenin and gliadin are two major components of gluten that are essentially required for developing a strong protein network for providing desired viscoelasticity of dough .
105714,desired,O,3676.0,Glutenin and gliadin are two major components of gluten that are essentially required for developing a strong protein network for providing desired viscoelasticity of dough .
105715,viscoelasticity,O,3676.0,Glutenin and gliadin are two major components of gluten that are essentially required for developing a strong protein network for providing desired viscoelasticity of dough .
105716,of,O,3676.0,Glutenin and gliadin are two major components of gluten that are essentially required for developing a strong protein network for providing desired viscoelasticity of dough .
105717,dough,B-AG.01.n,3676.0,Glutenin and gliadin are two major components of gluten that are essentially required for developing a strong protein network for providing desired viscoelasticity of dough .
105718,.,O,3676.0,Glutenin and gliadin are two major components of gluten that are essentially required for developing a strong protein network for providing desired viscoelasticity of dough .
105719,Many,O,3677.0,"Many non - gluten cereals and starches ( rice , corn , sorghum , millets , and potato / pea starch ) and various gluten replacers ( xanthan and guar gum ) have been used for retaining the physical - sensorial properties of gluten - free , cereal - based products ."
105720,non,B-AG.01.i,3677.0,"Many non - gluten cereals and starches ( rice , corn , sorghum , millets , and potato / pea starch ) and various gluten replacers ( xanthan and guar gum ) have been used for retaining the physical - sensorial properties of gluten - free , cereal - based products ."
105721,-,I-AG.01.i,3677.0,"Many non - gluten cereals and starches ( rice , corn , sorghum , millets , and potato / pea starch ) and various gluten replacers ( xanthan and guar gum ) have been used for retaining the physical - sensorial properties of gluten - free , cereal - based products ."
105722,gluten,I-AG.01.i,3677.0,"Many non - gluten cereals and starches ( rice , corn , sorghum , millets , and potato / pea starch ) and various gluten replacers ( xanthan and guar gum ) have been used for retaining the physical - sensorial properties of gluten - free , cereal - based products ."
105723,cereals,I-AG.01.i,3677.0,"Many non - gluten cereals and starches ( rice , corn , sorghum , millets , and potato / pea starch ) and various gluten replacers ( xanthan and guar gum ) have been used for retaining the physical - sensorial properties of gluten - free , cereal - based products ."
105724,and,O,3677.0,"Many non - gluten cereals and starches ( rice , corn , sorghum , millets , and potato / pea starch ) and various gluten replacers ( xanthan and guar gum ) have been used for retaining the physical - sensorial properties of gluten - free , cereal - based products ."
105725,starches,O,3677.0,"Many non - gluten cereals and starches ( rice , corn , sorghum , millets , and potato / pea starch ) and various gluten replacers ( xanthan and guar gum ) have been used for retaining the physical - sensorial properties of gluten - free , cereal - based products ."
105726,(,O,3677.0,"Many non - gluten cereals and starches ( rice , corn , sorghum , millets , and potato / pea starch ) and various gluten replacers ( xanthan and guar gum ) have been used for retaining the physical - sensorial properties of gluten - free , cereal - based products ."
105727,rice,B-AG.01.i,3677.0,"Many non - gluten cereals and starches ( rice , corn , sorghum , millets , and potato / pea starch ) and various gluten replacers ( xanthan and guar gum ) have been used for retaining the physical - sensorial properties of gluten - free , cereal - based products ."
105728,",",O,3677.0,"Many non - gluten cereals and starches ( rice , corn , sorghum , millets , and potato / pea starch ) and various gluten replacers ( xanthan and guar gum ) have been used for retaining the physical - sensorial properties of gluten - free , cereal - based products ."
105729,corn,B-AG.01.i,3677.0,"Many non - gluten cereals and starches ( rice , corn , sorghum , millets , and potato / pea starch ) and various gluten replacers ( xanthan and guar gum ) have been used for retaining the physical - sensorial properties of gluten - free , cereal - based products ."
105730,",",O,3677.0,"Many non - gluten cereals and starches ( rice , corn , sorghum , millets , and potato / pea starch ) and various gluten replacers ( xanthan and guar gum ) have been used for retaining the physical - sensorial properties of gluten - free , cereal - based products ."
105731,sorghum,B-AG.01.i,3677.0,"Many non - gluten cereals and starches ( rice , corn , sorghum , millets , and potato / pea starch ) and various gluten replacers ( xanthan and guar gum ) have been used for retaining the physical - sensorial properties of gluten - free , cereal - based products ."
105732,",",O,3677.0,"Many non - gluten cereals and starches ( rice , corn , sorghum , millets , and potato / pea starch ) and various gluten replacers ( xanthan and guar gum ) have been used for retaining the physical - sensorial properties of gluten - free , cereal - based products ."
105733,millets,B-AG.01.i,3677.0,"Many non - gluten cereals and starches ( rice , corn , sorghum , millets , and potato / pea starch ) and various gluten replacers ( xanthan and guar gum ) have been used for retaining the physical - sensorial properties of gluten - free , cereal - based products ."
105734,",",O,3677.0,"Many non - gluten cereals and starches ( rice , corn , sorghum , millets , and potato / pea starch ) and various gluten replacers ( xanthan and guar gum ) have been used for retaining the physical - sensorial properties of gluten - free , cereal - based products ."
105735,and,O,3677.0,"Many non - gluten cereals and starches ( rice , corn , sorghum , millets , and potato / pea starch ) and various gluten replacers ( xanthan and guar gum ) have been used for retaining the physical - sensorial properties of gluten - free , cereal - based products ."
105736,potato,B-AG.01.h.02.a,3677.0,"Many non - gluten cereals and starches ( rice , corn , sorghum , millets , and potato / pea starch ) and various gluten replacers ( xanthan and guar gum ) have been used for retaining the physical - sensorial properties of gluten - free , cereal - based products ."
105737,/,O,3677.0,"Many non - gluten cereals and starches ( rice , corn , sorghum , millets , and potato / pea starch ) and various gluten replacers ( xanthan and guar gum ) have been used for retaining the physical - sensorial properties of gluten - free , cereal - based products ."
105738,pea,B-AG.01.l,3677.0,"Many non - gluten cereals and starches ( rice , corn , sorghum , millets , and potato / pea starch ) and various gluten replacers ( xanthan and guar gum ) have been used for retaining the physical - sensorial properties of gluten - free , cereal - based products ."
105739,starch,I-AG.01.l,3677.0,"Many non - gluten cereals and starches ( rice , corn , sorghum , millets , and potato / pea starch ) and various gluten replacers ( xanthan and guar gum ) have been used for retaining the physical - sensorial properties of gluten - free , cereal - based products ."
105740,),O,3677.0,"Many non - gluten cereals and starches ( rice , corn , sorghum , millets , and potato / pea starch ) and various gluten replacers ( xanthan and guar gum ) have been used for retaining the physical - sensorial properties of gluten - free , cereal - based products ."
105741,and,O,3677.0,"Many non - gluten cereals and starches ( rice , corn , sorghum , millets , and potato / pea starch ) and various gluten replacers ( xanthan and guar gum ) have been used for retaining the physical - sensorial properties of gluten - free , cereal - based products ."
105742,various,O,3677.0,"Many non - gluten cereals and starches ( rice , corn , sorghum , millets , and potato / pea starch ) and various gluten replacers ( xanthan and guar gum ) have been used for retaining the physical - sensorial properties of gluten - free , cereal - based products ."
105743,gluten,O,3677.0,"Many non - gluten cereals and starches ( rice , corn , sorghum , millets , and potato / pea starch ) and various gluten replacers ( xanthan and guar gum ) have been used for retaining the physical - sensorial properties of gluten - free , cereal - based products ."
105744,replacers,O,3677.0,"Many non - gluten cereals and starches ( rice , corn , sorghum , millets , and potato / pea starch ) and various gluten replacers ( xanthan and guar gum ) have been used for retaining the physical - sensorial properties of gluten - free , cereal - based products ."
105745,(,O,3677.0,"Many non - gluten cereals and starches ( rice , corn , sorghum , millets , and potato / pea starch ) and various gluten replacers ( xanthan and guar gum ) have been used for retaining the physical - sensorial properties of gluten - free , cereal - based products ."
105746,xanthan,O,3677.0,"Many non - gluten cereals and starches ( rice , corn , sorghum , millets , and potato / pea starch ) and various gluten replacers ( xanthan and guar gum ) have been used for retaining the physical - sensorial properties of gluten - free , cereal - based products ."
105747,and,O,3677.0,"Many non - gluten cereals and starches ( rice , corn , sorghum , millets , and potato / pea starch ) and various gluten replacers ( xanthan and guar gum ) have been used for retaining the physical - sensorial properties of gluten - free , cereal - based products ."
105748,guar,O,3677.0,"Many non - gluten cereals and starches ( rice , corn , sorghum , millets , and potato / pea starch ) and various gluten replacers ( xanthan and guar gum ) have been used for retaining the physical - sensorial properties of gluten - free , cereal - based products ."
105749,gum,O,3677.0,"Many non - gluten cereals and starches ( rice , corn , sorghum , millets , and potato / pea starch ) and various gluten replacers ( xanthan and guar gum ) have been used for retaining the physical - sensorial properties of gluten - free , cereal - based products ."
105750,),O,3677.0,"Many non - gluten cereals and starches ( rice , corn , sorghum , millets , and potato / pea starch ) and various gluten replacers ( xanthan and guar gum ) have been used for retaining the physical - sensorial properties of gluten - free , cereal - based products ."
105751,have,O,3677.0,"Many non - gluten cereals and starches ( rice , corn , sorghum , millets , and potato / pea starch ) and various gluten replacers ( xanthan and guar gum ) have been used for retaining the physical - sensorial properties of gluten - free , cereal - based products ."
105752,been,O,3677.0,"Many non - gluten cereals and starches ( rice , corn , sorghum , millets , and potato / pea starch ) and various gluten replacers ( xanthan and guar gum ) have been used for retaining the physical - sensorial properties of gluten - free , cereal - based products ."
105753,used,O,3677.0,"Many non - gluten cereals and starches ( rice , corn , sorghum , millets , and potato / pea starch ) and various gluten replacers ( xanthan and guar gum ) have been used for retaining the physical - sensorial properties of gluten - free , cereal - based products ."
105754,for,O,3677.0,"Many non - gluten cereals and starches ( rice , corn , sorghum , millets , and potato / pea starch ) and various gluten replacers ( xanthan and guar gum ) have been used for retaining the physical - sensorial properties of gluten - free , cereal - based products ."
105755,retaining,O,3677.0,"Many non - gluten cereals and starches ( rice , corn , sorghum , millets , and potato / pea starch ) and various gluten replacers ( xanthan and guar gum ) have been used for retaining the physical - sensorial properties of gluten - free , cereal - based products ."
105756,the,O,3677.0,"Many non - gluten cereals and starches ( rice , corn , sorghum , millets , and potato / pea starch ) and various gluten replacers ( xanthan and guar gum ) have been used for retaining the physical - sensorial properties of gluten - free , cereal - based products ."
105757,physical,O,3677.0,"Many non - gluten cereals and starches ( rice , corn , sorghum , millets , and potato / pea starch ) and various gluten replacers ( xanthan and guar gum ) have been used for retaining the physical - sensorial properties of gluten - free , cereal - based products ."
105758,-,O,3677.0,"Many non - gluten cereals and starches ( rice , corn , sorghum , millets , and potato / pea starch ) and various gluten replacers ( xanthan and guar gum ) have been used for retaining the physical - sensorial properties of gluten - free , cereal - based products ."
105759,sensorial,O,3677.0,"Many non - gluten cereals and starches ( rice , corn , sorghum , millets , and potato / pea starch ) and various gluten replacers ( xanthan and guar gum ) have been used for retaining the physical - sensorial properties of gluten - free , cereal - based products ."
105760,properties,O,3677.0,"Many non - gluten cereals and starches ( rice , corn , sorghum , millets , and potato / pea starch ) and various gluten replacers ( xanthan and guar gum ) have been used for retaining the physical - sensorial properties of gluten - free , cereal - based products ."
105761,of,O,3677.0,"Many non - gluten cereals and starches ( rice , corn , sorghum , millets , and potato / pea starch ) and various gluten replacers ( xanthan and guar gum ) have been used for retaining the physical - sensorial properties of gluten - free , cereal - based products ."
105762,gluten,O,3677.0,"Many non - gluten cereals and starches ( rice , corn , sorghum , millets , and potato / pea starch ) and various gluten replacers ( xanthan and guar gum ) have been used for retaining the physical - sensorial properties of gluten - free , cereal - based products ."
105763,-,O,3677.0,"Many non - gluten cereals and starches ( rice , corn , sorghum , millets , and potato / pea starch ) and various gluten replacers ( xanthan and guar gum ) have been used for retaining the physical - sensorial properties of gluten - free , cereal - based products ."
105764,free,O,3677.0,"Many non - gluten cereals and starches ( rice , corn , sorghum , millets , and potato / pea starch ) and various gluten replacers ( xanthan and guar gum ) have been used for retaining the physical - sensorial properties of gluten - free , cereal - based products ."
105765,",",O,3677.0,"Many non - gluten cereals and starches ( rice , corn , sorghum , millets , and potato / pea starch ) and various gluten replacers ( xanthan and guar gum ) have been used for retaining the physical - sensorial properties of gluten - free , cereal - based products ."
105766,cereal,B-AG.01.i,3677.0,"Many non - gluten cereals and starches ( rice , corn , sorghum , millets , and potato / pea starch ) and various gluten replacers ( xanthan and guar gum ) have been used for retaining the physical - sensorial properties of gluten - free , cereal - based products ."
105767,-,I-AG.01.i,3677.0,"Many non - gluten cereals and starches ( rice , corn , sorghum , millets , and potato / pea starch ) and various gluten replacers ( xanthan and guar gum ) have been used for retaining the physical - sensorial properties of gluten - free , cereal - based products ."
105768,based,I-AG.01.i,3677.0,"Many non - gluten cereals and starches ( rice , corn , sorghum , millets , and potato / pea starch ) and various gluten replacers ( xanthan and guar gum ) have been used for retaining the physical - sensorial properties of gluten - free , cereal - based products ."
105769,products,I-AG.01.i,3677.0,"Many non - gluten cereals and starches ( rice , corn , sorghum , millets , and potato / pea starch ) and various gluten replacers ( xanthan and guar gum ) have been used for retaining the physical - sensorial properties of gluten - free , cereal - based products ."
105770,.,O,3677.0,"Many non - gluten cereals and starches ( rice , corn , sorghum , millets , and potato / pea starch ) and various gluten replacers ( xanthan and guar gum ) have been used for retaining the physical - sensorial properties of gluten - free , cereal - based products ."
105771,This,O,3678.0,"This paper reviews the recent advances in the formulation of cereal - based , gluten - free products by utilizing alternate flours , starches , gums , hydrocolloids , enzymes , novel ingredients , and processing techniques ."
105772,paper,O,3678.0,"This paper reviews the recent advances in the formulation of cereal - based , gluten - free products by utilizing alternate flours , starches , gums , hydrocolloids , enzymes , novel ingredients , and processing techniques ."
105773,reviews,O,3678.0,"This paper reviews the recent advances in the formulation of cereal - based , gluten - free products by utilizing alternate flours , starches , gums , hydrocolloids , enzymes , novel ingredients , and processing techniques ."
105774,the,O,3678.0,"This paper reviews the recent advances in the formulation of cereal - based , gluten - free products by utilizing alternate flours , starches , gums , hydrocolloids , enzymes , novel ingredients , and processing techniques ."
105775,recent,O,3678.0,"This paper reviews the recent advances in the formulation of cereal - based , gluten - free products by utilizing alternate flours , starches , gums , hydrocolloids , enzymes , novel ingredients , and processing techniques ."
105776,advances,O,3678.0,"This paper reviews the recent advances in the formulation of cereal - based , gluten - free products by utilizing alternate flours , starches , gums , hydrocolloids , enzymes , novel ingredients , and processing techniques ."
105777,in,O,3678.0,"This paper reviews the recent advances in the formulation of cereal - based , gluten - free products by utilizing alternate flours , starches , gums , hydrocolloids , enzymes , novel ingredients , and processing techniques ."
105778,the,O,3678.0,"This paper reviews the recent advances in the formulation of cereal - based , gluten - free products by utilizing alternate flours , starches , gums , hydrocolloids , enzymes , novel ingredients , and processing techniques ."
105779,formulation,O,3678.0,"This paper reviews the recent advances in the formulation of cereal - based , gluten - free products by utilizing alternate flours , starches , gums , hydrocolloids , enzymes , novel ingredients , and processing techniques ."
105780,of,O,3678.0,"This paper reviews the recent advances in the formulation of cereal - based , gluten - free products by utilizing alternate flours , starches , gums , hydrocolloids , enzymes , novel ingredients , and processing techniques ."
105781,cereal,B-AG.01.i,3678.0,"This paper reviews the recent advances in the formulation of cereal - based , gluten - free products by utilizing alternate flours , starches , gums , hydrocolloids , enzymes , novel ingredients , and processing techniques ."
105782,-,I-AG.01.i,3678.0,"This paper reviews the recent advances in the formulation of cereal - based , gluten - free products by utilizing alternate flours , starches , gums , hydrocolloids , enzymes , novel ingredients , and processing techniques ."
105783,based,I-AG.01.i,3678.0,"This paper reviews the recent advances in the formulation of cereal - based , gluten - free products by utilizing alternate flours , starches , gums , hydrocolloids , enzymes , novel ingredients , and processing techniques ."
105784,",",O,3678.0,"This paper reviews the recent advances in the formulation of cereal - based , gluten - free products by utilizing alternate flours , starches , gums , hydrocolloids , enzymes , novel ingredients , and processing techniques ."
105785,gluten,B-AG.01,3678.0,"This paper reviews the recent advances in the formulation of cereal - based , gluten - free products by utilizing alternate flours , starches , gums , hydrocolloids , enzymes , novel ingredients , and processing techniques ."
105786,-,I-AG.01,3678.0,"This paper reviews the recent advances in the formulation of cereal - based , gluten - free products by utilizing alternate flours , starches , gums , hydrocolloids , enzymes , novel ingredients , and processing techniques ."
105787,free,I-AG.01,3678.0,"This paper reviews the recent advances in the formulation of cereal - based , gluten - free products by utilizing alternate flours , starches , gums , hydrocolloids , enzymes , novel ingredients , and processing techniques ."
105788,products,I-AG.01,3678.0,"This paper reviews the recent advances in the formulation of cereal - based , gluten - free products by utilizing alternate flours , starches , gums , hydrocolloids , enzymes , novel ingredients , and processing techniques ."
105789,by,O,3678.0,"This paper reviews the recent advances in the formulation of cereal - based , gluten - free products by utilizing alternate flours , starches , gums , hydrocolloids , enzymes , novel ingredients , and processing techniques ."
105790,utilizing,O,3678.0,"This paper reviews the recent advances in the formulation of cereal - based , gluten - free products by utilizing alternate flours , starches , gums , hydrocolloids , enzymes , novel ingredients , and processing techniques ."
105791,alternate,O,3678.0,"This paper reviews the recent advances in the formulation of cereal - based , gluten - free products by utilizing alternate flours , starches , gums , hydrocolloids , enzymes , novel ingredients , and processing techniques ."
105792,flours,B-AG.01.k,3678.0,"This paper reviews the recent advances in the formulation of cereal - based , gluten - free products by utilizing alternate flours , starches , gums , hydrocolloids , enzymes , novel ingredients , and processing techniques ."
105793,",",O,3678.0,"This paper reviews the recent advances in the formulation of cereal - based , gluten - free products by utilizing alternate flours , starches , gums , hydrocolloids , enzymes , novel ingredients , and processing techniques ."
105794,starches,O,3678.0,"This paper reviews the recent advances in the formulation of cereal - based , gluten - free products by utilizing alternate flours , starches , gums , hydrocolloids , enzymes , novel ingredients , and processing techniques ."
105795,",",O,3678.0,"This paper reviews the recent advances in the formulation of cereal - based , gluten - free products by utilizing alternate flours , starches , gums , hydrocolloids , enzymes , novel ingredients , and processing techniques ."
105796,gums,O,3678.0,"This paper reviews the recent advances in the formulation of cereal - based , gluten - free products by utilizing alternate flours , starches , gums , hydrocolloids , enzymes , novel ingredients , and processing techniques ."
105797,",",O,3678.0,"This paper reviews the recent advances in the formulation of cereal - based , gluten - free products by utilizing alternate flours , starches , gums , hydrocolloids , enzymes , novel ingredients , and processing techniques ."
105798,hydrocolloids,O,3678.0,"This paper reviews the recent advances in the formulation of cereal - based , gluten - free products by utilizing alternate flours , starches , gums , hydrocolloids , enzymes , novel ingredients , and processing techniques ."
105799,",",O,3678.0,"This paper reviews the recent advances in the formulation of cereal - based , gluten - free products by utilizing alternate flours , starches , gums , hydrocolloids , enzymes , novel ingredients , and processing techniques ."
105800,enzymes,O,3678.0,"This paper reviews the recent advances in the formulation of cereal - based , gluten - free products by utilizing alternate flours , starches , gums , hydrocolloids , enzymes , novel ingredients , and processing techniques ."
105801,",",O,3678.0,"This paper reviews the recent advances in the formulation of cereal - based , gluten - free products by utilizing alternate flours , starches , gums , hydrocolloids , enzymes , novel ingredients , and processing techniques ."
105802,novel,O,3678.0,"This paper reviews the recent advances in the formulation of cereal - based , gluten - free products by utilizing alternate flours , starches , gums , hydrocolloids , enzymes , novel ingredients , and processing techniques ."
105803,ingredients,O,3678.0,"This paper reviews the recent advances in the formulation of cereal - based , gluten - free products by utilizing alternate flours , starches , gums , hydrocolloids , enzymes , novel ingredients , and processing techniques ."
105804,",",O,3678.0,"This paper reviews the recent advances in the formulation of cereal - based , gluten - free products by utilizing alternate flours , starches , gums , hydrocolloids , enzymes , novel ingredients , and processing techniques ."
105805,and,O,3678.0,"This paper reviews the recent advances in the formulation of cereal - based , gluten - free products by utilizing alternate flours , starches , gums , hydrocolloids , enzymes , novel ingredients , and processing techniques ."
105806,processing,O,3678.0,"This paper reviews the recent advances in the formulation of cereal - based , gluten - free products by utilizing alternate flours , starches , gums , hydrocolloids , enzymes , novel ingredients , and processing techniques ."
105807,techniques,O,3678.0,"This paper reviews the recent advances in the formulation of cereal - based , gluten - free products by utilizing alternate flours , starches , gums , hydrocolloids , enzymes , novel ingredients , and processing techniques ."
105808,.,O,3678.0,"This paper reviews the recent advances in the formulation of cereal - based , gluten - free products by utilizing alternate flours , starches , gums , hydrocolloids , enzymes , novel ingredients , and processing techniques ."
105809,The,O,3679.0,"The pseudo cereals amaranth , quinoa , and buckwheat , are promising in gluten - free diet formulation ."
105810,pseudo,B-AG.01.i,3679.0,"The pseudo cereals amaranth , quinoa , and buckwheat , are promising in gluten - free diet formulation ."
105811,cereals,I-AG.01.i,3679.0,"The pseudo cereals amaranth , quinoa , and buckwheat , are promising in gluten - free diet formulation ."
105812,amaranth,I-AG.01.i,3679.0,"The pseudo cereals amaranth , quinoa , and buckwheat , are promising in gluten - free diet formulation ."
105813,",",O,3679.0,"The pseudo cereals amaranth , quinoa , and buckwheat , are promising in gluten - free diet formulation ."
105814,quinoa,B-AG.01.i,3679.0,"The pseudo cereals amaranth , quinoa , and buckwheat , are promising in gluten - free diet formulation ."
105815,",",O,3679.0,"The pseudo cereals amaranth , quinoa , and buckwheat , are promising in gluten - free diet formulation ."
105816,and,O,3679.0,"The pseudo cereals amaranth , quinoa , and buckwheat , are promising in gluten - free diet formulation ."
105817,buckwheat,B-AG.01.i,3679.0,"The pseudo cereals amaranth , quinoa , and buckwheat , are promising in gluten - free diet formulation ."
105818,",",O,3679.0,"The pseudo cereals amaranth , quinoa , and buckwheat , are promising in gluten - free diet formulation ."
105819,are,O,3679.0,"The pseudo cereals amaranth , quinoa , and buckwheat , are promising in gluten - free diet formulation ."
105820,promising,O,3679.0,"The pseudo cereals amaranth , quinoa , and buckwheat , are promising in gluten - free diet formulation ."
105821,in,O,3679.0,"The pseudo cereals amaranth , quinoa , and buckwheat , are promising in gluten - free diet formulation ."
105822,gluten,O,3679.0,"The pseudo cereals amaranth , quinoa , and buckwheat , are promising in gluten - free diet formulation ."
105823,-,O,3679.0,"The pseudo cereals amaranth , quinoa , and buckwheat , are promising in gluten - free diet formulation ."
105824,free,O,3679.0,"The pseudo cereals amaranth , quinoa , and buckwheat , are promising in gluten - free diet formulation ."
105825,diet,O,3679.0,"The pseudo cereals amaranth , quinoa , and buckwheat , are promising in gluten - free diet formulation ."
105826,formulation,O,3679.0,"The pseudo cereals amaranth , quinoa , and buckwheat , are promising in gluten - free diet formulation ."
105827,.,O,3679.0,"The pseudo cereals amaranth , quinoa , and buckwheat , are promising in gluten - free diet formulation ."
